data_1g5w_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1g5w _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 4.0 p . . . . . 0 CA--C 1.577 2.002 0 N-CA-C 116.028 1.862 . . . . 0.0 116.028 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 -63.77 -45.53 89.35 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 117.817 2.525 . . . . 0.0 117.817 -174.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -56.74 -25.54 55.11 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 118.084 2.624 . . . . 0.0 118.084 172.513 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -67.8 -30.68 70.17 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 116.181 1.919 . . . . 0.0 116.181 165.355 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 32.9 mt -72.05 107.01 4.53 Favored 'General case' 0 N--CA 1.489 1.496 0 CA-C-N 120.182 1.355 . . . . 0.0 111.445 -167.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 163.33 169.54 26.93 Favored Glycine 0 CA--C 1.544 1.864 0 CA-C-O 122.645 1.136 . . . . 0.0 113.581 -169.349 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 73.7 m -86.35 142.48 28.45 Favored 'General case' 0 N--CA 1.491 1.595 0 CA-C-N 114.266 -0.967 . . . . 0.0 110.071 170.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 77.5 m95 -143.87 117.21 9.04 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 -174.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -101.08 145.6 28.54 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.9 -0.5 . . . . 0.0 110.38 176.263 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 22.2 tp -68.12 122.86 19.16 Favored 'General case' 0 N--CA 1.49 1.564 0 CA-C-O 122.169 0.985 . . . . 0.0 111.757 -178.525 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . 0.282 0.9 OUTLIER -101.31 -46.87 11.51 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.8 0 CA-C-N 113.752 -1.567 . . . . 0.0 111.516 179.082 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -139.81 145.26 37.95 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-N 119.714 1.143 . . . . 0.0 109.647 175.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 79.7 p -131.67 89.42 2.7 Favored 'General case' 0 N--CA 1.491 1.613 0 CA-C-O 121.671 0.748 . . . . 0.0 110.091 168.448 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -78.29 127.39 32.17 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 123.534 0.734 . . . . 0.0 110.378 178.046 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.254 42.1 m-20 68.74 32.97 3.9 Favored 'General case' 0 N--CA 1.505 2.304 0 N-CA-C 116.391 1.997 . . . . 0.0 116.391 178.907 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 42.2 t80 -68.9 -62.95 1.17 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.631 -1.293 . . . . 0.0 113.09 -175.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -44.89 -36.02 3.11 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 118.637 2.829 . . . . 0.0 118.637 168.209 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -65.55 -48.67 71.61 Favored 'General case' 0 N--CA 1.498 1.944 0 CA-C-N 120.745 1.611 . . . . 0.0 114.64 172.413 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 85.7 t80 -55.38 -46.97 76.49 Favored 'General case' 0 CA--C 1.572 1.815 0 N-CA-C 115.179 1.548 . . . . 0.0 115.179 167.623 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 16.3 mmm -59.52 -42.52 92.44 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 115.493 1.664 . . . . 0.0 115.493 174.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 70.1 tttt -64.96 -41.05 95.81 Favored 'General case' 0 CA--C 1.568 1.64 0 N-CA-C 115.248 1.573 . . . . 0.0 115.248 170.091 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 50.9 m -56.74 -41.8 78.15 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 116.031 1.863 . . . . 0.0 116.031 171.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 45.4 mt -66.11 -36.83 84.22 Favored 'General case' 0 CA--C 1.565 1.532 0 N-CA-C 117.088 2.255 . . . . 0.0 117.088 168.353 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 100.08 78.98 1.4 Allowed Glycine 0 CA--C 1.54 1.622 0 CA-C-N 118.867 0.758 . . . . 0.0 111.644 -169.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 57.3 t -136.59 122.08 27.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 N-CA-C 105.48 -2.045 . . . . 0.0 105.48 -179.639 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -64.04 159.51 39.99 Favored Glycine 0 CA--C 1.548 2.125 0 N-CA-C 116.19 1.236 . . . . 0.0 116.19 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 27.8 p90 -56.27 -40.82 74.85 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 118.854 2.909 . . . . 0.0 118.854 -167.04 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.06 -42.01 81.11 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 116.022 1.86 . . . . 0.0 116.022 176.333 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 41.0 m -70.09 -39.94 75.28 Favored 'General case' 0 N--CA 1.499 1.986 0 CA-C-N 119.377 0.99 . . . . 0.0 113.663 171.069 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 68.1 ttt-85 -55.99 -42.77 76.86 Favored 'General case' 0 CA--C 1.571 1.766 0 N-CA-C 115.989 1.848 . . . . 0.0 115.989 168.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 25.6 tt0 -77.84 -42.79 32.42 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 115.355 1.613 . . . . 0.0 115.355 175.169 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 75.7 t -65.2 -41.62 92.09 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 CA-C-N 119.756 1.162 . . . . 0.0 113.011 174.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -64.36 -33.0 74.84 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 116.873 2.175 . . . . 0.0 116.873 172.301 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 93.3 p -67.05 -42.88 84.04 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 115.506 1.669 . . . . 0.0 115.506 167.422 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 42.5 ttm -60.89 -36.66 79.79 Favored 'General case' 0 CA--C 1.572 1.798 0 N-CA-C 116.135 1.902 . . . . 0.0 116.135 167.234 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 99.4 m -69.06 136.26 52.07 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 124.49 1.116 . . . . 0.0 111.328 176.589 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -108.35 92.43 9.76 Favored Pre-proline 0 CA--C 1.569 1.683 0 C-N-CA 123.824 0.85 . . . . 0.0 108.973 172.211 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -81.92 145.38 14.1 Favored 'Trans proline' 0 C--N 1.37 1.706 0 C-N-CA 122.83 2.353 . . . . 0.0 113.237 -174.206 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 85.5 m -99.2 102.31 13.92 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 -173.579 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 94.3 m -80.42 120.8 24.92 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 123.773 0.829 . . . . 0.0 109.319 175.391 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 36.9 mt -123.73 111.4 28.94 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 N-CA-C 106.399 -1.704 . . . . 0.0 106.399 -176.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 3.9 mp -94.09 128.1 45.65 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 175.35 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 22.0 mm-40 -128.57 169.32 14.53 Favored 'General case' 0 N--CA 1.489 1.496 0 CA-C-O 122.095 0.95 . . . . 0.0 110.551 178.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.69 157.2 42.78 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 123.869 0.868 . . . . 0.0 111.526 178.427 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 65.0 m-80 -134.55 -78.51 0.46 Allowed 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 177.352 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -153.13 86.65 0.14 Allowed Glycine 0 N--CA 1.482 1.749 0 N-CA-C 108.1 -2.0 . . . . 0.0 108.1 168.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . 0.277 14.4 m-20 66.62 -12.05 0.22 Allowed 'General case' 0 N--CA 1.498 1.945 0 N-CA-C 117.726 2.491 . . . . 0.0 117.726 -161.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 26.8 mm -90.27 103.75 14.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 CA-C-N 120.147 1.34 . . . . 0.0 107.445 -177.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 44.4 mt -93.61 110.8 22.39 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 123.005 0.522 . . . . 0.0 110.79 -174.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 90.5 m -99.32 98.76 9.67 Favored 'General case' 0 CA--C 1.562 1.411 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 -170.295 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 9.6 tt -97.78 113.49 25.29 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 178.231 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 45.6 mtpt -112.05 106.98 15.78 Favored 'General case' 0 N--CA 1.484 1.262 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 -173.135 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 82.5 m -92.15 101.71 14.23 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 177.612 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 72.4 m80 -88.41 90.53 8.43 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 123.883 0.873 . . . . 0.0 110.533 -173.467 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 60.5 p . . . . . 0 N--CA 1.489 1.489 0 N-CA-C 113.265 0.839 . . . . 0.0 113.265 -178.295 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 70.9 m-20 . . . . . 0 N--CA 1.49 1.528 0 N-CA-C 110.433 -0.21 . . . . 0.0 110.433 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 61.6 p -98.56 129.43 45.11 Favored 'General case' 0 N--CA 1.493 1.721 0 CA-C-O 121.221 0.534 . . . . 0.0 110.886 -176.491 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -115.26 116.55 28.5 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 179.465 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 28.8 pt -113.08 129.6 68.46 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 176.442 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 77.6 p -117.8 114.3 23.07 Favored 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 123.871 0.868 . . . . 0.0 109.298 -176.219 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 51.0 p90 -141.12 139.42 33.97 Favored 'General case' 0 N--CA 1.499 1.982 0 N-CA-C 115.499 1.666 . . . . 0.0 115.499 -161.514 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 62.2 mtpt -105.99 23.9 13.26 Favored 'General case' 0 CA--C 1.574 1.867 0 N-CA-C 116.877 2.177 . . . . 0.0 116.877 -175.084 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . 0.284 1.2 mp 60.78 90.21 0.07 Allowed 'General case' 0 N--CA 1.495 1.825 0 CA-C-N 120.536 1.517 . . . . 0.0 114.772 171.545 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 87.76 38.51 7.47 Favored Glycine 0 CA--C 1.551 2.302 0 N-CA-C 116.779 1.472 . . . . 0.0 116.779 -166.581 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 82.6 t -139.3 120.45 15.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 N-CA-C 106.131 -1.803 . . . . 0.0 106.131 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -87.46 124.06 33.04 Favored 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 122.953 0.501 . . . . 0.0 111.122 178.304 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 45.8 p90 -127.58 133.99 49.72 Favored 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 123.775 0.83 . . . . 0.0 111.166 -172.56 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -70.58 128.8 37.34 Favored 'General case' 0 CA--C 1.564 1.513 0 O-C-N 121.447 -0.783 . . . . 0.0 112.567 173.352 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 14.7 tp10 -142.46 135.73 28.73 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 123.193 0.597 . . . . 0.0 109.963 -168.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 53.1 m -92.56 127.47 38.07 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 171.214 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 31.1 p -84.25 171.68 12.53 Favored 'General case' 0 N--CA 1.495 1.781 0 CA-C-O 121.429 0.633 . . . . 0.0 112.443 -177.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -62.88 -31.35 72.38 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 116.438 2.014 . . . . 0.0 116.438 166.646 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -81.0 21.06 0.73 Allowed 'General case' 0 CA--C 1.582 2.193 0 N-CA-C 114.956 1.465 . . . . 0.0 114.956 165.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 56.31 69.23 0.76 Allowed 'General case' 0 N--CA 1.496 1.837 0 C-N-CA 125.928 1.691 . . . . 0.0 114.517 176.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 50.8 mtm180 -144.12 126.84 16.14 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-O 121.116 0.484 . . . . 0.0 110.683 -174.519 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 62.5 pttt -66.12 118.29 9.65 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 123.957 0.903 . . . . 0.0 111.929 165.368 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 15.8 m -140.25 130.13 28.41 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 -173.342 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 30.5 mmmt -87.41 112.22 21.92 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-O 121.593 0.711 . . . . 0.0 109.669 178.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 67.3 m -109.99 105.92 15.25 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 123.515 0.726 . . . . 0.0 111.108 -158.155 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 6.9 tp -114.66 105.84 19.46 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 C-N-CA 123.795 0.838 . . . . 0.0 109.53 -175.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -115.92 126.23 73.35 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 C-N-CA 124.551 1.14 . . . . 0.0 108.933 178.223 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 15.4 t -132.24 157.13 45.17 Favored 'General case' 0 N--CA 1.492 1.644 0 CA-C-O 122.625 1.203 . . . . 0.0 111.296 172.005 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 17.6 tp -93.31 116.24 28.81 Favored 'General case' 0 N--CA 1.487 1.419 0 CA-C-N 114.837 -1.074 . . . . 0.0 110.785 -176.465 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -110.36 82.74 1.64 Allowed 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 123.576 0.75 . . . . 0.0 109.679 178.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 56.68 46.16 89.6 Favored Glycine 0 CA--C 1.552 2.369 0 N-CA-C 118.203 2.041 . . . . 0.0 118.203 -177.042 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 78.59 44.76 10.27 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 117.0 1.56 . . . . 0.0 117.0 -167.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 41.1 ttmt -151.13 111.28 4.12 Favored 'General case' 0 CA--C 1.551 0.994 0 N-CA-C 106.481 -1.674 . . . . 0.0 106.481 -177.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 65.5 mt -85.21 95.3 9.13 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-O 122.976 1.369 . . . . 0.0 109.428 177.526 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 88.7 t -87.1 97.76 6.67 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.334 0 CA-C-N 112.617 -2.083 . . . . 0.0 105.876 -178.405 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 22.7 t-160 -102.44 139.39 38.11 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 124.396 1.078 . . . . 0.0 109.405 -176.513 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 28.2 tp -136.69 115.29 11.98 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 178.514 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 89.4 mt-30 -104.22 115.77 30.99 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 175.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt -121.87 135.68 54.9 Favored 'General case' 0 N--CA 1.493 1.701 0 C-N-CA 123.335 0.654 . . . . 0.0 111.789 -171.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 16.3 p90 -159.0 110.91 2.15 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 123.333 0.653 . . . . 0.0 110.536 -174.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 5.7 t70 52.59 54.45 10.58 Favored 'General case' 0 N--CA 1.498 1.948 0 N-CA-C 116.567 2.062 . . . . 0.0 116.567 165.328 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 88.76 -46.0 3.27 Favored Glycine 0 CA--C 1.549 2.206 0 N-CA-C 116.434 1.334 . . . . 0.0 116.434 -169.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 16.3 mt-30 -83.6 129.21 34.96 Favored 'General case' 0 N--CA 1.488 1.446 0 CA-C-N 117.957 0.878 . . . . 0.0 111.233 -178.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -141.21 124.75 16.74 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 122.786 0.435 . . . . 0.0 110.664 177.005 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 13.0 t -110.8 135.52 51.24 Favored 'General case' 0 N--CA 1.492 1.656 0 C-N-CA 123.108 0.563 . . . . 0.0 110.643 176.273 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 37.9 p -100.27 131.02 46.44 Favored 'General case' 0 N--CA 1.492 1.628 0 C-N-CA 123.021 0.528 . . . . 0.0 110.761 174.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 5.4 mp -111.73 76.18 0.96 Allowed 'General case' 0 CA--C 1.563 1.447 0 C-N-CA 124.005 0.922 . . . . 0.0 108.783 -179.446 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 87.5 t -87.04 110.1 20.0 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 -168.242 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 83.9 mtt85 -102.38 118.49 36.99 Favored 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 122.975 0.51 . . . . 0.0 109.939 -175.777 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -135.32 127.96 30.85 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 123.34 0.656 . . . . 0.0 110.665 -169.539 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -80.91 114.64 19.93 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.833 -0.542 . . . . 0.0 111.395 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 85.8 mt -124.14 106.98 17.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 N-CA-C 105.015 -2.217 . . . . 0.0 105.015 178.512 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 23.4 m-20 58.17 50.3 10.1 Favored 'General case' 0 N--CA 1.499 1.989 0 N-CA-C 115.15 1.537 . . . . 0.0 115.15 177.031 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 60.73 31.24 74.76 Favored Glycine 0 CA--C 1.554 2.503 0 N-CA-C 118.964 2.346 . . . . 0.0 118.964 -169.453 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 92.1 mttt -133.65 128.55 35.3 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-N 119.135 1.468 . . . . 0.0 108.686 -175.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 12.3 tp -79.76 107.42 12.52 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 123.433 0.693 . . . . 0.0 109.389 177.61 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 31.6 mm -99.42 99.29 8.26 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 N-CA-C 106.536 -1.653 . . . . 0.0 106.536 -175.598 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 21.9 tp -87.86 102.99 15.24 Favored 'General case' 0 N--CA 1.486 1.372 0 CA-C-O 121.843 0.83 . . . . 0.0 109.549 178.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 90.9 m -95.76 103.61 15.5 Favored 'General case' 0 CA--C 1.561 1.389 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 -175.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 90.3 mt -97.61 100.49 11.89 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 123.581 0.752 . . . . 0.0 109.809 -174.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 8.1 m -113.89 125.28 53.87 Favored 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 -175.035 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 82.9 t60 -129.48 -102.9 0.31 Allowed 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.982 -0.748 . . . . 0.0 108.982 175.352 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -112.32 88.6 0.5 Allowed Glycine 0 N--CA 1.485 1.923 0 CA-C-N 119.183 0.901 . . . . 0.0 112.003 -171.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . 0.298 2.6 m 54.49 44.61 28.53 Favored 'General case' 0 CA--C 1.578 2.032 0 N-CA-C 115.381 1.623 . . . . 0.0 115.381 -175.68 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -163.66 95.68 0.82 Allowed 'General case' 0 N--CA 1.483 1.193 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 178.12 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 2.9 p -91.69 115.87 31.67 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 C-N-CA 123.402 0.681 . . . . 0.0 109.415 174.717 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 53.3 t -95.7 105.4 17.39 Favored 'General case' 0 CA--C 1.551 1.01 0 CA-C-O 121.302 0.573 . . . . 0.0 110.572 173.187 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 75.7 m -91.88 113.53 25.82 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 -178.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 83.3 mtp180 -113.53 109.36 18.52 Favored 'General case' 0 N--CA 1.486 1.332 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.615 -168.457 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 88.4 m -84.01 127.21 33.72 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 123.165 0.586 . . . . 0.0 109.947 178.058 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 43.1 m-85 -123.71 127.94 48.89 Favored 'General case' 0 CA--C 1.56 1.345 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 175.292 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -91.1 152.59 20.55 Favored 'General case' 0 N--CA 1.496 1.83 0 CA-C-O 121.879 0.847 . . . . 0.0 111.736 170.142 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 70.9 tttt -82.15 122.71 28.22 Favored 'General case' 0 N--CA 1.487 1.404 0 CA-C-O 121.587 0.708 . . . . 0.0 111.975 -171.456 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 24.5 mm-40 -119.04 50.94 1.16 Allowed 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 124.225 1.01 . . . . 0.0 111.605 -174.258 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 0.872 0 CA-C-O 123.155 1.455 . . . . 0.0 110.131 -162.634 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.253 5.1 p . . . . . 0 CA--C 1.576 1.968 0 N-CA-C 114.581 1.326 . . . . 0.0 114.581 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -85.12 -36.59 21.02 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 115.561 1.689 . . . . 0.0 115.561 -173.609 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -58.52 -24.73 61.28 Favored 'General case' 0 N--CA 1.497 1.891 0 N-CA-C 117.694 2.479 . . . . 0.0 117.694 168.558 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -68.72 -20.17 64.38 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 116.84 2.163 . . . . 0.0 116.84 167.101 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 56.2 mt -80.44 126.81 31.66 Favored 'General case' 0 N--CA 1.486 1.352 0 CA-C-N 120.627 1.558 . . . . 0.0 111.882 -170.402 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 155.79 178.14 29.7 Favored Glycine 0 CA--C 1.541 1.713 0 CA-C-O 122.03 0.795 . . . . 0.0 113.557 -178.112 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 43.1 m -92.94 135.69 33.93 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 168.53 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 89.3 m95 -137.21 113.79 10.26 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 -170.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 26.7 mtpt -93.49 148.69 21.85 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 121.927 0.87 . . . . 0.0 111.366 172.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 20.2 tp -71.4 135.61 47.34 Favored 'General case' 0 N--CA 1.486 1.368 0 CA-C-O 122.32 1.057 . . . . 0.0 112.53 -178.478 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . 0.271 1.1 t -114.52 -43.76 4.06 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.878 0 CA-C-N 113.786 -1.552 . . . . 0.0 111.953 -177.589 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -127.28 150.8 49.4 Favored 'General case' 0 N--CA 1.494 1.76 0 CA-C-N 119.986 1.267 . . . . 0.0 110.65 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 81.1 p -145.2 88.71 1.89 Allowed 'General case' 0 N--CA 1.49 1.544 0 CA-C-O 121.22 0.533 . . . . 0.0 110.244 167.484 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -102.22 125.24 48.87 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 123.4 0.68 . . . . 0.0 109.201 177.165 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.288 53.6 m-20 72.57 17.07 4.69 Favored 'General case' 0 N--CA 1.503 2.206 0 N-CA-C 117.491 2.404 . . . . 0.0 117.491 -178.904 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 30.9 t80 -68.77 -41.91 78.16 Favored 'General case' 0 N--CA 1.497 1.894 0 N-CA-C 115.091 1.515 . . . . 0.0 115.091 178.202 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -49.58 -49.01 48.28 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 116.009 1.855 . . . . 0.0 116.009 165.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 18.4 t0 -59.21 -50.59 73.44 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 115.397 1.628 . . . . 0.0 115.397 172.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 88.2 t80 -52.67 -51.79 58.67 Favored 'General case' 0 CA--C 1.572 1.794 0 N-CA-C 115.6 1.704 . . . . 0.0 115.6 170.349 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 5.5 mmm -64.78 -40.07 94.64 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 115.124 1.527 . . . . 0.0 115.124 176.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 21.7 ttmm -55.96 -45.29 78.92 Favored 'General case' 0 CA--C 1.571 1.769 0 N-CA-C 115.14 1.534 . . . . 0.0 115.14 166.317 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 12.8 t -59.77 -38.42 81.77 Favored 'General case' 0 CA--C 1.571 1.763 0 N-CA-C 116.407 2.003 . . . . 0.0 116.407 170.42 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 75.8 mt -65.16 -25.47 67.75 Favored 'General case' 0 CA--C 1.568 1.661 0 N-CA-C 117.601 2.445 . . . . 0.0 117.601 168.49 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 98.76 70.36 0.97 Allowed Glycine 0 N--CA 1.482 1.731 0 CA-C-N 119.085 0.857 . . . . 0.0 112.256 -171.026 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 45.3 t -142.28 120.13 7.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 N-CA-C 105.502 -2.036 . . . . 0.0 105.502 -178.338 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -81.1 -157.49 17.36 Favored Glycine 0 CA--C 1.547 2.065 0 N-CA-C 115.534 0.973 . . . . 0.0 115.534 -179.413 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 12.1 p90 -70.01 160.72 31.42 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 113.385 0.883 . . . . 0.0 113.385 179.637 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . 0.329 . . 78.25 -50.07 0.48 Allowed 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 115.439 1.644 . . . . 0.0 115.439 178.431 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 34.0 m -70.51 -37.49 74.17 Favored 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 113.604 0.964 . . . . 0.0 113.604 167.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 42.3 mtm105 -57.97 -44.6 87.2 Favored 'General case' 0 N--CA 1.498 1.97 0 N-CA-C 115.232 1.567 . . . . 0.0 115.232 164.52 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 10.3 tm0? -68.68 -52.8 27.1 Favored 'General case' 0 CA--C 1.561 1.389 0 N-CA-C 114.871 1.434 . . . . 0.0 114.871 176.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 85.5 t -66.4 -40.62 87.08 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 CA-C-O 117.763 -1.113 . . . . 0.0 113.166 -179.064 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -71.27 -26.84 63.06 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 117.052 2.241 . . . . 0.0 117.052 176.107 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 90.6 p -68.91 -47.37 65.96 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 115.022 1.49 . . . . 0.0 115.022 164.134 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 52.1 ttp -61.91 -39.6 92.56 Favored 'General case' 0 CA--C 1.57 1.731 0 N-CA-C 116.482 2.03 . . . . 0.0 116.482 171.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 52.7 m -67.35 146.97 53.55 Favored 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 124.764 1.225 . . . . 0.0 111.941 178.441 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -102.23 100.37 15.21 Favored Pre-proline 0 CA--C 1.57 1.744 0 N-CA-C 108.307 -0.998 . . . . 0.0 108.307 172.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -79.11 104.39 1.77 Allowed 'Trans proline' 0 CA--C 1.562 1.888 0 C-N-CA 123.223 2.615 . . . . 0.0 111.293 -178.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 96.2 m -80.16 108.33 13.67 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 123.352 0.661 . . . . 0.0 110.495 -164.714 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 28.7 m -91.39 109.79 21.07 Favored 'General case' 0 CA--C 1.559 1.318 0 C-N-CA 123.336 0.654 . . . . 0.0 110.03 -170.442 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 75.0 mt -100.56 109.36 25.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 N-CA-C 106.567 -1.642 . . . . 0.0 106.567 176.321 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 30.4 mt -104.82 118.31 51.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 N-CA-C 106.906 -1.516 . . . . 0.0 106.906 -179.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -137.79 117.24 12.86 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 -175.101 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 7.7 ttpm? -91.5 116.26 28.71 Favored 'General case' 0 CA--C 1.557 1.217 0 CA-C-O 121.439 0.637 . . . . 0.0 110.051 172.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 22.7 t-20 -71.64 -50.52 29.86 Favored 'General case' 0 CA--C 1.57 1.72 0 N-CA-C 112.982 0.734 . . . . 0.0 112.982 166.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -172.25 -82.4 0.05 OUTLIER Glycine 0 N--CA 1.481 1.659 0 N-CA-C 109.25 -1.54 . . . . 0.0 109.25 173.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 24.3 t0 -72.14 -37.69 69.38 Favored 'General case' 0 CA--C 1.57 1.741 0 N-CA-C 115.096 1.517 . . . . 0.0 115.096 162.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 31.6 mm -91.11 120.32 39.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 CA-C-N 118.993 0.815 . . . . 0.0 109.69 -173.524 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 12.7 mt -86.38 125.88 33.97 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 123.419 0.688 . . . . 0.0 109.811 158.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 57.7 m -113.91 103.79 11.52 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 -179.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 9.5 tt -102.48 108.55 19.9 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 178.598 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -104.75 111.8 24.65 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 -179.469 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 98.2 m -98.51 99.98 11.18 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 20.6 m-70 -90.48 95.96 10.42 Favored 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 123.393 0.677 . . . . 0.0 110.344 -172.198 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 22.8 t . . . . . 0 CA--C 1.554 1.121 0 CA-C-O 121.981 0.896 . . . . 0.0 110.322 -179.345 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 83.0 m-20 . . . . . 0 N--CA 1.489 1.524 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 31.8 p -105.58 132.39 51.79 Favored 'General case' 0 N--CA 1.496 1.874 0 C-N-CA 123.355 0.662 . . . . 0.0 110.825 -177.551 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -121.43 118.3 29.04 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 123.918 0.887 . . . . 0.0 108.813 -178.116 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 39.5 pt -110.35 129.57 65.18 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.875 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 173.684 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 52.2 p -115.75 114.26 24.55 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 178.276 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 45.9 p90 -142.68 146.54 34.52 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 114.306 1.225 . . . . 0.0 114.306 -161.162 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 50.2 mtmt -115.5 28.12 8.88 Favored 'General case' 0 CA--C 1.572 1.823 0 N-CA-C 115.678 1.733 . . . . 0.0 115.678 -171.122 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . 0.308 0.1 OUTLIER 52.81 82.73 0.07 Allowed 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 115.866 1.802 . . . . 0.0 115.866 175.551 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 101.88 39.24 2.96 Favored Glycine 0 CA--C 1.55 2.234 0 N-CA-C 116.336 1.294 . . . . 0.0 116.336 -171.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 94.7 t -139.74 127.52 25.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 N-CA-C 106.442 -1.688 . . . . 0.0 106.442 -179.199 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -89.01 128.92 35.73 Favored 'General case' 0 CA--C 1.564 1.499 0 C-N-CA 122.997 0.519 . . . . 0.0 110.366 175.592 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 43.5 p90 -138.91 123.14 18.1 Favored 'General case' 0 N--CA 1.494 1.764 0 C-N-CA 123.391 0.677 . . . . 0.0 109.855 -176.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -72.37 112.85 8.79 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.097 -1.002 . . . . 0.0 112.382 178.462 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -115.33 135.91 53.65 Favored 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 124.024 0.929 . . . . 0.0 110.241 -168.103 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 42.9 m -86.96 122.79 31.3 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-O 121.61 0.719 . . . . 0.0 109.529 173.173 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 43.1 p -82.45 177.76 8.58 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 113.197 0.814 . . . . 0.0 113.197 -173.546 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -55.85 -35.75 66.78 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 117.69 2.478 . . . . 0.0 117.69 168.46 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -92.47 17.19 10.36 Favored 'General case' 0 CA--C 1.577 1.991 0 N-CA-C 115.136 1.532 . . . . 0.0 115.136 170.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 63.01 80.17 0.24 Allowed 'General case' 0 N--CA 1.496 1.854 0 C-N-CA 125.281 1.432 . . . . 0.0 113.272 -178.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 14.9 ttm180 -146.09 126.13 13.71 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 -176.176 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.77 120.51 15.62 Favored 'General case' 0 N--CA 1.493 1.678 0 CA-C-N 118.124 0.42 . . . . 0.0 110.272 168.174 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 12.4 m -138.69 121.42 18.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 N-CA-C 107.999 -1.112 . . . . 0.0 107.999 -176.156 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 1.5 mptm? -76.76 104.13 7.09 Favored 'General case' 0 N--CA 1.489 1.487 0 CA-C-O 121.89 0.852 . . . . 0.0 109.599 -177.349 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 74.0 m -98.95 96.41 7.81 Favored 'General case' 0 N--CA 1.481 1.116 0 CA-C-N 114.894 -1.048 . . . . 0.0 109.92 -164.44 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -106.39 108.31 24.81 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 177.422 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 1.4 p -121.88 126.76 74.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 C-N-CA 124.025 0.93 . . . . 0.0 109.304 -174.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 9.8 t -146.34 152.1 38.57 Favored 'General case' 0 N--CA 1.489 1.515 0 CA-C-O 122.531 1.158 . . . . 0.0 110.643 -177.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 24.8 tp -87.73 103.47 15.64 Favored 'General case' 0 N--CA 1.49 1.536 0 CA-C-N 114.889 -1.051 . . . . 0.0 109.425 175.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -107.01 93.57 4.63 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 123.607 0.763 . . . . 0.0 109.41 -175.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 59.3 49.1 82.2 Favored Glycine 0 N--CA 1.488 2.108 0 N-CA-C 117.712 1.845 . . . . 0.0 117.712 -179.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 91.59 -37.44 3.39 Favored Glycine 0 CA--C 1.551 2.31 0 N-CA-C 117.232 1.653 . . . . 0.0 117.232 -170.352 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.72 122.32 29.64 Favored 'General case' 0 N--CA 1.486 1.368 0 CA-C-N 118.92 1.36 . . . . 0.0 110.328 -176.857 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 5.8 tt -85.98 95.86 9.64 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 108.569 -0.901 . . . . 0.0 108.569 179.032 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 53.0 t -97.61 108.09 21.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 -166.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 21.6 t-160 -101.92 108.64 20.17 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 123.255 0.622 . . . . 0.0 110.032 175.682 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 31.8 tp -98.0 116.32 29.97 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 175.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -100.22 129.45 46.23 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 168.64 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 16.7 ptmt -140.08 128.63 22.9 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.746 -0.596 . . . . 0.0 111.399 -173.238 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 30.8 p90 -154.44 119.17 4.9 Favored 'General case' 0 N--CA 1.491 1.606 0 C-N-CA 123.808 0.843 . . . . 0.0 109.727 -168.059 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 4.5 t70 45.34 59.58 3.48 Favored 'General case' 0 N--CA 1.503 2.18 0 N-CA-C 117.616 2.45 . . . . 0.0 117.616 164.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 63.8 31.05 79.48 Favored Glycine 0 CA--C 1.558 2.73 0 N-CA-C 119.42 2.528 . . . . 0.0 119.42 -171.617 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -152.44 123.6 7.6 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 106.705 -1.591 . . . . 0.0 106.705 -176.193 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -138.56 132.49 31.19 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.47 -0.769 . . . . 0.0 112.261 179.128 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 14.6 t -116.32 134.01 55.37 Favored 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 123.581 0.752 . . . . 0.0 110.406 173.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 34.9 p -100.8 131.07 46.86 Favored 'General case' 0 N--CA 1.493 1.699 0 CA-C-O 122.143 0.973 . . . . 0.0 110.128 169.292 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 5.4 mp -112.47 87.0 2.47 Favored 'General case' 0 CA--C 1.56 1.347 0 N-CA-C 106.407 -1.701 . . . . 0.0 106.407 -178.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 72.4 t -92.88 99.89 10.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 -169.186 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 20.5 mmt180 -86.27 125.26 33.46 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 124.126 0.971 . . . . 0.0 109.883 176.052 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -151.89 131.74 13.29 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.877 -0.514 . . . . 0.0 112.11 -173.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -78.73 120.24 23.09 Favored 'General case' 0 N--CA 1.49 1.525 0 CA-C-O 121.295 0.569 . . . . 0.0 111.755 177.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 92.3 mt -129.16 105.72 13.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 N-CA-C 104.603 -2.369 . . . . 0.0 104.603 176.445 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 57.75 52.31 8.28 Favored 'General case' 0 N--CA 1.499 2.001 0 N-CA-C 114.997 1.481 . . . . 0.0 114.997 175.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 67.85 12.07 61.63 Favored Glycine 0 CA--C 1.557 2.673 0 N-CA-C 119.962 2.745 . . . . 0.0 119.962 -171.655 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -124.73 126.59 45.92 Favored 'General case' 0 N--CA 1.486 1.358 0 CA-C-N 119.645 1.723 . . . . 0.0 108.626 -175.196 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 58.7 tp -83.96 108.57 17.01 Favored 'General case' 0 N--CA 1.483 1.189 0 CA-C-O 121.508 0.67 . . . . 0.0 110.226 -179.622 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 28.1 mm -97.51 106.8 19.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 -172.02 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 44.4 tp -86.04 111.84 20.69 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 123.557 0.743 . . . . 0.0 109.075 171.232 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 88.1 m -105.7 105.9 16.16 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 -176.347 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 88.6 mt -101.37 100.6 11.11 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 123.486 0.714 . . . . 0.0 109.948 -171.33 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 7.8 m -116.37 121.1 40.95 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 -174.516 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 83.1 t60 -126.42 -101.51 0.36 Allowed 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 175.571 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -111.0 92.71 0.68 Allowed Glycine 0 N--CA 1.483 1.814 0 CA-C-N 119.375 0.989 . . . . 0.0 111.454 -172.683 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . 0.395 6.4 t 49.03 40.38 17.0 Favored 'General case' 0 N--CA 1.499 2.011 0 N-CA-C 117.746 2.499 . . . . 0.0 117.746 -172.864 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -155.49 93.68 1.51 Allowed 'General case' 0 N--CA 1.483 1.211 0 O-C-N 121.569 -0.707 . . . . 0.0 109.217 178.384 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 4.3 p -89.39 121.23 39.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 C-N-CA 123.418 0.687 . . . . 0.0 109.602 172.352 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 45.0 t -105.28 120.44 41.57 Favored 'General case' 0 CA--C 1.553 1.077 0 C-N-CA 123.045 0.538 . . . . 0.0 111.4 177.65 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 80.1 m -87.21 110.61 20.28 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 175.196 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 6.2 mmm180 -115.03 95.87 5.42 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 107.448 -1.316 . . . . 0.0 107.448 -179.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 86.2 m -82.76 143.51 30.81 Favored 'General case' 0 N--CA 1.494 1.774 0 C-N-CA 123.721 0.809 . . . . 0.0 110.402 -177.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 47.1 m-85 -131.34 127.61 38.0 Favored 'General case' 0 CA--C 1.557 1.232 0 C-N-CA 123.442 0.697 . . . . 0.0 109.767 -178.096 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -95.77 156.89 16.14 Favored 'General case' 0 N--CA 1.492 1.668 0 CA-C-O 122.671 1.224 . . . . 0.0 111.294 165.115 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 73.8 tttt -90.47 114.49 26.67 Favored 'General case' 0 N--CA 1.484 1.244 0 CA-C-N 114.895 -1.048 . . . . 0.0 111.712 -165.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -74.11 -33.99 63.79 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 117.116 2.265 . . . . 0.0 117.116 172.452 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.125 0 CA-C-O 124.198 1.952 . . . . 0.0 108.527 173.731 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 5.4 p . . . . . 0 CA--C 1.578 2.041 0 N-CA-C 115.883 1.809 . . . . 0.0 115.883 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -64.85 -36.71 85.22 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 116.764 2.135 . . . . 0.0 116.764 -175.168 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -58.13 -29.25 65.38 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 117.742 2.497 . . . . 0.0 117.742 169.146 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -69.47 -25.29 64.01 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 116.231 1.937 . . . . 0.0 116.231 169.576 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 45.8 mt -77.37 110.22 11.94 Favored 'General case' 0 N--CA 1.489 1.518 0 CA-C-N 121.012 1.733 . . . . 0.0 111.466 -162.715 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 157.8 172.02 24.47 Favored Glycine 0 CA--C 1.546 2.024 0 CA-C-O 122.718 1.177 . . . . 0.0 112.797 -167.571 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.446 ' H ' ' HB2' ' A' ' 132' ' ' ALA . 54.1 m -87.25 139.42 30.58 Favored 'General case' 0 N--CA 1.494 1.731 0 CA-C-N 114.296 -0.952 . . . . 0.0 109.734 172.257 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 82.8 m95 -136.62 113.67 10.55 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 -177.444 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -95.41 146.51 24.35 Favored 'General case' 0 N--CA 1.494 1.726 0 CA-C-O 121.439 0.638 . . . . 0.0 110.292 173.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 48.6 tp -68.48 120.16 14.11 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-O 121.649 0.737 . . . . 0.0 111.738 -179.164 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . 0.263 1.1 t -83.66 -51.02 14.76 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.753 0 CA-C-N 114.676 -1.147 . . . . 0.0 111.666 170.495 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -148.36 125.39 11.36 Favored 'General case' 0 CA--C 1.557 1.244 0 CA-C-N 119.032 0.833 . . . . 0.0 109.619 -168.057 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 72.7 p -102.93 100.27 10.23 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 123.373 0.669 . . . . 0.0 110.441 172.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 33.7 mmtp -95.9 116.49 28.99 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 109.508 -0.552 . . . . 0.0 109.508 -179.225 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.258 28.6 m-20 71.2 24.53 3.8 Favored 'General case' 0 N--CA 1.504 2.265 0 N-CA-C 117.101 2.26 . . . . 0.0 117.101 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 40.0 t80 -69.58 -50.31 45.87 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 120.138 -1.601 . . . . 0.0 114.727 -175.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 71.1 m-20 -51.58 -27.76 12.0 Favored 'General case' 0 N--CA 1.497 1.925 0 N-CA-C 117.909 2.559 . . . . 0.0 117.909 168.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 24.2 t0 -66.35 -52.9 42.33 Favored 'General case' 0 N--CA 1.496 1.869 0 CA-C-N 120.251 1.387 . . . . 0.0 114.199 166.59 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 88.5 t80 -50.63 -46.23 58.15 Favored 'General case' 0 CA--C 1.573 1.852 0 N-CA-C 115.683 1.734 . . . . 0.0 115.683 168.369 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 47.9 mmm -63.49 -41.33 98.57 Favored 'General case' 0 CA--C 1.567 1.631 0 N-CA-C 114.718 1.377 . . . . 0.0 114.718 174.047 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 13.6 tmtt? -61.18 -44.79 96.73 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 115.248 1.573 . . . . 0.0 115.248 167.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 15.1 t -57.03 -39.62 75.15 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 116.31 1.967 . . . . 0.0 116.31 172.385 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 75.1 mt -65.07 -43.57 91.77 Favored 'General case' 0 CA--C 1.567 1.606 0 N-CA-C 115.572 1.693 . . . . 0.0 115.572 165.164 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 117.98 68.97 0.36 Allowed Glycine 0 N--CA 1.483 1.807 0 C-N-CA 124.148 0.88 . . . . 0.0 112.03 -178.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 18.3 t -140.74 114.98 5.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 N-CA-C 105.919 -1.882 . . . . 0.0 105.919 -174.208 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -85.99 -79.69 1.17 Allowed Glycine 0 N--CA 1.483 1.806 0 N-CA-C 114.724 0.65 . . . . 0.0 114.724 -175.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 20.8 p90 -132.16 163.32 28.8 Favored 'General case' 0 N--CA 1.492 1.655 0 C-N-CA 123.472 0.709 . . . . 0.0 111.474 -177.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . 0.333 . . 79.13 -58.13 0.41 Allowed 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 115.023 1.49 . . . . 0.0 115.023 173.335 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 80.2 m -69.98 -39.75 75.75 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 113.31 0.856 . . . . 0.0 113.31 166.069 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 45.0 ttp180 -63.77 -41.55 97.95 Favored 'General case' 0 CA--C 1.565 1.529 0 N-CA-C 114.966 1.469 . . . . 0.0 114.966 168.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 11.5 tm0? -66.55 -49.2 67.23 Favored 'General case' 0 CA--C 1.562 1.438 0 N-CA-C 115.127 1.529 . . . . 0.0 115.127 173.106 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 73.7 t -63.96 -42.39 95.58 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.026 0 CA-C-N 119.912 1.233 . . . . 0.0 113.271 178.593 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -73.15 -32.55 64.96 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 116.938 2.199 . . . . 0.0 116.938 176.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 85.7 p -68.63 -44.14 74.83 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 115.265 1.579 . . . . 0.0 115.265 167.248 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 51.7 tpp -68.7 -35.75 77.58 Favored 'General case' 0 CA--C 1.564 1.513 0 N-CA-C 116.459 2.022 . . . . 0.0 116.459 177.192 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 5.1 t -75.16 165.65 24.89 Favored 'General case' 0 N--CA 1.494 1.764 0 CA-C-N 119.9 1.227 . . . . 0.0 112.853 178.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.74 100.25 10.64 Favored Pre-proline 0 CA--C 1.57 1.746 0 CA-C-O 118.281 -0.866 . . . . 0.0 109.426 168.044 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -77.08 95.16 1.06 Allowed 'Trans proline' 0 C--N 1.373 1.83 0 C-N-CA 123.294 2.663 . . . . 0.0 111.124 -179.758 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 98.0 m -82.44 105.75 13.75 Favored 'General case' 0 N--CA 1.487 1.412 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.643 -158.466 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 93.5 m -81.34 112.97 19.12 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 123.746 0.818 . . . . 0.0 110.072 -175.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 79.1 mt -112.49 107.18 22.32 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 N-CA-C 105.985 -1.857 . . . . 0.0 105.985 -179.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 4.0 mp -94.7 123.67 46.9 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 175.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 5.8 tm-20 -136.11 112.18 9.67 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 -176.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 83.8 tttt -90.18 113.12 24.84 Favored 'General case' 0 CA--C 1.556 1.211 0 C-N-CA 123.023 0.529 . . . . 0.0 109.825 174.253 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 21.9 t-20 -80.56 -64.76 1.12 Allowed 'General case' 0 CA--C 1.564 1.504 0 C-N-CA 123.31 0.644 . . . . 0.0 111.768 179.233 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -131.68 -94.63 0.63 Allowed Glycine 0 N--CA 1.485 1.903 0 N-CA-C 108.941 -1.664 . . . . 0.0 108.941 169.024 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -77.46 -29.26 52.68 Favored 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 115.361 1.615 . . . . 0.0 115.361 162.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 35.3 mm -88.96 124.95 42.02 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.475 0 CA-C-N 119.108 0.867 . . . . 0.0 109.656 -168.438 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 21.2 mt -89.65 121.07 31.49 Favored 'General case' 0 N--CA 1.485 1.294 0 CA-C-N 114.901 -1.045 . . . . 0.0 110.53 169.103 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 87.0 m -108.8 104.07 13.26 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 179.371 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 7.9 tt -104.56 109.97 22.08 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -106.51 116.88 32.7 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 123.503 0.721 . . . . 0.0 109.205 178.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 94.1 m -102.91 101.28 11.29 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 177.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 23.0 m-70 -88.27 93.96 9.68 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 123.473 0.709 . . . . 0.0 111.838 -170.007 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 33.3 t . . . . . 0 CA--C 1.557 1.23 0 CA-C-O 122.019 0.914 . . . . 0.0 110.548 176.838 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 9.7 p30 . . . . . 0 N--CA 1.491 1.599 0 N-CA-C 112.311 0.485 . . . . 0.0 112.311 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 78.3 p -95.23 127.46 41.3 Favored 'General case' 0 N--CA 1.496 1.844 0 C-N-CA 122.917 0.487 . . . . 0.0 110.509 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -119.16 111.95 18.9 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 -176.63 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 39.1 pt -105.64 128.3 59.86 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 173.357 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 42.2 t -116.74 108.38 15.82 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 179.552 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 48.6 p90 -140.39 157.9 44.83 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 114.947 1.462 . . . . 0.0 114.947 -159.222 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 54.9 mtpt -120.15 150.38 40.72 Favored 'General case' 0 CA--C 1.563 1.449 0 CA-C-N 113.971 -1.468 . . . . 0.0 108.68 165.177 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -75.04 113.18 12.06 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.566 -0.709 . . . . 0.0 112.246 -170.213 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 83.61 39.68 9.49 Favored Glycine 0 CA--C 1.551 2.326 0 N-CA-C 116.631 1.412 . . . . 0.0 116.631 -169.522 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 76.5 t -140.76 117.64 8.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 N-CA-C 105.339 -2.097 . . . . 0.0 105.339 -175.284 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -83.17 135.62 34.73 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 122.823 0.449 . . . . 0.0 111.919 -179.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 36.0 p90 -140.92 133.43 28.52 Favored 'General case' 0 N--CA 1.494 1.743 0 C-N-CA 123.687 0.795 . . . . 0.0 110.83 -174.431 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -75.04 117.81 17.29 Favored 'General case' 0 CA--C 1.565 1.521 0 O-C-N 121.478 -0.764 . . . . 0.0 112.314 176.159 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 25.7 tp10 -118.31 135.52 54.26 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 123.954 0.902 . . . . 0.0 110.416 -171.406 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 84.8 m -97.01 119.79 36.15 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 171.648 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 22.9 p -86.14 -178.12 6.44 Favored 'General case' 0 N--CA 1.494 1.762 0 CA-C-O 122.192 0.996 . . . . 0.0 113.308 -171.636 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -52.7 -40.13 62.66 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 117.692 2.479 . . . . 0.0 117.692 167.097 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 42.5 m-20 -81.82 5.31 19.14 Favored 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 116.151 1.908 . . . . 0.0 116.151 169.377 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . 0.251 10.0 m-20 62.58 75.22 0.41 Allowed 'General case' 0 N--CA 1.496 1.868 0 C-N-CA 125.265 1.426 . . . . 0.0 112.048 -171.89 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 42.1 ttp180 -138.05 120.58 16.09 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 -168.051 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.16 95.39 5.59 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 123.407 0.683 . . . . 0.0 111.922 -178.634 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 12.0 m -116.74 127.05 74.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 -167.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 33.5 mmtp -83.6 104.44 13.73 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 123.605 0.762 . . . . 0.0 109.974 -178.593 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 74.5 m -102.28 107.87 19.05 Favored 'General case' 0 N--CA 1.483 1.189 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.022 -161.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 7.2 tp -115.92 104.22 16.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 C-N-CA 124.027 0.931 . . . . 0.0 108.64 -178.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -118.33 124.61 73.38 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 C-N-CA 124.127 0.971 . . . . 0.0 109.117 178.422 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 15.2 t -125.92 157.75 36.92 Favored 'General case' 0 N--CA 1.493 1.691 0 CA-C-O 122.471 1.129 . . . . 0.0 111.496 170.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 14.5 tp -92.49 122.61 35.09 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-N 114.938 -1.028 . . . . 0.0 110.138 175.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -122.75 79.58 1.65 Allowed 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 123.307 0.643 . . . . 0.0 109.885 -178.054 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 64.3 49.34 66.53 Favored Glycine 0 CA--C 1.55 2.235 0 N-CA-C 117.188 1.635 . . . . 0.0 117.188 -175.126 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 74.2 43.77 31.19 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 117.321 1.688 . . . . 0.0 117.321 -171.343 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -153.67 108.61 3.14 Favored 'General case' 0 CA--C 1.554 1.107 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 -169.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 50.9 mt -83.05 96.57 8.4 Favored 'General case' 0 N--CA 1.492 1.655 0 CA-C-O 122.812 1.292 . . . . 0.0 109.56 177.225 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 93.0 t -87.88 100.68 10.59 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.356 0 CA-C-N 112.972 -1.922 . . . . 0.0 105.944 179.125 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 22.6 t-160 -105.83 141.8 36.64 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 124.075 0.95 . . . . 0.0 109.598 -176.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 34.8 tp -140.13 121.24 14.75 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 177.231 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 87.7 mt-30 -115.55 110.38 19.15 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 -177.585 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -107.73 134.51 50.59 Favored 'General case' 0 N--CA 1.494 1.752 0 C-N-CA 122.986 0.514 . . . . 0.0 111.351 -174.101 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 17.5 p90 -151.04 108.72 3.66 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.398 -0.814 . . . . 0.0 109.877 177.539 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 7.1 t70 55.66 52.2 11.35 Favored 'General case' 0 N--CA 1.499 2.007 0 N-CA-C 116.408 2.003 . . . . 0.0 116.408 168.468 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 85.71 -42.55 3.16 Favored Glycine 0 CA--C 1.553 2.445 0 N-CA-C 116.768 1.467 . . . . 0.0 116.768 -169.339 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 62.9 mt-30 -78.62 125.8 29.86 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 123.744 0.818 . . . . 0.0 111.037 179.44 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -136.03 128.2 29.88 Favored 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 122.717 0.407 . . . . 0.0 111.452 178.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 7.7 t -113.44 132.57 55.6 Favored 'General case' 0 N--CA 1.495 1.791 0 C-N-CA 123.163 0.585 . . . . 0.0 110.921 177.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 41.2 p -101.01 130.39 47.0 Favored 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 122.896 0.478 . . . . 0.0 110.982 174.145 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 5.3 mp -111.16 79.68 1.23 Allowed 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.288 -1.005 . . . . 0.0 108.288 177.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 51.8 t -89.09 108.63 19.28 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 -169.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 80.5 mtt85 -104.35 113.95 27.86 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 122.946 0.498 . . . . 0.0 110.255 -174.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -126.0 136.99 53.62 Favored 'General case' 0 N--CA 1.493 1.677 0 C-N-CA 123.307 0.643 . . . . 0.0 111.617 179.08 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -81.81 115.69 21.14 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 123.277 0.631 . . . . 0.0 110.793 175.4 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 86.4 mt -124.75 107.94 19.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 N-CA-C 105.081 -2.192 . . . . 0.0 105.081 179.247 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 20.9 m-20 57.97 51.66 8.7 Favored 'General case' 0 N--CA 1.499 1.988 0 N-CA-C 114.971 1.471 . . . . 0.0 114.971 176.455 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 65.51 16.68 63.41 Favored Glycine 0 CA--C 1.555 2.584 0 N-CA-C 119.857 2.703 . . . . 0.0 119.857 -170.486 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 8.7 mtmp? -128.65 128.66 44.57 Favored 'General case' 0 N--CA 1.488 1.445 0 CA-C-N 119.877 1.838 . . . . 0.0 109.315 -173.447 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 22.2 tp -78.35 113.78 16.64 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 123.847 0.859 . . . . 0.0 109.843 178.501 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 34.9 mm -103.15 101.34 12.05 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 N-CA-C 106.42 -1.696 . . . . 0.0 106.42 -174.63 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 23.6 tp -90.17 103.0 15.72 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 123.915 0.886 . . . . 0.0 109.594 179.414 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 91.8 m -96.82 107.25 19.7 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 -175.335 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 71.9 mt -102.65 99.51 9.5 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 123.762 0.825 . . . . 0.0 109.476 -172.176 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 6.5 m -109.08 119.62 40.1 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 -176.414 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 75.6 t60 -141.12 120.62 13.22 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 171.032 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 74.88 -117.05 5.26 Favored Glycine 0 N--CA 1.484 1.863 0 CA-C-N 116.37 -0.377 . . . . 0.0 112.656 179.013 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 76.6 m -122.19 68.37 0.94 Allowed 'General case' 0 CA--C 1.565 1.553 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 167.471 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -164.06 99.09 0.85 Allowed 'General case' 0 N--CA 1.485 1.314 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 175.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 4.2 p -96.95 122.17 48.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 C-N-CA 123.929 0.892 . . . . 0.0 109.71 176.292 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 42.0 t -110.0 102.44 11.17 Favored 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 123.225 0.61 . . . . 0.0 110.731 178.063 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 63.9 m -90.74 100.39 13.25 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 -176.062 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 30.5 mtm180 -102.44 121.67 42.79 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 122.802 0.441 . . . . 0.0 111.106 -171.038 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 94.6 m -91.05 132.89 35.74 Favored 'General case' 0 CA--C 1.563 1.46 0 C-N-CA 123.763 0.825 . . . . 0.0 110.442 -177.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 37.5 m-85 -131.49 140.35 49.53 Favored 'General case' 0 CA--C 1.562 1.425 0 C-N-CA 124.298 1.039 . . . . 0.0 109.194 179.322 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 1.4 pp20? -111.31 157.8 19.76 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.637 -0.665 . . . . 0.0 111.837 166.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 22.9 ttpt -85.45 129.33 34.84 Favored 'General case' 0 N--CA 1.489 1.498 0 CA-C-O 121.906 0.86 . . . . 0.0 112.241 -167.67 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 28.2 mm-40 -118.27 55.76 0.89 Allowed 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 124.956 1.302 . . . . 0.0 111.089 -173.609 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . 0.446 ' HB2' ' H ' ' A' ' 7' ' ' THR . . . . . . . . 0 N--CA 1.477 0.9 0 CA-C-O 124.447 2.07 . . . . 0.0 109.074 -168.359 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 3.3 p . . . . . 0 CA--C 1.577 2.0 0 N-CA-C 116.112 1.894 . . . . 0.0 116.112 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -68.19 -33.21 74.02 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 116.709 2.114 . . . . 0.0 116.709 -175.495 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -59.44 -25.27 64.23 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 117.707 2.484 . . . . 0.0 117.707 168.192 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -73.72 -24.3 59.89 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 116.133 1.901 . . . . 0.0 116.133 167.785 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 52.0 mt -79.9 113.84 18.37 Favored 'General case' 0 N--CA 1.489 1.505 0 CA-C-N 120.975 1.716 . . . . 0.0 111.451 -166.369 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 158.91 177.39 31.95 Favored Glycine 0 CA--C 1.543 1.785 0 CA-C-O 122.798 1.221 . . . . 0.0 112.985 -175.063 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 63.1 m -84.81 142.88 29.46 Favored 'General case' 0 N--CA 1.492 1.641 0 CA-C-N 114.57 -0.815 . . . . 0.0 109.817 171.356 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 82.6 m95 -140.9 113.95 8.47 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 107.659 -1.237 . . . . 0.0 107.659 -176.402 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 58.9 mttp -97.68 141.17 31.03 Favored 'General case' 0 N--CA 1.492 1.636 0 CA-C-O 121.016 0.436 . . . . 0.0 109.999 175.476 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 55.8 tp -66.71 124.66 23.51 Favored 'General case' 0 N--CA 1.49 1.56 0 CA-C-O 122.135 0.969 . . . . 0.0 111.668 -178.615 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . 0.284 0.9 OUTLIER -103.78 -43.42 8.58 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.784 0 CA-C-N 113.893 -1.503 . . . . 0.0 112.036 -178.222 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -142.63 129.13 20.17 Favored 'General case' 0 N--CA 1.49 1.545 0 CA-C-N 120.336 1.425 . . . . 0.0 109.778 177.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 87.8 p -111.77 116.5 30.81 Favored 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 123.236 0.614 . . . . 0.0 109.82 167.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -83.99 -75.45 0.34 Allowed 'General case' 0 N--CA 1.492 1.664 0 C-N-CA 122.78 0.432 . . . . 0.0 111.66 -173.519 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 71.4 m-20 -106.44 44.2 1.08 Allowed 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 113.307 0.854 . . . . 0.0 113.307 179.671 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 15.2 t80 -91.37 65.69 5.37 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 120.714 -1.241 . . . . 0.0 111.796 -177.705 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -168.2 -53.47 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 126.534 1.934 . . . . 0.0 107.079 -176.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -55.54 -47.72 75.87 Favored 'General case' 0 N--CA 1.498 1.947 0 N-CA-C 115.228 1.566 . . . . 0.0 115.228 161.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 92.8 t80 -52.41 -55.58 20.79 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 114.786 1.402 . . . . 0.0 114.786 170.415 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 75.2 mtm -66.22 -31.65 72.6 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 116.481 2.03 . . . . 0.0 116.481 174.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -64.58 -45.26 87.75 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-N 120.197 1.362 . . . . 0.0 114.564 168.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 23.2 t -59.14 -38.88 80.75 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 115.762 1.764 . . . . 0.0 115.762 170.339 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 95.2 mt -64.22 -39.43 93.95 Favored 'General case' 0 CA--C 1.57 1.749 0 N-CA-C 115.472 1.656 . . . . 0.0 115.472 164.785 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 129.51 -95.49 0.36 Allowed Glycine 0 CA--C 1.54 1.604 0 N-CA-C 108.887 -1.685 . . . . 0.0 108.887 -174.028 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . 0.285 13.2 t 56.73 66.95 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.058 0 N-CA-C 114.044 1.127 . . . . 0.0 114.044 168.075 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 34.47 -128.73 0.56 Allowed Glycine 0 CA--C 1.553 2.435 0 N-CA-C 120.077 2.791 . . . . 0.0 120.077 177.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 43.0 p90 -146.37 -54.88 0.26 Allowed 'General case' 0 N--CA 1.494 1.749 0 C-N-CA 124.202 1.001 . . . . 0.0 110.044 169.323 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.96 -33.5 75.51 Favored 'General case' 0 CA--C 1.564 1.49 0 N-CA-C 116.245 1.943 . . . . 0.0 116.245 164.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 29.8 m -63.49 -38.76 92.36 Favored 'General case' 0 N--CA 1.498 1.925 0 CA-C-N 120.284 1.402 . . . . 0.0 114.258 168.14 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 22.7 ttp180 -58.33 -43.67 88.36 Favored 'General case' 0 CA--C 1.573 1.847 0 N-CA-C 115.102 1.519 . . . . 0.0 115.102 167.554 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 8.1 tm0? -65.87 -51.25 60.37 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 115.116 1.524 . . . . 0.0 115.116 173.137 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 94.2 t -60.6 -45.43 97.3 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 CA-C-N 119.249 0.932 . . . . 0.0 113.01 176.332 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -65.42 -36.79 84.99 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 116.472 2.027 . . . . 0.0 116.472 175.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 95.5 p -64.07 -42.14 97.08 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 116.161 1.912 . . . . 0.0 116.161 168.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 35.8 ttm -66.5 -39.71 88.84 Favored 'General case' 0 CA--C 1.57 1.722 0 N-CA-C 115.921 1.822 . . . . 0.0 115.921 169.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 54.1 m -70.77 144.25 50.95 Favored 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 124.354 1.062 . . . . 0.0 112.331 -176.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? -102.91 99.59 14.28 Favored Pre-proline 0 CA--C 1.573 1.864 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 173.107 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -78.48 111.0 2.95 Favored 'Trans proline' 0 CA--C 1.56 1.804 0 C-N-CA 123.388 2.725 . . . . 0.0 111.594 -178.254 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 97.0 m -78.65 104.84 9.53 Favored 'General case' 0 N--CA 1.491 1.625 0 CA-C-O 121.372 0.606 . . . . 0.0 109.969 -173.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 86.4 m -87.55 114.79 24.48 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 124.086 0.954 . . . . 0.0 109.091 -174.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 81.9 mt -112.46 108.47 25.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 N-CA-C 106.557 -1.646 . . . . 0.0 106.557 -177.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 17.0 mt -97.14 121.24 47.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 -179.21 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -140.7 118.0 11.38 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 -169.728 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 45.2 tttp -90.62 114.91 27.29 Favored 'General case' 0 CA--C 1.557 1.214 0 C-N-CA 123.267 0.627 . . . . 0.0 111.36 -176.365 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 51.4 m-80 -105.82 83.39 1.92 Allowed 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 -179.603 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 80.6 -97.63 1.73 Allowed Glycine 0 N--CA 1.486 2.028 0 O-C-N 121.704 -0.623 . . . . 0.0 112.13 -169.007 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -130.34 62.53 1.58 Allowed 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 159.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 30.8 mm -138.28 100.69 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 N-CA-C 104.818 -2.29 . . . . 0.0 104.818 -178.047 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 71.0 mt -85.35 99.9 11.47 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 122.663 0.385 . . . . 0.0 110.47 -179.132 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 46.9 m -92.4 105.51 17.69 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 107.14 -1.43 . . . . 0.0 107.14 -178.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 10.0 tt -104.68 96.45 6.58 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 106.957 -1.497 . . . . 0.0 106.957 -170.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 58.9 mttp -94.83 106.84 18.85 Favored 'General case' 0 N--CA 1.482 1.133 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 -163.41 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 45.4 m -90.08 92.03 8.8 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 -175.27 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 75.4 m80 -87.64 93.64 9.49 Favored 'General case' 0 N--CA 1.488 1.47 0 CA-C-O 121.733 0.778 . . . . 0.0 110.688 -173.282 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 41.9 t . . . . . 0 CA--C 1.555 1.144 0 C-N-CA 124.051 0.941 . . . . 0.0 110.078 -175.658 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 7.4 p-10 . . . . . 0 N--CA 1.488 1.44 0 CA-C-O 120.513 0.197 . . . . 0.0 111.501 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 73.7 p -133.87 132.68 40.63 Favored 'General case' 0 N--CA 1.496 1.836 0 C-N-CA 123.146 0.579 . . . . 0.0 110.076 -170.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -118.95 140.74 49.49 Favored 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 122.944 0.498 . . . . 0.0 112.161 178.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 42.9 pt -117.22 129.97 72.88 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 C-N-CA 123.405 0.682 . . . . 0.0 109.447 -178.66 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 88.2 p -106.46 118.49 36.78 Favored 'General case' 0 N--CA 1.493 1.7 0 C-N-CA 123.745 0.818 . . . . 0.0 110.209 -178.195 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 50.2 p90 -140.82 135.86 31.84 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 115.188 1.551 . . . . 0.0 115.188 -167.55 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 53.1 mtmt -102.74 19.33 19.42 Favored 'General case' 0 CA--C 1.574 1.883 0 N-CA-C 116.556 2.058 . . . . 0.0 116.556 -175.42 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . 0.294 1.3 mp 63.21 93.07 0.06 Allowed 'General case' 0 N--CA 1.494 1.739 0 CA-C-N 120.418 1.463 . . . . 0.0 114.293 173.365 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 85.79 39.59 8.06 Favored Glycine 0 CA--C 1.55 2.259 0 N-CA-C 116.716 1.446 . . . . 0.0 116.716 -167.072 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 87.7 t -139.47 122.71 18.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 N-CA-C 106.324 -1.732 . . . . 0.0 106.324 178.597 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -87.63 125.8 34.58 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 123.448 0.699 . . . . 0.0 110.948 176.41 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 40.8 p90 -132.79 127.7 35.15 Favored 'General case' 0 N--CA 1.493 1.722 0 C-N-CA 123.558 0.743 . . . . 0.0 110.65 -173.179 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -69.52 126.59 30.2 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.607 -0.683 . . . . 0.0 112.734 174.288 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 12.9 tp10 -138.73 133.87 32.79 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 123.193 0.597 . . . . 0.0 110.156 -167.164 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 58.9 m -92.55 121.33 33.89 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 176.22 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 32.0 p -81.41 172.0 14.07 Favored 'General case' 0 N--CA 1.493 1.705 0 CA-C-O 122.041 0.924 . . . . 0.0 113.316 -173.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -51.6 -35.34 41.12 Favored 'General case' 0 CA--C 1.568 1.638 0 N-CA-C 118.038 2.607 . . . . 0.0 118.038 166.415 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -111.18 51.32 0.78 Allowed 'General case' 0 CA--C 1.574 1.867 0 CA-C-N 119.197 0.908 . . . . 0.0 112.177 171.621 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 51.84 73.67 0.31 Allowed 'General case' 0 N--CA 1.5 2.044 0 N-CA-C 116.584 2.068 . . . . 0.0 116.584 168.678 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 67.9 mtt-85 -143.03 125.11 15.3 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.808 -0.558 . . . . 0.0 109.665 -176.094 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.75 91.8 8.06 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 123.411 0.685 . . . . 0.0 111.483 177.372 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 10.6 m -111.97 128.59 68.46 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 121.808 -0.558 . . . . 0.0 111.426 -163.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 29.8 mmtp -83.7 104.3 13.7 Favored 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 123.672 0.789 . . . . 0.0 110.514 178.734 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 68.8 m -103.26 99.86 9.73 Favored 'General case' 0 N--CA 1.483 1.216 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.952 -160.447 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 7.0 tp -110.6 105.07 18.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 C-N-CA 123.646 0.778 . . . . 0.0 109.264 -177.483 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -116.96 125.54 73.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 C-N-CA 124.447 1.099 . . . . 0.0 108.353 177.32 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 11.0 t -130.16 152.52 49.51 Favored 'General case' 0 N--CA 1.492 1.632 0 CA-C-O 122.577 1.179 . . . . 0.0 111.024 172.644 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 26.3 tp -87.33 109.13 19.32 Favored 'General case' 0 N--CA 1.487 1.404 0 CA-C-N 114.64 -1.163 . . . . 0.0 109.676 177.543 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -123.51 95.26 4.52 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 -174.592 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 63.32 49.48 70.27 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 117.343 1.697 . . . . 0.0 117.343 -177.559 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 67.27 24.24 73.44 Favored Glycine 0 CA--C 1.557 2.691 0 N-CA-C 119.001 2.36 . . . . 0.0 119.001 -169.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 56.3 mtmt -131.93 125.45 31.67 Favored 'General case' 0 N--CA 1.487 1.425 0 CA-C-N 118.735 1.267 . . . . 0.0 107.848 -176.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 58.8 mt -84.56 94.86 8.68 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-O 123.03 1.395 . . . . 0.0 109.467 171.173 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 98.4 t -89.17 101.12 11.7 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.361 0 CA-C-N 112.643 -2.071 . . . . 0.0 105.844 -174.332 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 22.4 t-160 -105.78 139.88 39.67 Favored 'General case' 0 N--CA 1.486 1.348 0 CA-C-N 114.94 -1.027 . . . . 0.0 109.883 -173.5 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 29.1 tp -138.53 121.2 16.32 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 176.709 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 88.9 mt-30 -113.28 121.52 44.67 Favored 'General case' 0 N--CA 1.487 1.425 0 C-N-CA 124.233 1.013 . . . . 0.0 108.45 179.328 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 9.8 mtmp? -123.76 133.15 53.9 Favored 'General case' 0 N--CA 1.497 1.895 0 C-N-CA 122.994 0.517 . . . . 0.0 111.008 -170.314 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 13.5 p90 -156.45 112.66 3.03 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.689 -0.632 . . . . 0.0 110.325 -175.414 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 9.1 t70 53.76 52.51 12.96 Favored 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 116.279 1.955 . . . . 0.0 116.279 167.574 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 87.41 -44.01 3.24 Favored Glycine 0 CA--C 1.551 2.324 0 N-CA-C 116.687 1.435 . . . . 0.0 116.687 -169.492 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 21.7 mt-30 -79.47 139.72 37.55 Favored 'General case' 0 N--CA 1.488 1.452 0 CA-C-N 117.841 0.82 . . . . 0.0 112.124 -178.179 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -144.16 130.25 19.57 Favored 'General case' 0 N--CA 1.491 1.586 0 CA-C-O 121.16 0.505 . . . . 0.0 111.779 177.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 12.4 t -118.63 131.15 56.18 Favored 'General case' 0 N--CA 1.492 1.673 0 C-N-CA 123.525 0.73 . . . . 0.0 110.717 177.554 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 35.5 p -99.01 137.77 37.06 Favored 'General case' 0 N--CA 1.492 1.654 0 CA-C-O 121.311 0.576 . . . . 0.0 111.188 173.203 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 5.3 mp -122.11 74.74 1.17 Allowed 'General case' 0 CA--C 1.564 1.518 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 -179.368 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 87.0 t -84.97 108.06 16.55 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 121.085 -1.01 . . . . 0.0 108.484 -169.555 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 82.9 mtt85 -99.53 120.96 40.48 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 123.234 0.614 . . . . 0.0 109.823 -175.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -141.35 130.81 23.81 Favored 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 123.107 0.563 . . . . 0.0 111.084 -170.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -81.69 112.52 18.95 Favored 'General case' 0 N--CA 1.487 1.413 0 CA-C-O 121.51 0.671 . . . . 0.0 111.029 -179.577 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 50.3 mm -118.5 105.46 17.79 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.352 0 N-CA-C 105.171 -2.159 . . . . 0.0 105.171 179.221 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 57.86 49.58 11.8 Favored 'General case' 0 N--CA 1.499 2.02 0 N-CA-C 114.763 1.394 . . . . 0.0 114.763 176.136 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 82.51 -29.28 3.28 Favored Glycine 0 CA--C 1.554 2.522 0 N-CA-C 118.807 2.283 . . . . 0.0 118.807 -169.504 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 89.9 mttt -93.72 136.11 34.33 Favored 'General case' 0 N--CA 1.486 1.371 0 CA-C-N 119.275 1.537 . . . . 0.0 111.189 -168.369 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 20.6 tp -80.73 115.93 20.48 Favored 'General case' 0 CA--C 1.558 1.279 0 C-N-CA 123.24 0.616 . . . . 0.0 110.105 177.551 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 39.2 mm -104.0 101.57 12.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 N-CA-C 106.835 -1.543 . . . . 0.0 106.835 -175.3 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 16.2 tp -91.81 102.22 14.81 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 124.009 0.924 . . . . 0.0 109.729 179.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 58.5 m -91.54 112.87 24.97 Favored 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 123.883 0.873 . . . . 0.0 109.286 -175.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 96.7 mt -111.09 97.48 6.84 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 123.71 0.804 . . . . 0.0 109.708 -169.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 10.2 m -113.08 117.75 32.86 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.875 -0.516 . . . . 0.0 109.788 -172.405 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 78.9 t60 -152.34 116.4 4.91 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 174.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 60.6 61.18 7.33 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 117.061 1.584 . . . . 0.0 117.061 171.39 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . 0.297 4.3 m 51.65 51.53 16.49 Favored 'General case' 0 CA--C 1.576 1.953 0 N-CA-C 114.928 1.455 . . . . 0.0 114.928 -172.098 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -158.11 86.62 0.9 Allowed 'General case' 0 N--CA 1.484 1.228 0 CA-C-O 121.542 0.687 . . . . 0.0 109.194 -179.618 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 3.4 p -91.23 111.85 24.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 C-N-CA 123.691 0.796 . . . . 0.0 109.257 175.4 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 48.4 t -105.17 102.05 11.57 Favored 'General case' 0 CA--C 1.552 1.032 0 CA-C-O 121.461 0.648 . . . . 0.0 109.662 176.052 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 86.0 m -90.56 94.2 9.61 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 -175.706 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 32.5 mtm180 -91.88 120.98 33.06 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 122.927 0.491 . . . . 0.0 111.019 -169.426 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 87.6 m -86.61 131.83 34.06 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 123.463 0.705 . . . . 0.0 110.096 179.09 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 35.9 m-85 -128.43 126.59 40.87 Favored 'General case' 0 CA--C 1.558 1.275 0 C-N-CA 123.82 0.848 . . . . 0.0 108.835 178.538 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -93.99 150.98 19.87 Favored 'General case' 0 N--CA 1.492 1.672 0 CA-C-O 122.08 0.943 . . . . 0.0 111.526 169.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 68.9 tttt -83.06 119.56 24.63 Favored 'General case' 0 N--CA 1.486 1.329 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.706 -169.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 11.8 mm-40 -110.09 49.36 0.85 Allowed 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 123.934 0.894 . . . . 0.0 113.03 179.49 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.301 0 CA-C-O 123.27 1.509 . . . . 0.0 113.569 169.928 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.303 8.5 t . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 118.248 -0.882 . . . . 0.0 112.984 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -60.48 -37.46 81.13 Favored 'General case' 0 N--CA 1.497 1.895 0 N-CA-C 116.224 1.935 . . . . 0.0 116.224 179.505 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -63.55 -29.07 70.39 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 117.047 2.24 . . . . 0.0 117.047 164.057 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -72.93 -21.67 60.84 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 116.145 1.905 . . . . 0.0 116.145 170.589 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 48.2 mt -69.64 114.74 8.14 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-N 121.516 1.962 . . . . 0.0 111.917 -172.541 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 157.93 172.94 25.72 Favored Glycine 0 CA--C 1.543 1.808 0 CA-C-O 122.442 1.023 . . . . 0.0 113.428 -173.554 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 80.1 m -92.88 140.52 29.41 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 171.177 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 85.2 m95 -138.7 114.75 10.16 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 -173.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 48.5 mtmt -97.18 147.16 24.37 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-O 121.54 0.686 . . . . 0.0 111.32 177.297 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 57.3 tp -70.76 126.26 29.1 Favored 'General case' 0 N--CA 1.487 1.421 0 CA-C-O 121.905 0.859 . . . . 0.0 112.438 -175.505 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . 0.271 1.1 t -104.58 -44.16 8.54 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.852 0 CA-C-N 114.327 -1.306 . . . . 0.0 112.421 178.542 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -140.45 134.31 30.55 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-N 120.004 1.275 . . . . 0.0 109.687 -178.487 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 79.9 p -122.17 113.99 20.24 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 123.456 0.702 . . . . 0.0 110.053 171.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 10.7 mtpm? -81.92 -88.16 0.09 Allowed 'General case' 0 N--CA 1.492 1.646 0 CA-C-O 118.962 -0.542 . . . . 0.0 111.472 -177.152 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 70.9 m-80 -98.1 43.03 1.07 Allowed 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 113.831 1.049 . . . . 0.0 113.831 -174.222 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 17.5 t80 -76.83 -43.11 37.67 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 115.722 1.749 . . . . 0.0 115.722 -168.325 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 33.3 m-20 -63.69 -36.51 84.1 Favored 'General case' 0 N--CA 1.499 1.999 0 N-CA-C 115.112 1.523 . . . . 0.0 115.112 169.763 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 24.1 t0 -60.87 -47.32 86.9 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 115.174 1.546 . . . . 0.0 115.174 167.226 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 83.7 t80 -53.95 -53.02 58.62 Favored 'General case' 0 CA--C 1.569 1.702 0 N-CA-C 115.194 1.553 . . . . 0.0 115.194 170.448 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 79.0 mtm -63.76 -34.58 78.21 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 116.149 1.907 . . . . 0.0 116.149 173.704 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -57.59 -50.61 72.55 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 114.65 1.352 . . . . 0.0 114.65 165.194 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 22.9 t -60.28 -36.58 78.15 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 116.318 1.97 . . . . 0.0 116.318 171.482 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.479 ' HB3' HH12 ' A' ' 78' ' ' ARG . 31.2 mt -64.1 -34.75 78.75 Favored 'General case' 0 CA--C 1.565 1.53 0 N-CA-C 117.309 2.337 . . . . 0.0 117.309 169.74 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 101.25 76.26 1.19 Allowed Glycine 0 N--CA 1.482 1.741 0 CA-C-N 119.118 0.872 . . . . 0.0 112.02 -171.415 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 58.3 t -138.33 122.76 21.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 N-CA-C 105.585 -2.006 . . . . 0.0 105.585 -179.554 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -63.27 147.53 50.53 Favored Glycine 0 N--CA 1.488 2.116 0 N-CA-C 115.431 0.932 . . . . 0.0 115.431 177.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . 0.257 25.2 p90 -55.34 -41.64 72.74 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 118.834 2.901 . . . . 0.0 118.834 -166.169 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.57 -44.48 96.21 Favored 'General case' 0 CA--C 1.565 1.541 0 N-CA-C 115.979 1.844 . . . . 0.0 115.979 175.157 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 86.6 m -68.78 -38.6 80.12 Favored 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 114.439 1.274 . . . . 0.0 114.439 168.772 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 48.8 ttp180 -56.57 -45.14 81.47 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 115.421 1.637 . . . . 0.0 115.421 174.373 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 18.8 mm100 -70.5 -38.13 74.3 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 115.167 1.543 . . . . 0.0 115.167 173.196 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 95.3 t -63.45 -44.09 98.71 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.094 0 CA-C-N 120.093 1.315 . . . . 0.0 113.46 171.525 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -63.98 -31.06 72.11 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 117.371 2.36 . . . . 0.0 117.371 174.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 93.7 p -68.57 -42.2 78.62 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 116.15 1.907 . . . . 0.0 116.15 168.072 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 3.7 ppp? -71.87 -26.91 62.54 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 117.582 2.438 . . . . 0.0 117.582 175.34 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 5.3 t -74.79 162.95 28.2 Favored 'General case' 0 N--CA 1.493 1.699 0 CA-C-N 120.335 1.425 . . . . 0.0 112.592 175.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -99.97 103.51 22.84 Favored Pre-proline 0 CA--C 1.567 1.61 0 CA-C-O 118.008 -0.996 . . . . 0.0 108.853 172.394 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -78.89 90.32 1.29 Allowed 'Trans proline' 0 CA--C 1.56 1.81 0 C-N-CA 123.208 2.606 . . . . 0.0 111.225 177.292 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 94.4 m -80.19 111.79 16.89 Favored 'General case' 0 N--CA 1.489 1.513 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.574 -161.164 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 36.5 m -86.42 113.28 22.24 Favored 'General case' 0 CA--C 1.559 1.323 0 C-N-CA 123.598 0.759 . . . . 0.0 109.446 -171.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 71.6 mt -109.59 103.62 15.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 N-CA-C 106.033 -1.84 . . . . 0.0 106.033 177.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 3.7 mp -91.68 123.41 43.79 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 N-CA-C 106.881 -1.526 . . . . 0.0 106.881 172.175 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -148.21 125.61 11.62 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 -169.626 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.32 153.65 29.68 Favored 'General case' 0 CA--C 1.565 1.54 0 CA-C-O 122.173 0.987 . . . . 0.0 113.656 178.249 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 67.1 m-80 -141.77 75.3 1.49 Allowed 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 106.389 -1.708 . . . . 0.0 106.389 171.16 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 71.17 -110.99 3.47 Favored Glycine 0 CA--C 1.548 2.108 0 O-C-N 121.885 -0.51 . . . . 0.0 112.86 -166.5 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 21.1 m-20 -82.75 -21.14 34.79 Favored 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 116.033 1.864 . . . . 0.0 116.033 168.024 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 42.8 mm -84.93 114.88 25.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 CA-C-N 119.863 1.21 . . . . 0.0 109.614 -168.191 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 44.5 mt -86.79 114.94 23.87 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 123.057 0.543 . . . . 0.0 110.342 174.164 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 88.5 m -107.81 102.82 12.0 Favored 'General case' 0 N--CA 1.486 1.342 0 N-CA-C 106.728 -1.582 . . . . 0.0 106.728 -174.358 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 8.9 tt -104.37 107.11 17.87 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -103.37 114.82 29.39 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 179.331 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 91.7 m -100.67 98.11 8.7 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 179.246 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 20.2 m-70 -85.08 91.26 8.06 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 123.411 0.684 . . . . 0.0 112.555 -169.456 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 15.2 t . . . . . 0 CA--C 1.557 1.241 0 C-N-CA 123.814 0.846 . . . . 0.0 110.302 174.486 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 8.8 p30 . . . . . 0 N--CA 1.49 1.534 0 CA-C-O 120.249 0.071 . . . . 0.0 110.952 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 77.9 p -90.67 122.63 33.61 Favored 'General case' 0 N--CA 1.492 1.661 0 CA-C-O 121.178 0.513 . . . . 0.0 110.775 -174.559 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.531 ' HE2' ' HB2' ' A' ' 63' ' ' SER . 2.3 tm-20 -108.12 115.82 30.83 Favored 'General case' 0 N--CA 1.486 1.341 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 -175.112 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 29.8 pt -111.24 129.63 66.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 N-CA-C 108.531 -0.915 . . . . 0.0 108.531 174.087 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' SER . . . . . 0.531 ' HB2' ' HE2' ' A' ' 61' ' ' GLU . 44.1 t -118.73 113.0 20.48 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.38 -0.971 . . . . 0.0 108.38 -174.574 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 43.8 p90 -144.89 140.77 28.55 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 115.093 1.516 . . . . 0.0 115.093 -162.1 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 29.5 mtpp -109.16 18.43 20.56 Favored 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 117.325 2.343 . . . . 0.0 117.325 -177.486 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . 0.296 1.3 mp 65.6 93.57 0.07 Allowed 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 125.03 1.332 . . . . 0.0 113.278 176.723 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 92.32 37.67 5.85 Favored Glycine 0 CA--C 1.55 2.228 0 N-CA-C 117.01 1.564 . . . . 0.0 117.01 -166.631 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 92.3 t -135.62 122.86 35.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 N-CA-C 107.035 -1.468 . . . . 0.0 107.035 178.311 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -88.08 131.91 34.5 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 123.401 0.68 . . . . 0.0 110.476 170.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 37.0 p90 -143.0 130.74 21.43 Favored 'General case' 0 N--CA 1.493 1.72 0 C-N-CA 123.333 0.653 . . . . 0.0 110.087 -174.069 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -72.56 114.02 10.24 Favored 'General case' 0 CA--C 1.564 1.501 0 O-C-N 121.546 -0.721 . . . . 0.0 111.933 175.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 14.0 tp10 -119.08 134.5 55.16 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 123.842 0.857 . . . . 0.0 109.782 -167.706 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 73.4 m -90.57 121.74 32.77 Favored 'General case' 0 N--CA 1.491 1.577 0 CA-C-O 121.258 0.551 . . . . 0.0 109.663 176.084 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 30.0 p -85.0 169.74 13.69 Favored 'General case' 0 N--CA 1.493 1.712 0 CA-C-O 121.54 0.686 . . . . 0.0 112.203 -177.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -59.37 -34.82 72.88 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 116.68 2.104 . . . . 0.0 116.68 166.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -76.53 9.24 2.84 Favored 'General case' 0 CA--C 1.581 2.144 0 N-CA-C 115.909 1.818 . . . . 0.0 115.909 167.309 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . 0.252 11.6 m-20 66.78 69.74 0.4 Allowed 'General case' 0 N--CA 1.494 1.77 0 C-N-CA 125.749 1.62 . . . . 0.0 112.669 176.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.479 HH12 ' HB3' ' A' ' 23' ' ' LEU . 60.4 mtm180 -143.56 128.17 18.1 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 122.915 0.486 . . . . 0.0 110.23 -175.117 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.36 117.56 13.05 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 123.491 0.716 . . . . 0.0 111.075 164.822 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 14.3 m -133.49 127.37 53.36 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 -171.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 33.2 mmtp -77.54 102.9 7.17 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 123.567 0.747 . . . . 0.0 110.557 -178.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 69.2 m -101.19 92.67 5.08 Favored 'General case' 0 N--CA 1.482 1.149 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.575 -165.074 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 7.2 tp -106.1 116.64 50.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 178.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 1.4 p -134.15 131.72 55.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 C-N-CA 123.806 0.842 . . . . 0.0 109.564 -170.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 10.1 t -148.63 152.17 36.25 Favored 'General case' 0 N--CA 1.49 1.533 0 CA-C-O 122.745 1.26 . . . . 0.0 110.359 179.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 26.4 tp -85.67 119.94 26.55 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-N 114.726 -1.125 . . . . 0.0 110.298 176.424 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -109.4 79.22 1.19 Allowed 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 123.52 0.728 . . . . 0.0 109.613 -178.357 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 54.9 44.26 81.96 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 118.477 2.151 . . . . 0.0 118.477 -177.454 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 107.12 -42.52 1.91 Allowed Glycine 0 N--CA 1.49 2.295 0 N-CA-C 116.558 1.383 . . . . 0.0 116.558 -168.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 35.9 ttmt -82.33 112.06 18.96 Favored 'General case' 0 CA--C 1.559 1.289 0 CA-C-N 118.164 0.982 . . . . 0.0 109.881 179.584 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.8 tt -88.28 102.72 15.12 Favored 'General case' 0 N--CA 1.488 1.459 0 CA-C-O 121.659 0.742 . . . . 0.0 109.311 -176.739 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 62.7 t -100.7 110.41 27.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 -166.656 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 22.8 t-160 -104.47 134.39 47.75 Favored 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 123.822 0.849 . . . . 0.0 109.713 171.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 24.4 tp -120.09 120.99 37.87 Favored 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 124.655 1.182 . . . . 0.0 107.944 172.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 27.6 mt-30 -109.2 113.71 26.79 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 171.522 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 38.0 ttmt -122.77 132.82 54.4 Favored 'General case' 0 CA--C 1.563 1.465 0 C-N-CA 123.461 0.704 . . . . 0.0 110.397 -174.592 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 34.9 p90 -149.09 115.2 5.76 Favored 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 123.36 0.664 . . . . 0.0 109.989 -176.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . 0.343 17.4 t70 67.15 -101.36 0.06 Allowed 'General case' 0 N--CA 1.495 1.796 0 C-N-CA 124.511 1.124 . . . . 0.0 111.972 176.179 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -127.88 56.23 0.74 Allowed Glycine 0 N--CA 1.487 2.059 0 CA-C-N 118.736 0.698 . . . . 0.0 113.16 162.568 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 49.1 mt-30 -149.15 110.41 4.41 Favored 'General case' 0 N--CA 1.485 1.31 0 N-CA-C 107.032 -1.47 . . . . 0.0 107.032 -177.481 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -117.01 124.42 49.27 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 122.894 0.477 . . . . 0.0 110.777 176.577 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 10.7 t -115.58 122.71 46.48 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 110.051 -0.351 . . . . 0.0 110.051 167.421 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 35.7 p -93.19 125.79 37.96 Favored 'General case' 0 N--CA 1.489 1.505 0 CA-C-O 121.274 0.559 . . . . 0.0 110.598 172.345 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 5.6 mp -99.08 86.73 3.51 Favored 'General case' 0 CA--C 1.561 1.387 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 175.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 93.3 t -94.21 108.53 20.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 -168.455 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 79.1 mtt85 -108.41 121.98 46.06 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 123.173 0.589 . . . . 0.0 110.143 -173.239 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -141.53 137.51 32.07 Favored 'General case' 0 N--CA 1.495 1.776 0 C-N-CA 123.114 0.566 . . . . 0.0 110.938 177.199 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -81.17 119.62 23.83 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.518 -0.739 . . . . 0.0 111.271 176.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 74.6 mt -123.97 110.89 26.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 N-CA-C 104.949 -2.241 . . . . 0.0 104.949 177.369 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 29.3 m-20 59.3 48.49 10.11 Favored 'General case' 0 N--CA 1.5 2.057 0 N-CA-C 114.767 1.395 . . . . 0.0 114.767 179.126 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 60.45 28.06 66.79 Favored Glycine 0 CA--C 1.554 2.473 0 N-CA-C 119.336 2.494 . . . . 0.0 119.336 -169.368 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 9.7 mtmp? -135.36 127.31 29.56 Favored 'General case' 0 N--CA 1.489 1.511 0 CA-C-N 119.482 1.641 . . . . 0.0 108.533 -173.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 35.0 tp -75.36 112.19 11.41 Favored 'General case' 0 CA--C 1.557 1.235 0 C-N-CA 123.493 0.717 . . . . 0.0 110.811 -179.561 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 31.0 mm -100.42 104.92 16.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 N-CA-C 106.409 -1.7 . . . . 0.0 106.409 -176.533 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 23.7 tp -97.96 101.17 12.59 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 123.81 0.844 . . . . 0.0 109.103 179.541 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 97.7 m -93.86 109.96 21.64 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 124.177 0.991 . . . . 0.0 108.769 -178.546 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 74.7 mt -103.8 90.32 3.6 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 123.913 0.885 . . . . 0.0 109.734 -168.534 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 7.5 m -100.06 118.18 35.88 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 -168.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 80.1 t60 -132.59 -105.49 0.25 Allowed 'General case' 0 N--CA 1.492 1.629 0 CA-C-O 118.77 -0.633 . . . . 0.0 109.652 176.105 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -119.63 91.14 0.49 Allowed Glycine 0 N--CA 1.486 1.989 0 CA-C-N 119.321 0.964 . . . . 0.0 112.65 -167.015 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . 0.297 1.6 m 54.62 34.37 21.27 Favored 'General case' 0 CA--C 1.582 2.179 0 N-CA-C 115.885 1.809 . . . . 0.0 115.885 -173.029 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -161.68 84.22 0.61 Allowed 'General case' 0 N--CA 1.485 1.308 0 O-C-N 121.15 -0.968 . . . . 0.0 108.768 -177.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 4.7 p -91.91 116.67 33.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 175.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 42.2 t -101.85 102.35 12.92 Favored 'General case' 0 CA--C 1.553 1.066 0 CA-C-O 121.187 0.518 . . . . 0.0 111.096 -179.63 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 96.2 m -87.7 111.75 21.64 Favored 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 177.424 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 28.9 mtm180 -114.4 119.28 36.39 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 122.898 0.479 . . . . 0.0 110.529 -170.347 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 88.9 m -84.42 134.97 34.45 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 123.234 0.614 . . . . 0.0 110.043 175.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 36.9 m-85 -130.11 128.43 41.83 Favored 'General case' 0 CA--C 1.56 1.345 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 178.367 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -93.77 150.72 20.16 Favored 'General case' 0 CA--C 1.564 1.503 0 CA-C-O 122.06 0.933 . . . . 0.0 111.202 172.173 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 69.3 tttt -82.97 124.83 30.76 Favored 'General case' 0 N--CA 1.486 1.342 0 N-CA-C 112.916 0.709 . . . . 0.0 112.916 -168.559 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 40.1 tp10 -99.06 47.95 0.96 Allowed 'General case' 0 CA--C 1.57 1.724 0 C-N-CA 123.772 0.829 . . . . 0.0 113.044 169.548 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.043 0 CA-C-O 124.263 1.982 . . . . 0.0 108.241 -176.94 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.306 5.0 t . . . . . 0 N--CA 1.49 1.526 0 CA-C-O 117.795 -1.098 . . . . 0.0 113.302 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -61.19 -36.99 81.38 Favored 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 115.991 1.849 . . . . 0.0 115.991 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -61.31 -32.23 72.09 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 116.957 2.206 . . . . 0.0 116.957 163.428 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -71.96 -25.41 61.86 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 115.978 1.844 . . . . 0.0 115.978 170.248 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 55.3 mt -71.71 117.32 13.14 Favored 'General case' 0 N--CA 1.492 1.652 0 CA-C-N 121.375 1.898 . . . . 0.0 111.112 -175.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 160.1 170.0 24.12 Favored Glycine 0 CA--C 1.54 1.627 0 CA-C-O 122.418 1.01 . . . . 0.0 113.853 -172.422 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 90.3 m -92.62 136.74 32.97 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-N 114.464 -0.868 . . . . 0.0 108.812 171.031 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 94.8 m95 -137.64 115.17 11.2 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.685 -0.858 . . . . 0.0 108.685 -170.193 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 23.0 mmmt -108.27 145.22 34.67 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-O 121.791 0.805 . . . . 0.0 110.536 179.627 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 25.8 tp -68.81 128.82 38.01 Favored 'General case' 0 N--CA 1.487 1.407 0 CA-C-O 122.222 1.011 . . . . 0.0 112.91 -171.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . 0.28 1.1 t -106.69 -45.67 8.01 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.725 0 CA-C-N 113.805 -1.543 . . . . 0.0 111.767 178.811 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 43.7 t0 -142.01 140.08 32.56 Favored 'General case' 0 N--CA 1.488 1.429 0 CA-C-N 119.437 1.017 . . . . 0.0 109.079 178.641 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 81.0 p -127.79 94.26 3.9 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.784 -0.572 . . . . 0.0 109.853 172.4 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 47.9 mtmt -91.99 120.8 32.97 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 123.57 0.748 . . . . 0.0 109.355 -176.408 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.264 42.1 m-20 71.53 21.17 4.56 Favored 'General case' 0 N--CA 1.504 2.264 0 N-CA-C 117.113 2.264 . . . . 0.0 117.113 -178.726 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 10.1 t80 -71.85 -41.13 68.47 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 115.853 1.797 . . . . 0.0 115.853 -175.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -60.52 -32.25 71.29 Favored 'General case' 0 N--CA 1.499 1.976 0 N-CA-C 116.014 1.857 . . . . 0.0 116.014 168.442 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 20.1 t0 -64.85 -50.72 65.54 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 114.331 1.234 . . . . 0.0 114.331 167.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 89.6 t80 -50.54 -54.83 19.39 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 115.349 1.611 . . . . 0.0 115.349 171.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 77.7 mtm -59.85 -41.85 92.35 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 115.231 1.567 . . . . 0.0 115.231 175.418 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.3 tmtp? -62.57 -43.94 97.57 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 114.788 1.403 . . . . 0.0 114.788 171.526 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 61.3 m -58.18 -39.39 78.8 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 116.574 2.064 . . . . 0.0 116.574 171.022 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 51.8 mt -61.54 -45.86 92.39 Favored 'General case' 0 CA--C 1.567 1.632 0 N-CA-C 115.747 1.758 . . . . 0.0 115.747 167.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 121.03 71.69 0.3 Allowed Glycine 0 N--CA 1.482 1.735 0 C-N-CA 123.979 0.8 . . . . 0.0 111.266 -172.101 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 40.5 t -141.6 122.0 12.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 N-CA-C 105.083 -2.191 . . . . 0.0 105.083 -176.294 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -77.15 -171.48 35.35 Favored Glycine 0 CA--C 1.548 2.154 0 N-CA-C 116.663 1.425 . . . . 0.0 116.663 -174.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 11.0 p90 -67.27 158.32 31.76 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 113.387 0.884 . . . . 0.0 113.387 176.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . 0.325 . . 78.76 -52.05 0.46 Allowed 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 114.995 1.48 . . . . 0.0 114.995 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 89.1 m -64.48 -40.93 96.61 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 114.241 1.201 . . . . 0.0 114.241 167.682 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 48.1 mtm180 -61.26 -43.66 98.52 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 114.996 1.48 . . . . 0.0 114.996 167.555 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -60.52 -49.81 76.07 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 115.058 1.503 . . . . 0.0 115.058 174.056 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 69.1 t -63.69 -43.84 98.2 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 CA-C-N 119.429 1.013 . . . . 0.0 112.742 174.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -62.7 -35.98 81.48 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 117.053 2.242 . . . . 0.0 117.053 176.234 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 96.7 p -65.66 -43.44 89.39 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 116.395 1.998 . . . . 0.0 116.395 170.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 20.0 ptm -68.21 -31.02 70.25 Favored 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 117.067 2.247 . . . . 0.0 117.067 168.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 38.0 m -71.85 143.47 49.41 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 124.279 1.031 . . . . 0.0 112.257 -178.025 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -104.52 102.97 37.16 Favored Pre-proline 0 CA--C 1.57 1.723 0 CA-C-O 118.145 -0.931 . . . . 0.0 109.1 175.25 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -79.2 116.88 3.72 Favored 'Trans proline' 0 CA--C 1.561 1.849 0 C-N-CA 122.913 2.409 . . . . 0.0 112.185 -178.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 24.4 m -78.8 105.36 10.06 Favored 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 123.675 0.79 . . . . 0.0 109.701 -170.536 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 61.0 m -101.12 106.77 18.05 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 -167.234 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 52.0 mt -111.69 107.19 22.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 N-CA-C 107.16 -1.422 . . . . 0.0 107.16 -172.149 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 3.9 mp -96.18 121.56 46.84 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 174.637 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 7.9 tm-20 -137.23 120.6 16.97 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 -178.03 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -86.23 115.9 24.07 Favored 'General case' 0 CA--C 1.56 1.339 0 C-N-CA 123.15 0.58 . . . . 0.0 111.052 179.431 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 12.5 t30 -105.79 86.87 2.46 Favored 'General case' 0 CA--C 1.561 1.374 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 179.282 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 80.92 -99.75 1.92 Allowed Glycine 0 N--CA 1.486 1.982 0 N-CA-C 111.883 -0.487 . . . . 0.0 111.883 -172.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -130.11 59.36 1.63 Allowed 'General case' 0 N--CA 1.494 1.747 0 CA-C-O 120.958 0.409 . . . . 0.0 110.065 160.399 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 42.6 mm -137.81 108.16 5.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 N-CA-C 104.889 -2.263 . . . . 0.0 104.889 -179.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 42.8 mt -83.11 106.67 15.1 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 122.756 0.422 . . . . 0.0 110.871 179.204 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 73.3 m -98.98 96.99 8.2 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 -173.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 9.1 tt -97.68 103.19 15.1 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 -179.227 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 91.3 mttt -98.94 111.14 23.62 Favored 'General case' 0 N--CA 1.485 1.276 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 -175.306 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 45.8 m -100.13 87.03 3.35 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 -177.601 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 12.0 m170 -89.87 98.63 11.88 Favored 'General case' 0 N--CA 1.492 1.642 0 CA-C-O 121.702 0.763 . . . . 0.0 110.053 -173.224 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 22.9 t . . . . . 0 N--CA 1.488 1.448 0 N-CA-C 116.962 2.208 . . . . 0.0 116.962 -172.54 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 8.9 p30 . . . . . 0 N--CA 1.487 1.42 0 CA-C-O 120.737 0.303 . . . . 0.0 110.777 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 60.2 p -96.19 127.85 42.56 Favored 'General case' 0 N--CA 1.494 1.75 0 CA-C-O 121.396 0.617 . . . . 0.0 109.949 -179.577 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -124.52 125.09 43.65 Favored 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 123.426 0.69 . . . . 0.0 109.344 -171.582 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 48.2 pt -117.6 131.48 70.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 C-N-CA 123.524 0.73 . . . . 0.0 109.077 175.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 80.6 p -121.2 104.14 9.52 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 -178.055 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 50.1 p90 -136.9 147.09 46.23 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 114.809 1.411 . . . . 0.0 114.809 -156.555 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 25.9 mtpp -110.77 20.29 17.74 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 117.679 2.474 . . . . 0.0 117.679 -170.693 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . 0.311 1.7 mp 60.65 88.7 0.08 Allowed 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 114.93 1.456 . . . . 0.0 114.93 172.639 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 92.39 39.81 5.26 Favored Glycine 0 CA--C 1.549 2.194 0 N-CA-C 115.951 1.141 . . . . 0.0 115.951 -168.506 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 74.9 t -141.62 123.86 14.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 N-CA-C 105.533 -2.025 . . . . 0.0 105.533 -176.421 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -88.14 129.55 35.29 Favored 'General case' 0 CA--C 1.565 1.547 0 C-N-CA 122.924 0.49 . . . . 0.0 110.497 176.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 48.6 p90 -138.95 131.55 28.87 Favored 'General case' 0 N--CA 1.496 1.831 0 C-N-CA 123.231 0.612 . . . . 0.0 111.435 -174.201 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -69.17 131.56 45.14 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.303 -0.873 . . . . 0.0 113.133 173.602 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 17.4 tp10 -142.97 137.85 29.67 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 123.426 0.69 . . . . 0.0 110.028 -168.343 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 56.6 m -93.06 122.8 35.8 Favored 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 123.035 0.534 . . . . 0.0 109.639 176.238 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 26.9 p -84.14 177.8 8.08 Favored 'General case' 0 N--CA 1.496 1.86 0 CA-C-O 121.415 0.626 . . . . 0.0 112.549 -177.3 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -67.4 -27.97 67.53 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 117.416 2.376 . . . . 0.0 117.416 169.612 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 25.6 m-20 -77.96 8.3 4.88 Favored 'General case' 0 CA--C 1.579 2.096 0 N-CA-C 115.918 1.822 . . . . 0.0 115.918 161.39 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 64.01 68.81 0.55 Allowed 'General case' 0 N--CA 1.496 1.837 0 C-N-CA 125.366 1.466 . . . . 0.0 112.891 -179.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 63.7 mtm180 -137.05 127.96 27.46 Favored 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 123.001 0.521 . . . . 0.0 109.74 -171.457 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.04 102.8 6.64 Favored 'General case' 0 CA--C 1.565 1.53 0 C-N-CA 123.331 0.652 . . . . 0.0 111.141 173.071 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 19.9 m -120.36 129.99 74.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 -170.622 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 69.6 mmtt -81.74 107.13 14.23 Favored 'General case' 0 N--CA 1.49 1.531 0 CA-C-O 121.841 0.829 . . . . 0.0 109.867 176.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 74.3 m -102.07 102.49 12.98 Favored 'General case' 0 N--CA 1.481 1.08 0 CA-C-N 114.838 -1.073 . . . . 0.0 110.114 -165.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -106.91 115.04 47.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 175.67 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -128.26 128.15 68.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 C-N-CA 123.799 0.84 . . . . 0.0 109.32 -178.835 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 9.3 t -139.97 151.26 45.37 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-O 122.705 1.24 . . . . 0.0 111.337 -179.249 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 50.5 tp -82.2 125.48 30.97 Favored 'General case' 0 N--CA 1.489 1.498 0 CA-C-N 114.523 -1.217 . . . . 0.0 109.921 176.476 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -126.5 83.44 2.17 Favored 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 123.462 0.705 . . . . 0.0 109.771 -178.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 58.56 46.13 93.63 Favored Glycine 0 CA--C 1.552 2.395 0 N-CA-C 117.934 1.933 . . . . 0.0 117.934 -178.444 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 76.77 31.82 52.33 Favored Glycine 0 CA--C 1.555 2.544 0 N-CA-C 117.833 1.893 . . . . 0.0 117.833 -166.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 60.4 mtpt -141.13 112.82 7.62 Favored 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 106.629 -1.619 . . . . 0.0 106.629 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 3.7 mp -81.67 111.04 17.58 Favored 'General case' 0 N--CA 1.487 1.404 0 CA-C-O 121.94 0.876 . . . . 0.0 109.858 173.76 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 95.6 t -106.84 102.03 13.35 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 N-CA-C 105.324 -2.102 . . . . 0.0 105.324 -172.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 23.6 t-160 -104.85 136.95 43.39 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 124.35 1.06 . . . . 0.0 109.474 -178.306 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 33.7 tp -132.65 119.4 20.38 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 177.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 81.9 mt-30 -111.87 111.84 23.08 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 179.372 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 10.3 ptpp? -120.04 138.61 53.42 Favored 'General case' 0 N--CA 1.494 1.732 0 C-N-CA 123.228 0.611 . . . . 0.0 112.027 -172.324 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 13.7 p90 -156.79 109.8 2.57 Favored 'General case' 0 N--CA 1.488 1.475 0 C-N-CA 123.379 0.672 . . . . 0.0 109.825 -174.165 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 6.7 t70 54.5 54.4 9.38 Favored 'General case' 0 N--CA 1.498 1.949 0 N-CA-C 116.066 1.876 . . . . 0.0 116.066 168.62 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 87.2 -41.91 3.12 Favored Glycine 0 CA--C 1.552 2.38 0 N-CA-C 116.919 1.528 . . . . 0.0 116.919 -169.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -86.17 135.71 33.48 Favored 'General case' 0 N--CA 1.483 1.208 0 CA-C-N 117.979 0.89 . . . . 0.0 111.454 -174.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -144.86 137.73 26.51 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.911 -0.493 . . . . 0.0 112.006 -178.868 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 9.9 t -131.46 129.25 40.94 Favored 'General case' 0 N--CA 1.493 1.722 0 C-N-CA 123.356 0.662 . . . . 0.0 110.682 179.648 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 41.8 p -98.52 129.57 45.09 Favored 'General case' 0 N--CA 1.494 1.732 0 C-N-CA 122.884 0.474 . . . . 0.0 111.769 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 5.7 mp -103.91 80.26 1.73 Allowed 'General case' 0 CA--C 1.564 1.51 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 177.059 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 59.9 t -89.69 108.85 19.77 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 -168.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 81.8 mtt85 -102.96 122.09 43.88 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 123.425 0.69 . . . . 0.0 110.234 -176.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -138.73 139.74 38.46 Favored 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 123.04 0.536 . . . . 0.0 111.66 178.035 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -83.12 118.04 23.29 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 123.084 0.554 . . . . 0.0 111.412 178.536 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 46.5 mm -119.01 105.72 18.09 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 N-CA-C 105.287 -2.116 . . . . 0.0 105.287 174.277 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 58.61 49.29 10.58 Favored 'General case' 0 N--CA 1.5 2.037 0 N-CA-C 115.316 1.599 . . . . 0.0 115.316 175.641 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 65.75 26.78 72.21 Favored Glycine 0 CA--C 1.555 2.575 0 N-CA-C 119.142 2.417 . . . . 0.0 119.142 -170.291 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -134.08 125.46 28.06 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-N 119.017 1.409 . . . . 0.0 108.457 -173.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 16.7 tp -77.64 110.05 12.14 Favored 'General case' 0 CA--C 1.558 1.28 0 C-N-CA 123.361 0.665 . . . . 0.0 110.381 179.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 30.7 mm -97.92 101.89 12.75 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 N-CA-C 106.544 -1.651 . . . . 0.0 106.544 -176.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 29.4 tp -92.7 99.49 12.17 Favored 'General case' 0 N--CA 1.486 1.359 0 CA-C-O 121.812 0.815 . . . . 0.0 109.258 178.052 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 87.1 m -93.87 105.84 17.84 Favored 'General case' 0 CA--C 1.56 1.361 0 CA-C-N 114.884 -1.053 . . . . 0.0 108.26 -178.007 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 83.5 mt -97.12 100.69 12.17 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 123.816 0.846 . . . . 0.0 109.13 -174.193 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 7.1 m -100.63 119.58 38.77 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.71 -0.619 . . . . 0.0 109.751 -170.636 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 74.7 t60 -151.7 114.63 4.69 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 122.475 0.31 . . . . 0.0 110.376 171.24 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 52.54 71.44 0.68 Allowed Glycine 0 N--CA 1.488 2.146 0 N-CA-C 117.745 1.858 . . . . 0.0 117.745 162.053 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . 0.506 2.7 t 66.58 -44.32 0.43 Allowed 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 117.676 2.472 . . . . 0.0 117.676 -166.729 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -86.39 94.35 9.36 Favored 'General case' 0 N--CA 1.483 1.191 0 CA-C-N 119.563 1.074 . . . . 0.0 112.405 -177.288 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 6.4 p -98.11 128.61 49.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 C-N-CA 123.825 0.85 . . . . 0.0 109.803 174.521 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 42.7 t -109.45 107.48 17.64 Favored 'General case' 0 CA--C 1.553 1.068 0 C-N-CA 123.035 0.534 . . . . 0.0 112.125 -179.206 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 89.0 m -86.19 112.1 21.02 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 176.184 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 71.1 mtp180 -113.25 114.18 26.35 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 -174.107 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 85.5 m -86.72 133.54 33.66 Favored 'General case' 0 N--CA 1.495 1.782 0 C-N-CA 123.288 0.635 . . . . 0.0 110.106 177.37 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 48.4 m-85 -129.77 125.52 36.0 Favored 'General case' 0 CA--C 1.558 1.264 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 179.245 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -93.23 154.55 17.96 Favored 'General case' 0 N--CA 1.493 1.724 0 CA-C-O 122.481 1.134 . . . . 0.0 111.783 171.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 72.5 tttt -84.88 129.11 34.86 Favored 'General case' 0 N--CA 1.485 1.278 0 CA-C-N 115.04 -0.982 . . . . 0.0 112.534 -167.319 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 14.6 mm-40 -111.52 50.97 0.8 Allowed 'General case' 0 CA--C 1.567 1.597 0 C-N-CA 124.125 0.97 . . . . 0.0 111.572 175.709 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.967 0 CA-C-O 124.28 1.991 . . . . 0.0 108.121 -171.257 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.266 8.0 p . . . . . 0 CA--C 1.577 2.016 0 N-CA-C 116.127 1.899 . . . . 0.0 116.127 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -69.8 -38.99 76.84 Favored 'General case' 0 N--CA 1.497 1.891 0 N-CA-C 116.385 1.995 . . . . 0.0 116.385 -177.625 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -59.08 -27.88 65.95 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 117.513 2.412 . . . . 0.0 117.513 168.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -68.6 -24.87 64.63 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 116.29 1.959 . . . . 0.0 116.29 169.008 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 34.6 mt -78.7 115.44 18.4 Favored 'General case' 0 N--CA 1.489 1.521 0 CA-C-N 121.09 1.768 . . . . 0.0 111.29 -167.297 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 161.1 172.58 28.63 Favored Glycine 0 CA--C 1.543 1.79 0 CA-C-O 122.467 1.037 . . . . 0.0 113.454 -172.321 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 81.7 m -85.11 141.62 30.09 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-N 114.739 -0.731 . . . . 0.0 109.733 168.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 80.4 m95 -141.88 112.79 7.36 Favored 'General case' 0 N--CA 1.484 1.235 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 -174.516 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 9.0 mtpm? -96.22 147.33 23.88 Favored 'General case' 0 N--CA 1.495 1.802 0 C-N-CA 122.771 0.429 . . . . 0.0 110.209 174.369 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 57.9 tp -69.5 120.89 15.99 Favored 'General case' 0 N--CA 1.491 1.617 0 CA-C-O 121.864 0.84 . . . . 0.0 111.51 179.663 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . 0.271 1.2 t -98.85 -43.47 11.65 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.82 0 CA-C-N 114.194 -1.366 . . . . 0.0 112.588 -179.565 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -146.35 139.71 25.85 Favored 'General case' 0 N--CA 1.49 1.543 0 CA-C-N 119.652 1.114 . . . . 0.0 109.179 -179.468 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 89.2 p -128.91 100.27 5.61 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.933 -0.479 . . . . 0.0 110.939 175.47 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 59.3 mtpt -86.88 127.96 35.05 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 123.149 0.58 . . . . 0.0 109.612 173.124 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 58.5 m-20 66.79 22.59 10.25 Favored 'General case' 0 N--CA 1.504 2.235 0 N-CA-C 118.082 2.623 . . . . 0.0 118.082 173.732 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 23.6 t80 -67.24 -45.33 77.08 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 120.215 -1.553 . . . . 0.0 115.083 -178.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 85.8 m-20 -62.13 -27.0 68.63 Favored 'General case' 0 CA--C 1.572 1.811 0 N-CA-C 116.613 2.079 . . . . 0.0 116.613 171.443 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -69.05 -49.91 53.24 Favored 'General case' 0 N--CA 1.497 1.914 0 CA-C-N 120.275 1.398 . . . . 0.0 114.36 166.381 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 87.8 t80 -51.43 -50.3 59.99 Favored 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 115.397 1.628 . . . . 0.0 115.397 169.139 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 16.7 mmm -57.98 -46.55 84.98 Favored 'General case' 0 CA--C 1.566 1.595 0 N-CA-C 114.647 1.351 . . . . 0.0 114.647 172.424 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.2 tmtp? -57.35 -48.41 79.08 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 115.408 1.633 . . . . 0.0 115.408 170.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 83.5 p -59.63 -36.33 76.14 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 117.151 2.278 . . . . 0.0 117.151 174.148 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 34.4 mt -66.46 -33.62 76.09 Favored 'General case' 0 CA--C 1.566 1.562 0 N-CA-C 116.945 2.202 . . . . 0.0 116.945 167.375 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 108.5 72.36 0.75 Allowed Glycine 0 N--CA 1.482 1.742 0 CA-C-N 118.878 0.763 . . . . 0.0 111.788 -173.133 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 43.0 t -141.78 130.46 22.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 N-CA-C 106.808 -1.552 . . . . 0.0 106.808 -176.232 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -72.53 173.2 47.15 Favored Glycine 0 CA--C 1.549 2.16 0 N-CA-C 116.791 1.476 . . . . 0.0 116.791 -179.599 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 38.9 p90 -66.7 -39.58 88.14 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 117.599 2.444 . . . . 0.0 117.599 -175.385 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.15 -43.95 96.88 Favored 'General case' 0 CA--C 1.561 1.397 0 N-CA-C 115.803 1.779 . . . . 0.0 115.803 179.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.1 t -78.02 -21.54 50.59 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 115.835 1.791 . . . . 0.0 115.835 171.53 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 62.3 mtm180 -58.72 -42.81 89.57 Favored 'General case' 0 N--CA 1.495 1.824 0 CA-C-N 120.915 1.689 . . . . 0.0 114.524 162.64 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -63.13 -56.49 16.38 Favored 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 114.304 1.224 . . . . 0.0 114.304 168.166 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 47.9 t -62.81 -40.89 90.42 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 N-CA-C 113.883 1.068 . . . . 0.0 113.883 -178.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -70.68 -32.49 69.76 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 116.724 2.12 . . . . 0.0 116.724 175.453 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 94.6 p -65.93 -45.28 82.45 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 115.666 1.728 . . . . 0.0 115.666 170.173 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 3.5 ppp? -63.44 -28.29 69.87 Favored 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 116.923 2.194 . . . . 0.0 116.923 167.259 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 97.2 m -70.95 138.91 50.43 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 124.11 0.964 . . . . 0.0 110.83 172.188 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.76 102.43 11.69 Favored Pre-proline 0 CA--C 1.57 1.715 0 CA-C-O 118.023 -0.989 . . . . 0.0 109.32 166.683 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -80.77 95.75 0.98 Allowed 'Trans proline' 0 C--N 1.371 1.744 0 C-N-CA 122.817 2.345 . . . . 0.0 111.135 -176.614 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 99.4 m -81.32 111.45 17.72 Favored 'General case' 0 N--CA 1.489 1.48 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.452 -159.654 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 87.4 m -87.14 116.23 25.07 Favored 'General case' 0 CA--C 1.56 1.338 0 C-N-CA 123.916 0.886 . . . . 0.0 109.233 -175.32 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 79.6 mt -112.33 110.41 32.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 N-CA-C 106.224 -1.769 . . . . 0.0 106.224 177.341 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 22.6 mt -100.95 119.03 48.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 -176.39 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -137.55 108.05 6.54 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 -169.595 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 83.8 tttt -85.55 121.95 28.98 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 123.385 0.674 . . . . 0.0 111.175 179.795 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 19.0 m120 -89.25 -69.15 0.73 Allowed 'General case' 0 N--CA 1.49 1.575 0 C-N-CA 123.654 0.782 . . . . 0.0 110.543 177.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -151.58 76.56 0.23 Allowed Glycine 0 N--CA 1.484 1.868 0 N-CA-C 110.116 -1.194 . . . . 0.0 110.116 169.309 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . 0.336 2.1 t70 70.99 -23.96 0.17 Allowed 'General case' 0 N--CA 1.499 2.006 0 N-CA-C 116.805 2.15 . . . . 0.0 116.805 -160.417 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 21.2 mm -75.34 106.6 5.24 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.561 0 C-N-CA 124.536 1.134 . . . . 0.0 108.05 173.198 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 26.4 mt -92.45 113.77 26.13 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 123.878 0.871 . . . . 0.0 109.66 -179.459 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 57.1 m -97.79 97.45 8.99 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 106.836 -1.542 . . . . 0.0 106.836 -177.712 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 9.4 tt -100.5 98.74 9.31 Favored 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 -177.302 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -93.66 115.57 28.03 Favored 'General case' 0 N--CA 1.484 1.26 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 -174.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 28.9 m -100.89 103.42 14.59 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 -179.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 21.1 m-70 -90.53 105.25 17.69 Favored 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 123.479 0.712 . . . . 0.0 109.444 -170.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 5.9 m . . . . . 0 N--CA 1.491 1.588 0 CA-C-O 121.234 0.54 . . . . 0.0 112.125 -164.524 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 17.4 t30 . . . . . 0 N--CA 1.484 1.257 0 N-CA-C 108.69 -0.855 . . . . 0.0 108.69 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 81.9 p -131.83 126.84 35.3 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 -164.537 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -109.66 120.27 41.96 Favored 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 177.659 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 43.0 pt -110.94 128.45 67.35 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 177.079 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 35.9 t -118.05 95.7 5.02 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 107.791 -1.189 . . . . 0.0 107.791 -175.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 45.1 p90 -130.71 142.25 50.42 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 114.241 1.201 . . . . 0.0 114.241 -156.645 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 29.6 mtpp -100.15 146.43 26.84 Favored 'General case' 0 N--CA 1.488 1.444 0 CA-C-N 115.218 -0.901 . . . . 0.0 109.126 165.608 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -73.44 116.89 14.54 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.433 -0.792 . . . . 0.0 112.106 -172.217 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 80.88 43.41 8.94 Favored Glycine 0 CA--C 1.549 2.186 0 N-CA-C 116.535 1.374 . . . . 0.0 116.535 -166.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 93.1 t -138.6 122.56 20.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 N-CA-C 106.469 -1.678 . . . . 0.0 106.469 177.603 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -85.64 133.34 34.04 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 123.634 0.773 . . . . 0.0 111.285 179.07 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -141.22 149.78 41.83 Favored 'General case' 0 N--CA 1.493 1.695 0 CA-C-O 121.764 0.793 . . . . 0.0 111.443 -173.784 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -74.24 136.08 42.71 Favored 'General case' 0 CA--C 1.565 1.542 0 O-C-N 121.387 -0.82 . . . . 0.0 112.866 172.195 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 32.1 tp10 -145.34 139.15 26.81 Favored 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 123.186 0.594 . . . . 0.0 110.018 -178.152 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 56.0 m -100.54 123.71 45.12 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 177.519 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 29.4 p -85.18 -179.69 7.06 Favored 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 113.432 0.901 . . . . 0.0 113.432 -174.746 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -54.38 -38.99 66.79 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 117.266 2.321 . . . . 0.0 117.266 167.683 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -83.54 13.32 4.64 Favored 'General case' 0 CA--C 1.578 2.035 0 N-CA-C 115.615 1.709 . . . . 0.0 115.615 170.704 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . 0.255 8.7 t70 58.33 72.51 0.52 Allowed 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 125.443 1.497 . . . . 0.0 113.446 -174.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 44.2 mtm180 -132.87 124.96 28.9 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 -174.011 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.6 106.89 8.52 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 123.096 0.558 . . . . 0.0 111.648 174.136 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 18.2 m -118.36 134.01 63.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 C-N-CA 122.996 0.518 . . . . 0.0 109.74 -169.131 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 31.5 mmtp -82.84 104.01 12.75 Favored 'General case' 0 N--CA 1.488 1.456 0 CA-C-O 121.92 0.867 . . . . 0.0 109.451 176.215 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 43.3 t -106.27 99.04 8.65 Favored 'General case' 0 CA--C 1.553 1.083 0 CA-C-N 114.68 -1.146 . . . . 0.0 110.044 -161.299 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 7.4 tp -110.61 116.82 53.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 C-N-CA 124.229 1.012 . . . . 0.0 108.631 -177.05 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -134.89 120.06 29.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 C-N-CA 123.612 0.765 . . . . 0.0 109.279 -174.062 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 10.5 t -129.4 157.96 40.5 Favored 'General case' 0 N--CA 1.493 1.676 0 CA-C-O 122.473 1.13 . . . . 0.0 112.223 178.241 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 61.1 tp -84.18 127.28 33.83 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-N 114.805 -1.088 . . . . 0.0 110.577 174.365 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -131.44 85.13 2.23 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 123.905 0.882 . . . . 0.0 109.249 -176.179 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 55.54 44.36 85.73 Favored Glycine 0 N--CA 1.493 2.447 0 N-CA-C 118.658 2.223 . . . . 0.0 118.658 -179.381 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 82.41 16.92 70.08 Favored Glycine 0 CA--C 1.557 2.66 0 N-CA-C 118.627 2.211 . . . . 0.0 118.627 -167.542 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 53.8 mtpt -129.55 119.82 24.31 Favored 'General case' 0 N--CA 1.487 1.39 0 CA-C-N 119.064 1.432 . . . . 0.0 107.691 177.104 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 3.1 mp -82.3 107.9 15.33 Favored 'General case' 0 N--CA 1.485 1.294 0 CA-C-O 122.071 0.939 . . . . 0.0 109.369 169.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 70.4 t -99.47 102.19 13.09 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.333 0 N-CA-C 105.16 -2.163 . . . . 0.0 105.16 -174.621 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 20.8 t-160 -107.35 131.81 53.83 Favored 'General case' 0 N--CA 1.484 1.226 0 CA-C-N 114.486 -1.233 . . . . 0.0 108.613 -175.546 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 35.6 tp -131.01 121.3 24.81 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 177.556 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 90.7 mt-30 -111.5 113.43 25.85 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 175.567 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 10.7 ptpp? -118.78 140.36 50.08 Favored 'General case' 0 N--CA 1.494 1.749 0 C-N-CA 123.25 0.62 . . . . 0.0 112.052 -176.336 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 30.5 p90 -153.61 110.81 3.45 Favored 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 123.15 0.58 . . . . 0.0 109.813 -175.68 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . 0.339 8.8 t70 66.84 -101.5 0.07 Allowed 'General case' 0 N--CA 1.494 1.734 0 C-N-CA 124.602 1.161 . . . . 0.0 112.63 172.833 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -124.43 50.27 0.87 Allowed Glycine 0 N--CA 1.488 2.155 0 CA-C-N 118.941 0.791 . . . . 0.0 114.482 164.713 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 52.3 mt-30 -153.42 124.85 7.59 Favored 'General case' 0 N--CA 1.485 1.289 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 -178.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -136.46 133.47 36.64 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.859 -0.525 . . . . 0.0 111.453 176.23 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 6.4 t -120.06 129.48 54.24 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 123.379 0.672 . . . . 0.0 110.718 175.462 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 41.0 p -95.71 133.88 39.28 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-O 121.528 0.68 . . . . 0.0 111.052 173.515 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 5.6 mp -111.68 74.01 0.85 Allowed 'General case' 0 CA--C 1.564 1.519 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 178.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 59.2 t -83.17 109.42 16.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 121.126 -0.984 . . . . 0.0 108.507 -167.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 76.6 mtt85 -101.32 120.72 40.69 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 123.269 0.628 . . . . 0.0 109.905 -174.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -141.72 127.46 19.19 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 122.872 0.469 . . . . 0.0 110.754 -169.52 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -79.23 114.85 18.5 Favored 'General case' 0 N--CA 1.487 1.418 0 CA-C-O 121.359 0.6 . . . . 0.0 111.331 -179.272 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 47.5 mm -121.4 106.39 18.21 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.338 0 N-CA-C 105.026 -2.213 . . . . 0.0 105.026 177.24 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 58.73 50.14 9.19 Favored 'General case' 0 N--CA 1.5 2.029 0 N-CA-C 115.064 1.505 . . . . 0.0 115.064 175.232 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 67.07 18.99 69.6 Favored Glycine 0 CA--C 1.555 2.577 0 N-CA-C 119.668 2.627 . . . . 0.0 119.668 -171.16 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 89.6 mttt -132.68 129.72 39.17 Favored 'General case' 0 N--CA 1.488 1.463 0 CA-C-N 119.63 1.715 . . . . 0.0 109.294 -174.387 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 18.2 tp -77.72 110.22 12.39 Favored 'General case' 0 CA--C 1.557 1.231 0 C-N-CA 123.98 0.912 . . . . 0.0 110.298 -179.523 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 30.5 mm -96.55 101.63 12.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 N-CA-C 106.748 -1.575 . . . . 0.0 106.748 -177.452 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 29.9 tp -88.99 101.36 14.01 Favored 'General case' 0 CA--C 1.559 1.307 0 C-N-CA 123.754 0.821 . . . . 0.0 109.361 176.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 87.4 m -95.61 105.94 17.97 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 -175.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 86.8 mt -99.3 98.77 9.69 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 123.588 0.755 . . . . 0.0 109.896 -171.302 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 6.7 m -113.6 115.8 28.5 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 -174.138 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 58.6 t60 -103.19 -87.46 0.42 Allowed 'General case' 0 N--CA 1.491 1.6 0 CA-C-O 118.5 -0.762 . . . . 0.0 108.986 170.411 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -106.64 -106.73 3.14 Favored Glycine 0 N--CA 1.484 1.869 0 CA-C-N 119.201 0.909 . . . . 0.0 111.09 179.359 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 13.8 t -100.79 49.24 0.89 Allowed 'General case' 0 N--CA 1.498 1.937 0 N-CA-C 113.346 0.869 . . . . 0.0 113.346 174.04 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -158.39 93.71 1.23 Allowed 'General case' 0 N--CA 1.483 1.223 0 O-C-N 121.206 -0.934 . . . . 0.0 108.648 175.398 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 4.2 p -91.47 121.26 41.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 C-N-CA 123.352 0.661 . . . . 0.0 109.753 175.36 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 45.7 t -101.44 100.03 10.43 Favored 'General case' 0 CA--C 1.553 1.081 0 CA-C-O 121.556 0.693 . . . . 0.0 111.214 175.424 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 63.0 m -86.14 111.06 20.0 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 179.433 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 32.8 mtm180 -114.99 118.33 33.13 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 122.992 0.517 . . . . 0.0 110.331 -172.104 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 93.3 m -86.79 132.87 33.72 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 123.433 0.693 . . . . 0.0 110.304 177.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 38.0 m-85 -127.47 127.05 43.41 Favored 'General case' 0 CA--C 1.559 1.296 0 C-N-CA 123.648 0.779 . . . . 0.0 109.253 178.321 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -90.83 151.15 21.27 Favored 'General case' 0 N--CA 1.487 1.404 0 CA-C-O 121.788 0.804 . . . . 0.0 111.889 173.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 67.3 tttt -80.68 119.29 23.1 Favored 'General case' 0 N--CA 1.486 1.335 0 CA-C-O 121.563 0.697 . . . . 0.0 111.655 -174.585 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 18.1 mm-40 -119.89 50.33 1.29 Allowed 'General case' 0 CA--C 1.564 1.512 0 C-N-CA 124.422 1.089 . . . . 0.0 111.306 -171.077 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.897 0 CA-C-O 124.654 2.168 . . . . 0.0 109.946 -160.521 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 71.4 t . . . . . 0 CA--C 1.56 1.337 0 N-CA-C 106.201 -1.777 . . . . 0.0 106.201 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -140.49 -55.44 0.52 Allowed 'General case' 0 N--CA 1.494 1.746 0 C-N-CA 124.021 0.928 . . . . 0.0 111.051 -174.31 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -57.39 -29.99 64.54 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 116.914 2.19 . . . . 0.0 116.914 160.662 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -60.82 -18.89 58.2 Favored 'General case' 0 CA--C 1.571 1.76 0 N-CA-C 117.813 2.523 . . . . 0.0 117.813 163.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 82.4 mt -84.2 125.94 32.67 Favored 'General case' 0 N--CA 1.489 1.513 0 CA-C-N 121.329 1.877 . . . . 0.0 111.77 -169.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 153.92 176.3 26.14 Favored Glycine 0 CA--C 1.542 1.728 0 CA-C-O 122.602 1.112 . . . . 0.0 113.317 -173.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 71.4 m -84.75 140.17 31.44 Favored 'General case' 0 N--CA 1.49 1.564 0 CA-C-N 114.679 -0.76 . . . . 0.0 109.262 165.063 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 85.8 m95 -141.85 113.23 7.64 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 -174.292 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 6.3 mtpm? -102.03 145.48 29.25 Favored 'General case' 0 N--CA 1.494 1.75 0 CA-C-O 121.034 0.445 . . . . 0.0 110.017 178.558 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 17.5 tp -65.95 127.06 30.56 Favored 'General case' 0 N--CA 1.491 1.59 0 CA-C-O 122.349 1.071 . . . . 0.0 112.495 -175.59 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . 0.283 1.0 OUTLIER -104.51 -46.65 9.68 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.897 0 CA-C-N 113.845 -1.525 . . . . 0.0 111.448 177.288 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -137.36 140.34 41.36 Favored 'General case' 0 N--CA 1.49 1.542 0 CA-C-N 119.994 1.27 . . . . 0.0 109.848 177.31 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 71.8 p -131.37 118.05 19.75 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 123.462 0.705 . . . . 0.0 109.532 169.246 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 30.6 mtpp -88.05 -87.14 0.16 Allowed 'General case' 0 N--CA 1.491 1.625 0 CA-C-O 119.14 -0.457 . . . . 0.0 111.335 -172.621 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 65.0 m-80 -95.12 49.58 1.22 Allowed 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 113.503 0.927 . . . . 0.0 113.503 -175.594 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 23.7 t80 -77.25 -54.48 6.43 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.6 -1.313 . . . . 0.0 113.462 -173.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -51.19 -35.64 37.31 Favored 'General case' 0 N--CA 1.499 2.014 0 N-CA-C 116.722 2.119 . . . . 0.0 116.722 166.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 35.4 t0 -63.11 -55.71 23.02 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 114.179 1.178 . . . . 0.0 114.179 168.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 85.7 t80 -49.99 -47.21 53.01 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 116.403 2.001 . . . . 0.0 116.403 169.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 26.0 mmm -62.47 -45.58 92.38 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 114.771 1.397 . . . . 0.0 114.771 177.033 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 42.0 tptt -64.16 -38.8 92.36 Favored 'General case' 0 CA--C 1.566 1.585 0 N-CA-C 115.787 1.773 . . . . 0.0 115.787 171.101 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 65.6 m -58.38 -40.41 82.27 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 115.937 1.828 . . . . 0.0 115.937 168.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 77.2 mt -61.96 -37.34 84.39 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 116.694 2.109 . . . . 0.0 116.694 166.662 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 112.08 69.77 0.56 Allowed Glycine 0 N--CA 1.481 1.681 0 C-N-CA 124.055 0.836 . . . . 0.0 111.875 -173.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 37.3 t -140.83 117.45 7.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 N-CA-C 105.006 -2.22 . . . . 0.0 105.006 -177.145 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -68.33 -80.61 0.22 Allowed Glycine 0 N--CA 1.485 1.963 0 N-CA-C 117.078 1.591 . . . . 0.0 117.078 -166.472 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . 0.262 46.2 p90 -149.05 -50.37 0.15 Allowed 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 114.543 1.312 . . . . 0.0 114.543 -175.565 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.66 -39.84 91.8 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 116.511 2.041 . . . . 0.0 116.511 -178.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 60.0 m -79.32 -36.81 38.95 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 113.635 0.976 . . . . 0.0 113.635 170.255 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 33.4 ttp85 -61.1 -44.2 97.73 Favored 'General case' 0 CA--C 1.566 1.591 0 N-CA-C 115.543 1.683 . . . . 0.0 115.543 174.565 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 39.1 mt-30 -79.6 -40.42 29.39 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 115.026 1.491 . . . . 0.0 115.026 177.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 47.1 t -74.48 -37.72 44.86 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 CA-C-N 120.503 1.501 . . . . 0.0 112.524 179.305 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -66.99 -34.36 77.57 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 116.612 2.078 . . . . 0.0 116.612 172.074 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 92.0 p -65.18 -44.72 87.52 Favored 'General case' 0 N--CA 1.493 1.725 0 N-CA-C 115.783 1.772 . . . . 0.0 115.783 167.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 44.6 ttm -62.0 -36.97 83.09 Favored 'General case' 0 CA--C 1.571 1.765 0 N-CA-C 116.141 1.904 . . . . 0.0 116.141 168.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 52.4 m -68.26 151.93 46.21 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 124.455 1.102 . . . . 0.0 112.523 176.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 4.2 ttmp? -104.09 97.47 11.54 Favored Pre-proline 0 CA--C 1.574 1.896 0 CA-C-N 115.173 -0.921 . . . . 0.0 109.674 176.378 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -75.57 145.72 29.87 Favored 'Trans proline' 0 CA--C 1.561 1.839 0 C-N-CA 123.697 2.931 . . . . 0.0 113.444 178.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 98.8 m -117.34 97.4 5.88 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 -171.003 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 90.9 m -79.48 117.41 20.41 Favored 'General case' 0 N--CA 1.492 1.664 0 C-N-CA 123.77 0.828 . . . . 0.0 110.037 178.687 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 62.3 mt -119.02 111.79 34.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 N-CA-C 106.324 -1.732 . . . . 0.0 106.324 -174.382 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 17.8 mt -110.79 116.81 53.45 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 -173.013 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -127.36 123.67 36.79 Favored 'General case' 0 N--CA 1.494 1.769 0 C-N-CA 123.485 0.714 . . . . 0.0 109.841 179.721 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 82.1 tttt -97.5 120.53 38.05 Favored 'General case' 0 CA--C 1.557 1.217 0 C-N-CA 123.649 0.78 . . . . 0.0 110.335 177.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 -83.61 -81.03 0.17 Allowed 'General case' 0 N--CA 1.49 1.545 0 CA-C-O 118.793 -0.622 . . . . 0.0 110.125 178.242 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -99.94 -87.2 1.94 Allowed Glycine 0 N--CA 1.486 2.013 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 166.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -119.15 55.84 0.93 Allowed 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 153.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 15.0 mm -128.94 104.91 12.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 N-CA-C 104.888 -2.264 . . . . 0.0 104.888 -176.127 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 36.0 mt -95.29 107.41 19.52 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 123.048 0.539 . . . . 0.0 111.24 -170.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 31.5 m -92.72 94.02 8.77 Favored 'General case' 0 CA--C 1.559 1.302 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 -176.561 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 10.4 tt -98.24 102.25 13.94 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 -176.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 50.7 mttp -102.47 106.37 17.09 Favored 'General case' 0 N--CA 1.486 1.341 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 -174.505 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 59.3 m -92.23 97.22 10.76 Favored 'General case' 0 N--CA 1.493 1.675 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 178.736 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 22.4 m170 -91.76 94.76 9.51 Favored 'General case' 0 N--CA 1.488 1.458 0 CA-C-O 121.909 0.862 . . . . 0.0 110.089 -174.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 27.9 t . . . . . 0 N--CA 1.484 1.265 0 CA-C-N 115.041 -0.981 . . . . 0.0 109.879 173.503 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 43.7 m-20 . . . . . 0 N--CA 1.492 1.643 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 61.9 p -126.45 131.36 51.69 Favored 'General case' 0 N--CA 1.496 1.869 0 C-N-CA 123.063 0.545 . . . . 0.0 110.069 -176.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -128.75 123.67 33.56 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 123.512 0.725 . . . . 0.0 109.556 -172.642 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 41.8 pt -118.65 134.2 63.04 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 C-N-CA 123.709 0.804 . . . . 0.0 108.976 174.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 67.2 p -119.73 104.38 10.19 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 178.478 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 53.0 p90 -132.27 141.15 48.88 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 115.204 1.557 . . . . 0.0 115.204 -159.404 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 62.4 mtpt -94.51 143.17 26.65 Favored 'General case' 0 CA--C 1.562 1.408 0 CA-C-N 114.378 -1.283 . . . . 0.0 109.761 166.197 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -77.91 120.57 22.97 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.851 -0.53 . . . . 0.0 111.606 -175.402 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 83.03 43.48 7.56 Favored Glycine 0 CA--C 1.549 2.19 0 N-CA-C 116.5 1.36 . . . . 0.0 116.5 -169.512 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 94.2 t -140.69 123.68 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 N-CA-C 106.458 -1.682 . . . . 0.0 106.458 -178.523 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -86.32 130.16 34.61 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 123.227 0.611 . . . . 0.0 110.872 171.654 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 45.3 p90 -144.23 128.9 18.21 Favored 'General case' 0 N--CA 1.492 1.656 0 C-N-CA 123.619 0.767 . . . . 0.0 109.744 -175.341 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -72.48 111.65 7.85 Favored 'General case' 0 CA--C 1.564 1.493 0 O-C-N 121.327 -0.858 . . . . 0.0 112.657 177.198 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 13.4 tp10 -113.64 132.92 55.59 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 124.29 1.036 . . . . 0.0 109.537 -171.591 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 57.1 m -92.86 122.62 35.42 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 176.532 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 24.1 p -85.9 172.26 10.86 Favored 'General case' 0 N--CA 1.495 1.808 0 CA-C-O 121.588 0.709 . . . . 0.0 112.403 -176.296 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -58.41 -35.17 71.65 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 117.306 2.336 . . . . 0.0 117.306 167.451 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -77.57 12.74 1.49 Allowed 'General case' 0 CA--C 1.581 2.157 0 N-CA-C 115.981 1.845 . . . . 0.0 115.981 167.399 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 10.4 t70 58.08 71.93 0.55 Allowed 'General case' 0 N--CA 1.492 1.643 0 C-N-CA 125.545 1.538 . . . . 0.0 113.483 -176.723 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 80.5 mtm180 -136.82 121.64 18.7 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 -176.271 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.55 99.32 5.68 Favored 'General case' 0 CA--C 1.563 1.452 0 C-N-CA 123.179 0.592 . . . . 0.0 111.042 170.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 10.7 m -113.51 128.05 70.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 -170.104 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 72.0 mmtt -77.72 99.41 5.84 Favored 'General case' 0 N--CA 1.488 1.474 0 CA-C-O 121.674 0.749 . . . . 0.0 110.04 177.139 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 47.6 m -93.36 93.22 8.06 Favored 'General case' 0 N--CA 1.48 1.056 0 CA-C-N 115.009 -0.996 . . . . 0.0 110.501 -169.415 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 6.0 tp -101.97 103.26 14.7 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 175.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.0 p -121.96 125.0 72.56 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.364 0 CA-C-N 115.307 -0.861 . . . . 0.0 109.209 -174.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 15.3 t -135.53 156.52 48.75 Favored 'General case' 0 N--CA 1.489 1.482 0 CA-C-O 122.921 1.343 . . . . 0.0 111.21 178.717 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 63.7 tp -89.52 108.36 19.61 Favored 'General case' 0 N--CA 1.486 1.368 0 CA-C-N 114.173 -1.376 . . . . 0.0 108.899 171.122 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -109.6 87.01 2.4 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 123.45 0.7 . . . . 0.0 109.993 -173.7 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 61.3 48.93 82.68 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 117.623 1.809 . . . . 0.0 117.623 -178.63 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 73.46 27.54 67.49 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 118.915 2.326 . . . . 0.0 118.915 -169.297 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -143.88 112.46 6.52 Favored 'General case' 0 CA--C 1.553 1.063 0 N-CA-C 107.134 -1.432 . . . . 0.0 107.134 -174.685 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 4.7 tt -86.61 102.88 14.58 Favored 'General case' 0 CA--C 1.561 1.376 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 -172.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 77.7 t -104.35 108.05 23.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 -171.578 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 21.8 t-160 -105.97 109.18 21.05 Favored 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 123.378 0.671 . . . . 0.0 109.954 177.013 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 38.0 tp -102.88 121.04 41.7 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 178.24 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 31.5 mt-30 -114.13 115.88 28.22 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 83.5 mttt -113.28 135.53 53.74 Favored 'General case' 0 N--CA 1.495 1.793 0 CA-C-N 118.812 0.733 . . . . 0.0 111.103 -178.364 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 27.3 p90 -152.69 110.57 3.63 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.354 -0.841 . . . . 0.0 109.898 178.713 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 3.8 t70 53.56 50.88 16.28 Favored 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 116.392 1.997 . . . . 0.0 116.392 170.008 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 89.66 -43.46 2.99 Favored Glycine 0 CA--C 1.551 2.311 0 N-CA-C 116.685 1.434 . . . . 0.0 116.685 -169.34 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 15.0 mt-30 -80.88 124.6 29.24 Favored 'General case' 0 N--CA 1.488 1.428 0 CA-C-N 118.309 1.054 . . . . 0.0 111.318 -177.114 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -132.61 131.39 41.38 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 123.072 0.549 . . . . 0.0 111.712 178.685 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 8.8 t -118.45 133.03 56.21 Favored 'General case' 0 N--CA 1.496 1.866 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.365 176.534 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 35.8 p -102.76 132.72 48.72 Favored 'General case' 0 N--CA 1.495 1.819 0 CA-C-O 121.678 0.751 . . . . 0.0 110.85 172.602 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 5.3 mp -114.54 89.36 3.08 Favored 'General case' 0 CA--C 1.562 1.412 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 -179.448 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 97.1 t -98.49 106.05 18.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 -167.543 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 83.9 mtt85 -99.51 125.13 45.22 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 123.179 0.592 . . . . 0.0 110.402 -176.367 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -140.14 130.12 24.79 Favored 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 123.084 0.554 . . . . 0.0 111.092 -174.764 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -82.43 112.88 19.78 Favored 'General case' 0 N--CA 1.488 1.463 0 CA-C-O 121.256 0.55 . . . . 0.0 111.086 -178.557 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 82.8 mt -123.46 109.43 23.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 N-CA-C 105.052 -2.203 . . . . 0.0 105.052 179.412 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 57.87 50.18 10.85 Favored 'General case' 0 N--CA 1.499 2.012 0 N-CA-C 114.849 1.425 . . . . 0.0 114.849 177.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 62.24 24.65 65.64 Favored Glycine 0 CA--C 1.555 2.536 0 N-CA-C 119.502 2.561 . . . . 0.0 119.502 -170.699 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 91.2 mttt -132.31 131.07 41.62 Favored 'General case' 0 N--CA 1.488 1.435 0 CA-C-N 119.951 1.876 . . . . 0.0 109.534 -176.093 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 20.1 tp -77.58 110.08 12.08 Favored 'General case' 0 N--CA 1.484 1.275 0 C-N-CA 123.955 0.902 . . . . 0.0 110.144 -179.644 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 27.7 mm -99.39 95.58 4.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 N-CA-C 107.062 -1.459 . . . . 0.0 107.062 -175.047 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 17.4 tp -86.94 104.4 16.22 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 124.068 0.947 . . . . 0.0 110.098 179.542 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 84.8 m -99.66 104.16 15.89 Favored 'General case' 0 CA--C 1.561 1.392 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 -173.098 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 91.1 mt -98.52 102.43 14.17 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 123.659 0.784 . . . . 0.0 110.111 -172.497 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 9.6 m -113.44 125.9 54.74 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 -176.124 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 83.3 t60 -136.45 -98.33 0.22 Allowed 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 175.408 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -110.45 93.0 0.71 Allowed Glycine 0 N--CA 1.483 1.829 0 CA-C-N 118.816 0.734 . . . . 0.0 111.684 -169.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . 0.387 5.2 t 47.47 39.33 9.18 Favored 'General case' 0 N--CA 1.5 2.07 0 N-CA-C 117.546 2.425 . . . . 0.0 117.546 -172.097 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -157.64 93.6 1.29 Allowed 'General case' 0 N--CA 1.483 1.197 0 O-C-N 121.484 -0.76 . . . . 0.0 109.575 -174.461 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 2.8 p -92.87 112.25 25.86 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 C-N-CA 123.643 0.777 . . . . 0.0 109.288 173.141 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 41.1 t -97.5 104.34 16.36 Favored 'General case' 0 CA--C 1.551 1.017 0 CA-C-O 121.016 0.436 . . . . 0.0 110.292 175.179 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 89.2 m -90.04 100.96 13.68 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 -178.581 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 59.3 mtp180 -103.43 114.74 29.25 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 123.107 0.563 . . . . 0.0 109.749 -167.535 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 56.6 m -84.8 131.92 34.48 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 123.091 0.556 . . . . 0.0 109.954 177.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 41.0 m-85 -129.49 126.31 38.37 Favored 'General case' 0 CA--C 1.561 1.385 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 178.378 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -88.62 150.54 22.99 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 123.515 0.726 . . . . 0.0 112.127 174.68 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 71.0 tttt -81.67 118.14 22.58 Favored 'General case' 0 N--CA 1.486 1.346 0 CA-C-O 121.43 0.633 . . . . 0.0 111.577 -174.503 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 37.3 mm-40 -118.24 51.38 1.08 Allowed 'General case' 0 CA--C 1.564 1.505 0 C-N-CA 124.216 1.007 . . . . 0.0 111.31 -174.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.875 0 CA-C-O 123.105 1.431 . . . . 0.0 110.151 -161.931 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 5.7 p . . . . . 0 CA--C 1.578 2.028 0 N-CA-C 115.24 1.571 . . . . 0.0 115.24 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -78.84 -38.71 37.32 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 115.648 1.721 . . . . 0.0 115.648 -176.087 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -58.95 -24.03 62.11 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 117.649 2.463 . . . . 0.0 117.649 167.428 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -69.62 -20.19 63.62 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 116.575 2.065 . . . . 0.0 116.575 167.333 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 42.9 mt -81.17 121.99 26.82 Favored 'General case' 0 N--CA 1.488 1.475 0 CA-C-N 120.829 1.65 . . . . 0.0 111.168 -170.709 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 157.34 174.75 27.45 Favored Glycine 0 CA--C 1.541 1.703 0 CA-C-O 122.379 0.988 . . . . 0.0 113.369 -172.283 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 63.0 m -93.12 136.88 32.97 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 170.516 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 87.5 m95 -138.34 113.37 9.24 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 -171.431 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 9.4 mtmp? -97.81 143.54 28.33 Favored 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 123.247 0.619 . . . . 0.0 110.547 -179.506 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 60.0 tp -70.87 117.27 12.16 Favored 'General case' 0 N--CA 1.492 1.639 0 CA-C-O 121.856 0.836 . . . . 0.0 111.177 -177.573 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . 0.27 1.0 OUTLIER -97.48 -42.38 11.62 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.757 0 CA-C-N 114.337 -1.301 . . . . 0.0 112.725 -178.702 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -148.06 134.82 19.99 Favored 'General case' 0 N--CA 1.487 1.386 0 CA-C-N 119.677 1.126 . . . . 0.0 109.035 -177.53 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 88.8 p -121.59 100.84 7.24 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 122.976 0.51 . . . . 0.0 110.496 176.741 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 61.1 mtpt -92.77 123.02 35.75 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 176.644 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 52.1 m-20 67.22 21.66 9.9 Favored 'General case' 0 N--CA 1.503 2.204 0 N-CA-C 117.513 2.412 . . . . 0.0 117.513 176.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 17.3 t80 -71.2 -40.21 71.31 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 119.988 -1.695 . . . . 0.0 115.345 -179.273 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -60.19 -31.45 70.14 Favored 'General case' 0 CA--C 1.571 1.766 0 N-CA-C 115.935 1.828 . . . . 0.0 115.935 165.337 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 14.3 t0 -64.92 -47.25 78.4 Favored 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 114.843 1.423 . . . . 0.0 114.843 166.012 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 94.2 t80 -54.0 -51.95 62.33 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 115.104 1.52 . . . . 0.0 115.104 172.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 75.8 mtm -63.67 -34.37 77.69 Favored 'General case' 0 CA--C 1.568 1.636 0 N-CA-C 115.697 1.74 . . . . 0.0 115.697 172.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 38.4 ttmt -61.44 -47.55 85.22 Favored 'General case' 0 CA--C 1.569 1.674 0 N-CA-C 114.412 1.264 . . . . 0.0 114.412 167.506 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 60.1 m -58.67 -36.15 73.71 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 116.412 2.004 . . . . 0.0 116.412 171.617 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 33.4 mt -63.05 -43.91 97.33 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 116.178 1.918 . . . . 0.0 116.178 166.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 120.22 71.1 0.32 Allowed Glycine 0 N--CA 1.483 1.781 0 C-N-CA 123.79 0.71 . . . . 0.0 111.588 -176.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 23.9 t -142.24 120.88 8.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 N-CA-C 105.166 -2.161 . . . . 0.0 105.166 -176.452 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -78.92 -86.48 0.52 Allowed Glycine 0 N--CA 1.488 2.129 0 N-CA-C 115.859 1.104 . . . . 0.0 115.859 -169.23 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 15.2 p90 -139.36 160.3 40.15 Favored 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 123.498 0.719 . . . . 0.0 110.767 178.605 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . 0.313 . . 76.41 -50.91 0.59 Allowed 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 115.386 1.625 . . . . 0.0 115.386 177.68 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 52.8 m -64.92 -39.86 94.16 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 113.964 1.098 . . . . 0.0 113.964 167.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 38.0 mtm180 -61.34 -43.59 98.62 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 115.063 1.505 . . . . 0.0 115.063 166.073 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 7.4 tm0? -61.74 -49.09 77.8 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 115.403 1.631 . . . . 0.0 115.403 174.074 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 97.2 t -64.56 -41.11 91.32 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 CA-C-N 119.503 1.047 . . . . 0.0 113.207 177.227 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -67.72 -40.71 84.23 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 116.504 2.038 . . . . 0.0 116.504 176.251 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 95.2 p -66.79 -39.42 87.77 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 116.332 1.975 . . . . 0.0 116.332 169.549 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 54.5 tpp -64.97 -37.21 86.91 Favored 'General case' 0 CA--C 1.569 1.7 0 N-CA-C 115.992 1.849 . . . . 0.0 115.992 169.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 54.4 m -69.96 145.88 51.55 Favored 'General case' 0 CA--C 1.566 1.589 0 C-N-CA 124.047 0.939 . . . . 0.0 111.79 174.649 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -103.12 100.73 18.28 Favored Pre-proline 0 CA--C 1.57 1.742 0 CA-C-O 118.143 -0.932 . . . . 0.0 109.147 173.224 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -81.82 100.67 1.11 Allowed 'Trans proline' 0 C--N 1.371 1.727 0 C-N-CA 123.027 2.485 . . . . 0.0 111.649 -179.379 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 99.8 m -79.15 112.95 16.87 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 123.522 0.729 . . . . 0.0 110.228 -168.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 46.5 m -87.28 114.78 24.19 Favored 'General case' 0 CA--C 1.561 1.395 0 C-N-CA 123.557 0.743 . . . . 0.0 109.147 -174.137 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 98.3 mt -108.75 108.45 25.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 N-CA-C 106.356 -1.72 . . . . 0.0 106.356 176.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 18.8 mt -101.72 120.3 51.16 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 -178.718 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 6.8 tm-20 -133.24 116.48 16.25 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 -172.233 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 80.7 tttt -93.62 114.97 27.42 Favored 'General case' 0 CA--C 1.557 1.243 0 C-N-CA 123.335 0.654 . . . . 0.0 110.374 176.523 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 23.8 t30 -86.78 -70.59 0.6 Allowed 'General case' 0 N--CA 1.492 1.628 0 C-N-CA 123.043 0.537 . . . . 0.0 111.026 178.307 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -143.11 75.92 0.31 Allowed Glycine 0 N--CA 1.487 2.068 0 N-CA-C 110.522 -1.031 . . . . 0.0 110.522 170.039 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . 0.284 6.3 t70 49.43 48.21 21.51 Favored 'General case' 0 N--CA 1.497 1.924 0 N-CA-C 115.518 1.673 . . . . 0.0 115.518 -155.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 31.0 mm -134.51 99.9 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 N-CA-C 103.589 -2.745 . . . . 0.0 103.589 178.47 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 65.2 mt -88.11 101.49 13.85 Favored 'General case' 0 N--CA 1.481 1.097 0 CA-C-O 121.281 0.562 . . . . 0.0 110.039 -177.614 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 91.1 m -94.46 97.02 9.87 Favored 'General case' 0 N--CA 1.485 1.29 0 N-CA-C 106.973 -1.492 . . . . 0.0 106.973 -176.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 9.8 tt -99.22 99.56 10.55 Favored 'General case' 0 N--CA 1.484 1.246 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 -174.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -96.6 126.65 41.93 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 123.782 0.833 . . . . 0.0 109.166 -175.675 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 28.0 m -102.63 93.7 5.25 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.134 -1.062 . . . . 0.0 108.134 -175.619 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 16.8 m-70 -86.25 104.33 15.69 Favored 'General case' 0 N--CA 1.491 1.591 0 CA-C-O 121.451 0.643 . . . . 0.0 109.709 -173.03 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 23.1 t . . . . . 0 N--CA 1.483 1.183 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.274 -161.813 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 53.6 m-80 . . . . . 0 N--CA 1.491 1.582 0 CA-C-O 121.052 0.453 . . . . 0.0 110.076 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 73.9 p -98.41 132.17 44.08 Favored 'General case' 0 N--CA 1.493 1.709 0 C-N-CA 123.417 0.687 . . . . 0.0 110.603 -177.013 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -123.87 123.57 40.73 Favored 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 123.674 0.79 . . . . 0.0 109.067 -176.714 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 40.8 pt -118.74 132.01 69.86 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 174.467 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 46.1 t -120.6 111.11 17.24 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 -177.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 50.4 p90 -140.94 140.72 34.48 Favored 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 115.119 1.525 . . . . 0.0 115.119 -160.015 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 63.6 mtpt -106.25 17.62 23.2 Favored 'General case' 0 CA--C 1.573 1.852 0 N-CA-C 117.011 2.226 . . . . 0.0 117.011 -172.608 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . 0.294 0.1 OUTLIER 60.35 92.7 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.736 0 CA-C-N 120.546 1.521 . . . . 0.0 114.292 177.981 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 92.68 38.73 5.46 Favored Glycine 0 CA--C 1.551 2.295 0 N-CA-C 116.863 1.505 . . . . 0.0 116.863 -167.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 86.6 t -140.06 122.7 16.68 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 N-CA-C 106.93 -1.507 . . . . 0.0 106.93 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -87.62 133.27 33.84 Favored 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 123.299 0.64 . . . . 0.0 111.136 173.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 47.5 p90 -145.56 133.72 21.6 Favored 'General case' 0 N--CA 1.493 1.682 0 C-N-CA 123.888 0.875 . . . . 0.0 109.306 -175.082 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -76.35 142.66 41.14 Favored 'General case' 0 N--CA 1.49 1.54 0 CA-C-O 123.028 1.394 . . . . 0.0 112.117 176.211 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 15.4 tp10 -146.54 138.91 25.04 Favored 'General case' 0 N--CA 1.488 1.444 0 CA-C-N 113.18 -1.827 . . . . 0.0 110.351 -167.053 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 55.7 m -97.18 121.96 39.65 Favored 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 123.281 0.633 . . . . 0.0 109.424 177.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 25.1 p -86.39 170.54 11.9 Favored 'General case' 0 N--CA 1.495 1.815 0 CA-C-O 121.894 0.854 . . . . 0.0 113.128 -173.565 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -58.77 -34.23 71.21 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 118.627 2.825 . . . . 0.0 118.627 173.267 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.425 ' N ' ' HD2' ' A' ' 76' ' ' ASP . 1.0 OUTLIER -101.57 54.72 0.82 Allowed 'General case' 0 CA--C 1.574 1.886 0 CA-C-N 119.327 0.967 . . . . 0.0 110.847 168.038 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 15.3 t70 34.89 80.75 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 117.827 2.528 . . . . 0.0 117.827 178.015 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 60.5 mtm-85 -141.45 130.41 23.16 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 110.165 -0.309 . . . . 0.0 110.165 177.497 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.04 121.24 16.27 Favored 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 122.878 0.471 . . . . 0.0 110.493 158.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 16.3 m -137.89 132.24 43.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 -176.013 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -85.29 104.01 14.75 Favored 'General case' 0 N--CA 1.486 1.336 0 CA-C-O 121.882 0.849 . . . . 0.0 109.265 177.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 53.3 m -92.52 97.7 10.99 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 124.353 1.061 . . . . 0.0 110.946 -170.668 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 6.8 tp -107.65 118.79 56.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 175.3 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 1.5 p -136.84 132.61 47.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 C-N-CA 123.677 0.791 . . . . 0.0 109.298 -169.708 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 13.1 t -146.82 159.02 44.03 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-O 122.738 1.256 . . . . 0.0 110.545 178.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 17.5 tp -89.3 106.36 18.4 Favored 'General case' 0 CA--C 1.561 1.403 0 CA-C-N 114.81 -1.086 . . . . 0.0 108.871 173.611 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -105.43 94.09 5.03 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 123.493 0.717 . . . . 0.0 109.534 -177.472 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 60.97 49.59 76.88 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 117.506 1.762 . . . . 0.0 117.506 -178.699 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 69.59 18.96 74.31 Favored Glycine 0 CA--C 1.557 2.663 0 N-CA-C 119.158 2.423 . . . . 0.0 119.158 -168.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 38.7 mtmm -127.96 117.77 22.34 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 -178.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 4.5 tt -82.82 99.36 9.65 Favored 'General case' 0 CA--C 1.563 1.468 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 -177.051 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 55.0 t -103.61 108.49 24.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 N-CA-C 106.748 -1.575 . . . . 0.0 106.748 -169.175 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 19.9 t-160 -108.83 107.14 17.44 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 123.447 0.699 . . . . 0.0 110.054 179.201 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 42.5 tp -96.84 122.99 40.41 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 123.523 0.729 . . . . 0.0 109.262 177.201 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 30.2 mt-30 -113.88 113.88 25.48 Favored 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 107.54 -1.281 . . . . 0.0 107.54 175.521 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.59 145.0 41.14 Favored 'General case' 0 N--CA 1.493 1.725 0 C-N-CA 123.223 0.609 . . . . 0.0 111.574 178.92 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 32.9 p90 -155.55 111.03 3.03 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 123.355 0.662 . . . . 0.0 110.012 -177.454 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . 0.336 12.1 t70 69.0 -96.08 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.854 0 C-N-CA 124.438 1.095 . . . . 0.0 112.484 173.591 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -132.85 56.3 0.74 Allowed Glycine 0 CA--C 1.547 2.067 0 CA-C-N 118.424 0.557 . . . . 0.0 113.066 162.234 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 46.7 mt-30 -154.83 124.61 6.58 Favored 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 106.936 -1.505 . . . . 0.0 106.936 -174.166 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -132.52 144.25 50.3 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.886 -0.509 . . . . 0.0 112.301 178.285 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 6.2 t -130.27 126.71 37.93 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 122.815 0.446 . . . . 0.0 111.115 171.538 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 40.0 p -94.1 128.87 40.75 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 121.982 0.896 . . . . 0.0 110.577 170.487 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 5.7 mp -103.94 88.32 3.0 Favored 'General case' 0 CA--C 1.558 1.256 0 N-CA-C 106.637 -1.616 . . . . 0.0 106.637 175.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 81.0 t -93.54 97.94 7.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 N-CA-C 107.354 -1.35 . . . . 0.0 107.354 -169.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 78.4 mtt85 -91.42 127.62 36.93 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 123.367 0.667 . . . . 0.0 109.579 177.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -148.06 133.36 18.48 Favored 'General case' 0 N--CA 1.493 1.719 0 CA-C-O 120.82 0.343 . . . . 0.0 111.284 -176.078 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -79.66 114.15 18.36 Favored 'General case' 0 N--CA 1.487 1.41 0 CA-C-O 121.318 0.58 . . . . 0.0 111.442 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 90.4 mt -122.7 109.08 22.92 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 N-CA-C 104.534 -2.395 . . . . 0.0 104.534 176.189 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 23.4 m-20 59.19 48.98 9.72 Favored 'General case' 0 N--CA 1.5 2.029 0 N-CA-C 114.934 1.457 . . . . 0.0 114.934 177.608 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 62.74 24.4 66.35 Favored Glycine 0 CA--C 1.555 2.545 0 N-CA-C 119.555 2.582 . . . . 0.0 119.555 -170.306 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 59.9 mtmt -130.97 131.21 44.25 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-N 119.589 1.695 . . . . 0.0 108.863 -174.005 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 15.7 tp -77.98 107.61 10.64 Favored 'General case' 0 CA--C 1.558 1.276 0 CA-C-O 121.42 0.629 . . . . 0.0 109.676 178.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 32.7 mm -99.33 98.87 7.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 N-CA-C 106.432 -1.692 . . . . 0.0 106.432 -175.466 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 32.3 tp -88.71 103.41 15.93 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 123.976 0.91 . . . . 0.0 109.352 179.088 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 88.1 m -98.96 108.33 20.98 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 -177.169 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 67.1 mt -100.62 101.48 12.39 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 123.705 0.802 . . . . 0.0 109.436 -171.663 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 6.9 m -113.89 111.91 22.49 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 -175.57 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 70.5 t60 -102.95 -85.32 0.45 Allowed 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 173.617 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -109.56 -108.99 3.21 Favored Glycine 0 N--CA 1.484 1.872 0 N-CA-C 110.635 -0.986 . . . . 0.0 110.635 178.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 45.4 m -100.93 66.34 1.15 Allowed 'General case' 0 N--CA 1.494 1.757 0 CA-C-O 121.348 0.594 . . . . 0.0 109.593 173.408 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -172.8 96.1 0.13 Allowed 'General case' 0 N--CA 1.484 1.237 0 N-CA-C 108.123 -1.065 . . . . 0.0 108.123 173.279 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 3.7 p -94.68 122.55 46.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 C-N-CA 123.482 0.713 . . . . 0.0 109.61 174.253 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 44.4 t -108.21 102.11 11.27 Favored 'General case' 0 CA--C 1.553 1.067 0 CA-C-O 121.455 0.645 . . . . 0.0 111.356 179.384 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 90.6 m -88.12 108.0 19.04 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 179.379 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 35.9 mtm180 -111.42 120.05 40.88 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 123.044 0.538 . . . . 0.0 110.394 -172.657 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 94.8 m -86.28 131.17 34.29 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 123.343 0.657 . . . . 0.0 110.309 178.552 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 40.9 m-85 -125.84 125.48 42.93 Favored 'General case' 0 CA--C 1.56 1.354 0 C-N-CA 123.566 0.746 . . . . 0.0 109.035 176.443 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -92.72 158.34 15.97 Favored 'General case' 0 N--CA 1.495 1.816 0 CA-C-O 122.345 1.069 . . . . 0.0 111.849 170.287 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 73.5 tttt -91.16 125.97 36.1 Favored 'General case' 0 N--CA 1.484 1.256 0 CA-C-N 115.512 -0.767 . . . . 0.0 112.46 -165.447 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -97.86 46.74 1.01 Allowed 'General case' 0 N--CA 1.495 1.788 0 C-N-CA 123.853 0.861 . . . . 0.0 112.896 166.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.152 0 CA-C-O 123.168 1.461 . . . . 0.0 108.312 -174.821 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.315 8.9 t . . . . . 0 N--CA 1.491 1.585 0 CA-C-O 117.625 -1.178 . . . . 0.0 113.394 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -60.03 -37.58 80.19 Favored 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 116.274 1.953 . . . . 0.0 116.274 -178.309 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -62.78 -28.89 70.3 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 117.252 2.316 . . . . 0.0 117.252 164.169 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -73.12 -25.09 60.72 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 116.131 1.9 . . . . 0.0 116.131 168.278 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 74.4 mt -73.25 108.42 6.12 Favored 'General case' 0 N--CA 1.49 1.56 0 CA-C-N 120.747 1.612 . . . . 0.0 111.381 -173.115 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 161.34 171.59 27.56 Favored Glycine 0 CA--C 1.538 1.509 0 CA-C-O 123.254 1.474 . . . . 0.0 113.892 -175.103 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 96.8 m -84.85 144.85 28.15 Favored 'General case' 0 N--CA 1.487 1.378 0 CA-C-N 113.531 -1.334 . . . . 0.0 110.004 172.436 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 84.4 m95 -140.4 113.35 8.27 Favored 'General case' 0 N--CA 1.483 1.222 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 -175.228 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 45.3 mtmt -102.91 141.43 35.72 Favored 'General case' 0 N--CA 1.492 1.648 0 CA-C-O 121.457 0.646 . . . . 0.0 110.104 173.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 55.7 tp -69.63 130.52 42.62 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-O 122.444 1.116 . . . . 0.0 113.244 -170.492 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . 0.272 1.6 t -110.38 -41.77 4.69 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.781 0 CA-C-N 113.512 -1.676 . . . . 0.0 111.818 -172.671 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -142.14 138.94 31.97 Favored 'General case' 0 N--CA 1.492 1.633 0 CA-C-N 120.249 1.386 . . . . 0.0 109.738 175.307 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 86.6 p -124.3 102.39 7.66 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 123.416 0.686 . . . . 0.0 110.832 176.33 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -101.09 127.2 47.74 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 123.207 0.603 . . . . 0.0 109.424 174.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 66.2 m-20 67.62 22.04 9.22 Favored 'General case' 0 N--CA 1.504 2.25 0 N-CA-C 117.813 2.523 . . . . 0.0 117.813 173.452 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -72.4 -38.47 68.42 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 115.905 1.817 . . . . 0.0 115.905 -175.4 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -58.41 -30.68 67.05 Favored 'General case' 0 N--CA 1.498 1.96 0 N-CA-C 116.477 2.028 . . . . 0.0 116.477 164.708 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 13.5 t0 -66.13 -50.93 62.29 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 114.28 1.215 . . . . 0.0 114.28 169.486 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 93.7 t80 -55.17 -50.33 69.59 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 115.296 1.591 . . . . 0.0 115.296 172.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 72.7 mtm -60.53 -44.43 96.07 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 114.992 1.478 . . . . 0.0 114.992 173.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 14.5 tmtt? -57.29 -45.16 84.39 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 115.611 1.708 . . . . 0.0 115.611 168.35 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 13.8 t -59.13 -37.75 78.0 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 116.473 2.027 . . . . 0.0 116.473 173.073 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 63.6 mt -66.58 -42.28 87.24 Favored 'General case' 0 CA--C 1.564 1.514 0 N-CA-C 116.451 2.019 . . . . 0.0 116.451 170.315 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 115.13 77.27 0.71 Allowed Glycine 0 N--CA 1.482 1.718 0 N-CA-C 110.73 -0.948 . . . . 0.0 110.73 -168.309 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 62.4 t -143.04 122.64 9.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 N-CA-C 105.103 -2.184 . . . . 0.0 105.103 -177.027 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -81.58 -164.3 32.9 Favored Glycine 0 CA--C 1.548 2.127 0 N-CA-C 116.25 1.26 . . . . 0.0 116.25 -177.321 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 83.6 t80 -67.22 145.56 55.08 Favored 'General case' 0 CA--C 1.566 1.588 0 C-N-CA 123.501 0.72 . . . . 0.0 112.608 177.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . 0.377 . . 79.83 -41.11 0.22 Allowed 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 116.364 1.987 . . . . 0.0 116.364 179.395 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 56.9 m -69.36 -40.79 77.28 Favored 'General case' 0 N--CA 1.501 2.076 0 CA-C-N 120.152 1.342 . . . . 0.0 113.374 162.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 72.0 mtp180 -50.49 -42.51 54.79 Favored 'General case' 0 N--CA 1.498 1.946 0 N-CA-C 116.073 1.879 . . . . 0.0 116.073 160.022 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 81.4 mt-30 -76.41 -48.98 17.93 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 115.033 1.494 . . . . 0.0 115.033 -178.239 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 58.7 t -63.8 -43.16 97.83 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 CA-C-N 119.534 1.061 . . . . 0.0 112.922 178.004 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -65.35 -37.83 88.25 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 116.625 2.083 . . . . 0.0 116.625 174.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 90.5 p -62.46 -42.4 99.45 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 116.355 1.983 . . . . 0.0 116.355 170.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 19.2 ptp -74.23 -31.26 62.53 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 117.163 2.283 . . . . 0.0 117.163 173.172 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 65.7 m -77.96 144.31 36.89 Favored 'General case' 0 N--CA 1.491 1.577 0 CA-C-N 119.184 0.902 . . . . 0.0 111.743 -173.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 17.7 ptpt -98.25 104.97 25.86 Favored Pre-proline 0 CA--C 1.572 1.799 0 CA-C-O 118.431 -0.795 . . . . 0.0 111.591 170.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -78.06 112.98 3.34 Favored 'Trans proline' 0 CA--C 1.563 1.944 0 C-N-CA 123.056 2.504 . . . . 0.0 112.671 178.709 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 94.6 m -72.5 104.38 3.81 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 124.975 1.31 . . . . 0.0 110.1 175.563 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 29.7 m -106.65 118.26 36.21 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.844 -0.535 . . . . 0.0 110.142 -173.011 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 4.5 mp -106.71 112.95 41.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 -177.366 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 52.9 mt -99.05 119.11 46.61 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 N-CA-C 106.938 -1.504 . . . . 0.0 106.938 172.505 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -137.86 123.94 20.3 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 -178.23 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 36.8 ttpt -84.0 116.57 22.89 Favored 'General case' 0 CA--C 1.559 1.31 0 C-N-CA 123.124 0.57 . . . . 0.0 111.201 179.27 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -107.93 73.52 0.9 Allowed 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 123.6 0.76 . . . . 0.0 109.051 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 62.66 69.34 1.34 Allowed Glycine 0 N--CA 1.49 2.264 0 N-CA-C 115.312 0.885 . . . . 0.0 115.312 -173.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . 0.278 10.5 m-20 64.81 -2.99 0.61 Allowed 'General case' 0 N--CA 1.501 2.093 0 N-CA-C 118.299 2.703 . . . . 0.0 118.299 -168.629 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 42.5 mm -99.27 99.44 8.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 N-CA-C 107.105 -1.443 . . . . 0.0 107.105 -177.044 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 40.7 mt -77.55 106.99 9.69 Favored 'General case' 0 N--CA 1.488 1.429 0 CA-C-O 121.487 0.66 . . . . 0.0 111.12 178.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 34.1 m -100.75 94.54 6.13 Favored 'General case' 0 CA--C 1.559 1.319 0 N-CA-C 107.084 -1.451 . . . . 0.0 107.084 -171.128 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 8.8 tt -92.22 107.93 19.57 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 -177.484 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 52.6 mttp -107.64 93.53 4.59 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 -169.103 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 42.1 m -84.14 92.63 7.96 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.718 -0.614 . . . . 0.0 109.658 -178.283 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 28.9 m170 -88.93 121.36 31.21 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 124.005 0.922 . . . . 0.0 109.214 -179.441 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 13.6 t . . . . . 0 N--CA 1.49 1.548 0 CA-C-O 121.657 0.742 . . . . 0.0 110.876 -176.6 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 8.1 m-20 . . . . . 0 N--CA 1.493 1.699 0 N-CA-C 107.921 -1.141 . . . . 0.0 107.921 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 35.8 p -122.91 133.11 54.41 Favored 'General case' 0 N--CA 1.495 1.806 0 C-N-CA 123.357 0.663 . . . . 0.0 110.832 -176.086 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -112.82 126.14 55.12 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 124.138 0.975 . . . . 0.0 109.222 179.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 12.0 pt -122.33 129.97 74.89 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 178.201 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 85.4 p -114.39 124.0 50.87 Favored 'General case' 0 N--CA 1.493 1.701 0 C-N-CA 123.635 0.774 . . . . 0.0 110.786 -173.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 41.8 p90 -146.41 139.12 25.35 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 116.069 1.877 . . . . 0.0 116.069 -168.631 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 57.1 mtmt -106.41 24.29 12.79 Favored 'General case' 0 N--CA 1.498 1.951 0 N-CA-C 116.518 2.044 . . . . 0.0 116.518 -178.371 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . 0.275 2.4 mp 61.95 92.43 0.06 Allowed 'General case' 0 N--CA 1.496 1.867 0 CA-C-N 120.904 1.684 . . . . 0.0 115.05 170.609 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 81.97 37.17 16.54 Favored Glycine 0 CA--C 1.55 2.28 0 N-CA-C 116.984 1.553 . . . . 0.0 116.984 -169.424 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 65.4 t -139.29 117.46 12.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 N-CA-C 105.534 -2.024 . . . . 0.0 105.534 -179.432 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -78.8 124.44 28.21 Favored 'General case' 0 N--CA 1.489 1.475 0 CA-C-O 121.415 0.626 . . . . 0.0 111.155 -179.638 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 14.9 p90 -127.07 134.1 50.33 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 124.393 1.077 . . . . 0.0 110.016 -176.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -72.05 137.23 47.01 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 112.873 0.694 . . . . 0.0 112.873 177.169 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -136.94 132.57 34.59 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 122.987 0.515 . . . . 0.0 110.518 -162.649 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 61.3 m -100.0 128.57 46.07 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 166.436 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 60.4 p -81.25 174.73 11.25 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 113.748 1.018 . . . . 0.0 113.748 -170.395 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -45.06 -37.15 3.97 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 118.591 2.811 . . . . 0.0 118.591 162.122 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -130.95 91.09 2.99 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 106.547 -1.649 . . . . 0.0 106.547 166.284 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -8.05 99.77 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.098 0 N-CA-C 119.301 3.074 . . . . 0.0 119.301 -175.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 3.3 ttm180 -136.27 13.68 3.28 Favored 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 116.961 2.208 . . . . 0.0 116.961 -175.046 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . 0.318 0.0 OUTLIER 42.93 77.04 0.07 Allowed 'General case' 0 N--CA 1.498 1.963 0 N-CA-C 116.898 2.185 . . . . 0.0 116.898 172.129 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 11.0 m -117.68 144.86 24.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 C-N-CA 123.378 0.671 . . . . 0.0 110.145 -166.576 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -96.35 102.65 14.46 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 178.497 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.52 ' HG ' ' HG2' ' A' ' 95' ' ' GLN . 58.0 m -90.41 125.79 35.67 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 123.401 0.68 . . . . 0.0 112.024 -171.364 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 6.2 tp -137.7 108.89 5.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 179.296 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -118.26 131.02 72.24 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 C-N-CA 124.558 1.143 . . . . 0.0 109.183 177.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 14.6 t -135.12 154.42 51.66 Favored 'General case' 0 N--CA 1.492 1.674 0 CA-C-O 122.777 1.275 . . . . 0.0 111.848 171.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 15.6 tp -88.56 113.3 23.99 Favored 'General case' 0 N--CA 1.487 1.419 0 CA-C-N 114.339 -1.3 . . . . 0.0 110.166 177.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -115.79 81.8 1.66 Allowed 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 123.42 0.688 . . . . 0.0 109.921 -176.195 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 62.65 48.58 80.38 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 117.299 1.68 . . . . 0.0 117.299 -175.06 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 74.28 44.06 29.68 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 117.446 1.739 . . . . 0.0 117.446 -171.155 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 40.5 ttpt -154.38 108.25 2.95 Favored 'General case' 0 CA--C 1.552 1.047 0 N-CA-C 106.549 -1.649 . . . . 0.0 106.549 -172.298 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 41.4 mt -81.72 96.86 7.68 Favored 'General case' 0 N--CA 1.491 1.579 0 CA-C-O 122.625 1.202 . . . . 0.0 110.109 175.526 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 96.2 t -87.81 98.57 7.68 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.235 0 CA-C-N 113.293 -1.776 . . . . 0.0 106.32 -178.477 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 22.4 t-160 -95.27 139.34 31.73 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 123.533 0.733 . . . . 0.0 109.818 177.262 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 20.5 tp -135.73 118.7 16.34 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 106.701 -1.592 . . . . 0.0 106.701 178.356 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . 0.52 ' HG2' ' HG ' ' A' ' 82' ' ' SER . 28.7 mt-30 -114.01 125.96 54.59 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 176.229 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -139.71 128.28 23.02 Favored 'General case' 0 N--CA 1.494 1.769 0 CA-C-N 118.685 0.675 . . . . 0.0 112.743 -165.402 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 21.4 p90 -151.32 115.8 5.11 Favored 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 123.908 0.883 . . . . 0.0 110.699 -167.178 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . 0.341 18.1 t70 67.96 -93.32 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.886 0 C-N-CA 124.766 1.226 . . . . 0.0 112.883 171.146 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -135.28 52.11 0.81 Allowed Glycine 0 CA--C 1.546 2.014 0 CA-C-O 119.743 -0.476 . . . . 0.0 113.887 163.159 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 15.6 mt-30 -151.02 131.29 13.61 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 176.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -133.42 116.2 15.74 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 123.089 0.556 . . . . 0.0 110.27 179.364 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 1.8 t -110.33 124.36 51.54 Favored 'General case' 0 N--CA 1.492 1.636 0 C-N-CA 123.265 0.626 . . . . 0.0 109.988 -178.523 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 35.6 p -100.72 137.95 38.43 Favored 'General case' 0 N--CA 1.492 1.633 0 CA-C-O 121.213 0.53 . . . . 0.0 111.244 179.38 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 5.0 mp -121.4 79.5 1.55 Allowed 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 -178.292 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 46.4 t -93.2 112.42 26.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 -165.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 45.3 mtt180 -102.71 129.42 49.32 Favored 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 122.854 0.462 . . . . 0.0 110.745 -177.589 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -148.83 139.33 22.58 Favored 'General case' 0 N--CA 1.494 1.744 0 C-N-CA 123.061 0.544 . . . . 0.0 111.97 178.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -83.7 113.97 21.25 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 123.094 0.558 . . . . 0.0 111.727 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 1.7 mp -103.79 102.02 13.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 N-CA-C 104.688 -2.338 . . . . 0.0 104.688 170.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 53.75 50.41 17.07 Favored 'General case' 0 N--CA 1.499 1.987 0 N-CA-C 115.257 1.577 . . . . 0.0 115.257 176.232 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 88.55 -37.93 3.25 Favored Glycine 0 CA--C 1.552 2.396 0 N-CA-C 117.857 1.903 . . . . 0.0 117.857 -169.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 10.4 mtmp? -85.93 127.45 34.62 Favored 'General case' 0 N--CA 1.487 1.377 0 CA-C-N 119.336 1.568 . . . . 0.0 111.08 -172.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 2.6 tt -80.14 118.77 22.13 Favored 'General case' 0 CA--C 1.556 1.202 0 CA-C-O 121.823 0.821 . . . . 0.0 111.082 -179.584 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 39.2 mm -100.91 108.81 23.99 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.347 0 N-CA-C 106.324 -1.732 . . . . 0.0 106.324 -178.502 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 47.2 tp -91.19 101.53 14.26 Favored 'General case' 0 CA--C 1.56 1.363 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 173.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 58.2 m -93.8 109.13 20.82 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 -177.622 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 62.7 mt -103.72 83.87 2.2 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 123.339 0.656 . . . . 0.0 110.372 -169.59 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 8.5 m -95.97 116.59 29.17 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.617 -0.677 . . . . 0.0 109.949 -170.173 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 85.0 t60 -146.49 115.9 7.09 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 176.342 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 75.82 -109.45 2.79 Favored Glycine 0 N--CA 1.484 1.86 0 C-N-CA 122.96 0.314 . . . . 0.0 113.538 173.675 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 14.9 t -129.82 55.09 1.8 Allowed 'General case' 0 N--CA 1.495 1.812 0 CA-C-O 121.405 0.621 . . . . 0.0 111.078 163.213 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -154.36 89.2 1.26 Allowed 'General case' 0 N--CA 1.483 1.177 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 177.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 5.6 p -92.96 117.93 37.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 C-N-CA 123.276 0.631 . . . . 0.0 110.004 176.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 44.2 t -99.98 104.39 16.0 Favored 'General case' 0 CA--C 1.553 1.093 0 CA-C-O 121.443 0.639 . . . . 0.0 111.419 175.302 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 57.5 m -92.02 110.18 21.54 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 -178.621 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 21.5 mtm105 -115.17 114.53 25.39 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 123.163 0.585 . . . . 0.0 110.561 -171.022 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 90.8 m -84.55 140.34 31.49 Favored 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 123.714 0.806 . . . . 0.0 110.987 -178.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 42.0 m-85 -133.98 135.92 43.78 Favored 'General case' 0 CA--C 1.559 1.298 0 C-N-CA 124.079 0.952 . . . . 0.0 109.903 -178.365 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -99.47 152.63 19.78 Favored 'General case' 0 N--CA 1.495 1.814 0 CA-C-O 122.058 0.932 . . . . 0.0 111.315 166.093 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 65.6 tttt -82.78 120.47 25.67 Favored 'General case' 0 N--CA 1.486 1.365 0 CA-C-N 115.465 -0.789 . . . . 0.0 111.19 -173.19 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 59.0 mm-40 -114.49 53.89 0.79 Allowed 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 124.073 0.949 . . . . 0.0 111.552 -172.205 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.894 0 CA-C-O 124.414 2.054 . . . . 0.0 108.956 -170.66 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.255 4.4 p . . . . . 0 CA--C 1.575 1.935 0 N-CA-C 116.141 1.904 . . . . 0.0 116.141 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -67.36 -39.61 85.74 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 116.385 1.995 . . . . 0.0 116.385 -177.011 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -59.59 -28.2 66.94 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 117.408 2.373 . . . . 0.0 117.408 167.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -68.21 -27.19 66.16 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 116.207 1.929 . . . . 0.0 116.207 166.568 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 79.9 mt -71.91 116.85 12.78 Favored 'General case' 0 N--CA 1.489 1.52 0 CA-C-N 120.967 1.712 . . . . 0.0 112.436 -170.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 159.41 173.36 27.76 Favored Glycine 0 CA--C 1.543 1.842 0 CA-C-O 122.484 1.047 . . . . 0.0 113.557 -178.597 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 53.9 m -85.19 141.08 30.41 Favored 'General case' 0 N--CA 1.493 1.714 0 CA-C-N 114.719 -0.74 . . . . 0.0 109.378 167.102 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 88.2 m95 -140.53 113.51 8.33 Favored 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 -174.046 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -100.69 150.01 23.19 Favored 'General case' 0 N--CA 1.496 1.863 0 CA-C-O 121.23 0.538 . . . . 0.0 110.554 176.047 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 22.5 tp -68.15 129.49 40.07 Favored 'General case' 0 N--CA 1.491 1.595 0 CA-C-O 121.932 0.872 . . . . 0.0 113.072 -174.437 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . 0.283 0.9 OUTLIER -105.05 -46.96 9.41 Favored 'Isoleucine or valine' 0 CA--C 1.576 1.967 0 CA-C-N 114.156 -1.384 . . . . 0.0 111.184 173.918 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -139.7 143.84 37.27 Favored 'General case' 0 N--CA 1.492 1.627 0 CA-C-N 119.754 1.161 . . . . 0.0 109.712 179.472 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 95.4 p -137.35 96.45 3.27 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.668 -0.645 . . . . 0.0 110.248 166.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -91.55 126.59 36.68 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 123.413 0.685 . . . . 0.0 109.679 177.385 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.27 62.6 m-20 69.45 37.17 2.05 Favored 'General case' 0 N--CA 1.502 2.174 0 N-CA-C 116.105 1.891 . . . . 0.0 116.105 -176.068 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 47.3 t80 -69.22 -59.56 2.93 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.759 -1.213 . . . . 0.0 112.8 175.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -45.91 -45.68 15.52 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 118.376 2.732 . . . . 0.0 118.376 171.076 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -61.12 -46.81 89.07 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 115.07 1.507 . . . . 0.0 115.07 172.516 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 87.2 t80 -55.84 -49.61 72.83 Favored 'General case' 0 CA--C 1.573 1.857 0 N-CA-C 115.025 1.491 . . . . 0.0 115.025 169.388 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 19.3 mmt -63.78 -44.61 92.85 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 114.829 1.418 . . . . 0.0 114.829 177.719 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 21.1 tptm -60.96 -37.65 83.17 Favored 'General case' 0 CA--C 1.571 1.753 0 N-CA-C 116.18 1.918 . . . . 0.0 116.18 167.67 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 17.1 t -58.85 -41.12 86.23 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 115.74 1.756 . . . . 0.0 115.74 169.47 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 79.1 mt -62.37 -44.3 96.79 Favored 'General case' 0 CA--C 1.568 1.641 0 N-CA-C 115.898 1.814 . . . . 0.0 115.898 166.315 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 123.63 65.24 0.2 Allowed Glycine 0 N--CA 1.483 1.813 0 C-N-CA 124.173 0.892 . . . . 0.0 111.991 -175.388 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 24.2 t -144.45 112.11 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 N-CA-C 105.084 -2.191 . . . . 0.0 105.084 -174.445 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -96.5 -100.27 1.93 Allowed Glycine 0 N--CA 1.484 1.834 0 N-CA-C 113.694 0.238 . . . . 0.0 113.694 -173.323 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 69.3 t80 -96.16 143.38 27.33 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 123.511 0.725 . . . . 0.0 111.784 -173.023 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . 0.352 . . 80.87 -51.04 0.31 Allowed 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 116.494 2.035 . . . . 0.0 116.494 168.516 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 91.8 m -70.28 -40.51 74.28 Favored 'General case' 0 N--CA 1.498 1.974 0 N-CA-C 113.938 1.088 . . . . 0.0 113.938 171.657 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 51.6 ttp180 -58.13 -41.04 82.78 Favored 'General case' 0 CA--C 1.572 1.818 0 N-CA-C 114.99 1.478 . . . . 0.0 114.99 164.457 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 42.9 mt-30 -73.94 -47.25 38.88 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 115.583 1.698 . . . . 0.0 115.583 178.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 81.3 t -63.84 -42.79 97.02 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.168 0 CA-C-N 120.01 1.277 . . . . 0.0 113.158 176.582 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -68.02 -31.61 71.42 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 117.052 2.242 . . . . 0.0 117.052 173.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 82.2 p -67.35 -39.38 85.73 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 115.889 1.811 . . . . 0.0 115.889 167.43 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 47.3 ttm -65.72 -41.7 91.96 Favored 'General case' 0 CA--C 1.566 1.575 0 N-CA-C 115.816 1.784 . . . . 0.0 115.816 175.595 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 5.9 t -81.0 165.73 21.45 Favored 'General case' 0 N--CA 1.493 1.686 0 CA-C-N 118.949 0.795 . . . . 0.0 112.933 178.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.17 105.68 33.9 Favored Pre-proline 0 CA--C 1.57 1.713 0 CA-C-O 118.093 -0.956 . . . . 0.0 110.127 172.54 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -80.76 99.77 1.16 Allowed 'Trans proline' 0 CA--C 1.558 1.715 0 C-N-CA 122.656 2.237 . . . . 0.0 112.308 -179.597 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 97.4 m -80.83 118.24 22.18 Favored 'General case' 0 N--CA 1.487 1.419 0 CA-C-N 115.417 -0.811 . . . . 0.0 110.934 -165.429 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 79.3 m -90.9 117.24 29.35 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 178.519 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 5.2 mp -108.41 109.29 27.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 N-CA-C 106.32 -1.733 . . . . 0.0 106.32 174.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 20.8 mt -100.49 117.35 45.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 N-CA-C 106.348 -1.723 . . . . 0.0 106.348 177.342 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -142.17 127.85 19.19 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.643 -0.661 . . . . 0.0 109.434 -170.386 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.68 156.1 32.83 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 113.972 1.101 . . . . 0.0 113.972 -178.727 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 25.9 t30 -141.91 74.74 1.46 Allowed 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 170.429 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 71.04 -102.23 1.05 Allowed Glycine 0 CA--C 1.546 1.991 0 O-C-N 122.119 -0.363 . . . . 0.0 112.732 -167.213 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 42.4 t0 -94.91 -20.76 19.13 Favored 'General case' 0 CA--C 1.573 1.86 0 N-CA-C 115.318 1.599 . . . . 0.0 115.318 166.816 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 18.6 mm -87.23 110.73 20.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 CA-C-N 120.542 1.519 . . . . 0.0 109.133 -169.081 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 30.7 mt -78.74 124.31 28.07 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 123.613 0.765 . . . . 0.0 111.935 176.275 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 86.7 m -109.19 99.48 8.76 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 106.922 -1.51 . . . . 0.0 106.922 179.532 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 9.7 tt -99.63 109.68 22.16 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 178.797 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -104.0 105.87 16.19 Favored 'General case' 0 N--CA 1.484 1.228 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 -179.187 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 48.8 m -89.02 95.26 10.25 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 174.441 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 22.0 m170 -76.9 175.58 9.38 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 124.132 0.973 . . . . 0.0 111.844 176.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 22.6 t . . . . . 0 N--CA 1.497 1.892 0 N-CA-C 115.069 1.507 . . . . 0.0 115.069 176.151 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 26.0 m-20 . . . . . 0 N--CA 1.491 1.622 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 60.4 p -106.59 131.98 53.13 Favored 'General case' 0 N--CA 1.496 1.865 0 C-N-CA 123.327 0.651 . . . . 0.0 110.952 -176.444 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 4.5 tm-20 -118.07 127.79 54.13 Favored 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 123.953 0.901 . . . . 0.0 110.081 -173.66 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 44.7 pt -116.94 132.76 65.74 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 C-N-CA 123.595 0.758 . . . . 0.0 109.267 172.196 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 73.5 p -116.2 112.95 22.38 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 176.397 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 40.2 p90 -144.35 146.33 32.49 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 114.498 1.295 . . . . 0.0 114.498 -161.331 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 57.6 mtmt -102.59 151.23 22.59 Favored 'General case' 0 N--CA 1.489 1.491 0 CA-C-N 115.133 -0.94 . . . . 0.0 109.126 159.146 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -74.15 115.95 14.23 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.66 -0.65 . . . . 0.0 111.709 -172.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 88.18 45.53 5.01 Favored Glycine 0 CA--C 1.55 2.225 0 N-CA-C 116.454 1.341 . . . . 0.0 116.454 -167.539 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 94.4 t -136.88 121.96 25.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 N-CA-C 107.024 -1.473 . . . . 0.0 107.024 178.086 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -87.97 125.73 34.68 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 123.05 0.54 . . . . 0.0 110.522 172.401 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 37.0 p90 -135.59 128.39 31.11 Favored 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 123.938 0.895 . . . . 0.0 109.026 -177.393 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -72.16 110.32 6.54 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.254 -0.904 . . . . 0.0 112.177 177.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 12.4 tp10 -109.9 129.13 55.69 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 123.804 0.842 . . . . 0.0 109.855 -169.314 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 67.6 m -96.91 118.87 34.27 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 175.635 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 38.8 p -88.2 168.33 12.84 Favored 'General case' 0 N--CA 1.49 1.54 0 CA-C-N 115.368 -0.833 . . . . 0.0 112.191 -172.612 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -62.2 -28.02 69.38 Favored 'General case' 0 CA--C 1.569 1.682 0 N-CA-C 117.154 2.279 . . . . 0.0 117.154 164.121 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -69.58 -1.22 8.21 Favored 'General case' 0 CA--C 1.58 2.105 0 N-CA-C 116.694 2.109 . . . . 0.0 116.694 164.247 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 65.32 67.31 0.51 Allowed 'General case' 0 N--CA 1.496 1.844 0 C-N-CA 125.449 1.5 . . . . 0.0 111.922 -176.183 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 38.9 ttp180 -148.2 117.49 6.9 Favored 'General case' 0 N--CA 1.485 1.307 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 -166.309 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -76.47 111.39 11.89 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 172.703 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 10.4 m -127.27 128.04 69.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 -172.241 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 47.5 mmtm -80.9 102.88 10.36 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 123.27 0.628 . . . . 0.0 109.526 -179.56 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 40.8 m -95.76 91.95 6.32 Favored 'General case' 0 N--CA 1.48 1.072 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.932 -167.077 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 6.1 tp -104.02 108.15 23.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 176.304 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 1.5 p -124.56 124.42 68.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 C-N-CA 123.851 0.861 . . . . 0.0 109.289 -173.28 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 9.8 t -138.53 152.78 48.52 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-O 122.467 1.127 . . . . 0.0 110.891 -178.794 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 35.3 tp -89.88 111.37 22.4 Favored 'General case' 0 N--CA 1.488 1.434 0 CA-C-N 114.85 -1.068 . . . . 0.0 109.394 174.099 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -104.61 81.99 1.85 Allowed 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 123.629 0.772 . . . . 0.0 110.266 -176.04 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 57.01 46.31 91.53 Favored Glycine 0 CA--C 1.551 2.327 0 N-CA-C 118.032 1.973 . . . . 0.0 118.032 -176.514 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 82.77 12.88 79.18 Favored Glycine 0 CA--C 1.557 2.681 0 N-CA-C 118.748 2.259 . . . . 0.0 118.748 -167.698 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 59.2 mtpt -125.2 103.88 8.21 Favored 'General case' 0 N--CA 1.487 1.394 0 CA-C-N 119.365 1.583 . . . . 0.0 106.799 177.825 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 5.5 tt -85.57 97.52 10.12 Favored 'General case' 0 CA--C 1.56 1.359 0 CA-C-O 122.013 0.911 . . . . 0.0 109.584 -174.824 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 71.6 t -96.37 110.47 24.7 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 N-CA-C 106.778 -1.564 . . . . 0.0 106.778 -170.308 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 20.1 t-160 -102.02 108.55 20.03 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 122.995 0.518 . . . . 0.0 109.697 173.681 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 40.8 tp -95.12 118.31 31.69 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 175.637 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 31.4 mt-30 -106.93 117.65 34.61 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 172.632 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 37.5 ttmt -124.76 127.37 47.11 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 123.195 0.598 . . . . 0.0 109.846 -172.617 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 32.3 p90 -145.93 114.76 6.89 Favored 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 123.241 0.616 . . . . 0.0 110.569 -174.575 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . 0.339 13.8 t70 67.04 -99.74 0.05 Allowed 'General case' 0 N--CA 1.494 1.751 0 C-N-CA 124.595 1.158 . . . . 0.0 112.403 173.01 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -128.61 50.54 0.89 Allowed Glycine 0 N--CA 1.487 2.04 0 CA-C-N 118.615 0.643 . . . . 0.0 114.197 163.216 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 14.1 mt-30 -150.65 128.85 11.95 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 177.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -137.09 130.79 31.79 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 123.139 0.576 . . . . 0.0 111.195 -176.756 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 7.1 t -121.88 129.3 52.47 Favored 'General case' 0 N--CA 1.495 1.809 0 C-N-CA 122.543 0.337 . . . . 0.0 111.486 176.129 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 39.7 p -99.31 124.62 44.55 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-O 121.755 0.788 . . . . 0.0 110.115 173.185 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 5.5 mp -100.91 88.27 3.51 Favored 'General case' 0 CA--C 1.559 1.29 0 N-CA-C 106.984 -1.487 . . . . 0.0 106.984 178.082 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 98.5 t -92.56 101.1 12.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 -168.102 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 77.7 mtt85 -96.47 125.44 40.96 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 123.221 0.608 . . . . 0.0 109.849 -178.309 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -144.95 128.17 16.73 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-O 120.847 0.356 . . . . 0.0 111.329 -172.367 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -82.42 115.64 21.53 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 123.144 0.577 . . . . 0.0 111.408 -177.245 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 96.1 mt -127.85 107.17 15.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 N-CA-C 104.993 -2.225 . . . . 0.0 104.993 179.701 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 23.4 m-20 58.08 52.76 7.32 Favored 'General case' 0 N--CA 1.5 2.063 0 N-CA-C 114.788 1.403 . . . . 0.0 114.788 176.523 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 63.15 21.21 63.7 Favored Glycine 0 CA--C 1.556 2.635 0 N-CA-C 119.734 2.653 . . . . 0.0 119.734 -171.258 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -128.92 127.54 41.96 Favored 'General case' 0 N--CA 1.488 1.445 0 CA-C-N 119.534 1.667 . . . . 0.0 108.51 -173.586 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 16.0 tp -79.33 109.99 14.19 Favored 'General case' 0 CA--C 1.557 1.236 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 176.751 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 32.5 mm -98.45 97.02 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 N-CA-C 106.467 -1.679 . . . . 0.0 106.467 -175.792 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 30.3 tp -87.23 103.96 15.93 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 124.003 0.921 . . . . 0.0 109.553 178.118 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 88.4 m -100.8 99.15 9.62 Favored 'General case' 0 CA--C 1.562 1.405 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 -177.408 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 71.0 mt -88.17 104.01 16.3 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 123.911 0.884 . . . . 0.0 109.672 -176.76 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 6.7 m -106.79 122.4 46.31 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.586 -0.696 . . . . 0.0 109.502 -171.83 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 77.8 t60 -148.15 113.5 5.59 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 173.797 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 74.89 -116.39 5.03 Favored Glycine 0 N--CA 1.484 1.883 0 C-N-CA 123.115 0.388 . . . . 0.0 113.849 173.083 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 15.2 t -119.22 53.45 1.02 Allowed 'General case' 0 N--CA 1.496 1.844 0 CA-C-O 121.271 0.557 . . . . 0.0 111.641 166.658 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -159.93 104.91 1.55 Allowed 'General case' 0 N--CA 1.483 1.203 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 175.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 7.4 p -111.24 125.89 68.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 C-N-CA 123.706 0.802 . . . . 0.0 110.113 -179.082 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 35.6 t -98.35 108.49 21.2 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 122.788 0.435 . . . . 0.0 111.693 175.626 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 88.6 m -92.2 117.19 29.63 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 177.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 75.6 mtp180 -124.46 115.78 21.46 Favored 'General case' 0 N--CA 1.488 1.444 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.054 -165.229 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 74.1 m -87.82 133.72 33.83 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 122.98 0.512 . . . . 0.0 109.794 178.017 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 40.0 m-85 -128.69 130.11 46.71 Favored 'General case' 0 CA--C 1.56 1.351 0 C-N-CA 123.388 0.675 . . . . 0.0 109.419 177.467 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -91.22 154.16 19.49 Favored 'General case' 0 N--CA 1.494 1.741 0 CA-C-O 122.23 1.014 . . . . 0.0 112.193 169.556 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 69.6 tttt -86.01 119.4 26.27 Favored 'General case' 0 N--CA 1.484 1.273 0 CA-C-N 115.257 -0.883 . . . . 0.0 111.414 -170.787 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 25.3 mm-40 -117.22 51.22 1.03 Allowed 'General case' 0 CA--C 1.564 1.508 0 C-N-CA 124.58 1.152 . . . . 0.0 111.26 -174.61 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 0.984 0 CA-C-O 123.059 1.409 . . . . 0.0 110.594 -159.732 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 4.1 p . . . . . 0 CA--C 1.576 1.971 0 N-CA-C 116.051 1.871 . . . . 0.0 116.051 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -66.86 -34.25 77.38 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 116.922 2.193 . . . . 0.0 116.922 -175.456 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -57.67 -31.63 66.51 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 117.387 2.366 . . . . 0.0 117.387 169.404 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -66.96 -26.5 66.86 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 116.686 2.106 . . . . 0.0 116.686 168.702 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 49.8 mt -77.07 107.07 9.17 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-N 120.887 1.676 . . . . 0.0 111.624 -164.057 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 157.18 176.97 29.85 Favored Glycine 0 CA--C 1.542 1.749 0 CA-C-O 122.511 1.062 . . . . 0.0 113.11 -169.744 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 85.6 m -91.78 143.56 26.4 Favored 'General case' 0 N--CA 1.489 1.48 0 CA-C-N 114.406 -0.897 . . . . 0.0 109.071 177.14 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 93.5 m95 -138.48 111.5 7.85 Favored 'General case' 0 N--CA 1.485 1.319 0 N-CA-C 107.548 -1.278 . . . . 0.0 107.548 -175.145 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -100.31 143.11 30.89 Favored 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 123.681 0.792 . . . . 0.0 110.648 -178.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 17.6 tp -66.91 124.62 23.49 Favored 'General case' 0 N--CA 1.488 1.445 0 CA-C-O 121.929 0.871 . . . . 0.0 113.135 -172.457 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . 0.267 1.2 t -97.37 -48.45 12.35 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.816 0 CA-C-N 114.261 -1.336 . . . . 0.0 111.601 174.472 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -143.89 150.25 38.12 Favored 'General case' 0 N--CA 1.489 1.494 0 CA-C-N 119.356 0.98 . . . . 0.0 110.046 178.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 88.1 p -130.65 98.14 4.57 Favored 'General case' 0 N--CA 1.489 1.514 0 CA-C-O 121.243 0.544 . . . . 0.0 109.922 170.042 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -84.51 128.27 34.5 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 123.168 0.587 . . . . 0.0 110.055 177.616 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 56.3 m-20 65.09 24.91 12.52 Favored 'General case' 0 N--CA 1.503 2.207 0 N-CA-C 117.964 2.579 . . . . 0.0 117.964 171.748 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 29.8 t80 -69.42 -53.24 20.31 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 120.032 -1.668 . . . . 0.0 113.982 -176.156 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -39.35 -44.64 1.34 Allowed 'General case' 0 N--CA 1.499 1.977 0 N-CA-C 118.948 2.944 . . . . 0.0 118.948 159.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -63.91 -50.35 69.06 Favored 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 115.214 1.561 . . . . 0.0 115.214 172.709 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 75.4 t80 -52.11 -48.0 64.99 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 115.591 1.7 . . . . 0.0 115.591 166.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 36.6 mmm -65.59 -40.11 92.33 Favored 'General case' 0 CA--C 1.565 1.548 0 N-CA-C 115.176 1.547 . . . . 0.0 115.176 176.352 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -60.85 -43.11 98.76 Favored 'General case' 0 CA--C 1.569 1.677 0 N-CA-C 114.873 1.435 . . . . 0.0 114.873 165.583 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 50.1 m -59.14 -39.45 82.44 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 115.82 1.785 . . . . 0.0 115.82 170.493 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 77.7 mt -64.62 -42.43 95.5 Favored 'General case' 0 CA--C 1.565 1.543 0 N-CA-C 116.214 1.931 . . . . 0.0 116.214 168.53 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 111.85 73.77 0.69 Allowed Glycine 0 N--CA 1.483 1.807 0 C-N-CA 123.708 0.671 . . . . 0.0 111.911 -172.445 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 37.6 t -136.3 127.84 43.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 N-CA-C 106.335 -1.728 . . . . 0.0 106.335 179.421 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -66.53 -80.19 0.19 Allowed Glycine 0 N--CA 1.485 1.966 0 N-CA-C 116.653 1.421 . . . . 0.0 116.653 -173.603 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 46.3 p90 -153.04 -50.29 0.1 Allowed 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 114.298 1.222 . . . . 0.0 114.298 -178.176 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.02 -41.67 96.99 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 116.871 2.175 . . . . 0.0 116.871 -176.519 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 59.0 m -80.06 -36.24 35.93 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 113.521 0.934 . . . . 0.0 113.521 169.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 44.2 ttp180 -58.72 -44.05 90.31 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 115.722 1.749 . . . . 0.0 115.722 176.677 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 18.2 mm100 -86.91 -33.64 19.65 Favored 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 115.315 1.598 . . . . 0.0 115.315 178.864 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 89.1 t -69.44 -46.19 76.86 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 CA-C-N 120.875 1.67 . . . . 0.0 111.941 173.373 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -65.97 -24.43 66.79 Favored 'General case' 0 CA--C 1.569 1.685 0 N-CA-C 117.559 2.429 . . . . 0.0 117.559 175.075 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 87.4 p -68.17 -49.48 60.66 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 114.863 1.431 . . . . 0.0 114.863 167.052 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 3.3 ppp? -65.26 -23.31 67.01 Favored 'General case' 0 N--CA 1.499 2.012 0 N-CA-C 117.792 2.516 . . . . 0.0 117.792 170.408 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 48.6 m -68.99 150.74 47.35 Favored 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 124.507 1.123 . . . . 0.0 112.119 177.189 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.8 98.81 6.64 Favored Pre-proline 0 CA--C 1.571 1.786 0 CA-C-O 118.072 -0.966 . . . . 0.0 110.022 166.319 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_endo -82.12 90.34 1.12 Allowed 'Trans proline' 0 CA--C 1.562 1.878 0 C-N-CA 122.805 2.337 . . . . 0.0 110.758 179.32 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 80.3 m -79.8 110.63 15.34 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 123.715 0.806 . . . . 0.0 110.487 -160.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 58.6 m -86.27 116.42 24.44 Favored 'General case' 0 CA--C 1.562 1.41 0 C-N-CA 123.085 0.554 . . . . 0.0 109.962 -171.247 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 71.9 mt -113.12 105.24 18.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 N-CA-C 106.434 -1.691 . . . . 0.0 106.434 178.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 3.8 mp -94.56 123.05 46.53 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 174.567 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -132.48 117.88 18.58 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 -176.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 38.7 ttpt -90.24 117.22 28.81 Favored 'General case' 0 CA--C 1.557 1.227 0 CA-C-O 121.296 0.57 . . . . 0.0 110.911 177.511 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 21.2 t-20 -77.27 -56.14 4.81 Favored 'General case' 0 CA--C 1.568 1.651 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.85 164.245 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -159.49 -85.62 0.05 OUTLIER Glycine 0 N--CA 1.48 1.614 0 N-CA-C 109.066 -1.613 . . . . 0.0 109.066 171.039 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -74.04 -37.87 64.17 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 114.502 1.297 . . . . 0.0 114.502 161.108 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 45.9 mm -76.68 120.54 27.09 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.514 0 C-N-CA 123.954 0.902 . . . . 0.0 110.466 -174.116 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 47.1 mt -99.67 108.99 21.48 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.745 0.818 . . . . 0.0 109.037 168.014 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 93.7 m -95.43 100.63 12.37 Favored 'General case' 0 CA--C 1.559 1.308 0 N-CA-C 107.513 -1.291 . . . . 0.0 107.513 -177.018 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 9.6 tt -100.44 106.38 17.95 Favored 'General case' 0 N--CA 1.483 1.178 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 -178.47 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -101.88 111.64 23.97 Favored 'General case' 0 N--CA 1.485 1.305 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 178.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 95.2 m -95.07 94.46 7.97 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 178.192 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 22.3 m-70 -81.12 100.99 9.34 Favored 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 123.276 0.63 . . . . 0.0 111.603 -171.257 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 32.1 t . . . . . 0 CA--C 1.555 1.152 0 C-N-CA 123.904 0.882 . . . . 0.0 109.397 -176.304 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 7.6 p-10 . . . . . 0 N--CA 1.49 1.548 0 N-CA-C 112.493 0.553 . . . . 0.0 112.493 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 73.1 p -93.85 126.37 39.0 Favored 'General case' 0 N--CA 1.493 1.716 0 C-N-CA 122.718 0.407 . . . . 0.0 110.538 178.783 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -105.81 113.92 27.76 Favored 'General case' 0 N--CA 1.485 1.292 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 174.037 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 19.8 pt -116.59 128.82 73.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 179.72 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 61.7 p -116.83 113.4 22.45 Favored 'General case' 0 N--CA 1.492 1.659 0 C-N-CA 123.741 0.817 . . . . 0.0 109.447 -172.466 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 42.6 p90 -141.31 145.65 35.75 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 114.929 1.455 . . . . 0.0 114.929 -165.228 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 34.8 mtmm -116.82 23.94 11.6 Favored 'General case' 0 N--CA 1.498 1.929 0 N-CA-C 115.982 1.845 . . . . 0.0 115.982 -174.168 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . 0.275 2.0 mp 65.75 94.21 0.06 Allowed 'General case' 0 N--CA 1.494 1.725 0 C-N-CA 124.964 1.306 . . . . 0.0 113.635 168.632 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 83.27 34.06 21.42 Favored Glycine 0 CA--C 1.551 2.323 0 N-CA-C 117.095 1.598 . . . . 0.0 117.095 -164.601 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 95.6 t -135.27 118.19 23.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 N-CA-C 106.453 -1.684 . . . . 0.0 106.453 -178.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -85.6 136.27 33.45 Favored 'General case' 0 CA--C 1.565 1.55 0 C-N-CA 123.563 0.745 . . . . 0.0 111.86 179.448 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 47.9 p90 -143.89 139.29 29.13 Favored 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 123.663 0.785 . . . . 0.0 111.392 -171.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -75.57 135.42 40.55 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.252 -0.905 . . . . 0.0 112.688 172.413 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -146.1 136.49 23.94 Favored 'General case' 0 N--CA 1.49 1.528 0 CA-C-O 120.997 0.427 . . . . 0.0 111.207 -170.53 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 79.3 m -96.88 130.09 44.23 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 172.037 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 26.7 p -89.2 171.8 9.54 Favored 'General case' 0 N--CA 1.492 1.671 0 CA-C-O 121.989 0.9 . . . . 0.0 112.661 -176.336 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -54.48 -40.33 68.39 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 117.207 2.299 . . . . 0.0 117.207 169.018 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -93.93 59.7 2.78 Favored 'General case' 0 N--CA 1.495 1.813 0 CA-C-N 119.362 0.983 . . . . 0.0 111.337 170.267 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 9.5 t70 21.7 76.26 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.007 0 N-CA-C 118.771 2.878 . . . . 0.0 118.771 -178.687 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 38.4 ttp180 -139.73 117.92 11.95 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 -169.204 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.42 114.81 12.06 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 122.901 0.48 . . . . 0.0 110.195 172.252 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 17.3 m -135.01 132.27 53.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 CA-C-O 121.431 0.634 . . . . 0.0 109.642 -170.135 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 39.5 ttpt -87.02 118.09 26.17 Favored 'General case' 0 CA--C 1.558 1.263 0 C-N-CA 123.829 0.852 . . . . 0.0 110.237 178.77 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 71.0 m -117.35 109.76 17.21 Favored 'General case' 0 N--CA 1.488 1.452 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.259 -157.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 6.6 tp -122.73 115.88 47.2 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 C-N-CA 123.834 0.854 . . . . 0.0 109.091 -179.105 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -123.53 129.58 74.57 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 C-N-CA 124.431 1.092 . . . . 0.0 109.29 178.76 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 15.1 t -133.89 156.97 47.14 Favored 'General case' 0 N--CA 1.493 1.693 0 CA-C-O 122.632 1.206 . . . . 0.0 111.34 169.532 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 19.3 tp -94.16 117.99 30.91 Favored 'General case' 0 N--CA 1.489 1.476 0 CA-C-N 114.726 -1.124 . . . . 0.0 110.558 -178.388 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -104.52 81.5 1.8 Allowed 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 123.231 0.612 . . . . 0.0 110.079 175.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 78.07 -74.92 1.96 Allowed Glycine 0 N--CA 1.487 2.1 0 CA-C-O 121.473 0.485 . . . . 0.0 113.832 -174.72 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -148.63 53.95 0.52 Allowed Glycine 0 CA--C 1.546 1.99 0 CA-C-N 114.425 -0.887 . . . . 0.0 112.885 167.451 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 38.7 mtmm -145.26 111.68 5.73 Favored 'General case' 0 N--CA 1.484 1.263 0 N-CA-C 106.682 -1.599 . . . . 0.0 106.682 -175.641 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 46.7 mt -82.4 96.35 7.94 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-O 122.757 1.265 . . . . 0.0 109.424 174.248 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 95.5 t -86.81 94.93 4.6 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.342 0 CA-C-N 113.029 -1.896 . . . . 0.0 105.936 -179.651 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 16.8 t-160 -98.89 147.95 24.43 Favored 'General case' 0 CA--C 1.559 1.319 0 C-N-CA 124.612 1.165 . . . . 0.0 109.608 179.209 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 23.2 tp -145.48 119.89 9.65 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 179.571 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 94.4 mt-30 -105.67 122.6 46.38 Favored 'General case' 0 N--CA 1.486 1.325 0 C-N-CA 124.707 1.203 . . . . 0.0 108.341 176.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 7.9 mtpm? -125.44 130.69 52.35 Favored 'General case' 0 N--CA 1.494 1.736 0 C-N-CA 123.023 0.529 . . . . 0.0 110.048 -170.779 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 19.2 p90 -153.34 112.85 3.83 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.67 -0.644 . . . . 0.0 110.091 -175.066 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 4.5 t70 51.93 53.73 12.07 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 116.552 2.056 . . . . 0.0 116.552 168.091 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 86.64 -40.66 3.07 Favored Glycine 0 CA--C 1.552 2.344 0 N-CA-C 117.387 1.715 . . . . 0.0 117.387 -171.473 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 19.2 mt-30 -85.31 137.39 33.0 Favored 'General case' 0 N--CA 1.49 1.562 0 CA-C-N 118.316 1.058 . . . . 0.0 111.168 -179.804 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -143.38 133.13 23.85 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 122.837 0.455 . . . . 0.0 111.727 -179.077 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 14.8 t -116.69 128.67 55.56 Favored 'General case' 0 N--CA 1.494 1.746 0 C-N-CA 123.108 0.563 . . . . 0.0 110.575 175.378 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 40.8 p -91.86 125.6 36.63 Favored 'General case' 0 N--CA 1.494 1.758 0 C-N-CA 122.965 0.506 . . . . 0.0 109.955 170.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 5.2 mp -105.63 82.1 1.76 Allowed 'General case' 0 CA--C 1.565 1.53 0 C-N-CA 124.187 0.995 . . . . 0.0 108.384 178.207 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 88.4 t -88.91 106.0 16.39 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 -172.153 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 74.8 mtt85 -97.88 117.53 32.4 Favored 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 123.137 0.575 . . . . 0.0 109.73 179.587 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -137.14 131.11 32.13 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 123.168 0.587 . . . . 0.0 111.185 -171.038 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -80.83 118.1 22.05 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.83 -0.544 . . . . 0.0 111.609 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 46.6 mm -125.47 101.85 9.21 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.28 0 N-CA-C 105.365 -2.087 . . . . 0.0 105.365 178.422 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 59.12 50.24 8.33 Favored 'General case' 0 N--CA 1.5 2.059 0 N-CA-C 115.408 1.633 . . . . 0.0 115.408 174.177 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 65.67 30.48 77.43 Favored Glycine 0 CA--C 1.555 2.556 0 N-CA-C 118.736 2.255 . . . . 0.0 118.736 -170.548 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -136.4 129.41 31.19 Favored 'General case' 0 N--CA 1.489 1.506 0 CA-C-N 118.458 1.129 . . . . 0.0 108.688 -176.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 12.2 tp -81.9 114.68 20.67 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 175.53 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 40.6 mm -104.74 100.04 9.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 N-CA-C 106.401 -1.703 . . . . 0.0 106.401 -174.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 38.6 tp -89.65 98.34 11.71 Favored 'General case' 0 CA--C 1.559 1.327 0 C-N-CA 123.657 0.783 . . . . 0.0 109.532 178.171 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 87.0 m -91.71 108.51 19.97 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 -178.771 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 87.7 mt -100.86 90.61 4.26 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 123.562 0.745 . . . . 0.0 109.467 -173.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 7.9 m -96.12 117.24 30.32 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.636 -0.665 . . . . 0.0 109.289 -173.489 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 83.4 t60 -127.57 91.02 3.22 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 168.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 73.1 -101.15 1.09 Allowed Glycine 0 N--CA 1.483 1.819 0 N-CA-C 114.49 0.556 . . . . 0.0 114.49 174.549 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 81.2 m -88.67 -54.52 4.12 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-O 118.486 -0.769 . . . . 0.0 112.045 175.62 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -85.1 106.36 16.51 Favored 'General case' 0 N--CA 1.484 1.246 0 CA-C-N 119.721 1.146 . . . . 0.0 112.256 -171.34 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 5.8 p -98.88 125.78 52.24 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 C-N-CA 123.83 0.852 . . . . 0.0 109.883 176.056 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 40.4 t -107.13 103.77 13.25 Favored 'General case' 0 CA--C 1.553 1.062 0 CA-C-O 121.41 0.624 . . . . 0.0 111.774 179.17 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 60.6 m -88.84 111.69 22.35 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 123.421 0.688 . . . . 0.0 109.187 179.587 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 22.3 mtp180 -106.11 111.86 24.66 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 -178.064 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 95.2 m -89.26 136.3 33.1 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 123.711 0.804 . . . . 0.0 109.98 -179.725 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 65.7 m-85 -132.07 132.68 43.55 Favored 'General case' 0 CA--C 1.56 1.361 0 C-N-CA 123.527 0.731 . . . . 0.0 110.259 -176.296 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -92.79 156.16 17.18 Favored 'General case' 0 N--CA 1.495 1.796 0 CA-C-O 122.249 1.023 . . . . 0.0 111.835 165.084 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 40.3 tttp -86.2 137.9 32.29 Favored 'General case' 0 N--CA 1.487 1.385 0 CA-C-N 115.528 -0.76 . . . . 0.0 112.817 -171.092 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -120.58 57.27 0.97 Allowed 'General case' 0 N--CA 1.494 1.733 0 C-N-CA 123.447 0.699 . . . . 0.0 111.952 171.137 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.437 0 CA-C-O 124.15 1.929 . . . . 0.0 112.444 -179.289 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 4.7 p . . . . . 0 CA--C 1.578 2.046 0 N-CA-C 115.675 1.732 . . . . 0.0 115.675 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -66.01 -48.39 71.3 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 117.231 2.308 . . . . 0.0 117.231 -173.401 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -55.84 -27.73 52.91 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 117.841 2.534 . . . . 0.0 117.841 171.09 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -68.61 -26.53 65.41 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 116.199 1.926 . . . . 0.0 116.199 167.642 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 40.6 mt -76.87 111.88 12.88 Favored 'General case' 0 N--CA 1.49 1.526 0 CA-C-N 120.78 1.627 . . . . 0.0 112.04 -168.768 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 164.63 176.05 35.99 Favored Glycine 0 CA--C 1.541 1.708 0 CA-C-O 122.706 1.17 . . . . 0.0 113.434 -173.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 63.3 m -90.0 140.22 29.85 Favored 'General case' 0 N--CA 1.493 1.699 0 CA-C-N 114.238 -0.981 . . . . 0.0 109.046 170.403 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 87.6 m95 -140.89 112.6 7.58 Favored 'General case' 0 N--CA 1.484 1.267 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 -174.044 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 8.6 mtpm? -96.67 146.04 25.23 Favored 'General case' 0 N--CA 1.495 1.789 0 CA-C-O 121.327 0.584 . . . . 0.0 110.273 174.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 23.8 tp -66.83 125.62 26.47 Favored 'General case' 0 N--CA 1.488 1.455 0 CA-C-O 121.89 0.853 . . . . 0.0 112.48 -177.062 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . 0.279 1.1 t -99.7 -47.93 11.87 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.795 0 CA-C-N 114.398 -1.274 . . . . 0.0 111.717 176.302 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -139.97 143.2 36.41 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-N 119.571 1.078 . . . . 0.0 109.67 177.528 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 78.5 p -126.09 94.07 3.99 Favored 'General case' 0 N--CA 1.49 1.526 0 CA-C-O 121.306 0.574 . . . . 0.0 110.486 169.067 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 57.5 tttp -83.22 119.49 24.62 Favored 'General case' 0 CA--C 1.557 1.243 0 C-N-CA 123.625 0.77 . . . . 0.0 109.71 175.528 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.259 24.5 m-20 73.45 26.47 1.99 Allowed 'General case' 0 N--CA 1.501 2.122 0 N-CA-C 116.736 2.125 . . . . 0.0 116.736 175.704 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.418 ' HB2' ' SG ' ' A' ' 124' ' ' CYS . 22.5 t80 -89.27 78.67 7.23 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.362 -1.461 . . . . 0.0 110.72 178.503 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -170.44 -58.03 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 125.0 1.32 . . . . 0.0 108.281 -176.576 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 29.0 t0 -54.45 -47.7 72.58 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 115.365 1.617 . . . . 0.0 115.365 166.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 92.3 t80 -49.3 -54.73 15.55 Favored 'General case' 0 CA--C 1.573 1.835 0 N-CA-C 115.133 1.531 . . . . 0.0 115.133 167.781 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 74.8 mtm -63.71 -41.17 98.14 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 116.01 1.855 . . . . 0.0 116.01 174.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 57.9 tttm -64.92 -43.28 93.34 Favored 'General case' 0 CA--C 1.567 1.626 0 N-CA-C 115.228 1.566 . . . . 0.0 115.228 173.432 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 60.9 m -59.97 -39.91 87.3 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 115.815 1.783 . . . . 0.0 115.815 169.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 64.9 mt -64.37 -30.84 71.87 Favored 'General case' 0 CA--C 1.566 1.568 0 N-CA-C 117.41 2.374 . . . . 0.0 117.41 168.587 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 91.32 75.92 1.31 Allowed Glycine 0 N--CA 1.482 1.722 0 CA-C-N 119.211 0.914 . . . . 0.0 111.978 -170.025 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 97.9 t -128.31 81.28 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 N-CA-C 106.643 -1.614 . . . . 0.0 106.643 -177.273 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 31.86 -118.51 0.13 Allowed Glycine 0 CA--C 1.55 2.273 0 N-CA-C 121.018 3.167 . . . . 0.0 121.018 174.361 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 10.7 t80 -148.43 -71.22 0.21 Allowed 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 178.485 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -72.69 -16.99 61.68 Favored 'General case' 0 CA--C 1.567 1.608 0 N-CA-C 116.615 2.08 . . . . 0.0 116.615 177.269 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 30.6 m -68.63 -42.63 77.75 Favored 'General case' 0 N--CA 1.497 1.904 0 CA-C-N 120.3 1.409 . . . . 0.0 113.495 162.76 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 37.1 ttp-105 -55.31 -44.64 75.97 Favored 'General case' 0 CA--C 1.571 1.787 0 N-CA-C 115.138 1.533 . . . . 0.0 115.138 164.64 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 5.9 tm0? -65.78 -52.33 51.74 Favored 'General case' 0 CA--C 1.565 1.547 0 N-CA-C 115.451 1.648 . . . . 0.0 115.451 174.38 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 92.6 t -66.1 -38.32 81.74 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.975 0 N-CA-C 113.583 0.957 . . . . 0.0 113.583 -179.602 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -65.68 -34.59 78.56 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 116.806 2.15 . . . . 0.0 116.806 175.755 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 88.4 p -67.63 -39.55 84.66 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 116.348 1.981 . . . . 0.0 116.348 167.01 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 38.3 ttm -64.65 -40.72 95.94 Favored 'General case' 0 CA--C 1.571 1.756 0 N-CA-C 115.87 1.804 . . . . 0.0 115.87 169.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 88.3 m -75.74 153.06 37.27 Favored 'General case' 0 CA--C 1.567 1.61 0 C-N-CA 124.276 1.031 . . . . 0.0 112.597 -177.015 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 64.0 mttp -102.91 100.06 15.66 Favored Pre-proline 0 CA--C 1.572 1.82 0 CA-C-N 115.405 -0.816 . . . . 0.0 109.735 172.268 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -82.36 113.62 2.36 Favored 'Trans proline' 0 CA--C 1.561 1.826 0 C-N-CA 123.36 2.707 . . . . 0.0 112.289 179.737 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 86.7 m -83.95 108.54 16.99 Favored 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 123.509 0.723 . . . . 0.0 110.67 -169.366 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 88.2 m -81.65 116.64 21.48 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 123.492 0.717 . . . . 0.0 109.808 -179.495 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 61.3 mt -115.56 107.87 23.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 N-CA-C 106.122 -1.807 . . . . 0.0 106.122 -176.584 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 22.8 mt -103.05 119.48 51.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 N-CA-C 107.653 -1.239 . . . . 0.0 107.653 -175.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -137.62 111.34 8.18 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 -169.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 60.4 tttm -86.46 114.56 23.32 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 123.369 0.668 . . . . 0.0 111.015 -179.306 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 33.5 t30 -115.87 82.47 1.77 Allowed 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 -179.481 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 61.23 59.53 9.84 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 116.411 1.324 . . . . 0.0 116.411 -174.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . 0.319 15.7 t0 68.92 -14.79 0.28 Allowed 'General case' 0 N--CA 1.498 1.946 0 N-CA-C 117.572 2.434 . . . . 0.0 117.572 -166.372 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 11.2 mm -87.72 98.96 8.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 CA-C-N 120.342 1.428 . . . . 0.0 107.631 -177.292 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 43.9 mt -80.21 107.31 12.9 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 123.523 0.729 . . . . 0.0 110.544 -178.41 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 30.6 m -97.48 94.56 7.09 Favored 'General case' 0 N--CA 1.485 1.292 0 N-CA-C 107.059 -1.46 . . . . 0.0 107.059 -175.059 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 9.7 tt -99.4 102.81 14.51 Favored 'General case' 0 N--CA 1.484 1.255 0 N-CA-C 108.007 -1.108 . . . . 0.0 108.007 -174.515 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 64.0 mttm -105.04 116.82 32.59 Favored 'General case' 0 N--CA 1.486 1.328 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 -173.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 89.1 m -100.55 92.05 4.95 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 -175.624 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 8.0 m170 -87.94 96.26 10.43 Favored 'General case' 0 N--CA 1.491 1.59 0 CA-C-O 122.373 1.083 . . . . 0.0 111.862 -169.676 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 28.1 t . . . . . 0 CA--C 1.561 1.385 0 CA-C-N 114.596 -1.184 . . . . 0.0 111.18 171.729 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 34.7 p-10 . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 121.093 0.473 . . . . 0.0 109.833 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 41.4 p -86.97 129.94 34.67 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-O 121.402 0.62 . . . . 0.0 111.028 -179.478 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -110.92 129.65 55.81 Favored 'General case' 0 N--CA 1.484 1.24 0 CA-C-N 115.127 -0.942 . . . . 0.0 109.416 178.763 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 41.5 pt -112.48 130.86 65.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 164.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 58.0 p -120.73 103.91 9.48 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 108.825 -0.805 . . . . 0.0 108.825 -177.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 45.7 p90 -138.8 133.67 32.39 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 114.052 1.131 . . . . 0.0 114.052 -158.829 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 56.4 mtmt -86.73 148.91 25.22 Favored 'General case' 0 CA--C 1.562 1.435 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.534 156.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -73.38 116.87 14.45 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.762 -0.586 . . . . 0.0 111.66 -174.602 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 90.69 45.19 4.34 Favored Glycine 0 CA--C 1.548 2.13 0 N-CA-C 116.515 1.366 . . . . 0.0 116.515 -167.352 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 96.3 t -135.4 122.25 34.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 N-CA-C 106.984 -1.487 . . . . 0.0 106.984 177.476 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -88.89 126.7 35.5 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 123.29 0.636 . . . . 0.0 110.386 170.334 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 43.0 p90 -139.62 133.06 30.15 Favored 'General case' 0 N--CA 1.494 1.766 0 C-N-CA 123.38 0.672 . . . . 0.0 111.172 -172.501 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -70.66 118.14 13.08 Favored 'General case' 0 CA--C 1.564 1.494 0 O-C-N 121.621 -0.675 . . . . 0.0 112.343 175.77 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 15.9 tp10 -125.72 136.44 53.19 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 123.775 0.83 . . . . 0.0 109.967 -170.324 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 57.8 m -91.24 123.46 34.7 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 174.461 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 31.7 p -82.48 170.68 14.97 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 113.056 0.762 . . . . 0.0 113.056 -175.695 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -53.28 -30.66 39.75 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 118.665 2.839 . . . . 0.0 118.665 173.078 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -78.7 -85.85 0.07 Allowed 'General case' 0 N--CA 1.489 1.488 0 CA-C-N 119.387 0.994 . . . . 0.0 109.23 168.261 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 179.01 82.86 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 168.634 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 22.0 mtm180 -140.22 124.81 18.05 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.847 -0.533 . . . . 0.0 109.92 -174.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.89 116.19 13.1 Favored 'General case' 0 CA--C 1.564 1.482 0 C-N-CA 123.63 0.772 . . . . 0.0 111.121 165.592 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 17.8 m -134.26 129.56 53.54 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 -170.246 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 46.2 mmtm -83.37 104.42 13.51 Favored 'General case' 0 N--CA 1.49 1.526 0 CA-C-O 121.759 0.79 . . . . 0.0 110.152 -178.076 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 75.2 m -101.24 95.86 6.81 Favored 'General case' 0 N--CA 1.484 1.238 0 CA-C-N 115.064 -0.971 . . . . 0.0 110.702 -162.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 7.2 tp -103.19 121.58 54.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 179.606 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 1.9 p -142.22 123.44 12.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 C-N-CA 123.171 0.589 . . . . 0.0 109.95 -172.085 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 15.1 t -136.96 159.72 41.03 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-O 122.579 1.18 . . . . 0.0 110.92 178.42 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 14.7 tp -90.54 111.17 22.36 Favored 'General case' 0 CA--C 1.562 1.437 0 CA-C-N 115.084 -0.962 . . . . 0.0 109.505 174.855 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -101.69 88.01 3.3 Favored 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 123.678 0.791 . . . . 0.0 109.793 -179.507 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 58.26 47.43 89.56 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 118.07 1.988 . . . . 0.0 118.07 -177.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 74.91 28.0 63.54 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 118.695 2.238 . . . . 0.0 118.695 -168.048 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 21.3 ttmm -134.51 116.7 15.39 Favored 'General case' 0 CA--C 1.552 1.044 0 N-CA-C 106.523 -1.658 . . . . 0.0 106.523 179.782 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 3.8 tt -86.45 97.98 10.77 Favored 'General case' 0 CA--C 1.563 1.475 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 -172.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 56.1 t -105.7 109.15 26.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 -165.097 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 23.6 t-160 -110.2 136.36 49.54 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 124.071 0.948 . . . . 0.0 109.905 179.638 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 30.3 tp -130.53 121.22 25.33 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 173.755 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 87.3 mt-30 -108.46 118.11 35.91 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 175.61 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 17.5 ptpt -121.76 134.9 54.93 Favored 'General case' 0 N--CA 1.496 1.849 0 CA-C-N 118.472 0.578 . . . . 0.0 111.933 -172.697 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 18.0 p90 -158.21 109.94 2.25 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 123.465 0.706 . . . . 0.0 109.897 -176.638 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 6.4 t70 53.44 54.11 10.61 Favored 'General case' 0 N--CA 1.501 2.077 0 N-CA-C 116.625 2.083 . . . . 0.0 116.625 164.236 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 87.96 -42.75 3.11 Favored Glycine 0 CA--C 1.552 2.35 0 N-CA-C 116.937 1.535 . . . . 0.0 116.937 -170.71 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 16.6 mt-30 -86.4 131.26 34.24 Favored 'General case' 0 N--CA 1.487 1.404 0 CA-C-N 118.086 0.943 . . . . 0.0 110.84 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -141.79 126.37 17.88 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 122.96 0.504 . . . . 0.0 110.36 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 1.4 t -121.07 124.07 43.89 Favored 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 123.528 0.731 . . . . 0.0 110.302 -175.032 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 40.1 p -97.76 141.96 30.13 Favored 'General case' 0 N--CA 1.492 1.648 0 CA-C-O 121.499 0.666 . . . . 0.0 111.738 179.764 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 5.6 mp -119.75 80.68 1.62 Allowed 'General case' 0 CA--C 1.564 1.494 0 N-CA-C 107.672 -1.233 . . . . 0.0 107.672 175.571 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 95.7 t -90.83 111.16 23.22 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 -172.464 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 83.7 mtt85 -104.63 130.21 52.66 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 123.292 0.637 . . . . 0.0 110.211 -177.383 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -145.94 129.26 16.78 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 123.167 0.587 . . . . 0.0 110.546 -174.095 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -79.71 116.8 20.1 Favored 'General case' 0 N--CA 1.488 1.469 0 CA-C-O 121.273 0.559 . . . . 0.0 111.108 177.117 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 48.9 mm -120.05 100.18 8.91 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.332 0 N-CA-C 105.485 -2.043 . . . . 0.0 105.485 177.72 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 57.38 49.78 12.5 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 114.915 1.45 . . . . 0.0 114.915 174.101 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 89.51 -38.61 3.19 Favored Glycine 0 CA--C 1.553 2.465 0 N-CA-C 117.572 1.789 . . . . 0.0 117.572 -169.019 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 54.0 mttm -82.64 132.79 35.18 Favored 'General case' 0 N--CA 1.488 1.448 0 CA-C-N 118.583 1.192 . . . . 0.0 112.075 -171.192 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 20.8 tp -81.66 112.66 19.05 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 172.68 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 37.6 mm -99.77 102.49 13.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 N-CA-C 106.732 -1.581 . . . . 0.0 106.732 -178.12 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 22.6 tp -90.43 102.73 15.46 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 123.815 0.846 . . . . 0.0 109.22 174.57 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 66.9 m -91.47 112.87 24.96 Favored 'General case' 0 CA--C 1.562 1.432 0 C-N-CA 124.181 0.992 . . . . 0.0 108.354 179.324 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 88.3 mt -104.61 87.34 2.67 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 123.746 0.818 . . . . 0.0 109.985 -171.819 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 9.9 m -103.17 112.51 25.41 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.727 -0.608 . . . . 0.0 109.576 -174.134 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 54.9 t60 -108.74 86.96 2.38 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 164.001 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 71.16 -101.54 0.97 Allowed Glycine 0 N--CA 1.483 1.795 0 N-CA-C 114.416 0.526 . . . . 0.0 114.416 179.461 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 61.2 m -87.19 -51.34 6.04 Favored 'General case' 0 CA--C 1.566 1.595 0 C-N-CA 123.653 0.781 . . . . 0.0 112.678 176.853 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -77.73 107.48 10.26 Favored 'General case' 0 N--CA 1.484 1.274 0 CA-C-N 119.756 1.162 . . . . 0.0 112.886 -173.641 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 4.7 p -107.68 124.18 63.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 C-N-CA 123.954 0.901 . . . . 0.0 110.37 -178.627 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' CYS . . . . . 0.418 ' SG ' ' HB2' ' A' ' 16' ' ' PHE . 2.7 t -101.25 108.57 20.25 Favored 'General case' 0 CA--C 1.556 1.188 0 C-N-CA 123.449 0.699 . . . . 0.0 110.614 173.134 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 53.5 m -89.2 111.06 21.76 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 177.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 36.1 mtt180 -108.06 117.23 33.58 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 123.187 0.595 . . . . 0.0 110.874 -179.296 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 86.0 m -88.91 134.34 33.99 Favored 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 123.53 0.732 . . . . 0.0 109.585 172.447 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 48.1 m-85 -128.58 135.62 49.61 Favored 'General case' 0 CA--C 1.559 1.308 0 C-N-CA 123.95 0.9 . . . . 0.0 109.371 179.127 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -100.99 154.0 19.06 Favored 'General case' 0 N--CA 1.493 1.718 0 CA-C-O 122.6 1.191 . . . . 0.0 111.414 167.439 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 36.2 tttp -84.86 125.69 32.84 Favored 'General case' 0 N--CA 1.483 1.218 0 CA-C-N 114.956 -1.02 . . . . 0.0 112.209 -168.367 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 16.7 mm-40 -123.3 50.14 1.6 Allowed 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 124.237 1.015 . . . . 0.0 111.712 -175.158 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 0.811 0 CA-C-O 123.005 1.384 . . . . 0.0 110.639 -161.36 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.32 2.5 t . . . . . 0 N--CA 1.489 1.487 0 CA-C-O 118.051 -0.976 . . . . 0.0 112.995 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -62.12 -36.13 80.84 Favored 'General case' 0 N--CA 1.497 1.881 0 N-CA-C 116.154 1.909 . . . . 0.0 116.154 179.587 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -62.41 -32.32 73.14 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 116.858 2.17 . . . . 0.0 116.858 163.259 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 88.8 m-85 -67.69 -27.62 66.99 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 116.146 1.906 . . . . 0.0 116.146 168.319 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 60.0 mt -72.75 116.42 13.22 Favored 'General case' 0 N--CA 1.49 1.543 0 CA-C-N 121.291 1.86 . . . . 0.0 111.512 -172.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 159.48 177.17 32.33 Favored Glycine 0 CA--C 1.541 1.692 0 CA-C-O 122.138 0.854 . . . . 0.0 114.133 -176.091 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 52.3 m -94.61 135.46 36.04 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 174.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 92.6 m95 -134.7 113.13 11.37 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 -172.247 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 7.7 mtmp? -98.76 144.21 28.25 Favored 'General case' 0 N--CA 1.489 1.477 0 CA-C-O 121.978 0.894 . . . . 0.0 110.541 175.084 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 51.4 tp -68.71 133.64 48.69 Favored 'General case' 0 N--CA 1.486 1.359 0 CA-C-O 122.283 1.039 . . . . 0.0 112.496 -176.469 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . 0.28 1.1 t -110.74 -43.3 5.2 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.744 0 CA-C-N 113.697 -1.592 . . . . 0.0 111.718 -178.411 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 41.8 t0 -143.78 131.89 21.79 Favored 'General case' 0 N--CA 1.49 1.525 0 CA-C-N 120.102 1.319 . . . . 0.0 109.63 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 86.4 p -112.93 96.83 6.16 Favored 'General case' 0 N--CA 1.492 1.663 0 CA-C-O 121.492 0.663 . . . . 0.0 110.366 171.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 43.7 mtmt -96.41 123.32 40.02 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 123.656 0.783 . . . . 0.0 108.92 -179.37 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 59.7 m-20 67.57 23.18 8.95 Favored 'General case' 0 N--CA 1.503 2.208 0 N-CA-C 117.532 2.419 . . . . 0.0 117.532 178.578 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 27.3 t80 -68.22 -51.75 41.9 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 120.155 -1.591 . . . . 0.0 113.981 -178.812 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -47.28 -36.19 8.86 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 117.542 2.423 . . . . 0.0 117.542 165.736 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 33.9 t0 -66.06 -55.49 16.33 Favored 'General case' 0 N--CA 1.499 2.021 0 CA-C-N 120.483 1.492 . . . . 0.0 114.245 172.232 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 71.6 t80 -48.22 -48.01 35.34 Favored 'General case' 0 CA--C 1.573 1.845 0 N-CA-C 116.135 1.902 . . . . 0.0 116.135 167.465 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 51.4 mmm -68.23 -46.03 71.67 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 114.84 1.422 . . . . 0.0 114.84 178.691 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -54.91 -46.34 74.84 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 115.533 1.679 . . . . 0.0 115.533 166.2 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 64.6 m -60.54 -38.55 84.85 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 116.199 1.926 . . . . 0.0 116.199 172.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 62.5 mt -63.06 -41.17 99.41 Favored 'General case' 0 CA--C 1.567 1.632 0 N-CA-C 115.78 1.771 . . . . 0.0 115.78 168.337 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 114.39 73.17 0.57 Allowed Glycine 0 N--CA 1.482 1.751 0 C-N-CA 123.899 0.762 . . . . 0.0 111.603 -176.192 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 57.3 t -140.36 121.82 14.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 N-CA-C 106.389 -1.708 . . . . 0.0 106.389 -173.772 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -72.18 170.69 49.68 Favored Glycine 0 CA--C 1.551 2.322 0 N-CA-C 116.414 1.326 . . . . 0.0 116.414 177.235 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . 0.25 33.0 p90 -57.47 -43.23 83.87 Favored 'General case' 0 N--CA 1.497 1.92 0 N-CA-C 118.92 2.933 . . . . 0.0 118.92 -167.515 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.36 -40.62 89.87 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 116.589 2.07 . . . . 0.0 116.589 178.75 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 94.7 m -71.52 -42.02 68.48 Favored 'General case' 0 N--CA 1.498 1.963 0 N-CA-C 113.792 1.034 . . . . 0.0 113.792 168.574 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 38.3 ttp180 -58.53 -38.91 78.75 Favored 'General case' 0 CA--C 1.569 1.708 0 N-CA-C 115.89 1.811 . . . . 0.0 115.89 173.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 51.4 mt-30 -81.66 -38.8 25.35 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 115.66 1.726 . . . . 0.0 115.66 176.71 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 46.9 t -73.11 -37.88 53.88 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.254 0 CA-C-N 121.381 1.901 . . . . 0.0 112.664 175.067 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -66.55 -31.37 72.05 Favored 'General case' 0 CA--C 1.567 1.601 0 N-CA-C 117.0 2.222 . . . . 0.0 117.0 170.462 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 85.9 p -67.0 -43.65 82.38 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 115.283 1.586 . . . . 0.0 115.283 164.257 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 49.6 ttm -64.73 -38.73 92.0 Favored 'General case' 0 CA--C 1.567 1.624 0 N-CA-C 116.49 2.033 . . . . 0.0 116.49 176.643 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 13.0 t -69.29 144.94 53.44 Favored 'General case' 0 N--CA 1.492 1.645 0 CA-C-N 119.432 1.014 . . . . 0.0 112.931 -179.417 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -102.69 103.16 30.85 Favored Pre-proline 0 CA--C 1.567 1.603 0 CA-C-O 118.201 -0.904 . . . . 0.0 108.802 176.009 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -72.96 119.78 6.26 Favored 'Trans proline' 0 CA--C 1.559 1.753 0 C-N-CA 123.052 2.501 . . . . 0.0 112.526 -179.244 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 95.7 m -84.58 99.59 10.85 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 179.859 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 86.9 m -97.37 104.53 16.56 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 -165.253 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 68.9 mt -100.5 112.69 33.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 N-CA-C 107.464 -1.31 . . . . 0.0 107.464 -174.45 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 35.8 mt -104.0 117.41 49.49 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 N-CA-C 107.121 -1.437 . . . . 0.0 107.121 179.548 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -141.43 119.42 11.97 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-O 121.078 0.466 . . . . 0.0 109.939 -170.154 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 56.3 tttm -91.84 121.95 33.92 Favored 'General case' 0 CA--C 1.56 1.347 0 C-N-CA 123.748 0.819 . . . . 0.0 111.802 -175.075 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 75.4 m-20 -116.61 92.16 3.79 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 -179.346 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 83.25 -92.95 1.68 Allowed Glycine 0 N--CA 1.486 1.998 0 O-C-N 121.774 -0.579 . . . . 0.0 111.776 -173.347 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -138.49 65.57 1.46 Allowed 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 155.808 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 33.9 mm -136.01 99.88 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 N-CA-C 105.258 -2.127 . . . . 0.0 105.258 -174.73 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 60.4 mt -81.45 102.09 10.31 Favored 'General case' 0 N--CA 1.486 1.342 0 CA-C-O 121.181 0.515 . . . . 0.0 110.482 -179.119 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 28.7 m -98.38 97.92 9.21 Favored 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 107.275 -1.379 . . . . 0.0 107.275 -173.301 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 10.4 tt -98.92 102.16 13.79 Favored 'General case' 0 N--CA 1.485 1.29 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 -177.402 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -98.77 111.5 23.86 Favored 'General case' 0 N--CA 1.484 1.25 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 -174.49 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 52.4 m -91.65 95.91 10.16 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 -179.366 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 23.1 m-70 -87.26 96.42 10.33 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 -176.556 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 37.4 t . . . . . 0 N--CA 1.484 1.227 0 C-N-CA 123.733 0.813 . . . . 0.0 109.96 -169.992 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 9.2 p30 . . . . . 0 N--CA 1.49 1.549 0 CA-C-O 120.333 0.111 . . . . 0.0 111.008 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 77.1 p -130.35 132.33 45.77 Favored 'General case' 0 N--CA 1.497 1.901 0 C-N-CA 123.091 0.556 . . . . 0.0 111.174 -169.561 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -117.89 130.55 56.31 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 123.784 0.833 . . . . 0.0 110.009 -176.433 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 39.1 pt -123.66 132.91 70.58 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 C-N-CA 123.456 0.703 . . . . 0.0 109.412 175.773 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 45.9 t -120.99 107.4 12.6 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 -176.669 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 49.0 p90 -136.42 136.73 39.8 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 115.204 1.557 . . . . 0.0 115.204 -159.435 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 50.5 mtmt -103.5 14.67 30.8 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 117.214 2.302 . . . . 0.0 117.214 -173.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . 0.295 3.3 mp 62.59 96.9 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.744 0 CA-C-N 120.648 1.567 . . . . 0.0 114.318 177.226 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 87.1 38.68 7.75 Favored Glycine 0 CA--C 1.55 2.28 0 N-CA-C 116.99 1.556 . . . . 0.0 116.99 -170.087 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 86.5 t -138.73 124.22 23.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 N-CA-C 106.839 -1.541 . . . . 0.0 106.839 -179.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -87.8 116.26 25.82 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 123.042 0.537 . . . . 0.0 109.961 171.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 45.0 p90 -125.43 131.8 52.84 Favored 'General case' 0 N--CA 1.491 1.624 0 C-N-CA 123.912 0.885 . . . . 0.0 109.851 -175.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -73.61 110.4 7.86 Favored 'General case' 0 CA--C 1.564 1.507 0 O-C-N 121.411 -0.806 . . . . 0.0 111.889 176.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 13.7 tp10 -106.41 132.94 51.84 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 124.115 0.966 . . . . 0.0 109.563 -174.441 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 52.2 m -96.96 117.59 31.49 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 174.255 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 20.3 p -84.9 166.83 16.5 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-O 121.664 0.745 . . . . 0.0 112.101 -174.704 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -67.36 -20.94 65.64 Favored 'General case' 0 CA--C 1.571 1.757 0 N-CA-C 117.677 2.473 . . . . 0.0 117.677 169.446 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -76.68 -0.24 22.84 Favored 'General case' 0 CA--C 1.581 2.137 0 N-CA-C 116.142 1.904 . . . . 0.0 116.142 160.536 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . 0.265 11.1 m-20 71.57 70.07 0.16 Allowed 'General case' 0 N--CA 1.495 1.811 0 C-N-CA 125.349 1.46 . . . . 0.0 111.729 -176.857 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 80.9 mtm180 -141.2 126.72 18.85 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 -175.302 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.57 97.17 8.9 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 123.37 0.668 . . . . 0.0 111.317 172.576 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 10.8 m -113.6 127.33 71.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 C-N-CA 123.165 0.586 . . . . 0.0 109.912 -168.268 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 29.9 mmtp -80.4 103.69 10.44 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 123.507 0.723 . . . . 0.0 110.118 179.632 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 70.8 m -100.21 95.84 7.07 Favored 'General case' 0 N--CA 1.483 1.198 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.947 -165.26 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 7.1 tp -107.71 113.84 44.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 177.35 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -130.4 128.12 63.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 C-N-CA 124.012 0.925 . . . . 0.0 109.129 -176.278 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 10.2 t -140.45 150.08 43.37 Favored 'General case' 0 N--CA 1.488 1.472 0 CA-C-O 122.719 1.247 . . . . 0.0 110.052 175.689 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 19.2 tp -85.07 114.18 22.02 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-N 114.616 -1.175 . . . . 0.0 109.321 176.501 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -101.63 81.09 2.12 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-O 121.239 0.542 . . . . 0.0 110.085 -178.562 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 57.07 45.14 92.74 Favored Glycine 0 N--CA 1.489 2.175 0 N-CA-C 118.016 1.967 . . . . 0.0 118.016 -177.127 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 102.87 -45.15 1.37 Allowed Glycine 0 N--CA 1.491 2.317 0 N-CA-C 116.481 1.352 . . . . 0.0 116.481 -165.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 83.6 tttt -81.33 106.81 13.59 Favored 'General case' 0 CA--C 1.559 1.3 0 C-N-CA 123.616 0.767 . . . . 0.0 110.87 -176.767 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 30.4 tp -82.52 114.59 21.03 Favored 'General case' 0 N--CA 1.484 1.232 0 CA-C-O 121.546 0.688 . . . . 0.0 110.948 -177.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 48.3 t -113.47 110.21 31.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 N-CA-C 106.72 -1.585 . . . . 0.0 106.72 -168.824 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 23.7 t-160 -106.2 142.46 35.84 Favored 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 124.113 0.965 . . . . 0.0 109.717 174.702 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 30.3 tp -131.74 122.81 26.47 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 174.441 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 81.9 mt-30 -115.41 105.61 13.04 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 176.089 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 71.0 mttt -107.36 135.69 48.43 Favored 'General case' 0 N--CA 1.495 1.782 0 C-N-CA 123.43 0.692 . . . . 0.0 111.656 -177.674 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 18.3 p90 -150.42 111.23 4.29 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 123.346 0.658 . . . . 0.0 109.946 178.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 4.8 t70 50.56 57.85 6.16 Favored 'General case' 0 N--CA 1.497 1.894 0 N-CA-C 116.304 1.965 . . . . 0.0 116.304 166.578 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 91.26 -44.8 2.8 Favored Glycine 0 CA--C 1.55 2.267 0 N-CA-C 116.789 1.476 . . . . 0.0 116.789 -171.62 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 19.6 mt-30 -92.34 134.72 34.65 Favored 'General case' 0 N--CA 1.489 1.52 0 CA-C-N 118.234 1.017 . . . . 0.0 111.577 -174.036 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -113.53 157.8 21.56 Favored 'General case' 0 N--CA 1.491 1.62 0 CA-C-O 121.612 0.72 . . . . 0.0 112.028 172.775 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 14.6 t -140.78 120.27 13.19 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 158.604 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 39.9 p -90.62 125.36 35.61 Favored 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 122.661 0.385 . . . . 0.0 110.519 172.15 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 5.5 mp -102.06 80.52 2.0 Allowed 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 177.57 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 71.1 t -88.69 105.71 16.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 -170.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 83.8 mtt85 -103.5 123.34 46.71 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 123.536 0.734 . . . . 0.0 109.742 -176.653 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -144.46 131.45 20.41 Favored 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 122.805 0.442 . . . . 0.0 110.974 -172.023 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -81.12 116.0 20.82 Favored 'General case' 0 N--CA 1.487 1.405 0 CA-C-O 121.281 0.562 . . . . 0.0 111.327 -179.131 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 86.1 mt -123.88 107.1 18.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 N-CA-C 104.66 -2.348 . . . . 0.0 104.66 176.518 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 58.4 50.48 9.37 Favored 'General case' 0 N--CA 1.5 2.029 0 N-CA-C 114.945 1.461 . . . . 0.0 114.945 176.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 66.91 18.13 68.3 Favored Glycine 0 CA--C 1.554 2.516 0 N-CA-C 119.758 2.663 . . . . 0.0 119.758 -171.833 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 38.8 mtmm -126.78 131.3 51.31 Favored 'General case' 0 N--CA 1.489 1.486 0 CA-C-N 119.981 1.891 . . . . 0.0 109.106 -173.626 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 14.1 tp -79.22 107.59 12.1 Favored 'General case' 0 CA--C 1.558 1.255 0 C-N-CA 123.334 0.654 . . . . 0.0 109.38 178.124 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 33.6 mm -99.54 100.41 10.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 N-CA-C 106.569 -1.641 . . . . 0.0 106.569 -175.255 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 29.8 tp -92.12 99.85 12.58 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 124.16 0.984 . . . . 0.0 109.647 178.234 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' THR . . . . . 0.446 HG23 ' HG1' ' A' ' 125' ' ' THR . 1.8 p -86.84 114.67 23.69 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 123.689 0.796 . . . . 0.0 109.589 171.839 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 85.1 mt -101.96 89.05 3.51 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 123.971 0.908 . . . . 0.0 108.979 -176.36 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' THR . . . . . 0.425 ' HG1' ' CG2' ' A' ' 123' ' ' VAL . 7.6 m -100.4 108.93 21.06 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 108.798 -0.815 . . . . 0.0 108.798 -171.682 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 2.2 t60 -76.86 -63.31 1.38 Allowed 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 122.454 0.301 . . . . 0.0 111.348 167.578 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -165.37 -76.47 0.03 OUTLIER Glycine 0 N--CA 1.479 1.543 0 N-CA-C 109.499 -1.441 . . . . 0.0 109.499 178.699 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 72.9 m -73.28 -54.42 8.45 Favored 'General case' 0 CA--C 1.568 1.668 0 CA-C-O 118.693 -0.67 . . . . 0.0 112.787 169.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -97.4 112.62 24.38 Favored 'General case' 0 N--CA 1.483 1.207 0 CA-C-N 119.405 1.002 . . . . 0.0 112.552 -172.505 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . 0.425 ' CG2' ' HG1' ' A' ' 118' ' ' THR . 6.0 p -95.91 127.63 47.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 C-N-CA 123.825 0.85 . . . . 0.0 110.058 169.187 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 44.0 t -100.81 108.1 19.81 Favored 'General case' 0 N--CA 1.481 1.102 0 CA-C-O 121.062 0.458 . . . . 0.0 111.261 171.428 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' THR . . . . . 0.446 ' HG1' HG23 ' A' ' 116' ' ' THR . 47.8 m -84.48 112.06 20.04 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 176.413 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 37.6 mtt180 -104.29 116.0 31.39 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 123.259 0.624 . . . . 0.0 110.114 175.045 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 92.9 m -90.09 129.32 36.4 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 173.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 58.7 m-85 -124.93 129.67 50.83 Favored 'General case' 0 CA--C 1.559 1.29 0 C-N-CA 123.546 0.738 . . . . 0.0 109.283 179.081 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -94.54 154.28 17.47 Favored 'General case' 0 N--CA 1.494 1.757 0 CA-C-O 122.326 1.06 . . . . 0.0 111.347 167.147 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 70.9 tttt -86.01 116.37 24.19 Favored 'General case' 0 N--CA 1.484 1.25 0 CA-C-N 115.554 -0.748 . . . . 0.0 112.059 -167.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 50.2 tp10 -75.03 -40.95 60.19 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 116.666 2.098 . . . . 0.0 116.666 172.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.97 0 CA-C-O 124.287 1.994 . . . . 0.0 107.882 173.749 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.251 4.0 p . . . . . 0 CA--C 1.576 1.971 0 N-CA-C 115.18 1.548 . . . . 0.0 115.18 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -77.5 -36.95 52.08 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 115.825 1.787 . . . . 0.0 115.825 -174.345 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -58.3 -24.49 59.75 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 117.714 2.487 . . . . 0.0 117.714 167.054 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -72.46 -19.46 61.56 Favored 'General case' 0 CA--C 1.566 1.566 0 N-CA-C 116.377 1.991 . . . . 0.0 116.377 168.833 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 44.4 mt -81.16 121.74 26.5 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-N 121.228 1.831 . . . . 0.0 111.554 -171.517 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 159.43 -177.23 36.04 Favored Glycine 0 N--CA 1.484 1.88 0 CA-C-O 121.9 0.722 . . . . 0.0 113.583 -179.159 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 63.7 m -92.11 139.79 30.28 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 170.702 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 90.2 m95 -141.19 109.5 5.88 Favored 'General case' 0 N--CA 1.487 1.381 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 -171.391 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 55.8 mttp -100.7 141.52 33.45 Favored 'General case' 0 N--CA 1.49 1.542 0 CA-C-O 121.222 0.534 . . . . 0.0 109.941 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 58.1 tp -68.08 123.01 19.46 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-O 122.178 0.99 . . . . 0.0 112.167 -175.135 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . 0.27 1.0 OUTLIER -103.5 -41.65 7.43 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.751 0 CA-C-N 113.9 -1.5 . . . . 0.0 112.737 -175.337 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -145.85 133.47 20.97 Favored 'General case' 0 N--CA 1.488 1.454 0 CA-C-N 119.922 1.237 . . . . 0.0 108.948 178.1 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 88.7 p -115.54 101.15 8.61 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 122.976 0.51 . . . . 0.0 110.662 175.021 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 59.2 mtpt -87.12 118.33 26.45 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 174.519 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 60.8 m-20 66.55 29.97 8.71 Favored 'General case' 0 N--CA 1.502 2.134 0 N-CA-C 117.173 2.286 . . . . 0.0 117.173 177.069 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.463 ' HB2' ' SG ' ' A' ' 124' ' ' CYS . 18.0 t80 -89.57 69.51 7.85 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 120.235 -1.54 . . . . 0.0 111.857 178.808 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 26.8 m-20 -162.61 -54.22 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 125.684 1.594 . . . . 0.0 108.044 -177.457 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 21.1 t0 -56.61 -45.27 81.56 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 115.422 1.638 . . . . 0.0 115.422 167.387 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 81.6 t80 -51.98 -54.43 29.89 Favored 'General case' 0 CA--C 1.57 1.716 0 N-CA-C 114.787 1.403 . . . . 0.0 114.787 169.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 70.4 mtm -63.98 -46.13 85.97 Favored 'General case' 0 N--CA 1.491 1.575 0 N-CA-C 115.539 1.681 . . . . 0.0 115.539 174.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -57.86 -44.99 86.92 Favored 'General case' 0 CA--C 1.57 1.713 0 N-CA-C 115.5 1.667 . . . . 0.0 115.5 173.582 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 23.3 t -61.51 -37.27 83.11 Favored 'General case' 0 CA--C 1.568 1.645 0 N-CA-C 116.367 1.988 . . . . 0.0 116.367 170.275 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 69.2 mt -64.79 -23.31 67.2 Favored 'General case' 0 CA--C 1.568 1.657 0 N-CA-C 117.96 2.578 . . . . 0.0 117.96 169.24 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 99.49 68.61 0.89 Allowed Glycine 0 N--CA 1.482 1.746 0 CA-C-N 119.416 1.007 . . . . 0.0 112.193 -171.156 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 33.8 t -144.95 112.66 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 N-CA-C 104.375 -2.454 . . . . 0.0 104.375 -177.842 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -70.83 -91.99 0.08 OUTLIER Glycine 0 N--CA 1.486 2.015 0 N-CA-C 117.676 1.83 . . . . 0.0 117.676 -160.763 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . 0.279 40.4 p90 -140.07 -60.91 0.53 Allowed 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 112.977 0.732 . . . . 0.0 112.977 -171.328 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.51 -39.91 92.39 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 115.575 1.695 . . . . 0.0 115.575 172.221 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 71.9 m -71.38 -37.44 71.59 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 113.961 1.097 . . . . 0.0 113.961 171.355 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 66.4 ttp85 -62.22 -42.79 99.63 Favored 'General case' 0 CA--C 1.572 1.795 0 N-CA-C 114.961 1.467 . . . . 0.0 114.961 170.117 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 9.5 tm0? -65.31 -49.87 67.83 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 114.497 1.295 . . . . 0.0 114.497 172.061 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 93.5 t -64.87 -36.68 78.29 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.925 0 CA-C-N 119.489 1.041 . . . . 0.0 113.762 177.72 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -64.6 -37.03 86.16 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 116.94 2.2 . . . . 0.0 116.94 172.688 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 96.6 p -67.65 -40.41 84.52 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 115.675 1.732 . . . . 0.0 115.675 165.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 48.9 ttp -69.35 -35.69 76.12 Favored 'General case' 0 CA--C 1.567 1.622 0 N-CA-C 116.979 2.214 . . . . 0.0 116.979 176.033 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 8.3 t -63.49 -31.4 72.55 Favored 'General case' 0 N--CA 1.498 1.965 0 N-CA-C 118.488 2.773 . . . . 0.0 118.488 -167.501 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . 0.261 34.2 ttpt 75.25 90.37 0.06 OUTLIER Pre-proline 0 CA--C 1.573 1.833 0 C-N-CA 124.832 1.253 . . . . 0.0 112.128 177.285 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -72.62 125.32 10.49 Favored 'Trans proline' 0 C--N 1.369 1.634 0 C-N-CA 123.292 2.661 . . . . 0.0 114.501 -176.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 97.9 m -97.06 92.71 6.19 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 -179.185 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 57.4 m -86.19 110.32 19.51 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 123.12 0.568 . . . . 0.0 110.099 -173.598 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 95.1 mt -101.64 110.31 28.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 N-CA-C 106.811 -1.552 . . . . 0.0 106.811 178.609 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 59.3 mt -100.48 116.19 43.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 -179.143 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 4.5 tm-20 -136.63 110.95 8.44 Favored 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 -171.506 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 81.7 tttt -95.0 113.24 24.92 Favored 'General case' 0 CA--C 1.554 1.126 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 171.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 14.6 t-20 -82.2 -58.65 2.86 Favored 'General case' 0 CA--C 1.564 1.511 0 C-N-CA 123.243 0.617 . . . . 0.0 112.478 -178.083 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -132.63 -95.55 0.6 Allowed Glycine 0 N--CA 1.483 1.816 0 N-CA-C 109.18 -1.568 . . . . 0.0 109.18 169.45 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -79.8 -30.9 40.68 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 114.917 1.451 . . . . 0.0 114.917 163.398 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 39.8 mm -77.93 111.85 15.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 CA-C-N 119.311 0.96 . . . . 0.0 109.507 -175.047 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 2.0 mt -78.72 137.95 38.02 Favored 'General case' 0 CA--C 1.561 1.376 0 C-N-CA 123.254 0.622 . . . . 0.0 110.379 160.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 10.7 m -133.72 103.43 5.87 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 -177.438 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 9.1 tt -96.7 112.31 24.11 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 107.358 -1.349 . . . . 0.0 107.358 177.095 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 89.4 mttt -112.87 98.88 7.47 Favored 'General case' 0 N--CA 1.485 1.285 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 -164.676 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 28.4 m -87.98 95.14 10.01 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.327 -0.858 . . . . 0.0 109.22 -174.467 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 77.8 m80 -85.03 28.83 0.68 Allowed 'General case' 0 CA--C 1.573 1.84 0 N-CA-C 116.59 2.07 . . . . 0.0 116.59 -173.273 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . 0.271 17.5 m . . . . . 0 CA--C 1.553 1.081 0 N-CA-C 105.29 -2.115 . . . . 0.0 105.29 153.138 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 42.9 m-20 . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 120.997 0.427 . . . . 0.0 111.787 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 40.4 p -105.2 133.78 49.4 Favored 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 123.532 0.733 . . . . 0.0 110.448 -174.158 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -122.48 122.14 38.24 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 123.344 0.658 . . . . 0.0 109.367 179.517 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 39.2 pt -93.64 136.26 25.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 C-N-CA 123.174 0.59 . . . . 0.0 109.587 163.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 33.0 t -125.02 116.69 22.53 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 173.655 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 41.2 p90 -149.4 148.18 29.16 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 113.837 1.051 . . . . 0.0 113.837 -153.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 62.7 mtpt -111.99 18.89 18.38 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 116.959 2.207 . . . . 0.0 116.959 -171.494 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . 0.28 1.5 mp 57.11 83.86 0.1 Allowed 'General case' 0 N--CA 1.495 1.802 0 CA-C-N 120.74 1.609 . . . . 0.0 114.532 177.678 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 98.02 42.9 2.95 Favored Glycine 0 CA--C 1.548 2.146 0 N-CA-C 116.221 1.248 . . . . 0.0 116.221 -171.429 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 70.8 t -145.08 127.72 10.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 N-CA-C 105.752 -1.944 . . . . 0.0 105.752 -178.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -87.25 116.72 25.53 Favored 'General case' 0 CA--C 1.566 1.566 0 CA-C-O 121.634 0.731 . . . . 0.0 110.129 173.079 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 25.4 p90 -114.91 -172.83 2.2 Favored 'General case' 0 N--CA 1.494 1.745 0 C-N-CA 124.796 1.238 . . . . 0.0 109.733 171.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -117.05 145.13 43.91 Favored 'General case' 0 N--CA 1.487 1.401 0 CA-C-O 123.25 1.5 . . . . 0.0 110.846 168.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 52.2 tp10 -129.34 148.15 51.24 Favored 'General case' 0 N--CA 1.488 1.456 0 CA-C-N 112.804 -1.998 . . . . 0.0 109.928 177.319 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 83.4 m -103.85 124.25 48.6 Favored 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 168.433 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 28.4 p -75.64 168.06 20.72 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-O 121.579 0.704 . . . . 0.0 112.851 -176.536 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -59.62 -29.41 67.99 Favored 'General case' 0 CA--C 1.563 1.454 0 N-CA-C 117.827 2.529 . . . . 0.0 117.827 178.748 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 62.5 m-20 -116.11 67.24 0.71 Allowed 'General case' 0 N--CA 1.491 1.625 0 CA-C-N 119.121 0.873 . . . . 0.0 110.491 165.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 47.06 72.46 0.24 Allowed 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 117.595 2.442 . . . . 0.0 117.595 164.84 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 63.1 mtm-85 -139.68 123.52 17.55 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 171.037 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -71.32 122.57 20.53 Favored 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 123.1 0.56 . . . . 0.0 110.505 164.3 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 32.8 m -138.92 135.09 42.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 -169.818 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 30.5 mmmt -82.17 101.02 10.17 Favored 'General case' 0 N--CA 1.488 1.434 0 CA-C-O 122.418 1.104 . . . . 0.0 110.224 178.267 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 22.4 p -93.1 107.14 18.99 Favored 'General case' 0 CA--C 1.555 1.164 0 CA-C-N 114.117 -1.401 . . . . 0.0 111.821 -170.637 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -113.33 121.26 65.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 174.424 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 1.1 p -131.76 130.42 61.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 C-N-CA 123.921 0.888 . . . . 0.0 109.598 -178.623 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 9.0 t -145.19 153.66 41.59 Favored 'General case' 0 N--CA 1.486 1.356 0 CA-C-O 122.942 1.353 . . . . 0.0 110.407 179.044 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 44.2 tp -86.42 123.58 31.81 Favored 'General case' 0 CA--C 1.562 1.438 0 CA-C-N 114.402 -1.272 . . . . 0.0 110.333 177.68 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -104.93 76.54 1.26 Allowed 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 123.54 0.736 . . . . 0.0 110.581 176.161 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 75.1 -76.4 1.24 Allowed Glycine 0 N--CA 1.487 2.069 0 N-CA-C 114.246 0.458 . . . . 0.0 114.246 -176.551 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -142.91 45.91 0.88 Allowed Glycine 0 CA--C 1.549 2.165 0 CA-C-N 114.428 -0.886 . . . . 0.0 114.293 167.043 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 56.3 mtpt -138.33 118.71 13.74 Favored 'General case' 0 N--CA 1.484 1.237 0 N-CA-C 105.593 -2.002 . . . . 0.0 105.593 178.115 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 4.4 tt -87.94 100.5 12.94 Favored 'General case' 0 CA--C 1.561 1.366 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 -178.482 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 78.6 t -106.33 102.28 13.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 N-CA-C 107.397 -1.334 . . . . 0.0 107.397 -164.466 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 20.5 t-160 -99.97 144.9 28.48 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 123.842 0.857 . . . . 0.0 110.329 173.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 17.8 tp -145.1 125.89 14.32 Favored 'General case' 0 N--CA 1.488 1.426 0 CA-C-O 122.035 0.921 . . . . 0.0 108.551 176.452 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 29.8 mt-30 -113.84 118.38 34.09 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 124.53 1.132 . . . . 0.0 108.615 -177.337 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -116.94 136.59 52.83 Favored 'General case' 0 N--CA 1.495 1.792 0 C-N-CA 123.26 0.624 . . . . 0.0 111.244 -173.351 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 16.7 p90 -153.59 111.02 3.49 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.231 -0.918 . . . . 0.0 110.64 -178.763 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 4.8 t70 55.07 55.0 8.14 Favored 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 116.009 1.855 . . . . 0.0 116.009 166.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 86.08 -45.76 3.52 Favored Glycine 0 CA--C 1.552 2.355 0 N-CA-C 116.389 1.316 . . . . 0.0 116.389 -168.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 25.4 mt-30 -78.09 149.97 33.81 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 123.547 0.739 . . . . 0.0 112.298 -178.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -150.07 150.49 31.8 Favored 'General case' 0 N--CA 1.488 1.451 0 CA-C-O 121.323 0.582 . . . . 0.0 111.735 175.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 14.2 t -128.47 124.95 37.44 Favored 'General case' 0 N--CA 1.49 1.56 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.353 170.189 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 36.1 p -85.99 134.19 33.88 Favored 'General case' 0 N--CA 1.492 1.665 0 CA-C-O 121.606 0.717 . . . . 0.0 110.251 168.032 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 5.2 mp -116.74 86.03 2.43 Favored 'General case' 0 CA--C 1.562 1.404 0 N-CA-C 106.727 -1.583 . . . . 0.0 106.727 176.159 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 52.1 t -94.22 100.11 10.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.775 0 N-CA-C 107.742 -1.206 . . . . 0.0 107.742 -170.076 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 20.0 mmt180 -90.0 126.27 35.69 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 123.929 0.891 . . . . 0.0 109.915 178.14 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -150.76 131.15 13.73 Favored 'General case' 0 N--CA 1.494 1.76 0 C-N-CA 122.605 0.362 . . . . 0.0 111.938 -172.016 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -77.69 117.53 19.19 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.5 -0.75 . . . . 0.0 111.403 175.378 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 84.3 mt -125.17 105.6 15.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 N-CA-C 104.764 -2.31 . . . . 0.0 104.764 176.653 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 57.16 53.73 7.53 Favored 'General case' 0 N--CA 1.499 1.978 0 N-CA-C 114.246 1.202 . . . . 0.0 114.246 177.63 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 79.65 -27.45 2.55 Favored Glycine 0 CA--C 1.555 2.574 0 N-CA-C 119.097 2.399 . . . . 0.0 119.097 -169.389 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 38.4 mtmm -102.28 131.61 48.75 Favored 'General case' 0 N--CA 1.486 1.336 0 CA-C-N 119.497 1.648 . . . . 0.0 110.214 -164.16 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 49.0 tp -83.98 114.21 21.54 Favored 'General case' 0 CA--C 1.556 1.195 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.797 -176.2 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 33.3 mm -102.88 108.82 25.11 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 -171.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 53.5 tp -89.16 111.06 21.75 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 123.9 0.88 . . . . 0.0 109.298 172.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 90.0 m -101.68 110.6 22.62 Favored 'General case' 0 N--CA 1.494 1.725 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 -179.421 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 97.7 mt -104.01 91.18 3.85 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 123.726 0.811 . . . . 0.0 110.227 -172.439 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 7.4 m -107.78 105.4 15.22 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 -175.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 16.7 t60 -83.07 -64.3 1.2 Allowed 'General case' 0 N--CA 1.493 1.684 0 C-N-CA 123.176 0.591 . . . . 0.0 111.631 172.3 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -152.2 -89.88 0.07 OUTLIER Glycine 0 N--CA 1.479 1.524 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 174.081 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 12.0 t -92.13 41.16 1.06 Allowed 'General case' 0 CA--C 1.577 1.995 0 N-CA-C 114.369 1.248 . . . . 0.0 114.369 169.825 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -158.86 97.69 1.43 Allowed 'General case' 0 N--CA 1.485 1.278 0 O-C-N 120.874 -1.141 . . . . 0.0 109.45 175.419 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 4.0 p -97.01 120.34 46.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 C-N-CA 123.842 0.857 . . . . 0.0 109.409 172.763 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' CYS . . . . . 0.463 ' SG ' ' HB2' ' A' ' 16' ' ' PHE . 41.4 t -112.03 102.87 11.06 Favored 'General case' 0 CA--C 1.557 1.214 0 CA-C-O 121.448 0.642 . . . . 0.0 110.943 177.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 90.5 m -92.43 110.19 21.59 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 123.756 0.822 . . . . 0.0 109.117 -176.367 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 38.4 mtm180 -113.26 121.07 43.32 Favored 'General case' 0 N--CA 1.488 1.475 0 C-N-CA 123.235 0.614 . . . . 0.0 110.912 -170.713 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 89.3 m -87.96 136.3 33.03 Favored 'General case' 0 N--CA 1.492 1.643 0 C-N-CA 123.751 0.82 . . . . 0.0 110.74 179.535 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 45.0 m-85 -130.66 125.98 35.4 Favored 'General case' 0 CA--C 1.56 1.343 0 C-N-CA 123.796 0.838 . . . . 0.0 109.162 -179.185 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -95.55 153.58 17.64 Favored 'General case' 0 N--CA 1.495 1.792 0 CA-C-O 122.239 1.018 . . . . 0.0 111.435 169.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 72.2 tttt -85.44 119.34 25.68 Favored 'General case' 0 N--CA 1.485 1.318 0 CA-C-N 115.221 -0.9 . . . . 0.0 111.559 -170.368 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -103.36 45.73 0.95 Allowed 'General case' 0 N--CA 1.492 1.675 0 N-CA-C 113.655 0.984 . . . . 0.0 113.655 176.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.02 0 CA-C-O 124.327 2.013 . . . . 0.0 107.841 -178.987 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.258 5.6 p . . . . . 0 CA--C 1.577 1.984 0 N-CA-C 115.993 1.849 . . . . 0.0 115.993 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -66.16 -40.08 90.27 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 116.27 1.952 . . . . 0.0 116.27 -176.343 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -59.53 -29.38 67.85 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 117.442 2.386 . . . . 0.0 117.442 168.687 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -68.26 -24.62 64.91 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 116.243 1.942 . . . . 0.0 116.243 167.728 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 39.3 mt -74.81 120.46 20.38 Favored 'General case' 0 N--CA 1.488 1.456 0 CA-C-N 120.759 1.618 . . . . 0.0 111.476 -174.282 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 162.76 168.95 25.46 Favored Glycine 0 N--CA 1.479 1.531 0 CA-C-O 122.822 1.235 . . . . 0.0 113.471 -173.459 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 78.3 m -86.75 136.42 33.01 Favored 'General case' 0 N--CA 1.49 1.535 0 CA-C-N 114.061 -1.069 . . . . 0.0 108.805 164.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 81.4 m95 -140.65 111.69 7.12 Favored 'General case' 0 N--CA 1.484 1.269 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 -174.258 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 8.9 mtpm? -91.97 145.61 24.4 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.866 -0.522 . . . . 0.0 110.278 173.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 48.7 tp -68.07 124.44 23.43 Favored 'General case' 0 N--CA 1.488 1.466 0 CA-C-O 121.94 0.876 . . . . 0.0 111.497 179.394 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . 0.279 1.2 t -96.91 -45.84 12.82 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.79 0 CA-C-N 114.313 -1.312 . . . . 0.0 112.032 177.563 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 51.5 t0 -144.19 129.35 18.68 Favored 'General case' 0 N--CA 1.49 1.528 0 CA-C-N 119.989 1.268 . . . . 0.0 109.806 -177.107 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 75.7 p -104.69 102.3 11.89 Favored 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 123.217 0.607 . . . . 0.0 110.57 169.153 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 61.1 mtpt -101.12 111.45 23.67 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 -178.798 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.256 30.8 m-20 71.12 21.14 4.92 Favored 'General case' 0 N--CA 1.505 2.287 0 N-CA-C 117.028 2.232 . . . . 0.0 117.028 -177.46 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 27.1 t80 -67.36 -47.4 70.54 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 119.989 -1.694 . . . . 0.0 114.548 -178.588 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -40.82 -48.57 3.09 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 118.399 2.74 . . . . 0.0 118.399 161.602 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 18.3 t0 -59.54 -52.87 63.69 Favored 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 115.067 1.506 . . . . 0.0 115.067 172.815 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 93.1 t80 -52.16 -50.29 62.1 Favored 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 115.64 1.719 . . . . 0.0 115.64 170.281 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 40.8 mmm -62.49 -51.76 66.18 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 114.804 1.409 . . . . 0.0 114.804 -179.637 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 21.7 tptm -60.36 -37.11 79.69 Favored 'General case' 0 CA--C 1.571 1.759 0 N-CA-C 115.893 1.812 . . . . 0.0 115.893 172.722 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 17.5 t -61.71 -40.07 93.73 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 116.263 1.949 . . . . 0.0 116.263 169.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 80.2 mt -62.03 -23.45 66.46 Favored 'General case' 0 CA--C 1.569 1.692 0 N-CA-C 117.828 2.529 . . . . 0.0 117.828 168.216 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 97.71 67.96 0.93 Allowed Glycine 0 N--CA 1.482 1.729 0 CA-C-N 119.074 0.852 . . . . 0.0 112.046 -166.667 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 41.2 t -143.64 109.99 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 N-CA-C 104.348 -2.464 . . . . 0.0 104.348 177.824 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -68.61 168.37 43.14 Favored Glycine 0 CA--C 1.546 2.016 0 N-CA-C 116.174 1.23 . . . . 0.0 116.174 -177.343 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 25.3 p90 -53.07 -38.6 62.64 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 119.127 3.01 . . . . 0.0 119.127 -170.121 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.32 -45.17 81.19 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 116.003 1.853 . . . . 0.0 116.003 176.48 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 56.0 m -72.51 -35.54 68.15 Favored 'General case' 0 N--CA 1.501 2.101 0 N-CA-C 114.045 1.128 . . . . 0.0 114.045 171.196 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 48.2 ttp180 -54.59 -49.3 70.73 Favored 'General case' 0 CA--C 1.569 1.681 0 N-CA-C 115.463 1.653 . . . . 0.0 115.463 169.092 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 24.1 mm100 -74.22 -39.43 63.11 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 115.388 1.625 . . . . 0.0 115.388 176.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 73.8 t -61.33 -47.08 95.12 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.03 0 CA-C-N 120.129 1.331 . . . . 0.0 113.135 172.589 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -68.58 -31.9 71.42 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 117.204 2.298 . . . . 0.0 117.204 176.141 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 94.0 p -68.62 -43.6 76.03 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 115.552 1.686 . . . . 0.0 115.552 167.467 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 49.7 ttp -60.33 -41.7 94.1 Favored 'General case' 0 CA--C 1.568 1.666 0 N-CA-C 115.782 1.771 . . . . 0.0 115.782 168.447 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 95.0 m -68.3 136.15 53.01 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 124.141 0.976 . . . . 0.0 110.591 170.668 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 5.3 mptp? -106.69 95.96 13.27 Favored Pre-proline 0 CA--C 1.567 1.621 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 175.401 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -83.22 147.12 12.78 Favored 'Trans proline' 0 C--N 1.372 1.804 0 C-N-CA 122.854 2.37 . . . . 0.0 113.452 -172.234 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 44.9 m -98.41 102.94 14.83 Favored 'General case' 0 CA--C 1.563 1.443 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.586 -169.758 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 79.8 m -80.09 113.4 18.24 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 123.896 0.879 . . . . 0.0 109.744 177.687 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 89.3 mt -115.61 107.69 23.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 N-CA-C 106.024 -1.843 . . . . 0.0 106.024 -175.131 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 4.2 mp -97.68 120.23 46.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 N-CA-C 107.378 -1.341 . . . . 0.0 107.378 174.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -134.99 116.2 14.39 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.245 -1.021 . . . . 0.0 108.245 -179.107 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 84.3 tttt -89.02 111.83 22.63 Favored 'General case' 0 CA--C 1.557 1.234 0 C-N-CA 123.175 0.59 . . . . 0.0 110.267 178.04 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 28.3 t30 -99.42 87.91 3.74 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.642 -0.874 . . . . 0.0 108.642 178.729 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 78.82 -96.4 1.43 Allowed Glycine 0 N--CA 1.484 1.869 0 CA-C-N 116.445 -0.343 . . . . 0.0 112.396 -171.817 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 86.4 m-20 -109.22 -17.11 13.92 Favored 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 115.265 1.58 . . . . 0.0 115.265 169.062 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 24.2 mm -93.34 118.46 39.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 CA-C-N 120.512 1.505 . . . . 0.0 109.14 -167.078 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 42.2 mt -84.87 114.33 22.03 Favored 'General case' 0 N--CA 1.486 1.325 0 C-N-CA 123.763 0.825 . . . . 0.0 111.434 179.701 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 87.6 m -102.25 102.29 12.67 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 -178.277 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 8.7 tt -104.15 105.21 15.3 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.307 -0.998 . . . . 0.0 108.307 -179.531 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -108.72 121.48 45.14 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 123.917 0.887 . . . . 0.0 109.565 -178.734 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 91.6 m -101.68 95.11 6.22 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 108.083 -1.081 . . . . 0.0 108.083 179.217 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 17.5 m-70 -81.26 99.79 8.8 Favored 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 123.564 0.745 . . . . 0.0 110.544 -170.312 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 85.6 p . . . . . 0 N--CA 1.491 1.617 0 N-CA-C 117.198 2.295 . . . . 0.0 117.198 -175.768 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 54.1 t30 . . . . . 0 N--CA 1.488 1.445 0 CA-C-O 120.662 0.268 . . . . 0.0 110.436 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 77.5 p -89.26 127.66 35.79 Favored 'General case' 0 N--CA 1.492 1.655 0 C-N-CA 122.855 0.462 . . . . 0.0 110.34 -179.777 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.479 ' HE2' ' HB3' ' A' ' 63' ' ' SER . 4.3 tm-20 -123.51 122.25 37.74 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 123.584 0.753 . . . . 0.0 109.427 -169.408 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 48.7 pt -116.67 126.63 74.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 169.371 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' SER . . . . . 0.479 ' HB3' ' HE2' ' A' ' 61' ' ' GLU . 77.4 p -116.06 101.76 9.03 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 177.815 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 43.1 p90 -132.86 142.4 48.92 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 114.522 1.304 . . . . 0.0 114.522 -157.561 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 30.6 mtpp -98.23 146.72 25.34 Favored 'General case' 0 N--CA 1.489 1.501 0 CA-C-N 115.132 -0.94 . . . . 0.0 109.789 160.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -74.23 113.38 11.37 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 -173.83 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 86.64 45.5 5.47 Favored Glycine 0 CA--C 1.548 2.132 0 N-CA-C 115.848 1.099 . . . . 0.0 115.848 -169.259 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 76.7 t -141.79 121.58 10.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 N-CA-C 106.242 -1.762 . . . . 0.0 106.242 179.663 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -85.69 133.05 34.04 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 123.074 0.55 . . . . 0.0 111.147 175.193 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 52.0 p90 -139.32 149.83 44.67 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 124.006 0.922 . . . . 0.0 111.138 -174.383 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -74.64 133.49 42.14 Favored 'General case' 0 CA--C 1.567 1.607 0 O-C-N 121.234 -0.916 . . . . 0.0 112.703 173.189 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 17.3 tp10 -145.82 136.73 24.5 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 123.362 0.665 . . . . 0.0 110.252 -173.477 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 63.1 m -111.08 128.24 55.81 Favored 'General case' 0 N--CA 1.495 1.791 0 C-N-CA 123.279 0.632 . . . . 0.0 109.545 178.666 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 27.0 p -86.45 164.0 17.23 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 113.195 0.813 . . . . 0.0 113.195 -175.749 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -54.82 -32.17 60.11 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 118.779 2.881 . . . . 0.0 118.779 174.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -77.47 -85.44 0.06 Allowed 'General case' 0 N--CA 1.494 1.774 0 CA-C-N 120.416 1.462 . . . . 0.0 109.23 171.299 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -176.67 87.5 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 165.472 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 52.1 mtm-85 -139.95 115.11 9.76 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 -179.844 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -79.83 114.8 19.03 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 123.032 0.533 . . . . 0.0 109.604 166.589 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 13.9 m -125.47 138.76 53.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 CA-C-O 121.365 0.602 . . . . 0.0 110.116 -167.58 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 71.9 mmtt -84.92 107.95 17.32 Favored 'General case' 0 N--CA 1.488 1.426 0 CA-C-O 121.916 0.865 . . . . 0.0 109.179 170.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 47.3 t -106.95 100.84 10.31 Favored 'General case' 0 CA--C 1.555 1.144 0 CA-C-N 114.907 -1.042 . . . . 0.0 110.381 -161.403 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 6.4 tp -113.15 115.8 50.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 -176.494 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 1.4 p -134.26 126.93 50.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 C-N-CA 123.618 0.767 . . . . 0.0 109.735 -175.758 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 15.3 t -133.01 157.7 44.57 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-O 122.65 1.214 . . . . 0.0 110.98 176.065 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 14.9 tp -88.5 113.81 24.47 Favored 'General case' 0 N--CA 1.489 1.486 0 CA-C-N 114.833 -1.076 . . . . 0.0 108.505 168.36 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -107.0 87.22 2.46 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 123.322 0.649 . . . . 0.0 109.415 -174.518 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 61.4 48.26 86.15 Favored Glycine 0 CA--C 1.551 2.311 0 N-CA-C 117.262 1.665 . . . . 0.0 117.262 -174.265 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 69.36 26.42 74.58 Favored Glycine 0 CA--C 1.556 2.625 0 N-CA-C 118.662 2.225 . . . . 0.0 118.662 -167.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.17 109.87 5.76 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 107.151 -1.426 . . . . 0.0 107.151 -175.77 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 4.6 tt -88.63 106.28 18.22 Favored 'General case' 0 CA--C 1.56 1.343 0 CA-C-O 121.705 0.764 . . . . 0.0 111.249 -162.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 83.2 t -103.72 110.71 30.89 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 N-CA-C 107.113 -1.44 . . . . 0.0 107.113 -170.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 23.2 t-160 -103.75 138.82 39.83 Favored 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 124.023 0.929 . . . . 0.0 109.554 173.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 41.2 tp -132.52 121.1 22.79 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 107.837 -1.172 . . . . 0.0 107.837 173.413 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 29.9 mt-30 -106.51 129.47 54.46 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 124.198 0.999 . . . . 0.0 108.515 172.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 46.1 mtpt -129.86 130.31 45.05 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.809 -0.557 . . . . 0.0 110.065 -169.471 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 26.3 p90 -154.46 112.16 3.46 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.384 -0.823 . . . . 0.0 111.193 -175.834 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . 0.341 13.2 t70 66.67 -108.73 0.13 Allowed 'General case' 0 N--CA 1.495 1.781 0 C-N-CA 124.582 1.153 . . . . 0.0 112.457 170.527 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -116.42 44.82 1.38 Allowed Glycine 0 N--CA 1.488 2.163 0 CA-C-N 118.887 0.767 . . . . 0.0 115.007 165.096 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 14.9 mt-30 -152.3 126.52 9.23 Favored 'General case' 0 N--CA 1.484 1.273 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 178.704 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 13.4 mp0 -139.41 130.86 27.0 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 -179.194 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 5.2 t -125.13 134.25 52.51 Favored 'General case' 0 N--CA 1.495 1.805 0 C-N-CA 123.144 0.578 . . . . 0.0 111.569 -178.4 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 57.8 p -95.53 138.64 32.92 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-O 121.596 0.712 . . . . 0.0 111.705 172.144 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 5.9 mp -113.6 82.11 1.63 Allowed 'General case' 0 CA--C 1.563 1.449 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 173.812 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 48.1 t -90.73 112.59 25.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 -169.147 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 83.4 mtt85 -106.13 127.7 53.38 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 123.021 0.528 . . . . 0.0 110.086 -177.383 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 8.7 pm0 -139.62 132.86 29.83 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 123.234 0.614 . . . . 0.0 110.816 -178.665 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -80.19 112.92 17.97 Favored 'General case' 0 N--CA 1.487 1.404 0 CA-C-O 121.355 0.597 . . . . 0.0 110.892 175.792 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 73.2 mt -118.71 107.06 20.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 N-CA-C 104.805 -2.294 . . . . 0.0 104.805 176.486 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 59.3 49.85 8.49 Favored 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 114.692 1.367 . . . . 0.0 114.692 177.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 63.32 21.18 64.03 Favored Glycine 0 CA--C 1.555 2.572 0 N-CA-C 119.726 2.65 . . . . 0.0 119.726 -170.629 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 49.0 mtpt -130.95 131.4 44.4 Favored 'General case' 0 N--CA 1.488 1.47 0 CA-C-N 119.713 1.756 . . . . 0.0 108.665 -173.178 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 20.5 tp -81.91 108.53 15.49 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.312 0.645 . . . . 0.0 109.95 -175.155 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 29.8 mm -100.59 103.23 14.53 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 N-CA-C 106.463 -1.681 . . . . 0.0 106.463 -175.872 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 23.9 tp -92.03 98.28 11.46 Favored 'General case' 0 CA--C 1.56 1.328 0 C-N-CA 124.04 0.936 . . . . 0.0 109.47 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 90.8 m -88.12 109.12 19.64 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 124.291 1.036 . . . . 0.0 108.729 178.019 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 90.3 mt -100.29 93.75 5.84 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 124.045 0.938 . . . . 0.0 109.164 -172.449 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 4.7 m -106.41 112.53 25.58 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 -172.291 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 19.9 t60 -100.65 -75.27 0.59 Allowed 'General case' 0 N--CA 1.491 1.591 0 CA-C-O 118.793 -0.623 . . . . 0.0 110.492 172.553 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -142.2 -97.91 0.29 Allowed Glycine 0 N--CA 1.483 1.773 0 N-CA-C 110.558 -1.017 . . . . 0.0 110.558 -178.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 8.2 t -89.1 30.78 0.92 Allowed 'General case' 0 N--CA 1.5 2.051 0 N-CA-C 115.498 1.666 . . . . 0.0 115.498 173.468 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -158.44 107.72 2.01 Favored 'General case' 0 N--CA 1.481 1.114 0 O-C-N 121.045 -1.034 . . . . 0.0 108.979 177.351 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 7.5 p -108.56 126.35 65.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 C-N-CA 123.583 0.753 . . . . 0.0 109.827 175.231 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 40.9 t -109.87 106.94 16.71 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 123.003 0.521 . . . . 0.0 111.851 179.033 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 77.5 m -90.18 100.51 13.32 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 178.866 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 33.5 mtm180 -99.41 121.13 40.69 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 123.108 0.563 . . . . 0.0 110.552 -174.667 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 95.7 m -89.78 131.27 35.82 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 123.438 0.695 . . . . 0.0 109.822 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 42.0 m-85 -127.26 131.13 50.61 Favored 'General case' 0 CA--C 1.559 1.297 0 C-N-CA 123.612 0.765 . . . . 0.0 109.587 178.634 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -96.31 150.12 20.92 Favored 'General case' 0 CA--C 1.56 1.358 0 CA-C-O 121.943 0.878 . . . . 0.0 111.457 172.481 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 67.4 tttt -80.77 127.07 32.09 Favored 'General case' 0 N--CA 1.486 1.33 0 CA-C-O 121.642 0.734 . . . . 0.0 112.204 -173.439 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 15.2 mm-40 -125.02 52.3 1.59 Allowed 'General case' 0 CA--C 1.563 1.449 0 C-N-CA 124.253 1.021 . . . . 0.0 111.252 -173.438 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.968 0 CA-C-O 123.057 1.408 . . . . 0.0 109.989 -163.688 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 79.0 t . . . . . 0 CA--C 1.559 1.3 0 N-CA-C 106.605 -1.628 . . . . 0.0 106.605 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -145.45 -53.36 0.28 Allowed 'General case' 0 N--CA 1.494 1.749 0 C-N-CA 123.9 0.88 . . . . 0.0 111.242 -175.373 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -57.8 -27.43 63.11 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 117.066 2.247 . . . . 0.0 117.066 161.571 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -63.8 -20.52 65.85 Favored 'General case' 0 CA--C 1.568 1.659 0 N-CA-C 117.209 2.3 . . . . 0.0 117.209 165.189 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 64.7 mt -82.45 120.16 25.11 Favored 'General case' 0 N--CA 1.487 1.425 0 CA-C-N 121.034 1.743 . . . . 0.0 111.361 -169.239 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 155.99 173.25 24.36 Favored Glycine 0 CA--C 1.543 1.83 0 CA-C-O 122.542 1.079 . . . . 0.0 113.013 -171.734 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.437 ' HG1' HG12 ' A' ' 41' ' ' ILE . 76.9 m -85.73 140.75 30.24 Favored 'General case' 0 N--CA 1.492 1.673 0 CA-C-N 114.548 -0.826 . . . . 0.0 109.475 168.21 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 88.7 m95 -140.68 112.86 7.82 Favored 'General case' 0 N--CA 1.485 1.319 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 -174.034 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 51.2 mtpt -99.11 147.86 24.65 Favored 'General case' 0 N--CA 1.494 1.74 0 CA-C-O 121.548 0.689 . . . . 0.0 110.702 177.069 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 61.8 tp -69.87 131.67 44.82 Favored 'General case' 0 N--CA 1.488 1.475 0 CA-C-O 121.847 0.832 . . . . 0.0 112.856 -175.586 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . 0.271 0.9 OUTLIER -116.7 -39.27 2.4 Favored 'Isoleucine or valine' 0 CA--C 1.576 1.971 0 CA-C-N 114.335 -1.302 . . . . 0.0 112.434 -176.87 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -136.22 132.63 36.13 Favored 'General case' 0 N--CA 1.491 1.618 0 CA-C-N 120.513 1.506 . . . . 0.0 109.474 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 83.5 p -128.52 90.41 3.06 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-O 121.5 0.667 . . . . 0.0 111.031 176.509 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -100.56 124.25 45.88 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 123.569 0.748 . . . . 0.0 109.26 177.827 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.267 57.2 m-20 71.33 16.13 6.17 Favored 'General case' 0 N--CA 1.506 2.367 0 N-CA-C 117.677 2.473 . . . . 0.0 117.677 177.788 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 20.4 t80 -70.41 -40.08 74.06 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 115.77 1.767 . . . . 0.0 115.77 -176.371 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -63.86 -29.5 70.68 Favored 'General case' 0 N--CA 1.499 1.995 0 N-CA-C 116.053 1.872 . . . . 0.0 116.053 170.55 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 27.8 t0 -64.45 -49.21 72.37 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 114.527 1.306 . . . . 0.0 114.527 165.329 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 90.9 t80 -52.45 -52.85 51.96 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 115.311 1.597 . . . . 0.0 115.311 172.203 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 77.9 mtm -62.02 -41.3 97.95 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 115.295 1.591 . . . . 0.0 115.295 175.053 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.4 tmtp? -58.77 -44.75 90.73 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 115.276 1.584 . . . . 0.0 115.276 168.818 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 49.3 m -58.72 -38.24 77.91 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 116.332 1.975 . . . . 0.0 116.332 172.009 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 80.3 mt -65.79 -41.38 92.01 Favored 'General case' 0 CA--C 1.567 1.6 0 N-CA-C 116.368 1.988 . . . . 0.0 116.368 169.516 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 113.7 76.33 0.72 Allowed Glycine 0 N--CA 1.483 1.778 0 N-CA-C 111.055 -0.818 . . . . 0.0 111.055 -171.467 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 67.5 t -141.98 123.04 12.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 N-CA-C 105.512 -2.032 . . . . 0.0 105.512 -175.445 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -69.41 160.29 52.83 Favored Glycine 0 CA--C 1.548 2.119 0 N-CA-C 115.948 1.139 . . . . 0.0 115.948 179.143 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 28.7 p90 -54.57 -41.25 69.62 Favored 'General case' 0 N--CA 1.498 1.95 0 N-CA-C 118.726 2.861 . . . . 0.0 118.726 -171.091 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.59 -43.31 94.22 Favored 'General case' 0 CA--C 1.564 1.499 0 N-CA-C 115.594 1.702 . . . . 0.0 115.594 173.769 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 58.7 m -67.28 -35.11 78.81 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 114.53 1.308 . . . . 0.0 114.53 170.064 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 58.1 mtm180 -58.36 -48.48 80.45 Favored 'General case' 0 N--CA 1.493 1.718 0 CA-C-N 120.407 1.458 . . . . 0.0 114.911 168.398 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 37.2 mm-40 -68.57 -39.79 80.86 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 115.455 1.65 . . . . 0.0 115.455 177.565 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 74.6 t -60.97 -47.84 91.74 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.019 0 CA-C-N 119.656 1.117 . . . . 0.0 113.103 169.622 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -67.74 -39.19 84.27 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 117.032 2.234 . . . . 0.0 117.032 178.544 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 87.8 p -65.52 -39.11 91.43 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 116.175 1.917 . . . . 0.0 116.175 168.53 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 54.7 tpp -66.87 -40.82 87.95 Favored 'General case' 0 CA--C 1.566 1.589 0 N-CA-C 115.997 1.851 . . . . 0.0 115.997 173.636 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 5.8 t -75.37 161.93 28.83 Favored 'General case' 0 N--CA 1.493 1.682 0 CA-C-N 119.428 1.013 . . . . 0.0 112.846 179.211 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 3.5 mtmt -99.28 104.0 23.9 Favored Pre-proline 0 CA--C 1.568 1.649 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 170.706 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -77.93 90.92 1.22 Allowed 'Trans proline' 0 CA--C 1.56 1.782 0 C-N-CA 123.165 2.577 . . . . 0.0 111.155 178.414 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 52.0 m -79.49 109.24 13.67 Favored 'General case' 0 N--CA 1.488 1.43 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.258 -161.216 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 90.7 m -83.59 116.61 22.68 Favored 'General case' 0 CA--C 1.56 1.349 0 C-N-CA 123.541 0.737 . . . . 0.0 109.468 -174.336 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.437 HG12 ' HG1' ' A' ' 7' ' ' THR . 73.7 mt -113.16 106.99 21.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 N-CA-C 105.805 -1.924 . . . . 0.0 105.805 179.02 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 20.6 mt -100.58 120.91 50.7 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 -177.512 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -136.35 111.82 9.25 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 -170.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 82.1 tttt -91.28 115.7 28.24 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 123.309 0.644 . . . . 0.0 110.789 -177.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 32.8 t30 -116.04 80.87 1.51 Allowed 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 178.821 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 62.91 59.77 8.64 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 116.209 1.244 . . . . 0.0 116.209 -173.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . 0.324 3.9 t70 71.25 -20.15 0.23 Allowed 'General case' 0 N--CA 1.499 2.021 0 N-CA-C 117.415 2.376 . . . . 0.0 117.415 -167.506 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 11.0 mm -82.3 102.73 8.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 CA-C-N 120.19 1.359 . . . . 0.0 107.906 -175.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 45.7 mt -89.0 104.98 17.49 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 123.146 0.578 . . . . 0.0 110.268 -174.069 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 64.1 m -92.19 95.27 9.64 Favored 'General case' 0 N--CA 1.484 1.272 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 -177.714 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 9.8 tt -99.57 101.77 13.08 Favored 'General case' 0 N--CA 1.484 1.234 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 -175.287 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -100.22 108.2 20.24 Favored 'General case' 0 N--CA 1.485 1.303 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 -175.826 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 89.2 m -94.64 99.5 11.61 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 -179.534 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 29.2 m170 -86.97 91.88 8.84 Favored 'General case' 0 N--CA 1.491 1.581 0 CA-C-O 121.578 0.704 . . . . 0.0 111.271 -172.221 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 25.2 t . . . . . 0 N--CA 1.486 1.33 0 C-N-CA 124.003 0.921 . . . . 0.0 110.783 177.447 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 8.9 p30 . . . . . 0 N--CA 1.49 1.529 0 N-CA-C 112.087 0.403 . . . . 0.0 112.087 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 82.7 p -91.81 128.83 37.8 Favored 'General case' 0 N--CA 1.493 1.715 0 C-N-CA 122.837 0.455 . . . . 0.0 110.871 -176.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -117.77 117.08 28.34 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 -179.782 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 37.9 pt -112.11 131.57 63.19 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 174.124 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 79.7 p -116.81 101.88 8.93 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 -179.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 46.6 p90 -130.85 133.11 45.64 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 114.137 1.162 . . . . 0.0 114.137 -161.167 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 30.8 mtpp -88.71 145.05 25.87 Favored 'General case' 0 CA--C 1.561 1.379 0 CA-C-N 114.883 -1.053 . . . . 0.0 109.625 161.299 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -74.79 117.7 16.92 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.831 -0.543 . . . . 0.0 111.882 -173.141 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 86.13 44.07 6.09 Favored Glycine 0 CA--C 1.549 2.157 0 N-CA-C 116.457 1.343 . . . . 0.0 116.457 -168.83 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 98.8 t -140.15 121.14 14.55 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 N-CA-C 106.332 -1.729 . . . . 0.0 106.332 179.767 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -86.09 128.73 34.93 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 123.072 0.549 . . . . 0.0 111.045 176.207 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 47.9 p90 -133.77 128.59 35.14 Favored 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 123.619 0.768 . . . . 0.0 110.475 -174.248 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -71.1 117.43 12.6 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.411 -0.806 . . . . 0.0 112.206 175.207 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 15.7 tp10 -124.38 133.63 53.36 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 123.435 0.694 . . . . 0.0 110.616 -168.349 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 61.0 m -95.24 123.4 38.72 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 172.277 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 43.1 p -85.67 172.99 10.44 Favored 'General case' 0 CA--C 1.568 1.662 0 CA-C-O 121.854 0.835 . . . . 0.0 112.758 -173.813 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -60.76 -35.24 75.9 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 117.344 2.35 . . . . 0.0 117.344 165.739 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -98.09 82.08 2.91 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 106.376 -1.713 . . . . 0.0 106.376 166.293 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -39.35 108.95 0.09 Allowed 'General case' 0 N--CA 1.497 1.881 0 N-CA-C 117.747 2.499 . . . . 0.0 117.747 -155.169 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 39.6 ttm-85 -149.04 126.59 11.64 Favored 'General case' 0 N--CA 1.487 1.389 0 CA-C-N 114.878 -1.055 . . . . 0.0 108.493 -167.727 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.44 117.87 15.71 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 170.58 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 13.6 m -135.57 125.7 42.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 -174.081 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 30.9 mmtp -82.35 103.47 11.94 Favored 'General case' 0 N--CA 1.489 1.476 0 CA-C-O 121.894 0.854 . . . . 0.0 109.472 179.116 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 44.5 t -103.56 100.16 9.99 Favored 'General case' 0 CA--C 1.554 1.119 0 CA-C-N 115.012 -0.994 . . . . 0.0 110.718 -160.677 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 6.5 tp -109.46 120.35 60.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 -178.045 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 1.6 p -139.99 123.64 18.16 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 -173.354 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 14.3 t -133.56 160.35 37.74 Favored 'General case' 0 N--CA 1.487 1.42 0 CA-C-O 122.978 1.371 . . . . 0.0 111.254 179.647 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 63.8 tp -88.64 107.86 19.15 Favored 'General case' 0 N--CA 1.487 1.424 0 CA-C-N 114.44 -1.254 . . . . 0.0 108.523 170.873 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -108.19 87.62 2.54 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 123.377 0.671 . . . . 0.0 109.351 -171.609 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 56.54 49.43 69.58 Favored Glycine 0 CA--C 1.548 2.14 0 N-CA-C 117.614 1.805 . . . . 0.0 117.614 -177.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 102.26 -45.85 1.32 Allowed Glycine 0 N--CA 1.488 2.136 0 N-CA-C 116.852 1.501 . . . . 0.0 116.852 -168.43 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 36.0 ttpt -90.01 130.4 36.21 Favored 'General case' 0 CA--C 1.556 1.175 0 CA-C-N 117.419 0.609 . . . . 0.0 111.704 -169.111 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 4.7 tt -84.53 103.57 13.78 Favored 'General case' 0 CA--C 1.563 1.455 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 178.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 78.8 t -109.65 111.62 36.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 -167.805 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 21.1 t-160 -113.11 125.32 54.24 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 124.416 1.086 . . . . 0.0 109.22 -177.241 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 25.8 tp -122.45 121.81 37.48 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 107.799 -1.185 . . . . 0.0 107.799 175.167 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 93.1 mt-30 -107.69 126.03 52.09 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 171.867 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 10.2 ptpp? -126.88 139.34 53.15 Favored 'General case' 0 N--CA 1.494 1.75 0 CA-C-O 121.343 0.592 . . . . 0.0 112.193 -176.686 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 26.6 p90 -157.57 110.25 2.44 Favored 'General case' 0 N--CA 1.488 1.475 0 C-N-CA 123.781 0.832 . . . . 0.0 108.953 -173.657 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 3.8 t70 54.52 50.69 15.51 Favored 'General case' 0 N--CA 1.499 1.977 0 N-CA-C 116.382 1.993 . . . . 0.0 116.382 167.346 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 86.08 -40.67 3.05 Favored Glycine 0 CA--C 1.554 2.478 0 N-CA-C 117.372 1.709 . . . . 0.0 117.372 -169.495 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 57.6 mt-30 -80.37 136.12 36.32 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 123.921 0.888 . . . . 0.0 111.138 179.727 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -145.61 130.23 17.96 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.827 -0.546 . . . . 0.0 111.442 178.892 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 7.7 t -114.23 134.57 54.83 Favored 'General case' 0 N--CA 1.494 1.74 0 C-N-CA 123.22 0.608 . . . . 0.0 111.009 175.725 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 39.3 p -103.53 129.11 50.67 Favored 'General case' 0 N--CA 1.49 1.575 0 CA-C-O 121.615 0.722 . . . . 0.0 110.885 173.222 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 5.6 mp -106.67 80.72 1.49 Allowed 'General case' 0 CA--C 1.565 1.554 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 176.333 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 67.9 t -88.8 108.21 18.68 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 N-CA-C 108.272 -1.011 . . . . 0.0 108.272 -169.322 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 80.1 mtt85 -100.93 125.66 47.52 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 123.265 0.626 . . . . 0.0 110.352 -177.6 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -143.26 133.6 24.67 Favored 'General case' 0 N--CA 1.491 1.606 0 C-N-CA 123.308 0.643 . . . . 0.0 111.157 -176.042 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -81.33 117.82 22.12 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.66 -0.65 . . . . 0.0 111.356 177.232 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 46.9 mm -120.83 104.9 15.94 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.374 0 N-CA-C 105.115 -2.18 . . . . 0.0 105.115 174.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 22.2 m-20 58.93 50.37 8.51 Favored 'General case' 0 N--CA 1.499 2.02 0 N-CA-C 115.101 1.519 . . . . 0.0 115.101 175.414 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 63.76 27.45 71.13 Favored Glycine 0 CA--C 1.555 2.566 0 N-CA-C 119.242 2.457 . . . . 0.0 119.242 -170.581 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -135.87 127.13 28.26 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-N 119.002 1.401 . . . . 0.0 108.339 -174.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 19.1 tp -78.4 111.46 14.44 Favored 'General case' 0 CA--C 1.559 1.312 0 C-N-CA 123.474 0.709 . . . . 0.0 110.374 -179.215 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 30.4 mm -98.89 100.85 11.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 -177.075 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 30.3 tp -91.5 104.48 16.98 Favored 'General case' 0 CA--C 1.559 1.305 0 C-N-CA 123.85 0.86 . . . . 0.0 109.276 177.65 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 85.5 m -97.42 114.62 26.48 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 124.083 0.953 . . . . 0.0 108.621 -177.161 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 85.2 mt -110.79 96.66 6.31 Favored 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 123.63 0.772 . . . . 0.0 109.375 -168.001 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 11.1 m -105.85 117.14 33.26 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.947 -0.471 . . . . 0.0 109.89 -171.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 53.9 t60 -156.4 122.16 4.88 Favored 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 123.157 0.583 . . . . 0.0 109.53 171.566 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 61.71 64.92 3.57 Favored Glycine 0 N--CA 1.488 2.143 0 N-CA-C 117.237 1.655 . . . . 0.0 117.237 165.605 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . 0.391 5.2 t 46.57 39.86 7.48 Favored 'General case' 0 N--CA 1.5 2.049 0 N-CA-C 117.624 2.453 . . . . 0.0 117.624 -169.041 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -153.14 88.57 1.32 Allowed 'General case' 0 N--CA 1.483 1.203 0 O-C-N 121.531 -0.731 . . . . 0.0 109.276 -176.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 4.5 p -92.9 119.77 41.14 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.401 0 C-N-CA 123.508 0.723 . . . . 0.0 109.582 173.771 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 42.2 t -110.31 100.76 9.58 Favored 'General case' 0 CA--C 1.551 1.014 0 CA-C-O 121.594 0.712 . . . . 0.0 110.25 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 87.6 m -90.74 106.24 18.37 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 -177.287 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 39.4 mtm180 -112.22 121.67 45.57 Favored 'General case' 0 N--CA 1.487 1.375 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.59 -169.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 89.8 m -85.02 136.61 33.51 Favored 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 123.35 0.66 . . . . 0.0 110.033 177.16 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 40.7 m-85 -129.73 126.11 37.46 Favored 'General case' 0 CA--C 1.558 1.259 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 177.308 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -92.62 152.12 19.75 Favored 'General case' 0 N--CA 1.494 1.726 0 CA-C-O 121.943 0.878 . . . . 0.0 111.82 173.23 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 71.2 tttt -83.03 121.58 27.2 Favored 'General case' 0 N--CA 1.486 1.364 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.926 -169.255 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -119.92 51.2 1.2 Allowed 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 124.283 1.033 . . . . 0.0 111.525 -174.302 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 0.829 0 CA-C-O 124.448 2.071 . . . . 0.0 109.882 -161.269 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.297 42.6 t . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 117.257 -1.354 . . . . 0.0 112.982 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -56.68 -41.3 77.07 Favored 'General case' 0 N--CA 1.499 1.995 0 N-CA-C 116.282 1.956 . . . . 0.0 116.282 178.648 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -61.38 -33.88 74.4 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 116.766 2.136 . . . . 0.0 116.766 164.697 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -70.96 -22.67 62.18 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 116.273 1.953 . . . . 0.0 116.273 169.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 82.6 mt -70.84 118.03 13.1 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-N 121.26 1.845 . . . . 0.0 111.476 -175.817 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 154.53 172.3 22.24 Favored Glycine 0 CA--C 1.54 1.632 0 CA-C-O 122.661 1.145 . . . . 0.0 112.941 -176.736 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 45.9 m -87.59 142.54 27.77 Favored 'General case' 0 N--CA 1.489 1.504 0 CA-C-N 114.555 -0.822 . . . . 0.0 109.095 172.624 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 92.1 m95 -136.43 110.73 8.43 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 -173.761 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 39.8 mttp -94.31 142.85 26.94 Favored 'General case' 0 N--CA 1.489 1.478 0 CA-C-O 121.612 0.72 . . . . 0.0 110.73 174.318 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 14.2 tp -70.1 123.55 21.89 Favored 'General case' 0 N--CA 1.487 1.393 0 CA-C-O 122.218 1.008 . . . . 0.0 111.806 -176.859 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . 0.286 1.1 t -96.02 -47.98 12.79 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.741 0 CA-C-N 113.711 -1.586 . . . . 0.0 111.661 175.875 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -142.38 145.38 33.8 Favored 'General case' 0 N--CA 1.49 1.536 0 CA-C-N 119.859 1.209 . . . . 0.0 110.099 176.865 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 88.0 p -121.94 100.87 7.22 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.75 -0.594 . . . . 0.0 110.075 170.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -89.23 119.56 29.82 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 36.7 m-20 67.47 30.83 6.62 Favored 'General case' 0 N--CA 1.5 2.046 0 N-CA-C 116.515 2.042 . . . . 0.0 116.515 178.163 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.427 ' HB2' ' SG ' ' A' ' 124' ' ' CYS . 31.1 t80 -90.4 69.56 6.95 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 120.236 -1.54 . . . . 0.0 111.955 -179.859 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -159.72 -52.32 0.06 Allowed 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 125.434 1.494 . . . . 0.0 108.689 179.106 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 22.0 t0 -53.81 -41.27 67.14 Favored 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 116.034 1.864 . . . . 0.0 116.034 164.771 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 81.6 t80 -55.03 -53.17 59.22 Favored 'General case' 0 CA--C 1.571 1.754 0 N-CA-C 114.536 1.31 . . . . 0.0 114.536 169.769 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 73.8 mtm -62.83 -38.53 91.14 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 115.879 1.807 . . . . 0.0 115.879 171.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 57.1 mtpt -58.23 -51.2 70.76 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 115.596 1.702 . . . . 0.0 115.596 168.539 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 21.3 t -62.95 -34.58 77.79 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 116.221 1.934 . . . . 0.0 116.221 174.44 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 68.1 mt -66.41 -39.95 89.29 Favored 'General case' 0 CA--C 1.565 1.545 0 N-CA-C 116.084 1.883 . . . . 0.0 116.084 168.364 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 105.46 78.47 1.2 Allowed Glycine 0 CA--C 1.54 1.649 0 CA-C-N 118.807 0.73 . . . . 0.0 111.474 -172.184 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 58.1 t -138.02 123.27 24.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 N-CA-C 105.752 -1.944 . . . . 0.0 105.752 -179.5 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -82.4 -157.93 22.58 Favored Glycine 0 CA--C 1.547 2.087 0 N-CA-C 115.965 1.146 . . . . 0.0 115.965 -177.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 8.6 p90 -69.39 156.61 38.54 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 113.319 0.859 . . . . 0.0 113.319 178.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . 0.317 . . 76.6 -50.1 0.57 Allowed 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 115.647 1.721 . . . . 0.0 115.647 179.616 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 30.4 m -70.98 -36.11 72.37 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 113.903 1.075 . . . . 0.0 113.903 170.322 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 27.8 mtm180 -57.18 -46.88 82.43 Favored 'General case' 0 N--CA 1.499 1.987 0 CA-C-N 120.819 1.645 . . . . 0.0 114.472 162.409 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 3.4 tm0? -66.3 -49.77 65.91 Favored 'General case' 0 CA--C 1.562 1.434 0 N-CA-C 114.756 1.391 . . . . 0.0 114.756 -178.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 95.6 t -65.69 -40.12 86.93 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 CA-C-N 119.42 1.009 . . . . 0.0 113.426 175.146 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -66.26 -39.91 89.79 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 116.383 1.994 . . . . 0.0 116.383 176.368 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 92.8 p -63.78 -40.72 97.34 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 116.144 1.905 . . . . 0.0 116.144 165.794 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 17.9 ttm -60.71 -47.16 87.52 Favored 'General case' 0 CA--C 1.568 1.653 0 N-CA-C 115.861 1.8 . . . . 0.0 115.861 171.752 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 5.4 t -78.79 158.26 28.25 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 113.511 0.93 . . . . 0.0 113.511 -166.302 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 14.1 mptt -102.34 101.69 21.01 Favored Pre-proline 0 CA--C 1.57 1.728 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 175.091 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -77.76 100.39 1.38 Allowed 'Trans proline' 0 CA--C 1.561 1.848 0 C-N-CA 123.027 2.485 . . . . 0.0 111.562 -177.198 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 80.9 m -83.55 102.72 12.34 Favored 'General case' 0 N--CA 1.489 1.486 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.808 -164.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 32.3 m -97.31 112.75 24.43 Favored 'General case' 0 N--CA 1.485 1.279 0 CA-C-O 120.63 0.252 . . . . 0.0 111.243 -167.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 5.2 mp -91.07 107.16 18.34 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.454 0 N-CA-C 107.103 -1.443 . . . . 0.0 107.103 170.774 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 44.9 mt -90.75 123.3 42.85 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 N-CA-C 106.762 -1.57 . . . . 0.0 106.762 167.372 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 15.0 tt0 -134.05 179.54 6.19 Favored 'General case' 0 CA--C 1.567 1.597 0 CA-C-O 121.817 0.817 . . . . 0.0 109.659 -175.233 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.49 157.77 45.83 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-O 122.515 1.15 . . . . 0.0 112.7 -178.865 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 33.2 t30 -150.62 82.59 1.35 Allowed 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 106.257 -1.757 . . . . 0.0 106.257 167.739 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 76.23 -107.96 2.46 Favored Glycine 0 CA--C 1.547 2.072 0 N-CA-C 111.944 -0.462 . . . . 0.0 111.944 -165.15 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -122.68 61.15 1.0 Allowed 'General case' 0 N--CA 1.493 1.696 0 CA-C-O 121.133 0.492 . . . . 0.0 109.9 159.279 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 39.4 mm -124.84 94.86 2.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 N-CA-C 103.368 -2.827 . . . . 0.0 103.368 172.04 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 36.1 mt -89.81 105.5 17.84 Favored 'General case' 0 N--CA 1.483 1.196 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.683 -165.508 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 85.5 m -97.32 100.6 12.05 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 -165.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 9.2 tt -101.9 100.86 11.21 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 107.802 -1.185 . . . . 0.0 107.802 -177.406 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -100.01 106.3 18.06 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 179.856 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 96.3 m -93.38 102.81 15.06 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 -179.616 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 31.4 m-70 -89.98 85.13 6.26 Favored 'General case' 0 N--CA 1.493 1.709 0 CA-C-O 122.132 0.968 . . . . 0.0 110.98 -174.408 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 24.7 t . . . . . 0 N--CA 1.485 1.319 0 CA-C-N 115.165 -0.925 . . . . 0.0 111.078 173.405 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 7.3 p30 . . . . . 0 N--CA 1.491 1.605 0 N-CA-C 111.985 0.365 . . . . 0.0 111.985 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 76.3 p -91.39 128.04 37.06 Favored 'General case' 0 N--CA 1.493 1.683 0 C-N-CA 122.809 0.444 . . . . 0.0 111.433 -173.516 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -111.23 115.92 30.17 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 179.303 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 35.4 pt -114.72 130.42 69.16 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 171.475 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 71.2 p -117.95 116.39 26.82 Favored 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 123.751 0.82 . . . . 0.0 108.983 -179.499 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 51.1 p90 -140.26 140.4 35.74 Favored 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 115.115 1.524 . . . . 0.0 115.115 -160.109 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 52.8 mtmt -102.81 14.3 32.28 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 117.29 2.33 . . . . 0.0 117.29 -172.69 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . 0.291 3.2 mp 61.74 98.81 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.731 0 CA-C-N 120.692 1.587 . . . . 0.0 114.484 177.173 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 86.22 37.27 9.16 Favored Glycine 0 CA--C 1.553 2.419 0 N-CA-C 116.859 1.504 . . . . 0.0 116.859 -167.441 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 88.0 t -139.21 124.67 21.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 -178.569 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -88.76 123.66 33.39 Favored 'General case' 0 CA--C 1.562 1.406 0 C-N-CA 123.55 0.74 . . . . 0.0 110.526 173.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 40.1 p90 -130.35 124.49 32.37 Favored 'General case' 0 N--CA 1.494 1.754 0 C-N-CA 123.605 0.762 . . . . 0.0 110.42 -175.152 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -71.07 117.41 12.54 Favored 'General case' 0 CA--C 1.564 1.512 0 O-C-N 121.599 -0.688 . . . . 0.0 112.505 177.209 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 12.2 tp10 -126.99 133.91 50.47 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 123.742 0.817 . . . . 0.0 110.091 -167.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 45.3 m -91.23 122.83 34.2 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 176.239 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 33.9 p -83.56 167.22 17.56 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 113.019 0.748 . . . . 0.0 113.019 -174.504 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -53.82 -28.01 32.89 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 118.646 2.832 . . . . 0.0 118.646 168.541 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -74.6 -91.14 0.02 OUTLIER 'General case' 0 CA--C 1.57 1.733 0 CA-C-N 119.734 1.152 . . . . 0.0 109.076 168.269 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -176.17 90.16 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 105.143 -2.169 . . . . 0.0 105.143 158.55 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 45.8 mtt-85 -142.19 123.07 14.4 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 122.257 -0.277 . . . . 0.0 110.371 -171.711 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.497 ' H ' ' HD3' ' A' ' 79' ' ' LYS . 0.0 OUTLIER -80.47 93.77 6.09 Favored 'General case' 0 CA--C 1.564 1.511 0 C-N-CA 124.094 0.958 . . . . 0.0 110.679 172.413 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 13.4 m -112.03 130.54 65.51 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 C-N-CA 122.998 0.519 . . . . 0.0 110.676 -167.559 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 1.5 mptm? -84.34 98.53 10.08 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 123.808 0.843 . . . . 0.0 109.339 -179.332 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 72.2 m -94.2 98.25 10.82 Favored 'General case' 0 N--CA 1.483 1.191 0 CA-C-N 115.133 -0.939 . . . . 0.0 110.933 -166.139 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 6.4 tp -107.77 115.44 48.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 -179.295 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.0 p -133.15 131.66 58.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 C-N-CA 124.03 0.932 . . . . 0.0 109.673 -172.639 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 15.1 t -143.68 159.9 41.65 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-O 122.495 1.14 . . . . 0.0 110.577 177.213 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 18.2 tp -93.9 107.13 19.06 Favored 'General case' 0 N--CA 1.489 1.506 0 CA-C-N 115.162 -0.926 . . . . 0.0 108.633 172.129 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -102.88 84.58 2.4 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 123.382 0.673 . . . . 0.0 109.662 -171.84 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 56.5 48.35 76.96 Favored Glycine 0 CA--C 1.548 2.141 0 N-CA-C 117.608 1.803 . . . . 0.0 117.608 -176.088 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 100.38 -47.6 1.25 Allowed Glycine 0 N--CA 1.489 2.172 0 N-CA-C 116.215 1.246 . . . . 0.0 116.215 -166.657 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 30.9 ttpt -84.62 116.33 23.12 Favored 'General case' 0 CA--C 1.556 1.2 0 CA-C-N 117.915 0.858 . . . . 0.0 111.131 -170.075 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 3.0 tt -88.05 101.77 14.11 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-O 121.686 0.755 . . . . 0.0 109.659 -173.005 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 54.3 t -104.66 107.4 22.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 -168.418 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 19.9 t-160 -99.35 140.1 34.02 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 123.943 0.897 . . . . 0.0 109.655 169.679 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 15.6 tp -138.9 124.91 19.96 Favored 'General case' 0 N--CA 1.488 1.44 0 CA-C-O 122.03 0.919 . . . . 0.0 108.803 175.557 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -107.92 126.62 52.9 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 124.603 1.161 . . . . 0.0 108.378 178.537 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -125.45 133.2 52.53 Favored 'General case' 0 N--CA 1.496 1.847 0 C-N-CA 122.986 0.514 . . . . 0.0 110.571 -173.734 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 22.9 p90 -158.18 114.57 2.8 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.125 -0.985 . . . . 0.0 110.5 -176.034 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 11.1 t70 50.21 58.07 5.89 Favored 'General case' 0 N--CA 1.503 2.176 0 N-CA-C 116.704 2.112 . . . . 0.0 116.704 163.508 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 80.89 -25.22 3.56 Favored Glycine 0 CA--C 1.559 2.79 0 N-CA-C 119.212 2.445 . . . . 0.0 119.212 -171.327 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 66.7 mt-30 -102.01 133.79 46.26 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 124.785 1.234 . . . . 0.0 110.464 -179.044 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -141.38 135.78 30.77 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.341 -0.849 . . . . 0.0 112.416 173.165 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 14.9 t -117.13 129.21 55.82 Favored 'General case' 0 N--CA 1.496 1.857 0 C-N-CA 123.302 0.641 . . . . 0.0 111.506 177.635 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 40.3 p -94.7 120.43 34.91 Favored 'General case' 0 N--CA 1.493 1.715 0 C-N-CA 123.306 0.642 . . . . 0.0 110.028 172.346 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 5.2 mp -103.56 90.86 3.8 Favored 'General case' 0 CA--C 1.562 1.428 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 174.729 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 92.9 t -94.99 102.66 13.84 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 N-CA-C 107.567 -1.272 . . . . 0.0 107.567 -174.294 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 45.8 mtt180 -91.5 128.08 37.19 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 122.966 0.506 . . . . 0.0 109.652 172.45 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -147.81 129.56 15.16 Favored 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 123.197 0.599 . . . . 0.0 110.429 -172.035 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -77.11 121.14 23.17 Favored 'General case' 0 N--CA 1.487 1.404 0 CA-C-O 121.865 0.841 . . . . 0.0 112.736 178.647 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . 0.279 1.5 mp -76.41 171.89 1.22 Allowed 'Isoleucine or valine' 0 CA--C 1.575 1.938 0 CA-C-N 114.94 -1.027 . . . . 0.0 109.231 143.12 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -68.62 73.72 0.25 Allowed 'General case' 0 CA--C 1.565 1.543 0 N-CA-C 114.866 1.432 . . . . 0.0 114.866 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 121.22 -56.95 0.61 Allowed Glycine 0 N--CA 1.485 1.911 0 CA-C-N 114.093 -1.412 . . . . 0.0 113.781 -171.003 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 51.1 mttp -91.12 139.72 30.49 Favored 'General case' 0 N--CA 1.487 1.376 0 CA-C-O 121.713 0.768 . . . . 0.0 112.172 -173.307 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 25.1 tp -92.9 135.93 33.7 Favored 'General case' 0 CA--C 1.557 1.247 0 C-N-CA 123.605 0.762 . . . . 0.0 110.741 173.783 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 44.5 mm -114.18 108.68 26.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 -178.156 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 48.8 tp -93.58 106.21 18.2 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 123.813 0.845 . . . . 0.0 109.195 173.108 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 83.7 m -97.74 112.56 24.4 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 -179.669 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 92.9 mt -106.88 98.48 8.14 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 123.698 0.799 . . . . 0.0 109.483 -173.09 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 7.5 m -109.88 115.65 30.2 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 -175.526 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 86.1 t60 -134.21 116.19 15.05 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 108.507 -0.924 . . . . 0.0 108.507 173.147 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 75.2 -111.14 3.26 Favored Glycine 0 N--CA 1.484 1.845 0 C-N-CA 122.928 0.299 . . . . 0.0 113.011 176.167 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 73.4 p -122.37 68.55 0.95 Allowed 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 108.987 -0.745 . . . . 0.0 108.987 163.763 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -160.37 93.96 1.06 Allowed 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 123.368 0.667 . . . . 0.0 109.533 178.674 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 4.9 p -96.51 121.75 47.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 C-N-CA 123.797 0.839 . . . . 0.0 109.801 175.713 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' CYS . . . . . 0.427 ' SG ' ' HB2' ' A' ' 16' ' ' PHE . 43.8 t -116.91 105.46 12.37 Favored 'General case' 0 CA--C 1.555 1.149 0 C-N-CA 123.334 0.654 . . . . 0.0 110.544 -179.466 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 91.7 m -92.54 105.34 17.53 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 123.648 0.779 . . . . 0.0 109.073 -175.252 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 53.6 mtp180 -105.64 116.99 32.88 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 123.144 0.578 . . . . 0.0 109.596 -172.53 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 41.7 m -86.73 141.37 28.94 Favored 'General case' 0 N--CA 1.493 1.701 0 C-N-CA 123.717 0.807 . . . . 0.0 110.511 178.765 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 40.6 m-85 -137.84 135.13 35.92 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 124.094 0.958 . . . . 0.0 109.497 -175.07 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -102.14 155.18 18.37 Favored 'General case' 0 N--CA 1.495 1.778 0 CA-C-O 122.421 1.105 . . . . 0.0 111.712 166.057 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 71.0 tttt -88.33 124.28 33.74 Favored 'General case' 0 N--CA 1.483 1.209 0 CA-C-N 115.199 -0.91 . . . . 0.0 111.816 -168.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -99.17 49.48 0.95 Allowed 'General case' 0 CA--C 1.57 1.738 0 C-N-CA 123.58 0.752 . . . . 0.0 112.354 170.541 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.129 0 CA-C-O 123.2 1.476 . . . . 0.0 108.252 -176.287 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 4.6 p . . . . . 0 CA--C 1.576 1.972 0 N-CA-C 116.227 1.936 . . . . 0.0 116.227 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -66.19 -35.43 80.44 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 116.669 2.1 . . . . 0.0 116.669 -176.045 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -61.0 -27.08 68.05 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 117.514 2.413 . . . . 0.0 117.514 168.128 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -72.18 -20.2 61.62 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 116.037 1.865 . . . . 0.0 116.037 168.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 55.0 mt -78.29 119.65 21.95 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-N 121.034 1.743 . . . . 0.0 111.69 -171.745 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 163.87 175.9 35.22 Favored Glycine 0 N--CA 1.481 1.666 0 CA-C-O 122.251 0.917 . . . . 0.0 113.239 -177.766 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 63.1 m -92.3 137.28 32.49 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 167.847 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 87.3 m95 -138.6 112.58 8.51 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 -170.142 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 52.4 mtmt -99.94 144.37 29.08 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 123.103 0.561 . . . . 0.0 110.228 178.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 25.0 tp -67.72 131.66 46.0 Favored 'General case' 0 N--CA 1.488 1.427 0 CA-C-O 122.371 1.082 . . . . 0.0 112.419 -177.609 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . 0.285 1.0 OUTLIER -111.81 -47.81 6.03 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.797 0 CA-C-N 113.669 -1.605 . . . . 0.0 110.875 179.054 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -137.07 140.12 41.79 Favored 'General case' 0 N--CA 1.487 1.412 0 CA-C-N 119.566 1.075 . . . . 0.0 109.505 175.539 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 78.8 p -132.94 114.48 14.06 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 168.444 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -77.22 -72.41 0.35 Allowed 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 112.532 0.567 . . . . 0.0 112.532 -172.614 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 62.6 m-80 -105.41 47.12 0.89 Allowed 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 113.291 0.848 . . . . 0.0 113.291 -178.854 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 11.9 t80 -92.74 74.18 4.96 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.795 -1.191 . . . . 0.0 110.352 177.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 179.76 -59.82 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 126.082 1.753 . . . . 0.0 106.648 -168.793 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 22.8 t0 -58.42 -46.65 86.06 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 115.01 1.485 . . . . 0.0 115.01 163.85 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 90.0 t80 -51.9 -55.07 22.43 Favored 'General case' 0 CA--C 1.57 1.735 0 N-CA-C 114.896 1.443 . . . . 0.0 114.896 170.315 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 72.9 mtm -62.84 -39.21 93.65 Favored 'General case' 0 CA--C 1.567 1.626 0 N-CA-C 115.947 1.832 . . . . 0.0 115.947 174.816 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 28.9 ttpp -58.63 -46.56 86.82 Favored 'General case' 0 CA--C 1.569 1.686 0 N-CA-C 115.115 1.524 . . . . 0.0 115.115 168.685 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 16.7 t -62.01 -34.83 76.92 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 116.59 2.07 . . . . 0.0 116.59 172.57 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 86.2 mt -65.31 -44.25 88.49 Favored 'General case' 0 CA--C 1.567 1.616 0 N-CA-C 115.64 1.718 . . . . 0.0 115.64 167.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 113.95 70.35 0.52 Allowed Glycine 0 N--CA 1.483 1.808 0 C-N-CA 123.966 0.793 . . . . 0.0 111.889 -172.058 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 66.8 t -127.67 122.27 58.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 N-CA-C 105.586 -2.005 . . . . 0.0 105.586 -176.785 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -63.25 153.92 45.28 Favored Glycine 0 CA--C 1.549 2.211 0 N-CA-C 115.801 1.08 . . . . 0.0 115.801 177.81 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 31.5 p90 -55.2 -42.78 73.73 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 118.663 2.838 . . . . 0.0 118.663 -167.191 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.85 -43.28 93.55 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 115.75 1.759 . . . . 0.0 115.75 175.307 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 63.2 m -69.38 -37.83 77.73 Favored 'General case' 0 N--CA 1.497 1.924 0 N-CA-C 114.185 1.18 . . . . 0.0 114.185 170.689 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 45.5 ttp85 -59.46 -45.37 91.8 Favored 'General case' 0 CA--C 1.57 1.728 0 N-CA-C 115.151 1.537 . . . . 0.0 115.151 171.528 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 46.4 mt-30 -72.71 -39.89 66.6 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 115.104 1.52 . . . . 0.0 115.104 176.077 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 69.4 t -63.68 -48.18 87.84 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 CA-C-N 119.943 1.247 . . . . 0.0 112.443 170.446 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -61.89 -31.17 71.44 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 117.595 2.442 . . . . 0.0 117.595 177.435 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 84.0 p -62.91 -47.04 84.98 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 115.96 1.837 . . . . 0.0 115.96 169.484 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 51.9 tpp -70.76 -34.49 71.89 Favored 'General case' 0 CA--C 1.572 1.824 0 N-CA-C 116.13 1.9 . . . . 0.0 116.13 170.731 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 46.4 m -66.48 144.06 56.71 Favored 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 124.825 1.25 . . . . 0.0 112.538 -179.22 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -108.08 99.89 33.59 Favored Pre-proline 0 CA--C 1.571 1.753 0 CA-C-O 118.38 -0.819 . . . . 0.0 110.028 -177.366 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -75.48 141.68 25.59 Favored 'Trans proline' 0 CA--C 1.561 1.839 0 C-N-CA 123.206 2.604 . . . . 0.0 114.077 -179.689 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 100.0 m -107.47 100.74 10.14 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 -174.135 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 44.2 m -90.72 111.33 22.64 Favored 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 123.666 0.786 . . . . 0.0 109.448 -175.133 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 47.5 mt -102.82 108.09 23.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 N-CA-C 106.629 -1.619 . . . . 0.0 106.629 -178.768 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 33.7 mt -101.91 115.12 43.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 N-CA-C 106.744 -1.576 . . . . 0.0 106.744 -178.641 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -139.39 112.13 7.85 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 -171.385 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 28.1 ttpp -84.4 112.0 19.95 Favored 'General case' 0 CA--C 1.561 1.37 0 CA-C-O 121.43 0.633 . . . . 0.0 110.212 174.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 19.6 t-20 -100.57 92.49 5.15 Favored 'General case' 0 N--CA 1.485 1.32 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 -175.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 77.03 -99.64 1.42 Allowed Glycine 0 N--CA 1.485 1.939 0 N-CA-C 111.197 -0.761 . . . . 0.0 111.197 -166.094 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 25.1 m-20 -133.43 63.52 1.63 Allowed 'General case' 0 N--CA 1.494 1.748 0 CA-C-O 121.073 0.463 . . . . 0.0 109.844 160.17 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 27.2 mm -139.47 104.63 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 N-CA-C 104.994 -2.224 . . . . 0.0 104.994 177.348 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 35.9 mt -74.94 110.58 9.35 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 122.873 0.469 . . . . 0.0 111.527 177.703 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 38.3 m -105.41 101.84 11.35 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 106.266 -1.754 . . . . 0.0 106.266 -179.65 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 9.4 tt -104.65 108.64 20.2 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 -174.241 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 43.7 mttp -109.5 96.81 6.53 Favored 'General case' 0 N--CA 1.483 1.175 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 -165.647 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 60.0 m -87.95 92.7 9.23 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 -177.377 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 70.2 m80 -83.54 91.65 7.46 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 123.824 0.85 . . . . 0.0 110.191 -176.271 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 82.5 p . . . . . 0 N--CA 1.489 1.518 0 N-CA-C 118.427 2.751 . . . . 0.0 118.427 -167.237 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 8.7 p30 . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 111.914 0.339 . . . . 0.0 111.914 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 45.6 p -97.98 130.89 44.81 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-O 121.212 0.53 . . . . 0.0 110.949 -173.471 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 5.4 mp0 -115.65 129.76 56.61 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 123.382 0.673 . . . . 0.0 109.84 179.76 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 49.3 pt -112.79 126.05 70.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 N-CA-C 108.091 -1.078 . . . . 0.0 108.091 168.638 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 39.0 t -109.54 109.68 20.54 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 107.208 -1.405 . . . . 0.0 107.208 175.704 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 42.9 p90 -140.34 141.8 35.64 Favored 'General case' 0 N--CA 1.489 1.501 0 CA-C-O 122.25 1.024 . . . . 0.0 113.737 -164.447 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 55.1 mtmt -100.87 150.96 22.29 Favored 'General case' 0 CA--C 1.562 1.437 0 CA-C-N 114.478 -1.237 . . . . 0.0 109.061 159.729 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -74.46 115.48 14.05 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.564 -0.71 . . . . 0.0 111.894 -171.426 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 89.31 44.59 4.95 Favored Glycine 0 CA--C 1.549 2.186 0 N-CA-C 116.582 1.393 . . . . 0.0 116.582 -166.688 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 92.3 t -136.0 123.66 35.17 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 178.345 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -87.73 132.67 34.05 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 123.464 0.705 . . . . 0.0 110.791 170.668 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 44.9 p90 -145.55 134.42 22.45 Favored 'General case' 0 N--CA 1.494 1.739 0 C-N-CA 123.318 0.647 . . . . 0.0 110.556 -174.399 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -73.04 117.88 15.31 Favored 'General case' 0 CA--C 1.564 1.481 0 O-C-N 121.558 -0.713 . . . . 0.0 112.644 178.207 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 15.1 tp10 -128.97 134.15 48.08 Favored 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 123.626 0.77 . . . . 0.0 110.088 -170.681 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 51.9 m -92.7 121.91 34.58 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 174.097 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 27.1 p -84.31 174.5 10.1 Favored 'General case' 0 N--CA 1.494 1.726 0 CA-C-O 121.663 0.744 . . . . 0.0 112.869 -175.013 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -60.07 -34.68 73.77 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 116.815 2.154 . . . . 0.0 116.815 171.258 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -89.02 31.66 0.86 Allowed 'General case' 0 CA--C 1.58 2.1 0 N-CA-C 114.601 1.334 . . . . 0.0 114.601 167.394 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 22.5 m-20 53.34 67.82 0.94 Allowed 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 115.057 1.503 . . . . 0.0 115.057 174.768 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 46.1 mtm105 -137.64 120.98 16.98 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 109.036 -0.728 . . . . 0.0 109.036 -175.74 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.06 108.99 8.17 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 123.379 0.671 . . . . 0.0 111.305 169.444 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 17.7 m -125.39 142.15 43.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 CA-C-O 121.335 0.588 . . . . 0.0 110.302 -168.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 4.7 mptp? -85.62 98.01 10.42 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 123.629 0.772 . . . . 0.0 109.122 176.575 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 58.0 m -91.38 93.37 9.0 Favored 'General case' 0 N--CA 1.485 1.283 0 CA-C-N 115.262 -0.881 . . . . 0.0 111.12 -170.549 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 6.8 tp -104.71 116.73 49.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 178.322 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 1.5 p -136.52 122.56 29.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 C-N-CA 123.343 0.657 . . . . 0.0 109.55 -169.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 14.9 t -136.88 157.5 46.61 Favored 'General case' 0 N--CA 1.491 1.592 0 CA-C-O 122.629 1.204 . . . . 0.0 111.351 178.384 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 15.2 tp -95.37 119.78 34.47 Favored 'General case' 0 N--CA 1.489 1.514 0 CA-C-N 114.768 -1.106 . . . . 0.0 110.067 177.832 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -106.52 81.23 1.57 Allowed 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 123.205 0.602 . . . . 0.0 110.604 -178.204 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 61.06 46.52 94.38 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 117.673 1.829 . . . . 0.0 117.673 -177.096 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 75.03 35.96 48.03 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 118.206 2.043 . . . . 0.0 118.206 -168.341 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -145.93 104.36 3.84 Favored 'General case' 0 CA--C 1.553 1.077 0 N-CA-C 105.369 -2.086 . . . . 0.0 105.369 -177.774 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -86.33 121.42 28.88 Favored 'General case' 0 N--CA 1.481 1.12 0 CA-C-O 121.903 0.858 . . . . 0.0 110.989 -170.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 61.2 t -122.98 107.42 19.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 N-CA-C 106.103 -1.814 . . . . 0.0 106.103 -166.138 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 20.6 t-160 -110.75 113.34 25.85 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 123.777 0.831 . . . . 0.0 109.78 179.514 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 31.5 tp -107.74 123.25 48.26 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 123.775 0.83 . . . . 0.0 108.857 177.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -110.86 120.8 43.58 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 178.186 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -117.39 137.63 52.35 Favored 'General case' 0 N--CA 1.495 1.796 0 CA-C-N 118.675 0.67 . . . . 0.0 111.134 -178.401 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 22.7 p90 -155.82 109.08 2.72 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.419 -0.8 . . . . 0.0 109.892 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 5.5 t70 55.96 50.16 14.41 Favored 'General case' 0 N--CA 1.499 2.015 0 N-CA-C 116.237 1.94 . . . . 0.0 116.237 168.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 86.99 -43.82 3.26 Favored Glycine 0 CA--C 1.552 2.396 0 N-CA-C 116.706 1.443 . . . . 0.0 116.706 -168.85 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 64.4 mt-30 -73.68 132.23 42.48 Favored 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 123.874 0.87 . . . . 0.0 111.571 179.372 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -141.77 135.02 29.3 Favored 'General case' 0 N--CA 1.49 1.542 0 CA-C-O 121.202 0.525 . . . . 0.0 112.237 176.553 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 13.7 t -118.07 133.26 56.08 Favored 'General case' 0 N--CA 1.495 1.79 0 CA-C-N 115.597 -0.728 . . . . 0.0 111.087 176.818 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 37.4 p -101.84 135.25 43.72 Favored 'General case' 0 N--CA 1.494 1.736 0 CA-C-O 122.057 0.932 . . . . 0.0 110.713 171.047 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 5.4 mp -118.26 85.52 2.37 Favored 'General case' 0 CA--C 1.562 1.415 0 N-CA-C 106.535 -1.654 . . . . 0.0 106.535 -178.575 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 99.5 t -95.02 103.66 14.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 -168.866 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 83.7 mtt85 -94.58 129.29 41.47 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 123.794 0.838 . . . . 0.0 110.181 179.416 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -146.91 132.23 18.51 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 122.849 0.459 . . . . 0.0 110.837 -176.741 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -80.6 114.73 19.7 Favored 'General case' 0 N--CA 1.486 1.337 0 CA-C-O 121.328 0.585 . . . . 0.0 111.315 179.506 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 48.3 mm -118.56 105.06 17.01 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.361 0 N-CA-C 105.075 -2.194 . . . . 0.0 105.075 175.362 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 58.68 50.4 8.95 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 115.204 1.557 . . . . 0.0 115.204 175.854 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 65.6 25.56 71.61 Favored Glycine 0 CA--C 1.555 2.583 0 N-CA-C 119.351 2.501 . . . . 0.0 119.351 -171.072 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 92.6 mttt -133.78 128.45 34.82 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-N 119.203 1.501 . . . . 0.0 108.678 -173.663 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 15.0 tp -78.53 109.71 12.96 Favored 'General case' 0 CA--C 1.558 1.288 0 C-N-CA 123.272 0.629 . . . . 0.0 110.306 -179.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 31.8 mm -98.95 97.34 5.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 N-CA-C 107.192 -1.41 . . . . 0.0 107.192 -175.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 24.6 tp -91.21 104.19 16.78 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 123.972 0.909 . . . . 0.0 109.996 -179.85 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 85.1 m -96.1 108.76 21.23 Favored 'General case' 0 CA--C 1.562 1.43 0 C-N-CA 124.0 0.92 . . . . 0.0 108.804 -176.277 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 92.4 mt -103.04 103.68 13.79 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 123.537 0.735 . . . . 0.0 109.956 -174.491 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 12.8 m -112.18 117.39 32.44 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 -175.402 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 73.5 t60 -152.84 117.16 4.93 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 174.496 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 60.41 61.9 6.59 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 117.418 1.727 . . . . 0.0 117.418 169.462 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . 0.291 3.2 m 52.36 50.28 18.67 Favored 'General case' 0 CA--C 1.576 1.97 0 N-CA-C 114.878 1.436 . . . . 0.0 114.878 -172.206 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -158.87 87.85 0.88 Allowed 'General case' 0 N--CA 1.485 1.291 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 -178.708 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 3.6 p -94.73 113.66 29.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 C-N-CA 123.649 0.78 . . . . 0.0 109.348 175.62 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 45.9 t -103.99 105.62 15.86 Favored 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 123.081 0.552 . . . . 0.0 110.062 176.585 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 91.8 m -90.06 103.52 16.18 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 -179.533 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 69.0 mtp180 -104.02 114.64 29.03 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 123.042 0.537 . . . . 0.0 109.893 -166.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 91.1 m -84.15 129.07 34.92 Favored 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 122.882 0.473 . . . . 0.0 109.905 176.188 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 40.7 m-85 -125.81 127.69 46.51 Favored 'General case' 0 CA--C 1.558 1.253 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 176.241 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -95.34 157.01 16.08 Favored 'General case' 0 N--CA 1.493 1.699 0 CA-C-O 122.431 1.11 . . . . 0.0 111.572 171.08 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 72.8 tttt -91.04 126.37 36.11 Favored 'General case' 0 N--CA 1.484 1.262 0 CA-C-N 115.423 -0.808 . . . . 0.0 112.51 -164.064 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -99.84 51.1 0.92 Allowed 'General case' 0 N--CA 1.497 1.92 0 CA-C-O 121.912 0.863 . . . . 0.0 111.383 167.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.063 0 CA-C-O 123.216 1.484 . . . . 0.0 107.638 -177.459 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.265 5.9 p . . . . . 0 CA--C 1.576 1.955 0 N-CA-C 116.376 1.991 . . . . 0.0 116.376 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -65.71 -37.84 87.53 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 116.449 2.018 . . . . 0.0 116.449 -178.61 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -59.56 -29.85 68.22 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 117.313 2.338 . . . . 0.0 117.313 167.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -69.98 -23.55 63.18 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 116.287 1.958 . . . . 0.0 116.287 168.337 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 58.5 mt -75.0 120.02 19.97 Favored 'General case' 0 N--CA 1.49 1.539 0 CA-C-N 121.028 1.74 . . . . 0.0 111.689 -173.645 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 160.29 176.39 32.33 Favored Glycine 0 CA--C 1.541 1.708 0 CA-C-O 122.447 1.026 . . . . 0.0 113.744 -176.007 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 75.2 m -93.22 135.46 34.4 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 170.495 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 94.2 m95 -138.4 115.63 11.06 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 -169.796 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 24.9 mmmt -102.17 145.65 29.08 Favored 'General case' 0 N--CA 1.492 1.628 0 CA-C-O 121.536 0.684 . . . . 0.0 111.021 178.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 43.9 tp -70.13 125.42 26.73 Favored 'General case' 0 N--CA 1.489 1.477 0 CA-C-O 122.039 0.923 . . . . 0.0 112.118 -176.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . 0.275 1.0 OUTLIER -107.84 -39.26 4.32 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.883 0 CA-C-N 113.997 -1.456 . . . . 0.0 112.435 -178.701 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -137.21 138.0 39.7 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-N 120.305 1.411 . . . . 0.0 109.64 176.15 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 78.3 p -121.56 103.47 8.94 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 167.624 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 8.9 tmtm? -79.92 -78.35 0.17 Allowed 'General case' 0 N--CA 1.491 1.602 0 CA-C-O 118.877 -0.582 . . . . 0.0 112.554 -167.309 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 85.0 m-20 -105.15 48.26 0.84 Allowed 'General case' 0 N--CA 1.498 1.967 0 CA-C-N 118.89 0.768 . . . . 0.0 112.795 177.684 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 10.0 t80 -92.09 75.78 5.44 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.704 -1.247 . . . . 0.0 110.973 -174.341 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -172.21 -61.27 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 124.668 1.187 . . . . 0.0 108.987 -168.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 12.3 t0 -61.66 -38.29 87.2 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 115.859 1.8 . . . . 0.0 115.859 166.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 87.9 t80 -48.74 -53.86 17.28 Favored 'General case' 0 CA--C 1.574 1.893 0 N-CA-C 114.755 1.391 . . . . 0.0 114.755 163.592 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 56.8 mtm -66.24 -29.98 70.34 Favored 'General case' 0 CA--C 1.571 1.768 0 N-CA-C 116.549 2.055 . . . . 0.0 116.549 171.735 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 55.8 mttp -61.18 -48.65 80.56 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 114.942 1.46 . . . . 0.0 114.942 166.459 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 23.1 t -66.26 -32.44 73.86 Favored 'General case' 0 CA--C 1.567 1.599 0 N-CA-C 116.465 2.024 . . . . 0.0 116.465 173.248 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 65.2 mt -66.27 -43.64 85.87 Favored 'General case' 0 CA--C 1.565 1.522 0 N-CA-C 116.084 1.883 . . . . 0.0 116.084 172.372 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 105.84 86.67 1.92 Allowed Glycine 0 N--CA 1.482 1.742 0 N-CA-C 110.744 -0.943 . . . . 0.0 110.744 -170.098 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 41.3 t -140.61 144.11 27.83 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 N-CA-C 107.575 -1.269 . . . . 0.0 107.575 -174.455 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -73.13 163.08 54.91 Favored Glycine 0 CA--C 1.552 2.361 0 O-C-N 120.958 -1.089 . . . . 0.0 115.137 169.045 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 25.2 p90 -62.93 -39.61 95.1 Favored 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 117.071 2.249 . . . . 0.0 117.071 -178.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.45 -45.08 94.71 Favored 'General case' 0 CA--C 1.56 1.347 0 N-CA-C 115.777 1.769 . . . . 0.0 115.777 177.799 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . 0.288 0.6 OUTLIER -81.51 -19.07 42.96 Favored 'General case' 0 N--CA 1.499 2.002 0 N-CA-C 116.177 1.917 . . . . 0.0 116.177 173.141 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 34.3 ttm105 -61.58 -46.92 87.83 Favored 'General case' 0 CA--C 1.57 1.744 0 CA-C-N 121.18 1.809 . . . . 0.0 113.646 160.756 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 22.7 tt0 -62.99 -49.42 74.78 Favored 'General case' 0 CA--C 1.563 1.473 0 N-CA-C 115.282 1.586 . . . . 0.0 115.282 171.414 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 89.1 t -63.66 -43.82 98.25 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 CA-C-O 117.273 -1.346 . . . . 0.0 112.983 174.345 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -63.07 -41.17 99.38 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 116.478 2.029 . . . . 0.0 116.478 177.754 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 97.3 p -61.15 -42.64 98.92 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 116.619 2.081 . . . . 0.0 116.619 168.254 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 48.1 ttp -66.61 -36.85 83.6 Favored 'General case' 0 CA--C 1.572 1.824 0 N-CA-C 116.421 2.008 . . . . 0.0 116.421 169.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 52.3 m -73.29 135.19 44.39 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 124.28 1.032 . . . . 0.0 111.807 -175.578 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -103.74 102.28 29.73 Favored Pre-proline 0 CA--C 1.571 1.77 0 CA-C-N 114.554 -1.203 . . . . 0.0 109.81 175.228 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -76.44 126.19 8.87 Favored 'Trans proline' 0 CA--C 1.562 1.893 0 C-N-CA 123.235 2.624 . . . . 0.0 112.861 -178.134 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 15.4 m -84.59 107.05 16.61 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 -179.828 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 47.5 m -100.93 104.3 15.49 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 -168.614 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 48.9 mt -98.68 112.15 30.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 N-CA-C 106.991 -1.485 . . . . 0.0 106.991 -179.169 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 42.7 mt -106.31 115.11 47.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 N-CA-C 106.733 -1.58 . . . . 0.0 106.733 -177.435 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -139.38 115.06 10.02 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 -173.591 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 84.7 tttt -87.49 112.64 22.42 Favored 'General case' 0 CA--C 1.556 1.211 0 C-N-CA 123.075 0.55 . . . . 0.0 110.025 173.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 20.4 t-20 -82.65 -69.78 0.6 Allowed 'General case' 0 CA--C 1.564 1.496 0 C-N-CA 123.314 0.646 . . . . 0.0 111.298 -176.359 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -149.56 89.55 0.14 Allowed Glycine 0 N--CA 1.482 1.74 0 N-CA-C 108.867 -1.693 . . . . 0.0 108.867 172.241 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . 0.295 12.6 m-20 69.54 -20.05 0.18 Allowed 'General case' 0 N--CA 1.499 1.978 0 N-CA-C 117.569 2.433 . . . . 0.0 117.569 -164.519 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 16.4 mm -101.19 111.9 32.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 -171.055 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 16.2 mt -79.97 115.18 19.4 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 123.611 0.764 . . . . 0.0 110.797 173.47 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 44.3 m -104.0 96.34 6.61 Favored 'General case' 0 CA--C 1.56 1.338 0 N-CA-C 106.557 -1.645 . . . . 0.0 106.557 -176.5 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 9.1 tt -96.85 102.92 14.79 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 -179.271 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -97.42 107.87 20.47 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 123.721 0.808 . . . . 0.0 108.87 -173.154 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 34.7 m -95.14 90.98 6.09 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 -176.167 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 20.6 m170 -84.76 101.88 12.58 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 -174.053 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 23.4 t . . . . . 0 N--CA 1.485 1.312 0 C-N-CA 123.556 0.743 . . . . 0.0 110.335 -167.313 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 9.8 p30 . . . . . 0 N--CA 1.489 1.518 0 N-CA-C 112.475 0.546 . . . . 0.0 112.475 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 75.1 p -101.08 126.66 47.79 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-O 121.405 0.622 . . . . 0.0 110.617 -174.764 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -110.01 118.25 35.92 Favored 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 177.126 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 14.3 pt -107.66 126.71 64.0 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 178.799 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 77.9 p -115.87 109.24 17.35 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 -175.662 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 48.1 p90 -141.33 138.39 33.06 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 114.682 1.364 . . . . 0.0 114.682 -161.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 60.7 mtpt -95.95 145.6 25.28 Favored 'General case' 0 CA--C 1.562 1.432 0 CA-C-N 115.036 -0.984 . . . . 0.0 109.148 162.086 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -73.47 116.66 14.3 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.575 -0.703 . . . . 0.0 112.208 -173.171 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 79.9 40.61 14.05 Favored Glycine 0 CA--C 1.549 2.2 0 N-CA-C 117.013 1.565 . . . . 0.0 117.013 -170.428 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 91.6 t -139.3 117.76 12.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 N-CA-C 105.34 -2.096 . . . . 0.0 105.34 -179.209 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -81.41 132.25 35.32 Favored 'General case' 0 N--CA 1.49 1.53 0 CA-C-O 121.578 0.704 . . . . 0.0 111.267 178.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 19.5 p90 -134.28 145.55 49.2 Favored 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 124.158 0.983 . . . . 0.0 110.313 -174.133 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -73.44 128.55 35.81 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 123.204 0.602 . . . . 0.0 112.413 178.355 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -131.41 131.81 43.89 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 123.267 0.627 . . . . 0.0 109.785 -168.35 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 90.6 m -112.82 119.32 37.6 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 107.135 -1.431 . . . . 0.0 107.135 170.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 42.7 p -80.87 175.3 10.8 Favored 'General case' 0 N--CA 1.495 1.785 0 CA-C-N 115.545 -0.752 . . . . 0.0 112.745 -174.078 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -59.49 -40.07 85.82 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 116.193 1.923 . . . . 0.0 116.193 169.864 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -74.97 -7.41 53.54 Favored 'General case' 0 CA--C 1.578 2.039 0 N-CA-C 116.256 1.947 . . . . 0.0 116.256 165.571 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . 0.256 6.1 m-20 67.48 68.18 0.38 Allowed 'General case' 0 N--CA 1.496 1.874 0 C-N-CA 125.512 1.525 . . . . 0.0 111.714 -178.103 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 31.0 ttm-85 -116.38 18.04 15.32 Favored 'General case' 0 N--CA 1.498 1.926 0 N-CA-C 116.11 1.892 . . . . 0.0 116.11 -167.745 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . 0.31 0.1 OUTLIER 39.4 71.47 0.17 Allowed 'General case' 0 N--CA 1.499 1.982 0 N-CA-C 118.14 2.644 . . . . 0.0 118.14 176.023 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 4.5 m -112.1 144.07 20.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 CA-C-O 121.386 0.613 . . . . 0.0 111.172 -166.454 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 1.2 mppt? -97.99 102.32 14.04 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 174.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 61.5 p -93.56 113.98 26.23 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.577 0.751 . . . . 0.0 111.874 -170.267 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 5.7 tp -123.0 117.38 51.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 179.004 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 1.1 p -134.11 125.97 49.08 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 C-N-CA 123.786 0.834 . . . . 0.0 109.729 -174.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 15.3 t -132.29 152.0 51.58 Favored 'General case' 0 N--CA 1.495 1.807 0 CA-C-O 122.331 1.062 . . . . 0.0 112.32 178.811 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 53.5 tp -82.75 128.79 34.71 Favored 'General case' 0 N--CA 1.491 1.59 0 CA-C-N 114.644 -1.162 . . . . 0.0 110.067 170.704 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -131.45 83.42 2.1 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 123.444 0.698 . . . . 0.0 109.519 -179.046 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 58.51 47.23 91.1 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 117.863 1.905 . . . . 0.0 117.863 -178.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 76.32 37.74 35.75 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 117.571 1.788 . . . . 0.0 117.571 -167.646 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 36.3 ttmt -149.67 105.93 3.49 Favored 'General case' 0 N--CA 1.481 1.091 0 N-CA-C 106.572 -1.64 . . . . 0.0 106.572 -176.567 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 3.7 mp -79.97 114.41 18.86 Favored 'General case' 0 N--CA 1.485 1.288 0 CA-C-O 121.607 0.718 . . . . 0.0 109.811 172.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 95.3 t -109.78 101.76 13.03 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 N-CA-C 104.964 -2.236 . . . . 0.0 104.964 -173.713 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 23.1 t-160 -99.38 136.92 38.62 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 123.807 0.843 . . . . 0.0 109.69 178.11 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 24.8 tp -134.99 120.23 18.92 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 176.775 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 29.7 mt-30 -112.0 126.2 54.89 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 177.117 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 9.8 mtmp? -126.49 134.45 50.91 Favored 'General case' 0 N--CA 1.496 1.835 0 C-N-CA 122.989 0.515 . . . . 0.0 110.902 -170.58 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 25.8 p90 -152.38 116.12 4.83 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.469 -0.769 . . . . 0.0 110.433 -175.459 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . 0.344 12.6 t70 67.37 -101.76 0.06 Allowed 'General case' 0 N--CA 1.495 1.797 0 C-N-CA 124.515 1.126 . . . . 0.0 112.319 172.965 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -127.41 55.06 0.76 Allowed Glycine 0 N--CA 1.488 2.151 0 CA-C-N 118.96 0.8 . . . . 0.0 113.377 162.331 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 47.7 mt-30 -154.34 129.98 9.98 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 -173.425 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -140.09 125.58 19.07 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.595 -0.691 . . . . 0.0 111.489 -179.311 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 14.3 t -107.94 134.03 51.44 Favored 'General case' 0 N--CA 1.495 1.782 0 C-N-CA 122.98 0.512 . . . . 0.0 110.534 173.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 33.7 p -100.74 134.81 43.15 Favored 'General case' 0 N--CA 1.492 1.669 0 CA-C-O 121.408 0.623 . . . . 0.0 110.77 168.826 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 5.3 mp -118.61 78.54 1.28 Allowed 'General case' 0 CA--C 1.561 1.404 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 178.202 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 62.8 t -86.53 103.41 12.94 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 121.108 -0.995 . . . . 0.0 108.489 -170.6 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 22.0 mmt180 -88.15 124.61 33.98 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 124.21 1.004 . . . . 0.0 109.71 177.081 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -149.52 127.86 12.17 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 122.115 -0.366 . . . . 0.0 111.455 -169.442 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -78.0 117.64 19.52 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.63 -0.669 . . . . 0.0 111.524 177.64 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 48.1 mm -117.58 100.41 10.12 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.312 0 N-CA-C 105.131 -2.174 . . . . 0.0 105.131 173.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 23.2 m-20 56.5 48.79 16.04 Favored 'General case' 0 N--CA 1.498 1.963 0 N-CA-C 115.094 1.516 . . . . 0.0 115.094 174.844 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 89.57 -42.14 3.0 Favored Glycine 0 CA--C 1.552 2.344 0 N-CA-C 117.35 1.7 . . . . 0.0 117.35 -169.53 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 50.7 mttp -83.06 128.69 34.7 Favored 'General case' 0 N--CA 1.487 1.4 0 CA-C-N 118.658 1.229 . . . . 0.0 111.842 -172.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 56.9 tp -86.08 116.33 24.23 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 123.486 0.714 . . . . 0.0 110.715 -177.354 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 33.5 mm -101.49 107.11 20.78 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 -172.09 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 52.7 tp -85.28 106.83 16.97 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 123.778 0.831 . . . . 0.0 109.359 171.399 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 75.5 m -99.73 106.14 18.02 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 -173.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 91.5 mt -103.78 96.44 6.7 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 123.274 0.63 . . . . 0.0 110.091 -169.699 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 9.2 m -111.68 116.06 30.14 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 -174.549 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 75.8 t60 -147.24 115.49 6.61 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 173.669 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 62.52 59.13 9.79 Favored Glycine 0 N--CA 1.488 2.143 0 N-CA-C 117.051 1.58 . . . . 0.0 117.051 172.475 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . 0.288 2.7 m 51.9 51.66 16.06 Favored 'General case' 0 CA--C 1.576 1.945 0 N-CA-C 115.129 1.529 . . . . 0.0 115.129 -172.445 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -157.24 89.26 1.05 Allowed 'General case' 0 N--CA 1.484 1.272 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 -179.614 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 4.8 p -94.34 116.28 35.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 C-N-CA 123.685 0.794 . . . . 0.0 109.88 178.187 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 42.9 t -103.69 110.3 22.33 Favored 'General case' 0 CA--C 1.553 1.058 0 C-N-CA 123.265 0.626 . . . . 0.0 110.026 174.252 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 79.8 m -90.64 97.76 11.37 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 -176.677 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 21.6 mtm180 -101.63 116.98 33.96 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 122.752 0.421 . . . . 0.0 111.042 -171.118 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 75.8 m -88.33 140.62 29.28 Favored 'General case' 0 N--CA 1.494 1.739 0 C-N-CA 123.544 0.737 . . . . 0.0 110.877 -177.214 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 34.6 m-85 -132.7 131.62 41.47 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 123.67 0.788 . . . . 0.0 109.825 -178.317 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -96.21 150.42 20.55 Favored 'General case' 0 N--CA 1.494 1.744 0 CA-C-O 122.121 0.963 . . . . 0.0 112.25 171.734 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 72.2 tttt -87.33 119.1 27.24 Favored 'General case' 0 N--CA 1.483 1.187 0 CA-C-N 115.142 -0.936 . . . . 0.0 111.149 -173.723 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 28.8 mm-40 -107.07 49.74 0.79 Allowed 'General case' 0 CA--C 1.567 1.629 0 C-N-CA 124.069 0.947 . . . . 0.0 111.709 178.566 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.035 0 CA-C-O 123.126 1.441 . . . . 0.0 108.397 -173.126 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 4.0 p . . . . . 0 CA--C 1.577 2.002 0 N-CA-C 116.028 1.862 . . . . 0.0 116.028 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 -63.77 -45.53 89.35 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 117.817 2.525 . . . . 0.0 117.817 -174.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -56.74 -25.54 55.11 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 118.084 2.624 . . . . 0.0 118.084 172.513 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -67.8 -30.68 70.17 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 116.181 1.919 . . . . 0.0 116.181 165.355 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 32.9 mt -72.05 107.01 4.53 Favored 'General case' 0 N--CA 1.489 1.496 0 CA-C-N 120.182 1.355 . . . . 0.0 111.445 -167.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 163.33 169.54 26.93 Favored Glycine 0 CA--C 1.544 1.864 0 CA-C-O 122.645 1.136 . . . . 0.0 113.581 -169.349 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 73.7 m -86.35 142.48 28.45 Favored 'General case' 0 N--CA 1.491 1.595 0 CA-C-N 114.266 -0.967 . . . . 0.0 110.071 170.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 77.5 m95 -143.87 117.21 9.04 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 -174.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -101.08 145.6 28.54 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.9 -0.5 . . . . 0.0 110.38 176.263 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 22.2 tp -68.12 122.86 19.16 Favored 'General case' 0 N--CA 1.49 1.564 0 CA-C-O 122.169 0.985 . . . . 0.0 111.757 -178.525 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . 0.282 0.9 OUTLIER -101.31 -46.87 11.51 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.8 0 CA-C-N 113.752 -1.567 . . . . 0.0 111.516 179.082 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -139.81 145.26 37.95 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-N 119.714 1.143 . . . . 0.0 109.647 175.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 79.7 p -131.67 89.42 2.7 Favored 'General case' 0 N--CA 1.491 1.613 0 CA-C-O 121.671 0.748 . . . . 0.0 110.091 168.448 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -78.29 127.39 32.17 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 123.534 0.734 . . . . 0.0 110.378 178.046 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.254 42.1 m-20 68.74 32.97 3.9 Favored 'General case' 0 N--CA 1.505 2.304 0 N-CA-C 116.391 1.997 . . . . 0.0 116.391 178.907 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 42.2 t80 -68.9 -62.95 1.17 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.631 -1.293 . . . . 0.0 113.09 -175.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -44.89 -36.02 3.11 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 118.637 2.829 . . . . 0.0 118.637 168.209 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -65.55 -48.67 71.61 Favored 'General case' 0 N--CA 1.498 1.944 0 CA-C-N 120.745 1.611 . . . . 0.0 114.64 172.413 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 85.7 t80 -55.38 -46.97 76.49 Favored 'General case' 0 CA--C 1.572 1.815 0 N-CA-C 115.179 1.548 . . . . 0.0 115.179 167.623 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 16.3 mmm -59.52 -42.52 92.44 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 115.493 1.664 . . . . 0.0 115.493 174.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 70.1 tttt -64.96 -41.05 95.81 Favored 'General case' 0 CA--C 1.568 1.64 0 N-CA-C 115.248 1.573 . . . . 0.0 115.248 170.091 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 50.9 m -56.74 -41.8 78.15 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 116.031 1.863 . . . . 0.0 116.031 171.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 45.4 mt -66.11 -36.83 84.22 Favored 'General case' 0 CA--C 1.565 1.532 0 N-CA-C 117.088 2.255 . . . . 0.0 117.088 168.353 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 100.08 78.98 1.4 Allowed Glycine 0 CA--C 1.54 1.622 0 CA-C-N 118.867 0.758 . . . . 0.0 111.644 -169.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 57.3 t -136.59 122.08 27.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 N-CA-C 105.48 -2.045 . . . . 0.0 105.48 -179.639 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -64.04 159.51 39.99 Favored Glycine 0 CA--C 1.548 2.125 0 N-CA-C 116.19 1.236 . . . . 0.0 116.19 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 27.8 p90 -56.27 -40.82 74.85 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 118.854 2.909 . . . . 0.0 118.854 -167.04 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.06 -42.01 81.11 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 116.022 1.86 . . . . 0.0 116.022 176.333 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 41.0 m -70.09 -39.94 75.28 Favored 'General case' 0 N--CA 1.499 1.986 0 CA-C-N 119.377 0.99 . . . . 0.0 113.663 171.069 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 68.1 ttt-85 -55.99 -42.77 76.86 Favored 'General case' 0 CA--C 1.571 1.766 0 N-CA-C 115.989 1.848 . . . . 0.0 115.989 168.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 25.6 tt0 -77.84 -42.79 32.42 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 115.355 1.613 . . . . 0.0 115.355 175.169 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 75.7 t -65.2 -41.62 92.09 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 CA-C-N 119.756 1.162 . . . . 0.0 113.011 174.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -64.36 -33.0 74.84 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 116.873 2.175 . . . . 0.0 116.873 172.301 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 93.3 p -67.05 -42.88 84.04 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 115.506 1.669 . . . . 0.0 115.506 167.422 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 42.5 ttm -60.89 -36.66 79.79 Favored 'General case' 0 CA--C 1.572 1.798 0 N-CA-C 116.135 1.902 . . . . 0.0 116.135 167.234 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 99.4 m -69.06 136.26 52.07 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 124.49 1.116 . . . . 0.0 111.328 176.589 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -108.35 92.43 9.76 Favored Pre-proline 0 CA--C 1.569 1.683 0 C-N-CA 123.824 0.85 . . . . 0.0 108.973 172.211 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -81.92 145.38 14.1 Favored 'Trans proline' 0 C--N 1.37 1.706 0 C-N-CA 122.83 2.353 . . . . 0.0 113.237 -174.206 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 85.5 m -99.2 102.31 13.92 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 -173.579 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 94.3 m -80.42 120.8 24.92 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 123.773 0.829 . . . . 0.0 109.319 175.391 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 36.9 mt -123.73 111.4 28.94 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 N-CA-C 106.399 -1.704 . . . . 0.0 106.399 -176.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 3.9 mp -94.09 128.1 45.65 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 175.35 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 22.0 mm-40 -128.57 169.32 14.53 Favored 'General case' 0 N--CA 1.489 1.496 0 CA-C-O 122.095 0.95 . . . . 0.0 110.551 178.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.69 157.2 42.78 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 123.869 0.868 . . . . 0.0 111.526 178.427 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 65.0 m-80 -134.55 -78.51 0.46 Allowed 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 177.352 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -153.13 86.65 0.14 Allowed Glycine 0 N--CA 1.482 1.749 0 N-CA-C 108.1 -2.0 . . . . 0.0 108.1 168.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . 0.277 14.4 m-20 66.62 -12.05 0.22 Allowed 'General case' 0 N--CA 1.498 1.945 0 N-CA-C 117.726 2.491 . . . . 0.0 117.726 -161.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 26.8 mm -90.27 103.75 14.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 CA-C-N 120.147 1.34 . . . . 0.0 107.445 -177.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 44.4 mt -93.61 110.8 22.39 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 123.005 0.522 . . . . 0.0 110.79 -174.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 90.5 m -99.32 98.76 9.67 Favored 'General case' 0 CA--C 1.562 1.411 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 -170.295 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 9.6 tt -97.78 113.49 25.29 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 178.231 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 45.6 mtpt -112.05 106.98 15.78 Favored 'General case' 0 N--CA 1.484 1.262 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 -173.135 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 82.5 m -92.15 101.71 14.23 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 177.612 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 72.4 m80 -88.41 90.53 8.43 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 123.883 0.873 . . . . 0.0 110.533 -173.467 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 60.5 p -103.49 161.12 14.13 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 113.265 0.839 . . . . 0.0 113.265 -178.295 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 17.8 m -86.02 60.41 6.22 Favored 'General case' 0 N--CA 1.498 1.945 0 CA-C-O 121.979 0.895 . . . . 0.0 110.697 163.414 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 20.6 t80 -157.04 -81.46 0.07 Allowed 'General case' 0 CA--C 1.559 1.316 0 N-CA-C 105.768 -1.938 . . . . 0.0 105.768 176.23 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 32.0 mtmm -143.15 133.64 24.88 Favored 'General case' 0 N--CA 1.491 1.595 0 CA-C-N 118.996 0.816 . . . . 0.0 108.836 166.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 70.9 m-20 -80.48 113.68 18.84 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 123.172 0.589 . . . . 0.0 110.433 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 61.6 p -98.56 129.43 45.11 Favored 'General case' 0 N--CA 1.493 1.721 0 CA-C-O 121.221 0.534 . . . . 0.0 110.886 -176.491 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -115.26 116.55 28.5 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 179.465 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 28.8 pt -113.08 129.6 68.46 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 176.442 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 77.6 p -117.8 114.3 23.07 Favored 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 123.871 0.868 . . . . 0.0 109.298 -176.219 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 51.0 p90 -141.12 139.42 33.97 Favored 'General case' 0 N--CA 1.499 1.982 0 N-CA-C 115.499 1.666 . . . . 0.0 115.499 -161.514 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 62.2 mtpt -105.99 23.9 13.26 Favored 'General case' 0 CA--C 1.574 1.867 0 N-CA-C 116.877 2.177 . . . . 0.0 116.877 -175.084 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . 0.284 1.2 mp 60.78 90.21 0.07 Allowed 'General case' 0 N--CA 1.495 1.825 0 CA-C-N 120.536 1.517 . . . . 0.0 114.772 171.545 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 87.76 38.51 7.47 Favored Glycine 0 CA--C 1.551 2.302 0 N-CA-C 116.779 1.472 . . . . 0.0 116.779 -166.581 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 82.6 t -139.3 120.45 15.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 N-CA-C 106.131 -1.803 . . . . 0.0 106.131 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -87.46 124.06 33.04 Favored 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 122.953 0.501 . . . . 0.0 111.122 178.304 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 45.8 p90 -127.58 133.99 49.72 Favored 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 123.775 0.83 . . . . 0.0 111.166 -172.56 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -70.58 128.8 37.34 Favored 'General case' 0 CA--C 1.564 1.513 0 O-C-N 121.447 -0.783 . . . . 0.0 112.567 173.352 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 14.7 tp10 -142.46 135.73 28.73 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 123.193 0.597 . . . . 0.0 109.963 -168.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 53.1 m -92.56 127.47 38.07 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 171.214 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 31.1 p -84.25 171.68 12.53 Favored 'General case' 0 N--CA 1.495 1.781 0 CA-C-O 121.429 0.633 . . . . 0.0 112.443 -177.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -62.88 -31.35 72.38 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 116.438 2.014 . . . . 0.0 116.438 166.646 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -81.0 21.06 0.73 Allowed 'General case' 0 CA--C 1.582 2.193 0 N-CA-C 114.956 1.465 . . . . 0.0 114.956 165.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 56.31 69.23 0.76 Allowed 'General case' 0 N--CA 1.496 1.837 0 C-N-CA 125.928 1.691 . . . . 0.0 114.517 176.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 50.8 mtm180 -144.12 126.84 16.14 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-O 121.116 0.484 . . . . 0.0 110.683 -174.519 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 62.5 pttt -66.12 118.29 9.65 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 123.957 0.903 . . . . 0.0 111.929 165.368 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 15.8 m -140.25 130.13 28.41 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 -173.342 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 30.5 mmmt -87.41 112.22 21.92 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-O 121.593 0.711 . . . . 0.0 109.669 178.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 67.3 m -109.99 105.92 15.25 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 123.515 0.726 . . . . 0.0 111.108 -158.155 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 6.9 tp -114.66 105.84 19.46 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 C-N-CA 123.795 0.838 . . . . 0.0 109.53 -175.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -115.92 126.23 73.35 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 C-N-CA 124.551 1.14 . . . . 0.0 108.933 178.223 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 15.4 t -132.24 157.13 45.17 Favored 'General case' 0 N--CA 1.492 1.644 0 CA-C-O 122.625 1.203 . . . . 0.0 111.296 172.005 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 17.6 tp -93.31 116.24 28.81 Favored 'General case' 0 N--CA 1.487 1.419 0 CA-C-N 114.837 -1.074 . . . . 0.0 110.785 -176.465 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -110.36 82.74 1.64 Allowed 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 123.576 0.75 . . . . 0.0 109.679 178.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 56.68 46.16 89.6 Favored Glycine 0 CA--C 1.552 2.369 0 N-CA-C 118.203 2.041 . . . . 0.0 118.203 -177.042 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 78.59 44.76 10.27 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 117.0 1.56 . . . . 0.0 117.0 -167.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 41.1 ttmt -151.13 111.28 4.12 Favored 'General case' 0 CA--C 1.551 0.994 0 N-CA-C 106.481 -1.674 . . . . 0.0 106.481 -177.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 65.5 mt -85.21 95.3 9.13 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-O 122.976 1.369 . . . . 0.0 109.428 177.526 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 88.7 t -87.1 97.76 6.67 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.334 0 CA-C-N 112.617 -2.083 . . . . 0.0 105.876 -178.405 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 22.7 t-160 -102.44 139.39 38.11 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 124.396 1.078 . . . . 0.0 109.405 -176.513 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 28.2 tp -136.69 115.29 11.98 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 178.514 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 89.4 mt-30 -104.22 115.77 30.99 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 175.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt -121.87 135.68 54.9 Favored 'General case' 0 N--CA 1.493 1.701 0 C-N-CA 123.335 0.654 . . . . 0.0 111.789 -171.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 16.3 p90 -159.0 110.91 2.15 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 123.333 0.653 . . . . 0.0 110.536 -174.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 5.7 t70 52.59 54.45 10.58 Favored 'General case' 0 N--CA 1.498 1.948 0 N-CA-C 116.567 2.062 . . . . 0.0 116.567 165.328 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 88.76 -46.0 3.27 Favored Glycine 0 CA--C 1.549 2.206 0 N-CA-C 116.434 1.334 . . . . 0.0 116.434 -169.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 16.3 mt-30 -83.6 129.21 34.96 Favored 'General case' 0 N--CA 1.488 1.446 0 CA-C-N 117.957 0.878 . . . . 0.0 111.233 -178.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -141.21 124.75 16.74 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 122.786 0.435 . . . . 0.0 110.664 177.005 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 13.0 t -110.8 135.52 51.24 Favored 'General case' 0 N--CA 1.492 1.656 0 C-N-CA 123.108 0.563 . . . . 0.0 110.643 176.273 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 37.9 p -100.27 131.02 46.44 Favored 'General case' 0 N--CA 1.492 1.628 0 C-N-CA 123.021 0.528 . . . . 0.0 110.761 174.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 5.4 mp -111.73 76.18 0.96 Allowed 'General case' 0 CA--C 1.563 1.447 0 C-N-CA 124.005 0.922 . . . . 0.0 108.783 -179.446 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 87.5 t -87.04 110.1 20.0 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 -168.242 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 83.9 mtt85 -102.38 118.49 36.99 Favored 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 122.975 0.51 . . . . 0.0 109.939 -175.777 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -135.32 127.96 30.85 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 123.34 0.656 . . . . 0.0 110.665 -169.539 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -80.91 114.64 19.93 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.833 -0.542 . . . . 0.0 111.395 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 85.8 mt -124.14 106.98 17.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 N-CA-C 105.015 -2.217 . . . . 0.0 105.015 178.512 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 23.4 m-20 58.17 50.3 10.1 Favored 'General case' 0 N--CA 1.499 1.989 0 N-CA-C 115.15 1.537 . . . . 0.0 115.15 177.031 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 60.73 31.24 74.76 Favored Glycine 0 CA--C 1.554 2.503 0 N-CA-C 118.964 2.346 . . . . 0.0 118.964 -169.453 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 92.1 mttt -133.65 128.55 35.3 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-N 119.135 1.468 . . . . 0.0 108.686 -175.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 12.3 tp -79.76 107.42 12.52 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 123.433 0.693 . . . . 0.0 109.389 177.61 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 31.6 mm -99.42 99.29 8.26 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 N-CA-C 106.536 -1.653 . . . . 0.0 106.536 -175.598 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 21.9 tp -87.86 102.99 15.24 Favored 'General case' 0 N--CA 1.486 1.372 0 CA-C-O 121.843 0.83 . . . . 0.0 109.549 178.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 90.9 m -95.76 103.61 15.5 Favored 'General case' 0 CA--C 1.561 1.389 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 -175.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 90.3 mt -97.61 100.49 11.89 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 123.581 0.752 . . . . 0.0 109.809 -174.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 8.1 m -113.89 125.28 53.87 Favored 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 -175.035 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 82.9 t60 -129.48 -102.9 0.31 Allowed 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.982 -0.748 . . . . 0.0 108.982 175.352 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -112.32 88.6 0.5 Allowed Glycine 0 N--CA 1.485 1.923 0 CA-C-N 119.183 0.901 . . . . 0.0 112.003 -171.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . 0.298 2.6 m 54.49 44.61 28.53 Favored 'General case' 0 CA--C 1.578 2.032 0 N-CA-C 115.381 1.623 . . . . 0.0 115.381 -175.68 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -163.66 95.68 0.82 Allowed 'General case' 0 N--CA 1.483 1.193 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 178.12 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 2.9 p -91.69 115.87 31.67 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 C-N-CA 123.402 0.681 . . . . 0.0 109.415 174.717 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 53.3 t -95.7 105.4 17.39 Favored 'General case' 0 CA--C 1.551 1.01 0 CA-C-O 121.302 0.573 . . . . 0.0 110.572 173.187 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 75.7 m -91.88 113.53 25.82 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 -178.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 83.3 mtp180 -113.53 109.36 18.52 Favored 'General case' 0 N--CA 1.486 1.332 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.615 -168.457 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 88.4 m -84.01 127.21 33.72 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 123.165 0.586 . . . . 0.0 109.947 178.058 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 43.1 m-85 -123.71 127.94 48.89 Favored 'General case' 0 CA--C 1.56 1.345 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 175.292 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -91.1 152.59 20.55 Favored 'General case' 0 N--CA 1.496 1.83 0 CA-C-O 121.879 0.847 . . . . 0.0 111.736 170.142 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 70.9 tttt -82.15 122.71 28.22 Favored 'General case' 0 N--CA 1.487 1.404 0 CA-C-O 121.587 0.708 . . . . 0.0 111.975 -171.456 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 24.5 mm-40 -119.04 50.94 1.16 Allowed 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 124.225 1.01 . . . . 0.0 111.605 -174.258 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 0.872 0 CA-C-O 123.155 1.455 . . . . 0.0 110.131 -162.634 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.253 5.1 p . . . . . 0 CA--C 1.576 1.968 0 N-CA-C 114.581 1.326 . . . . 0.0 114.581 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -85.12 -36.59 21.02 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 115.561 1.689 . . . . 0.0 115.561 -173.609 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -58.52 -24.73 61.28 Favored 'General case' 0 N--CA 1.497 1.891 0 N-CA-C 117.694 2.479 . . . . 0.0 117.694 168.558 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -68.72 -20.17 64.38 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 116.84 2.163 . . . . 0.0 116.84 167.101 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 56.2 mt -80.44 126.81 31.66 Favored 'General case' 0 N--CA 1.486 1.352 0 CA-C-N 120.627 1.558 . . . . 0.0 111.882 -170.402 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 155.79 178.14 29.7 Favored Glycine 0 CA--C 1.541 1.713 0 CA-C-O 122.03 0.795 . . . . 0.0 113.557 -178.112 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 43.1 m -92.94 135.69 33.93 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 168.53 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 89.3 m95 -137.21 113.79 10.26 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 -170.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 26.7 mtpt -93.49 148.69 21.85 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 121.927 0.87 . . . . 0.0 111.366 172.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 20.2 tp -71.4 135.61 47.34 Favored 'General case' 0 N--CA 1.486 1.368 0 CA-C-O 122.32 1.057 . . . . 0.0 112.53 -178.478 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . 0.271 1.1 t -114.52 -43.76 4.06 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.878 0 CA-C-N 113.786 -1.552 . . . . 0.0 111.953 -177.589 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -127.28 150.8 49.4 Favored 'General case' 0 N--CA 1.494 1.76 0 CA-C-N 119.986 1.267 . . . . 0.0 110.65 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 81.1 p -145.2 88.71 1.89 Allowed 'General case' 0 N--CA 1.49 1.544 0 CA-C-O 121.22 0.533 . . . . 0.0 110.244 167.484 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -102.22 125.24 48.87 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 123.4 0.68 . . . . 0.0 109.201 177.165 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.288 53.6 m-20 72.57 17.07 4.69 Favored 'General case' 0 N--CA 1.503 2.206 0 N-CA-C 117.491 2.404 . . . . 0.0 117.491 -178.904 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 30.9 t80 -68.77 -41.91 78.16 Favored 'General case' 0 N--CA 1.497 1.894 0 N-CA-C 115.091 1.515 . . . . 0.0 115.091 178.202 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -49.58 -49.01 48.28 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 116.009 1.855 . . . . 0.0 116.009 165.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 18.4 t0 -59.21 -50.59 73.44 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 115.397 1.628 . . . . 0.0 115.397 172.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 88.2 t80 -52.67 -51.79 58.67 Favored 'General case' 0 CA--C 1.572 1.794 0 N-CA-C 115.6 1.704 . . . . 0.0 115.6 170.349 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 5.5 mmm -64.78 -40.07 94.64 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 115.124 1.527 . . . . 0.0 115.124 176.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 21.7 ttmm -55.96 -45.29 78.92 Favored 'General case' 0 CA--C 1.571 1.769 0 N-CA-C 115.14 1.534 . . . . 0.0 115.14 166.317 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 12.8 t -59.77 -38.42 81.77 Favored 'General case' 0 CA--C 1.571 1.763 0 N-CA-C 116.407 2.003 . . . . 0.0 116.407 170.42 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 75.8 mt -65.16 -25.47 67.75 Favored 'General case' 0 CA--C 1.568 1.661 0 N-CA-C 117.601 2.445 . . . . 0.0 117.601 168.49 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 98.76 70.36 0.97 Allowed Glycine 0 N--CA 1.482 1.731 0 CA-C-N 119.085 0.857 . . . . 0.0 112.256 -171.026 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 45.3 t -142.28 120.13 7.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 N-CA-C 105.502 -2.036 . . . . 0.0 105.502 -178.338 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -81.1 -157.49 17.36 Favored Glycine 0 CA--C 1.547 2.065 0 N-CA-C 115.534 0.973 . . . . 0.0 115.534 -179.413 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 12.1 p90 -70.01 160.72 31.42 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 113.385 0.883 . . . . 0.0 113.385 179.637 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . 0.329 . . 78.25 -50.07 0.48 Allowed 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 115.439 1.644 . . . . 0.0 115.439 178.431 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 34.0 m -70.51 -37.49 74.17 Favored 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 113.604 0.964 . . . . 0.0 113.604 167.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 42.3 mtm105 -57.97 -44.6 87.2 Favored 'General case' 0 N--CA 1.498 1.97 0 N-CA-C 115.232 1.567 . . . . 0.0 115.232 164.52 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 10.3 tm0? -68.68 -52.8 27.1 Favored 'General case' 0 CA--C 1.561 1.389 0 N-CA-C 114.871 1.434 . . . . 0.0 114.871 176.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 85.5 t -66.4 -40.62 87.08 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 CA-C-O 117.763 -1.113 . . . . 0.0 113.166 -179.064 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -71.27 -26.84 63.06 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 117.052 2.241 . . . . 0.0 117.052 176.107 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 90.6 p -68.91 -47.37 65.96 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 115.022 1.49 . . . . 0.0 115.022 164.134 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 52.1 ttp -61.91 -39.6 92.56 Favored 'General case' 0 CA--C 1.57 1.731 0 N-CA-C 116.482 2.03 . . . . 0.0 116.482 171.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 52.7 m -67.35 146.97 53.55 Favored 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 124.764 1.225 . . . . 0.0 111.941 178.441 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -102.23 100.37 15.21 Favored Pre-proline 0 CA--C 1.57 1.744 0 N-CA-C 108.307 -0.998 . . . . 0.0 108.307 172.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -79.11 104.39 1.77 Allowed 'Trans proline' 0 CA--C 1.562 1.888 0 C-N-CA 123.223 2.615 . . . . 0.0 111.293 -178.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 96.2 m -80.16 108.33 13.67 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 123.352 0.661 . . . . 0.0 110.495 -164.714 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 28.7 m -91.39 109.79 21.07 Favored 'General case' 0 CA--C 1.559 1.318 0 C-N-CA 123.336 0.654 . . . . 0.0 110.03 -170.442 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 75.0 mt -100.56 109.36 25.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 N-CA-C 106.567 -1.642 . . . . 0.0 106.567 176.321 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 30.4 mt -104.82 118.31 51.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 N-CA-C 106.906 -1.516 . . . . 0.0 106.906 -179.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -137.79 117.24 12.86 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 -175.101 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 7.7 ttpm? -91.5 116.26 28.71 Favored 'General case' 0 CA--C 1.557 1.217 0 CA-C-O 121.439 0.637 . . . . 0.0 110.051 172.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 22.7 t-20 -71.64 -50.52 29.86 Favored 'General case' 0 CA--C 1.57 1.72 0 N-CA-C 112.982 0.734 . . . . 0.0 112.982 166.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -172.25 -82.4 0.05 OUTLIER Glycine 0 N--CA 1.481 1.659 0 N-CA-C 109.25 -1.54 . . . . 0.0 109.25 173.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 24.3 t0 -72.14 -37.69 69.38 Favored 'General case' 0 CA--C 1.57 1.741 0 N-CA-C 115.096 1.517 . . . . 0.0 115.096 162.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 31.6 mm -91.11 120.32 39.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 CA-C-N 118.993 0.815 . . . . 0.0 109.69 -173.524 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 12.7 mt -86.38 125.88 33.97 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 123.419 0.688 . . . . 0.0 109.811 158.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 57.7 m -113.91 103.79 11.52 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 -179.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 9.5 tt -102.48 108.55 19.9 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 178.598 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -104.75 111.8 24.65 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 -179.469 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 98.2 m -98.51 99.98 11.18 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 20.6 m-70 -90.48 95.96 10.42 Favored 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 123.393 0.677 . . . . 0.0 110.344 -172.198 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 22.8 t -109.52 150.44 28.14 Favored 'General case' 0 CA--C 1.554 1.121 0 CA-C-O 121.981 0.896 . . . . 0.0 110.322 -179.345 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 25.2 m -55.08 -24.01 23.31 Favored 'General case' 0 N--CA 1.499 2.016 0 N-CA-C 115.806 1.78 . . . . 0.0 115.806 163.74 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 72.0 t80 -78.69 -63.19 1.47 Allowed 'General case' 0 CA--C 1.564 1.512 0 CA-C-N 119.465 1.03 . . . . 0.0 111.913 172.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 14.5 ttpt -154.27 142.66 20.59 Favored 'General case' 0 N--CA 1.49 1.538 0 CA-C-N 119.332 0.969 . . . . 0.0 110.392 172.248 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 83.0 m-20 -84.17 111.31 19.24 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 123.145 0.578 . . . . 0.0 109.938 174.636 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 31.8 p -105.58 132.39 51.79 Favored 'General case' 0 N--CA 1.496 1.874 0 C-N-CA 123.355 0.662 . . . . 0.0 110.825 -177.551 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -121.43 118.3 29.04 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 123.918 0.887 . . . . 0.0 108.813 -178.116 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 39.5 pt -110.35 129.57 65.18 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.875 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 173.684 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 52.2 p -115.75 114.26 24.55 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 178.276 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 45.9 p90 -142.68 146.54 34.52 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 114.306 1.225 . . . . 0.0 114.306 -161.162 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 50.2 mtmt -115.5 28.12 8.88 Favored 'General case' 0 CA--C 1.572 1.823 0 N-CA-C 115.678 1.733 . . . . 0.0 115.678 -171.122 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . 0.308 0.1 OUTLIER 52.81 82.73 0.07 Allowed 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 115.866 1.802 . . . . 0.0 115.866 175.551 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 101.88 39.24 2.96 Favored Glycine 0 CA--C 1.55 2.234 0 N-CA-C 116.336 1.294 . . . . 0.0 116.336 -171.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 94.7 t -139.74 127.52 25.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 N-CA-C 106.442 -1.688 . . . . 0.0 106.442 -179.199 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -89.01 128.92 35.73 Favored 'General case' 0 CA--C 1.564 1.499 0 C-N-CA 122.997 0.519 . . . . 0.0 110.366 175.592 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 43.5 p90 -138.91 123.14 18.1 Favored 'General case' 0 N--CA 1.494 1.764 0 C-N-CA 123.391 0.677 . . . . 0.0 109.855 -176.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -72.37 112.85 8.79 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.097 -1.002 . . . . 0.0 112.382 178.462 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -115.33 135.91 53.65 Favored 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 124.024 0.929 . . . . 0.0 110.241 -168.103 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 42.9 m -86.96 122.79 31.3 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-O 121.61 0.719 . . . . 0.0 109.529 173.173 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 43.1 p -82.45 177.76 8.58 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 113.197 0.814 . . . . 0.0 113.197 -173.546 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -55.85 -35.75 66.78 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 117.69 2.478 . . . . 0.0 117.69 168.46 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -92.47 17.19 10.36 Favored 'General case' 0 CA--C 1.577 1.991 0 N-CA-C 115.136 1.532 . . . . 0.0 115.136 170.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 63.01 80.17 0.24 Allowed 'General case' 0 N--CA 1.496 1.854 0 C-N-CA 125.281 1.432 . . . . 0.0 113.272 -178.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 14.9 ttm180 -146.09 126.13 13.71 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 -176.176 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.77 120.51 15.62 Favored 'General case' 0 N--CA 1.493 1.678 0 CA-C-N 118.124 0.42 . . . . 0.0 110.272 168.174 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 12.4 m -138.69 121.42 18.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 N-CA-C 107.999 -1.112 . . . . 0.0 107.999 -176.156 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 1.5 mptm? -76.76 104.13 7.09 Favored 'General case' 0 N--CA 1.489 1.487 0 CA-C-O 121.89 0.852 . . . . 0.0 109.599 -177.349 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 74.0 m -98.95 96.41 7.81 Favored 'General case' 0 N--CA 1.481 1.116 0 CA-C-N 114.894 -1.048 . . . . 0.0 109.92 -164.44 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -106.39 108.31 24.81 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 177.422 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 1.4 p -121.88 126.76 74.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 C-N-CA 124.025 0.93 . . . . 0.0 109.304 -174.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 9.8 t -146.34 152.1 38.57 Favored 'General case' 0 N--CA 1.489 1.515 0 CA-C-O 122.531 1.158 . . . . 0.0 110.643 -177.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 24.8 tp -87.73 103.47 15.64 Favored 'General case' 0 N--CA 1.49 1.536 0 CA-C-N 114.889 -1.051 . . . . 0.0 109.425 175.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -107.01 93.57 4.63 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 123.607 0.763 . . . . 0.0 109.41 -175.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 59.3 49.1 82.2 Favored Glycine 0 N--CA 1.488 2.108 0 N-CA-C 117.712 1.845 . . . . 0.0 117.712 -179.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 91.59 -37.44 3.39 Favored Glycine 0 CA--C 1.551 2.31 0 N-CA-C 117.232 1.653 . . . . 0.0 117.232 -170.352 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.72 122.32 29.64 Favored 'General case' 0 N--CA 1.486 1.368 0 CA-C-N 118.92 1.36 . . . . 0.0 110.328 -176.857 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 5.8 tt -85.98 95.86 9.64 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 108.569 -0.901 . . . . 0.0 108.569 179.032 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 53.0 t -97.61 108.09 21.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 -166.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 21.6 t-160 -101.92 108.64 20.17 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 123.255 0.622 . . . . 0.0 110.032 175.682 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 31.8 tp -98.0 116.32 29.97 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 175.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -100.22 129.45 46.23 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 168.64 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 16.7 ptmt -140.08 128.63 22.9 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.746 -0.596 . . . . 0.0 111.399 -173.238 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 30.8 p90 -154.44 119.17 4.9 Favored 'General case' 0 N--CA 1.491 1.606 0 C-N-CA 123.808 0.843 . . . . 0.0 109.727 -168.059 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 4.5 t70 45.34 59.58 3.48 Favored 'General case' 0 N--CA 1.503 2.18 0 N-CA-C 117.616 2.45 . . . . 0.0 117.616 164.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 63.8 31.05 79.48 Favored Glycine 0 CA--C 1.558 2.73 0 N-CA-C 119.42 2.528 . . . . 0.0 119.42 -171.617 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -152.44 123.6 7.6 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 106.705 -1.591 . . . . 0.0 106.705 -176.193 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -138.56 132.49 31.19 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.47 -0.769 . . . . 0.0 112.261 179.128 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 14.6 t -116.32 134.01 55.37 Favored 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 123.581 0.752 . . . . 0.0 110.406 173.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 34.9 p -100.8 131.07 46.86 Favored 'General case' 0 N--CA 1.493 1.699 0 CA-C-O 122.143 0.973 . . . . 0.0 110.128 169.292 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 5.4 mp -112.47 87.0 2.47 Favored 'General case' 0 CA--C 1.56 1.347 0 N-CA-C 106.407 -1.701 . . . . 0.0 106.407 -178.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 72.4 t -92.88 99.89 10.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 -169.186 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 20.5 mmt180 -86.27 125.26 33.46 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 124.126 0.971 . . . . 0.0 109.883 176.052 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -151.89 131.74 13.29 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.877 -0.514 . . . . 0.0 112.11 -173.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -78.73 120.24 23.09 Favored 'General case' 0 N--CA 1.49 1.525 0 CA-C-O 121.295 0.569 . . . . 0.0 111.755 177.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 92.3 mt -129.16 105.72 13.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 N-CA-C 104.603 -2.369 . . . . 0.0 104.603 176.445 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 57.75 52.31 8.28 Favored 'General case' 0 N--CA 1.499 2.001 0 N-CA-C 114.997 1.481 . . . . 0.0 114.997 175.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 67.85 12.07 61.63 Favored Glycine 0 CA--C 1.557 2.673 0 N-CA-C 119.962 2.745 . . . . 0.0 119.962 -171.655 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -124.73 126.59 45.92 Favored 'General case' 0 N--CA 1.486 1.358 0 CA-C-N 119.645 1.723 . . . . 0.0 108.626 -175.196 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 58.7 tp -83.96 108.57 17.01 Favored 'General case' 0 N--CA 1.483 1.189 0 CA-C-O 121.508 0.67 . . . . 0.0 110.226 -179.622 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 28.1 mm -97.51 106.8 19.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 -172.02 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 44.4 tp -86.04 111.84 20.69 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 123.557 0.743 . . . . 0.0 109.075 171.232 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 88.1 m -105.7 105.9 16.16 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 -176.347 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 88.6 mt -101.37 100.6 11.11 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 123.486 0.714 . . . . 0.0 109.948 -171.33 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 7.8 m -116.37 121.1 40.95 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 -174.516 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 83.1 t60 -126.42 -101.51 0.36 Allowed 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 175.571 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -111.0 92.71 0.68 Allowed Glycine 0 N--CA 1.483 1.814 0 CA-C-N 119.375 0.989 . . . . 0.0 111.454 -172.683 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . 0.395 6.4 t 49.03 40.38 17.0 Favored 'General case' 0 N--CA 1.499 2.011 0 N-CA-C 117.746 2.499 . . . . 0.0 117.746 -172.864 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -155.49 93.68 1.51 Allowed 'General case' 0 N--CA 1.483 1.211 0 O-C-N 121.569 -0.707 . . . . 0.0 109.217 178.384 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 4.3 p -89.39 121.23 39.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 C-N-CA 123.418 0.687 . . . . 0.0 109.602 172.352 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 45.0 t -105.28 120.44 41.57 Favored 'General case' 0 CA--C 1.553 1.077 0 C-N-CA 123.045 0.538 . . . . 0.0 111.4 177.65 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 80.1 m -87.21 110.61 20.28 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 175.196 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 6.2 mmm180 -115.03 95.87 5.42 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 107.448 -1.316 . . . . 0.0 107.448 -179.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 86.2 m -82.76 143.51 30.81 Favored 'General case' 0 N--CA 1.494 1.774 0 C-N-CA 123.721 0.809 . . . . 0.0 110.402 -177.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 47.1 m-85 -131.34 127.61 38.0 Favored 'General case' 0 CA--C 1.557 1.232 0 C-N-CA 123.442 0.697 . . . . 0.0 109.767 -178.096 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -95.77 156.89 16.14 Favored 'General case' 0 N--CA 1.492 1.668 0 CA-C-O 122.671 1.224 . . . . 0.0 111.294 165.115 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 73.8 tttt -90.47 114.49 26.67 Favored 'General case' 0 N--CA 1.484 1.244 0 CA-C-N 114.895 -1.048 . . . . 0.0 111.712 -165.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -74.11 -33.99 63.79 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 117.116 2.265 . . . . 0.0 117.116 172.452 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.125 0 CA-C-O 124.198 1.952 . . . . 0.0 108.527 173.731 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 5.4 p . . . . . 0 CA--C 1.578 2.041 0 N-CA-C 115.883 1.809 . . . . 0.0 115.883 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -64.85 -36.71 85.22 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 116.764 2.135 . . . . 0.0 116.764 -175.168 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -58.13 -29.25 65.38 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 117.742 2.497 . . . . 0.0 117.742 169.146 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -69.47 -25.29 64.01 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 116.231 1.937 . . . . 0.0 116.231 169.576 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 45.8 mt -77.37 110.22 11.94 Favored 'General case' 0 N--CA 1.489 1.518 0 CA-C-N 121.012 1.733 . . . . 0.0 111.466 -162.715 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 157.8 172.02 24.47 Favored Glycine 0 CA--C 1.546 2.024 0 CA-C-O 122.718 1.177 . . . . 0.0 112.797 -167.571 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.446 ' H ' ' HB2' ' A' ' 132' ' ' ALA . 54.1 m -87.25 139.42 30.58 Favored 'General case' 0 N--CA 1.494 1.731 0 CA-C-N 114.296 -0.952 . . . . 0.0 109.734 172.257 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 82.8 m95 -136.62 113.67 10.55 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 -177.444 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -95.41 146.51 24.35 Favored 'General case' 0 N--CA 1.494 1.726 0 CA-C-O 121.439 0.638 . . . . 0.0 110.292 173.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 48.6 tp -68.48 120.16 14.11 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-O 121.649 0.737 . . . . 0.0 111.738 -179.164 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . 0.263 1.1 t -83.66 -51.02 14.76 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.753 0 CA-C-N 114.676 -1.147 . . . . 0.0 111.666 170.495 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -148.36 125.39 11.36 Favored 'General case' 0 CA--C 1.557 1.244 0 CA-C-N 119.032 0.833 . . . . 0.0 109.619 -168.057 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 72.7 p -102.93 100.27 10.23 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 123.373 0.669 . . . . 0.0 110.441 172.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 33.7 mmtp -95.9 116.49 28.99 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 109.508 -0.552 . . . . 0.0 109.508 -179.225 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.258 28.6 m-20 71.2 24.53 3.8 Favored 'General case' 0 N--CA 1.504 2.265 0 N-CA-C 117.101 2.26 . . . . 0.0 117.101 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 40.0 t80 -69.58 -50.31 45.87 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 120.138 -1.601 . . . . 0.0 114.727 -175.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 71.1 m-20 -51.58 -27.76 12.0 Favored 'General case' 0 N--CA 1.497 1.925 0 N-CA-C 117.909 2.559 . . . . 0.0 117.909 168.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 24.2 t0 -66.35 -52.9 42.33 Favored 'General case' 0 N--CA 1.496 1.869 0 CA-C-N 120.251 1.387 . . . . 0.0 114.199 166.59 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 88.5 t80 -50.63 -46.23 58.15 Favored 'General case' 0 CA--C 1.573 1.852 0 N-CA-C 115.683 1.734 . . . . 0.0 115.683 168.369 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 47.9 mmm -63.49 -41.33 98.57 Favored 'General case' 0 CA--C 1.567 1.631 0 N-CA-C 114.718 1.377 . . . . 0.0 114.718 174.047 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 13.6 tmtt? -61.18 -44.79 96.73 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 115.248 1.573 . . . . 0.0 115.248 167.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 15.1 t -57.03 -39.62 75.15 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 116.31 1.967 . . . . 0.0 116.31 172.385 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 75.1 mt -65.07 -43.57 91.77 Favored 'General case' 0 CA--C 1.567 1.606 0 N-CA-C 115.572 1.693 . . . . 0.0 115.572 165.164 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 117.98 68.97 0.36 Allowed Glycine 0 N--CA 1.483 1.807 0 C-N-CA 124.148 0.88 . . . . 0.0 112.03 -178.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 18.3 t -140.74 114.98 5.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 N-CA-C 105.919 -1.882 . . . . 0.0 105.919 -174.208 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -85.99 -79.69 1.17 Allowed Glycine 0 N--CA 1.483 1.806 0 N-CA-C 114.724 0.65 . . . . 0.0 114.724 -175.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 20.8 p90 -132.16 163.32 28.8 Favored 'General case' 0 N--CA 1.492 1.655 0 C-N-CA 123.472 0.709 . . . . 0.0 111.474 -177.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . 0.333 . . 79.13 -58.13 0.41 Allowed 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 115.023 1.49 . . . . 0.0 115.023 173.335 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 80.2 m -69.98 -39.75 75.75 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 113.31 0.856 . . . . 0.0 113.31 166.069 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 45.0 ttp180 -63.77 -41.55 97.95 Favored 'General case' 0 CA--C 1.565 1.529 0 N-CA-C 114.966 1.469 . . . . 0.0 114.966 168.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 11.5 tm0? -66.55 -49.2 67.23 Favored 'General case' 0 CA--C 1.562 1.438 0 N-CA-C 115.127 1.529 . . . . 0.0 115.127 173.106 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 73.7 t -63.96 -42.39 95.58 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.026 0 CA-C-N 119.912 1.233 . . . . 0.0 113.271 178.593 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -73.15 -32.55 64.96 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 116.938 2.199 . . . . 0.0 116.938 176.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 85.7 p -68.63 -44.14 74.83 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 115.265 1.579 . . . . 0.0 115.265 167.248 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 51.7 tpp -68.7 -35.75 77.58 Favored 'General case' 0 CA--C 1.564 1.513 0 N-CA-C 116.459 2.022 . . . . 0.0 116.459 177.192 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 5.1 t -75.16 165.65 24.89 Favored 'General case' 0 N--CA 1.494 1.764 0 CA-C-N 119.9 1.227 . . . . 0.0 112.853 178.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.74 100.25 10.64 Favored Pre-proline 0 CA--C 1.57 1.746 0 CA-C-O 118.281 -0.866 . . . . 0.0 109.426 168.044 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -77.08 95.16 1.06 Allowed 'Trans proline' 0 C--N 1.373 1.83 0 C-N-CA 123.294 2.663 . . . . 0.0 111.124 -179.758 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 98.0 m -82.44 105.75 13.75 Favored 'General case' 0 N--CA 1.487 1.412 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.643 -158.466 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 93.5 m -81.34 112.97 19.12 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 123.746 0.818 . . . . 0.0 110.072 -175.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 79.1 mt -112.49 107.18 22.32 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 N-CA-C 105.985 -1.857 . . . . 0.0 105.985 -179.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 4.0 mp -94.7 123.67 46.9 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 175.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 5.8 tm-20 -136.11 112.18 9.67 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 -176.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 83.8 tttt -90.18 113.12 24.84 Favored 'General case' 0 CA--C 1.556 1.211 0 C-N-CA 123.023 0.529 . . . . 0.0 109.825 174.253 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 21.9 t-20 -80.56 -64.76 1.12 Allowed 'General case' 0 CA--C 1.564 1.504 0 C-N-CA 123.31 0.644 . . . . 0.0 111.768 179.233 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -131.68 -94.63 0.63 Allowed Glycine 0 N--CA 1.485 1.903 0 N-CA-C 108.941 -1.664 . . . . 0.0 108.941 169.024 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -77.46 -29.26 52.68 Favored 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 115.361 1.615 . . . . 0.0 115.361 162.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 35.3 mm -88.96 124.95 42.02 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.475 0 CA-C-N 119.108 0.867 . . . . 0.0 109.656 -168.438 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 21.2 mt -89.65 121.07 31.49 Favored 'General case' 0 N--CA 1.485 1.294 0 CA-C-N 114.901 -1.045 . . . . 0.0 110.53 169.103 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 87.0 m -108.8 104.07 13.26 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 179.371 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 7.9 tt -104.56 109.97 22.08 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -106.51 116.88 32.7 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 123.503 0.721 . . . . 0.0 109.205 178.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 94.1 m -102.91 101.28 11.29 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 177.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 23.0 m-70 -88.27 93.96 9.68 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 123.473 0.709 . . . . 0.0 111.838 -170.007 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 33.3 t -101.06 154.79 18.41 Favored 'General case' 0 CA--C 1.557 1.23 0 CA-C-O 122.019 0.914 . . . . 0.0 110.548 176.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 47.0 m -59.79 -22.94 62.86 Favored 'General case' 0 CA--C 1.578 2.026 0 N-CA-C 115.439 1.644 . . . . 0.0 115.439 162.339 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 34.5 t80 -107.88 83.27 1.77 Allowed 'General case' 0 N--CA 1.488 1.43 0 CA-C-N 119.764 1.166 . . . . 0.0 108.234 169.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 28.1 mmmt 61.41 123.29 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 115.483 1.66 . . . . 0.0 115.483 174.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 9.7 p30 -80.83 126.66 31.61 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.502 -0.749 . . . . 0.0 112.311 175.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 78.3 p -95.23 127.46 41.3 Favored 'General case' 0 N--CA 1.496 1.844 0 C-N-CA 122.917 0.487 . . . . 0.0 110.509 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -119.16 111.95 18.9 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 -176.63 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 39.1 pt -105.64 128.3 59.86 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 173.357 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 42.2 t -116.74 108.38 15.82 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 179.552 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 48.6 p90 -140.39 157.9 44.83 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 114.947 1.462 . . . . 0.0 114.947 -159.222 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 54.9 mtpt -120.15 150.38 40.72 Favored 'General case' 0 CA--C 1.563 1.449 0 CA-C-N 113.971 -1.468 . . . . 0.0 108.68 165.177 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -75.04 113.18 12.06 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.566 -0.709 . . . . 0.0 112.246 -170.213 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 83.61 39.68 9.49 Favored Glycine 0 CA--C 1.551 2.326 0 N-CA-C 116.631 1.412 . . . . 0.0 116.631 -169.522 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 76.5 t -140.76 117.64 8.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 N-CA-C 105.339 -2.097 . . . . 0.0 105.339 -175.284 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -83.17 135.62 34.73 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 122.823 0.449 . . . . 0.0 111.919 -179.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 36.0 p90 -140.92 133.43 28.52 Favored 'General case' 0 N--CA 1.494 1.743 0 C-N-CA 123.687 0.795 . . . . 0.0 110.83 -174.431 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -75.04 117.81 17.29 Favored 'General case' 0 CA--C 1.565 1.521 0 O-C-N 121.478 -0.764 . . . . 0.0 112.314 176.159 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 25.7 tp10 -118.31 135.52 54.26 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 123.954 0.902 . . . . 0.0 110.416 -171.406 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 84.8 m -97.01 119.79 36.15 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 171.648 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 22.9 p -86.14 -178.12 6.44 Favored 'General case' 0 N--CA 1.494 1.762 0 CA-C-O 122.192 0.996 . . . . 0.0 113.308 -171.636 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -52.7 -40.13 62.66 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 117.692 2.479 . . . . 0.0 117.692 167.097 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 42.5 m-20 -81.82 5.31 19.14 Favored 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 116.151 1.908 . . . . 0.0 116.151 169.377 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . 0.251 10.0 m-20 62.58 75.22 0.41 Allowed 'General case' 0 N--CA 1.496 1.868 0 C-N-CA 125.265 1.426 . . . . 0.0 112.048 -171.89 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 42.1 ttp180 -138.05 120.58 16.09 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 -168.051 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.16 95.39 5.59 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 123.407 0.683 . . . . 0.0 111.922 -178.634 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 12.0 m -116.74 127.05 74.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 -167.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 33.5 mmtp -83.6 104.44 13.73 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 123.605 0.762 . . . . 0.0 109.974 -178.593 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 74.5 m -102.28 107.87 19.05 Favored 'General case' 0 N--CA 1.483 1.189 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.022 -161.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 7.2 tp -115.92 104.22 16.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 C-N-CA 124.027 0.931 . . . . 0.0 108.64 -178.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -118.33 124.61 73.38 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 C-N-CA 124.127 0.971 . . . . 0.0 109.117 178.422 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 15.2 t -125.92 157.75 36.92 Favored 'General case' 0 N--CA 1.493 1.691 0 CA-C-O 122.471 1.129 . . . . 0.0 111.496 170.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 14.5 tp -92.49 122.61 35.09 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-N 114.938 -1.028 . . . . 0.0 110.138 175.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -122.75 79.58 1.65 Allowed 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 123.307 0.643 . . . . 0.0 109.885 -178.054 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 64.3 49.34 66.53 Favored Glycine 0 CA--C 1.55 2.235 0 N-CA-C 117.188 1.635 . . . . 0.0 117.188 -175.126 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 74.2 43.77 31.19 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 117.321 1.688 . . . . 0.0 117.321 -171.343 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -153.67 108.61 3.14 Favored 'General case' 0 CA--C 1.554 1.107 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 -169.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 50.9 mt -83.05 96.57 8.4 Favored 'General case' 0 N--CA 1.492 1.655 0 CA-C-O 122.812 1.292 . . . . 0.0 109.56 177.225 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 93.0 t -87.88 100.68 10.59 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.356 0 CA-C-N 112.972 -1.922 . . . . 0.0 105.944 179.125 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 22.6 t-160 -105.83 141.8 36.64 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 124.075 0.95 . . . . 0.0 109.598 -176.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 34.8 tp -140.13 121.24 14.75 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 177.231 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 87.7 mt-30 -115.55 110.38 19.15 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 -177.585 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -107.73 134.51 50.59 Favored 'General case' 0 N--CA 1.494 1.752 0 C-N-CA 122.986 0.514 . . . . 0.0 111.351 -174.101 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 17.5 p90 -151.04 108.72 3.66 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.398 -0.814 . . . . 0.0 109.877 177.539 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 7.1 t70 55.66 52.2 11.35 Favored 'General case' 0 N--CA 1.499 2.007 0 N-CA-C 116.408 2.003 . . . . 0.0 116.408 168.468 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 85.71 -42.55 3.16 Favored Glycine 0 CA--C 1.553 2.445 0 N-CA-C 116.768 1.467 . . . . 0.0 116.768 -169.339 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 62.9 mt-30 -78.62 125.8 29.86 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 123.744 0.818 . . . . 0.0 111.037 179.44 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -136.03 128.2 29.88 Favored 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 122.717 0.407 . . . . 0.0 111.452 178.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 7.7 t -113.44 132.57 55.6 Favored 'General case' 0 N--CA 1.495 1.791 0 C-N-CA 123.163 0.585 . . . . 0.0 110.921 177.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 41.2 p -101.01 130.39 47.0 Favored 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 122.896 0.478 . . . . 0.0 110.982 174.145 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 5.3 mp -111.16 79.68 1.23 Allowed 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.288 -1.005 . . . . 0.0 108.288 177.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 51.8 t -89.09 108.63 19.28 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 -169.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 80.5 mtt85 -104.35 113.95 27.86 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 122.946 0.498 . . . . 0.0 110.255 -174.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -126.0 136.99 53.62 Favored 'General case' 0 N--CA 1.493 1.677 0 C-N-CA 123.307 0.643 . . . . 0.0 111.617 179.08 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -81.81 115.69 21.14 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 123.277 0.631 . . . . 0.0 110.793 175.4 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 86.4 mt -124.75 107.94 19.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 N-CA-C 105.081 -2.192 . . . . 0.0 105.081 179.247 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 20.9 m-20 57.97 51.66 8.7 Favored 'General case' 0 N--CA 1.499 1.988 0 N-CA-C 114.971 1.471 . . . . 0.0 114.971 176.455 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 65.51 16.68 63.41 Favored Glycine 0 CA--C 1.555 2.584 0 N-CA-C 119.857 2.703 . . . . 0.0 119.857 -170.486 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 8.7 mtmp? -128.65 128.66 44.57 Favored 'General case' 0 N--CA 1.488 1.445 0 CA-C-N 119.877 1.838 . . . . 0.0 109.315 -173.447 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 22.2 tp -78.35 113.78 16.64 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 123.847 0.859 . . . . 0.0 109.843 178.501 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 34.9 mm -103.15 101.34 12.05 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 N-CA-C 106.42 -1.696 . . . . 0.0 106.42 -174.63 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 23.6 tp -90.17 103.0 15.72 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 123.915 0.886 . . . . 0.0 109.594 179.414 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 91.8 m -96.82 107.25 19.7 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 -175.335 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 71.9 mt -102.65 99.51 9.5 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 123.762 0.825 . . . . 0.0 109.476 -172.176 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 6.5 m -109.08 119.62 40.1 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 -176.414 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 75.6 t60 -141.12 120.62 13.22 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 171.032 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 74.88 -117.05 5.26 Favored Glycine 0 N--CA 1.484 1.863 0 CA-C-N 116.37 -0.377 . . . . 0.0 112.656 179.013 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 76.6 m -122.19 68.37 0.94 Allowed 'General case' 0 CA--C 1.565 1.553 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 167.471 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -164.06 99.09 0.85 Allowed 'General case' 0 N--CA 1.485 1.314 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 175.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 4.2 p -96.95 122.17 48.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 C-N-CA 123.929 0.892 . . . . 0.0 109.71 176.292 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 42.0 t -110.0 102.44 11.17 Favored 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 123.225 0.61 . . . . 0.0 110.731 178.063 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 63.9 m -90.74 100.39 13.25 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 -176.062 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 30.5 mtm180 -102.44 121.67 42.79 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 122.802 0.441 . . . . 0.0 111.106 -171.038 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 94.6 m -91.05 132.89 35.74 Favored 'General case' 0 CA--C 1.563 1.46 0 C-N-CA 123.763 0.825 . . . . 0.0 110.442 -177.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 37.5 m-85 -131.49 140.35 49.53 Favored 'General case' 0 CA--C 1.562 1.425 0 C-N-CA 124.298 1.039 . . . . 0.0 109.194 179.322 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 1.4 pp20? -111.31 157.8 19.76 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.637 -0.665 . . . . 0.0 111.837 166.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 22.9 ttpt -85.45 129.33 34.84 Favored 'General case' 0 N--CA 1.489 1.498 0 CA-C-O 121.906 0.86 . . . . 0.0 112.241 -167.67 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 28.2 mm-40 -118.27 55.76 0.89 Allowed 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 124.956 1.302 . . . . 0.0 111.089 -173.609 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . 0.446 ' HB2' ' H ' ' A' ' 7' ' ' THR . . . . . . . . 0 N--CA 1.477 0.9 0 CA-C-O 124.447 2.07 . . . . 0.0 109.074 -168.359 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 3.3 p . . . . . 0 CA--C 1.577 2.0 0 N-CA-C 116.112 1.894 . . . . 0.0 116.112 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -68.19 -33.21 74.02 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 116.709 2.114 . . . . 0.0 116.709 -175.495 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -59.44 -25.27 64.23 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 117.707 2.484 . . . . 0.0 117.707 168.192 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -73.72 -24.3 59.89 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 116.133 1.901 . . . . 0.0 116.133 167.785 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 52.0 mt -79.9 113.84 18.37 Favored 'General case' 0 N--CA 1.489 1.505 0 CA-C-N 120.975 1.716 . . . . 0.0 111.451 -166.369 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 158.91 177.39 31.95 Favored Glycine 0 CA--C 1.543 1.785 0 CA-C-O 122.798 1.221 . . . . 0.0 112.985 -175.063 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 63.1 m -84.81 142.88 29.46 Favored 'General case' 0 N--CA 1.492 1.641 0 CA-C-N 114.57 -0.815 . . . . 0.0 109.817 171.356 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 82.6 m95 -140.9 113.95 8.47 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 107.659 -1.237 . . . . 0.0 107.659 -176.402 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 58.9 mttp -97.68 141.17 31.03 Favored 'General case' 0 N--CA 1.492 1.636 0 CA-C-O 121.016 0.436 . . . . 0.0 109.999 175.476 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 55.8 tp -66.71 124.66 23.51 Favored 'General case' 0 N--CA 1.49 1.56 0 CA-C-O 122.135 0.969 . . . . 0.0 111.668 -178.615 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . 0.284 0.9 OUTLIER -103.78 -43.42 8.58 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.784 0 CA-C-N 113.893 -1.503 . . . . 0.0 112.036 -178.222 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -142.63 129.13 20.17 Favored 'General case' 0 N--CA 1.49 1.545 0 CA-C-N 120.336 1.425 . . . . 0.0 109.778 177.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 87.8 p -111.77 116.5 30.81 Favored 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 123.236 0.614 . . . . 0.0 109.82 167.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -83.99 -75.45 0.34 Allowed 'General case' 0 N--CA 1.492 1.664 0 C-N-CA 122.78 0.432 . . . . 0.0 111.66 -173.519 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 71.4 m-20 -106.44 44.2 1.08 Allowed 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 113.307 0.854 . . . . 0.0 113.307 179.671 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 15.2 t80 -91.37 65.69 5.37 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 120.714 -1.241 . . . . 0.0 111.796 -177.705 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -168.2 -53.47 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 126.534 1.934 . . . . 0.0 107.079 -176.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -55.54 -47.72 75.87 Favored 'General case' 0 N--CA 1.498 1.947 0 N-CA-C 115.228 1.566 . . . . 0.0 115.228 161.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 92.8 t80 -52.41 -55.58 20.79 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 114.786 1.402 . . . . 0.0 114.786 170.415 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 75.2 mtm -66.22 -31.65 72.6 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 116.481 2.03 . . . . 0.0 116.481 174.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -64.58 -45.26 87.75 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-N 120.197 1.362 . . . . 0.0 114.564 168.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 23.2 t -59.14 -38.88 80.75 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 115.762 1.764 . . . . 0.0 115.762 170.339 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 95.2 mt -64.22 -39.43 93.95 Favored 'General case' 0 CA--C 1.57 1.749 0 N-CA-C 115.472 1.656 . . . . 0.0 115.472 164.785 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 129.51 -95.49 0.36 Allowed Glycine 0 CA--C 1.54 1.604 0 N-CA-C 108.887 -1.685 . . . . 0.0 108.887 -174.028 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . 0.285 13.2 t 56.73 66.95 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.058 0 N-CA-C 114.044 1.127 . . . . 0.0 114.044 168.075 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 34.47 -128.73 0.56 Allowed Glycine 0 CA--C 1.553 2.435 0 N-CA-C 120.077 2.791 . . . . 0.0 120.077 177.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 43.0 p90 -146.37 -54.88 0.26 Allowed 'General case' 0 N--CA 1.494 1.749 0 C-N-CA 124.202 1.001 . . . . 0.0 110.044 169.323 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.96 -33.5 75.51 Favored 'General case' 0 CA--C 1.564 1.49 0 N-CA-C 116.245 1.943 . . . . 0.0 116.245 164.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 29.8 m -63.49 -38.76 92.36 Favored 'General case' 0 N--CA 1.498 1.925 0 CA-C-N 120.284 1.402 . . . . 0.0 114.258 168.14 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 22.7 ttp180 -58.33 -43.67 88.36 Favored 'General case' 0 CA--C 1.573 1.847 0 N-CA-C 115.102 1.519 . . . . 0.0 115.102 167.554 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 8.1 tm0? -65.87 -51.25 60.37 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 115.116 1.524 . . . . 0.0 115.116 173.137 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 94.2 t -60.6 -45.43 97.3 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 CA-C-N 119.249 0.932 . . . . 0.0 113.01 176.332 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -65.42 -36.79 84.99 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 116.472 2.027 . . . . 0.0 116.472 175.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 95.5 p -64.07 -42.14 97.08 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 116.161 1.912 . . . . 0.0 116.161 168.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 35.8 ttm -66.5 -39.71 88.84 Favored 'General case' 0 CA--C 1.57 1.722 0 N-CA-C 115.921 1.822 . . . . 0.0 115.921 169.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 54.1 m -70.77 144.25 50.95 Favored 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 124.354 1.062 . . . . 0.0 112.331 -176.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? -102.91 99.59 14.28 Favored Pre-proline 0 CA--C 1.573 1.864 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 173.107 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -78.48 111.0 2.95 Favored 'Trans proline' 0 CA--C 1.56 1.804 0 C-N-CA 123.388 2.725 . . . . 0.0 111.594 -178.254 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 97.0 m -78.65 104.84 9.53 Favored 'General case' 0 N--CA 1.491 1.625 0 CA-C-O 121.372 0.606 . . . . 0.0 109.969 -173.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 86.4 m -87.55 114.79 24.48 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 124.086 0.954 . . . . 0.0 109.091 -174.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 81.9 mt -112.46 108.47 25.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 N-CA-C 106.557 -1.646 . . . . 0.0 106.557 -177.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 17.0 mt -97.14 121.24 47.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 -179.21 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -140.7 118.0 11.38 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 -169.728 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 45.2 tttp -90.62 114.91 27.29 Favored 'General case' 0 CA--C 1.557 1.214 0 C-N-CA 123.267 0.627 . . . . 0.0 111.36 -176.365 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 51.4 m-80 -105.82 83.39 1.92 Allowed 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 -179.603 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 80.6 -97.63 1.73 Allowed Glycine 0 N--CA 1.486 2.028 0 O-C-N 121.704 -0.623 . . . . 0.0 112.13 -169.007 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -130.34 62.53 1.58 Allowed 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 159.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 30.8 mm -138.28 100.69 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 N-CA-C 104.818 -2.29 . . . . 0.0 104.818 -178.047 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 71.0 mt -85.35 99.9 11.47 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 122.663 0.385 . . . . 0.0 110.47 -179.132 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 46.9 m -92.4 105.51 17.69 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 107.14 -1.43 . . . . 0.0 107.14 -178.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 10.0 tt -104.68 96.45 6.58 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 106.957 -1.497 . . . . 0.0 106.957 -170.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 58.9 mttp -94.83 106.84 18.85 Favored 'General case' 0 N--CA 1.482 1.133 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 -163.41 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 45.4 m -90.08 92.03 8.8 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 -175.27 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 75.4 m80 -87.64 93.64 9.49 Favored 'General case' 0 N--CA 1.488 1.47 0 CA-C-O 121.733 0.778 . . . . 0.0 110.688 -173.282 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 41.9 t -113.35 151.43 31.24 Favored 'General case' 0 CA--C 1.555 1.144 0 C-N-CA 124.051 0.941 . . . . 0.0 110.078 -175.658 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 27.2 m -55.92 -27.36 51.88 Favored 'General case' 0 N--CA 1.501 2.102 0 N-CA-C 115.265 1.579 . . . . 0.0 115.265 159.539 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 36.2 t80 -115.19 104.72 12.12 Favored 'General case' 0 N--CA 1.485 1.281 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 173.34 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 32.6 mmmt 62.55 90.51 0.07 Allowed 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 113.951 1.093 . . . . 0.0 113.951 168.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 7.4 p-10 -79.33 120.12 23.34 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 122.95 0.5 . . . . 0.0 111.501 177.142 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 73.7 p -133.87 132.68 40.63 Favored 'General case' 0 N--CA 1.496 1.836 0 C-N-CA 123.146 0.579 . . . . 0.0 110.076 -170.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -118.95 140.74 49.49 Favored 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 122.944 0.498 . . . . 0.0 112.161 178.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 42.9 pt -117.22 129.97 72.88 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 C-N-CA 123.405 0.682 . . . . 0.0 109.447 -178.66 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 88.2 p -106.46 118.49 36.78 Favored 'General case' 0 N--CA 1.493 1.7 0 C-N-CA 123.745 0.818 . . . . 0.0 110.209 -178.195 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 50.2 p90 -140.82 135.86 31.84 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 115.188 1.551 . . . . 0.0 115.188 -167.55 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 53.1 mtmt -102.74 19.33 19.42 Favored 'General case' 0 CA--C 1.574 1.883 0 N-CA-C 116.556 2.058 . . . . 0.0 116.556 -175.42 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . 0.294 1.3 mp 63.21 93.07 0.06 Allowed 'General case' 0 N--CA 1.494 1.739 0 CA-C-N 120.418 1.463 . . . . 0.0 114.293 173.365 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 85.79 39.59 8.06 Favored Glycine 0 CA--C 1.55 2.259 0 N-CA-C 116.716 1.446 . . . . 0.0 116.716 -167.072 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 87.7 t -139.47 122.71 18.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 N-CA-C 106.324 -1.732 . . . . 0.0 106.324 178.597 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -87.63 125.8 34.58 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 123.448 0.699 . . . . 0.0 110.948 176.41 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 40.8 p90 -132.79 127.7 35.15 Favored 'General case' 0 N--CA 1.493 1.722 0 C-N-CA 123.558 0.743 . . . . 0.0 110.65 -173.179 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -69.52 126.59 30.2 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.607 -0.683 . . . . 0.0 112.734 174.288 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 12.9 tp10 -138.73 133.87 32.79 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 123.193 0.597 . . . . 0.0 110.156 -167.164 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 58.9 m -92.55 121.33 33.89 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 176.22 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 32.0 p -81.41 172.0 14.07 Favored 'General case' 0 N--CA 1.493 1.705 0 CA-C-O 122.041 0.924 . . . . 0.0 113.316 -173.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -51.6 -35.34 41.12 Favored 'General case' 0 CA--C 1.568 1.638 0 N-CA-C 118.038 2.607 . . . . 0.0 118.038 166.415 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -111.18 51.32 0.78 Allowed 'General case' 0 CA--C 1.574 1.867 0 CA-C-N 119.197 0.908 . . . . 0.0 112.177 171.621 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 51.84 73.67 0.31 Allowed 'General case' 0 N--CA 1.5 2.044 0 N-CA-C 116.584 2.068 . . . . 0.0 116.584 168.678 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 67.9 mtt-85 -143.03 125.11 15.3 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.808 -0.558 . . . . 0.0 109.665 -176.094 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.75 91.8 8.06 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 123.411 0.685 . . . . 0.0 111.483 177.372 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 10.6 m -111.97 128.59 68.46 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 121.808 -0.558 . . . . 0.0 111.426 -163.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 29.8 mmtp -83.7 104.3 13.7 Favored 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 123.672 0.789 . . . . 0.0 110.514 178.734 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 68.8 m -103.26 99.86 9.73 Favored 'General case' 0 N--CA 1.483 1.216 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.952 -160.447 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 7.0 tp -110.6 105.07 18.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 C-N-CA 123.646 0.778 . . . . 0.0 109.264 -177.483 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -116.96 125.54 73.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 C-N-CA 124.447 1.099 . . . . 0.0 108.353 177.32 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 11.0 t -130.16 152.52 49.51 Favored 'General case' 0 N--CA 1.492 1.632 0 CA-C-O 122.577 1.179 . . . . 0.0 111.024 172.644 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 26.3 tp -87.33 109.13 19.32 Favored 'General case' 0 N--CA 1.487 1.404 0 CA-C-N 114.64 -1.163 . . . . 0.0 109.676 177.543 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -123.51 95.26 4.52 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 -174.592 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 63.32 49.48 70.27 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 117.343 1.697 . . . . 0.0 117.343 -177.559 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 67.27 24.24 73.44 Favored Glycine 0 CA--C 1.557 2.691 0 N-CA-C 119.001 2.36 . . . . 0.0 119.001 -169.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 56.3 mtmt -131.93 125.45 31.67 Favored 'General case' 0 N--CA 1.487 1.425 0 CA-C-N 118.735 1.267 . . . . 0.0 107.848 -176.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 58.8 mt -84.56 94.86 8.68 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-O 123.03 1.395 . . . . 0.0 109.467 171.173 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 98.4 t -89.17 101.12 11.7 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.361 0 CA-C-N 112.643 -2.071 . . . . 0.0 105.844 -174.332 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 22.4 t-160 -105.78 139.88 39.67 Favored 'General case' 0 N--CA 1.486 1.348 0 CA-C-N 114.94 -1.027 . . . . 0.0 109.883 -173.5 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 29.1 tp -138.53 121.2 16.32 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 176.709 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 88.9 mt-30 -113.28 121.52 44.67 Favored 'General case' 0 N--CA 1.487 1.425 0 C-N-CA 124.233 1.013 . . . . 0.0 108.45 179.328 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 9.8 mtmp? -123.76 133.15 53.9 Favored 'General case' 0 N--CA 1.497 1.895 0 C-N-CA 122.994 0.517 . . . . 0.0 111.008 -170.314 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 13.5 p90 -156.45 112.66 3.03 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.689 -0.632 . . . . 0.0 110.325 -175.414 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 9.1 t70 53.76 52.51 12.96 Favored 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 116.279 1.955 . . . . 0.0 116.279 167.574 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 87.41 -44.01 3.24 Favored Glycine 0 CA--C 1.551 2.324 0 N-CA-C 116.687 1.435 . . . . 0.0 116.687 -169.492 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 21.7 mt-30 -79.47 139.72 37.55 Favored 'General case' 0 N--CA 1.488 1.452 0 CA-C-N 117.841 0.82 . . . . 0.0 112.124 -178.179 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -144.16 130.25 19.57 Favored 'General case' 0 N--CA 1.491 1.586 0 CA-C-O 121.16 0.505 . . . . 0.0 111.779 177.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 12.4 t -118.63 131.15 56.18 Favored 'General case' 0 N--CA 1.492 1.673 0 C-N-CA 123.525 0.73 . . . . 0.0 110.717 177.554 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 35.5 p -99.01 137.77 37.06 Favored 'General case' 0 N--CA 1.492 1.654 0 CA-C-O 121.311 0.576 . . . . 0.0 111.188 173.203 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 5.3 mp -122.11 74.74 1.17 Allowed 'General case' 0 CA--C 1.564 1.518 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 -179.368 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 87.0 t -84.97 108.06 16.55 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 121.085 -1.01 . . . . 0.0 108.484 -169.555 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 82.9 mtt85 -99.53 120.96 40.48 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 123.234 0.614 . . . . 0.0 109.823 -175.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -141.35 130.81 23.81 Favored 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 123.107 0.563 . . . . 0.0 111.084 -170.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -81.69 112.52 18.95 Favored 'General case' 0 N--CA 1.487 1.413 0 CA-C-O 121.51 0.671 . . . . 0.0 111.029 -179.577 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 50.3 mm -118.5 105.46 17.79 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.352 0 N-CA-C 105.171 -2.159 . . . . 0.0 105.171 179.221 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 57.86 49.58 11.8 Favored 'General case' 0 N--CA 1.499 2.02 0 N-CA-C 114.763 1.394 . . . . 0.0 114.763 176.136 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 82.51 -29.28 3.28 Favored Glycine 0 CA--C 1.554 2.522 0 N-CA-C 118.807 2.283 . . . . 0.0 118.807 -169.504 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 89.9 mttt -93.72 136.11 34.33 Favored 'General case' 0 N--CA 1.486 1.371 0 CA-C-N 119.275 1.537 . . . . 0.0 111.189 -168.369 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 20.6 tp -80.73 115.93 20.48 Favored 'General case' 0 CA--C 1.558 1.279 0 C-N-CA 123.24 0.616 . . . . 0.0 110.105 177.551 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 39.2 mm -104.0 101.57 12.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 N-CA-C 106.835 -1.543 . . . . 0.0 106.835 -175.3 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 16.2 tp -91.81 102.22 14.81 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 124.009 0.924 . . . . 0.0 109.729 179.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 58.5 m -91.54 112.87 24.97 Favored 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 123.883 0.873 . . . . 0.0 109.286 -175.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 96.7 mt -111.09 97.48 6.84 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 123.71 0.804 . . . . 0.0 109.708 -169.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 10.2 m -113.08 117.75 32.86 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.875 -0.516 . . . . 0.0 109.788 -172.405 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 78.9 t60 -152.34 116.4 4.91 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 174.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 60.6 61.18 7.33 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 117.061 1.584 . . . . 0.0 117.061 171.39 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . 0.297 4.3 m 51.65 51.53 16.49 Favored 'General case' 0 CA--C 1.576 1.953 0 N-CA-C 114.928 1.455 . . . . 0.0 114.928 -172.098 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -158.11 86.62 0.9 Allowed 'General case' 0 N--CA 1.484 1.228 0 CA-C-O 121.542 0.687 . . . . 0.0 109.194 -179.618 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 3.4 p -91.23 111.85 24.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 C-N-CA 123.691 0.796 . . . . 0.0 109.257 175.4 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 48.4 t -105.17 102.05 11.57 Favored 'General case' 0 CA--C 1.552 1.032 0 CA-C-O 121.461 0.648 . . . . 0.0 109.662 176.052 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 86.0 m -90.56 94.2 9.61 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 -175.706 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 32.5 mtm180 -91.88 120.98 33.06 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 122.927 0.491 . . . . 0.0 111.019 -169.426 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 87.6 m -86.61 131.83 34.06 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 123.463 0.705 . . . . 0.0 110.096 179.09 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 35.9 m-85 -128.43 126.59 40.87 Favored 'General case' 0 CA--C 1.558 1.275 0 C-N-CA 123.82 0.848 . . . . 0.0 108.835 178.538 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -93.99 150.98 19.87 Favored 'General case' 0 N--CA 1.492 1.672 0 CA-C-O 122.08 0.943 . . . . 0.0 111.526 169.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 68.9 tttt -83.06 119.56 24.63 Favored 'General case' 0 N--CA 1.486 1.329 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.706 -169.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 11.8 mm-40 -110.09 49.36 0.85 Allowed 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 123.934 0.894 . . . . 0.0 113.03 179.49 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.301 0 CA-C-O 123.27 1.509 . . . . 0.0 113.569 169.928 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.303 8.5 t . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 118.248 -0.882 . . . . 0.0 112.984 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -60.48 -37.46 81.13 Favored 'General case' 0 N--CA 1.497 1.895 0 N-CA-C 116.224 1.935 . . . . 0.0 116.224 179.505 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -63.55 -29.07 70.39 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 117.047 2.24 . . . . 0.0 117.047 164.057 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -72.93 -21.67 60.84 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 116.145 1.905 . . . . 0.0 116.145 170.589 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 48.2 mt -69.64 114.74 8.14 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-N 121.516 1.962 . . . . 0.0 111.917 -172.541 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 157.93 172.94 25.72 Favored Glycine 0 CA--C 1.543 1.808 0 CA-C-O 122.442 1.023 . . . . 0.0 113.428 -173.554 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 80.1 m -92.88 140.52 29.41 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 171.177 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 85.2 m95 -138.7 114.75 10.16 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 -173.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 48.5 mtmt -97.18 147.16 24.37 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-O 121.54 0.686 . . . . 0.0 111.32 177.297 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 57.3 tp -70.76 126.26 29.1 Favored 'General case' 0 N--CA 1.487 1.421 0 CA-C-O 121.905 0.859 . . . . 0.0 112.438 -175.505 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . 0.271 1.1 t -104.58 -44.16 8.54 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.852 0 CA-C-N 114.327 -1.306 . . . . 0.0 112.421 178.542 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -140.45 134.31 30.55 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-N 120.004 1.275 . . . . 0.0 109.687 -178.487 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 79.9 p -122.17 113.99 20.24 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 123.456 0.702 . . . . 0.0 110.053 171.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 10.7 mtpm? -81.92 -88.16 0.09 Allowed 'General case' 0 N--CA 1.492 1.646 0 CA-C-O 118.962 -0.542 . . . . 0.0 111.472 -177.152 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 70.9 m-80 -98.1 43.03 1.07 Allowed 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 113.831 1.049 . . . . 0.0 113.831 -174.222 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 17.5 t80 -76.83 -43.11 37.67 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 115.722 1.749 . . . . 0.0 115.722 -168.325 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 33.3 m-20 -63.69 -36.51 84.1 Favored 'General case' 0 N--CA 1.499 1.999 0 N-CA-C 115.112 1.523 . . . . 0.0 115.112 169.763 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 24.1 t0 -60.87 -47.32 86.9 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 115.174 1.546 . . . . 0.0 115.174 167.226 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 83.7 t80 -53.95 -53.02 58.62 Favored 'General case' 0 CA--C 1.569 1.702 0 N-CA-C 115.194 1.553 . . . . 0.0 115.194 170.448 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 79.0 mtm -63.76 -34.58 78.21 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 116.149 1.907 . . . . 0.0 116.149 173.704 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -57.59 -50.61 72.55 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 114.65 1.352 . . . . 0.0 114.65 165.194 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 22.9 t -60.28 -36.58 78.15 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 116.318 1.97 . . . . 0.0 116.318 171.482 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.479 ' HB3' HH12 ' A' ' 78' ' ' ARG . 31.2 mt -64.1 -34.75 78.75 Favored 'General case' 0 CA--C 1.565 1.53 0 N-CA-C 117.309 2.337 . . . . 0.0 117.309 169.74 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 101.25 76.26 1.19 Allowed Glycine 0 N--CA 1.482 1.741 0 CA-C-N 119.118 0.872 . . . . 0.0 112.02 -171.415 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 58.3 t -138.33 122.76 21.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 N-CA-C 105.585 -2.006 . . . . 0.0 105.585 -179.554 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -63.27 147.53 50.53 Favored Glycine 0 N--CA 1.488 2.116 0 N-CA-C 115.431 0.932 . . . . 0.0 115.431 177.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . 0.257 25.2 p90 -55.34 -41.64 72.74 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 118.834 2.901 . . . . 0.0 118.834 -166.169 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.57 -44.48 96.21 Favored 'General case' 0 CA--C 1.565 1.541 0 N-CA-C 115.979 1.844 . . . . 0.0 115.979 175.157 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 86.6 m -68.78 -38.6 80.12 Favored 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 114.439 1.274 . . . . 0.0 114.439 168.772 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 48.8 ttp180 -56.57 -45.14 81.47 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 115.421 1.637 . . . . 0.0 115.421 174.373 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 18.8 mm100 -70.5 -38.13 74.3 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 115.167 1.543 . . . . 0.0 115.167 173.196 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 95.3 t -63.45 -44.09 98.71 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.094 0 CA-C-N 120.093 1.315 . . . . 0.0 113.46 171.525 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -63.98 -31.06 72.11 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 117.371 2.36 . . . . 0.0 117.371 174.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 93.7 p -68.57 -42.2 78.62 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 116.15 1.907 . . . . 0.0 116.15 168.072 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 3.7 ppp? -71.87 -26.91 62.54 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 117.582 2.438 . . . . 0.0 117.582 175.34 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 5.3 t -74.79 162.95 28.2 Favored 'General case' 0 N--CA 1.493 1.699 0 CA-C-N 120.335 1.425 . . . . 0.0 112.592 175.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -99.97 103.51 22.84 Favored Pre-proline 0 CA--C 1.567 1.61 0 CA-C-O 118.008 -0.996 . . . . 0.0 108.853 172.394 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -78.89 90.32 1.29 Allowed 'Trans proline' 0 CA--C 1.56 1.81 0 C-N-CA 123.208 2.606 . . . . 0.0 111.225 177.292 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 94.4 m -80.19 111.79 16.89 Favored 'General case' 0 N--CA 1.489 1.513 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.574 -161.164 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 36.5 m -86.42 113.28 22.24 Favored 'General case' 0 CA--C 1.559 1.323 0 C-N-CA 123.598 0.759 . . . . 0.0 109.446 -171.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 71.6 mt -109.59 103.62 15.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 N-CA-C 106.033 -1.84 . . . . 0.0 106.033 177.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 3.7 mp -91.68 123.41 43.79 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 N-CA-C 106.881 -1.526 . . . . 0.0 106.881 172.175 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -148.21 125.61 11.62 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 -169.626 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.32 153.65 29.68 Favored 'General case' 0 CA--C 1.565 1.54 0 CA-C-O 122.173 0.987 . . . . 0.0 113.656 178.249 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 67.1 m-80 -141.77 75.3 1.49 Allowed 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 106.389 -1.708 . . . . 0.0 106.389 171.16 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 71.17 -110.99 3.47 Favored Glycine 0 CA--C 1.548 2.108 0 O-C-N 121.885 -0.51 . . . . 0.0 112.86 -166.5 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 21.1 m-20 -82.75 -21.14 34.79 Favored 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 116.033 1.864 . . . . 0.0 116.033 168.024 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 42.8 mm -84.93 114.88 25.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 CA-C-N 119.863 1.21 . . . . 0.0 109.614 -168.191 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 44.5 mt -86.79 114.94 23.87 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 123.057 0.543 . . . . 0.0 110.342 174.164 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 88.5 m -107.81 102.82 12.0 Favored 'General case' 0 N--CA 1.486 1.342 0 N-CA-C 106.728 -1.582 . . . . 0.0 106.728 -174.358 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 8.9 tt -104.37 107.11 17.87 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -103.37 114.82 29.39 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 179.331 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 91.7 m -100.67 98.11 8.7 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 179.246 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 20.2 m-70 -85.08 91.26 8.06 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 123.411 0.684 . . . . 0.0 112.555 -169.456 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 15.2 t -100.65 155.09 18.08 Favored 'General case' 0 CA--C 1.557 1.241 0 C-N-CA 123.814 0.846 . . . . 0.0 110.302 174.486 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 63.4 p -59.19 -19.51 45.91 Favored 'General case' 0 N--CA 1.504 2.263 0 N-CA-C 116.459 2.022 . . . . 0.0 116.459 162.192 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 52.0 t80 -101.42 75.08 1.58 Allowed 'General case' 0 CA--C 1.562 1.408 0 CA-C-N 119.242 0.928 . . . . 0.0 108.903 165.213 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 31.9 mtmm 64.44 132.62 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 115.682 1.734 . . . . 0.0 115.682 176.165 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 8.8 p30 -81.98 112.83 19.43 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 123.054 0.541 . . . . 0.0 110.952 172.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 77.9 p -90.67 122.63 33.61 Favored 'General case' 0 N--CA 1.492 1.661 0 CA-C-O 121.178 0.513 . . . . 0.0 110.775 -174.559 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.531 ' HE2' ' HB2' ' A' ' 63' ' ' SER . 2.3 tm-20 -108.12 115.82 30.83 Favored 'General case' 0 N--CA 1.486 1.341 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 -175.112 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 29.8 pt -111.24 129.63 66.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 N-CA-C 108.531 -0.915 . . . . 0.0 108.531 174.087 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' SER . . . . . 0.531 ' HB2' ' HE2' ' A' ' 61' ' ' GLU . 44.1 t -118.73 113.0 20.48 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.38 -0.971 . . . . 0.0 108.38 -174.574 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 43.8 p90 -144.89 140.77 28.55 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 115.093 1.516 . . . . 0.0 115.093 -162.1 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 29.5 mtpp -109.16 18.43 20.56 Favored 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 117.325 2.343 . . . . 0.0 117.325 -177.486 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . 0.296 1.3 mp 65.6 93.57 0.07 Allowed 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 125.03 1.332 . . . . 0.0 113.278 176.723 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 92.32 37.67 5.85 Favored Glycine 0 CA--C 1.55 2.228 0 N-CA-C 117.01 1.564 . . . . 0.0 117.01 -166.631 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 92.3 t -135.62 122.86 35.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 N-CA-C 107.035 -1.468 . . . . 0.0 107.035 178.311 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -88.08 131.91 34.5 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 123.401 0.68 . . . . 0.0 110.476 170.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 37.0 p90 -143.0 130.74 21.43 Favored 'General case' 0 N--CA 1.493 1.72 0 C-N-CA 123.333 0.653 . . . . 0.0 110.087 -174.069 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -72.56 114.02 10.24 Favored 'General case' 0 CA--C 1.564 1.501 0 O-C-N 121.546 -0.721 . . . . 0.0 111.933 175.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 14.0 tp10 -119.08 134.5 55.16 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 123.842 0.857 . . . . 0.0 109.782 -167.706 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 73.4 m -90.57 121.74 32.77 Favored 'General case' 0 N--CA 1.491 1.577 0 CA-C-O 121.258 0.551 . . . . 0.0 109.663 176.084 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 30.0 p -85.0 169.74 13.69 Favored 'General case' 0 N--CA 1.493 1.712 0 CA-C-O 121.54 0.686 . . . . 0.0 112.203 -177.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -59.37 -34.82 72.88 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 116.68 2.104 . . . . 0.0 116.68 166.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -76.53 9.24 2.84 Favored 'General case' 0 CA--C 1.581 2.144 0 N-CA-C 115.909 1.818 . . . . 0.0 115.909 167.309 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . 0.252 11.6 m-20 66.78 69.74 0.4 Allowed 'General case' 0 N--CA 1.494 1.77 0 C-N-CA 125.749 1.62 . . . . 0.0 112.669 176.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.479 HH12 ' HB3' ' A' ' 23' ' ' LEU . 60.4 mtm180 -143.56 128.17 18.1 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 122.915 0.486 . . . . 0.0 110.23 -175.117 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.36 117.56 13.05 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 123.491 0.716 . . . . 0.0 111.075 164.822 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 14.3 m -133.49 127.37 53.36 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 -171.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 33.2 mmtp -77.54 102.9 7.17 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 123.567 0.747 . . . . 0.0 110.557 -178.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 69.2 m -101.19 92.67 5.08 Favored 'General case' 0 N--CA 1.482 1.149 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.575 -165.074 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 7.2 tp -106.1 116.64 50.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 178.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 1.4 p -134.15 131.72 55.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 C-N-CA 123.806 0.842 . . . . 0.0 109.564 -170.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 10.1 t -148.63 152.17 36.25 Favored 'General case' 0 N--CA 1.49 1.533 0 CA-C-O 122.745 1.26 . . . . 0.0 110.359 179.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 26.4 tp -85.67 119.94 26.55 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-N 114.726 -1.125 . . . . 0.0 110.298 176.424 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -109.4 79.22 1.19 Allowed 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 123.52 0.728 . . . . 0.0 109.613 -178.357 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 54.9 44.26 81.96 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 118.477 2.151 . . . . 0.0 118.477 -177.454 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 107.12 -42.52 1.91 Allowed Glycine 0 N--CA 1.49 2.295 0 N-CA-C 116.558 1.383 . . . . 0.0 116.558 -168.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 35.9 ttmt -82.33 112.06 18.96 Favored 'General case' 0 CA--C 1.559 1.289 0 CA-C-N 118.164 0.982 . . . . 0.0 109.881 179.584 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.8 tt -88.28 102.72 15.12 Favored 'General case' 0 N--CA 1.488 1.459 0 CA-C-O 121.659 0.742 . . . . 0.0 109.311 -176.739 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 62.7 t -100.7 110.41 27.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 -166.656 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 22.8 t-160 -104.47 134.39 47.75 Favored 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 123.822 0.849 . . . . 0.0 109.713 171.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 24.4 tp -120.09 120.99 37.87 Favored 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 124.655 1.182 . . . . 0.0 107.944 172.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 27.6 mt-30 -109.2 113.71 26.79 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 171.522 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 38.0 ttmt -122.77 132.82 54.4 Favored 'General case' 0 CA--C 1.563 1.465 0 C-N-CA 123.461 0.704 . . . . 0.0 110.397 -174.592 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 34.9 p90 -149.09 115.2 5.76 Favored 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 123.36 0.664 . . . . 0.0 109.989 -176.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . 0.343 17.4 t70 67.15 -101.36 0.06 Allowed 'General case' 0 N--CA 1.495 1.796 0 C-N-CA 124.511 1.124 . . . . 0.0 111.972 176.179 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -127.88 56.23 0.74 Allowed Glycine 0 N--CA 1.487 2.059 0 CA-C-N 118.736 0.698 . . . . 0.0 113.16 162.568 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 49.1 mt-30 -149.15 110.41 4.41 Favored 'General case' 0 N--CA 1.485 1.31 0 N-CA-C 107.032 -1.47 . . . . 0.0 107.032 -177.481 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -117.01 124.42 49.27 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 122.894 0.477 . . . . 0.0 110.777 176.577 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 10.7 t -115.58 122.71 46.48 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 110.051 -0.351 . . . . 0.0 110.051 167.421 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 35.7 p -93.19 125.79 37.96 Favored 'General case' 0 N--CA 1.489 1.505 0 CA-C-O 121.274 0.559 . . . . 0.0 110.598 172.345 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 5.6 mp -99.08 86.73 3.51 Favored 'General case' 0 CA--C 1.561 1.387 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 175.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 93.3 t -94.21 108.53 20.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 -168.455 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 79.1 mtt85 -108.41 121.98 46.06 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 123.173 0.589 . . . . 0.0 110.143 -173.239 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -141.53 137.51 32.07 Favored 'General case' 0 N--CA 1.495 1.776 0 C-N-CA 123.114 0.566 . . . . 0.0 110.938 177.199 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -81.17 119.62 23.83 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.518 -0.739 . . . . 0.0 111.271 176.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 74.6 mt -123.97 110.89 26.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 N-CA-C 104.949 -2.241 . . . . 0.0 104.949 177.369 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 29.3 m-20 59.3 48.49 10.11 Favored 'General case' 0 N--CA 1.5 2.057 0 N-CA-C 114.767 1.395 . . . . 0.0 114.767 179.126 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 60.45 28.06 66.79 Favored Glycine 0 CA--C 1.554 2.473 0 N-CA-C 119.336 2.494 . . . . 0.0 119.336 -169.368 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 9.7 mtmp? -135.36 127.31 29.56 Favored 'General case' 0 N--CA 1.489 1.511 0 CA-C-N 119.482 1.641 . . . . 0.0 108.533 -173.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 35.0 tp -75.36 112.19 11.41 Favored 'General case' 0 CA--C 1.557 1.235 0 C-N-CA 123.493 0.717 . . . . 0.0 110.811 -179.561 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 31.0 mm -100.42 104.92 16.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 N-CA-C 106.409 -1.7 . . . . 0.0 106.409 -176.533 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 23.7 tp -97.96 101.17 12.59 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 123.81 0.844 . . . . 0.0 109.103 179.541 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 97.7 m -93.86 109.96 21.64 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 124.177 0.991 . . . . 0.0 108.769 -178.546 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 74.7 mt -103.8 90.32 3.6 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 123.913 0.885 . . . . 0.0 109.734 -168.534 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 7.5 m -100.06 118.18 35.88 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 -168.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 80.1 t60 -132.59 -105.49 0.25 Allowed 'General case' 0 N--CA 1.492 1.629 0 CA-C-O 118.77 -0.633 . . . . 0.0 109.652 176.105 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -119.63 91.14 0.49 Allowed Glycine 0 N--CA 1.486 1.989 0 CA-C-N 119.321 0.964 . . . . 0.0 112.65 -167.015 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . 0.297 1.6 m 54.62 34.37 21.27 Favored 'General case' 0 CA--C 1.582 2.179 0 N-CA-C 115.885 1.809 . . . . 0.0 115.885 -173.029 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -161.68 84.22 0.61 Allowed 'General case' 0 N--CA 1.485 1.308 0 O-C-N 121.15 -0.968 . . . . 0.0 108.768 -177.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 4.7 p -91.91 116.67 33.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 175.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 42.2 t -101.85 102.35 12.92 Favored 'General case' 0 CA--C 1.553 1.066 0 CA-C-O 121.187 0.518 . . . . 0.0 111.096 -179.63 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 96.2 m -87.7 111.75 21.64 Favored 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 177.424 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 28.9 mtm180 -114.4 119.28 36.39 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 122.898 0.479 . . . . 0.0 110.529 -170.347 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 88.9 m -84.42 134.97 34.45 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 123.234 0.614 . . . . 0.0 110.043 175.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 36.9 m-85 -130.11 128.43 41.83 Favored 'General case' 0 CA--C 1.56 1.345 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 178.367 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -93.77 150.72 20.16 Favored 'General case' 0 CA--C 1.564 1.503 0 CA-C-O 122.06 0.933 . . . . 0.0 111.202 172.173 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 69.3 tttt -82.97 124.83 30.76 Favored 'General case' 0 N--CA 1.486 1.342 0 N-CA-C 112.916 0.709 . . . . 0.0 112.916 -168.559 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 40.1 tp10 -99.06 47.95 0.96 Allowed 'General case' 0 CA--C 1.57 1.724 0 C-N-CA 123.772 0.829 . . . . 0.0 113.044 169.548 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.043 0 CA-C-O 124.263 1.982 . . . . 0.0 108.241 -176.94 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.306 5.0 t . . . . . 0 N--CA 1.49 1.526 0 CA-C-O 117.795 -1.098 . . . . 0.0 113.302 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -61.19 -36.99 81.38 Favored 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 115.991 1.849 . . . . 0.0 115.991 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -61.31 -32.23 72.09 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 116.957 2.206 . . . . 0.0 116.957 163.428 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -71.96 -25.41 61.86 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 115.978 1.844 . . . . 0.0 115.978 170.248 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 55.3 mt -71.71 117.32 13.14 Favored 'General case' 0 N--CA 1.492 1.652 0 CA-C-N 121.375 1.898 . . . . 0.0 111.112 -175.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 160.1 170.0 24.12 Favored Glycine 0 CA--C 1.54 1.627 0 CA-C-O 122.418 1.01 . . . . 0.0 113.853 -172.422 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 90.3 m -92.62 136.74 32.97 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-N 114.464 -0.868 . . . . 0.0 108.812 171.031 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 94.8 m95 -137.64 115.17 11.2 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.685 -0.858 . . . . 0.0 108.685 -170.193 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 23.0 mmmt -108.27 145.22 34.67 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-O 121.791 0.805 . . . . 0.0 110.536 179.627 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 25.8 tp -68.81 128.82 38.01 Favored 'General case' 0 N--CA 1.487 1.407 0 CA-C-O 122.222 1.011 . . . . 0.0 112.91 -171.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . 0.28 1.1 t -106.69 -45.67 8.01 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.725 0 CA-C-N 113.805 -1.543 . . . . 0.0 111.767 178.811 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 43.7 t0 -142.01 140.08 32.56 Favored 'General case' 0 N--CA 1.488 1.429 0 CA-C-N 119.437 1.017 . . . . 0.0 109.079 178.641 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 81.0 p -127.79 94.26 3.9 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.784 -0.572 . . . . 0.0 109.853 172.4 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 47.9 mtmt -91.99 120.8 32.97 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 123.57 0.748 . . . . 0.0 109.355 -176.408 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.264 42.1 m-20 71.53 21.17 4.56 Favored 'General case' 0 N--CA 1.504 2.264 0 N-CA-C 117.113 2.264 . . . . 0.0 117.113 -178.726 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 10.1 t80 -71.85 -41.13 68.47 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 115.853 1.797 . . . . 0.0 115.853 -175.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -60.52 -32.25 71.29 Favored 'General case' 0 N--CA 1.499 1.976 0 N-CA-C 116.014 1.857 . . . . 0.0 116.014 168.442 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 20.1 t0 -64.85 -50.72 65.54 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 114.331 1.234 . . . . 0.0 114.331 167.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 89.6 t80 -50.54 -54.83 19.39 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 115.349 1.611 . . . . 0.0 115.349 171.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 77.7 mtm -59.85 -41.85 92.35 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 115.231 1.567 . . . . 0.0 115.231 175.418 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.3 tmtp? -62.57 -43.94 97.57 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 114.788 1.403 . . . . 0.0 114.788 171.526 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 61.3 m -58.18 -39.39 78.8 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 116.574 2.064 . . . . 0.0 116.574 171.022 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 51.8 mt -61.54 -45.86 92.39 Favored 'General case' 0 CA--C 1.567 1.632 0 N-CA-C 115.747 1.758 . . . . 0.0 115.747 167.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 121.03 71.69 0.3 Allowed Glycine 0 N--CA 1.482 1.735 0 C-N-CA 123.979 0.8 . . . . 0.0 111.266 -172.101 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 40.5 t -141.6 122.0 12.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 N-CA-C 105.083 -2.191 . . . . 0.0 105.083 -176.294 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -77.15 -171.48 35.35 Favored Glycine 0 CA--C 1.548 2.154 0 N-CA-C 116.663 1.425 . . . . 0.0 116.663 -174.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 11.0 p90 -67.27 158.32 31.76 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 113.387 0.884 . . . . 0.0 113.387 176.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . 0.325 . . 78.76 -52.05 0.46 Allowed 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 114.995 1.48 . . . . 0.0 114.995 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 89.1 m -64.48 -40.93 96.61 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 114.241 1.201 . . . . 0.0 114.241 167.682 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 48.1 mtm180 -61.26 -43.66 98.52 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 114.996 1.48 . . . . 0.0 114.996 167.555 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -60.52 -49.81 76.07 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 115.058 1.503 . . . . 0.0 115.058 174.056 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 69.1 t -63.69 -43.84 98.2 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 CA-C-N 119.429 1.013 . . . . 0.0 112.742 174.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -62.7 -35.98 81.48 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 117.053 2.242 . . . . 0.0 117.053 176.234 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 96.7 p -65.66 -43.44 89.39 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 116.395 1.998 . . . . 0.0 116.395 170.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 20.0 ptm -68.21 -31.02 70.25 Favored 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 117.067 2.247 . . . . 0.0 117.067 168.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 38.0 m -71.85 143.47 49.41 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 124.279 1.031 . . . . 0.0 112.257 -178.025 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -104.52 102.97 37.16 Favored Pre-proline 0 CA--C 1.57 1.723 0 CA-C-O 118.145 -0.931 . . . . 0.0 109.1 175.25 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -79.2 116.88 3.72 Favored 'Trans proline' 0 CA--C 1.561 1.849 0 C-N-CA 122.913 2.409 . . . . 0.0 112.185 -178.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 24.4 m -78.8 105.36 10.06 Favored 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 123.675 0.79 . . . . 0.0 109.701 -170.536 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 61.0 m -101.12 106.77 18.05 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 -167.234 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 52.0 mt -111.69 107.19 22.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 N-CA-C 107.16 -1.422 . . . . 0.0 107.16 -172.149 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 3.9 mp -96.18 121.56 46.84 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 174.637 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 7.9 tm-20 -137.23 120.6 16.97 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 -178.03 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -86.23 115.9 24.07 Favored 'General case' 0 CA--C 1.56 1.339 0 C-N-CA 123.15 0.58 . . . . 0.0 111.052 179.431 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 12.5 t30 -105.79 86.87 2.46 Favored 'General case' 0 CA--C 1.561 1.374 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 179.282 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 80.92 -99.75 1.92 Allowed Glycine 0 N--CA 1.486 1.982 0 N-CA-C 111.883 -0.487 . . . . 0.0 111.883 -172.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -130.11 59.36 1.63 Allowed 'General case' 0 N--CA 1.494 1.747 0 CA-C-O 120.958 0.409 . . . . 0.0 110.065 160.399 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 42.6 mm -137.81 108.16 5.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 N-CA-C 104.889 -2.263 . . . . 0.0 104.889 -179.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 42.8 mt -83.11 106.67 15.1 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 122.756 0.422 . . . . 0.0 110.871 179.204 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 73.3 m -98.98 96.99 8.2 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 -173.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 9.1 tt -97.68 103.19 15.1 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 -179.227 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 91.3 mttt -98.94 111.14 23.62 Favored 'General case' 0 N--CA 1.485 1.276 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 -175.306 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 45.8 m -100.13 87.03 3.35 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 -177.601 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 12.0 m170 -89.87 98.63 11.88 Favored 'General case' 0 N--CA 1.492 1.642 0 CA-C-O 121.702 0.763 . . . . 0.0 110.053 -173.224 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 22.9 t -98.09 -24.27 15.39 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 116.962 2.208 . . . . 0.0 116.962 -172.54 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . 0.363 4.4 m 89.4 -43.46 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.274 0 CA-C-N 121.074 1.761 . . . . 0.0 112.486 -161.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 73.4 t80 -62.1 -70.97 0.17 Allowed 'General case' 0 N--CA 1.491 1.618 0 CA-C-N 119.43 1.013 . . . . 0.0 111.611 166.399 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 54.5 mtpt -145.88 135.41 23.16 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 174.151 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -85.55 101.09 12.38 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 122.971 0.508 . . . . 0.0 110.777 173.134 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 60.2 p -96.19 127.85 42.56 Favored 'General case' 0 N--CA 1.494 1.75 0 CA-C-O 121.396 0.617 . . . . 0.0 109.949 -179.577 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -124.52 125.09 43.65 Favored 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 123.426 0.69 . . . . 0.0 109.344 -171.582 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 48.2 pt -117.6 131.48 70.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 C-N-CA 123.524 0.73 . . . . 0.0 109.077 175.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 80.6 p -121.2 104.14 9.52 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 -178.055 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 50.1 p90 -136.9 147.09 46.23 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 114.809 1.411 . . . . 0.0 114.809 -156.555 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 25.9 mtpp -110.77 20.29 17.74 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 117.679 2.474 . . . . 0.0 117.679 -170.693 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . 0.311 1.7 mp 60.65 88.7 0.08 Allowed 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 114.93 1.456 . . . . 0.0 114.93 172.639 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 92.39 39.81 5.26 Favored Glycine 0 CA--C 1.549 2.194 0 N-CA-C 115.951 1.141 . . . . 0.0 115.951 -168.506 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 74.9 t -141.62 123.86 14.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 N-CA-C 105.533 -2.025 . . . . 0.0 105.533 -176.421 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -88.14 129.55 35.29 Favored 'General case' 0 CA--C 1.565 1.547 0 C-N-CA 122.924 0.49 . . . . 0.0 110.497 176.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 48.6 p90 -138.95 131.55 28.87 Favored 'General case' 0 N--CA 1.496 1.831 0 C-N-CA 123.231 0.612 . . . . 0.0 111.435 -174.201 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -69.17 131.56 45.14 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.303 -0.873 . . . . 0.0 113.133 173.602 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 17.4 tp10 -142.97 137.85 29.67 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 123.426 0.69 . . . . 0.0 110.028 -168.343 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 56.6 m -93.06 122.8 35.8 Favored 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 123.035 0.534 . . . . 0.0 109.639 176.238 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 26.9 p -84.14 177.8 8.08 Favored 'General case' 0 N--CA 1.496 1.86 0 CA-C-O 121.415 0.626 . . . . 0.0 112.549 -177.3 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -67.4 -27.97 67.53 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 117.416 2.376 . . . . 0.0 117.416 169.612 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 25.6 m-20 -77.96 8.3 4.88 Favored 'General case' 0 CA--C 1.579 2.096 0 N-CA-C 115.918 1.822 . . . . 0.0 115.918 161.39 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 64.01 68.81 0.55 Allowed 'General case' 0 N--CA 1.496 1.837 0 C-N-CA 125.366 1.466 . . . . 0.0 112.891 -179.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 63.7 mtm180 -137.05 127.96 27.46 Favored 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 123.001 0.521 . . . . 0.0 109.74 -171.457 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.04 102.8 6.64 Favored 'General case' 0 CA--C 1.565 1.53 0 C-N-CA 123.331 0.652 . . . . 0.0 111.141 173.071 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 19.9 m -120.36 129.99 74.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 -170.622 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 69.6 mmtt -81.74 107.13 14.23 Favored 'General case' 0 N--CA 1.49 1.531 0 CA-C-O 121.841 0.829 . . . . 0.0 109.867 176.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 74.3 m -102.07 102.49 12.98 Favored 'General case' 0 N--CA 1.481 1.08 0 CA-C-N 114.838 -1.073 . . . . 0.0 110.114 -165.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -106.91 115.04 47.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 175.67 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -128.26 128.15 68.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 C-N-CA 123.799 0.84 . . . . 0.0 109.32 -178.835 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 9.3 t -139.97 151.26 45.37 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-O 122.705 1.24 . . . . 0.0 111.337 -179.249 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 50.5 tp -82.2 125.48 30.97 Favored 'General case' 0 N--CA 1.489 1.498 0 CA-C-N 114.523 -1.217 . . . . 0.0 109.921 176.476 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -126.5 83.44 2.17 Favored 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 123.462 0.705 . . . . 0.0 109.771 -178.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 58.56 46.13 93.63 Favored Glycine 0 CA--C 1.552 2.395 0 N-CA-C 117.934 1.933 . . . . 0.0 117.934 -178.444 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 76.77 31.82 52.33 Favored Glycine 0 CA--C 1.555 2.544 0 N-CA-C 117.833 1.893 . . . . 0.0 117.833 -166.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 60.4 mtpt -141.13 112.82 7.62 Favored 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 106.629 -1.619 . . . . 0.0 106.629 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 3.7 mp -81.67 111.04 17.58 Favored 'General case' 0 N--CA 1.487 1.404 0 CA-C-O 121.94 0.876 . . . . 0.0 109.858 173.76 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 95.6 t -106.84 102.03 13.35 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 N-CA-C 105.324 -2.102 . . . . 0.0 105.324 -172.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 23.6 t-160 -104.85 136.95 43.39 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 124.35 1.06 . . . . 0.0 109.474 -178.306 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 33.7 tp -132.65 119.4 20.38 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 177.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 81.9 mt-30 -111.87 111.84 23.08 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 179.372 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 10.3 ptpp? -120.04 138.61 53.42 Favored 'General case' 0 N--CA 1.494 1.732 0 C-N-CA 123.228 0.611 . . . . 0.0 112.027 -172.324 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 13.7 p90 -156.79 109.8 2.57 Favored 'General case' 0 N--CA 1.488 1.475 0 C-N-CA 123.379 0.672 . . . . 0.0 109.825 -174.165 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 6.7 t70 54.5 54.4 9.38 Favored 'General case' 0 N--CA 1.498 1.949 0 N-CA-C 116.066 1.876 . . . . 0.0 116.066 168.62 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 87.2 -41.91 3.12 Favored Glycine 0 CA--C 1.552 2.38 0 N-CA-C 116.919 1.528 . . . . 0.0 116.919 -169.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -86.17 135.71 33.48 Favored 'General case' 0 N--CA 1.483 1.208 0 CA-C-N 117.979 0.89 . . . . 0.0 111.454 -174.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -144.86 137.73 26.51 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.911 -0.493 . . . . 0.0 112.006 -178.868 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 9.9 t -131.46 129.25 40.94 Favored 'General case' 0 N--CA 1.493 1.722 0 C-N-CA 123.356 0.662 . . . . 0.0 110.682 179.648 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 41.8 p -98.52 129.57 45.09 Favored 'General case' 0 N--CA 1.494 1.732 0 C-N-CA 122.884 0.474 . . . . 0.0 111.769 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 5.7 mp -103.91 80.26 1.73 Allowed 'General case' 0 CA--C 1.564 1.51 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 177.059 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 59.9 t -89.69 108.85 19.77 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 -168.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 81.8 mtt85 -102.96 122.09 43.88 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 123.425 0.69 . . . . 0.0 110.234 -176.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -138.73 139.74 38.46 Favored 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 123.04 0.536 . . . . 0.0 111.66 178.035 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -83.12 118.04 23.29 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 123.084 0.554 . . . . 0.0 111.412 178.536 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 46.5 mm -119.01 105.72 18.09 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 N-CA-C 105.287 -2.116 . . . . 0.0 105.287 174.277 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 58.61 49.29 10.58 Favored 'General case' 0 N--CA 1.5 2.037 0 N-CA-C 115.316 1.599 . . . . 0.0 115.316 175.641 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 65.75 26.78 72.21 Favored Glycine 0 CA--C 1.555 2.575 0 N-CA-C 119.142 2.417 . . . . 0.0 119.142 -170.291 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -134.08 125.46 28.06 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-N 119.017 1.409 . . . . 0.0 108.457 -173.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 16.7 tp -77.64 110.05 12.14 Favored 'General case' 0 CA--C 1.558 1.28 0 C-N-CA 123.361 0.665 . . . . 0.0 110.381 179.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 30.7 mm -97.92 101.89 12.75 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 N-CA-C 106.544 -1.651 . . . . 0.0 106.544 -176.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 29.4 tp -92.7 99.49 12.17 Favored 'General case' 0 N--CA 1.486 1.359 0 CA-C-O 121.812 0.815 . . . . 0.0 109.258 178.052 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 87.1 m -93.87 105.84 17.84 Favored 'General case' 0 CA--C 1.56 1.361 0 CA-C-N 114.884 -1.053 . . . . 0.0 108.26 -178.007 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 83.5 mt -97.12 100.69 12.17 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 123.816 0.846 . . . . 0.0 109.13 -174.193 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 7.1 m -100.63 119.58 38.77 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.71 -0.619 . . . . 0.0 109.751 -170.636 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 74.7 t60 -151.7 114.63 4.69 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 122.475 0.31 . . . . 0.0 110.376 171.24 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 52.54 71.44 0.68 Allowed Glycine 0 N--CA 1.488 2.146 0 N-CA-C 117.745 1.858 . . . . 0.0 117.745 162.053 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . 0.506 2.7 t 66.58 -44.32 0.43 Allowed 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 117.676 2.472 . . . . 0.0 117.676 -166.729 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -86.39 94.35 9.36 Favored 'General case' 0 N--CA 1.483 1.191 0 CA-C-N 119.563 1.074 . . . . 0.0 112.405 -177.288 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 6.4 p -98.11 128.61 49.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 C-N-CA 123.825 0.85 . . . . 0.0 109.803 174.521 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 42.7 t -109.45 107.48 17.64 Favored 'General case' 0 CA--C 1.553 1.068 0 C-N-CA 123.035 0.534 . . . . 0.0 112.125 -179.206 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 89.0 m -86.19 112.1 21.02 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 176.184 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 71.1 mtp180 -113.25 114.18 26.35 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 -174.107 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 85.5 m -86.72 133.54 33.66 Favored 'General case' 0 N--CA 1.495 1.782 0 C-N-CA 123.288 0.635 . . . . 0.0 110.106 177.37 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 48.4 m-85 -129.77 125.52 36.0 Favored 'General case' 0 CA--C 1.558 1.264 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 179.245 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -93.23 154.55 17.96 Favored 'General case' 0 N--CA 1.493 1.724 0 CA-C-O 122.481 1.134 . . . . 0.0 111.783 171.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 72.5 tttt -84.88 129.11 34.86 Favored 'General case' 0 N--CA 1.485 1.278 0 CA-C-N 115.04 -0.982 . . . . 0.0 112.534 -167.319 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 14.6 mm-40 -111.52 50.97 0.8 Allowed 'General case' 0 CA--C 1.567 1.597 0 C-N-CA 124.125 0.97 . . . . 0.0 111.572 175.709 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.967 0 CA-C-O 124.28 1.991 . . . . 0.0 108.121 -171.257 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.266 8.0 p . . . . . 0 CA--C 1.577 2.016 0 N-CA-C 116.127 1.899 . . . . 0.0 116.127 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -69.8 -38.99 76.84 Favored 'General case' 0 N--CA 1.497 1.891 0 N-CA-C 116.385 1.995 . . . . 0.0 116.385 -177.625 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -59.08 -27.88 65.95 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 117.513 2.412 . . . . 0.0 117.513 168.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -68.6 -24.87 64.63 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 116.29 1.959 . . . . 0.0 116.29 169.008 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 34.6 mt -78.7 115.44 18.4 Favored 'General case' 0 N--CA 1.489 1.521 0 CA-C-N 121.09 1.768 . . . . 0.0 111.29 -167.297 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 161.1 172.58 28.63 Favored Glycine 0 CA--C 1.543 1.79 0 CA-C-O 122.467 1.037 . . . . 0.0 113.454 -172.321 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 81.7 m -85.11 141.62 30.09 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-N 114.739 -0.731 . . . . 0.0 109.733 168.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 80.4 m95 -141.88 112.79 7.36 Favored 'General case' 0 N--CA 1.484 1.235 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 -174.516 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 9.0 mtpm? -96.22 147.33 23.88 Favored 'General case' 0 N--CA 1.495 1.802 0 C-N-CA 122.771 0.429 . . . . 0.0 110.209 174.369 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 57.9 tp -69.5 120.89 15.99 Favored 'General case' 0 N--CA 1.491 1.617 0 CA-C-O 121.864 0.84 . . . . 0.0 111.51 179.663 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . 0.271 1.2 t -98.85 -43.47 11.65 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.82 0 CA-C-N 114.194 -1.366 . . . . 0.0 112.588 -179.565 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -146.35 139.71 25.85 Favored 'General case' 0 N--CA 1.49 1.543 0 CA-C-N 119.652 1.114 . . . . 0.0 109.179 -179.468 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 89.2 p -128.91 100.27 5.61 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.933 -0.479 . . . . 0.0 110.939 175.47 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 59.3 mtpt -86.88 127.96 35.05 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 123.149 0.58 . . . . 0.0 109.612 173.124 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 58.5 m-20 66.79 22.59 10.25 Favored 'General case' 0 N--CA 1.504 2.235 0 N-CA-C 118.082 2.623 . . . . 0.0 118.082 173.732 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 23.6 t80 -67.24 -45.33 77.08 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 120.215 -1.553 . . . . 0.0 115.083 -178.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 85.8 m-20 -62.13 -27.0 68.63 Favored 'General case' 0 CA--C 1.572 1.811 0 N-CA-C 116.613 2.079 . . . . 0.0 116.613 171.443 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -69.05 -49.91 53.24 Favored 'General case' 0 N--CA 1.497 1.914 0 CA-C-N 120.275 1.398 . . . . 0.0 114.36 166.381 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 87.8 t80 -51.43 -50.3 59.99 Favored 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 115.397 1.628 . . . . 0.0 115.397 169.139 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 16.7 mmm -57.98 -46.55 84.98 Favored 'General case' 0 CA--C 1.566 1.595 0 N-CA-C 114.647 1.351 . . . . 0.0 114.647 172.424 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.2 tmtp? -57.35 -48.41 79.08 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 115.408 1.633 . . . . 0.0 115.408 170.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 83.5 p -59.63 -36.33 76.14 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 117.151 2.278 . . . . 0.0 117.151 174.148 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 34.4 mt -66.46 -33.62 76.09 Favored 'General case' 0 CA--C 1.566 1.562 0 N-CA-C 116.945 2.202 . . . . 0.0 116.945 167.375 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 108.5 72.36 0.75 Allowed Glycine 0 N--CA 1.482 1.742 0 CA-C-N 118.878 0.763 . . . . 0.0 111.788 -173.133 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 43.0 t -141.78 130.46 22.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 N-CA-C 106.808 -1.552 . . . . 0.0 106.808 -176.232 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -72.53 173.2 47.15 Favored Glycine 0 CA--C 1.549 2.16 0 N-CA-C 116.791 1.476 . . . . 0.0 116.791 -179.599 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 38.9 p90 -66.7 -39.58 88.14 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 117.599 2.444 . . . . 0.0 117.599 -175.385 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.15 -43.95 96.88 Favored 'General case' 0 CA--C 1.561 1.397 0 N-CA-C 115.803 1.779 . . . . 0.0 115.803 179.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.1 t -78.02 -21.54 50.59 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 115.835 1.791 . . . . 0.0 115.835 171.53 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 62.3 mtm180 -58.72 -42.81 89.57 Favored 'General case' 0 N--CA 1.495 1.824 0 CA-C-N 120.915 1.689 . . . . 0.0 114.524 162.64 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -63.13 -56.49 16.38 Favored 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 114.304 1.224 . . . . 0.0 114.304 168.166 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 47.9 t -62.81 -40.89 90.42 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 N-CA-C 113.883 1.068 . . . . 0.0 113.883 -178.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -70.68 -32.49 69.76 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 116.724 2.12 . . . . 0.0 116.724 175.453 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 94.6 p -65.93 -45.28 82.45 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 115.666 1.728 . . . . 0.0 115.666 170.173 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 3.5 ppp? -63.44 -28.29 69.87 Favored 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 116.923 2.194 . . . . 0.0 116.923 167.259 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 97.2 m -70.95 138.91 50.43 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 124.11 0.964 . . . . 0.0 110.83 172.188 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.76 102.43 11.69 Favored Pre-proline 0 CA--C 1.57 1.715 0 CA-C-O 118.023 -0.989 . . . . 0.0 109.32 166.683 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -80.77 95.75 0.98 Allowed 'Trans proline' 0 C--N 1.371 1.744 0 C-N-CA 122.817 2.345 . . . . 0.0 111.135 -176.614 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 99.4 m -81.32 111.45 17.72 Favored 'General case' 0 N--CA 1.489 1.48 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.452 -159.654 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 87.4 m -87.14 116.23 25.07 Favored 'General case' 0 CA--C 1.56 1.338 0 C-N-CA 123.916 0.886 . . . . 0.0 109.233 -175.32 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 79.6 mt -112.33 110.41 32.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 N-CA-C 106.224 -1.769 . . . . 0.0 106.224 177.341 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 22.6 mt -100.95 119.03 48.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 -176.39 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -137.55 108.05 6.54 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 -169.595 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 83.8 tttt -85.55 121.95 28.98 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 123.385 0.674 . . . . 0.0 111.175 179.795 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 19.0 m120 -89.25 -69.15 0.73 Allowed 'General case' 0 N--CA 1.49 1.575 0 C-N-CA 123.654 0.782 . . . . 0.0 110.543 177.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -151.58 76.56 0.23 Allowed Glycine 0 N--CA 1.484 1.868 0 N-CA-C 110.116 -1.194 . . . . 0.0 110.116 169.309 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . 0.336 2.1 t70 70.99 -23.96 0.17 Allowed 'General case' 0 N--CA 1.499 2.006 0 N-CA-C 116.805 2.15 . . . . 0.0 116.805 -160.417 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 21.2 mm -75.34 106.6 5.24 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.561 0 C-N-CA 124.536 1.134 . . . . 0.0 108.05 173.198 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 26.4 mt -92.45 113.77 26.13 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 123.878 0.871 . . . . 0.0 109.66 -179.459 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 57.1 m -97.79 97.45 8.99 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 106.836 -1.542 . . . . 0.0 106.836 -177.712 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 9.4 tt -100.5 98.74 9.31 Favored 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 -177.302 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -93.66 115.57 28.03 Favored 'General case' 0 N--CA 1.484 1.26 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 -174.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 28.9 m -100.89 103.42 14.59 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 -179.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 21.1 m-70 -90.53 105.25 17.69 Favored 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 123.479 0.712 . . . . 0.0 109.444 -170.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 5.9 m -147.26 154.92 41.58 Favored 'General case' 0 N--CA 1.491 1.588 0 CA-C-O 121.234 0.54 . . . . 0.0 112.125 -164.524 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . 0.298 11.9 t -94.87 46.61 1.13 Allowed 'General case' 0 N--CA 1.501 2.082 0 N-CA-C 113.281 0.845 . . . . 0.0 113.281 154.648 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 69.2 t80 -164.41 -79.01 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 107.259 -1.386 . . . . 0.0 107.259 173.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 4.5 tppp? -92.92 72.98 4.81 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 123.462 0.705 . . . . 0.0 109.754 -179.509 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 17.4 t30 -91.27 81.95 5.48 Favored 'General case' 0 N--CA 1.484 1.257 0 N-CA-C 108.69 -0.855 . . . . 0.0 108.69 179.192 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 81.9 p -131.83 126.84 35.3 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 -164.537 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -109.66 120.27 41.96 Favored 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 177.659 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 43.0 pt -110.94 128.45 67.35 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 177.079 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 35.9 t -118.05 95.7 5.02 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 107.791 -1.189 . . . . 0.0 107.791 -175.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 45.1 p90 -130.71 142.25 50.42 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 114.241 1.201 . . . . 0.0 114.241 -156.645 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 29.6 mtpp -100.15 146.43 26.84 Favored 'General case' 0 N--CA 1.488 1.444 0 CA-C-N 115.218 -0.901 . . . . 0.0 109.126 165.608 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -73.44 116.89 14.54 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.433 -0.792 . . . . 0.0 112.106 -172.217 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 80.88 43.41 8.94 Favored Glycine 0 CA--C 1.549 2.186 0 N-CA-C 116.535 1.374 . . . . 0.0 116.535 -166.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 93.1 t -138.6 122.56 20.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 N-CA-C 106.469 -1.678 . . . . 0.0 106.469 177.603 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -85.64 133.34 34.04 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 123.634 0.773 . . . . 0.0 111.285 179.07 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -141.22 149.78 41.83 Favored 'General case' 0 N--CA 1.493 1.695 0 CA-C-O 121.764 0.793 . . . . 0.0 111.443 -173.784 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -74.24 136.08 42.71 Favored 'General case' 0 CA--C 1.565 1.542 0 O-C-N 121.387 -0.82 . . . . 0.0 112.866 172.195 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 32.1 tp10 -145.34 139.15 26.81 Favored 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 123.186 0.594 . . . . 0.0 110.018 -178.152 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 56.0 m -100.54 123.71 45.12 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 177.519 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 29.4 p -85.18 -179.69 7.06 Favored 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 113.432 0.901 . . . . 0.0 113.432 -174.746 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -54.38 -38.99 66.79 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 117.266 2.321 . . . . 0.0 117.266 167.683 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -83.54 13.32 4.64 Favored 'General case' 0 CA--C 1.578 2.035 0 N-CA-C 115.615 1.709 . . . . 0.0 115.615 170.704 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . 0.255 8.7 t70 58.33 72.51 0.52 Allowed 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 125.443 1.497 . . . . 0.0 113.446 -174.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 44.2 mtm180 -132.87 124.96 28.9 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 -174.011 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.6 106.89 8.52 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 123.096 0.558 . . . . 0.0 111.648 174.136 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 18.2 m -118.36 134.01 63.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 C-N-CA 122.996 0.518 . . . . 0.0 109.74 -169.131 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 31.5 mmtp -82.84 104.01 12.75 Favored 'General case' 0 N--CA 1.488 1.456 0 CA-C-O 121.92 0.867 . . . . 0.0 109.451 176.215 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 43.3 t -106.27 99.04 8.65 Favored 'General case' 0 CA--C 1.553 1.083 0 CA-C-N 114.68 -1.146 . . . . 0.0 110.044 -161.299 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 7.4 tp -110.61 116.82 53.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 C-N-CA 124.229 1.012 . . . . 0.0 108.631 -177.05 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -134.89 120.06 29.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 C-N-CA 123.612 0.765 . . . . 0.0 109.279 -174.062 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 10.5 t -129.4 157.96 40.5 Favored 'General case' 0 N--CA 1.493 1.676 0 CA-C-O 122.473 1.13 . . . . 0.0 112.223 178.241 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 61.1 tp -84.18 127.28 33.83 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-N 114.805 -1.088 . . . . 0.0 110.577 174.365 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -131.44 85.13 2.23 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 123.905 0.882 . . . . 0.0 109.249 -176.179 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 55.54 44.36 85.73 Favored Glycine 0 N--CA 1.493 2.447 0 N-CA-C 118.658 2.223 . . . . 0.0 118.658 -179.381 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 82.41 16.92 70.08 Favored Glycine 0 CA--C 1.557 2.66 0 N-CA-C 118.627 2.211 . . . . 0.0 118.627 -167.542 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 53.8 mtpt -129.55 119.82 24.31 Favored 'General case' 0 N--CA 1.487 1.39 0 CA-C-N 119.064 1.432 . . . . 0.0 107.691 177.104 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 3.1 mp -82.3 107.9 15.33 Favored 'General case' 0 N--CA 1.485 1.294 0 CA-C-O 122.071 0.939 . . . . 0.0 109.369 169.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 70.4 t -99.47 102.19 13.09 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.333 0 N-CA-C 105.16 -2.163 . . . . 0.0 105.16 -174.621 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 20.8 t-160 -107.35 131.81 53.83 Favored 'General case' 0 N--CA 1.484 1.226 0 CA-C-N 114.486 -1.233 . . . . 0.0 108.613 -175.546 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 35.6 tp -131.01 121.3 24.81 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 177.556 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 90.7 mt-30 -111.5 113.43 25.85 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 175.567 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 10.7 ptpp? -118.78 140.36 50.08 Favored 'General case' 0 N--CA 1.494 1.749 0 C-N-CA 123.25 0.62 . . . . 0.0 112.052 -176.336 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 30.5 p90 -153.61 110.81 3.45 Favored 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 123.15 0.58 . . . . 0.0 109.813 -175.68 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . 0.339 8.8 t70 66.84 -101.5 0.07 Allowed 'General case' 0 N--CA 1.494 1.734 0 C-N-CA 124.602 1.161 . . . . 0.0 112.63 172.833 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -124.43 50.27 0.87 Allowed Glycine 0 N--CA 1.488 2.155 0 CA-C-N 118.941 0.791 . . . . 0.0 114.482 164.713 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 52.3 mt-30 -153.42 124.85 7.59 Favored 'General case' 0 N--CA 1.485 1.289 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 -178.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -136.46 133.47 36.64 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.859 -0.525 . . . . 0.0 111.453 176.23 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 6.4 t -120.06 129.48 54.24 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 123.379 0.672 . . . . 0.0 110.718 175.462 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 41.0 p -95.71 133.88 39.28 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-O 121.528 0.68 . . . . 0.0 111.052 173.515 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 5.6 mp -111.68 74.01 0.85 Allowed 'General case' 0 CA--C 1.564 1.519 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 178.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 59.2 t -83.17 109.42 16.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 121.126 -0.984 . . . . 0.0 108.507 -167.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 76.6 mtt85 -101.32 120.72 40.69 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 123.269 0.628 . . . . 0.0 109.905 -174.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -141.72 127.46 19.19 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 122.872 0.469 . . . . 0.0 110.754 -169.52 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -79.23 114.85 18.5 Favored 'General case' 0 N--CA 1.487 1.418 0 CA-C-O 121.359 0.6 . . . . 0.0 111.331 -179.272 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 47.5 mm -121.4 106.39 18.21 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.338 0 N-CA-C 105.026 -2.213 . . . . 0.0 105.026 177.24 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 58.73 50.14 9.19 Favored 'General case' 0 N--CA 1.5 2.029 0 N-CA-C 115.064 1.505 . . . . 0.0 115.064 175.232 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 67.07 18.99 69.6 Favored Glycine 0 CA--C 1.555 2.577 0 N-CA-C 119.668 2.627 . . . . 0.0 119.668 -171.16 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 89.6 mttt -132.68 129.72 39.17 Favored 'General case' 0 N--CA 1.488 1.463 0 CA-C-N 119.63 1.715 . . . . 0.0 109.294 -174.387 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 18.2 tp -77.72 110.22 12.39 Favored 'General case' 0 CA--C 1.557 1.231 0 C-N-CA 123.98 0.912 . . . . 0.0 110.298 -179.523 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 30.5 mm -96.55 101.63 12.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 N-CA-C 106.748 -1.575 . . . . 0.0 106.748 -177.452 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 29.9 tp -88.99 101.36 14.01 Favored 'General case' 0 CA--C 1.559 1.307 0 C-N-CA 123.754 0.821 . . . . 0.0 109.361 176.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 87.4 m -95.61 105.94 17.97 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 -175.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 86.8 mt -99.3 98.77 9.69 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 123.588 0.755 . . . . 0.0 109.896 -171.302 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 6.7 m -113.6 115.8 28.5 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 -174.138 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 58.6 t60 -103.19 -87.46 0.42 Allowed 'General case' 0 N--CA 1.491 1.6 0 CA-C-O 118.5 -0.762 . . . . 0.0 108.986 170.411 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -106.64 -106.73 3.14 Favored Glycine 0 N--CA 1.484 1.869 0 CA-C-N 119.201 0.909 . . . . 0.0 111.09 179.359 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 13.8 t -100.79 49.24 0.89 Allowed 'General case' 0 N--CA 1.498 1.937 0 N-CA-C 113.346 0.869 . . . . 0.0 113.346 174.04 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -158.39 93.71 1.23 Allowed 'General case' 0 N--CA 1.483 1.223 0 O-C-N 121.206 -0.934 . . . . 0.0 108.648 175.398 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 4.2 p -91.47 121.26 41.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 C-N-CA 123.352 0.661 . . . . 0.0 109.753 175.36 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 45.7 t -101.44 100.03 10.43 Favored 'General case' 0 CA--C 1.553 1.081 0 CA-C-O 121.556 0.693 . . . . 0.0 111.214 175.424 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 63.0 m -86.14 111.06 20.0 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 179.433 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 32.8 mtm180 -114.99 118.33 33.13 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 122.992 0.517 . . . . 0.0 110.331 -172.104 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 93.3 m -86.79 132.87 33.72 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 123.433 0.693 . . . . 0.0 110.304 177.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 38.0 m-85 -127.47 127.05 43.41 Favored 'General case' 0 CA--C 1.559 1.296 0 C-N-CA 123.648 0.779 . . . . 0.0 109.253 178.321 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -90.83 151.15 21.27 Favored 'General case' 0 N--CA 1.487 1.404 0 CA-C-O 121.788 0.804 . . . . 0.0 111.889 173.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 67.3 tttt -80.68 119.29 23.1 Favored 'General case' 0 N--CA 1.486 1.335 0 CA-C-O 121.563 0.697 . . . . 0.0 111.655 -174.585 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 18.1 mm-40 -119.89 50.33 1.29 Allowed 'General case' 0 CA--C 1.564 1.512 0 C-N-CA 124.422 1.089 . . . . 0.0 111.306 -171.077 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.897 0 CA-C-O 124.654 2.168 . . . . 0.0 109.946 -160.521 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 71.4 t . . . . . 0 CA--C 1.56 1.337 0 N-CA-C 106.201 -1.777 . . . . 0.0 106.201 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -140.49 -55.44 0.52 Allowed 'General case' 0 N--CA 1.494 1.746 0 C-N-CA 124.021 0.928 . . . . 0.0 111.051 -174.31 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -57.39 -29.99 64.54 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 116.914 2.19 . . . . 0.0 116.914 160.662 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -60.82 -18.89 58.2 Favored 'General case' 0 CA--C 1.571 1.76 0 N-CA-C 117.813 2.523 . . . . 0.0 117.813 163.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 82.4 mt -84.2 125.94 32.67 Favored 'General case' 0 N--CA 1.489 1.513 0 CA-C-N 121.329 1.877 . . . . 0.0 111.77 -169.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 153.92 176.3 26.14 Favored Glycine 0 CA--C 1.542 1.728 0 CA-C-O 122.602 1.112 . . . . 0.0 113.317 -173.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 71.4 m -84.75 140.17 31.44 Favored 'General case' 0 N--CA 1.49 1.564 0 CA-C-N 114.679 -0.76 . . . . 0.0 109.262 165.063 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 85.8 m95 -141.85 113.23 7.64 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 -174.292 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 6.3 mtpm? -102.03 145.48 29.25 Favored 'General case' 0 N--CA 1.494 1.75 0 CA-C-O 121.034 0.445 . . . . 0.0 110.017 178.558 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 17.5 tp -65.95 127.06 30.56 Favored 'General case' 0 N--CA 1.491 1.59 0 CA-C-O 122.349 1.071 . . . . 0.0 112.495 -175.59 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . 0.283 1.0 OUTLIER -104.51 -46.65 9.68 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.897 0 CA-C-N 113.845 -1.525 . . . . 0.0 111.448 177.288 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -137.36 140.34 41.36 Favored 'General case' 0 N--CA 1.49 1.542 0 CA-C-N 119.994 1.27 . . . . 0.0 109.848 177.31 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 71.8 p -131.37 118.05 19.75 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 123.462 0.705 . . . . 0.0 109.532 169.246 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 30.6 mtpp -88.05 -87.14 0.16 Allowed 'General case' 0 N--CA 1.491 1.625 0 CA-C-O 119.14 -0.457 . . . . 0.0 111.335 -172.621 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 65.0 m-80 -95.12 49.58 1.22 Allowed 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 113.503 0.927 . . . . 0.0 113.503 -175.594 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 23.7 t80 -77.25 -54.48 6.43 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.6 -1.313 . . . . 0.0 113.462 -173.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -51.19 -35.64 37.31 Favored 'General case' 0 N--CA 1.499 2.014 0 N-CA-C 116.722 2.119 . . . . 0.0 116.722 166.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 35.4 t0 -63.11 -55.71 23.02 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 114.179 1.178 . . . . 0.0 114.179 168.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 85.7 t80 -49.99 -47.21 53.01 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 116.403 2.001 . . . . 0.0 116.403 169.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 26.0 mmm -62.47 -45.58 92.38 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 114.771 1.397 . . . . 0.0 114.771 177.033 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 42.0 tptt -64.16 -38.8 92.36 Favored 'General case' 0 CA--C 1.566 1.585 0 N-CA-C 115.787 1.773 . . . . 0.0 115.787 171.101 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 65.6 m -58.38 -40.41 82.27 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 115.937 1.828 . . . . 0.0 115.937 168.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 77.2 mt -61.96 -37.34 84.39 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 116.694 2.109 . . . . 0.0 116.694 166.662 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 112.08 69.77 0.56 Allowed Glycine 0 N--CA 1.481 1.681 0 C-N-CA 124.055 0.836 . . . . 0.0 111.875 -173.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 37.3 t -140.83 117.45 7.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 N-CA-C 105.006 -2.22 . . . . 0.0 105.006 -177.145 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -68.33 -80.61 0.22 Allowed Glycine 0 N--CA 1.485 1.963 0 N-CA-C 117.078 1.591 . . . . 0.0 117.078 -166.472 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . 0.262 46.2 p90 -149.05 -50.37 0.15 Allowed 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 114.543 1.312 . . . . 0.0 114.543 -175.565 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.66 -39.84 91.8 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 116.511 2.041 . . . . 0.0 116.511 -178.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 60.0 m -79.32 -36.81 38.95 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 113.635 0.976 . . . . 0.0 113.635 170.255 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 33.4 ttp85 -61.1 -44.2 97.73 Favored 'General case' 0 CA--C 1.566 1.591 0 N-CA-C 115.543 1.683 . . . . 0.0 115.543 174.565 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 39.1 mt-30 -79.6 -40.42 29.39 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 115.026 1.491 . . . . 0.0 115.026 177.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 47.1 t -74.48 -37.72 44.86 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 CA-C-N 120.503 1.501 . . . . 0.0 112.524 179.305 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -66.99 -34.36 77.57 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 116.612 2.078 . . . . 0.0 116.612 172.074 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 92.0 p -65.18 -44.72 87.52 Favored 'General case' 0 N--CA 1.493 1.725 0 N-CA-C 115.783 1.772 . . . . 0.0 115.783 167.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 44.6 ttm -62.0 -36.97 83.09 Favored 'General case' 0 CA--C 1.571 1.765 0 N-CA-C 116.141 1.904 . . . . 0.0 116.141 168.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 52.4 m -68.26 151.93 46.21 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 124.455 1.102 . . . . 0.0 112.523 176.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 4.2 ttmp? -104.09 97.47 11.54 Favored Pre-proline 0 CA--C 1.574 1.896 0 CA-C-N 115.173 -0.921 . . . . 0.0 109.674 176.378 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -75.57 145.72 29.87 Favored 'Trans proline' 0 CA--C 1.561 1.839 0 C-N-CA 123.697 2.931 . . . . 0.0 113.444 178.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 98.8 m -117.34 97.4 5.88 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 -171.003 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 90.9 m -79.48 117.41 20.41 Favored 'General case' 0 N--CA 1.492 1.664 0 C-N-CA 123.77 0.828 . . . . 0.0 110.037 178.687 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 62.3 mt -119.02 111.79 34.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 N-CA-C 106.324 -1.732 . . . . 0.0 106.324 -174.382 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 17.8 mt -110.79 116.81 53.45 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 -173.013 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -127.36 123.67 36.79 Favored 'General case' 0 N--CA 1.494 1.769 0 C-N-CA 123.485 0.714 . . . . 0.0 109.841 179.721 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 82.1 tttt -97.5 120.53 38.05 Favored 'General case' 0 CA--C 1.557 1.217 0 C-N-CA 123.649 0.78 . . . . 0.0 110.335 177.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 -83.61 -81.03 0.17 Allowed 'General case' 0 N--CA 1.49 1.545 0 CA-C-O 118.793 -0.622 . . . . 0.0 110.125 178.242 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -99.94 -87.2 1.94 Allowed Glycine 0 N--CA 1.486 2.013 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 166.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -119.15 55.84 0.93 Allowed 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 153.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 15.0 mm -128.94 104.91 12.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 N-CA-C 104.888 -2.264 . . . . 0.0 104.888 -176.127 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 36.0 mt -95.29 107.41 19.52 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 123.048 0.539 . . . . 0.0 111.24 -170.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 31.5 m -92.72 94.02 8.77 Favored 'General case' 0 CA--C 1.559 1.302 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 -176.561 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 10.4 tt -98.24 102.25 13.94 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 -176.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 50.7 mttp -102.47 106.37 17.09 Favored 'General case' 0 N--CA 1.486 1.341 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 -174.505 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 59.3 m -92.23 97.22 10.76 Favored 'General case' 0 N--CA 1.493 1.675 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 178.736 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 22.4 m170 -91.76 94.76 9.51 Favored 'General case' 0 N--CA 1.488 1.458 0 CA-C-O 121.909 0.862 . . . . 0.0 110.089 -174.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 27.9 t -105.3 147.22 28.36 Favored 'General case' 0 N--CA 1.484 1.265 0 CA-C-N 115.041 -0.981 . . . . 0.0 109.879 173.503 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 74.0 p -79.46 63.99 4.22 Favored 'General case' 0 N--CA 1.503 2.203 0 CA-C-O 122.582 1.182 . . . . 0.0 112.298 170.617 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 13.6 t80 -172.02 -60.99 0.02 OUTLIER 'General case' 0 CA--C 1.566 1.576 0 C-N-CA 125.892 1.677 . . . . 0.0 107.583 -178.24 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -146.66 124.54 11.97 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 123.715 0.806 . . . . 0.0 110.492 175.204 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 43.7 m-20 -91.86 128.55 37.74 Favored 'General case' 0 N--CA 1.492 1.643 0 C-N-CA 123.242 0.617 . . . . 0.0 109.765 174.286 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 61.9 p -126.45 131.36 51.69 Favored 'General case' 0 N--CA 1.496 1.869 0 C-N-CA 123.063 0.545 . . . . 0.0 110.069 -176.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -128.75 123.67 33.56 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 123.512 0.725 . . . . 0.0 109.556 -172.642 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 41.8 pt -118.65 134.2 63.04 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 C-N-CA 123.709 0.804 . . . . 0.0 108.976 174.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 67.2 p -119.73 104.38 10.19 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 178.478 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 53.0 p90 -132.27 141.15 48.88 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 115.204 1.557 . . . . 0.0 115.204 -159.404 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 62.4 mtpt -94.51 143.17 26.65 Favored 'General case' 0 CA--C 1.562 1.408 0 CA-C-N 114.378 -1.283 . . . . 0.0 109.761 166.197 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -77.91 120.57 22.97 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.851 -0.53 . . . . 0.0 111.606 -175.402 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 83.03 43.48 7.56 Favored Glycine 0 CA--C 1.549 2.19 0 N-CA-C 116.5 1.36 . . . . 0.0 116.5 -169.512 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 94.2 t -140.69 123.68 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 N-CA-C 106.458 -1.682 . . . . 0.0 106.458 -178.523 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -86.32 130.16 34.61 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 123.227 0.611 . . . . 0.0 110.872 171.654 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 45.3 p90 -144.23 128.9 18.21 Favored 'General case' 0 N--CA 1.492 1.656 0 C-N-CA 123.619 0.767 . . . . 0.0 109.744 -175.341 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -72.48 111.65 7.85 Favored 'General case' 0 CA--C 1.564 1.493 0 O-C-N 121.327 -0.858 . . . . 0.0 112.657 177.198 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 13.4 tp10 -113.64 132.92 55.59 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 124.29 1.036 . . . . 0.0 109.537 -171.591 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 57.1 m -92.86 122.62 35.42 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 176.532 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 24.1 p -85.9 172.26 10.86 Favored 'General case' 0 N--CA 1.495 1.808 0 CA-C-O 121.588 0.709 . . . . 0.0 112.403 -176.296 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -58.41 -35.17 71.65 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 117.306 2.336 . . . . 0.0 117.306 167.451 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -77.57 12.74 1.49 Allowed 'General case' 0 CA--C 1.581 2.157 0 N-CA-C 115.981 1.845 . . . . 0.0 115.981 167.399 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 10.4 t70 58.08 71.93 0.55 Allowed 'General case' 0 N--CA 1.492 1.643 0 C-N-CA 125.545 1.538 . . . . 0.0 113.483 -176.723 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 80.5 mtm180 -136.82 121.64 18.7 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 -176.271 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.55 99.32 5.68 Favored 'General case' 0 CA--C 1.563 1.452 0 C-N-CA 123.179 0.592 . . . . 0.0 111.042 170.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 10.7 m -113.51 128.05 70.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 -170.104 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 72.0 mmtt -77.72 99.41 5.84 Favored 'General case' 0 N--CA 1.488 1.474 0 CA-C-O 121.674 0.749 . . . . 0.0 110.04 177.139 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 47.6 m -93.36 93.22 8.06 Favored 'General case' 0 N--CA 1.48 1.056 0 CA-C-N 115.009 -0.996 . . . . 0.0 110.501 -169.415 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 6.0 tp -101.97 103.26 14.7 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 175.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.0 p -121.96 125.0 72.56 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.364 0 CA-C-N 115.307 -0.861 . . . . 0.0 109.209 -174.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 15.3 t -135.53 156.52 48.75 Favored 'General case' 0 N--CA 1.489 1.482 0 CA-C-O 122.921 1.343 . . . . 0.0 111.21 178.717 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 63.7 tp -89.52 108.36 19.61 Favored 'General case' 0 N--CA 1.486 1.368 0 CA-C-N 114.173 -1.376 . . . . 0.0 108.899 171.122 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -109.6 87.01 2.4 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 123.45 0.7 . . . . 0.0 109.993 -173.7 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 61.3 48.93 82.68 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 117.623 1.809 . . . . 0.0 117.623 -178.63 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 73.46 27.54 67.49 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 118.915 2.326 . . . . 0.0 118.915 -169.297 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -143.88 112.46 6.52 Favored 'General case' 0 CA--C 1.553 1.063 0 N-CA-C 107.134 -1.432 . . . . 0.0 107.134 -174.685 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 4.7 tt -86.61 102.88 14.58 Favored 'General case' 0 CA--C 1.561 1.376 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 -172.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 77.7 t -104.35 108.05 23.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 -171.578 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 21.8 t-160 -105.97 109.18 21.05 Favored 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 123.378 0.671 . . . . 0.0 109.954 177.013 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 38.0 tp -102.88 121.04 41.7 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 178.24 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 31.5 mt-30 -114.13 115.88 28.22 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 83.5 mttt -113.28 135.53 53.74 Favored 'General case' 0 N--CA 1.495 1.793 0 CA-C-N 118.812 0.733 . . . . 0.0 111.103 -178.364 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 27.3 p90 -152.69 110.57 3.63 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.354 -0.841 . . . . 0.0 109.898 178.713 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 3.8 t70 53.56 50.88 16.28 Favored 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 116.392 1.997 . . . . 0.0 116.392 170.008 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 89.66 -43.46 2.99 Favored Glycine 0 CA--C 1.551 2.311 0 N-CA-C 116.685 1.434 . . . . 0.0 116.685 -169.34 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 15.0 mt-30 -80.88 124.6 29.24 Favored 'General case' 0 N--CA 1.488 1.428 0 CA-C-N 118.309 1.054 . . . . 0.0 111.318 -177.114 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -132.61 131.39 41.38 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 123.072 0.549 . . . . 0.0 111.712 178.685 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 8.8 t -118.45 133.03 56.21 Favored 'General case' 0 N--CA 1.496 1.866 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.365 176.534 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 35.8 p -102.76 132.72 48.72 Favored 'General case' 0 N--CA 1.495 1.819 0 CA-C-O 121.678 0.751 . . . . 0.0 110.85 172.602 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 5.3 mp -114.54 89.36 3.08 Favored 'General case' 0 CA--C 1.562 1.412 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 -179.448 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 97.1 t -98.49 106.05 18.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 -167.543 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 83.9 mtt85 -99.51 125.13 45.22 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 123.179 0.592 . . . . 0.0 110.402 -176.367 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -140.14 130.12 24.79 Favored 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 123.084 0.554 . . . . 0.0 111.092 -174.764 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -82.43 112.88 19.78 Favored 'General case' 0 N--CA 1.488 1.463 0 CA-C-O 121.256 0.55 . . . . 0.0 111.086 -178.557 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 82.8 mt -123.46 109.43 23.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 N-CA-C 105.052 -2.203 . . . . 0.0 105.052 179.412 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 57.87 50.18 10.85 Favored 'General case' 0 N--CA 1.499 2.012 0 N-CA-C 114.849 1.425 . . . . 0.0 114.849 177.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 62.24 24.65 65.64 Favored Glycine 0 CA--C 1.555 2.536 0 N-CA-C 119.502 2.561 . . . . 0.0 119.502 -170.699 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 91.2 mttt -132.31 131.07 41.62 Favored 'General case' 0 N--CA 1.488 1.435 0 CA-C-N 119.951 1.876 . . . . 0.0 109.534 -176.093 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 20.1 tp -77.58 110.08 12.08 Favored 'General case' 0 N--CA 1.484 1.275 0 C-N-CA 123.955 0.902 . . . . 0.0 110.144 -179.644 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 27.7 mm -99.39 95.58 4.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 N-CA-C 107.062 -1.459 . . . . 0.0 107.062 -175.047 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 17.4 tp -86.94 104.4 16.22 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 124.068 0.947 . . . . 0.0 110.098 179.542 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 84.8 m -99.66 104.16 15.89 Favored 'General case' 0 CA--C 1.561 1.392 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 -173.098 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 91.1 mt -98.52 102.43 14.17 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 123.659 0.784 . . . . 0.0 110.111 -172.497 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 9.6 m -113.44 125.9 54.74 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 -176.124 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 83.3 t60 -136.45 -98.33 0.22 Allowed 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 175.408 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -110.45 93.0 0.71 Allowed Glycine 0 N--CA 1.483 1.829 0 CA-C-N 118.816 0.734 . . . . 0.0 111.684 -169.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . 0.387 5.2 t 47.47 39.33 9.18 Favored 'General case' 0 N--CA 1.5 2.07 0 N-CA-C 117.546 2.425 . . . . 0.0 117.546 -172.097 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -157.64 93.6 1.29 Allowed 'General case' 0 N--CA 1.483 1.197 0 O-C-N 121.484 -0.76 . . . . 0.0 109.575 -174.461 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 2.8 p -92.87 112.25 25.86 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 C-N-CA 123.643 0.777 . . . . 0.0 109.288 173.141 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 41.1 t -97.5 104.34 16.36 Favored 'General case' 0 CA--C 1.551 1.017 0 CA-C-O 121.016 0.436 . . . . 0.0 110.292 175.179 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 89.2 m -90.04 100.96 13.68 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 -178.581 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 59.3 mtp180 -103.43 114.74 29.25 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 123.107 0.563 . . . . 0.0 109.749 -167.535 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 56.6 m -84.8 131.92 34.48 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 123.091 0.556 . . . . 0.0 109.954 177.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 41.0 m-85 -129.49 126.31 38.37 Favored 'General case' 0 CA--C 1.561 1.385 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 178.378 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -88.62 150.54 22.99 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 123.515 0.726 . . . . 0.0 112.127 174.68 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 71.0 tttt -81.67 118.14 22.58 Favored 'General case' 0 N--CA 1.486 1.346 0 CA-C-O 121.43 0.633 . . . . 0.0 111.577 -174.503 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 37.3 mm-40 -118.24 51.38 1.08 Allowed 'General case' 0 CA--C 1.564 1.505 0 C-N-CA 124.216 1.007 . . . . 0.0 111.31 -174.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.875 0 CA-C-O 123.105 1.431 . . . . 0.0 110.151 -161.931 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 5.7 p . . . . . 0 CA--C 1.578 2.028 0 N-CA-C 115.24 1.571 . . . . 0.0 115.24 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -78.84 -38.71 37.32 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 115.648 1.721 . . . . 0.0 115.648 -176.087 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -58.95 -24.03 62.11 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 117.649 2.463 . . . . 0.0 117.649 167.428 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -69.62 -20.19 63.62 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 116.575 2.065 . . . . 0.0 116.575 167.333 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 42.9 mt -81.17 121.99 26.82 Favored 'General case' 0 N--CA 1.488 1.475 0 CA-C-N 120.829 1.65 . . . . 0.0 111.168 -170.709 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 157.34 174.75 27.45 Favored Glycine 0 CA--C 1.541 1.703 0 CA-C-O 122.379 0.988 . . . . 0.0 113.369 -172.283 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 63.0 m -93.12 136.88 32.97 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 170.516 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 87.5 m95 -138.34 113.37 9.24 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 -171.431 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 9.4 mtmp? -97.81 143.54 28.33 Favored 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 123.247 0.619 . . . . 0.0 110.547 -179.506 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 60.0 tp -70.87 117.27 12.16 Favored 'General case' 0 N--CA 1.492 1.639 0 CA-C-O 121.856 0.836 . . . . 0.0 111.177 -177.573 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . 0.27 1.0 OUTLIER -97.48 -42.38 11.62 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.757 0 CA-C-N 114.337 -1.301 . . . . 0.0 112.725 -178.702 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -148.06 134.82 19.99 Favored 'General case' 0 N--CA 1.487 1.386 0 CA-C-N 119.677 1.126 . . . . 0.0 109.035 -177.53 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 88.8 p -121.59 100.84 7.24 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 122.976 0.51 . . . . 0.0 110.496 176.741 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 61.1 mtpt -92.77 123.02 35.75 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 176.644 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 52.1 m-20 67.22 21.66 9.9 Favored 'General case' 0 N--CA 1.503 2.204 0 N-CA-C 117.513 2.412 . . . . 0.0 117.513 176.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 17.3 t80 -71.2 -40.21 71.31 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 119.988 -1.695 . . . . 0.0 115.345 -179.273 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -60.19 -31.45 70.14 Favored 'General case' 0 CA--C 1.571 1.766 0 N-CA-C 115.935 1.828 . . . . 0.0 115.935 165.337 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 14.3 t0 -64.92 -47.25 78.4 Favored 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 114.843 1.423 . . . . 0.0 114.843 166.012 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 94.2 t80 -54.0 -51.95 62.33 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 115.104 1.52 . . . . 0.0 115.104 172.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 75.8 mtm -63.67 -34.37 77.69 Favored 'General case' 0 CA--C 1.568 1.636 0 N-CA-C 115.697 1.74 . . . . 0.0 115.697 172.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 38.4 ttmt -61.44 -47.55 85.22 Favored 'General case' 0 CA--C 1.569 1.674 0 N-CA-C 114.412 1.264 . . . . 0.0 114.412 167.506 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 60.1 m -58.67 -36.15 73.71 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 116.412 2.004 . . . . 0.0 116.412 171.617 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 33.4 mt -63.05 -43.91 97.33 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 116.178 1.918 . . . . 0.0 116.178 166.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 120.22 71.1 0.32 Allowed Glycine 0 N--CA 1.483 1.781 0 C-N-CA 123.79 0.71 . . . . 0.0 111.588 -176.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 23.9 t -142.24 120.88 8.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 N-CA-C 105.166 -2.161 . . . . 0.0 105.166 -176.452 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -78.92 -86.48 0.52 Allowed Glycine 0 N--CA 1.488 2.129 0 N-CA-C 115.859 1.104 . . . . 0.0 115.859 -169.23 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 15.2 p90 -139.36 160.3 40.15 Favored 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 123.498 0.719 . . . . 0.0 110.767 178.605 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . 0.313 . . 76.41 -50.91 0.59 Allowed 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 115.386 1.625 . . . . 0.0 115.386 177.68 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 52.8 m -64.92 -39.86 94.16 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 113.964 1.098 . . . . 0.0 113.964 167.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 38.0 mtm180 -61.34 -43.59 98.62 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 115.063 1.505 . . . . 0.0 115.063 166.073 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 7.4 tm0? -61.74 -49.09 77.8 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 115.403 1.631 . . . . 0.0 115.403 174.074 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 97.2 t -64.56 -41.11 91.32 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 CA-C-N 119.503 1.047 . . . . 0.0 113.207 177.227 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -67.72 -40.71 84.23 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 116.504 2.038 . . . . 0.0 116.504 176.251 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 95.2 p -66.79 -39.42 87.77 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 116.332 1.975 . . . . 0.0 116.332 169.549 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 54.5 tpp -64.97 -37.21 86.91 Favored 'General case' 0 CA--C 1.569 1.7 0 N-CA-C 115.992 1.849 . . . . 0.0 115.992 169.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 54.4 m -69.96 145.88 51.55 Favored 'General case' 0 CA--C 1.566 1.589 0 C-N-CA 124.047 0.939 . . . . 0.0 111.79 174.649 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -103.12 100.73 18.28 Favored Pre-proline 0 CA--C 1.57 1.742 0 CA-C-O 118.143 -0.932 . . . . 0.0 109.147 173.224 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -81.82 100.67 1.11 Allowed 'Trans proline' 0 C--N 1.371 1.727 0 C-N-CA 123.027 2.485 . . . . 0.0 111.649 -179.379 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 99.8 m -79.15 112.95 16.87 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 123.522 0.729 . . . . 0.0 110.228 -168.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 46.5 m -87.28 114.78 24.19 Favored 'General case' 0 CA--C 1.561 1.395 0 C-N-CA 123.557 0.743 . . . . 0.0 109.147 -174.137 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 98.3 mt -108.75 108.45 25.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 N-CA-C 106.356 -1.72 . . . . 0.0 106.356 176.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 18.8 mt -101.72 120.3 51.16 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 -178.718 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 6.8 tm-20 -133.24 116.48 16.25 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 -172.233 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 80.7 tttt -93.62 114.97 27.42 Favored 'General case' 0 CA--C 1.557 1.243 0 C-N-CA 123.335 0.654 . . . . 0.0 110.374 176.523 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 23.8 t30 -86.78 -70.59 0.6 Allowed 'General case' 0 N--CA 1.492 1.628 0 C-N-CA 123.043 0.537 . . . . 0.0 111.026 178.307 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -143.11 75.92 0.31 Allowed Glycine 0 N--CA 1.487 2.068 0 N-CA-C 110.522 -1.031 . . . . 0.0 110.522 170.039 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . 0.284 6.3 t70 49.43 48.21 21.51 Favored 'General case' 0 N--CA 1.497 1.924 0 N-CA-C 115.518 1.673 . . . . 0.0 115.518 -155.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 31.0 mm -134.51 99.9 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 N-CA-C 103.589 -2.745 . . . . 0.0 103.589 178.47 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 65.2 mt -88.11 101.49 13.85 Favored 'General case' 0 N--CA 1.481 1.097 0 CA-C-O 121.281 0.562 . . . . 0.0 110.039 -177.614 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 91.1 m -94.46 97.02 9.87 Favored 'General case' 0 N--CA 1.485 1.29 0 N-CA-C 106.973 -1.492 . . . . 0.0 106.973 -176.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 9.8 tt -99.22 99.56 10.55 Favored 'General case' 0 N--CA 1.484 1.246 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 -174.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -96.6 126.65 41.93 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 123.782 0.833 . . . . 0.0 109.166 -175.675 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 28.0 m -102.63 93.7 5.25 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.134 -1.062 . . . . 0.0 108.134 -175.619 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 16.8 m-70 -86.25 104.33 15.69 Favored 'General case' 0 N--CA 1.491 1.591 0 CA-C-O 121.451 0.643 . . . . 0.0 109.709 -173.03 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 23.1 t -144.5 142.03 29.96 Favored 'General case' 0 N--CA 1.483 1.183 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.274 -161.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . 0.294 13.9 t -82.33 64.83 7.18 Favored 'General case' 0 N--CA 1.499 2.024 0 CA-C-O 122.552 1.167 . . . . 0.0 111.735 160.516 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 88.0 t80 -166.13 -70.16 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 106.78 -1.563 . . . . 0.0 106.78 -176.433 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 14.7 tptp -153.74 130.26 10.66 Favored 'General case' 0 CA--C 1.558 1.284 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 179.353 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 53.6 m-80 -92.94 91.48 7.42 Favored 'General case' 0 N--CA 1.491 1.582 0 CA-C-O 121.052 0.453 . . . . 0.0 110.076 175.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 73.9 p -98.41 132.17 44.08 Favored 'General case' 0 N--CA 1.493 1.709 0 C-N-CA 123.417 0.687 . . . . 0.0 110.603 -177.013 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -123.87 123.57 40.73 Favored 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 123.674 0.79 . . . . 0.0 109.067 -176.714 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 40.8 pt -118.74 132.01 69.86 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 174.467 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 46.1 t -120.6 111.11 17.24 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 -177.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 50.4 p90 -140.94 140.72 34.48 Favored 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 115.119 1.525 . . . . 0.0 115.119 -160.015 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 63.6 mtpt -106.25 17.62 23.2 Favored 'General case' 0 CA--C 1.573 1.852 0 N-CA-C 117.011 2.226 . . . . 0.0 117.011 -172.608 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . 0.294 0.1 OUTLIER 60.35 92.7 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.736 0 CA-C-N 120.546 1.521 . . . . 0.0 114.292 177.981 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 92.68 38.73 5.46 Favored Glycine 0 CA--C 1.551 2.295 0 N-CA-C 116.863 1.505 . . . . 0.0 116.863 -167.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 86.6 t -140.06 122.7 16.68 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 N-CA-C 106.93 -1.507 . . . . 0.0 106.93 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -87.62 133.27 33.84 Favored 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 123.299 0.64 . . . . 0.0 111.136 173.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 47.5 p90 -145.56 133.72 21.6 Favored 'General case' 0 N--CA 1.493 1.682 0 C-N-CA 123.888 0.875 . . . . 0.0 109.306 -175.082 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -76.35 142.66 41.14 Favored 'General case' 0 N--CA 1.49 1.54 0 CA-C-O 123.028 1.394 . . . . 0.0 112.117 176.211 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 15.4 tp10 -146.54 138.91 25.04 Favored 'General case' 0 N--CA 1.488 1.444 0 CA-C-N 113.18 -1.827 . . . . 0.0 110.351 -167.053 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 55.7 m -97.18 121.96 39.65 Favored 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 123.281 0.633 . . . . 0.0 109.424 177.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 25.1 p -86.39 170.54 11.9 Favored 'General case' 0 N--CA 1.495 1.815 0 CA-C-O 121.894 0.854 . . . . 0.0 113.128 -173.565 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -58.77 -34.23 71.21 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 118.627 2.825 . . . . 0.0 118.627 173.267 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.425 ' N ' ' HD2' ' A' ' 76' ' ' ASP . 1.0 OUTLIER -101.57 54.72 0.82 Allowed 'General case' 0 CA--C 1.574 1.886 0 CA-C-N 119.327 0.967 . . . . 0.0 110.847 168.038 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 15.3 t70 34.89 80.75 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 117.827 2.528 . . . . 0.0 117.827 178.015 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 60.5 mtm-85 -141.45 130.41 23.16 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 110.165 -0.309 . . . . 0.0 110.165 177.497 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.04 121.24 16.27 Favored 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 122.878 0.471 . . . . 0.0 110.493 158.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 16.3 m -137.89 132.24 43.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 -176.013 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -85.29 104.01 14.75 Favored 'General case' 0 N--CA 1.486 1.336 0 CA-C-O 121.882 0.849 . . . . 0.0 109.265 177.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 53.3 m -92.52 97.7 10.99 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 124.353 1.061 . . . . 0.0 110.946 -170.668 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 6.8 tp -107.65 118.79 56.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 175.3 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 1.5 p -136.84 132.61 47.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 C-N-CA 123.677 0.791 . . . . 0.0 109.298 -169.708 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 13.1 t -146.82 159.02 44.03 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-O 122.738 1.256 . . . . 0.0 110.545 178.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 17.5 tp -89.3 106.36 18.4 Favored 'General case' 0 CA--C 1.561 1.403 0 CA-C-N 114.81 -1.086 . . . . 0.0 108.871 173.611 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -105.43 94.09 5.03 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 123.493 0.717 . . . . 0.0 109.534 -177.472 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 60.97 49.59 76.88 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 117.506 1.762 . . . . 0.0 117.506 -178.699 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 69.59 18.96 74.31 Favored Glycine 0 CA--C 1.557 2.663 0 N-CA-C 119.158 2.423 . . . . 0.0 119.158 -168.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 38.7 mtmm -127.96 117.77 22.34 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 -178.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 4.5 tt -82.82 99.36 9.65 Favored 'General case' 0 CA--C 1.563 1.468 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 -177.051 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 55.0 t -103.61 108.49 24.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 N-CA-C 106.748 -1.575 . . . . 0.0 106.748 -169.175 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 19.9 t-160 -108.83 107.14 17.44 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 123.447 0.699 . . . . 0.0 110.054 179.201 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 42.5 tp -96.84 122.99 40.41 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 123.523 0.729 . . . . 0.0 109.262 177.201 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 30.2 mt-30 -113.88 113.88 25.48 Favored 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 107.54 -1.281 . . . . 0.0 107.54 175.521 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.59 145.0 41.14 Favored 'General case' 0 N--CA 1.493 1.725 0 C-N-CA 123.223 0.609 . . . . 0.0 111.574 178.92 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 32.9 p90 -155.55 111.03 3.03 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 123.355 0.662 . . . . 0.0 110.012 -177.454 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . 0.336 12.1 t70 69.0 -96.08 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.854 0 C-N-CA 124.438 1.095 . . . . 0.0 112.484 173.591 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -132.85 56.3 0.74 Allowed Glycine 0 CA--C 1.547 2.067 0 CA-C-N 118.424 0.557 . . . . 0.0 113.066 162.234 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 46.7 mt-30 -154.83 124.61 6.58 Favored 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 106.936 -1.505 . . . . 0.0 106.936 -174.166 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -132.52 144.25 50.3 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.886 -0.509 . . . . 0.0 112.301 178.285 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 6.2 t -130.27 126.71 37.93 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 122.815 0.446 . . . . 0.0 111.115 171.538 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 40.0 p -94.1 128.87 40.75 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 121.982 0.896 . . . . 0.0 110.577 170.487 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 5.7 mp -103.94 88.32 3.0 Favored 'General case' 0 CA--C 1.558 1.256 0 N-CA-C 106.637 -1.616 . . . . 0.0 106.637 175.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 81.0 t -93.54 97.94 7.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 N-CA-C 107.354 -1.35 . . . . 0.0 107.354 -169.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 78.4 mtt85 -91.42 127.62 36.93 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 123.367 0.667 . . . . 0.0 109.579 177.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -148.06 133.36 18.48 Favored 'General case' 0 N--CA 1.493 1.719 0 CA-C-O 120.82 0.343 . . . . 0.0 111.284 -176.078 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -79.66 114.15 18.36 Favored 'General case' 0 N--CA 1.487 1.41 0 CA-C-O 121.318 0.58 . . . . 0.0 111.442 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 90.4 mt -122.7 109.08 22.92 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 N-CA-C 104.534 -2.395 . . . . 0.0 104.534 176.189 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 23.4 m-20 59.19 48.98 9.72 Favored 'General case' 0 N--CA 1.5 2.029 0 N-CA-C 114.934 1.457 . . . . 0.0 114.934 177.608 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 62.74 24.4 66.35 Favored Glycine 0 CA--C 1.555 2.545 0 N-CA-C 119.555 2.582 . . . . 0.0 119.555 -170.306 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 59.9 mtmt -130.97 131.21 44.25 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-N 119.589 1.695 . . . . 0.0 108.863 -174.005 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 15.7 tp -77.98 107.61 10.64 Favored 'General case' 0 CA--C 1.558 1.276 0 CA-C-O 121.42 0.629 . . . . 0.0 109.676 178.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 32.7 mm -99.33 98.87 7.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 N-CA-C 106.432 -1.692 . . . . 0.0 106.432 -175.466 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 32.3 tp -88.71 103.41 15.93 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 123.976 0.91 . . . . 0.0 109.352 179.088 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 88.1 m -98.96 108.33 20.98 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 -177.169 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 67.1 mt -100.62 101.48 12.39 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 123.705 0.802 . . . . 0.0 109.436 -171.663 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 6.9 m -113.89 111.91 22.49 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 -175.57 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 70.5 t60 -102.95 -85.32 0.45 Allowed 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 173.617 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -109.56 -108.99 3.21 Favored Glycine 0 N--CA 1.484 1.872 0 N-CA-C 110.635 -0.986 . . . . 0.0 110.635 178.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 45.4 m -100.93 66.34 1.15 Allowed 'General case' 0 N--CA 1.494 1.757 0 CA-C-O 121.348 0.594 . . . . 0.0 109.593 173.408 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -172.8 96.1 0.13 Allowed 'General case' 0 N--CA 1.484 1.237 0 N-CA-C 108.123 -1.065 . . . . 0.0 108.123 173.279 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 3.7 p -94.68 122.55 46.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 C-N-CA 123.482 0.713 . . . . 0.0 109.61 174.253 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 44.4 t -108.21 102.11 11.27 Favored 'General case' 0 CA--C 1.553 1.067 0 CA-C-O 121.455 0.645 . . . . 0.0 111.356 179.384 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 90.6 m -88.12 108.0 19.04 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 179.379 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 35.9 mtm180 -111.42 120.05 40.88 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 123.044 0.538 . . . . 0.0 110.394 -172.657 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 94.8 m -86.28 131.17 34.29 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 123.343 0.657 . . . . 0.0 110.309 178.552 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 40.9 m-85 -125.84 125.48 42.93 Favored 'General case' 0 CA--C 1.56 1.354 0 C-N-CA 123.566 0.746 . . . . 0.0 109.035 176.443 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -92.72 158.34 15.97 Favored 'General case' 0 N--CA 1.495 1.816 0 CA-C-O 122.345 1.069 . . . . 0.0 111.849 170.287 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 73.5 tttt -91.16 125.97 36.1 Favored 'General case' 0 N--CA 1.484 1.256 0 CA-C-N 115.512 -0.767 . . . . 0.0 112.46 -165.447 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -97.86 46.74 1.01 Allowed 'General case' 0 N--CA 1.495 1.788 0 C-N-CA 123.853 0.861 . . . . 0.0 112.896 166.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.152 0 CA-C-O 123.168 1.461 . . . . 0.0 108.312 -174.821 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.315 8.9 t . . . . . 0 N--CA 1.491 1.585 0 CA-C-O 117.625 -1.178 . . . . 0.0 113.394 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -60.03 -37.58 80.19 Favored 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 116.274 1.953 . . . . 0.0 116.274 -178.309 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -62.78 -28.89 70.3 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 117.252 2.316 . . . . 0.0 117.252 164.169 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -73.12 -25.09 60.72 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 116.131 1.9 . . . . 0.0 116.131 168.278 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 74.4 mt -73.25 108.42 6.12 Favored 'General case' 0 N--CA 1.49 1.56 0 CA-C-N 120.747 1.612 . . . . 0.0 111.381 -173.115 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 161.34 171.59 27.56 Favored Glycine 0 CA--C 1.538 1.509 0 CA-C-O 123.254 1.474 . . . . 0.0 113.892 -175.103 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 96.8 m -84.85 144.85 28.15 Favored 'General case' 0 N--CA 1.487 1.378 0 CA-C-N 113.531 -1.334 . . . . 0.0 110.004 172.436 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 84.4 m95 -140.4 113.35 8.27 Favored 'General case' 0 N--CA 1.483 1.222 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 -175.228 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 45.3 mtmt -102.91 141.43 35.72 Favored 'General case' 0 N--CA 1.492 1.648 0 CA-C-O 121.457 0.646 . . . . 0.0 110.104 173.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 55.7 tp -69.63 130.52 42.62 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-O 122.444 1.116 . . . . 0.0 113.244 -170.492 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . 0.272 1.6 t -110.38 -41.77 4.69 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.781 0 CA-C-N 113.512 -1.676 . . . . 0.0 111.818 -172.671 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -142.14 138.94 31.97 Favored 'General case' 0 N--CA 1.492 1.633 0 CA-C-N 120.249 1.386 . . . . 0.0 109.738 175.307 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 86.6 p -124.3 102.39 7.66 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 123.416 0.686 . . . . 0.0 110.832 176.33 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -101.09 127.2 47.74 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 123.207 0.603 . . . . 0.0 109.424 174.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 66.2 m-20 67.62 22.04 9.22 Favored 'General case' 0 N--CA 1.504 2.25 0 N-CA-C 117.813 2.523 . . . . 0.0 117.813 173.452 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -72.4 -38.47 68.42 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 115.905 1.817 . . . . 0.0 115.905 -175.4 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -58.41 -30.68 67.05 Favored 'General case' 0 N--CA 1.498 1.96 0 N-CA-C 116.477 2.028 . . . . 0.0 116.477 164.708 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 13.5 t0 -66.13 -50.93 62.29 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 114.28 1.215 . . . . 0.0 114.28 169.486 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 93.7 t80 -55.17 -50.33 69.59 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 115.296 1.591 . . . . 0.0 115.296 172.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 72.7 mtm -60.53 -44.43 96.07 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 114.992 1.478 . . . . 0.0 114.992 173.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 14.5 tmtt? -57.29 -45.16 84.39 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 115.611 1.708 . . . . 0.0 115.611 168.35 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 13.8 t -59.13 -37.75 78.0 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 116.473 2.027 . . . . 0.0 116.473 173.073 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 63.6 mt -66.58 -42.28 87.24 Favored 'General case' 0 CA--C 1.564 1.514 0 N-CA-C 116.451 2.019 . . . . 0.0 116.451 170.315 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 115.13 77.27 0.71 Allowed Glycine 0 N--CA 1.482 1.718 0 N-CA-C 110.73 -0.948 . . . . 0.0 110.73 -168.309 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 62.4 t -143.04 122.64 9.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 N-CA-C 105.103 -2.184 . . . . 0.0 105.103 -177.027 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -81.58 -164.3 32.9 Favored Glycine 0 CA--C 1.548 2.127 0 N-CA-C 116.25 1.26 . . . . 0.0 116.25 -177.321 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 83.6 t80 -67.22 145.56 55.08 Favored 'General case' 0 CA--C 1.566 1.588 0 C-N-CA 123.501 0.72 . . . . 0.0 112.608 177.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . 0.377 . . 79.83 -41.11 0.22 Allowed 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 116.364 1.987 . . . . 0.0 116.364 179.395 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 56.9 m -69.36 -40.79 77.28 Favored 'General case' 0 N--CA 1.501 2.076 0 CA-C-N 120.152 1.342 . . . . 0.0 113.374 162.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 72.0 mtp180 -50.49 -42.51 54.79 Favored 'General case' 0 N--CA 1.498 1.946 0 N-CA-C 116.073 1.879 . . . . 0.0 116.073 160.022 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 81.4 mt-30 -76.41 -48.98 17.93 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 115.033 1.494 . . . . 0.0 115.033 -178.239 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 58.7 t -63.8 -43.16 97.83 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 CA-C-N 119.534 1.061 . . . . 0.0 112.922 178.004 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -65.35 -37.83 88.25 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 116.625 2.083 . . . . 0.0 116.625 174.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 90.5 p -62.46 -42.4 99.45 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 116.355 1.983 . . . . 0.0 116.355 170.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 19.2 ptp -74.23 -31.26 62.53 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 117.163 2.283 . . . . 0.0 117.163 173.172 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 65.7 m -77.96 144.31 36.89 Favored 'General case' 0 N--CA 1.491 1.577 0 CA-C-N 119.184 0.902 . . . . 0.0 111.743 -173.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 17.7 ptpt -98.25 104.97 25.86 Favored Pre-proline 0 CA--C 1.572 1.799 0 CA-C-O 118.431 -0.795 . . . . 0.0 111.591 170.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -78.06 112.98 3.34 Favored 'Trans proline' 0 CA--C 1.563 1.944 0 C-N-CA 123.056 2.504 . . . . 0.0 112.671 178.709 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 94.6 m -72.5 104.38 3.81 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 124.975 1.31 . . . . 0.0 110.1 175.563 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 29.7 m -106.65 118.26 36.21 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.844 -0.535 . . . . 0.0 110.142 -173.011 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 4.5 mp -106.71 112.95 41.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 -177.366 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 52.9 mt -99.05 119.11 46.61 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 N-CA-C 106.938 -1.504 . . . . 0.0 106.938 172.505 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -137.86 123.94 20.3 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 -178.23 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 36.8 ttpt -84.0 116.57 22.89 Favored 'General case' 0 CA--C 1.559 1.31 0 C-N-CA 123.124 0.57 . . . . 0.0 111.201 179.27 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -107.93 73.52 0.9 Allowed 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 123.6 0.76 . . . . 0.0 109.051 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 62.66 69.34 1.34 Allowed Glycine 0 N--CA 1.49 2.264 0 N-CA-C 115.312 0.885 . . . . 0.0 115.312 -173.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . 0.278 10.5 m-20 64.81 -2.99 0.61 Allowed 'General case' 0 N--CA 1.501 2.093 0 N-CA-C 118.299 2.703 . . . . 0.0 118.299 -168.629 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 42.5 mm -99.27 99.44 8.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 N-CA-C 107.105 -1.443 . . . . 0.0 107.105 -177.044 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 40.7 mt -77.55 106.99 9.69 Favored 'General case' 0 N--CA 1.488 1.429 0 CA-C-O 121.487 0.66 . . . . 0.0 111.12 178.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 34.1 m -100.75 94.54 6.13 Favored 'General case' 0 CA--C 1.559 1.319 0 N-CA-C 107.084 -1.451 . . . . 0.0 107.084 -171.128 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 8.8 tt -92.22 107.93 19.57 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 -177.484 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 52.6 mttp -107.64 93.53 4.59 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 -169.103 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 42.1 m -84.14 92.63 7.96 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.718 -0.614 . . . . 0.0 109.658 -178.283 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 28.9 m170 -88.93 121.36 31.21 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 124.005 0.922 . . . . 0.0 109.214 -179.441 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 13.6 t -137.39 159.21 42.58 Favored 'General case' 0 N--CA 1.49 1.548 0 CA-C-O 121.657 0.742 . . . . 0.0 110.876 -176.6 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 27.3 m -80.99 69.92 7.69 Favored 'General case' 0 N--CA 1.498 1.969 0 CA-C-O 122.099 0.952 . . . . 0.0 110.103 170.424 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 33.4 t80 170.96 -60.2 0.01 OUTLIER 'General case' 0 CA--C 1.571 1.778 0 C-N-CA 126.594 1.957 . . . . 0.0 107.506 -168.149 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.42 142.95 25.38 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 124.311 1.044 . . . . 0.0 111.006 -172.061 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 8.1 m-20 -120.35 110.82 16.99 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 107.921 -1.141 . . . . 0.0 107.921 172.009 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 35.8 p -122.91 133.11 54.41 Favored 'General case' 0 N--CA 1.495 1.806 0 C-N-CA 123.357 0.663 . . . . 0.0 110.832 -176.086 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -112.82 126.14 55.12 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 124.138 0.975 . . . . 0.0 109.222 179.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 12.0 pt -122.33 129.97 74.89 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 178.201 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 85.4 p -114.39 124.0 50.87 Favored 'General case' 0 N--CA 1.493 1.701 0 C-N-CA 123.635 0.774 . . . . 0.0 110.786 -173.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 41.8 p90 -146.41 139.12 25.35 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 116.069 1.877 . . . . 0.0 116.069 -168.631 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 57.1 mtmt -106.41 24.29 12.79 Favored 'General case' 0 N--CA 1.498 1.951 0 N-CA-C 116.518 2.044 . . . . 0.0 116.518 -178.371 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . 0.275 2.4 mp 61.95 92.43 0.06 Allowed 'General case' 0 N--CA 1.496 1.867 0 CA-C-N 120.904 1.684 . . . . 0.0 115.05 170.609 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 81.97 37.17 16.54 Favored Glycine 0 CA--C 1.55 2.28 0 N-CA-C 116.984 1.553 . . . . 0.0 116.984 -169.424 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 65.4 t -139.29 117.46 12.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 N-CA-C 105.534 -2.024 . . . . 0.0 105.534 -179.432 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -78.8 124.44 28.21 Favored 'General case' 0 N--CA 1.489 1.475 0 CA-C-O 121.415 0.626 . . . . 0.0 111.155 -179.638 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 14.9 p90 -127.07 134.1 50.33 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 124.393 1.077 . . . . 0.0 110.016 -176.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -72.05 137.23 47.01 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 112.873 0.694 . . . . 0.0 112.873 177.169 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -136.94 132.57 34.59 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 122.987 0.515 . . . . 0.0 110.518 -162.649 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 61.3 m -100.0 128.57 46.07 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 166.436 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 60.4 p -81.25 174.73 11.25 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 113.748 1.018 . . . . 0.0 113.748 -170.395 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -45.06 -37.15 3.97 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 118.591 2.811 . . . . 0.0 118.591 162.122 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -130.95 91.09 2.99 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 106.547 -1.649 . . . . 0.0 106.547 166.284 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -8.05 99.77 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.098 0 N-CA-C 119.301 3.074 . . . . 0.0 119.301 -175.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 3.3 ttm180 -136.27 13.68 3.28 Favored 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 116.961 2.208 . . . . 0.0 116.961 -175.046 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . 0.318 0.0 OUTLIER 42.93 77.04 0.07 Allowed 'General case' 0 N--CA 1.498 1.963 0 N-CA-C 116.898 2.185 . . . . 0.0 116.898 172.129 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 11.0 m -117.68 144.86 24.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 C-N-CA 123.378 0.671 . . . . 0.0 110.145 -166.576 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -96.35 102.65 14.46 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 178.497 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.52 ' HG ' ' HG2' ' A' ' 95' ' ' GLN . 58.0 m -90.41 125.79 35.67 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 123.401 0.68 . . . . 0.0 112.024 -171.364 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 6.2 tp -137.7 108.89 5.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 179.296 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -118.26 131.02 72.24 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 C-N-CA 124.558 1.143 . . . . 0.0 109.183 177.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 14.6 t -135.12 154.42 51.66 Favored 'General case' 0 N--CA 1.492 1.674 0 CA-C-O 122.777 1.275 . . . . 0.0 111.848 171.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 15.6 tp -88.56 113.3 23.99 Favored 'General case' 0 N--CA 1.487 1.419 0 CA-C-N 114.339 -1.3 . . . . 0.0 110.166 177.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -115.79 81.8 1.66 Allowed 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 123.42 0.688 . . . . 0.0 109.921 -176.195 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 62.65 48.58 80.38 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 117.299 1.68 . . . . 0.0 117.299 -175.06 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 74.28 44.06 29.68 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 117.446 1.739 . . . . 0.0 117.446 -171.155 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 40.5 ttpt -154.38 108.25 2.95 Favored 'General case' 0 CA--C 1.552 1.047 0 N-CA-C 106.549 -1.649 . . . . 0.0 106.549 -172.298 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 41.4 mt -81.72 96.86 7.68 Favored 'General case' 0 N--CA 1.491 1.579 0 CA-C-O 122.625 1.202 . . . . 0.0 110.109 175.526 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 96.2 t -87.81 98.57 7.68 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.235 0 CA-C-N 113.293 -1.776 . . . . 0.0 106.32 -178.477 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 22.4 t-160 -95.27 139.34 31.73 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 123.533 0.733 . . . . 0.0 109.818 177.262 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 20.5 tp -135.73 118.7 16.34 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 106.701 -1.592 . . . . 0.0 106.701 178.356 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . 0.52 ' HG2' ' HG ' ' A' ' 82' ' ' SER . 28.7 mt-30 -114.01 125.96 54.59 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 176.229 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -139.71 128.28 23.02 Favored 'General case' 0 N--CA 1.494 1.769 0 CA-C-N 118.685 0.675 . . . . 0.0 112.743 -165.402 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 21.4 p90 -151.32 115.8 5.11 Favored 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 123.908 0.883 . . . . 0.0 110.699 -167.178 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . 0.341 18.1 t70 67.96 -93.32 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.886 0 C-N-CA 124.766 1.226 . . . . 0.0 112.883 171.146 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -135.28 52.11 0.81 Allowed Glycine 0 CA--C 1.546 2.014 0 CA-C-O 119.743 -0.476 . . . . 0.0 113.887 163.159 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 15.6 mt-30 -151.02 131.29 13.61 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 176.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -133.42 116.2 15.74 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 123.089 0.556 . . . . 0.0 110.27 179.364 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 1.8 t -110.33 124.36 51.54 Favored 'General case' 0 N--CA 1.492 1.636 0 C-N-CA 123.265 0.626 . . . . 0.0 109.988 -178.523 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 35.6 p -100.72 137.95 38.43 Favored 'General case' 0 N--CA 1.492 1.633 0 CA-C-O 121.213 0.53 . . . . 0.0 111.244 179.38 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 5.0 mp -121.4 79.5 1.55 Allowed 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 -178.292 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 46.4 t -93.2 112.42 26.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 -165.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 45.3 mtt180 -102.71 129.42 49.32 Favored 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 122.854 0.462 . . . . 0.0 110.745 -177.589 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -148.83 139.33 22.58 Favored 'General case' 0 N--CA 1.494 1.744 0 C-N-CA 123.061 0.544 . . . . 0.0 111.97 178.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -83.7 113.97 21.25 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 123.094 0.558 . . . . 0.0 111.727 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 1.7 mp -103.79 102.02 13.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 N-CA-C 104.688 -2.338 . . . . 0.0 104.688 170.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 53.75 50.41 17.07 Favored 'General case' 0 N--CA 1.499 1.987 0 N-CA-C 115.257 1.577 . . . . 0.0 115.257 176.232 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 88.55 -37.93 3.25 Favored Glycine 0 CA--C 1.552 2.396 0 N-CA-C 117.857 1.903 . . . . 0.0 117.857 -169.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 10.4 mtmp? -85.93 127.45 34.62 Favored 'General case' 0 N--CA 1.487 1.377 0 CA-C-N 119.336 1.568 . . . . 0.0 111.08 -172.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 2.6 tt -80.14 118.77 22.13 Favored 'General case' 0 CA--C 1.556 1.202 0 CA-C-O 121.823 0.821 . . . . 0.0 111.082 -179.584 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 39.2 mm -100.91 108.81 23.99 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.347 0 N-CA-C 106.324 -1.732 . . . . 0.0 106.324 -178.502 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 47.2 tp -91.19 101.53 14.26 Favored 'General case' 0 CA--C 1.56 1.363 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 173.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 58.2 m -93.8 109.13 20.82 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 -177.622 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 62.7 mt -103.72 83.87 2.2 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 123.339 0.656 . . . . 0.0 110.372 -169.59 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 8.5 m -95.97 116.59 29.17 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.617 -0.677 . . . . 0.0 109.949 -170.173 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 85.0 t60 -146.49 115.9 7.09 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 176.342 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 75.82 -109.45 2.79 Favored Glycine 0 N--CA 1.484 1.86 0 C-N-CA 122.96 0.314 . . . . 0.0 113.538 173.675 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 14.9 t -129.82 55.09 1.8 Allowed 'General case' 0 N--CA 1.495 1.812 0 CA-C-O 121.405 0.621 . . . . 0.0 111.078 163.213 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -154.36 89.2 1.26 Allowed 'General case' 0 N--CA 1.483 1.177 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 177.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 5.6 p -92.96 117.93 37.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 C-N-CA 123.276 0.631 . . . . 0.0 110.004 176.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 44.2 t -99.98 104.39 16.0 Favored 'General case' 0 CA--C 1.553 1.093 0 CA-C-O 121.443 0.639 . . . . 0.0 111.419 175.302 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 57.5 m -92.02 110.18 21.54 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 -178.621 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 21.5 mtm105 -115.17 114.53 25.39 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 123.163 0.585 . . . . 0.0 110.561 -171.022 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 90.8 m -84.55 140.34 31.49 Favored 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 123.714 0.806 . . . . 0.0 110.987 -178.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 42.0 m-85 -133.98 135.92 43.78 Favored 'General case' 0 CA--C 1.559 1.298 0 C-N-CA 124.079 0.952 . . . . 0.0 109.903 -178.365 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -99.47 152.63 19.78 Favored 'General case' 0 N--CA 1.495 1.814 0 CA-C-O 122.058 0.932 . . . . 0.0 111.315 166.093 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 65.6 tttt -82.78 120.47 25.67 Favored 'General case' 0 N--CA 1.486 1.365 0 CA-C-N 115.465 -0.789 . . . . 0.0 111.19 -173.19 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 59.0 mm-40 -114.49 53.89 0.79 Allowed 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 124.073 0.949 . . . . 0.0 111.552 -172.205 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.894 0 CA-C-O 124.414 2.054 . . . . 0.0 108.956 -170.66 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.255 4.4 p . . . . . 0 CA--C 1.575 1.935 0 N-CA-C 116.141 1.904 . . . . 0.0 116.141 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -67.36 -39.61 85.74 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 116.385 1.995 . . . . 0.0 116.385 -177.011 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -59.59 -28.2 66.94 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 117.408 2.373 . . . . 0.0 117.408 167.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -68.21 -27.19 66.16 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 116.207 1.929 . . . . 0.0 116.207 166.568 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 79.9 mt -71.91 116.85 12.78 Favored 'General case' 0 N--CA 1.489 1.52 0 CA-C-N 120.967 1.712 . . . . 0.0 112.436 -170.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 159.41 173.36 27.76 Favored Glycine 0 CA--C 1.543 1.842 0 CA-C-O 122.484 1.047 . . . . 0.0 113.557 -178.597 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 53.9 m -85.19 141.08 30.41 Favored 'General case' 0 N--CA 1.493 1.714 0 CA-C-N 114.719 -0.74 . . . . 0.0 109.378 167.102 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 88.2 m95 -140.53 113.51 8.33 Favored 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 -174.046 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -100.69 150.01 23.19 Favored 'General case' 0 N--CA 1.496 1.863 0 CA-C-O 121.23 0.538 . . . . 0.0 110.554 176.047 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 22.5 tp -68.15 129.49 40.07 Favored 'General case' 0 N--CA 1.491 1.595 0 CA-C-O 121.932 0.872 . . . . 0.0 113.072 -174.437 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . 0.283 0.9 OUTLIER -105.05 -46.96 9.41 Favored 'Isoleucine or valine' 0 CA--C 1.576 1.967 0 CA-C-N 114.156 -1.384 . . . . 0.0 111.184 173.918 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -139.7 143.84 37.27 Favored 'General case' 0 N--CA 1.492 1.627 0 CA-C-N 119.754 1.161 . . . . 0.0 109.712 179.472 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 95.4 p -137.35 96.45 3.27 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.668 -0.645 . . . . 0.0 110.248 166.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -91.55 126.59 36.68 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 123.413 0.685 . . . . 0.0 109.679 177.385 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.27 62.6 m-20 69.45 37.17 2.05 Favored 'General case' 0 N--CA 1.502 2.174 0 N-CA-C 116.105 1.891 . . . . 0.0 116.105 -176.068 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 47.3 t80 -69.22 -59.56 2.93 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.759 -1.213 . . . . 0.0 112.8 175.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -45.91 -45.68 15.52 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 118.376 2.732 . . . . 0.0 118.376 171.076 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -61.12 -46.81 89.07 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 115.07 1.507 . . . . 0.0 115.07 172.516 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 87.2 t80 -55.84 -49.61 72.83 Favored 'General case' 0 CA--C 1.573 1.857 0 N-CA-C 115.025 1.491 . . . . 0.0 115.025 169.388 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 19.3 mmt -63.78 -44.61 92.85 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 114.829 1.418 . . . . 0.0 114.829 177.719 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 21.1 tptm -60.96 -37.65 83.17 Favored 'General case' 0 CA--C 1.571 1.753 0 N-CA-C 116.18 1.918 . . . . 0.0 116.18 167.67 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 17.1 t -58.85 -41.12 86.23 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 115.74 1.756 . . . . 0.0 115.74 169.47 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 79.1 mt -62.37 -44.3 96.79 Favored 'General case' 0 CA--C 1.568 1.641 0 N-CA-C 115.898 1.814 . . . . 0.0 115.898 166.315 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 123.63 65.24 0.2 Allowed Glycine 0 N--CA 1.483 1.813 0 C-N-CA 124.173 0.892 . . . . 0.0 111.991 -175.388 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 24.2 t -144.45 112.11 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 N-CA-C 105.084 -2.191 . . . . 0.0 105.084 -174.445 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -96.5 -100.27 1.93 Allowed Glycine 0 N--CA 1.484 1.834 0 N-CA-C 113.694 0.238 . . . . 0.0 113.694 -173.323 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 69.3 t80 -96.16 143.38 27.33 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 123.511 0.725 . . . . 0.0 111.784 -173.023 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . 0.352 . . 80.87 -51.04 0.31 Allowed 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 116.494 2.035 . . . . 0.0 116.494 168.516 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 91.8 m -70.28 -40.51 74.28 Favored 'General case' 0 N--CA 1.498 1.974 0 N-CA-C 113.938 1.088 . . . . 0.0 113.938 171.657 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 51.6 ttp180 -58.13 -41.04 82.78 Favored 'General case' 0 CA--C 1.572 1.818 0 N-CA-C 114.99 1.478 . . . . 0.0 114.99 164.457 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 42.9 mt-30 -73.94 -47.25 38.88 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 115.583 1.698 . . . . 0.0 115.583 178.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 81.3 t -63.84 -42.79 97.02 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.168 0 CA-C-N 120.01 1.277 . . . . 0.0 113.158 176.582 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -68.02 -31.61 71.42 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 117.052 2.242 . . . . 0.0 117.052 173.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 82.2 p -67.35 -39.38 85.73 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 115.889 1.811 . . . . 0.0 115.889 167.43 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 47.3 ttm -65.72 -41.7 91.96 Favored 'General case' 0 CA--C 1.566 1.575 0 N-CA-C 115.816 1.784 . . . . 0.0 115.816 175.595 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 5.9 t -81.0 165.73 21.45 Favored 'General case' 0 N--CA 1.493 1.686 0 CA-C-N 118.949 0.795 . . . . 0.0 112.933 178.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.17 105.68 33.9 Favored Pre-proline 0 CA--C 1.57 1.713 0 CA-C-O 118.093 -0.956 . . . . 0.0 110.127 172.54 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -80.76 99.77 1.16 Allowed 'Trans proline' 0 CA--C 1.558 1.715 0 C-N-CA 122.656 2.237 . . . . 0.0 112.308 -179.597 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 97.4 m -80.83 118.24 22.18 Favored 'General case' 0 N--CA 1.487 1.419 0 CA-C-N 115.417 -0.811 . . . . 0.0 110.934 -165.429 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 79.3 m -90.9 117.24 29.35 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 178.519 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 5.2 mp -108.41 109.29 27.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 N-CA-C 106.32 -1.733 . . . . 0.0 106.32 174.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 20.8 mt -100.49 117.35 45.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 N-CA-C 106.348 -1.723 . . . . 0.0 106.348 177.342 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -142.17 127.85 19.19 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.643 -0.661 . . . . 0.0 109.434 -170.386 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.68 156.1 32.83 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 113.972 1.101 . . . . 0.0 113.972 -178.727 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 25.9 t30 -141.91 74.74 1.46 Allowed 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 170.429 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 71.04 -102.23 1.05 Allowed Glycine 0 CA--C 1.546 1.991 0 O-C-N 122.119 -0.363 . . . . 0.0 112.732 -167.213 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 42.4 t0 -94.91 -20.76 19.13 Favored 'General case' 0 CA--C 1.573 1.86 0 N-CA-C 115.318 1.599 . . . . 0.0 115.318 166.816 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 18.6 mm -87.23 110.73 20.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 CA-C-N 120.542 1.519 . . . . 0.0 109.133 -169.081 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 30.7 mt -78.74 124.31 28.07 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 123.613 0.765 . . . . 0.0 111.935 176.275 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 86.7 m -109.19 99.48 8.76 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 106.922 -1.51 . . . . 0.0 106.922 179.532 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 9.7 tt -99.63 109.68 22.16 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 178.797 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -104.0 105.87 16.19 Favored 'General case' 0 N--CA 1.484 1.228 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 -179.187 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 48.8 m -89.02 95.26 10.25 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 174.441 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 22.0 m170 -76.9 175.58 9.38 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 124.132 0.973 . . . . 0.0 111.844 176.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 22.6 t -164.58 -25.89 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 115.069 1.507 . . . . 0.0 115.069 176.151 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . 0.296 6.7 m 62.59 50.44 3.54 Favored 'General case' 0 N--CA 1.504 2.264 0 CA-C-N 120.185 1.357 . . . . 0.0 111.978 -157.399 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 7.2 t80 -177.66 -67.73 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 106.082 -1.822 . . . . 0.0 106.082 -167.697 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.59 137.47 48.43 Favored 'General case' 0 CA--C 1.563 1.45 0 C-N-CA 124.064 0.946 . . . . 0.0 110.998 164.165 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 26.0 m-20 -119.78 104.17 9.99 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 173.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 60.4 p -106.59 131.98 53.13 Favored 'General case' 0 N--CA 1.496 1.865 0 C-N-CA 123.327 0.651 . . . . 0.0 110.952 -176.444 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 4.5 tm-20 -118.07 127.79 54.13 Favored 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 123.953 0.901 . . . . 0.0 110.081 -173.66 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 44.7 pt -116.94 132.76 65.74 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 C-N-CA 123.595 0.758 . . . . 0.0 109.267 172.196 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 73.5 p -116.2 112.95 22.38 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 176.397 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 40.2 p90 -144.35 146.33 32.49 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 114.498 1.295 . . . . 0.0 114.498 -161.331 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 57.6 mtmt -102.59 151.23 22.59 Favored 'General case' 0 N--CA 1.489 1.491 0 CA-C-N 115.133 -0.94 . . . . 0.0 109.126 159.146 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -74.15 115.95 14.23 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.66 -0.65 . . . . 0.0 111.709 -172.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 88.18 45.53 5.01 Favored Glycine 0 CA--C 1.55 2.225 0 N-CA-C 116.454 1.341 . . . . 0.0 116.454 -167.539 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 94.4 t -136.88 121.96 25.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 N-CA-C 107.024 -1.473 . . . . 0.0 107.024 178.086 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -87.97 125.73 34.68 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 123.05 0.54 . . . . 0.0 110.522 172.401 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 37.0 p90 -135.59 128.39 31.11 Favored 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 123.938 0.895 . . . . 0.0 109.026 -177.393 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -72.16 110.32 6.54 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.254 -0.904 . . . . 0.0 112.177 177.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 12.4 tp10 -109.9 129.13 55.69 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 123.804 0.842 . . . . 0.0 109.855 -169.314 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 67.6 m -96.91 118.87 34.27 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 175.635 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 38.8 p -88.2 168.33 12.84 Favored 'General case' 0 N--CA 1.49 1.54 0 CA-C-N 115.368 -0.833 . . . . 0.0 112.191 -172.612 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -62.2 -28.02 69.38 Favored 'General case' 0 CA--C 1.569 1.682 0 N-CA-C 117.154 2.279 . . . . 0.0 117.154 164.121 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -69.58 -1.22 8.21 Favored 'General case' 0 CA--C 1.58 2.105 0 N-CA-C 116.694 2.109 . . . . 0.0 116.694 164.247 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 65.32 67.31 0.51 Allowed 'General case' 0 N--CA 1.496 1.844 0 C-N-CA 125.449 1.5 . . . . 0.0 111.922 -176.183 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 38.9 ttp180 -148.2 117.49 6.9 Favored 'General case' 0 N--CA 1.485 1.307 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 -166.309 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -76.47 111.39 11.89 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 172.703 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 10.4 m -127.27 128.04 69.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 -172.241 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 47.5 mmtm -80.9 102.88 10.36 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 123.27 0.628 . . . . 0.0 109.526 -179.56 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 40.8 m -95.76 91.95 6.32 Favored 'General case' 0 N--CA 1.48 1.072 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.932 -167.077 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 6.1 tp -104.02 108.15 23.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 176.304 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 1.5 p -124.56 124.42 68.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 C-N-CA 123.851 0.861 . . . . 0.0 109.289 -173.28 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 9.8 t -138.53 152.78 48.52 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-O 122.467 1.127 . . . . 0.0 110.891 -178.794 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 35.3 tp -89.88 111.37 22.4 Favored 'General case' 0 N--CA 1.488 1.434 0 CA-C-N 114.85 -1.068 . . . . 0.0 109.394 174.099 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -104.61 81.99 1.85 Allowed 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 123.629 0.772 . . . . 0.0 110.266 -176.04 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 57.01 46.31 91.53 Favored Glycine 0 CA--C 1.551 2.327 0 N-CA-C 118.032 1.973 . . . . 0.0 118.032 -176.514 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 82.77 12.88 79.18 Favored Glycine 0 CA--C 1.557 2.681 0 N-CA-C 118.748 2.259 . . . . 0.0 118.748 -167.698 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 59.2 mtpt -125.2 103.88 8.21 Favored 'General case' 0 N--CA 1.487 1.394 0 CA-C-N 119.365 1.583 . . . . 0.0 106.799 177.825 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 5.5 tt -85.57 97.52 10.12 Favored 'General case' 0 CA--C 1.56 1.359 0 CA-C-O 122.013 0.911 . . . . 0.0 109.584 -174.824 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 71.6 t -96.37 110.47 24.7 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 N-CA-C 106.778 -1.564 . . . . 0.0 106.778 -170.308 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 20.1 t-160 -102.02 108.55 20.03 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 122.995 0.518 . . . . 0.0 109.697 173.681 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 40.8 tp -95.12 118.31 31.69 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 175.637 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 31.4 mt-30 -106.93 117.65 34.61 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 172.632 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 37.5 ttmt -124.76 127.37 47.11 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 123.195 0.598 . . . . 0.0 109.846 -172.617 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 32.3 p90 -145.93 114.76 6.89 Favored 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 123.241 0.616 . . . . 0.0 110.569 -174.575 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . 0.339 13.8 t70 67.04 -99.74 0.05 Allowed 'General case' 0 N--CA 1.494 1.751 0 C-N-CA 124.595 1.158 . . . . 0.0 112.403 173.01 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -128.61 50.54 0.89 Allowed Glycine 0 N--CA 1.487 2.04 0 CA-C-N 118.615 0.643 . . . . 0.0 114.197 163.216 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 14.1 mt-30 -150.65 128.85 11.95 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 177.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -137.09 130.79 31.79 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 123.139 0.576 . . . . 0.0 111.195 -176.756 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 7.1 t -121.88 129.3 52.47 Favored 'General case' 0 N--CA 1.495 1.809 0 C-N-CA 122.543 0.337 . . . . 0.0 111.486 176.129 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 39.7 p -99.31 124.62 44.55 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-O 121.755 0.788 . . . . 0.0 110.115 173.185 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 5.5 mp -100.91 88.27 3.51 Favored 'General case' 0 CA--C 1.559 1.29 0 N-CA-C 106.984 -1.487 . . . . 0.0 106.984 178.082 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 98.5 t -92.56 101.1 12.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 -168.102 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 77.7 mtt85 -96.47 125.44 40.96 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 123.221 0.608 . . . . 0.0 109.849 -178.309 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -144.95 128.17 16.73 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-O 120.847 0.356 . . . . 0.0 111.329 -172.367 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -82.42 115.64 21.53 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 123.144 0.577 . . . . 0.0 111.408 -177.245 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 96.1 mt -127.85 107.17 15.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 N-CA-C 104.993 -2.225 . . . . 0.0 104.993 179.701 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 23.4 m-20 58.08 52.76 7.32 Favored 'General case' 0 N--CA 1.5 2.063 0 N-CA-C 114.788 1.403 . . . . 0.0 114.788 176.523 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 63.15 21.21 63.7 Favored Glycine 0 CA--C 1.556 2.635 0 N-CA-C 119.734 2.653 . . . . 0.0 119.734 -171.258 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -128.92 127.54 41.96 Favored 'General case' 0 N--CA 1.488 1.445 0 CA-C-N 119.534 1.667 . . . . 0.0 108.51 -173.586 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 16.0 tp -79.33 109.99 14.19 Favored 'General case' 0 CA--C 1.557 1.236 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 176.751 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 32.5 mm -98.45 97.02 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 N-CA-C 106.467 -1.679 . . . . 0.0 106.467 -175.792 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 30.3 tp -87.23 103.96 15.93 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 124.003 0.921 . . . . 0.0 109.553 178.118 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 88.4 m -100.8 99.15 9.62 Favored 'General case' 0 CA--C 1.562 1.405 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 -177.408 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 71.0 mt -88.17 104.01 16.3 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 123.911 0.884 . . . . 0.0 109.672 -176.76 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 6.7 m -106.79 122.4 46.31 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.586 -0.696 . . . . 0.0 109.502 -171.83 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 77.8 t60 -148.15 113.5 5.59 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 173.797 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 74.89 -116.39 5.03 Favored Glycine 0 N--CA 1.484 1.883 0 C-N-CA 123.115 0.388 . . . . 0.0 113.849 173.083 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 15.2 t -119.22 53.45 1.02 Allowed 'General case' 0 N--CA 1.496 1.844 0 CA-C-O 121.271 0.557 . . . . 0.0 111.641 166.658 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -159.93 104.91 1.55 Allowed 'General case' 0 N--CA 1.483 1.203 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 175.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 7.4 p -111.24 125.89 68.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 C-N-CA 123.706 0.802 . . . . 0.0 110.113 -179.082 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 35.6 t -98.35 108.49 21.2 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 122.788 0.435 . . . . 0.0 111.693 175.626 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 88.6 m -92.2 117.19 29.63 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 177.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 75.6 mtp180 -124.46 115.78 21.46 Favored 'General case' 0 N--CA 1.488 1.444 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.054 -165.229 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 74.1 m -87.82 133.72 33.83 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 122.98 0.512 . . . . 0.0 109.794 178.017 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 40.0 m-85 -128.69 130.11 46.71 Favored 'General case' 0 CA--C 1.56 1.351 0 C-N-CA 123.388 0.675 . . . . 0.0 109.419 177.467 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -91.22 154.16 19.49 Favored 'General case' 0 N--CA 1.494 1.741 0 CA-C-O 122.23 1.014 . . . . 0.0 112.193 169.556 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 69.6 tttt -86.01 119.4 26.27 Favored 'General case' 0 N--CA 1.484 1.273 0 CA-C-N 115.257 -0.883 . . . . 0.0 111.414 -170.787 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 25.3 mm-40 -117.22 51.22 1.03 Allowed 'General case' 0 CA--C 1.564 1.508 0 C-N-CA 124.58 1.152 . . . . 0.0 111.26 -174.61 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 0.984 0 CA-C-O 123.059 1.409 . . . . 0.0 110.594 -159.732 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 4.1 p . . . . . 0 CA--C 1.576 1.971 0 N-CA-C 116.051 1.871 . . . . 0.0 116.051 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -66.86 -34.25 77.38 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 116.922 2.193 . . . . 0.0 116.922 -175.456 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -57.67 -31.63 66.51 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 117.387 2.366 . . . . 0.0 117.387 169.404 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -66.96 -26.5 66.86 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 116.686 2.106 . . . . 0.0 116.686 168.702 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 49.8 mt -77.07 107.07 9.17 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-N 120.887 1.676 . . . . 0.0 111.624 -164.057 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 157.18 176.97 29.85 Favored Glycine 0 CA--C 1.542 1.749 0 CA-C-O 122.511 1.062 . . . . 0.0 113.11 -169.744 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 85.6 m -91.78 143.56 26.4 Favored 'General case' 0 N--CA 1.489 1.48 0 CA-C-N 114.406 -0.897 . . . . 0.0 109.071 177.14 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 93.5 m95 -138.48 111.5 7.85 Favored 'General case' 0 N--CA 1.485 1.319 0 N-CA-C 107.548 -1.278 . . . . 0.0 107.548 -175.145 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -100.31 143.11 30.89 Favored 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 123.681 0.792 . . . . 0.0 110.648 -178.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 17.6 tp -66.91 124.62 23.49 Favored 'General case' 0 N--CA 1.488 1.445 0 CA-C-O 121.929 0.871 . . . . 0.0 113.135 -172.457 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . 0.267 1.2 t -97.37 -48.45 12.35 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.816 0 CA-C-N 114.261 -1.336 . . . . 0.0 111.601 174.472 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -143.89 150.25 38.12 Favored 'General case' 0 N--CA 1.489 1.494 0 CA-C-N 119.356 0.98 . . . . 0.0 110.046 178.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 88.1 p -130.65 98.14 4.57 Favored 'General case' 0 N--CA 1.489 1.514 0 CA-C-O 121.243 0.544 . . . . 0.0 109.922 170.042 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -84.51 128.27 34.5 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 123.168 0.587 . . . . 0.0 110.055 177.616 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 56.3 m-20 65.09 24.91 12.52 Favored 'General case' 0 N--CA 1.503 2.207 0 N-CA-C 117.964 2.579 . . . . 0.0 117.964 171.748 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 29.8 t80 -69.42 -53.24 20.31 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 120.032 -1.668 . . . . 0.0 113.982 -176.156 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -39.35 -44.64 1.34 Allowed 'General case' 0 N--CA 1.499 1.977 0 N-CA-C 118.948 2.944 . . . . 0.0 118.948 159.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -63.91 -50.35 69.06 Favored 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 115.214 1.561 . . . . 0.0 115.214 172.709 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 75.4 t80 -52.11 -48.0 64.99 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 115.591 1.7 . . . . 0.0 115.591 166.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 36.6 mmm -65.59 -40.11 92.33 Favored 'General case' 0 CA--C 1.565 1.548 0 N-CA-C 115.176 1.547 . . . . 0.0 115.176 176.352 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -60.85 -43.11 98.76 Favored 'General case' 0 CA--C 1.569 1.677 0 N-CA-C 114.873 1.435 . . . . 0.0 114.873 165.583 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 50.1 m -59.14 -39.45 82.44 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 115.82 1.785 . . . . 0.0 115.82 170.493 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 77.7 mt -64.62 -42.43 95.5 Favored 'General case' 0 CA--C 1.565 1.543 0 N-CA-C 116.214 1.931 . . . . 0.0 116.214 168.53 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 111.85 73.77 0.69 Allowed Glycine 0 N--CA 1.483 1.807 0 C-N-CA 123.708 0.671 . . . . 0.0 111.911 -172.445 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 37.6 t -136.3 127.84 43.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 N-CA-C 106.335 -1.728 . . . . 0.0 106.335 179.421 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -66.53 -80.19 0.19 Allowed Glycine 0 N--CA 1.485 1.966 0 N-CA-C 116.653 1.421 . . . . 0.0 116.653 -173.603 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 46.3 p90 -153.04 -50.29 0.1 Allowed 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 114.298 1.222 . . . . 0.0 114.298 -178.176 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.02 -41.67 96.99 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 116.871 2.175 . . . . 0.0 116.871 -176.519 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 59.0 m -80.06 -36.24 35.93 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 113.521 0.934 . . . . 0.0 113.521 169.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 44.2 ttp180 -58.72 -44.05 90.31 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 115.722 1.749 . . . . 0.0 115.722 176.677 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 18.2 mm100 -86.91 -33.64 19.65 Favored 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 115.315 1.598 . . . . 0.0 115.315 178.864 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 89.1 t -69.44 -46.19 76.86 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 CA-C-N 120.875 1.67 . . . . 0.0 111.941 173.373 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -65.97 -24.43 66.79 Favored 'General case' 0 CA--C 1.569 1.685 0 N-CA-C 117.559 2.429 . . . . 0.0 117.559 175.075 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 87.4 p -68.17 -49.48 60.66 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 114.863 1.431 . . . . 0.0 114.863 167.052 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 3.3 ppp? -65.26 -23.31 67.01 Favored 'General case' 0 N--CA 1.499 2.012 0 N-CA-C 117.792 2.516 . . . . 0.0 117.792 170.408 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 48.6 m -68.99 150.74 47.35 Favored 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 124.507 1.123 . . . . 0.0 112.119 177.189 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.8 98.81 6.64 Favored Pre-proline 0 CA--C 1.571 1.786 0 CA-C-O 118.072 -0.966 . . . . 0.0 110.022 166.319 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_endo -82.12 90.34 1.12 Allowed 'Trans proline' 0 CA--C 1.562 1.878 0 C-N-CA 122.805 2.337 . . . . 0.0 110.758 179.32 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 80.3 m -79.8 110.63 15.34 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 123.715 0.806 . . . . 0.0 110.487 -160.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 58.6 m -86.27 116.42 24.44 Favored 'General case' 0 CA--C 1.562 1.41 0 C-N-CA 123.085 0.554 . . . . 0.0 109.962 -171.247 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 71.9 mt -113.12 105.24 18.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 N-CA-C 106.434 -1.691 . . . . 0.0 106.434 178.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 3.8 mp -94.56 123.05 46.53 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 174.567 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -132.48 117.88 18.58 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 -176.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 38.7 ttpt -90.24 117.22 28.81 Favored 'General case' 0 CA--C 1.557 1.227 0 CA-C-O 121.296 0.57 . . . . 0.0 110.911 177.511 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 21.2 t-20 -77.27 -56.14 4.81 Favored 'General case' 0 CA--C 1.568 1.651 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.85 164.245 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -159.49 -85.62 0.05 OUTLIER Glycine 0 N--CA 1.48 1.614 0 N-CA-C 109.066 -1.613 . . . . 0.0 109.066 171.039 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -74.04 -37.87 64.17 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 114.502 1.297 . . . . 0.0 114.502 161.108 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 45.9 mm -76.68 120.54 27.09 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.514 0 C-N-CA 123.954 0.902 . . . . 0.0 110.466 -174.116 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 47.1 mt -99.67 108.99 21.48 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.745 0.818 . . . . 0.0 109.037 168.014 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 93.7 m -95.43 100.63 12.37 Favored 'General case' 0 CA--C 1.559 1.308 0 N-CA-C 107.513 -1.291 . . . . 0.0 107.513 -177.018 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 9.6 tt -100.44 106.38 17.95 Favored 'General case' 0 N--CA 1.483 1.178 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 -178.47 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -101.88 111.64 23.97 Favored 'General case' 0 N--CA 1.485 1.305 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 178.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 95.2 m -95.07 94.46 7.97 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 178.192 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 22.3 m-70 -81.12 100.99 9.34 Favored 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 123.276 0.63 . . . . 0.0 111.603 -171.257 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 32.1 t -112.68 145.41 40.51 Favored 'General case' 0 CA--C 1.555 1.152 0 C-N-CA 123.904 0.882 . . . . 0.0 109.397 -176.304 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 53.1 m -52.46 -25.24 9.57 Favored 'General case' 0 N--CA 1.502 2.154 0 N-CA-C 115.729 1.751 . . . . 0.0 115.729 158.731 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 72.2 t80 -109.43 83.07 1.69 Allowed 'General case' 0 CA--C 1.562 1.406 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 169.826 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 28.2 mtpp 61.79 115.55 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.997 0 N-CA-C 115.706 1.743 . . . . 0.0 115.706 172.495 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 7.6 p-10 -79.43 121.33 25.04 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.713 -0.617 . . . . 0.0 112.493 175.604 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 73.1 p -93.85 126.37 39.0 Favored 'General case' 0 N--CA 1.493 1.716 0 C-N-CA 122.718 0.407 . . . . 0.0 110.538 178.783 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -105.81 113.92 27.76 Favored 'General case' 0 N--CA 1.485 1.292 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 174.037 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 19.8 pt -116.59 128.82 73.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 179.72 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 61.7 p -116.83 113.4 22.45 Favored 'General case' 0 N--CA 1.492 1.659 0 C-N-CA 123.741 0.817 . . . . 0.0 109.447 -172.466 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 42.6 p90 -141.31 145.65 35.75 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 114.929 1.455 . . . . 0.0 114.929 -165.228 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 34.8 mtmm -116.82 23.94 11.6 Favored 'General case' 0 N--CA 1.498 1.929 0 N-CA-C 115.982 1.845 . . . . 0.0 115.982 -174.168 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . 0.275 2.0 mp 65.75 94.21 0.06 Allowed 'General case' 0 N--CA 1.494 1.725 0 C-N-CA 124.964 1.306 . . . . 0.0 113.635 168.632 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 83.27 34.06 21.42 Favored Glycine 0 CA--C 1.551 2.323 0 N-CA-C 117.095 1.598 . . . . 0.0 117.095 -164.601 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 95.6 t -135.27 118.19 23.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 N-CA-C 106.453 -1.684 . . . . 0.0 106.453 -178.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -85.6 136.27 33.45 Favored 'General case' 0 CA--C 1.565 1.55 0 C-N-CA 123.563 0.745 . . . . 0.0 111.86 179.448 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 47.9 p90 -143.89 139.29 29.13 Favored 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 123.663 0.785 . . . . 0.0 111.392 -171.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -75.57 135.42 40.55 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.252 -0.905 . . . . 0.0 112.688 172.413 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -146.1 136.49 23.94 Favored 'General case' 0 N--CA 1.49 1.528 0 CA-C-O 120.997 0.427 . . . . 0.0 111.207 -170.53 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 79.3 m -96.88 130.09 44.23 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 172.037 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 26.7 p -89.2 171.8 9.54 Favored 'General case' 0 N--CA 1.492 1.671 0 CA-C-O 121.989 0.9 . . . . 0.0 112.661 -176.336 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -54.48 -40.33 68.39 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 117.207 2.299 . . . . 0.0 117.207 169.018 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -93.93 59.7 2.78 Favored 'General case' 0 N--CA 1.495 1.813 0 CA-C-N 119.362 0.983 . . . . 0.0 111.337 170.267 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 9.5 t70 21.7 76.26 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.007 0 N-CA-C 118.771 2.878 . . . . 0.0 118.771 -178.687 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 38.4 ttp180 -139.73 117.92 11.95 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 -169.204 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.42 114.81 12.06 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 122.901 0.48 . . . . 0.0 110.195 172.252 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 17.3 m -135.01 132.27 53.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 CA-C-O 121.431 0.634 . . . . 0.0 109.642 -170.135 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 39.5 ttpt -87.02 118.09 26.17 Favored 'General case' 0 CA--C 1.558 1.263 0 C-N-CA 123.829 0.852 . . . . 0.0 110.237 178.77 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 71.0 m -117.35 109.76 17.21 Favored 'General case' 0 N--CA 1.488 1.452 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.259 -157.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 6.6 tp -122.73 115.88 47.2 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 C-N-CA 123.834 0.854 . . . . 0.0 109.091 -179.105 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -123.53 129.58 74.57 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 C-N-CA 124.431 1.092 . . . . 0.0 109.29 178.76 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 15.1 t -133.89 156.97 47.14 Favored 'General case' 0 N--CA 1.493 1.693 0 CA-C-O 122.632 1.206 . . . . 0.0 111.34 169.532 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 19.3 tp -94.16 117.99 30.91 Favored 'General case' 0 N--CA 1.489 1.476 0 CA-C-N 114.726 -1.124 . . . . 0.0 110.558 -178.388 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -104.52 81.5 1.8 Allowed 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 123.231 0.612 . . . . 0.0 110.079 175.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 78.07 -74.92 1.96 Allowed Glycine 0 N--CA 1.487 2.1 0 CA-C-O 121.473 0.485 . . . . 0.0 113.832 -174.72 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -148.63 53.95 0.52 Allowed Glycine 0 CA--C 1.546 1.99 0 CA-C-N 114.425 -0.887 . . . . 0.0 112.885 167.451 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 38.7 mtmm -145.26 111.68 5.73 Favored 'General case' 0 N--CA 1.484 1.263 0 N-CA-C 106.682 -1.599 . . . . 0.0 106.682 -175.641 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 46.7 mt -82.4 96.35 7.94 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-O 122.757 1.265 . . . . 0.0 109.424 174.248 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 95.5 t -86.81 94.93 4.6 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.342 0 CA-C-N 113.029 -1.896 . . . . 0.0 105.936 -179.651 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 16.8 t-160 -98.89 147.95 24.43 Favored 'General case' 0 CA--C 1.559 1.319 0 C-N-CA 124.612 1.165 . . . . 0.0 109.608 179.209 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 23.2 tp -145.48 119.89 9.65 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 179.571 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 94.4 mt-30 -105.67 122.6 46.38 Favored 'General case' 0 N--CA 1.486 1.325 0 C-N-CA 124.707 1.203 . . . . 0.0 108.341 176.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 7.9 mtpm? -125.44 130.69 52.35 Favored 'General case' 0 N--CA 1.494 1.736 0 C-N-CA 123.023 0.529 . . . . 0.0 110.048 -170.779 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 19.2 p90 -153.34 112.85 3.83 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.67 -0.644 . . . . 0.0 110.091 -175.066 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 4.5 t70 51.93 53.73 12.07 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 116.552 2.056 . . . . 0.0 116.552 168.091 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 86.64 -40.66 3.07 Favored Glycine 0 CA--C 1.552 2.344 0 N-CA-C 117.387 1.715 . . . . 0.0 117.387 -171.473 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 19.2 mt-30 -85.31 137.39 33.0 Favored 'General case' 0 N--CA 1.49 1.562 0 CA-C-N 118.316 1.058 . . . . 0.0 111.168 -179.804 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -143.38 133.13 23.85 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 122.837 0.455 . . . . 0.0 111.727 -179.077 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 14.8 t -116.69 128.67 55.56 Favored 'General case' 0 N--CA 1.494 1.746 0 C-N-CA 123.108 0.563 . . . . 0.0 110.575 175.378 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 40.8 p -91.86 125.6 36.63 Favored 'General case' 0 N--CA 1.494 1.758 0 C-N-CA 122.965 0.506 . . . . 0.0 109.955 170.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 5.2 mp -105.63 82.1 1.76 Allowed 'General case' 0 CA--C 1.565 1.53 0 C-N-CA 124.187 0.995 . . . . 0.0 108.384 178.207 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 88.4 t -88.91 106.0 16.39 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 -172.153 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 74.8 mtt85 -97.88 117.53 32.4 Favored 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 123.137 0.575 . . . . 0.0 109.73 179.587 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -137.14 131.11 32.13 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 123.168 0.587 . . . . 0.0 111.185 -171.038 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -80.83 118.1 22.05 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.83 -0.544 . . . . 0.0 111.609 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 46.6 mm -125.47 101.85 9.21 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.28 0 N-CA-C 105.365 -2.087 . . . . 0.0 105.365 178.422 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 59.12 50.24 8.33 Favored 'General case' 0 N--CA 1.5 2.059 0 N-CA-C 115.408 1.633 . . . . 0.0 115.408 174.177 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 65.67 30.48 77.43 Favored Glycine 0 CA--C 1.555 2.556 0 N-CA-C 118.736 2.255 . . . . 0.0 118.736 -170.548 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -136.4 129.41 31.19 Favored 'General case' 0 N--CA 1.489 1.506 0 CA-C-N 118.458 1.129 . . . . 0.0 108.688 -176.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 12.2 tp -81.9 114.68 20.67 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 175.53 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 40.6 mm -104.74 100.04 9.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 N-CA-C 106.401 -1.703 . . . . 0.0 106.401 -174.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 38.6 tp -89.65 98.34 11.71 Favored 'General case' 0 CA--C 1.559 1.327 0 C-N-CA 123.657 0.783 . . . . 0.0 109.532 178.171 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 87.0 m -91.71 108.51 19.97 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 -178.771 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 87.7 mt -100.86 90.61 4.26 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 123.562 0.745 . . . . 0.0 109.467 -173.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 7.9 m -96.12 117.24 30.32 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.636 -0.665 . . . . 0.0 109.289 -173.489 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 83.4 t60 -127.57 91.02 3.22 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 168.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 73.1 -101.15 1.09 Allowed Glycine 0 N--CA 1.483 1.819 0 N-CA-C 114.49 0.556 . . . . 0.0 114.49 174.549 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 81.2 m -88.67 -54.52 4.12 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-O 118.486 -0.769 . . . . 0.0 112.045 175.62 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -85.1 106.36 16.51 Favored 'General case' 0 N--CA 1.484 1.246 0 CA-C-N 119.721 1.146 . . . . 0.0 112.256 -171.34 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 5.8 p -98.88 125.78 52.24 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 C-N-CA 123.83 0.852 . . . . 0.0 109.883 176.056 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 40.4 t -107.13 103.77 13.25 Favored 'General case' 0 CA--C 1.553 1.062 0 CA-C-O 121.41 0.624 . . . . 0.0 111.774 179.17 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 60.6 m -88.84 111.69 22.35 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 123.421 0.688 . . . . 0.0 109.187 179.587 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 22.3 mtp180 -106.11 111.86 24.66 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 -178.064 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 95.2 m -89.26 136.3 33.1 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 123.711 0.804 . . . . 0.0 109.98 -179.725 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 65.7 m-85 -132.07 132.68 43.55 Favored 'General case' 0 CA--C 1.56 1.361 0 C-N-CA 123.527 0.731 . . . . 0.0 110.259 -176.296 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -92.79 156.16 17.18 Favored 'General case' 0 N--CA 1.495 1.796 0 CA-C-O 122.249 1.023 . . . . 0.0 111.835 165.084 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 40.3 tttp -86.2 137.9 32.29 Favored 'General case' 0 N--CA 1.487 1.385 0 CA-C-N 115.528 -0.76 . . . . 0.0 112.817 -171.092 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -120.58 57.27 0.97 Allowed 'General case' 0 N--CA 1.494 1.733 0 C-N-CA 123.447 0.699 . . . . 0.0 111.952 171.137 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.437 0 CA-C-O 124.15 1.929 . . . . 0.0 112.444 -179.289 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 4.7 p . . . . . 0 CA--C 1.578 2.046 0 N-CA-C 115.675 1.732 . . . . 0.0 115.675 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -66.01 -48.39 71.3 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 117.231 2.308 . . . . 0.0 117.231 -173.401 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -55.84 -27.73 52.91 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 117.841 2.534 . . . . 0.0 117.841 171.09 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -68.61 -26.53 65.41 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 116.199 1.926 . . . . 0.0 116.199 167.642 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 40.6 mt -76.87 111.88 12.88 Favored 'General case' 0 N--CA 1.49 1.526 0 CA-C-N 120.78 1.627 . . . . 0.0 112.04 -168.768 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 164.63 176.05 35.99 Favored Glycine 0 CA--C 1.541 1.708 0 CA-C-O 122.706 1.17 . . . . 0.0 113.434 -173.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 63.3 m -90.0 140.22 29.85 Favored 'General case' 0 N--CA 1.493 1.699 0 CA-C-N 114.238 -0.981 . . . . 0.0 109.046 170.403 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 87.6 m95 -140.89 112.6 7.58 Favored 'General case' 0 N--CA 1.484 1.267 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 -174.044 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 8.6 mtpm? -96.67 146.04 25.23 Favored 'General case' 0 N--CA 1.495 1.789 0 CA-C-O 121.327 0.584 . . . . 0.0 110.273 174.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 23.8 tp -66.83 125.62 26.47 Favored 'General case' 0 N--CA 1.488 1.455 0 CA-C-O 121.89 0.853 . . . . 0.0 112.48 -177.062 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . 0.279 1.1 t -99.7 -47.93 11.87 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.795 0 CA-C-N 114.398 -1.274 . . . . 0.0 111.717 176.302 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -139.97 143.2 36.41 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-N 119.571 1.078 . . . . 0.0 109.67 177.528 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 78.5 p -126.09 94.07 3.99 Favored 'General case' 0 N--CA 1.49 1.526 0 CA-C-O 121.306 0.574 . . . . 0.0 110.486 169.067 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 57.5 tttp -83.22 119.49 24.62 Favored 'General case' 0 CA--C 1.557 1.243 0 C-N-CA 123.625 0.77 . . . . 0.0 109.71 175.528 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.259 24.5 m-20 73.45 26.47 1.99 Allowed 'General case' 0 N--CA 1.501 2.122 0 N-CA-C 116.736 2.125 . . . . 0.0 116.736 175.704 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.418 ' HB2' ' SG ' ' A' ' 124' ' ' CYS . 22.5 t80 -89.27 78.67 7.23 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.362 -1.461 . . . . 0.0 110.72 178.503 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -170.44 -58.03 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 125.0 1.32 . . . . 0.0 108.281 -176.576 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 29.0 t0 -54.45 -47.7 72.58 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 115.365 1.617 . . . . 0.0 115.365 166.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 92.3 t80 -49.3 -54.73 15.55 Favored 'General case' 0 CA--C 1.573 1.835 0 N-CA-C 115.133 1.531 . . . . 0.0 115.133 167.781 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 74.8 mtm -63.71 -41.17 98.14 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 116.01 1.855 . . . . 0.0 116.01 174.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 57.9 tttm -64.92 -43.28 93.34 Favored 'General case' 0 CA--C 1.567 1.626 0 N-CA-C 115.228 1.566 . . . . 0.0 115.228 173.432 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 60.9 m -59.97 -39.91 87.3 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 115.815 1.783 . . . . 0.0 115.815 169.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 64.9 mt -64.37 -30.84 71.87 Favored 'General case' 0 CA--C 1.566 1.568 0 N-CA-C 117.41 2.374 . . . . 0.0 117.41 168.587 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 91.32 75.92 1.31 Allowed Glycine 0 N--CA 1.482 1.722 0 CA-C-N 119.211 0.914 . . . . 0.0 111.978 -170.025 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 97.9 t -128.31 81.28 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 N-CA-C 106.643 -1.614 . . . . 0.0 106.643 -177.273 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 31.86 -118.51 0.13 Allowed Glycine 0 CA--C 1.55 2.273 0 N-CA-C 121.018 3.167 . . . . 0.0 121.018 174.361 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 10.7 t80 -148.43 -71.22 0.21 Allowed 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 178.485 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -72.69 -16.99 61.68 Favored 'General case' 0 CA--C 1.567 1.608 0 N-CA-C 116.615 2.08 . . . . 0.0 116.615 177.269 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 30.6 m -68.63 -42.63 77.75 Favored 'General case' 0 N--CA 1.497 1.904 0 CA-C-N 120.3 1.409 . . . . 0.0 113.495 162.76 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 37.1 ttp-105 -55.31 -44.64 75.97 Favored 'General case' 0 CA--C 1.571 1.787 0 N-CA-C 115.138 1.533 . . . . 0.0 115.138 164.64 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 5.9 tm0? -65.78 -52.33 51.74 Favored 'General case' 0 CA--C 1.565 1.547 0 N-CA-C 115.451 1.648 . . . . 0.0 115.451 174.38 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 92.6 t -66.1 -38.32 81.74 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.975 0 N-CA-C 113.583 0.957 . . . . 0.0 113.583 -179.602 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -65.68 -34.59 78.56 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 116.806 2.15 . . . . 0.0 116.806 175.755 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 88.4 p -67.63 -39.55 84.66 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 116.348 1.981 . . . . 0.0 116.348 167.01 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 38.3 ttm -64.65 -40.72 95.94 Favored 'General case' 0 CA--C 1.571 1.756 0 N-CA-C 115.87 1.804 . . . . 0.0 115.87 169.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 88.3 m -75.74 153.06 37.27 Favored 'General case' 0 CA--C 1.567 1.61 0 C-N-CA 124.276 1.031 . . . . 0.0 112.597 -177.015 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 64.0 mttp -102.91 100.06 15.66 Favored Pre-proline 0 CA--C 1.572 1.82 0 CA-C-N 115.405 -0.816 . . . . 0.0 109.735 172.268 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -82.36 113.62 2.36 Favored 'Trans proline' 0 CA--C 1.561 1.826 0 C-N-CA 123.36 2.707 . . . . 0.0 112.289 179.737 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 86.7 m -83.95 108.54 16.99 Favored 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 123.509 0.723 . . . . 0.0 110.67 -169.366 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 88.2 m -81.65 116.64 21.48 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 123.492 0.717 . . . . 0.0 109.808 -179.495 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 61.3 mt -115.56 107.87 23.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 N-CA-C 106.122 -1.807 . . . . 0.0 106.122 -176.584 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 22.8 mt -103.05 119.48 51.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 N-CA-C 107.653 -1.239 . . . . 0.0 107.653 -175.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -137.62 111.34 8.18 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 -169.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 60.4 tttm -86.46 114.56 23.32 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 123.369 0.668 . . . . 0.0 111.015 -179.306 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 33.5 t30 -115.87 82.47 1.77 Allowed 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 -179.481 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 61.23 59.53 9.84 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 116.411 1.324 . . . . 0.0 116.411 -174.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . 0.319 15.7 t0 68.92 -14.79 0.28 Allowed 'General case' 0 N--CA 1.498 1.946 0 N-CA-C 117.572 2.434 . . . . 0.0 117.572 -166.372 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 11.2 mm -87.72 98.96 8.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 CA-C-N 120.342 1.428 . . . . 0.0 107.631 -177.292 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 43.9 mt -80.21 107.31 12.9 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 123.523 0.729 . . . . 0.0 110.544 -178.41 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 30.6 m -97.48 94.56 7.09 Favored 'General case' 0 N--CA 1.485 1.292 0 N-CA-C 107.059 -1.46 . . . . 0.0 107.059 -175.059 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 9.7 tt -99.4 102.81 14.51 Favored 'General case' 0 N--CA 1.484 1.255 0 N-CA-C 108.007 -1.108 . . . . 0.0 108.007 -174.515 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 64.0 mttm -105.04 116.82 32.59 Favored 'General case' 0 N--CA 1.486 1.328 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 -173.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 89.1 m -100.55 92.05 4.95 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 -175.624 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 8.0 m170 -87.94 96.26 10.43 Favored 'General case' 0 N--CA 1.491 1.59 0 CA-C-O 122.373 1.083 . . . . 0.0 111.862 -169.676 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 28.1 t -96.94 158.35 15.47 Favored 'General case' 0 CA--C 1.561 1.385 0 CA-C-N 114.596 -1.184 . . . . 0.0 111.18 171.729 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 76.7 p -81.45 65.92 6.78 Favored 'General case' 0 N--CA 1.501 2.102 0 CA-C-O 122.297 1.046 . . . . 0.0 111.179 163.762 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 33.3 t80 176.45 -59.8 0.01 OUTLIER 'General case' 0 CA--C 1.57 1.742 0 C-N-CA 126.001 1.72 . . . . 0.0 107.762 -166.558 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 1.5 pptp? -136.42 162.9 31.77 Favored 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 125.008 1.323 . . . . 0.0 111.316 -175.565 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 34.7 p-10 -143.19 87.58 1.97 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.015 -1.053 . . . . 0.0 109.833 164.767 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 41.4 p -86.97 129.94 34.67 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-O 121.402 0.62 . . . . 0.0 111.028 -179.478 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -110.92 129.65 55.81 Favored 'General case' 0 N--CA 1.484 1.24 0 CA-C-N 115.127 -0.942 . . . . 0.0 109.416 178.763 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 41.5 pt -112.48 130.86 65.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 164.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 58.0 p -120.73 103.91 9.48 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 108.825 -0.805 . . . . 0.0 108.825 -177.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 45.7 p90 -138.8 133.67 32.39 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 114.052 1.131 . . . . 0.0 114.052 -158.829 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 56.4 mtmt -86.73 148.91 25.22 Favored 'General case' 0 CA--C 1.562 1.435 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.534 156.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -73.38 116.87 14.45 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.762 -0.586 . . . . 0.0 111.66 -174.602 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 90.69 45.19 4.34 Favored Glycine 0 CA--C 1.548 2.13 0 N-CA-C 116.515 1.366 . . . . 0.0 116.515 -167.352 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 96.3 t -135.4 122.25 34.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 N-CA-C 106.984 -1.487 . . . . 0.0 106.984 177.476 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -88.89 126.7 35.5 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 123.29 0.636 . . . . 0.0 110.386 170.334 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 43.0 p90 -139.62 133.06 30.15 Favored 'General case' 0 N--CA 1.494 1.766 0 C-N-CA 123.38 0.672 . . . . 0.0 111.172 -172.501 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -70.66 118.14 13.08 Favored 'General case' 0 CA--C 1.564 1.494 0 O-C-N 121.621 -0.675 . . . . 0.0 112.343 175.77 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 15.9 tp10 -125.72 136.44 53.19 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 123.775 0.83 . . . . 0.0 109.967 -170.324 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 57.8 m -91.24 123.46 34.7 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 174.461 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 31.7 p -82.48 170.68 14.97 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 113.056 0.762 . . . . 0.0 113.056 -175.695 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -53.28 -30.66 39.75 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 118.665 2.839 . . . . 0.0 118.665 173.078 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -78.7 -85.85 0.07 Allowed 'General case' 0 N--CA 1.489 1.488 0 CA-C-N 119.387 0.994 . . . . 0.0 109.23 168.261 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 179.01 82.86 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 168.634 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 22.0 mtm180 -140.22 124.81 18.05 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.847 -0.533 . . . . 0.0 109.92 -174.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.89 116.19 13.1 Favored 'General case' 0 CA--C 1.564 1.482 0 C-N-CA 123.63 0.772 . . . . 0.0 111.121 165.592 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 17.8 m -134.26 129.56 53.54 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 -170.246 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 46.2 mmtm -83.37 104.42 13.51 Favored 'General case' 0 N--CA 1.49 1.526 0 CA-C-O 121.759 0.79 . . . . 0.0 110.152 -178.076 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 75.2 m -101.24 95.86 6.81 Favored 'General case' 0 N--CA 1.484 1.238 0 CA-C-N 115.064 -0.971 . . . . 0.0 110.702 -162.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 7.2 tp -103.19 121.58 54.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 179.606 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 1.9 p -142.22 123.44 12.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 C-N-CA 123.171 0.589 . . . . 0.0 109.95 -172.085 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 15.1 t -136.96 159.72 41.03 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-O 122.579 1.18 . . . . 0.0 110.92 178.42 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 14.7 tp -90.54 111.17 22.36 Favored 'General case' 0 CA--C 1.562 1.437 0 CA-C-N 115.084 -0.962 . . . . 0.0 109.505 174.855 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -101.69 88.01 3.3 Favored 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 123.678 0.791 . . . . 0.0 109.793 -179.507 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 58.26 47.43 89.56 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 118.07 1.988 . . . . 0.0 118.07 -177.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 74.91 28.0 63.54 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 118.695 2.238 . . . . 0.0 118.695 -168.048 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 21.3 ttmm -134.51 116.7 15.39 Favored 'General case' 0 CA--C 1.552 1.044 0 N-CA-C 106.523 -1.658 . . . . 0.0 106.523 179.782 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 3.8 tt -86.45 97.98 10.77 Favored 'General case' 0 CA--C 1.563 1.475 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 -172.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 56.1 t -105.7 109.15 26.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 -165.097 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 23.6 t-160 -110.2 136.36 49.54 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 124.071 0.948 . . . . 0.0 109.905 179.638 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 30.3 tp -130.53 121.22 25.33 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 173.755 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 87.3 mt-30 -108.46 118.11 35.91 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 175.61 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 17.5 ptpt -121.76 134.9 54.93 Favored 'General case' 0 N--CA 1.496 1.849 0 CA-C-N 118.472 0.578 . . . . 0.0 111.933 -172.697 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 18.0 p90 -158.21 109.94 2.25 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 123.465 0.706 . . . . 0.0 109.897 -176.638 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 6.4 t70 53.44 54.11 10.61 Favored 'General case' 0 N--CA 1.501 2.077 0 N-CA-C 116.625 2.083 . . . . 0.0 116.625 164.236 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 87.96 -42.75 3.11 Favored Glycine 0 CA--C 1.552 2.35 0 N-CA-C 116.937 1.535 . . . . 0.0 116.937 -170.71 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 16.6 mt-30 -86.4 131.26 34.24 Favored 'General case' 0 N--CA 1.487 1.404 0 CA-C-N 118.086 0.943 . . . . 0.0 110.84 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -141.79 126.37 17.88 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 122.96 0.504 . . . . 0.0 110.36 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 1.4 t -121.07 124.07 43.89 Favored 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 123.528 0.731 . . . . 0.0 110.302 -175.032 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 40.1 p -97.76 141.96 30.13 Favored 'General case' 0 N--CA 1.492 1.648 0 CA-C-O 121.499 0.666 . . . . 0.0 111.738 179.764 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 5.6 mp -119.75 80.68 1.62 Allowed 'General case' 0 CA--C 1.564 1.494 0 N-CA-C 107.672 -1.233 . . . . 0.0 107.672 175.571 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 95.7 t -90.83 111.16 23.22 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 -172.464 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 83.7 mtt85 -104.63 130.21 52.66 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 123.292 0.637 . . . . 0.0 110.211 -177.383 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -145.94 129.26 16.78 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 123.167 0.587 . . . . 0.0 110.546 -174.095 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -79.71 116.8 20.1 Favored 'General case' 0 N--CA 1.488 1.469 0 CA-C-O 121.273 0.559 . . . . 0.0 111.108 177.117 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 48.9 mm -120.05 100.18 8.91 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.332 0 N-CA-C 105.485 -2.043 . . . . 0.0 105.485 177.72 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 57.38 49.78 12.5 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 114.915 1.45 . . . . 0.0 114.915 174.101 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 89.51 -38.61 3.19 Favored Glycine 0 CA--C 1.553 2.465 0 N-CA-C 117.572 1.789 . . . . 0.0 117.572 -169.019 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 54.0 mttm -82.64 132.79 35.18 Favored 'General case' 0 N--CA 1.488 1.448 0 CA-C-N 118.583 1.192 . . . . 0.0 112.075 -171.192 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 20.8 tp -81.66 112.66 19.05 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 172.68 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 37.6 mm -99.77 102.49 13.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 N-CA-C 106.732 -1.581 . . . . 0.0 106.732 -178.12 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 22.6 tp -90.43 102.73 15.46 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 123.815 0.846 . . . . 0.0 109.22 174.57 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 66.9 m -91.47 112.87 24.96 Favored 'General case' 0 CA--C 1.562 1.432 0 C-N-CA 124.181 0.992 . . . . 0.0 108.354 179.324 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 88.3 mt -104.61 87.34 2.67 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 123.746 0.818 . . . . 0.0 109.985 -171.819 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 9.9 m -103.17 112.51 25.41 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.727 -0.608 . . . . 0.0 109.576 -174.134 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 54.9 t60 -108.74 86.96 2.38 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 164.001 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 71.16 -101.54 0.97 Allowed Glycine 0 N--CA 1.483 1.795 0 N-CA-C 114.416 0.526 . . . . 0.0 114.416 179.461 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 61.2 m -87.19 -51.34 6.04 Favored 'General case' 0 CA--C 1.566 1.595 0 C-N-CA 123.653 0.781 . . . . 0.0 112.678 176.853 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -77.73 107.48 10.26 Favored 'General case' 0 N--CA 1.484 1.274 0 CA-C-N 119.756 1.162 . . . . 0.0 112.886 -173.641 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 4.7 p -107.68 124.18 63.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 C-N-CA 123.954 0.901 . . . . 0.0 110.37 -178.627 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' CYS . . . . . 0.418 ' SG ' ' HB2' ' A' ' 16' ' ' PHE . 2.7 t -101.25 108.57 20.25 Favored 'General case' 0 CA--C 1.556 1.188 0 C-N-CA 123.449 0.699 . . . . 0.0 110.614 173.134 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 53.5 m -89.2 111.06 21.76 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 177.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 36.1 mtt180 -108.06 117.23 33.58 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 123.187 0.595 . . . . 0.0 110.874 -179.296 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 86.0 m -88.91 134.34 33.99 Favored 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 123.53 0.732 . . . . 0.0 109.585 172.447 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 48.1 m-85 -128.58 135.62 49.61 Favored 'General case' 0 CA--C 1.559 1.308 0 C-N-CA 123.95 0.9 . . . . 0.0 109.371 179.127 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -100.99 154.0 19.06 Favored 'General case' 0 N--CA 1.493 1.718 0 CA-C-O 122.6 1.191 . . . . 0.0 111.414 167.439 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 36.2 tttp -84.86 125.69 32.84 Favored 'General case' 0 N--CA 1.483 1.218 0 CA-C-N 114.956 -1.02 . . . . 0.0 112.209 -168.367 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 16.7 mm-40 -123.3 50.14 1.6 Allowed 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 124.237 1.015 . . . . 0.0 111.712 -175.158 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 0.811 0 CA-C-O 123.005 1.384 . . . . 0.0 110.639 -161.36 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.32 2.5 t . . . . . 0 N--CA 1.489 1.487 0 CA-C-O 118.051 -0.976 . . . . 0.0 112.995 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -62.12 -36.13 80.84 Favored 'General case' 0 N--CA 1.497 1.881 0 N-CA-C 116.154 1.909 . . . . 0.0 116.154 179.587 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -62.41 -32.32 73.14 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 116.858 2.17 . . . . 0.0 116.858 163.259 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 88.8 m-85 -67.69 -27.62 66.99 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 116.146 1.906 . . . . 0.0 116.146 168.319 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 60.0 mt -72.75 116.42 13.22 Favored 'General case' 0 N--CA 1.49 1.543 0 CA-C-N 121.291 1.86 . . . . 0.0 111.512 -172.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 159.48 177.17 32.33 Favored Glycine 0 CA--C 1.541 1.692 0 CA-C-O 122.138 0.854 . . . . 0.0 114.133 -176.091 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 52.3 m -94.61 135.46 36.04 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 174.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 92.6 m95 -134.7 113.13 11.37 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 -172.247 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 7.7 mtmp? -98.76 144.21 28.25 Favored 'General case' 0 N--CA 1.489 1.477 0 CA-C-O 121.978 0.894 . . . . 0.0 110.541 175.084 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 51.4 tp -68.71 133.64 48.69 Favored 'General case' 0 N--CA 1.486 1.359 0 CA-C-O 122.283 1.039 . . . . 0.0 112.496 -176.469 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . 0.28 1.1 t -110.74 -43.3 5.2 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.744 0 CA-C-N 113.697 -1.592 . . . . 0.0 111.718 -178.411 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 41.8 t0 -143.78 131.89 21.79 Favored 'General case' 0 N--CA 1.49 1.525 0 CA-C-N 120.102 1.319 . . . . 0.0 109.63 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 86.4 p -112.93 96.83 6.16 Favored 'General case' 0 N--CA 1.492 1.663 0 CA-C-O 121.492 0.663 . . . . 0.0 110.366 171.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 43.7 mtmt -96.41 123.32 40.02 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 123.656 0.783 . . . . 0.0 108.92 -179.37 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 59.7 m-20 67.57 23.18 8.95 Favored 'General case' 0 N--CA 1.503 2.208 0 N-CA-C 117.532 2.419 . . . . 0.0 117.532 178.578 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 27.3 t80 -68.22 -51.75 41.9 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 120.155 -1.591 . . . . 0.0 113.981 -178.812 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -47.28 -36.19 8.86 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 117.542 2.423 . . . . 0.0 117.542 165.736 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 33.9 t0 -66.06 -55.49 16.33 Favored 'General case' 0 N--CA 1.499 2.021 0 CA-C-N 120.483 1.492 . . . . 0.0 114.245 172.232 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 71.6 t80 -48.22 -48.01 35.34 Favored 'General case' 0 CA--C 1.573 1.845 0 N-CA-C 116.135 1.902 . . . . 0.0 116.135 167.465 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 51.4 mmm -68.23 -46.03 71.67 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 114.84 1.422 . . . . 0.0 114.84 178.691 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -54.91 -46.34 74.84 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 115.533 1.679 . . . . 0.0 115.533 166.2 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 64.6 m -60.54 -38.55 84.85 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 116.199 1.926 . . . . 0.0 116.199 172.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 62.5 mt -63.06 -41.17 99.41 Favored 'General case' 0 CA--C 1.567 1.632 0 N-CA-C 115.78 1.771 . . . . 0.0 115.78 168.337 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 114.39 73.17 0.57 Allowed Glycine 0 N--CA 1.482 1.751 0 C-N-CA 123.899 0.762 . . . . 0.0 111.603 -176.192 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 57.3 t -140.36 121.82 14.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 N-CA-C 106.389 -1.708 . . . . 0.0 106.389 -173.772 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -72.18 170.69 49.68 Favored Glycine 0 CA--C 1.551 2.322 0 N-CA-C 116.414 1.326 . . . . 0.0 116.414 177.235 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . 0.25 33.0 p90 -57.47 -43.23 83.87 Favored 'General case' 0 N--CA 1.497 1.92 0 N-CA-C 118.92 2.933 . . . . 0.0 118.92 -167.515 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.36 -40.62 89.87 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 116.589 2.07 . . . . 0.0 116.589 178.75 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 94.7 m -71.52 -42.02 68.48 Favored 'General case' 0 N--CA 1.498 1.963 0 N-CA-C 113.792 1.034 . . . . 0.0 113.792 168.574 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 38.3 ttp180 -58.53 -38.91 78.75 Favored 'General case' 0 CA--C 1.569 1.708 0 N-CA-C 115.89 1.811 . . . . 0.0 115.89 173.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 51.4 mt-30 -81.66 -38.8 25.35 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 115.66 1.726 . . . . 0.0 115.66 176.71 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 46.9 t -73.11 -37.88 53.88 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.254 0 CA-C-N 121.381 1.901 . . . . 0.0 112.664 175.067 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -66.55 -31.37 72.05 Favored 'General case' 0 CA--C 1.567 1.601 0 N-CA-C 117.0 2.222 . . . . 0.0 117.0 170.462 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 85.9 p -67.0 -43.65 82.38 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 115.283 1.586 . . . . 0.0 115.283 164.257 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 49.6 ttm -64.73 -38.73 92.0 Favored 'General case' 0 CA--C 1.567 1.624 0 N-CA-C 116.49 2.033 . . . . 0.0 116.49 176.643 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 13.0 t -69.29 144.94 53.44 Favored 'General case' 0 N--CA 1.492 1.645 0 CA-C-N 119.432 1.014 . . . . 0.0 112.931 -179.417 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -102.69 103.16 30.85 Favored Pre-proline 0 CA--C 1.567 1.603 0 CA-C-O 118.201 -0.904 . . . . 0.0 108.802 176.009 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -72.96 119.78 6.26 Favored 'Trans proline' 0 CA--C 1.559 1.753 0 C-N-CA 123.052 2.501 . . . . 0.0 112.526 -179.244 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 95.7 m -84.58 99.59 10.85 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 179.859 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 86.9 m -97.37 104.53 16.56 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 -165.253 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 68.9 mt -100.5 112.69 33.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 N-CA-C 107.464 -1.31 . . . . 0.0 107.464 -174.45 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 35.8 mt -104.0 117.41 49.49 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 N-CA-C 107.121 -1.437 . . . . 0.0 107.121 179.548 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -141.43 119.42 11.97 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-O 121.078 0.466 . . . . 0.0 109.939 -170.154 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 56.3 tttm -91.84 121.95 33.92 Favored 'General case' 0 CA--C 1.56 1.347 0 C-N-CA 123.748 0.819 . . . . 0.0 111.802 -175.075 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 75.4 m-20 -116.61 92.16 3.79 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 -179.346 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 83.25 -92.95 1.68 Allowed Glycine 0 N--CA 1.486 1.998 0 O-C-N 121.774 -0.579 . . . . 0.0 111.776 -173.347 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -138.49 65.57 1.46 Allowed 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 155.808 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 33.9 mm -136.01 99.88 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 N-CA-C 105.258 -2.127 . . . . 0.0 105.258 -174.73 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 60.4 mt -81.45 102.09 10.31 Favored 'General case' 0 N--CA 1.486 1.342 0 CA-C-O 121.181 0.515 . . . . 0.0 110.482 -179.119 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 28.7 m -98.38 97.92 9.21 Favored 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 107.275 -1.379 . . . . 0.0 107.275 -173.301 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 10.4 tt -98.92 102.16 13.79 Favored 'General case' 0 N--CA 1.485 1.29 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 -177.402 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -98.77 111.5 23.86 Favored 'General case' 0 N--CA 1.484 1.25 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 -174.49 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 52.4 m -91.65 95.91 10.16 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 -179.366 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 23.1 m-70 -87.26 96.42 10.33 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 -176.556 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 37.4 t -127.27 140.95 51.87 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 123.733 0.813 . . . . 0.0 109.96 -169.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 71.6 p -83.88 48.52 1.46 Allowed 'General case' 0 N--CA 1.498 1.96 0 N-CA-C 113.883 1.068 . . . . 0.0 113.883 174.553 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 13.3 t80 -159.08 -68.98 0.08 Allowed 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 163.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 13.5 ptmm? -125.14 100.52 6.59 Favored 'General case' 0 CA--C 1.56 1.354 0 C-N-CA 123.519 0.727 . . . . 0.0 109.761 179.079 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 9.2 p30 -90.55 124.52 35.09 Favored 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 123.764 0.826 . . . . 0.0 111.008 178.735 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 77.1 p -130.35 132.33 45.77 Favored 'General case' 0 N--CA 1.497 1.901 0 C-N-CA 123.091 0.556 . . . . 0.0 111.174 -169.561 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -117.89 130.55 56.31 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 123.784 0.833 . . . . 0.0 110.009 -176.433 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 39.1 pt -123.66 132.91 70.58 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 C-N-CA 123.456 0.703 . . . . 0.0 109.412 175.773 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 45.9 t -120.99 107.4 12.6 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 -176.669 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 49.0 p90 -136.42 136.73 39.8 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 115.204 1.557 . . . . 0.0 115.204 -159.435 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 50.5 mtmt -103.5 14.67 30.8 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 117.214 2.302 . . . . 0.0 117.214 -173.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . 0.295 3.3 mp 62.59 96.9 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.744 0 CA-C-N 120.648 1.567 . . . . 0.0 114.318 177.226 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 87.1 38.68 7.75 Favored Glycine 0 CA--C 1.55 2.28 0 N-CA-C 116.99 1.556 . . . . 0.0 116.99 -170.087 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 86.5 t -138.73 124.22 23.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 N-CA-C 106.839 -1.541 . . . . 0.0 106.839 -179.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -87.8 116.26 25.82 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 123.042 0.537 . . . . 0.0 109.961 171.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 45.0 p90 -125.43 131.8 52.84 Favored 'General case' 0 N--CA 1.491 1.624 0 C-N-CA 123.912 0.885 . . . . 0.0 109.851 -175.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -73.61 110.4 7.86 Favored 'General case' 0 CA--C 1.564 1.507 0 O-C-N 121.411 -0.806 . . . . 0.0 111.889 176.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 13.7 tp10 -106.41 132.94 51.84 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 124.115 0.966 . . . . 0.0 109.563 -174.441 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 52.2 m -96.96 117.59 31.49 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 174.255 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 20.3 p -84.9 166.83 16.5 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-O 121.664 0.745 . . . . 0.0 112.101 -174.704 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -67.36 -20.94 65.64 Favored 'General case' 0 CA--C 1.571 1.757 0 N-CA-C 117.677 2.473 . . . . 0.0 117.677 169.446 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -76.68 -0.24 22.84 Favored 'General case' 0 CA--C 1.581 2.137 0 N-CA-C 116.142 1.904 . . . . 0.0 116.142 160.536 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . 0.265 11.1 m-20 71.57 70.07 0.16 Allowed 'General case' 0 N--CA 1.495 1.811 0 C-N-CA 125.349 1.46 . . . . 0.0 111.729 -176.857 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 80.9 mtm180 -141.2 126.72 18.85 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 -175.302 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.57 97.17 8.9 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 123.37 0.668 . . . . 0.0 111.317 172.576 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 10.8 m -113.6 127.33 71.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 C-N-CA 123.165 0.586 . . . . 0.0 109.912 -168.268 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 29.9 mmtp -80.4 103.69 10.44 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 123.507 0.723 . . . . 0.0 110.118 179.632 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 70.8 m -100.21 95.84 7.07 Favored 'General case' 0 N--CA 1.483 1.198 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.947 -165.26 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 7.1 tp -107.71 113.84 44.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 177.35 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -130.4 128.12 63.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 C-N-CA 124.012 0.925 . . . . 0.0 109.129 -176.278 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 10.2 t -140.45 150.08 43.37 Favored 'General case' 0 N--CA 1.488 1.472 0 CA-C-O 122.719 1.247 . . . . 0.0 110.052 175.689 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 19.2 tp -85.07 114.18 22.02 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-N 114.616 -1.175 . . . . 0.0 109.321 176.501 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -101.63 81.09 2.12 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-O 121.239 0.542 . . . . 0.0 110.085 -178.562 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 57.07 45.14 92.74 Favored Glycine 0 N--CA 1.489 2.175 0 N-CA-C 118.016 1.967 . . . . 0.0 118.016 -177.127 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 102.87 -45.15 1.37 Allowed Glycine 0 N--CA 1.491 2.317 0 N-CA-C 116.481 1.352 . . . . 0.0 116.481 -165.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 83.6 tttt -81.33 106.81 13.59 Favored 'General case' 0 CA--C 1.559 1.3 0 C-N-CA 123.616 0.767 . . . . 0.0 110.87 -176.767 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 30.4 tp -82.52 114.59 21.03 Favored 'General case' 0 N--CA 1.484 1.232 0 CA-C-O 121.546 0.688 . . . . 0.0 110.948 -177.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 48.3 t -113.47 110.21 31.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 N-CA-C 106.72 -1.585 . . . . 0.0 106.72 -168.824 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 23.7 t-160 -106.2 142.46 35.84 Favored 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 124.113 0.965 . . . . 0.0 109.717 174.702 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 30.3 tp -131.74 122.81 26.47 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 174.441 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 81.9 mt-30 -115.41 105.61 13.04 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 176.089 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 71.0 mttt -107.36 135.69 48.43 Favored 'General case' 0 N--CA 1.495 1.782 0 C-N-CA 123.43 0.692 . . . . 0.0 111.656 -177.674 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 18.3 p90 -150.42 111.23 4.29 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 123.346 0.658 . . . . 0.0 109.946 178.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 4.8 t70 50.56 57.85 6.16 Favored 'General case' 0 N--CA 1.497 1.894 0 N-CA-C 116.304 1.965 . . . . 0.0 116.304 166.578 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 91.26 -44.8 2.8 Favored Glycine 0 CA--C 1.55 2.267 0 N-CA-C 116.789 1.476 . . . . 0.0 116.789 -171.62 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 19.6 mt-30 -92.34 134.72 34.65 Favored 'General case' 0 N--CA 1.489 1.52 0 CA-C-N 118.234 1.017 . . . . 0.0 111.577 -174.036 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -113.53 157.8 21.56 Favored 'General case' 0 N--CA 1.491 1.62 0 CA-C-O 121.612 0.72 . . . . 0.0 112.028 172.775 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 14.6 t -140.78 120.27 13.19 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 158.604 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 39.9 p -90.62 125.36 35.61 Favored 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 122.661 0.385 . . . . 0.0 110.519 172.15 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 5.5 mp -102.06 80.52 2.0 Allowed 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 177.57 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 71.1 t -88.69 105.71 16.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 -170.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 83.8 mtt85 -103.5 123.34 46.71 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 123.536 0.734 . . . . 0.0 109.742 -176.653 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -144.46 131.45 20.41 Favored 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 122.805 0.442 . . . . 0.0 110.974 -172.023 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -81.12 116.0 20.82 Favored 'General case' 0 N--CA 1.487 1.405 0 CA-C-O 121.281 0.562 . . . . 0.0 111.327 -179.131 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 86.1 mt -123.88 107.1 18.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 N-CA-C 104.66 -2.348 . . . . 0.0 104.66 176.518 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 58.4 50.48 9.37 Favored 'General case' 0 N--CA 1.5 2.029 0 N-CA-C 114.945 1.461 . . . . 0.0 114.945 176.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 66.91 18.13 68.3 Favored Glycine 0 CA--C 1.554 2.516 0 N-CA-C 119.758 2.663 . . . . 0.0 119.758 -171.833 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 38.8 mtmm -126.78 131.3 51.31 Favored 'General case' 0 N--CA 1.489 1.486 0 CA-C-N 119.981 1.891 . . . . 0.0 109.106 -173.626 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 14.1 tp -79.22 107.59 12.1 Favored 'General case' 0 CA--C 1.558 1.255 0 C-N-CA 123.334 0.654 . . . . 0.0 109.38 178.124 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 33.6 mm -99.54 100.41 10.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 N-CA-C 106.569 -1.641 . . . . 0.0 106.569 -175.255 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 29.8 tp -92.12 99.85 12.58 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 124.16 0.984 . . . . 0.0 109.647 178.234 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' THR . . . . . 0.446 HG23 ' HG1' ' A' ' 125' ' ' THR . 1.8 p -86.84 114.67 23.69 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 123.689 0.796 . . . . 0.0 109.589 171.839 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 85.1 mt -101.96 89.05 3.51 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 123.971 0.908 . . . . 0.0 108.979 -176.36 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.425 ' HG1' ' CG2' ' A' ' 123' ' ' VAL . 7.6 m -100.4 108.93 21.06 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 108.798 -0.815 . . . . 0.0 108.798 -171.682 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 2.2 t60 -76.86 -63.31 1.38 Allowed 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 122.454 0.301 . . . . 0.0 111.348 167.578 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -165.37 -76.47 0.03 OUTLIER Glycine 0 N--CA 1.479 1.543 0 N-CA-C 109.499 -1.441 . . . . 0.0 109.499 178.699 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 72.9 m -73.28 -54.42 8.45 Favored 'General case' 0 CA--C 1.568 1.668 0 CA-C-O 118.693 -0.67 . . . . 0.0 112.787 169.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -97.4 112.62 24.38 Favored 'General case' 0 N--CA 1.483 1.207 0 CA-C-N 119.405 1.002 . . . . 0.0 112.552 -172.505 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.425 ' CG2' ' HG1' ' A' ' 118' ' ' THR . 6.0 p -95.91 127.63 47.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 C-N-CA 123.825 0.85 . . . . 0.0 110.058 169.187 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 44.0 t -100.81 108.1 19.81 Favored 'General case' 0 N--CA 1.481 1.102 0 CA-C-O 121.062 0.458 . . . . 0.0 111.261 171.428 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' THR . . . . . 0.446 ' HG1' HG23 ' A' ' 116' ' ' THR . 47.8 m -84.48 112.06 20.04 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 176.413 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 37.6 mtt180 -104.29 116.0 31.39 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 123.259 0.624 . . . . 0.0 110.114 175.045 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 92.9 m -90.09 129.32 36.4 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 173.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 58.7 m-85 -124.93 129.67 50.83 Favored 'General case' 0 CA--C 1.559 1.29 0 C-N-CA 123.546 0.738 . . . . 0.0 109.283 179.081 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -94.54 154.28 17.47 Favored 'General case' 0 N--CA 1.494 1.757 0 CA-C-O 122.326 1.06 . . . . 0.0 111.347 167.147 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 70.9 tttt -86.01 116.37 24.19 Favored 'General case' 0 N--CA 1.484 1.25 0 CA-C-N 115.554 -0.748 . . . . 0.0 112.059 -167.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 50.2 tp10 -75.03 -40.95 60.19 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 116.666 2.098 . . . . 0.0 116.666 172.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.97 0 CA-C-O 124.287 1.994 . . . . 0.0 107.882 173.749 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.251 4.0 p . . . . . 0 CA--C 1.576 1.971 0 N-CA-C 115.18 1.548 . . . . 0.0 115.18 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -77.5 -36.95 52.08 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 115.825 1.787 . . . . 0.0 115.825 -174.345 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -58.3 -24.49 59.75 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 117.714 2.487 . . . . 0.0 117.714 167.054 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -72.46 -19.46 61.56 Favored 'General case' 0 CA--C 1.566 1.566 0 N-CA-C 116.377 1.991 . . . . 0.0 116.377 168.833 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 44.4 mt -81.16 121.74 26.5 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-N 121.228 1.831 . . . . 0.0 111.554 -171.517 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 159.43 -177.23 36.04 Favored Glycine 0 N--CA 1.484 1.88 0 CA-C-O 121.9 0.722 . . . . 0.0 113.583 -179.159 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 63.7 m -92.11 139.79 30.28 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 170.702 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 90.2 m95 -141.19 109.5 5.88 Favored 'General case' 0 N--CA 1.487 1.381 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 -171.391 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 55.8 mttp -100.7 141.52 33.45 Favored 'General case' 0 N--CA 1.49 1.542 0 CA-C-O 121.222 0.534 . . . . 0.0 109.941 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 58.1 tp -68.08 123.01 19.46 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-O 122.178 0.99 . . . . 0.0 112.167 -175.135 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . 0.27 1.0 OUTLIER -103.5 -41.65 7.43 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.751 0 CA-C-N 113.9 -1.5 . . . . 0.0 112.737 -175.337 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -145.85 133.47 20.97 Favored 'General case' 0 N--CA 1.488 1.454 0 CA-C-N 119.922 1.237 . . . . 0.0 108.948 178.1 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 88.7 p -115.54 101.15 8.61 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 122.976 0.51 . . . . 0.0 110.662 175.021 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 59.2 mtpt -87.12 118.33 26.45 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 174.519 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 60.8 m-20 66.55 29.97 8.71 Favored 'General case' 0 N--CA 1.502 2.134 0 N-CA-C 117.173 2.286 . . . . 0.0 117.173 177.069 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.463 ' HB2' ' SG ' ' A' ' 124' ' ' CYS . 18.0 t80 -89.57 69.51 7.85 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 120.235 -1.54 . . . . 0.0 111.857 178.808 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 26.8 m-20 -162.61 -54.22 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 125.684 1.594 . . . . 0.0 108.044 -177.457 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 21.1 t0 -56.61 -45.27 81.56 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 115.422 1.638 . . . . 0.0 115.422 167.387 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 81.6 t80 -51.98 -54.43 29.89 Favored 'General case' 0 CA--C 1.57 1.716 0 N-CA-C 114.787 1.403 . . . . 0.0 114.787 169.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 70.4 mtm -63.98 -46.13 85.97 Favored 'General case' 0 N--CA 1.491 1.575 0 N-CA-C 115.539 1.681 . . . . 0.0 115.539 174.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -57.86 -44.99 86.92 Favored 'General case' 0 CA--C 1.57 1.713 0 N-CA-C 115.5 1.667 . . . . 0.0 115.5 173.582 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 23.3 t -61.51 -37.27 83.11 Favored 'General case' 0 CA--C 1.568 1.645 0 N-CA-C 116.367 1.988 . . . . 0.0 116.367 170.275 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 69.2 mt -64.79 -23.31 67.2 Favored 'General case' 0 CA--C 1.568 1.657 0 N-CA-C 117.96 2.578 . . . . 0.0 117.96 169.24 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 99.49 68.61 0.89 Allowed Glycine 0 N--CA 1.482 1.746 0 CA-C-N 119.416 1.007 . . . . 0.0 112.193 -171.156 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 33.8 t -144.95 112.66 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 N-CA-C 104.375 -2.454 . . . . 0.0 104.375 -177.842 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -70.83 -91.99 0.08 OUTLIER Glycine 0 N--CA 1.486 2.015 0 N-CA-C 117.676 1.83 . . . . 0.0 117.676 -160.763 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . 0.279 40.4 p90 -140.07 -60.91 0.53 Allowed 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 112.977 0.732 . . . . 0.0 112.977 -171.328 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.51 -39.91 92.39 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 115.575 1.695 . . . . 0.0 115.575 172.221 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 71.9 m -71.38 -37.44 71.59 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 113.961 1.097 . . . . 0.0 113.961 171.355 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 66.4 ttp85 -62.22 -42.79 99.63 Favored 'General case' 0 CA--C 1.572 1.795 0 N-CA-C 114.961 1.467 . . . . 0.0 114.961 170.117 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 9.5 tm0? -65.31 -49.87 67.83 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 114.497 1.295 . . . . 0.0 114.497 172.061 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 93.5 t -64.87 -36.68 78.29 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.925 0 CA-C-N 119.489 1.041 . . . . 0.0 113.762 177.72 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -64.6 -37.03 86.16 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 116.94 2.2 . . . . 0.0 116.94 172.688 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 96.6 p -67.65 -40.41 84.52 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 115.675 1.732 . . . . 0.0 115.675 165.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 48.9 ttp -69.35 -35.69 76.12 Favored 'General case' 0 CA--C 1.567 1.622 0 N-CA-C 116.979 2.214 . . . . 0.0 116.979 176.033 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 8.3 t -63.49 -31.4 72.55 Favored 'General case' 0 N--CA 1.498 1.965 0 N-CA-C 118.488 2.773 . . . . 0.0 118.488 -167.501 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . 0.261 34.2 ttpt 75.25 90.37 0.06 OUTLIER Pre-proline 0 CA--C 1.573 1.833 0 C-N-CA 124.832 1.253 . . . . 0.0 112.128 177.285 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -72.62 125.32 10.49 Favored 'Trans proline' 0 C--N 1.369 1.634 0 C-N-CA 123.292 2.661 . . . . 0.0 114.501 -176.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 97.9 m -97.06 92.71 6.19 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 -179.185 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 57.4 m -86.19 110.32 19.51 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 123.12 0.568 . . . . 0.0 110.099 -173.598 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 95.1 mt -101.64 110.31 28.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 N-CA-C 106.811 -1.552 . . . . 0.0 106.811 178.609 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 59.3 mt -100.48 116.19 43.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 -179.143 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 4.5 tm-20 -136.63 110.95 8.44 Favored 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 -171.506 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 81.7 tttt -95.0 113.24 24.92 Favored 'General case' 0 CA--C 1.554 1.126 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 171.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 14.6 t-20 -82.2 -58.65 2.86 Favored 'General case' 0 CA--C 1.564 1.511 0 C-N-CA 123.243 0.617 . . . . 0.0 112.478 -178.083 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -132.63 -95.55 0.6 Allowed Glycine 0 N--CA 1.483 1.816 0 N-CA-C 109.18 -1.568 . . . . 0.0 109.18 169.45 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -79.8 -30.9 40.68 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 114.917 1.451 . . . . 0.0 114.917 163.398 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 39.8 mm -77.93 111.85 15.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 CA-C-N 119.311 0.96 . . . . 0.0 109.507 -175.047 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 2.0 mt -78.72 137.95 38.02 Favored 'General case' 0 CA--C 1.561 1.376 0 C-N-CA 123.254 0.622 . . . . 0.0 110.379 160.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 10.7 m -133.72 103.43 5.87 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 -177.438 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 9.1 tt -96.7 112.31 24.11 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 107.358 -1.349 . . . . 0.0 107.358 177.095 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 89.4 mttt -112.87 98.88 7.47 Favored 'General case' 0 N--CA 1.485 1.285 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 -164.676 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 28.4 m -87.98 95.14 10.01 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.327 -0.858 . . . . 0.0 109.22 -174.467 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 77.8 m80 -85.03 28.83 0.68 Allowed 'General case' 0 CA--C 1.573 1.84 0 N-CA-C 116.59 2.07 . . . . 0.0 116.59 -173.273 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . 0.271 17.5 m -145.17 -94.24 0.1 Allowed 'General case' 0 CA--C 1.553 1.081 0 N-CA-C 105.29 -2.115 . . . . 0.0 105.29 153.138 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . 0.444 2.9 t 44.88 23.49 0.08 Allowed 'General case' 0 N--CA 1.501 2.095 0 N-CA-C 119.076 2.991 . . . . 0.0 119.076 -170.615 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . 0.33 30.4 t80 85.11 -62.39 0.07 Allowed 'General case' 0 N--CA 1.497 1.905 0 C-N-CA 125.548 1.539 . . . . 0.0 111.972 -168.915 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -119.5 128.23 53.77 Favored 'General case' 0 N--CA 1.485 1.307 0 N-CA-C 106.378 -1.712 . . . . 0.0 106.378 175.846 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 42.9 m-20 -70.7 106.77 3.65 Favored 'General case' 0 N--CA 1.491 1.62 0 CA-C-O 120.997 0.427 . . . . 0.0 111.787 -173.814 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 40.4 p -105.2 133.78 49.4 Favored 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 123.532 0.733 . . . . 0.0 110.448 -174.158 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -122.48 122.14 38.24 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 123.344 0.658 . . . . 0.0 109.367 179.517 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 39.2 pt -93.64 136.26 25.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 C-N-CA 123.174 0.59 . . . . 0.0 109.587 163.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 33.0 t -125.02 116.69 22.53 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 173.655 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 41.2 p90 -149.4 148.18 29.16 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 113.837 1.051 . . . . 0.0 113.837 -153.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 62.7 mtpt -111.99 18.89 18.38 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 116.959 2.207 . . . . 0.0 116.959 -171.494 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . 0.28 1.5 mp 57.11 83.86 0.1 Allowed 'General case' 0 N--CA 1.495 1.802 0 CA-C-N 120.74 1.609 . . . . 0.0 114.532 177.678 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 98.02 42.9 2.95 Favored Glycine 0 CA--C 1.548 2.146 0 N-CA-C 116.221 1.248 . . . . 0.0 116.221 -171.429 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 70.8 t -145.08 127.72 10.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 N-CA-C 105.752 -1.944 . . . . 0.0 105.752 -178.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -87.25 116.72 25.53 Favored 'General case' 0 CA--C 1.566 1.566 0 CA-C-O 121.634 0.731 . . . . 0.0 110.129 173.079 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 25.4 p90 -114.91 -172.83 2.2 Favored 'General case' 0 N--CA 1.494 1.745 0 C-N-CA 124.796 1.238 . . . . 0.0 109.733 171.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -117.05 145.13 43.91 Favored 'General case' 0 N--CA 1.487 1.401 0 CA-C-O 123.25 1.5 . . . . 0.0 110.846 168.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 52.2 tp10 -129.34 148.15 51.24 Favored 'General case' 0 N--CA 1.488 1.456 0 CA-C-N 112.804 -1.998 . . . . 0.0 109.928 177.319 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 83.4 m -103.85 124.25 48.6 Favored 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 168.433 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 28.4 p -75.64 168.06 20.72 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-O 121.579 0.704 . . . . 0.0 112.851 -176.536 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -59.62 -29.41 67.99 Favored 'General case' 0 CA--C 1.563 1.454 0 N-CA-C 117.827 2.529 . . . . 0.0 117.827 178.748 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 62.5 m-20 -116.11 67.24 0.71 Allowed 'General case' 0 N--CA 1.491 1.625 0 CA-C-N 119.121 0.873 . . . . 0.0 110.491 165.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 47.06 72.46 0.24 Allowed 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 117.595 2.442 . . . . 0.0 117.595 164.84 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 63.1 mtm-85 -139.68 123.52 17.55 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 171.037 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -71.32 122.57 20.53 Favored 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 123.1 0.56 . . . . 0.0 110.505 164.3 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 32.8 m -138.92 135.09 42.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 -169.818 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 30.5 mmmt -82.17 101.02 10.17 Favored 'General case' 0 N--CA 1.488 1.434 0 CA-C-O 122.418 1.104 . . . . 0.0 110.224 178.267 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 22.4 p -93.1 107.14 18.99 Favored 'General case' 0 CA--C 1.555 1.164 0 CA-C-N 114.117 -1.401 . . . . 0.0 111.821 -170.637 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -113.33 121.26 65.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 174.424 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 1.1 p -131.76 130.42 61.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 C-N-CA 123.921 0.888 . . . . 0.0 109.598 -178.623 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 9.0 t -145.19 153.66 41.59 Favored 'General case' 0 N--CA 1.486 1.356 0 CA-C-O 122.942 1.353 . . . . 0.0 110.407 179.044 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 44.2 tp -86.42 123.58 31.81 Favored 'General case' 0 CA--C 1.562 1.438 0 CA-C-N 114.402 -1.272 . . . . 0.0 110.333 177.68 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -104.93 76.54 1.26 Allowed 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 123.54 0.736 . . . . 0.0 110.581 176.161 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 75.1 -76.4 1.24 Allowed Glycine 0 N--CA 1.487 2.069 0 N-CA-C 114.246 0.458 . . . . 0.0 114.246 -176.551 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -142.91 45.91 0.88 Allowed Glycine 0 CA--C 1.549 2.165 0 CA-C-N 114.428 -0.886 . . . . 0.0 114.293 167.043 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 56.3 mtpt -138.33 118.71 13.74 Favored 'General case' 0 N--CA 1.484 1.237 0 N-CA-C 105.593 -2.002 . . . . 0.0 105.593 178.115 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 4.4 tt -87.94 100.5 12.94 Favored 'General case' 0 CA--C 1.561 1.366 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 -178.482 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 78.6 t -106.33 102.28 13.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 N-CA-C 107.397 -1.334 . . . . 0.0 107.397 -164.466 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 20.5 t-160 -99.97 144.9 28.48 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 123.842 0.857 . . . . 0.0 110.329 173.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 17.8 tp -145.1 125.89 14.32 Favored 'General case' 0 N--CA 1.488 1.426 0 CA-C-O 122.035 0.921 . . . . 0.0 108.551 176.452 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 29.8 mt-30 -113.84 118.38 34.09 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 124.53 1.132 . . . . 0.0 108.615 -177.337 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -116.94 136.59 52.83 Favored 'General case' 0 N--CA 1.495 1.792 0 C-N-CA 123.26 0.624 . . . . 0.0 111.244 -173.351 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 16.7 p90 -153.59 111.02 3.49 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.231 -0.918 . . . . 0.0 110.64 -178.763 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 4.8 t70 55.07 55.0 8.14 Favored 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 116.009 1.855 . . . . 0.0 116.009 166.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 86.08 -45.76 3.52 Favored Glycine 0 CA--C 1.552 2.355 0 N-CA-C 116.389 1.316 . . . . 0.0 116.389 -168.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 25.4 mt-30 -78.09 149.97 33.81 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 123.547 0.739 . . . . 0.0 112.298 -178.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -150.07 150.49 31.8 Favored 'General case' 0 N--CA 1.488 1.451 0 CA-C-O 121.323 0.582 . . . . 0.0 111.735 175.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 14.2 t -128.47 124.95 37.44 Favored 'General case' 0 N--CA 1.49 1.56 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.353 170.189 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 36.1 p -85.99 134.19 33.88 Favored 'General case' 0 N--CA 1.492 1.665 0 CA-C-O 121.606 0.717 . . . . 0.0 110.251 168.032 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 5.2 mp -116.74 86.03 2.43 Favored 'General case' 0 CA--C 1.562 1.404 0 N-CA-C 106.727 -1.583 . . . . 0.0 106.727 176.159 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 52.1 t -94.22 100.11 10.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.775 0 N-CA-C 107.742 -1.206 . . . . 0.0 107.742 -170.076 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 20.0 mmt180 -90.0 126.27 35.69 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 123.929 0.891 . . . . 0.0 109.915 178.14 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -150.76 131.15 13.73 Favored 'General case' 0 N--CA 1.494 1.76 0 C-N-CA 122.605 0.362 . . . . 0.0 111.938 -172.016 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -77.69 117.53 19.19 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.5 -0.75 . . . . 0.0 111.403 175.378 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 84.3 mt -125.17 105.6 15.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 N-CA-C 104.764 -2.31 . . . . 0.0 104.764 176.653 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 57.16 53.73 7.53 Favored 'General case' 0 N--CA 1.499 1.978 0 N-CA-C 114.246 1.202 . . . . 0.0 114.246 177.63 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 79.65 -27.45 2.55 Favored Glycine 0 CA--C 1.555 2.574 0 N-CA-C 119.097 2.399 . . . . 0.0 119.097 -169.389 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 38.4 mtmm -102.28 131.61 48.75 Favored 'General case' 0 N--CA 1.486 1.336 0 CA-C-N 119.497 1.648 . . . . 0.0 110.214 -164.16 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 49.0 tp -83.98 114.21 21.54 Favored 'General case' 0 CA--C 1.556 1.195 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.797 -176.2 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 33.3 mm -102.88 108.82 25.11 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 -171.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 53.5 tp -89.16 111.06 21.75 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 123.9 0.88 . . . . 0.0 109.298 172.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 90.0 m -101.68 110.6 22.62 Favored 'General case' 0 N--CA 1.494 1.725 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 -179.421 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 97.7 mt -104.01 91.18 3.85 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 123.726 0.811 . . . . 0.0 110.227 -172.439 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 7.4 m -107.78 105.4 15.22 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 -175.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 16.7 t60 -83.07 -64.3 1.2 Allowed 'General case' 0 N--CA 1.493 1.684 0 C-N-CA 123.176 0.591 . . . . 0.0 111.631 172.3 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -152.2 -89.88 0.07 OUTLIER Glycine 0 N--CA 1.479 1.524 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 174.081 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 12.0 t -92.13 41.16 1.06 Allowed 'General case' 0 CA--C 1.577 1.995 0 N-CA-C 114.369 1.248 . . . . 0.0 114.369 169.825 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -158.86 97.69 1.43 Allowed 'General case' 0 N--CA 1.485 1.278 0 O-C-N 120.874 -1.141 . . . . 0.0 109.45 175.419 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 4.0 p -97.01 120.34 46.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 C-N-CA 123.842 0.857 . . . . 0.0 109.409 172.763 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' CYS . . . . . 0.463 ' SG ' ' HB2' ' A' ' 16' ' ' PHE . 41.4 t -112.03 102.87 11.06 Favored 'General case' 0 CA--C 1.557 1.214 0 CA-C-O 121.448 0.642 . . . . 0.0 110.943 177.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 90.5 m -92.43 110.19 21.59 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 123.756 0.822 . . . . 0.0 109.117 -176.367 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 38.4 mtm180 -113.26 121.07 43.32 Favored 'General case' 0 N--CA 1.488 1.475 0 C-N-CA 123.235 0.614 . . . . 0.0 110.912 -170.713 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 89.3 m -87.96 136.3 33.03 Favored 'General case' 0 N--CA 1.492 1.643 0 C-N-CA 123.751 0.82 . . . . 0.0 110.74 179.535 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 45.0 m-85 -130.66 125.98 35.4 Favored 'General case' 0 CA--C 1.56 1.343 0 C-N-CA 123.796 0.838 . . . . 0.0 109.162 -179.185 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -95.55 153.58 17.64 Favored 'General case' 0 N--CA 1.495 1.792 0 CA-C-O 122.239 1.018 . . . . 0.0 111.435 169.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 72.2 tttt -85.44 119.34 25.68 Favored 'General case' 0 N--CA 1.485 1.318 0 CA-C-N 115.221 -0.9 . . . . 0.0 111.559 -170.368 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -103.36 45.73 0.95 Allowed 'General case' 0 N--CA 1.492 1.675 0 N-CA-C 113.655 0.984 . . . . 0.0 113.655 176.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.02 0 CA-C-O 124.327 2.013 . . . . 0.0 107.841 -178.987 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.258 5.6 p . . . . . 0 CA--C 1.577 1.984 0 N-CA-C 115.993 1.849 . . . . 0.0 115.993 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -66.16 -40.08 90.27 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 116.27 1.952 . . . . 0.0 116.27 -176.343 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -59.53 -29.38 67.85 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 117.442 2.386 . . . . 0.0 117.442 168.687 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -68.26 -24.62 64.91 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 116.243 1.942 . . . . 0.0 116.243 167.728 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 39.3 mt -74.81 120.46 20.38 Favored 'General case' 0 N--CA 1.488 1.456 0 CA-C-N 120.759 1.618 . . . . 0.0 111.476 -174.282 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 162.76 168.95 25.46 Favored Glycine 0 N--CA 1.479 1.531 0 CA-C-O 122.822 1.235 . . . . 0.0 113.471 -173.459 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 78.3 m -86.75 136.42 33.01 Favored 'General case' 0 N--CA 1.49 1.535 0 CA-C-N 114.061 -1.069 . . . . 0.0 108.805 164.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 81.4 m95 -140.65 111.69 7.12 Favored 'General case' 0 N--CA 1.484 1.269 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 -174.258 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 8.9 mtpm? -91.97 145.61 24.4 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.866 -0.522 . . . . 0.0 110.278 173.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 48.7 tp -68.07 124.44 23.43 Favored 'General case' 0 N--CA 1.488 1.466 0 CA-C-O 121.94 0.876 . . . . 0.0 111.497 179.394 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . 0.279 1.2 t -96.91 -45.84 12.82 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.79 0 CA-C-N 114.313 -1.312 . . . . 0.0 112.032 177.563 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 51.5 t0 -144.19 129.35 18.68 Favored 'General case' 0 N--CA 1.49 1.528 0 CA-C-N 119.989 1.268 . . . . 0.0 109.806 -177.107 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 75.7 p -104.69 102.3 11.89 Favored 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 123.217 0.607 . . . . 0.0 110.57 169.153 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 61.1 mtpt -101.12 111.45 23.67 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 -178.798 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.256 30.8 m-20 71.12 21.14 4.92 Favored 'General case' 0 N--CA 1.505 2.287 0 N-CA-C 117.028 2.232 . . . . 0.0 117.028 -177.46 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 27.1 t80 -67.36 -47.4 70.54 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 119.989 -1.694 . . . . 0.0 114.548 -178.588 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -40.82 -48.57 3.09 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 118.399 2.74 . . . . 0.0 118.399 161.602 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 18.3 t0 -59.54 -52.87 63.69 Favored 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 115.067 1.506 . . . . 0.0 115.067 172.815 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 93.1 t80 -52.16 -50.29 62.1 Favored 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 115.64 1.719 . . . . 0.0 115.64 170.281 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 40.8 mmm -62.49 -51.76 66.18 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 114.804 1.409 . . . . 0.0 114.804 -179.637 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 21.7 tptm -60.36 -37.11 79.69 Favored 'General case' 0 CA--C 1.571 1.759 0 N-CA-C 115.893 1.812 . . . . 0.0 115.893 172.722 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 17.5 t -61.71 -40.07 93.73 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 116.263 1.949 . . . . 0.0 116.263 169.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 80.2 mt -62.03 -23.45 66.46 Favored 'General case' 0 CA--C 1.569 1.692 0 N-CA-C 117.828 2.529 . . . . 0.0 117.828 168.216 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 97.71 67.96 0.93 Allowed Glycine 0 N--CA 1.482 1.729 0 CA-C-N 119.074 0.852 . . . . 0.0 112.046 -166.667 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 41.2 t -143.64 109.99 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 N-CA-C 104.348 -2.464 . . . . 0.0 104.348 177.824 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -68.61 168.37 43.14 Favored Glycine 0 CA--C 1.546 2.016 0 N-CA-C 116.174 1.23 . . . . 0.0 116.174 -177.343 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 25.3 p90 -53.07 -38.6 62.64 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 119.127 3.01 . . . . 0.0 119.127 -170.121 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.32 -45.17 81.19 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 116.003 1.853 . . . . 0.0 116.003 176.48 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 56.0 m -72.51 -35.54 68.15 Favored 'General case' 0 N--CA 1.501 2.101 0 N-CA-C 114.045 1.128 . . . . 0.0 114.045 171.196 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 48.2 ttp180 -54.59 -49.3 70.73 Favored 'General case' 0 CA--C 1.569 1.681 0 N-CA-C 115.463 1.653 . . . . 0.0 115.463 169.092 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 24.1 mm100 -74.22 -39.43 63.11 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 115.388 1.625 . . . . 0.0 115.388 176.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 73.8 t -61.33 -47.08 95.12 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.03 0 CA-C-N 120.129 1.331 . . . . 0.0 113.135 172.589 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -68.58 -31.9 71.42 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 117.204 2.298 . . . . 0.0 117.204 176.141 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 94.0 p -68.62 -43.6 76.03 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 115.552 1.686 . . . . 0.0 115.552 167.467 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 49.7 ttp -60.33 -41.7 94.1 Favored 'General case' 0 CA--C 1.568 1.666 0 N-CA-C 115.782 1.771 . . . . 0.0 115.782 168.447 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 95.0 m -68.3 136.15 53.01 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 124.141 0.976 . . . . 0.0 110.591 170.668 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 5.3 mptp? -106.69 95.96 13.27 Favored Pre-proline 0 CA--C 1.567 1.621 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 175.401 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -83.22 147.12 12.78 Favored 'Trans proline' 0 C--N 1.372 1.804 0 C-N-CA 122.854 2.37 . . . . 0.0 113.452 -172.234 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 44.9 m -98.41 102.94 14.83 Favored 'General case' 0 CA--C 1.563 1.443 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.586 -169.758 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 79.8 m -80.09 113.4 18.24 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 123.896 0.879 . . . . 0.0 109.744 177.687 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 89.3 mt -115.61 107.69 23.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 N-CA-C 106.024 -1.843 . . . . 0.0 106.024 -175.131 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 4.2 mp -97.68 120.23 46.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 N-CA-C 107.378 -1.341 . . . . 0.0 107.378 174.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -134.99 116.2 14.39 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.245 -1.021 . . . . 0.0 108.245 -179.107 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 84.3 tttt -89.02 111.83 22.63 Favored 'General case' 0 CA--C 1.557 1.234 0 C-N-CA 123.175 0.59 . . . . 0.0 110.267 178.04 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 28.3 t30 -99.42 87.91 3.74 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.642 -0.874 . . . . 0.0 108.642 178.729 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 78.82 -96.4 1.43 Allowed Glycine 0 N--CA 1.484 1.869 0 CA-C-N 116.445 -0.343 . . . . 0.0 112.396 -171.817 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 86.4 m-20 -109.22 -17.11 13.92 Favored 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 115.265 1.58 . . . . 0.0 115.265 169.062 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 24.2 mm -93.34 118.46 39.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 CA-C-N 120.512 1.505 . . . . 0.0 109.14 -167.078 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 42.2 mt -84.87 114.33 22.03 Favored 'General case' 0 N--CA 1.486 1.325 0 C-N-CA 123.763 0.825 . . . . 0.0 111.434 179.701 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 87.6 m -102.25 102.29 12.67 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 -178.277 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 8.7 tt -104.15 105.21 15.3 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.307 -0.998 . . . . 0.0 108.307 -179.531 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -108.72 121.48 45.14 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 123.917 0.887 . . . . 0.0 109.565 -178.734 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 91.6 m -101.68 95.11 6.22 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 108.083 -1.081 . . . . 0.0 108.083 179.217 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 17.5 m-70 -81.26 99.79 8.8 Favored 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 123.564 0.745 . . . . 0.0 110.544 -170.312 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 85.6 p -100.09 -24.75 14.51 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 117.198 2.295 . . . . 0.0 117.198 -175.768 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . 0.361 5.9 m 84.61 -40.82 0.06 Allowed 'General case' 0 N--CA 1.506 2.368 0 CA-C-N 120.586 1.539 . . . . 0.0 113.44 -161.667 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 73.4 t80 -62.77 -77.9 0.05 OUTLIER 'General case' 0 CA--C 1.568 1.66 0 C-N-CA 124.487 1.115 . . . . 0.0 111.447 170.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 4.1 mppt? -144.31 131.85 21.03 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 167.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 54.1 t30 -80.11 113.82 18.56 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 123.179 0.591 . . . . 0.0 110.436 176.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 77.5 p -89.26 127.66 35.79 Favored 'General case' 0 N--CA 1.492 1.655 0 C-N-CA 122.855 0.462 . . . . 0.0 110.34 -179.777 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.479 ' HE2' ' HB3' ' A' ' 63' ' ' SER . 4.3 tm-20 -123.51 122.25 37.74 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 123.584 0.753 . . . . 0.0 109.427 -169.408 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 48.7 pt -116.67 126.63 74.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 169.371 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' SER . . . . . 0.479 ' HB3' ' HE2' ' A' ' 61' ' ' GLU . 77.4 p -116.06 101.76 9.03 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 177.815 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 43.1 p90 -132.86 142.4 48.92 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 114.522 1.304 . . . . 0.0 114.522 -157.561 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 30.6 mtpp -98.23 146.72 25.34 Favored 'General case' 0 N--CA 1.489 1.501 0 CA-C-N 115.132 -0.94 . . . . 0.0 109.789 160.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -74.23 113.38 11.37 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 -173.83 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 86.64 45.5 5.47 Favored Glycine 0 CA--C 1.548 2.132 0 N-CA-C 115.848 1.099 . . . . 0.0 115.848 -169.259 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 76.7 t -141.79 121.58 10.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 N-CA-C 106.242 -1.762 . . . . 0.0 106.242 179.663 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -85.69 133.05 34.04 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 123.074 0.55 . . . . 0.0 111.147 175.193 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 52.0 p90 -139.32 149.83 44.67 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 124.006 0.922 . . . . 0.0 111.138 -174.383 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -74.64 133.49 42.14 Favored 'General case' 0 CA--C 1.567 1.607 0 O-C-N 121.234 -0.916 . . . . 0.0 112.703 173.189 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 17.3 tp10 -145.82 136.73 24.5 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 123.362 0.665 . . . . 0.0 110.252 -173.477 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 63.1 m -111.08 128.24 55.81 Favored 'General case' 0 N--CA 1.495 1.791 0 C-N-CA 123.279 0.632 . . . . 0.0 109.545 178.666 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 27.0 p -86.45 164.0 17.23 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 113.195 0.813 . . . . 0.0 113.195 -175.749 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -54.82 -32.17 60.11 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 118.779 2.881 . . . . 0.0 118.779 174.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -77.47 -85.44 0.06 Allowed 'General case' 0 N--CA 1.494 1.774 0 CA-C-N 120.416 1.462 . . . . 0.0 109.23 171.299 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -176.67 87.5 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 165.472 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 52.1 mtm-85 -139.95 115.11 9.76 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 -179.844 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -79.83 114.8 19.03 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 123.032 0.533 . . . . 0.0 109.604 166.589 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 13.9 m -125.47 138.76 53.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 CA-C-O 121.365 0.602 . . . . 0.0 110.116 -167.58 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 71.9 mmtt -84.92 107.95 17.32 Favored 'General case' 0 N--CA 1.488 1.426 0 CA-C-O 121.916 0.865 . . . . 0.0 109.179 170.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 47.3 t -106.95 100.84 10.31 Favored 'General case' 0 CA--C 1.555 1.144 0 CA-C-N 114.907 -1.042 . . . . 0.0 110.381 -161.403 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 6.4 tp -113.15 115.8 50.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 -176.494 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 1.4 p -134.26 126.93 50.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 C-N-CA 123.618 0.767 . . . . 0.0 109.735 -175.758 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 15.3 t -133.01 157.7 44.57 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-O 122.65 1.214 . . . . 0.0 110.98 176.065 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 14.9 tp -88.5 113.81 24.47 Favored 'General case' 0 N--CA 1.489 1.486 0 CA-C-N 114.833 -1.076 . . . . 0.0 108.505 168.36 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -107.0 87.22 2.46 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 123.322 0.649 . . . . 0.0 109.415 -174.518 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 61.4 48.26 86.15 Favored Glycine 0 CA--C 1.551 2.311 0 N-CA-C 117.262 1.665 . . . . 0.0 117.262 -174.265 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 69.36 26.42 74.58 Favored Glycine 0 CA--C 1.556 2.625 0 N-CA-C 118.662 2.225 . . . . 0.0 118.662 -167.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.17 109.87 5.76 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 107.151 -1.426 . . . . 0.0 107.151 -175.77 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 4.6 tt -88.63 106.28 18.22 Favored 'General case' 0 CA--C 1.56 1.343 0 CA-C-O 121.705 0.764 . . . . 0.0 111.249 -162.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 83.2 t -103.72 110.71 30.89 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 N-CA-C 107.113 -1.44 . . . . 0.0 107.113 -170.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 23.2 t-160 -103.75 138.82 39.83 Favored 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 124.023 0.929 . . . . 0.0 109.554 173.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 41.2 tp -132.52 121.1 22.79 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 107.837 -1.172 . . . . 0.0 107.837 173.413 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 29.9 mt-30 -106.51 129.47 54.46 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 124.198 0.999 . . . . 0.0 108.515 172.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 46.1 mtpt -129.86 130.31 45.05 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.809 -0.557 . . . . 0.0 110.065 -169.471 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 26.3 p90 -154.46 112.16 3.46 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.384 -0.823 . . . . 0.0 111.193 -175.834 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . 0.341 13.2 t70 66.67 -108.73 0.13 Allowed 'General case' 0 N--CA 1.495 1.781 0 C-N-CA 124.582 1.153 . . . . 0.0 112.457 170.527 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -116.42 44.82 1.38 Allowed Glycine 0 N--CA 1.488 2.163 0 CA-C-N 118.887 0.767 . . . . 0.0 115.007 165.096 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 14.9 mt-30 -152.3 126.52 9.23 Favored 'General case' 0 N--CA 1.484 1.273 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 178.704 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 13.4 mp0 -139.41 130.86 27.0 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 -179.194 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 5.2 t -125.13 134.25 52.51 Favored 'General case' 0 N--CA 1.495 1.805 0 C-N-CA 123.144 0.578 . . . . 0.0 111.569 -178.4 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 57.8 p -95.53 138.64 32.92 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-O 121.596 0.712 . . . . 0.0 111.705 172.144 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 5.9 mp -113.6 82.11 1.63 Allowed 'General case' 0 CA--C 1.563 1.449 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 173.812 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 48.1 t -90.73 112.59 25.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 -169.147 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 83.4 mtt85 -106.13 127.7 53.38 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 123.021 0.528 . . . . 0.0 110.086 -177.383 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 8.7 pm0 -139.62 132.86 29.83 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 123.234 0.614 . . . . 0.0 110.816 -178.665 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -80.19 112.92 17.97 Favored 'General case' 0 N--CA 1.487 1.404 0 CA-C-O 121.355 0.597 . . . . 0.0 110.892 175.792 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 73.2 mt -118.71 107.06 20.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 N-CA-C 104.805 -2.294 . . . . 0.0 104.805 176.486 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 59.3 49.85 8.49 Favored 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 114.692 1.367 . . . . 0.0 114.692 177.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 63.32 21.18 64.03 Favored Glycine 0 CA--C 1.555 2.572 0 N-CA-C 119.726 2.65 . . . . 0.0 119.726 -170.629 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 49.0 mtpt -130.95 131.4 44.4 Favored 'General case' 0 N--CA 1.488 1.47 0 CA-C-N 119.713 1.756 . . . . 0.0 108.665 -173.178 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 20.5 tp -81.91 108.53 15.49 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.312 0.645 . . . . 0.0 109.95 -175.155 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 29.8 mm -100.59 103.23 14.53 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 N-CA-C 106.463 -1.681 . . . . 0.0 106.463 -175.872 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 23.9 tp -92.03 98.28 11.46 Favored 'General case' 0 CA--C 1.56 1.328 0 C-N-CA 124.04 0.936 . . . . 0.0 109.47 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 90.8 m -88.12 109.12 19.64 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 124.291 1.036 . . . . 0.0 108.729 178.019 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 90.3 mt -100.29 93.75 5.84 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 124.045 0.938 . . . . 0.0 109.164 -172.449 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 4.7 m -106.41 112.53 25.58 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 -172.291 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 19.9 t60 -100.65 -75.27 0.59 Allowed 'General case' 0 N--CA 1.491 1.591 0 CA-C-O 118.793 -0.623 . . . . 0.0 110.492 172.553 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -142.2 -97.91 0.29 Allowed Glycine 0 N--CA 1.483 1.773 0 N-CA-C 110.558 -1.017 . . . . 0.0 110.558 -178.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 8.2 t -89.1 30.78 0.92 Allowed 'General case' 0 N--CA 1.5 2.051 0 N-CA-C 115.498 1.666 . . . . 0.0 115.498 173.468 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -158.44 107.72 2.01 Favored 'General case' 0 N--CA 1.481 1.114 0 O-C-N 121.045 -1.034 . . . . 0.0 108.979 177.351 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 7.5 p -108.56 126.35 65.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 C-N-CA 123.583 0.753 . . . . 0.0 109.827 175.231 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 40.9 t -109.87 106.94 16.71 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 123.003 0.521 . . . . 0.0 111.851 179.033 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 77.5 m -90.18 100.51 13.32 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 178.866 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 33.5 mtm180 -99.41 121.13 40.69 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 123.108 0.563 . . . . 0.0 110.552 -174.667 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 95.7 m -89.78 131.27 35.82 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 123.438 0.695 . . . . 0.0 109.822 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 42.0 m-85 -127.26 131.13 50.61 Favored 'General case' 0 CA--C 1.559 1.297 0 C-N-CA 123.612 0.765 . . . . 0.0 109.587 178.634 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -96.31 150.12 20.92 Favored 'General case' 0 CA--C 1.56 1.358 0 CA-C-O 121.943 0.878 . . . . 0.0 111.457 172.481 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 67.4 tttt -80.77 127.07 32.09 Favored 'General case' 0 N--CA 1.486 1.33 0 CA-C-O 121.642 0.734 . . . . 0.0 112.204 -173.439 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 15.2 mm-40 -125.02 52.3 1.59 Allowed 'General case' 0 CA--C 1.563 1.449 0 C-N-CA 124.253 1.021 . . . . 0.0 111.252 -173.438 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.968 0 CA-C-O 123.057 1.408 . . . . 0.0 109.989 -163.688 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 79.0 t . . . . . 0 CA--C 1.559 1.3 0 N-CA-C 106.605 -1.628 . . . . 0.0 106.605 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -145.45 -53.36 0.28 Allowed 'General case' 0 N--CA 1.494 1.749 0 C-N-CA 123.9 0.88 . . . . 0.0 111.242 -175.373 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -57.8 -27.43 63.11 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 117.066 2.247 . . . . 0.0 117.066 161.571 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -63.8 -20.52 65.85 Favored 'General case' 0 CA--C 1.568 1.659 0 N-CA-C 117.209 2.3 . . . . 0.0 117.209 165.189 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 64.7 mt -82.45 120.16 25.11 Favored 'General case' 0 N--CA 1.487 1.425 0 CA-C-N 121.034 1.743 . . . . 0.0 111.361 -169.239 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 155.99 173.25 24.36 Favored Glycine 0 CA--C 1.543 1.83 0 CA-C-O 122.542 1.079 . . . . 0.0 113.013 -171.734 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.437 ' HG1' HG12 ' A' ' 41' ' ' ILE . 76.9 m -85.73 140.75 30.24 Favored 'General case' 0 N--CA 1.492 1.673 0 CA-C-N 114.548 -0.826 . . . . 0.0 109.475 168.21 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 88.7 m95 -140.68 112.86 7.82 Favored 'General case' 0 N--CA 1.485 1.319 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 -174.034 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 51.2 mtpt -99.11 147.86 24.65 Favored 'General case' 0 N--CA 1.494 1.74 0 CA-C-O 121.548 0.689 . . . . 0.0 110.702 177.069 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 61.8 tp -69.87 131.67 44.82 Favored 'General case' 0 N--CA 1.488 1.475 0 CA-C-O 121.847 0.832 . . . . 0.0 112.856 -175.586 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . 0.271 0.9 OUTLIER -116.7 -39.27 2.4 Favored 'Isoleucine or valine' 0 CA--C 1.576 1.971 0 CA-C-N 114.335 -1.302 . . . . 0.0 112.434 -176.87 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -136.22 132.63 36.13 Favored 'General case' 0 N--CA 1.491 1.618 0 CA-C-N 120.513 1.506 . . . . 0.0 109.474 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 83.5 p -128.52 90.41 3.06 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-O 121.5 0.667 . . . . 0.0 111.031 176.509 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -100.56 124.25 45.88 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 123.569 0.748 . . . . 0.0 109.26 177.827 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.267 57.2 m-20 71.33 16.13 6.17 Favored 'General case' 0 N--CA 1.506 2.367 0 N-CA-C 117.677 2.473 . . . . 0.0 117.677 177.788 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 20.4 t80 -70.41 -40.08 74.06 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 115.77 1.767 . . . . 0.0 115.77 -176.371 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -63.86 -29.5 70.68 Favored 'General case' 0 N--CA 1.499 1.995 0 N-CA-C 116.053 1.872 . . . . 0.0 116.053 170.55 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 27.8 t0 -64.45 -49.21 72.37 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 114.527 1.306 . . . . 0.0 114.527 165.329 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 90.9 t80 -52.45 -52.85 51.96 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 115.311 1.597 . . . . 0.0 115.311 172.203 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 77.9 mtm -62.02 -41.3 97.95 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 115.295 1.591 . . . . 0.0 115.295 175.053 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.4 tmtp? -58.77 -44.75 90.73 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 115.276 1.584 . . . . 0.0 115.276 168.818 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 49.3 m -58.72 -38.24 77.91 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 116.332 1.975 . . . . 0.0 116.332 172.009 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 80.3 mt -65.79 -41.38 92.01 Favored 'General case' 0 CA--C 1.567 1.6 0 N-CA-C 116.368 1.988 . . . . 0.0 116.368 169.516 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 113.7 76.33 0.72 Allowed Glycine 0 N--CA 1.483 1.778 0 N-CA-C 111.055 -0.818 . . . . 0.0 111.055 -171.467 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 67.5 t -141.98 123.04 12.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 N-CA-C 105.512 -2.032 . . . . 0.0 105.512 -175.445 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -69.41 160.29 52.83 Favored Glycine 0 CA--C 1.548 2.119 0 N-CA-C 115.948 1.139 . . . . 0.0 115.948 179.143 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 28.7 p90 -54.57 -41.25 69.62 Favored 'General case' 0 N--CA 1.498 1.95 0 N-CA-C 118.726 2.861 . . . . 0.0 118.726 -171.091 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.59 -43.31 94.22 Favored 'General case' 0 CA--C 1.564 1.499 0 N-CA-C 115.594 1.702 . . . . 0.0 115.594 173.769 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 58.7 m -67.28 -35.11 78.81 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 114.53 1.308 . . . . 0.0 114.53 170.064 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 58.1 mtm180 -58.36 -48.48 80.45 Favored 'General case' 0 N--CA 1.493 1.718 0 CA-C-N 120.407 1.458 . . . . 0.0 114.911 168.398 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 37.2 mm-40 -68.57 -39.79 80.86 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 115.455 1.65 . . . . 0.0 115.455 177.565 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 74.6 t -60.97 -47.84 91.74 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.019 0 CA-C-N 119.656 1.117 . . . . 0.0 113.103 169.622 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -67.74 -39.19 84.27 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 117.032 2.234 . . . . 0.0 117.032 178.544 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 87.8 p -65.52 -39.11 91.43 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 116.175 1.917 . . . . 0.0 116.175 168.53 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 54.7 tpp -66.87 -40.82 87.95 Favored 'General case' 0 CA--C 1.566 1.589 0 N-CA-C 115.997 1.851 . . . . 0.0 115.997 173.636 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 5.8 t -75.37 161.93 28.83 Favored 'General case' 0 N--CA 1.493 1.682 0 CA-C-N 119.428 1.013 . . . . 0.0 112.846 179.211 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 3.5 mtmt -99.28 104.0 23.9 Favored Pre-proline 0 CA--C 1.568 1.649 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 170.706 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -77.93 90.92 1.22 Allowed 'Trans proline' 0 CA--C 1.56 1.782 0 C-N-CA 123.165 2.577 . . . . 0.0 111.155 178.414 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 52.0 m -79.49 109.24 13.67 Favored 'General case' 0 N--CA 1.488 1.43 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.258 -161.216 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 90.7 m -83.59 116.61 22.68 Favored 'General case' 0 CA--C 1.56 1.349 0 C-N-CA 123.541 0.737 . . . . 0.0 109.468 -174.336 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.437 HG12 ' HG1' ' A' ' 7' ' ' THR . 73.7 mt -113.16 106.99 21.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 N-CA-C 105.805 -1.924 . . . . 0.0 105.805 179.02 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 20.6 mt -100.58 120.91 50.7 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 -177.512 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -136.35 111.82 9.25 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 -170.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 82.1 tttt -91.28 115.7 28.24 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 123.309 0.644 . . . . 0.0 110.789 -177.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 32.8 t30 -116.04 80.87 1.51 Allowed 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 178.821 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 62.91 59.77 8.64 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 116.209 1.244 . . . . 0.0 116.209 -173.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . 0.324 3.9 t70 71.25 -20.15 0.23 Allowed 'General case' 0 N--CA 1.499 2.021 0 N-CA-C 117.415 2.376 . . . . 0.0 117.415 -167.506 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 11.0 mm -82.3 102.73 8.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 CA-C-N 120.19 1.359 . . . . 0.0 107.906 -175.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 45.7 mt -89.0 104.98 17.49 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 123.146 0.578 . . . . 0.0 110.268 -174.069 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 64.1 m -92.19 95.27 9.64 Favored 'General case' 0 N--CA 1.484 1.272 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 -177.714 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 9.8 tt -99.57 101.77 13.08 Favored 'General case' 0 N--CA 1.484 1.234 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 -175.287 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -100.22 108.2 20.24 Favored 'General case' 0 N--CA 1.485 1.303 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 -175.826 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 89.2 m -94.64 99.5 11.61 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 -179.534 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 29.2 m170 -86.97 91.88 8.84 Favored 'General case' 0 N--CA 1.491 1.581 0 CA-C-O 121.578 0.704 . . . . 0.0 111.271 -172.221 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 25.2 t -101.67 153.85 19.4 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 124.003 0.921 . . . . 0.0 110.783 177.447 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 27.6 m -82.77 67.7 8.94 Favored 'General case' 0 N--CA 1.499 1.988 0 CA-C-O 122.081 0.943 . . . . 0.0 110.5 170.497 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 83.6 t80 -167.61 -81.18 0.02 OUTLIER 'General case' 0 CA--C 1.563 1.46 0 N-CA-C 104.755 -2.313 . . . . 0.0 104.755 -178.226 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 61.4 mtpt -147.83 123.82 10.71 Favored 'General case' 0 N--CA 1.486 1.342 0 N-CA-C 106.531 -1.655 . . . . 0.0 106.531 174.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -82.42 119.05 23.69 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.905 -0.497 . . . . 0.0 112.087 -179.748 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 82.7 p -91.81 128.83 37.8 Favored 'General case' 0 N--CA 1.493 1.715 0 C-N-CA 122.837 0.455 . . . . 0.0 110.871 -176.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -117.77 117.08 28.34 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 -179.782 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 37.9 pt -112.11 131.57 63.19 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 174.124 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 79.7 p -116.81 101.88 8.93 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 -179.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 46.6 p90 -130.85 133.11 45.64 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 114.137 1.162 . . . . 0.0 114.137 -161.167 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 30.8 mtpp -88.71 145.05 25.87 Favored 'General case' 0 CA--C 1.561 1.379 0 CA-C-N 114.883 -1.053 . . . . 0.0 109.625 161.299 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -74.79 117.7 16.92 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.831 -0.543 . . . . 0.0 111.882 -173.141 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 86.13 44.07 6.09 Favored Glycine 0 CA--C 1.549 2.157 0 N-CA-C 116.457 1.343 . . . . 0.0 116.457 -168.83 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 98.8 t -140.15 121.14 14.55 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 N-CA-C 106.332 -1.729 . . . . 0.0 106.332 179.767 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -86.09 128.73 34.93 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 123.072 0.549 . . . . 0.0 111.045 176.207 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 47.9 p90 -133.77 128.59 35.14 Favored 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 123.619 0.768 . . . . 0.0 110.475 -174.248 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -71.1 117.43 12.6 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.411 -0.806 . . . . 0.0 112.206 175.207 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 15.7 tp10 -124.38 133.63 53.36 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 123.435 0.694 . . . . 0.0 110.616 -168.349 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 61.0 m -95.24 123.4 38.72 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 172.277 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 43.1 p -85.67 172.99 10.44 Favored 'General case' 0 CA--C 1.568 1.662 0 CA-C-O 121.854 0.835 . . . . 0.0 112.758 -173.813 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -60.76 -35.24 75.9 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 117.344 2.35 . . . . 0.0 117.344 165.739 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -98.09 82.08 2.91 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 106.376 -1.713 . . . . 0.0 106.376 166.293 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -39.35 108.95 0.09 Allowed 'General case' 0 N--CA 1.497 1.881 0 N-CA-C 117.747 2.499 . . . . 0.0 117.747 -155.169 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 39.6 ttm-85 -149.04 126.59 11.64 Favored 'General case' 0 N--CA 1.487 1.389 0 CA-C-N 114.878 -1.055 . . . . 0.0 108.493 -167.727 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.44 117.87 15.71 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 170.58 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 13.6 m -135.57 125.7 42.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 -174.081 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 30.9 mmtp -82.35 103.47 11.94 Favored 'General case' 0 N--CA 1.489 1.476 0 CA-C-O 121.894 0.854 . . . . 0.0 109.472 179.116 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 44.5 t -103.56 100.16 9.99 Favored 'General case' 0 CA--C 1.554 1.119 0 CA-C-N 115.012 -0.994 . . . . 0.0 110.718 -160.677 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 6.5 tp -109.46 120.35 60.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 -178.045 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 1.6 p -139.99 123.64 18.16 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 -173.354 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 14.3 t -133.56 160.35 37.74 Favored 'General case' 0 N--CA 1.487 1.42 0 CA-C-O 122.978 1.371 . . . . 0.0 111.254 179.647 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 63.8 tp -88.64 107.86 19.15 Favored 'General case' 0 N--CA 1.487 1.424 0 CA-C-N 114.44 -1.254 . . . . 0.0 108.523 170.873 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -108.19 87.62 2.54 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 123.377 0.671 . . . . 0.0 109.351 -171.609 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 56.54 49.43 69.58 Favored Glycine 0 CA--C 1.548 2.14 0 N-CA-C 117.614 1.805 . . . . 0.0 117.614 -177.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 102.26 -45.85 1.32 Allowed Glycine 0 N--CA 1.488 2.136 0 N-CA-C 116.852 1.501 . . . . 0.0 116.852 -168.43 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 36.0 ttpt -90.01 130.4 36.21 Favored 'General case' 0 CA--C 1.556 1.175 0 CA-C-N 117.419 0.609 . . . . 0.0 111.704 -169.111 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 4.7 tt -84.53 103.57 13.78 Favored 'General case' 0 CA--C 1.563 1.455 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 178.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 78.8 t -109.65 111.62 36.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 -167.805 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 21.1 t-160 -113.11 125.32 54.24 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 124.416 1.086 . . . . 0.0 109.22 -177.241 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 25.8 tp -122.45 121.81 37.48 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 107.799 -1.185 . . . . 0.0 107.799 175.167 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 93.1 mt-30 -107.69 126.03 52.09 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 171.867 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 10.2 ptpp? -126.88 139.34 53.15 Favored 'General case' 0 N--CA 1.494 1.75 0 CA-C-O 121.343 0.592 . . . . 0.0 112.193 -176.686 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 26.6 p90 -157.57 110.25 2.44 Favored 'General case' 0 N--CA 1.488 1.475 0 C-N-CA 123.781 0.832 . . . . 0.0 108.953 -173.657 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 3.8 t70 54.52 50.69 15.51 Favored 'General case' 0 N--CA 1.499 1.977 0 N-CA-C 116.382 1.993 . . . . 0.0 116.382 167.346 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 86.08 -40.67 3.05 Favored Glycine 0 CA--C 1.554 2.478 0 N-CA-C 117.372 1.709 . . . . 0.0 117.372 -169.495 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 57.6 mt-30 -80.37 136.12 36.32 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 123.921 0.888 . . . . 0.0 111.138 179.727 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -145.61 130.23 17.96 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.827 -0.546 . . . . 0.0 111.442 178.892 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 7.7 t -114.23 134.57 54.83 Favored 'General case' 0 N--CA 1.494 1.74 0 C-N-CA 123.22 0.608 . . . . 0.0 111.009 175.725 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 39.3 p -103.53 129.11 50.67 Favored 'General case' 0 N--CA 1.49 1.575 0 CA-C-O 121.615 0.722 . . . . 0.0 110.885 173.222 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 5.6 mp -106.67 80.72 1.49 Allowed 'General case' 0 CA--C 1.565 1.554 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 176.333 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 67.9 t -88.8 108.21 18.68 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 N-CA-C 108.272 -1.011 . . . . 0.0 108.272 -169.322 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 80.1 mtt85 -100.93 125.66 47.52 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 123.265 0.626 . . . . 0.0 110.352 -177.6 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -143.26 133.6 24.67 Favored 'General case' 0 N--CA 1.491 1.606 0 C-N-CA 123.308 0.643 . . . . 0.0 111.157 -176.042 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -81.33 117.82 22.12 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.66 -0.65 . . . . 0.0 111.356 177.232 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 46.9 mm -120.83 104.9 15.94 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.374 0 N-CA-C 105.115 -2.18 . . . . 0.0 105.115 174.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 22.2 m-20 58.93 50.37 8.51 Favored 'General case' 0 N--CA 1.499 2.02 0 N-CA-C 115.101 1.519 . . . . 0.0 115.101 175.414 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 63.76 27.45 71.13 Favored Glycine 0 CA--C 1.555 2.566 0 N-CA-C 119.242 2.457 . . . . 0.0 119.242 -170.581 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -135.87 127.13 28.26 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-N 119.002 1.401 . . . . 0.0 108.339 -174.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 19.1 tp -78.4 111.46 14.44 Favored 'General case' 0 CA--C 1.559 1.312 0 C-N-CA 123.474 0.709 . . . . 0.0 110.374 -179.215 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 30.4 mm -98.89 100.85 11.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 -177.075 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 30.3 tp -91.5 104.48 16.98 Favored 'General case' 0 CA--C 1.559 1.305 0 C-N-CA 123.85 0.86 . . . . 0.0 109.276 177.65 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 85.5 m -97.42 114.62 26.48 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 124.083 0.953 . . . . 0.0 108.621 -177.161 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 85.2 mt -110.79 96.66 6.31 Favored 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 123.63 0.772 . . . . 0.0 109.375 -168.001 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 11.1 m -105.85 117.14 33.26 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.947 -0.471 . . . . 0.0 109.89 -171.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 53.9 t60 -156.4 122.16 4.88 Favored 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 123.157 0.583 . . . . 0.0 109.53 171.566 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 61.71 64.92 3.57 Favored Glycine 0 N--CA 1.488 2.143 0 N-CA-C 117.237 1.655 . . . . 0.0 117.237 165.605 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . 0.391 5.2 t 46.57 39.86 7.48 Favored 'General case' 0 N--CA 1.5 2.049 0 N-CA-C 117.624 2.453 . . . . 0.0 117.624 -169.041 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -153.14 88.57 1.32 Allowed 'General case' 0 N--CA 1.483 1.203 0 O-C-N 121.531 -0.731 . . . . 0.0 109.276 -176.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 4.5 p -92.9 119.77 41.14 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.401 0 C-N-CA 123.508 0.723 . . . . 0.0 109.582 173.771 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 42.2 t -110.31 100.76 9.58 Favored 'General case' 0 CA--C 1.551 1.014 0 CA-C-O 121.594 0.712 . . . . 0.0 110.25 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 87.6 m -90.74 106.24 18.37 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 -177.287 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 39.4 mtm180 -112.22 121.67 45.57 Favored 'General case' 0 N--CA 1.487 1.375 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.59 -169.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 89.8 m -85.02 136.61 33.51 Favored 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 123.35 0.66 . . . . 0.0 110.033 177.16 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 40.7 m-85 -129.73 126.11 37.46 Favored 'General case' 0 CA--C 1.558 1.259 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 177.308 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -92.62 152.12 19.75 Favored 'General case' 0 N--CA 1.494 1.726 0 CA-C-O 121.943 0.878 . . . . 0.0 111.82 173.23 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 71.2 tttt -83.03 121.58 27.2 Favored 'General case' 0 N--CA 1.486 1.364 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.926 -169.255 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -119.92 51.2 1.2 Allowed 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 124.283 1.033 . . . . 0.0 111.525 -174.302 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 0.829 0 CA-C-O 124.448 2.071 . . . . 0.0 109.882 -161.269 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.297 42.6 t . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 117.257 -1.354 . . . . 0.0 112.982 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -56.68 -41.3 77.07 Favored 'General case' 0 N--CA 1.499 1.995 0 N-CA-C 116.282 1.956 . . . . 0.0 116.282 178.648 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -61.38 -33.88 74.4 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 116.766 2.136 . . . . 0.0 116.766 164.697 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -70.96 -22.67 62.18 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 116.273 1.953 . . . . 0.0 116.273 169.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 82.6 mt -70.84 118.03 13.1 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-N 121.26 1.845 . . . . 0.0 111.476 -175.817 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 154.53 172.3 22.24 Favored Glycine 0 CA--C 1.54 1.632 0 CA-C-O 122.661 1.145 . . . . 0.0 112.941 -176.736 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 45.9 m -87.59 142.54 27.77 Favored 'General case' 0 N--CA 1.489 1.504 0 CA-C-N 114.555 -0.822 . . . . 0.0 109.095 172.624 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 92.1 m95 -136.43 110.73 8.43 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 -173.761 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 39.8 mttp -94.31 142.85 26.94 Favored 'General case' 0 N--CA 1.489 1.478 0 CA-C-O 121.612 0.72 . . . . 0.0 110.73 174.318 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 14.2 tp -70.1 123.55 21.89 Favored 'General case' 0 N--CA 1.487 1.393 0 CA-C-O 122.218 1.008 . . . . 0.0 111.806 -176.859 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . 0.286 1.1 t -96.02 -47.98 12.79 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.741 0 CA-C-N 113.711 -1.586 . . . . 0.0 111.661 175.875 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -142.38 145.38 33.8 Favored 'General case' 0 N--CA 1.49 1.536 0 CA-C-N 119.859 1.209 . . . . 0.0 110.099 176.865 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 88.0 p -121.94 100.87 7.22 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.75 -0.594 . . . . 0.0 110.075 170.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -89.23 119.56 29.82 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 36.7 m-20 67.47 30.83 6.62 Favored 'General case' 0 N--CA 1.5 2.046 0 N-CA-C 116.515 2.042 . . . . 0.0 116.515 178.163 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.427 ' HB2' ' SG ' ' A' ' 124' ' ' CYS . 31.1 t80 -90.4 69.56 6.95 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 120.236 -1.54 . . . . 0.0 111.955 -179.859 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -159.72 -52.32 0.06 Allowed 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 125.434 1.494 . . . . 0.0 108.689 179.106 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 22.0 t0 -53.81 -41.27 67.14 Favored 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 116.034 1.864 . . . . 0.0 116.034 164.771 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 81.6 t80 -55.03 -53.17 59.22 Favored 'General case' 0 CA--C 1.571 1.754 0 N-CA-C 114.536 1.31 . . . . 0.0 114.536 169.769 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 73.8 mtm -62.83 -38.53 91.14 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 115.879 1.807 . . . . 0.0 115.879 171.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 57.1 mtpt -58.23 -51.2 70.76 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 115.596 1.702 . . . . 0.0 115.596 168.539 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 21.3 t -62.95 -34.58 77.79 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 116.221 1.934 . . . . 0.0 116.221 174.44 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 68.1 mt -66.41 -39.95 89.29 Favored 'General case' 0 CA--C 1.565 1.545 0 N-CA-C 116.084 1.883 . . . . 0.0 116.084 168.364 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 105.46 78.47 1.2 Allowed Glycine 0 CA--C 1.54 1.649 0 CA-C-N 118.807 0.73 . . . . 0.0 111.474 -172.184 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 58.1 t -138.02 123.27 24.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 N-CA-C 105.752 -1.944 . . . . 0.0 105.752 -179.5 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -82.4 -157.93 22.58 Favored Glycine 0 CA--C 1.547 2.087 0 N-CA-C 115.965 1.146 . . . . 0.0 115.965 -177.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 8.6 p90 -69.39 156.61 38.54 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 113.319 0.859 . . . . 0.0 113.319 178.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . 0.317 . . 76.6 -50.1 0.57 Allowed 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 115.647 1.721 . . . . 0.0 115.647 179.616 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 30.4 m -70.98 -36.11 72.37 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 113.903 1.075 . . . . 0.0 113.903 170.322 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 27.8 mtm180 -57.18 -46.88 82.43 Favored 'General case' 0 N--CA 1.499 1.987 0 CA-C-N 120.819 1.645 . . . . 0.0 114.472 162.409 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 3.4 tm0? -66.3 -49.77 65.91 Favored 'General case' 0 CA--C 1.562 1.434 0 N-CA-C 114.756 1.391 . . . . 0.0 114.756 -178.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 95.6 t -65.69 -40.12 86.93 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 CA-C-N 119.42 1.009 . . . . 0.0 113.426 175.146 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -66.26 -39.91 89.79 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 116.383 1.994 . . . . 0.0 116.383 176.368 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 92.8 p -63.78 -40.72 97.34 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 116.144 1.905 . . . . 0.0 116.144 165.794 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 17.9 ttm -60.71 -47.16 87.52 Favored 'General case' 0 CA--C 1.568 1.653 0 N-CA-C 115.861 1.8 . . . . 0.0 115.861 171.752 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 5.4 t -78.79 158.26 28.25 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 113.511 0.93 . . . . 0.0 113.511 -166.302 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 14.1 mptt -102.34 101.69 21.01 Favored Pre-proline 0 CA--C 1.57 1.728 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 175.091 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -77.76 100.39 1.38 Allowed 'Trans proline' 0 CA--C 1.561 1.848 0 C-N-CA 123.027 2.485 . . . . 0.0 111.562 -177.198 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 80.9 m -83.55 102.72 12.34 Favored 'General case' 0 N--CA 1.489 1.486 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.808 -164.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 32.3 m -97.31 112.75 24.43 Favored 'General case' 0 N--CA 1.485 1.279 0 CA-C-O 120.63 0.252 . . . . 0.0 111.243 -167.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 5.2 mp -91.07 107.16 18.34 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.454 0 N-CA-C 107.103 -1.443 . . . . 0.0 107.103 170.774 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 44.9 mt -90.75 123.3 42.85 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 N-CA-C 106.762 -1.57 . . . . 0.0 106.762 167.372 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 15.0 tt0 -134.05 179.54 6.19 Favored 'General case' 0 CA--C 1.567 1.597 0 CA-C-O 121.817 0.817 . . . . 0.0 109.659 -175.233 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.49 157.77 45.83 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-O 122.515 1.15 . . . . 0.0 112.7 -178.865 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 33.2 t30 -150.62 82.59 1.35 Allowed 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 106.257 -1.757 . . . . 0.0 106.257 167.739 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 76.23 -107.96 2.46 Favored Glycine 0 CA--C 1.547 2.072 0 N-CA-C 111.944 -0.462 . . . . 0.0 111.944 -165.15 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -122.68 61.15 1.0 Allowed 'General case' 0 N--CA 1.493 1.696 0 CA-C-O 121.133 0.492 . . . . 0.0 109.9 159.279 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 39.4 mm -124.84 94.86 2.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 N-CA-C 103.368 -2.827 . . . . 0.0 103.368 172.04 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 36.1 mt -89.81 105.5 17.84 Favored 'General case' 0 N--CA 1.483 1.196 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.683 -165.508 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 85.5 m -97.32 100.6 12.05 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 -165.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 9.2 tt -101.9 100.86 11.21 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 107.802 -1.185 . . . . 0.0 107.802 -177.406 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -100.01 106.3 18.06 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 179.856 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 96.3 m -93.38 102.81 15.06 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 -179.616 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 31.4 m-70 -89.98 85.13 6.26 Favored 'General case' 0 N--CA 1.493 1.709 0 CA-C-O 122.132 0.968 . . . . 0.0 110.98 -174.408 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 24.7 t -92.11 161.56 14.71 Favored 'General case' 0 N--CA 1.485 1.319 0 CA-C-N 115.165 -0.925 . . . . 0.0 111.078 173.405 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 35.8 m -82.89 68.09 9.23 Favored 'General case' 0 N--CA 1.499 1.983 0 CA-C-O 121.949 0.881 . . . . 0.0 110.302 170.021 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 71.2 t80 -165.77 -81.98 0.02 OUTLIER 'General case' 0 CA--C 1.561 1.375 0 N-CA-C 105.302 -2.111 . . . . 0.0 105.302 179.384 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 62.6 mtpt -146.69 126.14 13.2 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 176.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -81.91 112.97 19.5 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 122.007 -0.433 . . . . 0.0 111.985 -178.665 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 76.3 p -91.39 128.04 37.06 Favored 'General case' 0 N--CA 1.493 1.683 0 C-N-CA 122.809 0.444 . . . . 0.0 111.433 -173.516 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -111.23 115.92 30.17 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 179.303 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 35.4 pt -114.72 130.42 69.16 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 171.475 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 71.2 p -117.95 116.39 26.82 Favored 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 123.751 0.82 . . . . 0.0 108.983 -179.499 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 51.1 p90 -140.26 140.4 35.74 Favored 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 115.115 1.524 . . . . 0.0 115.115 -160.109 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 52.8 mtmt -102.81 14.3 32.28 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 117.29 2.33 . . . . 0.0 117.29 -172.69 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . 0.291 3.2 mp 61.74 98.81 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.731 0 CA-C-N 120.692 1.587 . . . . 0.0 114.484 177.173 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 86.22 37.27 9.16 Favored Glycine 0 CA--C 1.553 2.419 0 N-CA-C 116.859 1.504 . . . . 0.0 116.859 -167.441 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 88.0 t -139.21 124.67 21.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 -178.569 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -88.76 123.66 33.39 Favored 'General case' 0 CA--C 1.562 1.406 0 C-N-CA 123.55 0.74 . . . . 0.0 110.526 173.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 40.1 p90 -130.35 124.49 32.37 Favored 'General case' 0 N--CA 1.494 1.754 0 C-N-CA 123.605 0.762 . . . . 0.0 110.42 -175.152 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -71.07 117.41 12.54 Favored 'General case' 0 CA--C 1.564 1.512 0 O-C-N 121.599 -0.688 . . . . 0.0 112.505 177.209 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 12.2 tp10 -126.99 133.91 50.47 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 123.742 0.817 . . . . 0.0 110.091 -167.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 45.3 m -91.23 122.83 34.2 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 176.239 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 33.9 p -83.56 167.22 17.56 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 113.019 0.748 . . . . 0.0 113.019 -174.504 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -53.82 -28.01 32.89 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 118.646 2.832 . . . . 0.0 118.646 168.541 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -74.6 -91.14 0.02 OUTLIER 'General case' 0 CA--C 1.57 1.733 0 CA-C-N 119.734 1.152 . . . . 0.0 109.076 168.269 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -176.17 90.16 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 105.143 -2.169 . . . . 0.0 105.143 158.55 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 45.8 mtt-85 -142.19 123.07 14.4 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 122.257 -0.277 . . . . 0.0 110.371 -171.711 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.497 ' H ' ' HD3' ' A' ' 79' ' ' LYS . 0.0 OUTLIER -80.47 93.77 6.09 Favored 'General case' 0 CA--C 1.564 1.511 0 C-N-CA 124.094 0.958 . . . . 0.0 110.679 172.413 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 13.4 m -112.03 130.54 65.51 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 C-N-CA 122.998 0.519 . . . . 0.0 110.676 -167.559 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 1.5 mptm? -84.34 98.53 10.08 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 123.808 0.843 . . . . 0.0 109.339 -179.332 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 72.2 m -94.2 98.25 10.82 Favored 'General case' 0 N--CA 1.483 1.191 0 CA-C-N 115.133 -0.939 . . . . 0.0 110.933 -166.139 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 6.4 tp -107.77 115.44 48.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 -179.295 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.0 p -133.15 131.66 58.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 C-N-CA 124.03 0.932 . . . . 0.0 109.673 -172.639 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 15.1 t -143.68 159.9 41.65 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-O 122.495 1.14 . . . . 0.0 110.577 177.213 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 18.2 tp -93.9 107.13 19.06 Favored 'General case' 0 N--CA 1.489 1.506 0 CA-C-N 115.162 -0.926 . . . . 0.0 108.633 172.129 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -102.88 84.58 2.4 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 123.382 0.673 . . . . 0.0 109.662 -171.84 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 56.5 48.35 76.96 Favored Glycine 0 CA--C 1.548 2.141 0 N-CA-C 117.608 1.803 . . . . 0.0 117.608 -176.088 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 100.38 -47.6 1.25 Allowed Glycine 0 N--CA 1.489 2.172 0 N-CA-C 116.215 1.246 . . . . 0.0 116.215 -166.657 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 30.9 ttpt -84.62 116.33 23.12 Favored 'General case' 0 CA--C 1.556 1.2 0 CA-C-N 117.915 0.858 . . . . 0.0 111.131 -170.075 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 3.0 tt -88.05 101.77 14.11 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-O 121.686 0.755 . . . . 0.0 109.659 -173.005 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 54.3 t -104.66 107.4 22.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 -168.418 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 19.9 t-160 -99.35 140.1 34.02 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 123.943 0.897 . . . . 0.0 109.655 169.679 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 15.6 tp -138.9 124.91 19.96 Favored 'General case' 0 N--CA 1.488 1.44 0 CA-C-O 122.03 0.919 . . . . 0.0 108.803 175.557 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -107.92 126.62 52.9 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 124.603 1.161 . . . . 0.0 108.378 178.537 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -125.45 133.2 52.53 Favored 'General case' 0 N--CA 1.496 1.847 0 C-N-CA 122.986 0.514 . . . . 0.0 110.571 -173.734 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 22.9 p90 -158.18 114.57 2.8 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.125 -0.985 . . . . 0.0 110.5 -176.034 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 11.1 t70 50.21 58.07 5.89 Favored 'General case' 0 N--CA 1.503 2.176 0 N-CA-C 116.704 2.112 . . . . 0.0 116.704 163.508 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 80.89 -25.22 3.56 Favored Glycine 0 CA--C 1.559 2.79 0 N-CA-C 119.212 2.445 . . . . 0.0 119.212 -171.327 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 66.7 mt-30 -102.01 133.79 46.26 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 124.785 1.234 . . . . 0.0 110.464 -179.044 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -141.38 135.78 30.77 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.341 -0.849 . . . . 0.0 112.416 173.165 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 14.9 t -117.13 129.21 55.82 Favored 'General case' 0 N--CA 1.496 1.857 0 C-N-CA 123.302 0.641 . . . . 0.0 111.506 177.635 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 40.3 p -94.7 120.43 34.91 Favored 'General case' 0 N--CA 1.493 1.715 0 C-N-CA 123.306 0.642 . . . . 0.0 110.028 172.346 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 5.2 mp -103.56 90.86 3.8 Favored 'General case' 0 CA--C 1.562 1.428 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 174.729 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 92.9 t -94.99 102.66 13.84 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 N-CA-C 107.567 -1.272 . . . . 0.0 107.567 -174.294 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 45.8 mtt180 -91.5 128.08 37.19 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 122.966 0.506 . . . . 0.0 109.652 172.45 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -147.81 129.56 15.16 Favored 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 123.197 0.599 . . . . 0.0 110.429 -172.035 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -77.11 121.14 23.17 Favored 'General case' 0 N--CA 1.487 1.404 0 CA-C-O 121.865 0.841 . . . . 0.0 112.736 178.647 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . 0.279 1.5 mp -76.41 171.89 1.22 Allowed 'Isoleucine or valine' 0 CA--C 1.575 1.938 0 CA-C-N 114.94 -1.027 . . . . 0.0 109.231 143.12 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -68.62 73.72 0.25 Allowed 'General case' 0 CA--C 1.565 1.543 0 N-CA-C 114.866 1.432 . . . . 0.0 114.866 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 121.22 -56.95 0.61 Allowed Glycine 0 N--CA 1.485 1.911 0 CA-C-N 114.093 -1.412 . . . . 0.0 113.781 -171.003 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 51.1 mttp -91.12 139.72 30.49 Favored 'General case' 0 N--CA 1.487 1.376 0 CA-C-O 121.713 0.768 . . . . 0.0 112.172 -173.307 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 25.1 tp -92.9 135.93 33.7 Favored 'General case' 0 CA--C 1.557 1.247 0 C-N-CA 123.605 0.762 . . . . 0.0 110.741 173.783 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 44.5 mm -114.18 108.68 26.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 -178.156 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 48.8 tp -93.58 106.21 18.2 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 123.813 0.845 . . . . 0.0 109.195 173.108 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 83.7 m -97.74 112.56 24.4 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 -179.669 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 92.9 mt -106.88 98.48 8.14 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 123.698 0.799 . . . . 0.0 109.483 -173.09 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 7.5 m -109.88 115.65 30.2 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 -175.526 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 86.1 t60 -134.21 116.19 15.05 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 108.507 -0.924 . . . . 0.0 108.507 173.147 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 75.2 -111.14 3.26 Favored Glycine 0 N--CA 1.484 1.845 0 C-N-CA 122.928 0.299 . . . . 0.0 113.011 176.167 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 73.4 p -122.37 68.55 0.95 Allowed 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 108.987 -0.745 . . . . 0.0 108.987 163.763 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -160.37 93.96 1.06 Allowed 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 123.368 0.667 . . . . 0.0 109.533 178.674 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 4.9 p -96.51 121.75 47.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 C-N-CA 123.797 0.839 . . . . 0.0 109.801 175.713 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' CYS . . . . . 0.427 ' SG ' ' HB2' ' A' ' 16' ' ' PHE . 43.8 t -116.91 105.46 12.37 Favored 'General case' 0 CA--C 1.555 1.149 0 C-N-CA 123.334 0.654 . . . . 0.0 110.544 -179.466 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 91.7 m -92.54 105.34 17.53 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 123.648 0.779 . . . . 0.0 109.073 -175.252 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 53.6 mtp180 -105.64 116.99 32.88 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 123.144 0.578 . . . . 0.0 109.596 -172.53 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 41.7 m -86.73 141.37 28.94 Favored 'General case' 0 N--CA 1.493 1.701 0 C-N-CA 123.717 0.807 . . . . 0.0 110.511 178.765 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 40.6 m-85 -137.84 135.13 35.92 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 124.094 0.958 . . . . 0.0 109.497 -175.07 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -102.14 155.18 18.37 Favored 'General case' 0 N--CA 1.495 1.778 0 CA-C-O 122.421 1.105 . . . . 0.0 111.712 166.057 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 71.0 tttt -88.33 124.28 33.74 Favored 'General case' 0 N--CA 1.483 1.209 0 CA-C-N 115.199 -0.91 . . . . 0.0 111.816 -168.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -99.17 49.48 0.95 Allowed 'General case' 0 CA--C 1.57 1.738 0 C-N-CA 123.58 0.752 . . . . 0.0 112.354 170.541 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.129 0 CA-C-O 123.2 1.476 . . . . 0.0 108.252 -176.287 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 4.6 p . . . . . 0 CA--C 1.576 1.972 0 N-CA-C 116.227 1.936 . . . . 0.0 116.227 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -66.19 -35.43 80.44 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 116.669 2.1 . . . . 0.0 116.669 -176.045 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -61.0 -27.08 68.05 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 117.514 2.413 . . . . 0.0 117.514 168.128 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -72.18 -20.2 61.62 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 116.037 1.865 . . . . 0.0 116.037 168.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 55.0 mt -78.29 119.65 21.95 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-N 121.034 1.743 . . . . 0.0 111.69 -171.745 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 163.87 175.9 35.22 Favored Glycine 0 N--CA 1.481 1.666 0 CA-C-O 122.251 0.917 . . . . 0.0 113.239 -177.766 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 63.1 m -92.3 137.28 32.49 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 167.847 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 87.3 m95 -138.6 112.58 8.51 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 -170.142 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 52.4 mtmt -99.94 144.37 29.08 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 123.103 0.561 . . . . 0.0 110.228 178.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 25.0 tp -67.72 131.66 46.0 Favored 'General case' 0 N--CA 1.488 1.427 0 CA-C-O 122.371 1.082 . . . . 0.0 112.419 -177.609 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . 0.285 1.0 OUTLIER -111.81 -47.81 6.03 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.797 0 CA-C-N 113.669 -1.605 . . . . 0.0 110.875 179.054 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -137.07 140.12 41.79 Favored 'General case' 0 N--CA 1.487 1.412 0 CA-C-N 119.566 1.075 . . . . 0.0 109.505 175.539 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 78.8 p -132.94 114.48 14.06 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 168.444 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -77.22 -72.41 0.35 Allowed 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 112.532 0.567 . . . . 0.0 112.532 -172.614 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 62.6 m-80 -105.41 47.12 0.89 Allowed 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 113.291 0.848 . . . . 0.0 113.291 -178.854 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 11.9 t80 -92.74 74.18 4.96 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.795 -1.191 . . . . 0.0 110.352 177.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 179.76 -59.82 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 126.082 1.753 . . . . 0.0 106.648 -168.793 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 22.8 t0 -58.42 -46.65 86.06 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 115.01 1.485 . . . . 0.0 115.01 163.85 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 90.0 t80 -51.9 -55.07 22.43 Favored 'General case' 0 CA--C 1.57 1.735 0 N-CA-C 114.896 1.443 . . . . 0.0 114.896 170.315 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 72.9 mtm -62.84 -39.21 93.65 Favored 'General case' 0 CA--C 1.567 1.626 0 N-CA-C 115.947 1.832 . . . . 0.0 115.947 174.816 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 28.9 ttpp -58.63 -46.56 86.82 Favored 'General case' 0 CA--C 1.569 1.686 0 N-CA-C 115.115 1.524 . . . . 0.0 115.115 168.685 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 16.7 t -62.01 -34.83 76.92 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 116.59 2.07 . . . . 0.0 116.59 172.57 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 86.2 mt -65.31 -44.25 88.49 Favored 'General case' 0 CA--C 1.567 1.616 0 N-CA-C 115.64 1.718 . . . . 0.0 115.64 167.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 113.95 70.35 0.52 Allowed Glycine 0 N--CA 1.483 1.808 0 C-N-CA 123.966 0.793 . . . . 0.0 111.889 -172.058 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 66.8 t -127.67 122.27 58.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 N-CA-C 105.586 -2.005 . . . . 0.0 105.586 -176.785 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -63.25 153.92 45.28 Favored Glycine 0 CA--C 1.549 2.211 0 N-CA-C 115.801 1.08 . . . . 0.0 115.801 177.81 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 31.5 p90 -55.2 -42.78 73.73 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 118.663 2.838 . . . . 0.0 118.663 -167.191 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.85 -43.28 93.55 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 115.75 1.759 . . . . 0.0 115.75 175.307 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 63.2 m -69.38 -37.83 77.73 Favored 'General case' 0 N--CA 1.497 1.924 0 N-CA-C 114.185 1.18 . . . . 0.0 114.185 170.689 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 45.5 ttp85 -59.46 -45.37 91.8 Favored 'General case' 0 CA--C 1.57 1.728 0 N-CA-C 115.151 1.537 . . . . 0.0 115.151 171.528 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 46.4 mt-30 -72.71 -39.89 66.6 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 115.104 1.52 . . . . 0.0 115.104 176.077 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 69.4 t -63.68 -48.18 87.84 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 CA-C-N 119.943 1.247 . . . . 0.0 112.443 170.446 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -61.89 -31.17 71.44 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 117.595 2.442 . . . . 0.0 117.595 177.435 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 84.0 p -62.91 -47.04 84.98 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 115.96 1.837 . . . . 0.0 115.96 169.484 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 51.9 tpp -70.76 -34.49 71.89 Favored 'General case' 0 CA--C 1.572 1.824 0 N-CA-C 116.13 1.9 . . . . 0.0 116.13 170.731 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 46.4 m -66.48 144.06 56.71 Favored 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 124.825 1.25 . . . . 0.0 112.538 -179.22 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -108.08 99.89 33.59 Favored Pre-proline 0 CA--C 1.571 1.753 0 CA-C-O 118.38 -0.819 . . . . 0.0 110.028 -177.366 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -75.48 141.68 25.59 Favored 'Trans proline' 0 CA--C 1.561 1.839 0 C-N-CA 123.206 2.604 . . . . 0.0 114.077 -179.689 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 100.0 m -107.47 100.74 10.14 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 -174.135 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 44.2 m -90.72 111.33 22.64 Favored 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 123.666 0.786 . . . . 0.0 109.448 -175.133 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 47.5 mt -102.82 108.09 23.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 N-CA-C 106.629 -1.619 . . . . 0.0 106.629 -178.768 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 33.7 mt -101.91 115.12 43.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 N-CA-C 106.744 -1.576 . . . . 0.0 106.744 -178.641 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -139.39 112.13 7.85 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 -171.385 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 28.1 ttpp -84.4 112.0 19.95 Favored 'General case' 0 CA--C 1.561 1.37 0 CA-C-O 121.43 0.633 . . . . 0.0 110.212 174.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 19.6 t-20 -100.57 92.49 5.15 Favored 'General case' 0 N--CA 1.485 1.32 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 -175.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 77.03 -99.64 1.42 Allowed Glycine 0 N--CA 1.485 1.939 0 N-CA-C 111.197 -0.761 . . . . 0.0 111.197 -166.094 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 25.1 m-20 -133.43 63.52 1.63 Allowed 'General case' 0 N--CA 1.494 1.748 0 CA-C-O 121.073 0.463 . . . . 0.0 109.844 160.17 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 27.2 mm -139.47 104.63 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 N-CA-C 104.994 -2.224 . . . . 0.0 104.994 177.348 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 35.9 mt -74.94 110.58 9.35 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 122.873 0.469 . . . . 0.0 111.527 177.703 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 38.3 m -105.41 101.84 11.35 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 106.266 -1.754 . . . . 0.0 106.266 -179.65 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 9.4 tt -104.65 108.64 20.2 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 -174.241 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 43.7 mttp -109.5 96.81 6.53 Favored 'General case' 0 N--CA 1.483 1.175 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 -165.647 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 60.0 m -87.95 92.7 9.23 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 -177.377 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 70.2 m80 -83.54 91.65 7.46 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 123.824 0.85 . . . . 0.0 110.191 -176.271 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 82.5 p -94.88 4.21 54.08 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 118.427 2.751 . . . . 0.0 118.427 -167.237 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . 0.315 6.8 m 74.46 -46.08 0.6 Allowed 'General case' 0 N--CA 1.504 2.232 0 CA-C-N 120.693 1.588 . . . . 0.0 113.848 -166.286 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 69.9 t80 -71.62 -74.6 0.15 Allowed 'General case' 0 CA--C 1.565 1.553 0 C-N-CA 124.323 1.049 . . . . 0.0 111.661 179.004 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 56.7 mtmt -141.88 120.57 12.6 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 173.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 8.7 p30 -77.03 111.01 12.14 Favored 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 122.969 0.508 . . . . 0.0 111.914 -177.717 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 45.6 p -97.98 130.89 44.81 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-O 121.212 0.53 . . . . 0.0 110.949 -173.471 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 5.4 mp0 -115.65 129.76 56.61 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 123.382 0.673 . . . . 0.0 109.84 179.76 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 49.3 pt -112.79 126.05 70.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 N-CA-C 108.091 -1.078 . . . . 0.0 108.091 168.638 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 39.0 t -109.54 109.68 20.54 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 107.208 -1.405 . . . . 0.0 107.208 175.704 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 42.9 p90 -140.34 141.8 35.64 Favored 'General case' 0 N--CA 1.489 1.501 0 CA-C-O 122.25 1.024 . . . . 0.0 113.737 -164.447 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 55.1 mtmt -100.87 150.96 22.29 Favored 'General case' 0 CA--C 1.562 1.437 0 CA-C-N 114.478 -1.237 . . . . 0.0 109.061 159.729 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -74.46 115.48 14.05 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.564 -0.71 . . . . 0.0 111.894 -171.426 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 89.31 44.59 4.95 Favored Glycine 0 CA--C 1.549 2.186 0 N-CA-C 116.582 1.393 . . . . 0.0 116.582 -166.688 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 92.3 t -136.0 123.66 35.17 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 178.345 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -87.73 132.67 34.05 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 123.464 0.705 . . . . 0.0 110.791 170.668 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 44.9 p90 -145.55 134.42 22.45 Favored 'General case' 0 N--CA 1.494 1.739 0 C-N-CA 123.318 0.647 . . . . 0.0 110.556 -174.399 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -73.04 117.88 15.31 Favored 'General case' 0 CA--C 1.564 1.481 0 O-C-N 121.558 -0.713 . . . . 0.0 112.644 178.207 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 15.1 tp10 -128.97 134.15 48.08 Favored 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 123.626 0.77 . . . . 0.0 110.088 -170.681 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 51.9 m -92.7 121.91 34.58 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 174.097 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 27.1 p -84.31 174.5 10.1 Favored 'General case' 0 N--CA 1.494 1.726 0 CA-C-O 121.663 0.744 . . . . 0.0 112.869 -175.013 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -60.07 -34.68 73.77 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 116.815 2.154 . . . . 0.0 116.815 171.258 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -89.02 31.66 0.86 Allowed 'General case' 0 CA--C 1.58 2.1 0 N-CA-C 114.601 1.334 . . . . 0.0 114.601 167.394 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 22.5 m-20 53.34 67.82 0.94 Allowed 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 115.057 1.503 . . . . 0.0 115.057 174.768 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 46.1 mtm105 -137.64 120.98 16.98 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 109.036 -0.728 . . . . 0.0 109.036 -175.74 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.06 108.99 8.17 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 123.379 0.671 . . . . 0.0 111.305 169.444 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 17.7 m -125.39 142.15 43.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 CA-C-O 121.335 0.588 . . . . 0.0 110.302 -168.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 4.7 mptp? -85.62 98.01 10.42 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 123.629 0.772 . . . . 0.0 109.122 176.575 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 58.0 m -91.38 93.37 9.0 Favored 'General case' 0 N--CA 1.485 1.283 0 CA-C-N 115.262 -0.881 . . . . 0.0 111.12 -170.549 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 6.8 tp -104.71 116.73 49.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 178.322 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 1.5 p -136.52 122.56 29.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 C-N-CA 123.343 0.657 . . . . 0.0 109.55 -169.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 14.9 t -136.88 157.5 46.61 Favored 'General case' 0 N--CA 1.491 1.592 0 CA-C-O 122.629 1.204 . . . . 0.0 111.351 178.384 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 15.2 tp -95.37 119.78 34.47 Favored 'General case' 0 N--CA 1.489 1.514 0 CA-C-N 114.768 -1.106 . . . . 0.0 110.067 177.832 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -106.52 81.23 1.57 Allowed 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 123.205 0.602 . . . . 0.0 110.604 -178.204 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 61.06 46.52 94.38 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 117.673 1.829 . . . . 0.0 117.673 -177.096 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 75.03 35.96 48.03 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 118.206 2.043 . . . . 0.0 118.206 -168.341 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -145.93 104.36 3.84 Favored 'General case' 0 CA--C 1.553 1.077 0 N-CA-C 105.369 -2.086 . . . . 0.0 105.369 -177.774 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -86.33 121.42 28.88 Favored 'General case' 0 N--CA 1.481 1.12 0 CA-C-O 121.903 0.858 . . . . 0.0 110.989 -170.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 61.2 t -122.98 107.42 19.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 N-CA-C 106.103 -1.814 . . . . 0.0 106.103 -166.138 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 20.6 t-160 -110.75 113.34 25.85 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 123.777 0.831 . . . . 0.0 109.78 179.514 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 31.5 tp -107.74 123.25 48.26 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 123.775 0.83 . . . . 0.0 108.857 177.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -110.86 120.8 43.58 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 178.186 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -117.39 137.63 52.35 Favored 'General case' 0 N--CA 1.495 1.796 0 CA-C-N 118.675 0.67 . . . . 0.0 111.134 -178.401 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 22.7 p90 -155.82 109.08 2.72 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.419 -0.8 . . . . 0.0 109.892 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 5.5 t70 55.96 50.16 14.41 Favored 'General case' 0 N--CA 1.499 2.015 0 N-CA-C 116.237 1.94 . . . . 0.0 116.237 168.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 86.99 -43.82 3.26 Favored Glycine 0 CA--C 1.552 2.396 0 N-CA-C 116.706 1.443 . . . . 0.0 116.706 -168.85 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 64.4 mt-30 -73.68 132.23 42.48 Favored 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 123.874 0.87 . . . . 0.0 111.571 179.372 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -141.77 135.02 29.3 Favored 'General case' 0 N--CA 1.49 1.542 0 CA-C-O 121.202 0.525 . . . . 0.0 112.237 176.553 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 13.7 t -118.07 133.26 56.08 Favored 'General case' 0 N--CA 1.495 1.79 0 CA-C-N 115.597 -0.728 . . . . 0.0 111.087 176.818 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 37.4 p -101.84 135.25 43.72 Favored 'General case' 0 N--CA 1.494 1.736 0 CA-C-O 122.057 0.932 . . . . 0.0 110.713 171.047 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 5.4 mp -118.26 85.52 2.37 Favored 'General case' 0 CA--C 1.562 1.415 0 N-CA-C 106.535 -1.654 . . . . 0.0 106.535 -178.575 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 99.5 t -95.02 103.66 14.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 -168.866 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 83.7 mtt85 -94.58 129.29 41.47 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 123.794 0.838 . . . . 0.0 110.181 179.416 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -146.91 132.23 18.51 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 122.849 0.459 . . . . 0.0 110.837 -176.741 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -80.6 114.73 19.7 Favored 'General case' 0 N--CA 1.486 1.337 0 CA-C-O 121.328 0.585 . . . . 0.0 111.315 179.506 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 48.3 mm -118.56 105.06 17.01 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.361 0 N-CA-C 105.075 -2.194 . . . . 0.0 105.075 175.362 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 58.68 50.4 8.95 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 115.204 1.557 . . . . 0.0 115.204 175.854 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 65.6 25.56 71.61 Favored Glycine 0 CA--C 1.555 2.583 0 N-CA-C 119.351 2.501 . . . . 0.0 119.351 -171.072 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 92.6 mttt -133.78 128.45 34.82 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-N 119.203 1.501 . . . . 0.0 108.678 -173.663 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 15.0 tp -78.53 109.71 12.96 Favored 'General case' 0 CA--C 1.558 1.288 0 C-N-CA 123.272 0.629 . . . . 0.0 110.306 -179.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 31.8 mm -98.95 97.34 5.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 N-CA-C 107.192 -1.41 . . . . 0.0 107.192 -175.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 24.6 tp -91.21 104.19 16.78 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 123.972 0.909 . . . . 0.0 109.996 -179.85 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 85.1 m -96.1 108.76 21.23 Favored 'General case' 0 CA--C 1.562 1.43 0 C-N-CA 124.0 0.92 . . . . 0.0 108.804 -176.277 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 92.4 mt -103.04 103.68 13.79 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 123.537 0.735 . . . . 0.0 109.956 -174.491 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 12.8 m -112.18 117.39 32.44 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 -175.402 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 73.5 t60 -152.84 117.16 4.93 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 174.496 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 60.41 61.9 6.59 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 117.418 1.727 . . . . 0.0 117.418 169.462 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . 0.291 3.2 m 52.36 50.28 18.67 Favored 'General case' 0 CA--C 1.576 1.97 0 N-CA-C 114.878 1.436 . . . . 0.0 114.878 -172.206 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -158.87 87.85 0.88 Allowed 'General case' 0 N--CA 1.485 1.291 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 -178.708 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 3.6 p -94.73 113.66 29.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 C-N-CA 123.649 0.78 . . . . 0.0 109.348 175.62 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 45.9 t -103.99 105.62 15.86 Favored 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 123.081 0.552 . . . . 0.0 110.062 176.585 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 91.8 m -90.06 103.52 16.18 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 -179.533 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 69.0 mtp180 -104.02 114.64 29.03 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 123.042 0.537 . . . . 0.0 109.893 -166.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 91.1 m -84.15 129.07 34.92 Favored 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 122.882 0.473 . . . . 0.0 109.905 176.188 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 40.7 m-85 -125.81 127.69 46.51 Favored 'General case' 0 CA--C 1.558 1.253 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 176.241 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -95.34 157.01 16.08 Favored 'General case' 0 N--CA 1.493 1.699 0 CA-C-O 122.431 1.11 . . . . 0.0 111.572 171.08 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 72.8 tttt -91.04 126.37 36.11 Favored 'General case' 0 N--CA 1.484 1.262 0 CA-C-N 115.423 -0.808 . . . . 0.0 112.51 -164.064 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -99.84 51.1 0.92 Allowed 'General case' 0 N--CA 1.497 1.92 0 CA-C-O 121.912 0.863 . . . . 0.0 111.383 167.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.063 0 CA-C-O 123.216 1.484 . . . . 0.0 107.638 -177.459 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.265 5.9 p . . . . . 0 CA--C 1.576 1.955 0 N-CA-C 116.376 1.991 . . . . 0.0 116.376 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -65.71 -37.84 87.53 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 116.449 2.018 . . . . 0.0 116.449 -178.61 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -59.56 -29.85 68.22 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 117.313 2.338 . . . . 0.0 117.313 167.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -69.98 -23.55 63.18 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 116.287 1.958 . . . . 0.0 116.287 168.337 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 58.5 mt -75.0 120.02 19.97 Favored 'General case' 0 N--CA 1.49 1.539 0 CA-C-N 121.028 1.74 . . . . 0.0 111.689 -173.645 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 160.29 176.39 32.33 Favored Glycine 0 CA--C 1.541 1.708 0 CA-C-O 122.447 1.026 . . . . 0.0 113.744 -176.007 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 75.2 m -93.22 135.46 34.4 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 170.495 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 94.2 m95 -138.4 115.63 11.06 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 -169.796 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 24.9 mmmt -102.17 145.65 29.08 Favored 'General case' 0 N--CA 1.492 1.628 0 CA-C-O 121.536 0.684 . . . . 0.0 111.021 178.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 43.9 tp -70.13 125.42 26.73 Favored 'General case' 0 N--CA 1.489 1.477 0 CA-C-O 122.039 0.923 . . . . 0.0 112.118 -176.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . 0.275 1.0 OUTLIER -107.84 -39.26 4.32 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.883 0 CA-C-N 113.997 -1.456 . . . . 0.0 112.435 -178.701 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -137.21 138.0 39.7 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-N 120.305 1.411 . . . . 0.0 109.64 176.15 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 78.3 p -121.56 103.47 8.94 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 167.624 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 8.9 tmtm? -79.92 -78.35 0.17 Allowed 'General case' 0 N--CA 1.491 1.602 0 CA-C-O 118.877 -0.582 . . . . 0.0 112.554 -167.309 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 85.0 m-20 -105.15 48.26 0.84 Allowed 'General case' 0 N--CA 1.498 1.967 0 CA-C-N 118.89 0.768 . . . . 0.0 112.795 177.684 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 10.0 t80 -92.09 75.78 5.44 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.704 -1.247 . . . . 0.0 110.973 -174.341 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -172.21 -61.27 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 124.668 1.187 . . . . 0.0 108.987 -168.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 12.3 t0 -61.66 -38.29 87.2 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 115.859 1.8 . . . . 0.0 115.859 166.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 87.9 t80 -48.74 -53.86 17.28 Favored 'General case' 0 CA--C 1.574 1.893 0 N-CA-C 114.755 1.391 . . . . 0.0 114.755 163.592 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 56.8 mtm -66.24 -29.98 70.34 Favored 'General case' 0 CA--C 1.571 1.768 0 N-CA-C 116.549 2.055 . . . . 0.0 116.549 171.735 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 55.8 mttp -61.18 -48.65 80.56 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 114.942 1.46 . . . . 0.0 114.942 166.459 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 23.1 t -66.26 -32.44 73.86 Favored 'General case' 0 CA--C 1.567 1.599 0 N-CA-C 116.465 2.024 . . . . 0.0 116.465 173.248 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 65.2 mt -66.27 -43.64 85.87 Favored 'General case' 0 CA--C 1.565 1.522 0 N-CA-C 116.084 1.883 . . . . 0.0 116.084 172.372 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 105.84 86.67 1.92 Allowed Glycine 0 N--CA 1.482 1.742 0 N-CA-C 110.744 -0.943 . . . . 0.0 110.744 -170.098 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 41.3 t -140.61 144.11 27.83 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 N-CA-C 107.575 -1.269 . . . . 0.0 107.575 -174.455 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -73.13 163.08 54.91 Favored Glycine 0 CA--C 1.552 2.361 0 O-C-N 120.958 -1.089 . . . . 0.0 115.137 169.045 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 25.2 p90 -62.93 -39.61 95.1 Favored 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 117.071 2.249 . . . . 0.0 117.071 -178.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.45 -45.08 94.71 Favored 'General case' 0 CA--C 1.56 1.347 0 N-CA-C 115.777 1.769 . . . . 0.0 115.777 177.799 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . 0.288 0.6 OUTLIER -81.51 -19.07 42.96 Favored 'General case' 0 N--CA 1.499 2.002 0 N-CA-C 116.177 1.917 . . . . 0.0 116.177 173.141 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 34.3 ttm105 -61.58 -46.92 87.83 Favored 'General case' 0 CA--C 1.57 1.744 0 CA-C-N 121.18 1.809 . . . . 0.0 113.646 160.756 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 22.7 tt0 -62.99 -49.42 74.78 Favored 'General case' 0 CA--C 1.563 1.473 0 N-CA-C 115.282 1.586 . . . . 0.0 115.282 171.414 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 89.1 t -63.66 -43.82 98.25 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 CA-C-O 117.273 -1.346 . . . . 0.0 112.983 174.345 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -63.07 -41.17 99.38 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 116.478 2.029 . . . . 0.0 116.478 177.754 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 97.3 p -61.15 -42.64 98.92 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 116.619 2.081 . . . . 0.0 116.619 168.254 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 48.1 ttp -66.61 -36.85 83.6 Favored 'General case' 0 CA--C 1.572 1.824 0 N-CA-C 116.421 2.008 . . . . 0.0 116.421 169.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 52.3 m -73.29 135.19 44.39 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 124.28 1.032 . . . . 0.0 111.807 -175.578 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -103.74 102.28 29.73 Favored Pre-proline 0 CA--C 1.571 1.77 0 CA-C-N 114.554 -1.203 . . . . 0.0 109.81 175.228 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -76.44 126.19 8.87 Favored 'Trans proline' 0 CA--C 1.562 1.893 0 C-N-CA 123.235 2.624 . . . . 0.0 112.861 -178.134 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 15.4 m -84.59 107.05 16.61 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 -179.828 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 47.5 m -100.93 104.3 15.49 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 -168.614 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 48.9 mt -98.68 112.15 30.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 N-CA-C 106.991 -1.485 . . . . 0.0 106.991 -179.169 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 42.7 mt -106.31 115.11 47.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 N-CA-C 106.733 -1.58 . . . . 0.0 106.733 -177.435 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -139.38 115.06 10.02 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 -173.591 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 84.7 tttt -87.49 112.64 22.42 Favored 'General case' 0 CA--C 1.556 1.211 0 C-N-CA 123.075 0.55 . . . . 0.0 110.025 173.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 20.4 t-20 -82.65 -69.78 0.6 Allowed 'General case' 0 CA--C 1.564 1.496 0 C-N-CA 123.314 0.646 . . . . 0.0 111.298 -176.359 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -149.56 89.55 0.14 Allowed Glycine 0 N--CA 1.482 1.74 0 N-CA-C 108.867 -1.693 . . . . 0.0 108.867 172.241 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . 0.295 12.6 m-20 69.54 -20.05 0.18 Allowed 'General case' 0 N--CA 1.499 1.978 0 N-CA-C 117.569 2.433 . . . . 0.0 117.569 -164.519 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 16.4 mm -101.19 111.9 32.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 -171.055 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 16.2 mt -79.97 115.18 19.4 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 123.611 0.764 . . . . 0.0 110.797 173.47 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 44.3 m -104.0 96.34 6.61 Favored 'General case' 0 CA--C 1.56 1.338 0 N-CA-C 106.557 -1.645 . . . . 0.0 106.557 -176.5 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 9.1 tt -96.85 102.92 14.79 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 -179.271 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -97.42 107.87 20.47 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 123.721 0.808 . . . . 0.0 108.87 -173.154 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 34.7 m -95.14 90.98 6.09 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 -176.167 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 20.6 m170 -84.76 101.88 12.58 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 -174.053 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 23.4 t -137.82 151.45 48.11 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 123.556 0.743 . . . . 0.0 110.335 -167.313 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 80.8 p -83.57 67.92 9.6 Favored 'General case' 0 N--CA 1.498 1.932 0 CA-C-O 122.134 0.968 . . . . 0.0 112.559 178.374 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 57.5 t80 -155.52 -95.61 0.04 OUTLIER 'General case' 0 CA--C 1.562 1.413 0 N-CA-C 103.777 -2.675 . . . . 0.0 103.777 170.792 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 3.9 mppt? -129.22 127.64 41.68 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 106.819 -1.549 . . . . 0.0 106.819 159.016 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 9.8 p30 -75.27 120.65 21.04 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 123.268 0.627 . . . . 0.0 112.475 -179.502 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 75.1 p -101.08 126.66 47.79 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-O 121.405 0.622 . . . . 0.0 110.617 -174.764 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -110.01 118.25 35.92 Favored 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 177.126 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 14.3 pt -107.66 126.71 64.0 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 178.799 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 77.9 p -115.87 109.24 17.35 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 -175.662 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 48.1 p90 -141.33 138.39 33.06 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 114.682 1.364 . . . . 0.0 114.682 -161.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 60.7 mtpt -95.95 145.6 25.28 Favored 'General case' 0 CA--C 1.562 1.432 0 CA-C-N 115.036 -0.984 . . . . 0.0 109.148 162.086 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -73.47 116.66 14.3 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.575 -0.703 . . . . 0.0 112.208 -173.171 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 79.9 40.61 14.05 Favored Glycine 0 CA--C 1.549 2.2 0 N-CA-C 117.013 1.565 . . . . 0.0 117.013 -170.428 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 91.6 t -139.3 117.76 12.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 N-CA-C 105.34 -2.096 . . . . 0.0 105.34 -179.209 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -81.41 132.25 35.32 Favored 'General case' 0 N--CA 1.49 1.53 0 CA-C-O 121.578 0.704 . . . . 0.0 111.267 178.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 19.5 p90 -134.28 145.55 49.2 Favored 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 124.158 0.983 . . . . 0.0 110.313 -174.133 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -73.44 128.55 35.81 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 123.204 0.602 . . . . 0.0 112.413 178.355 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -131.41 131.81 43.89 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 123.267 0.627 . . . . 0.0 109.785 -168.35 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 90.6 m -112.82 119.32 37.6 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 107.135 -1.431 . . . . 0.0 107.135 170.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 42.7 p -80.87 175.3 10.8 Favored 'General case' 0 N--CA 1.495 1.785 0 CA-C-N 115.545 -0.752 . . . . 0.0 112.745 -174.078 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -59.49 -40.07 85.82 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 116.193 1.923 . . . . 0.0 116.193 169.864 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -74.97 -7.41 53.54 Favored 'General case' 0 CA--C 1.578 2.039 0 N-CA-C 116.256 1.947 . . . . 0.0 116.256 165.571 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . 0.256 6.1 m-20 67.48 68.18 0.38 Allowed 'General case' 0 N--CA 1.496 1.874 0 C-N-CA 125.512 1.525 . . . . 0.0 111.714 -178.103 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 31.0 ttm-85 -116.38 18.04 15.32 Favored 'General case' 0 N--CA 1.498 1.926 0 N-CA-C 116.11 1.892 . . . . 0.0 116.11 -167.745 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . 0.31 0.1 OUTLIER 39.4 71.47 0.17 Allowed 'General case' 0 N--CA 1.499 1.982 0 N-CA-C 118.14 2.644 . . . . 0.0 118.14 176.023 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 4.5 m -112.1 144.07 20.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 CA-C-O 121.386 0.613 . . . . 0.0 111.172 -166.454 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 1.2 mppt? -97.99 102.32 14.04 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 174.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 61.5 p -93.56 113.98 26.23 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.577 0.751 . . . . 0.0 111.874 -170.267 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 5.7 tp -123.0 117.38 51.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 179.004 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 1.1 p -134.11 125.97 49.08 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 C-N-CA 123.786 0.834 . . . . 0.0 109.729 -174.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 15.3 t -132.29 152.0 51.58 Favored 'General case' 0 N--CA 1.495 1.807 0 CA-C-O 122.331 1.062 . . . . 0.0 112.32 178.811 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 53.5 tp -82.75 128.79 34.71 Favored 'General case' 0 N--CA 1.491 1.59 0 CA-C-N 114.644 -1.162 . . . . 0.0 110.067 170.704 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -131.45 83.42 2.1 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 123.444 0.698 . . . . 0.0 109.519 -179.046 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 58.51 47.23 91.1 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 117.863 1.905 . . . . 0.0 117.863 -178.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 76.32 37.74 35.75 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 117.571 1.788 . . . . 0.0 117.571 -167.646 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 36.3 ttmt -149.67 105.93 3.49 Favored 'General case' 0 N--CA 1.481 1.091 0 N-CA-C 106.572 -1.64 . . . . 0.0 106.572 -176.567 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 3.7 mp -79.97 114.41 18.86 Favored 'General case' 0 N--CA 1.485 1.288 0 CA-C-O 121.607 0.718 . . . . 0.0 109.811 172.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 95.3 t -109.78 101.76 13.03 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 N-CA-C 104.964 -2.236 . . . . 0.0 104.964 -173.713 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 23.1 t-160 -99.38 136.92 38.62 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 123.807 0.843 . . . . 0.0 109.69 178.11 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 24.8 tp -134.99 120.23 18.92 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 176.775 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 29.7 mt-30 -112.0 126.2 54.89 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 177.117 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 9.8 mtmp? -126.49 134.45 50.91 Favored 'General case' 0 N--CA 1.496 1.835 0 C-N-CA 122.989 0.515 . . . . 0.0 110.902 -170.58 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 25.8 p90 -152.38 116.12 4.83 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.469 -0.769 . . . . 0.0 110.433 -175.459 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . 0.344 12.6 t70 67.37 -101.76 0.06 Allowed 'General case' 0 N--CA 1.495 1.797 0 C-N-CA 124.515 1.126 . . . . 0.0 112.319 172.965 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -127.41 55.06 0.76 Allowed Glycine 0 N--CA 1.488 2.151 0 CA-C-N 118.96 0.8 . . . . 0.0 113.377 162.331 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 47.7 mt-30 -154.34 129.98 9.98 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 -173.425 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -140.09 125.58 19.07 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.595 -0.691 . . . . 0.0 111.489 -179.311 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 14.3 t -107.94 134.03 51.44 Favored 'General case' 0 N--CA 1.495 1.782 0 C-N-CA 122.98 0.512 . . . . 0.0 110.534 173.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 33.7 p -100.74 134.81 43.15 Favored 'General case' 0 N--CA 1.492 1.669 0 CA-C-O 121.408 0.623 . . . . 0.0 110.77 168.826 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 5.3 mp -118.61 78.54 1.28 Allowed 'General case' 0 CA--C 1.561 1.404 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 178.202 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 62.8 t -86.53 103.41 12.94 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 121.108 -0.995 . . . . 0.0 108.489 -170.6 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 22.0 mmt180 -88.15 124.61 33.98 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 124.21 1.004 . . . . 0.0 109.71 177.081 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -149.52 127.86 12.17 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 122.115 -0.366 . . . . 0.0 111.455 -169.442 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -78.0 117.64 19.52 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.63 -0.669 . . . . 0.0 111.524 177.64 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 48.1 mm -117.58 100.41 10.12 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.312 0 N-CA-C 105.131 -2.174 . . . . 0.0 105.131 173.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 23.2 m-20 56.5 48.79 16.04 Favored 'General case' 0 N--CA 1.498 1.963 0 N-CA-C 115.094 1.516 . . . . 0.0 115.094 174.844 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 89.57 -42.14 3.0 Favored Glycine 0 CA--C 1.552 2.344 0 N-CA-C 117.35 1.7 . . . . 0.0 117.35 -169.53 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 50.7 mttp -83.06 128.69 34.7 Favored 'General case' 0 N--CA 1.487 1.4 0 CA-C-N 118.658 1.229 . . . . 0.0 111.842 -172.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 56.9 tp -86.08 116.33 24.23 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 123.486 0.714 . . . . 0.0 110.715 -177.354 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 33.5 mm -101.49 107.11 20.78 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 -172.09 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 52.7 tp -85.28 106.83 16.97 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 123.778 0.831 . . . . 0.0 109.359 171.399 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 75.5 m -99.73 106.14 18.02 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 -173.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 91.5 mt -103.78 96.44 6.7 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 123.274 0.63 . . . . 0.0 110.091 -169.699 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 9.2 m -111.68 116.06 30.14 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 -174.549 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 75.8 t60 -147.24 115.49 6.61 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 173.669 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 62.52 59.13 9.79 Favored Glycine 0 N--CA 1.488 2.143 0 N-CA-C 117.051 1.58 . . . . 0.0 117.051 172.475 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . 0.288 2.7 m 51.9 51.66 16.06 Favored 'General case' 0 CA--C 1.576 1.945 0 N-CA-C 115.129 1.529 . . . . 0.0 115.129 -172.445 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -157.24 89.26 1.05 Allowed 'General case' 0 N--CA 1.484 1.272 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 -179.614 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 4.8 p -94.34 116.28 35.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 C-N-CA 123.685 0.794 . . . . 0.0 109.88 178.187 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 42.9 t -103.69 110.3 22.33 Favored 'General case' 0 CA--C 1.553 1.058 0 C-N-CA 123.265 0.626 . . . . 0.0 110.026 174.252 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 79.8 m -90.64 97.76 11.37 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 -176.677 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 21.6 mtm180 -101.63 116.98 33.96 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 122.752 0.421 . . . . 0.0 111.042 -171.118 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 75.8 m -88.33 140.62 29.28 Favored 'General case' 0 N--CA 1.494 1.739 0 C-N-CA 123.544 0.737 . . . . 0.0 110.877 -177.214 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 34.6 m-85 -132.7 131.62 41.47 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 123.67 0.788 . . . . 0.0 109.825 -178.317 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -96.21 150.42 20.55 Favored 'General case' 0 N--CA 1.494 1.744 0 CA-C-O 122.121 0.963 . . . . 0.0 112.25 171.734 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 72.2 tttt -87.33 119.1 27.24 Favored 'General case' 0 N--CA 1.483 1.187 0 CA-C-N 115.142 -0.936 . . . . 0.0 111.149 -173.723 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 28.8 mm-40 -107.07 49.74 0.79 Allowed 'General case' 0 CA--C 1.567 1.629 0 C-N-CA 124.069 0.947 . . . . 0.0 111.709 178.566 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.035 0 CA-C-O 123.126 1.441 . . . . 0.0 108.397 -173.126 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 4.0 p . . . . . 0 CA--C 1.577 2.002 0 N-CA-C 116.028 1.862 . . . . 0.0 116.028 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 -63.77 -45.53 89.35 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 117.817 2.525 . . . . 0.0 117.817 -174.973 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -56.74 -25.54 55.11 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 118.084 2.624 . . . . 0.0 118.084 172.513 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -67.8 -30.68 70.17 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 116.181 1.919 . . . . 0.0 116.181 165.355 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 32.9 mt -72.05 107.01 4.53 Favored 'General case' 0 N--CA 1.489 1.496 0 CA-C-N 120.182 1.355 . . . . 0.0 111.445 -167.594 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 163.33 169.54 26.93 Favored Glycine 0 CA--C 1.544 1.864 0 CA-C-O 122.645 1.136 . . . . 0.0 113.581 -169.349 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 73.7 m -86.35 142.48 28.45 Favored 'General case' 0 N--CA 1.491 1.595 0 CA-C-N 114.266 -0.967 . . . . 0.0 110.071 170.96 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 77.5 m95 -143.87 117.21 9.04 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 -174.97 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -101.08 145.6 28.54 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.9 -0.5 . . . . 0.0 110.38 176.263 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 22.2 tp -68.12 122.86 19.16 Favored 'General case' 0 N--CA 1.49 1.564 0 CA-C-O 122.169 0.985 . . . . 0.0 111.757 -178.525 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . 0.282 0.9 OUTLIER -101.31 -46.87 11.51 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.8 0 CA-C-N 113.752 -1.567 . . . . 0.0 111.516 179.082 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -139.81 145.26 37.95 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-N 119.714 1.143 . . . . 0.0 109.647 175.788 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 79.7 p -131.67 89.42 2.7 Favored 'General case' 0 N--CA 1.491 1.613 0 CA-C-O 121.671 0.748 . . . . 0.0 110.091 168.448 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -78.29 127.39 32.17 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 123.534 0.734 . . . . 0.0 110.378 178.046 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.254 42.1 m-20 68.74 32.97 3.9 Favored 'General case' 0 N--CA 1.505 2.304 0 N-CA-C 116.391 1.997 . . . . 0.0 116.391 178.907 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 42.2 t80 -68.9 -62.95 1.17 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.631 -1.293 . . . . 0.0 113.09 -175.653 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -44.89 -36.02 3.11 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 118.637 2.829 . . . . 0.0 118.637 168.209 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -65.55 -48.67 71.61 Favored 'General case' 0 N--CA 1.498 1.944 0 CA-C-N 120.745 1.611 . . . . 0.0 114.64 172.413 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 85.7 t80 -55.38 -46.97 76.49 Favored 'General case' 0 CA--C 1.572 1.815 0 N-CA-C 115.179 1.548 . . . . 0.0 115.179 167.623 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 16.3 mmm -59.52 -42.52 92.44 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 115.493 1.664 . . . . 0.0 115.493 174.924 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 70.1 tttt -64.96 -41.05 95.81 Favored 'General case' 0 CA--C 1.568 1.64 0 N-CA-C 115.248 1.573 . . . . 0.0 115.248 170.091 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 50.9 m -56.74 -41.8 78.15 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 116.031 1.863 . . . . 0.0 116.031 171.859 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 45.4 mt -66.11 -36.83 84.22 Favored 'General case' 0 CA--C 1.565 1.532 0 N-CA-C 117.088 2.255 . . . . 0.0 117.088 168.353 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 100.08 78.98 1.4 Allowed Glycine 0 CA--C 1.54 1.622 0 CA-C-N 118.867 0.758 . . . . 0.0 111.644 -169.718 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 57.3 t -136.59 122.08 27.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 N-CA-C 105.48 -2.045 . . . . 0.0 105.48 -179.639 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -64.04 159.51 39.99 Favored Glycine 0 CA--C 1.548 2.125 0 N-CA-C 116.19 1.236 . . . . 0.0 116.19 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 27.8 p90 -56.27 -40.82 74.85 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 118.854 2.909 . . . . 0.0 118.854 -167.04 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.06 -42.01 81.11 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 116.022 1.86 . . . . 0.0 116.022 176.333 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 41.0 m -70.09 -39.94 75.28 Favored 'General case' 0 N--CA 1.499 1.986 0 CA-C-N 119.377 0.99 . . . . 0.0 113.663 171.069 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 68.1 ttt-85 -55.99 -42.77 76.86 Favored 'General case' 0 CA--C 1.571 1.766 0 N-CA-C 115.989 1.848 . . . . 0.0 115.989 168.933 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 25.6 tt0 -77.84 -42.79 32.42 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 115.355 1.613 . . . . 0.0 115.355 175.169 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 75.7 t -65.2 -41.62 92.09 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 CA-C-N 119.756 1.162 . . . . 0.0 113.011 174.858 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -64.36 -33.0 74.84 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 116.873 2.175 . . . . 0.0 116.873 172.301 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 93.3 p -67.05 -42.88 84.04 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 115.506 1.669 . . . . 0.0 115.506 167.422 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 42.5 ttm -60.89 -36.66 79.79 Favored 'General case' 0 CA--C 1.572 1.798 0 N-CA-C 116.135 1.902 . . . . 0.0 116.135 167.234 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 99.4 m -69.06 136.26 52.07 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 124.49 1.116 . . . . 0.0 111.328 176.589 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -108.35 92.43 9.76 Favored Pre-proline 0 CA--C 1.569 1.683 0 C-N-CA 123.824 0.85 . . . . 0.0 108.973 172.211 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -81.92 145.38 14.1 Favored 'Trans proline' 0 C--N 1.37 1.706 0 C-N-CA 122.83 2.353 . . . . 0.0 113.237 -174.206 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 85.5 m -99.2 102.31 13.92 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 -173.579 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 94.3 m -80.42 120.8 24.92 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 123.773 0.829 . . . . 0.0 109.319 175.391 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 36.9 mt -123.73 111.4 28.94 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 N-CA-C 106.399 -1.704 . . . . 0.0 106.399 -176.938 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 3.9 mp -94.09 128.1 45.65 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 175.35 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 22.0 mm-40 -128.57 169.32 14.53 Favored 'General case' 0 N--CA 1.489 1.496 0 CA-C-O 122.095 0.95 . . . . 0.0 110.551 178.914 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.69 157.2 42.78 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 123.869 0.868 . . . . 0.0 111.526 178.427 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 65.0 m-80 -134.55 -78.51 0.46 Allowed 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 177.352 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -153.13 86.65 0.14 Allowed Glycine 0 N--CA 1.482 1.749 0 N-CA-C 108.1 -2.0 . . . . 0.0 108.1 168.925 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . 0.277 14.4 m-20 66.62 -12.05 0.22 Allowed 'General case' 0 N--CA 1.498 1.945 0 N-CA-C 117.726 2.491 . . . . 0.0 117.726 -161.906 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 26.8 mm -90.27 103.75 14.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 CA-C-N 120.147 1.34 . . . . 0.0 107.445 -177.941 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 44.4 mt -93.61 110.8 22.39 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 123.005 0.522 . . . . 0.0 110.79 -174.886 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 90.5 m -99.32 98.76 9.67 Favored 'General case' 0 CA--C 1.562 1.411 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 -170.295 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 9.6 tt -97.78 113.49 25.29 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 178.231 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 45.6 mtpt -112.05 106.98 15.78 Favored 'General case' 0 N--CA 1.484 1.262 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 -173.135 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 82.5 m -92.15 101.71 14.23 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 177.612 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 72.4 m80 -88.41 90.53 8.43 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 123.883 0.873 . . . . 0.0 110.533 -173.467 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 60.5 p . . . . . 0 N--CA 1.489 1.489 0 N-CA-C 113.265 0.839 . . . . 0.0 113.265 -178.295 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 70.9 m-20 . . . . . 0 N--CA 1.49 1.528 0 N-CA-C 110.433 -0.21 . . . . 0.0 110.433 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 61.6 p -98.56 129.43 45.11 Favored 'General case' 0 N--CA 1.493 1.721 0 CA-C-O 121.221 0.534 . . . . 0.0 110.886 -176.491 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -115.26 116.55 28.5 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 179.465 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 28.8 pt -113.08 129.6 68.46 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 176.442 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 77.6 p -117.8 114.3 23.07 Favored 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 123.871 0.868 . . . . 0.0 109.298 -176.219 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 51.0 p90 -141.12 139.42 33.97 Favored 'General case' 0 N--CA 1.499 1.982 0 N-CA-C 115.499 1.666 . . . . 0.0 115.499 -161.514 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 62.2 mtpt -105.99 23.9 13.26 Favored 'General case' 0 CA--C 1.574 1.867 0 N-CA-C 116.877 2.177 . . . . 0.0 116.877 -175.084 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . 0.284 1.2 mp 60.78 90.21 0.07 Allowed 'General case' 0 N--CA 1.495 1.825 0 CA-C-N 120.536 1.517 . . . . 0.0 114.772 171.545 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 87.76 38.51 7.47 Favored Glycine 0 CA--C 1.551 2.302 0 N-CA-C 116.779 1.472 . . . . 0.0 116.779 -166.581 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 82.6 t -139.3 120.45 15.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 N-CA-C 106.131 -1.803 . . . . 0.0 106.131 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -87.46 124.06 33.04 Favored 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 122.953 0.501 . . . . 0.0 111.122 178.304 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 45.8 p90 -127.58 133.99 49.72 Favored 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 123.775 0.83 . . . . 0.0 111.166 -172.56 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -70.58 128.8 37.34 Favored 'General case' 0 CA--C 1.564 1.513 0 O-C-N 121.447 -0.783 . . . . 0.0 112.567 173.352 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 14.7 tp10 -142.46 135.73 28.73 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 123.193 0.597 . . . . 0.0 109.963 -168.683 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 53.1 m -92.56 127.47 38.07 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 171.214 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 31.1 p -84.25 171.68 12.53 Favored 'General case' 0 N--CA 1.495 1.781 0 CA-C-O 121.429 0.633 . . . . 0.0 112.443 -177.689 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -62.88 -31.35 72.38 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 116.438 2.014 . . . . 0.0 116.438 166.646 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -81.0 21.06 0.73 Allowed 'General case' 0 CA--C 1.582 2.193 0 N-CA-C 114.956 1.465 . . . . 0.0 114.956 165.998 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 56.31 69.23 0.76 Allowed 'General case' 0 N--CA 1.496 1.837 0 C-N-CA 125.928 1.691 . . . . 0.0 114.517 176.858 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 50.8 mtm180 -144.12 126.84 16.14 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-O 121.116 0.484 . . . . 0.0 110.683 -174.519 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 62.5 pttt -66.12 118.29 9.65 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 123.957 0.903 . . . . 0.0 111.929 165.368 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 15.8 m -140.25 130.13 28.41 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 -173.342 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 30.5 mmmt -87.41 112.22 21.92 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-O 121.593 0.711 . . . . 0.0 109.669 178.78 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 67.3 m -109.99 105.92 15.25 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 123.515 0.726 . . . . 0.0 111.108 -158.155 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 6.9 tp -114.66 105.84 19.46 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 C-N-CA 123.795 0.838 . . . . 0.0 109.53 -175.833 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -115.92 126.23 73.35 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 C-N-CA 124.551 1.14 . . . . 0.0 108.933 178.223 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 15.4 t -132.24 157.13 45.17 Favored 'General case' 0 N--CA 1.492 1.644 0 CA-C-O 122.625 1.203 . . . . 0.0 111.296 172.005 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 17.6 tp -93.31 116.24 28.81 Favored 'General case' 0 N--CA 1.487 1.419 0 CA-C-N 114.837 -1.074 . . . . 0.0 110.785 -176.465 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -110.36 82.74 1.64 Allowed 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 123.576 0.75 . . . . 0.0 109.679 178.731 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 56.68 46.16 89.6 Favored Glycine 0 CA--C 1.552 2.369 0 N-CA-C 118.203 2.041 . . . . 0.0 118.203 -177.042 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 78.59 44.76 10.27 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 117.0 1.56 . . . . 0.0 117.0 -167.609 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 41.1 ttmt -151.13 111.28 4.12 Favored 'General case' 0 CA--C 1.551 0.994 0 N-CA-C 106.481 -1.674 . . . . 0.0 106.481 -177.755 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 65.5 mt -85.21 95.3 9.13 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-O 122.976 1.369 . . . . 0.0 109.428 177.526 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 88.7 t -87.1 97.76 6.67 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.334 0 CA-C-N 112.617 -2.083 . . . . 0.0 105.876 -178.405 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 22.7 t-160 -102.44 139.39 38.11 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 124.396 1.078 . . . . 0.0 109.405 -176.513 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 28.2 tp -136.69 115.29 11.98 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 178.514 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 89.4 mt-30 -104.22 115.77 30.99 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 175.726 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt -121.87 135.68 54.9 Favored 'General case' 0 N--CA 1.493 1.701 0 C-N-CA 123.335 0.654 . . . . 0.0 111.789 -171.741 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 16.3 p90 -159.0 110.91 2.15 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 123.333 0.653 . . . . 0.0 110.536 -174.607 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 5.7 t70 52.59 54.45 10.58 Favored 'General case' 0 N--CA 1.498 1.948 0 N-CA-C 116.567 2.062 . . . . 0.0 116.567 165.328 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 88.76 -46.0 3.27 Favored Glycine 0 CA--C 1.549 2.206 0 N-CA-C 116.434 1.334 . . . . 0.0 116.434 -169.943 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 16.3 mt-30 -83.6 129.21 34.96 Favored 'General case' 0 N--CA 1.488 1.446 0 CA-C-N 117.957 0.878 . . . . 0.0 111.233 -178.721 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -141.21 124.75 16.74 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 122.786 0.435 . . . . 0.0 110.664 177.005 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 13.0 t -110.8 135.52 51.24 Favored 'General case' 0 N--CA 1.492 1.656 0 C-N-CA 123.108 0.563 . . . . 0.0 110.643 176.273 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 37.9 p -100.27 131.02 46.44 Favored 'General case' 0 N--CA 1.492 1.628 0 C-N-CA 123.021 0.528 . . . . 0.0 110.761 174.608 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 5.4 mp -111.73 76.18 0.96 Allowed 'General case' 0 CA--C 1.563 1.447 0 C-N-CA 124.005 0.922 . . . . 0.0 108.783 -179.446 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 87.5 t -87.04 110.1 20.0 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 -168.242 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 83.9 mtt85 -102.38 118.49 36.99 Favored 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 122.975 0.51 . . . . 0.0 109.939 -175.777 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -135.32 127.96 30.85 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 123.34 0.656 . . . . 0.0 110.665 -169.539 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -80.91 114.64 19.93 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.833 -0.542 . . . . 0.0 111.395 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 85.8 mt -124.14 106.98 17.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 N-CA-C 105.015 -2.217 . . . . 0.0 105.015 178.512 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 23.4 m-20 58.17 50.3 10.1 Favored 'General case' 0 N--CA 1.499 1.989 0 N-CA-C 115.15 1.537 . . . . 0.0 115.15 177.031 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 60.73 31.24 74.76 Favored Glycine 0 CA--C 1.554 2.503 0 N-CA-C 118.964 2.346 . . . . 0.0 118.964 -169.453 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 92.1 mttt -133.65 128.55 35.3 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-N 119.135 1.468 . . . . 0.0 108.686 -175.892 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 12.3 tp -79.76 107.42 12.52 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 123.433 0.693 . . . . 0.0 109.389 177.61 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 31.6 mm -99.42 99.29 8.26 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 N-CA-C 106.536 -1.653 . . . . 0.0 106.536 -175.598 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 21.9 tp -87.86 102.99 15.24 Favored 'General case' 0 N--CA 1.486 1.372 0 CA-C-O 121.843 0.83 . . . . 0.0 109.549 178.699 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 90.9 m -95.76 103.61 15.5 Favored 'General case' 0 CA--C 1.561 1.389 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 -175.545 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 90.3 mt -97.61 100.49 11.89 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 123.581 0.752 . . . . 0.0 109.809 -174.989 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 8.1 m -113.89 125.28 53.87 Favored 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 -175.035 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 82.9 t60 -129.48 -102.9 0.31 Allowed 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.982 -0.748 . . . . 0.0 108.982 175.352 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -112.32 88.6 0.5 Allowed Glycine 0 N--CA 1.485 1.923 0 CA-C-N 119.183 0.901 . . . . 0.0 112.003 -171.78 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . 0.298 2.6 m 54.49 44.61 28.53 Favored 'General case' 0 CA--C 1.578 2.032 0 N-CA-C 115.381 1.623 . . . . 0.0 115.381 -175.68 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -163.66 95.68 0.82 Allowed 'General case' 0 N--CA 1.483 1.193 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 178.12 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 2.9 p -91.69 115.87 31.67 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 C-N-CA 123.402 0.681 . . . . 0.0 109.415 174.717 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 53.3 t -95.7 105.4 17.39 Favored 'General case' 0 CA--C 1.551 1.01 0 CA-C-O 121.302 0.573 . . . . 0.0 110.572 173.187 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 75.7 m -91.88 113.53 25.82 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 -178.64 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 83.3 mtp180 -113.53 109.36 18.52 Favored 'General case' 0 N--CA 1.486 1.332 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.615 -168.457 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 88.4 m -84.01 127.21 33.72 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 123.165 0.586 . . . . 0.0 109.947 178.058 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 43.1 m-85 -123.71 127.94 48.89 Favored 'General case' 0 CA--C 1.56 1.345 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 175.292 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -91.1 152.59 20.55 Favored 'General case' 0 N--CA 1.496 1.83 0 CA-C-O 121.879 0.847 . . . . 0.0 111.736 170.142 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 70.9 tttt -82.15 122.71 28.22 Favored 'General case' 0 N--CA 1.487 1.404 0 CA-C-O 121.587 0.708 . . . . 0.0 111.975 -171.456 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 24.5 mm-40 -119.04 50.94 1.16 Allowed 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 124.225 1.01 . . . . 0.0 111.605 -174.258 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 0.872 0 CA-C-O 123.155 1.455 . . . . 0.0 110.131 -162.634 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.253 5.1 p . . . . . 0 CA--C 1.576 1.968 0 N-CA-C 114.581 1.326 . . . . 0.0 114.581 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -85.12 -36.59 21.02 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 115.561 1.689 . . . . 0.0 115.561 -173.609 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -58.52 -24.73 61.28 Favored 'General case' 0 N--CA 1.497 1.891 0 N-CA-C 117.694 2.479 . . . . 0.0 117.694 168.558 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -68.72 -20.17 64.38 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 116.84 2.163 . . . . 0.0 116.84 167.101 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 56.2 mt -80.44 126.81 31.66 Favored 'General case' 0 N--CA 1.486 1.352 0 CA-C-N 120.627 1.558 . . . . 0.0 111.882 -170.402 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 155.79 178.14 29.7 Favored Glycine 0 CA--C 1.541 1.713 0 CA-C-O 122.03 0.795 . . . . 0.0 113.557 -178.112 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 43.1 m -92.94 135.69 33.93 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 168.53 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 89.3 m95 -137.21 113.79 10.26 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 -170.958 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 26.7 mtpt -93.49 148.69 21.85 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 121.927 0.87 . . . . 0.0 111.366 172.961 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 20.2 tp -71.4 135.61 47.34 Favored 'General case' 0 N--CA 1.486 1.368 0 CA-C-O 122.32 1.057 . . . . 0.0 112.53 -178.478 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . 0.271 1.1 t -114.52 -43.76 4.06 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.878 0 CA-C-N 113.786 -1.552 . . . . 0.0 111.953 -177.589 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -127.28 150.8 49.4 Favored 'General case' 0 N--CA 1.494 1.76 0 CA-C-N 119.986 1.267 . . . . 0.0 110.65 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 81.1 p -145.2 88.71 1.89 Allowed 'General case' 0 N--CA 1.49 1.544 0 CA-C-O 121.22 0.533 . . . . 0.0 110.244 167.484 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -102.22 125.24 48.87 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 123.4 0.68 . . . . 0.0 109.201 177.165 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.288 53.6 m-20 72.57 17.07 4.69 Favored 'General case' 0 N--CA 1.503 2.206 0 N-CA-C 117.491 2.404 . . . . 0.0 117.491 -178.904 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 30.9 t80 -68.77 -41.91 78.16 Favored 'General case' 0 N--CA 1.497 1.894 0 N-CA-C 115.091 1.515 . . . . 0.0 115.091 178.202 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -49.58 -49.01 48.28 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 116.009 1.855 . . . . 0.0 116.009 165.966 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 18.4 t0 -59.21 -50.59 73.44 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 115.397 1.628 . . . . 0.0 115.397 172.896 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 88.2 t80 -52.67 -51.79 58.67 Favored 'General case' 0 CA--C 1.572 1.794 0 N-CA-C 115.6 1.704 . . . . 0.0 115.6 170.349 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 5.5 mmm -64.78 -40.07 94.64 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 115.124 1.527 . . . . 0.0 115.124 176.908 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 21.7 ttmm -55.96 -45.29 78.92 Favored 'General case' 0 CA--C 1.571 1.769 0 N-CA-C 115.14 1.534 . . . . 0.0 115.14 166.317 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 12.8 t -59.77 -38.42 81.77 Favored 'General case' 0 CA--C 1.571 1.763 0 N-CA-C 116.407 2.003 . . . . 0.0 116.407 170.42 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 75.8 mt -65.16 -25.47 67.75 Favored 'General case' 0 CA--C 1.568 1.661 0 N-CA-C 117.601 2.445 . . . . 0.0 117.601 168.49 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 98.76 70.36 0.97 Allowed Glycine 0 N--CA 1.482 1.731 0 CA-C-N 119.085 0.857 . . . . 0.0 112.256 -171.026 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 45.3 t -142.28 120.13 7.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 N-CA-C 105.502 -2.036 . . . . 0.0 105.502 -178.338 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -81.1 -157.49 17.36 Favored Glycine 0 CA--C 1.547 2.065 0 N-CA-C 115.534 0.973 . . . . 0.0 115.534 -179.413 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 12.1 p90 -70.01 160.72 31.42 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 113.385 0.883 . . . . 0.0 113.385 179.637 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . 0.329 . . 78.25 -50.07 0.48 Allowed 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 115.439 1.644 . . . . 0.0 115.439 178.431 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 34.0 m -70.51 -37.49 74.17 Favored 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 113.604 0.964 . . . . 0.0 113.604 167.882 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 42.3 mtm105 -57.97 -44.6 87.2 Favored 'General case' 0 N--CA 1.498 1.97 0 N-CA-C 115.232 1.567 . . . . 0.0 115.232 164.52 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 10.3 tm0? -68.68 -52.8 27.1 Favored 'General case' 0 CA--C 1.561 1.389 0 N-CA-C 114.871 1.434 . . . . 0.0 114.871 176.697 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 85.5 t -66.4 -40.62 87.08 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 CA-C-O 117.763 -1.113 . . . . 0.0 113.166 -179.064 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -71.27 -26.84 63.06 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 117.052 2.241 . . . . 0.0 117.052 176.107 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 90.6 p -68.91 -47.37 65.96 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 115.022 1.49 . . . . 0.0 115.022 164.134 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 52.1 ttp -61.91 -39.6 92.56 Favored 'General case' 0 CA--C 1.57 1.731 0 N-CA-C 116.482 2.03 . . . . 0.0 116.482 171.952 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 52.7 m -67.35 146.97 53.55 Favored 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 124.764 1.225 . . . . 0.0 111.941 178.441 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -102.23 100.37 15.21 Favored Pre-proline 0 CA--C 1.57 1.744 0 N-CA-C 108.307 -0.998 . . . . 0.0 108.307 172.998 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -79.11 104.39 1.77 Allowed 'Trans proline' 0 CA--C 1.562 1.888 0 C-N-CA 123.223 2.615 . . . . 0.0 111.293 -178.994 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 96.2 m -80.16 108.33 13.67 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 123.352 0.661 . . . . 0.0 110.495 -164.714 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 28.7 m -91.39 109.79 21.07 Favored 'General case' 0 CA--C 1.559 1.318 0 C-N-CA 123.336 0.654 . . . . 0.0 110.03 -170.442 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 75.0 mt -100.56 109.36 25.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 N-CA-C 106.567 -1.642 . . . . 0.0 106.567 176.321 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 30.4 mt -104.82 118.31 51.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 N-CA-C 106.906 -1.516 . . . . 0.0 106.906 -179.824 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -137.79 117.24 12.86 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 -175.101 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 7.7 ttpm? -91.5 116.26 28.71 Favored 'General case' 0 CA--C 1.557 1.217 0 CA-C-O 121.439 0.637 . . . . 0.0 110.051 172.987 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 22.7 t-20 -71.64 -50.52 29.86 Favored 'General case' 0 CA--C 1.57 1.72 0 N-CA-C 112.982 0.734 . . . . 0.0 112.982 166.873 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -172.25 -82.4 0.05 OUTLIER Glycine 0 N--CA 1.481 1.659 0 N-CA-C 109.25 -1.54 . . . . 0.0 109.25 173.974 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 24.3 t0 -72.14 -37.69 69.38 Favored 'General case' 0 CA--C 1.57 1.741 0 N-CA-C 115.096 1.517 . . . . 0.0 115.096 162.915 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 31.6 mm -91.11 120.32 39.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 CA-C-N 118.993 0.815 . . . . 0.0 109.69 -173.524 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 12.7 mt -86.38 125.88 33.97 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 123.419 0.688 . . . . 0.0 109.811 158.651 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 57.7 m -113.91 103.79 11.52 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 -179.795 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 9.5 tt -102.48 108.55 19.9 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 178.598 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -104.75 111.8 24.65 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 -179.469 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 98.2 m -98.51 99.98 11.18 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 20.6 m-70 -90.48 95.96 10.42 Favored 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 123.393 0.677 . . . . 0.0 110.344 -172.198 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 22.8 t . . . . . 0 CA--C 1.554 1.121 0 CA-C-O 121.981 0.896 . . . . 0.0 110.322 -179.345 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 83.0 m-20 . . . . . 0 N--CA 1.489 1.524 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 31.8 p -105.58 132.39 51.79 Favored 'General case' 0 N--CA 1.496 1.874 0 C-N-CA 123.355 0.662 . . . . 0.0 110.825 -177.551 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -121.43 118.3 29.04 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 123.918 0.887 . . . . 0.0 108.813 -178.116 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 39.5 pt -110.35 129.57 65.18 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.875 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 173.684 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 52.2 p -115.75 114.26 24.55 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 178.276 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 45.9 p90 -142.68 146.54 34.52 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 114.306 1.225 . . . . 0.0 114.306 -161.162 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 50.2 mtmt -115.5 28.12 8.88 Favored 'General case' 0 CA--C 1.572 1.823 0 N-CA-C 115.678 1.733 . . . . 0.0 115.678 -171.122 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . 0.308 0.1 OUTLIER 52.81 82.73 0.07 Allowed 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 115.866 1.802 . . . . 0.0 115.866 175.551 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 101.88 39.24 2.96 Favored Glycine 0 CA--C 1.55 2.234 0 N-CA-C 116.336 1.294 . . . . 0.0 116.336 -171.878 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 94.7 t -139.74 127.52 25.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 N-CA-C 106.442 -1.688 . . . . 0.0 106.442 -179.199 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -89.01 128.92 35.73 Favored 'General case' 0 CA--C 1.564 1.499 0 C-N-CA 122.997 0.519 . . . . 0.0 110.366 175.592 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 43.5 p90 -138.91 123.14 18.1 Favored 'General case' 0 N--CA 1.494 1.764 0 C-N-CA 123.391 0.677 . . . . 0.0 109.855 -176.818 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -72.37 112.85 8.79 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.097 -1.002 . . . . 0.0 112.382 178.462 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -115.33 135.91 53.65 Favored 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 124.024 0.929 . . . . 0.0 110.241 -168.103 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 42.9 m -86.96 122.79 31.3 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-O 121.61 0.719 . . . . 0.0 109.529 173.173 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 43.1 p -82.45 177.76 8.58 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 113.197 0.814 . . . . 0.0 113.197 -173.546 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -55.85 -35.75 66.78 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 117.69 2.478 . . . . 0.0 117.69 168.46 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -92.47 17.19 10.36 Favored 'General case' 0 CA--C 1.577 1.991 0 N-CA-C 115.136 1.532 . . . . 0.0 115.136 170.896 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 63.01 80.17 0.24 Allowed 'General case' 0 N--CA 1.496 1.854 0 C-N-CA 125.281 1.432 . . . . 0.0 113.272 -178.955 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 14.9 ttm180 -146.09 126.13 13.71 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 -176.176 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.77 120.51 15.62 Favored 'General case' 0 N--CA 1.493 1.678 0 CA-C-N 118.124 0.42 . . . . 0.0 110.272 168.174 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 12.4 m -138.69 121.42 18.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 N-CA-C 107.999 -1.112 . . . . 0.0 107.999 -176.156 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 1.5 mptm? -76.76 104.13 7.09 Favored 'General case' 0 N--CA 1.489 1.487 0 CA-C-O 121.89 0.852 . . . . 0.0 109.599 -177.349 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 74.0 m -98.95 96.41 7.81 Favored 'General case' 0 N--CA 1.481 1.116 0 CA-C-N 114.894 -1.048 . . . . 0.0 109.92 -164.44 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -106.39 108.31 24.81 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 177.422 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 1.4 p -121.88 126.76 74.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 C-N-CA 124.025 0.93 . . . . 0.0 109.304 -174.906 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 9.8 t -146.34 152.1 38.57 Favored 'General case' 0 N--CA 1.489 1.515 0 CA-C-O 122.531 1.158 . . . . 0.0 110.643 -177.859 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 24.8 tp -87.73 103.47 15.64 Favored 'General case' 0 N--CA 1.49 1.536 0 CA-C-N 114.889 -1.051 . . . . 0.0 109.425 175.778 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -107.01 93.57 4.63 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 123.607 0.763 . . . . 0.0 109.41 -175.674 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 59.3 49.1 82.2 Favored Glycine 0 N--CA 1.488 2.108 0 N-CA-C 117.712 1.845 . . . . 0.0 117.712 -179.825 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 91.59 -37.44 3.39 Favored Glycine 0 CA--C 1.551 2.31 0 N-CA-C 117.232 1.653 . . . . 0.0 117.232 -170.352 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.72 122.32 29.64 Favored 'General case' 0 N--CA 1.486 1.368 0 CA-C-N 118.92 1.36 . . . . 0.0 110.328 -176.857 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 5.8 tt -85.98 95.86 9.64 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 108.569 -0.901 . . . . 0.0 108.569 179.032 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 53.0 t -97.61 108.09 21.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 -166.958 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 21.6 t-160 -101.92 108.64 20.17 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 123.255 0.622 . . . . 0.0 110.032 175.682 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 31.8 tp -98.0 116.32 29.97 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 175.587 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -100.22 129.45 46.23 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 168.64 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 16.7 ptmt -140.08 128.63 22.9 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.746 -0.596 . . . . 0.0 111.399 -173.238 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 30.8 p90 -154.44 119.17 4.9 Favored 'General case' 0 N--CA 1.491 1.606 0 C-N-CA 123.808 0.843 . . . . 0.0 109.727 -168.059 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 4.5 t70 45.34 59.58 3.48 Favored 'General case' 0 N--CA 1.503 2.18 0 N-CA-C 117.616 2.45 . . . . 0.0 117.616 164.858 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 63.8 31.05 79.48 Favored Glycine 0 CA--C 1.558 2.73 0 N-CA-C 119.42 2.528 . . . . 0.0 119.42 -171.617 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -152.44 123.6 7.6 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 106.705 -1.591 . . . . 0.0 106.705 -176.193 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -138.56 132.49 31.19 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.47 -0.769 . . . . 0.0 112.261 179.128 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 14.6 t -116.32 134.01 55.37 Favored 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 123.581 0.752 . . . . 0.0 110.406 173.755 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 34.9 p -100.8 131.07 46.86 Favored 'General case' 0 N--CA 1.493 1.699 0 CA-C-O 122.143 0.973 . . . . 0.0 110.128 169.292 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 5.4 mp -112.47 87.0 2.47 Favored 'General case' 0 CA--C 1.56 1.347 0 N-CA-C 106.407 -1.701 . . . . 0.0 106.407 -178.71 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 72.4 t -92.88 99.89 10.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 -169.186 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 20.5 mmt180 -86.27 125.26 33.46 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 124.126 0.971 . . . . 0.0 109.883 176.052 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -151.89 131.74 13.29 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.877 -0.514 . . . . 0.0 112.11 -173.844 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -78.73 120.24 23.09 Favored 'General case' 0 N--CA 1.49 1.525 0 CA-C-O 121.295 0.569 . . . . 0.0 111.755 177.945 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 92.3 mt -129.16 105.72 13.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 N-CA-C 104.603 -2.369 . . . . 0.0 104.603 176.445 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 57.75 52.31 8.28 Favored 'General case' 0 N--CA 1.499 2.001 0 N-CA-C 114.997 1.481 . . . . 0.0 114.997 175.893 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 67.85 12.07 61.63 Favored Glycine 0 CA--C 1.557 2.673 0 N-CA-C 119.962 2.745 . . . . 0.0 119.962 -171.655 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -124.73 126.59 45.92 Favored 'General case' 0 N--CA 1.486 1.358 0 CA-C-N 119.645 1.723 . . . . 0.0 108.626 -175.196 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 58.7 tp -83.96 108.57 17.01 Favored 'General case' 0 N--CA 1.483 1.189 0 CA-C-O 121.508 0.67 . . . . 0.0 110.226 -179.622 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 28.1 mm -97.51 106.8 19.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 -172.02 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 44.4 tp -86.04 111.84 20.69 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 123.557 0.743 . . . . 0.0 109.075 171.232 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 88.1 m -105.7 105.9 16.16 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 -176.347 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 88.6 mt -101.37 100.6 11.11 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 123.486 0.714 . . . . 0.0 109.948 -171.33 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 7.8 m -116.37 121.1 40.95 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 -174.516 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 83.1 t60 -126.42 -101.51 0.36 Allowed 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 175.571 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -111.0 92.71 0.68 Allowed Glycine 0 N--CA 1.483 1.814 0 CA-C-N 119.375 0.989 . . . . 0.0 111.454 -172.683 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . 0.395 6.4 t 49.03 40.38 17.0 Favored 'General case' 0 N--CA 1.499 2.011 0 N-CA-C 117.746 2.499 . . . . 0.0 117.746 -172.864 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -155.49 93.68 1.51 Allowed 'General case' 0 N--CA 1.483 1.211 0 O-C-N 121.569 -0.707 . . . . 0.0 109.217 178.384 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 4.3 p -89.39 121.23 39.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 C-N-CA 123.418 0.687 . . . . 0.0 109.602 172.352 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 45.0 t -105.28 120.44 41.57 Favored 'General case' 0 CA--C 1.553 1.077 0 C-N-CA 123.045 0.538 . . . . 0.0 111.4 177.65 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 80.1 m -87.21 110.61 20.28 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 175.196 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 6.2 mmm180 -115.03 95.87 5.42 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 107.448 -1.316 . . . . 0.0 107.448 -179.848 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 86.2 m -82.76 143.51 30.81 Favored 'General case' 0 N--CA 1.494 1.774 0 C-N-CA 123.721 0.809 . . . . 0.0 110.402 -177.968 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 47.1 m-85 -131.34 127.61 38.0 Favored 'General case' 0 CA--C 1.557 1.232 0 C-N-CA 123.442 0.697 . . . . 0.0 109.767 -178.096 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -95.77 156.89 16.14 Favored 'General case' 0 N--CA 1.492 1.668 0 CA-C-O 122.671 1.224 . . . . 0.0 111.294 165.115 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 73.8 tttt -90.47 114.49 26.67 Favored 'General case' 0 N--CA 1.484 1.244 0 CA-C-N 114.895 -1.048 . . . . 0.0 111.712 -165.698 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -74.11 -33.99 63.79 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 117.116 2.265 . . . . 0.0 117.116 172.452 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.125 0 CA-C-O 124.198 1.952 . . . . 0.0 108.527 173.731 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 5.4 p . . . . . 0 CA--C 1.578 2.041 0 N-CA-C 115.883 1.809 . . . . 0.0 115.883 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -64.85 -36.71 85.22 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 116.764 2.135 . . . . 0.0 116.764 -175.168 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -58.13 -29.25 65.38 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 117.742 2.497 . . . . 0.0 117.742 169.146 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -69.47 -25.29 64.01 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 116.231 1.937 . . . . 0.0 116.231 169.576 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 45.8 mt -77.37 110.22 11.94 Favored 'General case' 0 N--CA 1.489 1.518 0 CA-C-N 121.012 1.733 . . . . 0.0 111.466 -162.715 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 157.8 172.02 24.47 Favored Glycine 0 CA--C 1.546 2.024 0 CA-C-O 122.718 1.177 . . . . 0.0 112.797 -167.571 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 54.1 m -87.25 139.42 30.58 Favored 'General case' 0 N--CA 1.494 1.731 0 CA-C-N 114.296 -0.952 . . . . 0.0 109.734 172.257 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 82.8 m95 -136.62 113.67 10.55 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 -177.444 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -95.41 146.51 24.35 Favored 'General case' 0 N--CA 1.494 1.726 0 CA-C-O 121.439 0.638 . . . . 0.0 110.292 173.914 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 48.6 tp -68.48 120.16 14.11 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-O 121.649 0.737 . . . . 0.0 111.738 -179.164 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . 0.263 1.1 t -83.66 -51.02 14.76 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.753 0 CA-C-N 114.676 -1.147 . . . . 0.0 111.666 170.495 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -148.36 125.39 11.36 Favored 'General case' 0 CA--C 1.557 1.244 0 CA-C-N 119.032 0.833 . . . . 0.0 109.619 -168.057 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 72.7 p -102.93 100.27 10.23 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 123.373 0.669 . . . . 0.0 110.441 172.508 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 33.7 mmtp -95.9 116.49 28.99 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 109.508 -0.552 . . . . 0.0 109.508 -179.225 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.258 28.6 m-20 71.2 24.53 3.8 Favored 'General case' 0 N--CA 1.504 2.265 0 N-CA-C 117.101 2.26 . . . . 0.0 117.101 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 40.0 t80 -69.58 -50.31 45.87 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 120.138 -1.601 . . . . 0.0 114.727 -175.875 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 71.1 m-20 -51.58 -27.76 12.0 Favored 'General case' 0 N--CA 1.497 1.925 0 N-CA-C 117.909 2.559 . . . . 0.0 117.909 168.839 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 24.2 t0 -66.35 -52.9 42.33 Favored 'General case' 0 N--CA 1.496 1.869 0 CA-C-N 120.251 1.387 . . . . 0.0 114.199 166.59 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 88.5 t80 -50.63 -46.23 58.15 Favored 'General case' 0 CA--C 1.573 1.852 0 N-CA-C 115.683 1.734 . . . . 0.0 115.683 168.369 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 47.9 mmm -63.49 -41.33 98.57 Favored 'General case' 0 CA--C 1.567 1.631 0 N-CA-C 114.718 1.377 . . . . 0.0 114.718 174.047 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 13.6 tmtt? -61.18 -44.79 96.73 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 115.248 1.573 . . . . 0.0 115.248 167.879 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 15.1 t -57.03 -39.62 75.15 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 116.31 1.967 . . . . 0.0 116.31 172.385 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 75.1 mt -65.07 -43.57 91.77 Favored 'General case' 0 CA--C 1.567 1.606 0 N-CA-C 115.572 1.693 . . . . 0.0 115.572 165.164 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 117.98 68.97 0.36 Allowed Glycine 0 N--CA 1.483 1.807 0 C-N-CA 124.148 0.88 . . . . 0.0 112.03 -178.932 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 18.3 t -140.74 114.98 5.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 N-CA-C 105.919 -1.882 . . . . 0.0 105.919 -174.208 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -85.99 -79.69 1.17 Allowed Glycine 0 N--CA 1.483 1.806 0 N-CA-C 114.724 0.65 . . . . 0.0 114.724 -175.864 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 20.8 p90 -132.16 163.32 28.8 Favored 'General case' 0 N--CA 1.492 1.655 0 C-N-CA 123.472 0.709 . . . . 0.0 111.474 -177.903 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . 0.333 . . 79.13 -58.13 0.41 Allowed 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 115.023 1.49 . . . . 0.0 115.023 173.335 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 80.2 m -69.98 -39.75 75.75 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 113.31 0.856 . . . . 0.0 113.31 166.069 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 45.0 ttp180 -63.77 -41.55 97.95 Favored 'General case' 0 CA--C 1.565 1.529 0 N-CA-C 114.966 1.469 . . . . 0.0 114.966 168.704 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 11.5 tm0? -66.55 -49.2 67.23 Favored 'General case' 0 CA--C 1.562 1.438 0 N-CA-C 115.127 1.529 . . . . 0.0 115.127 173.106 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 73.7 t -63.96 -42.39 95.58 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.026 0 CA-C-N 119.912 1.233 . . . . 0.0 113.271 178.593 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -73.15 -32.55 64.96 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 116.938 2.199 . . . . 0.0 116.938 176.704 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 85.7 p -68.63 -44.14 74.83 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 115.265 1.579 . . . . 0.0 115.265 167.248 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 51.7 tpp -68.7 -35.75 77.58 Favored 'General case' 0 CA--C 1.564 1.513 0 N-CA-C 116.459 2.022 . . . . 0.0 116.459 177.192 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 5.1 t -75.16 165.65 24.89 Favored 'General case' 0 N--CA 1.494 1.764 0 CA-C-N 119.9 1.227 . . . . 0.0 112.853 178.726 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.74 100.25 10.64 Favored Pre-proline 0 CA--C 1.57 1.746 0 CA-C-O 118.281 -0.866 . . . . 0.0 109.426 168.044 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -77.08 95.16 1.06 Allowed 'Trans proline' 0 C--N 1.373 1.83 0 C-N-CA 123.294 2.663 . . . . 0.0 111.124 -179.758 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 98.0 m -82.44 105.75 13.75 Favored 'General case' 0 N--CA 1.487 1.412 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.643 -158.466 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 93.5 m -81.34 112.97 19.12 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 123.746 0.818 . . . . 0.0 110.072 -175.894 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 79.1 mt -112.49 107.18 22.32 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 N-CA-C 105.985 -1.857 . . . . 0.0 105.985 -179.833 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 4.0 mp -94.7 123.67 46.9 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 175.867 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 5.8 tm-20 -136.11 112.18 9.67 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 -176.867 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 83.8 tttt -90.18 113.12 24.84 Favored 'General case' 0 CA--C 1.556 1.211 0 C-N-CA 123.023 0.529 . . . . 0.0 109.825 174.253 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 21.9 t-20 -80.56 -64.76 1.12 Allowed 'General case' 0 CA--C 1.564 1.504 0 C-N-CA 123.31 0.644 . . . . 0.0 111.768 179.233 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -131.68 -94.63 0.63 Allowed Glycine 0 N--CA 1.485 1.903 0 N-CA-C 108.941 -1.664 . . . . 0.0 108.941 169.024 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -77.46 -29.26 52.68 Favored 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 115.361 1.615 . . . . 0.0 115.361 162.849 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 35.3 mm -88.96 124.95 42.02 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.475 0 CA-C-N 119.108 0.867 . . . . 0.0 109.656 -168.438 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 21.2 mt -89.65 121.07 31.49 Favored 'General case' 0 N--CA 1.485 1.294 0 CA-C-N 114.901 -1.045 . . . . 0.0 110.53 169.103 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 87.0 m -108.8 104.07 13.26 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 179.371 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 7.9 tt -104.56 109.97 22.08 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -106.51 116.88 32.7 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 123.503 0.721 . . . . 0.0 109.205 178.947 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 94.1 m -102.91 101.28 11.29 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 177.852 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 23.0 m-70 -88.27 93.96 9.68 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 123.473 0.709 . . . . 0.0 111.838 -170.007 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 33.3 t . . . . . 0 CA--C 1.557 1.23 0 CA-C-O 122.019 0.914 . . . . 0.0 110.548 176.838 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 9.7 p30 . . . . . 0 N--CA 1.491 1.599 0 N-CA-C 112.311 0.485 . . . . 0.0 112.311 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 78.3 p -95.23 127.46 41.3 Favored 'General case' 0 N--CA 1.496 1.844 0 C-N-CA 122.917 0.487 . . . . 0.0 110.509 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -119.16 111.95 18.9 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 -176.63 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 39.1 pt -105.64 128.3 59.86 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 173.357 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 42.2 t -116.74 108.38 15.82 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 179.552 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 48.6 p90 -140.39 157.9 44.83 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 114.947 1.462 . . . . 0.0 114.947 -159.222 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 54.9 mtpt -120.15 150.38 40.72 Favored 'General case' 0 CA--C 1.563 1.449 0 CA-C-N 113.971 -1.468 . . . . 0.0 108.68 165.177 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -75.04 113.18 12.06 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.566 -0.709 . . . . 0.0 112.246 -170.213 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 83.61 39.68 9.49 Favored Glycine 0 CA--C 1.551 2.326 0 N-CA-C 116.631 1.412 . . . . 0.0 116.631 -169.522 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 76.5 t -140.76 117.64 8.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 N-CA-C 105.339 -2.097 . . . . 0.0 105.339 -175.284 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -83.17 135.62 34.73 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 122.823 0.449 . . . . 0.0 111.919 -179.868 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 36.0 p90 -140.92 133.43 28.52 Favored 'General case' 0 N--CA 1.494 1.743 0 C-N-CA 123.687 0.795 . . . . 0.0 110.83 -174.431 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -75.04 117.81 17.29 Favored 'General case' 0 CA--C 1.565 1.521 0 O-C-N 121.478 -0.764 . . . . 0.0 112.314 176.159 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 25.7 tp10 -118.31 135.52 54.26 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 123.954 0.902 . . . . 0.0 110.416 -171.406 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 84.8 m -97.01 119.79 36.15 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 171.648 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 22.9 p -86.14 -178.12 6.44 Favored 'General case' 0 N--CA 1.494 1.762 0 CA-C-O 122.192 0.996 . . . . 0.0 113.308 -171.636 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -52.7 -40.13 62.66 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 117.692 2.479 . . . . 0.0 117.692 167.097 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 42.5 m-20 -81.82 5.31 19.14 Favored 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 116.151 1.908 . . . . 0.0 116.151 169.377 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . 0.251 10.0 m-20 62.58 75.22 0.41 Allowed 'General case' 0 N--CA 1.496 1.868 0 C-N-CA 125.265 1.426 . . . . 0.0 112.048 -171.89 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 42.1 ttp180 -138.05 120.58 16.09 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 -168.051 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.16 95.39 5.59 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 123.407 0.683 . . . . 0.0 111.922 -178.634 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 12.0 m -116.74 127.05 74.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 -167.938 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 33.5 mmtp -83.6 104.44 13.73 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 123.605 0.762 . . . . 0.0 109.974 -178.593 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 74.5 m -102.28 107.87 19.05 Favored 'General case' 0 N--CA 1.483 1.189 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.022 -161.686 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 7.2 tp -115.92 104.22 16.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 C-N-CA 124.027 0.931 . . . . 0.0 108.64 -178.976 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -118.33 124.61 73.38 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 C-N-CA 124.127 0.971 . . . . 0.0 109.117 178.422 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 15.2 t -125.92 157.75 36.92 Favored 'General case' 0 N--CA 1.493 1.691 0 CA-C-O 122.471 1.129 . . . . 0.0 111.496 170.751 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 14.5 tp -92.49 122.61 35.09 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-N 114.938 -1.028 . . . . 0.0 110.138 175.876 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -122.75 79.58 1.65 Allowed 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 123.307 0.643 . . . . 0.0 109.885 -178.054 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 64.3 49.34 66.53 Favored Glycine 0 CA--C 1.55 2.235 0 N-CA-C 117.188 1.635 . . . . 0.0 117.188 -175.126 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 74.2 43.77 31.19 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 117.321 1.688 . . . . 0.0 117.321 -171.343 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -153.67 108.61 3.14 Favored 'General case' 0 CA--C 1.554 1.107 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 -169.921 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 50.9 mt -83.05 96.57 8.4 Favored 'General case' 0 N--CA 1.492 1.655 0 CA-C-O 122.812 1.292 . . . . 0.0 109.56 177.225 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 93.0 t -87.88 100.68 10.59 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.356 0 CA-C-N 112.972 -1.922 . . . . 0.0 105.944 179.125 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 22.6 t-160 -105.83 141.8 36.64 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 124.075 0.95 . . . . 0.0 109.598 -176.896 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 34.8 tp -140.13 121.24 14.75 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 177.231 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 87.7 mt-30 -115.55 110.38 19.15 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 -177.585 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -107.73 134.51 50.59 Favored 'General case' 0 N--CA 1.494 1.752 0 C-N-CA 122.986 0.514 . . . . 0.0 111.351 -174.101 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 17.5 p90 -151.04 108.72 3.66 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.398 -0.814 . . . . 0.0 109.877 177.539 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 7.1 t70 55.66 52.2 11.35 Favored 'General case' 0 N--CA 1.499 2.007 0 N-CA-C 116.408 2.003 . . . . 0.0 116.408 168.468 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 85.71 -42.55 3.16 Favored Glycine 0 CA--C 1.553 2.445 0 N-CA-C 116.768 1.467 . . . . 0.0 116.768 -169.339 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 62.9 mt-30 -78.62 125.8 29.86 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 123.744 0.818 . . . . 0.0 111.037 179.44 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -136.03 128.2 29.88 Favored 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 122.717 0.407 . . . . 0.0 111.452 178.957 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 7.7 t -113.44 132.57 55.6 Favored 'General case' 0 N--CA 1.495 1.791 0 C-N-CA 123.163 0.585 . . . . 0.0 110.921 177.941 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 41.2 p -101.01 130.39 47.0 Favored 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 122.896 0.478 . . . . 0.0 110.982 174.145 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 5.3 mp -111.16 79.68 1.23 Allowed 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.288 -1.005 . . . . 0.0 108.288 177.756 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 51.8 t -89.09 108.63 19.28 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 -169.938 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 80.5 mtt85 -104.35 113.95 27.86 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 122.946 0.498 . . . . 0.0 110.255 -174.776 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -126.0 136.99 53.62 Favored 'General case' 0 N--CA 1.493 1.677 0 C-N-CA 123.307 0.643 . . . . 0.0 111.617 179.08 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -81.81 115.69 21.14 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 123.277 0.631 . . . . 0.0 110.793 175.4 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 86.4 mt -124.75 107.94 19.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 N-CA-C 105.081 -2.192 . . . . 0.0 105.081 179.247 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 20.9 m-20 57.97 51.66 8.7 Favored 'General case' 0 N--CA 1.499 1.988 0 N-CA-C 114.971 1.471 . . . . 0.0 114.971 176.455 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 65.51 16.68 63.41 Favored Glycine 0 CA--C 1.555 2.584 0 N-CA-C 119.857 2.703 . . . . 0.0 119.857 -170.486 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 8.7 mtmp? -128.65 128.66 44.57 Favored 'General case' 0 N--CA 1.488 1.445 0 CA-C-N 119.877 1.838 . . . . 0.0 109.315 -173.447 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 22.2 tp -78.35 113.78 16.64 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 123.847 0.859 . . . . 0.0 109.843 178.501 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 34.9 mm -103.15 101.34 12.05 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 N-CA-C 106.42 -1.696 . . . . 0.0 106.42 -174.63 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 23.6 tp -90.17 103.0 15.72 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 123.915 0.886 . . . . 0.0 109.594 179.414 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 91.8 m -96.82 107.25 19.7 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 -175.335 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 71.9 mt -102.65 99.51 9.5 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 123.762 0.825 . . . . 0.0 109.476 -172.176 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 6.5 m -109.08 119.62 40.1 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 -176.414 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 75.6 t60 -141.12 120.62 13.22 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 171.032 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 74.88 -117.05 5.26 Favored Glycine 0 N--CA 1.484 1.863 0 CA-C-N 116.37 -0.377 . . . . 0.0 112.656 179.013 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 76.6 m -122.19 68.37 0.94 Allowed 'General case' 0 CA--C 1.565 1.553 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 167.471 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -164.06 99.09 0.85 Allowed 'General case' 0 N--CA 1.485 1.314 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 175.788 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 4.2 p -96.95 122.17 48.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 C-N-CA 123.929 0.892 . . . . 0.0 109.71 176.292 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 42.0 t -110.0 102.44 11.17 Favored 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 123.225 0.61 . . . . 0.0 110.731 178.063 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 63.9 m -90.74 100.39 13.25 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 -176.062 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 30.5 mtm180 -102.44 121.67 42.79 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 122.802 0.441 . . . . 0.0 111.106 -171.038 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 94.6 m -91.05 132.89 35.74 Favored 'General case' 0 CA--C 1.563 1.46 0 C-N-CA 123.763 0.825 . . . . 0.0 110.442 -177.999 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 37.5 m-85 -131.49 140.35 49.53 Favored 'General case' 0 CA--C 1.562 1.425 0 C-N-CA 124.298 1.039 . . . . 0.0 109.194 179.322 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 1.4 pp20? -111.31 157.8 19.76 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.637 -0.665 . . . . 0.0 111.837 166.943 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 22.9 ttpt -85.45 129.33 34.84 Favored 'General case' 0 N--CA 1.489 1.498 0 CA-C-O 121.906 0.86 . . . . 0.0 112.241 -167.67 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 28.2 mm-40 -118.27 55.76 0.89 Allowed 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 124.956 1.302 . . . . 0.0 111.089 -173.609 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.9 0 CA-C-O 124.447 2.07 . . . . 0.0 109.074 -168.359 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 3.3 p . . . . . 0 CA--C 1.577 2.0 0 N-CA-C 116.112 1.894 . . . . 0.0 116.112 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -68.19 -33.21 74.02 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 116.709 2.114 . . . . 0.0 116.709 -175.495 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -59.44 -25.27 64.23 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 117.707 2.484 . . . . 0.0 117.707 168.192 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -73.72 -24.3 59.89 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 116.133 1.901 . . . . 0.0 116.133 167.785 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 52.0 mt -79.9 113.84 18.37 Favored 'General case' 0 N--CA 1.489 1.505 0 CA-C-N 120.975 1.716 . . . . 0.0 111.451 -166.369 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 158.91 177.39 31.95 Favored Glycine 0 CA--C 1.543 1.785 0 CA-C-O 122.798 1.221 . . . . 0.0 112.985 -175.063 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 63.1 m -84.81 142.88 29.46 Favored 'General case' 0 N--CA 1.492 1.641 0 CA-C-N 114.57 -0.815 . . . . 0.0 109.817 171.356 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 82.6 m95 -140.9 113.95 8.47 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 107.659 -1.237 . . . . 0.0 107.659 -176.402 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 58.9 mttp -97.68 141.17 31.03 Favored 'General case' 0 N--CA 1.492 1.636 0 CA-C-O 121.016 0.436 . . . . 0.0 109.999 175.476 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 55.8 tp -66.71 124.66 23.51 Favored 'General case' 0 N--CA 1.49 1.56 0 CA-C-O 122.135 0.969 . . . . 0.0 111.668 -178.615 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . 0.284 0.9 OUTLIER -103.78 -43.42 8.58 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.784 0 CA-C-N 113.893 -1.503 . . . . 0.0 112.036 -178.222 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -142.63 129.13 20.17 Favored 'General case' 0 N--CA 1.49 1.545 0 CA-C-N 120.336 1.425 . . . . 0.0 109.778 177.926 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 87.8 p -111.77 116.5 30.81 Favored 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 123.236 0.614 . . . . 0.0 109.82 167.84 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -83.99 -75.45 0.34 Allowed 'General case' 0 N--CA 1.492 1.664 0 C-N-CA 122.78 0.432 . . . . 0.0 111.66 -173.519 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 71.4 m-20 -106.44 44.2 1.08 Allowed 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 113.307 0.854 . . . . 0.0 113.307 179.671 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 15.2 t80 -91.37 65.69 5.37 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 120.714 -1.241 . . . . 0.0 111.796 -177.705 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -168.2 -53.47 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 126.534 1.934 . . . . 0.0 107.079 -176.994 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -55.54 -47.72 75.87 Favored 'General case' 0 N--CA 1.498 1.947 0 N-CA-C 115.228 1.566 . . . . 0.0 115.228 161.648 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 92.8 t80 -52.41 -55.58 20.79 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 114.786 1.402 . . . . 0.0 114.786 170.415 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 75.2 mtm -66.22 -31.65 72.6 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 116.481 2.03 . . . . 0.0 116.481 174.787 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -64.58 -45.26 87.75 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-N 120.197 1.362 . . . . 0.0 114.564 168.795 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 23.2 t -59.14 -38.88 80.75 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 115.762 1.764 . . . . 0.0 115.762 170.339 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 95.2 mt -64.22 -39.43 93.95 Favored 'General case' 0 CA--C 1.57 1.749 0 N-CA-C 115.472 1.656 . . . . 0.0 115.472 164.785 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 129.51 -95.49 0.36 Allowed Glycine 0 CA--C 1.54 1.604 0 N-CA-C 108.887 -1.685 . . . . 0.0 108.887 -174.028 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . 0.285 13.2 t 56.73 66.95 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.058 0 N-CA-C 114.044 1.127 . . . . 0.0 114.044 168.075 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 34.47 -128.73 0.56 Allowed Glycine 0 CA--C 1.553 2.435 0 N-CA-C 120.077 2.791 . . . . 0.0 120.077 177.841 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 43.0 p90 -146.37 -54.88 0.26 Allowed 'General case' 0 N--CA 1.494 1.749 0 C-N-CA 124.202 1.001 . . . . 0.0 110.044 169.323 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.96 -33.5 75.51 Favored 'General case' 0 CA--C 1.564 1.49 0 N-CA-C 116.245 1.943 . . . . 0.0 116.245 164.801 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 29.8 m -63.49 -38.76 92.36 Favored 'General case' 0 N--CA 1.498 1.925 0 CA-C-N 120.284 1.402 . . . . 0.0 114.258 168.14 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 22.7 ttp180 -58.33 -43.67 88.36 Favored 'General case' 0 CA--C 1.573 1.847 0 N-CA-C 115.102 1.519 . . . . 0.0 115.102 167.554 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 8.1 tm0? -65.87 -51.25 60.37 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 115.116 1.524 . . . . 0.0 115.116 173.137 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 94.2 t -60.6 -45.43 97.3 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 CA-C-N 119.249 0.932 . . . . 0.0 113.01 176.332 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -65.42 -36.79 84.99 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 116.472 2.027 . . . . 0.0 116.472 175.921 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 95.5 p -64.07 -42.14 97.08 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 116.161 1.912 . . . . 0.0 116.161 168.871 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 35.8 ttm -66.5 -39.71 88.84 Favored 'General case' 0 CA--C 1.57 1.722 0 N-CA-C 115.921 1.822 . . . . 0.0 115.921 169.806 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 54.1 m -70.77 144.25 50.95 Favored 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 124.354 1.062 . . . . 0.0 112.331 -176.609 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? -102.91 99.59 14.28 Favored Pre-proline 0 CA--C 1.573 1.864 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 173.107 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -78.48 111.0 2.95 Favored 'Trans proline' 0 CA--C 1.56 1.804 0 C-N-CA 123.388 2.725 . . . . 0.0 111.594 -178.254 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 97.0 m -78.65 104.84 9.53 Favored 'General case' 0 N--CA 1.491 1.625 0 CA-C-O 121.372 0.606 . . . . 0.0 109.969 -173.876 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 86.4 m -87.55 114.79 24.48 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 124.086 0.954 . . . . 0.0 109.091 -174.871 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 81.9 mt -112.46 108.47 25.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 N-CA-C 106.557 -1.646 . . . . 0.0 106.557 -177.934 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 17.0 mt -97.14 121.24 47.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 -179.21 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -140.7 118.0 11.38 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 -169.728 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 45.2 tttp -90.62 114.91 27.29 Favored 'General case' 0 CA--C 1.557 1.214 0 C-N-CA 123.267 0.627 . . . . 0.0 111.36 -176.365 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 51.4 m-80 -105.82 83.39 1.92 Allowed 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 -179.603 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 80.6 -97.63 1.73 Allowed Glycine 0 N--CA 1.486 2.028 0 O-C-N 121.704 -0.623 . . . . 0.0 112.13 -169.007 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -130.34 62.53 1.58 Allowed 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 159.811 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 30.8 mm -138.28 100.69 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 N-CA-C 104.818 -2.29 . . . . 0.0 104.818 -178.047 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 71.0 mt -85.35 99.9 11.47 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 122.663 0.385 . . . . 0.0 110.47 -179.132 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 46.9 m -92.4 105.51 17.69 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 107.14 -1.43 . . . . 0.0 107.14 -178.82 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 10.0 tt -104.68 96.45 6.58 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 106.957 -1.497 . . . . 0.0 106.957 -170.957 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 58.9 mttp -94.83 106.84 18.85 Favored 'General case' 0 N--CA 1.482 1.133 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 -163.41 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 45.4 m -90.08 92.03 8.8 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 -175.27 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 75.4 m80 -87.64 93.64 9.49 Favored 'General case' 0 N--CA 1.488 1.47 0 CA-C-O 121.733 0.778 . . . . 0.0 110.688 -173.282 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 41.9 t . . . . . 0 CA--C 1.555 1.144 0 C-N-CA 124.051 0.941 . . . . 0.0 110.078 -175.658 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 7.4 p-10 . . . . . 0 N--CA 1.488 1.44 0 CA-C-O 120.513 0.197 . . . . 0.0 111.501 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 73.7 p -133.87 132.68 40.63 Favored 'General case' 0 N--CA 1.496 1.836 0 C-N-CA 123.146 0.579 . . . . 0.0 110.076 -170.805 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -118.95 140.74 49.49 Favored 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 122.944 0.498 . . . . 0.0 112.161 178.868 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 42.9 pt -117.22 129.97 72.88 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 C-N-CA 123.405 0.682 . . . . 0.0 109.447 -178.66 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 88.2 p -106.46 118.49 36.78 Favored 'General case' 0 N--CA 1.493 1.7 0 C-N-CA 123.745 0.818 . . . . 0.0 110.209 -178.195 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 50.2 p90 -140.82 135.86 31.84 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 115.188 1.551 . . . . 0.0 115.188 -167.55 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 53.1 mtmt -102.74 19.33 19.42 Favored 'General case' 0 CA--C 1.574 1.883 0 N-CA-C 116.556 2.058 . . . . 0.0 116.556 -175.42 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . 0.294 1.3 mp 63.21 93.07 0.06 Allowed 'General case' 0 N--CA 1.494 1.739 0 CA-C-N 120.418 1.463 . . . . 0.0 114.293 173.365 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 85.79 39.59 8.06 Favored Glycine 0 CA--C 1.55 2.259 0 N-CA-C 116.716 1.446 . . . . 0.0 116.716 -167.072 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 87.7 t -139.47 122.71 18.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 N-CA-C 106.324 -1.732 . . . . 0.0 106.324 178.597 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -87.63 125.8 34.58 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 123.448 0.699 . . . . 0.0 110.948 176.41 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 40.8 p90 -132.79 127.7 35.15 Favored 'General case' 0 N--CA 1.493 1.722 0 C-N-CA 123.558 0.743 . . . . 0.0 110.65 -173.179 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -69.52 126.59 30.2 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.607 -0.683 . . . . 0.0 112.734 174.288 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 12.9 tp10 -138.73 133.87 32.79 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 123.193 0.597 . . . . 0.0 110.156 -167.164 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 58.9 m -92.55 121.33 33.89 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 176.22 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 32.0 p -81.41 172.0 14.07 Favored 'General case' 0 N--CA 1.493 1.705 0 CA-C-O 122.041 0.924 . . . . 0.0 113.316 -173.854 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -51.6 -35.34 41.12 Favored 'General case' 0 CA--C 1.568 1.638 0 N-CA-C 118.038 2.607 . . . . 0.0 118.038 166.415 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -111.18 51.32 0.78 Allowed 'General case' 0 CA--C 1.574 1.867 0 CA-C-N 119.197 0.908 . . . . 0.0 112.177 171.621 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 51.84 73.67 0.31 Allowed 'General case' 0 N--CA 1.5 2.044 0 N-CA-C 116.584 2.068 . . . . 0.0 116.584 168.678 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 67.9 mtt-85 -143.03 125.11 15.3 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.808 -0.558 . . . . 0.0 109.665 -176.094 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.75 91.8 8.06 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 123.411 0.685 . . . . 0.0 111.483 177.372 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 10.6 m -111.97 128.59 68.46 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 121.808 -0.558 . . . . 0.0 111.426 -163.858 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 29.8 mmtp -83.7 104.3 13.7 Favored 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 123.672 0.789 . . . . 0.0 110.514 178.734 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 68.8 m -103.26 99.86 9.73 Favored 'General case' 0 N--CA 1.483 1.216 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.952 -160.447 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 7.0 tp -110.6 105.07 18.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 C-N-CA 123.646 0.778 . . . . 0.0 109.264 -177.483 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -116.96 125.54 73.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 C-N-CA 124.447 1.099 . . . . 0.0 108.353 177.32 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 11.0 t -130.16 152.52 49.51 Favored 'General case' 0 N--CA 1.492 1.632 0 CA-C-O 122.577 1.179 . . . . 0.0 111.024 172.644 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 26.3 tp -87.33 109.13 19.32 Favored 'General case' 0 N--CA 1.487 1.404 0 CA-C-N 114.64 -1.163 . . . . 0.0 109.676 177.543 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -123.51 95.26 4.52 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 -174.592 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 63.32 49.48 70.27 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 117.343 1.697 . . . . 0.0 117.343 -177.559 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 67.27 24.24 73.44 Favored Glycine 0 CA--C 1.557 2.691 0 N-CA-C 119.001 2.36 . . . . 0.0 119.001 -169.746 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 56.3 mtmt -131.93 125.45 31.67 Favored 'General case' 0 N--CA 1.487 1.425 0 CA-C-N 118.735 1.267 . . . . 0.0 107.848 -176.947 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 58.8 mt -84.56 94.86 8.68 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-O 123.03 1.395 . . . . 0.0 109.467 171.173 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 98.4 t -89.17 101.12 11.7 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.361 0 CA-C-N 112.643 -2.071 . . . . 0.0 105.844 -174.332 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 22.4 t-160 -105.78 139.88 39.67 Favored 'General case' 0 N--CA 1.486 1.348 0 CA-C-N 114.94 -1.027 . . . . 0.0 109.883 -173.5 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 29.1 tp -138.53 121.2 16.32 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 176.709 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 88.9 mt-30 -113.28 121.52 44.67 Favored 'General case' 0 N--CA 1.487 1.425 0 C-N-CA 124.233 1.013 . . . . 0.0 108.45 179.328 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 9.8 mtmp? -123.76 133.15 53.9 Favored 'General case' 0 N--CA 1.497 1.895 0 C-N-CA 122.994 0.517 . . . . 0.0 111.008 -170.314 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 13.5 p90 -156.45 112.66 3.03 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.689 -0.632 . . . . 0.0 110.325 -175.414 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 9.1 t70 53.76 52.51 12.96 Favored 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 116.279 1.955 . . . . 0.0 116.279 167.574 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 87.41 -44.01 3.24 Favored Glycine 0 CA--C 1.551 2.324 0 N-CA-C 116.687 1.435 . . . . 0.0 116.687 -169.492 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 21.7 mt-30 -79.47 139.72 37.55 Favored 'General case' 0 N--CA 1.488 1.452 0 CA-C-N 117.841 0.82 . . . . 0.0 112.124 -178.179 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -144.16 130.25 19.57 Favored 'General case' 0 N--CA 1.491 1.586 0 CA-C-O 121.16 0.505 . . . . 0.0 111.779 177.931 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 12.4 t -118.63 131.15 56.18 Favored 'General case' 0 N--CA 1.492 1.673 0 C-N-CA 123.525 0.73 . . . . 0.0 110.717 177.554 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 35.5 p -99.01 137.77 37.06 Favored 'General case' 0 N--CA 1.492 1.654 0 CA-C-O 121.311 0.576 . . . . 0.0 111.188 173.203 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 5.3 mp -122.11 74.74 1.17 Allowed 'General case' 0 CA--C 1.564 1.518 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 -179.368 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 87.0 t -84.97 108.06 16.55 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 121.085 -1.01 . . . . 0.0 108.484 -169.555 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 82.9 mtt85 -99.53 120.96 40.48 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 123.234 0.614 . . . . 0.0 109.823 -175.963 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -141.35 130.81 23.81 Favored 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 123.107 0.563 . . . . 0.0 111.084 -170.689 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -81.69 112.52 18.95 Favored 'General case' 0 N--CA 1.487 1.413 0 CA-C-O 121.51 0.671 . . . . 0.0 111.029 -179.577 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 50.3 mm -118.5 105.46 17.79 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.352 0 N-CA-C 105.171 -2.159 . . . . 0.0 105.171 179.221 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 57.86 49.58 11.8 Favored 'General case' 0 N--CA 1.499 2.02 0 N-CA-C 114.763 1.394 . . . . 0.0 114.763 176.136 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 82.51 -29.28 3.28 Favored Glycine 0 CA--C 1.554 2.522 0 N-CA-C 118.807 2.283 . . . . 0.0 118.807 -169.504 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 89.9 mttt -93.72 136.11 34.33 Favored 'General case' 0 N--CA 1.486 1.371 0 CA-C-N 119.275 1.537 . . . . 0.0 111.189 -168.369 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 20.6 tp -80.73 115.93 20.48 Favored 'General case' 0 CA--C 1.558 1.279 0 C-N-CA 123.24 0.616 . . . . 0.0 110.105 177.551 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 39.2 mm -104.0 101.57 12.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 N-CA-C 106.835 -1.543 . . . . 0.0 106.835 -175.3 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 16.2 tp -91.81 102.22 14.81 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 124.009 0.924 . . . . 0.0 109.729 179.604 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 58.5 m -91.54 112.87 24.97 Favored 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 123.883 0.873 . . . . 0.0 109.286 -175.808 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 96.7 mt -111.09 97.48 6.84 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 123.71 0.804 . . . . 0.0 109.708 -169.95 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 10.2 m -113.08 117.75 32.86 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.875 -0.516 . . . . 0.0 109.788 -172.405 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 78.9 t60 -152.34 116.4 4.91 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 174.929 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 60.6 61.18 7.33 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 117.061 1.584 . . . . 0.0 117.061 171.39 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . 0.297 4.3 m 51.65 51.53 16.49 Favored 'General case' 0 CA--C 1.576 1.953 0 N-CA-C 114.928 1.455 . . . . 0.0 114.928 -172.098 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -158.11 86.62 0.9 Allowed 'General case' 0 N--CA 1.484 1.228 0 CA-C-O 121.542 0.687 . . . . 0.0 109.194 -179.618 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 3.4 p -91.23 111.85 24.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 C-N-CA 123.691 0.796 . . . . 0.0 109.257 175.4 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 48.4 t -105.17 102.05 11.57 Favored 'General case' 0 CA--C 1.552 1.032 0 CA-C-O 121.461 0.648 . . . . 0.0 109.662 176.052 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 86.0 m -90.56 94.2 9.61 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 -175.706 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 32.5 mtm180 -91.88 120.98 33.06 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 122.927 0.491 . . . . 0.0 111.019 -169.426 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 87.6 m -86.61 131.83 34.06 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 123.463 0.705 . . . . 0.0 110.096 179.09 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 35.9 m-85 -128.43 126.59 40.87 Favored 'General case' 0 CA--C 1.558 1.275 0 C-N-CA 123.82 0.848 . . . . 0.0 108.835 178.538 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -93.99 150.98 19.87 Favored 'General case' 0 N--CA 1.492 1.672 0 CA-C-O 122.08 0.943 . . . . 0.0 111.526 169.921 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 68.9 tttt -83.06 119.56 24.63 Favored 'General case' 0 N--CA 1.486 1.329 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.706 -169.884 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 11.8 mm-40 -110.09 49.36 0.85 Allowed 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 123.934 0.894 . . . . 0.0 113.03 179.49 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.301 0 CA-C-O 123.27 1.509 . . . . 0.0 113.569 169.928 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.303 8.5 t . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 118.248 -0.882 . . . . 0.0 112.984 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -60.48 -37.46 81.13 Favored 'General case' 0 N--CA 1.497 1.895 0 N-CA-C 116.224 1.935 . . . . 0.0 116.224 179.505 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -63.55 -29.07 70.39 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 117.047 2.24 . . . . 0.0 117.047 164.057 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -72.93 -21.67 60.84 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 116.145 1.905 . . . . 0.0 116.145 170.589 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 48.2 mt -69.64 114.74 8.14 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-N 121.516 1.962 . . . . 0.0 111.917 -172.541 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 157.93 172.94 25.72 Favored Glycine 0 CA--C 1.543 1.808 0 CA-C-O 122.442 1.023 . . . . 0.0 113.428 -173.554 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 80.1 m -92.88 140.52 29.41 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 171.177 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 85.2 m95 -138.7 114.75 10.16 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 -173.936 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 48.5 mtmt -97.18 147.16 24.37 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-O 121.54 0.686 . . . . 0.0 111.32 177.297 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 57.3 tp -70.76 126.26 29.1 Favored 'General case' 0 N--CA 1.487 1.421 0 CA-C-O 121.905 0.859 . . . . 0.0 112.438 -175.505 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . 0.271 1.1 t -104.58 -44.16 8.54 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.852 0 CA-C-N 114.327 -1.306 . . . . 0.0 112.421 178.542 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -140.45 134.31 30.55 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-N 120.004 1.275 . . . . 0.0 109.687 -178.487 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 79.9 p -122.17 113.99 20.24 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 123.456 0.702 . . . . 0.0 110.053 171.855 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 10.7 mtpm? -81.92 -88.16 0.09 Allowed 'General case' 0 N--CA 1.492 1.646 0 CA-C-O 118.962 -0.542 . . . . 0.0 111.472 -177.152 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 70.9 m-80 -98.1 43.03 1.07 Allowed 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 113.831 1.049 . . . . 0.0 113.831 -174.222 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 17.5 t80 -76.83 -43.11 37.67 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 115.722 1.749 . . . . 0.0 115.722 -168.325 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 33.3 m-20 -63.69 -36.51 84.1 Favored 'General case' 0 N--CA 1.499 1.999 0 N-CA-C 115.112 1.523 . . . . 0.0 115.112 169.763 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 24.1 t0 -60.87 -47.32 86.9 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 115.174 1.546 . . . . 0.0 115.174 167.226 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 83.7 t80 -53.95 -53.02 58.62 Favored 'General case' 0 CA--C 1.569 1.702 0 N-CA-C 115.194 1.553 . . . . 0.0 115.194 170.448 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 79.0 mtm -63.76 -34.58 78.21 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 116.149 1.907 . . . . 0.0 116.149 173.704 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -57.59 -50.61 72.55 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 114.65 1.352 . . . . 0.0 114.65 165.194 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 22.9 t -60.28 -36.58 78.15 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 116.318 1.97 . . . . 0.0 116.318 171.482 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.493 ' HB3' HH12 ' A' ' 78' ' ' ARG . 31.2 mt -64.1 -34.75 78.75 Favored 'General case' 0 CA--C 1.565 1.53 0 N-CA-C 117.309 2.337 . . . . 0.0 117.309 169.74 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 101.25 76.26 1.19 Allowed Glycine 0 N--CA 1.482 1.741 0 CA-C-N 119.118 0.872 . . . . 0.0 112.02 -171.415 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 58.3 t -138.33 122.76 21.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 N-CA-C 105.585 -2.006 . . . . 0.0 105.585 -179.554 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -63.27 147.53 50.53 Favored Glycine 0 N--CA 1.488 2.116 0 N-CA-C 115.431 0.932 . . . . 0.0 115.431 177.978 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . 0.257 25.2 p90 -55.34 -41.64 72.74 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 118.834 2.901 . . . . 0.0 118.834 -166.169 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.57 -44.48 96.21 Favored 'General case' 0 CA--C 1.565 1.541 0 N-CA-C 115.979 1.844 . . . . 0.0 115.979 175.157 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 86.6 m -68.78 -38.6 80.12 Favored 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 114.439 1.274 . . . . 0.0 114.439 168.772 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 48.8 ttp180 -56.57 -45.14 81.47 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 115.421 1.637 . . . . 0.0 115.421 174.373 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 18.8 mm100 -70.5 -38.13 74.3 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 115.167 1.543 . . . . 0.0 115.167 173.196 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 95.3 t -63.45 -44.09 98.71 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.094 0 CA-C-N 120.093 1.315 . . . . 0.0 113.46 171.525 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -63.98 -31.06 72.11 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 117.371 2.36 . . . . 0.0 117.371 174.641 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 93.7 p -68.57 -42.2 78.62 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 116.15 1.907 . . . . 0.0 116.15 168.072 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 3.7 ppp? -71.87 -26.91 62.54 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 117.582 2.438 . . . . 0.0 117.582 175.34 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 5.3 t -74.79 162.95 28.2 Favored 'General case' 0 N--CA 1.493 1.699 0 CA-C-N 120.335 1.425 . . . . 0.0 112.592 175.956 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -99.97 103.51 22.84 Favored Pre-proline 0 CA--C 1.567 1.61 0 CA-C-O 118.008 -0.996 . . . . 0.0 108.853 172.394 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -78.89 90.32 1.29 Allowed 'Trans proline' 0 CA--C 1.56 1.81 0 C-N-CA 123.208 2.606 . . . . 0.0 111.225 177.292 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 94.4 m -80.19 111.79 16.89 Favored 'General case' 0 N--CA 1.489 1.513 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.574 -161.164 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 36.5 m -86.42 113.28 22.24 Favored 'General case' 0 CA--C 1.559 1.323 0 C-N-CA 123.598 0.759 . . . . 0.0 109.446 -171.711 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 71.6 mt -109.59 103.62 15.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 N-CA-C 106.033 -1.84 . . . . 0.0 106.033 177.649 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 3.7 mp -91.68 123.41 43.79 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 N-CA-C 106.881 -1.526 . . . . 0.0 106.881 172.175 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -148.21 125.61 11.62 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 -169.626 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.32 153.65 29.68 Favored 'General case' 0 CA--C 1.565 1.54 0 CA-C-O 122.173 0.987 . . . . 0.0 113.656 178.249 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 67.1 m-80 -141.77 75.3 1.49 Allowed 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 106.389 -1.708 . . . . 0.0 106.389 171.16 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 71.17 -110.99 3.47 Favored Glycine 0 CA--C 1.548 2.108 0 O-C-N 121.885 -0.51 . . . . 0.0 112.86 -166.5 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 21.1 m-20 -82.75 -21.14 34.79 Favored 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 116.033 1.864 . . . . 0.0 116.033 168.024 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 42.8 mm -84.93 114.88 25.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 CA-C-N 119.863 1.21 . . . . 0.0 109.614 -168.191 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.4 HD12 HD13 ' A' ' 66' ' ' LEU . 44.5 mt -86.79 114.94 23.87 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 123.057 0.543 . . . . 0.0 110.342 174.164 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 88.5 m -107.81 102.82 12.0 Favored 'General case' 0 N--CA 1.486 1.342 0 N-CA-C 106.728 -1.582 . . . . 0.0 106.728 -174.358 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 8.9 tt -104.37 107.11 17.87 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -103.37 114.82 29.39 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 179.331 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 91.7 m -100.67 98.11 8.7 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 179.246 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 20.2 m-70 -85.08 91.26 8.06 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 123.411 0.684 . . . . 0.0 112.555 -169.456 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 15.2 t . . . . . 0 CA--C 1.557 1.241 0 C-N-CA 123.814 0.846 . . . . 0.0 110.302 174.486 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 8.8 p30 . . . . . 0 N--CA 1.49 1.534 0 CA-C-O 120.249 0.071 . . . . 0.0 110.952 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 77.9 p -90.67 122.63 33.61 Favored 'General case' 0 N--CA 1.492 1.661 0 CA-C-O 121.178 0.513 . . . . 0.0 110.775 -174.559 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -108.12 115.82 30.83 Favored 'General case' 0 N--CA 1.486 1.341 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 -175.112 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 29.8 pt -111.24 129.63 66.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 N-CA-C 108.531 -0.915 . . . . 0.0 108.531 174.087 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 44.1 t -118.73 113.0 20.48 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.38 -0.971 . . . . 0.0 108.38 -174.574 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 43.8 p90 -144.89 140.77 28.55 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 115.093 1.516 . . . . 0.0 115.093 -162.1 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 29.5 mtpp -109.16 18.43 20.56 Favored 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 117.325 2.343 . . . . 0.0 117.325 -177.486 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.4 HD13 HD12 ' A' ' 49' ' ' LEU 0.296 1.3 mp 65.6 93.57 0.07 Allowed 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 125.03 1.332 . . . . 0.0 113.278 176.723 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 92.32 37.67 5.85 Favored Glycine 0 CA--C 1.55 2.228 0 N-CA-C 117.01 1.564 . . . . 0.0 117.01 -166.631 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 92.3 t -135.62 122.86 35.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 N-CA-C 107.035 -1.468 . . . . 0.0 107.035 178.311 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -88.08 131.91 34.5 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 123.401 0.68 . . . . 0.0 110.476 170.793 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 37.0 p90 -143.0 130.74 21.43 Favored 'General case' 0 N--CA 1.493 1.72 0 C-N-CA 123.333 0.653 . . . . 0.0 110.087 -174.069 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -72.56 114.02 10.24 Favored 'General case' 0 CA--C 1.564 1.501 0 O-C-N 121.546 -0.721 . . . . 0.0 111.933 175.934 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 14.0 tp10 -119.08 134.5 55.16 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 123.842 0.857 . . . . 0.0 109.782 -167.706 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 73.4 m -90.57 121.74 32.77 Favored 'General case' 0 N--CA 1.491 1.577 0 CA-C-O 121.258 0.551 . . . . 0.0 109.663 176.084 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 30.0 p -85.0 169.74 13.69 Favored 'General case' 0 N--CA 1.493 1.712 0 CA-C-O 121.54 0.686 . . . . 0.0 112.203 -177.951 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -59.37 -34.82 72.88 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 116.68 2.104 . . . . 0.0 116.68 166.89 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -76.53 9.24 2.84 Favored 'General case' 0 CA--C 1.581 2.144 0 N-CA-C 115.909 1.818 . . . . 0.0 115.909 167.309 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . 0.252 11.6 m-20 66.78 69.74 0.4 Allowed 'General case' 0 N--CA 1.494 1.77 0 C-N-CA 125.749 1.62 . . . . 0.0 112.669 176.971 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.493 HH12 ' HB3' ' A' ' 23' ' ' LEU . 60.4 mtm180 -143.56 128.17 18.1 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 122.915 0.486 . . . . 0.0 110.23 -175.117 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.36 117.56 13.05 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 123.491 0.716 . . . . 0.0 111.075 164.822 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 14.3 m -133.49 127.37 53.36 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 -171.865 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 33.2 mmtp -77.54 102.9 7.17 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 123.567 0.747 . . . . 0.0 110.557 -178.886 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 69.2 m -101.19 92.67 5.08 Favored 'General case' 0 N--CA 1.482 1.149 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.575 -165.074 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 7.2 tp -106.1 116.64 50.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 178.915 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 1.4 p -134.15 131.72 55.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 C-N-CA 123.806 0.842 . . . . 0.0 109.564 -170.808 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 10.1 t -148.63 152.17 36.25 Favored 'General case' 0 N--CA 1.49 1.533 0 CA-C-O 122.745 1.26 . . . . 0.0 110.359 179.691 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 26.4 tp -85.67 119.94 26.55 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-N 114.726 -1.125 . . . . 0.0 110.298 176.424 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -109.4 79.22 1.19 Allowed 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 123.52 0.728 . . . . 0.0 109.613 -178.357 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 54.9 44.26 81.96 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 118.477 2.151 . . . . 0.0 118.477 -177.454 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 107.12 -42.52 1.91 Allowed Glycine 0 N--CA 1.49 2.295 0 N-CA-C 116.558 1.383 . . . . 0.0 116.558 -168.885 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 35.9 ttmt -82.33 112.06 18.96 Favored 'General case' 0 CA--C 1.559 1.289 0 CA-C-N 118.164 0.982 . . . . 0.0 109.881 179.584 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.8 tt -88.28 102.72 15.12 Favored 'General case' 0 N--CA 1.488 1.459 0 CA-C-O 121.659 0.742 . . . . 0.0 109.311 -176.739 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 62.7 t -100.7 110.41 27.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 -166.656 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 22.8 t-160 -104.47 134.39 47.75 Favored 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 123.822 0.849 . . . . 0.0 109.713 171.774 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 24.4 tp -120.09 120.99 37.87 Favored 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 124.655 1.182 . . . . 0.0 107.944 172.829 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 27.6 mt-30 -109.2 113.71 26.79 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 171.522 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 38.0 ttmt -122.77 132.82 54.4 Favored 'General case' 0 CA--C 1.563 1.465 0 C-N-CA 123.461 0.704 . . . . 0.0 110.397 -174.592 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 34.9 p90 -149.09 115.2 5.76 Favored 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 123.36 0.664 . . . . 0.0 109.989 -176.941 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . 0.343 17.4 t70 67.15 -101.36 0.06 Allowed 'General case' 0 N--CA 1.495 1.796 0 C-N-CA 124.511 1.124 . . . . 0.0 111.972 176.179 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -127.88 56.23 0.74 Allowed Glycine 0 N--CA 1.487 2.059 0 CA-C-N 118.736 0.698 . . . . 0.0 113.16 162.568 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 49.1 mt-30 -149.15 110.41 4.41 Favored 'General case' 0 N--CA 1.485 1.31 0 N-CA-C 107.032 -1.47 . . . . 0.0 107.032 -177.481 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -117.01 124.42 49.27 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 122.894 0.477 . . . . 0.0 110.777 176.577 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 10.7 t -115.58 122.71 46.48 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 110.051 -0.351 . . . . 0.0 110.051 167.421 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 35.7 p -93.19 125.79 37.96 Favored 'General case' 0 N--CA 1.489 1.505 0 CA-C-O 121.274 0.559 . . . . 0.0 110.598 172.345 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 5.6 mp -99.08 86.73 3.51 Favored 'General case' 0 CA--C 1.561 1.387 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 175.924 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 93.3 t -94.21 108.53 20.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 -168.455 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 79.1 mtt85 -108.41 121.98 46.06 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 123.173 0.589 . . . . 0.0 110.143 -173.239 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -141.53 137.51 32.07 Favored 'General case' 0 N--CA 1.495 1.776 0 C-N-CA 123.114 0.566 . . . . 0.0 110.938 177.199 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -81.17 119.62 23.83 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.518 -0.739 . . . . 0.0 111.271 176.765 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 74.6 mt -123.97 110.89 26.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 N-CA-C 104.949 -2.241 . . . . 0.0 104.949 177.369 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 29.3 m-20 59.3 48.49 10.11 Favored 'General case' 0 N--CA 1.5 2.057 0 N-CA-C 114.767 1.395 . . . . 0.0 114.767 179.126 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 60.45 28.06 66.79 Favored Glycine 0 CA--C 1.554 2.473 0 N-CA-C 119.336 2.494 . . . . 0.0 119.336 -169.368 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 9.7 mtmp? -135.36 127.31 29.56 Favored 'General case' 0 N--CA 1.489 1.511 0 CA-C-N 119.482 1.641 . . . . 0.0 108.533 -173.649 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 35.0 tp -75.36 112.19 11.41 Favored 'General case' 0 CA--C 1.557 1.235 0 C-N-CA 123.493 0.717 . . . . 0.0 110.811 -179.561 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 31.0 mm -100.42 104.92 16.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 N-CA-C 106.409 -1.7 . . . . 0.0 106.409 -176.533 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 23.7 tp -97.96 101.17 12.59 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 123.81 0.844 . . . . 0.0 109.103 179.541 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 97.7 m -93.86 109.96 21.64 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 124.177 0.991 . . . . 0.0 108.769 -178.546 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 74.7 mt -103.8 90.32 3.6 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 123.913 0.885 . . . . 0.0 109.734 -168.534 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 7.5 m -100.06 118.18 35.88 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 -168.932 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 80.1 t60 -132.59 -105.49 0.25 Allowed 'General case' 0 N--CA 1.492 1.629 0 CA-C-O 118.77 -0.633 . . . . 0.0 109.652 176.105 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -119.63 91.14 0.49 Allowed Glycine 0 N--CA 1.486 1.989 0 CA-C-N 119.321 0.964 . . . . 0.0 112.65 -167.015 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . 0.297 1.6 m 54.62 34.37 21.27 Favored 'General case' 0 CA--C 1.582 2.179 0 N-CA-C 115.885 1.809 . . . . 0.0 115.885 -173.029 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -161.68 84.22 0.61 Allowed 'General case' 0 N--CA 1.485 1.308 0 O-C-N 121.15 -0.968 . . . . 0.0 108.768 -177.905 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 4.7 p -91.91 116.67 33.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 175.996 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 42.2 t -101.85 102.35 12.92 Favored 'General case' 0 CA--C 1.553 1.066 0 CA-C-O 121.187 0.518 . . . . 0.0 111.096 -179.63 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 96.2 m -87.7 111.75 21.64 Favored 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 177.424 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 28.9 mtm180 -114.4 119.28 36.39 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 122.898 0.479 . . . . 0.0 110.529 -170.347 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 88.9 m -84.42 134.97 34.45 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 123.234 0.614 . . . . 0.0 110.043 175.881 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 36.9 m-85 -130.11 128.43 41.83 Favored 'General case' 0 CA--C 1.56 1.345 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 178.367 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -93.77 150.72 20.16 Favored 'General case' 0 CA--C 1.564 1.503 0 CA-C-O 122.06 0.933 . . . . 0.0 111.202 172.173 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 69.3 tttt -82.97 124.83 30.76 Favored 'General case' 0 N--CA 1.486 1.342 0 N-CA-C 112.916 0.709 . . . . 0.0 112.916 -168.559 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 40.1 tp10 -99.06 47.95 0.96 Allowed 'General case' 0 CA--C 1.57 1.724 0 C-N-CA 123.772 0.829 . . . . 0.0 113.044 169.548 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.043 0 CA-C-O 124.263 1.982 . . . . 0.0 108.241 -176.94 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.306 5.0 t . . . . . 0 N--CA 1.49 1.526 0 CA-C-O 117.795 -1.098 . . . . 0.0 113.302 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -61.19 -36.99 81.38 Favored 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 115.991 1.849 . . . . 0.0 115.991 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -61.31 -32.23 72.09 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 116.957 2.206 . . . . 0.0 116.957 163.428 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -71.96 -25.41 61.86 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 115.978 1.844 . . . . 0.0 115.978 170.248 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 55.3 mt -71.71 117.32 13.14 Favored 'General case' 0 N--CA 1.492 1.652 0 CA-C-N 121.375 1.898 . . . . 0.0 111.112 -175.925 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 160.1 170.0 24.12 Favored Glycine 0 CA--C 1.54 1.627 0 CA-C-O 122.418 1.01 . . . . 0.0 113.853 -172.422 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 90.3 m -92.62 136.74 32.97 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-N 114.464 -0.868 . . . . 0.0 108.812 171.031 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 94.8 m95 -137.64 115.17 11.2 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.685 -0.858 . . . . 0.0 108.685 -170.193 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 23.0 mmmt -108.27 145.22 34.67 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-O 121.791 0.805 . . . . 0.0 110.536 179.627 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 25.8 tp -68.81 128.82 38.01 Favored 'General case' 0 N--CA 1.487 1.407 0 CA-C-O 122.222 1.011 . . . . 0.0 112.91 -171.789 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . 0.28 1.1 t -106.69 -45.67 8.01 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.725 0 CA-C-N 113.805 -1.543 . . . . 0.0 111.767 178.811 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 43.7 t0 -142.01 140.08 32.56 Favored 'General case' 0 N--CA 1.488 1.429 0 CA-C-N 119.437 1.017 . . . . 0.0 109.079 178.641 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 81.0 p -127.79 94.26 3.9 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.784 -0.572 . . . . 0.0 109.853 172.4 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 47.9 mtmt -91.99 120.8 32.97 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 123.57 0.748 . . . . 0.0 109.355 -176.408 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.264 42.1 m-20 71.53 21.17 4.56 Favored 'General case' 0 N--CA 1.504 2.264 0 N-CA-C 117.113 2.264 . . . . 0.0 117.113 -178.726 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 10.1 t80 -71.85 -41.13 68.47 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 115.853 1.797 . . . . 0.0 115.853 -175.799 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -60.52 -32.25 71.29 Favored 'General case' 0 N--CA 1.499 1.976 0 N-CA-C 116.014 1.857 . . . . 0.0 116.014 168.442 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 20.1 t0 -64.85 -50.72 65.54 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 114.331 1.234 . . . . 0.0 114.331 167.776 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 89.6 t80 -50.54 -54.83 19.39 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 115.349 1.611 . . . . 0.0 115.349 171.74 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 77.7 mtm -59.85 -41.85 92.35 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 115.231 1.567 . . . . 0.0 115.231 175.418 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.3 tmtp? -62.57 -43.94 97.57 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 114.788 1.403 . . . . 0.0 114.788 171.526 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 61.3 m -58.18 -39.39 78.8 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 116.574 2.064 . . . . 0.0 116.574 171.022 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 51.8 mt -61.54 -45.86 92.39 Favored 'General case' 0 CA--C 1.567 1.632 0 N-CA-C 115.747 1.758 . . . . 0.0 115.747 167.94 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 121.03 71.69 0.3 Allowed Glycine 0 N--CA 1.482 1.735 0 C-N-CA 123.979 0.8 . . . . 0.0 111.266 -172.101 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 40.5 t -141.6 122.0 12.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 N-CA-C 105.083 -2.191 . . . . 0.0 105.083 -176.294 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -77.15 -171.48 35.35 Favored Glycine 0 CA--C 1.548 2.154 0 N-CA-C 116.663 1.425 . . . . 0.0 116.663 -174.853 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 11.0 p90 -67.27 158.32 31.76 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 113.387 0.884 . . . . 0.0 113.387 176.836 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . 0.325 . . 78.76 -52.05 0.46 Allowed 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 114.995 1.48 . . . . 0.0 114.995 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 89.1 m -64.48 -40.93 96.61 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 114.241 1.201 . . . . 0.0 114.241 167.682 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 48.1 mtm180 -61.26 -43.66 98.52 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 114.996 1.48 . . . . 0.0 114.996 167.555 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -60.52 -49.81 76.07 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 115.058 1.503 . . . . 0.0 115.058 174.056 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 69.1 t -63.69 -43.84 98.2 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 CA-C-N 119.429 1.013 . . . . 0.0 112.742 174.819 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -62.7 -35.98 81.48 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 117.053 2.242 . . . . 0.0 117.053 176.234 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 96.7 p -65.66 -43.44 89.39 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 116.395 1.998 . . . . 0.0 116.395 170.884 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 20.0 ptm -68.21 -31.02 70.25 Favored 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 117.067 2.247 . . . . 0.0 117.067 168.886 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 38.0 m -71.85 143.47 49.41 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 124.279 1.031 . . . . 0.0 112.257 -178.025 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -104.52 102.97 37.16 Favored Pre-proline 0 CA--C 1.57 1.723 0 CA-C-O 118.145 -0.931 . . . . 0.0 109.1 175.25 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -79.2 116.88 3.72 Favored 'Trans proline' 0 CA--C 1.561 1.849 0 C-N-CA 122.913 2.409 . . . . 0.0 112.185 -178.909 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 24.4 m -78.8 105.36 10.06 Favored 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 123.675 0.79 . . . . 0.0 109.701 -170.536 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 61.0 m -101.12 106.77 18.05 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 -167.234 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 52.0 mt -111.69 107.19 22.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 N-CA-C 107.16 -1.422 . . . . 0.0 107.16 -172.149 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 3.9 mp -96.18 121.56 46.84 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 174.637 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 7.9 tm-20 -137.23 120.6 16.97 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 -178.03 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -86.23 115.9 24.07 Favored 'General case' 0 CA--C 1.56 1.339 0 C-N-CA 123.15 0.58 . . . . 0.0 111.052 179.431 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 12.5 t30 -105.79 86.87 2.46 Favored 'General case' 0 CA--C 1.561 1.374 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 179.282 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 80.92 -99.75 1.92 Allowed Glycine 0 N--CA 1.486 1.982 0 N-CA-C 111.883 -0.487 . . . . 0.0 111.883 -172.91 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -130.11 59.36 1.63 Allowed 'General case' 0 N--CA 1.494 1.747 0 CA-C-O 120.958 0.409 . . . . 0.0 110.065 160.399 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 42.6 mm -137.81 108.16 5.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 N-CA-C 104.889 -2.263 . . . . 0.0 104.889 -179.813 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 42.8 mt -83.11 106.67 15.1 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 122.756 0.422 . . . . 0.0 110.871 179.204 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 73.3 m -98.98 96.99 8.2 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 -173.95 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 9.1 tt -97.68 103.19 15.1 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 -179.227 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 91.3 mttt -98.94 111.14 23.62 Favored 'General case' 0 N--CA 1.485 1.276 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 -175.306 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 45.8 m -100.13 87.03 3.35 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 -177.601 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 12.0 m170 -89.87 98.63 11.88 Favored 'General case' 0 N--CA 1.492 1.642 0 CA-C-O 121.702 0.763 . . . . 0.0 110.053 -173.224 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 22.9 t . . . . . 0 N--CA 1.488 1.448 0 N-CA-C 116.962 2.208 . . . . 0.0 116.962 -172.54 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 8.9 p30 . . . . . 0 N--CA 1.487 1.42 0 CA-C-O 120.737 0.303 . . . . 0.0 110.777 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 60.2 p -96.19 127.85 42.56 Favored 'General case' 0 N--CA 1.494 1.75 0 CA-C-O 121.396 0.617 . . . . 0.0 109.949 -179.577 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -124.52 125.09 43.65 Favored 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 123.426 0.69 . . . . 0.0 109.344 -171.582 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 48.2 pt -117.6 131.48 70.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 C-N-CA 123.524 0.73 . . . . 0.0 109.077 175.644 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 80.6 p -121.2 104.14 9.52 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 -178.055 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 50.1 p90 -136.9 147.09 46.23 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 114.809 1.411 . . . . 0.0 114.809 -156.555 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 25.9 mtpp -110.77 20.29 17.74 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 117.679 2.474 . . . . 0.0 117.679 -170.693 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . 0.311 1.7 mp 60.65 88.7 0.08 Allowed 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 114.93 1.456 . . . . 0.0 114.93 172.639 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 92.39 39.81 5.26 Favored Glycine 0 CA--C 1.549 2.194 0 N-CA-C 115.951 1.141 . . . . 0.0 115.951 -168.506 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 74.9 t -141.62 123.86 14.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 N-CA-C 105.533 -2.025 . . . . 0.0 105.533 -176.421 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -88.14 129.55 35.29 Favored 'General case' 0 CA--C 1.565 1.547 0 C-N-CA 122.924 0.49 . . . . 0.0 110.497 176.915 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 48.6 p90 -138.95 131.55 28.87 Favored 'General case' 0 N--CA 1.496 1.831 0 C-N-CA 123.231 0.612 . . . . 0.0 111.435 -174.201 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -69.17 131.56 45.14 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.303 -0.873 . . . . 0.0 113.133 173.602 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 17.4 tp10 -142.97 137.85 29.67 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 123.426 0.69 . . . . 0.0 110.028 -168.343 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 56.6 m -93.06 122.8 35.8 Favored 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 123.035 0.534 . . . . 0.0 109.639 176.238 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 26.9 p -84.14 177.8 8.08 Favored 'General case' 0 N--CA 1.496 1.86 0 CA-C-O 121.415 0.626 . . . . 0.0 112.549 -177.3 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -67.4 -27.97 67.53 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 117.416 2.376 . . . . 0.0 117.416 169.612 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 25.6 m-20 -77.96 8.3 4.88 Favored 'General case' 0 CA--C 1.579 2.096 0 N-CA-C 115.918 1.822 . . . . 0.0 115.918 161.39 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 64.01 68.81 0.55 Allowed 'General case' 0 N--CA 1.496 1.837 0 C-N-CA 125.366 1.466 . . . . 0.0 112.891 -179.802 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 63.7 mtm180 -137.05 127.96 27.46 Favored 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 123.001 0.521 . . . . 0.0 109.74 -171.457 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.04 102.8 6.64 Favored 'General case' 0 CA--C 1.565 1.53 0 C-N-CA 123.331 0.652 . . . . 0.0 111.141 173.071 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 19.9 m -120.36 129.99 74.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 -170.622 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 69.6 mmtt -81.74 107.13 14.23 Favored 'General case' 0 N--CA 1.49 1.531 0 CA-C-O 121.841 0.829 . . . . 0.0 109.867 176.87 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 74.3 m -102.07 102.49 12.98 Favored 'General case' 0 N--CA 1.481 1.08 0 CA-C-N 114.838 -1.073 . . . . 0.0 110.114 -165.906 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -106.91 115.04 47.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 175.67 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -128.26 128.15 68.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 C-N-CA 123.799 0.84 . . . . 0.0 109.32 -178.835 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 9.3 t -139.97 151.26 45.37 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-O 122.705 1.24 . . . . 0.0 111.337 -179.249 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 50.5 tp -82.2 125.48 30.97 Favored 'General case' 0 N--CA 1.489 1.498 0 CA-C-N 114.523 -1.217 . . . . 0.0 109.921 176.476 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -126.5 83.44 2.17 Favored 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 123.462 0.705 . . . . 0.0 109.771 -178.826 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 58.56 46.13 93.63 Favored Glycine 0 CA--C 1.552 2.395 0 N-CA-C 117.934 1.933 . . . . 0.0 117.934 -178.444 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 76.77 31.82 52.33 Favored Glycine 0 CA--C 1.555 2.544 0 N-CA-C 117.833 1.893 . . . . 0.0 117.833 -166.924 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 60.4 mtpt -141.13 112.82 7.62 Favored 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 106.629 -1.619 . . . . 0.0 106.629 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 3.7 mp -81.67 111.04 17.58 Favored 'General case' 0 N--CA 1.487 1.404 0 CA-C-O 121.94 0.876 . . . . 0.0 109.858 173.76 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 95.6 t -106.84 102.03 13.35 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 N-CA-C 105.324 -2.102 . . . . 0.0 105.324 -172.646 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 23.6 t-160 -104.85 136.95 43.39 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 124.35 1.06 . . . . 0.0 109.474 -178.306 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 33.7 tp -132.65 119.4 20.38 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 177.782 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 81.9 mt-30 -111.87 111.84 23.08 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 179.372 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 10.3 ptpp? -120.04 138.61 53.42 Favored 'General case' 0 N--CA 1.494 1.732 0 C-N-CA 123.228 0.611 . . . . 0.0 112.027 -172.324 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 13.7 p90 -156.79 109.8 2.57 Favored 'General case' 0 N--CA 1.488 1.475 0 C-N-CA 123.379 0.672 . . . . 0.0 109.825 -174.165 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 6.7 t70 54.5 54.4 9.38 Favored 'General case' 0 N--CA 1.498 1.949 0 N-CA-C 116.066 1.876 . . . . 0.0 116.066 168.62 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 87.2 -41.91 3.12 Favored Glycine 0 CA--C 1.552 2.38 0 N-CA-C 116.919 1.528 . . . . 0.0 116.919 -169.797 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -86.17 135.71 33.48 Favored 'General case' 0 N--CA 1.483 1.208 0 CA-C-N 117.979 0.89 . . . . 0.0 111.454 -174.94 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -144.86 137.73 26.51 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.911 -0.493 . . . . 0.0 112.006 -178.868 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 9.9 t -131.46 129.25 40.94 Favored 'General case' 0 N--CA 1.493 1.722 0 C-N-CA 123.356 0.662 . . . . 0.0 110.682 179.648 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 41.8 p -98.52 129.57 45.09 Favored 'General case' 0 N--CA 1.494 1.732 0 C-N-CA 122.884 0.474 . . . . 0.0 111.769 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 5.7 mp -103.91 80.26 1.73 Allowed 'General case' 0 CA--C 1.564 1.51 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 177.059 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 59.9 t -89.69 108.85 19.77 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 -168.73 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 81.8 mtt85 -102.96 122.09 43.88 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 123.425 0.69 . . . . 0.0 110.234 -176.735 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -138.73 139.74 38.46 Favored 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 123.04 0.536 . . . . 0.0 111.66 178.035 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -83.12 118.04 23.29 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 123.084 0.554 . . . . 0.0 111.412 178.536 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 46.5 mm -119.01 105.72 18.09 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 N-CA-C 105.287 -2.116 . . . . 0.0 105.287 174.277 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 58.61 49.29 10.58 Favored 'General case' 0 N--CA 1.5 2.037 0 N-CA-C 115.316 1.599 . . . . 0.0 115.316 175.641 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 65.75 26.78 72.21 Favored Glycine 0 CA--C 1.555 2.575 0 N-CA-C 119.142 2.417 . . . . 0.0 119.142 -170.291 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -134.08 125.46 28.06 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-N 119.017 1.409 . . . . 0.0 108.457 -173.785 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 16.7 tp -77.64 110.05 12.14 Favored 'General case' 0 CA--C 1.558 1.28 0 C-N-CA 123.361 0.665 . . . . 0.0 110.381 179.841 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 30.7 mm -97.92 101.89 12.75 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 N-CA-C 106.544 -1.651 . . . . 0.0 106.544 -176.893 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 29.4 tp -92.7 99.49 12.17 Favored 'General case' 0 N--CA 1.486 1.359 0 CA-C-O 121.812 0.815 . . . . 0.0 109.258 178.052 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 87.1 m -93.87 105.84 17.84 Favored 'General case' 0 CA--C 1.56 1.361 0 CA-C-N 114.884 -1.053 . . . . 0.0 108.26 -178.007 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 83.5 mt -97.12 100.69 12.17 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 123.816 0.846 . . . . 0.0 109.13 -174.193 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 7.1 m -100.63 119.58 38.77 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.71 -0.619 . . . . 0.0 109.751 -170.636 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 74.7 t60 -151.7 114.63 4.69 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 122.475 0.31 . . . . 0.0 110.376 171.24 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 52.54 71.44 0.68 Allowed Glycine 0 N--CA 1.488 2.146 0 N-CA-C 117.745 1.858 . . . . 0.0 117.745 162.053 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . 0.506 2.7 t 66.58 -44.32 0.43 Allowed 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 117.676 2.472 . . . . 0.0 117.676 -166.729 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -86.39 94.35 9.36 Favored 'General case' 0 N--CA 1.483 1.191 0 CA-C-N 119.563 1.074 . . . . 0.0 112.405 -177.288 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 6.4 p -98.11 128.61 49.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 C-N-CA 123.825 0.85 . . . . 0.0 109.803 174.521 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 42.7 t -109.45 107.48 17.64 Favored 'General case' 0 CA--C 1.553 1.068 0 C-N-CA 123.035 0.534 . . . . 0.0 112.125 -179.206 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 89.0 m -86.19 112.1 21.02 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 176.184 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 71.1 mtp180 -113.25 114.18 26.35 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 -174.107 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 85.5 m -86.72 133.54 33.66 Favored 'General case' 0 N--CA 1.495 1.782 0 C-N-CA 123.288 0.635 . . . . 0.0 110.106 177.37 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 48.4 m-85 -129.77 125.52 36.0 Favored 'General case' 0 CA--C 1.558 1.264 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 179.245 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -93.23 154.55 17.96 Favored 'General case' 0 N--CA 1.493 1.724 0 CA-C-O 122.481 1.134 . . . . 0.0 111.783 171.984 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 72.5 tttt -84.88 129.11 34.86 Favored 'General case' 0 N--CA 1.485 1.278 0 CA-C-N 115.04 -0.982 . . . . 0.0 112.534 -167.319 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 14.6 mm-40 -111.52 50.97 0.8 Allowed 'General case' 0 CA--C 1.567 1.597 0 C-N-CA 124.125 0.97 . . . . 0.0 111.572 175.709 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.967 0 CA-C-O 124.28 1.991 . . . . 0.0 108.121 -171.257 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.266 8.0 p . . . . . 0 CA--C 1.577 2.016 0 N-CA-C 116.127 1.899 . . . . 0.0 116.127 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -69.8 -38.99 76.84 Favored 'General case' 0 N--CA 1.497 1.891 0 N-CA-C 116.385 1.995 . . . . 0.0 116.385 -177.625 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -59.08 -27.88 65.95 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 117.513 2.412 . . . . 0.0 117.513 168.987 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -68.6 -24.87 64.63 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 116.29 1.959 . . . . 0.0 116.29 169.008 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 34.6 mt -78.7 115.44 18.4 Favored 'General case' 0 N--CA 1.489 1.521 0 CA-C-N 121.09 1.768 . . . . 0.0 111.29 -167.297 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 161.1 172.58 28.63 Favored Glycine 0 CA--C 1.543 1.79 0 CA-C-O 122.467 1.037 . . . . 0.0 113.454 -172.321 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 81.7 m -85.11 141.62 30.09 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-N 114.739 -0.731 . . . . 0.0 109.733 168.89 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 80.4 m95 -141.88 112.79 7.36 Favored 'General case' 0 N--CA 1.484 1.235 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 -174.516 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 9.0 mtpm? -96.22 147.33 23.88 Favored 'General case' 0 N--CA 1.495 1.802 0 C-N-CA 122.771 0.429 . . . . 0.0 110.209 174.369 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 57.9 tp -69.5 120.89 15.99 Favored 'General case' 0 N--CA 1.491 1.617 0 CA-C-O 121.864 0.84 . . . . 0.0 111.51 179.663 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . 0.271 1.2 t -98.85 -43.47 11.65 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.82 0 CA-C-N 114.194 -1.366 . . . . 0.0 112.588 -179.565 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -146.35 139.71 25.85 Favored 'General case' 0 N--CA 1.49 1.543 0 CA-C-N 119.652 1.114 . . . . 0.0 109.179 -179.468 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 89.2 p -128.91 100.27 5.61 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.933 -0.479 . . . . 0.0 110.939 175.47 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 59.3 mtpt -86.88 127.96 35.05 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 123.149 0.58 . . . . 0.0 109.612 173.124 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 58.5 m-20 66.79 22.59 10.25 Favored 'General case' 0 N--CA 1.504 2.235 0 N-CA-C 118.082 2.623 . . . . 0.0 118.082 173.732 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 23.6 t80 -67.24 -45.33 77.08 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 120.215 -1.553 . . . . 0.0 115.083 -178.806 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 85.8 m-20 -62.13 -27.0 68.63 Favored 'General case' 0 CA--C 1.572 1.811 0 N-CA-C 116.613 2.079 . . . . 0.0 116.613 171.443 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -69.05 -49.91 53.24 Favored 'General case' 0 N--CA 1.497 1.914 0 CA-C-N 120.275 1.398 . . . . 0.0 114.36 166.381 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 87.8 t80 -51.43 -50.3 59.99 Favored 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 115.397 1.628 . . . . 0.0 115.397 169.139 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 16.7 mmm -57.98 -46.55 84.98 Favored 'General case' 0 CA--C 1.566 1.595 0 N-CA-C 114.647 1.351 . . . . 0.0 114.647 172.424 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.2 tmtp? -57.35 -48.41 79.08 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 115.408 1.633 . . . . 0.0 115.408 170.806 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 83.5 p -59.63 -36.33 76.14 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 117.151 2.278 . . . . 0.0 117.151 174.148 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 34.4 mt -66.46 -33.62 76.09 Favored 'General case' 0 CA--C 1.566 1.562 0 N-CA-C 116.945 2.202 . . . . 0.0 116.945 167.375 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 108.5 72.36 0.75 Allowed Glycine 0 N--CA 1.482 1.742 0 CA-C-N 118.878 0.763 . . . . 0.0 111.788 -173.133 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 43.0 t -141.78 130.46 22.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 N-CA-C 106.808 -1.552 . . . . 0.0 106.808 -176.232 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -72.53 173.2 47.15 Favored Glycine 0 CA--C 1.549 2.16 0 N-CA-C 116.791 1.476 . . . . 0.0 116.791 -179.599 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 38.9 p90 -66.7 -39.58 88.14 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 117.599 2.444 . . . . 0.0 117.599 -175.385 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.15 -43.95 96.88 Favored 'General case' 0 CA--C 1.561 1.397 0 N-CA-C 115.803 1.779 . . . . 0.0 115.803 179.762 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.1 t -78.02 -21.54 50.59 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 115.835 1.791 . . . . 0.0 115.835 171.53 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 62.3 mtm180 -58.72 -42.81 89.57 Favored 'General case' 0 N--CA 1.495 1.824 0 CA-C-N 120.915 1.689 . . . . 0.0 114.524 162.64 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -63.13 -56.49 16.38 Favored 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 114.304 1.224 . . . . 0.0 114.304 168.166 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 47.9 t -62.81 -40.89 90.42 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 N-CA-C 113.883 1.068 . . . . 0.0 113.883 -178.81 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -70.68 -32.49 69.76 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 116.724 2.12 . . . . 0.0 116.724 175.453 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 94.6 p -65.93 -45.28 82.45 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 115.666 1.728 . . . . 0.0 115.666 170.173 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 3.5 ppp? -63.44 -28.29 69.87 Favored 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 116.923 2.194 . . . . 0.0 116.923 167.259 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 97.2 m -70.95 138.91 50.43 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 124.11 0.964 . . . . 0.0 110.83 172.188 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.76 102.43 11.69 Favored Pre-proline 0 CA--C 1.57 1.715 0 CA-C-O 118.023 -0.989 . . . . 0.0 109.32 166.683 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -80.77 95.75 0.98 Allowed 'Trans proline' 0 C--N 1.371 1.744 0 C-N-CA 122.817 2.345 . . . . 0.0 111.135 -176.614 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 99.4 m -81.32 111.45 17.72 Favored 'General case' 0 N--CA 1.489 1.48 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.452 -159.654 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 87.4 m -87.14 116.23 25.07 Favored 'General case' 0 CA--C 1.56 1.338 0 C-N-CA 123.916 0.886 . . . . 0.0 109.233 -175.32 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 79.6 mt -112.33 110.41 32.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 N-CA-C 106.224 -1.769 . . . . 0.0 106.224 177.341 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 22.6 mt -100.95 119.03 48.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 -176.39 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -137.55 108.05 6.54 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 -169.595 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 83.8 tttt -85.55 121.95 28.98 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 123.385 0.674 . . . . 0.0 111.175 179.795 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 19.0 m120 -89.25 -69.15 0.73 Allowed 'General case' 0 N--CA 1.49 1.575 0 C-N-CA 123.654 0.782 . . . . 0.0 110.543 177.947 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -151.58 76.56 0.23 Allowed Glycine 0 N--CA 1.484 1.868 0 N-CA-C 110.116 -1.194 . . . . 0.0 110.116 169.309 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . 0.336 2.1 t70 70.99 -23.96 0.17 Allowed 'General case' 0 N--CA 1.499 2.006 0 N-CA-C 116.805 2.15 . . . . 0.0 116.805 -160.417 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 21.2 mm -75.34 106.6 5.24 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.561 0 C-N-CA 124.536 1.134 . . . . 0.0 108.05 173.198 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 26.4 mt -92.45 113.77 26.13 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 123.878 0.871 . . . . 0.0 109.66 -179.459 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 57.1 m -97.79 97.45 8.99 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 106.836 -1.542 . . . . 0.0 106.836 -177.712 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 9.4 tt -100.5 98.74 9.31 Favored 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 -177.302 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -93.66 115.57 28.03 Favored 'General case' 0 N--CA 1.484 1.26 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 -174.869 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 28.9 m -100.89 103.42 14.59 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 -179.7 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 21.1 m-70 -90.53 105.25 17.69 Favored 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 123.479 0.712 . . . . 0.0 109.444 -170.848 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 5.9 m . . . . . 0 N--CA 1.491 1.588 0 CA-C-O 121.234 0.54 . . . . 0.0 112.125 -164.524 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 17.4 t30 . . . . . 0 N--CA 1.484 1.257 0 N-CA-C 108.69 -0.855 . . . . 0.0 108.69 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 81.9 p -131.83 126.84 35.3 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 -164.537 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -109.66 120.27 41.96 Favored 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 177.659 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 43.0 pt -110.94 128.45 67.35 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 177.079 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 35.9 t -118.05 95.7 5.02 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 107.791 -1.189 . . . . 0.0 107.791 -175.858 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 45.1 p90 -130.71 142.25 50.42 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 114.241 1.201 . . . . 0.0 114.241 -156.645 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 29.6 mtpp -100.15 146.43 26.84 Favored 'General case' 0 N--CA 1.488 1.444 0 CA-C-N 115.218 -0.901 . . . . 0.0 109.126 165.608 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -73.44 116.89 14.54 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.433 -0.792 . . . . 0.0 112.106 -172.217 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 80.88 43.41 8.94 Favored Glycine 0 CA--C 1.549 2.186 0 N-CA-C 116.535 1.374 . . . . 0.0 116.535 -166.912 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 93.1 t -138.6 122.56 20.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 N-CA-C 106.469 -1.678 . . . . 0.0 106.469 177.603 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -85.64 133.34 34.04 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 123.634 0.773 . . . . 0.0 111.285 179.07 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -141.22 149.78 41.83 Favored 'General case' 0 N--CA 1.493 1.695 0 CA-C-O 121.764 0.793 . . . . 0.0 111.443 -173.784 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -74.24 136.08 42.71 Favored 'General case' 0 CA--C 1.565 1.542 0 O-C-N 121.387 -0.82 . . . . 0.0 112.866 172.195 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 32.1 tp10 -145.34 139.15 26.81 Favored 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 123.186 0.594 . . . . 0.0 110.018 -178.152 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 56.0 m -100.54 123.71 45.12 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 177.519 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 29.4 p -85.18 -179.69 7.06 Favored 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 113.432 0.901 . . . . 0.0 113.432 -174.746 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -54.38 -38.99 66.79 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 117.266 2.321 . . . . 0.0 117.266 167.683 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -83.54 13.32 4.64 Favored 'General case' 0 CA--C 1.578 2.035 0 N-CA-C 115.615 1.709 . . . . 0.0 115.615 170.704 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . 0.255 8.7 t70 58.33 72.51 0.52 Allowed 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 125.443 1.497 . . . . 0.0 113.446 -174.947 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 44.2 mtm180 -132.87 124.96 28.9 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 -174.011 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.6 106.89 8.52 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 123.096 0.558 . . . . 0.0 111.648 174.136 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 18.2 m -118.36 134.01 63.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 C-N-CA 122.996 0.518 . . . . 0.0 109.74 -169.131 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 31.5 mmtp -82.84 104.01 12.75 Favored 'General case' 0 N--CA 1.488 1.456 0 CA-C-O 121.92 0.867 . . . . 0.0 109.451 176.215 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 43.3 t -106.27 99.04 8.65 Favored 'General case' 0 CA--C 1.553 1.083 0 CA-C-N 114.68 -1.146 . . . . 0.0 110.044 -161.299 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 7.4 tp -110.61 116.82 53.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 C-N-CA 124.229 1.012 . . . . 0.0 108.631 -177.05 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -134.89 120.06 29.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 C-N-CA 123.612 0.765 . . . . 0.0 109.279 -174.062 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 10.5 t -129.4 157.96 40.5 Favored 'General case' 0 N--CA 1.493 1.676 0 CA-C-O 122.473 1.13 . . . . 0.0 112.223 178.241 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 61.1 tp -84.18 127.28 33.83 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-N 114.805 -1.088 . . . . 0.0 110.577 174.365 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -131.44 85.13 2.23 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 123.905 0.882 . . . . 0.0 109.249 -176.179 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 55.54 44.36 85.73 Favored Glycine 0 N--CA 1.493 2.447 0 N-CA-C 118.658 2.223 . . . . 0.0 118.658 -179.381 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 82.41 16.92 70.08 Favored Glycine 0 CA--C 1.557 2.66 0 N-CA-C 118.627 2.211 . . . . 0.0 118.627 -167.542 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 53.8 mtpt -129.55 119.82 24.31 Favored 'General case' 0 N--CA 1.487 1.39 0 CA-C-N 119.064 1.432 . . . . 0.0 107.691 177.104 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 3.1 mp -82.3 107.9 15.33 Favored 'General case' 0 N--CA 1.485 1.294 0 CA-C-O 122.071 0.939 . . . . 0.0 109.369 169.905 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 70.4 t -99.47 102.19 13.09 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.333 0 N-CA-C 105.16 -2.163 . . . . 0.0 105.16 -174.621 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 20.8 t-160 -107.35 131.81 53.83 Favored 'General case' 0 N--CA 1.484 1.226 0 CA-C-N 114.486 -1.233 . . . . 0.0 108.613 -175.546 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 35.6 tp -131.01 121.3 24.81 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 177.556 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 90.7 mt-30 -111.5 113.43 25.85 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 175.567 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 10.7 ptpp? -118.78 140.36 50.08 Favored 'General case' 0 N--CA 1.494 1.749 0 C-N-CA 123.25 0.62 . . . . 0.0 112.052 -176.336 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 30.5 p90 -153.61 110.81 3.45 Favored 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 123.15 0.58 . . . . 0.0 109.813 -175.68 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . 0.339 8.8 t70 66.84 -101.5 0.07 Allowed 'General case' 0 N--CA 1.494 1.734 0 C-N-CA 124.602 1.161 . . . . 0.0 112.63 172.833 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -124.43 50.27 0.87 Allowed Glycine 0 N--CA 1.488 2.155 0 CA-C-N 118.941 0.791 . . . . 0.0 114.482 164.713 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 52.3 mt-30 -153.42 124.85 7.59 Favored 'General case' 0 N--CA 1.485 1.289 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 -178.952 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -136.46 133.47 36.64 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.859 -0.525 . . . . 0.0 111.453 176.23 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 6.4 t -120.06 129.48 54.24 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 123.379 0.672 . . . . 0.0 110.718 175.462 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 41.0 p -95.71 133.88 39.28 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-O 121.528 0.68 . . . . 0.0 111.052 173.515 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 5.6 mp -111.68 74.01 0.85 Allowed 'General case' 0 CA--C 1.564 1.519 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 178.811 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 59.2 t -83.17 109.42 16.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 121.126 -0.984 . . . . 0.0 108.507 -167.919 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 76.6 mtt85 -101.32 120.72 40.69 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 123.269 0.628 . . . . 0.0 109.905 -174.967 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -141.72 127.46 19.19 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 122.872 0.469 . . . . 0.0 110.754 -169.52 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -79.23 114.85 18.5 Favored 'General case' 0 N--CA 1.487 1.418 0 CA-C-O 121.359 0.6 . . . . 0.0 111.331 -179.272 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 47.5 mm -121.4 106.39 18.21 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.338 0 N-CA-C 105.026 -2.213 . . . . 0.0 105.026 177.24 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 58.73 50.14 9.19 Favored 'General case' 0 N--CA 1.5 2.029 0 N-CA-C 115.064 1.505 . . . . 0.0 115.064 175.232 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 67.07 18.99 69.6 Favored Glycine 0 CA--C 1.555 2.577 0 N-CA-C 119.668 2.627 . . . . 0.0 119.668 -171.16 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 89.6 mttt -132.68 129.72 39.17 Favored 'General case' 0 N--CA 1.488 1.463 0 CA-C-N 119.63 1.715 . . . . 0.0 109.294 -174.387 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 18.2 tp -77.72 110.22 12.39 Favored 'General case' 0 CA--C 1.557 1.231 0 C-N-CA 123.98 0.912 . . . . 0.0 110.298 -179.523 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 30.5 mm -96.55 101.63 12.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 N-CA-C 106.748 -1.575 . . . . 0.0 106.748 -177.452 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 29.9 tp -88.99 101.36 14.01 Favored 'General case' 0 CA--C 1.559 1.307 0 C-N-CA 123.754 0.821 . . . . 0.0 109.361 176.977 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 87.4 m -95.61 105.94 17.97 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 -175.996 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 86.8 mt -99.3 98.77 9.69 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 123.588 0.755 . . . . 0.0 109.896 -171.302 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 6.7 m -113.6 115.8 28.5 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 -174.138 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 58.6 t60 -103.19 -87.46 0.42 Allowed 'General case' 0 N--CA 1.491 1.6 0 CA-C-O 118.5 -0.762 . . . . 0.0 108.986 170.411 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -106.64 -106.73 3.14 Favored Glycine 0 N--CA 1.484 1.869 0 CA-C-N 119.201 0.909 . . . . 0.0 111.09 179.359 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 13.8 t -100.79 49.24 0.89 Allowed 'General case' 0 N--CA 1.498 1.937 0 N-CA-C 113.346 0.869 . . . . 0.0 113.346 174.04 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -158.39 93.71 1.23 Allowed 'General case' 0 N--CA 1.483 1.223 0 O-C-N 121.206 -0.934 . . . . 0.0 108.648 175.398 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 4.2 p -91.47 121.26 41.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 C-N-CA 123.352 0.661 . . . . 0.0 109.753 175.36 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 45.7 t -101.44 100.03 10.43 Favored 'General case' 0 CA--C 1.553 1.081 0 CA-C-O 121.556 0.693 . . . . 0.0 111.214 175.424 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 63.0 m -86.14 111.06 20.0 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 179.433 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 32.8 mtm180 -114.99 118.33 33.13 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 122.992 0.517 . . . . 0.0 110.331 -172.104 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 93.3 m -86.79 132.87 33.72 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 123.433 0.693 . . . . 0.0 110.304 177.863 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 38.0 m-85 -127.47 127.05 43.41 Favored 'General case' 0 CA--C 1.559 1.296 0 C-N-CA 123.648 0.779 . . . . 0.0 109.253 178.321 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -90.83 151.15 21.27 Favored 'General case' 0 N--CA 1.487 1.404 0 CA-C-O 121.788 0.804 . . . . 0.0 111.889 173.805 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 67.3 tttt -80.68 119.29 23.1 Favored 'General case' 0 N--CA 1.486 1.335 0 CA-C-O 121.563 0.697 . . . . 0.0 111.655 -174.585 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 18.1 mm-40 -119.89 50.33 1.29 Allowed 'General case' 0 CA--C 1.564 1.512 0 C-N-CA 124.422 1.089 . . . . 0.0 111.306 -171.077 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.897 0 CA-C-O 124.654 2.168 . . . . 0.0 109.946 -160.521 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 71.4 t . . . . . 0 CA--C 1.56 1.337 0 N-CA-C 106.201 -1.777 . . . . 0.0 106.201 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -140.49 -55.44 0.52 Allowed 'General case' 0 N--CA 1.494 1.746 0 C-N-CA 124.021 0.928 . . . . 0.0 111.051 -174.31 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -57.39 -29.99 64.54 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 116.914 2.19 . . . . 0.0 116.914 160.662 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -60.82 -18.89 58.2 Favored 'General case' 0 CA--C 1.571 1.76 0 N-CA-C 117.813 2.523 . . . . 0.0 117.813 163.768 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 82.4 mt -84.2 125.94 32.67 Favored 'General case' 0 N--CA 1.489 1.513 0 CA-C-N 121.329 1.877 . . . . 0.0 111.77 -169.904 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 153.92 176.3 26.14 Favored Glycine 0 CA--C 1.542 1.728 0 CA-C-O 122.602 1.112 . . . . 0.0 113.317 -173.81 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 71.4 m -84.75 140.17 31.44 Favored 'General case' 0 N--CA 1.49 1.564 0 CA-C-N 114.679 -0.76 . . . . 0.0 109.262 165.063 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 85.8 m95 -141.85 113.23 7.64 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 -174.292 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 6.3 mtpm? -102.03 145.48 29.25 Favored 'General case' 0 N--CA 1.494 1.75 0 CA-C-O 121.034 0.445 . . . . 0.0 110.017 178.558 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 17.5 tp -65.95 127.06 30.56 Favored 'General case' 0 N--CA 1.491 1.59 0 CA-C-O 122.349 1.071 . . . . 0.0 112.495 -175.59 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . 0.283 1.0 OUTLIER -104.51 -46.65 9.68 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.897 0 CA-C-N 113.845 -1.525 . . . . 0.0 111.448 177.288 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -137.36 140.34 41.36 Favored 'General case' 0 N--CA 1.49 1.542 0 CA-C-N 119.994 1.27 . . . . 0.0 109.848 177.31 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 71.8 p -131.37 118.05 19.75 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 123.462 0.705 . . . . 0.0 109.532 169.246 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 30.6 mtpp -88.05 -87.14 0.16 Allowed 'General case' 0 N--CA 1.491 1.625 0 CA-C-O 119.14 -0.457 . . . . 0.0 111.335 -172.621 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 65.0 m-80 -95.12 49.58 1.22 Allowed 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 113.503 0.927 . . . . 0.0 113.503 -175.594 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 23.7 t80 -77.25 -54.48 6.43 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.6 -1.313 . . . . 0.0 113.462 -173.902 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -51.19 -35.64 37.31 Favored 'General case' 0 N--CA 1.499 2.014 0 N-CA-C 116.722 2.119 . . . . 0.0 116.722 166.75 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 35.4 t0 -63.11 -55.71 23.02 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 114.179 1.178 . . . . 0.0 114.179 168.915 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 85.7 t80 -49.99 -47.21 53.01 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 116.403 2.001 . . . . 0.0 116.403 169.853 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 26.0 mmm -62.47 -45.58 92.38 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 114.771 1.397 . . . . 0.0 114.771 177.033 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 42.0 tptt -64.16 -38.8 92.36 Favored 'General case' 0 CA--C 1.566 1.585 0 N-CA-C 115.787 1.773 . . . . 0.0 115.787 171.101 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 65.6 m -58.38 -40.41 82.27 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 115.937 1.828 . . . . 0.0 115.937 168.841 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 77.2 mt -61.96 -37.34 84.39 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 116.694 2.109 . . . . 0.0 116.694 166.662 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 112.08 69.77 0.56 Allowed Glycine 0 N--CA 1.481 1.681 0 C-N-CA 124.055 0.836 . . . . 0.0 111.875 -173.704 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 37.3 t -140.83 117.45 7.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 N-CA-C 105.006 -2.22 . . . . 0.0 105.006 -177.145 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -68.33 -80.61 0.22 Allowed Glycine 0 N--CA 1.485 1.963 0 N-CA-C 117.078 1.591 . . . . 0.0 117.078 -166.472 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . 0.262 46.2 p90 -149.05 -50.37 0.15 Allowed 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 114.543 1.312 . . . . 0.0 114.543 -175.565 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.66 -39.84 91.8 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 116.511 2.041 . . . . 0.0 116.511 -178.87 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 60.0 m -79.32 -36.81 38.95 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 113.635 0.976 . . . . 0.0 113.635 170.255 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 33.4 ttp85 -61.1 -44.2 97.73 Favored 'General case' 0 CA--C 1.566 1.591 0 N-CA-C 115.543 1.683 . . . . 0.0 115.543 174.565 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 39.1 mt-30 -79.6 -40.42 29.39 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 115.026 1.491 . . . . 0.0 115.026 177.738 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 47.1 t -74.48 -37.72 44.86 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 CA-C-N 120.503 1.501 . . . . 0.0 112.524 179.305 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -66.99 -34.36 77.57 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 116.612 2.078 . . . . 0.0 116.612 172.074 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 92.0 p -65.18 -44.72 87.52 Favored 'General case' 0 N--CA 1.493 1.725 0 N-CA-C 115.783 1.772 . . . . 0.0 115.783 167.69 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 44.6 ttm -62.0 -36.97 83.09 Favored 'General case' 0 CA--C 1.571 1.765 0 N-CA-C 116.141 1.904 . . . . 0.0 116.141 168.894 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 52.4 m -68.26 151.93 46.21 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 124.455 1.102 . . . . 0.0 112.523 176.842 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 4.2 ttmp? -104.09 97.47 11.54 Favored Pre-proline 0 CA--C 1.574 1.896 0 CA-C-N 115.173 -0.921 . . . . 0.0 109.674 176.378 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -75.57 145.72 29.87 Favored 'Trans proline' 0 CA--C 1.561 1.839 0 C-N-CA 123.697 2.931 . . . . 0.0 113.444 178.979 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 98.8 m -117.34 97.4 5.88 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 -171.003 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 90.9 m -79.48 117.41 20.41 Favored 'General case' 0 N--CA 1.492 1.664 0 C-N-CA 123.77 0.828 . . . . 0.0 110.037 178.687 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 62.3 mt -119.02 111.79 34.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 N-CA-C 106.324 -1.732 . . . . 0.0 106.324 -174.382 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 17.8 mt -110.79 116.81 53.45 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 -173.013 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -127.36 123.67 36.79 Favored 'General case' 0 N--CA 1.494 1.769 0 C-N-CA 123.485 0.714 . . . . 0.0 109.841 179.721 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 82.1 tttt -97.5 120.53 38.05 Favored 'General case' 0 CA--C 1.557 1.217 0 C-N-CA 123.649 0.78 . . . . 0.0 110.335 177.779 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 -83.61 -81.03 0.17 Allowed 'General case' 0 N--CA 1.49 1.545 0 CA-C-O 118.793 -0.622 . . . . 0.0 110.125 178.242 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -99.94 -87.2 1.94 Allowed Glycine 0 N--CA 1.486 2.013 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 166.782 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -119.15 55.84 0.93 Allowed 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 153.69 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 15.0 mm -128.94 104.91 12.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 N-CA-C 104.888 -2.264 . . . . 0.0 104.888 -176.127 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 36.0 mt -95.29 107.41 19.52 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 123.048 0.539 . . . . 0.0 111.24 -170.798 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 31.5 m -92.72 94.02 8.77 Favored 'General case' 0 CA--C 1.559 1.302 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 -176.561 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 10.4 tt -98.24 102.25 13.94 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 -176.89 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 50.7 mttp -102.47 106.37 17.09 Favored 'General case' 0 N--CA 1.486 1.341 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 -174.505 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 59.3 m -92.23 97.22 10.76 Favored 'General case' 0 N--CA 1.493 1.675 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 178.736 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 22.4 m170 -91.76 94.76 9.51 Favored 'General case' 0 N--CA 1.488 1.458 0 CA-C-O 121.909 0.862 . . . . 0.0 110.089 -174.967 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 27.9 t . . . . . 0 N--CA 1.484 1.265 0 CA-C-N 115.041 -0.981 . . . . 0.0 109.879 173.503 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 43.7 m-20 . . . . . 0 N--CA 1.492 1.643 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 61.9 p -126.45 131.36 51.69 Favored 'General case' 0 N--CA 1.496 1.869 0 C-N-CA 123.063 0.545 . . . . 0.0 110.069 -176.767 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -128.75 123.67 33.56 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 123.512 0.725 . . . . 0.0 109.556 -172.642 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 41.8 pt -118.65 134.2 63.04 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 C-N-CA 123.709 0.804 . . . . 0.0 108.976 174.907 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 67.2 p -119.73 104.38 10.19 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 178.478 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 53.0 p90 -132.27 141.15 48.88 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 115.204 1.557 . . . . 0.0 115.204 -159.404 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 62.4 mtpt -94.51 143.17 26.65 Favored 'General case' 0 CA--C 1.562 1.408 0 CA-C-N 114.378 -1.283 . . . . 0.0 109.761 166.197 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -77.91 120.57 22.97 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.851 -0.53 . . . . 0.0 111.606 -175.402 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 83.03 43.48 7.56 Favored Glycine 0 CA--C 1.549 2.19 0 N-CA-C 116.5 1.36 . . . . 0.0 116.5 -169.512 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 94.2 t -140.69 123.68 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 N-CA-C 106.458 -1.682 . . . . 0.0 106.458 -178.523 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -86.32 130.16 34.61 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 123.227 0.611 . . . . 0.0 110.872 171.654 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 45.3 p90 -144.23 128.9 18.21 Favored 'General case' 0 N--CA 1.492 1.656 0 C-N-CA 123.619 0.767 . . . . 0.0 109.744 -175.341 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -72.48 111.65 7.85 Favored 'General case' 0 CA--C 1.564 1.493 0 O-C-N 121.327 -0.858 . . . . 0.0 112.657 177.198 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 13.4 tp10 -113.64 132.92 55.59 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 124.29 1.036 . . . . 0.0 109.537 -171.591 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 57.1 m -92.86 122.62 35.42 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 176.532 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 24.1 p -85.9 172.26 10.86 Favored 'General case' 0 N--CA 1.495 1.808 0 CA-C-O 121.588 0.709 . . . . 0.0 112.403 -176.296 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -58.41 -35.17 71.65 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 117.306 2.336 . . . . 0.0 117.306 167.451 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -77.57 12.74 1.49 Allowed 'General case' 0 CA--C 1.581 2.157 0 N-CA-C 115.981 1.845 . . . . 0.0 115.981 167.399 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 10.4 t70 58.08 71.93 0.55 Allowed 'General case' 0 N--CA 1.492 1.643 0 C-N-CA 125.545 1.538 . . . . 0.0 113.483 -176.723 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 80.5 mtm180 -136.82 121.64 18.7 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 -176.271 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.55 99.32 5.68 Favored 'General case' 0 CA--C 1.563 1.452 0 C-N-CA 123.179 0.592 . . . . 0.0 111.042 170.985 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 10.7 m -113.51 128.05 70.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 -170.104 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 72.0 mmtt -77.72 99.41 5.84 Favored 'General case' 0 N--CA 1.488 1.474 0 CA-C-O 121.674 0.749 . . . . 0.0 110.04 177.139 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 47.6 m -93.36 93.22 8.06 Favored 'General case' 0 N--CA 1.48 1.056 0 CA-C-N 115.009 -0.996 . . . . 0.0 110.501 -169.415 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 6.0 tp -101.97 103.26 14.7 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 175.817 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.0 p -121.96 125.0 72.56 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.364 0 CA-C-N 115.307 -0.861 . . . . 0.0 109.209 -174.639 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 15.3 t -135.53 156.52 48.75 Favored 'General case' 0 N--CA 1.489 1.482 0 CA-C-O 122.921 1.343 . . . . 0.0 111.21 178.717 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 63.7 tp -89.52 108.36 19.61 Favored 'General case' 0 N--CA 1.486 1.368 0 CA-C-N 114.173 -1.376 . . . . 0.0 108.899 171.122 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -109.6 87.01 2.4 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 123.45 0.7 . . . . 0.0 109.993 -173.7 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 61.3 48.93 82.68 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 117.623 1.809 . . . . 0.0 117.623 -178.63 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 73.46 27.54 67.49 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 118.915 2.326 . . . . 0.0 118.915 -169.297 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -143.88 112.46 6.52 Favored 'General case' 0 CA--C 1.553 1.063 0 N-CA-C 107.134 -1.432 . . . . 0.0 107.134 -174.685 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 4.7 tt -86.61 102.88 14.58 Favored 'General case' 0 CA--C 1.561 1.376 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 -172.815 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 77.7 t -104.35 108.05 23.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 -171.578 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 21.8 t-160 -105.97 109.18 21.05 Favored 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 123.378 0.671 . . . . 0.0 109.954 177.013 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 38.0 tp -102.88 121.04 41.7 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 178.24 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 31.5 mt-30 -114.13 115.88 28.22 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 83.5 mttt -113.28 135.53 53.74 Favored 'General case' 0 N--CA 1.495 1.793 0 CA-C-N 118.812 0.733 . . . . 0.0 111.103 -178.364 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 27.3 p90 -152.69 110.57 3.63 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.354 -0.841 . . . . 0.0 109.898 178.713 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 3.8 t70 53.56 50.88 16.28 Favored 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 116.392 1.997 . . . . 0.0 116.392 170.008 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 89.66 -43.46 2.99 Favored Glycine 0 CA--C 1.551 2.311 0 N-CA-C 116.685 1.434 . . . . 0.0 116.685 -169.34 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 15.0 mt-30 -80.88 124.6 29.24 Favored 'General case' 0 N--CA 1.488 1.428 0 CA-C-N 118.309 1.054 . . . . 0.0 111.318 -177.114 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -132.61 131.39 41.38 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 123.072 0.549 . . . . 0.0 111.712 178.685 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 8.8 t -118.45 133.03 56.21 Favored 'General case' 0 N--CA 1.496 1.866 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.365 176.534 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 35.8 p -102.76 132.72 48.72 Favored 'General case' 0 N--CA 1.495 1.819 0 CA-C-O 121.678 0.751 . . . . 0.0 110.85 172.602 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 5.3 mp -114.54 89.36 3.08 Favored 'General case' 0 CA--C 1.562 1.412 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 -179.448 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 97.1 t -98.49 106.05 18.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 -167.543 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 83.9 mtt85 -99.51 125.13 45.22 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 123.179 0.592 . . . . 0.0 110.402 -176.367 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -140.14 130.12 24.79 Favored 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 123.084 0.554 . . . . 0.0 111.092 -174.764 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -82.43 112.88 19.78 Favored 'General case' 0 N--CA 1.488 1.463 0 CA-C-O 121.256 0.55 . . . . 0.0 111.086 -178.557 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 82.8 mt -123.46 109.43 23.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 N-CA-C 105.052 -2.203 . . . . 0.0 105.052 179.412 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 57.87 50.18 10.85 Favored 'General case' 0 N--CA 1.499 2.012 0 N-CA-C 114.849 1.425 . . . . 0.0 114.849 177.804 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 62.24 24.65 65.64 Favored Glycine 0 CA--C 1.555 2.536 0 N-CA-C 119.502 2.561 . . . . 0.0 119.502 -170.699 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 91.2 mttt -132.31 131.07 41.62 Favored 'General case' 0 N--CA 1.488 1.435 0 CA-C-N 119.951 1.876 . . . . 0.0 109.534 -176.093 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 20.1 tp -77.58 110.08 12.08 Favored 'General case' 0 N--CA 1.484 1.275 0 C-N-CA 123.955 0.902 . . . . 0.0 110.144 -179.644 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 27.7 mm -99.39 95.58 4.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 N-CA-C 107.062 -1.459 . . . . 0.0 107.062 -175.047 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 17.4 tp -86.94 104.4 16.22 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 124.068 0.947 . . . . 0.0 110.098 179.542 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 84.8 m -99.66 104.16 15.89 Favored 'General case' 0 CA--C 1.561 1.392 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 -173.098 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 91.1 mt -98.52 102.43 14.17 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 123.659 0.784 . . . . 0.0 110.111 -172.497 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 9.6 m -113.44 125.9 54.74 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 -176.124 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 83.3 t60 -136.45 -98.33 0.22 Allowed 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 175.408 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -110.45 93.0 0.71 Allowed Glycine 0 N--CA 1.483 1.829 0 CA-C-N 118.816 0.734 . . . . 0.0 111.684 -169.871 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . 0.387 5.2 t 47.47 39.33 9.18 Favored 'General case' 0 N--CA 1.5 2.07 0 N-CA-C 117.546 2.425 . . . . 0.0 117.546 -172.097 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -157.64 93.6 1.29 Allowed 'General case' 0 N--CA 1.483 1.197 0 O-C-N 121.484 -0.76 . . . . 0.0 109.575 -174.461 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 2.8 p -92.87 112.25 25.86 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 C-N-CA 123.643 0.777 . . . . 0.0 109.288 173.141 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 41.1 t -97.5 104.34 16.36 Favored 'General case' 0 CA--C 1.551 1.017 0 CA-C-O 121.016 0.436 . . . . 0.0 110.292 175.179 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 89.2 m -90.04 100.96 13.68 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 -178.581 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 59.3 mtp180 -103.43 114.74 29.25 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 123.107 0.563 . . . . 0.0 109.749 -167.535 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 56.6 m -84.8 131.92 34.48 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 123.091 0.556 . . . . 0.0 109.954 177.772 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 41.0 m-85 -129.49 126.31 38.37 Favored 'General case' 0 CA--C 1.561 1.385 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 178.378 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -88.62 150.54 22.99 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 123.515 0.726 . . . . 0.0 112.127 174.68 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 71.0 tttt -81.67 118.14 22.58 Favored 'General case' 0 N--CA 1.486 1.346 0 CA-C-O 121.43 0.633 . . . . 0.0 111.577 -174.503 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 37.3 mm-40 -118.24 51.38 1.08 Allowed 'General case' 0 CA--C 1.564 1.505 0 C-N-CA 124.216 1.007 . . . . 0.0 111.31 -174.999 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.875 0 CA-C-O 123.105 1.431 . . . . 0.0 110.151 -161.931 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 5.7 p . . . . . 0 CA--C 1.578 2.028 0 N-CA-C 115.24 1.571 . . . . 0.0 115.24 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -78.84 -38.71 37.32 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 115.648 1.721 . . . . 0.0 115.648 -176.087 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -58.95 -24.03 62.11 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 117.649 2.463 . . . . 0.0 117.649 167.428 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -69.62 -20.19 63.62 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 116.575 2.065 . . . . 0.0 116.575 167.333 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 42.9 mt -81.17 121.99 26.82 Favored 'General case' 0 N--CA 1.488 1.475 0 CA-C-N 120.829 1.65 . . . . 0.0 111.168 -170.709 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 157.34 174.75 27.45 Favored Glycine 0 CA--C 1.541 1.703 0 CA-C-O 122.379 0.988 . . . . 0.0 113.369 -172.283 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 63.0 m -93.12 136.88 32.97 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 170.516 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 87.5 m95 -138.34 113.37 9.24 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 -171.431 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 9.4 mtmp? -97.81 143.54 28.33 Favored 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 123.247 0.619 . . . . 0.0 110.547 -179.506 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 60.0 tp -70.87 117.27 12.16 Favored 'General case' 0 N--CA 1.492 1.639 0 CA-C-O 121.856 0.836 . . . . 0.0 111.177 -177.573 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . 0.27 1.0 OUTLIER -97.48 -42.38 11.62 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.757 0 CA-C-N 114.337 -1.301 . . . . 0.0 112.725 -178.702 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -148.06 134.82 19.99 Favored 'General case' 0 N--CA 1.487 1.386 0 CA-C-N 119.677 1.126 . . . . 0.0 109.035 -177.53 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 88.8 p -121.59 100.84 7.24 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 122.976 0.51 . . . . 0.0 110.496 176.741 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 61.1 mtpt -92.77 123.02 35.75 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 176.644 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 52.1 m-20 67.22 21.66 9.9 Favored 'General case' 0 N--CA 1.503 2.204 0 N-CA-C 117.513 2.412 . . . . 0.0 117.513 176.989 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 17.3 t80 -71.2 -40.21 71.31 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 119.988 -1.695 . . . . 0.0 115.345 -179.273 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -60.19 -31.45 70.14 Favored 'General case' 0 CA--C 1.571 1.766 0 N-CA-C 115.935 1.828 . . . . 0.0 115.935 165.337 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 14.3 t0 -64.92 -47.25 78.4 Favored 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 114.843 1.423 . . . . 0.0 114.843 166.012 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 94.2 t80 -54.0 -51.95 62.33 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 115.104 1.52 . . . . 0.0 115.104 172.696 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 75.8 mtm -63.67 -34.37 77.69 Favored 'General case' 0 CA--C 1.568 1.636 0 N-CA-C 115.697 1.74 . . . . 0.0 115.697 172.84 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 38.4 ttmt -61.44 -47.55 85.22 Favored 'General case' 0 CA--C 1.569 1.674 0 N-CA-C 114.412 1.264 . . . . 0.0 114.412 167.506 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 60.1 m -58.67 -36.15 73.71 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 116.412 2.004 . . . . 0.0 116.412 171.617 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 33.4 mt -63.05 -43.91 97.33 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 116.178 1.918 . . . . 0.0 116.178 166.838 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 120.22 71.1 0.32 Allowed Glycine 0 N--CA 1.483 1.781 0 C-N-CA 123.79 0.71 . . . . 0.0 111.588 -176.847 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 23.9 t -142.24 120.88 8.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 N-CA-C 105.166 -2.161 . . . . 0.0 105.166 -176.452 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -78.92 -86.48 0.52 Allowed Glycine 0 N--CA 1.488 2.129 0 N-CA-C 115.859 1.104 . . . . 0.0 115.859 -169.23 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 15.2 p90 -139.36 160.3 40.15 Favored 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 123.498 0.719 . . . . 0.0 110.767 178.605 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . 0.313 . . 76.41 -50.91 0.59 Allowed 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 115.386 1.625 . . . . 0.0 115.386 177.68 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 52.8 m -64.92 -39.86 94.16 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 113.964 1.098 . . . . 0.0 113.964 167.745 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 38.0 mtm180 -61.34 -43.59 98.62 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 115.063 1.505 . . . . 0.0 115.063 166.073 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 7.4 tm0? -61.74 -49.09 77.8 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 115.403 1.631 . . . . 0.0 115.403 174.074 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 97.2 t -64.56 -41.11 91.32 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 CA-C-N 119.503 1.047 . . . . 0.0 113.207 177.227 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -67.72 -40.71 84.23 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 116.504 2.038 . . . . 0.0 116.504 176.251 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 95.2 p -66.79 -39.42 87.77 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 116.332 1.975 . . . . 0.0 116.332 169.549 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 54.5 tpp -64.97 -37.21 86.91 Favored 'General case' 0 CA--C 1.569 1.7 0 N-CA-C 115.992 1.849 . . . . 0.0 115.992 169.856 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 54.4 m -69.96 145.88 51.55 Favored 'General case' 0 CA--C 1.566 1.589 0 C-N-CA 124.047 0.939 . . . . 0.0 111.79 174.649 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -103.12 100.73 18.28 Favored Pre-proline 0 CA--C 1.57 1.742 0 CA-C-O 118.143 -0.932 . . . . 0.0 109.147 173.224 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -81.82 100.67 1.11 Allowed 'Trans proline' 0 C--N 1.371 1.727 0 C-N-CA 123.027 2.485 . . . . 0.0 111.649 -179.379 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 99.8 m -79.15 112.95 16.87 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 123.522 0.729 . . . . 0.0 110.228 -168.849 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 46.5 m -87.28 114.78 24.19 Favored 'General case' 0 CA--C 1.561 1.395 0 C-N-CA 123.557 0.743 . . . . 0.0 109.147 -174.137 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 98.3 mt -108.75 108.45 25.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 N-CA-C 106.356 -1.72 . . . . 0.0 106.356 176.893 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 18.8 mt -101.72 120.3 51.16 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 -178.718 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 6.8 tm-20 -133.24 116.48 16.25 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 -172.233 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 80.7 tttt -93.62 114.97 27.42 Favored 'General case' 0 CA--C 1.557 1.243 0 C-N-CA 123.335 0.654 . . . . 0.0 110.374 176.523 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 23.8 t30 -86.78 -70.59 0.6 Allowed 'General case' 0 N--CA 1.492 1.628 0 C-N-CA 123.043 0.537 . . . . 0.0 111.026 178.307 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -143.11 75.92 0.31 Allowed Glycine 0 N--CA 1.487 2.068 0 N-CA-C 110.522 -1.031 . . . . 0.0 110.522 170.039 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . 0.284 6.3 t70 49.43 48.21 21.51 Favored 'General case' 0 N--CA 1.497 1.924 0 N-CA-C 115.518 1.673 . . . . 0.0 115.518 -155.954 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 31.0 mm -134.51 99.9 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 N-CA-C 103.589 -2.745 . . . . 0.0 103.589 178.47 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 65.2 mt -88.11 101.49 13.85 Favored 'General case' 0 N--CA 1.481 1.097 0 CA-C-O 121.281 0.562 . . . . 0.0 110.039 -177.614 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 91.1 m -94.46 97.02 9.87 Favored 'General case' 0 N--CA 1.485 1.29 0 N-CA-C 106.973 -1.492 . . . . 0.0 106.973 -176.94 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 9.8 tt -99.22 99.56 10.55 Favored 'General case' 0 N--CA 1.484 1.246 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 -174.893 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -96.6 126.65 41.93 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 123.782 0.833 . . . . 0.0 109.166 -175.675 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 28.0 m -102.63 93.7 5.25 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.134 -1.062 . . . . 0.0 108.134 -175.619 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 16.8 m-70 -86.25 104.33 15.69 Favored 'General case' 0 N--CA 1.491 1.591 0 CA-C-O 121.451 0.643 . . . . 0.0 109.709 -173.03 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 23.1 t . . . . . 0 N--CA 1.483 1.183 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.274 -161.813 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 53.6 m-80 . . . . . 0 N--CA 1.491 1.582 0 CA-C-O 121.052 0.453 . . . . 0.0 110.076 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 73.9 p -98.41 132.17 44.08 Favored 'General case' 0 N--CA 1.493 1.709 0 C-N-CA 123.417 0.687 . . . . 0.0 110.603 -177.013 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -123.87 123.57 40.73 Favored 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 123.674 0.79 . . . . 0.0 109.067 -176.714 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 40.8 pt -118.74 132.01 69.86 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 174.467 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 46.1 t -120.6 111.11 17.24 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 -177.817 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 50.4 p90 -140.94 140.72 34.48 Favored 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 115.119 1.525 . . . . 0.0 115.119 -160.015 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 63.6 mtpt -106.25 17.62 23.2 Favored 'General case' 0 CA--C 1.573 1.852 0 N-CA-C 117.011 2.226 . . . . 0.0 117.011 -172.608 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . 0.294 0.1 OUTLIER 60.35 92.7 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.736 0 CA-C-N 120.546 1.521 . . . . 0.0 114.292 177.981 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 92.68 38.73 5.46 Favored Glycine 0 CA--C 1.551 2.295 0 N-CA-C 116.863 1.505 . . . . 0.0 116.863 -167.883 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 86.6 t -140.06 122.7 16.68 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 N-CA-C 106.93 -1.507 . . . . 0.0 106.93 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -87.62 133.27 33.84 Favored 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 123.299 0.64 . . . . 0.0 111.136 173.749 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 47.5 p90 -145.56 133.72 21.6 Favored 'General case' 0 N--CA 1.493 1.682 0 C-N-CA 123.888 0.875 . . . . 0.0 109.306 -175.082 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -76.35 142.66 41.14 Favored 'General case' 0 N--CA 1.49 1.54 0 CA-C-O 123.028 1.394 . . . . 0.0 112.117 176.211 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 15.4 tp10 -146.54 138.91 25.04 Favored 'General case' 0 N--CA 1.488 1.444 0 CA-C-N 113.18 -1.827 . . . . 0.0 110.351 -167.053 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 55.7 m -97.18 121.96 39.65 Favored 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 123.281 0.633 . . . . 0.0 109.424 177.755 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 25.1 p -86.39 170.54 11.9 Favored 'General case' 0 N--CA 1.495 1.815 0 CA-C-O 121.894 0.854 . . . . 0.0 113.128 -173.565 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -58.77 -34.23 71.21 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 118.627 2.825 . . . . 0.0 118.627 173.267 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -101.57 54.72 0.82 Allowed 'General case' 0 CA--C 1.574 1.886 0 CA-C-N 119.327 0.967 . . . . 0.0 110.847 168.038 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 15.3 t70 34.89 80.75 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 117.827 2.528 . . . . 0.0 117.827 178.015 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 60.5 mtm-85 -141.45 130.41 23.16 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 110.165 -0.309 . . . . 0.0 110.165 177.497 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.04 121.24 16.27 Favored 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 122.878 0.471 . . . . 0.0 110.493 158.95 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 16.3 m -137.89 132.24 43.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 -176.013 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -85.29 104.01 14.75 Favored 'General case' 0 N--CA 1.486 1.336 0 CA-C-O 121.882 0.849 . . . . 0.0 109.265 177.993 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 53.3 m -92.52 97.7 10.99 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 124.353 1.061 . . . . 0.0 110.946 -170.668 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 6.8 tp -107.65 118.79 56.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 175.3 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 1.5 p -136.84 132.61 47.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 C-N-CA 123.677 0.791 . . . . 0.0 109.298 -169.708 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 13.1 t -146.82 159.02 44.03 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-O 122.738 1.256 . . . . 0.0 110.545 178.858 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 17.5 tp -89.3 106.36 18.4 Favored 'General case' 0 CA--C 1.561 1.403 0 CA-C-N 114.81 -1.086 . . . . 0.0 108.871 173.611 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -105.43 94.09 5.03 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 123.493 0.717 . . . . 0.0 109.534 -177.472 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 60.97 49.59 76.88 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 117.506 1.762 . . . . 0.0 117.506 -178.699 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 69.59 18.96 74.31 Favored Glycine 0 CA--C 1.557 2.663 0 N-CA-C 119.158 2.423 . . . . 0.0 119.158 -168.882 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 38.7 mtmm -127.96 117.77 22.34 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 -178.852 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 4.5 tt -82.82 99.36 9.65 Favored 'General case' 0 CA--C 1.563 1.468 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 -177.051 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 55.0 t -103.61 108.49 24.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 N-CA-C 106.748 -1.575 . . . . 0.0 106.748 -169.175 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 19.9 t-160 -108.83 107.14 17.44 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 123.447 0.699 . . . . 0.0 110.054 179.201 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 42.5 tp -96.84 122.99 40.41 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 123.523 0.729 . . . . 0.0 109.262 177.201 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 30.2 mt-30 -113.88 113.88 25.48 Favored 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 107.54 -1.281 . . . . 0.0 107.54 175.521 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.59 145.0 41.14 Favored 'General case' 0 N--CA 1.493 1.725 0 C-N-CA 123.223 0.609 . . . . 0.0 111.574 178.92 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 32.9 p90 -155.55 111.03 3.03 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 123.355 0.662 . . . . 0.0 110.012 -177.454 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . 0.336 12.1 t70 69.0 -96.08 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.854 0 C-N-CA 124.438 1.095 . . . . 0.0 112.484 173.591 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -132.85 56.3 0.74 Allowed Glycine 0 CA--C 1.547 2.067 0 CA-C-N 118.424 0.557 . . . . 0.0 113.066 162.234 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 46.7 mt-30 -154.83 124.61 6.58 Favored 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 106.936 -1.505 . . . . 0.0 106.936 -174.166 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -132.52 144.25 50.3 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.886 -0.509 . . . . 0.0 112.301 178.285 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 6.2 t -130.27 126.71 37.93 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 122.815 0.446 . . . . 0.0 111.115 171.538 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 40.0 p -94.1 128.87 40.75 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 121.982 0.896 . . . . 0.0 110.577 170.487 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 5.7 mp -103.94 88.32 3.0 Favored 'General case' 0 CA--C 1.558 1.256 0 N-CA-C 106.637 -1.616 . . . . 0.0 106.637 175.813 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 81.0 t -93.54 97.94 7.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 N-CA-C 107.354 -1.35 . . . . 0.0 107.354 -169.815 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 78.4 mtt85 -91.42 127.62 36.93 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 123.367 0.667 . . . . 0.0 109.579 177.908 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -148.06 133.36 18.48 Favored 'General case' 0 N--CA 1.493 1.719 0 CA-C-O 120.82 0.343 . . . . 0.0 111.284 -176.078 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -79.66 114.15 18.36 Favored 'General case' 0 N--CA 1.487 1.41 0 CA-C-O 121.318 0.58 . . . . 0.0 111.442 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 90.4 mt -122.7 109.08 22.92 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 N-CA-C 104.534 -2.395 . . . . 0.0 104.534 176.189 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 23.4 m-20 59.19 48.98 9.72 Favored 'General case' 0 N--CA 1.5 2.029 0 N-CA-C 114.934 1.457 . . . . 0.0 114.934 177.608 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 62.74 24.4 66.35 Favored Glycine 0 CA--C 1.555 2.545 0 N-CA-C 119.555 2.582 . . . . 0.0 119.555 -170.306 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 59.9 mtmt -130.97 131.21 44.25 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-N 119.589 1.695 . . . . 0.0 108.863 -174.005 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 15.7 tp -77.98 107.61 10.64 Favored 'General case' 0 CA--C 1.558 1.276 0 CA-C-O 121.42 0.629 . . . . 0.0 109.676 178.778 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 32.7 mm -99.33 98.87 7.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 N-CA-C 106.432 -1.692 . . . . 0.0 106.432 -175.466 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 32.3 tp -88.71 103.41 15.93 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 123.976 0.91 . . . . 0.0 109.352 179.088 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 88.1 m -98.96 108.33 20.98 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 -177.169 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 67.1 mt -100.62 101.48 12.39 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 123.705 0.802 . . . . 0.0 109.436 -171.663 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 6.9 m -113.89 111.91 22.49 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 -175.57 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 70.5 t60 -102.95 -85.32 0.45 Allowed 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 173.617 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -109.56 -108.99 3.21 Favored Glycine 0 N--CA 1.484 1.872 0 N-CA-C 110.635 -0.986 . . . . 0.0 110.635 178.983 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 45.4 m -100.93 66.34 1.15 Allowed 'General case' 0 N--CA 1.494 1.757 0 CA-C-O 121.348 0.594 . . . . 0.0 109.593 173.408 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -172.8 96.1 0.13 Allowed 'General case' 0 N--CA 1.484 1.237 0 N-CA-C 108.123 -1.065 . . . . 0.0 108.123 173.279 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 3.7 p -94.68 122.55 46.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 C-N-CA 123.482 0.713 . . . . 0.0 109.61 174.253 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 44.4 t -108.21 102.11 11.27 Favored 'General case' 0 CA--C 1.553 1.067 0 CA-C-O 121.455 0.645 . . . . 0.0 111.356 179.384 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 90.6 m -88.12 108.0 19.04 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 179.379 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 35.9 mtm180 -111.42 120.05 40.88 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 123.044 0.538 . . . . 0.0 110.394 -172.657 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 94.8 m -86.28 131.17 34.29 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 123.343 0.657 . . . . 0.0 110.309 178.552 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 40.9 m-85 -125.84 125.48 42.93 Favored 'General case' 0 CA--C 1.56 1.354 0 C-N-CA 123.566 0.746 . . . . 0.0 109.035 176.443 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -92.72 158.34 15.97 Favored 'General case' 0 N--CA 1.495 1.816 0 CA-C-O 122.345 1.069 . . . . 0.0 111.849 170.287 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 73.5 tttt -91.16 125.97 36.1 Favored 'General case' 0 N--CA 1.484 1.256 0 CA-C-N 115.512 -0.767 . . . . 0.0 112.46 -165.447 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -97.86 46.74 1.01 Allowed 'General case' 0 N--CA 1.495 1.788 0 C-N-CA 123.853 0.861 . . . . 0.0 112.896 166.926 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.152 0 CA-C-O 123.168 1.461 . . . . 0.0 108.312 -174.821 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.315 8.9 t . . . . . 0 N--CA 1.491 1.585 0 CA-C-O 117.625 -1.178 . . . . 0.0 113.394 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -60.03 -37.58 80.19 Favored 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 116.274 1.953 . . . . 0.0 116.274 -178.309 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -62.78 -28.89 70.3 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 117.252 2.316 . . . . 0.0 117.252 164.169 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -73.12 -25.09 60.72 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 116.131 1.9 . . . . 0.0 116.131 168.278 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 74.4 mt -73.25 108.42 6.12 Favored 'General case' 0 N--CA 1.49 1.56 0 CA-C-N 120.747 1.612 . . . . 0.0 111.381 -173.115 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 161.34 171.59 27.56 Favored Glycine 0 CA--C 1.538 1.509 0 CA-C-O 123.254 1.474 . . . . 0.0 113.892 -175.103 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 96.8 m -84.85 144.85 28.15 Favored 'General case' 0 N--CA 1.487 1.378 0 CA-C-N 113.531 -1.334 . . . . 0.0 110.004 172.436 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 84.4 m95 -140.4 113.35 8.27 Favored 'General case' 0 N--CA 1.483 1.222 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 -175.228 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 45.3 mtmt -102.91 141.43 35.72 Favored 'General case' 0 N--CA 1.492 1.648 0 CA-C-O 121.457 0.646 . . . . 0.0 110.104 173.74 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 55.7 tp -69.63 130.52 42.62 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-O 122.444 1.116 . . . . 0.0 113.244 -170.492 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . 0.272 1.6 t -110.38 -41.77 4.69 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.781 0 CA-C-N 113.512 -1.676 . . . . 0.0 111.818 -172.671 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -142.14 138.94 31.97 Favored 'General case' 0 N--CA 1.492 1.633 0 CA-C-N 120.249 1.386 . . . . 0.0 109.738 175.307 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 86.6 p -124.3 102.39 7.66 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 123.416 0.686 . . . . 0.0 110.832 176.33 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -101.09 127.2 47.74 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 123.207 0.603 . . . . 0.0 109.424 174.872 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 66.2 m-20 67.62 22.04 9.22 Favored 'General case' 0 N--CA 1.504 2.25 0 N-CA-C 117.813 2.523 . . . . 0.0 117.813 173.452 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -72.4 -38.47 68.42 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 115.905 1.817 . . . . 0.0 115.905 -175.4 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -58.41 -30.68 67.05 Favored 'General case' 0 N--CA 1.498 1.96 0 N-CA-C 116.477 2.028 . . . . 0.0 116.477 164.708 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 13.5 t0 -66.13 -50.93 62.29 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 114.28 1.215 . . . . 0.0 114.28 169.486 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 93.7 t80 -55.17 -50.33 69.59 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 115.296 1.591 . . . . 0.0 115.296 172.806 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 72.7 mtm -60.53 -44.43 96.07 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 114.992 1.478 . . . . 0.0 114.992 173.981 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 14.5 tmtt? -57.29 -45.16 84.39 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 115.611 1.708 . . . . 0.0 115.611 168.35 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 13.8 t -59.13 -37.75 78.0 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 116.473 2.027 . . . . 0.0 116.473 173.073 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 63.6 mt -66.58 -42.28 87.24 Favored 'General case' 0 CA--C 1.564 1.514 0 N-CA-C 116.451 2.019 . . . . 0.0 116.451 170.315 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 115.13 77.27 0.71 Allowed Glycine 0 N--CA 1.482 1.718 0 N-CA-C 110.73 -0.948 . . . . 0.0 110.73 -168.309 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 62.4 t -143.04 122.64 9.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 N-CA-C 105.103 -2.184 . . . . 0.0 105.103 -177.027 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -81.58 -164.3 32.9 Favored Glycine 0 CA--C 1.548 2.127 0 N-CA-C 116.25 1.26 . . . . 0.0 116.25 -177.321 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 83.6 t80 -67.22 145.56 55.08 Favored 'General case' 0 CA--C 1.566 1.588 0 C-N-CA 123.501 0.72 . . . . 0.0 112.608 177.924 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . 0.377 . . 79.83 -41.11 0.22 Allowed 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 116.364 1.987 . . . . 0.0 116.364 179.395 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 56.9 m -69.36 -40.79 77.28 Favored 'General case' 0 N--CA 1.501 2.076 0 CA-C-N 120.152 1.342 . . . . 0.0 113.374 162.756 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 72.0 mtp180 -50.49 -42.51 54.79 Favored 'General case' 0 N--CA 1.498 1.946 0 N-CA-C 116.073 1.879 . . . . 0.0 116.073 160.022 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 81.4 mt-30 -76.41 -48.98 17.93 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 115.033 1.494 . . . . 0.0 115.033 -178.239 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 58.7 t -63.8 -43.16 97.83 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 CA-C-N 119.534 1.061 . . . . 0.0 112.922 178.004 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -65.35 -37.83 88.25 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 116.625 2.083 . . . . 0.0 116.625 174.883 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 90.5 p -62.46 -42.4 99.45 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 116.355 1.983 . . . . 0.0 116.355 170.692 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 19.2 ptp -74.23 -31.26 62.53 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 117.163 2.283 . . . . 0.0 117.163 173.172 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 65.7 m -77.96 144.31 36.89 Favored 'General case' 0 N--CA 1.491 1.577 0 CA-C-N 119.184 0.902 . . . . 0.0 111.743 -173.976 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 17.7 ptpt -98.25 104.97 25.86 Favored Pre-proline 0 CA--C 1.572 1.799 0 CA-C-O 118.431 -0.795 . . . . 0.0 111.591 170.847 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -78.06 112.98 3.34 Favored 'Trans proline' 0 CA--C 1.563 1.944 0 C-N-CA 123.056 2.504 . . . . 0.0 112.671 178.709 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 94.6 m -72.5 104.38 3.81 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 124.975 1.31 . . . . 0.0 110.1 175.563 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 29.7 m -106.65 118.26 36.21 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.844 -0.535 . . . . 0.0 110.142 -173.011 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 4.5 mp -106.71 112.95 41.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 -177.366 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 52.9 mt -99.05 119.11 46.61 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 N-CA-C 106.938 -1.504 . . . . 0.0 106.938 172.505 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -137.86 123.94 20.3 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 -178.23 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 36.8 ttpt -84.0 116.57 22.89 Favored 'General case' 0 CA--C 1.559 1.31 0 C-N-CA 123.124 0.57 . . . . 0.0 111.201 179.27 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -107.93 73.52 0.9 Allowed 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 123.6 0.76 . . . . 0.0 109.051 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 62.66 69.34 1.34 Allowed Glycine 0 N--CA 1.49 2.264 0 N-CA-C 115.312 0.885 . . . . 0.0 115.312 -173.755 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . 0.278 10.5 m-20 64.81 -2.99 0.61 Allowed 'General case' 0 N--CA 1.501 2.093 0 N-CA-C 118.299 2.703 . . . . 0.0 118.299 -168.629 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 42.5 mm -99.27 99.44 8.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 N-CA-C 107.105 -1.443 . . . . 0.0 107.105 -177.044 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 40.7 mt -77.55 106.99 9.69 Favored 'General case' 0 N--CA 1.488 1.429 0 CA-C-O 121.487 0.66 . . . . 0.0 111.12 178.728 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 34.1 m -100.75 94.54 6.13 Favored 'General case' 0 CA--C 1.559 1.319 0 N-CA-C 107.084 -1.451 . . . . 0.0 107.084 -171.128 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 8.8 tt -92.22 107.93 19.57 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 -177.484 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 52.6 mttp -107.64 93.53 4.59 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 -169.103 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 42.1 m -84.14 92.63 7.96 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.718 -0.614 . . . . 0.0 109.658 -178.283 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 28.9 m170 -88.93 121.36 31.21 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 124.005 0.922 . . . . 0.0 109.214 -179.441 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 13.6 t . . . . . 0 N--CA 1.49 1.548 0 CA-C-O 121.657 0.742 . . . . 0.0 110.876 -176.6 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 8.1 m-20 . . . . . 0 N--CA 1.493 1.699 0 N-CA-C 107.921 -1.141 . . . . 0.0 107.921 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 35.8 p -122.91 133.11 54.41 Favored 'General case' 0 N--CA 1.495 1.806 0 C-N-CA 123.357 0.663 . . . . 0.0 110.832 -176.086 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -112.82 126.14 55.12 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 124.138 0.975 . . . . 0.0 109.222 179.794 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 12.0 pt -122.33 129.97 74.89 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 178.201 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 85.4 p -114.39 124.0 50.87 Favored 'General case' 0 N--CA 1.493 1.701 0 C-N-CA 123.635 0.774 . . . . 0.0 110.786 -173.934 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 41.8 p90 -146.41 139.12 25.35 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 116.069 1.877 . . . . 0.0 116.069 -168.631 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 57.1 mtmt -106.41 24.29 12.79 Favored 'General case' 0 N--CA 1.498 1.951 0 N-CA-C 116.518 2.044 . . . . 0.0 116.518 -178.371 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . 0.275 2.4 mp 61.95 92.43 0.06 Allowed 'General case' 0 N--CA 1.496 1.867 0 CA-C-N 120.904 1.684 . . . . 0.0 115.05 170.609 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 81.97 37.17 16.54 Favored Glycine 0 CA--C 1.55 2.28 0 N-CA-C 116.984 1.553 . . . . 0.0 116.984 -169.424 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 65.4 t -139.29 117.46 12.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 N-CA-C 105.534 -2.024 . . . . 0.0 105.534 -179.432 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -78.8 124.44 28.21 Favored 'General case' 0 N--CA 1.489 1.475 0 CA-C-O 121.415 0.626 . . . . 0.0 111.155 -179.638 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 14.9 p90 -127.07 134.1 50.33 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 124.393 1.077 . . . . 0.0 110.016 -176.936 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -72.05 137.23 47.01 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 112.873 0.694 . . . . 0.0 112.873 177.169 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -136.94 132.57 34.59 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 122.987 0.515 . . . . 0.0 110.518 -162.649 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 61.3 m -100.0 128.57 46.07 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 166.436 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 60.4 p -81.25 174.73 11.25 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 113.748 1.018 . . . . 0.0 113.748 -170.395 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -45.06 -37.15 3.97 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 118.591 2.811 . . . . 0.0 118.591 162.122 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -130.95 91.09 2.99 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 106.547 -1.649 . . . . 0.0 106.547 166.284 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -8.05 99.77 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.098 0 N-CA-C 119.301 3.074 . . . . 0.0 119.301 -175.827 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 3.3 ttm180 -136.27 13.68 3.28 Favored 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 116.961 2.208 . . . . 0.0 116.961 -175.046 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . 0.318 0.0 OUTLIER 42.93 77.04 0.07 Allowed 'General case' 0 N--CA 1.498 1.963 0 N-CA-C 116.898 2.185 . . . . 0.0 116.898 172.129 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 11.0 m -117.68 144.86 24.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 C-N-CA 123.378 0.671 . . . . 0.0 110.145 -166.576 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -96.35 102.65 14.46 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 178.497 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 58.0 m -90.41 125.79 35.67 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 123.401 0.68 . . . . 0.0 112.024 -171.364 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 6.2 tp -137.7 108.89 5.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 179.296 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -118.26 131.02 72.24 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 C-N-CA 124.558 1.143 . . . . 0.0 109.183 177.923 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 14.6 t -135.12 154.42 51.66 Favored 'General case' 0 N--CA 1.492 1.674 0 CA-C-O 122.777 1.275 . . . . 0.0 111.848 171.91 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 15.6 tp -88.56 113.3 23.99 Favored 'General case' 0 N--CA 1.487 1.419 0 CA-C-N 114.339 -1.3 . . . . 0.0 110.166 177.753 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -115.79 81.8 1.66 Allowed 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 123.42 0.688 . . . . 0.0 109.921 -176.195 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 62.65 48.58 80.38 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 117.299 1.68 . . . . 0.0 117.299 -175.06 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 74.28 44.06 29.68 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 117.446 1.739 . . . . 0.0 117.446 -171.155 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 40.5 ttpt -154.38 108.25 2.95 Favored 'General case' 0 CA--C 1.552 1.047 0 N-CA-C 106.549 -1.649 . . . . 0.0 106.549 -172.298 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 41.4 mt -81.72 96.86 7.68 Favored 'General case' 0 N--CA 1.491 1.579 0 CA-C-O 122.625 1.202 . . . . 0.0 110.109 175.526 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 96.2 t -87.81 98.57 7.68 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.235 0 CA-C-N 113.293 -1.776 . . . . 0.0 106.32 -178.477 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 22.4 t-160 -95.27 139.34 31.73 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 123.533 0.733 . . . . 0.0 109.818 177.262 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 20.5 tp -135.73 118.7 16.34 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 106.701 -1.592 . . . . 0.0 106.701 178.356 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 28.7 mt-30 -114.01 125.96 54.59 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 176.229 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -139.71 128.28 23.02 Favored 'General case' 0 N--CA 1.494 1.769 0 CA-C-N 118.685 0.675 . . . . 0.0 112.743 -165.402 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 21.4 p90 -151.32 115.8 5.11 Favored 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 123.908 0.883 . . . . 0.0 110.699 -167.178 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . 0.341 18.1 t70 67.96 -93.32 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.886 0 C-N-CA 124.766 1.226 . . . . 0.0 112.883 171.146 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -135.28 52.11 0.81 Allowed Glycine 0 CA--C 1.546 2.014 0 CA-C-O 119.743 -0.476 . . . . 0.0 113.887 163.159 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 15.6 mt-30 -151.02 131.29 13.61 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 176.849 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -133.42 116.2 15.74 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 123.089 0.556 . . . . 0.0 110.27 179.364 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 1.8 t -110.33 124.36 51.54 Favored 'General case' 0 N--CA 1.492 1.636 0 C-N-CA 123.265 0.626 . . . . 0.0 109.988 -178.523 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 35.6 p -100.72 137.95 38.43 Favored 'General case' 0 N--CA 1.492 1.633 0 CA-C-O 121.213 0.53 . . . . 0.0 111.244 179.38 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 5.0 mp -121.4 79.5 1.55 Allowed 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 -178.292 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 46.4 t -93.2 112.42 26.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 -165.797 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 45.3 mtt180 -102.71 129.42 49.32 Favored 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 122.854 0.462 . . . . 0.0 110.745 -177.589 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -148.83 139.33 22.58 Favored 'General case' 0 N--CA 1.494 1.744 0 C-N-CA 123.061 0.544 . . . . 0.0 111.97 178.964 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -83.7 113.97 21.25 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 123.094 0.558 . . . . 0.0 111.727 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 1.7 mp -103.79 102.02 13.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 N-CA-C 104.688 -2.338 . . . . 0.0 104.688 170.835 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 53.75 50.41 17.07 Favored 'General case' 0 N--CA 1.499 1.987 0 N-CA-C 115.257 1.577 . . . . 0.0 115.257 176.232 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 88.55 -37.93 3.25 Favored Glycine 0 CA--C 1.552 2.396 0 N-CA-C 117.857 1.903 . . . . 0.0 117.857 -169.914 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 10.4 mtmp? -85.93 127.45 34.62 Favored 'General case' 0 N--CA 1.487 1.377 0 CA-C-N 119.336 1.568 . . . . 0.0 111.08 -172.698 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 2.6 tt -80.14 118.77 22.13 Favored 'General case' 0 CA--C 1.556 1.202 0 CA-C-O 121.823 0.821 . . . . 0.0 111.082 -179.584 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 39.2 mm -100.91 108.81 23.99 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.347 0 N-CA-C 106.324 -1.732 . . . . 0.0 106.324 -178.502 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 47.2 tp -91.19 101.53 14.26 Favored 'General case' 0 CA--C 1.56 1.363 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 173.954 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 58.2 m -93.8 109.13 20.82 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 -177.622 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 62.7 mt -103.72 83.87 2.2 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 123.339 0.656 . . . . 0.0 110.372 -169.59 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 8.5 m -95.97 116.59 29.17 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.617 -0.677 . . . . 0.0 109.949 -170.173 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 85.0 t60 -146.49 115.9 7.09 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 176.342 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 75.82 -109.45 2.79 Favored Glycine 0 N--CA 1.484 1.86 0 C-N-CA 122.96 0.314 . . . . 0.0 113.538 173.675 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 14.9 t -129.82 55.09 1.8 Allowed 'General case' 0 N--CA 1.495 1.812 0 CA-C-O 121.405 0.621 . . . . 0.0 111.078 163.213 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -154.36 89.2 1.26 Allowed 'General case' 0 N--CA 1.483 1.177 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 177.878 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 5.6 p -92.96 117.93 37.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 C-N-CA 123.276 0.631 . . . . 0.0 110.004 176.964 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 44.2 t -99.98 104.39 16.0 Favored 'General case' 0 CA--C 1.553 1.093 0 CA-C-O 121.443 0.639 . . . . 0.0 111.419 175.302 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 57.5 m -92.02 110.18 21.54 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 -178.621 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 21.5 mtm105 -115.17 114.53 25.39 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 123.163 0.585 . . . . 0.0 110.561 -171.022 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 90.8 m -84.55 140.34 31.49 Favored 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 123.714 0.806 . . . . 0.0 110.987 -178.891 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 42.0 m-85 -133.98 135.92 43.78 Favored 'General case' 0 CA--C 1.559 1.298 0 C-N-CA 124.079 0.952 . . . . 0.0 109.903 -178.365 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -99.47 152.63 19.78 Favored 'General case' 0 N--CA 1.495 1.814 0 CA-C-O 122.058 0.932 . . . . 0.0 111.315 166.093 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 65.6 tttt -82.78 120.47 25.67 Favored 'General case' 0 N--CA 1.486 1.365 0 CA-C-N 115.465 -0.789 . . . . 0.0 111.19 -173.19 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 59.0 mm-40 -114.49 53.89 0.79 Allowed 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 124.073 0.949 . . . . 0.0 111.552 -172.205 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.894 0 CA-C-O 124.414 2.054 . . . . 0.0 108.956 -170.66 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.255 4.4 p . . . . . 0 CA--C 1.575 1.935 0 N-CA-C 116.141 1.904 . . . . 0.0 116.141 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -67.36 -39.61 85.74 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 116.385 1.995 . . . . 0.0 116.385 -177.011 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -59.59 -28.2 66.94 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 117.408 2.373 . . . . 0.0 117.408 167.888 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -68.21 -27.19 66.16 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 116.207 1.929 . . . . 0.0 116.207 166.568 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 79.9 mt -71.91 116.85 12.78 Favored 'General case' 0 N--CA 1.489 1.52 0 CA-C-N 120.967 1.712 . . . . 0.0 112.436 -170.855 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 159.41 173.36 27.76 Favored Glycine 0 CA--C 1.543 1.842 0 CA-C-O 122.484 1.047 . . . . 0.0 113.557 -178.597 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 53.9 m -85.19 141.08 30.41 Favored 'General case' 0 N--CA 1.493 1.714 0 CA-C-N 114.719 -0.74 . . . . 0.0 109.378 167.102 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 88.2 m95 -140.53 113.51 8.33 Favored 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 -174.046 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -100.69 150.01 23.19 Favored 'General case' 0 N--CA 1.496 1.863 0 CA-C-O 121.23 0.538 . . . . 0.0 110.554 176.047 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 22.5 tp -68.15 129.49 40.07 Favored 'General case' 0 N--CA 1.491 1.595 0 CA-C-O 121.932 0.872 . . . . 0.0 113.072 -174.437 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . 0.283 0.9 OUTLIER -105.05 -46.96 9.41 Favored 'Isoleucine or valine' 0 CA--C 1.576 1.967 0 CA-C-N 114.156 -1.384 . . . . 0.0 111.184 173.918 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -139.7 143.84 37.27 Favored 'General case' 0 N--CA 1.492 1.627 0 CA-C-N 119.754 1.161 . . . . 0.0 109.712 179.472 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 95.4 p -137.35 96.45 3.27 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.668 -0.645 . . . . 0.0 110.248 166.819 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -91.55 126.59 36.68 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 123.413 0.685 . . . . 0.0 109.679 177.385 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.27 62.6 m-20 69.45 37.17 2.05 Favored 'General case' 0 N--CA 1.502 2.174 0 N-CA-C 116.105 1.891 . . . . 0.0 116.105 -176.068 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 47.3 t80 -69.22 -59.56 2.93 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.759 -1.213 . . . . 0.0 112.8 175.917 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -45.91 -45.68 15.52 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 118.376 2.732 . . . . 0.0 118.376 171.076 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -61.12 -46.81 89.07 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 115.07 1.507 . . . . 0.0 115.07 172.516 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 87.2 t80 -55.84 -49.61 72.83 Favored 'General case' 0 CA--C 1.573 1.857 0 N-CA-C 115.025 1.491 . . . . 0.0 115.025 169.388 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 19.3 mmt -63.78 -44.61 92.85 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 114.829 1.418 . . . . 0.0 114.829 177.719 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 21.1 tptm -60.96 -37.65 83.17 Favored 'General case' 0 CA--C 1.571 1.753 0 N-CA-C 116.18 1.918 . . . . 0.0 116.18 167.67 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 17.1 t -58.85 -41.12 86.23 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 115.74 1.756 . . . . 0.0 115.74 169.47 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 79.1 mt -62.37 -44.3 96.79 Favored 'General case' 0 CA--C 1.568 1.641 0 N-CA-C 115.898 1.814 . . . . 0.0 115.898 166.315 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 123.63 65.24 0.2 Allowed Glycine 0 N--CA 1.483 1.813 0 C-N-CA 124.173 0.892 . . . . 0.0 111.991 -175.388 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 24.2 t -144.45 112.11 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 N-CA-C 105.084 -2.191 . . . . 0.0 105.084 -174.445 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -96.5 -100.27 1.93 Allowed Glycine 0 N--CA 1.484 1.834 0 N-CA-C 113.694 0.238 . . . . 0.0 113.694 -173.323 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 69.3 t80 -96.16 143.38 27.33 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 123.511 0.725 . . . . 0.0 111.784 -173.023 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . 0.352 . . 80.87 -51.04 0.31 Allowed 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 116.494 2.035 . . . . 0.0 116.494 168.516 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 91.8 m -70.28 -40.51 74.28 Favored 'General case' 0 N--CA 1.498 1.974 0 N-CA-C 113.938 1.088 . . . . 0.0 113.938 171.657 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 51.6 ttp180 -58.13 -41.04 82.78 Favored 'General case' 0 CA--C 1.572 1.818 0 N-CA-C 114.99 1.478 . . . . 0.0 114.99 164.457 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 42.9 mt-30 -73.94 -47.25 38.88 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 115.583 1.698 . . . . 0.0 115.583 178.922 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 81.3 t -63.84 -42.79 97.02 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.168 0 CA-C-N 120.01 1.277 . . . . 0.0 113.158 176.582 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -68.02 -31.61 71.42 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 117.052 2.242 . . . . 0.0 117.052 173.954 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 82.2 p -67.35 -39.38 85.73 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 115.889 1.811 . . . . 0.0 115.889 167.43 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 47.3 ttm -65.72 -41.7 91.96 Favored 'General case' 0 CA--C 1.566 1.575 0 N-CA-C 115.816 1.784 . . . . 0.0 115.816 175.595 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 5.9 t -81.0 165.73 21.45 Favored 'General case' 0 N--CA 1.493 1.686 0 CA-C-N 118.949 0.795 . . . . 0.0 112.933 178.981 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.17 105.68 33.9 Favored Pre-proline 0 CA--C 1.57 1.713 0 CA-C-O 118.093 -0.956 . . . . 0.0 110.127 172.54 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -80.76 99.77 1.16 Allowed 'Trans proline' 0 CA--C 1.558 1.715 0 C-N-CA 122.656 2.237 . . . . 0.0 112.308 -179.597 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 97.4 m -80.83 118.24 22.18 Favored 'General case' 0 N--CA 1.487 1.419 0 CA-C-N 115.417 -0.811 . . . . 0.0 110.934 -165.429 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 79.3 m -90.9 117.24 29.35 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 178.519 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 5.2 mp -108.41 109.29 27.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 N-CA-C 106.32 -1.733 . . . . 0.0 106.32 174.851 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 20.8 mt -100.49 117.35 45.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 N-CA-C 106.348 -1.723 . . . . 0.0 106.348 177.342 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -142.17 127.85 19.19 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.643 -0.661 . . . . 0.0 109.434 -170.386 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.68 156.1 32.83 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 113.972 1.101 . . . . 0.0 113.972 -178.727 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 25.9 t30 -141.91 74.74 1.46 Allowed 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 170.429 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 71.04 -102.23 1.05 Allowed Glycine 0 CA--C 1.546 1.991 0 O-C-N 122.119 -0.363 . . . . 0.0 112.732 -167.213 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 42.4 t0 -94.91 -20.76 19.13 Favored 'General case' 0 CA--C 1.573 1.86 0 N-CA-C 115.318 1.599 . . . . 0.0 115.318 166.816 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 18.6 mm -87.23 110.73 20.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 CA-C-N 120.542 1.519 . . . . 0.0 109.133 -169.081 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 30.7 mt -78.74 124.31 28.07 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 123.613 0.765 . . . . 0.0 111.935 176.275 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 86.7 m -109.19 99.48 8.76 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 106.922 -1.51 . . . . 0.0 106.922 179.532 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 9.7 tt -99.63 109.68 22.16 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 178.797 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -104.0 105.87 16.19 Favored 'General case' 0 N--CA 1.484 1.228 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 -179.187 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 48.8 m -89.02 95.26 10.25 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 174.441 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 22.0 m170 -76.9 175.58 9.38 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 124.132 0.973 . . . . 0.0 111.844 176.927 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 22.6 t . . . . . 0 N--CA 1.497 1.892 0 N-CA-C 115.069 1.507 . . . . 0.0 115.069 176.151 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 26.0 m-20 . . . . . 0 N--CA 1.491 1.622 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 60.4 p -106.59 131.98 53.13 Favored 'General case' 0 N--CA 1.496 1.865 0 C-N-CA 123.327 0.651 . . . . 0.0 110.952 -176.444 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 4.5 tm-20 -118.07 127.79 54.13 Favored 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 123.953 0.901 . . . . 0.0 110.081 -173.66 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 44.7 pt -116.94 132.76 65.74 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 C-N-CA 123.595 0.758 . . . . 0.0 109.267 172.196 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 73.5 p -116.2 112.95 22.38 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 176.397 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 40.2 p90 -144.35 146.33 32.49 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 114.498 1.295 . . . . 0.0 114.498 -161.331 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 57.6 mtmt -102.59 151.23 22.59 Favored 'General case' 0 N--CA 1.489 1.491 0 CA-C-N 115.133 -0.94 . . . . 0.0 109.126 159.146 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -74.15 115.95 14.23 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.66 -0.65 . . . . 0.0 111.709 -172.893 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 88.18 45.53 5.01 Favored Glycine 0 CA--C 1.55 2.225 0 N-CA-C 116.454 1.341 . . . . 0.0 116.454 -167.539 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 94.4 t -136.88 121.96 25.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 N-CA-C 107.024 -1.473 . . . . 0.0 107.024 178.086 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -87.97 125.73 34.68 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 123.05 0.54 . . . . 0.0 110.522 172.401 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 37.0 p90 -135.59 128.39 31.11 Favored 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 123.938 0.895 . . . . 0.0 109.026 -177.393 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -72.16 110.32 6.54 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.254 -0.904 . . . . 0.0 112.177 177.872 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 12.4 tp10 -109.9 129.13 55.69 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 123.804 0.842 . . . . 0.0 109.855 -169.314 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 67.6 m -96.91 118.87 34.27 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 175.635 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 38.8 p -88.2 168.33 12.84 Favored 'General case' 0 N--CA 1.49 1.54 0 CA-C-N 115.368 -0.833 . . . . 0.0 112.191 -172.612 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -62.2 -28.02 69.38 Favored 'General case' 0 CA--C 1.569 1.682 0 N-CA-C 117.154 2.279 . . . . 0.0 117.154 164.121 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -69.58 -1.22 8.21 Favored 'General case' 0 CA--C 1.58 2.105 0 N-CA-C 116.694 2.109 . . . . 0.0 116.694 164.247 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 65.32 67.31 0.51 Allowed 'General case' 0 N--CA 1.496 1.844 0 C-N-CA 125.449 1.5 . . . . 0.0 111.922 -176.183 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 38.9 ttp180 -148.2 117.49 6.9 Favored 'General case' 0 N--CA 1.485 1.307 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 -166.309 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -76.47 111.39 11.89 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 172.703 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 10.4 m -127.27 128.04 69.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 -172.241 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 47.5 mmtm -80.9 102.88 10.36 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 123.27 0.628 . . . . 0.0 109.526 -179.56 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 40.8 m -95.76 91.95 6.32 Favored 'General case' 0 N--CA 1.48 1.072 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.932 -167.077 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 6.1 tp -104.02 108.15 23.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 176.304 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 1.5 p -124.56 124.42 68.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 C-N-CA 123.851 0.861 . . . . 0.0 109.289 -173.28 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 9.8 t -138.53 152.78 48.52 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-O 122.467 1.127 . . . . 0.0 110.891 -178.794 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 35.3 tp -89.88 111.37 22.4 Favored 'General case' 0 N--CA 1.488 1.434 0 CA-C-N 114.85 -1.068 . . . . 0.0 109.394 174.099 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -104.61 81.99 1.85 Allowed 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 123.629 0.772 . . . . 0.0 110.266 -176.04 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 57.01 46.31 91.53 Favored Glycine 0 CA--C 1.551 2.327 0 N-CA-C 118.032 1.973 . . . . 0.0 118.032 -176.514 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 82.77 12.88 79.18 Favored Glycine 0 CA--C 1.557 2.681 0 N-CA-C 118.748 2.259 . . . . 0.0 118.748 -167.698 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 59.2 mtpt -125.2 103.88 8.21 Favored 'General case' 0 N--CA 1.487 1.394 0 CA-C-N 119.365 1.583 . . . . 0.0 106.799 177.825 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 5.5 tt -85.57 97.52 10.12 Favored 'General case' 0 CA--C 1.56 1.359 0 CA-C-O 122.013 0.911 . . . . 0.0 109.584 -174.824 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 71.6 t -96.37 110.47 24.7 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 N-CA-C 106.778 -1.564 . . . . 0.0 106.778 -170.308 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 20.1 t-160 -102.02 108.55 20.03 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 122.995 0.518 . . . . 0.0 109.697 173.681 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 40.8 tp -95.12 118.31 31.69 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 175.637 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 31.4 mt-30 -106.93 117.65 34.61 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 172.632 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 37.5 ttmt -124.76 127.37 47.11 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 123.195 0.598 . . . . 0.0 109.846 -172.617 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 32.3 p90 -145.93 114.76 6.89 Favored 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 123.241 0.616 . . . . 0.0 110.569 -174.575 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . 0.339 13.8 t70 67.04 -99.74 0.05 Allowed 'General case' 0 N--CA 1.494 1.751 0 C-N-CA 124.595 1.158 . . . . 0.0 112.403 173.01 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -128.61 50.54 0.89 Allowed Glycine 0 N--CA 1.487 2.04 0 CA-C-N 118.615 0.643 . . . . 0.0 114.197 163.216 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 14.1 mt-30 -150.65 128.85 11.95 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 177.807 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -137.09 130.79 31.79 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 123.139 0.576 . . . . 0.0 111.195 -176.756 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 7.1 t -121.88 129.3 52.47 Favored 'General case' 0 N--CA 1.495 1.809 0 C-N-CA 122.543 0.337 . . . . 0.0 111.486 176.129 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 39.7 p -99.31 124.62 44.55 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-O 121.755 0.788 . . . . 0.0 110.115 173.185 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 5.5 mp -100.91 88.27 3.51 Favored 'General case' 0 CA--C 1.559 1.29 0 N-CA-C 106.984 -1.487 . . . . 0.0 106.984 178.082 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 98.5 t -92.56 101.1 12.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 -168.102 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 77.7 mtt85 -96.47 125.44 40.96 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 123.221 0.608 . . . . 0.0 109.849 -178.309 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -144.95 128.17 16.73 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-O 120.847 0.356 . . . . 0.0 111.329 -172.367 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -82.42 115.64 21.53 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 123.144 0.577 . . . . 0.0 111.408 -177.245 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 96.1 mt -127.85 107.17 15.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 N-CA-C 104.993 -2.225 . . . . 0.0 104.993 179.701 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 23.4 m-20 58.08 52.76 7.32 Favored 'General case' 0 N--CA 1.5 2.063 0 N-CA-C 114.788 1.403 . . . . 0.0 114.788 176.523 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 63.15 21.21 63.7 Favored Glycine 0 CA--C 1.556 2.635 0 N-CA-C 119.734 2.653 . . . . 0.0 119.734 -171.258 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -128.92 127.54 41.96 Favored 'General case' 0 N--CA 1.488 1.445 0 CA-C-N 119.534 1.667 . . . . 0.0 108.51 -173.586 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 16.0 tp -79.33 109.99 14.19 Favored 'General case' 0 CA--C 1.557 1.236 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 176.751 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 32.5 mm -98.45 97.02 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 N-CA-C 106.467 -1.679 . . . . 0.0 106.467 -175.792 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 30.3 tp -87.23 103.96 15.93 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 124.003 0.921 . . . . 0.0 109.553 178.118 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 88.4 m -100.8 99.15 9.62 Favored 'General case' 0 CA--C 1.562 1.405 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 -177.408 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 71.0 mt -88.17 104.01 16.3 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 123.911 0.884 . . . . 0.0 109.672 -176.76 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 6.7 m -106.79 122.4 46.31 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.586 -0.696 . . . . 0.0 109.502 -171.83 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 77.8 t60 -148.15 113.5 5.59 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 173.797 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 74.89 -116.39 5.03 Favored Glycine 0 N--CA 1.484 1.883 0 C-N-CA 123.115 0.388 . . . . 0.0 113.849 173.083 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 15.2 t -119.22 53.45 1.02 Allowed 'General case' 0 N--CA 1.496 1.844 0 CA-C-O 121.271 0.557 . . . . 0.0 111.641 166.658 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -159.93 104.91 1.55 Allowed 'General case' 0 N--CA 1.483 1.203 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 175.89 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 7.4 p -111.24 125.89 68.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 C-N-CA 123.706 0.802 . . . . 0.0 110.113 -179.082 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 35.6 t -98.35 108.49 21.2 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 122.788 0.435 . . . . 0.0 111.693 175.626 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 88.6 m -92.2 117.19 29.63 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 177.868 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 75.6 mtp180 -124.46 115.78 21.46 Favored 'General case' 0 N--CA 1.488 1.444 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.054 -165.229 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 74.1 m -87.82 133.72 33.83 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 122.98 0.512 . . . . 0.0 109.794 178.017 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 40.0 m-85 -128.69 130.11 46.71 Favored 'General case' 0 CA--C 1.56 1.351 0 C-N-CA 123.388 0.675 . . . . 0.0 109.419 177.467 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -91.22 154.16 19.49 Favored 'General case' 0 N--CA 1.494 1.741 0 CA-C-O 122.23 1.014 . . . . 0.0 112.193 169.556 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 69.6 tttt -86.01 119.4 26.27 Favored 'General case' 0 N--CA 1.484 1.273 0 CA-C-N 115.257 -0.883 . . . . 0.0 111.414 -170.787 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 25.3 mm-40 -117.22 51.22 1.03 Allowed 'General case' 0 CA--C 1.564 1.508 0 C-N-CA 124.58 1.152 . . . . 0.0 111.26 -174.61 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 0.984 0 CA-C-O 123.059 1.409 . . . . 0.0 110.594 -159.732 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 4.1 p . . . . . 0 CA--C 1.576 1.971 0 N-CA-C 116.051 1.871 . . . . 0.0 116.051 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -66.86 -34.25 77.38 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 116.922 2.193 . . . . 0.0 116.922 -175.456 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -57.67 -31.63 66.51 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 117.387 2.366 . . . . 0.0 117.387 169.404 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -66.96 -26.5 66.86 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 116.686 2.106 . . . . 0.0 116.686 168.702 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 49.8 mt -77.07 107.07 9.17 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-N 120.887 1.676 . . . . 0.0 111.624 -164.057 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 157.18 176.97 29.85 Favored Glycine 0 CA--C 1.542 1.749 0 CA-C-O 122.511 1.062 . . . . 0.0 113.11 -169.744 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 85.6 m -91.78 143.56 26.4 Favored 'General case' 0 N--CA 1.489 1.48 0 CA-C-N 114.406 -0.897 . . . . 0.0 109.071 177.14 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 93.5 m95 -138.48 111.5 7.85 Favored 'General case' 0 N--CA 1.485 1.319 0 N-CA-C 107.548 -1.278 . . . . 0.0 107.548 -175.145 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -100.31 143.11 30.89 Favored 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 123.681 0.792 . . . . 0.0 110.648 -178.957 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 17.6 tp -66.91 124.62 23.49 Favored 'General case' 0 N--CA 1.488 1.445 0 CA-C-O 121.929 0.871 . . . . 0.0 113.135 -172.457 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . 0.267 1.2 t -97.37 -48.45 12.35 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.816 0 CA-C-N 114.261 -1.336 . . . . 0.0 111.601 174.472 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -143.89 150.25 38.12 Favored 'General case' 0 N--CA 1.489 1.494 0 CA-C-N 119.356 0.98 . . . . 0.0 110.046 178.904 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 88.1 p -130.65 98.14 4.57 Favored 'General case' 0 N--CA 1.489 1.514 0 CA-C-O 121.243 0.544 . . . . 0.0 109.922 170.042 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -84.51 128.27 34.5 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 123.168 0.587 . . . . 0.0 110.055 177.616 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 56.3 m-20 65.09 24.91 12.52 Favored 'General case' 0 N--CA 1.503 2.207 0 N-CA-C 117.964 2.579 . . . . 0.0 117.964 171.748 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 29.8 t80 -69.42 -53.24 20.31 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 120.032 -1.668 . . . . 0.0 113.982 -176.156 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -39.35 -44.64 1.34 Allowed 'General case' 0 N--CA 1.499 1.977 0 N-CA-C 118.948 2.944 . . . . 0.0 118.948 159.951 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -63.91 -50.35 69.06 Favored 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 115.214 1.561 . . . . 0.0 115.214 172.709 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 75.4 t80 -52.11 -48.0 64.99 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 115.591 1.7 . . . . 0.0 115.591 166.866 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 36.6 mmm -65.59 -40.11 92.33 Favored 'General case' 0 CA--C 1.565 1.548 0 N-CA-C 115.176 1.547 . . . . 0.0 115.176 176.352 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -60.85 -43.11 98.76 Favored 'General case' 0 CA--C 1.569 1.677 0 N-CA-C 114.873 1.435 . . . . 0.0 114.873 165.583 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 50.1 m -59.14 -39.45 82.44 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 115.82 1.785 . . . . 0.0 115.82 170.493 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 77.7 mt -64.62 -42.43 95.5 Favored 'General case' 0 CA--C 1.565 1.543 0 N-CA-C 116.214 1.931 . . . . 0.0 116.214 168.53 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 111.85 73.77 0.69 Allowed Glycine 0 N--CA 1.483 1.807 0 C-N-CA 123.708 0.671 . . . . 0.0 111.911 -172.445 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 37.6 t -136.3 127.84 43.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 N-CA-C 106.335 -1.728 . . . . 0.0 106.335 179.421 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -66.53 -80.19 0.19 Allowed Glycine 0 N--CA 1.485 1.966 0 N-CA-C 116.653 1.421 . . . . 0.0 116.653 -173.603 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 46.3 p90 -153.04 -50.29 0.1 Allowed 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 114.298 1.222 . . . . 0.0 114.298 -178.176 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.02 -41.67 96.99 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 116.871 2.175 . . . . 0.0 116.871 -176.519 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 59.0 m -80.06 -36.24 35.93 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 113.521 0.934 . . . . 0.0 113.521 169.89 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 44.2 ttp180 -58.72 -44.05 90.31 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 115.722 1.749 . . . . 0.0 115.722 176.677 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 18.2 mm100 -86.91 -33.64 19.65 Favored 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 115.315 1.598 . . . . 0.0 115.315 178.864 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 89.1 t -69.44 -46.19 76.86 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 CA-C-N 120.875 1.67 . . . . 0.0 111.941 173.373 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -65.97 -24.43 66.79 Favored 'General case' 0 CA--C 1.569 1.685 0 N-CA-C 117.559 2.429 . . . . 0.0 117.559 175.075 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 87.4 p -68.17 -49.48 60.66 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 114.863 1.431 . . . . 0.0 114.863 167.052 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 3.3 ppp? -65.26 -23.31 67.01 Favored 'General case' 0 N--CA 1.499 2.012 0 N-CA-C 117.792 2.516 . . . . 0.0 117.792 170.408 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 48.6 m -68.99 150.74 47.35 Favored 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 124.507 1.123 . . . . 0.0 112.119 177.189 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.8 98.81 6.64 Favored Pre-proline 0 CA--C 1.571 1.786 0 CA-C-O 118.072 -0.966 . . . . 0.0 110.022 166.319 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_endo -82.12 90.34 1.12 Allowed 'Trans proline' 0 CA--C 1.562 1.878 0 C-N-CA 122.805 2.337 . . . . 0.0 110.758 179.32 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 80.3 m -79.8 110.63 15.34 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 123.715 0.806 . . . . 0.0 110.487 -160.959 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 58.6 m -86.27 116.42 24.44 Favored 'General case' 0 CA--C 1.562 1.41 0 C-N-CA 123.085 0.554 . . . . 0.0 109.962 -171.247 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 71.9 mt -113.12 105.24 18.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 N-CA-C 106.434 -1.691 . . . . 0.0 106.434 178.926 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 3.8 mp -94.56 123.05 46.53 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 174.567 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -132.48 117.88 18.58 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 -176.866 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 38.7 ttpt -90.24 117.22 28.81 Favored 'General case' 0 CA--C 1.557 1.227 0 CA-C-O 121.296 0.57 . . . . 0.0 110.911 177.511 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 21.2 t-20 -77.27 -56.14 4.81 Favored 'General case' 0 CA--C 1.568 1.651 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.85 164.245 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -159.49 -85.62 0.05 OUTLIER Glycine 0 N--CA 1.48 1.614 0 N-CA-C 109.066 -1.613 . . . . 0.0 109.066 171.039 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -74.04 -37.87 64.17 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 114.502 1.297 . . . . 0.0 114.502 161.108 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 45.9 mm -76.68 120.54 27.09 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.514 0 C-N-CA 123.954 0.902 . . . . 0.0 110.466 -174.116 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 47.1 mt -99.67 108.99 21.48 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.745 0.818 . . . . 0.0 109.037 168.014 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 93.7 m -95.43 100.63 12.37 Favored 'General case' 0 CA--C 1.559 1.308 0 N-CA-C 107.513 -1.291 . . . . 0.0 107.513 -177.018 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 9.6 tt -100.44 106.38 17.95 Favored 'General case' 0 N--CA 1.483 1.178 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 -178.47 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -101.88 111.64 23.97 Favored 'General case' 0 N--CA 1.485 1.305 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 178.884 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 95.2 m -95.07 94.46 7.97 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 178.192 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 22.3 m-70 -81.12 100.99 9.34 Favored 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 123.276 0.63 . . . . 0.0 111.603 -171.257 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 32.1 t . . . . . 0 CA--C 1.555 1.152 0 C-N-CA 123.904 0.882 . . . . 0.0 109.397 -176.304 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 7.6 p-10 . . . . . 0 N--CA 1.49 1.548 0 N-CA-C 112.493 0.553 . . . . 0.0 112.493 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 73.1 p -93.85 126.37 39.0 Favored 'General case' 0 N--CA 1.493 1.716 0 C-N-CA 122.718 0.407 . . . . 0.0 110.538 178.783 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -105.81 113.92 27.76 Favored 'General case' 0 N--CA 1.485 1.292 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 174.037 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 19.8 pt -116.59 128.82 73.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 179.72 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 61.7 p -116.83 113.4 22.45 Favored 'General case' 0 N--CA 1.492 1.659 0 C-N-CA 123.741 0.817 . . . . 0.0 109.447 -172.466 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 42.6 p90 -141.31 145.65 35.75 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 114.929 1.455 . . . . 0.0 114.929 -165.228 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 34.8 mtmm -116.82 23.94 11.6 Favored 'General case' 0 N--CA 1.498 1.929 0 N-CA-C 115.982 1.845 . . . . 0.0 115.982 -174.168 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . 0.275 2.0 mp 65.75 94.21 0.06 Allowed 'General case' 0 N--CA 1.494 1.725 0 C-N-CA 124.964 1.306 . . . . 0.0 113.635 168.632 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 83.27 34.06 21.42 Favored Glycine 0 CA--C 1.551 2.323 0 N-CA-C 117.095 1.598 . . . . 0.0 117.095 -164.601 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 95.6 t -135.27 118.19 23.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 N-CA-C 106.453 -1.684 . . . . 0.0 106.453 -178.948 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -85.6 136.27 33.45 Favored 'General case' 0 CA--C 1.565 1.55 0 C-N-CA 123.563 0.745 . . . . 0.0 111.86 179.448 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 47.9 p90 -143.89 139.29 29.13 Favored 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 123.663 0.785 . . . . 0.0 111.392 -171.872 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -75.57 135.42 40.55 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.252 -0.905 . . . . 0.0 112.688 172.413 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -146.1 136.49 23.94 Favored 'General case' 0 N--CA 1.49 1.528 0 CA-C-O 120.997 0.427 . . . . 0.0 111.207 -170.53 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 79.3 m -96.88 130.09 44.23 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 172.037 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 26.7 p -89.2 171.8 9.54 Favored 'General case' 0 N--CA 1.492 1.671 0 CA-C-O 121.989 0.9 . . . . 0.0 112.661 -176.336 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -54.48 -40.33 68.39 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 117.207 2.299 . . . . 0.0 117.207 169.018 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -93.93 59.7 2.78 Favored 'General case' 0 N--CA 1.495 1.813 0 CA-C-N 119.362 0.983 . . . . 0.0 111.337 170.267 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 9.5 t70 21.7 76.26 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.007 0 N-CA-C 118.771 2.878 . . . . 0.0 118.771 -178.687 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 38.4 ttp180 -139.73 117.92 11.95 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 -169.204 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.42 114.81 12.06 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 122.901 0.48 . . . . 0.0 110.195 172.252 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 17.3 m -135.01 132.27 53.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 CA-C-O 121.431 0.634 . . . . 0.0 109.642 -170.135 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 39.5 ttpt -87.02 118.09 26.17 Favored 'General case' 0 CA--C 1.558 1.263 0 C-N-CA 123.829 0.852 . . . . 0.0 110.237 178.77 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 71.0 m -117.35 109.76 17.21 Favored 'General case' 0 N--CA 1.488 1.452 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.259 -157.85 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 6.6 tp -122.73 115.88 47.2 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 C-N-CA 123.834 0.854 . . . . 0.0 109.091 -179.105 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -123.53 129.58 74.57 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 C-N-CA 124.431 1.092 . . . . 0.0 109.29 178.76 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 15.1 t -133.89 156.97 47.14 Favored 'General case' 0 N--CA 1.493 1.693 0 CA-C-O 122.632 1.206 . . . . 0.0 111.34 169.532 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 19.3 tp -94.16 117.99 30.91 Favored 'General case' 0 N--CA 1.489 1.476 0 CA-C-N 114.726 -1.124 . . . . 0.0 110.558 -178.388 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -104.52 81.5 1.8 Allowed 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 123.231 0.612 . . . . 0.0 110.079 175.835 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 78.07 -74.92 1.96 Allowed Glycine 0 N--CA 1.487 2.1 0 CA-C-O 121.473 0.485 . . . . 0.0 113.832 -174.72 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -148.63 53.95 0.52 Allowed Glycine 0 CA--C 1.546 1.99 0 CA-C-N 114.425 -0.887 . . . . 0.0 112.885 167.451 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 38.7 mtmm -145.26 111.68 5.73 Favored 'General case' 0 N--CA 1.484 1.263 0 N-CA-C 106.682 -1.599 . . . . 0.0 106.682 -175.641 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 46.7 mt -82.4 96.35 7.94 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-O 122.757 1.265 . . . . 0.0 109.424 174.248 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 95.5 t -86.81 94.93 4.6 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.342 0 CA-C-N 113.029 -1.896 . . . . 0.0 105.936 -179.651 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 16.8 t-160 -98.89 147.95 24.43 Favored 'General case' 0 CA--C 1.559 1.319 0 C-N-CA 124.612 1.165 . . . . 0.0 109.608 179.209 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.414 HD11 ' HB2' ' A' ' 101' ' ' GLU . 23.2 tp -145.48 119.89 9.65 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 179.571 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 94.4 mt-30 -105.67 122.6 46.38 Favored 'General case' 0 N--CA 1.486 1.325 0 C-N-CA 124.707 1.203 . . . . 0.0 108.341 176.991 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 7.9 mtpm? -125.44 130.69 52.35 Favored 'General case' 0 N--CA 1.494 1.736 0 C-N-CA 123.023 0.529 . . . . 0.0 110.048 -170.779 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 19.2 p90 -153.34 112.85 3.83 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.67 -0.644 . . . . 0.0 110.091 -175.066 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 4.5 t70 51.93 53.73 12.07 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 116.552 2.056 . . . . 0.0 116.552 168.091 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 86.64 -40.66 3.07 Favored Glycine 0 CA--C 1.552 2.344 0 N-CA-C 117.387 1.715 . . . . 0.0 117.387 -171.473 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 19.2 mt-30 -85.31 137.39 33.0 Favored 'General case' 0 N--CA 1.49 1.562 0 CA-C-N 118.316 1.058 . . . . 0.0 111.168 -179.804 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.414 ' HB2' HD11 ' A' ' 94' ' ' LEU . 12.5 pt-20 -143.38 133.13 23.85 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 122.837 0.455 . . . . 0.0 111.727 -179.077 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 14.8 t -116.69 128.67 55.56 Favored 'General case' 0 N--CA 1.494 1.746 0 C-N-CA 123.108 0.563 . . . . 0.0 110.575 175.378 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 40.8 p -91.86 125.6 36.63 Favored 'General case' 0 N--CA 1.494 1.758 0 C-N-CA 122.965 0.506 . . . . 0.0 109.955 170.866 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 5.2 mp -105.63 82.1 1.76 Allowed 'General case' 0 CA--C 1.565 1.53 0 C-N-CA 124.187 0.995 . . . . 0.0 108.384 178.207 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 88.4 t -88.91 106.0 16.39 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 -172.153 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 74.8 mtt85 -97.88 117.53 32.4 Favored 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 123.137 0.575 . . . . 0.0 109.73 179.587 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -137.14 131.11 32.13 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 123.168 0.587 . . . . 0.0 111.185 -171.038 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -80.83 118.1 22.05 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.83 -0.544 . . . . 0.0 111.609 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 46.6 mm -125.47 101.85 9.21 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.28 0 N-CA-C 105.365 -2.087 . . . . 0.0 105.365 178.422 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 59.12 50.24 8.33 Favored 'General case' 0 N--CA 1.5 2.059 0 N-CA-C 115.408 1.633 . . . . 0.0 115.408 174.177 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 65.67 30.48 77.43 Favored Glycine 0 CA--C 1.555 2.556 0 N-CA-C 118.736 2.255 . . . . 0.0 118.736 -170.548 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -136.4 129.41 31.19 Favored 'General case' 0 N--CA 1.489 1.506 0 CA-C-N 118.458 1.129 . . . . 0.0 108.688 -176.914 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 12.2 tp -81.9 114.68 20.67 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 175.53 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 40.6 mm -104.74 100.04 9.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 N-CA-C 106.401 -1.703 . . . . 0.0 106.401 -174.882 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 38.6 tp -89.65 98.34 11.71 Favored 'General case' 0 CA--C 1.559 1.327 0 C-N-CA 123.657 0.783 . . . . 0.0 109.532 178.171 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 87.0 m -91.71 108.51 19.97 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 -178.771 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 87.7 mt -100.86 90.61 4.26 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 123.562 0.745 . . . . 0.0 109.467 -173.84 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 7.9 m -96.12 117.24 30.32 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.636 -0.665 . . . . 0.0 109.289 -173.489 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 83.4 t60 -127.57 91.02 3.22 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 168.99 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 73.1 -101.15 1.09 Allowed Glycine 0 N--CA 1.483 1.819 0 N-CA-C 114.49 0.556 . . . . 0.0 114.49 174.549 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 81.2 m -88.67 -54.52 4.12 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-O 118.486 -0.769 . . . . 0.0 112.045 175.62 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -85.1 106.36 16.51 Favored 'General case' 0 N--CA 1.484 1.246 0 CA-C-N 119.721 1.146 . . . . 0.0 112.256 -171.34 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 5.8 p -98.88 125.78 52.24 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 C-N-CA 123.83 0.852 . . . . 0.0 109.883 176.056 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 40.4 t -107.13 103.77 13.25 Favored 'General case' 0 CA--C 1.553 1.062 0 CA-C-O 121.41 0.624 . . . . 0.0 111.774 179.17 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 60.6 m -88.84 111.69 22.35 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 123.421 0.688 . . . . 0.0 109.187 179.587 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 22.3 mtp180 -106.11 111.86 24.66 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 -178.064 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 95.2 m -89.26 136.3 33.1 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 123.711 0.804 . . . . 0.0 109.98 -179.725 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 65.7 m-85 -132.07 132.68 43.55 Favored 'General case' 0 CA--C 1.56 1.361 0 C-N-CA 123.527 0.731 . . . . 0.0 110.259 -176.296 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -92.79 156.16 17.18 Favored 'General case' 0 N--CA 1.495 1.796 0 CA-C-O 122.249 1.023 . . . . 0.0 111.835 165.084 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 40.3 tttp -86.2 137.9 32.29 Favored 'General case' 0 N--CA 1.487 1.385 0 CA-C-N 115.528 -0.76 . . . . 0.0 112.817 -171.092 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -120.58 57.27 0.97 Allowed 'General case' 0 N--CA 1.494 1.733 0 C-N-CA 123.447 0.699 . . . . 0.0 111.952 171.137 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.437 0 CA-C-O 124.15 1.929 . . . . 0.0 112.444 -179.289 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 4.7 p . . . . . 0 CA--C 1.578 2.046 0 N-CA-C 115.675 1.732 . . . . 0.0 115.675 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -66.01 -48.39 71.3 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 117.231 2.308 . . . . 0.0 117.231 -173.401 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -55.84 -27.73 52.91 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 117.841 2.534 . . . . 0.0 117.841 171.09 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -68.61 -26.53 65.41 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 116.199 1.926 . . . . 0.0 116.199 167.642 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 40.6 mt -76.87 111.88 12.88 Favored 'General case' 0 N--CA 1.49 1.526 0 CA-C-N 120.78 1.627 . . . . 0.0 112.04 -168.768 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 164.63 176.05 35.99 Favored Glycine 0 CA--C 1.541 1.708 0 CA-C-O 122.706 1.17 . . . . 0.0 113.434 -173.938 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 63.3 m -90.0 140.22 29.85 Favored 'General case' 0 N--CA 1.493 1.699 0 CA-C-N 114.238 -0.981 . . . . 0.0 109.046 170.403 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 87.6 m95 -140.89 112.6 7.58 Favored 'General case' 0 N--CA 1.484 1.267 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 -174.044 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 8.6 mtpm? -96.67 146.04 25.23 Favored 'General case' 0 N--CA 1.495 1.789 0 CA-C-O 121.327 0.584 . . . . 0.0 110.273 174.833 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 23.8 tp -66.83 125.62 26.47 Favored 'General case' 0 N--CA 1.488 1.455 0 CA-C-O 121.89 0.853 . . . . 0.0 112.48 -177.062 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . 0.279 1.1 t -99.7 -47.93 11.87 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.795 0 CA-C-N 114.398 -1.274 . . . . 0.0 111.717 176.302 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -139.97 143.2 36.41 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-N 119.571 1.078 . . . . 0.0 109.67 177.528 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 78.5 p -126.09 94.07 3.99 Favored 'General case' 0 N--CA 1.49 1.526 0 CA-C-O 121.306 0.574 . . . . 0.0 110.486 169.067 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 57.5 tttp -83.22 119.49 24.62 Favored 'General case' 0 CA--C 1.557 1.243 0 C-N-CA 123.625 0.77 . . . . 0.0 109.71 175.528 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.259 24.5 m-20 73.45 26.47 1.99 Allowed 'General case' 0 N--CA 1.501 2.122 0 N-CA-C 116.736 2.125 . . . . 0.0 116.736 175.704 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.424 ' HD1' ' HG ' ' A' ' 124' ' ' CYS . 22.5 t80 -89.27 78.67 7.23 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.362 -1.461 . . . . 0.0 110.72 178.503 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -170.44 -58.03 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 125.0 1.32 . . . . 0.0 108.281 -176.576 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 29.0 t0 -54.45 -47.7 72.58 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 115.365 1.617 . . . . 0.0 115.365 166.9 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 92.3 t80 -49.3 -54.73 15.55 Favored 'General case' 0 CA--C 1.573 1.835 0 N-CA-C 115.133 1.531 . . . . 0.0 115.133 167.781 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 74.8 mtm -63.71 -41.17 98.14 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 116.01 1.855 . . . . 0.0 116.01 174.907 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 57.9 tttm -64.92 -43.28 93.34 Favored 'General case' 0 CA--C 1.567 1.626 0 N-CA-C 115.228 1.566 . . . . 0.0 115.228 173.432 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 60.9 m -59.97 -39.91 87.3 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 115.815 1.783 . . . . 0.0 115.815 169.837 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 64.9 mt -64.37 -30.84 71.87 Favored 'General case' 0 CA--C 1.566 1.568 0 N-CA-C 117.41 2.374 . . . . 0.0 117.41 168.587 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 91.32 75.92 1.31 Allowed Glycine 0 N--CA 1.482 1.722 0 CA-C-N 119.211 0.914 . . . . 0.0 111.978 -170.025 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 97.9 t -128.31 81.28 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 N-CA-C 106.643 -1.614 . . . . 0.0 106.643 -177.273 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 31.86 -118.51 0.13 Allowed Glycine 0 CA--C 1.55 2.273 0 N-CA-C 121.018 3.167 . . . . 0.0 121.018 174.361 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 10.7 t80 -148.43 -71.22 0.21 Allowed 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 178.485 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -72.69 -16.99 61.68 Favored 'General case' 0 CA--C 1.567 1.608 0 N-CA-C 116.615 2.08 . . . . 0.0 116.615 177.269 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 30.6 m -68.63 -42.63 77.75 Favored 'General case' 0 N--CA 1.497 1.904 0 CA-C-N 120.3 1.409 . . . . 0.0 113.495 162.76 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 37.1 ttp-105 -55.31 -44.64 75.97 Favored 'General case' 0 CA--C 1.571 1.787 0 N-CA-C 115.138 1.533 . . . . 0.0 115.138 164.64 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 5.9 tm0? -65.78 -52.33 51.74 Favored 'General case' 0 CA--C 1.565 1.547 0 N-CA-C 115.451 1.648 . . . . 0.0 115.451 174.38 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 92.6 t -66.1 -38.32 81.74 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.975 0 N-CA-C 113.583 0.957 . . . . 0.0 113.583 -179.602 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -65.68 -34.59 78.56 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 116.806 2.15 . . . . 0.0 116.806 175.755 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 88.4 p -67.63 -39.55 84.66 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 116.348 1.981 . . . . 0.0 116.348 167.01 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 38.3 ttm -64.65 -40.72 95.94 Favored 'General case' 0 CA--C 1.571 1.756 0 N-CA-C 115.87 1.804 . . . . 0.0 115.87 169.875 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 88.3 m -75.74 153.06 37.27 Favored 'General case' 0 CA--C 1.567 1.61 0 C-N-CA 124.276 1.031 . . . . 0.0 112.597 -177.015 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 64.0 mttp -102.91 100.06 15.66 Favored Pre-proline 0 CA--C 1.572 1.82 0 CA-C-N 115.405 -0.816 . . . . 0.0 109.735 172.268 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -82.36 113.62 2.36 Favored 'Trans proline' 0 CA--C 1.561 1.826 0 C-N-CA 123.36 2.707 . . . . 0.0 112.289 179.737 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 86.7 m -83.95 108.54 16.99 Favored 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 123.509 0.723 . . . . 0.0 110.67 -169.366 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 88.2 m -81.65 116.64 21.48 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 123.492 0.717 . . . . 0.0 109.808 -179.495 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 61.3 mt -115.56 107.87 23.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 N-CA-C 106.122 -1.807 . . . . 0.0 106.122 -176.584 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 22.8 mt -103.05 119.48 51.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 N-CA-C 107.653 -1.239 . . . . 0.0 107.653 -175.995 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -137.62 111.34 8.18 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 -169.889 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 60.4 tttm -86.46 114.56 23.32 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 123.369 0.668 . . . . 0.0 111.015 -179.306 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 33.5 t30 -115.87 82.47 1.77 Allowed 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 -179.481 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 61.23 59.53 9.84 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 116.411 1.324 . . . . 0.0 116.411 -174.876 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . 0.319 15.7 t0 68.92 -14.79 0.28 Allowed 'General case' 0 N--CA 1.498 1.946 0 N-CA-C 117.572 2.434 . . . . 0.0 117.572 -166.372 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 11.2 mm -87.72 98.96 8.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 CA-C-N 120.342 1.428 . . . . 0.0 107.631 -177.292 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 43.9 mt -80.21 107.31 12.9 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 123.523 0.729 . . . . 0.0 110.544 -178.41 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 30.6 m -97.48 94.56 7.09 Favored 'General case' 0 N--CA 1.485 1.292 0 N-CA-C 107.059 -1.46 . . . . 0.0 107.059 -175.059 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 9.7 tt -99.4 102.81 14.51 Favored 'General case' 0 N--CA 1.484 1.255 0 N-CA-C 108.007 -1.108 . . . . 0.0 108.007 -174.515 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 64.0 mttm -105.04 116.82 32.59 Favored 'General case' 0 N--CA 1.486 1.328 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 -173.973 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 89.1 m -100.55 92.05 4.95 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 -175.624 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 8.0 m170 -87.94 96.26 10.43 Favored 'General case' 0 N--CA 1.491 1.59 0 CA-C-O 122.373 1.083 . . . . 0.0 111.862 -169.676 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 28.1 t . . . . . 0 CA--C 1.561 1.385 0 CA-C-N 114.596 -1.184 . . . . 0.0 111.18 171.729 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 34.7 p-10 . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 121.093 0.473 . . . . 0.0 109.833 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 41.4 p -86.97 129.94 34.67 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-O 121.402 0.62 . . . . 0.0 111.028 -179.478 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -110.92 129.65 55.81 Favored 'General case' 0 N--CA 1.484 1.24 0 CA-C-N 115.127 -0.942 . . . . 0.0 109.416 178.763 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 41.5 pt -112.48 130.86 65.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 164.906 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 58.0 p -120.73 103.91 9.48 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 108.825 -0.805 . . . . 0.0 108.825 -177.81 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 45.7 p90 -138.8 133.67 32.39 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 114.052 1.131 . . . . 0.0 114.052 -158.829 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 56.4 mtmt -86.73 148.91 25.22 Favored 'General case' 0 CA--C 1.562 1.435 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.534 156.904 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -73.38 116.87 14.45 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.762 -0.586 . . . . 0.0 111.66 -174.602 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 90.69 45.19 4.34 Favored Glycine 0 CA--C 1.548 2.13 0 N-CA-C 116.515 1.366 . . . . 0.0 116.515 -167.352 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 96.3 t -135.4 122.25 34.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 N-CA-C 106.984 -1.487 . . . . 0.0 106.984 177.476 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -88.89 126.7 35.5 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 123.29 0.636 . . . . 0.0 110.386 170.334 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 43.0 p90 -139.62 133.06 30.15 Favored 'General case' 0 N--CA 1.494 1.766 0 C-N-CA 123.38 0.672 . . . . 0.0 111.172 -172.501 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -70.66 118.14 13.08 Favored 'General case' 0 CA--C 1.564 1.494 0 O-C-N 121.621 -0.675 . . . . 0.0 112.343 175.77 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 15.9 tp10 -125.72 136.44 53.19 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 123.775 0.83 . . . . 0.0 109.967 -170.324 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 57.8 m -91.24 123.46 34.7 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 174.461 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 31.7 p -82.48 170.68 14.97 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 113.056 0.762 . . . . 0.0 113.056 -175.695 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -53.28 -30.66 39.75 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 118.665 2.839 . . . . 0.0 118.665 173.078 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -78.7 -85.85 0.07 Allowed 'General case' 0 N--CA 1.489 1.488 0 CA-C-N 119.387 0.994 . . . . 0.0 109.23 168.261 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 179.01 82.86 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 168.634 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 22.0 mtm180 -140.22 124.81 18.05 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.847 -0.533 . . . . 0.0 109.92 -174.889 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.89 116.19 13.1 Favored 'General case' 0 CA--C 1.564 1.482 0 C-N-CA 123.63 0.772 . . . . 0.0 111.121 165.592 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 17.8 m -134.26 129.56 53.54 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 -170.246 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 46.2 mmtm -83.37 104.42 13.51 Favored 'General case' 0 N--CA 1.49 1.526 0 CA-C-O 121.759 0.79 . . . . 0.0 110.152 -178.076 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 75.2 m -101.24 95.86 6.81 Favored 'General case' 0 N--CA 1.484 1.238 0 CA-C-N 115.064 -0.971 . . . . 0.0 110.702 -162.954 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 7.2 tp -103.19 121.58 54.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 179.606 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 1.9 p -142.22 123.44 12.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 C-N-CA 123.171 0.589 . . . . 0.0 109.95 -172.085 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 15.1 t -136.96 159.72 41.03 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-O 122.579 1.18 . . . . 0.0 110.92 178.42 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 14.7 tp -90.54 111.17 22.36 Favored 'General case' 0 CA--C 1.562 1.437 0 CA-C-N 115.084 -0.962 . . . . 0.0 109.505 174.855 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -101.69 88.01 3.3 Favored 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 123.678 0.791 . . . . 0.0 109.793 -179.507 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 58.26 47.43 89.56 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 118.07 1.988 . . . . 0.0 118.07 -177.948 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 74.91 28.0 63.54 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 118.695 2.238 . . . . 0.0 118.695 -168.048 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 21.3 ttmm -134.51 116.7 15.39 Favored 'General case' 0 CA--C 1.552 1.044 0 N-CA-C 106.523 -1.658 . . . . 0.0 106.523 179.782 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 3.8 tt -86.45 97.98 10.77 Favored 'General case' 0 CA--C 1.563 1.475 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 -172.871 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 56.1 t -105.7 109.15 26.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 -165.097 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 23.6 t-160 -110.2 136.36 49.54 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 124.071 0.948 . . . . 0.0 109.905 179.638 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 30.3 tp -130.53 121.22 25.33 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 173.755 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 87.3 mt-30 -108.46 118.11 35.91 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 175.61 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 17.5 ptpt -121.76 134.9 54.93 Favored 'General case' 0 N--CA 1.496 1.849 0 CA-C-N 118.472 0.578 . . . . 0.0 111.933 -172.697 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 18.0 p90 -158.21 109.94 2.25 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 123.465 0.706 . . . . 0.0 109.897 -176.638 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 6.4 t70 53.44 54.11 10.61 Favored 'General case' 0 N--CA 1.501 2.077 0 N-CA-C 116.625 2.083 . . . . 0.0 116.625 164.236 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 87.96 -42.75 3.11 Favored Glycine 0 CA--C 1.552 2.35 0 N-CA-C 116.937 1.535 . . . . 0.0 116.937 -170.71 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 16.6 mt-30 -86.4 131.26 34.24 Favored 'General case' 0 N--CA 1.487 1.404 0 CA-C-N 118.086 0.943 . . . . 0.0 110.84 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -141.79 126.37 17.88 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 122.96 0.504 . . . . 0.0 110.36 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 1.4 t -121.07 124.07 43.89 Favored 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 123.528 0.731 . . . . 0.0 110.302 -175.032 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 40.1 p -97.76 141.96 30.13 Favored 'General case' 0 N--CA 1.492 1.648 0 CA-C-O 121.499 0.666 . . . . 0.0 111.738 179.764 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 5.6 mp -119.75 80.68 1.62 Allowed 'General case' 0 CA--C 1.564 1.494 0 N-CA-C 107.672 -1.233 . . . . 0.0 107.672 175.571 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 95.7 t -90.83 111.16 23.22 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 -172.464 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 83.7 mtt85 -104.63 130.21 52.66 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 123.292 0.637 . . . . 0.0 110.211 -177.383 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -145.94 129.26 16.78 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 123.167 0.587 . . . . 0.0 110.546 -174.095 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -79.71 116.8 20.1 Favored 'General case' 0 N--CA 1.488 1.469 0 CA-C-O 121.273 0.559 . . . . 0.0 111.108 177.117 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 48.9 mm -120.05 100.18 8.91 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.332 0 N-CA-C 105.485 -2.043 . . . . 0.0 105.485 177.72 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 57.38 49.78 12.5 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 114.915 1.45 . . . . 0.0 114.915 174.101 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 89.51 -38.61 3.19 Favored Glycine 0 CA--C 1.553 2.465 0 N-CA-C 117.572 1.789 . . . . 0.0 117.572 -169.019 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 54.0 mttm -82.64 132.79 35.18 Favored 'General case' 0 N--CA 1.488 1.448 0 CA-C-N 118.583 1.192 . . . . 0.0 112.075 -171.192 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 20.8 tp -81.66 112.66 19.05 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 172.68 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 37.6 mm -99.77 102.49 13.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 N-CA-C 106.732 -1.581 . . . . 0.0 106.732 -178.12 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 22.6 tp -90.43 102.73 15.46 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 123.815 0.846 . . . . 0.0 109.22 174.57 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 66.9 m -91.47 112.87 24.96 Favored 'General case' 0 CA--C 1.562 1.432 0 C-N-CA 124.181 0.992 . . . . 0.0 108.354 179.324 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 88.3 mt -104.61 87.34 2.67 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 123.746 0.818 . . . . 0.0 109.985 -171.819 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 9.9 m -103.17 112.51 25.41 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.727 -0.608 . . . . 0.0 109.576 -174.134 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 54.9 t60 -108.74 86.96 2.38 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 164.001 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 71.16 -101.54 0.97 Allowed Glycine 0 N--CA 1.483 1.795 0 N-CA-C 114.416 0.526 . . . . 0.0 114.416 179.461 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 61.2 m -87.19 -51.34 6.04 Favored 'General case' 0 CA--C 1.566 1.595 0 C-N-CA 123.653 0.781 . . . . 0.0 112.678 176.853 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -77.73 107.48 10.26 Favored 'General case' 0 N--CA 1.484 1.274 0 CA-C-N 119.756 1.162 . . . . 0.0 112.886 -173.641 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 4.7 p -107.68 124.18 63.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 C-N-CA 123.954 0.901 . . . . 0.0 110.37 -178.627 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' CYS . . . . . 0.424 ' HG ' ' HD1' ' A' ' 16' ' ' PHE . 2.7 t -101.25 108.57 20.25 Favored 'General case' 0 CA--C 1.556 1.188 0 C-N-CA 123.449 0.699 . . . . 0.0 110.614 173.134 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 53.5 m -89.2 111.06 21.76 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 177.925 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 36.1 mtt180 -108.06 117.23 33.58 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 123.187 0.595 . . . . 0.0 110.874 -179.296 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 86.0 m -88.91 134.34 33.99 Favored 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 123.53 0.732 . . . . 0.0 109.585 172.447 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 48.1 m-85 -128.58 135.62 49.61 Favored 'General case' 0 CA--C 1.559 1.308 0 C-N-CA 123.95 0.9 . . . . 0.0 109.371 179.127 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -100.99 154.0 19.06 Favored 'General case' 0 N--CA 1.493 1.718 0 CA-C-O 122.6 1.191 . . . . 0.0 111.414 167.439 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 36.2 tttp -84.86 125.69 32.84 Favored 'General case' 0 N--CA 1.483 1.218 0 CA-C-N 114.956 -1.02 . . . . 0.0 112.209 -168.367 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 16.7 mm-40 -123.3 50.14 1.6 Allowed 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 124.237 1.015 . . . . 0.0 111.712 -175.158 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 0.811 0 CA-C-O 123.005 1.384 . . . . 0.0 110.639 -161.36 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.32 2.5 t . . . . . 0 N--CA 1.489 1.487 0 CA-C-O 118.051 -0.976 . . . . 0.0 112.995 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -62.12 -36.13 80.84 Favored 'General case' 0 N--CA 1.497 1.881 0 N-CA-C 116.154 1.909 . . . . 0.0 116.154 179.587 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -62.41 -32.32 73.14 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 116.858 2.17 . . . . 0.0 116.858 163.259 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 88.8 m-85 -67.69 -27.62 66.99 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 116.146 1.906 . . . . 0.0 116.146 168.319 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 60.0 mt -72.75 116.42 13.22 Favored 'General case' 0 N--CA 1.49 1.543 0 CA-C-N 121.291 1.86 . . . . 0.0 111.512 -172.953 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 159.48 177.17 32.33 Favored Glycine 0 CA--C 1.541 1.692 0 CA-C-O 122.138 0.854 . . . . 0.0 114.133 -176.091 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 52.3 m -94.61 135.46 36.04 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 174.986 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 92.6 m95 -134.7 113.13 11.37 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 -172.247 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 7.7 mtmp? -98.76 144.21 28.25 Favored 'General case' 0 N--CA 1.489 1.477 0 CA-C-O 121.978 0.894 . . . . 0.0 110.541 175.084 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 51.4 tp -68.71 133.64 48.69 Favored 'General case' 0 N--CA 1.486 1.359 0 CA-C-O 122.283 1.039 . . . . 0.0 112.496 -176.469 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . 0.28 1.1 t -110.74 -43.3 5.2 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.744 0 CA-C-N 113.697 -1.592 . . . . 0.0 111.718 -178.411 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 41.8 t0 -143.78 131.89 21.79 Favored 'General case' 0 N--CA 1.49 1.525 0 CA-C-N 120.102 1.319 . . . . 0.0 109.63 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 86.4 p -112.93 96.83 6.16 Favored 'General case' 0 N--CA 1.492 1.663 0 CA-C-O 121.492 0.663 . . . . 0.0 110.366 171.93 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 43.7 mtmt -96.41 123.32 40.02 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 123.656 0.783 . . . . 0.0 108.92 -179.37 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 59.7 m-20 67.57 23.18 8.95 Favored 'General case' 0 N--CA 1.503 2.208 0 N-CA-C 117.532 2.419 . . . . 0.0 117.532 178.578 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 27.3 t80 -68.22 -51.75 41.9 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 120.155 -1.591 . . . . 0.0 113.981 -178.812 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -47.28 -36.19 8.86 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 117.542 2.423 . . . . 0.0 117.542 165.736 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 33.9 t0 -66.06 -55.49 16.33 Favored 'General case' 0 N--CA 1.499 2.021 0 CA-C-N 120.483 1.492 . . . . 0.0 114.245 172.232 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 71.6 t80 -48.22 -48.01 35.34 Favored 'General case' 0 CA--C 1.573 1.845 0 N-CA-C 116.135 1.902 . . . . 0.0 116.135 167.465 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 51.4 mmm -68.23 -46.03 71.67 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 114.84 1.422 . . . . 0.0 114.84 178.691 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -54.91 -46.34 74.84 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 115.533 1.679 . . . . 0.0 115.533 166.2 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 64.6 m -60.54 -38.55 84.85 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 116.199 1.926 . . . . 0.0 116.199 172.88 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 62.5 mt -63.06 -41.17 99.41 Favored 'General case' 0 CA--C 1.567 1.632 0 N-CA-C 115.78 1.771 . . . . 0.0 115.78 168.337 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 114.39 73.17 0.57 Allowed Glycine 0 N--CA 1.482 1.751 0 C-N-CA 123.899 0.762 . . . . 0.0 111.603 -176.192 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 57.3 t -140.36 121.82 14.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 N-CA-C 106.389 -1.708 . . . . 0.0 106.389 -173.772 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -72.18 170.69 49.68 Favored Glycine 0 CA--C 1.551 2.322 0 N-CA-C 116.414 1.326 . . . . 0.0 116.414 177.235 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . 0.25 33.0 p90 -57.47 -43.23 83.87 Favored 'General case' 0 N--CA 1.497 1.92 0 N-CA-C 118.92 2.933 . . . . 0.0 118.92 -167.515 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.36 -40.62 89.87 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 116.589 2.07 . . . . 0.0 116.589 178.75 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 94.7 m -71.52 -42.02 68.48 Favored 'General case' 0 N--CA 1.498 1.963 0 N-CA-C 113.792 1.034 . . . . 0.0 113.792 168.574 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 38.3 ttp180 -58.53 -38.91 78.75 Favored 'General case' 0 CA--C 1.569 1.708 0 N-CA-C 115.89 1.811 . . . . 0.0 115.89 173.879 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 51.4 mt-30 -81.66 -38.8 25.35 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 115.66 1.726 . . . . 0.0 115.66 176.71 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 46.9 t -73.11 -37.88 53.88 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.254 0 CA-C-N 121.381 1.901 . . . . 0.0 112.664 175.067 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -66.55 -31.37 72.05 Favored 'General case' 0 CA--C 1.567 1.601 0 N-CA-C 117.0 2.222 . . . . 0.0 117.0 170.462 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 85.9 p -67.0 -43.65 82.38 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 115.283 1.586 . . . . 0.0 115.283 164.257 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 49.6 ttm -64.73 -38.73 92.0 Favored 'General case' 0 CA--C 1.567 1.624 0 N-CA-C 116.49 2.033 . . . . 0.0 116.49 176.643 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 13.0 t -69.29 144.94 53.44 Favored 'General case' 0 N--CA 1.492 1.645 0 CA-C-N 119.432 1.014 . . . . 0.0 112.931 -179.417 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -102.69 103.16 30.85 Favored Pre-proline 0 CA--C 1.567 1.603 0 CA-C-O 118.201 -0.904 . . . . 0.0 108.802 176.009 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -72.96 119.78 6.26 Favored 'Trans proline' 0 CA--C 1.559 1.753 0 C-N-CA 123.052 2.501 . . . . 0.0 112.526 -179.244 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 95.7 m -84.58 99.59 10.85 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 179.859 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 86.9 m -97.37 104.53 16.56 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 -165.253 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 68.9 mt -100.5 112.69 33.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 N-CA-C 107.464 -1.31 . . . . 0.0 107.464 -174.45 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 35.8 mt -104.0 117.41 49.49 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 N-CA-C 107.121 -1.437 . . . . 0.0 107.121 179.548 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -141.43 119.42 11.97 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-O 121.078 0.466 . . . . 0.0 109.939 -170.154 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 56.3 tttm -91.84 121.95 33.92 Favored 'General case' 0 CA--C 1.56 1.347 0 C-N-CA 123.748 0.819 . . . . 0.0 111.802 -175.075 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 75.4 m-20 -116.61 92.16 3.79 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 -179.346 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 83.25 -92.95 1.68 Allowed Glycine 0 N--CA 1.486 1.998 0 O-C-N 121.774 -0.579 . . . . 0.0 111.776 -173.347 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -138.49 65.57 1.46 Allowed 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 155.808 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 33.9 mm -136.01 99.88 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 N-CA-C 105.258 -2.127 . . . . 0.0 105.258 -174.73 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 60.4 mt -81.45 102.09 10.31 Favored 'General case' 0 N--CA 1.486 1.342 0 CA-C-O 121.181 0.515 . . . . 0.0 110.482 -179.119 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 28.7 m -98.38 97.92 9.21 Favored 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 107.275 -1.379 . . . . 0.0 107.275 -173.301 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 10.4 tt -98.92 102.16 13.79 Favored 'General case' 0 N--CA 1.485 1.29 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 -177.402 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -98.77 111.5 23.86 Favored 'General case' 0 N--CA 1.484 1.25 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 -174.49 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 52.4 m -91.65 95.91 10.16 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 -179.366 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 23.1 m-70 -87.26 96.42 10.33 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 -176.556 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 37.4 t . . . . . 0 N--CA 1.484 1.227 0 C-N-CA 123.733 0.813 . . . . 0.0 109.96 -169.992 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 9.2 p30 . . . . . 0 N--CA 1.49 1.549 0 CA-C-O 120.333 0.111 . . . . 0.0 111.008 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 77.1 p -130.35 132.33 45.77 Favored 'General case' 0 N--CA 1.497 1.901 0 C-N-CA 123.091 0.556 . . . . 0.0 111.174 -169.561 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -117.89 130.55 56.31 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 123.784 0.833 . . . . 0.0 110.009 -176.433 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 39.1 pt -123.66 132.91 70.58 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 C-N-CA 123.456 0.703 . . . . 0.0 109.412 175.773 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 45.9 t -120.99 107.4 12.6 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 -176.669 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 49.0 p90 -136.42 136.73 39.8 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 115.204 1.557 . . . . 0.0 115.204 -159.435 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 50.5 mtmt -103.5 14.67 30.8 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 117.214 2.302 . . . . 0.0 117.214 -173.94 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . 0.295 3.3 mp 62.59 96.9 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.744 0 CA-C-N 120.648 1.567 . . . . 0.0 114.318 177.226 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 87.1 38.68 7.75 Favored Glycine 0 CA--C 1.55 2.28 0 N-CA-C 116.99 1.556 . . . . 0.0 116.99 -170.087 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 86.5 t -138.73 124.22 23.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 N-CA-C 106.839 -1.541 . . . . 0.0 106.839 -179.902 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -87.8 116.26 25.82 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 123.042 0.537 . . . . 0.0 109.961 171.936 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 45.0 p90 -125.43 131.8 52.84 Favored 'General case' 0 N--CA 1.491 1.624 0 C-N-CA 123.912 0.885 . . . . 0.0 109.851 -175.969 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -73.61 110.4 7.86 Favored 'General case' 0 CA--C 1.564 1.507 0 O-C-N 121.411 -0.806 . . . . 0.0 111.889 176.816 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 13.7 tp10 -106.41 132.94 51.84 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 124.115 0.966 . . . . 0.0 109.563 -174.441 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 52.2 m -96.96 117.59 31.49 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 174.255 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 20.3 p -84.9 166.83 16.5 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-O 121.664 0.745 . . . . 0.0 112.101 -174.704 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -67.36 -20.94 65.64 Favored 'General case' 0 CA--C 1.571 1.757 0 N-CA-C 117.677 2.473 . . . . 0.0 117.677 169.446 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -76.68 -0.24 22.84 Favored 'General case' 0 CA--C 1.581 2.137 0 N-CA-C 116.142 1.904 . . . . 0.0 116.142 160.536 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . 0.265 11.1 m-20 71.57 70.07 0.16 Allowed 'General case' 0 N--CA 1.495 1.811 0 C-N-CA 125.349 1.46 . . . . 0.0 111.729 -176.857 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 80.9 mtm180 -141.2 126.72 18.85 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 -175.302 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.57 97.17 8.9 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 123.37 0.668 . . . . 0.0 111.317 172.576 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 10.8 m -113.6 127.33 71.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 C-N-CA 123.165 0.586 . . . . 0.0 109.912 -168.268 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 29.9 mmtp -80.4 103.69 10.44 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 123.507 0.723 . . . . 0.0 110.118 179.632 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 70.8 m -100.21 95.84 7.07 Favored 'General case' 0 N--CA 1.483 1.198 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.947 -165.26 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 7.1 tp -107.71 113.84 44.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 177.35 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -130.4 128.12 63.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 C-N-CA 124.012 0.925 . . . . 0.0 109.129 -176.278 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 10.2 t -140.45 150.08 43.37 Favored 'General case' 0 N--CA 1.488 1.472 0 CA-C-O 122.719 1.247 . . . . 0.0 110.052 175.689 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 19.2 tp -85.07 114.18 22.02 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-N 114.616 -1.175 . . . . 0.0 109.321 176.501 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -101.63 81.09 2.12 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-O 121.239 0.542 . . . . 0.0 110.085 -178.562 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 57.07 45.14 92.74 Favored Glycine 0 N--CA 1.489 2.175 0 N-CA-C 118.016 1.967 . . . . 0.0 118.016 -177.127 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 102.87 -45.15 1.37 Allowed Glycine 0 N--CA 1.491 2.317 0 N-CA-C 116.481 1.352 . . . . 0.0 116.481 -165.993 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 83.6 tttt -81.33 106.81 13.59 Favored 'General case' 0 CA--C 1.559 1.3 0 C-N-CA 123.616 0.767 . . . . 0.0 110.87 -176.767 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 30.4 tp -82.52 114.59 21.03 Favored 'General case' 0 N--CA 1.484 1.232 0 CA-C-O 121.546 0.688 . . . . 0.0 110.948 -177.839 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 48.3 t -113.47 110.21 31.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 N-CA-C 106.72 -1.585 . . . . 0.0 106.72 -168.824 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 23.7 t-160 -106.2 142.46 35.84 Favored 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 124.113 0.965 . . . . 0.0 109.717 174.702 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 30.3 tp -131.74 122.81 26.47 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 174.441 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 81.9 mt-30 -115.41 105.61 13.04 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 176.089 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 71.0 mttt -107.36 135.69 48.43 Favored 'General case' 0 N--CA 1.495 1.782 0 C-N-CA 123.43 0.692 . . . . 0.0 111.656 -177.674 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 18.3 p90 -150.42 111.23 4.29 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 123.346 0.658 . . . . 0.0 109.946 178.926 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 4.8 t70 50.56 57.85 6.16 Favored 'General case' 0 N--CA 1.497 1.894 0 N-CA-C 116.304 1.965 . . . . 0.0 116.304 166.578 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 91.26 -44.8 2.8 Favored Glycine 0 CA--C 1.55 2.267 0 N-CA-C 116.789 1.476 . . . . 0.0 116.789 -171.62 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 19.6 mt-30 -92.34 134.72 34.65 Favored 'General case' 0 N--CA 1.489 1.52 0 CA-C-N 118.234 1.017 . . . . 0.0 111.577 -174.036 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -113.53 157.8 21.56 Favored 'General case' 0 N--CA 1.491 1.62 0 CA-C-O 121.612 0.72 . . . . 0.0 112.028 172.775 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 14.6 t -140.78 120.27 13.19 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 158.604 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 39.9 p -90.62 125.36 35.61 Favored 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 122.661 0.385 . . . . 0.0 110.519 172.15 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 5.5 mp -102.06 80.52 2.0 Allowed 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 177.57 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 71.1 t -88.69 105.71 16.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 -170.941 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 83.8 mtt85 -103.5 123.34 46.71 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 123.536 0.734 . . . . 0.0 109.742 -176.653 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -144.46 131.45 20.41 Favored 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 122.805 0.442 . . . . 0.0 110.974 -172.023 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -81.12 116.0 20.82 Favored 'General case' 0 N--CA 1.487 1.405 0 CA-C-O 121.281 0.562 . . . . 0.0 111.327 -179.131 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 86.1 mt -123.88 107.1 18.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 N-CA-C 104.66 -2.348 . . . . 0.0 104.66 176.518 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 58.4 50.48 9.37 Favored 'General case' 0 N--CA 1.5 2.029 0 N-CA-C 114.945 1.461 . . . . 0.0 114.945 176.925 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 66.91 18.13 68.3 Favored Glycine 0 CA--C 1.554 2.516 0 N-CA-C 119.758 2.663 . . . . 0.0 119.758 -171.833 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 38.8 mtmm -126.78 131.3 51.31 Favored 'General case' 0 N--CA 1.489 1.486 0 CA-C-N 119.981 1.891 . . . . 0.0 109.106 -173.626 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 14.1 tp -79.22 107.59 12.1 Favored 'General case' 0 CA--C 1.558 1.255 0 C-N-CA 123.334 0.654 . . . . 0.0 109.38 178.124 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 33.6 mm -99.54 100.41 10.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 N-CA-C 106.569 -1.641 . . . . 0.0 106.569 -175.255 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 29.8 tp -92.12 99.85 12.58 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 124.16 0.984 . . . . 0.0 109.647 178.234 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 1.8 p -86.84 114.67 23.69 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 123.689 0.796 . . . . 0.0 109.589 171.839 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 85.1 mt -101.96 89.05 3.51 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 123.971 0.908 . . . . 0.0 108.979 -176.36 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 7.6 m -100.4 108.93 21.06 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 108.798 -0.815 . . . . 0.0 108.798 -171.682 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 2.2 t60 -76.86 -63.31 1.38 Allowed 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 122.454 0.301 . . . . 0.0 111.348 167.578 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -165.37 -76.47 0.03 OUTLIER Glycine 0 N--CA 1.479 1.543 0 N-CA-C 109.499 -1.441 . . . . 0.0 109.499 178.699 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 72.9 m -73.28 -54.42 8.45 Favored 'General case' 0 CA--C 1.568 1.668 0 CA-C-O 118.693 -0.67 . . . . 0.0 112.787 169.884 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -97.4 112.62 24.38 Favored 'General case' 0 N--CA 1.483 1.207 0 CA-C-N 119.405 1.002 . . . . 0.0 112.552 -172.505 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 6.0 p -95.91 127.63 47.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 C-N-CA 123.825 0.85 . . . . 0.0 110.058 169.187 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 44.0 t -100.81 108.1 19.81 Favored 'General case' 0 N--CA 1.481 1.102 0 CA-C-O 121.062 0.458 . . . . 0.0 111.261 171.428 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 47.8 m -84.48 112.06 20.04 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 176.413 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 37.6 mtt180 -104.29 116.0 31.39 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 123.259 0.624 . . . . 0.0 110.114 175.045 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 92.9 m -90.09 129.32 36.4 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 173.848 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 58.7 m-85 -124.93 129.67 50.83 Favored 'General case' 0 CA--C 1.559 1.29 0 C-N-CA 123.546 0.738 . . . . 0.0 109.283 179.081 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -94.54 154.28 17.47 Favored 'General case' 0 N--CA 1.494 1.757 0 CA-C-O 122.326 1.06 . . . . 0.0 111.347 167.147 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 70.9 tttt -86.01 116.37 24.19 Favored 'General case' 0 N--CA 1.484 1.25 0 CA-C-N 115.554 -0.748 . . . . 0.0 112.059 -167.904 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 50.2 tp10 -75.03 -40.95 60.19 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 116.666 2.098 . . . . 0.0 116.666 172.88 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.97 0 CA-C-O 124.287 1.994 . . . . 0.0 107.882 173.749 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.251 4.0 p . . . . . 0 CA--C 1.576 1.971 0 N-CA-C 115.18 1.548 . . . . 0.0 115.18 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -77.5 -36.95 52.08 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 115.825 1.787 . . . . 0.0 115.825 -174.345 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -58.3 -24.49 59.75 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 117.714 2.487 . . . . 0.0 117.714 167.054 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -72.46 -19.46 61.56 Favored 'General case' 0 CA--C 1.566 1.566 0 N-CA-C 116.377 1.991 . . . . 0.0 116.377 168.833 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 44.4 mt -81.16 121.74 26.5 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-N 121.228 1.831 . . . . 0.0 111.554 -171.517 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 159.43 -177.23 36.04 Favored Glycine 0 N--CA 1.484 1.88 0 CA-C-O 121.9 0.722 . . . . 0.0 113.583 -179.159 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 63.7 m -92.11 139.79 30.28 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 170.702 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 90.2 m95 -141.19 109.5 5.88 Favored 'General case' 0 N--CA 1.487 1.381 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 -171.391 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 55.8 mttp -100.7 141.52 33.45 Favored 'General case' 0 N--CA 1.49 1.542 0 CA-C-O 121.222 0.534 . . . . 0.0 109.941 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 58.1 tp -68.08 123.01 19.46 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-O 122.178 0.99 . . . . 0.0 112.167 -175.135 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . 0.27 1.0 OUTLIER -103.5 -41.65 7.43 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.751 0 CA-C-N 113.9 -1.5 . . . . 0.0 112.737 -175.337 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -145.85 133.47 20.97 Favored 'General case' 0 N--CA 1.488 1.454 0 CA-C-N 119.922 1.237 . . . . 0.0 108.948 178.1 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 88.7 p -115.54 101.15 8.61 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 122.976 0.51 . . . . 0.0 110.662 175.021 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 59.2 mtpt -87.12 118.33 26.45 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 174.519 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 60.8 m-20 66.55 29.97 8.71 Favored 'General case' 0 N--CA 1.502 2.134 0 N-CA-C 117.173 2.286 . . . . 0.0 117.173 177.069 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.472 ' HB2' ' SG ' ' A' ' 124' ' ' CYS . 18.0 t80 -89.57 69.51 7.85 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 120.235 -1.54 . . . . 0.0 111.857 178.808 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 26.8 m-20 -162.61 -54.22 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 125.684 1.594 . . . . 0.0 108.044 -177.457 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 21.1 t0 -56.61 -45.27 81.56 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 115.422 1.638 . . . . 0.0 115.422 167.387 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 81.6 t80 -51.98 -54.43 29.89 Favored 'General case' 0 CA--C 1.57 1.716 0 N-CA-C 114.787 1.403 . . . . 0.0 114.787 169.849 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 70.4 mtm -63.98 -46.13 85.97 Favored 'General case' 0 N--CA 1.491 1.575 0 N-CA-C 115.539 1.681 . . . . 0.0 115.539 174.995 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -57.86 -44.99 86.92 Favored 'General case' 0 CA--C 1.57 1.713 0 N-CA-C 115.5 1.667 . . . . 0.0 115.5 173.582 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 23.3 t -61.51 -37.27 83.11 Favored 'General case' 0 CA--C 1.568 1.645 0 N-CA-C 116.367 1.988 . . . . 0.0 116.367 170.275 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 69.2 mt -64.79 -23.31 67.2 Favored 'General case' 0 CA--C 1.568 1.657 0 N-CA-C 117.96 2.578 . . . . 0.0 117.96 169.24 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 99.49 68.61 0.89 Allowed Glycine 0 N--CA 1.482 1.746 0 CA-C-N 119.416 1.007 . . . . 0.0 112.193 -171.156 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 33.8 t -144.95 112.66 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 N-CA-C 104.375 -2.454 . . . . 0.0 104.375 -177.842 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -70.83 -91.99 0.08 OUTLIER Glycine 0 N--CA 1.486 2.015 0 N-CA-C 117.676 1.83 . . . . 0.0 117.676 -160.763 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . 0.279 40.4 p90 -140.07 -60.91 0.53 Allowed 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 112.977 0.732 . . . . 0.0 112.977 -171.328 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.51 -39.91 92.39 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 115.575 1.695 . . . . 0.0 115.575 172.221 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 71.9 m -71.38 -37.44 71.59 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 113.961 1.097 . . . . 0.0 113.961 171.355 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 66.4 ttp85 -62.22 -42.79 99.63 Favored 'General case' 0 CA--C 1.572 1.795 0 N-CA-C 114.961 1.467 . . . . 0.0 114.961 170.117 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 9.5 tm0? -65.31 -49.87 67.83 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 114.497 1.295 . . . . 0.0 114.497 172.061 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 93.5 t -64.87 -36.68 78.29 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.925 0 CA-C-N 119.489 1.041 . . . . 0.0 113.762 177.72 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -64.6 -37.03 86.16 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 116.94 2.2 . . . . 0.0 116.94 172.688 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 96.6 p -67.65 -40.41 84.52 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 115.675 1.732 . . . . 0.0 115.675 165.839 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 48.9 ttp -69.35 -35.69 76.12 Favored 'General case' 0 CA--C 1.567 1.622 0 N-CA-C 116.979 2.214 . . . . 0.0 116.979 176.033 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 8.3 t -63.49 -31.4 72.55 Favored 'General case' 0 N--CA 1.498 1.965 0 N-CA-C 118.488 2.773 . . . . 0.0 118.488 -167.501 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . 0.261 34.2 ttpt 75.25 90.37 0.06 OUTLIER Pre-proline 0 CA--C 1.573 1.833 0 C-N-CA 124.832 1.253 . . . . 0.0 112.128 177.285 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -72.62 125.32 10.49 Favored 'Trans proline' 0 C--N 1.369 1.634 0 C-N-CA 123.292 2.661 . . . . 0.0 114.501 -176.944 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 97.9 m -97.06 92.71 6.19 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 -179.185 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 57.4 m -86.19 110.32 19.51 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 123.12 0.568 . . . . 0.0 110.099 -173.598 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 95.1 mt -101.64 110.31 28.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 N-CA-C 106.811 -1.552 . . . . 0.0 106.811 178.609 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 59.3 mt -100.48 116.19 43.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 -179.143 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 4.5 tm-20 -136.63 110.95 8.44 Favored 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 -171.506 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 81.7 tttt -95.0 113.24 24.92 Favored 'General case' 0 CA--C 1.554 1.126 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 171.848 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 14.6 t-20 -82.2 -58.65 2.86 Favored 'General case' 0 CA--C 1.564 1.511 0 C-N-CA 123.243 0.617 . . . . 0.0 112.478 -178.083 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -132.63 -95.55 0.6 Allowed Glycine 0 N--CA 1.483 1.816 0 N-CA-C 109.18 -1.568 . . . . 0.0 109.18 169.45 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -79.8 -30.9 40.68 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 114.917 1.451 . . . . 0.0 114.917 163.398 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 39.8 mm -77.93 111.85 15.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 CA-C-N 119.311 0.96 . . . . 0.0 109.507 -175.047 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 2.0 mt -78.72 137.95 38.02 Favored 'General case' 0 CA--C 1.561 1.376 0 C-N-CA 123.254 0.622 . . . . 0.0 110.379 160.965 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 10.7 m -133.72 103.43 5.87 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 -177.438 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 9.1 tt -96.7 112.31 24.11 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 107.358 -1.349 . . . . 0.0 107.358 177.095 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 89.4 mttt -112.87 98.88 7.47 Favored 'General case' 0 N--CA 1.485 1.285 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 -164.676 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 28.4 m -87.98 95.14 10.01 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.327 -0.858 . . . . 0.0 109.22 -174.467 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 77.8 m80 -85.03 28.83 0.68 Allowed 'General case' 0 CA--C 1.573 1.84 0 N-CA-C 116.59 2.07 . . . . 0.0 116.59 -173.273 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . 0.271 17.5 m . . . . . 0 CA--C 1.553 1.081 0 N-CA-C 105.29 -2.115 . . . . 0.0 105.29 153.138 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 42.9 m-20 . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 120.997 0.427 . . . . 0.0 111.787 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 40.4 p -105.2 133.78 49.4 Favored 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 123.532 0.733 . . . . 0.0 110.448 -174.158 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -122.48 122.14 38.24 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 123.344 0.658 . . . . 0.0 109.367 179.517 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 39.2 pt -93.64 136.26 25.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 C-N-CA 123.174 0.59 . . . . 0.0 109.587 163.927 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 33.0 t -125.02 116.69 22.53 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 173.655 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 41.2 p90 -149.4 148.18 29.16 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 113.837 1.051 . . . . 0.0 113.837 -153.992 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 62.7 mtpt -111.99 18.89 18.38 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 116.959 2.207 . . . . 0.0 116.959 -171.494 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . 0.28 1.5 mp 57.11 83.86 0.1 Allowed 'General case' 0 N--CA 1.495 1.802 0 CA-C-N 120.74 1.609 . . . . 0.0 114.532 177.678 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 98.02 42.9 2.95 Favored Glycine 0 CA--C 1.548 2.146 0 N-CA-C 116.221 1.248 . . . . 0.0 116.221 -171.429 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 70.8 t -145.08 127.72 10.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 N-CA-C 105.752 -1.944 . . . . 0.0 105.752 -178.964 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -87.25 116.72 25.53 Favored 'General case' 0 CA--C 1.566 1.566 0 CA-C-O 121.634 0.731 . . . . 0.0 110.129 173.079 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 25.4 p90 -114.91 -172.83 2.2 Favored 'General case' 0 N--CA 1.494 1.745 0 C-N-CA 124.796 1.238 . . . . 0.0 109.733 171.89 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -117.05 145.13 43.91 Favored 'General case' 0 N--CA 1.487 1.401 0 CA-C-O 123.25 1.5 . . . . 0.0 110.846 168.962 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 52.2 tp10 -129.34 148.15 51.24 Favored 'General case' 0 N--CA 1.488 1.456 0 CA-C-N 112.804 -1.998 . . . . 0.0 109.928 177.319 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 83.4 m -103.85 124.25 48.6 Favored 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 168.433 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 28.4 p -75.64 168.06 20.72 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-O 121.579 0.704 . . . . 0.0 112.851 -176.536 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -59.62 -29.41 67.99 Favored 'General case' 0 CA--C 1.563 1.454 0 N-CA-C 117.827 2.529 . . . . 0.0 117.827 178.748 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 62.5 m-20 -116.11 67.24 0.71 Allowed 'General case' 0 N--CA 1.491 1.625 0 CA-C-N 119.121 0.873 . . . . 0.0 110.491 165.982 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 47.06 72.46 0.24 Allowed 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 117.595 2.442 . . . . 0.0 117.595 164.84 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 63.1 mtm-85 -139.68 123.52 17.55 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 171.037 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -71.32 122.57 20.53 Favored 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 123.1 0.56 . . . . 0.0 110.505 164.3 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 32.8 m -138.92 135.09 42.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 -169.818 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 30.5 mmmt -82.17 101.02 10.17 Favored 'General case' 0 N--CA 1.488 1.434 0 CA-C-O 122.418 1.104 . . . . 0.0 110.224 178.267 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 22.4 p -93.1 107.14 18.99 Favored 'General case' 0 CA--C 1.555 1.164 0 CA-C-N 114.117 -1.401 . . . . 0.0 111.821 -170.637 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -113.33 121.26 65.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 174.424 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 1.1 p -131.76 130.42 61.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 C-N-CA 123.921 0.888 . . . . 0.0 109.598 -178.623 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 9.0 t -145.19 153.66 41.59 Favored 'General case' 0 N--CA 1.486 1.356 0 CA-C-O 122.942 1.353 . . . . 0.0 110.407 179.044 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 44.2 tp -86.42 123.58 31.81 Favored 'General case' 0 CA--C 1.562 1.438 0 CA-C-N 114.402 -1.272 . . . . 0.0 110.333 177.68 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -104.93 76.54 1.26 Allowed 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 123.54 0.736 . . . . 0.0 110.581 176.161 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 75.1 -76.4 1.24 Allowed Glycine 0 N--CA 1.487 2.069 0 N-CA-C 114.246 0.458 . . . . 0.0 114.246 -176.551 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -142.91 45.91 0.88 Allowed Glycine 0 CA--C 1.549 2.165 0 CA-C-N 114.428 -0.886 . . . . 0.0 114.293 167.043 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 56.3 mtpt -138.33 118.71 13.74 Favored 'General case' 0 N--CA 1.484 1.237 0 N-CA-C 105.593 -2.002 . . . . 0.0 105.593 178.115 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 4.4 tt -87.94 100.5 12.94 Favored 'General case' 0 CA--C 1.561 1.366 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 -178.482 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 78.6 t -106.33 102.28 13.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 N-CA-C 107.397 -1.334 . . . . 0.0 107.397 -164.466 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 20.5 t-160 -99.97 144.9 28.48 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 123.842 0.857 . . . . 0.0 110.329 173.942 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 17.8 tp -145.1 125.89 14.32 Favored 'General case' 0 N--CA 1.488 1.426 0 CA-C-O 122.035 0.921 . . . . 0.0 108.551 176.452 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 29.8 mt-30 -113.84 118.38 34.09 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 124.53 1.132 . . . . 0.0 108.615 -177.337 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -116.94 136.59 52.83 Favored 'General case' 0 N--CA 1.495 1.792 0 C-N-CA 123.26 0.624 . . . . 0.0 111.244 -173.351 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 16.7 p90 -153.59 111.02 3.49 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.231 -0.918 . . . . 0.0 110.64 -178.763 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 4.8 t70 55.07 55.0 8.14 Favored 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 116.009 1.855 . . . . 0.0 116.009 166.943 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 86.08 -45.76 3.52 Favored Glycine 0 CA--C 1.552 2.355 0 N-CA-C 116.389 1.316 . . . . 0.0 116.389 -168.951 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 25.4 mt-30 -78.09 149.97 33.81 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 123.547 0.739 . . . . 0.0 112.298 -178.905 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -150.07 150.49 31.8 Favored 'General case' 0 N--CA 1.488 1.451 0 CA-C-O 121.323 0.582 . . . . 0.0 111.735 175.983 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 14.2 t -128.47 124.95 37.44 Favored 'General case' 0 N--CA 1.49 1.56 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.353 170.189 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 36.1 p -85.99 134.19 33.88 Favored 'General case' 0 N--CA 1.492 1.665 0 CA-C-O 121.606 0.717 . . . . 0.0 110.251 168.032 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 5.2 mp -116.74 86.03 2.43 Favored 'General case' 0 CA--C 1.562 1.404 0 N-CA-C 106.727 -1.583 . . . . 0.0 106.727 176.159 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 52.1 t -94.22 100.11 10.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.775 0 N-CA-C 107.742 -1.206 . . . . 0.0 107.742 -170.076 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 20.0 mmt180 -90.0 126.27 35.69 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 123.929 0.891 . . . . 0.0 109.915 178.14 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -150.76 131.15 13.73 Favored 'General case' 0 N--CA 1.494 1.76 0 C-N-CA 122.605 0.362 . . . . 0.0 111.938 -172.016 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -77.69 117.53 19.19 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.5 -0.75 . . . . 0.0 111.403 175.378 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 84.3 mt -125.17 105.6 15.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 N-CA-C 104.764 -2.31 . . . . 0.0 104.764 176.653 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 57.16 53.73 7.53 Favored 'General case' 0 N--CA 1.499 1.978 0 N-CA-C 114.246 1.202 . . . . 0.0 114.246 177.63 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 79.65 -27.45 2.55 Favored Glycine 0 CA--C 1.555 2.574 0 N-CA-C 119.097 2.399 . . . . 0.0 119.097 -169.389 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 38.4 mtmm -102.28 131.61 48.75 Favored 'General case' 0 N--CA 1.486 1.336 0 CA-C-N 119.497 1.648 . . . . 0.0 110.214 -164.16 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 49.0 tp -83.98 114.21 21.54 Favored 'General case' 0 CA--C 1.556 1.195 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.797 -176.2 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 33.3 mm -102.88 108.82 25.11 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 -171.99 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 53.5 tp -89.16 111.06 21.75 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 123.9 0.88 . . . . 0.0 109.298 172.905 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 90.0 m -101.68 110.6 22.62 Favored 'General case' 0 N--CA 1.494 1.725 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 -179.421 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 97.7 mt -104.01 91.18 3.85 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 123.726 0.811 . . . . 0.0 110.227 -172.439 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 7.4 m -107.78 105.4 15.22 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 -175.864 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 16.7 t60 -83.07 -64.3 1.2 Allowed 'General case' 0 N--CA 1.493 1.684 0 C-N-CA 123.176 0.591 . . . . 0.0 111.631 172.3 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -152.2 -89.88 0.07 OUTLIER Glycine 0 N--CA 1.479 1.524 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 174.081 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 12.0 t -92.13 41.16 1.06 Allowed 'General case' 0 CA--C 1.577 1.995 0 N-CA-C 114.369 1.248 . . . . 0.0 114.369 169.825 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -158.86 97.69 1.43 Allowed 'General case' 0 N--CA 1.485 1.278 0 O-C-N 120.874 -1.141 . . . . 0.0 109.45 175.419 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 4.0 p -97.01 120.34 46.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 C-N-CA 123.842 0.857 . . . . 0.0 109.409 172.763 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 124' ' ' CYS . . . . . 0.472 ' SG ' ' HB2' ' A' ' 16' ' ' PHE . 41.4 t -112.03 102.87 11.06 Favored 'General case' 0 CA--C 1.557 1.214 0 CA-C-O 121.448 0.642 . . . . 0.0 110.943 177.966 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 90.5 m -92.43 110.19 21.59 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 123.756 0.822 . . . . 0.0 109.117 -176.367 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 38.4 mtm180 -113.26 121.07 43.32 Favored 'General case' 0 N--CA 1.488 1.475 0 C-N-CA 123.235 0.614 . . . . 0.0 110.912 -170.713 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 89.3 m -87.96 136.3 33.03 Favored 'General case' 0 N--CA 1.492 1.643 0 C-N-CA 123.751 0.82 . . . . 0.0 110.74 179.535 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 45.0 m-85 -130.66 125.98 35.4 Favored 'General case' 0 CA--C 1.56 1.343 0 C-N-CA 123.796 0.838 . . . . 0.0 109.162 -179.185 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -95.55 153.58 17.64 Favored 'General case' 0 N--CA 1.495 1.792 0 CA-C-O 122.239 1.018 . . . . 0.0 111.435 169.891 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 72.2 tttt -85.44 119.34 25.68 Favored 'General case' 0 N--CA 1.485 1.318 0 CA-C-N 115.221 -0.9 . . . . 0.0 111.559 -170.368 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -103.36 45.73 0.95 Allowed 'General case' 0 N--CA 1.492 1.675 0 N-CA-C 113.655 0.984 . . . . 0.0 113.655 176.865 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.02 0 CA-C-O 124.327 2.013 . . . . 0.0 107.841 -178.987 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.258 5.6 p . . . . . 0 CA--C 1.577 1.984 0 N-CA-C 115.993 1.849 . . . . 0.0 115.993 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -66.16 -40.08 90.27 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 116.27 1.952 . . . . 0.0 116.27 -176.343 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -59.53 -29.38 67.85 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 117.442 2.386 . . . . 0.0 117.442 168.687 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -68.26 -24.62 64.91 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 116.243 1.942 . . . . 0.0 116.243 167.728 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 39.3 mt -74.81 120.46 20.38 Favored 'General case' 0 N--CA 1.488 1.456 0 CA-C-N 120.759 1.618 . . . . 0.0 111.476 -174.282 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 162.76 168.95 25.46 Favored Glycine 0 N--CA 1.479 1.531 0 CA-C-O 122.822 1.235 . . . . 0.0 113.471 -173.459 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 78.3 m -86.75 136.42 33.01 Favored 'General case' 0 N--CA 1.49 1.535 0 CA-C-N 114.061 -1.069 . . . . 0.0 108.805 164.949 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 81.4 m95 -140.65 111.69 7.12 Favored 'General case' 0 N--CA 1.484 1.269 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 -174.258 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 8.9 mtpm? -91.97 145.61 24.4 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.866 -0.522 . . . . 0.0 110.278 173.953 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 48.7 tp -68.07 124.44 23.43 Favored 'General case' 0 N--CA 1.488 1.466 0 CA-C-O 121.94 0.876 . . . . 0.0 111.497 179.394 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . 0.279 1.2 t -96.91 -45.84 12.82 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.79 0 CA-C-N 114.313 -1.312 . . . . 0.0 112.032 177.563 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 51.5 t0 -144.19 129.35 18.68 Favored 'General case' 0 N--CA 1.49 1.528 0 CA-C-N 119.989 1.268 . . . . 0.0 109.806 -177.107 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 75.7 p -104.69 102.3 11.89 Favored 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 123.217 0.607 . . . . 0.0 110.57 169.153 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 61.1 mtpt -101.12 111.45 23.67 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 -178.798 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.256 30.8 m-20 71.12 21.14 4.92 Favored 'General case' 0 N--CA 1.505 2.287 0 N-CA-C 117.028 2.232 . . . . 0.0 117.028 -177.46 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 27.1 t80 -67.36 -47.4 70.54 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 119.989 -1.694 . . . . 0.0 114.548 -178.588 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -40.82 -48.57 3.09 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 118.399 2.74 . . . . 0.0 118.399 161.602 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 18.3 t0 -59.54 -52.87 63.69 Favored 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 115.067 1.506 . . . . 0.0 115.067 172.815 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 93.1 t80 -52.16 -50.29 62.1 Favored 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 115.64 1.719 . . . . 0.0 115.64 170.281 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 40.8 mmm -62.49 -51.76 66.18 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 114.804 1.409 . . . . 0.0 114.804 -179.637 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 21.7 tptm -60.36 -37.11 79.69 Favored 'General case' 0 CA--C 1.571 1.759 0 N-CA-C 115.893 1.812 . . . . 0.0 115.893 172.722 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 17.5 t -61.71 -40.07 93.73 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 116.263 1.949 . . . . 0.0 116.263 169.917 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 80.2 mt -62.03 -23.45 66.46 Favored 'General case' 0 CA--C 1.569 1.692 0 N-CA-C 117.828 2.529 . . . . 0.0 117.828 168.216 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 97.71 67.96 0.93 Allowed Glycine 0 N--CA 1.482 1.729 0 CA-C-N 119.074 0.852 . . . . 0.0 112.046 -166.667 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 41.2 t -143.64 109.99 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 N-CA-C 104.348 -2.464 . . . . 0.0 104.348 177.824 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -68.61 168.37 43.14 Favored Glycine 0 CA--C 1.546 2.016 0 N-CA-C 116.174 1.23 . . . . 0.0 116.174 -177.343 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 25.3 p90 -53.07 -38.6 62.64 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 119.127 3.01 . . . . 0.0 119.127 -170.121 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.32 -45.17 81.19 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 116.003 1.853 . . . . 0.0 116.003 176.48 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 56.0 m -72.51 -35.54 68.15 Favored 'General case' 0 N--CA 1.501 2.101 0 N-CA-C 114.045 1.128 . . . . 0.0 114.045 171.196 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 48.2 ttp180 -54.59 -49.3 70.73 Favored 'General case' 0 CA--C 1.569 1.681 0 N-CA-C 115.463 1.653 . . . . 0.0 115.463 169.092 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 24.1 mm100 -74.22 -39.43 63.11 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 115.388 1.625 . . . . 0.0 115.388 176.973 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 73.8 t -61.33 -47.08 95.12 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.03 0 CA-C-N 120.129 1.331 . . . . 0.0 113.135 172.589 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -68.58 -31.9 71.42 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 117.204 2.298 . . . . 0.0 117.204 176.141 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 94.0 p -68.62 -43.6 76.03 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 115.552 1.686 . . . . 0.0 115.552 167.467 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 49.7 ttp -60.33 -41.7 94.1 Favored 'General case' 0 CA--C 1.568 1.666 0 N-CA-C 115.782 1.771 . . . . 0.0 115.782 168.447 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 95.0 m -68.3 136.15 53.01 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 124.141 0.976 . . . . 0.0 110.591 170.668 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 5.3 mptp? -106.69 95.96 13.27 Favored Pre-proline 0 CA--C 1.567 1.621 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 175.401 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -83.22 147.12 12.78 Favored 'Trans proline' 0 C--N 1.372 1.804 0 C-N-CA 122.854 2.37 . . . . 0.0 113.452 -172.234 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 44.9 m -98.41 102.94 14.83 Favored 'General case' 0 CA--C 1.563 1.443 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.586 -169.758 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 79.8 m -80.09 113.4 18.24 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 123.896 0.879 . . . . 0.0 109.744 177.687 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 89.3 mt -115.61 107.69 23.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 N-CA-C 106.024 -1.843 . . . . 0.0 106.024 -175.131 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 4.2 mp -97.68 120.23 46.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 N-CA-C 107.378 -1.341 . . . . 0.0 107.378 174.954 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -134.99 116.2 14.39 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.245 -1.021 . . . . 0.0 108.245 -179.107 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 84.3 tttt -89.02 111.83 22.63 Favored 'General case' 0 CA--C 1.557 1.234 0 C-N-CA 123.175 0.59 . . . . 0.0 110.267 178.04 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 28.3 t30 -99.42 87.91 3.74 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.642 -0.874 . . . . 0.0 108.642 178.729 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 78.82 -96.4 1.43 Allowed Glycine 0 N--CA 1.484 1.869 0 CA-C-N 116.445 -0.343 . . . . 0.0 112.396 -171.817 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 86.4 m-20 -109.22 -17.11 13.92 Favored 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 115.265 1.58 . . . . 0.0 115.265 169.062 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 24.2 mm -93.34 118.46 39.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 CA-C-N 120.512 1.505 . . . . 0.0 109.14 -167.078 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 42.2 mt -84.87 114.33 22.03 Favored 'General case' 0 N--CA 1.486 1.325 0 C-N-CA 123.763 0.825 . . . . 0.0 111.434 179.701 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 87.6 m -102.25 102.29 12.67 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 -178.277 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 8.7 tt -104.15 105.21 15.3 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.307 -0.998 . . . . 0.0 108.307 -179.531 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -108.72 121.48 45.14 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 123.917 0.887 . . . . 0.0 109.565 -178.734 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 91.6 m -101.68 95.11 6.22 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 108.083 -1.081 . . . . 0.0 108.083 179.217 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 17.5 m-70 -81.26 99.79 8.8 Favored 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 123.564 0.745 . . . . 0.0 110.544 -170.312 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 85.6 p . . . . . 0 N--CA 1.491 1.617 0 N-CA-C 117.198 2.295 . . . . 0.0 117.198 -175.768 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 54.1 t30 . . . . . 0 N--CA 1.488 1.445 0 CA-C-O 120.662 0.268 . . . . 0.0 110.436 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 77.5 p -89.26 127.66 35.79 Favored 'General case' 0 N--CA 1.492 1.655 0 C-N-CA 122.855 0.462 . . . . 0.0 110.34 -179.777 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -123.51 122.25 37.74 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 123.584 0.753 . . . . 0.0 109.427 -169.408 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 48.7 pt -116.67 126.63 74.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 169.371 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 77.4 p -116.06 101.76 9.03 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 177.815 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 43.1 p90 -132.86 142.4 48.92 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 114.522 1.304 . . . . 0.0 114.522 -157.561 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 30.6 mtpp -98.23 146.72 25.34 Favored 'General case' 0 N--CA 1.489 1.501 0 CA-C-N 115.132 -0.94 . . . . 0.0 109.789 160.98 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -74.23 113.38 11.37 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 -173.83 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 86.64 45.5 5.47 Favored Glycine 0 CA--C 1.548 2.132 0 N-CA-C 115.848 1.099 . . . . 0.0 115.848 -169.259 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 76.7 t -141.79 121.58 10.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 N-CA-C 106.242 -1.762 . . . . 0.0 106.242 179.663 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -85.69 133.05 34.04 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 123.074 0.55 . . . . 0.0 111.147 175.193 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 52.0 p90 -139.32 149.83 44.67 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 124.006 0.922 . . . . 0.0 111.138 -174.383 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -74.64 133.49 42.14 Favored 'General case' 0 CA--C 1.567 1.607 0 O-C-N 121.234 -0.916 . . . . 0.0 112.703 173.189 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 17.3 tp10 -145.82 136.73 24.5 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 123.362 0.665 . . . . 0.0 110.252 -173.477 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 63.1 m -111.08 128.24 55.81 Favored 'General case' 0 N--CA 1.495 1.791 0 C-N-CA 123.279 0.632 . . . . 0.0 109.545 178.666 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 27.0 p -86.45 164.0 17.23 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 113.195 0.813 . . . . 0.0 113.195 -175.749 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -54.82 -32.17 60.11 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 118.779 2.881 . . . . 0.0 118.779 174.902 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -77.47 -85.44 0.06 Allowed 'General case' 0 N--CA 1.494 1.774 0 CA-C-N 120.416 1.462 . . . . 0.0 109.23 171.299 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -176.67 87.5 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 165.472 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 52.1 mtm-85 -139.95 115.11 9.76 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 -179.844 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -79.83 114.8 19.03 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 123.032 0.533 . . . . 0.0 109.604 166.589 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 13.9 m -125.47 138.76 53.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 CA-C-O 121.365 0.602 . . . . 0.0 110.116 -167.58 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 71.9 mmtt -84.92 107.95 17.32 Favored 'General case' 0 N--CA 1.488 1.426 0 CA-C-O 121.916 0.865 . . . . 0.0 109.179 170.961 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 47.3 t -106.95 100.84 10.31 Favored 'General case' 0 CA--C 1.555 1.144 0 CA-C-N 114.907 -1.042 . . . . 0.0 110.381 -161.403 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 6.4 tp -113.15 115.8 50.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 -176.494 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 1.4 p -134.26 126.93 50.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 C-N-CA 123.618 0.767 . . . . 0.0 109.735 -175.758 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 15.3 t -133.01 157.7 44.57 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-O 122.65 1.214 . . . . 0.0 110.98 176.065 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 14.9 tp -88.5 113.81 24.47 Favored 'General case' 0 N--CA 1.489 1.486 0 CA-C-N 114.833 -1.076 . . . . 0.0 108.505 168.36 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -107.0 87.22 2.46 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 123.322 0.649 . . . . 0.0 109.415 -174.518 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 61.4 48.26 86.15 Favored Glycine 0 CA--C 1.551 2.311 0 N-CA-C 117.262 1.665 . . . . 0.0 117.262 -174.265 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 69.36 26.42 74.58 Favored Glycine 0 CA--C 1.556 2.625 0 N-CA-C 118.662 2.225 . . . . 0.0 118.662 -167.912 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.17 109.87 5.76 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 107.151 -1.426 . . . . 0.0 107.151 -175.77 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 4.6 tt -88.63 106.28 18.22 Favored 'General case' 0 CA--C 1.56 1.343 0 CA-C-O 121.705 0.764 . . . . 0.0 111.249 -162.998 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 83.2 t -103.72 110.71 30.89 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 N-CA-C 107.113 -1.44 . . . . 0.0 107.113 -170.884 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 23.2 t-160 -103.75 138.82 39.83 Favored 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 124.023 0.929 . . . . 0.0 109.554 173.91 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 41.2 tp -132.52 121.1 22.79 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 107.837 -1.172 . . . . 0.0 107.837 173.413 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 29.9 mt-30 -106.51 129.47 54.46 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 124.198 0.999 . . . . 0.0 108.515 172.945 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 46.1 mtpt -129.86 130.31 45.05 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.809 -0.557 . . . . 0.0 110.065 -169.471 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 26.3 p90 -154.46 112.16 3.46 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.384 -0.823 . . . . 0.0 111.193 -175.834 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . 0.341 13.2 t70 66.67 -108.73 0.13 Allowed 'General case' 0 N--CA 1.495 1.781 0 C-N-CA 124.582 1.153 . . . . 0.0 112.457 170.527 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -116.42 44.82 1.38 Allowed Glycine 0 N--CA 1.488 2.163 0 CA-C-N 118.887 0.767 . . . . 0.0 115.007 165.096 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 14.9 mt-30 -152.3 126.52 9.23 Favored 'General case' 0 N--CA 1.484 1.273 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 178.704 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 13.4 mp0 -139.41 130.86 27.0 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 -179.194 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 5.2 t -125.13 134.25 52.51 Favored 'General case' 0 N--CA 1.495 1.805 0 C-N-CA 123.144 0.578 . . . . 0.0 111.569 -178.4 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 57.8 p -95.53 138.64 32.92 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-O 121.596 0.712 . . . . 0.0 111.705 172.144 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 5.9 mp -113.6 82.11 1.63 Allowed 'General case' 0 CA--C 1.563 1.449 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 173.812 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 48.1 t -90.73 112.59 25.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 -169.147 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 83.4 mtt85 -106.13 127.7 53.38 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 123.021 0.528 . . . . 0.0 110.086 -177.383 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 8.7 pm0 -139.62 132.86 29.83 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 123.234 0.614 . . . . 0.0 110.816 -178.665 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -80.19 112.92 17.97 Favored 'General case' 0 N--CA 1.487 1.404 0 CA-C-O 121.355 0.597 . . . . 0.0 110.892 175.792 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 73.2 mt -118.71 107.06 20.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 N-CA-C 104.805 -2.294 . . . . 0.0 104.805 176.486 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 59.3 49.85 8.49 Favored 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 114.692 1.367 . . . . 0.0 114.692 177.962 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 63.32 21.18 64.03 Favored Glycine 0 CA--C 1.555 2.572 0 N-CA-C 119.726 2.65 . . . . 0.0 119.726 -170.629 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 49.0 mtpt -130.95 131.4 44.4 Favored 'General case' 0 N--CA 1.488 1.47 0 CA-C-N 119.713 1.756 . . . . 0.0 108.665 -173.178 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 20.5 tp -81.91 108.53 15.49 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.312 0.645 . . . . 0.0 109.95 -175.155 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 29.8 mm -100.59 103.23 14.53 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 N-CA-C 106.463 -1.681 . . . . 0.0 106.463 -175.872 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 23.9 tp -92.03 98.28 11.46 Favored 'General case' 0 CA--C 1.56 1.328 0 C-N-CA 124.04 0.936 . . . . 0.0 109.47 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 90.8 m -88.12 109.12 19.64 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 124.291 1.036 . . . . 0.0 108.729 178.019 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 90.3 mt -100.29 93.75 5.84 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 124.045 0.938 . . . . 0.0 109.164 -172.449 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 4.7 m -106.41 112.53 25.58 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 -172.291 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 19.9 t60 -100.65 -75.27 0.59 Allowed 'General case' 0 N--CA 1.491 1.591 0 CA-C-O 118.793 -0.623 . . . . 0.0 110.492 172.553 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -142.2 -97.91 0.29 Allowed Glycine 0 N--CA 1.483 1.773 0 N-CA-C 110.558 -1.017 . . . . 0.0 110.558 -178.883 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 8.2 t -89.1 30.78 0.92 Allowed 'General case' 0 N--CA 1.5 2.051 0 N-CA-C 115.498 1.666 . . . . 0.0 115.498 173.468 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -158.44 107.72 2.01 Favored 'General case' 0 N--CA 1.481 1.114 0 O-C-N 121.045 -1.034 . . . . 0.0 108.979 177.351 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 7.5 p -108.56 126.35 65.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 C-N-CA 123.583 0.753 . . . . 0.0 109.827 175.231 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 40.9 t -109.87 106.94 16.71 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 123.003 0.521 . . . . 0.0 111.851 179.033 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 77.5 m -90.18 100.51 13.32 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 178.866 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 33.5 mtm180 -99.41 121.13 40.69 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 123.108 0.563 . . . . 0.0 110.552 -174.667 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 95.7 m -89.78 131.27 35.82 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 123.438 0.695 . . . . 0.0 109.822 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 42.0 m-85 -127.26 131.13 50.61 Favored 'General case' 0 CA--C 1.559 1.297 0 C-N-CA 123.612 0.765 . . . . 0.0 109.587 178.634 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -96.31 150.12 20.92 Favored 'General case' 0 CA--C 1.56 1.358 0 CA-C-O 121.943 0.878 . . . . 0.0 111.457 172.481 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 67.4 tttt -80.77 127.07 32.09 Favored 'General case' 0 N--CA 1.486 1.33 0 CA-C-O 121.642 0.734 . . . . 0.0 112.204 -173.439 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 15.2 mm-40 -125.02 52.3 1.59 Allowed 'General case' 0 CA--C 1.563 1.449 0 C-N-CA 124.253 1.021 . . . . 0.0 111.252 -173.438 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.968 0 CA-C-O 123.057 1.408 . . . . 0.0 109.989 -163.688 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 79.0 t . . . . . 0 CA--C 1.559 1.3 0 N-CA-C 106.605 -1.628 . . . . 0.0 106.605 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -145.45 -53.36 0.28 Allowed 'General case' 0 N--CA 1.494 1.749 0 C-N-CA 123.9 0.88 . . . . 0.0 111.242 -175.373 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -57.8 -27.43 63.11 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 117.066 2.247 . . . . 0.0 117.066 161.571 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -63.8 -20.52 65.85 Favored 'General case' 0 CA--C 1.568 1.659 0 N-CA-C 117.209 2.3 . . . . 0.0 117.209 165.189 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 64.7 mt -82.45 120.16 25.11 Favored 'General case' 0 N--CA 1.487 1.425 0 CA-C-N 121.034 1.743 . . . . 0.0 111.361 -169.239 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 155.99 173.25 24.36 Favored Glycine 0 CA--C 1.543 1.83 0 CA-C-O 122.542 1.079 . . . . 0.0 113.013 -171.734 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 76.9 m -85.73 140.75 30.24 Favored 'General case' 0 N--CA 1.492 1.673 0 CA-C-N 114.548 -0.826 . . . . 0.0 109.475 168.21 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 88.7 m95 -140.68 112.86 7.82 Favored 'General case' 0 N--CA 1.485 1.319 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 -174.034 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 51.2 mtpt -99.11 147.86 24.65 Favored 'General case' 0 N--CA 1.494 1.74 0 CA-C-O 121.548 0.689 . . . . 0.0 110.702 177.069 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 61.8 tp -69.87 131.67 44.82 Favored 'General case' 0 N--CA 1.488 1.475 0 CA-C-O 121.847 0.832 . . . . 0.0 112.856 -175.586 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . 0.271 0.9 OUTLIER -116.7 -39.27 2.4 Favored 'Isoleucine or valine' 0 CA--C 1.576 1.971 0 CA-C-N 114.335 -1.302 . . . . 0.0 112.434 -176.87 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -136.22 132.63 36.13 Favored 'General case' 0 N--CA 1.491 1.618 0 CA-C-N 120.513 1.506 . . . . 0.0 109.474 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 83.5 p -128.52 90.41 3.06 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-O 121.5 0.667 . . . . 0.0 111.031 176.509 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -100.56 124.25 45.88 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 123.569 0.748 . . . . 0.0 109.26 177.827 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.267 57.2 m-20 71.33 16.13 6.17 Favored 'General case' 0 N--CA 1.506 2.367 0 N-CA-C 117.677 2.473 . . . . 0.0 117.677 177.788 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 20.4 t80 -70.41 -40.08 74.06 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 115.77 1.767 . . . . 0.0 115.77 -176.371 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -63.86 -29.5 70.68 Favored 'General case' 0 N--CA 1.499 1.995 0 N-CA-C 116.053 1.872 . . . . 0.0 116.053 170.55 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 27.8 t0 -64.45 -49.21 72.37 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 114.527 1.306 . . . . 0.0 114.527 165.329 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 90.9 t80 -52.45 -52.85 51.96 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 115.311 1.597 . . . . 0.0 115.311 172.203 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 77.9 mtm -62.02 -41.3 97.95 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 115.295 1.591 . . . . 0.0 115.295 175.053 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.4 tmtp? -58.77 -44.75 90.73 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 115.276 1.584 . . . . 0.0 115.276 168.818 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 49.3 m -58.72 -38.24 77.91 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 116.332 1.975 . . . . 0.0 116.332 172.009 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 80.3 mt -65.79 -41.38 92.01 Favored 'General case' 0 CA--C 1.567 1.6 0 N-CA-C 116.368 1.988 . . . . 0.0 116.368 169.516 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 113.7 76.33 0.72 Allowed Glycine 0 N--CA 1.483 1.778 0 N-CA-C 111.055 -0.818 . . . . 0.0 111.055 -171.467 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 67.5 t -141.98 123.04 12.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 N-CA-C 105.512 -2.032 . . . . 0.0 105.512 -175.445 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -69.41 160.29 52.83 Favored Glycine 0 CA--C 1.548 2.119 0 N-CA-C 115.948 1.139 . . . . 0.0 115.948 179.143 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 28.7 p90 -54.57 -41.25 69.62 Favored 'General case' 0 N--CA 1.498 1.95 0 N-CA-C 118.726 2.861 . . . . 0.0 118.726 -171.091 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.59 -43.31 94.22 Favored 'General case' 0 CA--C 1.564 1.499 0 N-CA-C 115.594 1.702 . . . . 0.0 115.594 173.769 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 58.7 m -67.28 -35.11 78.81 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 114.53 1.308 . . . . 0.0 114.53 170.064 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 58.1 mtm180 -58.36 -48.48 80.45 Favored 'General case' 0 N--CA 1.493 1.718 0 CA-C-N 120.407 1.458 . . . . 0.0 114.911 168.398 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 37.2 mm-40 -68.57 -39.79 80.86 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 115.455 1.65 . . . . 0.0 115.455 177.565 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 74.6 t -60.97 -47.84 91.74 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.019 0 CA-C-N 119.656 1.117 . . . . 0.0 113.103 169.622 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -67.74 -39.19 84.27 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 117.032 2.234 . . . . 0.0 117.032 178.544 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 87.8 p -65.52 -39.11 91.43 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 116.175 1.917 . . . . 0.0 116.175 168.53 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 54.7 tpp -66.87 -40.82 87.95 Favored 'General case' 0 CA--C 1.566 1.589 0 N-CA-C 115.997 1.851 . . . . 0.0 115.997 173.636 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 5.8 t -75.37 161.93 28.83 Favored 'General case' 0 N--CA 1.493 1.682 0 CA-C-N 119.428 1.013 . . . . 0.0 112.846 179.211 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 3.5 mtmt -99.28 104.0 23.9 Favored Pre-proline 0 CA--C 1.568 1.649 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 170.706 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -77.93 90.92 1.22 Allowed 'Trans proline' 0 CA--C 1.56 1.782 0 C-N-CA 123.165 2.577 . . . . 0.0 111.155 178.414 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 52.0 m -79.49 109.24 13.67 Favored 'General case' 0 N--CA 1.488 1.43 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.258 -161.216 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 90.7 m -83.59 116.61 22.68 Favored 'General case' 0 CA--C 1.56 1.349 0 C-N-CA 123.541 0.737 . . . . 0.0 109.468 -174.336 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 73.7 mt -113.16 106.99 21.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 N-CA-C 105.805 -1.924 . . . . 0.0 105.805 179.02 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 20.6 mt -100.58 120.91 50.7 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 -177.512 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -136.35 111.82 9.25 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 -170.886 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 82.1 tttt -91.28 115.7 28.24 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 123.309 0.644 . . . . 0.0 110.789 -177.969 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 32.8 t30 -116.04 80.87 1.51 Allowed 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 178.821 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 62.91 59.77 8.64 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 116.209 1.244 . . . . 0.0 116.209 -173.902 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . 0.324 3.9 t70 71.25 -20.15 0.23 Allowed 'General case' 0 N--CA 1.499 2.021 0 N-CA-C 117.415 2.376 . . . . 0.0 117.415 -167.506 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 11.0 mm -82.3 102.73 8.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 CA-C-N 120.19 1.359 . . . . 0.0 107.906 -175.982 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 45.7 mt -89.0 104.98 17.49 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 123.146 0.578 . . . . 0.0 110.268 -174.069 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 64.1 m -92.19 95.27 9.64 Favored 'General case' 0 N--CA 1.484 1.272 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 -177.714 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 9.8 tt -99.57 101.77 13.08 Favored 'General case' 0 N--CA 1.484 1.234 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 -175.287 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -100.22 108.2 20.24 Favored 'General case' 0 N--CA 1.485 1.303 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 -175.826 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 89.2 m -94.64 99.5 11.61 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 -179.534 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 29.2 m170 -86.97 91.88 8.84 Favored 'General case' 0 N--CA 1.491 1.581 0 CA-C-O 121.578 0.704 . . . . 0.0 111.271 -172.221 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 25.2 t . . . . . 0 N--CA 1.486 1.33 0 C-N-CA 124.003 0.921 . . . . 0.0 110.783 177.447 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 8.9 p30 . . . . . 0 N--CA 1.49 1.529 0 N-CA-C 112.087 0.403 . . . . 0.0 112.087 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 82.7 p -91.81 128.83 37.8 Favored 'General case' 0 N--CA 1.493 1.715 0 C-N-CA 122.837 0.455 . . . . 0.0 110.871 -176.905 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -117.77 117.08 28.34 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 -179.782 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 37.9 pt -112.11 131.57 63.19 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 174.124 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 79.7 p -116.81 101.88 8.93 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 -179.853 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 46.6 p90 -130.85 133.11 45.64 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 114.137 1.162 . . . . 0.0 114.137 -161.167 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 30.8 mtpp -88.71 145.05 25.87 Favored 'General case' 0 CA--C 1.561 1.379 0 CA-C-N 114.883 -1.053 . . . . 0.0 109.625 161.299 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -74.79 117.7 16.92 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.831 -0.543 . . . . 0.0 111.882 -173.141 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 86.13 44.07 6.09 Favored Glycine 0 CA--C 1.549 2.157 0 N-CA-C 116.457 1.343 . . . . 0.0 116.457 -168.83 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 98.8 t -140.15 121.14 14.55 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 N-CA-C 106.332 -1.729 . . . . 0.0 106.332 179.767 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -86.09 128.73 34.93 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 123.072 0.549 . . . . 0.0 111.045 176.207 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 47.9 p90 -133.77 128.59 35.14 Favored 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 123.619 0.768 . . . . 0.0 110.475 -174.248 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -71.1 117.43 12.6 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.411 -0.806 . . . . 0.0 112.206 175.207 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 15.7 tp10 -124.38 133.63 53.36 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 123.435 0.694 . . . . 0.0 110.616 -168.349 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 61.0 m -95.24 123.4 38.72 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 172.277 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 43.1 p -85.67 172.99 10.44 Favored 'General case' 0 CA--C 1.568 1.662 0 CA-C-O 121.854 0.835 . . . . 0.0 112.758 -173.813 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -60.76 -35.24 75.9 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 117.344 2.35 . . . . 0.0 117.344 165.739 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -98.09 82.08 2.91 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 106.376 -1.713 . . . . 0.0 106.376 166.293 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -39.35 108.95 0.09 Allowed 'General case' 0 N--CA 1.497 1.881 0 N-CA-C 117.747 2.499 . . . . 0.0 117.747 -155.169 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 39.6 ttm-85 -149.04 126.59 11.64 Favored 'General case' 0 N--CA 1.487 1.389 0 CA-C-N 114.878 -1.055 . . . . 0.0 108.493 -167.727 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.44 117.87 15.71 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 170.58 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 13.6 m -135.57 125.7 42.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 -174.081 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 30.9 mmtp -82.35 103.47 11.94 Favored 'General case' 0 N--CA 1.489 1.476 0 CA-C-O 121.894 0.854 . . . . 0.0 109.472 179.116 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 44.5 t -103.56 100.16 9.99 Favored 'General case' 0 CA--C 1.554 1.119 0 CA-C-N 115.012 -0.994 . . . . 0.0 110.718 -160.677 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 6.5 tp -109.46 120.35 60.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 -178.045 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 1.6 p -139.99 123.64 18.16 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 -173.354 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 14.3 t -133.56 160.35 37.74 Favored 'General case' 0 N--CA 1.487 1.42 0 CA-C-O 122.978 1.371 . . . . 0.0 111.254 179.647 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 63.8 tp -88.64 107.86 19.15 Favored 'General case' 0 N--CA 1.487 1.424 0 CA-C-N 114.44 -1.254 . . . . 0.0 108.523 170.873 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -108.19 87.62 2.54 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 123.377 0.671 . . . . 0.0 109.351 -171.609 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 56.54 49.43 69.58 Favored Glycine 0 CA--C 1.548 2.14 0 N-CA-C 117.614 1.805 . . . . 0.0 117.614 -177.89 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 102.26 -45.85 1.32 Allowed Glycine 0 N--CA 1.488 2.136 0 N-CA-C 116.852 1.501 . . . . 0.0 116.852 -168.43 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 36.0 ttpt -90.01 130.4 36.21 Favored 'General case' 0 CA--C 1.556 1.175 0 CA-C-N 117.419 0.609 . . . . 0.0 111.704 -169.111 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 4.7 tt -84.53 103.57 13.78 Favored 'General case' 0 CA--C 1.563 1.455 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 178.985 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 78.8 t -109.65 111.62 36.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 -167.805 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 21.1 t-160 -113.11 125.32 54.24 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 124.416 1.086 . . . . 0.0 109.22 -177.241 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 25.8 tp -122.45 121.81 37.48 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 107.799 -1.185 . . . . 0.0 107.799 175.167 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 93.1 mt-30 -107.69 126.03 52.09 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 171.867 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 10.2 ptpp? -126.88 139.34 53.15 Favored 'General case' 0 N--CA 1.494 1.75 0 CA-C-O 121.343 0.592 . . . . 0.0 112.193 -176.686 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 26.6 p90 -157.57 110.25 2.44 Favored 'General case' 0 N--CA 1.488 1.475 0 C-N-CA 123.781 0.832 . . . . 0.0 108.953 -173.657 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 3.8 t70 54.52 50.69 15.51 Favored 'General case' 0 N--CA 1.499 1.977 0 N-CA-C 116.382 1.993 . . . . 0.0 116.382 167.346 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 86.08 -40.67 3.05 Favored Glycine 0 CA--C 1.554 2.478 0 N-CA-C 117.372 1.709 . . . . 0.0 117.372 -169.495 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 57.6 mt-30 -80.37 136.12 36.32 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 123.921 0.888 . . . . 0.0 111.138 179.727 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -145.61 130.23 17.96 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.827 -0.546 . . . . 0.0 111.442 178.892 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 7.7 t -114.23 134.57 54.83 Favored 'General case' 0 N--CA 1.494 1.74 0 C-N-CA 123.22 0.608 . . . . 0.0 111.009 175.725 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 39.3 p -103.53 129.11 50.67 Favored 'General case' 0 N--CA 1.49 1.575 0 CA-C-O 121.615 0.722 . . . . 0.0 110.885 173.222 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 5.6 mp -106.67 80.72 1.49 Allowed 'General case' 0 CA--C 1.565 1.554 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 176.333 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 67.9 t -88.8 108.21 18.68 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 N-CA-C 108.272 -1.011 . . . . 0.0 108.272 -169.322 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 80.1 mtt85 -100.93 125.66 47.52 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 123.265 0.626 . . . . 0.0 110.352 -177.6 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -143.26 133.6 24.67 Favored 'General case' 0 N--CA 1.491 1.606 0 C-N-CA 123.308 0.643 . . . . 0.0 111.157 -176.042 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -81.33 117.82 22.12 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.66 -0.65 . . . . 0.0 111.356 177.232 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 46.9 mm -120.83 104.9 15.94 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.374 0 N-CA-C 105.115 -2.18 . . . . 0.0 105.115 174.931 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 22.2 m-20 58.93 50.37 8.51 Favored 'General case' 0 N--CA 1.499 2.02 0 N-CA-C 115.101 1.519 . . . . 0.0 115.101 175.414 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 63.76 27.45 71.13 Favored Glycine 0 CA--C 1.555 2.566 0 N-CA-C 119.242 2.457 . . . . 0.0 119.242 -170.581 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -135.87 127.13 28.26 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-N 119.002 1.401 . . . . 0.0 108.339 -174.997 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 19.1 tp -78.4 111.46 14.44 Favored 'General case' 0 CA--C 1.559 1.312 0 C-N-CA 123.474 0.709 . . . . 0.0 110.374 -179.215 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 30.4 mm -98.89 100.85 11.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 -177.075 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 30.3 tp -91.5 104.48 16.98 Favored 'General case' 0 CA--C 1.559 1.305 0 C-N-CA 123.85 0.86 . . . . 0.0 109.276 177.65 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 85.5 m -97.42 114.62 26.48 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 124.083 0.953 . . . . 0.0 108.621 -177.161 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 85.2 mt -110.79 96.66 6.31 Favored 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 123.63 0.772 . . . . 0.0 109.375 -168.001 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 11.1 m -105.85 117.14 33.26 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.947 -0.471 . . . . 0.0 109.89 -171.993 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 53.9 t60 -156.4 122.16 4.88 Favored 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 123.157 0.583 . . . . 0.0 109.53 171.566 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 61.71 64.92 3.57 Favored Glycine 0 N--CA 1.488 2.143 0 N-CA-C 117.237 1.655 . . . . 0.0 117.237 165.605 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . 0.391 5.2 t 46.57 39.86 7.48 Favored 'General case' 0 N--CA 1.5 2.049 0 N-CA-C 117.624 2.453 . . . . 0.0 117.624 -169.041 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -153.14 88.57 1.32 Allowed 'General case' 0 N--CA 1.483 1.203 0 O-C-N 121.531 -0.731 . . . . 0.0 109.276 -176.924 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 4.5 p -92.9 119.77 41.14 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.401 0 C-N-CA 123.508 0.723 . . . . 0.0 109.582 173.771 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 42.2 t -110.31 100.76 9.58 Favored 'General case' 0 CA--C 1.551 1.014 0 CA-C-O 121.594 0.712 . . . . 0.0 110.25 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 87.6 m -90.74 106.24 18.37 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 -177.287 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 39.4 mtm180 -112.22 121.67 45.57 Favored 'General case' 0 N--CA 1.487 1.375 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.59 -169.881 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 89.8 m -85.02 136.61 33.51 Favored 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 123.35 0.66 . . . . 0.0 110.033 177.16 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 40.7 m-85 -129.73 126.11 37.46 Favored 'General case' 0 CA--C 1.558 1.259 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 177.308 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -92.62 152.12 19.75 Favored 'General case' 0 N--CA 1.494 1.726 0 CA-C-O 121.943 0.878 . . . . 0.0 111.82 173.23 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 71.2 tttt -83.03 121.58 27.2 Favored 'General case' 0 N--CA 1.486 1.364 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.926 -169.255 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -119.92 51.2 1.2 Allowed 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 124.283 1.033 . . . . 0.0 111.525 -174.302 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 0.829 0 CA-C-O 124.448 2.071 . . . . 0.0 109.882 -161.269 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.297 42.6 t . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 117.257 -1.354 . . . . 0.0 112.982 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -56.68 -41.3 77.07 Favored 'General case' 0 N--CA 1.499 1.995 0 N-CA-C 116.282 1.956 . . . . 0.0 116.282 178.648 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -61.38 -33.88 74.4 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 116.766 2.136 . . . . 0.0 116.766 164.697 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -70.96 -22.67 62.18 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 116.273 1.953 . . . . 0.0 116.273 169.945 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 82.6 mt -70.84 118.03 13.1 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-N 121.26 1.845 . . . . 0.0 111.476 -175.817 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 154.53 172.3 22.24 Favored Glycine 0 CA--C 1.54 1.632 0 CA-C-O 122.661 1.145 . . . . 0.0 112.941 -176.736 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 45.9 m -87.59 142.54 27.77 Favored 'General case' 0 N--CA 1.489 1.504 0 CA-C-N 114.555 -0.822 . . . . 0.0 109.095 172.624 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 92.1 m95 -136.43 110.73 8.43 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 -173.761 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 39.8 mttp -94.31 142.85 26.94 Favored 'General case' 0 N--CA 1.489 1.478 0 CA-C-O 121.612 0.72 . . . . 0.0 110.73 174.318 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 14.2 tp -70.1 123.55 21.89 Favored 'General case' 0 N--CA 1.487 1.393 0 CA-C-O 122.218 1.008 . . . . 0.0 111.806 -176.859 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . 0.286 1.1 t -96.02 -47.98 12.79 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.741 0 CA-C-N 113.711 -1.586 . . . . 0.0 111.661 175.875 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -142.38 145.38 33.8 Favored 'General case' 0 N--CA 1.49 1.536 0 CA-C-N 119.859 1.209 . . . . 0.0 110.099 176.865 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 88.0 p -121.94 100.87 7.22 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.75 -0.594 . . . . 0.0 110.075 170.979 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -89.23 119.56 29.82 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 36.7 m-20 67.47 30.83 6.62 Favored 'General case' 0 N--CA 1.5 2.046 0 N-CA-C 116.515 2.042 . . . . 0.0 116.515 178.163 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.431 ' HB2' ' SG ' ' A' ' 124' ' ' CYS . 31.1 t80 -90.4 69.56 6.95 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 120.236 -1.54 . . . . 0.0 111.955 -179.859 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -159.72 -52.32 0.06 Allowed 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 125.434 1.494 . . . . 0.0 108.689 179.106 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 22.0 t0 -53.81 -41.27 67.14 Favored 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 116.034 1.864 . . . . 0.0 116.034 164.771 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 81.6 t80 -55.03 -53.17 59.22 Favored 'General case' 0 CA--C 1.571 1.754 0 N-CA-C 114.536 1.31 . . . . 0.0 114.536 169.769 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 73.8 mtm -62.83 -38.53 91.14 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 115.879 1.807 . . . . 0.0 115.879 171.957 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 57.1 mtpt -58.23 -51.2 70.76 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 115.596 1.702 . . . . 0.0 115.596 168.539 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 21.3 t -62.95 -34.58 77.79 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 116.221 1.934 . . . . 0.0 116.221 174.44 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 68.1 mt -66.41 -39.95 89.29 Favored 'General case' 0 CA--C 1.565 1.545 0 N-CA-C 116.084 1.883 . . . . 0.0 116.084 168.364 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 105.46 78.47 1.2 Allowed Glycine 0 CA--C 1.54 1.649 0 CA-C-N 118.807 0.73 . . . . 0.0 111.474 -172.184 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 58.1 t -138.02 123.27 24.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 N-CA-C 105.752 -1.944 . . . . 0.0 105.752 -179.5 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -82.4 -157.93 22.58 Favored Glycine 0 CA--C 1.547 2.087 0 N-CA-C 115.965 1.146 . . . . 0.0 115.965 -177.926 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 8.6 p90 -69.39 156.61 38.54 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 113.319 0.859 . . . . 0.0 113.319 178.951 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . 0.317 . . 76.6 -50.1 0.57 Allowed 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 115.647 1.721 . . . . 0.0 115.647 179.616 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 30.4 m -70.98 -36.11 72.37 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 113.903 1.075 . . . . 0.0 113.903 170.322 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 27.8 mtm180 -57.18 -46.88 82.43 Favored 'General case' 0 N--CA 1.499 1.987 0 CA-C-N 120.819 1.645 . . . . 0.0 114.472 162.409 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 3.4 tm0? -66.3 -49.77 65.91 Favored 'General case' 0 CA--C 1.562 1.434 0 N-CA-C 114.756 1.391 . . . . 0.0 114.756 -178.864 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 95.6 t -65.69 -40.12 86.93 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 CA-C-N 119.42 1.009 . . . . 0.0 113.426 175.146 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -66.26 -39.91 89.79 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 116.383 1.994 . . . . 0.0 116.383 176.368 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 92.8 p -63.78 -40.72 97.34 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 116.144 1.905 . . . . 0.0 116.144 165.794 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 17.9 ttm -60.71 -47.16 87.52 Favored 'General case' 0 CA--C 1.568 1.653 0 N-CA-C 115.861 1.8 . . . . 0.0 115.861 171.752 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 5.4 t -78.79 158.26 28.25 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 113.511 0.93 . . . . 0.0 113.511 -166.302 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 14.1 mptt -102.34 101.69 21.01 Favored Pre-proline 0 CA--C 1.57 1.728 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 175.091 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -77.76 100.39 1.38 Allowed 'Trans proline' 0 CA--C 1.561 1.848 0 C-N-CA 123.027 2.485 . . . . 0.0 111.562 -177.198 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 80.9 m -83.55 102.72 12.34 Favored 'General case' 0 N--CA 1.489 1.486 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.808 -164.995 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 32.3 m -97.31 112.75 24.43 Favored 'General case' 0 N--CA 1.485 1.279 0 CA-C-O 120.63 0.252 . . . . 0.0 111.243 -167.898 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 5.2 mp -91.07 107.16 18.34 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.454 0 N-CA-C 107.103 -1.443 . . . . 0.0 107.103 170.774 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.413 HD11 HH11 ' A' ' 106' ' ' ARG . 44.9 mt -90.75 123.3 42.85 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 N-CA-C 106.762 -1.57 . . . . 0.0 106.762 167.372 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 15.0 tt0 -134.05 179.54 6.19 Favored 'General case' 0 CA--C 1.567 1.597 0 CA-C-O 121.817 0.817 . . . . 0.0 109.659 -175.233 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.49 157.77 45.83 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-O 122.515 1.15 . . . . 0.0 112.7 -178.865 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 33.2 t30 -150.62 82.59 1.35 Allowed 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 106.257 -1.757 . . . . 0.0 106.257 167.739 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 76.23 -107.96 2.46 Favored Glycine 0 CA--C 1.547 2.072 0 N-CA-C 111.944 -0.462 . . . . 0.0 111.944 -165.15 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -122.68 61.15 1.0 Allowed 'General case' 0 N--CA 1.493 1.696 0 CA-C-O 121.133 0.492 . . . . 0.0 109.9 159.279 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 39.4 mm -124.84 94.86 2.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 N-CA-C 103.368 -2.827 . . . . 0.0 103.368 172.04 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 36.1 mt -89.81 105.5 17.84 Favored 'General case' 0 N--CA 1.483 1.196 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.683 -165.508 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 85.5 m -97.32 100.6 12.05 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 -165.908 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 9.2 tt -101.9 100.86 11.21 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 107.802 -1.185 . . . . 0.0 107.802 -177.406 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -100.01 106.3 18.06 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 179.856 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 96.3 m -93.38 102.81 15.06 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 -179.616 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 31.4 m-70 -89.98 85.13 6.26 Favored 'General case' 0 N--CA 1.493 1.709 0 CA-C-O 122.132 0.968 . . . . 0.0 110.98 -174.408 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 24.7 t . . . . . 0 N--CA 1.485 1.319 0 CA-C-N 115.165 -0.925 . . . . 0.0 111.078 173.405 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 7.3 p30 . . . . . 0 N--CA 1.491 1.605 0 N-CA-C 111.985 0.365 . . . . 0.0 111.985 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 76.3 p -91.39 128.04 37.06 Favored 'General case' 0 N--CA 1.493 1.683 0 C-N-CA 122.809 0.444 . . . . 0.0 111.433 -173.516 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -111.23 115.92 30.17 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 179.303 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 35.4 pt -114.72 130.42 69.16 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 171.475 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 71.2 p -117.95 116.39 26.82 Favored 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 123.751 0.82 . . . . 0.0 108.983 -179.499 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 51.1 p90 -140.26 140.4 35.74 Favored 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 115.115 1.524 . . . . 0.0 115.115 -160.109 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 52.8 mtmt -102.81 14.3 32.28 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 117.29 2.33 . . . . 0.0 117.29 -172.69 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . 0.291 3.2 mp 61.74 98.81 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.731 0 CA-C-N 120.692 1.587 . . . . 0.0 114.484 177.173 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 86.22 37.27 9.16 Favored Glycine 0 CA--C 1.553 2.419 0 N-CA-C 116.859 1.504 . . . . 0.0 116.859 -167.441 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 88.0 t -139.21 124.67 21.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 -178.569 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -88.76 123.66 33.39 Favored 'General case' 0 CA--C 1.562 1.406 0 C-N-CA 123.55 0.74 . . . . 0.0 110.526 173.846 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 40.1 p90 -130.35 124.49 32.37 Favored 'General case' 0 N--CA 1.494 1.754 0 C-N-CA 123.605 0.762 . . . . 0.0 110.42 -175.152 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -71.07 117.41 12.54 Favored 'General case' 0 CA--C 1.564 1.512 0 O-C-N 121.599 -0.688 . . . . 0.0 112.505 177.209 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 12.2 tp10 -126.99 133.91 50.47 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 123.742 0.817 . . . . 0.0 110.091 -167.882 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 45.3 m -91.23 122.83 34.2 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 176.239 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 33.9 p -83.56 167.22 17.56 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 113.019 0.748 . . . . 0.0 113.019 -174.504 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -53.82 -28.01 32.89 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 118.646 2.832 . . . . 0.0 118.646 168.541 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -74.6 -91.14 0.02 OUTLIER 'General case' 0 CA--C 1.57 1.733 0 CA-C-N 119.734 1.152 . . . . 0.0 109.076 168.269 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -176.17 90.16 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 105.143 -2.169 . . . . 0.0 105.143 158.55 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 45.8 mtt-85 -142.19 123.07 14.4 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 122.257 -0.277 . . . . 0.0 110.371 -171.711 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.586 ' H ' ' HD3' ' A' ' 79' ' ' LYS . 0.0 OUTLIER -80.47 93.77 6.09 Favored 'General case' 0 CA--C 1.564 1.511 0 C-N-CA 124.094 0.958 . . . . 0.0 110.679 172.413 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 13.4 m -112.03 130.54 65.51 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 C-N-CA 122.998 0.519 . . . . 0.0 110.676 -167.559 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 1.5 mptm? -84.34 98.53 10.08 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 123.808 0.843 . . . . 0.0 109.339 -179.332 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 72.2 m -94.2 98.25 10.82 Favored 'General case' 0 N--CA 1.483 1.191 0 CA-C-N 115.133 -0.939 . . . . 0.0 110.933 -166.139 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 6.4 tp -107.77 115.44 48.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 -179.295 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.0 p -133.15 131.66 58.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 C-N-CA 124.03 0.932 . . . . 0.0 109.673 -172.639 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 15.1 t -143.68 159.9 41.65 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-O 122.495 1.14 . . . . 0.0 110.577 177.213 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 18.2 tp -93.9 107.13 19.06 Favored 'General case' 0 N--CA 1.489 1.506 0 CA-C-N 115.162 -0.926 . . . . 0.0 108.633 172.129 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -102.88 84.58 2.4 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 123.382 0.673 . . . . 0.0 109.662 -171.84 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 56.5 48.35 76.96 Favored Glycine 0 CA--C 1.548 2.141 0 N-CA-C 117.608 1.803 . . . . 0.0 117.608 -176.088 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 100.38 -47.6 1.25 Allowed Glycine 0 N--CA 1.489 2.172 0 N-CA-C 116.215 1.246 . . . . 0.0 116.215 -166.657 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 30.9 ttpt -84.62 116.33 23.12 Favored 'General case' 0 CA--C 1.556 1.2 0 CA-C-N 117.915 0.858 . . . . 0.0 111.131 -170.075 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 3.0 tt -88.05 101.77 14.11 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-O 121.686 0.755 . . . . 0.0 109.659 -173.005 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 54.3 t -104.66 107.4 22.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 -168.418 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 19.9 t-160 -99.35 140.1 34.02 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 123.943 0.897 . . . . 0.0 109.655 169.679 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 15.6 tp -138.9 124.91 19.96 Favored 'General case' 0 N--CA 1.488 1.44 0 CA-C-O 122.03 0.919 . . . . 0.0 108.803 175.557 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -107.92 126.62 52.9 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 124.603 1.161 . . . . 0.0 108.378 178.537 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -125.45 133.2 52.53 Favored 'General case' 0 N--CA 1.496 1.847 0 C-N-CA 122.986 0.514 . . . . 0.0 110.571 -173.734 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 22.9 p90 -158.18 114.57 2.8 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.125 -0.985 . . . . 0.0 110.5 -176.034 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 11.1 t70 50.21 58.07 5.89 Favored 'General case' 0 N--CA 1.503 2.176 0 N-CA-C 116.704 2.112 . . . . 0.0 116.704 163.508 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 80.89 -25.22 3.56 Favored Glycine 0 CA--C 1.559 2.79 0 N-CA-C 119.212 2.445 . . . . 0.0 119.212 -171.327 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 66.7 mt-30 -102.01 133.79 46.26 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 124.785 1.234 . . . . 0.0 110.464 -179.044 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -141.38 135.78 30.77 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.341 -0.849 . . . . 0.0 112.416 173.165 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 14.9 t -117.13 129.21 55.82 Favored 'General case' 0 N--CA 1.496 1.857 0 C-N-CA 123.302 0.641 . . . . 0.0 111.506 177.635 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 40.3 p -94.7 120.43 34.91 Favored 'General case' 0 N--CA 1.493 1.715 0 C-N-CA 123.306 0.642 . . . . 0.0 110.028 172.346 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 5.2 mp -103.56 90.86 3.8 Favored 'General case' 0 CA--C 1.562 1.428 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 174.729 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 92.9 t -94.99 102.66 13.84 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 N-CA-C 107.567 -1.272 . . . . 0.0 107.567 -174.294 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.413 HH11 HD11 ' A' ' 42' ' ' ILE . 45.8 mtt180 -91.5 128.08 37.19 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 122.966 0.506 . . . . 0.0 109.652 172.45 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -147.81 129.56 15.16 Favored 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 123.197 0.599 . . . . 0.0 110.429 -172.035 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -77.11 121.14 23.17 Favored 'General case' 0 N--CA 1.487 1.404 0 CA-C-O 121.865 0.841 . . . . 0.0 112.736 178.647 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . 0.279 1.5 mp -76.41 171.89 1.22 Allowed 'Isoleucine or valine' 0 CA--C 1.575 1.938 0 CA-C-N 114.94 -1.027 . . . . 0.0 109.231 143.12 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -68.62 73.72 0.25 Allowed 'General case' 0 CA--C 1.565 1.543 0 N-CA-C 114.866 1.432 . . . . 0.0 114.866 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 121.22 -56.95 0.61 Allowed Glycine 0 N--CA 1.485 1.911 0 CA-C-N 114.093 -1.412 . . . . 0.0 113.781 -171.003 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 51.1 mttp -91.12 139.72 30.49 Favored 'General case' 0 N--CA 1.487 1.376 0 CA-C-O 121.713 0.768 . . . . 0.0 112.172 -173.307 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 25.1 tp -92.9 135.93 33.7 Favored 'General case' 0 CA--C 1.557 1.247 0 C-N-CA 123.605 0.762 . . . . 0.0 110.741 173.783 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 44.5 mm -114.18 108.68 26.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 -178.156 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 48.8 tp -93.58 106.21 18.2 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 123.813 0.845 . . . . 0.0 109.195 173.108 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 83.7 m -97.74 112.56 24.4 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 -179.669 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 92.9 mt -106.88 98.48 8.14 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 123.698 0.799 . . . . 0.0 109.483 -173.09 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 7.5 m -109.88 115.65 30.2 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 -175.526 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 86.1 t60 -134.21 116.19 15.05 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 108.507 -0.924 . . . . 0.0 108.507 173.147 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 75.2 -111.14 3.26 Favored Glycine 0 N--CA 1.484 1.845 0 C-N-CA 122.928 0.299 . . . . 0.0 113.011 176.167 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 73.4 p -122.37 68.55 0.95 Allowed 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 108.987 -0.745 . . . . 0.0 108.987 163.763 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -160.37 93.96 1.06 Allowed 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 123.368 0.667 . . . . 0.0 109.533 178.674 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 4.9 p -96.51 121.75 47.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 C-N-CA 123.797 0.839 . . . . 0.0 109.801 175.713 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 124' ' ' CYS . . . . . 0.431 ' SG ' ' HB2' ' A' ' 16' ' ' PHE . 43.8 t -116.91 105.46 12.37 Favored 'General case' 0 CA--C 1.555 1.149 0 C-N-CA 123.334 0.654 . . . . 0.0 110.544 -179.466 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 91.7 m -92.54 105.34 17.53 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 123.648 0.779 . . . . 0.0 109.073 -175.252 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 53.6 mtp180 -105.64 116.99 32.88 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 123.144 0.578 . . . . 0.0 109.596 -172.53 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 41.7 m -86.73 141.37 28.94 Favored 'General case' 0 N--CA 1.493 1.701 0 C-N-CA 123.717 0.807 . . . . 0.0 110.511 178.765 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 40.6 m-85 -137.84 135.13 35.92 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 124.094 0.958 . . . . 0.0 109.497 -175.07 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -102.14 155.18 18.37 Favored 'General case' 0 N--CA 1.495 1.778 0 CA-C-O 122.421 1.105 . . . . 0.0 111.712 166.057 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 71.0 tttt -88.33 124.28 33.74 Favored 'General case' 0 N--CA 1.483 1.209 0 CA-C-N 115.199 -0.91 . . . . 0.0 111.816 -168.931 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -99.17 49.48 0.95 Allowed 'General case' 0 CA--C 1.57 1.738 0 C-N-CA 123.58 0.752 . . . . 0.0 112.354 170.541 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.129 0 CA-C-O 123.2 1.476 . . . . 0.0 108.252 -176.287 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 4.6 p . . . . . 0 CA--C 1.576 1.972 0 N-CA-C 116.227 1.936 . . . . 0.0 116.227 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -66.19 -35.43 80.44 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 116.669 2.1 . . . . 0.0 116.669 -176.045 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -61.0 -27.08 68.05 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 117.514 2.413 . . . . 0.0 117.514 168.128 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -72.18 -20.2 61.62 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 116.037 1.865 . . . . 0.0 116.037 168.962 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 55.0 mt -78.29 119.65 21.95 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-N 121.034 1.743 . . . . 0.0 111.69 -171.745 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 163.87 175.9 35.22 Favored Glycine 0 N--CA 1.481 1.666 0 CA-C-O 122.251 0.917 . . . . 0.0 113.239 -177.766 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 63.1 m -92.3 137.28 32.49 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 167.847 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 87.3 m95 -138.6 112.58 8.51 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 -170.142 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 52.4 mtmt -99.94 144.37 29.08 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 123.103 0.561 . . . . 0.0 110.228 178.93 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 25.0 tp -67.72 131.66 46.0 Favored 'General case' 0 N--CA 1.488 1.427 0 CA-C-O 122.371 1.082 . . . . 0.0 112.419 -177.609 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . 0.285 1.0 OUTLIER -111.81 -47.81 6.03 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.797 0 CA-C-N 113.669 -1.605 . . . . 0.0 110.875 179.054 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -137.07 140.12 41.79 Favored 'General case' 0 N--CA 1.487 1.412 0 CA-C-N 119.566 1.075 . . . . 0.0 109.505 175.539 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 78.8 p -132.94 114.48 14.06 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 168.444 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -77.22 -72.41 0.35 Allowed 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 112.532 0.567 . . . . 0.0 112.532 -172.614 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 62.6 m-80 -105.41 47.12 0.89 Allowed 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 113.291 0.848 . . . . 0.0 113.291 -178.854 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 11.9 t80 -92.74 74.18 4.96 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.795 -1.191 . . . . 0.0 110.352 177.993 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 179.76 -59.82 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 126.082 1.753 . . . . 0.0 106.648 -168.793 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 22.8 t0 -58.42 -46.65 86.06 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 115.01 1.485 . . . . 0.0 115.01 163.85 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 90.0 t80 -51.9 -55.07 22.43 Favored 'General case' 0 CA--C 1.57 1.735 0 N-CA-C 114.896 1.443 . . . . 0.0 114.896 170.315 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 72.9 mtm -62.84 -39.21 93.65 Favored 'General case' 0 CA--C 1.567 1.626 0 N-CA-C 115.947 1.832 . . . . 0.0 115.947 174.816 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 28.9 ttpp -58.63 -46.56 86.82 Favored 'General case' 0 CA--C 1.569 1.686 0 N-CA-C 115.115 1.524 . . . . 0.0 115.115 168.685 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 16.7 t -62.01 -34.83 76.92 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 116.59 2.07 . . . . 0.0 116.59 172.57 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 86.2 mt -65.31 -44.25 88.49 Favored 'General case' 0 CA--C 1.567 1.616 0 N-CA-C 115.64 1.718 . . . . 0.0 115.64 167.929 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 113.95 70.35 0.52 Allowed Glycine 0 N--CA 1.483 1.808 0 C-N-CA 123.966 0.793 . . . . 0.0 111.889 -172.058 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 66.8 t -127.67 122.27 58.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 N-CA-C 105.586 -2.005 . . . . 0.0 105.586 -176.785 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -63.25 153.92 45.28 Favored Glycine 0 CA--C 1.549 2.211 0 N-CA-C 115.801 1.08 . . . . 0.0 115.801 177.81 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 31.5 p90 -55.2 -42.78 73.73 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 118.663 2.838 . . . . 0.0 118.663 -167.191 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.85 -43.28 93.55 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 115.75 1.759 . . . . 0.0 115.75 175.307 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 63.2 m -69.38 -37.83 77.73 Favored 'General case' 0 N--CA 1.497 1.924 0 N-CA-C 114.185 1.18 . . . . 0.0 114.185 170.689 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 45.5 ttp85 -59.46 -45.37 91.8 Favored 'General case' 0 CA--C 1.57 1.728 0 N-CA-C 115.151 1.537 . . . . 0.0 115.151 171.528 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 46.4 mt-30 -72.71 -39.89 66.6 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 115.104 1.52 . . . . 0.0 115.104 176.077 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 69.4 t -63.68 -48.18 87.84 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 CA-C-N 119.943 1.247 . . . . 0.0 112.443 170.446 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -61.89 -31.17 71.44 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 117.595 2.442 . . . . 0.0 117.595 177.435 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 84.0 p -62.91 -47.04 84.98 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 115.96 1.837 . . . . 0.0 115.96 169.484 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 51.9 tpp -70.76 -34.49 71.89 Favored 'General case' 0 CA--C 1.572 1.824 0 N-CA-C 116.13 1.9 . . . . 0.0 116.13 170.731 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 46.4 m -66.48 144.06 56.71 Favored 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 124.825 1.25 . . . . 0.0 112.538 -179.22 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -108.08 99.89 33.59 Favored Pre-proline 0 CA--C 1.571 1.753 0 CA-C-O 118.38 -0.819 . . . . 0.0 110.028 -177.366 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -75.48 141.68 25.59 Favored 'Trans proline' 0 CA--C 1.561 1.839 0 C-N-CA 123.206 2.604 . . . . 0.0 114.077 -179.689 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 100.0 m -107.47 100.74 10.14 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 -174.135 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 44.2 m -90.72 111.33 22.64 Favored 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 123.666 0.786 . . . . 0.0 109.448 -175.133 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 47.5 mt -102.82 108.09 23.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 N-CA-C 106.629 -1.619 . . . . 0.0 106.629 -178.768 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 33.7 mt -101.91 115.12 43.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 N-CA-C 106.744 -1.576 . . . . 0.0 106.744 -178.641 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -139.39 112.13 7.85 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 -171.385 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 28.1 ttpp -84.4 112.0 19.95 Favored 'General case' 0 CA--C 1.561 1.37 0 CA-C-O 121.43 0.633 . . . . 0.0 110.212 174.911 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 19.6 t-20 -100.57 92.49 5.15 Favored 'General case' 0 N--CA 1.485 1.32 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 -175.942 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 77.03 -99.64 1.42 Allowed Glycine 0 N--CA 1.485 1.939 0 N-CA-C 111.197 -0.761 . . . . 0.0 111.197 -166.094 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 25.1 m-20 -133.43 63.52 1.63 Allowed 'General case' 0 N--CA 1.494 1.748 0 CA-C-O 121.073 0.463 . . . . 0.0 109.844 160.17 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 27.2 mm -139.47 104.63 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 N-CA-C 104.994 -2.224 . . . . 0.0 104.994 177.348 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 35.9 mt -74.94 110.58 9.35 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 122.873 0.469 . . . . 0.0 111.527 177.703 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 38.3 m -105.41 101.84 11.35 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 106.266 -1.754 . . . . 0.0 106.266 -179.65 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 9.4 tt -104.65 108.64 20.2 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 -174.241 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 43.7 mttp -109.5 96.81 6.53 Favored 'General case' 0 N--CA 1.483 1.175 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 -165.647 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 60.0 m -87.95 92.7 9.23 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 -177.377 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 70.2 m80 -83.54 91.65 7.46 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 123.824 0.85 . . . . 0.0 110.191 -176.271 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 82.5 p . . . . . 0 N--CA 1.489 1.518 0 N-CA-C 118.427 2.751 . . . . 0.0 118.427 -167.237 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 111.914 0.339 . . . . 0.0 111.914 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 45.6 p -97.98 130.89 44.81 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-O 121.212 0.53 . . . . 0.0 110.949 -173.471 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 5.4 mp0 -115.65 129.76 56.61 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 123.382 0.673 . . . . 0.0 109.84 179.76 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 49.3 pt -112.79 126.05 70.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 N-CA-C 108.091 -1.078 . . . . 0.0 108.091 168.638 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 39.0 t -109.54 109.68 20.54 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 107.208 -1.405 . . . . 0.0 107.208 175.704 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 42.9 p90 -140.34 141.8 35.64 Favored 'General case' 0 N--CA 1.489 1.501 0 CA-C-O 122.25 1.024 . . . . 0.0 113.737 -164.447 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 55.1 mtmt -100.87 150.96 22.29 Favored 'General case' 0 CA--C 1.562 1.437 0 CA-C-N 114.478 -1.237 . . . . 0.0 109.061 159.729 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -74.46 115.48 14.05 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.564 -0.71 . . . . 0.0 111.894 -171.426 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 89.31 44.59 4.95 Favored Glycine 0 CA--C 1.549 2.186 0 N-CA-C 116.582 1.393 . . . . 0.0 116.582 -166.688 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 92.3 t -136.0 123.66 35.17 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 178.345 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -87.73 132.67 34.05 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 123.464 0.705 . . . . 0.0 110.791 170.668 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 44.9 p90 -145.55 134.42 22.45 Favored 'General case' 0 N--CA 1.494 1.739 0 C-N-CA 123.318 0.647 . . . . 0.0 110.556 -174.399 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -73.04 117.88 15.31 Favored 'General case' 0 CA--C 1.564 1.481 0 O-C-N 121.558 -0.713 . . . . 0.0 112.644 178.207 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 15.1 tp10 -128.97 134.15 48.08 Favored 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 123.626 0.77 . . . . 0.0 110.088 -170.681 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 51.9 m -92.7 121.91 34.58 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 174.097 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 27.1 p -84.31 174.5 10.1 Favored 'General case' 0 N--CA 1.494 1.726 0 CA-C-O 121.663 0.744 . . . . 0.0 112.869 -175.013 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -60.07 -34.68 73.77 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 116.815 2.154 . . . . 0.0 116.815 171.258 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -89.02 31.66 0.86 Allowed 'General case' 0 CA--C 1.58 2.1 0 N-CA-C 114.601 1.334 . . . . 0.0 114.601 167.394 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 22.5 m-20 53.34 67.82 0.94 Allowed 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 115.057 1.503 . . . . 0.0 115.057 174.768 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 46.1 mtm105 -137.64 120.98 16.98 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 109.036 -0.728 . . . . 0.0 109.036 -175.74 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.06 108.99 8.17 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 123.379 0.671 . . . . 0.0 111.305 169.444 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 17.7 m -125.39 142.15 43.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 CA-C-O 121.335 0.588 . . . . 0.0 110.302 -168.912 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 4.7 mptp? -85.62 98.01 10.42 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 123.629 0.772 . . . . 0.0 109.122 176.575 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 58.0 m -91.38 93.37 9.0 Favored 'General case' 0 N--CA 1.485 1.283 0 CA-C-N 115.262 -0.881 . . . . 0.0 111.12 -170.549 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 6.8 tp -104.71 116.73 49.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 178.322 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 1.5 p -136.52 122.56 29.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 C-N-CA 123.343 0.657 . . . . 0.0 109.55 -169.856 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 14.9 t -136.88 157.5 46.61 Favored 'General case' 0 N--CA 1.491 1.592 0 CA-C-O 122.629 1.204 . . . . 0.0 111.351 178.384 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 15.2 tp -95.37 119.78 34.47 Favored 'General case' 0 N--CA 1.489 1.514 0 CA-C-N 114.768 -1.106 . . . . 0.0 110.067 177.832 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -106.52 81.23 1.57 Allowed 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 123.205 0.602 . . . . 0.0 110.604 -178.204 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 61.06 46.52 94.38 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 117.673 1.829 . . . . 0.0 117.673 -177.096 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 75.03 35.96 48.03 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 118.206 2.043 . . . . 0.0 118.206 -168.341 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -145.93 104.36 3.84 Favored 'General case' 0 CA--C 1.553 1.077 0 N-CA-C 105.369 -2.086 . . . . 0.0 105.369 -177.774 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -86.33 121.42 28.88 Favored 'General case' 0 N--CA 1.481 1.12 0 CA-C-O 121.903 0.858 . . . . 0.0 110.989 -170.853 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 61.2 t -122.98 107.42 19.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 N-CA-C 106.103 -1.814 . . . . 0.0 106.103 -166.138 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 20.6 t-160 -110.75 113.34 25.85 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 123.777 0.831 . . . . 0.0 109.78 179.514 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 31.5 tp -107.74 123.25 48.26 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 123.775 0.83 . . . . 0.0 108.857 177.925 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -110.86 120.8 43.58 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 178.186 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -117.39 137.63 52.35 Favored 'General case' 0 N--CA 1.495 1.796 0 CA-C-N 118.675 0.67 . . . . 0.0 111.134 -178.401 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 22.7 p90 -155.82 109.08 2.72 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.419 -0.8 . . . . 0.0 109.892 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 5.5 t70 55.96 50.16 14.41 Favored 'General case' 0 N--CA 1.499 2.015 0 N-CA-C 116.237 1.94 . . . . 0.0 116.237 168.999 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 86.99 -43.82 3.26 Favored Glycine 0 CA--C 1.552 2.396 0 N-CA-C 116.706 1.443 . . . . 0.0 116.706 -168.85 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 64.4 mt-30 -73.68 132.23 42.48 Favored 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 123.874 0.87 . . . . 0.0 111.571 179.372 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -141.77 135.02 29.3 Favored 'General case' 0 N--CA 1.49 1.542 0 CA-C-O 121.202 0.525 . . . . 0.0 112.237 176.553 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 13.7 t -118.07 133.26 56.08 Favored 'General case' 0 N--CA 1.495 1.79 0 CA-C-N 115.597 -0.728 . . . . 0.0 111.087 176.818 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 37.4 p -101.84 135.25 43.72 Favored 'General case' 0 N--CA 1.494 1.736 0 CA-C-O 122.057 0.932 . . . . 0.0 110.713 171.047 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 5.4 mp -118.26 85.52 2.37 Favored 'General case' 0 CA--C 1.562 1.415 0 N-CA-C 106.535 -1.654 . . . . 0.0 106.535 -178.575 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 99.5 t -95.02 103.66 14.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 -168.866 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 83.7 mtt85 -94.58 129.29 41.47 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 123.794 0.838 . . . . 0.0 110.181 179.416 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -146.91 132.23 18.51 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 122.849 0.459 . . . . 0.0 110.837 -176.741 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -80.6 114.73 19.7 Favored 'General case' 0 N--CA 1.486 1.337 0 CA-C-O 121.328 0.585 . . . . 0.0 111.315 179.506 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 48.3 mm -118.56 105.06 17.01 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.361 0 N-CA-C 105.075 -2.194 . . . . 0.0 105.075 175.362 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 58.68 50.4 8.95 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 115.204 1.557 . . . . 0.0 115.204 175.854 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 65.6 25.56 71.61 Favored Glycine 0 CA--C 1.555 2.583 0 N-CA-C 119.351 2.501 . . . . 0.0 119.351 -171.072 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 92.6 mttt -133.78 128.45 34.82 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-N 119.203 1.501 . . . . 0.0 108.678 -173.663 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 15.0 tp -78.53 109.71 12.96 Favored 'General case' 0 CA--C 1.558 1.288 0 C-N-CA 123.272 0.629 . . . . 0.0 110.306 -179.917 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 31.8 mm -98.95 97.34 5.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 N-CA-C 107.192 -1.41 . . . . 0.0 107.192 -175.919 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 24.6 tp -91.21 104.19 16.78 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 123.972 0.909 . . . . 0.0 109.996 -179.85 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 85.1 m -96.1 108.76 21.23 Favored 'General case' 0 CA--C 1.562 1.43 0 C-N-CA 124.0 0.92 . . . . 0.0 108.804 -176.277 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 92.4 mt -103.04 103.68 13.79 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 123.537 0.735 . . . . 0.0 109.956 -174.491 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 12.8 m -112.18 117.39 32.44 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 -175.402 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 73.5 t60 -152.84 117.16 4.93 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 174.496 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 60.41 61.9 6.59 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 117.418 1.727 . . . . 0.0 117.418 169.462 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . 0.291 3.2 m 52.36 50.28 18.67 Favored 'General case' 0 CA--C 1.576 1.97 0 N-CA-C 114.878 1.436 . . . . 0.0 114.878 -172.206 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -158.87 87.85 0.88 Allowed 'General case' 0 N--CA 1.485 1.291 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 -178.708 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 3.6 p -94.73 113.66 29.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 C-N-CA 123.649 0.78 . . . . 0.0 109.348 175.62 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 45.9 t -103.99 105.62 15.86 Favored 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 123.081 0.552 . . . . 0.0 110.062 176.585 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 91.8 m -90.06 103.52 16.18 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 -179.533 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 69.0 mtp180 -104.02 114.64 29.03 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 123.042 0.537 . . . . 0.0 109.893 -166.929 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 91.1 m -84.15 129.07 34.92 Favored 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 122.882 0.473 . . . . 0.0 109.905 176.188 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 40.7 m-85 -125.81 127.69 46.51 Favored 'General case' 0 CA--C 1.558 1.253 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 176.241 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -95.34 157.01 16.08 Favored 'General case' 0 N--CA 1.493 1.699 0 CA-C-O 122.431 1.11 . . . . 0.0 111.572 171.08 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 72.8 tttt -91.04 126.37 36.11 Favored 'General case' 0 N--CA 1.484 1.262 0 CA-C-N 115.423 -0.808 . . . . 0.0 112.51 -164.064 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -99.84 51.1 0.92 Allowed 'General case' 0 N--CA 1.497 1.92 0 CA-C-O 121.912 0.863 . . . . 0.0 111.383 167.88 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.063 0 CA-C-O 123.216 1.484 . . . . 0.0 107.638 -177.459 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.265 5.9 p . . . . . 0 CA--C 1.576 1.955 0 N-CA-C 116.376 1.991 . . . . 0.0 116.376 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -65.71 -37.84 87.53 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 116.449 2.018 . . . . 0.0 116.449 -178.61 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -59.56 -29.85 68.22 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 117.313 2.338 . . . . 0.0 117.313 167.909 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -69.98 -23.55 63.18 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 116.287 1.958 . . . . 0.0 116.287 168.337 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 58.5 mt -75.0 120.02 19.97 Favored 'General case' 0 N--CA 1.49 1.539 0 CA-C-N 121.028 1.74 . . . . 0.0 111.689 -173.645 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 160.29 176.39 32.33 Favored Glycine 0 CA--C 1.541 1.708 0 CA-C-O 122.447 1.026 . . . . 0.0 113.744 -176.007 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 75.2 m -93.22 135.46 34.4 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 170.495 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 94.2 m95 -138.4 115.63 11.06 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 -169.796 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 24.9 mmmt -102.17 145.65 29.08 Favored 'General case' 0 N--CA 1.492 1.628 0 CA-C-O 121.536 0.684 . . . . 0.0 111.021 178.933 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 43.9 tp -70.13 125.42 26.73 Favored 'General case' 0 N--CA 1.489 1.477 0 CA-C-O 122.039 0.923 . . . . 0.0 112.118 -176.852 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . 0.275 1.0 OUTLIER -107.84 -39.26 4.32 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.883 0 CA-C-N 113.997 -1.456 . . . . 0.0 112.435 -178.701 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -137.21 138.0 39.7 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-N 120.305 1.411 . . . . 0.0 109.64 176.15 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 78.3 p -121.56 103.47 8.94 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 167.624 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 8.9 tmtm? -79.92 -78.35 0.17 Allowed 'General case' 0 N--CA 1.491 1.602 0 CA-C-O 118.877 -0.582 . . . . 0.0 112.554 -167.309 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 85.0 m-20 -105.15 48.26 0.84 Allowed 'General case' 0 N--CA 1.498 1.967 0 CA-C-N 118.89 0.768 . . . . 0.0 112.795 177.684 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 10.0 t80 -92.09 75.78 5.44 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.704 -1.247 . . . . 0.0 110.973 -174.341 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -172.21 -61.27 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 124.668 1.187 . . . . 0.0 108.987 -168.967 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 12.3 t0 -61.66 -38.29 87.2 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 115.859 1.8 . . . . 0.0 115.859 166.924 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 87.9 t80 -48.74 -53.86 17.28 Favored 'General case' 0 CA--C 1.574 1.893 0 N-CA-C 114.755 1.391 . . . . 0.0 114.755 163.592 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 56.8 mtm -66.24 -29.98 70.34 Favored 'General case' 0 CA--C 1.571 1.768 0 N-CA-C 116.549 2.055 . . . . 0.0 116.549 171.735 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 55.8 mttp -61.18 -48.65 80.56 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 114.942 1.46 . . . . 0.0 114.942 166.459 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 23.1 t -66.26 -32.44 73.86 Favored 'General case' 0 CA--C 1.567 1.599 0 N-CA-C 116.465 2.024 . . . . 0.0 116.465 173.248 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 65.2 mt -66.27 -43.64 85.87 Favored 'General case' 0 CA--C 1.565 1.522 0 N-CA-C 116.084 1.883 . . . . 0.0 116.084 172.372 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 105.84 86.67 1.92 Allowed Glycine 0 N--CA 1.482 1.742 0 N-CA-C 110.744 -0.943 . . . . 0.0 110.744 -170.098 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 41.3 t -140.61 144.11 27.83 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 N-CA-C 107.575 -1.269 . . . . 0.0 107.575 -174.455 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -73.13 163.08 54.91 Favored Glycine 0 CA--C 1.552 2.361 0 O-C-N 120.958 -1.089 . . . . 0.0 115.137 169.045 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 25.2 p90 -62.93 -39.61 95.1 Favored 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 117.071 2.249 . . . . 0.0 117.071 -178.962 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.45 -45.08 94.71 Favored 'General case' 0 CA--C 1.56 1.347 0 N-CA-C 115.777 1.769 . . . . 0.0 115.777 177.799 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . 0.288 0.6 OUTLIER -81.51 -19.07 42.96 Favored 'General case' 0 N--CA 1.499 2.002 0 N-CA-C 116.177 1.917 . . . . 0.0 116.177 173.141 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 34.3 ttm105 -61.58 -46.92 87.83 Favored 'General case' 0 CA--C 1.57 1.744 0 CA-C-N 121.18 1.809 . . . . 0.0 113.646 160.756 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 22.7 tt0 -62.99 -49.42 74.78 Favored 'General case' 0 CA--C 1.563 1.473 0 N-CA-C 115.282 1.586 . . . . 0.0 115.282 171.414 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 89.1 t -63.66 -43.82 98.25 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 CA-C-O 117.273 -1.346 . . . . 0.0 112.983 174.345 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -63.07 -41.17 99.38 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 116.478 2.029 . . . . 0.0 116.478 177.754 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 97.3 p -61.15 -42.64 98.92 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 116.619 2.081 . . . . 0.0 116.619 168.254 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 48.1 ttp -66.61 -36.85 83.6 Favored 'General case' 0 CA--C 1.572 1.824 0 N-CA-C 116.421 2.008 . . . . 0.0 116.421 169.95 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 52.3 m -73.29 135.19 44.39 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 124.28 1.032 . . . . 0.0 111.807 -175.578 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -103.74 102.28 29.73 Favored Pre-proline 0 CA--C 1.571 1.77 0 CA-C-N 114.554 -1.203 . . . . 0.0 109.81 175.228 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -76.44 126.19 8.87 Favored 'Trans proline' 0 CA--C 1.562 1.893 0 C-N-CA 123.235 2.624 . . . . 0.0 112.861 -178.134 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 15.4 m -84.59 107.05 16.61 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 -179.828 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 47.5 m -100.93 104.3 15.49 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 -168.614 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 48.9 mt -98.68 112.15 30.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 N-CA-C 106.991 -1.485 . . . . 0.0 106.991 -179.169 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 42.7 mt -106.31 115.11 47.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 N-CA-C 106.733 -1.58 . . . . 0.0 106.733 -177.435 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -139.38 115.06 10.02 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 -173.591 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 84.7 tttt -87.49 112.64 22.42 Favored 'General case' 0 CA--C 1.556 1.211 0 C-N-CA 123.075 0.55 . . . . 0.0 110.025 173.907 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 20.4 t-20 -82.65 -69.78 0.6 Allowed 'General case' 0 CA--C 1.564 1.496 0 C-N-CA 123.314 0.646 . . . . 0.0 111.298 -176.359 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -149.56 89.55 0.14 Allowed Glycine 0 N--CA 1.482 1.74 0 N-CA-C 108.867 -1.693 . . . . 0.0 108.867 172.241 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . 0.295 12.6 m-20 69.54 -20.05 0.18 Allowed 'General case' 0 N--CA 1.499 1.978 0 N-CA-C 117.569 2.433 . . . . 0.0 117.569 -164.519 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 16.4 mm -101.19 111.9 32.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 -171.055 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 16.2 mt -79.97 115.18 19.4 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 123.611 0.764 . . . . 0.0 110.797 173.47 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 44.3 m -104.0 96.34 6.61 Favored 'General case' 0 CA--C 1.56 1.338 0 N-CA-C 106.557 -1.645 . . . . 0.0 106.557 -176.5 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 9.1 tt -96.85 102.92 14.79 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 -179.271 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -97.42 107.87 20.47 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 123.721 0.808 . . . . 0.0 108.87 -173.154 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 34.7 m -95.14 90.98 6.09 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 -176.167 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 20.6 m170 -84.76 101.88 12.58 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 -174.053 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 23.4 t . . . . . 0 N--CA 1.485 1.312 0 C-N-CA 123.556 0.743 . . . . 0.0 110.335 -167.313 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 9.8 p30 . . . . . 0 N--CA 1.489 1.518 0 N-CA-C 112.475 0.546 . . . . 0.0 112.475 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 75.1 p -101.08 126.66 47.79 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-O 121.405 0.622 . . . . 0.0 110.617 -174.764 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -110.01 118.25 35.92 Favored 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 177.126 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 14.3 pt -107.66 126.71 64.0 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 178.799 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 77.9 p -115.87 109.24 17.35 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 -175.662 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 48.1 p90 -141.33 138.39 33.06 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 114.682 1.364 . . . . 0.0 114.682 -161.832 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 60.7 mtpt -95.95 145.6 25.28 Favored 'General case' 0 CA--C 1.562 1.432 0 CA-C-N 115.036 -0.984 . . . . 0.0 109.148 162.086 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -73.47 116.66 14.3 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.575 -0.703 . . . . 0.0 112.208 -173.171 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 79.9 40.61 14.05 Favored Glycine 0 CA--C 1.549 2.2 0 N-CA-C 117.013 1.565 . . . . 0.0 117.013 -170.428 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 91.6 t -139.3 117.76 12.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 N-CA-C 105.34 -2.096 . . . . 0.0 105.34 -179.209 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -81.41 132.25 35.32 Favored 'General case' 0 N--CA 1.49 1.53 0 CA-C-O 121.578 0.704 . . . . 0.0 111.267 178.905 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 19.5 p90 -134.28 145.55 49.2 Favored 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 124.158 0.983 . . . . 0.0 110.313 -174.133 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -73.44 128.55 35.81 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 123.204 0.602 . . . . 0.0 112.413 178.355 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -131.41 131.81 43.89 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 123.267 0.627 . . . . 0.0 109.785 -168.35 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 90.6 m -112.82 119.32 37.6 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 107.135 -1.431 . . . . 0.0 107.135 170.932 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 42.7 p -80.87 175.3 10.8 Favored 'General case' 0 N--CA 1.495 1.785 0 CA-C-N 115.545 -0.752 . . . . 0.0 112.745 -174.078 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -59.49 -40.07 85.82 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 116.193 1.923 . . . . 0.0 116.193 169.864 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -74.97 -7.41 53.54 Favored 'General case' 0 CA--C 1.578 2.039 0 N-CA-C 116.256 1.947 . . . . 0.0 116.256 165.571 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . 0.256 6.1 m-20 67.48 68.18 0.38 Allowed 'General case' 0 N--CA 1.496 1.874 0 C-N-CA 125.512 1.525 . . . . 0.0 111.714 -178.103 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 31.0 ttm-85 -116.38 18.04 15.32 Favored 'General case' 0 N--CA 1.498 1.926 0 N-CA-C 116.11 1.892 . . . . 0.0 116.11 -167.745 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . 0.31 0.1 OUTLIER 39.4 71.47 0.17 Allowed 'General case' 0 N--CA 1.499 1.982 0 N-CA-C 118.14 2.644 . . . . 0.0 118.14 176.023 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 4.5 m -112.1 144.07 20.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 CA-C-O 121.386 0.613 . . . . 0.0 111.172 -166.454 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 1.2 mppt? -97.99 102.32 14.04 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 174.898 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 61.5 p -93.56 113.98 26.23 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.577 0.751 . . . . 0.0 111.874 -170.267 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 5.7 tp -123.0 117.38 51.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 179.004 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 1.1 p -134.11 125.97 49.08 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 C-N-CA 123.786 0.834 . . . . 0.0 109.729 -174.96 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 15.3 t -132.29 152.0 51.58 Favored 'General case' 0 N--CA 1.495 1.807 0 CA-C-O 122.331 1.062 . . . . 0.0 112.32 178.811 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 53.5 tp -82.75 128.79 34.71 Favored 'General case' 0 N--CA 1.491 1.59 0 CA-C-N 114.644 -1.162 . . . . 0.0 110.067 170.704 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -131.45 83.42 2.1 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 123.444 0.698 . . . . 0.0 109.519 -179.046 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 58.51 47.23 91.1 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 117.863 1.905 . . . . 0.0 117.863 -178.822 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 76.32 37.74 35.75 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 117.571 1.788 . . . . 0.0 117.571 -167.646 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 36.3 ttmt -149.67 105.93 3.49 Favored 'General case' 0 N--CA 1.481 1.091 0 N-CA-C 106.572 -1.64 . . . . 0.0 106.572 -176.567 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 3.7 mp -79.97 114.41 18.86 Favored 'General case' 0 N--CA 1.485 1.288 0 CA-C-O 121.607 0.718 . . . . 0.0 109.811 172.979 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 95.3 t -109.78 101.76 13.03 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 N-CA-C 104.964 -2.236 . . . . 0.0 104.964 -173.713 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 23.1 t-160 -99.38 136.92 38.62 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 123.807 0.843 . . . . 0.0 109.69 178.11 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 24.8 tp -134.99 120.23 18.92 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 176.775 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 29.7 mt-30 -112.0 126.2 54.89 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 177.117 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 9.8 mtmp? -126.49 134.45 50.91 Favored 'General case' 0 N--CA 1.496 1.835 0 C-N-CA 122.989 0.515 . . . . 0.0 110.902 -170.58 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 25.8 p90 -152.38 116.12 4.83 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.469 -0.769 . . . . 0.0 110.433 -175.459 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . 0.344 12.6 t70 67.37 -101.76 0.06 Allowed 'General case' 0 N--CA 1.495 1.797 0 C-N-CA 124.515 1.126 . . . . 0.0 112.319 172.965 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -127.41 55.06 0.76 Allowed Glycine 0 N--CA 1.488 2.151 0 CA-C-N 118.96 0.8 . . . . 0.0 113.377 162.331 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 -154.34 129.98 9.98 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 -173.425 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -140.09 125.58 19.07 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.595 -0.691 . . . . 0.0 111.489 -179.311 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 14.3 t -107.94 134.03 51.44 Favored 'General case' 0 N--CA 1.495 1.782 0 C-N-CA 122.98 0.512 . . . . 0.0 110.534 173.911 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 33.7 p -100.74 134.81 43.15 Favored 'General case' 0 N--CA 1.492 1.669 0 CA-C-O 121.408 0.623 . . . . 0.0 110.77 168.826 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 5.3 mp -118.61 78.54 1.28 Allowed 'General case' 0 CA--C 1.561 1.404 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 178.202 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 62.8 t -86.53 103.41 12.94 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 121.108 -0.995 . . . . 0.0 108.489 -170.6 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 22.0 mmt180 -88.15 124.61 33.98 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 124.21 1.004 . . . . 0.0 109.71 177.081 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -149.52 127.86 12.17 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 122.115 -0.366 . . . . 0.0 111.455 -169.442 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -78.0 117.64 19.52 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.63 -0.669 . . . . 0.0 111.524 177.64 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 48.1 mm -117.58 100.41 10.12 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.312 0 N-CA-C 105.131 -2.174 . . . . 0.0 105.131 173.979 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 23.2 m-20 56.5 48.79 16.04 Favored 'General case' 0 N--CA 1.498 1.963 0 N-CA-C 115.094 1.516 . . . . 0.0 115.094 174.844 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 89.57 -42.14 3.0 Favored Glycine 0 CA--C 1.552 2.344 0 N-CA-C 117.35 1.7 . . . . 0.0 117.35 -169.53 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 50.7 mttp -83.06 128.69 34.7 Favored 'General case' 0 N--CA 1.487 1.4 0 CA-C-N 118.658 1.229 . . . . 0.0 111.842 -172.984 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 56.9 tp -86.08 116.33 24.23 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 123.486 0.714 . . . . 0.0 110.715 -177.354 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 33.5 mm -101.49 107.11 20.78 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 -172.09 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 52.7 tp -85.28 106.83 16.97 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 123.778 0.831 . . . . 0.0 109.359 171.399 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 75.5 m -99.73 106.14 18.02 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 -173.994 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 91.5 mt -103.78 96.44 6.7 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 123.274 0.63 . . . . 0.0 110.091 -169.699 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 9.2 m -111.68 116.06 30.14 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 -174.549 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 75.8 t60 -147.24 115.49 6.61 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 173.669 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 62.52 59.13 9.79 Favored Glycine 0 N--CA 1.488 2.143 0 N-CA-C 117.051 1.58 . . . . 0.0 117.051 172.475 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . 0.288 2.7 m 51.9 51.66 16.06 Favored 'General case' 0 CA--C 1.576 1.945 0 N-CA-C 115.129 1.529 . . . . 0.0 115.129 -172.445 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -157.24 89.26 1.05 Allowed 'General case' 0 N--CA 1.484 1.272 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 -179.614 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 4.8 p -94.34 116.28 35.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 C-N-CA 123.685 0.794 . . . . 0.0 109.88 178.187 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 42.9 t -103.69 110.3 22.33 Favored 'General case' 0 CA--C 1.553 1.058 0 C-N-CA 123.265 0.626 . . . . 0.0 110.026 174.252 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 79.8 m -90.64 97.76 11.37 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 -176.677 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 21.6 mtm180 -101.63 116.98 33.96 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 122.752 0.421 . . . . 0.0 111.042 -171.118 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 75.8 m -88.33 140.62 29.28 Favored 'General case' 0 N--CA 1.494 1.739 0 C-N-CA 123.544 0.737 . . . . 0.0 110.877 -177.214 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 34.6 m-85 -132.7 131.62 41.47 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 123.67 0.788 . . . . 0.0 109.825 -178.317 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -96.21 150.42 20.55 Favored 'General case' 0 N--CA 1.494 1.744 0 CA-C-O 122.121 0.963 . . . . 0.0 112.25 171.734 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 72.2 tttt -87.33 119.1 27.24 Favored 'General case' 0 N--CA 1.483 1.187 0 CA-C-N 115.142 -0.936 . . . . 0.0 111.149 -173.723 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 28.8 mm-40 -107.07 49.74 0.79 Allowed 'General case' 0 CA--C 1.567 1.629 0 C-N-CA 124.069 0.947 . . . . 0.0 111.709 178.566 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.035 0 CA-C-O 123.126 1.441 . . . . 0.0 108.397 -173.126 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 4.0 p . . . . . 0 CA--C 1.577 2.002 0 N-CA-C 116.028 1.862 . . . . 0.0 116.028 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 -63.77 -45.53 89.35 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 117.817 2.525 . . . . 0.0 117.817 -174.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -56.74 -25.54 55.11 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 118.084 2.624 . . . . 0.0 118.084 172.513 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -67.8 -30.68 70.17 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 116.181 1.919 . . . . 0.0 116.181 165.355 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 32.9 mt -72.05 107.01 4.53 Favored 'General case' 0 N--CA 1.489 1.496 0 CA-C-N 120.182 1.355 . . . . 0.0 111.445 -167.594 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 163.33 169.54 26.93 Favored Glycine 0 CA--C 1.544 1.864 0 CA-C-O 122.645 1.136 . . . . 0.0 113.581 -169.349 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 73.7 m -86.35 142.48 28.45 Favored 'General case' 0 N--CA 1.491 1.595 0 CA-C-N 114.266 -0.967 . . . . 0.0 110.071 170.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 77.5 m95 -143.87 117.21 9.04 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 -174.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -101.08 145.6 28.54 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.9 -0.5 . . . . 0.0 110.38 176.263 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 22.2 tp -68.12 122.86 19.16 Favored 'General case' 0 N--CA 1.49 1.564 0 CA-C-O 122.169 0.985 . . . . 0.0 111.757 -178.525 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . 0.282 0.9 OUTLIER -101.31 -46.87 11.51 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.8 0 CA-C-N 113.752 -1.567 . . . . 0.0 111.516 179.082 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -139.81 145.26 37.95 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-N 119.714 1.143 . . . . 0.0 109.647 175.788 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 79.7 p -131.67 89.42 2.7 Favored 'General case' 0 N--CA 1.491 1.613 0 CA-C-O 121.671 0.748 . . . . 0.0 110.091 168.448 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -78.29 127.39 32.17 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 123.534 0.734 . . . . 0.0 110.378 178.046 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.254 42.1 m-20 68.74 32.97 3.9 Favored 'General case' 0 N--CA 1.505 2.304 0 N-CA-C 116.391 1.997 . . . . 0.0 116.391 178.907 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 42.2 t80 -68.9 -62.95 1.17 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.631 -1.293 . . . . 0.0 113.09 -175.653 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -44.89 -36.02 3.11 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 118.637 2.829 . . . . 0.0 118.637 168.209 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -65.55 -48.67 71.61 Favored 'General case' 0 N--CA 1.498 1.944 0 CA-C-N 120.745 1.611 . . . . 0.0 114.64 172.413 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 85.7 t80 -55.38 -46.97 76.49 Favored 'General case' 0 CA--C 1.572 1.815 0 N-CA-C 115.179 1.548 . . . . 0.0 115.179 167.623 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 16.3 mmm -59.52 -42.52 92.44 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 115.493 1.664 . . . . 0.0 115.493 174.924 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 70.1 tttt -64.96 -41.05 95.81 Favored 'General case' 0 CA--C 1.568 1.64 0 N-CA-C 115.248 1.573 . . . . 0.0 115.248 170.091 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 50.9 m -56.74 -41.8 78.15 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 116.031 1.863 . . . . 0.0 116.031 171.859 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 45.4 mt -66.11 -36.83 84.22 Favored 'General case' 0 CA--C 1.565 1.532 0 N-CA-C 117.088 2.255 . . . . 0.0 117.088 168.353 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 100.08 78.98 1.4 Allowed Glycine 0 CA--C 1.54 1.622 0 CA-C-N 118.867 0.758 . . . . 0.0 111.644 -169.718 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 57.3 t -136.59 122.08 27.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 N-CA-C 105.48 -2.045 . . . . 0.0 105.48 -179.639 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -64.04 159.51 39.99 Favored Glycine 0 CA--C 1.548 2.125 0 N-CA-C 116.19 1.236 . . . . 0.0 116.19 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 27.8 p90 -56.27 -40.82 74.85 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 118.854 2.909 . . . . 0.0 118.854 -167.04 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.06 -42.01 81.11 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 116.022 1.86 . . . . 0.0 116.022 176.333 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 41.0 m -70.09 -39.94 75.28 Favored 'General case' 0 N--CA 1.499 1.986 0 CA-C-N 119.377 0.99 . . . . 0.0 113.663 171.069 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 68.1 ttt-85 -55.99 -42.77 76.86 Favored 'General case' 0 CA--C 1.571 1.766 0 N-CA-C 115.989 1.848 . . . . 0.0 115.989 168.933 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 25.6 tt0 -77.84 -42.79 32.42 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 115.355 1.613 . . . . 0.0 115.355 175.169 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 75.7 t -65.2 -41.62 92.09 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 CA-C-N 119.756 1.162 . . . . 0.0 113.011 174.858 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -64.36 -33.0 74.84 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 116.873 2.175 . . . . 0.0 116.873 172.301 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 93.3 p -67.05 -42.88 84.04 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 115.506 1.669 . . . . 0.0 115.506 167.422 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 42.5 ttm -60.89 -36.66 79.79 Favored 'General case' 0 CA--C 1.572 1.798 0 N-CA-C 116.135 1.902 . . . . 0.0 116.135 167.234 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 99.4 m -69.06 136.26 52.07 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 124.49 1.116 . . . . 0.0 111.328 176.589 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -108.35 92.43 9.76 Favored Pre-proline 0 CA--C 1.569 1.683 0 C-N-CA 123.824 0.85 . . . . 0.0 108.973 172.211 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -81.92 145.38 14.1 Favored 'Trans proline' 0 C--N 1.37 1.706 0 C-N-CA 122.83 2.353 . . . . 0.0 113.237 -174.206 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 85.5 m -99.2 102.31 13.92 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 -173.579 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 94.3 m -80.42 120.8 24.92 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 123.773 0.829 . . . . 0.0 109.319 175.391 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 36.9 mt -123.73 111.4 28.94 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 N-CA-C 106.399 -1.704 . . . . 0.0 106.399 -176.938 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 3.9 mp -94.09 128.1 45.65 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 175.35 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 22.0 mm-40 -128.57 169.32 14.53 Favored 'General case' 0 N--CA 1.489 1.496 0 CA-C-O 122.095 0.95 . . . . 0.0 110.551 178.914 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.69 157.2 42.78 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 123.869 0.868 . . . . 0.0 111.526 178.427 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 65.0 m-80 -134.55 -78.51 0.46 Allowed 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 177.352 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -153.13 86.65 0.14 Allowed Glycine 0 N--CA 1.482 1.749 0 N-CA-C 108.1 -2.0 . . . . 0.0 108.1 168.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . 0.277 14.4 m-20 66.62 -12.05 0.22 Allowed 'General case' 0 N--CA 1.498 1.945 0 N-CA-C 117.726 2.491 . . . . 0.0 117.726 -161.906 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 26.8 mm -90.27 103.75 14.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 CA-C-N 120.147 1.34 . . . . 0.0 107.445 -177.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 44.4 mt -93.61 110.8 22.39 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 123.005 0.522 . . . . 0.0 110.79 -174.886 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 90.5 m -99.32 98.76 9.67 Favored 'General case' 0 CA--C 1.562 1.411 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 -170.295 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 9.6 tt -97.78 113.49 25.29 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 178.231 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 45.6 mtpt -112.05 106.98 15.78 Favored 'General case' 0 N--CA 1.484 1.262 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 -173.135 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 82.5 m -92.15 101.71 14.23 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 177.612 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 72.4 m80 -88.41 90.53 8.43 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 123.883 0.873 . . . . 0.0 110.533 -173.467 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 60.5 p -103.49 161.12 14.13 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 113.265 0.839 . . . . 0.0 113.265 -178.295 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 17.8 m -86.02 60.41 6.22 Favored 'General case' 0 N--CA 1.498 1.945 0 CA-C-O 121.979 0.895 . . . . 0.0 110.697 163.414 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 20.6 t80 -157.04 -81.46 0.07 Allowed 'General case' 0 CA--C 1.559 1.316 0 N-CA-C 105.768 -1.938 . . . . 0.0 105.768 176.23 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 32.0 mtmm -143.15 133.64 24.88 Favored 'General case' 0 N--CA 1.491 1.595 0 CA-C-N 118.996 0.816 . . . . 0.0 108.836 166.822 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 70.9 m-20 -80.48 113.68 18.84 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 123.172 0.589 . . . . 0.0 110.433 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 61.6 p -98.56 129.43 45.11 Favored 'General case' 0 N--CA 1.493 1.721 0 CA-C-O 121.221 0.534 . . . . 0.0 110.886 -176.491 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -115.26 116.55 28.5 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 179.465 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 28.8 pt -113.08 129.6 68.46 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 176.442 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 77.6 p -117.8 114.3 23.07 Favored 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 123.871 0.868 . . . . 0.0 109.298 -176.219 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 51.0 p90 -141.12 139.42 33.97 Favored 'General case' 0 N--CA 1.499 1.982 0 N-CA-C 115.499 1.666 . . . . 0.0 115.499 -161.514 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 62.2 mtpt -105.99 23.9 13.26 Favored 'General case' 0 CA--C 1.574 1.867 0 N-CA-C 116.877 2.177 . . . . 0.0 116.877 -175.084 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . 0.284 1.2 mp 60.78 90.21 0.07 Allowed 'General case' 0 N--CA 1.495 1.825 0 CA-C-N 120.536 1.517 . . . . 0.0 114.772 171.545 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 87.76 38.51 7.47 Favored Glycine 0 CA--C 1.551 2.302 0 N-CA-C 116.779 1.472 . . . . 0.0 116.779 -166.581 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 82.6 t -139.3 120.45 15.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 N-CA-C 106.131 -1.803 . . . . 0.0 106.131 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -87.46 124.06 33.04 Favored 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 122.953 0.501 . . . . 0.0 111.122 178.304 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 45.8 p90 -127.58 133.99 49.72 Favored 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 123.775 0.83 . . . . 0.0 111.166 -172.56 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -70.58 128.8 37.34 Favored 'General case' 0 CA--C 1.564 1.513 0 O-C-N 121.447 -0.783 . . . . 0.0 112.567 173.352 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 14.7 tp10 -142.46 135.73 28.73 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 123.193 0.597 . . . . 0.0 109.963 -168.683 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 53.1 m -92.56 127.47 38.07 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 171.214 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 31.1 p -84.25 171.68 12.53 Favored 'General case' 0 N--CA 1.495 1.781 0 CA-C-O 121.429 0.633 . . . . 0.0 112.443 -177.689 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -62.88 -31.35 72.38 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 116.438 2.014 . . . . 0.0 116.438 166.646 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -81.0 21.06 0.73 Allowed 'General case' 0 CA--C 1.582 2.193 0 N-CA-C 114.956 1.465 . . . . 0.0 114.956 165.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 56.31 69.23 0.76 Allowed 'General case' 0 N--CA 1.496 1.837 0 C-N-CA 125.928 1.691 . . . . 0.0 114.517 176.858 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 50.8 mtm180 -144.12 126.84 16.14 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-O 121.116 0.484 . . . . 0.0 110.683 -174.519 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 62.5 pttt -66.12 118.29 9.65 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 123.957 0.903 . . . . 0.0 111.929 165.368 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 15.8 m -140.25 130.13 28.41 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 -173.342 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 30.5 mmmt -87.41 112.22 21.92 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-O 121.593 0.711 . . . . 0.0 109.669 178.78 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 67.3 m -109.99 105.92 15.25 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 123.515 0.726 . . . . 0.0 111.108 -158.155 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 6.9 tp -114.66 105.84 19.46 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 C-N-CA 123.795 0.838 . . . . 0.0 109.53 -175.833 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -115.92 126.23 73.35 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 C-N-CA 124.551 1.14 . . . . 0.0 108.933 178.223 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 15.4 t -132.24 157.13 45.17 Favored 'General case' 0 N--CA 1.492 1.644 0 CA-C-O 122.625 1.203 . . . . 0.0 111.296 172.005 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 17.6 tp -93.31 116.24 28.81 Favored 'General case' 0 N--CA 1.487 1.419 0 CA-C-N 114.837 -1.074 . . . . 0.0 110.785 -176.465 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -110.36 82.74 1.64 Allowed 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 123.576 0.75 . . . . 0.0 109.679 178.731 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 56.68 46.16 89.6 Favored Glycine 0 CA--C 1.552 2.369 0 N-CA-C 118.203 2.041 . . . . 0.0 118.203 -177.042 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 78.59 44.76 10.27 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 117.0 1.56 . . . . 0.0 117.0 -167.609 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 41.1 ttmt -151.13 111.28 4.12 Favored 'General case' 0 CA--C 1.551 0.994 0 N-CA-C 106.481 -1.674 . . . . 0.0 106.481 -177.755 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 65.5 mt -85.21 95.3 9.13 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-O 122.976 1.369 . . . . 0.0 109.428 177.526 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 88.7 t -87.1 97.76 6.67 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.334 0 CA-C-N 112.617 -2.083 . . . . 0.0 105.876 -178.405 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 22.7 t-160 -102.44 139.39 38.11 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 124.396 1.078 . . . . 0.0 109.405 -176.513 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 28.2 tp -136.69 115.29 11.98 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 178.514 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 89.4 mt-30 -104.22 115.77 30.99 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 175.726 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt -121.87 135.68 54.9 Favored 'General case' 0 N--CA 1.493 1.701 0 C-N-CA 123.335 0.654 . . . . 0.0 111.789 -171.741 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 16.3 p90 -159.0 110.91 2.15 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 123.333 0.653 . . . . 0.0 110.536 -174.607 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 5.7 t70 52.59 54.45 10.58 Favored 'General case' 0 N--CA 1.498 1.948 0 N-CA-C 116.567 2.062 . . . . 0.0 116.567 165.328 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 88.76 -46.0 3.27 Favored Glycine 0 CA--C 1.549 2.206 0 N-CA-C 116.434 1.334 . . . . 0.0 116.434 -169.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 16.3 mt-30 -83.6 129.21 34.96 Favored 'General case' 0 N--CA 1.488 1.446 0 CA-C-N 117.957 0.878 . . . . 0.0 111.233 -178.721 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -141.21 124.75 16.74 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 122.786 0.435 . . . . 0.0 110.664 177.005 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 13.0 t -110.8 135.52 51.24 Favored 'General case' 0 N--CA 1.492 1.656 0 C-N-CA 123.108 0.563 . . . . 0.0 110.643 176.273 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 37.9 p -100.27 131.02 46.44 Favored 'General case' 0 N--CA 1.492 1.628 0 C-N-CA 123.021 0.528 . . . . 0.0 110.761 174.608 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 5.4 mp -111.73 76.18 0.96 Allowed 'General case' 0 CA--C 1.563 1.447 0 C-N-CA 124.005 0.922 . . . . 0.0 108.783 -179.446 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 87.5 t -87.04 110.1 20.0 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 -168.242 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 83.9 mtt85 -102.38 118.49 36.99 Favored 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 122.975 0.51 . . . . 0.0 109.939 -175.777 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -135.32 127.96 30.85 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 123.34 0.656 . . . . 0.0 110.665 -169.539 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -80.91 114.64 19.93 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.833 -0.542 . . . . 0.0 111.395 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 85.8 mt -124.14 106.98 17.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 N-CA-C 105.015 -2.217 . . . . 0.0 105.015 178.512 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 23.4 m-20 58.17 50.3 10.1 Favored 'General case' 0 N--CA 1.499 1.989 0 N-CA-C 115.15 1.537 . . . . 0.0 115.15 177.031 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 60.73 31.24 74.76 Favored Glycine 0 CA--C 1.554 2.503 0 N-CA-C 118.964 2.346 . . . . 0.0 118.964 -169.453 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 92.1 mttt -133.65 128.55 35.3 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-N 119.135 1.468 . . . . 0.0 108.686 -175.892 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 12.3 tp -79.76 107.42 12.52 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 123.433 0.693 . . . . 0.0 109.389 177.61 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 31.6 mm -99.42 99.29 8.26 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 N-CA-C 106.536 -1.653 . . . . 0.0 106.536 -175.598 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 21.9 tp -87.86 102.99 15.24 Favored 'General case' 0 N--CA 1.486 1.372 0 CA-C-O 121.843 0.83 . . . . 0.0 109.549 178.699 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 90.9 m -95.76 103.61 15.5 Favored 'General case' 0 CA--C 1.561 1.389 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 -175.545 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 90.3 mt -97.61 100.49 11.89 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 123.581 0.752 . . . . 0.0 109.809 -174.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 8.1 m -113.89 125.28 53.87 Favored 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 -175.035 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 82.9 t60 -129.48 -102.9 0.31 Allowed 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.982 -0.748 . . . . 0.0 108.982 175.352 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -112.32 88.6 0.5 Allowed Glycine 0 N--CA 1.485 1.923 0 CA-C-N 119.183 0.901 . . . . 0.0 112.003 -171.78 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . 0.298 2.6 m 54.49 44.61 28.53 Favored 'General case' 0 CA--C 1.578 2.032 0 N-CA-C 115.381 1.623 . . . . 0.0 115.381 -175.68 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -163.66 95.68 0.82 Allowed 'General case' 0 N--CA 1.483 1.193 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 178.12 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 2.9 p -91.69 115.87 31.67 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 C-N-CA 123.402 0.681 . . . . 0.0 109.415 174.717 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 53.3 t -95.7 105.4 17.39 Favored 'General case' 0 CA--C 1.551 1.01 0 CA-C-O 121.302 0.573 . . . . 0.0 110.572 173.187 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 75.7 m -91.88 113.53 25.82 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 -178.64 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 83.3 mtp180 -113.53 109.36 18.52 Favored 'General case' 0 N--CA 1.486 1.332 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.615 -168.457 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 88.4 m -84.01 127.21 33.72 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 123.165 0.586 . . . . 0.0 109.947 178.058 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 43.1 m-85 -123.71 127.94 48.89 Favored 'General case' 0 CA--C 1.56 1.345 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 175.292 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -91.1 152.59 20.55 Favored 'General case' 0 N--CA 1.496 1.83 0 CA-C-O 121.879 0.847 . . . . 0.0 111.736 170.142 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 70.9 tttt -82.15 122.71 28.22 Favored 'General case' 0 N--CA 1.487 1.404 0 CA-C-O 121.587 0.708 . . . . 0.0 111.975 -171.456 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 24.5 mm-40 -119.04 50.94 1.16 Allowed 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 124.225 1.01 . . . . 0.0 111.605 -174.258 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 0.872 0 CA-C-O 123.155 1.455 . . . . 0.0 110.131 -162.634 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.253 5.1 p . . . . . 0 CA--C 1.576 1.968 0 N-CA-C 114.581 1.326 . . . . 0.0 114.581 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -85.12 -36.59 21.02 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 115.561 1.689 . . . . 0.0 115.561 -173.609 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -58.52 -24.73 61.28 Favored 'General case' 0 N--CA 1.497 1.891 0 N-CA-C 117.694 2.479 . . . . 0.0 117.694 168.558 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -68.72 -20.17 64.38 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 116.84 2.163 . . . . 0.0 116.84 167.101 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 56.2 mt -80.44 126.81 31.66 Favored 'General case' 0 N--CA 1.486 1.352 0 CA-C-N 120.627 1.558 . . . . 0.0 111.882 -170.402 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 155.79 178.14 29.7 Favored Glycine 0 CA--C 1.541 1.713 0 CA-C-O 122.03 0.795 . . . . 0.0 113.557 -178.112 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 43.1 m -92.94 135.69 33.93 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 168.53 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 89.3 m95 -137.21 113.79 10.26 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 -170.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 26.7 mtpt -93.49 148.69 21.85 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 121.927 0.87 . . . . 0.0 111.366 172.961 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 20.2 tp -71.4 135.61 47.34 Favored 'General case' 0 N--CA 1.486 1.368 0 CA-C-O 122.32 1.057 . . . . 0.0 112.53 -178.478 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . 0.271 1.1 t -114.52 -43.76 4.06 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.878 0 CA-C-N 113.786 -1.552 . . . . 0.0 111.953 -177.589 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -127.28 150.8 49.4 Favored 'General case' 0 N--CA 1.494 1.76 0 CA-C-N 119.986 1.267 . . . . 0.0 110.65 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 81.1 p -145.2 88.71 1.89 Allowed 'General case' 0 N--CA 1.49 1.544 0 CA-C-O 121.22 0.533 . . . . 0.0 110.244 167.484 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -102.22 125.24 48.87 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 123.4 0.68 . . . . 0.0 109.201 177.165 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.288 53.6 m-20 72.57 17.07 4.69 Favored 'General case' 0 N--CA 1.503 2.206 0 N-CA-C 117.491 2.404 . . . . 0.0 117.491 -178.904 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 30.9 t80 -68.77 -41.91 78.16 Favored 'General case' 0 N--CA 1.497 1.894 0 N-CA-C 115.091 1.515 . . . . 0.0 115.091 178.202 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -49.58 -49.01 48.28 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 116.009 1.855 . . . . 0.0 116.009 165.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 18.4 t0 -59.21 -50.59 73.44 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 115.397 1.628 . . . . 0.0 115.397 172.896 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 88.2 t80 -52.67 -51.79 58.67 Favored 'General case' 0 CA--C 1.572 1.794 0 N-CA-C 115.6 1.704 . . . . 0.0 115.6 170.349 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 5.5 mmm -64.78 -40.07 94.64 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 115.124 1.527 . . . . 0.0 115.124 176.908 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 21.7 ttmm -55.96 -45.29 78.92 Favored 'General case' 0 CA--C 1.571 1.769 0 N-CA-C 115.14 1.534 . . . . 0.0 115.14 166.317 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 12.8 t -59.77 -38.42 81.77 Favored 'General case' 0 CA--C 1.571 1.763 0 N-CA-C 116.407 2.003 . . . . 0.0 116.407 170.42 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 75.8 mt -65.16 -25.47 67.75 Favored 'General case' 0 CA--C 1.568 1.661 0 N-CA-C 117.601 2.445 . . . . 0.0 117.601 168.49 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 98.76 70.36 0.97 Allowed Glycine 0 N--CA 1.482 1.731 0 CA-C-N 119.085 0.857 . . . . 0.0 112.256 -171.026 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 45.3 t -142.28 120.13 7.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 N-CA-C 105.502 -2.036 . . . . 0.0 105.502 -178.338 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -81.1 -157.49 17.36 Favored Glycine 0 CA--C 1.547 2.065 0 N-CA-C 115.534 0.973 . . . . 0.0 115.534 -179.413 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 12.1 p90 -70.01 160.72 31.42 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 113.385 0.883 . . . . 0.0 113.385 179.637 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . 0.329 . . 78.25 -50.07 0.48 Allowed 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 115.439 1.644 . . . . 0.0 115.439 178.431 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 34.0 m -70.51 -37.49 74.17 Favored 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 113.604 0.964 . . . . 0.0 113.604 167.882 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 42.3 mtm105 -57.97 -44.6 87.2 Favored 'General case' 0 N--CA 1.498 1.97 0 N-CA-C 115.232 1.567 . . . . 0.0 115.232 164.52 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 10.3 tm0? -68.68 -52.8 27.1 Favored 'General case' 0 CA--C 1.561 1.389 0 N-CA-C 114.871 1.434 . . . . 0.0 114.871 176.697 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 85.5 t -66.4 -40.62 87.08 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 CA-C-O 117.763 -1.113 . . . . 0.0 113.166 -179.064 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -71.27 -26.84 63.06 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 117.052 2.241 . . . . 0.0 117.052 176.107 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 90.6 p -68.91 -47.37 65.96 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 115.022 1.49 . . . . 0.0 115.022 164.134 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 52.1 ttp -61.91 -39.6 92.56 Favored 'General case' 0 CA--C 1.57 1.731 0 N-CA-C 116.482 2.03 . . . . 0.0 116.482 171.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 52.7 m -67.35 146.97 53.55 Favored 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 124.764 1.225 . . . . 0.0 111.941 178.441 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -102.23 100.37 15.21 Favored Pre-proline 0 CA--C 1.57 1.744 0 N-CA-C 108.307 -0.998 . . . . 0.0 108.307 172.998 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -79.11 104.39 1.77 Allowed 'Trans proline' 0 CA--C 1.562 1.888 0 C-N-CA 123.223 2.615 . . . . 0.0 111.293 -178.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 96.2 m -80.16 108.33 13.67 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 123.352 0.661 . . . . 0.0 110.495 -164.714 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 28.7 m -91.39 109.79 21.07 Favored 'General case' 0 CA--C 1.559 1.318 0 C-N-CA 123.336 0.654 . . . . 0.0 110.03 -170.442 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 75.0 mt -100.56 109.36 25.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 N-CA-C 106.567 -1.642 . . . . 0.0 106.567 176.321 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 30.4 mt -104.82 118.31 51.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 N-CA-C 106.906 -1.516 . . . . 0.0 106.906 -179.824 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -137.79 117.24 12.86 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 -175.101 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 7.7 ttpm? -91.5 116.26 28.71 Favored 'General case' 0 CA--C 1.557 1.217 0 CA-C-O 121.439 0.637 . . . . 0.0 110.051 172.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 22.7 t-20 -71.64 -50.52 29.86 Favored 'General case' 0 CA--C 1.57 1.72 0 N-CA-C 112.982 0.734 . . . . 0.0 112.982 166.873 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -172.25 -82.4 0.05 OUTLIER Glycine 0 N--CA 1.481 1.659 0 N-CA-C 109.25 -1.54 . . . . 0.0 109.25 173.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 24.3 t0 -72.14 -37.69 69.38 Favored 'General case' 0 CA--C 1.57 1.741 0 N-CA-C 115.096 1.517 . . . . 0.0 115.096 162.915 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 31.6 mm -91.11 120.32 39.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 CA-C-N 118.993 0.815 . . . . 0.0 109.69 -173.524 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 12.7 mt -86.38 125.88 33.97 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 123.419 0.688 . . . . 0.0 109.811 158.651 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 57.7 m -113.91 103.79 11.52 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 -179.795 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 9.5 tt -102.48 108.55 19.9 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 178.598 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -104.75 111.8 24.65 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 -179.469 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 98.2 m -98.51 99.98 11.18 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 20.6 m-70 -90.48 95.96 10.42 Favored 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 123.393 0.677 . . . . 0.0 110.344 -172.198 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 22.8 t -109.52 150.44 28.14 Favored 'General case' 0 CA--C 1.554 1.121 0 CA-C-O 121.981 0.896 . . . . 0.0 110.322 -179.345 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 25.2 m -55.08 -24.01 23.31 Favored 'General case' 0 N--CA 1.499 2.016 0 N-CA-C 115.806 1.78 . . . . 0.0 115.806 163.74 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 72.0 t80 -78.69 -63.19 1.47 Allowed 'General case' 0 CA--C 1.564 1.512 0 CA-C-N 119.465 1.03 . . . . 0.0 111.913 172.947 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 14.5 ttpt -154.27 142.66 20.59 Favored 'General case' 0 N--CA 1.49 1.538 0 CA-C-N 119.332 0.969 . . . . 0.0 110.392 172.248 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 83.0 m-20 -84.17 111.31 19.24 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 123.145 0.578 . . . . 0.0 109.938 174.636 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 31.8 p -105.58 132.39 51.79 Favored 'General case' 0 N--CA 1.496 1.874 0 C-N-CA 123.355 0.662 . . . . 0.0 110.825 -177.551 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -121.43 118.3 29.04 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 123.918 0.887 . . . . 0.0 108.813 -178.116 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 39.5 pt -110.35 129.57 65.18 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.875 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 173.684 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 52.2 p -115.75 114.26 24.55 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 178.276 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 45.9 p90 -142.68 146.54 34.52 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 114.306 1.225 . . . . 0.0 114.306 -161.162 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 50.2 mtmt -115.5 28.12 8.88 Favored 'General case' 0 CA--C 1.572 1.823 0 N-CA-C 115.678 1.733 . . . . 0.0 115.678 -171.122 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . 0.308 0.1 OUTLIER 52.81 82.73 0.07 Allowed 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 115.866 1.802 . . . . 0.0 115.866 175.551 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 101.88 39.24 2.96 Favored Glycine 0 CA--C 1.55 2.234 0 N-CA-C 116.336 1.294 . . . . 0.0 116.336 -171.878 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 94.7 t -139.74 127.52 25.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 N-CA-C 106.442 -1.688 . . . . 0.0 106.442 -179.199 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -89.01 128.92 35.73 Favored 'General case' 0 CA--C 1.564 1.499 0 C-N-CA 122.997 0.519 . . . . 0.0 110.366 175.592 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 43.5 p90 -138.91 123.14 18.1 Favored 'General case' 0 N--CA 1.494 1.764 0 C-N-CA 123.391 0.677 . . . . 0.0 109.855 -176.818 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -72.37 112.85 8.79 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.097 -1.002 . . . . 0.0 112.382 178.462 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -115.33 135.91 53.65 Favored 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 124.024 0.929 . . . . 0.0 110.241 -168.103 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 42.9 m -86.96 122.79 31.3 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-O 121.61 0.719 . . . . 0.0 109.529 173.173 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 43.1 p -82.45 177.76 8.58 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 113.197 0.814 . . . . 0.0 113.197 -173.546 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -55.85 -35.75 66.78 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 117.69 2.478 . . . . 0.0 117.69 168.46 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -92.47 17.19 10.36 Favored 'General case' 0 CA--C 1.577 1.991 0 N-CA-C 115.136 1.532 . . . . 0.0 115.136 170.896 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 63.01 80.17 0.24 Allowed 'General case' 0 N--CA 1.496 1.854 0 C-N-CA 125.281 1.432 . . . . 0.0 113.272 -178.955 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 14.9 ttm180 -146.09 126.13 13.71 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 -176.176 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.77 120.51 15.62 Favored 'General case' 0 N--CA 1.493 1.678 0 CA-C-N 118.124 0.42 . . . . 0.0 110.272 168.174 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 12.4 m -138.69 121.42 18.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 N-CA-C 107.999 -1.112 . . . . 0.0 107.999 -176.156 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 1.5 mptm? -76.76 104.13 7.09 Favored 'General case' 0 N--CA 1.489 1.487 0 CA-C-O 121.89 0.852 . . . . 0.0 109.599 -177.349 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 74.0 m -98.95 96.41 7.81 Favored 'General case' 0 N--CA 1.481 1.116 0 CA-C-N 114.894 -1.048 . . . . 0.0 109.92 -164.44 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -106.39 108.31 24.81 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 177.422 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 1.4 p -121.88 126.76 74.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 C-N-CA 124.025 0.93 . . . . 0.0 109.304 -174.906 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 9.8 t -146.34 152.1 38.57 Favored 'General case' 0 N--CA 1.489 1.515 0 CA-C-O 122.531 1.158 . . . . 0.0 110.643 -177.859 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 24.8 tp -87.73 103.47 15.64 Favored 'General case' 0 N--CA 1.49 1.536 0 CA-C-N 114.889 -1.051 . . . . 0.0 109.425 175.778 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -107.01 93.57 4.63 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 123.607 0.763 . . . . 0.0 109.41 -175.674 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 59.3 49.1 82.2 Favored Glycine 0 N--CA 1.488 2.108 0 N-CA-C 117.712 1.845 . . . . 0.0 117.712 -179.825 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 91.59 -37.44 3.39 Favored Glycine 0 CA--C 1.551 2.31 0 N-CA-C 117.232 1.653 . . . . 0.0 117.232 -170.352 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.72 122.32 29.64 Favored 'General case' 0 N--CA 1.486 1.368 0 CA-C-N 118.92 1.36 . . . . 0.0 110.328 -176.857 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 5.8 tt -85.98 95.86 9.64 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 108.569 -0.901 . . . . 0.0 108.569 179.032 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 53.0 t -97.61 108.09 21.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 -166.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 21.6 t-160 -101.92 108.64 20.17 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 123.255 0.622 . . . . 0.0 110.032 175.682 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 31.8 tp -98.0 116.32 29.97 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 175.587 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -100.22 129.45 46.23 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 168.64 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 16.7 ptmt -140.08 128.63 22.9 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.746 -0.596 . . . . 0.0 111.399 -173.238 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 30.8 p90 -154.44 119.17 4.9 Favored 'General case' 0 N--CA 1.491 1.606 0 C-N-CA 123.808 0.843 . . . . 0.0 109.727 -168.059 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 4.5 t70 45.34 59.58 3.48 Favored 'General case' 0 N--CA 1.503 2.18 0 N-CA-C 117.616 2.45 . . . . 0.0 117.616 164.858 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 63.8 31.05 79.48 Favored Glycine 0 CA--C 1.558 2.73 0 N-CA-C 119.42 2.528 . . . . 0.0 119.42 -171.617 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -152.44 123.6 7.6 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 106.705 -1.591 . . . . 0.0 106.705 -176.193 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -138.56 132.49 31.19 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.47 -0.769 . . . . 0.0 112.261 179.128 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 14.6 t -116.32 134.01 55.37 Favored 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 123.581 0.752 . . . . 0.0 110.406 173.755 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 34.9 p -100.8 131.07 46.86 Favored 'General case' 0 N--CA 1.493 1.699 0 CA-C-O 122.143 0.973 . . . . 0.0 110.128 169.292 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 5.4 mp -112.47 87.0 2.47 Favored 'General case' 0 CA--C 1.56 1.347 0 N-CA-C 106.407 -1.701 . . . . 0.0 106.407 -178.71 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 72.4 t -92.88 99.89 10.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 -169.186 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 20.5 mmt180 -86.27 125.26 33.46 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 124.126 0.971 . . . . 0.0 109.883 176.052 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -151.89 131.74 13.29 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.877 -0.514 . . . . 0.0 112.11 -173.844 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -78.73 120.24 23.09 Favored 'General case' 0 N--CA 1.49 1.525 0 CA-C-O 121.295 0.569 . . . . 0.0 111.755 177.945 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 92.3 mt -129.16 105.72 13.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 N-CA-C 104.603 -2.369 . . . . 0.0 104.603 176.445 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 57.75 52.31 8.28 Favored 'General case' 0 N--CA 1.499 2.001 0 N-CA-C 114.997 1.481 . . . . 0.0 114.997 175.893 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 67.85 12.07 61.63 Favored Glycine 0 CA--C 1.557 2.673 0 N-CA-C 119.962 2.745 . . . . 0.0 119.962 -171.655 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -124.73 126.59 45.92 Favored 'General case' 0 N--CA 1.486 1.358 0 CA-C-N 119.645 1.723 . . . . 0.0 108.626 -175.196 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 58.7 tp -83.96 108.57 17.01 Favored 'General case' 0 N--CA 1.483 1.189 0 CA-C-O 121.508 0.67 . . . . 0.0 110.226 -179.622 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 28.1 mm -97.51 106.8 19.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 -172.02 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 44.4 tp -86.04 111.84 20.69 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 123.557 0.743 . . . . 0.0 109.075 171.232 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 88.1 m -105.7 105.9 16.16 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 -176.347 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 88.6 mt -101.37 100.6 11.11 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 123.486 0.714 . . . . 0.0 109.948 -171.33 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 7.8 m -116.37 121.1 40.95 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 -174.516 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 83.1 t60 -126.42 -101.51 0.36 Allowed 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 175.571 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -111.0 92.71 0.68 Allowed Glycine 0 N--CA 1.483 1.814 0 CA-C-N 119.375 0.989 . . . . 0.0 111.454 -172.683 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . 0.395 6.4 t 49.03 40.38 17.0 Favored 'General case' 0 N--CA 1.499 2.011 0 N-CA-C 117.746 2.499 . . . . 0.0 117.746 -172.864 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -155.49 93.68 1.51 Allowed 'General case' 0 N--CA 1.483 1.211 0 O-C-N 121.569 -0.707 . . . . 0.0 109.217 178.384 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 4.3 p -89.39 121.23 39.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 C-N-CA 123.418 0.687 . . . . 0.0 109.602 172.352 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 45.0 t -105.28 120.44 41.57 Favored 'General case' 0 CA--C 1.553 1.077 0 C-N-CA 123.045 0.538 . . . . 0.0 111.4 177.65 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 80.1 m -87.21 110.61 20.28 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 175.196 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 6.2 mmm180 -115.03 95.87 5.42 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 107.448 -1.316 . . . . 0.0 107.448 -179.848 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 86.2 m -82.76 143.51 30.81 Favored 'General case' 0 N--CA 1.494 1.774 0 C-N-CA 123.721 0.809 . . . . 0.0 110.402 -177.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 47.1 m-85 -131.34 127.61 38.0 Favored 'General case' 0 CA--C 1.557 1.232 0 C-N-CA 123.442 0.697 . . . . 0.0 109.767 -178.096 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -95.77 156.89 16.14 Favored 'General case' 0 N--CA 1.492 1.668 0 CA-C-O 122.671 1.224 . . . . 0.0 111.294 165.115 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 73.8 tttt -90.47 114.49 26.67 Favored 'General case' 0 N--CA 1.484 1.244 0 CA-C-N 114.895 -1.048 . . . . 0.0 111.712 -165.698 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -74.11 -33.99 63.79 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 117.116 2.265 . . . . 0.0 117.116 172.452 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.125 0 CA-C-O 124.198 1.952 . . . . 0.0 108.527 173.731 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 5.4 p . . . . . 0 CA--C 1.578 2.041 0 N-CA-C 115.883 1.809 . . . . 0.0 115.883 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -64.85 -36.71 85.22 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 116.764 2.135 . . . . 0.0 116.764 -175.168 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -58.13 -29.25 65.38 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 117.742 2.497 . . . . 0.0 117.742 169.146 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -69.47 -25.29 64.01 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 116.231 1.937 . . . . 0.0 116.231 169.576 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 45.8 mt -77.37 110.22 11.94 Favored 'General case' 0 N--CA 1.489 1.518 0 CA-C-N 121.012 1.733 . . . . 0.0 111.466 -162.715 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 157.8 172.02 24.47 Favored Glycine 0 CA--C 1.546 2.024 0 CA-C-O 122.718 1.177 . . . . 0.0 112.797 -167.571 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 54.1 m -87.25 139.42 30.58 Favored 'General case' 0 N--CA 1.494 1.731 0 CA-C-N 114.296 -0.952 . . . . 0.0 109.734 172.257 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 82.8 m95 -136.62 113.67 10.55 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 -177.444 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -95.41 146.51 24.35 Favored 'General case' 0 N--CA 1.494 1.726 0 CA-C-O 121.439 0.638 . . . . 0.0 110.292 173.914 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 48.6 tp -68.48 120.16 14.11 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-O 121.649 0.737 . . . . 0.0 111.738 -179.164 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . 0.263 1.1 t -83.66 -51.02 14.76 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.753 0 CA-C-N 114.676 -1.147 . . . . 0.0 111.666 170.495 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -148.36 125.39 11.36 Favored 'General case' 0 CA--C 1.557 1.244 0 CA-C-N 119.032 0.833 . . . . 0.0 109.619 -168.057 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 72.7 p -102.93 100.27 10.23 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 123.373 0.669 . . . . 0.0 110.441 172.508 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 33.7 mmtp -95.9 116.49 28.99 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 109.508 -0.552 . . . . 0.0 109.508 -179.225 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.258 28.6 m-20 71.2 24.53 3.8 Favored 'General case' 0 N--CA 1.504 2.265 0 N-CA-C 117.101 2.26 . . . . 0.0 117.101 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 40.0 t80 -69.58 -50.31 45.87 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 120.138 -1.601 . . . . 0.0 114.727 -175.875 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 71.1 m-20 -51.58 -27.76 12.0 Favored 'General case' 0 N--CA 1.497 1.925 0 N-CA-C 117.909 2.559 . . . . 0.0 117.909 168.839 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 24.2 t0 -66.35 -52.9 42.33 Favored 'General case' 0 N--CA 1.496 1.869 0 CA-C-N 120.251 1.387 . . . . 0.0 114.199 166.59 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 88.5 t80 -50.63 -46.23 58.15 Favored 'General case' 0 CA--C 1.573 1.852 0 N-CA-C 115.683 1.734 . . . . 0.0 115.683 168.369 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 47.9 mmm -63.49 -41.33 98.57 Favored 'General case' 0 CA--C 1.567 1.631 0 N-CA-C 114.718 1.377 . . . . 0.0 114.718 174.047 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 13.6 tmtt? -61.18 -44.79 96.73 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 115.248 1.573 . . . . 0.0 115.248 167.879 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 15.1 t -57.03 -39.62 75.15 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 116.31 1.967 . . . . 0.0 116.31 172.385 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 75.1 mt -65.07 -43.57 91.77 Favored 'General case' 0 CA--C 1.567 1.606 0 N-CA-C 115.572 1.693 . . . . 0.0 115.572 165.164 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 117.98 68.97 0.36 Allowed Glycine 0 N--CA 1.483 1.807 0 C-N-CA 124.148 0.88 . . . . 0.0 112.03 -178.932 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 18.3 t -140.74 114.98 5.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 N-CA-C 105.919 -1.882 . . . . 0.0 105.919 -174.208 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -85.99 -79.69 1.17 Allowed Glycine 0 N--CA 1.483 1.806 0 N-CA-C 114.724 0.65 . . . . 0.0 114.724 -175.864 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 20.8 p90 -132.16 163.32 28.8 Favored 'General case' 0 N--CA 1.492 1.655 0 C-N-CA 123.472 0.709 . . . . 0.0 111.474 -177.903 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . 0.333 . . 79.13 -58.13 0.41 Allowed 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 115.023 1.49 . . . . 0.0 115.023 173.335 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 80.2 m -69.98 -39.75 75.75 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 113.31 0.856 . . . . 0.0 113.31 166.069 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 45.0 ttp180 -63.77 -41.55 97.95 Favored 'General case' 0 CA--C 1.565 1.529 0 N-CA-C 114.966 1.469 . . . . 0.0 114.966 168.704 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 11.5 tm0? -66.55 -49.2 67.23 Favored 'General case' 0 CA--C 1.562 1.438 0 N-CA-C 115.127 1.529 . . . . 0.0 115.127 173.106 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 73.7 t -63.96 -42.39 95.58 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.026 0 CA-C-N 119.912 1.233 . . . . 0.0 113.271 178.593 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -73.15 -32.55 64.96 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 116.938 2.199 . . . . 0.0 116.938 176.704 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 85.7 p -68.63 -44.14 74.83 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 115.265 1.579 . . . . 0.0 115.265 167.248 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 51.7 tpp -68.7 -35.75 77.58 Favored 'General case' 0 CA--C 1.564 1.513 0 N-CA-C 116.459 2.022 . . . . 0.0 116.459 177.192 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 5.1 t -75.16 165.65 24.89 Favored 'General case' 0 N--CA 1.494 1.764 0 CA-C-N 119.9 1.227 . . . . 0.0 112.853 178.726 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.74 100.25 10.64 Favored Pre-proline 0 CA--C 1.57 1.746 0 CA-C-O 118.281 -0.866 . . . . 0.0 109.426 168.044 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -77.08 95.16 1.06 Allowed 'Trans proline' 0 C--N 1.373 1.83 0 C-N-CA 123.294 2.663 . . . . 0.0 111.124 -179.758 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 98.0 m -82.44 105.75 13.75 Favored 'General case' 0 N--CA 1.487 1.412 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.643 -158.466 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 93.5 m -81.34 112.97 19.12 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 123.746 0.818 . . . . 0.0 110.072 -175.894 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 79.1 mt -112.49 107.18 22.32 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 N-CA-C 105.985 -1.857 . . . . 0.0 105.985 -179.833 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 4.0 mp -94.7 123.67 46.9 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 175.867 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 5.8 tm-20 -136.11 112.18 9.67 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 -176.867 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 83.8 tttt -90.18 113.12 24.84 Favored 'General case' 0 CA--C 1.556 1.211 0 C-N-CA 123.023 0.529 . . . . 0.0 109.825 174.253 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 21.9 t-20 -80.56 -64.76 1.12 Allowed 'General case' 0 CA--C 1.564 1.504 0 C-N-CA 123.31 0.644 . . . . 0.0 111.768 179.233 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -131.68 -94.63 0.63 Allowed Glycine 0 N--CA 1.485 1.903 0 N-CA-C 108.941 -1.664 . . . . 0.0 108.941 169.024 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -77.46 -29.26 52.68 Favored 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 115.361 1.615 . . . . 0.0 115.361 162.849 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 35.3 mm -88.96 124.95 42.02 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.475 0 CA-C-N 119.108 0.867 . . . . 0.0 109.656 -168.438 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 21.2 mt -89.65 121.07 31.49 Favored 'General case' 0 N--CA 1.485 1.294 0 CA-C-N 114.901 -1.045 . . . . 0.0 110.53 169.103 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 87.0 m -108.8 104.07 13.26 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 179.371 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 7.9 tt -104.56 109.97 22.08 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -106.51 116.88 32.7 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 123.503 0.721 . . . . 0.0 109.205 178.947 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 94.1 m -102.91 101.28 11.29 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 177.852 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 23.0 m-70 -88.27 93.96 9.68 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 123.473 0.709 . . . . 0.0 111.838 -170.007 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 33.3 t -101.06 154.79 18.41 Favored 'General case' 0 CA--C 1.557 1.23 0 CA-C-O 122.019 0.914 . . . . 0.0 110.548 176.838 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 47.0 m -59.79 -22.94 62.86 Favored 'General case' 0 CA--C 1.578 2.026 0 N-CA-C 115.439 1.644 . . . . 0.0 115.439 162.339 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 34.5 t80 -107.88 83.27 1.77 Allowed 'General case' 0 N--CA 1.488 1.43 0 CA-C-N 119.764 1.166 . . . . 0.0 108.234 169.873 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 28.1 mmmt 61.41 123.29 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 115.483 1.66 . . . . 0.0 115.483 174.923 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 9.7 p30 -80.83 126.66 31.61 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.502 -0.749 . . . . 0.0 112.311 175.949 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 78.3 p -95.23 127.46 41.3 Favored 'General case' 0 N--CA 1.496 1.844 0 C-N-CA 122.917 0.487 . . . . 0.0 110.509 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -119.16 111.95 18.9 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 -176.63 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 39.1 pt -105.64 128.3 59.86 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 173.357 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 42.2 t -116.74 108.38 15.82 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 179.552 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 48.6 p90 -140.39 157.9 44.83 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 114.947 1.462 . . . . 0.0 114.947 -159.222 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 54.9 mtpt -120.15 150.38 40.72 Favored 'General case' 0 CA--C 1.563 1.449 0 CA-C-N 113.971 -1.468 . . . . 0.0 108.68 165.177 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -75.04 113.18 12.06 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.566 -0.709 . . . . 0.0 112.246 -170.213 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 83.61 39.68 9.49 Favored Glycine 0 CA--C 1.551 2.326 0 N-CA-C 116.631 1.412 . . . . 0.0 116.631 -169.522 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 76.5 t -140.76 117.64 8.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 N-CA-C 105.339 -2.097 . . . . 0.0 105.339 -175.284 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -83.17 135.62 34.73 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 122.823 0.449 . . . . 0.0 111.919 -179.868 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 36.0 p90 -140.92 133.43 28.52 Favored 'General case' 0 N--CA 1.494 1.743 0 C-N-CA 123.687 0.795 . . . . 0.0 110.83 -174.431 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -75.04 117.81 17.29 Favored 'General case' 0 CA--C 1.565 1.521 0 O-C-N 121.478 -0.764 . . . . 0.0 112.314 176.159 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 25.7 tp10 -118.31 135.52 54.26 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 123.954 0.902 . . . . 0.0 110.416 -171.406 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 84.8 m -97.01 119.79 36.15 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 171.648 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 22.9 p -86.14 -178.12 6.44 Favored 'General case' 0 N--CA 1.494 1.762 0 CA-C-O 122.192 0.996 . . . . 0.0 113.308 -171.636 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -52.7 -40.13 62.66 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 117.692 2.479 . . . . 0.0 117.692 167.097 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 42.5 m-20 -81.82 5.31 19.14 Favored 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 116.151 1.908 . . . . 0.0 116.151 169.377 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . 0.251 10.0 m-20 62.58 75.22 0.41 Allowed 'General case' 0 N--CA 1.496 1.868 0 C-N-CA 125.265 1.426 . . . . 0.0 112.048 -171.89 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 42.1 ttp180 -138.05 120.58 16.09 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 -168.051 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.16 95.39 5.59 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 123.407 0.683 . . . . 0.0 111.922 -178.634 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 12.0 m -116.74 127.05 74.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 -167.938 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 33.5 mmtp -83.6 104.44 13.73 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 123.605 0.762 . . . . 0.0 109.974 -178.593 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 74.5 m -102.28 107.87 19.05 Favored 'General case' 0 N--CA 1.483 1.189 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.022 -161.686 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 7.2 tp -115.92 104.22 16.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 C-N-CA 124.027 0.931 . . . . 0.0 108.64 -178.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -118.33 124.61 73.38 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 C-N-CA 124.127 0.971 . . . . 0.0 109.117 178.422 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 15.2 t -125.92 157.75 36.92 Favored 'General case' 0 N--CA 1.493 1.691 0 CA-C-O 122.471 1.129 . . . . 0.0 111.496 170.751 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 14.5 tp -92.49 122.61 35.09 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-N 114.938 -1.028 . . . . 0.0 110.138 175.876 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -122.75 79.58 1.65 Allowed 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 123.307 0.643 . . . . 0.0 109.885 -178.054 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 64.3 49.34 66.53 Favored Glycine 0 CA--C 1.55 2.235 0 N-CA-C 117.188 1.635 . . . . 0.0 117.188 -175.126 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 74.2 43.77 31.19 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 117.321 1.688 . . . . 0.0 117.321 -171.343 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -153.67 108.61 3.14 Favored 'General case' 0 CA--C 1.554 1.107 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 -169.921 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 50.9 mt -83.05 96.57 8.4 Favored 'General case' 0 N--CA 1.492 1.655 0 CA-C-O 122.812 1.292 . . . . 0.0 109.56 177.225 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 93.0 t -87.88 100.68 10.59 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.356 0 CA-C-N 112.972 -1.922 . . . . 0.0 105.944 179.125 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 22.6 t-160 -105.83 141.8 36.64 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 124.075 0.95 . . . . 0.0 109.598 -176.896 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 34.8 tp -140.13 121.24 14.75 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 177.231 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 87.7 mt-30 -115.55 110.38 19.15 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 -177.585 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -107.73 134.51 50.59 Favored 'General case' 0 N--CA 1.494 1.752 0 C-N-CA 122.986 0.514 . . . . 0.0 111.351 -174.101 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 17.5 p90 -151.04 108.72 3.66 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.398 -0.814 . . . . 0.0 109.877 177.539 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 7.1 t70 55.66 52.2 11.35 Favored 'General case' 0 N--CA 1.499 2.007 0 N-CA-C 116.408 2.003 . . . . 0.0 116.408 168.468 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 85.71 -42.55 3.16 Favored Glycine 0 CA--C 1.553 2.445 0 N-CA-C 116.768 1.467 . . . . 0.0 116.768 -169.339 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 62.9 mt-30 -78.62 125.8 29.86 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 123.744 0.818 . . . . 0.0 111.037 179.44 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -136.03 128.2 29.88 Favored 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 122.717 0.407 . . . . 0.0 111.452 178.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 7.7 t -113.44 132.57 55.6 Favored 'General case' 0 N--CA 1.495 1.791 0 C-N-CA 123.163 0.585 . . . . 0.0 110.921 177.941 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 41.2 p -101.01 130.39 47.0 Favored 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 122.896 0.478 . . . . 0.0 110.982 174.145 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 5.3 mp -111.16 79.68 1.23 Allowed 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.288 -1.005 . . . . 0.0 108.288 177.756 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 51.8 t -89.09 108.63 19.28 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 -169.938 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 80.5 mtt85 -104.35 113.95 27.86 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 122.946 0.498 . . . . 0.0 110.255 -174.776 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -126.0 136.99 53.62 Favored 'General case' 0 N--CA 1.493 1.677 0 C-N-CA 123.307 0.643 . . . . 0.0 111.617 179.08 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -81.81 115.69 21.14 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 123.277 0.631 . . . . 0.0 110.793 175.4 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 86.4 mt -124.75 107.94 19.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 N-CA-C 105.081 -2.192 . . . . 0.0 105.081 179.247 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 20.9 m-20 57.97 51.66 8.7 Favored 'General case' 0 N--CA 1.499 1.988 0 N-CA-C 114.971 1.471 . . . . 0.0 114.971 176.455 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 65.51 16.68 63.41 Favored Glycine 0 CA--C 1.555 2.584 0 N-CA-C 119.857 2.703 . . . . 0.0 119.857 -170.486 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 8.7 mtmp? -128.65 128.66 44.57 Favored 'General case' 0 N--CA 1.488 1.445 0 CA-C-N 119.877 1.838 . . . . 0.0 109.315 -173.447 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 22.2 tp -78.35 113.78 16.64 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 123.847 0.859 . . . . 0.0 109.843 178.501 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 34.9 mm -103.15 101.34 12.05 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 N-CA-C 106.42 -1.696 . . . . 0.0 106.42 -174.63 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 23.6 tp -90.17 103.0 15.72 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 123.915 0.886 . . . . 0.0 109.594 179.414 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 91.8 m -96.82 107.25 19.7 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 -175.335 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 71.9 mt -102.65 99.51 9.5 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 123.762 0.825 . . . . 0.0 109.476 -172.176 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 6.5 m -109.08 119.62 40.1 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 -176.414 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 75.6 t60 -141.12 120.62 13.22 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 171.032 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 74.88 -117.05 5.26 Favored Glycine 0 N--CA 1.484 1.863 0 CA-C-N 116.37 -0.377 . . . . 0.0 112.656 179.013 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 76.6 m -122.19 68.37 0.94 Allowed 'General case' 0 CA--C 1.565 1.553 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 167.471 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -164.06 99.09 0.85 Allowed 'General case' 0 N--CA 1.485 1.314 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 175.788 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 4.2 p -96.95 122.17 48.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 C-N-CA 123.929 0.892 . . . . 0.0 109.71 176.292 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 42.0 t -110.0 102.44 11.17 Favored 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 123.225 0.61 . . . . 0.0 110.731 178.063 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 63.9 m -90.74 100.39 13.25 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 -176.062 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 30.5 mtm180 -102.44 121.67 42.79 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 122.802 0.441 . . . . 0.0 111.106 -171.038 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 94.6 m -91.05 132.89 35.74 Favored 'General case' 0 CA--C 1.563 1.46 0 C-N-CA 123.763 0.825 . . . . 0.0 110.442 -177.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 37.5 m-85 -131.49 140.35 49.53 Favored 'General case' 0 CA--C 1.562 1.425 0 C-N-CA 124.298 1.039 . . . . 0.0 109.194 179.322 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 1.4 pp20? -111.31 157.8 19.76 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.637 -0.665 . . . . 0.0 111.837 166.943 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 22.9 ttpt -85.45 129.33 34.84 Favored 'General case' 0 N--CA 1.489 1.498 0 CA-C-O 121.906 0.86 . . . . 0.0 112.241 -167.67 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 28.2 mm-40 -118.27 55.76 0.89 Allowed 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 124.956 1.302 . . . . 0.0 111.089 -173.609 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.9 0 CA-C-O 124.447 2.07 . . . . 0.0 109.074 -168.359 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 3.3 p . . . . . 0 CA--C 1.577 2.0 0 N-CA-C 116.112 1.894 . . . . 0.0 116.112 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -68.19 -33.21 74.02 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 116.709 2.114 . . . . 0.0 116.709 -175.495 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -59.44 -25.27 64.23 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 117.707 2.484 . . . . 0.0 117.707 168.192 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -73.72 -24.3 59.89 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 116.133 1.901 . . . . 0.0 116.133 167.785 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 52.0 mt -79.9 113.84 18.37 Favored 'General case' 0 N--CA 1.489 1.505 0 CA-C-N 120.975 1.716 . . . . 0.0 111.451 -166.369 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 158.91 177.39 31.95 Favored Glycine 0 CA--C 1.543 1.785 0 CA-C-O 122.798 1.221 . . . . 0.0 112.985 -175.063 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 63.1 m -84.81 142.88 29.46 Favored 'General case' 0 N--CA 1.492 1.641 0 CA-C-N 114.57 -0.815 . . . . 0.0 109.817 171.356 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 82.6 m95 -140.9 113.95 8.47 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 107.659 -1.237 . . . . 0.0 107.659 -176.402 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 58.9 mttp -97.68 141.17 31.03 Favored 'General case' 0 N--CA 1.492 1.636 0 CA-C-O 121.016 0.436 . . . . 0.0 109.999 175.476 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 55.8 tp -66.71 124.66 23.51 Favored 'General case' 0 N--CA 1.49 1.56 0 CA-C-O 122.135 0.969 . . . . 0.0 111.668 -178.615 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . 0.284 0.9 OUTLIER -103.78 -43.42 8.58 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.784 0 CA-C-N 113.893 -1.503 . . . . 0.0 112.036 -178.222 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -142.63 129.13 20.17 Favored 'General case' 0 N--CA 1.49 1.545 0 CA-C-N 120.336 1.425 . . . . 0.0 109.778 177.926 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 87.8 p -111.77 116.5 30.81 Favored 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 123.236 0.614 . . . . 0.0 109.82 167.84 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -83.99 -75.45 0.34 Allowed 'General case' 0 N--CA 1.492 1.664 0 C-N-CA 122.78 0.432 . . . . 0.0 111.66 -173.519 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 71.4 m-20 -106.44 44.2 1.08 Allowed 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 113.307 0.854 . . . . 0.0 113.307 179.671 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 15.2 t80 -91.37 65.69 5.37 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 120.714 -1.241 . . . . 0.0 111.796 -177.705 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -168.2 -53.47 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 126.534 1.934 . . . . 0.0 107.079 -176.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -55.54 -47.72 75.87 Favored 'General case' 0 N--CA 1.498 1.947 0 N-CA-C 115.228 1.566 . . . . 0.0 115.228 161.648 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 92.8 t80 -52.41 -55.58 20.79 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 114.786 1.402 . . . . 0.0 114.786 170.415 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 75.2 mtm -66.22 -31.65 72.6 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 116.481 2.03 . . . . 0.0 116.481 174.787 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -64.58 -45.26 87.75 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-N 120.197 1.362 . . . . 0.0 114.564 168.795 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 23.2 t -59.14 -38.88 80.75 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 115.762 1.764 . . . . 0.0 115.762 170.339 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 95.2 mt -64.22 -39.43 93.95 Favored 'General case' 0 CA--C 1.57 1.749 0 N-CA-C 115.472 1.656 . . . . 0.0 115.472 164.785 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 129.51 -95.49 0.36 Allowed Glycine 0 CA--C 1.54 1.604 0 N-CA-C 108.887 -1.685 . . . . 0.0 108.887 -174.028 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . 0.285 13.2 t 56.73 66.95 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.058 0 N-CA-C 114.044 1.127 . . . . 0.0 114.044 168.075 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 34.47 -128.73 0.56 Allowed Glycine 0 CA--C 1.553 2.435 0 N-CA-C 120.077 2.791 . . . . 0.0 120.077 177.841 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 43.0 p90 -146.37 -54.88 0.26 Allowed 'General case' 0 N--CA 1.494 1.749 0 C-N-CA 124.202 1.001 . . . . 0.0 110.044 169.323 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.96 -33.5 75.51 Favored 'General case' 0 CA--C 1.564 1.49 0 N-CA-C 116.245 1.943 . . . . 0.0 116.245 164.801 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 29.8 m -63.49 -38.76 92.36 Favored 'General case' 0 N--CA 1.498 1.925 0 CA-C-N 120.284 1.402 . . . . 0.0 114.258 168.14 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 22.7 ttp180 -58.33 -43.67 88.36 Favored 'General case' 0 CA--C 1.573 1.847 0 N-CA-C 115.102 1.519 . . . . 0.0 115.102 167.554 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 8.1 tm0? -65.87 -51.25 60.37 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 115.116 1.524 . . . . 0.0 115.116 173.137 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 94.2 t -60.6 -45.43 97.3 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 CA-C-N 119.249 0.932 . . . . 0.0 113.01 176.332 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -65.42 -36.79 84.99 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 116.472 2.027 . . . . 0.0 116.472 175.921 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 95.5 p -64.07 -42.14 97.08 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 116.161 1.912 . . . . 0.0 116.161 168.871 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 35.8 ttm -66.5 -39.71 88.84 Favored 'General case' 0 CA--C 1.57 1.722 0 N-CA-C 115.921 1.822 . . . . 0.0 115.921 169.806 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 54.1 m -70.77 144.25 50.95 Favored 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 124.354 1.062 . . . . 0.0 112.331 -176.609 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? -102.91 99.59 14.28 Favored Pre-proline 0 CA--C 1.573 1.864 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 173.107 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -78.48 111.0 2.95 Favored 'Trans proline' 0 CA--C 1.56 1.804 0 C-N-CA 123.388 2.725 . . . . 0.0 111.594 -178.254 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 97.0 m -78.65 104.84 9.53 Favored 'General case' 0 N--CA 1.491 1.625 0 CA-C-O 121.372 0.606 . . . . 0.0 109.969 -173.876 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 86.4 m -87.55 114.79 24.48 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 124.086 0.954 . . . . 0.0 109.091 -174.871 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 81.9 mt -112.46 108.47 25.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 N-CA-C 106.557 -1.646 . . . . 0.0 106.557 -177.934 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 17.0 mt -97.14 121.24 47.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 -179.21 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -140.7 118.0 11.38 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 -169.728 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 45.2 tttp -90.62 114.91 27.29 Favored 'General case' 0 CA--C 1.557 1.214 0 C-N-CA 123.267 0.627 . . . . 0.0 111.36 -176.365 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 51.4 m-80 -105.82 83.39 1.92 Allowed 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 -179.603 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 80.6 -97.63 1.73 Allowed Glycine 0 N--CA 1.486 2.028 0 O-C-N 121.704 -0.623 . . . . 0.0 112.13 -169.007 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -130.34 62.53 1.58 Allowed 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 159.811 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 30.8 mm -138.28 100.69 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 N-CA-C 104.818 -2.29 . . . . 0.0 104.818 -178.047 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 71.0 mt -85.35 99.9 11.47 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 122.663 0.385 . . . . 0.0 110.47 -179.132 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 46.9 m -92.4 105.51 17.69 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 107.14 -1.43 . . . . 0.0 107.14 -178.82 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 10.0 tt -104.68 96.45 6.58 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 106.957 -1.497 . . . . 0.0 106.957 -170.957 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 58.9 mttp -94.83 106.84 18.85 Favored 'General case' 0 N--CA 1.482 1.133 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 -163.41 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 45.4 m -90.08 92.03 8.8 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 -175.27 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 75.4 m80 -87.64 93.64 9.49 Favored 'General case' 0 N--CA 1.488 1.47 0 CA-C-O 121.733 0.778 . . . . 0.0 110.688 -173.282 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 41.9 t -113.35 151.43 31.24 Favored 'General case' 0 CA--C 1.555 1.144 0 C-N-CA 124.051 0.941 . . . . 0.0 110.078 -175.658 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 27.2 m -55.92 -27.36 51.88 Favored 'General case' 0 N--CA 1.501 2.102 0 N-CA-C 115.265 1.579 . . . . 0.0 115.265 159.539 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 36.2 t80 -115.19 104.72 12.12 Favored 'General case' 0 N--CA 1.485 1.281 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 173.34 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 32.6 mmmt 62.55 90.51 0.07 Allowed 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 113.951 1.093 . . . . 0.0 113.951 168.831 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 7.4 p-10 -79.33 120.12 23.34 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 122.95 0.5 . . . . 0.0 111.501 177.142 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 73.7 p -133.87 132.68 40.63 Favored 'General case' 0 N--CA 1.496 1.836 0 C-N-CA 123.146 0.579 . . . . 0.0 110.076 -170.805 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -118.95 140.74 49.49 Favored 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 122.944 0.498 . . . . 0.0 112.161 178.868 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 42.9 pt -117.22 129.97 72.88 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 C-N-CA 123.405 0.682 . . . . 0.0 109.447 -178.66 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 88.2 p -106.46 118.49 36.78 Favored 'General case' 0 N--CA 1.493 1.7 0 C-N-CA 123.745 0.818 . . . . 0.0 110.209 -178.195 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 50.2 p90 -140.82 135.86 31.84 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 115.188 1.551 . . . . 0.0 115.188 -167.55 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 53.1 mtmt -102.74 19.33 19.42 Favored 'General case' 0 CA--C 1.574 1.883 0 N-CA-C 116.556 2.058 . . . . 0.0 116.556 -175.42 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . 0.294 1.3 mp 63.21 93.07 0.06 Allowed 'General case' 0 N--CA 1.494 1.739 0 CA-C-N 120.418 1.463 . . . . 0.0 114.293 173.365 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 85.79 39.59 8.06 Favored Glycine 0 CA--C 1.55 2.259 0 N-CA-C 116.716 1.446 . . . . 0.0 116.716 -167.072 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 87.7 t -139.47 122.71 18.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 N-CA-C 106.324 -1.732 . . . . 0.0 106.324 178.597 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -87.63 125.8 34.58 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 123.448 0.699 . . . . 0.0 110.948 176.41 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 40.8 p90 -132.79 127.7 35.15 Favored 'General case' 0 N--CA 1.493 1.722 0 C-N-CA 123.558 0.743 . . . . 0.0 110.65 -173.179 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -69.52 126.59 30.2 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.607 -0.683 . . . . 0.0 112.734 174.288 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 12.9 tp10 -138.73 133.87 32.79 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 123.193 0.597 . . . . 0.0 110.156 -167.164 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 58.9 m -92.55 121.33 33.89 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 176.22 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 32.0 p -81.41 172.0 14.07 Favored 'General case' 0 N--CA 1.493 1.705 0 CA-C-O 122.041 0.924 . . . . 0.0 113.316 -173.854 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -51.6 -35.34 41.12 Favored 'General case' 0 CA--C 1.568 1.638 0 N-CA-C 118.038 2.607 . . . . 0.0 118.038 166.415 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -111.18 51.32 0.78 Allowed 'General case' 0 CA--C 1.574 1.867 0 CA-C-N 119.197 0.908 . . . . 0.0 112.177 171.621 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 51.84 73.67 0.31 Allowed 'General case' 0 N--CA 1.5 2.044 0 N-CA-C 116.584 2.068 . . . . 0.0 116.584 168.678 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 67.9 mtt-85 -143.03 125.11 15.3 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.808 -0.558 . . . . 0.0 109.665 -176.094 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.75 91.8 8.06 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 123.411 0.685 . . . . 0.0 111.483 177.372 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 10.6 m -111.97 128.59 68.46 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 121.808 -0.558 . . . . 0.0 111.426 -163.858 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 29.8 mmtp -83.7 104.3 13.7 Favored 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 123.672 0.789 . . . . 0.0 110.514 178.734 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 68.8 m -103.26 99.86 9.73 Favored 'General case' 0 N--CA 1.483 1.216 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.952 -160.447 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 7.0 tp -110.6 105.07 18.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 C-N-CA 123.646 0.778 . . . . 0.0 109.264 -177.483 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -116.96 125.54 73.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 C-N-CA 124.447 1.099 . . . . 0.0 108.353 177.32 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 11.0 t -130.16 152.52 49.51 Favored 'General case' 0 N--CA 1.492 1.632 0 CA-C-O 122.577 1.179 . . . . 0.0 111.024 172.644 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 26.3 tp -87.33 109.13 19.32 Favored 'General case' 0 N--CA 1.487 1.404 0 CA-C-N 114.64 -1.163 . . . . 0.0 109.676 177.543 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -123.51 95.26 4.52 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 -174.592 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 63.32 49.48 70.27 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 117.343 1.697 . . . . 0.0 117.343 -177.559 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 67.27 24.24 73.44 Favored Glycine 0 CA--C 1.557 2.691 0 N-CA-C 119.001 2.36 . . . . 0.0 119.001 -169.746 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 56.3 mtmt -131.93 125.45 31.67 Favored 'General case' 0 N--CA 1.487 1.425 0 CA-C-N 118.735 1.267 . . . . 0.0 107.848 -176.947 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 58.8 mt -84.56 94.86 8.68 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-O 123.03 1.395 . . . . 0.0 109.467 171.173 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 98.4 t -89.17 101.12 11.7 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.361 0 CA-C-N 112.643 -2.071 . . . . 0.0 105.844 -174.332 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 22.4 t-160 -105.78 139.88 39.67 Favored 'General case' 0 N--CA 1.486 1.348 0 CA-C-N 114.94 -1.027 . . . . 0.0 109.883 -173.5 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 29.1 tp -138.53 121.2 16.32 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 176.709 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 88.9 mt-30 -113.28 121.52 44.67 Favored 'General case' 0 N--CA 1.487 1.425 0 C-N-CA 124.233 1.013 . . . . 0.0 108.45 179.328 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 9.8 mtmp? -123.76 133.15 53.9 Favored 'General case' 0 N--CA 1.497 1.895 0 C-N-CA 122.994 0.517 . . . . 0.0 111.008 -170.314 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 13.5 p90 -156.45 112.66 3.03 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.689 -0.632 . . . . 0.0 110.325 -175.414 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 9.1 t70 53.76 52.51 12.96 Favored 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 116.279 1.955 . . . . 0.0 116.279 167.574 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 87.41 -44.01 3.24 Favored Glycine 0 CA--C 1.551 2.324 0 N-CA-C 116.687 1.435 . . . . 0.0 116.687 -169.492 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 21.7 mt-30 -79.47 139.72 37.55 Favored 'General case' 0 N--CA 1.488 1.452 0 CA-C-N 117.841 0.82 . . . . 0.0 112.124 -178.179 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -144.16 130.25 19.57 Favored 'General case' 0 N--CA 1.491 1.586 0 CA-C-O 121.16 0.505 . . . . 0.0 111.779 177.931 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 12.4 t -118.63 131.15 56.18 Favored 'General case' 0 N--CA 1.492 1.673 0 C-N-CA 123.525 0.73 . . . . 0.0 110.717 177.554 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 35.5 p -99.01 137.77 37.06 Favored 'General case' 0 N--CA 1.492 1.654 0 CA-C-O 121.311 0.576 . . . . 0.0 111.188 173.203 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 5.3 mp -122.11 74.74 1.17 Allowed 'General case' 0 CA--C 1.564 1.518 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 -179.368 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 87.0 t -84.97 108.06 16.55 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 121.085 -1.01 . . . . 0.0 108.484 -169.555 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 82.9 mtt85 -99.53 120.96 40.48 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 123.234 0.614 . . . . 0.0 109.823 -175.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -141.35 130.81 23.81 Favored 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 123.107 0.563 . . . . 0.0 111.084 -170.689 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -81.69 112.52 18.95 Favored 'General case' 0 N--CA 1.487 1.413 0 CA-C-O 121.51 0.671 . . . . 0.0 111.029 -179.577 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 50.3 mm -118.5 105.46 17.79 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.352 0 N-CA-C 105.171 -2.159 . . . . 0.0 105.171 179.221 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 57.86 49.58 11.8 Favored 'General case' 0 N--CA 1.499 2.02 0 N-CA-C 114.763 1.394 . . . . 0.0 114.763 176.136 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 82.51 -29.28 3.28 Favored Glycine 0 CA--C 1.554 2.522 0 N-CA-C 118.807 2.283 . . . . 0.0 118.807 -169.504 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 89.9 mttt -93.72 136.11 34.33 Favored 'General case' 0 N--CA 1.486 1.371 0 CA-C-N 119.275 1.537 . . . . 0.0 111.189 -168.369 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 20.6 tp -80.73 115.93 20.48 Favored 'General case' 0 CA--C 1.558 1.279 0 C-N-CA 123.24 0.616 . . . . 0.0 110.105 177.551 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 39.2 mm -104.0 101.57 12.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 N-CA-C 106.835 -1.543 . . . . 0.0 106.835 -175.3 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 16.2 tp -91.81 102.22 14.81 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 124.009 0.924 . . . . 0.0 109.729 179.604 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 58.5 m -91.54 112.87 24.97 Favored 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 123.883 0.873 . . . . 0.0 109.286 -175.808 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 96.7 mt -111.09 97.48 6.84 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 123.71 0.804 . . . . 0.0 109.708 -169.95 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 10.2 m -113.08 117.75 32.86 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.875 -0.516 . . . . 0.0 109.788 -172.405 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 78.9 t60 -152.34 116.4 4.91 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 174.929 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 60.6 61.18 7.33 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 117.061 1.584 . . . . 0.0 117.061 171.39 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . 0.297 4.3 m 51.65 51.53 16.49 Favored 'General case' 0 CA--C 1.576 1.953 0 N-CA-C 114.928 1.455 . . . . 0.0 114.928 -172.098 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -158.11 86.62 0.9 Allowed 'General case' 0 N--CA 1.484 1.228 0 CA-C-O 121.542 0.687 . . . . 0.0 109.194 -179.618 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 3.4 p -91.23 111.85 24.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 C-N-CA 123.691 0.796 . . . . 0.0 109.257 175.4 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 48.4 t -105.17 102.05 11.57 Favored 'General case' 0 CA--C 1.552 1.032 0 CA-C-O 121.461 0.648 . . . . 0.0 109.662 176.052 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 86.0 m -90.56 94.2 9.61 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 -175.706 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 32.5 mtm180 -91.88 120.98 33.06 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 122.927 0.491 . . . . 0.0 111.019 -169.426 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 87.6 m -86.61 131.83 34.06 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 123.463 0.705 . . . . 0.0 110.096 179.09 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 35.9 m-85 -128.43 126.59 40.87 Favored 'General case' 0 CA--C 1.558 1.275 0 C-N-CA 123.82 0.848 . . . . 0.0 108.835 178.538 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -93.99 150.98 19.87 Favored 'General case' 0 N--CA 1.492 1.672 0 CA-C-O 122.08 0.943 . . . . 0.0 111.526 169.921 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 68.9 tttt -83.06 119.56 24.63 Favored 'General case' 0 N--CA 1.486 1.329 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.706 -169.884 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 11.8 mm-40 -110.09 49.36 0.85 Allowed 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 123.934 0.894 . . . . 0.0 113.03 179.49 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.301 0 CA-C-O 123.27 1.509 . . . . 0.0 113.569 169.928 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.303 8.5 t . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 118.248 -0.882 . . . . 0.0 112.984 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -60.48 -37.46 81.13 Favored 'General case' 0 N--CA 1.497 1.895 0 N-CA-C 116.224 1.935 . . . . 0.0 116.224 179.505 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -63.55 -29.07 70.39 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 117.047 2.24 . . . . 0.0 117.047 164.057 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -72.93 -21.67 60.84 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 116.145 1.905 . . . . 0.0 116.145 170.589 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 48.2 mt -69.64 114.74 8.14 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-N 121.516 1.962 . . . . 0.0 111.917 -172.541 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 157.93 172.94 25.72 Favored Glycine 0 CA--C 1.543 1.808 0 CA-C-O 122.442 1.023 . . . . 0.0 113.428 -173.554 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 80.1 m -92.88 140.52 29.41 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 171.177 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 85.2 m95 -138.7 114.75 10.16 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 -173.936 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 48.5 mtmt -97.18 147.16 24.37 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-O 121.54 0.686 . . . . 0.0 111.32 177.297 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 57.3 tp -70.76 126.26 29.1 Favored 'General case' 0 N--CA 1.487 1.421 0 CA-C-O 121.905 0.859 . . . . 0.0 112.438 -175.505 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . 0.271 1.1 t -104.58 -44.16 8.54 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.852 0 CA-C-N 114.327 -1.306 . . . . 0.0 112.421 178.542 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -140.45 134.31 30.55 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-N 120.004 1.275 . . . . 0.0 109.687 -178.487 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 79.9 p -122.17 113.99 20.24 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 123.456 0.702 . . . . 0.0 110.053 171.855 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 10.7 mtpm? -81.92 -88.16 0.09 Allowed 'General case' 0 N--CA 1.492 1.646 0 CA-C-O 118.962 -0.542 . . . . 0.0 111.472 -177.152 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 70.9 m-80 -98.1 43.03 1.07 Allowed 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 113.831 1.049 . . . . 0.0 113.831 -174.222 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 17.5 t80 -76.83 -43.11 37.67 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 115.722 1.749 . . . . 0.0 115.722 -168.325 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 33.3 m-20 -63.69 -36.51 84.1 Favored 'General case' 0 N--CA 1.499 1.999 0 N-CA-C 115.112 1.523 . . . . 0.0 115.112 169.763 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 24.1 t0 -60.87 -47.32 86.9 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 115.174 1.546 . . . . 0.0 115.174 167.226 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 83.7 t80 -53.95 -53.02 58.62 Favored 'General case' 0 CA--C 1.569 1.702 0 N-CA-C 115.194 1.553 . . . . 0.0 115.194 170.448 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 79.0 mtm -63.76 -34.58 78.21 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 116.149 1.907 . . . . 0.0 116.149 173.704 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -57.59 -50.61 72.55 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 114.65 1.352 . . . . 0.0 114.65 165.194 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 22.9 t -60.28 -36.58 78.15 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 116.318 1.97 . . . . 0.0 116.318 171.482 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.493 ' HB3' HH12 ' A' ' 78' ' ' ARG . 31.2 mt -64.1 -34.75 78.75 Favored 'General case' 0 CA--C 1.565 1.53 0 N-CA-C 117.309 2.337 . . . . 0.0 117.309 169.74 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 101.25 76.26 1.19 Allowed Glycine 0 N--CA 1.482 1.741 0 CA-C-N 119.118 0.872 . . . . 0.0 112.02 -171.415 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 58.3 t -138.33 122.76 21.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 N-CA-C 105.585 -2.006 . . . . 0.0 105.585 -179.554 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -63.27 147.53 50.53 Favored Glycine 0 N--CA 1.488 2.116 0 N-CA-C 115.431 0.932 . . . . 0.0 115.431 177.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . 0.257 25.2 p90 -55.34 -41.64 72.74 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 118.834 2.901 . . . . 0.0 118.834 -166.169 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.57 -44.48 96.21 Favored 'General case' 0 CA--C 1.565 1.541 0 N-CA-C 115.979 1.844 . . . . 0.0 115.979 175.157 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 86.6 m -68.78 -38.6 80.12 Favored 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 114.439 1.274 . . . . 0.0 114.439 168.772 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 48.8 ttp180 -56.57 -45.14 81.47 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 115.421 1.637 . . . . 0.0 115.421 174.373 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 18.8 mm100 -70.5 -38.13 74.3 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 115.167 1.543 . . . . 0.0 115.167 173.196 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 95.3 t -63.45 -44.09 98.71 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.094 0 CA-C-N 120.093 1.315 . . . . 0.0 113.46 171.525 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -63.98 -31.06 72.11 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 117.371 2.36 . . . . 0.0 117.371 174.641 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 93.7 p -68.57 -42.2 78.62 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 116.15 1.907 . . . . 0.0 116.15 168.072 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 3.7 ppp? -71.87 -26.91 62.54 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 117.582 2.438 . . . . 0.0 117.582 175.34 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 5.3 t -74.79 162.95 28.2 Favored 'General case' 0 N--CA 1.493 1.699 0 CA-C-N 120.335 1.425 . . . . 0.0 112.592 175.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -99.97 103.51 22.84 Favored Pre-proline 0 CA--C 1.567 1.61 0 CA-C-O 118.008 -0.996 . . . . 0.0 108.853 172.394 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -78.89 90.32 1.29 Allowed 'Trans proline' 0 CA--C 1.56 1.81 0 C-N-CA 123.208 2.606 . . . . 0.0 111.225 177.292 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 94.4 m -80.19 111.79 16.89 Favored 'General case' 0 N--CA 1.489 1.513 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.574 -161.164 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 36.5 m -86.42 113.28 22.24 Favored 'General case' 0 CA--C 1.559 1.323 0 C-N-CA 123.598 0.759 . . . . 0.0 109.446 -171.711 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 71.6 mt -109.59 103.62 15.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 N-CA-C 106.033 -1.84 . . . . 0.0 106.033 177.649 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 3.7 mp -91.68 123.41 43.79 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 N-CA-C 106.881 -1.526 . . . . 0.0 106.881 172.175 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -148.21 125.61 11.62 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 -169.626 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.32 153.65 29.68 Favored 'General case' 0 CA--C 1.565 1.54 0 CA-C-O 122.173 0.987 . . . . 0.0 113.656 178.249 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 67.1 m-80 -141.77 75.3 1.49 Allowed 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 106.389 -1.708 . . . . 0.0 106.389 171.16 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 71.17 -110.99 3.47 Favored Glycine 0 CA--C 1.548 2.108 0 O-C-N 121.885 -0.51 . . . . 0.0 112.86 -166.5 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 21.1 m-20 -82.75 -21.14 34.79 Favored 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 116.033 1.864 . . . . 0.0 116.033 168.024 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 42.8 mm -84.93 114.88 25.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 CA-C-N 119.863 1.21 . . . . 0.0 109.614 -168.191 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.4 HD12 HD13 ' A' ' 66' ' ' LEU . 44.5 mt -86.79 114.94 23.87 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 123.057 0.543 . . . . 0.0 110.342 174.164 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 88.5 m -107.81 102.82 12.0 Favored 'General case' 0 N--CA 1.486 1.342 0 N-CA-C 106.728 -1.582 . . . . 0.0 106.728 -174.358 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 8.9 tt -104.37 107.11 17.87 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -103.37 114.82 29.39 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 179.331 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 91.7 m -100.67 98.11 8.7 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 179.246 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 20.2 m-70 -85.08 91.26 8.06 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 123.411 0.684 . . . . 0.0 112.555 -169.456 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 15.2 t -100.65 155.09 18.08 Favored 'General case' 0 CA--C 1.557 1.241 0 C-N-CA 123.814 0.846 . . . . 0.0 110.302 174.486 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 63.4 p -59.19 -19.51 45.91 Favored 'General case' 0 N--CA 1.504 2.263 0 N-CA-C 116.459 2.022 . . . . 0.0 116.459 162.192 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 52.0 t80 -101.42 75.08 1.58 Allowed 'General case' 0 CA--C 1.562 1.408 0 CA-C-N 119.242 0.928 . . . . 0.0 108.903 165.213 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 31.9 mtmm 64.44 132.62 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 115.682 1.734 . . . . 0.0 115.682 176.165 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 8.8 p30 -81.98 112.83 19.43 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 123.054 0.541 . . . . 0.0 110.952 172.849 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 77.9 p -90.67 122.63 33.61 Favored 'General case' 0 N--CA 1.492 1.661 0 CA-C-O 121.178 0.513 . . . . 0.0 110.775 -174.559 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -108.12 115.82 30.83 Favored 'General case' 0 N--CA 1.486 1.341 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 -175.112 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 29.8 pt -111.24 129.63 66.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 N-CA-C 108.531 -0.915 . . . . 0.0 108.531 174.087 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 44.1 t -118.73 113.0 20.48 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.38 -0.971 . . . . 0.0 108.38 -174.574 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 43.8 p90 -144.89 140.77 28.55 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 115.093 1.516 . . . . 0.0 115.093 -162.1 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 29.5 mtpp -109.16 18.43 20.56 Favored 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 117.325 2.343 . . . . 0.0 117.325 -177.486 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.4 HD13 HD12 ' A' ' 49' ' ' LEU 0.296 1.3 mp 65.6 93.57 0.07 Allowed 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 125.03 1.332 . . . . 0.0 113.278 176.723 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 92.32 37.67 5.85 Favored Glycine 0 CA--C 1.55 2.228 0 N-CA-C 117.01 1.564 . . . . 0.0 117.01 -166.631 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 92.3 t -135.62 122.86 35.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 N-CA-C 107.035 -1.468 . . . . 0.0 107.035 178.311 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -88.08 131.91 34.5 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 123.401 0.68 . . . . 0.0 110.476 170.793 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 37.0 p90 -143.0 130.74 21.43 Favored 'General case' 0 N--CA 1.493 1.72 0 C-N-CA 123.333 0.653 . . . . 0.0 110.087 -174.069 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -72.56 114.02 10.24 Favored 'General case' 0 CA--C 1.564 1.501 0 O-C-N 121.546 -0.721 . . . . 0.0 111.933 175.934 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 14.0 tp10 -119.08 134.5 55.16 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 123.842 0.857 . . . . 0.0 109.782 -167.706 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 73.4 m -90.57 121.74 32.77 Favored 'General case' 0 N--CA 1.491 1.577 0 CA-C-O 121.258 0.551 . . . . 0.0 109.663 176.084 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 30.0 p -85.0 169.74 13.69 Favored 'General case' 0 N--CA 1.493 1.712 0 CA-C-O 121.54 0.686 . . . . 0.0 112.203 -177.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -59.37 -34.82 72.88 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 116.68 2.104 . . . . 0.0 116.68 166.89 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -76.53 9.24 2.84 Favored 'General case' 0 CA--C 1.581 2.144 0 N-CA-C 115.909 1.818 . . . . 0.0 115.909 167.309 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . 0.252 11.6 m-20 66.78 69.74 0.4 Allowed 'General case' 0 N--CA 1.494 1.77 0 C-N-CA 125.749 1.62 . . . . 0.0 112.669 176.971 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.493 HH12 ' HB3' ' A' ' 23' ' ' LEU . 60.4 mtm180 -143.56 128.17 18.1 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 122.915 0.486 . . . . 0.0 110.23 -175.117 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.36 117.56 13.05 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 123.491 0.716 . . . . 0.0 111.075 164.822 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 14.3 m -133.49 127.37 53.36 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 -171.865 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 33.2 mmtp -77.54 102.9 7.17 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 123.567 0.747 . . . . 0.0 110.557 -178.886 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 69.2 m -101.19 92.67 5.08 Favored 'General case' 0 N--CA 1.482 1.149 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.575 -165.074 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 7.2 tp -106.1 116.64 50.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 178.915 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 1.4 p -134.15 131.72 55.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 C-N-CA 123.806 0.842 . . . . 0.0 109.564 -170.808 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 10.1 t -148.63 152.17 36.25 Favored 'General case' 0 N--CA 1.49 1.533 0 CA-C-O 122.745 1.26 . . . . 0.0 110.359 179.691 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 26.4 tp -85.67 119.94 26.55 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-N 114.726 -1.125 . . . . 0.0 110.298 176.424 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -109.4 79.22 1.19 Allowed 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 123.52 0.728 . . . . 0.0 109.613 -178.357 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 54.9 44.26 81.96 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 118.477 2.151 . . . . 0.0 118.477 -177.454 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 107.12 -42.52 1.91 Allowed Glycine 0 N--CA 1.49 2.295 0 N-CA-C 116.558 1.383 . . . . 0.0 116.558 -168.885 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 35.9 ttmt -82.33 112.06 18.96 Favored 'General case' 0 CA--C 1.559 1.289 0 CA-C-N 118.164 0.982 . . . . 0.0 109.881 179.584 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.8 tt -88.28 102.72 15.12 Favored 'General case' 0 N--CA 1.488 1.459 0 CA-C-O 121.659 0.742 . . . . 0.0 109.311 -176.739 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 62.7 t -100.7 110.41 27.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 -166.656 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 22.8 t-160 -104.47 134.39 47.75 Favored 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 123.822 0.849 . . . . 0.0 109.713 171.774 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 24.4 tp -120.09 120.99 37.87 Favored 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 124.655 1.182 . . . . 0.0 107.944 172.829 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 27.6 mt-30 -109.2 113.71 26.79 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 171.522 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 38.0 ttmt -122.77 132.82 54.4 Favored 'General case' 0 CA--C 1.563 1.465 0 C-N-CA 123.461 0.704 . . . . 0.0 110.397 -174.592 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 34.9 p90 -149.09 115.2 5.76 Favored 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 123.36 0.664 . . . . 0.0 109.989 -176.941 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . 0.343 17.4 t70 67.15 -101.36 0.06 Allowed 'General case' 0 N--CA 1.495 1.796 0 C-N-CA 124.511 1.124 . . . . 0.0 111.972 176.179 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -127.88 56.23 0.74 Allowed Glycine 0 N--CA 1.487 2.059 0 CA-C-N 118.736 0.698 . . . . 0.0 113.16 162.568 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 49.1 mt-30 -149.15 110.41 4.41 Favored 'General case' 0 N--CA 1.485 1.31 0 N-CA-C 107.032 -1.47 . . . . 0.0 107.032 -177.481 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -117.01 124.42 49.27 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 122.894 0.477 . . . . 0.0 110.777 176.577 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 10.7 t -115.58 122.71 46.48 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 110.051 -0.351 . . . . 0.0 110.051 167.421 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 35.7 p -93.19 125.79 37.96 Favored 'General case' 0 N--CA 1.489 1.505 0 CA-C-O 121.274 0.559 . . . . 0.0 110.598 172.345 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 5.6 mp -99.08 86.73 3.51 Favored 'General case' 0 CA--C 1.561 1.387 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 175.924 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 93.3 t -94.21 108.53 20.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 -168.455 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 79.1 mtt85 -108.41 121.98 46.06 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 123.173 0.589 . . . . 0.0 110.143 -173.239 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -141.53 137.51 32.07 Favored 'General case' 0 N--CA 1.495 1.776 0 C-N-CA 123.114 0.566 . . . . 0.0 110.938 177.199 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -81.17 119.62 23.83 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.518 -0.739 . . . . 0.0 111.271 176.765 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 74.6 mt -123.97 110.89 26.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 N-CA-C 104.949 -2.241 . . . . 0.0 104.949 177.369 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 29.3 m-20 59.3 48.49 10.11 Favored 'General case' 0 N--CA 1.5 2.057 0 N-CA-C 114.767 1.395 . . . . 0.0 114.767 179.126 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 60.45 28.06 66.79 Favored Glycine 0 CA--C 1.554 2.473 0 N-CA-C 119.336 2.494 . . . . 0.0 119.336 -169.368 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 9.7 mtmp? -135.36 127.31 29.56 Favored 'General case' 0 N--CA 1.489 1.511 0 CA-C-N 119.482 1.641 . . . . 0.0 108.533 -173.649 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 35.0 tp -75.36 112.19 11.41 Favored 'General case' 0 CA--C 1.557 1.235 0 C-N-CA 123.493 0.717 . . . . 0.0 110.811 -179.561 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 31.0 mm -100.42 104.92 16.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 N-CA-C 106.409 -1.7 . . . . 0.0 106.409 -176.533 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 23.7 tp -97.96 101.17 12.59 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 123.81 0.844 . . . . 0.0 109.103 179.541 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 97.7 m -93.86 109.96 21.64 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 124.177 0.991 . . . . 0.0 108.769 -178.546 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 74.7 mt -103.8 90.32 3.6 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 123.913 0.885 . . . . 0.0 109.734 -168.534 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 7.5 m -100.06 118.18 35.88 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 -168.932 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 80.1 t60 -132.59 -105.49 0.25 Allowed 'General case' 0 N--CA 1.492 1.629 0 CA-C-O 118.77 -0.633 . . . . 0.0 109.652 176.105 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -119.63 91.14 0.49 Allowed Glycine 0 N--CA 1.486 1.989 0 CA-C-N 119.321 0.964 . . . . 0.0 112.65 -167.015 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . 0.297 1.6 m 54.62 34.37 21.27 Favored 'General case' 0 CA--C 1.582 2.179 0 N-CA-C 115.885 1.809 . . . . 0.0 115.885 -173.029 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -161.68 84.22 0.61 Allowed 'General case' 0 N--CA 1.485 1.308 0 O-C-N 121.15 -0.968 . . . . 0.0 108.768 -177.905 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 4.7 p -91.91 116.67 33.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 175.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 42.2 t -101.85 102.35 12.92 Favored 'General case' 0 CA--C 1.553 1.066 0 CA-C-O 121.187 0.518 . . . . 0.0 111.096 -179.63 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 96.2 m -87.7 111.75 21.64 Favored 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 177.424 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 28.9 mtm180 -114.4 119.28 36.39 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 122.898 0.479 . . . . 0.0 110.529 -170.347 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 88.9 m -84.42 134.97 34.45 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 123.234 0.614 . . . . 0.0 110.043 175.881 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 36.9 m-85 -130.11 128.43 41.83 Favored 'General case' 0 CA--C 1.56 1.345 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 178.367 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -93.77 150.72 20.16 Favored 'General case' 0 CA--C 1.564 1.503 0 CA-C-O 122.06 0.933 . . . . 0.0 111.202 172.173 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 69.3 tttt -82.97 124.83 30.76 Favored 'General case' 0 N--CA 1.486 1.342 0 N-CA-C 112.916 0.709 . . . . 0.0 112.916 -168.559 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 40.1 tp10 -99.06 47.95 0.96 Allowed 'General case' 0 CA--C 1.57 1.724 0 C-N-CA 123.772 0.829 . . . . 0.0 113.044 169.548 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.043 0 CA-C-O 124.263 1.982 . . . . 0.0 108.241 -176.94 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.306 5.0 t . . . . . 0 N--CA 1.49 1.526 0 CA-C-O 117.795 -1.098 . . . . 0.0 113.302 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -61.19 -36.99 81.38 Favored 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 115.991 1.849 . . . . 0.0 115.991 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -61.31 -32.23 72.09 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 116.957 2.206 . . . . 0.0 116.957 163.428 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -71.96 -25.41 61.86 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 115.978 1.844 . . . . 0.0 115.978 170.248 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 55.3 mt -71.71 117.32 13.14 Favored 'General case' 0 N--CA 1.492 1.652 0 CA-C-N 121.375 1.898 . . . . 0.0 111.112 -175.925 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 160.1 170.0 24.12 Favored Glycine 0 CA--C 1.54 1.627 0 CA-C-O 122.418 1.01 . . . . 0.0 113.853 -172.422 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 90.3 m -92.62 136.74 32.97 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-N 114.464 -0.868 . . . . 0.0 108.812 171.031 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 94.8 m95 -137.64 115.17 11.2 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.685 -0.858 . . . . 0.0 108.685 -170.193 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 23.0 mmmt -108.27 145.22 34.67 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-O 121.791 0.805 . . . . 0.0 110.536 179.627 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 25.8 tp -68.81 128.82 38.01 Favored 'General case' 0 N--CA 1.487 1.407 0 CA-C-O 122.222 1.011 . . . . 0.0 112.91 -171.789 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . 0.28 1.1 t -106.69 -45.67 8.01 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.725 0 CA-C-N 113.805 -1.543 . . . . 0.0 111.767 178.811 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 43.7 t0 -142.01 140.08 32.56 Favored 'General case' 0 N--CA 1.488 1.429 0 CA-C-N 119.437 1.017 . . . . 0.0 109.079 178.641 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 81.0 p -127.79 94.26 3.9 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.784 -0.572 . . . . 0.0 109.853 172.4 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 47.9 mtmt -91.99 120.8 32.97 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 123.57 0.748 . . . . 0.0 109.355 -176.408 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.264 42.1 m-20 71.53 21.17 4.56 Favored 'General case' 0 N--CA 1.504 2.264 0 N-CA-C 117.113 2.264 . . . . 0.0 117.113 -178.726 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 10.1 t80 -71.85 -41.13 68.47 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 115.853 1.797 . . . . 0.0 115.853 -175.799 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -60.52 -32.25 71.29 Favored 'General case' 0 N--CA 1.499 1.976 0 N-CA-C 116.014 1.857 . . . . 0.0 116.014 168.442 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 20.1 t0 -64.85 -50.72 65.54 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 114.331 1.234 . . . . 0.0 114.331 167.776 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 89.6 t80 -50.54 -54.83 19.39 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 115.349 1.611 . . . . 0.0 115.349 171.74 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 77.7 mtm -59.85 -41.85 92.35 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 115.231 1.567 . . . . 0.0 115.231 175.418 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.3 tmtp? -62.57 -43.94 97.57 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 114.788 1.403 . . . . 0.0 114.788 171.526 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 61.3 m -58.18 -39.39 78.8 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 116.574 2.064 . . . . 0.0 116.574 171.022 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 51.8 mt -61.54 -45.86 92.39 Favored 'General case' 0 CA--C 1.567 1.632 0 N-CA-C 115.747 1.758 . . . . 0.0 115.747 167.94 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 121.03 71.69 0.3 Allowed Glycine 0 N--CA 1.482 1.735 0 C-N-CA 123.979 0.8 . . . . 0.0 111.266 -172.101 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 40.5 t -141.6 122.0 12.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 N-CA-C 105.083 -2.191 . . . . 0.0 105.083 -176.294 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -77.15 -171.48 35.35 Favored Glycine 0 CA--C 1.548 2.154 0 N-CA-C 116.663 1.425 . . . . 0.0 116.663 -174.853 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 11.0 p90 -67.27 158.32 31.76 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 113.387 0.884 . . . . 0.0 113.387 176.836 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . 0.325 . . 78.76 -52.05 0.46 Allowed 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 114.995 1.48 . . . . 0.0 114.995 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 89.1 m -64.48 -40.93 96.61 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 114.241 1.201 . . . . 0.0 114.241 167.682 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 48.1 mtm180 -61.26 -43.66 98.52 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 114.996 1.48 . . . . 0.0 114.996 167.555 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -60.52 -49.81 76.07 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 115.058 1.503 . . . . 0.0 115.058 174.056 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 69.1 t -63.69 -43.84 98.2 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 CA-C-N 119.429 1.013 . . . . 0.0 112.742 174.819 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -62.7 -35.98 81.48 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 117.053 2.242 . . . . 0.0 117.053 176.234 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 96.7 p -65.66 -43.44 89.39 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 116.395 1.998 . . . . 0.0 116.395 170.884 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 20.0 ptm -68.21 -31.02 70.25 Favored 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 117.067 2.247 . . . . 0.0 117.067 168.886 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 38.0 m -71.85 143.47 49.41 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 124.279 1.031 . . . . 0.0 112.257 -178.025 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -104.52 102.97 37.16 Favored Pre-proline 0 CA--C 1.57 1.723 0 CA-C-O 118.145 -0.931 . . . . 0.0 109.1 175.25 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -79.2 116.88 3.72 Favored 'Trans proline' 0 CA--C 1.561 1.849 0 C-N-CA 122.913 2.409 . . . . 0.0 112.185 -178.909 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 24.4 m -78.8 105.36 10.06 Favored 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 123.675 0.79 . . . . 0.0 109.701 -170.536 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 61.0 m -101.12 106.77 18.05 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 -167.234 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 52.0 mt -111.69 107.19 22.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 N-CA-C 107.16 -1.422 . . . . 0.0 107.16 -172.149 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 3.9 mp -96.18 121.56 46.84 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 174.637 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 7.9 tm-20 -137.23 120.6 16.97 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 -178.03 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -86.23 115.9 24.07 Favored 'General case' 0 CA--C 1.56 1.339 0 C-N-CA 123.15 0.58 . . . . 0.0 111.052 179.431 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 12.5 t30 -105.79 86.87 2.46 Favored 'General case' 0 CA--C 1.561 1.374 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 179.282 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 80.92 -99.75 1.92 Allowed Glycine 0 N--CA 1.486 1.982 0 N-CA-C 111.883 -0.487 . . . . 0.0 111.883 -172.91 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -130.11 59.36 1.63 Allowed 'General case' 0 N--CA 1.494 1.747 0 CA-C-O 120.958 0.409 . . . . 0.0 110.065 160.399 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 42.6 mm -137.81 108.16 5.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 N-CA-C 104.889 -2.263 . . . . 0.0 104.889 -179.813 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 42.8 mt -83.11 106.67 15.1 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 122.756 0.422 . . . . 0.0 110.871 179.204 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 73.3 m -98.98 96.99 8.2 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 -173.95 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 9.1 tt -97.68 103.19 15.1 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 -179.227 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 91.3 mttt -98.94 111.14 23.62 Favored 'General case' 0 N--CA 1.485 1.276 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 -175.306 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 45.8 m -100.13 87.03 3.35 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 -177.601 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 12.0 m170 -89.87 98.63 11.88 Favored 'General case' 0 N--CA 1.492 1.642 0 CA-C-O 121.702 0.763 . . . . 0.0 110.053 -173.224 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 22.9 t -98.09 -24.27 15.39 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 116.962 2.208 . . . . 0.0 116.962 -172.54 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . 0.363 4.4 m 89.4 -43.46 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.274 0 CA-C-N 121.074 1.761 . . . . 0.0 112.486 -161.982 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 73.4 t80 -62.1 -70.97 0.17 Allowed 'General case' 0 N--CA 1.491 1.618 0 CA-C-N 119.43 1.013 . . . . 0.0 111.611 166.399 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 54.5 mtpt -145.88 135.41 23.16 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 174.151 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -85.55 101.09 12.38 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 122.971 0.508 . . . . 0.0 110.777 173.134 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 60.2 p -96.19 127.85 42.56 Favored 'General case' 0 N--CA 1.494 1.75 0 CA-C-O 121.396 0.617 . . . . 0.0 109.949 -179.577 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -124.52 125.09 43.65 Favored 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 123.426 0.69 . . . . 0.0 109.344 -171.582 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 48.2 pt -117.6 131.48 70.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 C-N-CA 123.524 0.73 . . . . 0.0 109.077 175.644 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 80.6 p -121.2 104.14 9.52 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 -178.055 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 50.1 p90 -136.9 147.09 46.23 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 114.809 1.411 . . . . 0.0 114.809 -156.555 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 25.9 mtpp -110.77 20.29 17.74 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 117.679 2.474 . . . . 0.0 117.679 -170.693 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . 0.311 1.7 mp 60.65 88.7 0.08 Allowed 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 114.93 1.456 . . . . 0.0 114.93 172.639 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 92.39 39.81 5.26 Favored Glycine 0 CA--C 1.549 2.194 0 N-CA-C 115.951 1.141 . . . . 0.0 115.951 -168.506 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 74.9 t -141.62 123.86 14.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 N-CA-C 105.533 -2.025 . . . . 0.0 105.533 -176.421 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -88.14 129.55 35.29 Favored 'General case' 0 CA--C 1.565 1.547 0 C-N-CA 122.924 0.49 . . . . 0.0 110.497 176.915 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 48.6 p90 -138.95 131.55 28.87 Favored 'General case' 0 N--CA 1.496 1.831 0 C-N-CA 123.231 0.612 . . . . 0.0 111.435 -174.201 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -69.17 131.56 45.14 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.303 -0.873 . . . . 0.0 113.133 173.602 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 17.4 tp10 -142.97 137.85 29.67 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 123.426 0.69 . . . . 0.0 110.028 -168.343 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 56.6 m -93.06 122.8 35.8 Favored 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 123.035 0.534 . . . . 0.0 109.639 176.238 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 26.9 p -84.14 177.8 8.08 Favored 'General case' 0 N--CA 1.496 1.86 0 CA-C-O 121.415 0.626 . . . . 0.0 112.549 -177.3 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -67.4 -27.97 67.53 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 117.416 2.376 . . . . 0.0 117.416 169.612 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 25.6 m-20 -77.96 8.3 4.88 Favored 'General case' 0 CA--C 1.579 2.096 0 N-CA-C 115.918 1.822 . . . . 0.0 115.918 161.39 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 64.01 68.81 0.55 Allowed 'General case' 0 N--CA 1.496 1.837 0 C-N-CA 125.366 1.466 . . . . 0.0 112.891 -179.802 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 63.7 mtm180 -137.05 127.96 27.46 Favored 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 123.001 0.521 . . . . 0.0 109.74 -171.457 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.04 102.8 6.64 Favored 'General case' 0 CA--C 1.565 1.53 0 C-N-CA 123.331 0.652 . . . . 0.0 111.141 173.071 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 19.9 m -120.36 129.99 74.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 -170.622 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 69.6 mmtt -81.74 107.13 14.23 Favored 'General case' 0 N--CA 1.49 1.531 0 CA-C-O 121.841 0.829 . . . . 0.0 109.867 176.87 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 74.3 m -102.07 102.49 12.98 Favored 'General case' 0 N--CA 1.481 1.08 0 CA-C-N 114.838 -1.073 . . . . 0.0 110.114 -165.906 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -106.91 115.04 47.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 175.67 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -128.26 128.15 68.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 C-N-CA 123.799 0.84 . . . . 0.0 109.32 -178.835 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 9.3 t -139.97 151.26 45.37 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-O 122.705 1.24 . . . . 0.0 111.337 -179.249 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 50.5 tp -82.2 125.48 30.97 Favored 'General case' 0 N--CA 1.489 1.498 0 CA-C-N 114.523 -1.217 . . . . 0.0 109.921 176.476 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -126.5 83.44 2.17 Favored 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 123.462 0.705 . . . . 0.0 109.771 -178.826 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 58.56 46.13 93.63 Favored Glycine 0 CA--C 1.552 2.395 0 N-CA-C 117.934 1.933 . . . . 0.0 117.934 -178.444 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 76.77 31.82 52.33 Favored Glycine 0 CA--C 1.555 2.544 0 N-CA-C 117.833 1.893 . . . . 0.0 117.833 -166.924 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 60.4 mtpt -141.13 112.82 7.62 Favored 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 106.629 -1.619 . . . . 0.0 106.629 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 3.7 mp -81.67 111.04 17.58 Favored 'General case' 0 N--CA 1.487 1.404 0 CA-C-O 121.94 0.876 . . . . 0.0 109.858 173.76 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 95.6 t -106.84 102.03 13.35 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 N-CA-C 105.324 -2.102 . . . . 0.0 105.324 -172.646 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 23.6 t-160 -104.85 136.95 43.39 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 124.35 1.06 . . . . 0.0 109.474 -178.306 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 33.7 tp -132.65 119.4 20.38 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 177.782 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 81.9 mt-30 -111.87 111.84 23.08 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 179.372 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 10.3 ptpp? -120.04 138.61 53.42 Favored 'General case' 0 N--CA 1.494 1.732 0 C-N-CA 123.228 0.611 . . . . 0.0 112.027 -172.324 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 13.7 p90 -156.79 109.8 2.57 Favored 'General case' 0 N--CA 1.488 1.475 0 C-N-CA 123.379 0.672 . . . . 0.0 109.825 -174.165 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 6.7 t70 54.5 54.4 9.38 Favored 'General case' 0 N--CA 1.498 1.949 0 N-CA-C 116.066 1.876 . . . . 0.0 116.066 168.62 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 87.2 -41.91 3.12 Favored Glycine 0 CA--C 1.552 2.38 0 N-CA-C 116.919 1.528 . . . . 0.0 116.919 -169.797 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -86.17 135.71 33.48 Favored 'General case' 0 N--CA 1.483 1.208 0 CA-C-N 117.979 0.89 . . . . 0.0 111.454 -174.94 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -144.86 137.73 26.51 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.911 -0.493 . . . . 0.0 112.006 -178.868 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 9.9 t -131.46 129.25 40.94 Favored 'General case' 0 N--CA 1.493 1.722 0 C-N-CA 123.356 0.662 . . . . 0.0 110.682 179.648 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 41.8 p -98.52 129.57 45.09 Favored 'General case' 0 N--CA 1.494 1.732 0 C-N-CA 122.884 0.474 . . . . 0.0 111.769 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 5.7 mp -103.91 80.26 1.73 Allowed 'General case' 0 CA--C 1.564 1.51 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 177.059 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 59.9 t -89.69 108.85 19.77 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 -168.73 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 81.8 mtt85 -102.96 122.09 43.88 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 123.425 0.69 . . . . 0.0 110.234 -176.735 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -138.73 139.74 38.46 Favored 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 123.04 0.536 . . . . 0.0 111.66 178.035 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -83.12 118.04 23.29 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 123.084 0.554 . . . . 0.0 111.412 178.536 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 46.5 mm -119.01 105.72 18.09 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 N-CA-C 105.287 -2.116 . . . . 0.0 105.287 174.277 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 58.61 49.29 10.58 Favored 'General case' 0 N--CA 1.5 2.037 0 N-CA-C 115.316 1.599 . . . . 0.0 115.316 175.641 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 65.75 26.78 72.21 Favored Glycine 0 CA--C 1.555 2.575 0 N-CA-C 119.142 2.417 . . . . 0.0 119.142 -170.291 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -134.08 125.46 28.06 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-N 119.017 1.409 . . . . 0.0 108.457 -173.785 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 16.7 tp -77.64 110.05 12.14 Favored 'General case' 0 CA--C 1.558 1.28 0 C-N-CA 123.361 0.665 . . . . 0.0 110.381 179.841 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 30.7 mm -97.92 101.89 12.75 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 N-CA-C 106.544 -1.651 . . . . 0.0 106.544 -176.893 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 29.4 tp -92.7 99.49 12.17 Favored 'General case' 0 N--CA 1.486 1.359 0 CA-C-O 121.812 0.815 . . . . 0.0 109.258 178.052 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 87.1 m -93.87 105.84 17.84 Favored 'General case' 0 CA--C 1.56 1.361 0 CA-C-N 114.884 -1.053 . . . . 0.0 108.26 -178.007 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 83.5 mt -97.12 100.69 12.17 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 123.816 0.846 . . . . 0.0 109.13 -174.193 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 7.1 m -100.63 119.58 38.77 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.71 -0.619 . . . . 0.0 109.751 -170.636 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 74.7 t60 -151.7 114.63 4.69 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 122.475 0.31 . . . . 0.0 110.376 171.24 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 52.54 71.44 0.68 Allowed Glycine 0 N--CA 1.488 2.146 0 N-CA-C 117.745 1.858 . . . . 0.0 117.745 162.053 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . 0.506 2.7 t 66.58 -44.32 0.43 Allowed 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 117.676 2.472 . . . . 0.0 117.676 -166.729 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -86.39 94.35 9.36 Favored 'General case' 0 N--CA 1.483 1.191 0 CA-C-N 119.563 1.074 . . . . 0.0 112.405 -177.288 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 6.4 p -98.11 128.61 49.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 C-N-CA 123.825 0.85 . . . . 0.0 109.803 174.521 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 42.7 t -109.45 107.48 17.64 Favored 'General case' 0 CA--C 1.553 1.068 0 C-N-CA 123.035 0.534 . . . . 0.0 112.125 -179.206 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 89.0 m -86.19 112.1 21.02 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 176.184 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 71.1 mtp180 -113.25 114.18 26.35 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 -174.107 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 85.5 m -86.72 133.54 33.66 Favored 'General case' 0 N--CA 1.495 1.782 0 C-N-CA 123.288 0.635 . . . . 0.0 110.106 177.37 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 48.4 m-85 -129.77 125.52 36.0 Favored 'General case' 0 CA--C 1.558 1.264 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 179.245 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -93.23 154.55 17.96 Favored 'General case' 0 N--CA 1.493 1.724 0 CA-C-O 122.481 1.134 . . . . 0.0 111.783 171.984 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 72.5 tttt -84.88 129.11 34.86 Favored 'General case' 0 N--CA 1.485 1.278 0 CA-C-N 115.04 -0.982 . . . . 0.0 112.534 -167.319 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 14.6 mm-40 -111.52 50.97 0.8 Allowed 'General case' 0 CA--C 1.567 1.597 0 C-N-CA 124.125 0.97 . . . . 0.0 111.572 175.709 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.967 0 CA-C-O 124.28 1.991 . . . . 0.0 108.121 -171.257 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.266 8.0 p . . . . . 0 CA--C 1.577 2.016 0 N-CA-C 116.127 1.899 . . . . 0.0 116.127 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -69.8 -38.99 76.84 Favored 'General case' 0 N--CA 1.497 1.891 0 N-CA-C 116.385 1.995 . . . . 0.0 116.385 -177.625 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -59.08 -27.88 65.95 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 117.513 2.412 . . . . 0.0 117.513 168.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -68.6 -24.87 64.63 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 116.29 1.959 . . . . 0.0 116.29 169.008 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 34.6 mt -78.7 115.44 18.4 Favored 'General case' 0 N--CA 1.489 1.521 0 CA-C-N 121.09 1.768 . . . . 0.0 111.29 -167.297 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 161.1 172.58 28.63 Favored Glycine 0 CA--C 1.543 1.79 0 CA-C-O 122.467 1.037 . . . . 0.0 113.454 -172.321 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 81.7 m -85.11 141.62 30.09 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-N 114.739 -0.731 . . . . 0.0 109.733 168.89 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 80.4 m95 -141.88 112.79 7.36 Favored 'General case' 0 N--CA 1.484 1.235 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 -174.516 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 9.0 mtpm? -96.22 147.33 23.88 Favored 'General case' 0 N--CA 1.495 1.802 0 C-N-CA 122.771 0.429 . . . . 0.0 110.209 174.369 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 57.9 tp -69.5 120.89 15.99 Favored 'General case' 0 N--CA 1.491 1.617 0 CA-C-O 121.864 0.84 . . . . 0.0 111.51 179.663 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . 0.271 1.2 t -98.85 -43.47 11.65 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.82 0 CA-C-N 114.194 -1.366 . . . . 0.0 112.588 -179.565 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -146.35 139.71 25.85 Favored 'General case' 0 N--CA 1.49 1.543 0 CA-C-N 119.652 1.114 . . . . 0.0 109.179 -179.468 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 89.2 p -128.91 100.27 5.61 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.933 -0.479 . . . . 0.0 110.939 175.47 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 59.3 mtpt -86.88 127.96 35.05 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 123.149 0.58 . . . . 0.0 109.612 173.124 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 58.5 m-20 66.79 22.59 10.25 Favored 'General case' 0 N--CA 1.504 2.235 0 N-CA-C 118.082 2.623 . . . . 0.0 118.082 173.732 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 23.6 t80 -67.24 -45.33 77.08 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 120.215 -1.553 . . . . 0.0 115.083 -178.806 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 85.8 m-20 -62.13 -27.0 68.63 Favored 'General case' 0 CA--C 1.572 1.811 0 N-CA-C 116.613 2.079 . . . . 0.0 116.613 171.443 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -69.05 -49.91 53.24 Favored 'General case' 0 N--CA 1.497 1.914 0 CA-C-N 120.275 1.398 . . . . 0.0 114.36 166.381 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 87.8 t80 -51.43 -50.3 59.99 Favored 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 115.397 1.628 . . . . 0.0 115.397 169.139 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 16.7 mmm -57.98 -46.55 84.98 Favored 'General case' 0 CA--C 1.566 1.595 0 N-CA-C 114.647 1.351 . . . . 0.0 114.647 172.424 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.2 tmtp? -57.35 -48.41 79.08 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 115.408 1.633 . . . . 0.0 115.408 170.806 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 83.5 p -59.63 -36.33 76.14 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 117.151 2.278 . . . . 0.0 117.151 174.148 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 34.4 mt -66.46 -33.62 76.09 Favored 'General case' 0 CA--C 1.566 1.562 0 N-CA-C 116.945 2.202 . . . . 0.0 116.945 167.375 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 108.5 72.36 0.75 Allowed Glycine 0 N--CA 1.482 1.742 0 CA-C-N 118.878 0.763 . . . . 0.0 111.788 -173.133 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 43.0 t -141.78 130.46 22.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 N-CA-C 106.808 -1.552 . . . . 0.0 106.808 -176.232 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -72.53 173.2 47.15 Favored Glycine 0 CA--C 1.549 2.16 0 N-CA-C 116.791 1.476 . . . . 0.0 116.791 -179.599 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 38.9 p90 -66.7 -39.58 88.14 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 117.599 2.444 . . . . 0.0 117.599 -175.385 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.15 -43.95 96.88 Favored 'General case' 0 CA--C 1.561 1.397 0 N-CA-C 115.803 1.779 . . . . 0.0 115.803 179.762 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.1 t -78.02 -21.54 50.59 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 115.835 1.791 . . . . 0.0 115.835 171.53 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 62.3 mtm180 -58.72 -42.81 89.57 Favored 'General case' 0 N--CA 1.495 1.824 0 CA-C-N 120.915 1.689 . . . . 0.0 114.524 162.64 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -63.13 -56.49 16.38 Favored 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 114.304 1.224 . . . . 0.0 114.304 168.166 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 47.9 t -62.81 -40.89 90.42 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 N-CA-C 113.883 1.068 . . . . 0.0 113.883 -178.81 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -70.68 -32.49 69.76 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 116.724 2.12 . . . . 0.0 116.724 175.453 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 94.6 p -65.93 -45.28 82.45 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 115.666 1.728 . . . . 0.0 115.666 170.173 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 3.5 ppp? -63.44 -28.29 69.87 Favored 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 116.923 2.194 . . . . 0.0 116.923 167.259 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 97.2 m -70.95 138.91 50.43 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 124.11 0.964 . . . . 0.0 110.83 172.188 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.76 102.43 11.69 Favored Pre-proline 0 CA--C 1.57 1.715 0 CA-C-O 118.023 -0.989 . . . . 0.0 109.32 166.683 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -80.77 95.75 0.98 Allowed 'Trans proline' 0 C--N 1.371 1.744 0 C-N-CA 122.817 2.345 . . . . 0.0 111.135 -176.614 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 99.4 m -81.32 111.45 17.72 Favored 'General case' 0 N--CA 1.489 1.48 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.452 -159.654 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 87.4 m -87.14 116.23 25.07 Favored 'General case' 0 CA--C 1.56 1.338 0 C-N-CA 123.916 0.886 . . . . 0.0 109.233 -175.32 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 79.6 mt -112.33 110.41 32.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 N-CA-C 106.224 -1.769 . . . . 0.0 106.224 177.341 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 22.6 mt -100.95 119.03 48.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 -176.39 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -137.55 108.05 6.54 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 -169.595 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 83.8 tttt -85.55 121.95 28.98 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 123.385 0.674 . . . . 0.0 111.175 179.795 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 19.0 m120 -89.25 -69.15 0.73 Allowed 'General case' 0 N--CA 1.49 1.575 0 C-N-CA 123.654 0.782 . . . . 0.0 110.543 177.947 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -151.58 76.56 0.23 Allowed Glycine 0 N--CA 1.484 1.868 0 N-CA-C 110.116 -1.194 . . . . 0.0 110.116 169.309 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . 0.336 2.1 t70 70.99 -23.96 0.17 Allowed 'General case' 0 N--CA 1.499 2.006 0 N-CA-C 116.805 2.15 . . . . 0.0 116.805 -160.417 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 21.2 mm -75.34 106.6 5.24 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.561 0 C-N-CA 124.536 1.134 . . . . 0.0 108.05 173.198 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 26.4 mt -92.45 113.77 26.13 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 123.878 0.871 . . . . 0.0 109.66 -179.459 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 57.1 m -97.79 97.45 8.99 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 106.836 -1.542 . . . . 0.0 106.836 -177.712 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 9.4 tt -100.5 98.74 9.31 Favored 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 -177.302 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -93.66 115.57 28.03 Favored 'General case' 0 N--CA 1.484 1.26 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 -174.869 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 28.9 m -100.89 103.42 14.59 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 -179.7 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 21.1 m-70 -90.53 105.25 17.69 Favored 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 123.479 0.712 . . . . 0.0 109.444 -170.848 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 5.9 m -147.26 154.92 41.58 Favored 'General case' 0 N--CA 1.491 1.588 0 CA-C-O 121.234 0.54 . . . . 0.0 112.125 -164.524 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . 0.298 11.9 t -94.87 46.61 1.13 Allowed 'General case' 0 N--CA 1.501 2.082 0 N-CA-C 113.281 0.845 . . . . 0.0 113.281 154.648 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 69.2 t80 -164.41 -79.01 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 107.259 -1.386 . . . . 0.0 107.259 173.876 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 4.5 tppp? -92.92 72.98 4.81 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 123.462 0.705 . . . . 0.0 109.754 -179.509 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 17.4 t30 -91.27 81.95 5.48 Favored 'General case' 0 N--CA 1.484 1.257 0 N-CA-C 108.69 -0.855 . . . . 0.0 108.69 179.192 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 81.9 p -131.83 126.84 35.3 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 -164.537 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -109.66 120.27 41.96 Favored 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 177.659 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 43.0 pt -110.94 128.45 67.35 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 177.079 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 35.9 t -118.05 95.7 5.02 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 107.791 -1.189 . . . . 0.0 107.791 -175.858 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 45.1 p90 -130.71 142.25 50.42 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 114.241 1.201 . . . . 0.0 114.241 -156.645 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 29.6 mtpp -100.15 146.43 26.84 Favored 'General case' 0 N--CA 1.488 1.444 0 CA-C-N 115.218 -0.901 . . . . 0.0 109.126 165.608 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -73.44 116.89 14.54 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.433 -0.792 . . . . 0.0 112.106 -172.217 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 80.88 43.41 8.94 Favored Glycine 0 CA--C 1.549 2.186 0 N-CA-C 116.535 1.374 . . . . 0.0 116.535 -166.912 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 93.1 t -138.6 122.56 20.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 N-CA-C 106.469 -1.678 . . . . 0.0 106.469 177.603 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -85.64 133.34 34.04 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 123.634 0.773 . . . . 0.0 111.285 179.07 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -141.22 149.78 41.83 Favored 'General case' 0 N--CA 1.493 1.695 0 CA-C-O 121.764 0.793 . . . . 0.0 111.443 -173.784 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -74.24 136.08 42.71 Favored 'General case' 0 CA--C 1.565 1.542 0 O-C-N 121.387 -0.82 . . . . 0.0 112.866 172.195 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 32.1 tp10 -145.34 139.15 26.81 Favored 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 123.186 0.594 . . . . 0.0 110.018 -178.152 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 56.0 m -100.54 123.71 45.12 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 177.519 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 29.4 p -85.18 -179.69 7.06 Favored 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 113.432 0.901 . . . . 0.0 113.432 -174.746 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -54.38 -38.99 66.79 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 117.266 2.321 . . . . 0.0 117.266 167.683 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -83.54 13.32 4.64 Favored 'General case' 0 CA--C 1.578 2.035 0 N-CA-C 115.615 1.709 . . . . 0.0 115.615 170.704 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . 0.255 8.7 t70 58.33 72.51 0.52 Allowed 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 125.443 1.497 . . . . 0.0 113.446 -174.947 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 44.2 mtm180 -132.87 124.96 28.9 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 -174.011 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.6 106.89 8.52 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 123.096 0.558 . . . . 0.0 111.648 174.136 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 18.2 m -118.36 134.01 63.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 C-N-CA 122.996 0.518 . . . . 0.0 109.74 -169.131 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 31.5 mmtp -82.84 104.01 12.75 Favored 'General case' 0 N--CA 1.488 1.456 0 CA-C-O 121.92 0.867 . . . . 0.0 109.451 176.215 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 43.3 t -106.27 99.04 8.65 Favored 'General case' 0 CA--C 1.553 1.083 0 CA-C-N 114.68 -1.146 . . . . 0.0 110.044 -161.299 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 7.4 tp -110.61 116.82 53.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 C-N-CA 124.229 1.012 . . . . 0.0 108.631 -177.05 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -134.89 120.06 29.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 C-N-CA 123.612 0.765 . . . . 0.0 109.279 -174.062 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 10.5 t -129.4 157.96 40.5 Favored 'General case' 0 N--CA 1.493 1.676 0 CA-C-O 122.473 1.13 . . . . 0.0 112.223 178.241 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 61.1 tp -84.18 127.28 33.83 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-N 114.805 -1.088 . . . . 0.0 110.577 174.365 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -131.44 85.13 2.23 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 123.905 0.882 . . . . 0.0 109.249 -176.179 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 55.54 44.36 85.73 Favored Glycine 0 N--CA 1.493 2.447 0 N-CA-C 118.658 2.223 . . . . 0.0 118.658 -179.381 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 82.41 16.92 70.08 Favored Glycine 0 CA--C 1.557 2.66 0 N-CA-C 118.627 2.211 . . . . 0.0 118.627 -167.542 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 53.8 mtpt -129.55 119.82 24.31 Favored 'General case' 0 N--CA 1.487 1.39 0 CA-C-N 119.064 1.432 . . . . 0.0 107.691 177.104 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 3.1 mp -82.3 107.9 15.33 Favored 'General case' 0 N--CA 1.485 1.294 0 CA-C-O 122.071 0.939 . . . . 0.0 109.369 169.905 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 70.4 t -99.47 102.19 13.09 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.333 0 N-CA-C 105.16 -2.163 . . . . 0.0 105.16 -174.621 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 20.8 t-160 -107.35 131.81 53.83 Favored 'General case' 0 N--CA 1.484 1.226 0 CA-C-N 114.486 -1.233 . . . . 0.0 108.613 -175.546 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 35.6 tp -131.01 121.3 24.81 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 177.556 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 90.7 mt-30 -111.5 113.43 25.85 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 175.567 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 10.7 ptpp? -118.78 140.36 50.08 Favored 'General case' 0 N--CA 1.494 1.749 0 C-N-CA 123.25 0.62 . . . . 0.0 112.052 -176.336 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 30.5 p90 -153.61 110.81 3.45 Favored 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 123.15 0.58 . . . . 0.0 109.813 -175.68 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . 0.339 8.8 t70 66.84 -101.5 0.07 Allowed 'General case' 0 N--CA 1.494 1.734 0 C-N-CA 124.602 1.161 . . . . 0.0 112.63 172.833 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -124.43 50.27 0.87 Allowed Glycine 0 N--CA 1.488 2.155 0 CA-C-N 118.941 0.791 . . . . 0.0 114.482 164.713 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 52.3 mt-30 -153.42 124.85 7.59 Favored 'General case' 0 N--CA 1.485 1.289 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 -178.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -136.46 133.47 36.64 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.859 -0.525 . . . . 0.0 111.453 176.23 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 6.4 t -120.06 129.48 54.24 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 123.379 0.672 . . . . 0.0 110.718 175.462 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 41.0 p -95.71 133.88 39.28 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-O 121.528 0.68 . . . . 0.0 111.052 173.515 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 5.6 mp -111.68 74.01 0.85 Allowed 'General case' 0 CA--C 1.564 1.519 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 178.811 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 59.2 t -83.17 109.42 16.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 121.126 -0.984 . . . . 0.0 108.507 -167.919 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 76.6 mtt85 -101.32 120.72 40.69 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 123.269 0.628 . . . . 0.0 109.905 -174.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -141.72 127.46 19.19 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 122.872 0.469 . . . . 0.0 110.754 -169.52 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -79.23 114.85 18.5 Favored 'General case' 0 N--CA 1.487 1.418 0 CA-C-O 121.359 0.6 . . . . 0.0 111.331 -179.272 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 47.5 mm -121.4 106.39 18.21 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.338 0 N-CA-C 105.026 -2.213 . . . . 0.0 105.026 177.24 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 58.73 50.14 9.19 Favored 'General case' 0 N--CA 1.5 2.029 0 N-CA-C 115.064 1.505 . . . . 0.0 115.064 175.232 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 67.07 18.99 69.6 Favored Glycine 0 CA--C 1.555 2.577 0 N-CA-C 119.668 2.627 . . . . 0.0 119.668 -171.16 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 89.6 mttt -132.68 129.72 39.17 Favored 'General case' 0 N--CA 1.488 1.463 0 CA-C-N 119.63 1.715 . . . . 0.0 109.294 -174.387 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 18.2 tp -77.72 110.22 12.39 Favored 'General case' 0 CA--C 1.557 1.231 0 C-N-CA 123.98 0.912 . . . . 0.0 110.298 -179.523 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 30.5 mm -96.55 101.63 12.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 N-CA-C 106.748 -1.575 . . . . 0.0 106.748 -177.452 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 29.9 tp -88.99 101.36 14.01 Favored 'General case' 0 CA--C 1.559 1.307 0 C-N-CA 123.754 0.821 . . . . 0.0 109.361 176.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 87.4 m -95.61 105.94 17.97 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 -175.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 86.8 mt -99.3 98.77 9.69 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 123.588 0.755 . . . . 0.0 109.896 -171.302 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 6.7 m -113.6 115.8 28.5 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 -174.138 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 58.6 t60 -103.19 -87.46 0.42 Allowed 'General case' 0 N--CA 1.491 1.6 0 CA-C-O 118.5 -0.762 . . . . 0.0 108.986 170.411 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -106.64 -106.73 3.14 Favored Glycine 0 N--CA 1.484 1.869 0 CA-C-N 119.201 0.909 . . . . 0.0 111.09 179.359 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 13.8 t -100.79 49.24 0.89 Allowed 'General case' 0 N--CA 1.498 1.937 0 N-CA-C 113.346 0.869 . . . . 0.0 113.346 174.04 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -158.39 93.71 1.23 Allowed 'General case' 0 N--CA 1.483 1.223 0 O-C-N 121.206 -0.934 . . . . 0.0 108.648 175.398 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 4.2 p -91.47 121.26 41.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 C-N-CA 123.352 0.661 . . . . 0.0 109.753 175.36 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 45.7 t -101.44 100.03 10.43 Favored 'General case' 0 CA--C 1.553 1.081 0 CA-C-O 121.556 0.693 . . . . 0.0 111.214 175.424 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 63.0 m -86.14 111.06 20.0 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 179.433 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 32.8 mtm180 -114.99 118.33 33.13 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 122.992 0.517 . . . . 0.0 110.331 -172.104 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 93.3 m -86.79 132.87 33.72 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 123.433 0.693 . . . . 0.0 110.304 177.863 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 38.0 m-85 -127.47 127.05 43.41 Favored 'General case' 0 CA--C 1.559 1.296 0 C-N-CA 123.648 0.779 . . . . 0.0 109.253 178.321 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -90.83 151.15 21.27 Favored 'General case' 0 N--CA 1.487 1.404 0 CA-C-O 121.788 0.804 . . . . 0.0 111.889 173.805 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 67.3 tttt -80.68 119.29 23.1 Favored 'General case' 0 N--CA 1.486 1.335 0 CA-C-O 121.563 0.697 . . . . 0.0 111.655 -174.585 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 18.1 mm-40 -119.89 50.33 1.29 Allowed 'General case' 0 CA--C 1.564 1.512 0 C-N-CA 124.422 1.089 . . . . 0.0 111.306 -171.077 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.897 0 CA-C-O 124.654 2.168 . . . . 0.0 109.946 -160.521 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 71.4 t . . . . . 0 CA--C 1.56 1.337 0 N-CA-C 106.201 -1.777 . . . . 0.0 106.201 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -140.49 -55.44 0.52 Allowed 'General case' 0 N--CA 1.494 1.746 0 C-N-CA 124.021 0.928 . . . . 0.0 111.051 -174.31 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -57.39 -29.99 64.54 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 116.914 2.19 . . . . 0.0 116.914 160.662 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -60.82 -18.89 58.2 Favored 'General case' 0 CA--C 1.571 1.76 0 N-CA-C 117.813 2.523 . . . . 0.0 117.813 163.768 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 82.4 mt -84.2 125.94 32.67 Favored 'General case' 0 N--CA 1.489 1.513 0 CA-C-N 121.329 1.877 . . . . 0.0 111.77 -169.904 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 153.92 176.3 26.14 Favored Glycine 0 CA--C 1.542 1.728 0 CA-C-O 122.602 1.112 . . . . 0.0 113.317 -173.81 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 71.4 m -84.75 140.17 31.44 Favored 'General case' 0 N--CA 1.49 1.564 0 CA-C-N 114.679 -0.76 . . . . 0.0 109.262 165.063 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 85.8 m95 -141.85 113.23 7.64 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 -174.292 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 6.3 mtpm? -102.03 145.48 29.25 Favored 'General case' 0 N--CA 1.494 1.75 0 CA-C-O 121.034 0.445 . . . . 0.0 110.017 178.558 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 17.5 tp -65.95 127.06 30.56 Favored 'General case' 0 N--CA 1.491 1.59 0 CA-C-O 122.349 1.071 . . . . 0.0 112.495 -175.59 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . 0.283 1.0 OUTLIER -104.51 -46.65 9.68 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.897 0 CA-C-N 113.845 -1.525 . . . . 0.0 111.448 177.288 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -137.36 140.34 41.36 Favored 'General case' 0 N--CA 1.49 1.542 0 CA-C-N 119.994 1.27 . . . . 0.0 109.848 177.31 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 71.8 p -131.37 118.05 19.75 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 123.462 0.705 . . . . 0.0 109.532 169.246 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 30.6 mtpp -88.05 -87.14 0.16 Allowed 'General case' 0 N--CA 1.491 1.625 0 CA-C-O 119.14 -0.457 . . . . 0.0 111.335 -172.621 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 65.0 m-80 -95.12 49.58 1.22 Allowed 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 113.503 0.927 . . . . 0.0 113.503 -175.594 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 23.7 t80 -77.25 -54.48 6.43 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.6 -1.313 . . . . 0.0 113.462 -173.902 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -51.19 -35.64 37.31 Favored 'General case' 0 N--CA 1.499 2.014 0 N-CA-C 116.722 2.119 . . . . 0.0 116.722 166.75 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 35.4 t0 -63.11 -55.71 23.02 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 114.179 1.178 . . . . 0.0 114.179 168.915 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 85.7 t80 -49.99 -47.21 53.01 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 116.403 2.001 . . . . 0.0 116.403 169.853 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 26.0 mmm -62.47 -45.58 92.38 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 114.771 1.397 . . . . 0.0 114.771 177.033 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 42.0 tptt -64.16 -38.8 92.36 Favored 'General case' 0 CA--C 1.566 1.585 0 N-CA-C 115.787 1.773 . . . . 0.0 115.787 171.101 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 65.6 m -58.38 -40.41 82.27 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 115.937 1.828 . . . . 0.0 115.937 168.841 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 77.2 mt -61.96 -37.34 84.39 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 116.694 2.109 . . . . 0.0 116.694 166.662 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 112.08 69.77 0.56 Allowed Glycine 0 N--CA 1.481 1.681 0 C-N-CA 124.055 0.836 . . . . 0.0 111.875 -173.704 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 37.3 t -140.83 117.45 7.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 N-CA-C 105.006 -2.22 . . . . 0.0 105.006 -177.145 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -68.33 -80.61 0.22 Allowed Glycine 0 N--CA 1.485 1.963 0 N-CA-C 117.078 1.591 . . . . 0.0 117.078 -166.472 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . 0.262 46.2 p90 -149.05 -50.37 0.15 Allowed 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 114.543 1.312 . . . . 0.0 114.543 -175.565 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.66 -39.84 91.8 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 116.511 2.041 . . . . 0.0 116.511 -178.87 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 60.0 m -79.32 -36.81 38.95 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 113.635 0.976 . . . . 0.0 113.635 170.255 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 33.4 ttp85 -61.1 -44.2 97.73 Favored 'General case' 0 CA--C 1.566 1.591 0 N-CA-C 115.543 1.683 . . . . 0.0 115.543 174.565 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 39.1 mt-30 -79.6 -40.42 29.39 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 115.026 1.491 . . . . 0.0 115.026 177.738 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 47.1 t -74.48 -37.72 44.86 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 CA-C-N 120.503 1.501 . . . . 0.0 112.524 179.305 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -66.99 -34.36 77.57 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 116.612 2.078 . . . . 0.0 116.612 172.074 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 92.0 p -65.18 -44.72 87.52 Favored 'General case' 0 N--CA 1.493 1.725 0 N-CA-C 115.783 1.772 . . . . 0.0 115.783 167.69 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 44.6 ttm -62.0 -36.97 83.09 Favored 'General case' 0 CA--C 1.571 1.765 0 N-CA-C 116.141 1.904 . . . . 0.0 116.141 168.894 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 52.4 m -68.26 151.93 46.21 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 124.455 1.102 . . . . 0.0 112.523 176.842 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 4.2 ttmp? -104.09 97.47 11.54 Favored Pre-proline 0 CA--C 1.574 1.896 0 CA-C-N 115.173 -0.921 . . . . 0.0 109.674 176.378 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -75.57 145.72 29.87 Favored 'Trans proline' 0 CA--C 1.561 1.839 0 C-N-CA 123.697 2.931 . . . . 0.0 113.444 178.979 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 98.8 m -117.34 97.4 5.88 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 -171.003 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 90.9 m -79.48 117.41 20.41 Favored 'General case' 0 N--CA 1.492 1.664 0 C-N-CA 123.77 0.828 . . . . 0.0 110.037 178.687 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 62.3 mt -119.02 111.79 34.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 N-CA-C 106.324 -1.732 . . . . 0.0 106.324 -174.382 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 17.8 mt -110.79 116.81 53.45 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 -173.013 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -127.36 123.67 36.79 Favored 'General case' 0 N--CA 1.494 1.769 0 C-N-CA 123.485 0.714 . . . . 0.0 109.841 179.721 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 82.1 tttt -97.5 120.53 38.05 Favored 'General case' 0 CA--C 1.557 1.217 0 C-N-CA 123.649 0.78 . . . . 0.0 110.335 177.779 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 -83.61 -81.03 0.17 Allowed 'General case' 0 N--CA 1.49 1.545 0 CA-C-O 118.793 -0.622 . . . . 0.0 110.125 178.242 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -99.94 -87.2 1.94 Allowed Glycine 0 N--CA 1.486 2.013 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 166.782 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -119.15 55.84 0.93 Allowed 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 153.69 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 15.0 mm -128.94 104.91 12.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 N-CA-C 104.888 -2.264 . . . . 0.0 104.888 -176.127 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 36.0 mt -95.29 107.41 19.52 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 123.048 0.539 . . . . 0.0 111.24 -170.798 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 31.5 m -92.72 94.02 8.77 Favored 'General case' 0 CA--C 1.559 1.302 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 -176.561 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 10.4 tt -98.24 102.25 13.94 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 -176.89 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 50.7 mttp -102.47 106.37 17.09 Favored 'General case' 0 N--CA 1.486 1.341 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 -174.505 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 59.3 m -92.23 97.22 10.76 Favored 'General case' 0 N--CA 1.493 1.675 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 178.736 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 22.4 m170 -91.76 94.76 9.51 Favored 'General case' 0 N--CA 1.488 1.458 0 CA-C-O 121.909 0.862 . . . . 0.0 110.089 -174.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 27.9 t -105.3 147.22 28.36 Favored 'General case' 0 N--CA 1.484 1.265 0 CA-C-N 115.041 -0.981 . . . . 0.0 109.879 173.503 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 74.0 p -79.46 63.99 4.22 Favored 'General case' 0 N--CA 1.503 2.203 0 CA-C-O 122.582 1.182 . . . . 0.0 112.298 170.617 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 13.6 t80 -172.02 -60.99 0.02 OUTLIER 'General case' 0 CA--C 1.566 1.576 0 C-N-CA 125.892 1.677 . . . . 0.0 107.583 -178.24 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -146.66 124.54 11.97 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 123.715 0.806 . . . . 0.0 110.492 175.204 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 43.7 m-20 -91.86 128.55 37.74 Favored 'General case' 0 N--CA 1.492 1.643 0 C-N-CA 123.242 0.617 . . . . 0.0 109.765 174.286 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 61.9 p -126.45 131.36 51.69 Favored 'General case' 0 N--CA 1.496 1.869 0 C-N-CA 123.063 0.545 . . . . 0.0 110.069 -176.767 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -128.75 123.67 33.56 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 123.512 0.725 . . . . 0.0 109.556 -172.642 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 41.8 pt -118.65 134.2 63.04 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 C-N-CA 123.709 0.804 . . . . 0.0 108.976 174.907 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 67.2 p -119.73 104.38 10.19 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 178.478 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 53.0 p90 -132.27 141.15 48.88 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 115.204 1.557 . . . . 0.0 115.204 -159.404 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 62.4 mtpt -94.51 143.17 26.65 Favored 'General case' 0 CA--C 1.562 1.408 0 CA-C-N 114.378 -1.283 . . . . 0.0 109.761 166.197 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -77.91 120.57 22.97 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.851 -0.53 . . . . 0.0 111.606 -175.402 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 83.03 43.48 7.56 Favored Glycine 0 CA--C 1.549 2.19 0 N-CA-C 116.5 1.36 . . . . 0.0 116.5 -169.512 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 94.2 t -140.69 123.68 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 N-CA-C 106.458 -1.682 . . . . 0.0 106.458 -178.523 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -86.32 130.16 34.61 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 123.227 0.611 . . . . 0.0 110.872 171.654 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 45.3 p90 -144.23 128.9 18.21 Favored 'General case' 0 N--CA 1.492 1.656 0 C-N-CA 123.619 0.767 . . . . 0.0 109.744 -175.341 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -72.48 111.65 7.85 Favored 'General case' 0 CA--C 1.564 1.493 0 O-C-N 121.327 -0.858 . . . . 0.0 112.657 177.198 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 13.4 tp10 -113.64 132.92 55.59 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 124.29 1.036 . . . . 0.0 109.537 -171.591 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 57.1 m -92.86 122.62 35.42 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 176.532 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 24.1 p -85.9 172.26 10.86 Favored 'General case' 0 N--CA 1.495 1.808 0 CA-C-O 121.588 0.709 . . . . 0.0 112.403 -176.296 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -58.41 -35.17 71.65 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 117.306 2.336 . . . . 0.0 117.306 167.451 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -77.57 12.74 1.49 Allowed 'General case' 0 CA--C 1.581 2.157 0 N-CA-C 115.981 1.845 . . . . 0.0 115.981 167.399 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 10.4 t70 58.08 71.93 0.55 Allowed 'General case' 0 N--CA 1.492 1.643 0 C-N-CA 125.545 1.538 . . . . 0.0 113.483 -176.723 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 80.5 mtm180 -136.82 121.64 18.7 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 -176.271 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.55 99.32 5.68 Favored 'General case' 0 CA--C 1.563 1.452 0 C-N-CA 123.179 0.592 . . . . 0.0 111.042 170.985 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 10.7 m -113.51 128.05 70.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 -170.104 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 72.0 mmtt -77.72 99.41 5.84 Favored 'General case' 0 N--CA 1.488 1.474 0 CA-C-O 121.674 0.749 . . . . 0.0 110.04 177.139 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 47.6 m -93.36 93.22 8.06 Favored 'General case' 0 N--CA 1.48 1.056 0 CA-C-N 115.009 -0.996 . . . . 0.0 110.501 -169.415 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 6.0 tp -101.97 103.26 14.7 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 175.817 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.0 p -121.96 125.0 72.56 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.364 0 CA-C-N 115.307 -0.861 . . . . 0.0 109.209 -174.639 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 15.3 t -135.53 156.52 48.75 Favored 'General case' 0 N--CA 1.489 1.482 0 CA-C-O 122.921 1.343 . . . . 0.0 111.21 178.717 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 63.7 tp -89.52 108.36 19.61 Favored 'General case' 0 N--CA 1.486 1.368 0 CA-C-N 114.173 -1.376 . . . . 0.0 108.899 171.122 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -109.6 87.01 2.4 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 123.45 0.7 . . . . 0.0 109.993 -173.7 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 61.3 48.93 82.68 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 117.623 1.809 . . . . 0.0 117.623 -178.63 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 73.46 27.54 67.49 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 118.915 2.326 . . . . 0.0 118.915 -169.297 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -143.88 112.46 6.52 Favored 'General case' 0 CA--C 1.553 1.063 0 N-CA-C 107.134 -1.432 . . . . 0.0 107.134 -174.685 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 4.7 tt -86.61 102.88 14.58 Favored 'General case' 0 CA--C 1.561 1.376 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 -172.815 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 77.7 t -104.35 108.05 23.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 -171.578 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 21.8 t-160 -105.97 109.18 21.05 Favored 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 123.378 0.671 . . . . 0.0 109.954 177.013 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 38.0 tp -102.88 121.04 41.7 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 178.24 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 31.5 mt-30 -114.13 115.88 28.22 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 83.5 mttt -113.28 135.53 53.74 Favored 'General case' 0 N--CA 1.495 1.793 0 CA-C-N 118.812 0.733 . . . . 0.0 111.103 -178.364 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 27.3 p90 -152.69 110.57 3.63 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.354 -0.841 . . . . 0.0 109.898 178.713 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 3.8 t70 53.56 50.88 16.28 Favored 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 116.392 1.997 . . . . 0.0 116.392 170.008 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 89.66 -43.46 2.99 Favored Glycine 0 CA--C 1.551 2.311 0 N-CA-C 116.685 1.434 . . . . 0.0 116.685 -169.34 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 15.0 mt-30 -80.88 124.6 29.24 Favored 'General case' 0 N--CA 1.488 1.428 0 CA-C-N 118.309 1.054 . . . . 0.0 111.318 -177.114 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -132.61 131.39 41.38 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 123.072 0.549 . . . . 0.0 111.712 178.685 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 8.8 t -118.45 133.03 56.21 Favored 'General case' 0 N--CA 1.496 1.866 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.365 176.534 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 35.8 p -102.76 132.72 48.72 Favored 'General case' 0 N--CA 1.495 1.819 0 CA-C-O 121.678 0.751 . . . . 0.0 110.85 172.602 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 5.3 mp -114.54 89.36 3.08 Favored 'General case' 0 CA--C 1.562 1.412 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 -179.448 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 97.1 t -98.49 106.05 18.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 -167.543 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 83.9 mtt85 -99.51 125.13 45.22 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 123.179 0.592 . . . . 0.0 110.402 -176.367 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -140.14 130.12 24.79 Favored 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 123.084 0.554 . . . . 0.0 111.092 -174.764 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -82.43 112.88 19.78 Favored 'General case' 0 N--CA 1.488 1.463 0 CA-C-O 121.256 0.55 . . . . 0.0 111.086 -178.557 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 82.8 mt -123.46 109.43 23.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 N-CA-C 105.052 -2.203 . . . . 0.0 105.052 179.412 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 57.87 50.18 10.85 Favored 'General case' 0 N--CA 1.499 2.012 0 N-CA-C 114.849 1.425 . . . . 0.0 114.849 177.804 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 62.24 24.65 65.64 Favored Glycine 0 CA--C 1.555 2.536 0 N-CA-C 119.502 2.561 . . . . 0.0 119.502 -170.699 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 91.2 mttt -132.31 131.07 41.62 Favored 'General case' 0 N--CA 1.488 1.435 0 CA-C-N 119.951 1.876 . . . . 0.0 109.534 -176.093 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 20.1 tp -77.58 110.08 12.08 Favored 'General case' 0 N--CA 1.484 1.275 0 C-N-CA 123.955 0.902 . . . . 0.0 110.144 -179.644 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 27.7 mm -99.39 95.58 4.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 N-CA-C 107.062 -1.459 . . . . 0.0 107.062 -175.047 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 17.4 tp -86.94 104.4 16.22 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 124.068 0.947 . . . . 0.0 110.098 179.542 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 84.8 m -99.66 104.16 15.89 Favored 'General case' 0 CA--C 1.561 1.392 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 -173.098 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 91.1 mt -98.52 102.43 14.17 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 123.659 0.784 . . . . 0.0 110.111 -172.497 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 9.6 m -113.44 125.9 54.74 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 -176.124 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 83.3 t60 -136.45 -98.33 0.22 Allowed 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 175.408 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -110.45 93.0 0.71 Allowed Glycine 0 N--CA 1.483 1.829 0 CA-C-N 118.816 0.734 . . . . 0.0 111.684 -169.871 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . 0.387 5.2 t 47.47 39.33 9.18 Favored 'General case' 0 N--CA 1.5 2.07 0 N-CA-C 117.546 2.425 . . . . 0.0 117.546 -172.097 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -157.64 93.6 1.29 Allowed 'General case' 0 N--CA 1.483 1.197 0 O-C-N 121.484 -0.76 . . . . 0.0 109.575 -174.461 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 2.8 p -92.87 112.25 25.86 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 C-N-CA 123.643 0.777 . . . . 0.0 109.288 173.141 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 41.1 t -97.5 104.34 16.36 Favored 'General case' 0 CA--C 1.551 1.017 0 CA-C-O 121.016 0.436 . . . . 0.0 110.292 175.179 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 89.2 m -90.04 100.96 13.68 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 -178.581 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 59.3 mtp180 -103.43 114.74 29.25 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 123.107 0.563 . . . . 0.0 109.749 -167.535 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 56.6 m -84.8 131.92 34.48 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 123.091 0.556 . . . . 0.0 109.954 177.772 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 41.0 m-85 -129.49 126.31 38.37 Favored 'General case' 0 CA--C 1.561 1.385 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 178.378 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -88.62 150.54 22.99 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 123.515 0.726 . . . . 0.0 112.127 174.68 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 71.0 tttt -81.67 118.14 22.58 Favored 'General case' 0 N--CA 1.486 1.346 0 CA-C-O 121.43 0.633 . . . . 0.0 111.577 -174.503 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 37.3 mm-40 -118.24 51.38 1.08 Allowed 'General case' 0 CA--C 1.564 1.505 0 C-N-CA 124.216 1.007 . . . . 0.0 111.31 -174.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.875 0 CA-C-O 123.105 1.431 . . . . 0.0 110.151 -161.931 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 5.7 p . . . . . 0 CA--C 1.578 2.028 0 N-CA-C 115.24 1.571 . . . . 0.0 115.24 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -78.84 -38.71 37.32 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 115.648 1.721 . . . . 0.0 115.648 -176.087 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -58.95 -24.03 62.11 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 117.649 2.463 . . . . 0.0 117.649 167.428 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -69.62 -20.19 63.62 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 116.575 2.065 . . . . 0.0 116.575 167.333 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 42.9 mt -81.17 121.99 26.82 Favored 'General case' 0 N--CA 1.488 1.475 0 CA-C-N 120.829 1.65 . . . . 0.0 111.168 -170.709 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 157.34 174.75 27.45 Favored Glycine 0 CA--C 1.541 1.703 0 CA-C-O 122.379 0.988 . . . . 0.0 113.369 -172.283 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 63.0 m -93.12 136.88 32.97 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 170.516 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 87.5 m95 -138.34 113.37 9.24 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 -171.431 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 9.4 mtmp? -97.81 143.54 28.33 Favored 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 123.247 0.619 . . . . 0.0 110.547 -179.506 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 60.0 tp -70.87 117.27 12.16 Favored 'General case' 0 N--CA 1.492 1.639 0 CA-C-O 121.856 0.836 . . . . 0.0 111.177 -177.573 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . 0.27 1.0 OUTLIER -97.48 -42.38 11.62 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.757 0 CA-C-N 114.337 -1.301 . . . . 0.0 112.725 -178.702 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -148.06 134.82 19.99 Favored 'General case' 0 N--CA 1.487 1.386 0 CA-C-N 119.677 1.126 . . . . 0.0 109.035 -177.53 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 88.8 p -121.59 100.84 7.24 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 122.976 0.51 . . . . 0.0 110.496 176.741 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 61.1 mtpt -92.77 123.02 35.75 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 176.644 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 52.1 m-20 67.22 21.66 9.9 Favored 'General case' 0 N--CA 1.503 2.204 0 N-CA-C 117.513 2.412 . . . . 0.0 117.513 176.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 17.3 t80 -71.2 -40.21 71.31 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 119.988 -1.695 . . . . 0.0 115.345 -179.273 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -60.19 -31.45 70.14 Favored 'General case' 0 CA--C 1.571 1.766 0 N-CA-C 115.935 1.828 . . . . 0.0 115.935 165.337 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 14.3 t0 -64.92 -47.25 78.4 Favored 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 114.843 1.423 . . . . 0.0 114.843 166.012 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 94.2 t80 -54.0 -51.95 62.33 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 115.104 1.52 . . . . 0.0 115.104 172.696 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 75.8 mtm -63.67 -34.37 77.69 Favored 'General case' 0 CA--C 1.568 1.636 0 N-CA-C 115.697 1.74 . . . . 0.0 115.697 172.84 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 38.4 ttmt -61.44 -47.55 85.22 Favored 'General case' 0 CA--C 1.569 1.674 0 N-CA-C 114.412 1.264 . . . . 0.0 114.412 167.506 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 60.1 m -58.67 -36.15 73.71 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 116.412 2.004 . . . . 0.0 116.412 171.617 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 33.4 mt -63.05 -43.91 97.33 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 116.178 1.918 . . . . 0.0 116.178 166.838 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 120.22 71.1 0.32 Allowed Glycine 0 N--CA 1.483 1.781 0 C-N-CA 123.79 0.71 . . . . 0.0 111.588 -176.847 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 23.9 t -142.24 120.88 8.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 N-CA-C 105.166 -2.161 . . . . 0.0 105.166 -176.452 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -78.92 -86.48 0.52 Allowed Glycine 0 N--CA 1.488 2.129 0 N-CA-C 115.859 1.104 . . . . 0.0 115.859 -169.23 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 15.2 p90 -139.36 160.3 40.15 Favored 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 123.498 0.719 . . . . 0.0 110.767 178.605 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . 0.313 . . 76.41 -50.91 0.59 Allowed 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 115.386 1.625 . . . . 0.0 115.386 177.68 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 52.8 m -64.92 -39.86 94.16 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 113.964 1.098 . . . . 0.0 113.964 167.745 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 38.0 mtm180 -61.34 -43.59 98.62 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 115.063 1.505 . . . . 0.0 115.063 166.073 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 7.4 tm0? -61.74 -49.09 77.8 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 115.403 1.631 . . . . 0.0 115.403 174.074 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 97.2 t -64.56 -41.11 91.32 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 CA-C-N 119.503 1.047 . . . . 0.0 113.207 177.227 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -67.72 -40.71 84.23 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 116.504 2.038 . . . . 0.0 116.504 176.251 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 95.2 p -66.79 -39.42 87.77 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 116.332 1.975 . . . . 0.0 116.332 169.549 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 54.5 tpp -64.97 -37.21 86.91 Favored 'General case' 0 CA--C 1.569 1.7 0 N-CA-C 115.992 1.849 . . . . 0.0 115.992 169.856 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 54.4 m -69.96 145.88 51.55 Favored 'General case' 0 CA--C 1.566 1.589 0 C-N-CA 124.047 0.939 . . . . 0.0 111.79 174.649 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -103.12 100.73 18.28 Favored Pre-proline 0 CA--C 1.57 1.742 0 CA-C-O 118.143 -0.932 . . . . 0.0 109.147 173.224 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -81.82 100.67 1.11 Allowed 'Trans proline' 0 C--N 1.371 1.727 0 C-N-CA 123.027 2.485 . . . . 0.0 111.649 -179.379 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 99.8 m -79.15 112.95 16.87 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 123.522 0.729 . . . . 0.0 110.228 -168.849 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 46.5 m -87.28 114.78 24.19 Favored 'General case' 0 CA--C 1.561 1.395 0 C-N-CA 123.557 0.743 . . . . 0.0 109.147 -174.137 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 98.3 mt -108.75 108.45 25.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 N-CA-C 106.356 -1.72 . . . . 0.0 106.356 176.893 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 18.8 mt -101.72 120.3 51.16 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 -178.718 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 6.8 tm-20 -133.24 116.48 16.25 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 -172.233 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 80.7 tttt -93.62 114.97 27.42 Favored 'General case' 0 CA--C 1.557 1.243 0 C-N-CA 123.335 0.654 . . . . 0.0 110.374 176.523 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 23.8 t30 -86.78 -70.59 0.6 Allowed 'General case' 0 N--CA 1.492 1.628 0 C-N-CA 123.043 0.537 . . . . 0.0 111.026 178.307 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -143.11 75.92 0.31 Allowed Glycine 0 N--CA 1.487 2.068 0 N-CA-C 110.522 -1.031 . . . . 0.0 110.522 170.039 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . 0.284 6.3 t70 49.43 48.21 21.51 Favored 'General case' 0 N--CA 1.497 1.924 0 N-CA-C 115.518 1.673 . . . . 0.0 115.518 -155.954 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 31.0 mm -134.51 99.9 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 N-CA-C 103.589 -2.745 . . . . 0.0 103.589 178.47 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 65.2 mt -88.11 101.49 13.85 Favored 'General case' 0 N--CA 1.481 1.097 0 CA-C-O 121.281 0.562 . . . . 0.0 110.039 -177.614 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 91.1 m -94.46 97.02 9.87 Favored 'General case' 0 N--CA 1.485 1.29 0 N-CA-C 106.973 -1.492 . . . . 0.0 106.973 -176.94 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 9.8 tt -99.22 99.56 10.55 Favored 'General case' 0 N--CA 1.484 1.246 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 -174.893 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -96.6 126.65 41.93 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 123.782 0.833 . . . . 0.0 109.166 -175.675 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 28.0 m -102.63 93.7 5.25 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.134 -1.062 . . . . 0.0 108.134 -175.619 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 16.8 m-70 -86.25 104.33 15.69 Favored 'General case' 0 N--CA 1.491 1.591 0 CA-C-O 121.451 0.643 . . . . 0.0 109.709 -173.03 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 23.1 t -144.5 142.03 29.96 Favored 'General case' 0 N--CA 1.483 1.183 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.274 -161.813 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . 0.294 13.9 t -82.33 64.83 7.18 Favored 'General case' 0 N--CA 1.499 2.024 0 CA-C-O 122.552 1.167 . . . . 0.0 111.735 160.516 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 88.0 t80 -166.13 -70.16 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 106.78 -1.563 . . . . 0.0 106.78 -176.433 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 14.7 tptp -153.74 130.26 10.66 Favored 'General case' 0 CA--C 1.558 1.284 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 179.353 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 53.6 m-80 -92.94 91.48 7.42 Favored 'General case' 0 N--CA 1.491 1.582 0 CA-C-O 121.052 0.453 . . . . 0.0 110.076 175.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 73.9 p -98.41 132.17 44.08 Favored 'General case' 0 N--CA 1.493 1.709 0 C-N-CA 123.417 0.687 . . . . 0.0 110.603 -177.013 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -123.87 123.57 40.73 Favored 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 123.674 0.79 . . . . 0.0 109.067 -176.714 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 40.8 pt -118.74 132.01 69.86 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 174.467 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 46.1 t -120.6 111.11 17.24 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 -177.817 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 50.4 p90 -140.94 140.72 34.48 Favored 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 115.119 1.525 . . . . 0.0 115.119 -160.015 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 63.6 mtpt -106.25 17.62 23.2 Favored 'General case' 0 CA--C 1.573 1.852 0 N-CA-C 117.011 2.226 . . . . 0.0 117.011 -172.608 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . 0.294 0.1 OUTLIER 60.35 92.7 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.736 0 CA-C-N 120.546 1.521 . . . . 0.0 114.292 177.981 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 92.68 38.73 5.46 Favored Glycine 0 CA--C 1.551 2.295 0 N-CA-C 116.863 1.505 . . . . 0.0 116.863 -167.883 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 86.6 t -140.06 122.7 16.68 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 N-CA-C 106.93 -1.507 . . . . 0.0 106.93 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -87.62 133.27 33.84 Favored 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 123.299 0.64 . . . . 0.0 111.136 173.749 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 47.5 p90 -145.56 133.72 21.6 Favored 'General case' 0 N--CA 1.493 1.682 0 C-N-CA 123.888 0.875 . . . . 0.0 109.306 -175.082 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -76.35 142.66 41.14 Favored 'General case' 0 N--CA 1.49 1.54 0 CA-C-O 123.028 1.394 . . . . 0.0 112.117 176.211 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 15.4 tp10 -146.54 138.91 25.04 Favored 'General case' 0 N--CA 1.488 1.444 0 CA-C-N 113.18 -1.827 . . . . 0.0 110.351 -167.053 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 55.7 m -97.18 121.96 39.65 Favored 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 123.281 0.633 . . . . 0.0 109.424 177.755 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 25.1 p -86.39 170.54 11.9 Favored 'General case' 0 N--CA 1.495 1.815 0 CA-C-O 121.894 0.854 . . . . 0.0 113.128 -173.565 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -58.77 -34.23 71.21 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 118.627 2.825 . . . . 0.0 118.627 173.267 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -101.57 54.72 0.82 Allowed 'General case' 0 CA--C 1.574 1.886 0 CA-C-N 119.327 0.967 . . . . 0.0 110.847 168.038 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 15.3 t70 34.89 80.75 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 117.827 2.528 . . . . 0.0 117.827 178.015 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 60.5 mtm-85 -141.45 130.41 23.16 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 110.165 -0.309 . . . . 0.0 110.165 177.497 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.04 121.24 16.27 Favored 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 122.878 0.471 . . . . 0.0 110.493 158.95 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 16.3 m -137.89 132.24 43.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 -176.013 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -85.29 104.01 14.75 Favored 'General case' 0 N--CA 1.486 1.336 0 CA-C-O 121.882 0.849 . . . . 0.0 109.265 177.993 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 53.3 m -92.52 97.7 10.99 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 124.353 1.061 . . . . 0.0 110.946 -170.668 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 6.8 tp -107.65 118.79 56.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 175.3 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 1.5 p -136.84 132.61 47.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 C-N-CA 123.677 0.791 . . . . 0.0 109.298 -169.708 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 13.1 t -146.82 159.02 44.03 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-O 122.738 1.256 . . . . 0.0 110.545 178.858 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 17.5 tp -89.3 106.36 18.4 Favored 'General case' 0 CA--C 1.561 1.403 0 CA-C-N 114.81 -1.086 . . . . 0.0 108.871 173.611 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -105.43 94.09 5.03 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 123.493 0.717 . . . . 0.0 109.534 -177.472 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 60.97 49.59 76.88 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 117.506 1.762 . . . . 0.0 117.506 -178.699 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 69.59 18.96 74.31 Favored Glycine 0 CA--C 1.557 2.663 0 N-CA-C 119.158 2.423 . . . . 0.0 119.158 -168.882 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 38.7 mtmm -127.96 117.77 22.34 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 -178.852 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 4.5 tt -82.82 99.36 9.65 Favored 'General case' 0 CA--C 1.563 1.468 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 -177.051 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 55.0 t -103.61 108.49 24.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 N-CA-C 106.748 -1.575 . . . . 0.0 106.748 -169.175 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 19.9 t-160 -108.83 107.14 17.44 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 123.447 0.699 . . . . 0.0 110.054 179.201 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 42.5 tp -96.84 122.99 40.41 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 123.523 0.729 . . . . 0.0 109.262 177.201 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 30.2 mt-30 -113.88 113.88 25.48 Favored 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 107.54 -1.281 . . . . 0.0 107.54 175.521 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.59 145.0 41.14 Favored 'General case' 0 N--CA 1.493 1.725 0 C-N-CA 123.223 0.609 . . . . 0.0 111.574 178.92 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 32.9 p90 -155.55 111.03 3.03 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 123.355 0.662 . . . . 0.0 110.012 -177.454 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . 0.336 12.1 t70 69.0 -96.08 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.854 0 C-N-CA 124.438 1.095 . . . . 0.0 112.484 173.591 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -132.85 56.3 0.74 Allowed Glycine 0 CA--C 1.547 2.067 0 CA-C-N 118.424 0.557 . . . . 0.0 113.066 162.234 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 46.7 mt-30 -154.83 124.61 6.58 Favored 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 106.936 -1.505 . . . . 0.0 106.936 -174.166 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -132.52 144.25 50.3 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.886 -0.509 . . . . 0.0 112.301 178.285 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 6.2 t -130.27 126.71 37.93 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 122.815 0.446 . . . . 0.0 111.115 171.538 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 40.0 p -94.1 128.87 40.75 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 121.982 0.896 . . . . 0.0 110.577 170.487 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 5.7 mp -103.94 88.32 3.0 Favored 'General case' 0 CA--C 1.558 1.256 0 N-CA-C 106.637 -1.616 . . . . 0.0 106.637 175.813 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 81.0 t -93.54 97.94 7.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 N-CA-C 107.354 -1.35 . . . . 0.0 107.354 -169.815 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 78.4 mtt85 -91.42 127.62 36.93 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 123.367 0.667 . . . . 0.0 109.579 177.908 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -148.06 133.36 18.48 Favored 'General case' 0 N--CA 1.493 1.719 0 CA-C-O 120.82 0.343 . . . . 0.0 111.284 -176.078 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -79.66 114.15 18.36 Favored 'General case' 0 N--CA 1.487 1.41 0 CA-C-O 121.318 0.58 . . . . 0.0 111.442 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 90.4 mt -122.7 109.08 22.92 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 N-CA-C 104.534 -2.395 . . . . 0.0 104.534 176.189 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 23.4 m-20 59.19 48.98 9.72 Favored 'General case' 0 N--CA 1.5 2.029 0 N-CA-C 114.934 1.457 . . . . 0.0 114.934 177.608 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 62.74 24.4 66.35 Favored Glycine 0 CA--C 1.555 2.545 0 N-CA-C 119.555 2.582 . . . . 0.0 119.555 -170.306 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 59.9 mtmt -130.97 131.21 44.25 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-N 119.589 1.695 . . . . 0.0 108.863 -174.005 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 15.7 tp -77.98 107.61 10.64 Favored 'General case' 0 CA--C 1.558 1.276 0 CA-C-O 121.42 0.629 . . . . 0.0 109.676 178.778 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 32.7 mm -99.33 98.87 7.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 N-CA-C 106.432 -1.692 . . . . 0.0 106.432 -175.466 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 32.3 tp -88.71 103.41 15.93 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 123.976 0.91 . . . . 0.0 109.352 179.088 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 88.1 m -98.96 108.33 20.98 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 -177.169 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 67.1 mt -100.62 101.48 12.39 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 123.705 0.802 . . . . 0.0 109.436 -171.663 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 6.9 m -113.89 111.91 22.49 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 -175.57 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 70.5 t60 -102.95 -85.32 0.45 Allowed 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 173.617 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -109.56 -108.99 3.21 Favored Glycine 0 N--CA 1.484 1.872 0 N-CA-C 110.635 -0.986 . . . . 0.0 110.635 178.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 45.4 m -100.93 66.34 1.15 Allowed 'General case' 0 N--CA 1.494 1.757 0 CA-C-O 121.348 0.594 . . . . 0.0 109.593 173.408 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -172.8 96.1 0.13 Allowed 'General case' 0 N--CA 1.484 1.237 0 N-CA-C 108.123 -1.065 . . . . 0.0 108.123 173.279 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 3.7 p -94.68 122.55 46.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 C-N-CA 123.482 0.713 . . . . 0.0 109.61 174.253 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 44.4 t -108.21 102.11 11.27 Favored 'General case' 0 CA--C 1.553 1.067 0 CA-C-O 121.455 0.645 . . . . 0.0 111.356 179.384 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 90.6 m -88.12 108.0 19.04 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 179.379 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 35.9 mtm180 -111.42 120.05 40.88 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 123.044 0.538 . . . . 0.0 110.394 -172.657 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 94.8 m -86.28 131.17 34.29 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 123.343 0.657 . . . . 0.0 110.309 178.552 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 40.9 m-85 -125.84 125.48 42.93 Favored 'General case' 0 CA--C 1.56 1.354 0 C-N-CA 123.566 0.746 . . . . 0.0 109.035 176.443 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -92.72 158.34 15.97 Favored 'General case' 0 N--CA 1.495 1.816 0 CA-C-O 122.345 1.069 . . . . 0.0 111.849 170.287 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 73.5 tttt -91.16 125.97 36.1 Favored 'General case' 0 N--CA 1.484 1.256 0 CA-C-N 115.512 -0.767 . . . . 0.0 112.46 -165.447 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -97.86 46.74 1.01 Allowed 'General case' 0 N--CA 1.495 1.788 0 C-N-CA 123.853 0.861 . . . . 0.0 112.896 166.926 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.152 0 CA-C-O 123.168 1.461 . . . . 0.0 108.312 -174.821 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.315 8.9 t . . . . . 0 N--CA 1.491 1.585 0 CA-C-O 117.625 -1.178 . . . . 0.0 113.394 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -60.03 -37.58 80.19 Favored 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 116.274 1.953 . . . . 0.0 116.274 -178.309 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -62.78 -28.89 70.3 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 117.252 2.316 . . . . 0.0 117.252 164.169 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -73.12 -25.09 60.72 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 116.131 1.9 . . . . 0.0 116.131 168.278 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 74.4 mt -73.25 108.42 6.12 Favored 'General case' 0 N--CA 1.49 1.56 0 CA-C-N 120.747 1.612 . . . . 0.0 111.381 -173.115 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 161.34 171.59 27.56 Favored Glycine 0 CA--C 1.538 1.509 0 CA-C-O 123.254 1.474 . . . . 0.0 113.892 -175.103 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 96.8 m -84.85 144.85 28.15 Favored 'General case' 0 N--CA 1.487 1.378 0 CA-C-N 113.531 -1.334 . . . . 0.0 110.004 172.436 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 84.4 m95 -140.4 113.35 8.27 Favored 'General case' 0 N--CA 1.483 1.222 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 -175.228 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 45.3 mtmt -102.91 141.43 35.72 Favored 'General case' 0 N--CA 1.492 1.648 0 CA-C-O 121.457 0.646 . . . . 0.0 110.104 173.74 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 55.7 tp -69.63 130.52 42.62 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-O 122.444 1.116 . . . . 0.0 113.244 -170.492 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . 0.272 1.6 t -110.38 -41.77 4.69 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.781 0 CA-C-N 113.512 -1.676 . . . . 0.0 111.818 -172.671 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -142.14 138.94 31.97 Favored 'General case' 0 N--CA 1.492 1.633 0 CA-C-N 120.249 1.386 . . . . 0.0 109.738 175.307 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 86.6 p -124.3 102.39 7.66 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 123.416 0.686 . . . . 0.0 110.832 176.33 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -101.09 127.2 47.74 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 123.207 0.603 . . . . 0.0 109.424 174.872 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 66.2 m-20 67.62 22.04 9.22 Favored 'General case' 0 N--CA 1.504 2.25 0 N-CA-C 117.813 2.523 . . . . 0.0 117.813 173.452 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -72.4 -38.47 68.42 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 115.905 1.817 . . . . 0.0 115.905 -175.4 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -58.41 -30.68 67.05 Favored 'General case' 0 N--CA 1.498 1.96 0 N-CA-C 116.477 2.028 . . . . 0.0 116.477 164.708 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 13.5 t0 -66.13 -50.93 62.29 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 114.28 1.215 . . . . 0.0 114.28 169.486 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 93.7 t80 -55.17 -50.33 69.59 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 115.296 1.591 . . . . 0.0 115.296 172.806 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 72.7 mtm -60.53 -44.43 96.07 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 114.992 1.478 . . . . 0.0 114.992 173.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 14.5 tmtt? -57.29 -45.16 84.39 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 115.611 1.708 . . . . 0.0 115.611 168.35 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 13.8 t -59.13 -37.75 78.0 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 116.473 2.027 . . . . 0.0 116.473 173.073 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 63.6 mt -66.58 -42.28 87.24 Favored 'General case' 0 CA--C 1.564 1.514 0 N-CA-C 116.451 2.019 . . . . 0.0 116.451 170.315 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 115.13 77.27 0.71 Allowed Glycine 0 N--CA 1.482 1.718 0 N-CA-C 110.73 -0.948 . . . . 0.0 110.73 -168.309 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 62.4 t -143.04 122.64 9.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 N-CA-C 105.103 -2.184 . . . . 0.0 105.103 -177.027 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -81.58 -164.3 32.9 Favored Glycine 0 CA--C 1.548 2.127 0 N-CA-C 116.25 1.26 . . . . 0.0 116.25 -177.321 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 83.6 t80 -67.22 145.56 55.08 Favored 'General case' 0 CA--C 1.566 1.588 0 C-N-CA 123.501 0.72 . . . . 0.0 112.608 177.924 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . 0.377 . . 79.83 -41.11 0.22 Allowed 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 116.364 1.987 . . . . 0.0 116.364 179.395 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 56.9 m -69.36 -40.79 77.28 Favored 'General case' 0 N--CA 1.501 2.076 0 CA-C-N 120.152 1.342 . . . . 0.0 113.374 162.756 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 72.0 mtp180 -50.49 -42.51 54.79 Favored 'General case' 0 N--CA 1.498 1.946 0 N-CA-C 116.073 1.879 . . . . 0.0 116.073 160.022 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 81.4 mt-30 -76.41 -48.98 17.93 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 115.033 1.494 . . . . 0.0 115.033 -178.239 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 58.7 t -63.8 -43.16 97.83 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 CA-C-N 119.534 1.061 . . . . 0.0 112.922 178.004 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -65.35 -37.83 88.25 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 116.625 2.083 . . . . 0.0 116.625 174.883 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 90.5 p -62.46 -42.4 99.45 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 116.355 1.983 . . . . 0.0 116.355 170.692 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 19.2 ptp -74.23 -31.26 62.53 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 117.163 2.283 . . . . 0.0 117.163 173.172 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 65.7 m -77.96 144.31 36.89 Favored 'General case' 0 N--CA 1.491 1.577 0 CA-C-N 119.184 0.902 . . . . 0.0 111.743 -173.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 17.7 ptpt -98.25 104.97 25.86 Favored Pre-proline 0 CA--C 1.572 1.799 0 CA-C-O 118.431 -0.795 . . . . 0.0 111.591 170.847 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -78.06 112.98 3.34 Favored 'Trans proline' 0 CA--C 1.563 1.944 0 C-N-CA 123.056 2.504 . . . . 0.0 112.671 178.709 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 94.6 m -72.5 104.38 3.81 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 124.975 1.31 . . . . 0.0 110.1 175.563 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 29.7 m -106.65 118.26 36.21 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.844 -0.535 . . . . 0.0 110.142 -173.011 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 4.5 mp -106.71 112.95 41.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 -177.366 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 52.9 mt -99.05 119.11 46.61 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 N-CA-C 106.938 -1.504 . . . . 0.0 106.938 172.505 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -137.86 123.94 20.3 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 -178.23 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 36.8 ttpt -84.0 116.57 22.89 Favored 'General case' 0 CA--C 1.559 1.31 0 C-N-CA 123.124 0.57 . . . . 0.0 111.201 179.27 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -107.93 73.52 0.9 Allowed 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 123.6 0.76 . . . . 0.0 109.051 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 62.66 69.34 1.34 Allowed Glycine 0 N--CA 1.49 2.264 0 N-CA-C 115.312 0.885 . . . . 0.0 115.312 -173.755 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . 0.278 10.5 m-20 64.81 -2.99 0.61 Allowed 'General case' 0 N--CA 1.501 2.093 0 N-CA-C 118.299 2.703 . . . . 0.0 118.299 -168.629 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 42.5 mm -99.27 99.44 8.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 N-CA-C 107.105 -1.443 . . . . 0.0 107.105 -177.044 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 40.7 mt -77.55 106.99 9.69 Favored 'General case' 0 N--CA 1.488 1.429 0 CA-C-O 121.487 0.66 . . . . 0.0 111.12 178.728 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 34.1 m -100.75 94.54 6.13 Favored 'General case' 0 CA--C 1.559 1.319 0 N-CA-C 107.084 -1.451 . . . . 0.0 107.084 -171.128 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 8.8 tt -92.22 107.93 19.57 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 -177.484 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 52.6 mttp -107.64 93.53 4.59 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 -169.103 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 42.1 m -84.14 92.63 7.96 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.718 -0.614 . . . . 0.0 109.658 -178.283 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 28.9 m170 -88.93 121.36 31.21 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 124.005 0.922 . . . . 0.0 109.214 -179.441 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 13.6 t -137.39 159.21 42.58 Favored 'General case' 0 N--CA 1.49 1.548 0 CA-C-O 121.657 0.742 . . . . 0.0 110.876 -176.6 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 27.3 m -80.99 69.92 7.69 Favored 'General case' 0 N--CA 1.498 1.969 0 CA-C-O 122.099 0.952 . . . . 0.0 110.103 170.424 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 33.4 t80 170.96 -60.2 0.01 OUTLIER 'General case' 0 CA--C 1.571 1.778 0 C-N-CA 126.594 1.957 . . . . 0.0 107.506 -168.149 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.42 142.95 25.38 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 124.311 1.044 . . . . 0.0 111.006 -172.061 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 8.1 m-20 -120.35 110.82 16.99 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 107.921 -1.141 . . . . 0.0 107.921 172.009 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 35.8 p -122.91 133.11 54.41 Favored 'General case' 0 N--CA 1.495 1.806 0 C-N-CA 123.357 0.663 . . . . 0.0 110.832 -176.086 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -112.82 126.14 55.12 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 124.138 0.975 . . . . 0.0 109.222 179.794 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 12.0 pt -122.33 129.97 74.89 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 178.201 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 85.4 p -114.39 124.0 50.87 Favored 'General case' 0 N--CA 1.493 1.701 0 C-N-CA 123.635 0.774 . . . . 0.0 110.786 -173.934 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 41.8 p90 -146.41 139.12 25.35 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 116.069 1.877 . . . . 0.0 116.069 -168.631 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 57.1 mtmt -106.41 24.29 12.79 Favored 'General case' 0 N--CA 1.498 1.951 0 N-CA-C 116.518 2.044 . . . . 0.0 116.518 -178.371 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . 0.275 2.4 mp 61.95 92.43 0.06 Allowed 'General case' 0 N--CA 1.496 1.867 0 CA-C-N 120.904 1.684 . . . . 0.0 115.05 170.609 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 81.97 37.17 16.54 Favored Glycine 0 CA--C 1.55 2.28 0 N-CA-C 116.984 1.553 . . . . 0.0 116.984 -169.424 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 65.4 t -139.29 117.46 12.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 N-CA-C 105.534 -2.024 . . . . 0.0 105.534 -179.432 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -78.8 124.44 28.21 Favored 'General case' 0 N--CA 1.489 1.475 0 CA-C-O 121.415 0.626 . . . . 0.0 111.155 -179.638 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 14.9 p90 -127.07 134.1 50.33 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 124.393 1.077 . . . . 0.0 110.016 -176.936 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -72.05 137.23 47.01 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 112.873 0.694 . . . . 0.0 112.873 177.169 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -136.94 132.57 34.59 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 122.987 0.515 . . . . 0.0 110.518 -162.649 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 61.3 m -100.0 128.57 46.07 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 166.436 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 60.4 p -81.25 174.73 11.25 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 113.748 1.018 . . . . 0.0 113.748 -170.395 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -45.06 -37.15 3.97 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 118.591 2.811 . . . . 0.0 118.591 162.122 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -130.95 91.09 2.99 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 106.547 -1.649 . . . . 0.0 106.547 166.284 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -8.05 99.77 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.098 0 N-CA-C 119.301 3.074 . . . . 0.0 119.301 -175.827 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 3.3 ttm180 -136.27 13.68 3.28 Favored 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 116.961 2.208 . . . . 0.0 116.961 -175.046 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . 0.318 0.0 OUTLIER 42.93 77.04 0.07 Allowed 'General case' 0 N--CA 1.498 1.963 0 N-CA-C 116.898 2.185 . . . . 0.0 116.898 172.129 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 11.0 m -117.68 144.86 24.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 C-N-CA 123.378 0.671 . . . . 0.0 110.145 -166.576 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -96.35 102.65 14.46 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 178.497 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 58.0 m -90.41 125.79 35.67 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 123.401 0.68 . . . . 0.0 112.024 -171.364 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 6.2 tp -137.7 108.89 5.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 179.296 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -118.26 131.02 72.24 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 C-N-CA 124.558 1.143 . . . . 0.0 109.183 177.923 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 14.6 t -135.12 154.42 51.66 Favored 'General case' 0 N--CA 1.492 1.674 0 CA-C-O 122.777 1.275 . . . . 0.0 111.848 171.91 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 15.6 tp -88.56 113.3 23.99 Favored 'General case' 0 N--CA 1.487 1.419 0 CA-C-N 114.339 -1.3 . . . . 0.0 110.166 177.753 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -115.79 81.8 1.66 Allowed 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 123.42 0.688 . . . . 0.0 109.921 -176.195 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 62.65 48.58 80.38 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 117.299 1.68 . . . . 0.0 117.299 -175.06 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 74.28 44.06 29.68 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 117.446 1.739 . . . . 0.0 117.446 -171.155 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 40.5 ttpt -154.38 108.25 2.95 Favored 'General case' 0 CA--C 1.552 1.047 0 N-CA-C 106.549 -1.649 . . . . 0.0 106.549 -172.298 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 41.4 mt -81.72 96.86 7.68 Favored 'General case' 0 N--CA 1.491 1.579 0 CA-C-O 122.625 1.202 . . . . 0.0 110.109 175.526 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 96.2 t -87.81 98.57 7.68 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.235 0 CA-C-N 113.293 -1.776 . . . . 0.0 106.32 -178.477 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 22.4 t-160 -95.27 139.34 31.73 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 123.533 0.733 . . . . 0.0 109.818 177.262 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 20.5 tp -135.73 118.7 16.34 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 106.701 -1.592 . . . . 0.0 106.701 178.356 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 28.7 mt-30 -114.01 125.96 54.59 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 176.229 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -139.71 128.28 23.02 Favored 'General case' 0 N--CA 1.494 1.769 0 CA-C-N 118.685 0.675 . . . . 0.0 112.743 -165.402 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 21.4 p90 -151.32 115.8 5.11 Favored 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 123.908 0.883 . . . . 0.0 110.699 -167.178 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . 0.341 18.1 t70 67.96 -93.32 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.886 0 C-N-CA 124.766 1.226 . . . . 0.0 112.883 171.146 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -135.28 52.11 0.81 Allowed Glycine 0 CA--C 1.546 2.014 0 CA-C-O 119.743 -0.476 . . . . 0.0 113.887 163.159 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 15.6 mt-30 -151.02 131.29 13.61 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 176.849 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -133.42 116.2 15.74 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 123.089 0.556 . . . . 0.0 110.27 179.364 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 1.8 t -110.33 124.36 51.54 Favored 'General case' 0 N--CA 1.492 1.636 0 C-N-CA 123.265 0.626 . . . . 0.0 109.988 -178.523 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 35.6 p -100.72 137.95 38.43 Favored 'General case' 0 N--CA 1.492 1.633 0 CA-C-O 121.213 0.53 . . . . 0.0 111.244 179.38 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 5.0 mp -121.4 79.5 1.55 Allowed 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 -178.292 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 46.4 t -93.2 112.42 26.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 -165.797 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 45.3 mtt180 -102.71 129.42 49.32 Favored 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 122.854 0.462 . . . . 0.0 110.745 -177.589 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -148.83 139.33 22.58 Favored 'General case' 0 N--CA 1.494 1.744 0 C-N-CA 123.061 0.544 . . . . 0.0 111.97 178.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -83.7 113.97 21.25 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 123.094 0.558 . . . . 0.0 111.727 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 1.7 mp -103.79 102.02 13.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 N-CA-C 104.688 -2.338 . . . . 0.0 104.688 170.835 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 53.75 50.41 17.07 Favored 'General case' 0 N--CA 1.499 1.987 0 N-CA-C 115.257 1.577 . . . . 0.0 115.257 176.232 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 88.55 -37.93 3.25 Favored Glycine 0 CA--C 1.552 2.396 0 N-CA-C 117.857 1.903 . . . . 0.0 117.857 -169.914 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 10.4 mtmp? -85.93 127.45 34.62 Favored 'General case' 0 N--CA 1.487 1.377 0 CA-C-N 119.336 1.568 . . . . 0.0 111.08 -172.698 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 2.6 tt -80.14 118.77 22.13 Favored 'General case' 0 CA--C 1.556 1.202 0 CA-C-O 121.823 0.821 . . . . 0.0 111.082 -179.584 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 39.2 mm -100.91 108.81 23.99 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.347 0 N-CA-C 106.324 -1.732 . . . . 0.0 106.324 -178.502 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 47.2 tp -91.19 101.53 14.26 Favored 'General case' 0 CA--C 1.56 1.363 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 173.954 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 58.2 m -93.8 109.13 20.82 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 -177.622 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 62.7 mt -103.72 83.87 2.2 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 123.339 0.656 . . . . 0.0 110.372 -169.59 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 8.5 m -95.97 116.59 29.17 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.617 -0.677 . . . . 0.0 109.949 -170.173 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 85.0 t60 -146.49 115.9 7.09 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 176.342 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 75.82 -109.45 2.79 Favored Glycine 0 N--CA 1.484 1.86 0 C-N-CA 122.96 0.314 . . . . 0.0 113.538 173.675 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 14.9 t -129.82 55.09 1.8 Allowed 'General case' 0 N--CA 1.495 1.812 0 CA-C-O 121.405 0.621 . . . . 0.0 111.078 163.213 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -154.36 89.2 1.26 Allowed 'General case' 0 N--CA 1.483 1.177 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 177.878 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 5.6 p -92.96 117.93 37.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 C-N-CA 123.276 0.631 . . . . 0.0 110.004 176.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 44.2 t -99.98 104.39 16.0 Favored 'General case' 0 CA--C 1.553 1.093 0 CA-C-O 121.443 0.639 . . . . 0.0 111.419 175.302 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 57.5 m -92.02 110.18 21.54 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 -178.621 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 21.5 mtm105 -115.17 114.53 25.39 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 123.163 0.585 . . . . 0.0 110.561 -171.022 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 90.8 m -84.55 140.34 31.49 Favored 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 123.714 0.806 . . . . 0.0 110.987 -178.891 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 42.0 m-85 -133.98 135.92 43.78 Favored 'General case' 0 CA--C 1.559 1.298 0 C-N-CA 124.079 0.952 . . . . 0.0 109.903 -178.365 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -99.47 152.63 19.78 Favored 'General case' 0 N--CA 1.495 1.814 0 CA-C-O 122.058 0.932 . . . . 0.0 111.315 166.093 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 65.6 tttt -82.78 120.47 25.67 Favored 'General case' 0 N--CA 1.486 1.365 0 CA-C-N 115.465 -0.789 . . . . 0.0 111.19 -173.19 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 59.0 mm-40 -114.49 53.89 0.79 Allowed 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 124.073 0.949 . . . . 0.0 111.552 -172.205 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.894 0 CA-C-O 124.414 2.054 . . . . 0.0 108.956 -170.66 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.255 4.4 p . . . . . 0 CA--C 1.575 1.935 0 N-CA-C 116.141 1.904 . . . . 0.0 116.141 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -67.36 -39.61 85.74 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 116.385 1.995 . . . . 0.0 116.385 -177.011 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -59.59 -28.2 66.94 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 117.408 2.373 . . . . 0.0 117.408 167.888 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -68.21 -27.19 66.16 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 116.207 1.929 . . . . 0.0 116.207 166.568 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 79.9 mt -71.91 116.85 12.78 Favored 'General case' 0 N--CA 1.489 1.52 0 CA-C-N 120.967 1.712 . . . . 0.0 112.436 -170.855 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 159.41 173.36 27.76 Favored Glycine 0 CA--C 1.543 1.842 0 CA-C-O 122.484 1.047 . . . . 0.0 113.557 -178.597 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 53.9 m -85.19 141.08 30.41 Favored 'General case' 0 N--CA 1.493 1.714 0 CA-C-N 114.719 -0.74 . . . . 0.0 109.378 167.102 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 88.2 m95 -140.53 113.51 8.33 Favored 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 -174.046 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -100.69 150.01 23.19 Favored 'General case' 0 N--CA 1.496 1.863 0 CA-C-O 121.23 0.538 . . . . 0.0 110.554 176.047 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 22.5 tp -68.15 129.49 40.07 Favored 'General case' 0 N--CA 1.491 1.595 0 CA-C-O 121.932 0.872 . . . . 0.0 113.072 -174.437 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . 0.283 0.9 OUTLIER -105.05 -46.96 9.41 Favored 'Isoleucine or valine' 0 CA--C 1.576 1.967 0 CA-C-N 114.156 -1.384 . . . . 0.0 111.184 173.918 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -139.7 143.84 37.27 Favored 'General case' 0 N--CA 1.492 1.627 0 CA-C-N 119.754 1.161 . . . . 0.0 109.712 179.472 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 95.4 p -137.35 96.45 3.27 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.668 -0.645 . . . . 0.0 110.248 166.819 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -91.55 126.59 36.68 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 123.413 0.685 . . . . 0.0 109.679 177.385 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.27 62.6 m-20 69.45 37.17 2.05 Favored 'General case' 0 N--CA 1.502 2.174 0 N-CA-C 116.105 1.891 . . . . 0.0 116.105 -176.068 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 47.3 t80 -69.22 -59.56 2.93 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.759 -1.213 . . . . 0.0 112.8 175.917 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -45.91 -45.68 15.52 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 118.376 2.732 . . . . 0.0 118.376 171.076 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -61.12 -46.81 89.07 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 115.07 1.507 . . . . 0.0 115.07 172.516 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 87.2 t80 -55.84 -49.61 72.83 Favored 'General case' 0 CA--C 1.573 1.857 0 N-CA-C 115.025 1.491 . . . . 0.0 115.025 169.388 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 19.3 mmt -63.78 -44.61 92.85 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 114.829 1.418 . . . . 0.0 114.829 177.719 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 21.1 tptm -60.96 -37.65 83.17 Favored 'General case' 0 CA--C 1.571 1.753 0 N-CA-C 116.18 1.918 . . . . 0.0 116.18 167.67 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 17.1 t -58.85 -41.12 86.23 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 115.74 1.756 . . . . 0.0 115.74 169.47 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 79.1 mt -62.37 -44.3 96.79 Favored 'General case' 0 CA--C 1.568 1.641 0 N-CA-C 115.898 1.814 . . . . 0.0 115.898 166.315 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 123.63 65.24 0.2 Allowed Glycine 0 N--CA 1.483 1.813 0 C-N-CA 124.173 0.892 . . . . 0.0 111.991 -175.388 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 24.2 t -144.45 112.11 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 N-CA-C 105.084 -2.191 . . . . 0.0 105.084 -174.445 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -96.5 -100.27 1.93 Allowed Glycine 0 N--CA 1.484 1.834 0 N-CA-C 113.694 0.238 . . . . 0.0 113.694 -173.323 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 69.3 t80 -96.16 143.38 27.33 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 123.511 0.725 . . . . 0.0 111.784 -173.023 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . 0.352 . . 80.87 -51.04 0.31 Allowed 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 116.494 2.035 . . . . 0.0 116.494 168.516 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 91.8 m -70.28 -40.51 74.28 Favored 'General case' 0 N--CA 1.498 1.974 0 N-CA-C 113.938 1.088 . . . . 0.0 113.938 171.657 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 51.6 ttp180 -58.13 -41.04 82.78 Favored 'General case' 0 CA--C 1.572 1.818 0 N-CA-C 114.99 1.478 . . . . 0.0 114.99 164.457 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 42.9 mt-30 -73.94 -47.25 38.88 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 115.583 1.698 . . . . 0.0 115.583 178.922 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 81.3 t -63.84 -42.79 97.02 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.168 0 CA-C-N 120.01 1.277 . . . . 0.0 113.158 176.582 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -68.02 -31.61 71.42 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 117.052 2.242 . . . . 0.0 117.052 173.954 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 82.2 p -67.35 -39.38 85.73 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 115.889 1.811 . . . . 0.0 115.889 167.43 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 47.3 ttm -65.72 -41.7 91.96 Favored 'General case' 0 CA--C 1.566 1.575 0 N-CA-C 115.816 1.784 . . . . 0.0 115.816 175.595 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 5.9 t -81.0 165.73 21.45 Favored 'General case' 0 N--CA 1.493 1.686 0 CA-C-N 118.949 0.795 . . . . 0.0 112.933 178.981 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.17 105.68 33.9 Favored Pre-proline 0 CA--C 1.57 1.713 0 CA-C-O 118.093 -0.956 . . . . 0.0 110.127 172.54 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -80.76 99.77 1.16 Allowed 'Trans proline' 0 CA--C 1.558 1.715 0 C-N-CA 122.656 2.237 . . . . 0.0 112.308 -179.597 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 97.4 m -80.83 118.24 22.18 Favored 'General case' 0 N--CA 1.487 1.419 0 CA-C-N 115.417 -0.811 . . . . 0.0 110.934 -165.429 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 79.3 m -90.9 117.24 29.35 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 178.519 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 5.2 mp -108.41 109.29 27.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 N-CA-C 106.32 -1.733 . . . . 0.0 106.32 174.851 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 20.8 mt -100.49 117.35 45.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 N-CA-C 106.348 -1.723 . . . . 0.0 106.348 177.342 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -142.17 127.85 19.19 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.643 -0.661 . . . . 0.0 109.434 -170.386 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.68 156.1 32.83 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 113.972 1.101 . . . . 0.0 113.972 -178.727 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 25.9 t30 -141.91 74.74 1.46 Allowed 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 170.429 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 71.04 -102.23 1.05 Allowed Glycine 0 CA--C 1.546 1.991 0 O-C-N 122.119 -0.363 . . . . 0.0 112.732 -167.213 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 42.4 t0 -94.91 -20.76 19.13 Favored 'General case' 0 CA--C 1.573 1.86 0 N-CA-C 115.318 1.599 . . . . 0.0 115.318 166.816 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 18.6 mm -87.23 110.73 20.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 CA-C-N 120.542 1.519 . . . . 0.0 109.133 -169.081 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 30.7 mt -78.74 124.31 28.07 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 123.613 0.765 . . . . 0.0 111.935 176.275 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 86.7 m -109.19 99.48 8.76 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 106.922 -1.51 . . . . 0.0 106.922 179.532 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 9.7 tt -99.63 109.68 22.16 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 178.797 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -104.0 105.87 16.19 Favored 'General case' 0 N--CA 1.484 1.228 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 -179.187 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 48.8 m -89.02 95.26 10.25 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 174.441 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 22.0 m170 -76.9 175.58 9.38 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 124.132 0.973 . . . . 0.0 111.844 176.927 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 22.6 t -164.58 -25.89 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 115.069 1.507 . . . . 0.0 115.069 176.151 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . 0.296 6.7 m 62.59 50.44 3.54 Favored 'General case' 0 N--CA 1.504 2.264 0 CA-C-N 120.185 1.357 . . . . 0.0 111.978 -157.399 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 7.2 t80 -177.66 -67.73 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 106.082 -1.822 . . . . 0.0 106.082 -167.697 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.59 137.47 48.43 Favored 'General case' 0 CA--C 1.563 1.45 0 C-N-CA 124.064 0.946 . . . . 0.0 110.998 164.165 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 26.0 m-20 -119.78 104.17 9.99 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 173.966 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 60.4 p -106.59 131.98 53.13 Favored 'General case' 0 N--CA 1.496 1.865 0 C-N-CA 123.327 0.651 . . . . 0.0 110.952 -176.444 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 4.5 tm-20 -118.07 127.79 54.13 Favored 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 123.953 0.901 . . . . 0.0 110.081 -173.66 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 44.7 pt -116.94 132.76 65.74 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 C-N-CA 123.595 0.758 . . . . 0.0 109.267 172.196 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 73.5 p -116.2 112.95 22.38 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 176.397 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 40.2 p90 -144.35 146.33 32.49 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 114.498 1.295 . . . . 0.0 114.498 -161.331 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 57.6 mtmt -102.59 151.23 22.59 Favored 'General case' 0 N--CA 1.489 1.491 0 CA-C-N 115.133 -0.94 . . . . 0.0 109.126 159.146 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -74.15 115.95 14.23 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.66 -0.65 . . . . 0.0 111.709 -172.893 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 88.18 45.53 5.01 Favored Glycine 0 CA--C 1.55 2.225 0 N-CA-C 116.454 1.341 . . . . 0.0 116.454 -167.539 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 94.4 t -136.88 121.96 25.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 N-CA-C 107.024 -1.473 . . . . 0.0 107.024 178.086 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -87.97 125.73 34.68 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 123.05 0.54 . . . . 0.0 110.522 172.401 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 37.0 p90 -135.59 128.39 31.11 Favored 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 123.938 0.895 . . . . 0.0 109.026 -177.393 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -72.16 110.32 6.54 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.254 -0.904 . . . . 0.0 112.177 177.872 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 12.4 tp10 -109.9 129.13 55.69 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 123.804 0.842 . . . . 0.0 109.855 -169.314 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 67.6 m -96.91 118.87 34.27 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 175.635 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 38.8 p -88.2 168.33 12.84 Favored 'General case' 0 N--CA 1.49 1.54 0 CA-C-N 115.368 -0.833 . . . . 0.0 112.191 -172.612 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -62.2 -28.02 69.38 Favored 'General case' 0 CA--C 1.569 1.682 0 N-CA-C 117.154 2.279 . . . . 0.0 117.154 164.121 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -69.58 -1.22 8.21 Favored 'General case' 0 CA--C 1.58 2.105 0 N-CA-C 116.694 2.109 . . . . 0.0 116.694 164.247 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 65.32 67.31 0.51 Allowed 'General case' 0 N--CA 1.496 1.844 0 C-N-CA 125.449 1.5 . . . . 0.0 111.922 -176.183 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 38.9 ttp180 -148.2 117.49 6.9 Favored 'General case' 0 N--CA 1.485 1.307 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 -166.309 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -76.47 111.39 11.89 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 172.703 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 10.4 m -127.27 128.04 69.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 -172.241 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 47.5 mmtm -80.9 102.88 10.36 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 123.27 0.628 . . . . 0.0 109.526 -179.56 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 40.8 m -95.76 91.95 6.32 Favored 'General case' 0 N--CA 1.48 1.072 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.932 -167.077 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 6.1 tp -104.02 108.15 23.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 176.304 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 1.5 p -124.56 124.42 68.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 C-N-CA 123.851 0.861 . . . . 0.0 109.289 -173.28 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 9.8 t -138.53 152.78 48.52 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-O 122.467 1.127 . . . . 0.0 110.891 -178.794 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 35.3 tp -89.88 111.37 22.4 Favored 'General case' 0 N--CA 1.488 1.434 0 CA-C-N 114.85 -1.068 . . . . 0.0 109.394 174.099 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -104.61 81.99 1.85 Allowed 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 123.629 0.772 . . . . 0.0 110.266 -176.04 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 57.01 46.31 91.53 Favored Glycine 0 CA--C 1.551 2.327 0 N-CA-C 118.032 1.973 . . . . 0.0 118.032 -176.514 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 82.77 12.88 79.18 Favored Glycine 0 CA--C 1.557 2.681 0 N-CA-C 118.748 2.259 . . . . 0.0 118.748 -167.698 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 59.2 mtpt -125.2 103.88 8.21 Favored 'General case' 0 N--CA 1.487 1.394 0 CA-C-N 119.365 1.583 . . . . 0.0 106.799 177.825 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 5.5 tt -85.57 97.52 10.12 Favored 'General case' 0 CA--C 1.56 1.359 0 CA-C-O 122.013 0.911 . . . . 0.0 109.584 -174.824 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 71.6 t -96.37 110.47 24.7 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 N-CA-C 106.778 -1.564 . . . . 0.0 106.778 -170.308 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 20.1 t-160 -102.02 108.55 20.03 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 122.995 0.518 . . . . 0.0 109.697 173.681 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 40.8 tp -95.12 118.31 31.69 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 175.637 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 31.4 mt-30 -106.93 117.65 34.61 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 172.632 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 37.5 ttmt -124.76 127.37 47.11 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 123.195 0.598 . . . . 0.0 109.846 -172.617 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 32.3 p90 -145.93 114.76 6.89 Favored 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 123.241 0.616 . . . . 0.0 110.569 -174.575 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . 0.339 13.8 t70 67.04 -99.74 0.05 Allowed 'General case' 0 N--CA 1.494 1.751 0 C-N-CA 124.595 1.158 . . . . 0.0 112.403 173.01 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -128.61 50.54 0.89 Allowed Glycine 0 N--CA 1.487 2.04 0 CA-C-N 118.615 0.643 . . . . 0.0 114.197 163.216 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 14.1 mt-30 -150.65 128.85 11.95 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 177.807 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -137.09 130.79 31.79 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 123.139 0.576 . . . . 0.0 111.195 -176.756 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 7.1 t -121.88 129.3 52.47 Favored 'General case' 0 N--CA 1.495 1.809 0 C-N-CA 122.543 0.337 . . . . 0.0 111.486 176.129 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 39.7 p -99.31 124.62 44.55 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-O 121.755 0.788 . . . . 0.0 110.115 173.185 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 5.5 mp -100.91 88.27 3.51 Favored 'General case' 0 CA--C 1.559 1.29 0 N-CA-C 106.984 -1.487 . . . . 0.0 106.984 178.082 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 98.5 t -92.56 101.1 12.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 -168.102 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 77.7 mtt85 -96.47 125.44 40.96 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 123.221 0.608 . . . . 0.0 109.849 -178.309 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -144.95 128.17 16.73 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-O 120.847 0.356 . . . . 0.0 111.329 -172.367 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -82.42 115.64 21.53 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 123.144 0.577 . . . . 0.0 111.408 -177.245 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 96.1 mt -127.85 107.17 15.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 N-CA-C 104.993 -2.225 . . . . 0.0 104.993 179.701 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 23.4 m-20 58.08 52.76 7.32 Favored 'General case' 0 N--CA 1.5 2.063 0 N-CA-C 114.788 1.403 . . . . 0.0 114.788 176.523 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 63.15 21.21 63.7 Favored Glycine 0 CA--C 1.556 2.635 0 N-CA-C 119.734 2.653 . . . . 0.0 119.734 -171.258 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -128.92 127.54 41.96 Favored 'General case' 0 N--CA 1.488 1.445 0 CA-C-N 119.534 1.667 . . . . 0.0 108.51 -173.586 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 16.0 tp -79.33 109.99 14.19 Favored 'General case' 0 CA--C 1.557 1.236 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 176.751 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 32.5 mm -98.45 97.02 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 N-CA-C 106.467 -1.679 . . . . 0.0 106.467 -175.792 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 30.3 tp -87.23 103.96 15.93 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 124.003 0.921 . . . . 0.0 109.553 178.118 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 88.4 m -100.8 99.15 9.62 Favored 'General case' 0 CA--C 1.562 1.405 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 -177.408 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 71.0 mt -88.17 104.01 16.3 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 123.911 0.884 . . . . 0.0 109.672 -176.76 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 6.7 m -106.79 122.4 46.31 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.586 -0.696 . . . . 0.0 109.502 -171.83 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 77.8 t60 -148.15 113.5 5.59 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 173.797 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 74.89 -116.39 5.03 Favored Glycine 0 N--CA 1.484 1.883 0 C-N-CA 123.115 0.388 . . . . 0.0 113.849 173.083 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 15.2 t -119.22 53.45 1.02 Allowed 'General case' 0 N--CA 1.496 1.844 0 CA-C-O 121.271 0.557 . . . . 0.0 111.641 166.658 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -159.93 104.91 1.55 Allowed 'General case' 0 N--CA 1.483 1.203 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 175.89 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 7.4 p -111.24 125.89 68.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 C-N-CA 123.706 0.802 . . . . 0.0 110.113 -179.082 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 35.6 t -98.35 108.49 21.2 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 122.788 0.435 . . . . 0.0 111.693 175.626 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 88.6 m -92.2 117.19 29.63 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 177.868 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 75.6 mtp180 -124.46 115.78 21.46 Favored 'General case' 0 N--CA 1.488 1.444 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.054 -165.229 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 74.1 m -87.82 133.72 33.83 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 122.98 0.512 . . . . 0.0 109.794 178.017 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 40.0 m-85 -128.69 130.11 46.71 Favored 'General case' 0 CA--C 1.56 1.351 0 C-N-CA 123.388 0.675 . . . . 0.0 109.419 177.467 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -91.22 154.16 19.49 Favored 'General case' 0 N--CA 1.494 1.741 0 CA-C-O 122.23 1.014 . . . . 0.0 112.193 169.556 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 69.6 tttt -86.01 119.4 26.27 Favored 'General case' 0 N--CA 1.484 1.273 0 CA-C-N 115.257 -0.883 . . . . 0.0 111.414 -170.787 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 25.3 mm-40 -117.22 51.22 1.03 Allowed 'General case' 0 CA--C 1.564 1.508 0 C-N-CA 124.58 1.152 . . . . 0.0 111.26 -174.61 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 0.984 0 CA-C-O 123.059 1.409 . . . . 0.0 110.594 -159.732 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 4.1 p . . . . . 0 CA--C 1.576 1.971 0 N-CA-C 116.051 1.871 . . . . 0.0 116.051 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -66.86 -34.25 77.38 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 116.922 2.193 . . . . 0.0 116.922 -175.456 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -57.67 -31.63 66.51 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 117.387 2.366 . . . . 0.0 117.387 169.404 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -66.96 -26.5 66.86 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 116.686 2.106 . . . . 0.0 116.686 168.702 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 49.8 mt -77.07 107.07 9.17 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-N 120.887 1.676 . . . . 0.0 111.624 -164.057 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 157.18 176.97 29.85 Favored Glycine 0 CA--C 1.542 1.749 0 CA-C-O 122.511 1.062 . . . . 0.0 113.11 -169.744 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 85.6 m -91.78 143.56 26.4 Favored 'General case' 0 N--CA 1.489 1.48 0 CA-C-N 114.406 -0.897 . . . . 0.0 109.071 177.14 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 93.5 m95 -138.48 111.5 7.85 Favored 'General case' 0 N--CA 1.485 1.319 0 N-CA-C 107.548 -1.278 . . . . 0.0 107.548 -175.145 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -100.31 143.11 30.89 Favored 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 123.681 0.792 . . . . 0.0 110.648 -178.957 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 17.6 tp -66.91 124.62 23.49 Favored 'General case' 0 N--CA 1.488 1.445 0 CA-C-O 121.929 0.871 . . . . 0.0 113.135 -172.457 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . 0.267 1.2 t -97.37 -48.45 12.35 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.816 0 CA-C-N 114.261 -1.336 . . . . 0.0 111.601 174.472 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -143.89 150.25 38.12 Favored 'General case' 0 N--CA 1.489 1.494 0 CA-C-N 119.356 0.98 . . . . 0.0 110.046 178.904 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 88.1 p -130.65 98.14 4.57 Favored 'General case' 0 N--CA 1.489 1.514 0 CA-C-O 121.243 0.544 . . . . 0.0 109.922 170.042 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -84.51 128.27 34.5 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 123.168 0.587 . . . . 0.0 110.055 177.616 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 56.3 m-20 65.09 24.91 12.52 Favored 'General case' 0 N--CA 1.503 2.207 0 N-CA-C 117.964 2.579 . . . . 0.0 117.964 171.748 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 29.8 t80 -69.42 -53.24 20.31 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 120.032 -1.668 . . . . 0.0 113.982 -176.156 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -39.35 -44.64 1.34 Allowed 'General case' 0 N--CA 1.499 1.977 0 N-CA-C 118.948 2.944 . . . . 0.0 118.948 159.951 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -63.91 -50.35 69.06 Favored 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 115.214 1.561 . . . . 0.0 115.214 172.709 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 75.4 t80 -52.11 -48.0 64.99 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 115.591 1.7 . . . . 0.0 115.591 166.866 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 36.6 mmm -65.59 -40.11 92.33 Favored 'General case' 0 CA--C 1.565 1.548 0 N-CA-C 115.176 1.547 . . . . 0.0 115.176 176.352 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -60.85 -43.11 98.76 Favored 'General case' 0 CA--C 1.569 1.677 0 N-CA-C 114.873 1.435 . . . . 0.0 114.873 165.583 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 50.1 m -59.14 -39.45 82.44 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 115.82 1.785 . . . . 0.0 115.82 170.493 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 77.7 mt -64.62 -42.43 95.5 Favored 'General case' 0 CA--C 1.565 1.543 0 N-CA-C 116.214 1.931 . . . . 0.0 116.214 168.53 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 111.85 73.77 0.69 Allowed Glycine 0 N--CA 1.483 1.807 0 C-N-CA 123.708 0.671 . . . . 0.0 111.911 -172.445 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 37.6 t -136.3 127.84 43.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 N-CA-C 106.335 -1.728 . . . . 0.0 106.335 179.421 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -66.53 -80.19 0.19 Allowed Glycine 0 N--CA 1.485 1.966 0 N-CA-C 116.653 1.421 . . . . 0.0 116.653 -173.603 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 46.3 p90 -153.04 -50.29 0.1 Allowed 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 114.298 1.222 . . . . 0.0 114.298 -178.176 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.02 -41.67 96.99 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 116.871 2.175 . . . . 0.0 116.871 -176.519 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 59.0 m -80.06 -36.24 35.93 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 113.521 0.934 . . . . 0.0 113.521 169.89 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 44.2 ttp180 -58.72 -44.05 90.31 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 115.722 1.749 . . . . 0.0 115.722 176.677 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 18.2 mm100 -86.91 -33.64 19.65 Favored 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 115.315 1.598 . . . . 0.0 115.315 178.864 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 89.1 t -69.44 -46.19 76.86 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 CA-C-N 120.875 1.67 . . . . 0.0 111.941 173.373 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -65.97 -24.43 66.79 Favored 'General case' 0 CA--C 1.569 1.685 0 N-CA-C 117.559 2.429 . . . . 0.0 117.559 175.075 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 87.4 p -68.17 -49.48 60.66 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 114.863 1.431 . . . . 0.0 114.863 167.052 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 3.3 ppp? -65.26 -23.31 67.01 Favored 'General case' 0 N--CA 1.499 2.012 0 N-CA-C 117.792 2.516 . . . . 0.0 117.792 170.408 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 48.6 m -68.99 150.74 47.35 Favored 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 124.507 1.123 . . . . 0.0 112.119 177.189 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.8 98.81 6.64 Favored Pre-proline 0 CA--C 1.571 1.786 0 CA-C-O 118.072 -0.966 . . . . 0.0 110.022 166.319 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_endo -82.12 90.34 1.12 Allowed 'Trans proline' 0 CA--C 1.562 1.878 0 C-N-CA 122.805 2.337 . . . . 0.0 110.758 179.32 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 80.3 m -79.8 110.63 15.34 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 123.715 0.806 . . . . 0.0 110.487 -160.959 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 58.6 m -86.27 116.42 24.44 Favored 'General case' 0 CA--C 1.562 1.41 0 C-N-CA 123.085 0.554 . . . . 0.0 109.962 -171.247 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 71.9 mt -113.12 105.24 18.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 N-CA-C 106.434 -1.691 . . . . 0.0 106.434 178.926 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 3.8 mp -94.56 123.05 46.53 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 174.567 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -132.48 117.88 18.58 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 -176.866 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 38.7 ttpt -90.24 117.22 28.81 Favored 'General case' 0 CA--C 1.557 1.227 0 CA-C-O 121.296 0.57 . . . . 0.0 110.911 177.511 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 21.2 t-20 -77.27 -56.14 4.81 Favored 'General case' 0 CA--C 1.568 1.651 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.85 164.245 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -159.49 -85.62 0.05 OUTLIER Glycine 0 N--CA 1.48 1.614 0 N-CA-C 109.066 -1.613 . . . . 0.0 109.066 171.039 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -74.04 -37.87 64.17 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 114.502 1.297 . . . . 0.0 114.502 161.108 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 45.9 mm -76.68 120.54 27.09 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.514 0 C-N-CA 123.954 0.902 . . . . 0.0 110.466 -174.116 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 47.1 mt -99.67 108.99 21.48 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.745 0.818 . . . . 0.0 109.037 168.014 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 93.7 m -95.43 100.63 12.37 Favored 'General case' 0 CA--C 1.559 1.308 0 N-CA-C 107.513 -1.291 . . . . 0.0 107.513 -177.018 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 9.6 tt -100.44 106.38 17.95 Favored 'General case' 0 N--CA 1.483 1.178 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 -178.47 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -101.88 111.64 23.97 Favored 'General case' 0 N--CA 1.485 1.305 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 178.884 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 95.2 m -95.07 94.46 7.97 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 178.192 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 22.3 m-70 -81.12 100.99 9.34 Favored 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 123.276 0.63 . . . . 0.0 111.603 -171.257 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 32.1 t -112.68 145.41 40.51 Favored 'General case' 0 CA--C 1.555 1.152 0 C-N-CA 123.904 0.882 . . . . 0.0 109.397 -176.304 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 53.1 m -52.46 -25.24 9.57 Favored 'General case' 0 N--CA 1.502 2.154 0 N-CA-C 115.729 1.751 . . . . 0.0 115.729 158.731 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 72.2 t80 -109.43 83.07 1.69 Allowed 'General case' 0 CA--C 1.562 1.406 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 169.826 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 28.2 mtpp 61.79 115.55 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.997 0 N-CA-C 115.706 1.743 . . . . 0.0 115.706 172.495 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 7.6 p-10 -79.43 121.33 25.04 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.713 -0.617 . . . . 0.0 112.493 175.604 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 73.1 p -93.85 126.37 39.0 Favored 'General case' 0 N--CA 1.493 1.716 0 C-N-CA 122.718 0.407 . . . . 0.0 110.538 178.783 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -105.81 113.92 27.76 Favored 'General case' 0 N--CA 1.485 1.292 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 174.037 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 19.8 pt -116.59 128.82 73.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 179.72 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 61.7 p -116.83 113.4 22.45 Favored 'General case' 0 N--CA 1.492 1.659 0 C-N-CA 123.741 0.817 . . . . 0.0 109.447 -172.466 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 42.6 p90 -141.31 145.65 35.75 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 114.929 1.455 . . . . 0.0 114.929 -165.228 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 34.8 mtmm -116.82 23.94 11.6 Favored 'General case' 0 N--CA 1.498 1.929 0 N-CA-C 115.982 1.845 . . . . 0.0 115.982 -174.168 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . 0.275 2.0 mp 65.75 94.21 0.06 Allowed 'General case' 0 N--CA 1.494 1.725 0 C-N-CA 124.964 1.306 . . . . 0.0 113.635 168.632 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 83.27 34.06 21.42 Favored Glycine 0 CA--C 1.551 2.323 0 N-CA-C 117.095 1.598 . . . . 0.0 117.095 -164.601 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 95.6 t -135.27 118.19 23.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 N-CA-C 106.453 -1.684 . . . . 0.0 106.453 -178.948 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -85.6 136.27 33.45 Favored 'General case' 0 CA--C 1.565 1.55 0 C-N-CA 123.563 0.745 . . . . 0.0 111.86 179.448 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 47.9 p90 -143.89 139.29 29.13 Favored 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 123.663 0.785 . . . . 0.0 111.392 -171.872 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -75.57 135.42 40.55 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.252 -0.905 . . . . 0.0 112.688 172.413 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -146.1 136.49 23.94 Favored 'General case' 0 N--CA 1.49 1.528 0 CA-C-O 120.997 0.427 . . . . 0.0 111.207 -170.53 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 79.3 m -96.88 130.09 44.23 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 172.037 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 26.7 p -89.2 171.8 9.54 Favored 'General case' 0 N--CA 1.492 1.671 0 CA-C-O 121.989 0.9 . . . . 0.0 112.661 -176.336 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -54.48 -40.33 68.39 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 117.207 2.299 . . . . 0.0 117.207 169.018 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -93.93 59.7 2.78 Favored 'General case' 0 N--CA 1.495 1.813 0 CA-C-N 119.362 0.983 . . . . 0.0 111.337 170.267 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 9.5 t70 21.7 76.26 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.007 0 N-CA-C 118.771 2.878 . . . . 0.0 118.771 -178.687 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 38.4 ttp180 -139.73 117.92 11.95 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 -169.204 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.42 114.81 12.06 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 122.901 0.48 . . . . 0.0 110.195 172.252 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 17.3 m -135.01 132.27 53.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 CA-C-O 121.431 0.634 . . . . 0.0 109.642 -170.135 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 39.5 ttpt -87.02 118.09 26.17 Favored 'General case' 0 CA--C 1.558 1.263 0 C-N-CA 123.829 0.852 . . . . 0.0 110.237 178.77 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 71.0 m -117.35 109.76 17.21 Favored 'General case' 0 N--CA 1.488 1.452 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.259 -157.85 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 6.6 tp -122.73 115.88 47.2 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 C-N-CA 123.834 0.854 . . . . 0.0 109.091 -179.105 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -123.53 129.58 74.57 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 C-N-CA 124.431 1.092 . . . . 0.0 109.29 178.76 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 15.1 t -133.89 156.97 47.14 Favored 'General case' 0 N--CA 1.493 1.693 0 CA-C-O 122.632 1.206 . . . . 0.0 111.34 169.532 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 19.3 tp -94.16 117.99 30.91 Favored 'General case' 0 N--CA 1.489 1.476 0 CA-C-N 114.726 -1.124 . . . . 0.0 110.558 -178.388 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -104.52 81.5 1.8 Allowed 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 123.231 0.612 . . . . 0.0 110.079 175.835 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 78.07 -74.92 1.96 Allowed Glycine 0 N--CA 1.487 2.1 0 CA-C-O 121.473 0.485 . . . . 0.0 113.832 -174.72 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -148.63 53.95 0.52 Allowed Glycine 0 CA--C 1.546 1.99 0 CA-C-N 114.425 -0.887 . . . . 0.0 112.885 167.451 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 38.7 mtmm -145.26 111.68 5.73 Favored 'General case' 0 N--CA 1.484 1.263 0 N-CA-C 106.682 -1.599 . . . . 0.0 106.682 -175.641 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 46.7 mt -82.4 96.35 7.94 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-O 122.757 1.265 . . . . 0.0 109.424 174.248 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 95.5 t -86.81 94.93 4.6 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.342 0 CA-C-N 113.029 -1.896 . . . . 0.0 105.936 -179.651 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 16.8 t-160 -98.89 147.95 24.43 Favored 'General case' 0 CA--C 1.559 1.319 0 C-N-CA 124.612 1.165 . . . . 0.0 109.608 179.209 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.414 HD11 ' HB2' ' A' ' 101' ' ' GLU . 23.2 tp -145.48 119.89 9.65 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 179.571 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 94.4 mt-30 -105.67 122.6 46.38 Favored 'General case' 0 N--CA 1.486 1.325 0 C-N-CA 124.707 1.203 . . . . 0.0 108.341 176.991 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 7.9 mtpm? -125.44 130.69 52.35 Favored 'General case' 0 N--CA 1.494 1.736 0 C-N-CA 123.023 0.529 . . . . 0.0 110.048 -170.779 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 19.2 p90 -153.34 112.85 3.83 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.67 -0.644 . . . . 0.0 110.091 -175.066 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 4.5 t70 51.93 53.73 12.07 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 116.552 2.056 . . . . 0.0 116.552 168.091 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 86.64 -40.66 3.07 Favored Glycine 0 CA--C 1.552 2.344 0 N-CA-C 117.387 1.715 . . . . 0.0 117.387 -171.473 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 19.2 mt-30 -85.31 137.39 33.0 Favored 'General case' 0 N--CA 1.49 1.562 0 CA-C-N 118.316 1.058 . . . . 0.0 111.168 -179.804 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.414 ' HB2' HD11 ' A' ' 94' ' ' LEU . 12.5 pt-20 -143.38 133.13 23.85 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 122.837 0.455 . . . . 0.0 111.727 -179.077 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 14.8 t -116.69 128.67 55.56 Favored 'General case' 0 N--CA 1.494 1.746 0 C-N-CA 123.108 0.563 . . . . 0.0 110.575 175.378 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 40.8 p -91.86 125.6 36.63 Favored 'General case' 0 N--CA 1.494 1.758 0 C-N-CA 122.965 0.506 . . . . 0.0 109.955 170.866 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 5.2 mp -105.63 82.1 1.76 Allowed 'General case' 0 CA--C 1.565 1.53 0 C-N-CA 124.187 0.995 . . . . 0.0 108.384 178.207 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 88.4 t -88.91 106.0 16.39 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 -172.153 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 74.8 mtt85 -97.88 117.53 32.4 Favored 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 123.137 0.575 . . . . 0.0 109.73 179.587 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -137.14 131.11 32.13 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 123.168 0.587 . . . . 0.0 111.185 -171.038 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -80.83 118.1 22.05 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.83 -0.544 . . . . 0.0 111.609 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 46.6 mm -125.47 101.85 9.21 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.28 0 N-CA-C 105.365 -2.087 . . . . 0.0 105.365 178.422 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 59.12 50.24 8.33 Favored 'General case' 0 N--CA 1.5 2.059 0 N-CA-C 115.408 1.633 . . . . 0.0 115.408 174.177 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 65.67 30.48 77.43 Favored Glycine 0 CA--C 1.555 2.556 0 N-CA-C 118.736 2.255 . . . . 0.0 118.736 -170.548 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -136.4 129.41 31.19 Favored 'General case' 0 N--CA 1.489 1.506 0 CA-C-N 118.458 1.129 . . . . 0.0 108.688 -176.914 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 12.2 tp -81.9 114.68 20.67 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 175.53 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 40.6 mm -104.74 100.04 9.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 N-CA-C 106.401 -1.703 . . . . 0.0 106.401 -174.882 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 38.6 tp -89.65 98.34 11.71 Favored 'General case' 0 CA--C 1.559 1.327 0 C-N-CA 123.657 0.783 . . . . 0.0 109.532 178.171 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 87.0 m -91.71 108.51 19.97 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 -178.771 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 87.7 mt -100.86 90.61 4.26 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 123.562 0.745 . . . . 0.0 109.467 -173.84 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 7.9 m -96.12 117.24 30.32 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.636 -0.665 . . . . 0.0 109.289 -173.489 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 83.4 t60 -127.57 91.02 3.22 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 168.99 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 73.1 -101.15 1.09 Allowed Glycine 0 N--CA 1.483 1.819 0 N-CA-C 114.49 0.556 . . . . 0.0 114.49 174.549 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 81.2 m -88.67 -54.52 4.12 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-O 118.486 -0.769 . . . . 0.0 112.045 175.62 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -85.1 106.36 16.51 Favored 'General case' 0 N--CA 1.484 1.246 0 CA-C-N 119.721 1.146 . . . . 0.0 112.256 -171.34 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 5.8 p -98.88 125.78 52.24 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 C-N-CA 123.83 0.852 . . . . 0.0 109.883 176.056 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 40.4 t -107.13 103.77 13.25 Favored 'General case' 0 CA--C 1.553 1.062 0 CA-C-O 121.41 0.624 . . . . 0.0 111.774 179.17 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 60.6 m -88.84 111.69 22.35 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 123.421 0.688 . . . . 0.0 109.187 179.587 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 22.3 mtp180 -106.11 111.86 24.66 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 -178.064 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 95.2 m -89.26 136.3 33.1 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 123.711 0.804 . . . . 0.0 109.98 -179.725 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 65.7 m-85 -132.07 132.68 43.55 Favored 'General case' 0 CA--C 1.56 1.361 0 C-N-CA 123.527 0.731 . . . . 0.0 110.259 -176.296 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -92.79 156.16 17.18 Favored 'General case' 0 N--CA 1.495 1.796 0 CA-C-O 122.249 1.023 . . . . 0.0 111.835 165.084 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 40.3 tttp -86.2 137.9 32.29 Favored 'General case' 0 N--CA 1.487 1.385 0 CA-C-N 115.528 -0.76 . . . . 0.0 112.817 -171.092 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -120.58 57.27 0.97 Allowed 'General case' 0 N--CA 1.494 1.733 0 C-N-CA 123.447 0.699 . . . . 0.0 111.952 171.137 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.437 0 CA-C-O 124.15 1.929 . . . . 0.0 112.444 -179.289 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 4.7 p . . . . . 0 CA--C 1.578 2.046 0 N-CA-C 115.675 1.732 . . . . 0.0 115.675 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -66.01 -48.39 71.3 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 117.231 2.308 . . . . 0.0 117.231 -173.401 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -55.84 -27.73 52.91 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 117.841 2.534 . . . . 0.0 117.841 171.09 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -68.61 -26.53 65.41 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 116.199 1.926 . . . . 0.0 116.199 167.642 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 40.6 mt -76.87 111.88 12.88 Favored 'General case' 0 N--CA 1.49 1.526 0 CA-C-N 120.78 1.627 . . . . 0.0 112.04 -168.768 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 164.63 176.05 35.99 Favored Glycine 0 CA--C 1.541 1.708 0 CA-C-O 122.706 1.17 . . . . 0.0 113.434 -173.938 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 63.3 m -90.0 140.22 29.85 Favored 'General case' 0 N--CA 1.493 1.699 0 CA-C-N 114.238 -0.981 . . . . 0.0 109.046 170.403 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 87.6 m95 -140.89 112.6 7.58 Favored 'General case' 0 N--CA 1.484 1.267 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 -174.044 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 8.6 mtpm? -96.67 146.04 25.23 Favored 'General case' 0 N--CA 1.495 1.789 0 CA-C-O 121.327 0.584 . . . . 0.0 110.273 174.833 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 23.8 tp -66.83 125.62 26.47 Favored 'General case' 0 N--CA 1.488 1.455 0 CA-C-O 121.89 0.853 . . . . 0.0 112.48 -177.062 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . 0.279 1.1 t -99.7 -47.93 11.87 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.795 0 CA-C-N 114.398 -1.274 . . . . 0.0 111.717 176.302 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -139.97 143.2 36.41 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-N 119.571 1.078 . . . . 0.0 109.67 177.528 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 78.5 p -126.09 94.07 3.99 Favored 'General case' 0 N--CA 1.49 1.526 0 CA-C-O 121.306 0.574 . . . . 0.0 110.486 169.067 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 57.5 tttp -83.22 119.49 24.62 Favored 'General case' 0 CA--C 1.557 1.243 0 C-N-CA 123.625 0.77 . . . . 0.0 109.71 175.528 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.259 24.5 m-20 73.45 26.47 1.99 Allowed 'General case' 0 N--CA 1.501 2.122 0 N-CA-C 116.736 2.125 . . . . 0.0 116.736 175.704 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.424 ' HD1' ' HG ' ' A' ' 124' ' ' CYS . 22.5 t80 -89.27 78.67 7.23 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.362 -1.461 . . . . 0.0 110.72 178.503 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -170.44 -58.03 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 125.0 1.32 . . . . 0.0 108.281 -176.576 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 29.0 t0 -54.45 -47.7 72.58 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 115.365 1.617 . . . . 0.0 115.365 166.9 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 92.3 t80 -49.3 -54.73 15.55 Favored 'General case' 0 CA--C 1.573 1.835 0 N-CA-C 115.133 1.531 . . . . 0.0 115.133 167.781 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 74.8 mtm -63.71 -41.17 98.14 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 116.01 1.855 . . . . 0.0 116.01 174.907 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 57.9 tttm -64.92 -43.28 93.34 Favored 'General case' 0 CA--C 1.567 1.626 0 N-CA-C 115.228 1.566 . . . . 0.0 115.228 173.432 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 60.9 m -59.97 -39.91 87.3 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 115.815 1.783 . . . . 0.0 115.815 169.837 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 64.9 mt -64.37 -30.84 71.87 Favored 'General case' 0 CA--C 1.566 1.568 0 N-CA-C 117.41 2.374 . . . . 0.0 117.41 168.587 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 91.32 75.92 1.31 Allowed Glycine 0 N--CA 1.482 1.722 0 CA-C-N 119.211 0.914 . . . . 0.0 111.978 -170.025 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 97.9 t -128.31 81.28 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 N-CA-C 106.643 -1.614 . . . . 0.0 106.643 -177.273 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 31.86 -118.51 0.13 Allowed Glycine 0 CA--C 1.55 2.273 0 N-CA-C 121.018 3.167 . . . . 0.0 121.018 174.361 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 10.7 t80 -148.43 -71.22 0.21 Allowed 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 178.485 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -72.69 -16.99 61.68 Favored 'General case' 0 CA--C 1.567 1.608 0 N-CA-C 116.615 2.08 . . . . 0.0 116.615 177.269 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 30.6 m -68.63 -42.63 77.75 Favored 'General case' 0 N--CA 1.497 1.904 0 CA-C-N 120.3 1.409 . . . . 0.0 113.495 162.76 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 37.1 ttp-105 -55.31 -44.64 75.97 Favored 'General case' 0 CA--C 1.571 1.787 0 N-CA-C 115.138 1.533 . . . . 0.0 115.138 164.64 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 5.9 tm0? -65.78 -52.33 51.74 Favored 'General case' 0 CA--C 1.565 1.547 0 N-CA-C 115.451 1.648 . . . . 0.0 115.451 174.38 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 92.6 t -66.1 -38.32 81.74 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.975 0 N-CA-C 113.583 0.957 . . . . 0.0 113.583 -179.602 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -65.68 -34.59 78.56 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 116.806 2.15 . . . . 0.0 116.806 175.755 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 88.4 p -67.63 -39.55 84.66 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 116.348 1.981 . . . . 0.0 116.348 167.01 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 38.3 ttm -64.65 -40.72 95.94 Favored 'General case' 0 CA--C 1.571 1.756 0 N-CA-C 115.87 1.804 . . . . 0.0 115.87 169.875 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 88.3 m -75.74 153.06 37.27 Favored 'General case' 0 CA--C 1.567 1.61 0 C-N-CA 124.276 1.031 . . . . 0.0 112.597 -177.015 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 64.0 mttp -102.91 100.06 15.66 Favored Pre-proline 0 CA--C 1.572 1.82 0 CA-C-N 115.405 -0.816 . . . . 0.0 109.735 172.268 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -82.36 113.62 2.36 Favored 'Trans proline' 0 CA--C 1.561 1.826 0 C-N-CA 123.36 2.707 . . . . 0.0 112.289 179.737 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 86.7 m -83.95 108.54 16.99 Favored 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 123.509 0.723 . . . . 0.0 110.67 -169.366 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 88.2 m -81.65 116.64 21.48 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 123.492 0.717 . . . . 0.0 109.808 -179.495 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 61.3 mt -115.56 107.87 23.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 N-CA-C 106.122 -1.807 . . . . 0.0 106.122 -176.584 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 22.8 mt -103.05 119.48 51.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 N-CA-C 107.653 -1.239 . . . . 0.0 107.653 -175.995 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -137.62 111.34 8.18 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 -169.889 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 60.4 tttm -86.46 114.56 23.32 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 123.369 0.668 . . . . 0.0 111.015 -179.306 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 33.5 t30 -115.87 82.47 1.77 Allowed 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 -179.481 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 61.23 59.53 9.84 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 116.411 1.324 . . . . 0.0 116.411 -174.876 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . 0.319 15.7 t0 68.92 -14.79 0.28 Allowed 'General case' 0 N--CA 1.498 1.946 0 N-CA-C 117.572 2.434 . . . . 0.0 117.572 -166.372 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 11.2 mm -87.72 98.96 8.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 CA-C-N 120.342 1.428 . . . . 0.0 107.631 -177.292 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 43.9 mt -80.21 107.31 12.9 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 123.523 0.729 . . . . 0.0 110.544 -178.41 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 30.6 m -97.48 94.56 7.09 Favored 'General case' 0 N--CA 1.485 1.292 0 N-CA-C 107.059 -1.46 . . . . 0.0 107.059 -175.059 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 9.7 tt -99.4 102.81 14.51 Favored 'General case' 0 N--CA 1.484 1.255 0 N-CA-C 108.007 -1.108 . . . . 0.0 108.007 -174.515 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 64.0 mttm -105.04 116.82 32.59 Favored 'General case' 0 N--CA 1.486 1.328 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 -173.973 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 89.1 m -100.55 92.05 4.95 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 -175.624 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 8.0 m170 -87.94 96.26 10.43 Favored 'General case' 0 N--CA 1.491 1.59 0 CA-C-O 122.373 1.083 . . . . 0.0 111.862 -169.676 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 28.1 t -96.94 158.35 15.47 Favored 'General case' 0 CA--C 1.561 1.385 0 CA-C-N 114.596 -1.184 . . . . 0.0 111.18 171.729 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 76.7 p -81.45 65.92 6.78 Favored 'General case' 0 N--CA 1.501 2.102 0 CA-C-O 122.297 1.046 . . . . 0.0 111.179 163.762 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 33.3 t80 176.45 -59.8 0.01 OUTLIER 'General case' 0 CA--C 1.57 1.742 0 C-N-CA 126.001 1.72 . . . . 0.0 107.762 -166.558 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 1.5 pptp? -136.42 162.9 31.77 Favored 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 125.008 1.323 . . . . 0.0 111.316 -175.565 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 34.7 p-10 -143.19 87.58 1.97 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.015 -1.053 . . . . 0.0 109.833 164.767 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 41.4 p -86.97 129.94 34.67 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-O 121.402 0.62 . . . . 0.0 111.028 -179.478 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -110.92 129.65 55.81 Favored 'General case' 0 N--CA 1.484 1.24 0 CA-C-N 115.127 -0.942 . . . . 0.0 109.416 178.763 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 41.5 pt -112.48 130.86 65.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 164.906 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 58.0 p -120.73 103.91 9.48 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 108.825 -0.805 . . . . 0.0 108.825 -177.81 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 45.7 p90 -138.8 133.67 32.39 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 114.052 1.131 . . . . 0.0 114.052 -158.829 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 56.4 mtmt -86.73 148.91 25.22 Favored 'General case' 0 CA--C 1.562 1.435 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.534 156.904 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -73.38 116.87 14.45 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.762 -0.586 . . . . 0.0 111.66 -174.602 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 90.69 45.19 4.34 Favored Glycine 0 CA--C 1.548 2.13 0 N-CA-C 116.515 1.366 . . . . 0.0 116.515 -167.352 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 96.3 t -135.4 122.25 34.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 N-CA-C 106.984 -1.487 . . . . 0.0 106.984 177.476 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -88.89 126.7 35.5 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 123.29 0.636 . . . . 0.0 110.386 170.334 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 43.0 p90 -139.62 133.06 30.15 Favored 'General case' 0 N--CA 1.494 1.766 0 C-N-CA 123.38 0.672 . . . . 0.0 111.172 -172.501 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -70.66 118.14 13.08 Favored 'General case' 0 CA--C 1.564 1.494 0 O-C-N 121.621 -0.675 . . . . 0.0 112.343 175.77 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 15.9 tp10 -125.72 136.44 53.19 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 123.775 0.83 . . . . 0.0 109.967 -170.324 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 57.8 m -91.24 123.46 34.7 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 174.461 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 31.7 p -82.48 170.68 14.97 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 113.056 0.762 . . . . 0.0 113.056 -175.695 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -53.28 -30.66 39.75 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 118.665 2.839 . . . . 0.0 118.665 173.078 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -78.7 -85.85 0.07 Allowed 'General case' 0 N--CA 1.489 1.488 0 CA-C-N 119.387 0.994 . . . . 0.0 109.23 168.261 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 179.01 82.86 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 168.634 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 22.0 mtm180 -140.22 124.81 18.05 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.847 -0.533 . . . . 0.0 109.92 -174.889 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.89 116.19 13.1 Favored 'General case' 0 CA--C 1.564 1.482 0 C-N-CA 123.63 0.772 . . . . 0.0 111.121 165.592 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 17.8 m -134.26 129.56 53.54 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 -170.246 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 46.2 mmtm -83.37 104.42 13.51 Favored 'General case' 0 N--CA 1.49 1.526 0 CA-C-O 121.759 0.79 . . . . 0.0 110.152 -178.076 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 75.2 m -101.24 95.86 6.81 Favored 'General case' 0 N--CA 1.484 1.238 0 CA-C-N 115.064 -0.971 . . . . 0.0 110.702 -162.954 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 7.2 tp -103.19 121.58 54.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 179.606 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 1.9 p -142.22 123.44 12.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 C-N-CA 123.171 0.589 . . . . 0.0 109.95 -172.085 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 15.1 t -136.96 159.72 41.03 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-O 122.579 1.18 . . . . 0.0 110.92 178.42 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 14.7 tp -90.54 111.17 22.36 Favored 'General case' 0 CA--C 1.562 1.437 0 CA-C-N 115.084 -0.962 . . . . 0.0 109.505 174.855 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -101.69 88.01 3.3 Favored 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 123.678 0.791 . . . . 0.0 109.793 -179.507 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 58.26 47.43 89.56 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 118.07 1.988 . . . . 0.0 118.07 -177.948 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 74.91 28.0 63.54 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 118.695 2.238 . . . . 0.0 118.695 -168.048 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 21.3 ttmm -134.51 116.7 15.39 Favored 'General case' 0 CA--C 1.552 1.044 0 N-CA-C 106.523 -1.658 . . . . 0.0 106.523 179.782 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 3.8 tt -86.45 97.98 10.77 Favored 'General case' 0 CA--C 1.563 1.475 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 -172.871 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 56.1 t -105.7 109.15 26.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 -165.097 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 23.6 t-160 -110.2 136.36 49.54 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 124.071 0.948 . . . . 0.0 109.905 179.638 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 30.3 tp -130.53 121.22 25.33 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 173.755 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 87.3 mt-30 -108.46 118.11 35.91 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 175.61 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 17.5 ptpt -121.76 134.9 54.93 Favored 'General case' 0 N--CA 1.496 1.849 0 CA-C-N 118.472 0.578 . . . . 0.0 111.933 -172.697 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 18.0 p90 -158.21 109.94 2.25 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 123.465 0.706 . . . . 0.0 109.897 -176.638 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 6.4 t70 53.44 54.11 10.61 Favored 'General case' 0 N--CA 1.501 2.077 0 N-CA-C 116.625 2.083 . . . . 0.0 116.625 164.236 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 87.96 -42.75 3.11 Favored Glycine 0 CA--C 1.552 2.35 0 N-CA-C 116.937 1.535 . . . . 0.0 116.937 -170.71 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 16.6 mt-30 -86.4 131.26 34.24 Favored 'General case' 0 N--CA 1.487 1.404 0 CA-C-N 118.086 0.943 . . . . 0.0 110.84 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -141.79 126.37 17.88 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 122.96 0.504 . . . . 0.0 110.36 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 1.4 t -121.07 124.07 43.89 Favored 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 123.528 0.731 . . . . 0.0 110.302 -175.032 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 40.1 p -97.76 141.96 30.13 Favored 'General case' 0 N--CA 1.492 1.648 0 CA-C-O 121.499 0.666 . . . . 0.0 111.738 179.764 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 5.6 mp -119.75 80.68 1.62 Allowed 'General case' 0 CA--C 1.564 1.494 0 N-CA-C 107.672 -1.233 . . . . 0.0 107.672 175.571 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 95.7 t -90.83 111.16 23.22 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 -172.464 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 83.7 mtt85 -104.63 130.21 52.66 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 123.292 0.637 . . . . 0.0 110.211 -177.383 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -145.94 129.26 16.78 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 123.167 0.587 . . . . 0.0 110.546 -174.095 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -79.71 116.8 20.1 Favored 'General case' 0 N--CA 1.488 1.469 0 CA-C-O 121.273 0.559 . . . . 0.0 111.108 177.117 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 48.9 mm -120.05 100.18 8.91 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.332 0 N-CA-C 105.485 -2.043 . . . . 0.0 105.485 177.72 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 57.38 49.78 12.5 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 114.915 1.45 . . . . 0.0 114.915 174.101 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 89.51 -38.61 3.19 Favored Glycine 0 CA--C 1.553 2.465 0 N-CA-C 117.572 1.789 . . . . 0.0 117.572 -169.019 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 54.0 mttm -82.64 132.79 35.18 Favored 'General case' 0 N--CA 1.488 1.448 0 CA-C-N 118.583 1.192 . . . . 0.0 112.075 -171.192 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 20.8 tp -81.66 112.66 19.05 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 172.68 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 37.6 mm -99.77 102.49 13.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 N-CA-C 106.732 -1.581 . . . . 0.0 106.732 -178.12 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 22.6 tp -90.43 102.73 15.46 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 123.815 0.846 . . . . 0.0 109.22 174.57 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 66.9 m -91.47 112.87 24.96 Favored 'General case' 0 CA--C 1.562 1.432 0 C-N-CA 124.181 0.992 . . . . 0.0 108.354 179.324 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 88.3 mt -104.61 87.34 2.67 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 123.746 0.818 . . . . 0.0 109.985 -171.819 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 9.9 m -103.17 112.51 25.41 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.727 -0.608 . . . . 0.0 109.576 -174.134 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 54.9 t60 -108.74 86.96 2.38 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 164.001 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 71.16 -101.54 0.97 Allowed Glycine 0 N--CA 1.483 1.795 0 N-CA-C 114.416 0.526 . . . . 0.0 114.416 179.461 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 61.2 m -87.19 -51.34 6.04 Favored 'General case' 0 CA--C 1.566 1.595 0 C-N-CA 123.653 0.781 . . . . 0.0 112.678 176.853 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -77.73 107.48 10.26 Favored 'General case' 0 N--CA 1.484 1.274 0 CA-C-N 119.756 1.162 . . . . 0.0 112.886 -173.641 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 4.7 p -107.68 124.18 63.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 C-N-CA 123.954 0.901 . . . . 0.0 110.37 -178.627 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' CYS . . . . . 0.424 ' HG ' ' HD1' ' A' ' 16' ' ' PHE . 2.7 t -101.25 108.57 20.25 Favored 'General case' 0 CA--C 1.556 1.188 0 C-N-CA 123.449 0.699 . . . . 0.0 110.614 173.134 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 53.5 m -89.2 111.06 21.76 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 177.925 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 36.1 mtt180 -108.06 117.23 33.58 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 123.187 0.595 . . . . 0.0 110.874 -179.296 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 86.0 m -88.91 134.34 33.99 Favored 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 123.53 0.732 . . . . 0.0 109.585 172.447 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 48.1 m-85 -128.58 135.62 49.61 Favored 'General case' 0 CA--C 1.559 1.308 0 C-N-CA 123.95 0.9 . . . . 0.0 109.371 179.127 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -100.99 154.0 19.06 Favored 'General case' 0 N--CA 1.493 1.718 0 CA-C-O 122.6 1.191 . . . . 0.0 111.414 167.439 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 36.2 tttp -84.86 125.69 32.84 Favored 'General case' 0 N--CA 1.483 1.218 0 CA-C-N 114.956 -1.02 . . . . 0.0 112.209 -168.367 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 16.7 mm-40 -123.3 50.14 1.6 Allowed 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 124.237 1.015 . . . . 0.0 111.712 -175.158 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 0.811 0 CA-C-O 123.005 1.384 . . . . 0.0 110.639 -161.36 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.32 2.5 t . . . . . 0 N--CA 1.489 1.487 0 CA-C-O 118.051 -0.976 . . . . 0.0 112.995 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -62.12 -36.13 80.84 Favored 'General case' 0 N--CA 1.497 1.881 0 N-CA-C 116.154 1.909 . . . . 0.0 116.154 179.587 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -62.41 -32.32 73.14 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 116.858 2.17 . . . . 0.0 116.858 163.259 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 88.8 m-85 -67.69 -27.62 66.99 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 116.146 1.906 . . . . 0.0 116.146 168.319 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 60.0 mt -72.75 116.42 13.22 Favored 'General case' 0 N--CA 1.49 1.543 0 CA-C-N 121.291 1.86 . . . . 0.0 111.512 -172.953 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 159.48 177.17 32.33 Favored Glycine 0 CA--C 1.541 1.692 0 CA-C-O 122.138 0.854 . . . . 0.0 114.133 -176.091 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 52.3 m -94.61 135.46 36.04 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 174.986 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 92.6 m95 -134.7 113.13 11.37 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 -172.247 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 7.7 mtmp? -98.76 144.21 28.25 Favored 'General case' 0 N--CA 1.489 1.477 0 CA-C-O 121.978 0.894 . . . . 0.0 110.541 175.084 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 51.4 tp -68.71 133.64 48.69 Favored 'General case' 0 N--CA 1.486 1.359 0 CA-C-O 122.283 1.039 . . . . 0.0 112.496 -176.469 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . 0.28 1.1 t -110.74 -43.3 5.2 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.744 0 CA-C-N 113.697 -1.592 . . . . 0.0 111.718 -178.411 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 41.8 t0 -143.78 131.89 21.79 Favored 'General case' 0 N--CA 1.49 1.525 0 CA-C-N 120.102 1.319 . . . . 0.0 109.63 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 86.4 p -112.93 96.83 6.16 Favored 'General case' 0 N--CA 1.492 1.663 0 CA-C-O 121.492 0.663 . . . . 0.0 110.366 171.93 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 43.7 mtmt -96.41 123.32 40.02 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 123.656 0.783 . . . . 0.0 108.92 -179.37 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 59.7 m-20 67.57 23.18 8.95 Favored 'General case' 0 N--CA 1.503 2.208 0 N-CA-C 117.532 2.419 . . . . 0.0 117.532 178.578 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 27.3 t80 -68.22 -51.75 41.9 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 120.155 -1.591 . . . . 0.0 113.981 -178.812 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -47.28 -36.19 8.86 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 117.542 2.423 . . . . 0.0 117.542 165.736 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 33.9 t0 -66.06 -55.49 16.33 Favored 'General case' 0 N--CA 1.499 2.021 0 CA-C-N 120.483 1.492 . . . . 0.0 114.245 172.232 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 71.6 t80 -48.22 -48.01 35.34 Favored 'General case' 0 CA--C 1.573 1.845 0 N-CA-C 116.135 1.902 . . . . 0.0 116.135 167.465 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 51.4 mmm -68.23 -46.03 71.67 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 114.84 1.422 . . . . 0.0 114.84 178.691 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -54.91 -46.34 74.84 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 115.533 1.679 . . . . 0.0 115.533 166.2 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 64.6 m -60.54 -38.55 84.85 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 116.199 1.926 . . . . 0.0 116.199 172.88 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 62.5 mt -63.06 -41.17 99.41 Favored 'General case' 0 CA--C 1.567 1.632 0 N-CA-C 115.78 1.771 . . . . 0.0 115.78 168.337 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 114.39 73.17 0.57 Allowed Glycine 0 N--CA 1.482 1.751 0 C-N-CA 123.899 0.762 . . . . 0.0 111.603 -176.192 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 57.3 t -140.36 121.82 14.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 N-CA-C 106.389 -1.708 . . . . 0.0 106.389 -173.772 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -72.18 170.69 49.68 Favored Glycine 0 CA--C 1.551 2.322 0 N-CA-C 116.414 1.326 . . . . 0.0 116.414 177.235 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . 0.25 33.0 p90 -57.47 -43.23 83.87 Favored 'General case' 0 N--CA 1.497 1.92 0 N-CA-C 118.92 2.933 . . . . 0.0 118.92 -167.515 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.36 -40.62 89.87 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 116.589 2.07 . . . . 0.0 116.589 178.75 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 94.7 m -71.52 -42.02 68.48 Favored 'General case' 0 N--CA 1.498 1.963 0 N-CA-C 113.792 1.034 . . . . 0.0 113.792 168.574 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 38.3 ttp180 -58.53 -38.91 78.75 Favored 'General case' 0 CA--C 1.569 1.708 0 N-CA-C 115.89 1.811 . . . . 0.0 115.89 173.879 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 51.4 mt-30 -81.66 -38.8 25.35 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 115.66 1.726 . . . . 0.0 115.66 176.71 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 46.9 t -73.11 -37.88 53.88 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.254 0 CA-C-N 121.381 1.901 . . . . 0.0 112.664 175.067 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -66.55 -31.37 72.05 Favored 'General case' 0 CA--C 1.567 1.601 0 N-CA-C 117.0 2.222 . . . . 0.0 117.0 170.462 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 85.9 p -67.0 -43.65 82.38 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 115.283 1.586 . . . . 0.0 115.283 164.257 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 49.6 ttm -64.73 -38.73 92.0 Favored 'General case' 0 CA--C 1.567 1.624 0 N-CA-C 116.49 2.033 . . . . 0.0 116.49 176.643 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 13.0 t -69.29 144.94 53.44 Favored 'General case' 0 N--CA 1.492 1.645 0 CA-C-N 119.432 1.014 . . . . 0.0 112.931 -179.417 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -102.69 103.16 30.85 Favored Pre-proline 0 CA--C 1.567 1.603 0 CA-C-O 118.201 -0.904 . . . . 0.0 108.802 176.009 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -72.96 119.78 6.26 Favored 'Trans proline' 0 CA--C 1.559 1.753 0 C-N-CA 123.052 2.501 . . . . 0.0 112.526 -179.244 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 95.7 m -84.58 99.59 10.85 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 179.859 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 86.9 m -97.37 104.53 16.56 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 -165.253 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 68.9 mt -100.5 112.69 33.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 N-CA-C 107.464 -1.31 . . . . 0.0 107.464 -174.45 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 35.8 mt -104.0 117.41 49.49 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 N-CA-C 107.121 -1.437 . . . . 0.0 107.121 179.548 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -141.43 119.42 11.97 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-O 121.078 0.466 . . . . 0.0 109.939 -170.154 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 56.3 tttm -91.84 121.95 33.92 Favored 'General case' 0 CA--C 1.56 1.347 0 C-N-CA 123.748 0.819 . . . . 0.0 111.802 -175.075 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 75.4 m-20 -116.61 92.16 3.79 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 -179.346 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 83.25 -92.95 1.68 Allowed Glycine 0 N--CA 1.486 1.998 0 O-C-N 121.774 -0.579 . . . . 0.0 111.776 -173.347 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -138.49 65.57 1.46 Allowed 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 155.808 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 33.9 mm -136.01 99.88 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 N-CA-C 105.258 -2.127 . . . . 0.0 105.258 -174.73 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 60.4 mt -81.45 102.09 10.31 Favored 'General case' 0 N--CA 1.486 1.342 0 CA-C-O 121.181 0.515 . . . . 0.0 110.482 -179.119 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 28.7 m -98.38 97.92 9.21 Favored 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 107.275 -1.379 . . . . 0.0 107.275 -173.301 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 10.4 tt -98.92 102.16 13.79 Favored 'General case' 0 N--CA 1.485 1.29 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 -177.402 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -98.77 111.5 23.86 Favored 'General case' 0 N--CA 1.484 1.25 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 -174.49 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 52.4 m -91.65 95.91 10.16 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 -179.366 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 23.1 m-70 -87.26 96.42 10.33 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 -176.556 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 37.4 t -127.27 140.95 51.87 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 123.733 0.813 . . . . 0.0 109.96 -169.992 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 71.6 p -83.88 48.52 1.46 Allowed 'General case' 0 N--CA 1.498 1.96 0 N-CA-C 113.883 1.068 . . . . 0.0 113.883 174.553 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 13.3 t80 -159.08 -68.98 0.08 Allowed 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 163.855 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 13.5 ptmm? -125.14 100.52 6.59 Favored 'General case' 0 CA--C 1.56 1.354 0 C-N-CA 123.519 0.727 . . . . 0.0 109.761 179.079 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 9.2 p30 -90.55 124.52 35.09 Favored 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 123.764 0.826 . . . . 0.0 111.008 178.735 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 77.1 p -130.35 132.33 45.77 Favored 'General case' 0 N--CA 1.497 1.901 0 C-N-CA 123.091 0.556 . . . . 0.0 111.174 -169.561 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -117.89 130.55 56.31 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 123.784 0.833 . . . . 0.0 110.009 -176.433 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 39.1 pt -123.66 132.91 70.58 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 C-N-CA 123.456 0.703 . . . . 0.0 109.412 175.773 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 45.9 t -120.99 107.4 12.6 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 -176.669 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 49.0 p90 -136.42 136.73 39.8 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 115.204 1.557 . . . . 0.0 115.204 -159.435 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 50.5 mtmt -103.5 14.67 30.8 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 117.214 2.302 . . . . 0.0 117.214 -173.94 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . 0.295 3.3 mp 62.59 96.9 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.744 0 CA-C-N 120.648 1.567 . . . . 0.0 114.318 177.226 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 87.1 38.68 7.75 Favored Glycine 0 CA--C 1.55 2.28 0 N-CA-C 116.99 1.556 . . . . 0.0 116.99 -170.087 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 86.5 t -138.73 124.22 23.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 N-CA-C 106.839 -1.541 . . . . 0.0 106.839 -179.902 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -87.8 116.26 25.82 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 123.042 0.537 . . . . 0.0 109.961 171.936 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 45.0 p90 -125.43 131.8 52.84 Favored 'General case' 0 N--CA 1.491 1.624 0 C-N-CA 123.912 0.885 . . . . 0.0 109.851 -175.969 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -73.61 110.4 7.86 Favored 'General case' 0 CA--C 1.564 1.507 0 O-C-N 121.411 -0.806 . . . . 0.0 111.889 176.816 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 13.7 tp10 -106.41 132.94 51.84 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 124.115 0.966 . . . . 0.0 109.563 -174.441 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 52.2 m -96.96 117.59 31.49 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 174.255 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 20.3 p -84.9 166.83 16.5 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-O 121.664 0.745 . . . . 0.0 112.101 -174.704 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -67.36 -20.94 65.64 Favored 'General case' 0 CA--C 1.571 1.757 0 N-CA-C 117.677 2.473 . . . . 0.0 117.677 169.446 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -76.68 -0.24 22.84 Favored 'General case' 0 CA--C 1.581 2.137 0 N-CA-C 116.142 1.904 . . . . 0.0 116.142 160.536 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . 0.265 11.1 m-20 71.57 70.07 0.16 Allowed 'General case' 0 N--CA 1.495 1.811 0 C-N-CA 125.349 1.46 . . . . 0.0 111.729 -176.857 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 80.9 mtm180 -141.2 126.72 18.85 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 -175.302 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.57 97.17 8.9 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 123.37 0.668 . . . . 0.0 111.317 172.576 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 10.8 m -113.6 127.33 71.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 C-N-CA 123.165 0.586 . . . . 0.0 109.912 -168.268 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 29.9 mmtp -80.4 103.69 10.44 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 123.507 0.723 . . . . 0.0 110.118 179.632 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 70.8 m -100.21 95.84 7.07 Favored 'General case' 0 N--CA 1.483 1.198 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.947 -165.26 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 7.1 tp -107.71 113.84 44.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 177.35 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -130.4 128.12 63.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 C-N-CA 124.012 0.925 . . . . 0.0 109.129 -176.278 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 10.2 t -140.45 150.08 43.37 Favored 'General case' 0 N--CA 1.488 1.472 0 CA-C-O 122.719 1.247 . . . . 0.0 110.052 175.689 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 19.2 tp -85.07 114.18 22.02 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-N 114.616 -1.175 . . . . 0.0 109.321 176.501 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -101.63 81.09 2.12 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-O 121.239 0.542 . . . . 0.0 110.085 -178.562 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 57.07 45.14 92.74 Favored Glycine 0 N--CA 1.489 2.175 0 N-CA-C 118.016 1.967 . . . . 0.0 118.016 -177.127 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 102.87 -45.15 1.37 Allowed Glycine 0 N--CA 1.491 2.317 0 N-CA-C 116.481 1.352 . . . . 0.0 116.481 -165.993 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 83.6 tttt -81.33 106.81 13.59 Favored 'General case' 0 CA--C 1.559 1.3 0 C-N-CA 123.616 0.767 . . . . 0.0 110.87 -176.767 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 30.4 tp -82.52 114.59 21.03 Favored 'General case' 0 N--CA 1.484 1.232 0 CA-C-O 121.546 0.688 . . . . 0.0 110.948 -177.839 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 48.3 t -113.47 110.21 31.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 N-CA-C 106.72 -1.585 . . . . 0.0 106.72 -168.824 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 23.7 t-160 -106.2 142.46 35.84 Favored 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 124.113 0.965 . . . . 0.0 109.717 174.702 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 30.3 tp -131.74 122.81 26.47 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 174.441 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 81.9 mt-30 -115.41 105.61 13.04 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 176.089 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 71.0 mttt -107.36 135.69 48.43 Favored 'General case' 0 N--CA 1.495 1.782 0 C-N-CA 123.43 0.692 . . . . 0.0 111.656 -177.674 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 18.3 p90 -150.42 111.23 4.29 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 123.346 0.658 . . . . 0.0 109.946 178.926 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 4.8 t70 50.56 57.85 6.16 Favored 'General case' 0 N--CA 1.497 1.894 0 N-CA-C 116.304 1.965 . . . . 0.0 116.304 166.578 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 91.26 -44.8 2.8 Favored Glycine 0 CA--C 1.55 2.267 0 N-CA-C 116.789 1.476 . . . . 0.0 116.789 -171.62 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 19.6 mt-30 -92.34 134.72 34.65 Favored 'General case' 0 N--CA 1.489 1.52 0 CA-C-N 118.234 1.017 . . . . 0.0 111.577 -174.036 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -113.53 157.8 21.56 Favored 'General case' 0 N--CA 1.491 1.62 0 CA-C-O 121.612 0.72 . . . . 0.0 112.028 172.775 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 14.6 t -140.78 120.27 13.19 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 158.604 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 39.9 p -90.62 125.36 35.61 Favored 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 122.661 0.385 . . . . 0.0 110.519 172.15 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 5.5 mp -102.06 80.52 2.0 Allowed 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 177.57 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 71.1 t -88.69 105.71 16.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 -170.941 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 83.8 mtt85 -103.5 123.34 46.71 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 123.536 0.734 . . . . 0.0 109.742 -176.653 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -144.46 131.45 20.41 Favored 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 122.805 0.442 . . . . 0.0 110.974 -172.023 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -81.12 116.0 20.82 Favored 'General case' 0 N--CA 1.487 1.405 0 CA-C-O 121.281 0.562 . . . . 0.0 111.327 -179.131 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 86.1 mt -123.88 107.1 18.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 N-CA-C 104.66 -2.348 . . . . 0.0 104.66 176.518 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 58.4 50.48 9.37 Favored 'General case' 0 N--CA 1.5 2.029 0 N-CA-C 114.945 1.461 . . . . 0.0 114.945 176.925 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 66.91 18.13 68.3 Favored Glycine 0 CA--C 1.554 2.516 0 N-CA-C 119.758 2.663 . . . . 0.0 119.758 -171.833 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 38.8 mtmm -126.78 131.3 51.31 Favored 'General case' 0 N--CA 1.489 1.486 0 CA-C-N 119.981 1.891 . . . . 0.0 109.106 -173.626 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 14.1 tp -79.22 107.59 12.1 Favored 'General case' 0 CA--C 1.558 1.255 0 C-N-CA 123.334 0.654 . . . . 0.0 109.38 178.124 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 33.6 mm -99.54 100.41 10.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 N-CA-C 106.569 -1.641 . . . . 0.0 106.569 -175.255 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 29.8 tp -92.12 99.85 12.58 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 124.16 0.984 . . . . 0.0 109.647 178.234 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 1.8 p -86.84 114.67 23.69 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 123.689 0.796 . . . . 0.0 109.589 171.839 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 85.1 mt -101.96 89.05 3.51 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 123.971 0.908 . . . . 0.0 108.979 -176.36 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 7.6 m -100.4 108.93 21.06 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 108.798 -0.815 . . . . 0.0 108.798 -171.682 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 2.2 t60 -76.86 -63.31 1.38 Allowed 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 122.454 0.301 . . . . 0.0 111.348 167.578 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -165.37 -76.47 0.03 OUTLIER Glycine 0 N--CA 1.479 1.543 0 N-CA-C 109.499 -1.441 . . . . 0.0 109.499 178.699 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 72.9 m -73.28 -54.42 8.45 Favored 'General case' 0 CA--C 1.568 1.668 0 CA-C-O 118.693 -0.67 . . . . 0.0 112.787 169.884 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -97.4 112.62 24.38 Favored 'General case' 0 N--CA 1.483 1.207 0 CA-C-N 119.405 1.002 . . . . 0.0 112.552 -172.505 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 6.0 p -95.91 127.63 47.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 C-N-CA 123.825 0.85 . . . . 0.0 110.058 169.187 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 44.0 t -100.81 108.1 19.81 Favored 'General case' 0 N--CA 1.481 1.102 0 CA-C-O 121.062 0.458 . . . . 0.0 111.261 171.428 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 47.8 m -84.48 112.06 20.04 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 176.413 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 37.6 mtt180 -104.29 116.0 31.39 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 123.259 0.624 . . . . 0.0 110.114 175.045 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 92.9 m -90.09 129.32 36.4 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 173.848 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 58.7 m-85 -124.93 129.67 50.83 Favored 'General case' 0 CA--C 1.559 1.29 0 C-N-CA 123.546 0.738 . . . . 0.0 109.283 179.081 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -94.54 154.28 17.47 Favored 'General case' 0 N--CA 1.494 1.757 0 CA-C-O 122.326 1.06 . . . . 0.0 111.347 167.147 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 70.9 tttt -86.01 116.37 24.19 Favored 'General case' 0 N--CA 1.484 1.25 0 CA-C-N 115.554 -0.748 . . . . 0.0 112.059 -167.904 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 50.2 tp10 -75.03 -40.95 60.19 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 116.666 2.098 . . . . 0.0 116.666 172.88 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.97 0 CA-C-O 124.287 1.994 . . . . 0.0 107.882 173.749 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.251 4.0 p . . . . . 0 CA--C 1.576 1.971 0 N-CA-C 115.18 1.548 . . . . 0.0 115.18 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -77.5 -36.95 52.08 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 115.825 1.787 . . . . 0.0 115.825 -174.345 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -58.3 -24.49 59.75 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 117.714 2.487 . . . . 0.0 117.714 167.054 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -72.46 -19.46 61.56 Favored 'General case' 0 CA--C 1.566 1.566 0 N-CA-C 116.377 1.991 . . . . 0.0 116.377 168.833 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 44.4 mt -81.16 121.74 26.5 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-N 121.228 1.831 . . . . 0.0 111.554 -171.517 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 159.43 -177.23 36.04 Favored Glycine 0 N--CA 1.484 1.88 0 CA-C-O 121.9 0.722 . . . . 0.0 113.583 -179.159 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 63.7 m -92.11 139.79 30.28 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 170.702 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 90.2 m95 -141.19 109.5 5.88 Favored 'General case' 0 N--CA 1.487 1.381 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 -171.391 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 55.8 mttp -100.7 141.52 33.45 Favored 'General case' 0 N--CA 1.49 1.542 0 CA-C-O 121.222 0.534 . . . . 0.0 109.941 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 58.1 tp -68.08 123.01 19.46 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-O 122.178 0.99 . . . . 0.0 112.167 -175.135 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . 0.27 1.0 OUTLIER -103.5 -41.65 7.43 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.751 0 CA-C-N 113.9 -1.5 . . . . 0.0 112.737 -175.337 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -145.85 133.47 20.97 Favored 'General case' 0 N--CA 1.488 1.454 0 CA-C-N 119.922 1.237 . . . . 0.0 108.948 178.1 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 88.7 p -115.54 101.15 8.61 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 122.976 0.51 . . . . 0.0 110.662 175.021 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 59.2 mtpt -87.12 118.33 26.45 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 174.519 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 60.8 m-20 66.55 29.97 8.71 Favored 'General case' 0 N--CA 1.502 2.134 0 N-CA-C 117.173 2.286 . . . . 0.0 117.173 177.069 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.472 ' HB2' ' SG ' ' A' ' 124' ' ' CYS . 18.0 t80 -89.57 69.51 7.85 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 120.235 -1.54 . . . . 0.0 111.857 178.808 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 26.8 m-20 -162.61 -54.22 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 125.684 1.594 . . . . 0.0 108.044 -177.457 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 21.1 t0 -56.61 -45.27 81.56 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 115.422 1.638 . . . . 0.0 115.422 167.387 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 81.6 t80 -51.98 -54.43 29.89 Favored 'General case' 0 CA--C 1.57 1.716 0 N-CA-C 114.787 1.403 . . . . 0.0 114.787 169.849 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 70.4 mtm -63.98 -46.13 85.97 Favored 'General case' 0 N--CA 1.491 1.575 0 N-CA-C 115.539 1.681 . . . . 0.0 115.539 174.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -57.86 -44.99 86.92 Favored 'General case' 0 CA--C 1.57 1.713 0 N-CA-C 115.5 1.667 . . . . 0.0 115.5 173.582 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 23.3 t -61.51 -37.27 83.11 Favored 'General case' 0 CA--C 1.568 1.645 0 N-CA-C 116.367 1.988 . . . . 0.0 116.367 170.275 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 69.2 mt -64.79 -23.31 67.2 Favored 'General case' 0 CA--C 1.568 1.657 0 N-CA-C 117.96 2.578 . . . . 0.0 117.96 169.24 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 99.49 68.61 0.89 Allowed Glycine 0 N--CA 1.482 1.746 0 CA-C-N 119.416 1.007 . . . . 0.0 112.193 -171.156 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 33.8 t -144.95 112.66 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 N-CA-C 104.375 -2.454 . . . . 0.0 104.375 -177.842 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -70.83 -91.99 0.08 OUTLIER Glycine 0 N--CA 1.486 2.015 0 N-CA-C 117.676 1.83 . . . . 0.0 117.676 -160.763 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . 0.279 40.4 p90 -140.07 -60.91 0.53 Allowed 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 112.977 0.732 . . . . 0.0 112.977 -171.328 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.51 -39.91 92.39 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 115.575 1.695 . . . . 0.0 115.575 172.221 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 71.9 m -71.38 -37.44 71.59 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 113.961 1.097 . . . . 0.0 113.961 171.355 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 66.4 ttp85 -62.22 -42.79 99.63 Favored 'General case' 0 CA--C 1.572 1.795 0 N-CA-C 114.961 1.467 . . . . 0.0 114.961 170.117 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 9.5 tm0? -65.31 -49.87 67.83 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 114.497 1.295 . . . . 0.0 114.497 172.061 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 93.5 t -64.87 -36.68 78.29 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.925 0 CA-C-N 119.489 1.041 . . . . 0.0 113.762 177.72 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -64.6 -37.03 86.16 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 116.94 2.2 . . . . 0.0 116.94 172.688 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 96.6 p -67.65 -40.41 84.52 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 115.675 1.732 . . . . 0.0 115.675 165.839 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 48.9 ttp -69.35 -35.69 76.12 Favored 'General case' 0 CA--C 1.567 1.622 0 N-CA-C 116.979 2.214 . . . . 0.0 116.979 176.033 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 8.3 t -63.49 -31.4 72.55 Favored 'General case' 0 N--CA 1.498 1.965 0 N-CA-C 118.488 2.773 . . . . 0.0 118.488 -167.501 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . 0.261 34.2 ttpt 75.25 90.37 0.06 OUTLIER Pre-proline 0 CA--C 1.573 1.833 0 C-N-CA 124.832 1.253 . . . . 0.0 112.128 177.285 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -72.62 125.32 10.49 Favored 'Trans proline' 0 C--N 1.369 1.634 0 C-N-CA 123.292 2.661 . . . . 0.0 114.501 -176.944 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 97.9 m -97.06 92.71 6.19 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 -179.185 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 57.4 m -86.19 110.32 19.51 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 123.12 0.568 . . . . 0.0 110.099 -173.598 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 95.1 mt -101.64 110.31 28.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 N-CA-C 106.811 -1.552 . . . . 0.0 106.811 178.609 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 59.3 mt -100.48 116.19 43.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 -179.143 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 4.5 tm-20 -136.63 110.95 8.44 Favored 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 -171.506 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 81.7 tttt -95.0 113.24 24.92 Favored 'General case' 0 CA--C 1.554 1.126 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 171.848 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 14.6 t-20 -82.2 -58.65 2.86 Favored 'General case' 0 CA--C 1.564 1.511 0 C-N-CA 123.243 0.617 . . . . 0.0 112.478 -178.083 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -132.63 -95.55 0.6 Allowed Glycine 0 N--CA 1.483 1.816 0 N-CA-C 109.18 -1.568 . . . . 0.0 109.18 169.45 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -79.8 -30.9 40.68 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 114.917 1.451 . . . . 0.0 114.917 163.398 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 39.8 mm -77.93 111.85 15.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 CA-C-N 119.311 0.96 . . . . 0.0 109.507 -175.047 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 2.0 mt -78.72 137.95 38.02 Favored 'General case' 0 CA--C 1.561 1.376 0 C-N-CA 123.254 0.622 . . . . 0.0 110.379 160.965 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 10.7 m -133.72 103.43 5.87 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 -177.438 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 9.1 tt -96.7 112.31 24.11 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 107.358 -1.349 . . . . 0.0 107.358 177.095 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 89.4 mttt -112.87 98.88 7.47 Favored 'General case' 0 N--CA 1.485 1.285 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 -164.676 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 28.4 m -87.98 95.14 10.01 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.327 -0.858 . . . . 0.0 109.22 -174.467 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 77.8 m80 -85.03 28.83 0.68 Allowed 'General case' 0 CA--C 1.573 1.84 0 N-CA-C 116.59 2.07 . . . . 0.0 116.59 -173.273 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . 0.271 17.5 m -145.17 -94.24 0.1 Allowed 'General case' 0 CA--C 1.553 1.081 0 N-CA-C 105.29 -2.115 . . . . 0.0 105.29 153.138 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . 0.444 2.9 t 44.88 23.49 0.08 Allowed 'General case' 0 N--CA 1.501 2.095 0 N-CA-C 119.076 2.991 . . . . 0.0 119.076 -170.615 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . 0.33 30.4 t80 85.11 -62.39 0.07 Allowed 'General case' 0 N--CA 1.497 1.905 0 C-N-CA 125.548 1.539 . . . . 0.0 111.972 -168.915 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -119.5 128.23 53.77 Favored 'General case' 0 N--CA 1.485 1.307 0 N-CA-C 106.378 -1.712 . . . . 0.0 106.378 175.846 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 42.9 m-20 -70.7 106.77 3.65 Favored 'General case' 0 N--CA 1.491 1.62 0 CA-C-O 120.997 0.427 . . . . 0.0 111.787 -173.814 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 40.4 p -105.2 133.78 49.4 Favored 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 123.532 0.733 . . . . 0.0 110.448 -174.158 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -122.48 122.14 38.24 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 123.344 0.658 . . . . 0.0 109.367 179.517 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 39.2 pt -93.64 136.26 25.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 C-N-CA 123.174 0.59 . . . . 0.0 109.587 163.927 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 33.0 t -125.02 116.69 22.53 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 173.655 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 41.2 p90 -149.4 148.18 29.16 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 113.837 1.051 . . . . 0.0 113.837 -153.992 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 62.7 mtpt -111.99 18.89 18.38 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 116.959 2.207 . . . . 0.0 116.959 -171.494 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . 0.28 1.5 mp 57.11 83.86 0.1 Allowed 'General case' 0 N--CA 1.495 1.802 0 CA-C-N 120.74 1.609 . . . . 0.0 114.532 177.678 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 98.02 42.9 2.95 Favored Glycine 0 CA--C 1.548 2.146 0 N-CA-C 116.221 1.248 . . . . 0.0 116.221 -171.429 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 70.8 t -145.08 127.72 10.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 N-CA-C 105.752 -1.944 . . . . 0.0 105.752 -178.964 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -87.25 116.72 25.53 Favored 'General case' 0 CA--C 1.566 1.566 0 CA-C-O 121.634 0.731 . . . . 0.0 110.129 173.079 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 25.4 p90 -114.91 -172.83 2.2 Favored 'General case' 0 N--CA 1.494 1.745 0 C-N-CA 124.796 1.238 . . . . 0.0 109.733 171.89 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -117.05 145.13 43.91 Favored 'General case' 0 N--CA 1.487 1.401 0 CA-C-O 123.25 1.5 . . . . 0.0 110.846 168.962 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 52.2 tp10 -129.34 148.15 51.24 Favored 'General case' 0 N--CA 1.488 1.456 0 CA-C-N 112.804 -1.998 . . . . 0.0 109.928 177.319 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 83.4 m -103.85 124.25 48.6 Favored 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 168.433 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 28.4 p -75.64 168.06 20.72 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-O 121.579 0.704 . . . . 0.0 112.851 -176.536 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -59.62 -29.41 67.99 Favored 'General case' 0 CA--C 1.563 1.454 0 N-CA-C 117.827 2.529 . . . . 0.0 117.827 178.748 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 62.5 m-20 -116.11 67.24 0.71 Allowed 'General case' 0 N--CA 1.491 1.625 0 CA-C-N 119.121 0.873 . . . . 0.0 110.491 165.982 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 47.06 72.46 0.24 Allowed 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 117.595 2.442 . . . . 0.0 117.595 164.84 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 63.1 mtm-85 -139.68 123.52 17.55 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 171.037 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -71.32 122.57 20.53 Favored 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 123.1 0.56 . . . . 0.0 110.505 164.3 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 32.8 m -138.92 135.09 42.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 -169.818 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 30.5 mmmt -82.17 101.02 10.17 Favored 'General case' 0 N--CA 1.488 1.434 0 CA-C-O 122.418 1.104 . . . . 0.0 110.224 178.267 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 22.4 p -93.1 107.14 18.99 Favored 'General case' 0 CA--C 1.555 1.164 0 CA-C-N 114.117 -1.401 . . . . 0.0 111.821 -170.637 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -113.33 121.26 65.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 174.424 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 1.1 p -131.76 130.42 61.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 C-N-CA 123.921 0.888 . . . . 0.0 109.598 -178.623 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 9.0 t -145.19 153.66 41.59 Favored 'General case' 0 N--CA 1.486 1.356 0 CA-C-O 122.942 1.353 . . . . 0.0 110.407 179.044 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 44.2 tp -86.42 123.58 31.81 Favored 'General case' 0 CA--C 1.562 1.438 0 CA-C-N 114.402 -1.272 . . . . 0.0 110.333 177.68 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -104.93 76.54 1.26 Allowed 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 123.54 0.736 . . . . 0.0 110.581 176.161 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 75.1 -76.4 1.24 Allowed Glycine 0 N--CA 1.487 2.069 0 N-CA-C 114.246 0.458 . . . . 0.0 114.246 -176.551 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -142.91 45.91 0.88 Allowed Glycine 0 CA--C 1.549 2.165 0 CA-C-N 114.428 -0.886 . . . . 0.0 114.293 167.043 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 56.3 mtpt -138.33 118.71 13.74 Favored 'General case' 0 N--CA 1.484 1.237 0 N-CA-C 105.593 -2.002 . . . . 0.0 105.593 178.115 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 4.4 tt -87.94 100.5 12.94 Favored 'General case' 0 CA--C 1.561 1.366 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 -178.482 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 78.6 t -106.33 102.28 13.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 N-CA-C 107.397 -1.334 . . . . 0.0 107.397 -164.466 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 20.5 t-160 -99.97 144.9 28.48 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 123.842 0.857 . . . . 0.0 110.329 173.942 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 17.8 tp -145.1 125.89 14.32 Favored 'General case' 0 N--CA 1.488 1.426 0 CA-C-O 122.035 0.921 . . . . 0.0 108.551 176.452 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 29.8 mt-30 -113.84 118.38 34.09 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 124.53 1.132 . . . . 0.0 108.615 -177.337 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -116.94 136.59 52.83 Favored 'General case' 0 N--CA 1.495 1.792 0 C-N-CA 123.26 0.624 . . . . 0.0 111.244 -173.351 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 16.7 p90 -153.59 111.02 3.49 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.231 -0.918 . . . . 0.0 110.64 -178.763 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 4.8 t70 55.07 55.0 8.14 Favored 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 116.009 1.855 . . . . 0.0 116.009 166.943 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 86.08 -45.76 3.52 Favored Glycine 0 CA--C 1.552 2.355 0 N-CA-C 116.389 1.316 . . . . 0.0 116.389 -168.951 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 25.4 mt-30 -78.09 149.97 33.81 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 123.547 0.739 . . . . 0.0 112.298 -178.905 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -150.07 150.49 31.8 Favored 'General case' 0 N--CA 1.488 1.451 0 CA-C-O 121.323 0.582 . . . . 0.0 111.735 175.983 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 14.2 t -128.47 124.95 37.44 Favored 'General case' 0 N--CA 1.49 1.56 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.353 170.189 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 36.1 p -85.99 134.19 33.88 Favored 'General case' 0 N--CA 1.492 1.665 0 CA-C-O 121.606 0.717 . . . . 0.0 110.251 168.032 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 5.2 mp -116.74 86.03 2.43 Favored 'General case' 0 CA--C 1.562 1.404 0 N-CA-C 106.727 -1.583 . . . . 0.0 106.727 176.159 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 52.1 t -94.22 100.11 10.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.775 0 N-CA-C 107.742 -1.206 . . . . 0.0 107.742 -170.076 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 20.0 mmt180 -90.0 126.27 35.69 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 123.929 0.891 . . . . 0.0 109.915 178.14 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -150.76 131.15 13.73 Favored 'General case' 0 N--CA 1.494 1.76 0 C-N-CA 122.605 0.362 . . . . 0.0 111.938 -172.016 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -77.69 117.53 19.19 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.5 -0.75 . . . . 0.0 111.403 175.378 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 84.3 mt -125.17 105.6 15.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 N-CA-C 104.764 -2.31 . . . . 0.0 104.764 176.653 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 57.16 53.73 7.53 Favored 'General case' 0 N--CA 1.499 1.978 0 N-CA-C 114.246 1.202 . . . . 0.0 114.246 177.63 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 79.65 -27.45 2.55 Favored Glycine 0 CA--C 1.555 2.574 0 N-CA-C 119.097 2.399 . . . . 0.0 119.097 -169.389 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 38.4 mtmm -102.28 131.61 48.75 Favored 'General case' 0 N--CA 1.486 1.336 0 CA-C-N 119.497 1.648 . . . . 0.0 110.214 -164.16 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 49.0 tp -83.98 114.21 21.54 Favored 'General case' 0 CA--C 1.556 1.195 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.797 -176.2 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 33.3 mm -102.88 108.82 25.11 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 -171.99 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 53.5 tp -89.16 111.06 21.75 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 123.9 0.88 . . . . 0.0 109.298 172.905 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 90.0 m -101.68 110.6 22.62 Favored 'General case' 0 N--CA 1.494 1.725 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 -179.421 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 97.7 mt -104.01 91.18 3.85 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 123.726 0.811 . . . . 0.0 110.227 -172.439 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 7.4 m -107.78 105.4 15.22 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 -175.864 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 16.7 t60 -83.07 -64.3 1.2 Allowed 'General case' 0 N--CA 1.493 1.684 0 C-N-CA 123.176 0.591 . . . . 0.0 111.631 172.3 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -152.2 -89.88 0.07 OUTLIER Glycine 0 N--CA 1.479 1.524 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 174.081 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 12.0 t -92.13 41.16 1.06 Allowed 'General case' 0 CA--C 1.577 1.995 0 N-CA-C 114.369 1.248 . . . . 0.0 114.369 169.825 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -158.86 97.69 1.43 Allowed 'General case' 0 N--CA 1.485 1.278 0 O-C-N 120.874 -1.141 . . . . 0.0 109.45 175.419 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 4.0 p -97.01 120.34 46.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 C-N-CA 123.842 0.857 . . . . 0.0 109.409 172.763 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' CYS . . . . . 0.472 ' SG ' ' HB2' ' A' ' 16' ' ' PHE . 41.4 t -112.03 102.87 11.06 Favored 'General case' 0 CA--C 1.557 1.214 0 CA-C-O 121.448 0.642 . . . . 0.0 110.943 177.966 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 90.5 m -92.43 110.19 21.59 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 123.756 0.822 . . . . 0.0 109.117 -176.367 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 38.4 mtm180 -113.26 121.07 43.32 Favored 'General case' 0 N--CA 1.488 1.475 0 C-N-CA 123.235 0.614 . . . . 0.0 110.912 -170.713 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 89.3 m -87.96 136.3 33.03 Favored 'General case' 0 N--CA 1.492 1.643 0 C-N-CA 123.751 0.82 . . . . 0.0 110.74 179.535 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 45.0 m-85 -130.66 125.98 35.4 Favored 'General case' 0 CA--C 1.56 1.343 0 C-N-CA 123.796 0.838 . . . . 0.0 109.162 -179.185 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -95.55 153.58 17.64 Favored 'General case' 0 N--CA 1.495 1.792 0 CA-C-O 122.239 1.018 . . . . 0.0 111.435 169.891 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 72.2 tttt -85.44 119.34 25.68 Favored 'General case' 0 N--CA 1.485 1.318 0 CA-C-N 115.221 -0.9 . . . . 0.0 111.559 -170.368 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -103.36 45.73 0.95 Allowed 'General case' 0 N--CA 1.492 1.675 0 N-CA-C 113.655 0.984 . . . . 0.0 113.655 176.865 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.02 0 CA-C-O 124.327 2.013 . . . . 0.0 107.841 -178.987 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.258 5.6 p . . . . . 0 CA--C 1.577 1.984 0 N-CA-C 115.993 1.849 . . . . 0.0 115.993 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -66.16 -40.08 90.27 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 116.27 1.952 . . . . 0.0 116.27 -176.343 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -59.53 -29.38 67.85 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 117.442 2.386 . . . . 0.0 117.442 168.687 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -68.26 -24.62 64.91 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 116.243 1.942 . . . . 0.0 116.243 167.728 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 39.3 mt -74.81 120.46 20.38 Favored 'General case' 0 N--CA 1.488 1.456 0 CA-C-N 120.759 1.618 . . . . 0.0 111.476 -174.282 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 162.76 168.95 25.46 Favored Glycine 0 N--CA 1.479 1.531 0 CA-C-O 122.822 1.235 . . . . 0.0 113.471 -173.459 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 78.3 m -86.75 136.42 33.01 Favored 'General case' 0 N--CA 1.49 1.535 0 CA-C-N 114.061 -1.069 . . . . 0.0 108.805 164.949 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 81.4 m95 -140.65 111.69 7.12 Favored 'General case' 0 N--CA 1.484 1.269 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 -174.258 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 8.9 mtpm? -91.97 145.61 24.4 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.866 -0.522 . . . . 0.0 110.278 173.953 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 48.7 tp -68.07 124.44 23.43 Favored 'General case' 0 N--CA 1.488 1.466 0 CA-C-O 121.94 0.876 . . . . 0.0 111.497 179.394 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . 0.279 1.2 t -96.91 -45.84 12.82 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.79 0 CA-C-N 114.313 -1.312 . . . . 0.0 112.032 177.563 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 51.5 t0 -144.19 129.35 18.68 Favored 'General case' 0 N--CA 1.49 1.528 0 CA-C-N 119.989 1.268 . . . . 0.0 109.806 -177.107 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 75.7 p -104.69 102.3 11.89 Favored 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 123.217 0.607 . . . . 0.0 110.57 169.153 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 61.1 mtpt -101.12 111.45 23.67 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 -178.798 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.256 30.8 m-20 71.12 21.14 4.92 Favored 'General case' 0 N--CA 1.505 2.287 0 N-CA-C 117.028 2.232 . . . . 0.0 117.028 -177.46 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 27.1 t80 -67.36 -47.4 70.54 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 119.989 -1.694 . . . . 0.0 114.548 -178.588 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -40.82 -48.57 3.09 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 118.399 2.74 . . . . 0.0 118.399 161.602 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 18.3 t0 -59.54 -52.87 63.69 Favored 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 115.067 1.506 . . . . 0.0 115.067 172.815 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 93.1 t80 -52.16 -50.29 62.1 Favored 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 115.64 1.719 . . . . 0.0 115.64 170.281 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 40.8 mmm -62.49 -51.76 66.18 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 114.804 1.409 . . . . 0.0 114.804 -179.637 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 21.7 tptm -60.36 -37.11 79.69 Favored 'General case' 0 CA--C 1.571 1.759 0 N-CA-C 115.893 1.812 . . . . 0.0 115.893 172.722 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 17.5 t -61.71 -40.07 93.73 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 116.263 1.949 . . . . 0.0 116.263 169.917 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 80.2 mt -62.03 -23.45 66.46 Favored 'General case' 0 CA--C 1.569 1.692 0 N-CA-C 117.828 2.529 . . . . 0.0 117.828 168.216 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 97.71 67.96 0.93 Allowed Glycine 0 N--CA 1.482 1.729 0 CA-C-N 119.074 0.852 . . . . 0.0 112.046 -166.667 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 41.2 t -143.64 109.99 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 N-CA-C 104.348 -2.464 . . . . 0.0 104.348 177.824 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -68.61 168.37 43.14 Favored Glycine 0 CA--C 1.546 2.016 0 N-CA-C 116.174 1.23 . . . . 0.0 116.174 -177.343 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 25.3 p90 -53.07 -38.6 62.64 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 119.127 3.01 . . . . 0.0 119.127 -170.121 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.32 -45.17 81.19 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 116.003 1.853 . . . . 0.0 116.003 176.48 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 56.0 m -72.51 -35.54 68.15 Favored 'General case' 0 N--CA 1.501 2.101 0 N-CA-C 114.045 1.128 . . . . 0.0 114.045 171.196 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 48.2 ttp180 -54.59 -49.3 70.73 Favored 'General case' 0 CA--C 1.569 1.681 0 N-CA-C 115.463 1.653 . . . . 0.0 115.463 169.092 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 24.1 mm100 -74.22 -39.43 63.11 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 115.388 1.625 . . . . 0.0 115.388 176.973 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 73.8 t -61.33 -47.08 95.12 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.03 0 CA-C-N 120.129 1.331 . . . . 0.0 113.135 172.589 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -68.58 -31.9 71.42 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 117.204 2.298 . . . . 0.0 117.204 176.141 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 94.0 p -68.62 -43.6 76.03 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 115.552 1.686 . . . . 0.0 115.552 167.467 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 49.7 ttp -60.33 -41.7 94.1 Favored 'General case' 0 CA--C 1.568 1.666 0 N-CA-C 115.782 1.771 . . . . 0.0 115.782 168.447 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 95.0 m -68.3 136.15 53.01 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 124.141 0.976 . . . . 0.0 110.591 170.668 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 5.3 mptp? -106.69 95.96 13.27 Favored Pre-proline 0 CA--C 1.567 1.621 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 175.401 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -83.22 147.12 12.78 Favored 'Trans proline' 0 C--N 1.372 1.804 0 C-N-CA 122.854 2.37 . . . . 0.0 113.452 -172.234 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 44.9 m -98.41 102.94 14.83 Favored 'General case' 0 CA--C 1.563 1.443 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.586 -169.758 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 79.8 m -80.09 113.4 18.24 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 123.896 0.879 . . . . 0.0 109.744 177.687 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 89.3 mt -115.61 107.69 23.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 N-CA-C 106.024 -1.843 . . . . 0.0 106.024 -175.131 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 4.2 mp -97.68 120.23 46.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 N-CA-C 107.378 -1.341 . . . . 0.0 107.378 174.954 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -134.99 116.2 14.39 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.245 -1.021 . . . . 0.0 108.245 -179.107 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 84.3 tttt -89.02 111.83 22.63 Favored 'General case' 0 CA--C 1.557 1.234 0 C-N-CA 123.175 0.59 . . . . 0.0 110.267 178.04 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 28.3 t30 -99.42 87.91 3.74 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.642 -0.874 . . . . 0.0 108.642 178.729 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 78.82 -96.4 1.43 Allowed Glycine 0 N--CA 1.484 1.869 0 CA-C-N 116.445 -0.343 . . . . 0.0 112.396 -171.817 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 86.4 m-20 -109.22 -17.11 13.92 Favored 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 115.265 1.58 . . . . 0.0 115.265 169.062 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 24.2 mm -93.34 118.46 39.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 CA-C-N 120.512 1.505 . . . . 0.0 109.14 -167.078 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 42.2 mt -84.87 114.33 22.03 Favored 'General case' 0 N--CA 1.486 1.325 0 C-N-CA 123.763 0.825 . . . . 0.0 111.434 179.701 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 87.6 m -102.25 102.29 12.67 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 -178.277 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 8.7 tt -104.15 105.21 15.3 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.307 -0.998 . . . . 0.0 108.307 -179.531 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -108.72 121.48 45.14 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 123.917 0.887 . . . . 0.0 109.565 -178.734 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 91.6 m -101.68 95.11 6.22 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 108.083 -1.081 . . . . 0.0 108.083 179.217 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 17.5 m-70 -81.26 99.79 8.8 Favored 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 123.564 0.745 . . . . 0.0 110.544 -170.312 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 85.6 p -100.09 -24.75 14.51 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 117.198 2.295 . . . . 0.0 117.198 -175.768 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . 0.361 5.9 m 84.61 -40.82 0.06 Allowed 'General case' 0 N--CA 1.506 2.368 0 CA-C-N 120.586 1.539 . . . . 0.0 113.44 -161.667 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 73.4 t80 -62.77 -77.9 0.05 OUTLIER 'General case' 0 CA--C 1.568 1.66 0 C-N-CA 124.487 1.115 . . . . 0.0 111.447 170.956 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 4.1 mppt? -144.31 131.85 21.03 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 167.964 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 54.1 t30 -80.11 113.82 18.56 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 123.179 0.591 . . . . 0.0 110.436 176.906 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 77.5 p -89.26 127.66 35.79 Favored 'General case' 0 N--CA 1.492 1.655 0 C-N-CA 122.855 0.462 . . . . 0.0 110.34 -179.777 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -123.51 122.25 37.74 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 123.584 0.753 . . . . 0.0 109.427 -169.408 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 48.7 pt -116.67 126.63 74.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 169.371 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 77.4 p -116.06 101.76 9.03 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 177.815 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 43.1 p90 -132.86 142.4 48.92 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 114.522 1.304 . . . . 0.0 114.522 -157.561 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 30.6 mtpp -98.23 146.72 25.34 Favored 'General case' 0 N--CA 1.489 1.501 0 CA-C-N 115.132 -0.94 . . . . 0.0 109.789 160.98 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -74.23 113.38 11.37 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 -173.83 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 86.64 45.5 5.47 Favored Glycine 0 CA--C 1.548 2.132 0 N-CA-C 115.848 1.099 . . . . 0.0 115.848 -169.259 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 76.7 t -141.79 121.58 10.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 N-CA-C 106.242 -1.762 . . . . 0.0 106.242 179.663 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -85.69 133.05 34.04 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 123.074 0.55 . . . . 0.0 111.147 175.193 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 52.0 p90 -139.32 149.83 44.67 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 124.006 0.922 . . . . 0.0 111.138 -174.383 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -74.64 133.49 42.14 Favored 'General case' 0 CA--C 1.567 1.607 0 O-C-N 121.234 -0.916 . . . . 0.0 112.703 173.189 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 17.3 tp10 -145.82 136.73 24.5 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 123.362 0.665 . . . . 0.0 110.252 -173.477 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 63.1 m -111.08 128.24 55.81 Favored 'General case' 0 N--CA 1.495 1.791 0 C-N-CA 123.279 0.632 . . . . 0.0 109.545 178.666 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 27.0 p -86.45 164.0 17.23 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 113.195 0.813 . . . . 0.0 113.195 -175.749 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -54.82 -32.17 60.11 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 118.779 2.881 . . . . 0.0 118.779 174.902 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -77.47 -85.44 0.06 Allowed 'General case' 0 N--CA 1.494 1.774 0 CA-C-N 120.416 1.462 . . . . 0.0 109.23 171.299 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -176.67 87.5 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 165.472 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 52.1 mtm-85 -139.95 115.11 9.76 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 -179.844 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -79.83 114.8 19.03 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 123.032 0.533 . . . . 0.0 109.604 166.589 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 13.9 m -125.47 138.76 53.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 CA-C-O 121.365 0.602 . . . . 0.0 110.116 -167.58 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 71.9 mmtt -84.92 107.95 17.32 Favored 'General case' 0 N--CA 1.488 1.426 0 CA-C-O 121.916 0.865 . . . . 0.0 109.179 170.961 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 47.3 t -106.95 100.84 10.31 Favored 'General case' 0 CA--C 1.555 1.144 0 CA-C-N 114.907 -1.042 . . . . 0.0 110.381 -161.403 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 6.4 tp -113.15 115.8 50.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 -176.494 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 1.4 p -134.26 126.93 50.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 C-N-CA 123.618 0.767 . . . . 0.0 109.735 -175.758 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 15.3 t -133.01 157.7 44.57 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-O 122.65 1.214 . . . . 0.0 110.98 176.065 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 14.9 tp -88.5 113.81 24.47 Favored 'General case' 0 N--CA 1.489 1.486 0 CA-C-N 114.833 -1.076 . . . . 0.0 108.505 168.36 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -107.0 87.22 2.46 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 123.322 0.649 . . . . 0.0 109.415 -174.518 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 61.4 48.26 86.15 Favored Glycine 0 CA--C 1.551 2.311 0 N-CA-C 117.262 1.665 . . . . 0.0 117.262 -174.265 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 69.36 26.42 74.58 Favored Glycine 0 CA--C 1.556 2.625 0 N-CA-C 118.662 2.225 . . . . 0.0 118.662 -167.912 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.17 109.87 5.76 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 107.151 -1.426 . . . . 0.0 107.151 -175.77 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 4.6 tt -88.63 106.28 18.22 Favored 'General case' 0 CA--C 1.56 1.343 0 CA-C-O 121.705 0.764 . . . . 0.0 111.249 -162.998 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 83.2 t -103.72 110.71 30.89 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 N-CA-C 107.113 -1.44 . . . . 0.0 107.113 -170.884 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 23.2 t-160 -103.75 138.82 39.83 Favored 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 124.023 0.929 . . . . 0.0 109.554 173.91 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 41.2 tp -132.52 121.1 22.79 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 107.837 -1.172 . . . . 0.0 107.837 173.413 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 29.9 mt-30 -106.51 129.47 54.46 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 124.198 0.999 . . . . 0.0 108.515 172.945 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 46.1 mtpt -129.86 130.31 45.05 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.809 -0.557 . . . . 0.0 110.065 -169.471 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 26.3 p90 -154.46 112.16 3.46 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.384 -0.823 . . . . 0.0 111.193 -175.834 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . 0.341 13.2 t70 66.67 -108.73 0.13 Allowed 'General case' 0 N--CA 1.495 1.781 0 C-N-CA 124.582 1.153 . . . . 0.0 112.457 170.527 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -116.42 44.82 1.38 Allowed Glycine 0 N--CA 1.488 2.163 0 CA-C-N 118.887 0.767 . . . . 0.0 115.007 165.096 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 14.9 mt-30 -152.3 126.52 9.23 Favored 'General case' 0 N--CA 1.484 1.273 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 178.704 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 13.4 mp0 -139.41 130.86 27.0 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 -179.194 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 5.2 t -125.13 134.25 52.51 Favored 'General case' 0 N--CA 1.495 1.805 0 C-N-CA 123.144 0.578 . . . . 0.0 111.569 -178.4 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 57.8 p -95.53 138.64 32.92 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-O 121.596 0.712 . . . . 0.0 111.705 172.144 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 5.9 mp -113.6 82.11 1.63 Allowed 'General case' 0 CA--C 1.563 1.449 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 173.812 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 48.1 t -90.73 112.59 25.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 -169.147 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 83.4 mtt85 -106.13 127.7 53.38 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 123.021 0.528 . . . . 0.0 110.086 -177.383 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 8.7 pm0 -139.62 132.86 29.83 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 123.234 0.614 . . . . 0.0 110.816 -178.665 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -80.19 112.92 17.97 Favored 'General case' 0 N--CA 1.487 1.404 0 CA-C-O 121.355 0.597 . . . . 0.0 110.892 175.792 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 73.2 mt -118.71 107.06 20.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 N-CA-C 104.805 -2.294 . . . . 0.0 104.805 176.486 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 59.3 49.85 8.49 Favored 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 114.692 1.367 . . . . 0.0 114.692 177.962 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 63.32 21.18 64.03 Favored Glycine 0 CA--C 1.555 2.572 0 N-CA-C 119.726 2.65 . . . . 0.0 119.726 -170.629 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 49.0 mtpt -130.95 131.4 44.4 Favored 'General case' 0 N--CA 1.488 1.47 0 CA-C-N 119.713 1.756 . . . . 0.0 108.665 -173.178 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 20.5 tp -81.91 108.53 15.49 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.312 0.645 . . . . 0.0 109.95 -175.155 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 29.8 mm -100.59 103.23 14.53 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 N-CA-C 106.463 -1.681 . . . . 0.0 106.463 -175.872 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 23.9 tp -92.03 98.28 11.46 Favored 'General case' 0 CA--C 1.56 1.328 0 C-N-CA 124.04 0.936 . . . . 0.0 109.47 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 90.8 m -88.12 109.12 19.64 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 124.291 1.036 . . . . 0.0 108.729 178.019 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 90.3 mt -100.29 93.75 5.84 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 124.045 0.938 . . . . 0.0 109.164 -172.449 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 4.7 m -106.41 112.53 25.58 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 -172.291 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 19.9 t60 -100.65 -75.27 0.59 Allowed 'General case' 0 N--CA 1.491 1.591 0 CA-C-O 118.793 -0.623 . . . . 0.0 110.492 172.553 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -142.2 -97.91 0.29 Allowed Glycine 0 N--CA 1.483 1.773 0 N-CA-C 110.558 -1.017 . . . . 0.0 110.558 -178.883 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 8.2 t -89.1 30.78 0.92 Allowed 'General case' 0 N--CA 1.5 2.051 0 N-CA-C 115.498 1.666 . . . . 0.0 115.498 173.468 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -158.44 107.72 2.01 Favored 'General case' 0 N--CA 1.481 1.114 0 O-C-N 121.045 -1.034 . . . . 0.0 108.979 177.351 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 7.5 p -108.56 126.35 65.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 C-N-CA 123.583 0.753 . . . . 0.0 109.827 175.231 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 40.9 t -109.87 106.94 16.71 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 123.003 0.521 . . . . 0.0 111.851 179.033 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 77.5 m -90.18 100.51 13.32 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 178.866 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 33.5 mtm180 -99.41 121.13 40.69 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 123.108 0.563 . . . . 0.0 110.552 -174.667 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 95.7 m -89.78 131.27 35.82 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 123.438 0.695 . . . . 0.0 109.822 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 42.0 m-85 -127.26 131.13 50.61 Favored 'General case' 0 CA--C 1.559 1.297 0 C-N-CA 123.612 0.765 . . . . 0.0 109.587 178.634 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -96.31 150.12 20.92 Favored 'General case' 0 CA--C 1.56 1.358 0 CA-C-O 121.943 0.878 . . . . 0.0 111.457 172.481 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 67.4 tttt -80.77 127.07 32.09 Favored 'General case' 0 N--CA 1.486 1.33 0 CA-C-O 121.642 0.734 . . . . 0.0 112.204 -173.439 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 15.2 mm-40 -125.02 52.3 1.59 Allowed 'General case' 0 CA--C 1.563 1.449 0 C-N-CA 124.253 1.021 . . . . 0.0 111.252 -173.438 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.968 0 CA-C-O 123.057 1.408 . . . . 0.0 109.989 -163.688 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 79.0 t . . . . . 0 CA--C 1.559 1.3 0 N-CA-C 106.605 -1.628 . . . . 0.0 106.605 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -145.45 -53.36 0.28 Allowed 'General case' 0 N--CA 1.494 1.749 0 C-N-CA 123.9 0.88 . . . . 0.0 111.242 -175.373 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -57.8 -27.43 63.11 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 117.066 2.247 . . . . 0.0 117.066 161.571 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -63.8 -20.52 65.85 Favored 'General case' 0 CA--C 1.568 1.659 0 N-CA-C 117.209 2.3 . . . . 0.0 117.209 165.189 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 64.7 mt -82.45 120.16 25.11 Favored 'General case' 0 N--CA 1.487 1.425 0 CA-C-N 121.034 1.743 . . . . 0.0 111.361 -169.239 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 155.99 173.25 24.36 Favored Glycine 0 CA--C 1.543 1.83 0 CA-C-O 122.542 1.079 . . . . 0.0 113.013 -171.734 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 76.9 m -85.73 140.75 30.24 Favored 'General case' 0 N--CA 1.492 1.673 0 CA-C-N 114.548 -0.826 . . . . 0.0 109.475 168.21 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 88.7 m95 -140.68 112.86 7.82 Favored 'General case' 0 N--CA 1.485 1.319 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 -174.034 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 51.2 mtpt -99.11 147.86 24.65 Favored 'General case' 0 N--CA 1.494 1.74 0 CA-C-O 121.548 0.689 . . . . 0.0 110.702 177.069 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 61.8 tp -69.87 131.67 44.82 Favored 'General case' 0 N--CA 1.488 1.475 0 CA-C-O 121.847 0.832 . . . . 0.0 112.856 -175.586 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . 0.271 0.9 OUTLIER -116.7 -39.27 2.4 Favored 'Isoleucine or valine' 0 CA--C 1.576 1.971 0 CA-C-N 114.335 -1.302 . . . . 0.0 112.434 -176.87 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -136.22 132.63 36.13 Favored 'General case' 0 N--CA 1.491 1.618 0 CA-C-N 120.513 1.506 . . . . 0.0 109.474 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 83.5 p -128.52 90.41 3.06 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-O 121.5 0.667 . . . . 0.0 111.031 176.509 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -100.56 124.25 45.88 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 123.569 0.748 . . . . 0.0 109.26 177.827 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.267 57.2 m-20 71.33 16.13 6.17 Favored 'General case' 0 N--CA 1.506 2.367 0 N-CA-C 117.677 2.473 . . . . 0.0 117.677 177.788 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 20.4 t80 -70.41 -40.08 74.06 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 115.77 1.767 . . . . 0.0 115.77 -176.371 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -63.86 -29.5 70.68 Favored 'General case' 0 N--CA 1.499 1.995 0 N-CA-C 116.053 1.872 . . . . 0.0 116.053 170.55 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 27.8 t0 -64.45 -49.21 72.37 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 114.527 1.306 . . . . 0.0 114.527 165.329 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 90.9 t80 -52.45 -52.85 51.96 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 115.311 1.597 . . . . 0.0 115.311 172.203 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 77.9 mtm -62.02 -41.3 97.95 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 115.295 1.591 . . . . 0.0 115.295 175.053 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.4 tmtp? -58.77 -44.75 90.73 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 115.276 1.584 . . . . 0.0 115.276 168.818 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 49.3 m -58.72 -38.24 77.91 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 116.332 1.975 . . . . 0.0 116.332 172.009 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 80.3 mt -65.79 -41.38 92.01 Favored 'General case' 0 CA--C 1.567 1.6 0 N-CA-C 116.368 1.988 . . . . 0.0 116.368 169.516 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 113.7 76.33 0.72 Allowed Glycine 0 N--CA 1.483 1.778 0 N-CA-C 111.055 -0.818 . . . . 0.0 111.055 -171.467 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 67.5 t -141.98 123.04 12.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 N-CA-C 105.512 -2.032 . . . . 0.0 105.512 -175.445 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -69.41 160.29 52.83 Favored Glycine 0 CA--C 1.548 2.119 0 N-CA-C 115.948 1.139 . . . . 0.0 115.948 179.143 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 28.7 p90 -54.57 -41.25 69.62 Favored 'General case' 0 N--CA 1.498 1.95 0 N-CA-C 118.726 2.861 . . . . 0.0 118.726 -171.091 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.59 -43.31 94.22 Favored 'General case' 0 CA--C 1.564 1.499 0 N-CA-C 115.594 1.702 . . . . 0.0 115.594 173.769 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 58.7 m -67.28 -35.11 78.81 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 114.53 1.308 . . . . 0.0 114.53 170.064 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 58.1 mtm180 -58.36 -48.48 80.45 Favored 'General case' 0 N--CA 1.493 1.718 0 CA-C-N 120.407 1.458 . . . . 0.0 114.911 168.398 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 37.2 mm-40 -68.57 -39.79 80.86 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 115.455 1.65 . . . . 0.0 115.455 177.565 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 74.6 t -60.97 -47.84 91.74 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.019 0 CA-C-N 119.656 1.117 . . . . 0.0 113.103 169.622 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -67.74 -39.19 84.27 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 117.032 2.234 . . . . 0.0 117.032 178.544 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 87.8 p -65.52 -39.11 91.43 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 116.175 1.917 . . . . 0.0 116.175 168.53 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 54.7 tpp -66.87 -40.82 87.95 Favored 'General case' 0 CA--C 1.566 1.589 0 N-CA-C 115.997 1.851 . . . . 0.0 115.997 173.636 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 5.8 t -75.37 161.93 28.83 Favored 'General case' 0 N--CA 1.493 1.682 0 CA-C-N 119.428 1.013 . . . . 0.0 112.846 179.211 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 3.5 mtmt -99.28 104.0 23.9 Favored Pre-proline 0 CA--C 1.568 1.649 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 170.706 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -77.93 90.92 1.22 Allowed 'Trans proline' 0 CA--C 1.56 1.782 0 C-N-CA 123.165 2.577 . . . . 0.0 111.155 178.414 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 52.0 m -79.49 109.24 13.67 Favored 'General case' 0 N--CA 1.488 1.43 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.258 -161.216 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 90.7 m -83.59 116.61 22.68 Favored 'General case' 0 CA--C 1.56 1.349 0 C-N-CA 123.541 0.737 . . . . 0.0 109.468 -174.336 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 73.7 mt -113.16 106.99 21.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 N-CA-C 105.805 -1.924 . . . . 0.0 105.805 179.02 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 20.6 mt -100.58 120.91 50.7 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 -177.512 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -136.35 111.82 9.25 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 -170.886 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 82.1 tttt -91.28 115.7 28.24 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 123.309 0.644 . . . . 0.0 110.789 -177.969 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 32.8 t30 -116.04 80.87 1.51 Allowed 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 178.821 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 62.91 59.77 8.64 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 116.209 1.244 . . . . 0.0 116.209 -173.902 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . 0.324 3.9 t70 71.25 -20.15 0.23 Allowed 'General case' 0 N--CA 1.499 2.021 0 N-CA-C 117.415 2.376 . . . . 0.0 117.415 -167.506 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 11.0 mm -82.3 102.73 8.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 CA-C-N 120.19 1.359 . . . . 0.0 107.906 -175.982 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 45.7 mt -89.0 104.98 17.49 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 123.146 0.578 . . . . 0.0 110.268 -174.069 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 64.1 m -92.19 95.27 9.64 Favored 'General case' 0 N--CA 1.484 1.272 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 -177.714 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 9.8 tt -99.57 101.77 13.08 Favored 'General case' 0 N--CA 1.484 1.234 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 -175.287 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -100.22 108.2 20.24 Favored 'General case' 0 N--CA 1.485 1.303 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 -175.826 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 89.2 m -94.64 99.5 11.61 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 -179.534 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 29.2 m170 -86.97 91.88 8.84 Favored 'General case' 0 N--CA 1.491 1.581 0 CA-C-O 121.578 0.704 . . . . 0.0 111.271 -172.221 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 25.2 t -101.67 153.85 19.4 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 124.003 0.921 . . . . 0.0 110.783 177.447 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 27.6 m -82.77 67.7 8.94 Favored 'General case' 0 N--CA 1.499 1.988 0 CA-C-O 122.081 0.943 . . . . 0.0 110.5 170.497 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 83.6 t80 -167.61 -81.18 0.02 OUTLIER 'General case' 0 CA--C 1.563 1.46 0 N-CA-C 104.755 -2.313 . . . . 0.0 104.755 -178.226 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 61.4 mtpt -147.83 123.82 10.71 Favored 'General case' 0 N--CA 1.486 1.342 0 N-CA-C 106.531 -1.655 . . . . 0.0 106.531 174.995 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -82.42 119.05 23.69 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.905 -0.497 . . . . 0.0 112.087 -179.748 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 82.7 p -91.81 128.83 37.8 Favored 'General case' 0 N--CA 1.493 1.715 0 C-N-CA 122.837 0.455 . . . . 0.0 110.871 -176.905 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -117.77 117.08 28.34 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 -179.782 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 37.9 pt -112.11 131.57 63.19 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 174.124 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 79.7 p -116.81 101.88 8.93 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 -179.853 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 46.6 p90 -130.85 133.11 45.64 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 114.137 1.162 . . . . 0.0 114.137 -161.167 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 30.8 mtpp -88.71 145.05 25.87 Favored 'General case' 0 CA--C 1.561 1.379 0 CA-C-N 114.883 -1.053 . . . . 0.0 109.625 161.299 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -74.79 117.7 16.92 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.831 -0.543 . . . . 0.0 111.882 -173.141 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 86.13 44.07 6.09 Favored Glycine 0 CA--C 1.549 2.157 0 N-CA-C 116.457 1.343 . . . . 0.0 116.457 -168.83 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 98.8 t -140.15 121.14 14.55 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 N-CA-C 106.332 -1.729 . . . . 0.0 106.332 179.767 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -86.09 128.73 34.93 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 123.072 0.549 . . . . 0.0 111.045 176.207 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 47.9 p90 -133.77 128.59 35.14 Favored 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 123.619 0.768 . . . . 0.0 110.475 -174.248 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -71.1 117.43 12.6 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.411 -0.806 . . . . 0.0 112.206 175.207 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 15.7 tp10 -124.38 133.63 53.36 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 123.435 0.694 . . . . 0.0 110.616 -168.349 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 61.0 m -95.24 123.4 38.72 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 172.277 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 43.1 p -85.67 172.99 10.44 Favored 'General case' 0 CA--C 1.568 1.662 0 CA-C-O 121.854 0.835 . . . . 0.0 112.758 -173.813 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -60.76 -35.24 75.9 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 117.344 2.35 . . . . 0.0 117.344 165.739 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -98.09 82.08 2.91 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 106.376 -1.713 . . . . 0.0 106.376 166.293 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -39.35 108.95 0.09 Allowed 'General case' 0 N--CA 1.497 1.881 0 N-CA-C 117.747 2.499 . . . . 0.0 117.747 -155.169 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 39.6 ttm-85 -149.04 126.59 11.64 Favored 'General case' 0 N--CA 1.487 1.389 0 CA-C-N 114.878 -1.055 . . . . 0.0 108.493 -167.727 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.44 117.87 15.71 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 170.58 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 13.6 m -135.57 125.7 42.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 -174.081 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 30.9 mmtp -82.35 103.47 11.94 Favored 'General case' 0 N--CA 1.489 1.476 0 CA-C-O 121.894 0.854 . . . . 0.0 109.472 179.116 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 44.5 t -103.56 100.16 9.99 Favored 'General case' 0 CA--C 1.554 1.119 0 CA-C-N 115.012 -0.994 . . . . 0.0 110.718 -160.677 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 6.5 tp -109.46 120.35 60.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 -178.045 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 1.6 p -139.99 123.64 18.16 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 -173.354 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 14.3 t -133.56 160.35 37.74 Favored 'General case' 0 N--CA 1.487 1.42 0 CA-C-O 122.978 1.371 . . . . 0.0 111.254 179.647 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 63.8 tp -88.64 107.86 19.15 Favored 'General case' 0 N--CA 1.487 1.424 0 CA-C-N 114.44 -1.254 . . . . 0.0 108.523 170.873 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -108.19 87.62 2.54 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 123.377 0.671 . . . . 0.0 109.351 -171.609 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 56.54 49.43 69.58 Favored Glycine 0 CA--C 1.548 2.14 0 N-CA-C 117.614 1.805 . . . . 0.0 117.614 -177.89 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 102.26 -45.85 1.32 Allowed Glycine 0 N--CA 1.488 2.136 0 N-CA-C 116.852 1.501 . . . . 0.0 116.852 -168.43 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 36.0 ttpt -90.01 130.4 36.21 Favored 'General case' 0 CA--C 1.556 1.175 0 CA-C-N 117.419 0.609 . . . . 0.0 111.704 -169.111 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 4.7 tt -84.53 103.57 13.78 Favored 'General case' 0 CA--C 1.563 1.455 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 178.985 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 78.8 t -109.65 111.62 36.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 -167.805 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 21.1 t-160 -113.11 125.32 54.24 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 124.416 1.086 . . . . 0.0 109.22 -177.241 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 25.8 tp -122.45 121.81 37.48 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 107.799 -1.185 . . . . 0.0 107.799 175.167 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 93.1 mt-30 -107.69 126.03 52.09 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 171.867 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 10.2 ptpp? -126.88 139.34 53.15 Favored 'General case' 0 N--CA 1.494 1.75 0 CA-C-O 121.343 0.592 . . . . 0.0 112.193 -176.686 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 26.6 p90 -157.57 110.25 2.44 Favored 'General case' 0 N--CA 1.488 1.475 0 C-N-CA 123.781 0.832 . . . . 0.0 108.953 -173.657 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 3.8 t70 54.52 50.69 15.51 Favored 'General case' 0 N--CA 1.499 1.977 0 N-CA-C 116.382 1.993 . . . . 0.0 116.382 167.346 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 86.08 -40.67 3.05 Favored Glycine 0 CA--C 1.554 2.478 0 N-CA-C 117.372 1.709 . . . . 0.0 117.372 -169.495 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 57.6 mt-30 -80.37 136.12 36.32 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 123.921 0.888 . . . . 0.0 111.138 179.727 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -145.61 130.23 17.96 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.827 -0.546 . . . . 0.0 111.442 178.892 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 7.7 t -114.23 134.57 54.83 Favored 'General case' 0 N--CA 1.494 1.74 0 C-N-CA 123.22 0.608 . . . . 0.0 111.009 175.725 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 39.3 p -103.53 129.11 50.67 Favored 'General case' 0 N--CA 1.49 1.575 0 CA-C-O 121.615 0.722 . . . . 0.0 110.885 173.222 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 5.6 mp -106.67 80.72 1.49 Allowed 'General case' 0 CA--C 1.565 1.554 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 176.333 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 67.9 t -88.8 108.21 18.68 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 N-CA-C 108.272 -1.011 . . . . 0.0 108.272 -169.322 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 80.1 mtt85 -100.93 125.66 47.52 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 123.265 0.626 . . . . 0.0 110.352 -177.6 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -143.26 133.6 24.67 Favored 'General case' 0 N--CA 1.491 1.606 0 C-N-CA 123.308 0.643 . . . . 0.0 111.157 -176.042 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -81.33 117.82 22.12 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.66 -0.65 . . . . 0.0 111.356 177.232 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 46.9 mm -120.83 104.9 15.94 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.374 0 N-CA-C 105.115 -2.18 . . . . 0.0 105.115 174.931 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 22.2 m-20 58.93 50.37 8.51 Favored 'General case' 0 N--CA 1.499 2.02 0 N-CA-C 115.101 1.519 . . . . 0.0 115.101 175.414 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 63.76 27.45 71.13 Favored Glycine 0 CA--C 1.555 2.566 0 N-CA-C 119.242 2.457 . . . . 0.0 119.242 -170.581 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -135.87 127.13 28.26 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-N 119.002 1.401 . . . . 0.0 108.339 -174.997 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 19.1 tp -78.4 111.46 14.44 Favored 'General case' 0 CA--C 1.559 1.312 0 C-N-CA 123.474 0.709 . . . . 0.0 110.374 -179.215 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 30.4 mm -98.89 100.85 11.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 -177.075 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 30.3 tp -91.5 104.48 16.98 Favored 'General case' 0 CA--C 1.559 1.305 0 C-N-CA 123.85 0.86 . . . . 0.0 109.276 177.65 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 85.5 m -97.42 114.62 26.48 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 124.083 0.953 . . . . 0.0 108.621 -177.161 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 85.2 mt -110.79 96.66 6.31 Favored 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 123.63 0.772 . . . . 0.0 109.375 -168.001 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 11.1 m -105.85 117.14 33.26 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.947 -0.471 . . . . 0.0 109.89 -171.993 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 53.9 t60 -156.4 122.16 4.88 Favored 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 123.157 0.583 . . . . 0.0 109.53 171.566 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 61.71 64.92 3.57 Favored Glycine 0 N--CA 1.488 2.143 0 N-CA-C 117.237 1.655 . . . . 0.0 117.237 165.605 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . 0.391 5.2 t 46.57 39.86 7.48 Favored 'General case' 0 N--CA 1.5 2.049 0 N-CA-C 117.624 2.453 . . . . 0.0 117.624 -169.041 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -153.14 88.57 1.32 Allowed 'General case' 0 N--CA 1.483 1.203 0 O-C-N 121.531 -0.731 . . . . 0.0 109.276 -176.924 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 4.5 p -92.9 119.77 41.14 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.401 0 C-N-CA 123.508 0.723 . . . . 0.0 109.582 173.771 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 42.2 t -110.31 100.76 9.58 Favored 'General case' 0 CA--C 1.551 1.014 0 CA-C-O 121.594 0.712 . . . . 0.0 110.25 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 87.6 m -90.74 106.24 18.37 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 -177.287 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 39.4 mtm180 -112.22 121.67 45.57 Favored 'General case' 0 N--CA 1.487 1.375 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.59 -169.881 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 89.8 m -85.02 136.61 33.51 Favored 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 123.35 0.66 . . . . 0.0 110.033 177.16 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 40.7 m-85 -129.73 126.11 37.46 Favored 'General case' 0 CA--C 1.558 1.259 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 177.308 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -92.62 152.12 19.75 Favored 'General case' 0 N--CA 1.494 1.726 0 CA-C-O 121.943 0.878 . . . . 0.0 111.82 173.23 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 71.2 tttt -83.03 121.58 27.2 Favored 'General case' 0 N--CA 1.486 1.364 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.926 -169.255 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -119.92 51.2 1.2 Allowed 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 124.283 1.033 . . . . 0.0 111.525 -174.302 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 0.829 0 CA-C-O 124.448 2.071 . . . . 0.0 109.882 -161.269 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.297 42.6 t . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 117.257 -1.354 . . . . 0.0 112.982 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -56.68 -41.3 77.07 Favored 'General case' 0 N--CA 1.499 1.995 0 N-CA-C 116.282 1.956 . . . . 0.0 116.282 178.648 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -61.38 -33.88 74.4 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 116.766 2.136 . . . . 0.0 116.766 164.697 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -70.96 -22.67 62.18 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 116.273 1.953 . . . . 0.0 116.273 169.945 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 82.6 mt -70.84 118.03 13.1 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-N 121.26 1.845 . . . . 0.0 111.476 -175.817 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 154.53 172.3 22.24 Favored Glycine 0 CA--C 1.54 1.632 0 CA-C-O 122.661 1.145 . . . . 0.0 112.941 -176.736 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 45.9 m -87.59 142.54 27.77 Favored 'General case' 0 N--CA 1.489 1.504 0 CA-C-N 114.555 -0.822 . . . . 0.0 109.095 172.624 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 92.1 m95 -136.43 110.73 8.43 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 -173.761 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 39.8 mttp -94.31 142.85 26.94 Favored 'General case' 0 N--CA 1.489 1.478 0 CA-C-O 121.612 0.72 . . . . 0.0 110.73 174.318 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 14.2 tp -70.1 123.55 21.89 Favored 'General case' 0 N--CA 1.487 1.393 0 CA-C-O 122.218 1.008 . . . . 0.0 111.806 -176.859 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . 0.286 1.1 t -96.02 -47.98 12.79 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.741 0 CA-C-N 113.711 -1.586 . . . . 0.0 111.661 175.875 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -142.38 145.38 33.8 Favored 'General case' 0 N--CA 1.49 1.536 0 CA-C-N 119.859 1.209 . . . . 0.0 110.099 176.865 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 88.0 p -121.94 100.87 7.22 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.75 -0.594 . . . . 0.0 110.075 170.979 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -89.23 119.56 29.82 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 36.7 m-20 67.47 30.83 6.62 Favored 'General case' 0 N--CA 1.5 2.046 0 N-CA-C 116.515 2.042 . . . . 0.0 116.515 178.163 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.431 ' HB2' ' SG ' ' A' ' 124' ' ' CYS . 31.1 t80 -90.4 69.56 6.95 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 120.236 -1.54 . . . . 0.0 111.955 -179.859 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -159.72 -52.32 0.06 Allowed 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 125.434 1.494 . . . . 0.0 108.689 179.106 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 22.0 t0 -53.81 -41.27 67.14 Favored 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 116.034 1.864 . . . . 0.0 116.034 164.771 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 81.6 t80 -55.03 -53.17 59.22 Favored 'General case' 0 CA--C 1.571 1.754 0 N-CA-C 114.536 1.31 . . . . 0.0 114.536 169.769 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 73.8 mtm -62.83 -38.53 91.14 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 115.879 1.807 . . . . 0.0 115.879 171.957 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 57.1 mtpt -58.23 -51.2 70.76 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 115.596 1.702 . . . . 0.0 115.596 168.539 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 21.3 t -62.95 -34.58 77.79 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 116.221 1.934 . . . . 0.0 116.221 174.44 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 68.1 mt -66.41 -39.95 89.29 Favored 'General case' 0 CA--C 1.565 1.545 0 N-CA-C 116.084 1.883 . . . . 0.0 116.084 168.364 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 105.46 78.47 1.2 Allowed Glycine 0 CA--C 1.54 1.649 0 CA-C-N 118.807 0.73 . . . . 0.0 111.474 -172.184 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 58.1 t -138.02 123.27 24.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 N-CA-C 105.752 -1.944 . . . . 0.0 105.752 -179.5 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -82.4 -157.93 22.58 Favored Glycine 0 CA--C 1.547 2.087 0 N-CA-C 115.965 1.146 . . . . 0.0 115.965 -177.926 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 8.6 p90 -69.39 156.61 38.54 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 113.319 0.859 . . . . 0.0 113.319 178.951 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . 0.317 . . 76.6 -50.1 0.57 Allowed 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 115.647 1.721 . . . . 0.0 115.647 179.616 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 30.4 m -70.98 -36.11 72.37 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 113.903 1.075 . . . . 0.0 113.903 170.322 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 27.8 mtm180 -57.18 -46.88 82.43 Favored 'General case' 0 N--CA 1.499 1.987 0 CA-C-N 120.819 1.645 . . . . 0.0 114.472 162.409 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 3.4 tm0? -66.3 -49.77 65.91 Favored 'General case' 0 CA--C 1.562 1.434 0 N-CA-C 114.756 1.391 . . . . 0.0 114.756 -178.864 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 95.6 t -65.69 -40.12 86.93 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 CA-C-N 119.42 1.009 . . . . 0.0 113.426 175.146 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -66.26 -39.91 89.79 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 116.383 1.994 . . . . 0.0 116.383 176.368 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 92.8 p -63.78 -40.72 97.34 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 116.144 1.905 . . . . 0.0 116.144 165.794 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 17.9 ttm -60.71 -47.16 87.52 Favored 'General case' 0 CA--C 1.568 1.653 0 N-CA-C 115.861 1.8 . . . . 0.0 115.861 171.752 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 5.4 t -78.79 158.26 28.25 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 113.511 0.93 . . . . 0.0 113.511 -166.302 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 14.1 mptt -102.34 101.69 21.01 Favored Pre-proline 0 CA--C 1.57 1.728 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 175.091 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -77.76 100.39 1.38 Allowed 'Trans proline' 0 CA--C 1.561 1.848 0 C-N-CA 123.027 2.485 . . . . 0.0 111.562 -177.198 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 80.9 m -83.55 102.72 12.34 Favored 'General case' 0 N--CA 1.489 1.486 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.808 -164.995 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 32.3 m -97.31 112.75 24.43 Favored 'General case' 0 N--CA 1.485 1.279 0 CA-C-O 120.63 0.252 . . . . 0.0 111.243 -167.898 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 5.2 mp -91.07 107.16 18.34 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.454 0 N-CA-C 107.103 -1.443 . . . . 0.0 107.103 170.774 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.413 HD11 HH11 ' A' ' 106' ' ' ARG . 44.9 mt -90.75 123.3 42.85 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 N-CA-C 106.762 -1.57 . . . . 0.0 106.762 167.372 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 15.0 tt0 -134.05 179.54 6.19 Favored 'General case' 0 CA--C 1.567 1.597 0 CA-C-O 121.817 0.817 . . . . 0.0 109.659 -175.233 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.49 157.77 45.83 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-O 122.515 1.15 . . . . 0.0 112.7 -178.865 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 33.2 t30 -150.62 82.59 1.35 Allowed 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 106.257 -1.757 . . . . 0.0 106.257 167.739 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 76.23 -107.96 2.46 Favored Glycine 0 CA--C 1.547 2.072 0 N-CA-C 111.944 -0.462 . . . . 0.0 111.944 -165.15 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -122.68 61.15 1.0 Allowed 'General case' 0 N--CA 1.493 1.696 0 CA-C-O 121.133 0.492 . . . . 0.0 109.9 159.279 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 39.4 mm -124.84 94.86 2.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 N-CA-C 103.368 -2.827 . . . . 0.0 103.368 172.04 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 36.1 mt -89.81 105.5 17.84 Favored 'General case' 0 N--CA 1.483 1.196 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.683 -165.508 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 85.5 m -97.32 100.6 12.05 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 -165.908 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 9.2 tt -101.9 100.86 11.21 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 107.802 -1.185 . . . . 0.0 107.802 -177.406 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -100.01 106.3 18.06 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 179.856 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 96.3 m -93.38 102.81 15.06 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 -179.616 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 31.4 m-70 -89.98 85.13 6.26 Favored 'General case' 0 N--CA 1.493 1.709 0 CA-C-O 122.132 0.968 . . . . 0.0 110.98 -174.408 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 24.7 t -92.11 161.56 14.71 Favored 'General case' 0 N--CA 1.485 1.319 0 CA-C-N 115.165 -0.925 . . . . 0.0 111.078 173.405 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 35.8 m -82.89 68.09 9.23 Favored 'General case' 0 N--CA 1.499 1.983 0 CA-C-O 121.949 0.881 . . . . 0.0 110.302 170.021 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 71.2 t80 -165.77 -81.98 0.02 OUTLIER 'General case' 0 CA--C 1.561 1.375 0 N-CA-C 105.302 -2.111 . . . . 0.0 105.302 179.384 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 62.6 mtpt -146.69 126.14 13.2 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 176.941 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -81.91 112.97 19.5 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 122.007 -0.433 . . . . 0.0 111.985 -178.665 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 76.3 p -91.39 128.04 37.06 Favored 'General case' 0 N--CA 1.493 1.683 0 C-N-CA 122.809 0.444 . . . . 0.0 111.433 -173.516 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -111.23 115.92 30.17 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 179.303 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 35.4 pt -114.72 130.42 69.16 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 171.475 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 71.2 p -117.95 116.39 26.82 Favored 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 123.751 0.82 . . . . 0.0 108.983 -179.499 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 51.1 p90 -140.26 140.4 35.74 Favored 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 115.115 1.524 . . . . 0.0 115.115 -160.109 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 52.8 mtmt -102.81 14.3 32.28 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 117.29 2.33 . . . . 0.0 117.29 -172.69 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . 0.291 3.2 mp 61.74 98.81 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.731 0 CA-C-N 120.692 1.587 . . . . 0.0 114.484 177.173 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 86.22 37.27 9.16 Favored Glycine 0 CA--C 1.553 2.419 0 N-CA-C 116.859 1.504 . . . . 0.0 116.859 -167.441 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 88.0 t -139.21 124.67 21.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 -178.569 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -88.76 123.66 33.39 Favored 'General case' 0 CA--C 1.562 1.406 0 C-N-CA 123.55 0.74 . . . . 0.0 110.526 173.846 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 40.1 p90 -130.35 124.49 32.37 Favored 'General case' 0 N--CA 1.494 1.754 0 C-N-CA 123.605 0.762 . . . . 0.0 110.42 -175.152 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -71.07 117.41 12.54 Favored 'General case' 0 CA--C 1.564 1.512 0 O-C-N 121.599 -0.688 . . . . 0.0 112.505 177.209 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 12.2 tp10 -126.99 133.91 50.47 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 123.742 0.817 . . . . 0.0 110.091 -167.882 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 45.3 m -91.23 122.83 34.2 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 176.239 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 33.9 p -83.56 167.22 17.56 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 113.019 0.748 . . . . 0.0 113.019 -174.504 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -53.82 -28.01 32.89 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 118.646 2.832 . . . . 0.0 118.646 168.541 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -74.6 -91.14 0.02 OUTLIER 'General case' 0 CA--C 1.57 1.733 0 CA-C-N 119.734 1.152 . . . . 0.0 109.076 168.269 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -176.17 90.16 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 105.143 -2.169 . . . . 0.0 105.143 158.55 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 45.8 mtt-85 -142.19 123.07 14.4 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 122.257 -0.277 . . . . 0.0 110.371 -171.711 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.586 ' H ' ' HD3' ' A' ' 79' ' ' LYS . 0.0 OUTLIER -80.47 93.77 6.09 Favored 'General case' 0 CA--C 1.564 1.511 0 C-N-CA 124.094 0.958 . . . . 0.0 110.679 172.413 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 13.4 m -112.03 130.54 65.51 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 C-N-CA 122.998 0.519 . . . . 0.0 110.676 -167.559 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 1.5 mptm? -84.34 98.53 10.08 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 123.808 0.843 . . . . 0.0 109.339 -179.332 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 72.2 m -94.2 98.25 10.82 Favored 'General case' 0 N--CA 1.483 1.191 0 CA-C-N 115.133 -0.939 . . . . 0.0 110.933 -166.139 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 6.4 tp -107.77 115.44 48.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 -179.295 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.0 p -133.15 131.66 58.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 C-N-CA 124.03 0.932 . . . . 0.0 109.673 -172.639 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 15.1 t -143.68 159.9 41.65 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-O 122.495 1.14 . . . . 0.0 110.577 177.213 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 18.2 tp -93.9 107.13 19.06 Favored 'General case' 0 N--CA 1.489 1.506 0 CA-C-N 115.162 -0.926 . . . . 0.0 108.633 172.129 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -102.88 84.58 2.4 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 123.382 0.673 . . . . 0.0 109.662 -171.84 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 56.5 48.35 76.96 Favored Glycine 0 CA--C 1.548 2.141 0 N-CA-C 117.608 1.803 . . . . 0.0 117.608 -176.088 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 100.38 -47.6 1.25 Allowed Glycine 0 N--CA 1.489 2.172 0 N-CA-C 116.215 1.246 . . . . 0.0 116.215 -166.657 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 30.9 ttpt -84.62 116.33 23.12 Favored 'General case' 0 CA--C 1.556 1.2 0 CA-C-N 117.915 0.858 . . . . 0.0 111.131 -170.075 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 3.0 tt -88.05 101.77 14.11 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-O 121.686 0.755 . . . . 0.0 109.659 -173.005 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 54.3 t -104.66 107.4 22.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 -168.418 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 19.9 t-160 -99.35 140.1 34.02 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 123.943 0.897 . . . . 0.0 109.655 169.679 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 15.6 tp -138.9 124.91 19.96 Favored 'General case' 0 N--CA 1.488 1.44 0 CA-C-O 122.03 0.919 . . . . 0.0 108.803 175.557 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -107.92 126.62 52.9 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 124.603 1.161 . . . . 0.0 108.378 178.537 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -125.45 133.2 52.53 Favored 'General case' 0 N--CA 1.496 1.847 0 C-N-CA 122.986 0.514 . . . . 0.0 110.571 -173.734 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 22.9 p90 -158.18 114.57 2.8 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.125 -0.985 . . . . 0.0 110.5 -176.034 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 11.1 t70 50.21 58.07 5.89 Favored 'General case' 0 N--CA 1.503 2.176 0 N-CA-C 116.704 2.112 . . . . 0.0 116.704 163.508 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 80.89 -25.22 3.56 Favored Glycine 0 CA--C 1.559 2.79 0 N-CA-C 119.212 2.445 . . . . 0.0 119.212 -171.327 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 66.7 mt-30 -102.01 133.79 46.26 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 124.785 1.234 . . . . 0.0 110.464 -179.044 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -141.38 135.78 30.77 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.341 -0.849 . . . . 0.0 112.416 173.165 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 14.9 t -117.13 129.21 55.82 Favored 'General case' 0 N--CA 1.496 1.857 0 C-N-CA 123.302 0.641 . . . . 0.0 111.506 177.635 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 40.3 p -94.7 120.43 34.91 Favored 'General case' 0 N--CA 1.493 1.715 0 C-N-CA 123.306 0.642 . . . . 0.0 110.028 172.346 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 5.2 mp -103.56 90.86 3.8 Favored 'General case' 0 CA--C 1.562 1.428 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 174.729 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 92.9 t -94.99 102.66 13.84 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 N-CA-C 107.567 -1.272 . . . . 0.0 107.567 -174.294 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.413 HH11 HD11 ' A' ' 42' ' ' ILE . 45.8 mtt180 -91.5 128.08 37.19 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 122.966 0.506 . . . . 0.0 109.652 172.45 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -147.81 129.56 15.16 Favored 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 123.197 0.599 . . . . 0.0 110.429 -172.035 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -77.11 121.14 23.17 Favored 'General case' 0 N--CA 1.487 1.404 0 CA-C-O 121.865 0.841 . . . . 0.0 112.736 178.647 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . 0.279 1.5 mp -76.41 171.89 1.22 Allowed 'Isoleucine or valine' 0 CA--C 1.575 1.938 0 CA-C-N 114.94 -1.027 . . . . 0.0 109.231 143.12 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -68.62 73.72 0.25 Allowed 'General case' 0 CA--C 1.565 1.543 0 N-CA-C 114.866 1.432 . . . . 0.0 114.866 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 121.22 -56.95 0.61 Allowed Glycine 0 N--CA 1.485 1.911 0 CA-C-N 114.093 -1.412 . . . . 0.0 113.781 -171.003 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 51.1 mttp -91.12 139.72 30.49 Favored 'General case' 0 N--CA 1.487 1.376 0 CA-C-O 121.713 0.768 . . . . 0.0 112.172 -173.307 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 25.1 tp -92.9 135.93 33.7 Favored 'General case' 0 CA--C 1.557 1.247 0 C-N-CA 123.605 0.762 . . . . 0.0 110.741 173.783 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 44.5 mm -114.18 108.68 26.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 -178.156 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 48.8 tp -93.58 106.21 18.2 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 123.813 0.845 . . . . 0.0 109.195 173.108 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 83.7 m -97.74 112.56 24.4 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 -179.669 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 92.9 mt -106.88 98.48 8.14 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 123.698 0.799 . . . . 0.0 109.483 -173.09 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 7.5 m -109.88 115.65 30.2 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 -175.526 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 86.1 t60 -134.21 116.19 15.05 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 108.507 -0.924 . . . . 0.0 108.507 173.147 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 75.2 -111.14 3.26 Favored Glycine 0 N--CA 1.484 1.845 0 C-N-CA 122.928 0.299 . . . . 0.0 113.011 176.167 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 73.4 p -122.37 68.55 0.95 Allowed 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 108.987 -0.745 . . . . 0.0 108.987 163.763 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -160.37 93.96 1.06 Allowed 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 123.368 0.667 . . . . 0.0 109.533 178.674 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 4.9 p -96.51 121.75 47.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 C-N-CA 123.797 0.839 . . . . 0.0 109.801 175.713 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' CYS . . . . . 0.431 ' SG ' ' HB2' ' A' ' 16' ' ' PHE . 43.8 t -116.91 105.46 12.37 Favored 'General case' 0 CA--C 1.555 1.149 0 C-N-CA 123.334 0.654 . . . . 0.0 110.544 -179.466 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 91.7 m -92.54 105.34 17.53 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 123.648 0.779 . . . . 0.0 109.073 -175.252 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 53.6 mtp180 -105.64 116.99 32.88 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 123.144 0.578 . . . . 0.0 109.596 -172.53 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 41.7 m -86.73 141.37 28.94 Favored 'General case' 0 N--CA 1.493 1.701 0 C-N-CA 123.717 0.807 . . . . 0.0 110.511 178.765 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 40.6 m-85 -137.84 135.13 35.92 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 124.094 0.958 . . . . 0.0 109.497 -175.07 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -102.14 155.18 18.37 Favored 'General case' 0 N--CA 1.495 1.778 0 CA-C-O 122.421 1.105 . . . . 0.0 111.712 166.057 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 71.0 tttt -88.33 124.28 33.74 Favored 'General case' 0 N--CA 1.483 1.209 0 CA-C-N 115.199 -0.91 . . . . 0.0 111.816 -168.931 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -99.17 49.48 0.95 Allowed 'General case' 0 CA--C 1.57 1.738 0 C-N-CA 123.58 0.752 . . . . 0.0 112.354 170.541 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.129 0 CA-C-O 123.2 1.476 . . . . 0.0 108.252 -176.287 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 4.6 p . . . . . 0 CA--C 1.576 1.972 0 N-CA-C 116.227 1.936 . . . . 0.0 116.227 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -66.19 -35.43 80.44 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 116.669 2.1 . . . . 0.0 116.669 -176.045 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -61.0 -27.08 68.05 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 117.514 2.413 . . . . 0.0 117.514 168.128 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -72.18 -20.2 61.62 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 116.037 1.865 . . . . 0.0 116.037 168.962 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 55.0 mt -78.29 119.65 21.95 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-N 121.034 1.743 . . . . 0.0 111.69 -171.745 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 163.87 175.9 35.22 Favored Glycine 0 N--CA 1.481 1.666 0 CA-C-O 122.251 0.917 . . . . 0.0 113.239 -177.766 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 63.1 m -92.3 137.28 32.49 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 167.847 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 87.3 m95 -138.6 112.58 8.51 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 -170.142 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 52.4 mtmt -99.94 144.37 29.08 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 123.103 0.561 . . . . 0.0 110.228 178.93 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 25.0 tp -67.72 131.66 46.0 Favored 'General case' 0 N--CA 1.488 1.427 0 CA-C-O 122.371 1.082 . . . . 0.0 112.419 -177.609 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . 0.285 1.0 OUTLIER -111.81 -47.81 6.03 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.797 0 CA-C-N 113.669 -1.605 . . . . 0.0 110.875 179.054 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -137.07 140.12 41.79 Favored 'General case' 0 N--CA 1.487 1.412 0 CA-C-N 119.566 1.075 . . . . 0.0 109.505 175.539 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 78.8 p -132.94 114.48 14.06 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 168.444 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -77.22 -72.41 0.35 Allowed 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 112.532 0.567 . . . . 0.0 112.532 -172.614 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 62.6 m-80 -105.41 47.12 0.89 Allowed 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 113.291 0.848 . . . . 0.0 113.291 -178.854 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 11.9 t80 -92.74 74.18 4.96 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.795 -1.191 . . . . 0.0 110.352 177.993 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 179.76 -59.82 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 126.082 1.753 . . . . 0.0 106.648 -168.793 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 22.8 t0 -58.42 -46.65 86.06 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 115.01 1.485 . . . . 0.0 115.01 163.85 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 90.0 t80 -51.9 -55.07 22.43 Favored 'General case' 0 CA--C 1.57 1.735 0 N-CA-C 114.896 1.443 . . . . 0.0 114.896 170.315 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 72.9 mtm -62.84 -39.21 93.65 Favored 'General case' 0 CA--C 1.567 1.626 0 N-CA-C 115.947 1.832 . . . . 0.0 115.947 174.816 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 28.9 ttpp -58.63 -46.56 86.82 Favored 'General case' 0 CA--C 1.569 1.686 0 N-CA-C 115.115 1.524 . . . . 0.0 115.115 168.685 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 16.7 t -62.01 -34.83 76.92 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 116.59 2.07 . . . . 0.0 116.59 172.57 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 86.2 mt -65.31 -44.25 88.49 Favored 'General case' 0 CA--C 1.567 1.616 0 N-CA-C 115.64 1.718 . . . . 0.0 115.64 167.929 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 113.95 70.35 0.52 Allowed Glycine 0 N--CA 1.483 1.808 0 C-N-CA 123.966 0.793 . . . . 0.0 111.889 -172.058 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 66.8 t -127.67 122.27 58.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 N-CA-C 105.586 -2.005 . . . . 0.0 105.586 -176.785 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -63.25 153.92 45.28 Favored Glycine 0 CA--C 1.549 2.211 0 N-CA-C 115.801 1.08 . . . . 0.0 115.801 177.81 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 31.5 p90 -55.2 -42.78 73.73 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 118.663 2.838 . . . . 0.0 118.663 -167.191 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.85 -43.28 93.55 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 115.75 1.759 . . . . 0.0 115.75 175.307 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 63.2 m -69.38 -37.83 77.73 Favored 'General case' 0 N--CA 1.497 1.924 0 N-CA-C 114.185 1.18 . . . . 0.0 114.185 170.689 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 45.5 ttp85 -59.46 -45.37 91.8 Favored 'General case' 0 CA--C 1.57 1.728 0 N-CA-C 115.151 1.537 . . . . 0.0 115.151 171.528 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 46.4 mt-30 -72.71 -39.89 66.6 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 115.104 1.52 . . . . 0.0 115.104 176.077 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 69.4 t -63.68 -48.18 87.84 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 CA-C-N 119.943 1.247 . . . . 0.0 112.443 170.446 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -61.89 -31.17 71.44 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 117.595 2.442 . . . . 0.0 117.595 177.435 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 84.0 p -62.91 -47.04 84.98 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 115.96 1.837 . . . . 0.0 115.96 169.484 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 51.9 tpp -70.76 -34.49 71.89 Favored 'General case' 0 CA--C 1.572 1.824 0 N-CA-C 116.13 1.9 . . . . 0.0 116.13 170.731 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 46.4 m -66.48 144.06 56.71 Favored 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 124.825 1.25 . . . . 0.0 112.538 -179.22 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -108.08 99.89 33.59 Favored Pre-proline 0 CA--C 1.571 1.753 0 CA-C-O 118.38 -0.819 . . . . 0.0 110.028 -177.366 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -75.48 141.68 25.59 Favored 'Trans proline' 0 CA--C 1.561 1.839 0 C-N-CA 123.206 2.604 . . . . 0.0 114.077 -179.689 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 100.0 m -107.47 100.74 10.14 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 -174.135 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 44.2 m -90.72 111.33 22.64 Favored 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 123.666 0.786 . . . . 0.0 109.448 -175.133 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 47.5 mt -102.82 108.09 23.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 N-CA-C 106.629 -1.619 . . . . 0.0 106.629 -178.768 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 33.7 mt -101.91 115.12 43.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 N-CA-C 106.744 -1.576 . . . . 0.0 106.744 -178.641 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -139.39 112.13 7.85 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 -171.385 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 28.1 ttpp -84.4 112.0 19.95 Favored 'General case' 0 CA--C 1.561 1.37 0 CA-C-O 121.43 0.633 . . . . 0.0 110.212 174.911 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 19.6 t-20 -100.57 92.49 5.15 Favored 'General case' 0 N--CA 1.485 1.32 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 -175.942 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 77.03 -99.64 1.42 Allowed Glycine 0 N--CA 1.485 1.939 0 N-CA-C 111.197 -0.761 . . . . 0.0 111.197 -166.094 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 25.1 m-20 -133.43 63.52 1.63 Allowed 'General case' 0 N--CA 1.494 1.748 0 CA-C-O 121.073 0.463 . . . . 0.0 109.844 160.17 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 27.2 mm -139.47 104.63 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 N-CA-C 104.994 -2.224 . . . . 0.0 104.994 177.348 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 35.9 mt -74.94 110.58 9.35 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 122.873 0.469 . . . . 0.0 111.527 177.703 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 38.3 m -105.41 101.84 11.35 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 106.266 -1.754 . . . . 0.0 106.266 -179.65 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 9.4 tt -104.65 108.64 20.2 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 -174.241 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 43.7 mttp -109.5 96.81 6.53 Favored 'General case' 0 N--CA 1.483 1.175 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 -165.647 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 60.0 m -87.95 92.7 9.23 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 -177.377 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 70.2 m80 -83.54 91.65 7.46 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 123.824 0.85 . . . . 0.0 110.191 -176.271 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 82.5 p -94.88 4.21 54.08 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 118.427 2.751 . . . . 0.0 118.427 -167.237 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . 0.315 6.8 m 74.46 -46.08 0.6 Allowed 'General case' 0 N--CA 1.504 2.232 0 CA-C-N 120.693 1.588 . . . . 0.0 113.848 -166.286 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 69.9 t80 -71.62 -74.6 0.15 Allowed 'General case' 0 CA--C 1.565 1.553 0 C-N-CA 124.323 1.049 . . . . 0.0 111.661 179.004 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 56.7 mtmt -141.88 120.57 12.6 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 173.98 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -77.03 111.01 12.14 Favored 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 122.969 0.508 . . . . 0.0 111.914 -177.717 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 45.6 p -97.98 130.89 44.81 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-O 121.212 0.53 . . . . 0.0 110.949 -173.471 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 5.4 mp0 -115.65 129.76 56.61 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 123.382 0.673 . . . . 0.0 109.84 179.76 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 49.3 pt -112.79 126.05 70.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 N-CA-C 108.091 -1.078 . . . . 0.0 108.091 168.638 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 39.0 t -109.54 109.68 20.54 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 107.208 -1.405 . . . . 0.0 107.208 175.704 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 42.9 p90 -140.34 141.8 35.64 Favored 'General case' 0 N--CA 1.489 1.501 0 CA-C-O 122.25 1.024 . . . . 0.0 113.737 -164.447 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 55.1 mtmt -100.87 150.96 22.29 Favored 'General case' 0 CA--C 1.562 1.437 0 CA-C-N 114.478 -1.237 . . . . 0.0 109.061 159.729 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -74.46 115.48 14.05 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.564 -0.71 . . . . 0.0 111.894 -171.426 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 89.31 44.59 4.95 Favored Glycine 0 CA--C 1.549 2.186 0 N-CA-C 116.582 1.393 . . . . 0.0 116.582 -166.688 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 92.3 t -136.0 123.66 35.17 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 178.345 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -87.73 132.67 34.05 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 123.464 0.705 . . . . 0.0 110.791 170.668 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 44.9 p90 -145.55 134.42 22.45 Favored 'General case' 0 N--CA 1.494 1.739 0 C-N-CA 123.318 0.647 . . . . 0.0 110.556 -174.399 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -73.04 117.88 15.31 Favored 'General case' 0 CA--C 1.564 1.481 0 O-C-N 121.558 -0.713 . . . . 0.0 112.644 178.207 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 15.1 tp10 -128.97 134.15 48.08 Favored 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 123.626 0.77 . . . . 0.0 110.088 -170.681 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 51.9 m -92.7 121.91 34.58 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 174.097 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 27.1 p -84.31 174.5 10.1 Favored 'General case' 0 N--CA 1.494 1.726 0 CA-C-O 121.663 0.744 . . . . 0.0 112.869 -175.013 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -60.07 -34.68 73.77 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 116.815 2.154 . . . . 0.0 116.815 171.258 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -89.02 31.66 0.86 Allowed 'General case' 0 CA--C 1.58 2.1 0 N-CA-C 114.601 1.334 . . . . 0.0 114.601 167.394 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 22.5 m-20 53.34 67.82 0.94 Allowed 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 115.057 1.503 . . . . 0.0 115.057 174.768 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 46.1 mtm105 -137.64 120.98 16.98 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 109.036 -0.728 . . . . 0.0 109.036 -175.74 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.06 108.99 8.17 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 123.379 0.671 . . . . 0.0 111.305 169.444 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 17.7 m -125.39 142.15 43.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 CA-C-O 121.335 0.588 . . . . 0.0 110.302 -168.912 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 4.7 mptp? -85.62 98.01 10.42 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 123.629 0.772 . . . . 0.0 109.122 176.575 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 58.0 m -91.38 93.37 9.0 Favored 'General case' 0 N--CA 1.485 1.283 0 CA-C-N 115.262 -0.881 . . . . 0.0 111.12 -170.549 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 6.8 tp -104.71 116.73 49.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 178.322 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 1.5 p -136.52 122.56 29.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 C-N-CA 123.343 0.657 . . . . 0.0 109.55 -169.856 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 14.9 t -136.88 157.5 46.61 Favored 'General case' 0 N--CA 1.491 1.592 0 CA-C-O 122.629 1.204 . . . . 0.0 111.351 178.384 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 15.2 tp -95.37 119.78 34.47 Favored 'General case' 0 N--CA 1.489 1.514 0 CA-C-N 114.768 -1.106 . . . . 0.0 110.067 177.832 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -106.52 81.23 1.57 Allowed 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 123.205 0.602 . . . . 0.0 110.604 -178.204 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 61.06 46.52 94.38 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 117.673 1.829 . . . . 0.0 117.673 -177.096 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 75.03 35.96 48.03 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 118.206 2.043 . . . . 0.0 118.206 -168.341 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -145.93 104.36 3.84 Favored 'General case' 0 CA--C 1.553 1.077 0 N-CA-C 105.369 -2.086 . . . . 0.0 105.369 -177.774 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -86.33 121.42 28.88 Favored 'General case' 0 N--CA 1.481 1.12 0 CA-C-O 121.903 0.858 . . . . 0.0 110.989 -170.853 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 61.2 t -122.98 107.42 19.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 N-CA-C 106.103 -1.814 . . . . 0.0 106.103 -166.138 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 20.6 t-160 -110.75 113.34 25.85 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 123.777 0.831 . . . . 0.0 109.78 179.514 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 31.5 tp -107.74 123.25 48.26 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 123.775 0.83 . . . . 0.0 108.857 177.925 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -110.86 120.8 43.58 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 178.186 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -117.39 137.63 52.35 Favored 'General case' 0 N--CA 1.495 1.796 0 CA-C-N 118.675 0.67 . . . . 0.0 111.134 -178.401 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 22.7 p90 -155.82 109.08 2.72 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.419 -0.8 . . . . 0.0 109.892 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 5.5 t70 55.96 50.16 14.41 Favored 'General case' 0 N--CA 1.499 2.015 0 N-CA-C 116.237 1.94 . . . . 0.0 116.237 168.999 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 86.99 -43.82 3.26 Favored Glycine 0 CA--C 1.552 2.396 0 N-CA-C 116.706 1.443 . . . . 0.0 116.706 -168.85 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 64.4 mt-30 -73.68 132.23 42.48 Favored 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 123.874 0.87 . . . . 0.0 111.571 179.372 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -141.77 135.02 29.3 Favored 'General case' 0 N--CA 1.49 1.542 0 CA-C-O 121.202 0.525 . . . . 0.0 112.237 176.553 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 13.7 t -118.07 133.26 56.08 Favored 'General case' 0 N--CA 1.495 1.79 0 CA-C-N 115.597 -0.728 . . . . 0.0 111.087 176.818 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 37.4 p -101.84 135.25 43.72 Favored 'General case' 0 N--CA 1.494 1.736 0 CA-C-O 122.057 0.932 . . . . 0.0 110.713 171.047 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 5.4 mp -118.26 85.52 2.37 Favored 'General case' 0 CA--C 1.562 1.415 0 N-CA-C 106.535 -1.654 . . . . 0.0 106.535 -178.575 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 99.5 t -95.02 103.66 14.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 -168.866 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 83.7 mtt85 -94.58 129.29 41.47 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 123.794 0.838 . . . . 0.0 110.181 179.416 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -146.91 132.23 18.51 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 122.849 0.459 . . . . 0.0 110.837 -176.741 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -80.6 114.73 19.7 Favored 'General case' 0 N--CA 1.486 1.337 0 CA-C-O 121.328 0.585 . . . . 0.0 111.315 179.506 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 48.3 mm -118.56 105.06 17.01 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.361 0 N-CA-C 105.075 -2.194 . . . . 0.0 105.075 175.362 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 58.68 50.4 8.95 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 115.204 1.557 . . . . 0.0 115.204 175.854 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 65.6 25.56 71.61 Favored Glycine 0 CA--C 1.555 2.583 0 N-CA-C 119.351 2.501 . . . . 0.0 119.351 -171.072 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 92.6 mttt -133.78 128.45 34.82 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-N 119.203 1.501 . . . . 0.0 108.678 -173.663 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 15.0 tp -78.53 109.71 12.96 Favored 'General case' 0 CA--C 1.558 1.288 0 C-N-CA 123.272 0.629 . . . . 0.0 110.306 -179.917 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 31.8 mm -98.95 97.34 5.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 N-CA-C 107.192 -1.41 . . . . 0.0 107.192 -175.919 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 24.6 tp -91.21 104.19 16.78 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 123.972 0.909 . . . . 0.0 109.996 -179.85 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 85.1 m -96.1 108.76 21.23 Favored 'General case' 0 CA--C 1.562 1.43 0 C-N-CA 124.0 0.92 . . . . 0.0 108.804 -176.277 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 92.4 mt -103.04 103.68 13.79 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 123.537 0.735 . . . . 0.0 109.956 -174.491 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 12.8 m -112.18 117.39 32.44 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 -175.402 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 73.5 t60 -152.84 117.16 4.93 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 174.496 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 60.41 61.9 6.59 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 117.418 1.727 . . . . 0.0 117.418 169.462 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . 0.291 3.2 m 52.36 50.28 18.67 Favored 'General case' 0 CA--C 1.576 1.97 0 N-CA-C 114.878 1.436 . . . . 0.0 114.878 -172.206 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -158.87 87.85 0.88 Allowed 'General case' 0 N--CA 1.485 1.291 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 -178.708 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 3.6 p -94.73 113.66 29.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 C-N-CA 123.649 0.78 . . . . 0.0 109.348 175.62 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 45.9 t -103.99 105.62 15.86 Favored 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 123.081 0.552 . . . . 0.0 110.062 176.585 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 91.8 m -90.06 103.52 16.18 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 -179.533 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 69.0 mtp180 -104.02 114.64 29.03 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 123.042 0.537 . . . . 0.0 109.893 -166.929 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 91.1 m -84.15 129.07 34.92 Favored 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 122.882 0.473 . . . . 0.0 109.905 176.188 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 40.7 m-85 -125.81 127.69 46.51 Favored 'General case' 0 CA--C 1.558 1.253 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 176.241 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -95.34 157.01 16.08 Favored 'General case' 0 N--CA 1.493 1.699 0 CA-C-O 122.431 1.11 . . . . 0.0 111.572 171.08 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 72.8 tttt -91.04 126.37 36.11 Favored 'General case' 0 N--CA 1.484 1.262 0 CA-C-N 115.423 -0.808 . . . . 0.0 112.51 -164.064 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -99.84 51.1 0.92 Allowed 'General case' 0 N--CA 1.497 1.92 0 CA-C-O 121.912 0.863 . . . . 0.0 111.383 167.88 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.063 0 CA-C-O 123.216 1.484 . . . . 0.0 107.638 -177.459 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.265 5.9 p . . . . . 0 CA--C 1.576 1.955 0 N-CA-C 116.376 1.991 . . . . 0.0 116.376 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -65.71 -37.84 87.53 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 116.449 2.018 . . . . 0.0 116.449 -178.61 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -59.56 -29.85 68.22 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 117.313 2.338 . . . . 0.0 117.313 167.909 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -69.98 -23.55 63.18 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 116.287 1.958 . . . . 0.0 116.287 168.337 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 58.5 mt -75.0 120.02 19.97 Favored 'General case' 0 N--CA 1.49 1.539 0 CA-C-N 121.028 1.74 . . . . 0.0 111.689 -173.645 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 160.29 176.39 32.33 Favored Glycine 0 CA--C 1.541 1.708 0 CA-C-O 122.447 1.026 . . . . 0.0 113.744 -176.007 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 75.2 m -93.22 135.46 34.4 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 170.495 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 94.2 m95 -138.4 115.63 11.06 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 -169.796 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 24.9 mmmt -102.17 145.65 29.08 Favored 'General case' 0 N--CA 1.492 1.628 0 CA-C-O 121.536 0.684 . . . . 0.0 111.021 178.933 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 43.9 tp -70.13 125.42 26.73 Favored 'General case' 0 N--CA 1.489 1.477 0 CA-C-O 122.039 0.923 . . . . 0.0 112.118 -176.852 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . 0.275 1.0 OUTLIER -107.84 -39.26 4.32 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.883 0 CA-C-N 113.997 -1.456 . . . . 0.0 112.435 -178.701 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -137.21 138.0 39.7 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-N 120.305 1.411 . . . . 0.0 109.64 176.15 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 78.3 p -121.56 103.47 8.94 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 167.624 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 8.9 tmtm? -79.92 -78.35 0.17 Allowed 'General case' 0 N--CA 1.491 1.602 0 CA-C-O 118.877 -0.582 . . . . 0.0 112.554 -167.309 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 85.0 m-20 -105.15 48.26 0.84 Allowed 'General case' 0 N--CA 1.498 1.967 0 CA-C-N 118.89 0.768 . . . . 0.0 112.795 177.684 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 10.0 t80 -92.09 75.78 5.44 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.704 -1.247 . . . . 0.0 110.973 -174.341 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -172.21 -61.27 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 124.668 1.187 . . . . 0.0 108.987 -168.967 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 12.3 t0 -61.66 -38.29 87.2 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 115.859 1.8 . . . . 0.0 115.859 166.924 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 87.9 t80 -48.74 -53.86 17.28 Favored 'General case' 0 CA--C 1.574 1.893 0 N-CA-C 114.755 1.391 . . . . 0.0 114.755 163.592 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 56.8 mtm -66.24 -29.98 70.34 Favored 'General case' 0 CA--C 1.571 1.768 0 N-CA-C 116.549 2.055 . . . . 0.0 116.549 171.735 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 55.8 mttp -61.18 -48.65 80.56 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 114.942 1.46 . . . . 0.0 114.942 166.459 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 23.1 t -66.26 -32.44 73.86 Favored 'General case' 0 CA--C 1.567 1.599 0 N-CA-C 116.465 2.024 . . . . 0.0 116.465 173.248 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 65.2 mt -66.27 -43.64 85.87 Favored 'General case' 0 CA--C 1.565 1.522 0 N-CA-C 116.084 1.883 . . . . 0.0 116.084 172.372 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 105.84 86.67 1.92 Allowed Glycine 0 N--CA 1.482 1.742 0 N-CA-C 110.744 -0.943 . . . . 0.0 110.744 -170.098 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 41.3 t -140.61 144.11 27.83 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 N-CA-C 107.575 -1.269 . . . . 0.0 107.575 -174.455 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -73.13 163.08 54.91 Favored Glycine 0 CA--C 1.552 2.361 0 O-C-N 120.958 -1.089 . . . . 0.0 115.137 169.045 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 25.2 p90 -62.93 -39.61 95.1 Favored 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 117.071 2.249 . . . . 0.0 117.071 -178.962 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.45 -45.08 94.71 Favored 'General case' 0 CA--C 1.56 1.347 0 N-CA-C 115.777 1.769 . . . . 0.0 115.777 177.799 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . 0.288 0.6 OUTLIER -81.51 -19.07 42.96 Favored 'General case' 0 N--CA 1.499 2.002 0 N-CA-C 116.177 1.917 . . . . 0.0 116.177 173.141 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 34.3 ttm105 -61.58 -46.92 87.83 Favored 'General case' 0 CA--C 1.57 1.744 0 CA-C-N 121.18 1.809 . . . . 0.0 113.646 160.756 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 22.7 tt0 -62.99 -49.42 74.78 Favored 'General case' 0 CA--C 1.563 1.473 0 N-CA-C 115.282 1.586 . . . . 0.0 115.282 171.414 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 89.1 t -63.66 -43.82 98.25 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 CA-C-O 117.273 -1.346 . . . . 0.0 112.983 174.345 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -63.07 -41.17 99.38 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 116.478 2.029 . . . . 0.0 116.478 177.754 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 97.3 p -61.15 -42.64 98.92 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 116.619 2.081 . . . . 0.0 116.619 168.254 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 48.1 ttp -66.61 -36.85 83.6 Favored 'General case' 0 CA--C 1.572 1.824 0 N-CA-C 116.421 2.008 . . . . 0.0 116.421 169.95 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 52.3 m -73.29 135.19 44.39 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 124.28 1.032 . . . . 0.0 111.807 -175.578 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -103.74 102.28 29.73 Favored Pre-proline 0 CA--C 1.571 1.77 0 CA-C-N 114.554 -1.203 . . . . 0.0 109.81 175.228 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -76.44 126.19 8.87 Favored 'Trans proline' 0 CA--C 1.562 1.893 0 C-N-CA 123.235 2.624 . . . . 0.0 112.861 -178.134 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 15.4 m -84.59 107.05 16.61 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 -179.828 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 47.5 m -100.93 104.3 15.49 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 -168.614 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 48.9 mt -98.68 112.15 30.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 N-CA-C 106.991 -1.485 . . . . 0.0 106.991 -179.169 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 42.7 mt -106.31 115.11 47.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 N-CA-C 106.733 -1.58 . . . . 0.0 106.733 -177.435 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -139.38 115.06 10.02 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 -173.591 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 84.7 tttt -87.49 112.64 22.42 Favored 'General case' 0 CA--C 1.556 1.211 0 C-N-CA 123.075 0.55 . . . . 0.0 110.025 173.907 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 20.4 t-20 -82.65 -69.78 0.6 Allowed 'General case' 0 CA--C 1.564 1.496 0 C-N-CA 123.314 0.646 . . . . 0.0 111.298 -176.359 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -149.56 89.55 0.14 Allowed Glycine 0 N--CA 1.482 1.74 0 N-CA-C 108.867 -1.693 . . . . 0.0 108.867 172.241 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . 0.295 12.6 m-20 69.54 -20.05 0.18 Allowed 'General case' 0 N--CA 1.499 1.978 0 N-CA-C 117.569 2.433 . . . . 0.0 117.569 -164.519 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 16.4 mm -101.19 111.9 32.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 -171.055 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 16.2 mt -79.97 115.18 19.4 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 123.611 0.764 . . . . 0.0 110.797 173.47 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 44.3 m -104.0 96.34 6.61 Favored 'General case' 0 CA--C 1.56 1.338 0 N-CA-C 106.557 -1.645 . . . . 0.0 106.557 -176.5 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 9.1 tt -96.85 102.92 14.79 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 -179.271 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -97.42 107.87 20.47 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 123.721 0.808 . . . . 0.0 108.87 -173.154 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 34.7 m -95.14 90.98 6.09 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 -176.167 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 20.6 m170 -84.76 101.88 12.58 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 -174.053 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 23.4 t -137.82 151.45 48.11 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 123.556 0.743 . . . . 0.0 110.335 -167.313 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 80.8 p -83.57 67.92 9.6 Favored 'General case' 0 N--CA 1.498 1.932 0 CA-C-O 122.134 0.968 . . . . 0.0 112.559 178.374 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 57.5 t80 -155.52 -95.61 0.04 OUTLIER 'General case' 0 CA--C 1.562 1.413 0 N-CA-C 103.777 -2.675 . . . . 0.0 103.777 170.792 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 3.9 mppt? -129.22 127.64 41.68 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 106.819 -1.549 . . . . 0.0 106.819 159.016 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 9.8 p30 -75.27 120.65 21.04 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 123.268 0.627 . . . . 0.0 112.475 -179.502 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 75.1 p -101.08 126.66 47.79 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-O 121.405 0.622 . . . . 0.0 110.617 -174.764 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -110.01 118.25 35.92 Favored 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 177.126 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 14.3 pt -107.66 126.71 64.0 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 178.799 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 77.9 p -115.87 109.24 17.35 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 -175.662 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 48.1 p90 -141.33 138.39 33.06 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 114.682 1.364 . . . . 0.0 114.682 -161.832 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 60.7 mtpt -95.95 145.6 25.28 Favored 'General case' 0 CA--C 1.562 1.432 0 CA-C-N 115.036 -0.984 . . . . 0.0 109.148 162.086 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -73.47 116.66 14.3 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.575 -0.703 . . . . 0.0 112.208 -173.171 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 79.9 40.61 14.05 Favored Glycine 0 CA--C 1.549 2.2 0 N-CA-C 117.013 1.565 . . . . 0.0 117.013 -170.428 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 91.6 t -139.3 117.76 12.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 N-CA-C 105.34 -2.096 . . . . 0.0 105.34 -179.209 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -81.41 132.25 35.32 Favored 'General case' 0 N--CA 1.49 1.53 0 CA-C-O 121.578 0.704 . . . . 0.0 111.267 178.905 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 19.5 p90 -134.28 145.55 49.2 Favored 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 124.158 0.983 . . . . 0.0 110.313 -174.133 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -73.44 128.55 35.81 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 123.204 0.602 . . . . 0.0 112.413 178.355 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -131.41 131.81 43.89 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 123.267 0.627 . . . . 0.0 109.785 -168.35 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 90.6 m -112.82 119.32 37.6 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 107.135 -1.431 . . . . 0.0 107.135 170.932 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 42.7 p -80.87 175.3 10.8 Favored 'General case' 0 N--CA 1.495 1.785 0 CA-C-N 115.545 -0.752 . . . . 0.0 112.745 -174.078 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -59.49 -40.07 85.82 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 116.193 1.923 . . . . 0.0 116.193 169.864 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -74.97 -7.41 53.54 Favored 'General case' 0 CA--C 1.578 2.039 0 N-CA-C 116.256 1.947 . . . . 0.0 116.256 165.571 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . 0.256 6.1 m-20 67.48 68.18 0.38 Allowed 'General case' 0 N--CA 1.496 1.874 0 C-N-CA 125.512 1.525 . . . . 0.0 111.714 -178.103 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 31.0 ttm-85 -116.38 18.04 15.32 Favored 'General case' 0 N--CA 1.498 1.926 0 N-CA-C 116.11 1.892 . . . . 0.0 116.11 -167.745 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . 0.31 0.1 OUTLIER 39.4 71.47 0.17 Allowed 'General case' 0 N--CA 1.499 1.982 0 N-CA-C 118.14 2.644 . . . . 0.0 118.14 176.023 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 4.5 m -112.1 144.07 20.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 CA-C-O 121.386 0.613 . . . . 0.0 111.172 -166.454 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 1.2 mppt? -97.99 102.32 14.04 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 174.898 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 61.5 p -93.56 113.98 26.23 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.577 0.751 . . . . 0.0 111.874 -170.267 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 5.7 tp -123.0 117.38 51.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 179.004 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 1.1 p -134.11 125.97 49.08 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 C-N-CA 123.786 0.834 . . . . 0.0 109.729 -174.96 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 15.3 t -132.29 152.0 51.58 Favored 'General case' 0 N--CA 1.495 1.807 0 CA-C-O 122.331 1.062 . . . . 0.0 112.32 178.811 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 53.5 tp -82.75 128.79 34.71 Favored 'General case' 0 N--CA 1.491 1.59 0 CA-C-N 114.644 -1.162 . . . . 0.0 110.067 170.704 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -131.45 83.42 2.1 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 123.444 0.698 . . . . 0.0 109.519 -179.046 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 58.51 47.23 91.1 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 117.863 1.905 . . . . 0.0 117.863 -178.822 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 76.32 37.74 35.75 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 117.571 1.788 . . . . 0.0 117.571 -167.646 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 36.3 ttmt -149.67 105.93 3.49 Favored 'General case' 0 N--CA 1.481 1.091 0 N-CA-C 106.572 -1.64 . . . . 0.0 106.572 -176.567 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 3.7 mp -79.97 114.41 18.86 Favored 'General case' 0 N--CA 1.485 1.288 0 CA-C-O 121.607 0.718 . . . . 0.0 109.811 172.979 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 95.3 t -109.78 101.76 13.03 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 N-CA-C 104.964 -2.236 . . . . 0.0 104.964 -173.713 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 23.1 t-160 -99.38 136.92 38.62 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 123.807 0.843 . . . . 0.0 109.69 178.11 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 24.8 tp -134.99 120.23 18.92 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 176.775 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 29.7 mt-30 -112.0 126.2 54.89 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 177.117 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 9.8 mtmp? -126.49 134.45 50.91 Favored 'General case' 0 N--CA 1.496 1.835 0 C-N-CA 122.989 0.515 . . . . 0.0 110.902 -170.58 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 25.8 p90 -152.38 116.12 4.83 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.469 -0.769 . . . . 0.0 110.433 -175.459 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . 0.344 12.6 t70 67.37 -101.76 0.06 Allowed 'General case' 0 N--CA 1.495 1.797 0 C-N-CA 124.515 1.126 . . . . 0.0 112.319 172.965 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -127.41 55.06 0.76 Allowed Glycine 0 N--CA 1.488 2.151 0 CA-C-N 118.96 0.8 . . . . 0.0 113.377 162.331 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 -154.34 129.98 9.98 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 -173.425 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -140.09 125.58 19.07 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.595 -0.691 . . . . 0.0 111.489 -179.311 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 14.3 t -107.94 134.03 51.44 Favored 'General case' 0 N--CA 1.495 1.782 0 C-N-CA 122.98 0.512 . . . . 0.0 110.534 173.911 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 33.7 p -100.74 134.81 43.15 Favored 'General case' 0 N--CA 1.492 1.669 0 CA-C-O 121.408 0.623 . . . . 0.0 110.77 168.826 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 5.3 mp -118.61 78.54 1.28 Allowed 'General case' 0 CA--C 1.561 1.404 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 178.202 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 62.8 t -86.53 103.41 12.94 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 121.108 -0.995 . . . . 0.0 108.489 -170.6 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 22.0 mmt180 -88.15 124.61 33.98 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 124.21 1.004 . . . . 0.0 109.71 177.081 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -149.52 127.86 12.17 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 122.115 -0.366 . . . . 0.0 111.455 -169.442 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -78.0 117.64 19.52 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.63 -0.669 . . . . 0.0 111.524 177.64 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 48.1 mm -117.58 100.41 10.12 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.312 0 N-CA-C 105.131 -2.174 . . . . 0.0 105.131 173.979 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 23.2 m-20 56.5 48.79 16.04 Favored 'General case' 0 N--CA 1.498 1.963 0 N-CA-C 115.094 1.516 . . . . 0.0 115.094 174.844 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 89.57 -42.14 3.0 Favored Glycine 0 CA--C 1.552 2.344 0 N-CA-C 117.35 1.7 . . . . 0.0 117.35 -169.53 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 50.7 mttp -83.06 128.69 34.7 Favored 'General case' 0 N--CA 1.487 1.4 0 CA-C-N 118.658 1.229 . . . . 0.0 111.842 -172.984 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 56.9 tp -86.08 116.33 24.23 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 123.486 0.714 . . . . 0.0 110.715 -177.354 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 33.5 mm -101.49 107.11 20.78 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 -172.09 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 52.7 tp -85.28 106.83 16.97 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 123.778 0.831 . . . . 0.0 109.359 171.399 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 75.5 m -99.73 106.14 18.02 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 -173.994 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 91.5 mt -103.78 96.44 6.7 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 123.274 0.63 . . . . 0.0 110.091 -169.699 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 9.2 m -111.68 116.06 30.14 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 -174.549 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 75.8 t60 -147.24 115.49 6.61 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 173.669 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 62.52 59.13 9.79 Favored Glycine 0 N--CA 1.488 2.143 0 N-CA-C 117.051 1.58 . . . . 0.0 117.051 172.475 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . 0.288 2.7 m 51.9 51.66 16.06 Favored 'General case' 0 CA--C 1.576 1.945 0 N-CA-C 115.129 1.529 . . . . 0.0 115.129 -172.445 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -157.24 89.26 1.05 Allowed 'General case' 0 N--CA 1.484 1.272 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 -179.614 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 4.8 p -94.34 116.28 35.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 C-N-CA 123.685 0.794 . . . . 0.0 109.88 178.187 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 42.9 t -103.69 110.3 22.33 Favored 'General case' 0 CA--C 1.553 1.058 0 C-N-CA 123.265 0.626 . . . . 0.0 110.026 174.252 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 79.8 m -90.64 97.76 11.37 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 -176.677 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 21.6 mtm180 -101.63 116.98 33.96 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 122.752 0.421 . . . . 0.0 111.042 -171.118 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 75.8 m -88.33 140.62 29.28 Favored 'General case' 0 N--CA 1.494 1.739 0 C-N-CA 123.544 0.737 . . . . 0.0 110.877 -177.214 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 34.6 m-85 -132.7 131.62 41.47 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 123.67 0.788 . . . . 0.0 109.825 -178.317 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -96.21 150.42 20.55 Favored 'General case' 0 N--CA 1.494 1.744 0 CA-C-O 122.121 0.963 . . . . 0.0 112.25 171.734 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 72.2 tttt -87.33 119.1 27.24 Favored 'General case' 0 N--CA 1.483 1.187 0 CA-C-N 115.142 -0.936 . . . . 0.0 111.149 -173.723 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 28.8 mm-40 -107.07 49.74 0.79 Allowed 'General case' 0 CA--C 1.567 1.629 0 C-N-CA 124.069 0.947 . . . . 0.0 111.709 178.566 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.035 0 CA-C-O 123.126 1.441 . . . . 0.0 108.397 -173.126 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 4.0 p . . . . . 0 CA--C 1.577 2.002 0 N-CA-C 116.028 1.862 . . . . 0.0 116.028 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 -63.77 -45.53 89.35 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 117.817 2.525 . . . . 0.0 117.817 -174.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -56.74 -25.54 55.11 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 118.084 2.624 . . . . 0.0 118.084 172.513 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -67.8 -30.68 70.17 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 116.181 1.919 . . . . 0.0 116.181 165.355 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 32.9 mt -72.05 107.01 4.53 Favored 'General case' 0 N--CA 1.489 1.496 0 CA-C-N 120.182 1.355 . . . . 0.0 111.445 -167.594 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 163.33 169.54 26.93 Favored Glycine 0 CA--C 1.544 1.864 0 CA-C-O 122.645 1.136 . . . . 0.0 113.581 -169.349 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 73.7 m -86.35 142.48 28.45 Favored 'General case' 0 N--CA 1.491 1.595 0 CA-C-N 114.266 -0.967 . . . . 0.0 110.071 170.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 77.5 m95 -143.87 117.21 9.04 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 -174.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -101.08 145.6 28.54 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.9 -0.5 . . . . 0.0 110.38 176.263 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 22.2 tp -68.12 122.86 19.16 Favored 'General case' 0 N--CA 1.49 1.564 0 CA-C-O 122.169 0.985 . . . . 0.0 111.757 -178.525 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . 0.282 0.9 OUTLIER -101.31 -46.87 11.51 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.8 0 CA-C-N 113.752 -1.567 . . . . 0.0 111.516 179.082 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -139.81 145.26 37.95 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-N 119.714 1.143 . . . . 0.0 109.647 175.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 79.7 p -131.67 89.42 2.7 Favored 'General case' 0 N--CA 1.491 1.613 0 CA-C-O 121.671 0.748 . . . . 0.0 110.091 168.448 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -78.29 127.39 32.17 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 123.534 0.734 . . . . 0.0 110.378 178.046 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.254 42.1 m-20 68.74 32.97 3.9 Favored 'General case' 0 N--CA 1.505 2.304 0 N-CA-C 116.391 1.997 . . . . 0.0 116.391 178.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 42.2 t80 -68.9 -62.95 1.17 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.631 -1.293 . . . . 0.0 113.09 -175.653 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -44.89 -36.02 3.11 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 118.637 2.829 . . . . 0.0 118.637 168.209 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -65.55 -48.67 71.61 Favored 'General case' 0 N--CA 1.498 1.944 0 CA-C-N 120.745 1.611 . . . . 0.0 114.64 172.413 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 85.7 t80 -55.38 -46.97 76.49 Favored 'General case' 0 CA--C 1.572 1.815 0 N-CA-C 115.179 1.548 . . . . 0.0 115.179 167.623 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 16.3 mmm -59.52 -42.52 92.44 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 115.493 1.664 . . . . 0.0 115.493 174.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 70.1 tttt -64.96 -41.05 95.81 Favored 'General case' 0 CA--C 1.568 1.64 0 N-CA-C 115.248 1.573 . . . . 0.0 115.248 170.091 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 50.9 m -56.74 -41.8 78.15 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 116.031 1.863 . . . . 0.0 116.031 171.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 45.4 mt -66.11 -36.83 84.22 Favored 'General case' 0 CA--C 1.565 1.532 0 N-CA-C 117.088 2.255 . . . . 0.0 117.088 168.353 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 100.08 78.98 1.4 Allowed Glycine 0 CA--C 1.54 1.622 0 CA-C-N 118.867 0.758 . . . . 0.0 111.644 -169.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 57.3 t -136.59 122.08 27.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 N-CA-C 105.48 -2.045 . . . . 0.0 105.48 -179.639 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -64.04 159.51 39.99 Favored Glycine 0 CA--C 1.548 2.125 0 N-CA-C 116.19 1.236 . . . . 0.0 116.19 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 27.8 p90 -56.27 -40.82 74.85 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 118.854 2.909 . . . . 0.0 118.854 -167.04 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.06 -42.01 81.11 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 116.022 1.86 . . . . 0.0 116.022 176.333 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 41.0 m -70.09 -39.94 75.28 Favored 'General case' 0 N--CA 1.499 1.986 0 CA-C-N 119.377 0.99 . . . . 0.0 113.663 171.069 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 68.1 ttt-85 -55.99 -42.77 76.86 Favored 'General case' 0 CA--C 1.571 1.766 0 N-CA-C 115.989 1.848 . . . . 0.0 115.989 168.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 25.6 tt0 -77.84 -42.79 32.42 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 115.355 1.613 . . . . 0.0 115.355 175.169 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 75.7 t -65.2 -41.62 92.09 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 CA-C-N 119.756 1.162 . . . . 0.0 113.011 174.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -64.36 -33.0 74.84 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 116.873 2.175 . . . . 0.0 116.873 172.301 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 93.3 p -67.05 -42.88 84.04 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 115.506 1.669 . . . . 0.0 115.506 167.422 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 42.5 ttm -60.89 -36.66 79.79 Favored 'General case' 0 CA--C 1.572 1.798 0 N-CA-C 116.135 1.902 . . . . 0.0 116.135 167.234 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 99.4 m -69.06 136.26 52.07 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 124.49 1.116 . . . . 0.0 111.328 176.589 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -108.35 92.43 9.76 Favored Pre-proline 0 CA--C 1.569 1.683 0 C-N-CA 123.824 0.85 . . . . 0.0 108.973 172.211 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -81.92 145.38 14.1 Favored 'Trans proline' 0 C--N 1.37 1.706 0 C-N-CA 122.83 2.353 . . . . 0.0 113.237 -174.206 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 85.5 m -99.2 102.31 13.92 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 -173.579 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 94.3 m -80.42 120.8 24.92 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 123.773 0.829 . . . . 0.0 109.319 175.391 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 36.9 mt -123.73 111.4 28.94 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 N-CA-C 106.399 -1.704 . . . . 0.0 106.399 -176.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 3.9 mp -94.09 128.1 45.65 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 175.35 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 22.0 mm-40 -128.57 169.32 14.53 Favored 'General case' 0 N--CA 1.489 1.496 0 CA-C-O 122.095 0.95 . . . . 0.0 110.551 178.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.69 157.2 42.78 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 123.869 0.868 . . . . 0.0 111.526 178.427 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 65.0 m-80 -134.55 -78.51 0.46 Allowed 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 177.352 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -153.13 86.65 0.14 Allowed Glycine 0 N--CA 1.482 1.749 0 N-CA-C 108.1 -2.0 . . . . 0.0 108.1 168.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . 0.277 14.4 m-20 66.62 -12.05 0.22 Allowed 'General case' 0 N--CA 1.498 1.945 0 N-CA-C 117.726 2.491 . . . . 0.0 117.726 -161.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 26.8 mm -90.27 103.75 14.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 CA-C-N 120.147 1.34 . . . . 0.0 107.445 -177.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 44.4 mt -93.61 110.8 22.39 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 123.005 0.522 . . . . 0.0 110.79 -174.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 90.5 m -99.32 98.76 9.67 Favored 'General case' 0 CA--C 1.562 1.411 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 -170.295 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 9.6 tt -97.78 113.49 25.29 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 178.231 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 45.6 mtpt -112.05 106.98 15.78 Favored 'General case' 0 N--CA 1.484 1.262 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 -173.135 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 82.5 m -92.15 101.71 14.23 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 177.612 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 72.4 m80 -88.41 90.53 8.43 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 123.883 0.873 . . . . 0.0 110.533 -173.467 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 60.5 p . . . . . 0 N--CA 1.489 1.489 0 N-CA-C 113.265 0.839 . . . . 0.0 113.265 -178.295 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 70.9 m-20 . . . . . 0 N--CA 1.49 1.528 0 N-CA-C 110.433 -0.21 . . . . 0.0 110.433 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 61.6 p -98.56 129.43 45.11 Favored 'General case' 0 N--CA 1.493 1.721 0 CA-C-O 121.221 0.534 . . . . 0.0 110.886 -176.491 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -115.26 116.55 28.5 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 179.465 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 28.8 pt -113.08 129.6 68.46 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 176.442 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 77.6 p -117.8 114.3 23.07 Favored 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 123.871 0.868 . . . . 0.0 109.298 -176.219 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 51.0 p90 -141.12 139.42 33.97 Favored 'General case' 0 N--CA 1.499 1.982 0 N-CA-C 115.499 1.666 . . . . 0.0 115.499 -161.514 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 62.2 mtpt -105.99 23.9 13.26 Favored 'General case' 0 CA--C 1.574 1.867 0 N-CA-C 116.877 2.177 . . . . 0.0 116.877 -175.084 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . 0.284 1.2 mp 60.78 90.21 0.07 Allowed 'General case' 0 N--CA 1.495 1.825 0 CA-C-N 120.536 1.517 . . . . 0.0 114.772 171.545 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 87.76 38.51 7.47 Favored Glycine 0 CA--C 1.551 2.302 0 N-CA-C 116.779 1.472 . . . . 0.0 116.779 -166.581 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 82.6 t -139.3 120.45 15.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 N-CA-C 106.131 -1.803 . . . . 0.0 106.131 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -87.46 124.06 33.04 Favored 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 122.953 0.501 . . . . 0.0 111.122 178.304 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 45.8 p90 -127.58 133.99 49.72 Favored 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 123.775 0.83 . . . . 0.0 111.166 -172.56 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -70.58 128.8 37.34 Favored 'General case' 0 CA--C 1.564 1.513 0 O-C-N 121.447 -0.783 . . . . 0.0 112.567 173.352 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 14.7 tp10 -142.46 135.73 28.73 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 123.193 0.597 . . . . 0.0 109.963 -168.683 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 53.1 m -92.56 127.47 38.07 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 171.214 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 31.1 p -84.25 171.68 12.53 Favored 'General case' 0 N--CA 1.495 1.781 0 CA-C-O 121.429 0.633 . . . . 0.0 112.443 -177.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -62.88 -31.35 72.38 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 116.438 2.014 . . . . 0.0 116.438 166.646 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -81.0 21.06 0.73 Allowed 'General case' 0 CA--C 1.582 2.193 0 N-CA-C 114.956 1.465 . . . . 0.0 114.956 165.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 56.31 69.23 0.76 Allowed 'General case' 0 N--CA 1.496 1.837 0 C-N-CA 125.928 1.691 . . . . 0.0 114.517 176.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 50.8 mtm180 -144.12 126.84 16.14 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-O 121.116 0.484 . . . . 0.0 110.683 -174.519 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 62.5 pttt -66.12 118.29 9.65 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 123.957 0.903 . . . . 0.0 111.929 165.368 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 15.8 m -140.25 130.13 28.41 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 -173.342 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 30.5 mmmt -87.41 112.22 21.92 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-O 121.593 0.711 . . . . 0.0 109.669 178.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 67.3 m -109.99 105.92 15.25 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 123.515 0.726 . . . . 0.0 111.108 -158.155 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 6.9 tp -114.66 105.84 19.46 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 C-N-CA 123.795 0.838 . . . . 0.0 109.53 -175.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -115.92 126.23 73.35 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 C-N-CA 124.551 1.14 . . . . 0.0 108.933 178.223 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 15.4 t -132.24 157.13 45.17 Favored 'General case' 0 N--CA 1.492 1.644 0 CA-C-O 122.625 1.203 . . . . 0.0 111.296 172.005 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 17.6 tp -93.31 116.24 28.81 Favored 'General case' 0 N--CA 1.487 1.419 0 CA-C-N 114.837 -1.074 . . . . 0.0 110.785 -176.465 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -110.36 82.74 1.64 Allowed 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 123.576 0.75 . . . . 0.0 109.679 178.731 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 56.68 46.16 89.6 Favored Glycine 0 CA--C 1.552 2.369 0 N-CA-C 118.203 2.041 . . . . 0.0 118.203 -177.042 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 78.59 44.76 10.27 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 117.0 1.56 . . . . 0.0 117.0 -167.609 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 41.1 ttmt -151.13 111.28 4.12 Favored 'General case' 0 CA--C 1.551 0.994 0 N-CA-C 106.481 -1.674 . . . . 0.0 106.481 -177.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 65.5 mt -85.21 95.3 9.13 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-O 122.976 1.369 . . . . 0.0 109.428 177.526 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 88.7 t -87.1 97.76 6.67 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.334 0 CA-C-N 112.617 -2.083 . . . . 0.0 105.876 -178.405 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 22.7 t-160 -102.44 139.39 38.11 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 124.396 1.078 . . . . 0.0 109.405 -176.513 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 28.2 tp -136.69 115.29 11.98 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 178.514 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 89.4 mt-30 -104.22 115.77 30.99 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 175.726 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt -121.87 135.68 54.9 Favored 'General case' 0 N--CA 1.493 1.701 0 C-N-CA 123.335 0.654 . . . . 0.0 111.789 -171.741 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 16.3 p90 -159.0 110.91 2.15 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 123.333 0.653 . . . . 0.0 110.536 -174.607 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 5.7 t70 52.59 54.45 10.58 Favored 'General case' 0 N--CA 1.498 1.948 0 N-CA-C 116.567 2.062 . . . . 0.0 116.567 165.328 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 88.76 -46.0 3.27 Favored Glycine 0 CA--C 1.549 2.206 0 N-CA-C 116.434 1.334 . . . . 0.0 116.434 -169.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 16.3 mt-30 -83.6 129.21 34.96 Favored 'General case' 0 N--CA 1.488 1.446 0 CA-C-N 117.957 0.878 . . . . 0.0 111.233 -178.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -141.21 124.75 16.74 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 122.786 0.435 . . . . 0.0 110.664 177.005 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 13.0 t -110.8 135.52 51.24 Favored 'General case' 0 N--CA 1.492 1.656 0 C-N-CA 123.108 0.563 . . . . 0.0 110.643 176.273 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 37.9 p -100.27 131.02 46.44 Favored 'General case' 0 N--CA 1.492 1.628 0 C-N-CA 123.021 0.528 . . . . 0.0 110.761 174.608 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 5.4 mp -111.73 76.18 0.96 Allowed 'General case' 0 CA--C 1.563 1.447 0 C-N-CA 124.005 0.922 . . . . 0.0 108.783 -179.446 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 87.5 t -87.04 110.1 20.0 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 -168.242 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 83.9 mtt85 -102.38 118.49 36.99 Favored 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 122.975 0.51 . . . . 0.0 109.939 -175.777 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -135.32 127.96 30.85 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 123.34 0.656 . . . . 0.0 110.665 -169.539 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -80.91 114.64 19.93 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.833 -0.542 . . . . 0.0 111.395 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 85.8 mt -124.14 106.98 17.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 N-CA-C 105.015 -2.217 . . . . 0.0 105.015 178.512 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 23.4 m-20 58.17 50.3 10.1 Favored 'General case' 0 N--CA 1.499 1.989 0 N-CA-C 115.15 1.537 . . . . 0.0 115.15 177.031 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 60.73 31.24 74.76 Favored Glycine 0 CA--C 1.554 2.503 0 N-CA-C 118.964 2.346 . . . . 0.0 118.964 -169.453 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 92.1 mttt -133.65 128.55 35.3 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-N 119.135 1.468 . . . . 0.0 108.686 -175.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 12.3 tp -79.76 107.42 12.52 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 123.433 0.693 . . . . 0.0 109.389 177.61 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 31.6 mm -99.42 99.29 8.26 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 N-CA-C 106.536 -1.653 . . . . 0.0 106.536 -175.598 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 21.9 tp -87.86 102.99 15.24 Favored 'General case' 0 N--CA 1.486 1.372 0 CA-C-O 121.843 0.83 . . . . 0.0 109.549 178.699 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 90.9 m -95.76 103.61 15.5 Favored 'General case' 0 CA--C 1.561 1.389 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 -175.545 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 90.3 mt -97.61 100.49 11.89 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 123.581 0.752 . . . . 0.0 109.809 -174.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 8.1 m -113.89 125.28 53.87 Favored 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 -175.035 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 82.9 t60 -129.48 -102.9 0.31 Allowed 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.982 -0.748 . . . . 0.0 108.982 175.352 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -112.32 88.6 0.5 Allowed Glycine 0 N--CA 1.485 1.923 0 CA-C-N 119.183 0.901 . . . . 0.0 112.003 -171.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . 0.298 2.6 m 54.49 44.61 28.53 Favored 'General case' 0 CA--C 1.578 2.032 0 N-CA-C 115.381 1.623 . . . . 0.0 115.381 -175.68 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -163.66 95.68 0.82 Allowed 'General case' 0 N--CA 1.483 1.193 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 178.12 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 2.9 p -91.69 115.87 31.67 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 C-N-CA 123.402 0.681 . . . . 0.0 109.415 174.717 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 53.3 t -95.7 105.4 17.39 Favored 'General case' 0 CA--C 1.551 1.01 0 CA-C-O 121.302 0.573 . . . . 0.0 110.572 173.187 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 75.7 m -91.88 113.53 25.82 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 -178.64 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 83.3 mtp180 -113.53 109.36 18.52 Favored 'General case' 0 N--CA 1.486 1.332 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.615 -168.457 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 88.4 m -84.01 127.21 33.72 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 123.165 0.586 . . . . 0.0 109.947 178.058 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 43.1 m-85 -123.71 127.94 48.89 Favored 'General case' 0 CA--C 1.56 1.345 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 175.292 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -91.1 152.59 20.55 Favored 'General case' 0 N--CA 1.496 1.83 0 CA-C-O 121.879 0.847 . . . . 0.0 111.736 170.142 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 70.9 tttt -82.15 122.71 28.22 Favored 'General case' 0 N--CA 1.487 1.404 0 CA-C-O 121.587 0.708 . . . . 0.0 111.975 -171.456 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 24.5 mm-40 -119.04 50.94 1.16 Allowed 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 124.225 1.01 . . . . 0.0 111.605 -174.258 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 0.872 0 CA-C-O 123.155 1.455 . . . . 0.0 110.131 -162.634 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.253 5.1 p . . . . . 0 CA--C 1.576 1.968 0 N-CA-C 114.581 1.326 . . . . 0.0 114.581 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -85.12 -36.59 21.02 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 115.561 1.689 . . . . 0.0 115.561 -173.609 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -58.52 -24.73 61.28 Favored 'General case' 0 N--CA 1.497 1.891 0 N-CA-C 117.694 2.479 . . . . 0.0 117.694 168.558 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -68.72 -20.17 64.38 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 116.84 2.163 . . . . 0.0 116.84 167.101 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 56.2 mt -80.44 126.81 31.66 Favored 'General case' 0 N--CA 1.486 1.352 0 CA-C-N 120.627 1.558 . . . . 0.0 111.882 -170.402 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 155.79 178.14 29.7 Favored Glycine 0 CA--C 1.541 1.713 0 CA-C-O 122.03 0.795 . . . . 0.0 113.557 -178.112 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 43.1 m -92.94 135.69 33.93 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 168.53 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 89.3 m95 -137.21 113.79 10.26 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 -170.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 26.7 mtpt -93.49 148.69 21.85 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 121.927 0.87 . . . . 0.0 111.366 172.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 20.2 tp -71.4 135.61 47.34 Favored 'General case' 0 N--CA 1.486 1.368 0 CA-C-O 122.32 1.057 . . . . 0.0 112.53 -178.478 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . 0.271 1.1 t -114.52 -43.76 4.06 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.878 0 CA-C-N 113.786 -1.552 . . . . 0.0 111.953 -177.589 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -127.28 150.8 49.4 Favored 'General case' 0 N--CA 1.494 1.76 0 CA-C-N 119.986 1.267 . . . . 0.0 110.65 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 81.1 p -145.2 88.71 1.89 Allowed 'General case' 0 N--CA 1.49 1.544 0 CA-C-O 121.22 0.533 . . . . 0.0 110.244 167.484 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -102.22 125.24 48.87 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 123.4 0.68 . . . . 0.0 109.201 177.165 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.288 53.6 m-20 72.57 17.07 4.69 Favored 'General case' 0 N--CA 1.503 2.206 0 N-CA-C 117.491 2.404 . . . . 0.0 117.491 -178.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 30.9 t80 -68.77 -41.91 78.16 Favored 'General case' 0 N--CA 1.497 1.894 0 N-CA-C 115.091 1.515 . . . . 0.0 115.091 178.202 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -49.58 -49.01 48.28 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 116.009 1.855 . . . . 0.0 116.009 165.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 18.4 t0 -59.21 -50.59 73.44 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 115.397 1.628 . . . . 0.0 115.397 172.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 88.2 t80 -52.67 -51.79 58.67 Favored 'General case' 0 CA--C 1.572 1.794 0 N-CA-C 115.6 1.704 . . . . 0.0 115.6 170.349 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 5.5 mmm -64.78 -40.07 94.64 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 115.124 1.527 . . . . 0.0 115.124 176.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 21.7 ttmm -55.96 -45.29 78.92 Favored 'General case' 0 CA--C 1.571 1.769 0 N-CA-C 115.14 1.534 . . . . 0.0 115.14 166.317 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 12.8 t -59.77 -38.42 81.77 Favored 'General case' 0 CA--C 1.571 1.763 0 N-CA-C 116.407 2.003 . . . . 0.0 116.407 170.42 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 75.8 mt -65.16 -25.47 67.75 Favored 'General case' 0 CA--C 1.568 1.661 0 N-CA-C 117.601 2.445 . . . . 0.0 117.601 168.49 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 98.76 70.36 0.97 Allowed Glycine 0 N--CA 1.482 1.731 0 CA-C-N 119.085 0.857 . . . . 0.0 112.256 -171.026 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 45.3 t -142.28 120.13 7.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 N-CA-C 105.502 -2.036 . . . . 0.0 105.502 -178.338 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -81.1 -157.49 17.36 Favored Glycine 0 CA--C 1.547 2.065 0 N-CA-C 115.534 0.973 . . . . 0.0 115.534 -179.413 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 12.1 p90 -70.01 160.72 31.42 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 113.385 0.883 . . . . 0.0 113.385 179.637 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . 0.329 . . 78.25 -50.07 0.48 Allowed 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 115.439 1.644 . . . . 0.0 115.439 178.431 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 34.0 m -70.51 -37.49 74.17 Favored 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 113.604 0.964 . . . . 0.0 113.604 167.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 42.3 mtm105 -57.97 -44.6 87.2 Favored 'General case' 0 N--CA 1.498 1.97 0 N-CA-C 115.232 1.567 . . . . 0.0 115.232 164.52 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 10.3 tm0? -68.68 -52.8 27.1 Favored 'General case' 0 CA--C 1.561 1.389 0 N-CA-C 114.871 1.434 . . . . 0.0 114.871 176.697 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 85.5 t -66.4 -40.62 87.08 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 CA-C-O 117.763 -1.113 . . . . 0.0 113.166 -179.064 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -71.27 -26.84 63.06 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 117.052 2.241 . . . . 0.0 117.052 176.107 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 90.6 p -68.91 -47.37 65.96 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 115.022 1.49 . . . . 0.0 115.022 164.134 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 52.1 ttp -61.91 -39.6 92.56 Favored 'General case' 0 CA--C 1.57 1.731 0 N-CA-C 116.482 2.03 . . . . 0.0 116.482 171.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 52.7 m -67.35 146.97 53.55 Favored 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 124.764 1.225 . . . . 0.0 111.941 178.441 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -102.23 100.37 15.21 Favored Pre-proline 0 CA--C 1.57 1.744 0 N-CA-C 108.307 -0.998 . . . . 0.0 108.307 172.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -79.11 104.39 1.77 Allowed 'Trans proline' 0 CA--C 1.562 1.888 0 C-N-CA 123.223 2.615 . . . . 0.0 111.293 -178.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 96.2 m -80.16 108.33 13.67 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 123.352 0.661 . . . . 0.0 110.495 -164.714 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 28.7 m -91.39 109.79 21.07 Favored 'General case' 0 CA--C 1.559 1.318 0 C-N-CA 123.336 0.654 . . . . 0.0 110.03 -170.442 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 75.0 mt -100.56 109.36 25.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 N-CA-C 106.567 -1.642 . . . . 0.0 106.567 176.321 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 30.4 mt -104.82 118.31 51.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 N-CA-C 106.906 -1.516 . . . . 0.0 106.906 -179.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -137.79 117.24 12.86 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 -175.101 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 7.7 ttpm? -91.5 116.26 28.71 Favored 'General case' 0 CA--C 1.557 1.217 0 CA-C-O 121.439 0.637 . . . . 0.0 110.051 172.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 22.7 t-20 -71.64 -50.52 29.86 Favored 'General case' 0 CA--C 1.57 1.72 0 N-CA-C 112.982 0.734 . . . . 0.0 112.982 166.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -172.25 -82.4 0.05 OUTLIER Glycine 0 N--CA 1.481 1.659 0 N-CA-C 109.25 -1.54 . . . . 0.0 109.25 173.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 24.3 t0 -72.14 -37.69 69.38 Favored 'General case' 0 CA--C 1.57 1.741 0 N-CA-C 115.096 1.517 . . . . 0.0 115.096 162.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 31.6 mm -91.11 120.32 39.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 CA-C-N 118.993 0.815 . . . . 0.0 109.69 -173.524 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 12.7 mt -86.38 125.88 33.97 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 123.419 0.688 . . . . 0.0 109.811 158.651 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 57.7 m -113.91 103.79 11.52 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 -179.795 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 9.5 tt -102.48 108.55 19.9 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 178.598 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -104.75 111.8 24.65 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 -179.469 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 98.2 m -98.51 99.98 11.18 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 20.6 m-70 -90.48 95.96 10.42 Favored 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 123.393 0.677 . . . . 0.0 110.344 -172.198 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 22.8 t . . . . . 0 CA--C 1.554 1.121 0 CA-C-O 121.981 0.896 . . . . 0.0 110.322 -179.345 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 83.0 m-20 . . . . . 0 N--CA 1.489 1.524 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 31.8 p -105.58 132.39 51.79 Favored 'General case' 0 N--CA 1.496 1.874 0 C-N-CA 123.355 0.662 . . . . 0.0 110.825 -177.551 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -121.43 118.3 29.04 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 123.918 0.887 . . . . 0.0 108.813 -178.116 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 39.5 pt -110.35 129.57 65.18 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.875 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 173.684 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 52.2 p -115.75 114.26 24.55 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 178.276 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 45.9 p90 -142.68 146.54 34.52 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 114.306 1.225 . . . . 0.0 114.306 -161.162 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 50.2 mtmt -115.5 28.12 8.88 Favored 'General case' 0 CA--C 1.572 1.823 0 N-CA-C 115.678 1.733 . . . . 0.0 115.678 -171.122 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . 0.308 0.1 OUTLIER 52.81 82.73 0.07 Allowed 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 115.866 1.802 . . . . 0.0 115.866 175.551 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 101.88 39.24 2.96 Favored Glycine 0 CA--C 1.55 2.234 0 N-CA-C 116.336 1.294 . . . . 0.0 116.336 -171.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 94.7 t -139.74 127.52 25.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 N-CA-C 106.442 -1.688 . . . . 0.0 106.442 -179.199 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -89.01 128.92 35.73 Favored 'General case' 0 CA--C 1.564 1.499 0 C-N-CA 122.997 0.519 . . . . 0.0 110.366 175.592 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 43.5 p90 -138.91 123.14 18.1 Favored 'General case' 0 N--CA 1.494 1.764 0 C-N-CA 123.391 0.677 . . . . 0.0 109.855 -176.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -72.37 112.85 8.79 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.097 -1.002 . . . . 0.0 112.382 178.462 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -115.33 135.91 53.65 Favored 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 124.024 0.929 . . . . 0.0 110.241 -168.103 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 42.9 m -86.96 122.79 31.3 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-O 121.61 0.719 . . . . 0.0 109.529 173.173 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 43.1 p -82.45 177.76 8.58 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 113.197 0.814 . . . . 0.0 113.197 -173.546 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -55.85 -35.75 66.78 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 117.69 2.478 . . . . 0.0 117.69 168.46 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -92.47 17.19 10.36 Favored 'General case' 0 CA--C 1.577 1.991 0 N-CA-C 115.136 1.532 . . . . 0.0 115.136 170.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 63.01 80.17 0.24 Allowed 'General case' 0 N--CA 1.496 1.854 0 C-N-CA 125.281 1.432 . . . . 0.0 113.272 -178.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 14.9 ttm180 -146.09 126.13 13.71 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 -176.176 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.77 120.51 15.62 Favored 'General case' 0 N--CA 1.493 1.678 0 CA-C-N 118.124 0.42 . . . . 0.0 110.272 168.174 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 12.4 m -138.69 121.42 18.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 N-CA-C 107.999 -1.112 . . . . 0.0 107.999 -176.156 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 1.5 mptm? -76.76 104.13 7.09 Favored 'General case' 0 N--CA 1.489 1.487 0 CA-C-O 121.89 0.852 . . . . 0.0 109.599 -177.349 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 74.0 m -98.95 96.41 7.81 Favored 'General case' 0 N--CA 1.481 1.116 0 CA-C-N 114.894 -1.048 . . . . 0.0 109.92 -164.44 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -106.39 108.31 24.81 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 177.422 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 1.4 p -121.88 126.76 74.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 C-N-CA 124.025 0.93 . . . . 0.0 109.304 -174.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 9.8 t -146.34 152.1 38.57 Favored 'General case' 0 N--CA 1.489 1.515 0 CA-C-O 122.531 1.158 . . . . 0.0 110.643 -177.859 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 24.8 tp -87.73 103.47 15.64 Favored 'General case' 0 N--CA 1.49 1.536 0 CA-C-N 114.889 -1.051 . . . . 0.0 109.425 175.778 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -107.01 93.57 4.63 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 123.607 0.763 . . . . 0.0 109.41 -175.674 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 59.3 49.1 82.2 Favored Glycine 0 N--CA 1.488 2.108 0 N-CA-C 117.712 1.845 . . . . 0.0 117.712 -179.825 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 91.59 -37.44 3.39 Favored Glycine 0 CA--C 1.551 2.31 0 N-CA-C 117.232 1.653 . . . . 0.0 117.232 -170.352 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.72 122.32 29.64 Favored 'General case' 0 N--CA 1.486 1.368 0 CA-C-N 118.92 1.36 . . . . 0.0 110.328 -176.857 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 5.8 tt -85.98 95.86 9.64 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 108.569 -0.901 . . . . 0.0 108.569 179.032 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 53.0 t -97.61 108.09 21.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 -166.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 21.6 t-160 -101.92 108.64 20.17 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 123.255 0.622 . . . . 0.0 110.032 175.682 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 31.8 tp -98.0 116.32 29.97 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 175.587 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -100.22 129.45 46.23 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 168.64 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 16.7 ptmt -140.08 128.63 22.9 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.746 -0.596 . . . . 0.0 111.399 -173.238 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 30.8 p90 -154.44 119.17 4.9 Favored 'General case' 0 N--CA 1.491 1.606 0 C-N-CA 123.808 0.843 . . . . 0.0 109.727 -168.059 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 4.5 t70 45.34 59.58 3.48 Favored 'General case' 0 N--CA 1.503 2.18 0 N-CA-C 117.616 2.45 . . . . 0.0 117.616 164.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 63.8 31.05 79.48 Favored Glycine 0 CA--C 1.558 2.73 0 N-CA-C 119.42 2.528 . . . . 0.0 119.42 -171.617 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -152.44 123.6 7.6 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 106.705 -1.591 . . . . 0.0 106.705 -176.193 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -138.56 132.49 31.19 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.47 -0.769 . . . . 0.0 112.261 179.128 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 14.6 t -116.32 134.01 55.37 Favored 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 123.581 0.752 . . . . 0.0 110.406 173.755 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 34.9 p -100.8 131.07 46.86 Favored 'General case' 0 N--CA 1.493 1.699 0 CA-C-O 122.143 0.973 . . . . 0.0 110.128 169.292 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 5.4 mp -112.47 87.0 2.47 Favored 'General case' 0 CA--C 1.56 1.347 0 N-CA-C 106.407 -1.701 . . . . 0.0 106.407 -178.71 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 72.4 t -92.88 99.89 10.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 -169.186 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 20.5 mmt180 -86.27 125.26 33.46 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 124.126 0.971 . . . . 0.0 109.883 176.052 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -151.89 131.74 13.29 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.877 -0.514 . . . . 0.0 112.11 -173.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -78.73 120.24 23.09 Favored 'General case' 0 N--CA 1.49 1.525 0 CA-C-O 121.295 0.569 . . . . 0.0 111.755 177.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 92.3 mt -129.16 105.72 13.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 N-CA-C 104.603 -2.369 . . . . 0.0 104.603 176.445 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 57.75 52.31 8.28 Favored 'General case' 0 N--CA 1.499 2.001 0 N-CA-C 114.997 1.481 . . . . 0.0 114.997 175.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 67.85 12.07 61.63 Favored Glycine 0 CA--C 1.557 2.673 0 N-CA-C 119.962 2.745 . . . . 0.0 119.962 -171.655 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -124.73 126.59 45.92 Favored 'General case' 0 N--CA 1.486 1.358 0 CA-C-N 119.645 1.723 . . . . 0.0 108.626 -175.196 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 58.7 tp -83.96 108.57 17.01 Favored 'General case' 0 N--CA 1.483 1.189 0 CA-C-O 121.508 0.67 . . . . 0.0 110.226 -179.622 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 28.1 mm -97.51 106.8 19.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 -172.02 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 44.4 tp -86.04 111.84 20.69 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 123.557 0.743 . . . . 0.0 109.075 171.232 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 88.1 m -105.7 105.9 16.16 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 -176.347 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 88.6 mt -101.37 100.6 11.11 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 123.486 0.714 . . . . 0.0 109.948 -171.33 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 7.8 m -116.37 121.1 40.95 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 -174.516 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 83.1 t60 -126.42 -101.51 0.36 Allowed 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 175.571 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -111.0 92.71 0.68 Allowed Glycine 0 N--CA 1.483 1.814 0 CA-C-N 119.375 0.989 . . . . 0.0 111.454 -172.683 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . 0.395 6.4 t 49.03 40.38 17.0 Favored 'General case' 0 N--CA 1.499 2.011 0 N-CA-C 117.746 2.499 . . . . 0.0 117.746 -172.864 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -155.49 93.68 1.51 Allowed 'General case' 0 N--CA 1.483 1.211 0 O-C-N 121.569 -0.707 . . . . 0.0 109.217 178.384 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 4.3 p -89.39 121.23 39.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 C-N-CA 123.418 0.687 . . . . 0.0 109.602 172.352 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 45.0 t -105.28 120.44 41.57 Favored 'General case' 0 CA--C 1.553 1.077 0 C-N-CA 123.045 0.538 . . . . 0.0 111.4 177.65 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 80.1 m -87.21 110.61 20.28 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 175.196 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 6.2 mmm180 -115.03 95.87 5.42 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 107.448 -1.316 . . . . 0.0 107.448 -179.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 86.2 m -82.76 143.51 30.81 Favored 'General case' 0 N--CA 1.494 1.774 0 C-N-CA 123.721 0.809 . . . . 0.0 110.402 -177.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 47.1 m-85 -131.34 127.61 38.0 Favored 'General case' 0 CA--C 1.557 1.232 0 C-N-CA 123.442 0.697 . . . . 0.0 109.767 -178.096 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -95.77 156.89 16.14 Favored 'General case' 0 N--CA 1.492 1.668 0 CA-C-O 122.671 1.224 . . . . 0.0 111.294 165.115 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 73.8 tttt -90.47 114.49 26.67 Favored 'General case' 0 N--CA 1.484 1.244 0 CA-C-N 114.895 -1.048 . . . . 0.0 111.712 -165.698 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -74.11 -33.99 63.79 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 117.116 2.265 . . . . 0.0 117.116 172.452 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.125 0 CA-C-O 124.198 1.952 . . . . 0.0 108.527 173.731 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 5.4 p . . . . . 0 CA--C 1.578 2.041 0 N-CA-C 115.883 1.809 . . . . 0.0 115.883 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -64.85 -36.71 85.22 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 116.764 2.135 . . . . 0.0 116.764 -175.168 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -58.13 -29.25 65.38 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 117.742 2.497 . . . . 0.0 117.742 169.146 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -69.47 -25.29 64.01 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 116.231 1.937 . . . . 0.0 116.231 169.576 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 45.8 mt -77.37 110.22 11.94 Favored 'General case' 0 N--CA 1.489 1.518 0 CA-C-N 121.012 1.733 . . . . 0.0 111.466 -162.715 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 157.8 172.02 24.47 Favored Glycine 0 CA--C 1.546 2.024 0 CA-C-O 122.718 1.177 . . . . 0.0 112.797 -167.571 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 54.1 m -87.25 139.42 30.58 Favored 'General case' 0 N--CA 1.494 1.731 0 CA-C-N 114.296 -0.952 . . . . 0.0 109.734 172.257 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 82.8 m95 -136.62 113.67 10.55 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 -177.444 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -95.41 146.51 24.35 Favored 'General case' 0 N--CA 1.494 1.726 0 CA-C-O 121.439 0.638 . . . . 0.0 110.292 173.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 48.6 tp -68.48 120.16 14.11 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-O 121.649 0.737 . . . . 0.0 111.738 -179.164 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . 0.263 1.1 t -83.66 -51.02 14.76 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.753 0 CA-C-N 114.676 -1.147 . . . . 0.0 111.666 170.495 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -148.36 125.39 11.36 Favored 'General case' 0 CA--C 1.557 1.244 0 CA-C-N 119.032 0.833 . . . . 0.0 109.619 -168.057 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 72.7 p -102.93 100.27 10.23 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 123.373 0.669 . . . . 0.0 110.441 172.508 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 33.7 mmtp -95.9 116.49 28.99 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 109.508 -0.552 . . . . 0.0 109.508 -179.225 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.258 28.6 m-20 71.2 24.53 3.8 Favored 'General case' 0 N--CA 1.504 2.265 0 N-CA-C 117.101 2.26 . . . . 0.0 117.101 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 40.0 t80 -69.58 -50.31 45.87 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 120.138 -1.601 . . . . 0.0 114.727 -175.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 71.1 m-20 -51.58 -27.76 12.0 Favored 'General case' 0 N--CA 1.497 1.925 0 N-CA-C 117.909 2.559 . . . . 0.0 117.909 168.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 24.2 t0 -66.35 -52.9 42.33 Favored 'General case' 0 N--CA 1.496 1.869 0 CA-C-N 120.251 1.387 . . . . 0.0 114.199 166.59 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 88.5 t80 -50.63 -46.23 58.15 Favored 'General case' 0 CA--C 1.573 1.852 0 N-CA-C 115.683 1.734 . . . . 0.0 115.683 168.369 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 47.9 mmm -63.49 -41.33 98.57 Favored 'General case' 0 CA--C 1.567 1.631 0 N-CA-C 114.718 1.377 . . . . 0.0 114.718 174.047 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 13.6 tmtt? -61.18 -44.79 96.73 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 115.248 1.573 . . . . 0.0 115.248 167.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 15.1 t -57.03 -39.62 75.15 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 116.31 1.967 . . . . 0.0 116.31 172.385 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 75.1 mt -65.07 -43.57 91.77 Favored 'General case' 0 CA--C 1.567 1.606 0 N-CA-C 115.572 1.693 . . . . 0.0 115.572 165.164 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 117.98 68.97 0.36 Allowed Glycine 0 N--CA 1.483 1.807 0 C-N-CA 124.148 0.88 . . . . 0.0 112.03 -178.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 18.3 t -140.74 114.98 5.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 N-CA-C 105.919 -1.882 . . . . 0.0 105.919 -174.208 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -85.99 -79.69 1.17 Allowed Glycine 0 N--CA 1.483 1.806 0 N-CA-C 114.724 0.65 . . . . 0.0 114.724 -175.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 20.8 p90 -132.16 163.32 28.8 Favored 'General case' 0 N--CA 1.492 1.655 0 C-N-CA 123.472 0.709 . . . . 0.0 111.474 -177.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . 0.333 . . 79.13 -58.13 0.41 Allowed 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 115.023 1.49 . . . . 0.0 115.023 173.335 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 80.2 m -69.98 -39.75 75.75 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 113.31 0.856 . . . . 0.0 113.31 166.069 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 45.0 ttp180 -63.77 -41.55 97.95 Favored 'General case' 0 CA--C 1.565 1.529 0 N-CA-C 114.966 1.469 . . . . 0.0 114.966 168.704 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 11.5 tm0? -66.55 -49.2 67.23 Favored 'General case' 0 CA--C 1.562 1.438 0 N-CA-C 115.127 1.529 . . . . 0.0 115.127 173.106 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 73.7 t -63.96 -42.39 95.58 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.026 0 CA-C-N 119.912 1.233 . . . . 0.0 113.271 178.593 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -73.15 -32.55 64.96 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 116.938 2.199 . . . . 0.0 116.938 176.704 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 85.7 p -68.63 -44.14 74.83 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 115.265 1.579 . . . . 0.0 115.265 167.248 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 51.7 tpp -68.7 -35.75 77.58 Favored 'General case' 0 CA--C 1.564 1.513 0 N-CA-C 116.459 2.022 . . . . 0.0 116.459 177.192 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 5.1 t -75.16 165.65 24.89 Favored 'General case' 0 N--CA 1.494 1.764 0 CA-C-N 119.9 1.227 . . . . 0.0 112.853 178.726 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.74 100.25 10.64 Favored Pre-proline 0 CA--C 1.57 1.746 0 CA-C-O 118.281 -0.866 . . . . 0.0 109.426 168.044 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -77.08 95.16 1.06 Allowed 'Trans proline' 0 C--N 1.373 1.83 0 C-N-CA 123.294 2.663 . . . . 0.0 111.124 -179.758 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 98.0 m -82.44 105.75 13.75 Favored 'General case' 0 N--CA 1.487 1.412 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.643 -158.466 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 93.5 m -81.34 112.97 19.12 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 123.746 0.818 . . . . 0.0 110.072 -175.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 79.1 mt -112.49 107.18 22.32 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 N-CA-C 105.985 -1.857 . . . . 0.0 105.985 -179.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 4.0 mp -94.7 123.67 46.9 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 175.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 5.8 tm-20 -136.11 112.18 9.67 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 -176.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 83.8 tttt -90.18 113.12 24.84 Favored 'General case' 0 CA--C 1.556 1.211 0 C-N-CA 123.023 0.529 . . . . 0.0 109.825 174.253 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 21.9 t-20 -80.56 -64.76 1.12 Allowed 'General case' 0 CA--C 1.564 1.504 0 C-N-CA 123.31 0.644 . . . . 0.0 111.768 179.233 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -131.68 -94.63 0.63 Allowed Glycine 0 N--CA 1.485 1.903 0 N-CA-C 108.941 -1.664 . . . . 0.0 108.941 169.024 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -77.46 -29.26 52.68 Favored 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 115.361 1.615 . . . . 0.0 115.361 162.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 35.3 mm -88.96 124.95 42.02 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.475 0 CA-C-N 119.108 0.867 . . . . 0.0 109.656 -168.438 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 21.2 mt -89.65 121.07 31.49 Favored 'General case' 0 N--CA 1.485 1.294 0 CA-C-N 114.901 -1.045 . . . . 0.0 110.53 169.103 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 87.0 m -108.8 104.07 13.26 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 179.371 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 7.9 tt -104.56 109.97 22.08 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -106.51 116.88 32.7 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 123.503 0.721 . . . . 0.0 109.205 178.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 94.1 m -102.91 101.28 11.29 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 177.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 23.0 m-70 -88.27 93.96 9.68 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 123.473 0.709 . . . . 0.0 111.838 -170.007 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 33.3 t . . . . . 0 CA--C 1.557 1.23 0 CA-C-O 122.019 0.914 . . . . 0.0 110.548 176.838 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 9.7 p30 . . . . . 0 N--CA 1.491 1.599 0 N-CA-C 112.311 0.485 . . . . 0.0 112.311 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 78.3 p -95.23 127.46 41.3 Favored 'General case' 0 N--CA 1.496 1.844 0 C-N-CA 122.917 0.487 . . . . 0.0 110.509 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -119.16 111.95 18.9 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 -176.63 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 39.1 pt -105.64 128.3 59.86 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 173.357 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 42.2 t -116.74 108.38 15.82 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 179.552 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 48.6 p90 -140.39 157.9 44.83 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 114.947 1.462 . . . . 0.0 114.947 -159.222 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 54.9 mtpt -120.15 150.38 40.72 Favored 'General case' 0 CA--C 1.563 1.449 0 CA-C-N 113.971 -1.468 . . . . 0.0 108.68 165.177 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -75.04 113.18 12.06 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.566 -0.709 . . . . 0.0 112.246 -170.213 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 83.61 39.68 9.49 Favored Glycine 0 CA--C 1.551 2.326 0 N-CA-C 116.631 1.412 . . . . 0.0 116.631 -169.522 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 76.5 t -140.76 117.64 8.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 N-CA-C 105.339 -2.097 . . . . 0.0 105.339 -175.284 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -83.17 135.62 34.73 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 122.823 0.449 . . . . 0.0 111.919 -179.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 36.0 p90 -140.92 133.43 28.52 Favored 'General case' 0 N--CA 1.494 1.743 0 C-N-CA 123.687 0.795 . . . . 0.0 110.83 -174.431 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -75.04 117.81 17.29 Favored 'General case' 0 CA--C 1.565 1.521 0 O-C-N 121.478 -0.764 . . . . 0.0 112.314 176.159 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 25.7 tp10 -118.31 135.52 54.26 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 123.954 0.902 . . . . 0.0 110.416 -171.406 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 84.8 m -97.01 119.79 36.15 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 171.648 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 22.9 p -86.14 -178.12 6.44 Favored 'General case' 0 N--CA 1.494 1.762 0 CA-C-O 122.192 0.996 . . . . 0.0 113.308 -171.636 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -52.7 -40.13 62.66 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 117.692 2.479 . . . . 0.0 117.692 167.097 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 42.5 m-20 -81.82 5.31 19.14 Favored 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 116.151 1.908 . . . . 0.0 116.151 169.377 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . 0.251 10.0 m-20 62.58 75.22 0.41 Allowed 'General case' 0 N--CA 1.496 1.868 0 C-N-CA 125.265 1.426 . . . . 0.0 112.048 -171.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 42.1 ttp180 -138.05 120.58 16.09 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 -168.051 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.16 95.39 5.59 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 123.407 0.683 . . . . 0.0 111.922 -178.634 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 12.0 m -116.74 127.05 74.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 -167.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 33.5 mmtp -83.6 104.44 13.73 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 123.605 0.762 . . . . 0.0 109.974 -178.593 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 74.5 m -102.28 107.87 19.05 Favored 'General case' 0 N--CA 1.483 1.189 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.022 -161.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 7.2 tp -115.92 104.22 16.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 C-N-CA 124.027 0.931 . . . . 0.0 108.64 -178.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -118.33 124.61 73.38 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 C-N-CA 124.127 0.971 . . . . 0.0 109.117 178.422 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 15.2 t -125.92 157.75 36.92 Favored 'General case' 0 N--CA 1.493 1.691 0 CA-C-O 122.471 1.129 . . . . 0.0 111.496 170.751 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 14.5 tp -92.49 122.61 35.09 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-N 114.938 -1.028 . . . . 0.0 110.138 175.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -122.75 79.58 1.65 Allowed 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 123.307 0.643 . . . . 0.0 109.885 -178.054 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 64.3 49.34 66.53 Favored Glycine 0 CA--C 1.55 2.235 0 N-CA-C 117.188 1.635 . . . . 0.0 117.188 -175.126 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 74.2 43.77 31.19 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 117.321 1.688 . . . . 0.0 117.321 -171.343 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -153.67 108.61 3.14 Favored 'General case' 0 CA--C 1.554 1.107 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 -169.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 50.9 mt -83.05 96.57 8.4 Favored 'General case' 0 N--CA 1.492 1.655 0 CA-C-O 122.812 1.292 . . . . 0.0 109.56 177.225 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 93.0 t -87.88 100.68 10.59 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.356 0 CA-C-N 112.972 -1.922 . . . . 0.0 105.944 179.125 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 22.6 t-160 -105.83 141.8 36.64 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 124.075 0.95 . . . . 0.0 109.598 -176.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 34.8 tp -140.13 121.24 14.75 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 177.231 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 87.7 mt-30 -115.55 110.38 19.15 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 -177.585 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -107.73 134.51 50.59 Favored 'General case' 0 N--CA 1.494 1.752 0 C-N-CA 122.986 0.514 . . . . 0.0 111.351 -174.101 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 17.5 p90 -151.04 108.72 3.66 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.398 -0.814 . . . . 0.0 109.877 177.539 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 7.1 t70 55.66 52.2 11.35 Favored 'General case' 0 N--CA 1.499 2.007 0 N-CA-C 116.408 2.003 . . . . 0.0 116.408 168.468 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 85.71 -42.55 3.16 Favored Glycine 0 CA--C 1.553 2.445 0 N-CA-C 116.768 1.467 . . . . 0.0 116.768 -169.339 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 62.9 mt-30 -78.62 125.8 29.86 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 123.744 0.818 . . . . 0.0 111.037 179.44 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -136.03 128.2 29.88 Favored 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 122.717 0.407 . . . . 0.0 111.452 178.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 7.7 t -113.44 132.57 55.6 Favored 'General case' 0 N--CA 1.495 1.791 0 C-N-CA 123.163 0.585 . . . . 0.0 110.921 177.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 41.2 p -101.01 130.39 47.0 Favored 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 122.896 0.478 . . . . 0.0 110.982 174.145 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 5.3 mp -111.16 79.68 1.23 Allowed 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.288 -1.005 . . . . 0.0 108.288 177.756 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 51.8 t -89.09 108.63 19.28 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 -169.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 80.5 mtt85 -104.35 113.95 27.86 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 122.946 0.498 . . . . 0.0 110.255 -174.776 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -126.0 136.99 53.62 Favored 'General case' 0 N--CA 1.493 1.677 0 C-N-CA 123.307 0.643 . . . . 0.0 111.617 179.08 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -81.81 115.69 21.14 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 123.277 0.631 . . . . 0.0 110.793 175.4 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 86.4 mt -124.75 107.94 19.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 N-CA-C 105.081 -2.192 . . . . 0.0 105.081 179.247 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 20.9 m-20 57.97 51.66 8.7 Favored 'General case' 0 N--CA 1.499 1.988 0 N-CA-C 114.971 1.471 . . . . 0.0 114.971 176.455 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 65.51 16.68 63.41 Favored Glycine 0 CA--C 1.555 2.584 0 N-CA-C 119.857 2.703 . . . . 0.0 119.857 -170.486 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 8.7 mtmp? -128.65 128.66 44.57 Favored 'General case' 0 N--CA 1.488 1.445 0 CA-C-N 119.877 1.838 . . . . 0.0 109.315 -173.447 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 22.2 tp -78.35 113.78 16.64 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 123.847 0.859 . . . . 0.0 109.843 178.501 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 34.9 mm -103.15 101.34 12.05 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 N-CA-C 106.42 -1.696 . . . . 0.0 106.42 -174.63 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 23.6 tp -90.17 103.0 15.72 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 123.915 0.886 . . . . 0.0 109.594 179.414 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 91.8 m -96.82 107.25 19.7 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 -175.335 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 71.9 mt -102.65 99.51 9.5 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 123.762 0.825 . . . . 0.0 109.476 -172.176 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 6.5 m -109.08 119.62 40.1 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 -176.414 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 75.6 t60 -141.12 120.62 13.22 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 171.032 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 74.88 -117.05 5.26 Favored Glycine 0 N--CA 1.484 1.863 0 CA-C-N 116.37 -0.377 . . . . 0.0 112.656 179.013 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 76.6 m -122.19 68.37 0.94 Allowed 'General case' 0 CA--C 1.565 1.553 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 167.471 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -164.06 99.09 0.85 Allowed 'General case' 0 N--CA 1.485 1.314 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 175.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 4.2 p -96.95 122.17 48.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 C-N-CA 123.929 0.892 . . . . 0.0 109.71 176.292 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 42.0 t -110.0 102.44 11.17 Favored 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 123.225 0.61 . . . . 0.0 110.731 178.063 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 63.9 m -90.74 100.39 13.25 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 -176.062 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 30.5 mtm180 -102.44 121.67 42.79 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 122.802 0.441 . . . . 0.0 111.106 -171.038 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 94.6 m -91.05 132.89 35.74 Favored 'General case' 0 CA--C 1.563 1.46 0 C-N-CA 123.763 0.825 . . . . 0.0 110.442 -177.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 37.5 m-85 -131.49 140.35 49.53 Favored 'General case' 0 CA--C 1.562 1.425 0 C-N-CA 124.298 1.039 . . . . 0.0 109.194 179.322 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 1.4 pp20? -111.31 157.8 19.76 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.637 -0.665 . . . . 0.0 111.837 166.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 22.9 ttpt -85.45 129.33 34.84 Favored 'General case' 0 N--CA 1.489 1.498 0 CA-C-O 121.906 0.86 . . . . 0.0 112.241 -167.67 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 28.2 mm-40 -118.27 55.76 0.89 Allowed 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 124.956 1.302 . . . . 0.0 111.089 -173.609 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.9 0 CA-C-O 124.447 2.07 . . . . 0.0 109.074 -168.359 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 3.3 p . . . . . 0 CA--C 1.577 2.0 0 N-CA-C 116.112 1.894 . . . . 0.0 116.112 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -68.19 -33.21 74.02 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 116.709 2.114 . . . . 0.0 116.709 -175.495 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -59.44 -25.27 64.23 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 117.707 2.484 . . . . 0.0 117.707 168.192 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -73.72 -24.3 59.89 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 116.133 1.901 . . . . 0.0 116.133 167.785 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 52.0 mt -79.9 113.84 18.37 Favored 'General case' 0 N--CA 1.489 1.505 0 CA-C-N 120.975 1.716 . . . . 0.0 111.451 -166.369 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 158.91 177.39 31.95 Favored Glycine 0 CA--C 1.543 1.785 0 CA-C-O 122.798 1.221 . . . . 0.0 112.985 -175.063 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 63.1 m -84.81 142.88 29.46 Favored 'General case' 0 N--CA 1.492 1.641 0 CA-C-N 114.57 -0.815 . . . . 0.0 109.817 171.356 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 82.6 m95 -140.9 113.95 8.47 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 107.659 -1.237 . . . . 0.0 107.659 -176.402 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 58.9 mttp -97.68 141.17 31.03 Favored 'General case' 0 N--CA 1.492 1.636 0 CA-C-O 121.016 0.436 . . . . 0.0 109.999 175.476 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 55.8 tp -66.71 124.66 23.51 Favored 'General case' 0 N--CA 1.49 1.56 0 CA-C-O 122.135 0.969 . . . . 0.0 111.668 -178.615 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . 0.284 0.9 OUTLIER -103.78 -43.42 8.58 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.784 0 CA-C-N 113.893 -1.503 . . . . 0.0 112.036 -178.222 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -142.63 129.13 20.17 Favored 'General case' 0 N--CA 1.49 1.545 0 CA-C-N 120.336 1.425 . . . . 0.0 109.778 177.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 87.8 p -111.77 116.5 30.81 Favored 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 123.236 0.614 . . . . 0.0 109.82 167.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -83.99 -75.45 0.34 Allowed 'General case' 0 N--CA 1.492 1.664 0 C-N-CA 122.78 0.432 . . . . 0.0 111.66 -173.519 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 71.4 m-20 -106.44 44.2 1.08 Allowed 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 113.307 0.854 . . . . 0.0 113.307 179.671 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 15.2 t80 -91.37 65.69 5.37 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 120.714 -1.241 . . . . 0.0 111.796 -177.705 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -168.2 -53.47 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 126.534 1.934 . . . . 0.0 107.079 -176.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -55.54 -47.72 75.87 Favored 'General case' 0 N--CA 1.498 1.947 0 N-CA-C 115.228 1.566 . . . . 0.0 115.228 161.648 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 92.8 t80 -52.41 -55.58 20.79 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 114.786 1.402 . . . . 0.0 114.786 170.415 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 75.2 mtm -66.22 -31.65 72.6 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 116.481 2.03 . . . . 0.0 116.481 174.787 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -64.58 -45.26 87.75 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-N 120.197 1.362 . . . . 0.0 114.564 168.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 23.2 t -59.14 -38.88 80.75 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 115.762 1.764 . . . . 0.0 115.762 170.339 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 95.2 mt -64.22 -39.43 93.95 Favored 'General case' 0 CA--C 1.57 1.749 0 N-CA-C 115.472 1.656 . . . . 0.0 115.472 164.785 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 129.51 -95.49 0.36 Allowed Glycine 0 CA--C 1.54 1.604 0 N-CA-C 108.887 -1.685 . . . . 0.0 108.887 -174.028 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . 0.285 13.2 t 56.73 66.95 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.058 0 N-CA-C 114.044 1.127 . . . . 0.0 114.044 168.075 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 34.47 -128.73 0.56 Allowed Glycine 0 CA--C 1.553 2.435 0 N-CA-C 120.077 2.791 . . . . 0.0 120.077 177.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 43.0 p90 -146.37 -54.88 0.26 Allowed 'General case' 0 N--CA 1.494 1.749 0 C-N-CA 124.202 1.001 . . . . 0.0 110.044 169.323 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.96 -33.5 75.51 Favored 'General case' 0 CA--C 1.564 1.49 0 N-CA-C 116.245 1.943 . . . . 0.0 116.245 164.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 29.8 m -63.49 -38.76 92.36 Favored 'General case' 0 N--CA 1.498 1.925 0 CA-C-N 120.284 1.402 . . . . 0.0 114.258 168.14 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 22.7 ttp180 -58.33 -43.67 88.36 Favored 'General case' 0 CA--C 1.573 1.847 0 N-CA-C 115.102 1.519 . . . . 0.0 115.102 167.554 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 8.1 tm0? -65.87 -51.25 60.37 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 115.116 1.524 . . . . 0.0 115.116 173.137 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 94.2 t -60.6 -45.43 97.3 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 CA-C-N 119.249 0.932 . . . . 0.0 113.01 176.332 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -65.42 -36.79 84.99 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 116.472 2.027 . . . . 0.0 116.472 175.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 95.5 p -64.07 -42.14 97.08 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 116.161 1.912 . . . . 0.0 116.161 168.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 35.8 ttm -66.5 -39.71 88.84 Favored 'General case' 0 CA--C 1.57 1.722 0 N-CA-C 115.921 1.822 . . . . 0.0 115.921 169.806 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 54.1 m -70.77 144.25 50.95 Favored 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 124.354 1.062 . . . . 0.0 112.331 -176.609 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? -102.91 99.59 14.28 Favored Pre-proline 0 CA--C 1.573 1.864 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 173.107 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -78.48 111.0 2.95 Favored 'Trans proline' 0 CA--C 1.56 1.804 0 C-N-CA 123.388 2.725 . . . . 0.0 111.594 -178.254 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 97.0 m -78.65 104.84 9.53 Favored 'General case' 0 N--CA 1.491 1.625 0 CA-C-O 121.372 0.606 . . . . 0.0 109.969 -173.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 86.4 m -87.55 114.79 24.48 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 124.086 0.954 . . . . 0.0 109.091 -174.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 81.9 mt -112.46 108.47 25.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 N-CA-C 106.557 -1.646 . . . . 0.0 106.557 -177.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 17.0 mt -97.14 121.24 47.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 -179.21 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -140.7 118.0 11.38 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 -169.728 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 45.2 tttp -90.62 114.91 27.29 Favored 'General case' 0 CA--C 1.557 1.214 0 C-N-CA 123.267 0.627 . . . . 0.0 111.36 -176.365 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 51.4 m-80 -105.82 83.39 1.92 Allowed 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 -179.603 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 80.6 -97.63 1.73 Allowed Glycine 0 N--CA 1.486 2.028 0 O-C-N 121.704 -0.623 . . . . 0.0 112.13 -169.007 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -130.34 62.53 1.58 Allowed 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 159.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 30.8 mm -138.28 100.69 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 N-CA-C 104.818 -2.29 . . . . 0.0 104.818 -178.047 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 71.0 mt -85.35 99.9 11.47 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 122.663 0.385 . . . . 0.0 110.47 -179.132 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 46.9 m -92.4 105.51 17.69 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 107.14 -1.43 . . . . 0.0 107.14 -178.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 10.0 tt -104.68 96.45 6.58 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 106.957 -1.497 . . . . 0.0 106.957 -170.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 58.9 mttp -94.83 106.84 18.85 Favored 'General case' 0 N--CA 1.482 1.133 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 -163.41 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 45.4 m -90.08 92.03 8.8 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 -175.27 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 75.4 m80 -87.64 93.64 9.49 Favored 'General case' 0 N--CA 1.488 1.47 0 CA-C-O 121.733 0.778 . . . . 0.0 110.688 -173.282 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 41.9 t . . . . . 0 CA--C 1.555 1.144 0 C-N-CA 124.051 0.941 . . . . 0.0 110.078 -175.658 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 7.4 p-10 . . . . . 0 N--CA 1.488 1.44 0 CA-C-O 120.513 0.197 . . . . 0.0 111.501 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 73.7 p -133.87 132.68 40.63 Favored 'General case' 0 N--CA 1.496 1.836 0 C-N-CA 123.146 0.579 . . . . 0.0 110.076 -170.805 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -118.95 140.74 49.49 Favored 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 122.944 0.498 . . . . 0.0 112.161 178.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 42.9 pt -117.22 129.97 72.88 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 C-N-CA 123.405 0.682 . . . . 0.0 109.447 -178.66 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 88.2 p -106.46 118.49 36.78 Favored 'General case' 0 N--CA 1.493 1.7 0 C-N-CA 123.745 0.818 . . . . 0.0 110.209 -178.195 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 50.2 p90 -140.82 135.86 31.84 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 115.188 1.551 . . . . 0.0 115.188 -167.55 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 53.1 mtmt -102.74 19.33 19.42 Favored 'General case' 0 CA--C 1.574 1.883 0 N-CA-C 116.556 2.058 . . . . 0.0 116.556 -175.42 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . 0.294 1.3 mp 63.21 93.07 0.06 Allowed 'General case' 0 N--CA 1.494 1.739 0 CA-C-N 120.418 1.463 . . . . 0.0 114.293 173.365 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 85.79 39.59 8.06 Favored Glycine 0 CA--C 1.55 2.259 0 N-CA-C 116.716 1.446 . . . . 0.0 116.716 -167.072 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 87.7 t -139.47 122.71 18.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 N-CA-C 106.324 -1.732 . . . . 0.0 106.324 178.597 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -87.63 125.8 34.58 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 123.448 0.699 . . . . 0.0 110.948 176.41 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 40.8 p90 -132.79 127.7 35.15 Favored 'General case' 0 N--CA 1.493 1.722 0 C-N-CA 123.558 0.743 . . . . 0.0 110.65 -173.179 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -69.52 126.59 30.2 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.607 -0.683 . . . . 0.0 112.734 174.288 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 12.9 tp10 -138.73 133.87 32.79 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 123.193 0.597 . . . . 0.0 110.156 -167.164 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 58.9 m -92.55 121.33 33.89 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 176.22 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 32.0 p -81.41 172.0 14.07 Favored 'General case' 0 N--CA 1.493 1.705 0 CA-C-O 122.041 0.924 . . . . 0.0 113.316 -173.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -51.6 -35.34 41.12 Favored 'General case' 0 CA--C 1.568 1.638 0 N-CA-C 118.038 2.607 . . . . 0.0 118.038 166.415 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -111.18 51.32 0.78 Allowed 'General case' 0 CA--C 1.574 1.867 0 CA-C-N 119.197 0.908 . . . . 0.0 112.177 171.621 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 51.84 73.67 0.31 Allowed 'General case' 0 N--CA 1.5 2.044 0 N-CA-C 116.584 2.068 . . . . 0.0 116.584 168.678 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 67.9 mtt-85 -143.03 125.11 15.3 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.808 -0.558 . . . . 0.0 109.665 -176.094 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.75 91.8 8.06 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 123.411 0.685 . . . . 0.0 111.483 177.372 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 10.6 m -111.97 128.59 68.46 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 121.808 -0.558 . . . . 0.0 111.426 -163.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 29.8 mmtp -83.7 104.3 13.7 Favored 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 123.672 0.789 . . . . 0.0 110.514 178.734 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 68.8 m -103.26 99.86 9.73 Favored 'General case' 0 N--CA 1.483 1.216 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.952 -160.447 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 7.0 tp -110.6 105.07 18.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 C-N-CA 123.646 0.778 . . . . 0.0 109.264 -177.483 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -116.96 125.54 73.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 C-N-CA 124.447 1.099 . . . . 0.0 108.353 177.32 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 11.0 t -130.16 152.52 49.51 Favored 'General case' 0 N--CA 1.492 1.632 0 CA-C-O 122.577 1.179 . . . . 0.0 111.024 172.644 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 26.3 tp -87.33 109.13 19.32 Favored 'General case' 0 N--CA 1.487 1.404 0 CA-C-N 114.64 -1.163 . . . . 0.0 109.676 177.543 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -123.51 95.26 4.52 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 -174.592 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 63.32 49.48 70.27 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 117.343 1.697 . . . . 0.0 117.343 -177.559 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 67.27 24.24 73.44 Favored Glycine 0 CA--C 1.557 2.691 0 N-CA-C 119.001 2.36 . . . . 0.0 119.001 -169.746 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 56.3 mtmt -131.93 125.45 31.67 Favored 'General case' 0 N--CA 1.487 1.425 0 CA-C-N 118.735 1.267 . . . . 0.0 107.848 -176.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 58.8 mt -84.56 94.86 8.68 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-O 123.03 1.395 . . . . 0.0 109.467 171.173 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 98.4 t -89.17 101.12 11.7 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.361 0 CA-C-N 112.643 -2.071 . . . . 0.0 105.844 -174.332 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 22.4 t-160 -105.78 139.88 39.67 Favored 'General case' 0 N--CA 1.486 1.348 0 CA-C-N 114.94 -1.027 . . . . 0.0 109.883 -173.5 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 29.1 tp -138.53 121.2 16.32 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 176.709 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 88.9 mt-30 -113.28 121.52 44.67 Favored 'General case' 0 N--CA 1.487 1.425 0 C-N-CA 124.233 1.013 . . . . 0.0 108.45 179.328 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 9.8 mtmp? -123.76 133.15 53.9 Favored 'General case' 0 N--CA 1.497 1.895 0 C-N-CA 122.994 0.517 . . . . 0.0 111.008 -170.314 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 13.5 p90 -156.45 112.66 3.03 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.689 -0.632 . . . . 0.0 110.325 -175.414 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 9.1 t70 53.76 52.51 12.96 Favored 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 116.279 1.955 . . . . 0.0 116.279 167.574 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 87.41 -44.01 3.24 Favored Glycine 0 CA--C 1.551 2.324 0 N-CA-C 116.687 1.435 . . . . 0.0 116.687 -169.492 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 21.7 mt-30 -79.47 139.72 37.55 Favored 'General case' 0 N--CA 1.488 1.452 0 CA-C-N 117.841 0.82 . . . . 0.0 112.124 -178.179 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -144.16 130.25 19.57 Favored 'General case' 0 N--CA 1.491 1.586 0 CA-C-O 121.16 0.505 . . . . 0.0 111.779 177.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 12.4 t -118.63 131.15 56.18 Favored 'General case' 0 N--CA 1.492 1.673 0 C-N-CA 123.525 0.73 . . . . 0.0 110.717 177.554 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 35.5 p -99.01 137.77 37.06 Favored 'General case' 0 N--CA 1.492 1.654 0 CA-C-O 121.311 0.576 . . . . 0.0 111.188 173.203 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 5.3 mp -122.11 74.74 1.17 Allowed 'General case' 0 CA--C 1.564 1.518 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 -179.368 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 87.0 t -84.97 108.06 16.55 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 121.085 -1.01 . . . . 0.0 108.484 -169.555 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 82.9 mtt85 -99.53 120.96 40.48 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 123.234 0.614 . . . . 0.0 109.823 -175.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -141.35 130.81 23.81 Favored 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 123.107 0.563 . . . . 0.0 111.084 -170.689 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -81.69 112.52 18.95 Favored 'General case' 0 N--CA 1.487 1.413 0 CA-C-O 121.51 0.671 . . . . 0.0 111.029 -179.577 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 50.3 mm -118.5 105.46 17.79 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.352 0 N-CA-C 105.171 -2.159 . . . . 0.0 105.171 179.221 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 57.86 49.58 11.8 Favored 'General case' 0 N--CA 1.499 2.02 0 N-CA-C 114.763 1.394 . . . . 0.0 114.763 176.136 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 82.51 -29.28 3.28 Favored Glycine 0 CA--C 1.554 2.522 0 N-CA-C 118.807 2.283 . . . . 0.0 118.807 -169.504 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 89.9 mttt -93.72 136.11 34.33 Favored 'General case' 0 N--CA 1.486 1.371 0 CA-C-N 119.275 1.537 . . . . 0.0 111.189 -168.369 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 20.6 tp -80.73 115.93 20.48 Favored 'General case' 0 CA--C 1.558 1.279 0 C-N-CA 123.24 0.616 . . . . 0.0 110.105 177.551 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 39.2 mm -104.0 101.57 12.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 N-CA-C 106.835 -1.543 . . . . 0.0 106.835 -175.3 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 16.2 tp -91.81 102.22 14.81 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 124.009 0.924 . . . . 0.0 109.729 179.604 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 58.5 m -91.54 112.87 24.97 Favored 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 123.883 0.873 . . . . 0.0 109.286 -175.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 96.7 mt -111.09 97.48 6.84 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 123.71 0.804 . . . . 0.0 109.708 -169.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 10.2 m -113.08 117.75 32.86 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.875 -0.516 . . . . 0.0 109.788 -172.405 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 78.9 t60 -152.34 116.4 4.91 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 174.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 60.6 61.18 7.33 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 117.061 1.584 . . . . 0.0 117.061 171.39 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . 0.297 4.3 m 51.65 51.53 16.49 Favored 'General case' 0 CA--C 1.576 1.953 0 N-CA-C 114.928 1.455 . . . . 0.0 114.928 -172.098 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -158.11 86.62 0.9 Allowed 'General case' 0 N--CA 1.484 1.228 0 CA-C-O 121.542 0.687 . . . . 0.0 109.194 -179.618 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 3.4 p -91.23 111.85 24.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 C-N-CA 123.691 0.796 . . . . 0.0 109.257 175.4 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 48.4 t -105.17 102.05 11.57 Favored 'General case' 0 CA--C 1.552 1.032 0 CA-C-O 121.461 0.648 . . . . 0.0 109.662 176.052 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 86.0 m -90.56 94.2 9.61 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 -175.706 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 32.5 mtm180 -91.88 120.98 33.06 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 122.927 0.491 . . . . 0.0 111.019 -169.426 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 87.6 m -86.61 131.83 34.06 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 123.463 0.705 . . . . 0.0 110.096 179.09 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 35.9 m-85 -128.43 126.59 40.87 Favored 'General case' 0 CA--C 1.558 1.275 0 C-N-CA 123.82 0.848 . . . . 0.0 108.835 178.538 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -93.99 150.98 19.87 Favored 'General case' 0 N--CA 1.492 1.672 0 CA-C-O 122.08 0.943 . . . . 0.0 111.526 169.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 68.9 tttt -83.06 119.56 24.63 Favored 'General case' 0 N--CA 1.486 1.329 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.706 -169.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 11.8 mm-40 -110.09 49.36 0.85 Allowed 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 123.934 0.894 . . . . 0.0 113.03 179.49 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.301 0 CA-C-O 123.27 1.509 . . . . 0.0 113.569 169.928 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.303 8.5 t . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 118.248 -0.882 . . . . 0.0 112.984 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -60.48 -37.46 81.13 Favored 'General case' 0 N--CA 1.497 1.895 0 N-CA-C 116.224 1.935 . . . . 0.0 116.224 179.505 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -63.55 -29.07 70.39 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 117.047 2.24 . . . . 0.0 117.047 164.057 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -72.93 -21.67 60.84 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 116.145 1.905 . . . . 0.0 116.145 170.589 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 48.2 mt -69.64 114.74 8.14 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-N 121.516 1.962 . . . . 0.0 111.917 -172.541 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 157.93 172.94 25.72 Favored Glycine 0 CA--C 1.543 1.808 0 CA-C-O 122.442 1.023 . . . . 0.0 113.428 -173.554 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 80.1 m -92.88 140.52 29.41 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 171.177 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 85.2 m95 -138.7 114.75 10.16 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 -173.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 48.5 mtmt -97.18 147.16 24.37 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-O 121.54 0.686 . . . . 0.0 111.32 177.297 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 57.3 tp -70.76 126.26 29.1 Favored 'General case' 0 N--CA 1.487 1.421 0 CA-C-O 121.905 0.859 . . . . 0.0 112.438 -175.505 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . 0.271 1.1 t -104.58 -44.16 8.54 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.852 0 CA-C-N 114.327 -1.306 . . . . 0.0 112.421 178.542 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -140.45 134.31 30.55 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-N 120.004 1.275 . . . . 0.0 109.687 -178.487 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 79.9 p -122.17 113.99 20.24 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 123.456 0.702 . . . . 0.0 110.053 171.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 10.7 mtpm? -81.92 -88.16 0.09 Allowed 'General case' 0 N--CA 1.492 1.646 0 CA-C-O 118.962 -0.542 . . . . 0.0 111.472 -177.152 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 70.9 m-80 -98.1 43.03 1.07 Allowed 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 113.831 1.049 . . . . 0.0 113.831 -174.222 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 17.5 t80 -76.83 -43.11 37.67 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 115.722 1.749 . . . . 0.0 115.722 -168.325 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 33.3 m-20 -63.69 -36.51 84.1 Favored 'General case' 0 N--CA 1.499 1.999 0 N-CA-C 115.112 1.523 . . . . 0.0 115.112 169.763 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 24.1 t0 -60.87 -47.32 86.9 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 115.174 1.546 . . . . 0.0 115.174 167.226 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 83.7 t80 -53.95 -53.02 58.62 Favored 'General case' 0 CA--C 1.569 1.702 0 N-CA-C 115.194 1.553 . . . . 0.0 115.194 170.448 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 79.0 mtm -63.76 -34.58 78.21 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 116.149 1.907 . . . . 0.0 116.149 173.704 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -57.59 -50.61 72.55 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 114.65 1.352 . . . . 0.0 114.65 165.194 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 22.9 t -60.28 -36.58 78.15 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 116.318 1.97 . . . . 0.0 116.318 171.482 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.493 ' HB3' HH12 ' A' ' 78' ' ' ARG . 31.2 mt -64.1 -34.75 78.75 Favored 'General case' 0 CA--C 1.565 1.53 0 N-CA-C 117.309 2.337 . . . . 0.0 117.309 169.74 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 101.25 76.26 1.19 Allowed Glycine 0 N--CA 1.482 1.741 0 CA-C-N 119.118 0.872 . . . . 0.0 112.02 -171.415 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 58.3 t -138.33 122.76 21.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 N-CA-C 105.585 -2.006 . . . . 0.0 105.585 -179.554 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -63.27 147.53 50.53 Favored Glycine 0 N--CA 1.488 2.116 0 N-CA-C 115.431 0.932 . . . . 0.0 115.431 177.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . 0.257 25.2 p90 -55.34 -41.64 72.74 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 118.834 2.901 . . . . 0.0 118.834 -166.169 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.57 -44.48 96.21 Favored 'General case' 0 CA--C 1.565 1.541 0 N-CA-C 115.979 1.844 . . . . 0.0 115.979 175.157 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 86.6 m -68.78 -38.6 80.12 Favored 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 114.439 1.274 . . . . 0.0 114.439 168.772 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 48.8 ttp180 -56.57 -45.14 81.47 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 115.421 1.637 . . . . 0.0 115.421 174.373 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 18.8 mm100 -70.5 -38.13 74.3 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 115.167 1.543 . . . . 0.0 115.167 173.196 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 95.3 t -63.45 -44.09 98.71 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.094 0 CA-C-N 120.093 1.315 . . . . 0.0 113.46 171.525 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -63.98 -31.06 72.11 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 117.371 2.36 . . . . 0.0 117.371 174.641 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 93.7 p -68.57 -42.2 78.62 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 116.15 1.907 . . . . 0.0 116.15 168.072 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 3.7 ppp? -71.87 -26.91 62.54 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 117.582 2.438 . . . . 0.0 117.582 175.34 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 5.3 t -74.79 162.95 28.2 Favored 'General case' 0 N--CA 1.493 1.699 0 CA-C-N 120.335 1.425 . . . . 0.0 112.592 175.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -99.97 103.51 22.84 Favored Pre-proline 0 CA--C 1.567 1.61 0 CA-C-O 118.008 -0.996 . . . . 0.0 108.853 172.394 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -78.89 90.32 1.29 Allowed 'Trans proline' 0 CA--C 1.56 1.81 0 C-N-CA 123.208 2.606 . . . . 0.0 111.225 177.292 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 94.4 m -80.19 111.79 16.89 Favored 'General case' 0 N--CA 1.489 1.513 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.574 -161.164 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 36.5 m -86.42 113.28 22.24 Favored 'General case' 0 CA--C 1.559 1.323 0 C-N-CA 123.598 0.759 . . . . 0.0 109.446 -171.711 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 71.6 mt -109.59 103.62 15.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 N-CA-C 106.033 -1.84 . . . . 0.0 106.033 177.649 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 3.7 mp -91.68 123.41 43.79 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 N-CA-C 106.881 -1.526 . . . . 0.0 106.881 172.175 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -148.21 125.61 11.62 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 -169.626 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.32 153.65 29.68 Favored 'General case' 0 CA--C 1.565 1.54 0 CA-C-O 122.173 0.987 . . . . 0.0 113.656 178.249 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 67.1 m-80 -141.77 75.3 1.49 Allowed 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 106.389 -1.708 . . . . 0.0 106.389 171.16 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 71.17 -110.99 3.47 Favored Glycine 0 CA--C 1.548 2.108 0 O-C-N 121.885 -0.51 . . . . 0.0 112.86 -166.5 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 21.1 m-20 -82.75 -21.14 34.79 Favored 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 116.033 1.864 . . . . 0.0 116.033 168.024 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 42.8 mm -84.93 114.88 25.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 CA-C-N 119.863 1.21 . . . . 0.0 109.614 -168.191 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.4 HD12 HD13 ' A' ' 66' ' ' LEU . 44.5 mt -86.79 114.94 23.87 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 123.057 0.543 . . . . 0.0 110.342 174.164 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 88.5 m -107.81 102.82 12.0 Favored 'General case' 0 N--CA 1.486 1.342 0 N-CA-C 106.728 -1.582 . . . . 0.0 106.728 -174.358 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 8.9 tt -104.37 107.11 17.87 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -103.37 114.82 29.39 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 179.331 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 91.7 m -100.67 98.11 8.7 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 179.246 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 20.2 m-70 -85.08 91.26 8.06 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 123.411 0.684 . . . . 0.0 112.555 -169.456 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 15.2 t . . . . . 0 CA--C 1.557 1.241 0 C-N-CA 123.814 0.846 . . . . 0.0 110.302 174.486 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 8.8 p30 . . . . . 0 N--CA 1.49 1.534 0 CA-C-O 120.249 0.071 . . . . 0.0 110.952 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 77.9 p -90.67 122.63 33.61 Favored 'General case' 0 N--CA 1.492 1.661 0 CA-C-O 121.178 0.513 . . . . 0.0 110.775 -174.559 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -108.12 115.82 30.83 Favored 'General case' 0 N--CA 1.486 1.341 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 -175.112 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 29.8 pt -111.24 129.63 66.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 N-CA-C 108.531 -0.915 . . . . 0.0 108.531 174.087 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 44.1 t -118.73 113.0 20.48 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.38 -0.971 . . . . 0.0 108.38 -174.574 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 43.8 p90 -144.89 140.77 28.55 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 115.093 1.516 . . . . 0.0 115.093 -162.1 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 29.5 mtpp -109.16 18.43 20.56 Favored 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 117.325 2.343 . . . . 0.0 117.325 -177.486 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.4 HD13 HD12 ' A' ' 49' ' ' LEU 0.296 1.3 mp 65.6 93.57 0.07 Allowed 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 125.03 1.332 . . . . 0.0 113.278 176.723 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 92.32 37.67 5.85 Favored Glycine 0 CA--C 1.55 2.228 0 N-CA-C 117.01 1.564 . . . . 0.0 117.01 -166.631 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 92.3 t -135.62 122.86 35.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 N-CA-C 107.035 -1.468 . . . . 0.0 107.035 178.311 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -88.08 131.91 34.5 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 123.401 0.68 . . . . 0.0 110.476 170.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 37.0 p90 -143.0 130.74 21.43 Favored 'General case' 0 N--CA 1.493 1.72 0 C-N-CA 123.333 0.653 . . . . 0.0 110.087 -174.069 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -72.56 114.02 10.24 Favored 'General case' 0 CA--C 1.564 1.501 0 O-C-N 121.546 -0.721 . . . . 0.0 111.933 175.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 14.0 tp10 -119.08 134.5 55.16 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 123.842 0.857 . . . . 0.0 109.782 -167.706 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 73.4 m -90.57 121.74 32.77 Favored 'General case' 0 N--CA 1.491 1.577 0 CA-C-O 121.258 0.551 . . . . 0.0 109.663 176.084 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 30.0 p -85.0 169.74 13.69 Favored 'General case' 0 N--CA 1.493 1.712 0 CA-C-O 121.54 0.686 . . . . 0.0 112.203 -177.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -59.37 -34.82 72.88 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 116.68 2.104 . . . . 0.0 116.68 166.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -76.53 9.24 2.84 Favored 'General case' 0 CA--C 1.581 2.144 0 N-CA-C 115.909 1.818 . . . . 0.0 115.909 167.309 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . 0.252 11.6 m-20 66.78 69.74 0.4 Allowed 'General case' 0 N--CA 1.494 1.77 0 C-N-CA 125.749 1.62 . . . . 0.0 112.669 176.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.493 HH12 ' HB3' ' A' ' 23' ' ' LEU . 60.4 mtm180 -143.56 128.17 18.1 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 122.915 0.486 . . . . 0.0 110.23 -175.117 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.36 117.56 13.05 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 123.491 0.716 . . . . 0.0 111.075 164.822 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 14.3 m -133.49 127.37 53.36 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 -171.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 33.2 mmtp -77.54 102.9 7.17 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 123.567 0.747 . . . . 0.0 110.557 -178.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 69.2 m -101.19 92.67 5.08 Favored 'General case' 0 N--CA 1.482 1.149 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.575 -165.074 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 7.2 tp -106.1 116.64 50.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 178.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 1.4 p -134.15 131.72 55.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 C-N-CA 123.806 0.842 . . . . 0.0 109.564 -170.808 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 10.1 t -148.63 152.17 36.25 Favored 'General case' 0 N--CA 1.49 1.533 0 CA-C-O 122.745 1.26 . . . . 0.0 110.359 179.691 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 26.4 tp -85.67 119.94 26.55 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-N 114.726 -1.125 . . . . 0.0 110.298 176.424 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -109.4 79.22 1.19 Allowed 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 123.52 0.728 . . . . 0.0 109.613 -178.357 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 54.9 44.26 81.96 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 118.477 2.151 . . . . 0.0 118.477 -177.454 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 107.12 -42.52 1.91 Allowed Glycine 0 N--CA 1.49 2.295 0 N-CA-C 116.558 1.383 . . . . 0.0 116.558 -168.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 35.9 ttmt -82.33 112.06 18.96 Favored 'General case' 0 CA--C 1.559 1.289 0 CA-C-N 118.164 0.982 . . . . 0.0 109.881 179.584 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.8 tt -88.28 102.72 15.12 Favored 'General case' 0 N--CA 1.488 1.459 0 CA-C-O 121.659 0.742 . . . . 0.0 109.311 -176.739 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 62.7 t -100.7 110.41 27.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 -166.656 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 22.8 t-160 -104.47 134.39 47.75 Favored 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 123.822 0.849 . . . . 0.0 109.713 171.774 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 24.4 tp -120.09 120.99 37.87 Favored 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 124.655 1.182 . . . . 0.0 107.944 172.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 27.6 mt-30 -109.2 113.71 26.79 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 171.522 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 38.0 ttmt -122.77 132.82 54.4 Favored 'General case' 0 CA--C 1.563 1.465 0 C-N-CA 123.461 0.704 . . . . 0.0 110.397 -174.592 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 34.9 p90 -149.09 115.2 5.76 Favored 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 123.36 0.664 . . . . 0.0 109.989 -176.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . 0.343 17.4 t70 67.15 -101.36 0.06 Allowed 'General case' 0 N--CA 1.495 1.796 0 C-N-CA 124.511 1.124 . . . . 0.0 111.972 176.179 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -127.88 56.23 0.74 Allowed Glycine 0 N--CA 1.487 2.059 0 CA-C-N 118.736 0.698 . . . . 0.0 113.16 162.568 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 49.1 mt-30 -149.15 110.41 4.41 Favored 'General case' 0 N--CA 1.485 1.31 0 N-CA-C 107.032 -1.47 . . . . 0.0 107.032 -177.481 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -117.01 124.42 49.27 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 122.894 0.477 . . . . 0.0 110.777 176.577 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 10.7 t -115.58 122.71 46.48 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 110.051 -0.351 . . . . 0.0 110.051 167.421 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 35.7 p -93.19 125.79 37.96 Favored 'General case' 0 N--CA 1.489 1.505 0 CA-C-O 121.274 0.559 . . . . 0.0 110.598 172.345 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 5.6 mp -99.08 86.73 3.51 Favored 'General case' 0 CA--C 1.561 1.387 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 175.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 93.3 t -94.21 108.53 20.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 -168.455 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 79.1 mtt85 -108.41 121.98 46.06 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 123.173 0.589 . . . . 0.0 110.143 -173.239 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -141.53 137.51 32.07 Favored 'General case' 0 N--CA 1.495 1.776 0 C-N-CA 123.114 0.566 . . . . 0.0 110.938 177.199 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -81.17 119.62 23.83 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.518 -0.739 . . . . 0.0 111.271 176.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 74.6 mt -123.97 110.89 26.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 N-CA-C 104.949 -2.241 . . . . 0.0 104.949 177.369 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 29.3 m-20 59.3 48.49 10.11 Favored 'General case' 0 N--CA 1.5 2.057 0 N-CA-C 114.767 1.395 . . . . 0.0 114.767 179.126 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 60.45 28.06 66.79 Favored Glycine 0 CA--C 1.554 2.473 0 N-CA-C 119.336 2.494 . . . . 0.0 119.336 -169.368 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 9.7 mtmp? -135.36 127.31 29.56 Favored 'General case' 0 N--CA 1.489 1.511 0 CA-C-N 119.482 1.641 . . . . 0.0 108.533 -173.649 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 35.0 tp -75.36 112.19 11.41 Favored 'General case' 0 CA--C 1.557 1.235 0 C-N-CA 123.493 0.717 . . . . 0.0 110.811 -179.561 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 31.0 mm -100.42 104.92 16.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 N-CA-C 106.409 -1.7 . . . . 0.0 106.409 -176.533 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 23.7 tp -97.96 101.17 12.59 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 123.81 0.844 . . . . 0.0 109.103 179.541 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 97.7 m -93.86 109.96 21.64 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 124.177 0.991 . . . . 0.0 108.769 -178.546 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 74.7 mt -103.8 90.32 3.6 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 123.913 0.885 . . . . 0.0 109.734 -168.534 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 7.5 m -100.06 118.18 35.88 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 -168.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 80.1 t60 -132.59 -105.49 0.25 Allowed 'General case' 0 N--CA 1.492 1.629 0 CA-C-O 118.77 -0.633 . . . . 0.0 109.652 176.105 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -119.63 91.14 0.49 Allowed Glycine 0 N--CA 1.486 1.989 0 CA-C-N 119.321 0.964 . . . . 0.0 112.65 -167.015 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . 0.297 1.6 m 54.62 34.37 21.27 Favored 'General case' 0 CA--C 1.582 2.179 0 N-CA-C 115.885 1.809 . . . . 0.0 115.885 -173.029 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -161.68 84.22 0.61 Allowed 'General case' 0 N--CA 1.485 1.308 0 O-C-N 121.15 -0.968 . . . . 0.0 108.768 -177.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 4.7 p -91.91 116.67 33.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 175.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 42.2 t -101.85 102.35 12.92 Favored 'General case' 0 CA--C 1.553 1.066 0 CA-C-O 121.187 0.518 . . . . 0.0 111.096 -179.63 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 96.2 m -87.7 111.75 21.64 Favored 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 177.424 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 28.9 mtm180 -114.4 119.28 36.39 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 122.898 0.479 . . . . 0.0 110.529 -170.347 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 88.9 m -84.42 134.97 34.45 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 123.234 0.614 . . . . 0.0 110.043 175.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 36.9 m-85 -130.11 128.43 41.83 Favored 'General case' 0 CA--C 1.56 1.345 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 178.367 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -93.77 150.72 20.16 Favored 'General case' 0 CA--C 1.564 1.503 0 CA-C-O 122.06 0.933 . . . . 0.0 111.202 172.173 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 69.3 tttt -82.97 124.83 30.76 Favored 'General case' 0 N--CA 1.486 1.342 0 N-CA-C 112.916 0.709 . . . . 0.0 112.916 -168.559 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 40.1 tp10 -99.06 47.95 0.96 Allowed 'General case' 0 CA--C 1.57 1.724 0 C-N-CA 123.772 0.829 . . . . 0.0 113.044 169.548 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.043 0 CA-C-O 124.263 1.982 . . . . 0.0 108.241 -176.94 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.306 5.0 t . . . . . 0 N--CA 1.49 1.526 0 CA-C-O 117.795 -1.098 . . . . 0.0 113.302 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -61.19 -36.99 81.38 Favored 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 115.991 1.849 . . . . 0.0 115.991 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -61.31 -32.23 72.09 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 116.957 2.206 . . . . 0.0 116.957 163.428 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -71.96 -25.41 61.86 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 115.978 1.844 . . . . 0.0 115.978 170.248 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 55.3 mt -71.71 117.32 13.14 Favored 'General case' 0 N--CA 1.492 1.652 0 CA-C-N 121.375 1.898 . . . . 0.0 111.112 -175.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 160.1 170.0 24.12 Favored Glycine 0 CA--C 1.54 1.627 0 CA-C-O 122.418 1.01 . . . . 0.0 113.853 -172.422 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 90.3 m -92.62 136.74 32.97 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-N 114.464 -0.868 . . . . 0.0 108.812 171.031 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 94.8 m95 -137.64 115.17 11.2 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.685 -0.858 . . . . 0.0 108.685 -170.193 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 23.0 mmmt -108.27 145.22 34.67 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-O 121.791 0.805 . . . . 0.0 110.536 179.627 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 25.8 tp -68.81 128.82 38.01 Favored 'General case' 0 N--CA 1.487 1.407 0 CA-C-O 122.222 1.011 . . . . 0.0 112.91 -171.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . 0.28 1.1 t -106.69 -45.67 8.01 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.725 0 CA-C-N 113.805 -1.543 . . . . 0.0 111.767 178.811 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 43.7 t0 -142.01 140.08 32.56 Favored 'General case' 0 N--CA 1.488 1.429 0 CA-C-N 119.437 1.017 . . . . 0.0 109.079 178.641 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 81.0 p -127.79 94.26 3.9 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.784 -0.572 . . . . 0.0 109.853 172.4 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 47.9 mtmt -91.99 120.8 32.97 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 123.57 0.748 . . . . 0.0 109.355 -176.408 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.264 42.1 m-20 71.53 21.17 4.56 Favored 'General case' 0 N--CA 1.504 2.264 0 N-CA-C 117.113 2.264 . . . . 0.0 117.113 -178.726 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 10.1 t80 -71.85 -41.13 68.47 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 115.853 1.797 . . . . 0.0 115.853 -175.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -60.52 -32.25 71.29 Favored 'General case' 0 N--CA 1.499 1.976 0 N-CA-C 116.014 1.857 . . . . 0.0 116.014 168.442 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 20.1 t0 -64.85 -50.72 65.54 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 114.331 1.234 . . . . 0.0 114.331 167.776 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 89.6 t80 -50.54 -54.83 19.39 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 115.349 1.611 . . . . 0.0 115.349 171.74 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 77.7 mtm -59.85 -41.85 92.35 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 115.231 1.567 . . . . 0.0 115.231 175.418 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.3 tmtp? -62.57 -43.94 97.57 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 114.788 1.403 . . . . 0.0 114.788 171.526 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 61.3 m -58.18 -39.39 78.8 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 116.574 2.064 . . . . 0.0 116.574 171.022 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 51.8 mt -61.54 -45.86 92.39 Favored 'General case' 0 CA--C 1.567 1.632 0 N-CA-C 115.747 1.758 . . . . 0.0 115.747 167.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 121.03 71.69 0.3 Allowed Glycine 0 N--CA 1.482 1.735 0 C-N-CA 123.979 0.8 . . . . 0.0 111.266 -172.101 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 40.5 t -141.6 122.0 12.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 N-CA-C 105.083 -2.191 . . . . 0.0 105.083 -176.294 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -77.15 -171.48 35.35 Favored Glycine 0 CA--C 1.548 2.154 0 N-CA-C 116.663 1.425 . . . . 0.0 116.663 -174.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 11.0 p90 -67.27 158.32 31.76 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 113.387 0.884 . . . . 0.0 113.387 176.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . 0.325 . . 78.76 -52.05 0.46 Allowed 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 114.995 1.48 . . . . 0.0 114.995 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 89.1 m -64.48 -40.93 96.61 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 114.241 1.201 . . . . 0.0 114.241 167.682 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 48.1 mtm180 -61.26 -43.66 98.52 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 114.996 1.48 . . . . 0.0 114.996 167.555 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -60.52 -49.81 76.07 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 115.058 1.503 . . . . 0.0 115.058 174.056 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 69.1 t -63.69 -43.84 98.2 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 CA-C-N 119.429 1.013 . . . . 0.0 112.742 174.819 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -62.7 -35.98 81.48 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 117.053 2.242 . . . . 0.0 117.053 176.234 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 96.7 p -65.66 -43.44 89.39 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 116.395 1.998 . . . . 0.0 116.395 170.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 20.0 ptm -68.21 -31.02 70.25 Favored 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 117.067 2.247 . . . . 0.0 117.067 168.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 38.0 m -71.85 143.47 49.41 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 124.279 1.031 . . . . 0.0 112.257 -178.025 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -104.52 102.97 37.16 Favored Pre-proline 0 CA--C 1.57 1.723 0 CA-C-O 118.145 -0.931 . . . . 0.0 109.1 175.25 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -79.2 116.88 3.72 Favored 'Trans proline' 0 CA--C 1.561 1.849 0 C-N-CA 122.913 2.409 . . . . 0.0 112.185 -178.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 24.4 m -78.8 105.36 10.06 Favored 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 123.675 0.79 . . . . 0.0 109.701 -170.536 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 61.0 m -101.12 106.77 18.05 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 -167.234 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 52.0 mt -111.69 107.19 22.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 N-CA-C 107.16 -1.422 . . . . 0.0 107.16 -172.149 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 3.9 mp -96.18 121.56 46.84 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 174.637 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 7.9 tm-20 -137.23 120.6 16.97 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 -178.03 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -86.23 115.9 24.07 Favored 'General case' 0 CA--C 1.56 1.339 0 C-N-CA 123.15 0.58 . . . . 0.0 111.052 179.431 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 12.5 t30 -105.79 86.87 2.46 Favored 'General case' 0 CA--C 1.561 1.374 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 179.282 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 80.92 -99.75 1.92 Allowed Glycine 0 N--CA 1.486 1.982 0 N-CA-C 111.883 -0.487 . . . . 0.0 111.883 -172.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -130.11 59.36 1.63 Allowed 'General case' 0 N--CA 1.494 1.747 0 CA-C-O 120.958 0.409 . . . . 0.0 110.065 160.399 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 42.6 mm -137.81 108.16 5.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 N-CA-C 104.889 -2.263 . . . . 0.0 104.889 -179.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 42.8 mt -83.11 106.67 15.1 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 122.756 0.422 . . . . 0.0 110.871 179.204 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 73.3 m -98.98 96.99 8.2 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 -173.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 9.1 tt -97.68 103.19 15.1 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 -179.227 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 91.3 mttt -98.94 111.14 23.62 Favored 'General case' 0 N--CA 1.485 1.276 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 -175.306 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 45.8 m -100.13 87.03 3.35 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 -177.601 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 12.0 m170 -89.87 98.63 11.88 Favored 'General case' 0 N--CA 1.492 1.642 0 CA-C-O 121.702 0.763 . . . . 0.0 110.053 -173.224 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 22.9 t . . . . . 0 N--CA 1.488 1.448 0 N-CA-C 116.962 2.208 . . . . 0.0 116.962 -172.54 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 8.9 p30 . . . . . 0 N--CA 1.487 1.42 0 CA-C-O 120.737 0.303 . . . . 0.0 110.777 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 60.2 p -96.19 127.85 42.56 Favored 'General case' 0 N--CA 1.494 1.75 0 CA-C-O 121.396 0.617 . . . . 0.0 109.949 -179.577 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -124.52 125.09 43.65 Favored 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 123.426 0.69 . . . . 0.0 109.344 -171.582 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 48.2 pt -117.6 131.48 70.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 C-N-CA 123.524 0.73 . . . . 0.0 109.077 175.644 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 80.6 p -121.2 104.14 9.52 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 -178.055 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 50.1 p90 -136.9 147.09 46.23 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 114.809 1.411 . . . . 0.0 114.809 -156.555 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 25.9 mtpp -110.77 20.29 17.74 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 117.679 2.474 . . . . 0.0 117.679 -170.693 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . 0.311 1.7 mp 60.65 88.7 0.08 Allowed 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 114.93 1.456 . . . . 0.0 114.93 172.639 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 92.39 39.81 5.26 Favored Glycine 0 CA--C 1.549 2.194 0 N-CA-C 115.951 1.141 . . . . 0.0 115.951 -168.506 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 74.9 t -141.62 123.86 14.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 N-CA-C 105.533 -2.025 . . . . 0.0 105.533 -176.421 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -88.14 129.55 35.29 Favored 'General case' 0 CA--C 1.565 1.547 0 C-N-CA 122.924 0.49 . . . . 0.0 110.497 176.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 48.6 p90 -138.95 131.55 28.87 Favored 'General case' 0 N--CA 1.496 1.831 0 C-N-CA 123.231 0.612 . . . . 0.0 111.435 -174.201 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -69.17 131.56 45.14 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.303 -0.873 . . . . 0.0 113.133 173.602 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 17.4 tp10 -142.97 137.85 29.67 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 123.426 0.69 . . . . 0.0 110.028 -168.343 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 56.6 m -93.06 122.8 35.8 Favored 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 123.035 0.534 . . . . 0.0 109.639 176.238 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 26.9 p -84.14 177.8 8.08 Favored 'General case' 0 N--CA 1.496 1.86 0 CA-C-O 121.415 0.626 . . . . 0.0 112.549 -177.3 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -67.4 -27.97 67.53 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 117.416 2.376 . . . . 0.0 117.416 169.612 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 25.6 m-20 -77.96 8.3 4.88 Favored 'General case' 0 CA--C 1.579 2.096 0 N-CA-C 115.918 1.822 . . . . 0.0 115.918 161.39 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 64.01 68.81 0.55 Allowed 'General case' 0 N--CA 1.496 1.837 0 C-N-CA 125.366 1.466 . . . . 0.0 112.891 -179.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 63.7 mtm180 -137.05 127.96 27.46 Favored 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 123.001 0.521 . . . . 0.0 109.74 -171.457 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.04 102.8 6.64 Favored 'General case' 0 CA--C 1.565 1.53 0 C-N-CA 123.331 0.652 . . . . 0.0 111.141 173.071 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 19.9 m -120.36 129.99 74.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 -170.622 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 69.6 mmtt -81.74 107.13 14.23 Favored 'General case' 0 N--CA 1.49 1.531 0 CA-C-O 121.841 0.829 . . . . 0.0 109.867 176.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 74.3 m -102.07 102.49 12.98 Favored 'General case' 0 N--CA 1.481 1.08 0 CA-C-N 114.838 -1.073 . . . . 0.0 110.114 -165.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -106.91 115.04 47.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 175.67 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -128.26 128.15 68.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 C-N-CA 123.799 0.84 . . . . 0.0 109.32 -178.835 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 9.3 t -139.97 151.26 45.37 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-O 122.705 1.24 . . . . 0.0 111.337 -179.249 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 50.5 tp -82.2 125.48 30.97 Favored 'General case' 0 N--CA 1.489 1.498 0 CA-C-N 114.523 -1.217 . . . . 0.0 109.921 176.476 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -126.5 83.44 2.17 Favored 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 123.462 0.705 . . . . 0.0 109.771 -178.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 58.56 46.13 93.63 Favored Glycine 0 CA--C 1.552 2.395 0 N-CA-C 117.934 1.933 . . . . 0.0 117.934 -178.444 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 76.77 31.82 52.33 Favored Glycine 0 CA--C 1.555 2.544 0 N-CA-C 117.833 1.893 . . . . 0.0 117.833 -166.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 60.4 mtpt -141.13 112.82 7.62 Favored 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 106.629 -1.619 . . . . 0.0 106.629 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 3.7 mp -81.67 111.04 17.58 Favored 'General case' 0 N--CA 1.487 1.404 0 CA-C-O 121.94 0.876 . . . . 0.0 109.858 173.76 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 95.6 t -106.84 102.03 13.35 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 N-CA-C 105.324 -2.102 . . . . 0.0 105.324 -172.646 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 23.6 t-160 -104.85 136.95 43.39 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 124.35 1.06 . . . . 0.0 109.474 -178.306 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 33.7 tp -132.65 119.4 20.38 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 177.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 81.9 mt-30 -111.87 111.84 23.08 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 179.372 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 10.3 ptpp? -120.04 138.61 53.42 Favored 'General case' 0 N--CA 1.494 1.732 0 C-N-CA 123.228 0.611 . . . . 0.0 112.027 -172.324 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 13.7 p90 -156.79 109.8 2.57 Favored 'General case' 0 N--CA 1.488 1.475 0 C-N-CA 123.379 0.672 . . . . 0.0 109.825 -174.165 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 6.7 t70 54.5 54.4 9.38 Favored 'General case' 0 N--CA 1.498 1.949 0 N-CA-C 116.066 1.876 . . . . 0.0 116.066 168.62 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 87.2 -41.91 3.12 Favored Glycine 0 CA--C 1.552 2.38 0 N-CA-C 116.919 1.528 . . . . 0.0 116.919 -169.797 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -86.17 135.71 33.48 Favored 'General case' 0 N--CA 1.483 1.208 0 CA-C-N 117.979 0.89 . . . . 0.0 111.454 -174.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -144.86 137.73 26.51 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.911 -0.493 . . . . 0.0 112.006 -178.868 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 9.9 t -131.46 129.25 40.94 Favored 'General case' 0 N--CA 1.493 1.722 0 C-N-CA 123.356 0.662 . . . . 0.0 110.682 179.648 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 41.8 p -98.52 129.57 45.09 Favored 'General case' 0 N--CA 1.494 1.732 0 C-N-CA 122.884 0.474 . . . . 0.0 111.769 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 5.7 mp -103.91 80.26 1.73 Allowed 'General case' 0 CA--C 1.564 1.51 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 177.059 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 59.9 t -89.69 108.85 19.77 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 -168.73 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 81.8 mtt85 -102.96 122.09 43.88 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 123.425 0.69 . . . . 0.0 110.234 -176.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -138.73 139.74 38.46 Favored 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 123.04 0.536 . . . . 0.0 111.66 178.035 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -83.12 118.04 23.29 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 123.084 0.554 . . . . 0.0 111.412 178.536 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 46.5 mm -119.01 105.72 18.09 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 N-CA-C 105.287 -2.116 . . . . 0.0 105.287 174.277 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 58.61 49.29 10.58 Favored 'General case' 0 N--CA 1.5 2.037 0 N-CA-C 115.316 1.599 . . . . 0.0 115.316 175.641 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 65.75 26.78 72.21 Favored Glycine 0 CA--C 1.555 2.575 0 N-CA-C 119.142 2.417 . . . . 0.0 119.142 -170.291 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -134.08 125.46 28.06 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-N 119.017 1.409 . . . . 0.0 108.457 -173.785 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 16.7 tp -77.64 110.05 12.14 Favored 'General case' 0 CA--C 1.558 1.28 0 C-N-CA 123.361 0.665 . . . . 0.0 110.381 179.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 30.7 mm -97.92 101.89 12.75 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 N-CA-C 106.544 -1.651 . . . . 0.0 106.544 -176.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 29.4 tp -92.7 99.49 12.17 Favored 'General case' 0 N--CA 1.486 1.359 0 CA-C-O 121.812 0.815 . . . . 0.0 109.258 178.052 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 87.1 m -93.87 105.84 17.84 Favored 'General case' 0 CA--C 1.56 1.361 0 CA-C-N 114.884 -1.053 . . . . 0.0 108.26 -178.007 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 83.5 mt -97.12 100.69 12.17 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 123.816 0.846 . . . . 0.0 109.13 -174.193 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 7.1 m -100.63 119.58 38.77 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.71 -0.619 . . . . 0.0 109.751 -170.636 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 74.7 t60 -151.7 114.63 4.69 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 122.475 0.31 . . . . 0.0 110.376 171.24 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 52.54 71.44 0.68 Allowed Glycine 0 N--CA 1.488 2.146 0 N-CA-C 117.745 1.858 . . . . 0.0 117.745 162.053 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . 0.506 2.7 t 66.58 -44.32 0.43 Allowed 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 117.676 2.472 . . . . 0.0 117.676 -166.729 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -86.39 94.35 9.36 Favored 'General case' 0 N--CA 1.483 1.191 0 CA-C-N 119.563 1.074 . . . . 0.0 112.405 -177.288 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 6.4 p -98.11 128.61 49.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 C-N-CA 123.825 0.85 . . . . 0.0 109.803 174.521 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 42.7 t -109.45 107.48 17.64 Favored 'General case' 0 CA--C 1.553 1.068 0 C-N-CA 123.035 0.534 . . . . 0.0 112.125 -179.206 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 89.0 m -86.19 112.1 21.02 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 176.184 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 71.1 mtp180 -113.25 114.18 26.35 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 -174.107 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 85.5 m -86.72 133.54 33.66 Favored 'General case' 0 N--CA 1.495 1.782 0 C-N-CA 123.288 0.635 . . . . 0.0 110.106 177.37 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 48.4 m-85 -129.77 125.52 36.0 Favored 'General case' 0 CA--C 1.558 1.264 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 179.245 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -93.23 154.55 17.96 Favored 'General case' 0 N--CA 1.493 1.724 0 CA-C-O 122.481 1.134 . . . . 0.0 111.783 171.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 72.5 tttt -84.88 129.11 34.86 Favored 'General case' 0 N--CA 1.485 1.278 0 CA-C-N 115.04 -0.982 . . . . 0.0 112.534 -167.319 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 14.6 mm-40 -111.52 50.97 0.8 Allowed 'General case' 0 CA--C 1.567 1.597 0 C-N-CA 124.125 0.97 . . . . 0.0 111.572 175.709 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.967 0 CA-C-O 124.28 1.991 . . . . 0.0 108.121 -171.257 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.266 8.0 p . . . . . 0 CA--C 1.577 2.016 0 N-CA-C 116.127 1.899 . . . . 0.0 116.127 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -69.8 -38.99 76.84 Favored 'General case' 0 N--CA 1.497 1.891 0 N-CA-C 116.385 1.995 . . . . 0.0 116.385 -177.625 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -59.08 -27.88 65.95 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 117.513 2.412 . . . . 0.0 117.513 168.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -68.6 -24.87 64.63 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 116.29 1.959 . . . . 0.0 116.29 169.008 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 34.6 mt -78.7 115.44 18.4 Favored 'General case' 0 N--CA 1.489 1.521 0 CA-C-N 121.09 1.768 . . . . 0.0 111.29 -167.297 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 161.1 172.58 28.63 Favored Glycine 0 CA--C 1.543 1.79 0 CA-C-O 122.467 1.037 . . . . 0.0 113.454 -172.321 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 81.7 m -85.11 141.62 30.09 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-N 114.739 -0.731 . . . . 0.0 109.733 168.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 80.4 m95 -141.88 112.79 7.36 Favored 'General case' 0 N--CA 1.484 1.235 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 -174.516 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 9.0 mtpm? -96.22 147.33 23.88 Favored 'General case' 0 N--CA 1.495 1.802 0 C-N-CA 122.771 0.429 . . . . 0.0 110.209 174.369 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 57.9 tp -69.5 120.89 15.99 Favored 'General case' 0 N--CA 1.491 1.617 0 CA-C-O 121.864 0.84 . . . . 0.0 111.51 179.663 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . 0.271 1.2 t -98.85 -43.47 11.65 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.82 0 CA-C-N 114.194 -1.366 . . . . 0.0 112.588 -179.565 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -146.35 139.71 25.85 Favored 'General case' 0 N--CA 1.49 1.543 0 CA-C-N 119.652 1.114 . . . . 0.0 109.179 -179.468 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 89.2 p -128.91 100.27 5.61 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.933 -0.479 . . . . 0.0 110.939 175.47 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 59.3 mtpt -86.88 127.96 35.05 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 123.149 0.58 . . . . 0.0 109.612 173.124 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 58.5 m-20 66.79 22.59 10.25 Favored 'General case' 0 N--CA 1.504 2.235 0 N-CA-C 118.082 2.623 . . . . 0.0 118.082 173.732 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 23.6 t80 -67.24 -45.33 77.08 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 120.215 -1.553 . . . . 0.0 115.083 -178.806 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 85.8 m-20 -62.13 -27.0 68.63 Favored 'General case' 0 CA--C 1.572 1.811 0 N-CA-C 116.613 2.079 . . . . 0.0 116.613 171.443 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -69.05 -49.91 53.24 Favored 'General case' 0 N--CA 1.497 1.914 0 CA-C-N 120.275 1.398 . . . . 0.0 114.36 166.381 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 87.8 t80 -51.43 -50.3 59.99 Favored 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 115.397 1.628 . . . . 0.0 115.397 169.139 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 16.7 mmm -57.98 -46.55 84.98 Favored 'General case' 0 CA--C 1.566 1.595 0 N-CA-C 114.647 1.351 . . . . 0.0 114.647 172.424 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.2 tmtp? -57.35 -48.41 79.08 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 115.408 1.633 . . . . 0.0 115.408 170.806 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 83.5 p -59.63 -36.33 76.14 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 117.151 2.278 . . . . 0.0 117.151 174.148 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 34.4 mt -66.46 -33.62 76.09 Favored 'General case' 0 CA--C 1.566 1.562 0 N-CA-C 116.945 2.202 . . . . 0.0 116.945 167.375 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 108.5 72.36 0.75 Allowed Glycine 0 N--CA 1.482 1.742 0 CA-C-N 118.878 0.763 . . . . 0.0 111.788 -173.133 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 43.0 t -141.78 130.46 22.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 N-CA-C 106.808 -1.552 . . . . 0.0 106.808 -176.232 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -72.53 173.2 47.15 Favored Glycine 0 CA--C 1.549 2.16 0 N-CA-C 116.791 1.476 . . . . 0.0 116.791 -179.599 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 38.9 p90 -66.7 -39.58 88.14 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 117.599 2.444 . . . . 0.0 117.599 -175.385 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.15 -43.95 96.88 Favored 'General case' 0 CA--C 1.561 1.397 0 N-CA-C 115.803 1.779 . . . . 0.0 115.803 179.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.1 t -78.02 -21.54 50.59 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 115.835 1.791 . . . . 0.0 115.835 171.53 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 62.3 mtm180 -58.72 -42.81 89.57 Favored 'General case' 0 N--CA 1.495 1.824 0 CA-C-N 120.915 1.689 . . . . 0.0 114.524 162.64 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -63.13 -56.49 16.38 Favored 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 114.304 1.224 . . . . 0.0 114.304 168.166 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 47.9 t -62.81 -40.89 90.42 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 N-CA-C 113.883 1.068 . . . . 0.0 113.883 -178.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -70.68 -32.49 69.76 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 116.724 2.12 . . . . 0.0 116.724 175.453 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 94.6 p -65.93 -45.28 82.45 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 115.666 1.728 . . . . 0.0 115.666 170.173 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 3.5 ppp? -63.44 -28.29 69.87 Favored 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 116.923 2.194 . . . . 0.0 116.923 167.259 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 97.2 m -70.95 138.91 50.43 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 124.11 0.964 . . . . 0.0 110.83 172.188 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.76 102.43 11.69 Favored Pre-proline 0 CA--C 1.57 1.715 0 CA-C-O 118.023 -0.989 . . . . 0.0 109.32 166.683 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -80.77 95.75 0.98 Allowed 'Trans proline' 0 C--N 1.371 1.744 0 C-N-CA 122.817 2.345 . . . . 0.0 111.135 -176.614 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 99.4 m -81.32 111.45 17.72 Favored 'General case' 0 N--CA 1.489 1.48 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.452 -159.654 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 87.4 m -87.14 116.23 25.07 Favored 'General case' 0 CA--C 1.56 1.338 0 C-N-CA 123.916 0.886 . . . . 0.0 109.233 -175.32 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 79.6 mt -112.33 110.41 32.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 N-CA-C 106.224 -1.769 . . . . 0.0 106.224 177.341 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 22.6 mt -100.95 119.03 48.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 -176.39 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -137.55 108.05 6.54 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 -169.595 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 83.8 tttt -85.55 121.95 28.98 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 123.385 0.674 . . . . 0.0 111.175 179.795 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 19.0 m120 -89.25 -69.15 0.73 Allowed 'General case' 0 N--CA 1.49 1.575 0 C-N-CA 123.654 0.782 . . . . 0.0 110.543 177.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -151.58 76.56 0.23 Allowed Glycine 0 N--CA 1.484 1.868 0 N-CA-C 110.116 -1.194 . . . . 0.0 110.116 169.309 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . 0.336 2.1 t70 70.99 -23.96 0.17 Allowed 'General case' 0 N--CA 1.499 2.006 0 N-CA-C 116.805 2.15 . . . . 0.0 116.805 -160.417 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 21.2 mm -75.34 106.6 5.24 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.561 0 C-N-CA 124.536 1.134 . . . . 0.0 108.05 173.198 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 26.4 mt -92.45 113.77 26.13 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 123.878 0.871 . . . . 0.0 109.66 -179.459 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 57.1 m -97.79 97.45 8.99 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 106.836 -1.542 . . . . 0.0 106.836 -177.712 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 9.4 tt -100.5 98.74 9.31 Favored 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 -177.302 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -93.66 115.57 28.03 Favored 'General case' 0 N--CA 1.484 1.26 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 -174.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 28.9 m -100.89 103.42 14.59 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 -179.7 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 21.1 m-70 -90.53 105.25 17.69 Favored 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 123.479 0.712 . . . . 0.0 109.444 -170.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 5.9 m . . . . . 0 N--CA 1.491 1.588 0 CA-C-O 121.234 0.54 . . . . 0.0 112.125 -164.524 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 17.4 t30 . . . . . 0 N--CA 1.484 1.257 0 N-CA-C 108.69 -0.855 . . . . 0.0 108.69 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 81.9 p -131.83 126.84 35.3 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 -164.537 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -109.66 120.27 41.96 Favored 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 177.659 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 43.0 pt -110.94 128.45 67.35 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 177.079 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 35.9 t -118.05 95.7 5.02 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 107.791 -1.189 . . . . 0.0 107.791 -175.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 45.1 p90 -130.71 142.25 50.42 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 114.241 1.201 . . . . 0.0 114.241 -156.645 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 29.6 mtpp -100.15 146.43 26.84 Favored 'General case' 0 N--CA 1.488 1.444 0 CA-C-N 115.218 -0.901 . . . . 0.0 109.126 165.608 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -73.44 116.89 14.54 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.433 -0.792 . . . . 0.0 112.106 -172.217 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 80.88 43.41 8.94 Favored Glycine 0 CA--C 1.549 2.186 0 N-CA-C 116.535 1.374 . . . . 0.0 116.535 -166.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 93.1 t -138.6 122.56 20.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 N-CA-C 106.469 -1.678 . . . . 0.0 106.469 177.603 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -85.64 133.34 34.04 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 123.634 0.773 . . . . 0.0 111.285 179.07 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -141.22 149.78 41.83 Favored 'General case' 0 N--CA 1.493 1.695 0 CA-C-O 121.764 0.793 . . . . 0.0 111.443 -173.784 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -74.24 136.08 42.71 Favored 'General case' 0 CA--C 1.565 1.542 0 O-C-N 121.387 -0.82 . . . . 0.0 112.866 172.195 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 32.1 tp10 -145.34 139.15 26.81 Favored 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 123.186 0.594 . . . . 0.0 110.018 -178.152 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 56.0 m -100.54 123.71 45.12 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 177.519 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 29.4 p -85.18 -179.69 7.06 Favored 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 113.432 0.901 . . . . 0.0 113.432 -174.746 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -54.38 -38.99 66.79 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 117.266 2.321 . . . . 0.0 117.266 167.683 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -83.54 13.32 4.64 Favored 'General case' 0 CA--C 1.578 2.035 0 N-CA-C 115.615 1.709 . . . . 0.0 115.615 170.704 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . 0.255 8.7 t70 58.33 72.51 0.52 Allowed 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 125.443 1.497 . . . . 0.0 113.446 -174.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 44.2 mtm180 -132.87 124.96 28.9 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 -174.011 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.6 106.89 8.52 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 123.096 0.558 . . . . 0.0 111.648 174.136 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 18.2 m -118.36 134.01 63.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 C-N-CA 122.996 0.518 . . . . 0.0 109.74 -169.131 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 31.5 mmtp -82.84 104.01 12.75 Favored 'General case' 0 N--CA 1.488 1.456 0 CA-C-O 121.92 0.867 . . . . 0.0 109.451 176.215 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 43.3 t -106.27 99.04 8.65 Favored 'General case' 0 CA--C 1.553 1.083 0 CA-C-N 114.68 -1.146 . . . . 0.0 110.044 -161.299 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 7.4 tp -110.61 116.82 53.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 C-N-CA 124.229 1.012 . . . . 0.0 108.631 -177.05 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -134.89 120.06 29.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 C-N-CA 123.612 0.765 . . . . 0.0 109.279 -174.062 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 10.5 t -129.4 157.96 40.5 Favored 'General case' 0 N--CA 1.493 1.676 0 CA-C-O 122.473 1.13 . . . . 0.0 112.223 178.241 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 61.1 tp -84.18 127.28 33.83 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-N 114.805 -1.088 . . . . 0.0 110.577 174.365 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -131.44 85.13 2.23 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 123.905 0.882 . . . . 0.0 109.249 -176.179 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 55.54 44.36 85.73 Favored Glycine 0 N--CA 1.493 2.447 0 N-CA-C 118.658 2.223 . . . . 0.0 118.658 -179.381 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 82.41 16.92 70.08 Favored Glycine 0 CA--C 1.557 2.66 0 N-CA-C 118.627 2.211 . . . . 0.0 118.627 -167.542 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 53.8 mtpt -129.55 119.82 24.31 Favored 'General case' 0 N--CA 1.487 1.39 0 CA-C-N 119.064 1.432 . . . . 0.0 107.691 177.104 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 3.1 mp -82.3 107.9 15.33 Favored 'General case' 0 N--CA 1.485 1.294 0 CA-C-O 122.071 0.939 . . . . 0.0 109.369 169.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 70.4 t -99.47 102.19 13.09 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.333 0 N-CA-C 105.16 -2.163 . . . . 0.0 105.16 -174.621 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 20.8 t-160 -107.35 131.81 53.83 Favored 'General case' 0 N--CA 1.484 1.226 0 CA-C-N 114.486 -1.233 . . . . 0.0 108.613 -175.546 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 35.6 tp -131.01 121.3 24.81 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 177.556 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 90.7 mt-30 -111.5 113.43 25.85 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 175.567 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 10.7 ptpp? -118.78 140.36 50.08 Favored 'General case' 0 N--CA 1.494 1.749 0 C-N-CA 123.25 0.62 . . . . 0.0 112.052 -176.336 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 30.5 p90 -153.61 110.81 3.45 Favored 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 123.15 0.58 . . . . 0.0 109.813 -175.68 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . 0.339 8.8 t70 66.84 -101.5 0.07 Allowed 'General case' 0 N--CA 1.494 1.734 0 C-N-CA 124.602 1.161 . . . . 0.0 112.63 172.833 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -124.43 50.27 0.87 Allowed Glycine 0 N--CA 1.488 2.155 0 CA-C-N 118.941 0.791 . . . . 0.0 114.482 164.713 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 52.3 mt-30 -153.42 124.85 7.59 Favored 'General case' 0 N--CA 1.485 1.289 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 -178.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -136.46 133.47 36.64 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.859 -0.525 . . . . 0.0 111.453 176.23 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 6.4 t -120.06 129.48 54.24 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 123.379 0.672 . . . . 0.0 110.718 175.462 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 41.0 p -95.71 133.88 39.28 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-O 121.528 0.68 . . . . 0.0 111.052 173.515 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 5.6 mp -111.68 74.01 0.85 Allowed 'General case' 0 CA--C 1.564 1.519 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 178.811 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 59.2 t -83.17 109.42 16.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 121.126 -0.984 . . . . 0.0 108.507 -167.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 76.6 mtt85 -101.32 120.72 40.69 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 123.269 0.628 . . . . 0.0 109.905 -174.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -141.72 127.46 19.19 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 122.872 0.469 . . . . 0.0 110.754 -169.52 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -79.23 114.85 18.5 Favored 'General case' 0 N--CA 1.487 1.418 0 CA-C-O 121.359 0.6 . . . . 0.0 111.331 -179.272 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 47.5 mm -121.4 106.39 18.21 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.338 0 N-CA-C 105.026 -2.213 . . . . 0.0 105.026 177.24 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 58.73 50.14 9.19 Favored 'General case' 0 N--CA 1.5 2.029 0 N-CA-C 115.064 1.505 . . . . 0.0 115.064 175.232 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 67.07 18.99 69.6 Favored Glycine 0 CA--C 1.555 2.577 0 N-CA-C 119.668 2.627 . . . . 0.0 119.668 -171.16 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 89.6 mttt -132.68 129.72 39.17 Favored 'General case' 0 N--CA 1.488 1.463 0 CA-C-N 119.63 1.715 . . . . 0.0 109.294 -174.387 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 18.2 tp -77.72 110.22 12.39 Favored 'General case' 0 CA--C 1.557 1.231 0 C-N-CA 123.98 0.912 . . . . 0.0 110.298 -179.523 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 30.5 mm -96.55 101.63 12.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 N-CA-C 106.748 -1.575 . . . . 0.0 106.748 -177.452 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 29.9 tp -88.99 101.36 14.01 Favored 'General case' 0 CA--C 1.559 1.307 0 C-N-CA 123.754 0.821 . . . . 0.0 109.361 176.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 87.4 m -95.61 105.94 17.97 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 -175.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 86.8 mt -99.3 98.77 9.69 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 123.588 0.755 . . . . 0.0 109.896 -171.302 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 6.7 m -113.6 115.8 28.5 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 -174.138 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 58.6 t60 -103.19 -87.46 0.42 Allowed 'General case' 0 N--CA 1.491 1.6 0 CA-C-O 118.5 -0.762 . . . . 0.0 108.986 170.411 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -106.64 -106.73 3.14 Favored Glycine 0 N--CA 1.484 1.869 0 CA-C-N 119.201 0.909 . . . . 0.0 111.09 179.359 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 13.8 t -100.79 49.24 0.89 Allowed 'General case' 0 N--CA 1.498 1.937 0 N-CA-C 113.346 0.869 . . . . 0.0 113.346 174.04 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -158.39 93.71 1.23 Allowed 'General case' 0 N--CA 1.483 1.223 0 O-C-N 121.206 -0.934 . . . . 0.0 108.648 175.398 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 4.2 p -91.47 121.26 41.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 C-N-CA 123.352 0.661 . . . . 0.0 109.753 175.36 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 45.7 t -101.44 100.03 10.43 Favored 'General case' 0 CA--C 1.553 1.081 0 CA-C-O 121.556 0.693 . . . . 0.0 111.214 175.424 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 63.0 m -86.14 111.06 20.0 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 179.433 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 32.8 mtm180 -114.99 118.33 33.13 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 122.992 0.517 . . . . 0.0 110.331 -172.104 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 93.3 m -86.79 132.87 33.72 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 123.433 0.693 . . . . 0.0 110.304 177.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 38.0 m-85 -127.47 127.05 43.41 Favored 'General case' 0 CA--C 1.559 1.296 0 C-N-CA 123.648 0.779 . . . . 0.0 109.253 178.321 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -90.83 151.15 21.27 Favored 'General case' 0 N--CA 1.487 1.404 0 CA-C-O 121.788 0.804 . . . . 0.0 111.889 173.805 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 67.3 tttt -80.68 119.29 23.1 Favored 'General case' 0 N--CA 1.486 1.335 0 CA-C-O 121.563 0.697 . . . . 0.0 111.655 -174.585 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 18.1 mm-40 -119.89 50.33 1.29 Allowed 'General case' 0 CA--C 1.564 1.512 0 C-N-CA 124.422 1.089 . . . . 0.0 111.306 -171.077 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.897 0 CA-C-O 124.654 2.168 . . . . 0.0 109.946 -160.521 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 71.4 t . . . . . 0 CA--C 1.56 1.337 0 N-CA-C 106.201 -1.777 . . . . 0.0 106.201 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -140.49 -55.44 0.52 Allowed 'General case' 0 N--CA 1.494 1.746 0 C-N-CA 124.021 0.928 . . . . 0.0 111.051 -174.31 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -57.39 -29.99 64.54 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 116.914 2.19 . . . . 0.0 116.914 160.662 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -60.82 -18.89 58.2 Favored 'General case' 0 CA--C 1.571 1.76 0 N-CA-C 117.813 2.523 . . . . 0.0 117.813 163.768 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 82.4 mt -84.2 125.94 32.67 Favored 'General case' 0 N--CA 1.489 1.513 0 CA-C-N 121.329 1.877 . . . . 0.0 111.77 -169.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 153.92 176.3 26.14 Favored Glycine 0 CA--C 1.542 1.728 0 CA-C-O 122.602 1.112 . . . . 0.0 113.317 -173.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 71.4 m -84.75 140.17 31.44 Favored 'General case' 0 N--CA 1.49 1.564 0 CA-C-N 114.679 -0.76 . . . . 0.0 109.262 165.063 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 85.8 m95 -141.85 113.23 7.64 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 -174.292 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 6.3 mtpm? -102.03 145.48 29.25 Favored 'General case' 0 N--CA 1.494 1.75 0 CA-C-O 121.034 0.445 . . . . 0.0 110.017 178.558 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 17.5 tp -65.95 127.06 30.56 Favored 'General case' 0 N--CA 1.491 1.59 0 CA-C-O 122.349 1.071 . . . . 0.0 112.495 -175.59 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . 0.283 1.0 OUTLIER -104.51 -46.65 9.68 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.897 0 CA-C-N 113.845 -1.525 . . . . 0.0 111.448 177.288 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -137.36 140.34 41.36 Favored 'General case' 0 N--CA 1.49 1.542 0 CA-C-N 119.994 1.27 . . . . 0.0 109.848 177.31 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 71.8 p -131.37 118.05 19.75 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 123.462 0.705 . . . . 0.0 109.532 169.246 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 30.6 mtpp -88.05 -87.14 0.16 Allowed 'General case' 0 N--CA 1.491 1.625 0 CA-C-O 119.14 -0.457 . . . . 0.0 111.335 -172.621 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 65.0 m-80 -95.12 49.58 1.22 Allowed 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 113.503 0.927 . . . . 0.0 113.503 -175.594 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 23.7 t80 -77.25 -54.48 6.43 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.6 -1.313 . . . . 0.0 113.462 -173.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -51.19 -35.64 37.31 Favored 'General case' 0 N--CA 1.499 2.014 0 N-CA-C 116.722 2.119 . . . . 0.0 116.722 166.75 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 35.4 t0 -63.11 -55.71 23.02 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 114.179 1.178 . . . . 0.0 114.179 168.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 85.7 t80 -49.99 -47.21 53.01 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 116.403 2.001 . . . . 0.0 116.403 169.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 26.0 mmm -62.47 -45.58 92.38 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 114.771 1.397 . . . . 0.0 114.771 177.033 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 42.0 tptt -64.16 -38.8 92.36 Favored 'General case' 0 CA--C 1.566 1.585 0 N-CA-C 115.787 1.773 . . . . 0.0 115.787 171.101 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 65.6 m -58.38 -40.41 82.27 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 115.937 1.828 . . . . 0.0 115.937 168.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 77.2 mt -61.96 -37.34 84.39 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 116.694 2.109 . . . . 0.0 116.694 166.662 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 112.08 69.77 0.56 Allowed Glycine 0 N--CA 1.481 1.681 0 C-N-CA 124.055 0.836 . . . . 0.0 111.875 -173.704 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 37.3 t -140.83 117.45 7.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 N-CA-C 105.006 -2.22 . . . . 0.0 105.006 -177.145 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -68.33 -80.61 0.22 Allowed Glycine 0 N--CA 1.485 1.963 0 N-CA-C 117.078 1.591 . . . . 0.0 117.078 -166.472 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . 0.262 46.2 p90 -149.05 -50.37 0.15 Allowed 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 114.543 1.312 . . . . 0.0 114.543 -175.565 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.66 -39.84 91.8 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 116.511 2.041 . . . . 0.0 116.511 -178.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 60.0 m -79.32 -36.81 38.95 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 113.635 0.976 . . . . 0.0 113.635 170.255 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 33.4 ttp85 -61.1 -44.2 97.73 Favored 'General case' 0 CA--C 1.566 1.591 0 N-CA-C 115.543 1.683 . . . . 0.0 115.543 174.565 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 39.1 mt-30 -79.6 -40.42 29.39 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 115.026 1.491 . . . . 0.0 115.026 177.738 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 47.1 t -74.48 -37.72 44.86 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 CA-C-N 120.503 1.501 . . . . 0.0 112.524 179.305 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -66.99 -34.36 77.57 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 116.612 2.078 . . . . 0.0 116.612 172.074 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 92.0 p -65.18 -44.72 87.52 Favored 'General case' 0 N--CA 1.493 1.725 0 N-CA-C 115.783 1.772 . . . . 0.0 115.783 167.69 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 44.6 ttm -62.0 -36.97 83.09 Favored 'General case' 0 CA--C 1.571 1.765 0 N-CA-C 116.141 1.904 . . . . 0.0 116.141 168.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 52.4 m -68.26 151.93 46.21 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 124.455 1.102 . . . . 0.0 112.523 176.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 4.2 ttmp? -104.09 97.47 11.54 Favored Pre-proline 0 CA--C 1.574 1.896 0 CA-C-N 115.173 -0.921 . . . . 0.0 109.674 176.378 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -75.57 145.72 29.87 Favored 'Trans proline' 0 CA--C 1.561 1.839 0 C-N-CA 123.697 2.931 . . . . 0.0 113.444 178.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 98.8 m -117.34 97.4 5.88 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 -171.003 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 90.9 m -79.48 117.41 20.41 Favored 'General case' 0 N--CA 1.492 1.664 0 C-N-CA 123.77 0.828 . . . . 0.0 110.037 178.687 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 62.3 mt -119.02 111.79 34.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 N-CA-C 106.324 -1.732 . . . . 0.0 106.324 -174.382 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 17.8 mt -110.79 116.81 53.45 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 -173.013 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -127.36 123.67 36.79 Favored 'General case' 0 N--CA 1.494 1.769 0 C-N-CA 123.485 0.714 . . . . 0.0 109.841 179.721 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 82.1 tttt -97.5 120.53 38.05 Favored 'General case' 0 CA--C 1.557 1.217 0 C-N-CA 123.649 0.78 . . . . 0.0 110.335 177.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 -83.61 -81.03 0.17 Allowed 'General case' 0 N--CA 1.49 1.545 0 CA-C-O 118.793 -0.622 . . . . 0.0 110.125 178.242 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -99.94 -87.2 1.94 Allowed Glycine 0 N--CA 1.486 2.013 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 166.782 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -119.15 55.84 0.93 Allowed 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 153.69 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 15.0 mm -128.94 104.91 12.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 N-CA-C 104.888 -2.264 . . . . 0.0 104.888 -176.127 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 36.0 mt -95.29 107.41 19.52 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 123.048 0.539 . . . . 0.0 111.24 -170.798 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 31.5 m -92.72 94.02 8.77 Favored 'General case' 0 CA--C 1.559 1.302 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 -176.561 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 10.4 tt -98.24 102.25 13.94 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 -176.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 50.7 mttp -102.47 106.37 17.09 Favored 'General case' 0 N--CA 1.486 1.341 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 -174.505 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 59.3 m -92.23 97.22 10.76 Favored 'General case' 0 N--CA 1.493 1.675 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 178.736 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 22.4 m170 -91.76 94.76 9.51 Favored 'General case' 0 N--CA 1.488 1.458 0 CA-C-O 121.909 0.862 . . . . 0.0 110.089 -174.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 27.9 t . . . . . 0 N--CA 1.484 1.265 0 CA-C-N 115.041 -0.981 . . . . 0.0 109.879 173.503 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 43.7 m-20 . . . . . 0 N--CA 1.492 1.643 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 61.9 p -126.45 131.36 51.69 Favored 'General case' 0 N--CA 1.496 1.869 0 C-N-CA 123.063 0.545 . . . . 0.0 110.069 -176.767 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -128.75 123.67 33.56 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 123.512 0.725 . . . . 0.0 109.556 -172.642 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 41.8 pt -118.65 134.2 63.04 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 C-N-CA 123.709 0.804 . . . . 0.0 108.976 174.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 67.2 p -119.73 104.38 10.19 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 178.478 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 53.0 p90 -132.27 141.15 48.88 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 115.204 1.557 . . . . 0.0 115.204 -159.404 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 62.4 mtpt -94.51 143.17 26.65 Favored 'General case' 0 CA--C 1.562 1.408 0 CA-C-N 114.378 -1.283 . . . . 0.0 109.761 166.197 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -77.91 120.57 22.97 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.851 -0.53 . . . . 0.0 111.606 -175.402 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 83.03 43.48 7.56 Favored Glycine 0 CA--C 1.549 2.19 0 N-CA-C 116.5 1.36 . . . . 0.0 116.5 -169.512 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 94.2 t -140.69 123.68 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 N-CA-C 106.458 -1.682 . . . . 0.0 106.458 -178.523 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -86.32 130.16 34.61 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 123.227 0.611 . . . . 0.0 110.872 171.654 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 45.3 p90 -144.23 128.9 18.21 Favored 'General case' 0 N--CA 1.492 1.656 0 C-N-CA 123.619 0.767 . . . . 0.0 109.744 -175.341 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -72.48 111.65 7.85 Favored 'General case' 0 CA--C 1.564 1.493 0 O-C-N 121.327 -0.858 . . . . 0.0 112.657 177.198 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 13.4 tp10 -113.64 132.92 55.59 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 124.29 1.036 . . . . 0.0 109.537 -171.591 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 57.1 m -92.86 122.62 35.42 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 176.532 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 24.1 p -85.9 172.26 10.86 Favored 'General case' 0 N--CA 1.495 1.808 0 CA-C-O 121.588 0.709 . . . . 0.0 112.403 -176.296 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -58.41 -35.17 71.65 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 117.306 2.336 . . . . 0.0 117.306 167.451 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -77.57 12.74 1.49 Allowed 'General case' 0 CA--C 1.581 2.157 0 N-CA-C 115.981 1.845 . . . . 0.0 115.981 167.399 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 10.4 t70 58.08 71.93 0.55 Allowed 'General case' 0 N--CA 1.492 1.643 0 C-N-CA 125.545 1.538 . . . . 0.0 113.483 -176.723 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 80.5 mtm180 -136.82 121.64 18.7 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 -176.271 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.55 99.32 5.68 Favored 'General case' 0 CA--C 1.563 1.452 0 C-N-CA 123.179 0.592 . . . . 0.0 111.042 170.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 10.7 m -113.51 128.05 70.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 -170.104 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 72.0 mmtt -77.72 99.41 5.84 Favored 'General case' 0 N--CA 1.488 1.474 0 CA-C-O 121.674 0.749 . . . . 0.0 110.04 177.139 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 47.6 m -93.36 93.22 8.06 Favored 'General case' 0 N--CA 1.48 1.056 0 CA-C-N 115.009 -0.996 . . . . 0.0 110.501 -169.415 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 6.0 tp -101.97 103.26 14.7 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 175.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.0 p -121.96 125.0 72.56 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.364 0 CA-C-N 115.307 -0.861 . . . . 0.0 109.209 -174.639 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 15.3 t -135.53 156.52 48.75 Favored 'General case' 0 N--CA 1.489 1.482 0 CA-C-O 122.921 1.343 . . . . 0.0 111.21 178.717 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 63.7 tp -89.52 108.36 19.61 Favored 'General case' 0 N--CA 1.486 1.368 0 CA-C-N 114.173 -1.376 . . . . 0.0 108.899 171.122 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -109.6 87.01 2.4 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 123.45 0.7 . . . . 0.0 109.993 -173.7 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 61.3 48.93 82.68 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 117.623 1.809 . . . . 0.0 117.623 -178.63 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 73.46 27.54 67.49 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 118.915 2.326 . . . . 0.0 118.915 -169.297 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -143.88 112.46 6.52 Favored 'General case' 0 CA--C 1.553 1.063 0 N-CA-C 107.134 -1.432 . . . . 0.0 107.134 -174.685 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 4.7 tt -86.61 102.88 14.58 Favored 'General case' 0 CA--C 1.561 1.376 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 -172.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 77.7 t -104.35 108.05 23.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 -171.578 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 21.8 t-160 -105.97 109.18 21.05 Favored 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 123.378 0.671 . . . . 0.0 109.954 177.013 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 38.0 tp -102.88 121.04 41.7 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 178.24 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 31.5 mt-30 -114.13 115.88 28.22 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 83.5 mttt -113.28 135.53 53.74 Favored 'General case' 0 N--CA 1.495 1.793 0 CA-C-N 118.812 0.733 . . . . 0.0 111.103 -178.364 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 27.3 p90 -152.69 110.57 3.63 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.354 -0.841 . . . . 0.0 109.898 178.713 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 3.8 t70 53.56 50.88 16.28 Favored 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 116.392 1.997 . . . . 0.0 116.392 170.008 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 89.66 -43.46 2.99 Favored Glycine 0 CA--C 1.551 2.311 0 N-CA-C 116.685 1.434 . . . . 0.0 116.685 -169.34 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 15.0 mt-30 -80.88 124.6 29.24 Favored 'General case' 0 N--CA 1.488 1.428 0 CA-C-N 118.309 1.054 . . . . 0.0 111.318 -177.114 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -132.61 131.39 41.38 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 123.072 0.549 . . . . 0.0 111.712 178.685 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 8.8 t -118.45 133.03 56.21 Favored 'General case' 0 N--CA 1.496 1.866 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.365 176.534 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 35.8 p -102.76 132.72 48.72 Favored 'General case' 0 N--CA 1.495 1.819 0 CA-C-O 121.678 0.751 . . . . 0.0 110.85 172.602 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 5.3 mp -114.54 89.36 3.08 Favored 'General case' 0 CA--C 1.562 1.412 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 -179.448 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 97.1 t -98.49 106.05 18.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 -167.543 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 83.9 mtt85 -99.51 125.13 45.22 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 123.179 0.592 . . . . 0.0 110.402 -176.367 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -140.14 130.12 24.79 Favored 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 123.084 0.554 . . . . 0.0 111.092 -174.764 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -82.43 112.88 19.78 Favored 'General case' 0 N--CA 1.488 1.463 0 CA-C-O 121.256 0.55 . . . . 0.0 111.086 -178.557 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 82.8 mt -123.46 109.43 23.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 N-CA-C 105.052 -2.203 . . . . 0.0 105.052 179.412 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 57.87 50.18 10.85 Favored 'General case' 0 N--CA 1.499 2.012 0 N-CA-C 114.849 1.425 . . . . 0.0 114.849 177.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 62.24 24.65 65.64 Favored Glycine 0 CA--C 1.555 2.536 0 N-CA-C 119.502 2.561 . . . . 0.0 119.502 -170.699 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 91.2 mttt -132.31 131.07 41.62 Favored 'General case' 0 N--CA 1.488 1.435 0 CA-C-N 119.951 1.876 . . . . 0.0 109.534 -176.093 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 20.1 tp -77.58 110.08 12.08 Favored 'General case' 0 N--CA 1.484 1.275 0 C-N-CA 123.955 0.902 . . . . 0.0 110.144 -179.644 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 27.7 mm -99.39 95.58 4.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 N-CA-C 107.062 -1.459 . . . . 0.0 107.062 -175.047 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 17.4 tp -86.94 104.4 16.22 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 124.068 0.947 . . . . 0.0 110.098 179.542 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 84.8 m -99.66 104.16 15.89 Favored 'General case' 0 CA--C 1.561 1.392 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 -173.098 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 91.1 mt -98.52 102.43 14.17 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 123.659 0.784 . . . . 0.0 110.111 -172.497 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 9.6 m -113.44 125.9 54.74 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 -176.124 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 83.3 t60 -136.45 -98.33 0.22 Allowed 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 175.408 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -110.45 93.0 0.71 Allowed Glycine 0 N--CA 1.483 1.829 0 CA-C-N 118.816 0.734 . . . . 0.0 111.684 -169.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . 0.387 5.2 t 47.47 39.33 9.18 Favored 'General case' 0 N--CA 1.5 2.07 0 N-CA-C 117.546 2.425 . . . . 0.0 117.546 -172.097 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -157.64 93.6 1.29 Allowed 'General case' 0 N--CA 1.483 1.197 0 O-C-N 121.484 -0.76 . . . . 0.0 109.575 -174.461 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 2.8 p -92.87 112.25 25.86 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 C-N-CA 123.643 0.777 . . . . 0.0 109.288 173.141 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 41.1 t -97.5 104.34 16.36 Favored 'General case' 0 CA--C 1.551 1.017 0 CA-C-O 121.016 0.436 . . . . 0.0 110.292 175.179 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 89.2 m -90.04 100.96 13.68 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 -178.581 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 59.3 mtp180 -103.43 114.74 29.25 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 123.107 0.563 . . . . 0.0 109.749 -167.535 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 56.6 m -84.8 131.92 34.48 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 123.091 0.556 . . . . 0.0 109.954 177.772 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 41.0 m-85 -129.49 126.31 38.37 Favored 'General case' 0 CA--C 1.561 1.385 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 178.378 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -88.62 150.54 22.99 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 123.515 0.726 . . . . 0.0 112.127 174.68 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 71.0 tttt -81.67 118.14 22.58 Favored 'General case' 0 N--CA 1.486 1.346 0 CA-C-O 121.43 0.633 . . . . 0.0 111.577 -174.503 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 37.3 mm-40 -118.24 51.38 1.08 Allowed 'General case' 0 CA--C 1.564 1.505 0 C-N-CA 124.216 1.007 . . . . 0.0 111.31 -174.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.875 0 CA-C-O 123.105 1.431 . . . . 0.0 110.151 -161.931 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 5.7 p . . . . . 0 CA--C 1.578 2.028 0 N-CA-C 115.24 1.571 . . . . 0.0 115.24 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -78.84 -38.71 37.32 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 115.648 1.721 . . . . 0.0 115.648 -176.087 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -58.95 -24.03 62.11 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 117.649 2.463 . . . . 0.0 117.649 167.428 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -69.62 -20.19 63.62 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 116.575 2.065 . . . . 0.0 116.575 167.333 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 42.9 mt -81.17 121.99 26.82 Favored 'General case' 0 N--CA 1.488 1.475 0 CA-C-N 120.829 1.65 . . . . 0.0 111.168 -170.709 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 157.34 174.75 27.45 Favored Glycine 0 CA--C 1.541 1.703 0 CA-C-O 122.379 0.988 . . . . 0.0 113.369 -172.283 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 63.0 m -93.12 136.88 32.97 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 170.516 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 87.5 m95 -138.34 113.37 9.24 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 -171.431 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 9.4 mtmp? -97.81 143.54 28.33 Favored 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 123.247 0.619 . . . . 0.0 110.547 -179.506 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 60.0 tp -70.87 117.27 12.16 Favored 'General case' 0 N--CA 1.492 1.639 0 CA-C-O 121.856 0.836 . . . . 0.0 111.177 -177.573 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . 0.27 1.0 OUTLIER -97.48 -42.38 11.62 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.757 0 CA-C-N 114.337 -1.301 . . . . 0.0 112.725 -178.702 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -148.06 134.82 19.99 Favored 'General case' 0 N--CA 1.487 1.386 0 CA-C-N 119.677 1.126 . . . . 0.0 109.035 -177.53 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 88.8 p -121.59 100.84 7.24 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 122.976 0.51 . . . . 0.0 110.496 176.741 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 61.1 mtpt -92.77 123.02 35.75 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 176.644 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 52.1 m-20 67.22 21.66 9.9 Favored 'General case' 0 N--CA 1.503 2.204 0 N-CA-C 117.513 2.412 . . . . 0.0 117.513 176.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 17.3 t80 -71.2 -40.21 71.31 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 119.988 -1.695 . . . . 0.0 115.345 -179.273 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -60.19 -31.45 70.14 Favored 'General case' 0 CA--C 1.571 1.766 0 N-CA-C 115.935 1.828 . . . . 0.0 115.935 165.337 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 14.3 t0 -64.92 -47.25 78.4 Favored 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 114.843 1.423 . . . . 0.0 114.843 166.012 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 94.2 t80 -54.0 -51.95 62.33 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 115.104 1.52 . . . . 0.0 115.104 172.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 75.8 mtm -63.67 -34.37 77.69 Favored 'General case' 0 CA--C 1.568 1.636 0 N-CA-C 115.697 1.74 . . . . 0.0 115.697 172.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 38.4 ttmt -61.44 -47.55 85.22 Favored 'General case' 0 CA--C 1.569 1.674 0 N-CA-C 114.412 1.264 . . . . 0.0 114.412 167.506 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 60.1 m -58.67 -36.15 73.71 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 116.412 2.004 . . . . 0.0 116.412 171.617 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 33.4 mt -63.05 -43.91 97.33 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 116.178 1.918 . . . . 0.0 116.178 166.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 120.22 71.1 0.32 Allowed Glycine 0 N--CA 1.483 1.781 0 C-N-CA 123.79 0.71 . . . . 0.0 111.588 -176.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 23.9 t -142.24 120.88 8.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 N-CA-C 105.166 -2.161 . . . . 0.0 105.166 -176.452 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -78.92 -86.48 0.52 Allowed Glycine 0 N--CA 1.488 2.129 0 N-CA-C 115.859 1.104 . . . . 0.0 115.859 -169.23 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 15.2 p90 -139.36 160.3 40.15 Favored 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 123.498 0.719 . . . . 0.0 110.767 178.605 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . 0.313 . . 76.41 -50.91 0.59 Allowed 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 115.386 1.625 . . . . 0.0 115.386 177.68 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 52.8 m -64.92 -39.86 94.16 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 113.964 1.098 . . . . 0.0 113.964 167.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 38.0 mtm180 -61.34 -43.59 98.62 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 115.063 1.505 . . . . 0.0 115.063 166.073 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 7.4 tm0? -61.74 -49.09 77.8 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 115.403 1.631 . . . . 0.0 115.403 174.074 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 97.2 t -64.56 -41.11 91.32 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 CA-C-N 119.503 1.047 . . . . 0.0 113.207 177.227 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -67.72 -40.71 84.23 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 116.504 2.038 . . . . 0.0 116.504 176.251 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 95.2 p -66.79 -39.42 87.77 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 116.332 1.975 . . . . 0.0 116.332 169.549 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 54.5 tpp -64.97 -37.21 86.91 Favored 'General case' 0 CA--C 1.569 1.7 0 N-CA-C 115.992 1.849 . . . . 0.0 115.992 169.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 54.4 m -69.96 145.88 51.55 Favored 'General case' 0 CA--C 1.566 1.589 0 C-N-CA 124.047 0.939 . . . . 0.0 111.79 174.649 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -103.12 100.73 18.28 Favored Pre-proline 0 CA--C 1.57 1.742 0 CA-C-O 118.143 -0.932 . . . . 0.0 109.147 173.224 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -81.82 100.67 1.11 Allowed 'Trans proline' 0 C--N 1.371 1.727 0 C-N-CA 123.027 2.485 . . . . 0.0 111.649 -179.379 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 99.8 m -79.15 112.95 16.87 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 123.522 0.729 . . . . 0.0 110.228 -168.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 46.5 m -87.28 114.78 24.19 Favored 'General case' 0 CA--C 1.561 1.395 0 C-N-CA 123.557 0.743 . . . . 0.0 109.147 -174.137 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 98.3 mt -108.75 108.45 25.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 N-CA-C 106.356 -1.72 . . . . 0.0 106.356 176.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 18.8 mt -101.72 120.3 51.16 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 -178.718 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 6.8 tm-20 -133.24 116.48 16.25 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 -172.233 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 80.7 tttt -93.62 114.97 27.42 Favored 'General case' 0 CA--C 1.557 1.243 0 C-N-CA 123.335 0.654 . . . . 0.0 110.374 176.523 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 23.8 t30 -86.78 -70.59 0.6 Allowed 'General case' 0 N--CA 1.492 1.628 0 C-N-CA 123.043 0.537 . . . . 0.0 111.026 178.307 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -143.11 75.92 0.31 Allowed Glycine 0 N--CA 1.487 2.068 0 N-CA-C 110.522 -1.031 . . . . 0.0 110.522 170.039 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . 0.284 6.3 t70 49.43 48.21 21.51 Favored 'General case' 0 N--CA 1.497 1.924 0 N-CA-C 115.518 1.673 . . . . 0.0 115.518 -155.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 31.0 mm -134.51 99.9 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 N-CA-C 103.589 -2.745 . . . . 0.0 103.589 178.47 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 65.2 mt -88.11 101.49 13.85 Favored 'General case' 0 N--CA 1.481 1.097 0 CA-C-O 121.281 0.562 . . . . 0.0 110.039 -177.614 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 91.1 m -94.46 97.02 9.87 Favored 'General case' 0 N--CA 1.485 1.29 0 N-CA-C 106.973 -1.492 . . . . 0.0 106.973 -176.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 9.8 tt -99.22 99.56 10.55 Favored 'General case' 0 N--CA 1.484 1.246 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 -174.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -96.6 126.65 41.93 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 123.782 0.833 . . . . 0.0 109.166 -175.675 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 28.0 m -102.63 93.7 5.25 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.134 -1.062 . . . . 0.0 108.134 -175.619 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 16.8 m-70 -86.25 104.33 15.69 Favored 'General case' 0 N--CA 1.491 1.591 0 CA-C-O 121.451 0.643 . . . . 0.0 109.709 -173.03 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 23.1 t . . . . . 0 N--CA 1.483 1.183 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.274 -161.813 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 53.6 m-80 . . . . . 0 N--CA 1.491 1.582 0 CA-C-O 121.052 0.453 . . . . 0.0 110.076 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 73.9 p -98.41 132.17 44.08 Favored 'General case' 0 N--CA 1.493 1.709 0 C-N-CA 123.417 0.687 . . . . 0.0 110.603 -177.013 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -123.87 123.57 40.73 Favored 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 123.674 0.79 . . . . 0.0 109.067 -176.714 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 40.8 pt -118.74 132.01 69.86 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 174.467 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 46.1 t -120.6 111.11 17.24 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 -177.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 50.4 p90 -140.94 140.72 34.48 Favored 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 115.119 1.525 . . . . 0.0 115.119 -160.015 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 63.6 mtpt -106.25 17.62 23.2 Favored 'General case' 0 CA--C 1.573 1.852 0 N-CA-C 117.011 2.226 . . . . 0.0 117.011 -172.608 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . 0.294 0.1 OUTLIER 60.35 92.7 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.736 0 CA-C-N 120.546 1.521 . . . . 0.0 114.292 177.981 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 92.68 38.73 5.46 Favored Glycine 0 CA--C 1.551 2.295 0 N-CA-C 116.863 1.505 . . . . 0.0 116.863 -167.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 86.6 t -140.06 122.7 16.68 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 N-CA-C 106.93 -1.507 . . . . 0.0 106.93 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -87.62 133.27 33.84 Favored 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 123.299 0.64 . . . . 0.0 111.136 173.749 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 47.5 p90 -145.56 133.72 21.6 Favored 'General case' 0 N--CA 1.493 1.682 0 C-N-CA 123.888 0.875 . . . . 0.0 109.306 -175.082 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -76.35 142.66 41.14 Favored 'General case' 0 N--CA 1.49 1.54 0 CA-C-O 123.028 1.394 . . . . 0.0 112.117 176.211 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 15.4 tp10 -146.54 138.91 25.04 Favored 'General case' 0 N--CA 1.488 1.444 0 CA-C-N 113.18 -1.827 . . . . 0.0 110.351 -167.053 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 55.7 m -97.18 121.96 39.65 Favored 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 123.281 0.633 . . . . 0.0 109.424 177.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 25.1 p -86.39 170.54 11.9 Favored 'General case' 0 N--CA 1.495 1.815 0 CA-C-O 121.894 0.854 . . . . 0.0 113.128 -173.565 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -58.77 -34.23 71.21 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 118.627 2.825 . . . . 0.0 118.627 173.267 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -101.57 54.72 0.82 Allowed 'General case' 0 CA--C 1.574 1.886 0 CA-C-N 119.327 0.967 . . . . 0.0 110.847 168.038 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 15.3 t70 34.89 80.75 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 117.827 2.528 . . . . 0.0 117.827 178.015 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 60.5 mtm-85 -141.45 130.41 23.16 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 110.165 -0.309 . . . . 0.0 110.165 177.497 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.04 121.24 16.27 Favored 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 122.878 0.471 . . . . 0.0 110.493 158.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 16.3 m -137.89 132.24 43.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 -176.013 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -85.29 104.01 14.75 Favored 'General case' 0 N--CA 1.486 1.336 0 CA-C-O 121.882 0.849 . . . . 0.0 109.265 177.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 53.3 m -92.52 97.7 10.99 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 124.353 1.061 . . . . 0.0 110.946 -170.668 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 6.8 tp -107.65 118.79 56.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 175.3 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 1.5 p -136.84 132.61 47.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 C-N-CA 123.677 0.791 . . . . 0.0 109.298 -169.708 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 13.1 t -146.82 159.02 44.03 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-O 122.738 1.256 . . . . 0.0 110.545 178.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 17.5 tp -89.3 106.36 18.4 Favored 'General case' 0 CA--C 1.561 1.403 0 CA-C-N 114.81 -1.086 . . . . 0.0 108.871 173.611 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -105.43 94.09 5.03 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 123.493 0.717 . . . . 0.0 109.534 -177.472 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 60.97 49.59 76.88 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 117.506 1.762 . . . . 0.0 117.506 -178.699 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 69.59 18.96 74.31 Favored Glycine 0 CA--C 1.557 2.663 0 N-CA-C 119.158 2.423 . . . . 0.0 119.158 -168.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 38.7 mtmm -127.96 117.77 22.34 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 -178.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 4.5 tt -82.82 99.36 9.65 Favored 'General case' 0 CA--C 1.563 1.468 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 -177.051 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 55.0 t -103.61 108.49 24.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 N-CA-C 106.748 -1.575 . . . . 0.0 106.748 -169.175 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 19.9 t-160 -108.83 107.14 17.44 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 123.447 0.699 . . . . 0.0 110.054 179.201 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 42.5 tp -96.84 122.99 40.41 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 123.523 0.729 . . . . 0.0 109.262 177.201 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 30.2 mt-30 -113.88 113.88 25.48 Favored 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 107.54 -1.281 . . . . 0.0 107.54 175.521 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.59 145.0 41.14 Favored 'General case' 0 N--CA 1.493 1.725 0 C-N-CA 123.223 0.609 . . . . 0.0 111.574 178.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 32.9 p90 -155.55 111.03 3.03 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 123.355 0.662 . . . . 0.0 110.012 -177.454 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . 0.336 12.1 t70 69.0 -96.08 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.854 0 C-N-CA 124.438 1.095 . . . . 0.0 112.484 173.591 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -132.85 56.3 0.74 Allowed Glycine 0 CA--C 1.547 2.067 0 CA-C-N 118.424 0.557 . . . . 0.0 113.066 162.234 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 46.7 mt-30 -154.83 124.61 6.58 Favored 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 106.936 -1.505 . . . . 0.0 106.936 -174.166 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -132.52 144.25 50.3 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.886 -0.509 . . . . 0.0 112.301 178.285 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 6.2 t -130.27 126.71 37.93 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 122.815 0.446 . . . . 0.0 111.115 171.538 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 40.0 p -94.1 128.87 40.75 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 121.982 0.896 . . . . 0.0 110.577 170.487 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 5.7 mp -103.94 88.32 3.0 Favored 'General case' 0 CA--C 1.558 1.256 0 N-CA-C 106.637 -1.616 . . . . 0.0 106.637 175.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 81.0 t -93.54 97.94 7.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 N-CA-C 107.354 -1.35 . . . . 0.0 107.354 -169.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 78.4 mtt85 -91.42 127.62 36.93 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 123.367 0.667 . . . . 0.0 109.579 177.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -148.06 133.36 18.48 Favored 'General case' 0 N--CA 1.493 1.719 0 CA-C-O 120.82 0.343 . . . . 0.0 111.284 -176.078 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -79.66 114.15 18.36 Favored 'General case' 0 N--CA 1.487 1.41 0 CA-C-O 121.318 0.58 . . . . 0.0 111.442 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 90.4 mt -122.7 109.08 22.92 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 N-CA-C 104.534 -2.395 . . . . 0.0 104.534 176.189 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 23.4 m-20 59.19 48.98 9.72 Favored 'General case' 0 N--CA 1.5 2.029 0 N-CA-C 114.934 1.457 . . . . 0.0 114.934 177.608 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 62.74 24.4 66.35 Favored Glycine 0 CA--C 1.555 2.545 0 N-CA-C 119.555 2.582 . . . . 0.0 119.555 -170.306 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 59.9 mtmt -130.97 131.21 44.25 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-N 119.589 1.695 . . . . 0.0 108.863 -174.005 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 15.7 tp -77.98 107.61 10.64 Favored 'General case' 0 CA--C 1.558 1.276 0 CA-C-O 121.42 0.629 . . . . 0.0 109.676 178.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 32.7 mm -99.33 98.87 7.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 N-CA-C 106.432 -1.692 . . . . 0.0 106.432 -175.466 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 32.3 tp -88.71 103.41 15.93 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 123.976 0.91 . . . . 0.0 109.352 179.088 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 88.1 m -98.96 108.33 20.98 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 -177.169 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 67.1 mt -100.62 101.48 12.39 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 123.705 0.802 . . . . 0.0 109.436 -171.663 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 6.9 m -113.89 111.91 22.49 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 -175.57 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 70.5 t60 -102.95 -85.32 0.45 Allowed 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 173.617 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -109.56 -108.99 3.21 Favored Glycine 0 N--CA 1.484 1.872 0 N-CA-C 110.635 -0.986 . . . . 0.0 110.635 178.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 45.4 m -100.93 66.34 1.15 Allowed 'General case' 0 N--CA 1.494 1.757 0 CA-C-O 121.348 0.594 . . . . 0.0 109.593 173.408 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -172.8 96.1 0.13 Allowed 'General case' 0 N--CA 1.484 1.237 0 N-CA-C 108.123 -1.065 . . . . 0.0 108.123 173.279 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 3.7 p -94.68 122.55 46.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 C-N-CA 123.482 0.713 . . . . 0.0 109.61 174.253 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 44.4 t -108.21 102.11 11.27 Favored 'General case' 0 CA--C 1.553 1.067 0 CA-C-O 121.455 0.645 . . . . 0.0 111.356 179.384 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 90.6 m -88.12 108.0 19.04 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 179.379 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 35.9 mtm180 -111.42 120.05 40.88 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 123.044 0.538 . . . . 0.0 110.394 -172.657 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 94.8 m -86.28 131.17 34.29 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 123.343 0.657 . . . . 0.0 110.309 178.552 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 40.9 m-85 -125.84 125.48 42.93 Favored 'General case' 0 CA--C 1.56 1.354 0 C-N-CA 123.566 0.746 . . . . 0.0 109.035 176.443 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -92.72 158.34 15.97 Favored 'General case' 0 N--CA 1.495 1.816 0 CA-C-O 122.345 1.069 . . . . 0.0 111.849 170.287 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 73.5 tttt -91.16 125.97 36.1 Favored 'General case' 0 N--CA 1.484 1.256 0 CA-C-N 115.512 -0.767 . . . . 0.0 112.46 -165.447 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -97.86 46.74 1.01 Allowed 'General case' 0 N--CA 1.495 1.788 0 C-N-CA 123.853 0.861 . . . . 0.0 112.896 166.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.152 0 CA-C-O 123.168 1.461 . . . . 0.0 108.312 -174.821 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.315 8.9 t . . . . . 0 N--CA 1.491 1.585 0 CA-C-O 117.625 -1.178 . . . . 0.0 113.394 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -60.03 -37.58 80.19 Favored 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 116.274 1.953 . . . . 0.0 116.274 -178.309 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -62.78 -28.89 70.3 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 117.252 2.316 . . . . 0.0 117.252 164.169 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -73.12 -25.09 60.72 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 116.131 1.9 . . . . 0.0 116.131 168.278 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 74.4 mt -73.25 108.42 6.12 Favored 'General case' 0 N--CA 1.49 1.56 0 CA-C-N 120.747 1.612 . . . . 0.0 111.381 -173.115 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 161.34 171.59 27.56 Favored Glycine 0 CA--C 1.538 1.509 0 CA-C-O 123.254 1.474 . . . . 0.0 113.892 -175.103 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 96.8 m -84.85 144.85 28.15 Favored 'General case' 0 N--CA 1.487 1.378 0 CA-C-N 113.531 -1.334 . . . . 0.0 110.004 172.436 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 84.4 m95 -140.4 113.35 8.27 Favored 'General case' 0 N--CA 1.483 1.222 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 -175.228 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 45.3 mtmt -102.91 141.43 35.72 Favored 'General case' 0 N--CA 1.492 1.648 0 CA-C-O 121.457 0.646 . . . . 0.0 110.104 173.74 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 55.7 tp -69.63 130.52 42.62 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-O 122.444 1.116 . . . . 0.0 113.244 -170.492 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . 0.272 1.6 t -110.38 -41.77 4.69 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.781 0 CA-C-N 113.512 -1.676 . . . . 0.0 111.818 -172.671 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -142.14 138.94 31.97 Favored 'General case' 0 N--CA 1.492 1.633 0 CA-C-N 120.249 1.386 . . . . 0.0 109.738 175.307 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 86.6 p -124.3 102.39 7.66 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 123.416 0.686 . . . . 0.0 110.832 176.33 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -101.09 127.2 47.74 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 123.207 0.603 . . . . 0.0 109.424 174.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 66.2 m-20 67.62 22.04 9.22 Favored 'General case' 0 N--CA 1.504 2.25 0 N-CA-C 117.813 2.523 . . . . 0.0 117.813 173.452 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -72.4 -38.47 68.42 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 115.905 1.817 . . . . 0.0 115.905 -175.4 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -58.41 -30.68 67.05 Favored 'General case' 0 N--CA 1.498 1.96 0 N-CA-C 116.477 2.028 . . . . 0.0 116.477 164.708 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 13.5 t0 -66.13 -50.93 62.29 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 114.28 1.215 . . . . 0.0 114.28 169.486 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 93.7 t80 -55.17 -50.33 69.59 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 115.296 1.591 . . . . 0.0 115.296 172.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 72.7 mtm -60.53 -44.43 96.07 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 114.992 1.478 . . . . 0.0 114.992 173.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 14.5 tmtt? -57.29 -45.16 84.39 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 115.611 1.708 . . . . 0.0 115.611 168.35 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 13.8 t -59.13 -37.75 78.0 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 116.473 2.027 . . . . 0.0 116.473 173.073 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 63.6 mt -66.58 -42.28 87.24 Favored 'General case' 0 CA--C 1.564 1.514 0 N-CA-C 116.451 2.019 . . . . 0.0 116.451 170.315 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 115.13 77.27 0.71 Allowed Glycine 0 N--CA 1.482 1.718 0 N-CA-C 110.73 -0.948 . . . . 0.0 110.73 -168.309 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 62.4 t -143.04 122.64 9.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 N-CA-C 105.103 -2.184 . . . . 0.0 105.103 -177.027 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -81.58 -164.3 32.9 Favored Glycine 0 CA--C 1.548 2.127 0 N-CA-C 116.25 1.26 . . . . 0.0 116.25 -177.321 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 83.6 t80 -67.22 145.56 55.08 Favored 'General case' 0 CA--C 1.566 1.588 0 C-N-CA 123.501 0.72 . . . . 0.0 112.608 177.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . 0.377 . . 79.83 -41.11 0.22 Allowed 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 116.364 1.987 . . . . 0.0 116.364 179.395 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 56.9 m -69.36 -40.79 77.28 Favored 'General case' 0 N--CA 1.501 2.076 0 CA-C-N 120.152 1.342 . . . . 0.0 113.374 162.756 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 72.0 mtp180 -50.49 -42.51 54.79 Favored 'General case' 0 N--CA 1.498 1.946 0 N-CA-C 116.073 1.879 . . . . 0.0 116.073 160.022 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 81.4 mt-30 -76.41 -48.98 17.93 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 115.033 1.494 . . . . 0.0 115.033 -178.239 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 58.7 t -63.8 -43.16 97.83 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 CA-C-N 119.534 1.061 . . . . 0.0 112.922 178.004 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -65.35 -37.83 88.25 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 116.625 2.083 . . . . 0.0 116.625 174.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 90.5 p -62.46 -42.4 99.45 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 116.355 1.983 . . . . 0.0 116.355 170.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 19.2 ptp -74.23 -31.26 62.53 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 117.163 2.283 . . . . 0.0 117.163 173.172 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 65.7 m -77.96 144.31 36.89 Favored 'General case' 0 N--CA 1.491 1.577 0 CA-C-N 119.184 0.902 . . . . 0.0 111.743 -173.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 17.7 ptpt -98.25 104.97 25.86 Favored Pre-proline 0 CA--C 1.572 1.799 0 CA-C-O 118.431 -0.795 . . . . 0.0 111.591 170.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -78.06 112.98 3.34 Favored 'Trans proline' 0 CA--C 1.563 1.944 0 C-N-CA 123.056 2.504 . . . . 0.0 112.671 178.709 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 94.6 m -72.5 104.38 3.81 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 124.975 1.31 . . . . 0.0 110.1 175.563 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 29.7 m -106.65 118.26 36.21 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.844 -0.535 . . . . 0.0 110.142 -173.011 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 4.5 mp -106.71 112.95 41.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 -177.366 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 52.9 mt -99.05 119.11 46.61 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 N-CA-C 106.938 -1.504 . . . . 0.0 106.938 172.505 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -137.86 123.94 20.3 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 -178.23 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 36.8 ttpt -84.0 116.57 22.89 Favored 'General case' 0 CA--C 1.559 1.31 0 C-N-CA 123.124 0.57 . . . . 0.0 111.201 179.27 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -107.93 73.52 0.9 Allowed 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 123.6 0.76 . . . . 0.0 109.051 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 62.66 69.34 1.34 Allowed Glycine 0 N--CA 1.49 2.264 0 N-CA-C 115.312 0.885 . . . . 0.0 115.312 -173.755 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . 0.278 10.5 m-20 64.81 -2.99 0.61 Allowed 'General case' 0 N--CA 1.501 2.093 0 N-CA-C 118.299 2.703 . . . . 0.0 118.299 -168.629 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 42.5 mm -99.27 99.44 8.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 N-CA-C 107.105 -1.443 . . . . 0.0 107.105 -177.044 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 40.7 mt -77.55 106.99 9.69 Favored 'General case' 0 N--CA 1.488 1.429 0 CA-C-O 121.487 0.66 . . . . 0.0 111.12 178.728 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 34.1 m -100.75 94.54 6.13 Favored 'General case' 0 CA--C 1.559 1.319 0 N-CA-C 107.084 -1.451 . . . . 0.0 107.084 -171.128 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 8.8 tt -92.22 107.93 19.57 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 -177.484 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 52.6 mttp -107.64 93.53 4.59 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 -169.103 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 42.1 m -84.14 92.63 7.96 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.718 -0.614 . . . . 0.0 109.658 -178.283 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 28.9 m170 -88.93 121.36 31.21 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 124.005 0.922 . . . . 0.0 109.214 -179.441 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 13.6 t . . . . . 0 N--CA 1.49 1.548 0 CA-C-O 121.657 0.742 . . . . 0.0 110.876 -176.6 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 8.1 m-20 . . . . . 0 N--CA 1.493 1.699 0 N-CA-C 107.921 -1.141 . . . . 0.0 107.921 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 35.8 p -122.91 133.11 54.41 Favored 'General case' 0 N--CA 1.495 1.806 0 C-N-CA 123.357 0.663 . . . . 0.0 110.832 -176.086 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -112.82 126.14 55.12 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 124.138 0.975 . . . . 0.0 109.222 179.794 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 12.0 pt -122.33 129.97 74.89 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 178.201 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 85.4 p -114.39 124.0 50.87 Favored 'General case' 0 N--CA 1.493 1.701 0 C-N-CA 123.635 0.774 . . . . 0.0 110.786 -173.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 41.8 p90 -146.41 139.12 25.35 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 116.069 1.877 . . . . 0.0 116.069 -168.631 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 57.1 mtmt -106.41 24.29 12.79 Favored 'General case' 0 N--CA 1.498 1.951 0 N-CA-C 116.518 2.044 . . . . 0.0 116.518 -178.371 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . 0.275 2.4 mp 61.95 92.43 0.06 Allowed 'General case' 0 N--CA 1.496 1.867 0 CA-C-N 120.904 1.684 . . . . 0.0 115.05 170.609 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 81.97 37.17 16.54 Favored Glycine 0 CA--C 1.55 2.28 0 N-CA-C 116.984 1.553 . . . . 0.0 116.984 -169.424 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 65.4 t -139.29 117.46 12.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 N-CA-C 105.534 -2.024 . . . . 0.0 105.534 -179.432 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -78.8 124.44 28.21 Favored 'General case' 0 N--CA 1.489 1.475 0 CA-C-O 121.415 0.626 . . . . 0.0 111.155 -179.638 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 14.9 p90 -127.07 134.1 50.33 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 124.393 1.077 . . . . 0.0 110.016 -176.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -72.05 137.23 47.01 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 112.873 0.694 . . . . 0.0 112.873 177.169 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -136.94 132.57 34.59 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 122.987 0.515 . . . . 0.0 110.518 -162.649 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 61.3 m -100.0 128.57 46.07 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 166.436 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 60.4 p -81.25 174.73 11.25 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 113.748 1.018 . . . . 0.0 113.748 -170.395 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -45.06 -37.15 3.97 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 118.591 2.811 . . . . 0.0 118.591 162.122 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -130.95 91.09 2.99 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 106.547 -1.649 . . . . 0.0 106.547 166.284 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -8.05 99.77 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.098 0 N-CA-C 119.301 3.074 . . . . 0.0 119.301 -175.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 3.3 ttm180 -136.27 13.68 3.28 Favored 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 116.961 2.208 . . . . 0.0 116.961 -175.046 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . 0.318 0.0 OUTLIER 42.93 77.04 0.07 Allowed 'General case' 0 N--CA 1.498 1.963 0 N-CA-C 116.898 2.185 . . . . 0.0 116.898 172.129 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 11.0 m -117.68 144.86 24.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 C-N-CA 123.378 0.671 . . . . 0.0 110.145 -166.576 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -96.35 102.65 14.46 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 178.497 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 58.0 m -90.41 125.79 35.67 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 123.401 0.68 . . . . 0.0 112.024 -171.364 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 6.2 tp -137.7 108.89 5.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 179.296 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -118.26 131.02 72.24 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 C-N-CA 124.558 1.143 . . . . 0.0 109.183 177.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 14.6 t -135.12 154.42 51.66 Favored 'General case' 0 N--CA 1.492 1.674 0 CA-C-O 122.777 1.275 . . . . 0.0 111.848 171.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 15.6 tp -88.56 113.3 23.99 Favored 'General case' 0 N--CA 1.487 1.419 0 CA-C-N 114.339 -1.3 . . . . 0.0 110.166 177.753 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -115.79 81.8 1.66 Allowed 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 123.42 0.688 . . . . 0.0 109.921 -176.195 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 62.65 48.58 80.38 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 117.299 1.68 . . . . 0.0 117.299 -175.06 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 74.28 44.06 29.68 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 117.446 1.739 . . . . 0.0 117.446 -171.155 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 40.5 ttpt -154.38 108.25 2.95 Favored 'General case' 0 CA--C 1.552 1.047 0 N-CA-C 106.549 -1.649 . . . . 0.0 106.549 -172.298 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 41.4 mt -81.72 96.86 7.68 Favored 'General case' 0 N--CA 1.491 1.579 0 CA-C-O 122.625 1.202 . . . . 0.0 110.109 175.526 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 96.2 t -87.81 98.57 7.68 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.235 0 CA-C-N 113.293 -1.776 . . . . 0.0 106.32 -178.477 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 22.4 t-160 -95.27 139.34 31.73 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 123.533 0.733 . . . . 0.0 109.818 177.262 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 20.5 tp -135.73 118.7 16.34 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 106.701 -1.592 . . . . 0.0 106.701 178.356 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 28.7 mt-30 -114.01 125.96 54.59 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 176.229 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -139.71 128.28 23.02 Favored 'General case' 0 N--CA 1.494 1.769 0 CA-C-N 118.685 0.675 . . . . 0.0 112.743 -165.402 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 21.4 p90 -151.32 115.8 5.11 Favored 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 123.908 0.883 . . . . 0.0 110.699 -167.178 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . 0.341 18.1 t70 67.96 -93.32 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.886 0 C-N-CA 124.766 1.226 . . . . 0.0 112.883 171.146 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -135.28 52.11 0.81 Allowed Glycine 0 CA--C 1.546 2.014 0 CA-C-O 119.743 -0.476 . . . . 0.0 113.887 163.159 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 15.6 mt-30 -151.02 131.29 13.61 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 176.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -133.42 116.2 15.74 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 123.089 0.556 . . . . 0.0 110.27 179.364 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 1.8 t -110.33 124.36 51.54 Favored 'General case' 0 N--CA 1.492 1.636 0 C-N-CA 123.265 0.626 . . . . 0.0 109.988 -178.523 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 35.6 p -100.72 137.95 38.43 Favored 'General case' 0 N--CA 1.492 1.633 0 CA-C-O 121.213 0.53 . . . . 0.0 111.244 179.38 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 5.0 mp -121.4 79.5 1.55 Allowed 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 -178.292 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 46.4 t -93.2 112.42 26.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 -165.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 45.3 mtt180 -102.71 129.42 49.32 Favored 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 122.854 0.462 . . . . 0.0 110.745 -177.589 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -148.83 139.33 22.58 Favored 'General case' 0 N--CA 1.494 1.744 0 C-N-CA 123.061 0.544 . . . . 0.0 111.97 178.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -83.7 113.97 21.25 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 123.094 0.558 . . . . 0.0 111.727 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 1.7 mp -103.79 102.02 13.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 N-CA-C 104.688 -2.338 . . . . 0.0 104.688 170.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 53.75 50.41 17.07 Favored 'General case' 0 N--CA 1.499 1.987 0 N-CA-C 115.257 1.577 . . . . 0.0 115.257 176.232 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 88.55 -37.93 3.25 Favored Glycine 0 CA--C 1.552 2.396 0 N-CA-C 117.857 1.903 . . . . 0.0 117.857 -169.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 10.4 mtmp? -85.93 127.45 34.62 Favored 'General case' 0 N--CA 1.487 1.377 0 CA-C-N 119.336 1.568 . . . . 0.0 111.08 -172.698 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 2.6 tt -80.14 118.77 22.13 Favored 'General case' 0 CA--C 1.556 1.202 0 CA-C-O 121.823 0.821 . . . . 0.0 111.082 -179.584 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 39.2 mm -100.91 108.81 23.99 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.347 0 N-CA-C 106.324 -1.732 . . . . 0.0 106.324 -178.502 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 47.2 tp -91.19 101.53 14.26 Favored 'General case' 0 CA--C 1.56 1.363 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 173.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 58.2 m -93.8 109.13 20.82 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 -177.622 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 62.7 mt -103.72 83.87 2.2 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 123.339 0.656 . . . . 0.0 110.372 -169.59 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 8.5 m -95.97 116.59 29.17 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.617 -0.677 . . . . 0.0 109.949 -170.173 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 85.0 t60 -146.49 115.9 7.09 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 176.342 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 75.82 -109.45 2.79 Favored Glycine 0 N--CA 1.484 1.86 0 C-N-CA 122.96 0.314 . . . . 0.0 113.538 173.675 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 14.9 t -129.82 55.09 1.8 Allowed 'General case' 0 N--CA 1.495 1.812 0 CA-C-O 121.405 0.621 . . . . 0.0 111.078 163.213 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -154.36 89.2 1.26 Allowed 'General case' 0 N--CA 1.483 1.177 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 177.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 5.6 p -92.96 117.93 37.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 C-N-CA 123.276 0.631 . . . . 0.0 110.004 176.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 44.2 t -99.98 104.39 16.0 Favored 'General case' 0 CA--C 1.553 1.093 0 CA-C-O 121.443 0.639 . . . . 0.0 111.419 175.302 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 57.5 m -92.02 110.18 21.54 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 -178.621 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 21.5 mtm105 -115.17 114.53 25.39 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 123.163 0.585 . . . . 0.0 110.561 -171.022 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 90.8 m -84.55 140.34 31.49 Favored 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 123.714 0.806 . . . . 0.0 110.987 -178.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 42.0 m-85 -133.98 135.92 43.78 Favored 'General case' 0 CA--C 1.559 1.298 0 C-N-CA 124.079 0.952 . . . . 0.0 109.903 -178.365 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -99.47 152.63 19.78 Favored 'General case' 0 N--CA 1.495 1.814 0 CA-C-O 122.058 0.932 . . . . 0.0 111.315 166.093 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 65.6 tttt -82.78 120.47 25.67 Favored 'General case' 0 N--CA 1.486 1.365 0 CA-C-N 115.465 -0.789 . . . . 0.0 111.19 -173.19 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 59.0 mm-40 -114.49 53.89 0.79 Allowed 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 124.073 0.949 . . . . 0.0 111.552 -172.205 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.894 0 CA-C-O 124.414 2.054 . . . . 0.0 108.956 -170.66 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.255 4.4 p . . . . . 0 CA--C 1.575 1.935 0 N-CA-C 116.141 1.904 . . . . 0.0 116.141 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -67.36 -39.61 85.74 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 116.385 1.995 . . . . 0.0 116.385 -177.011 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -59.59 -28.2 66.94 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 117.408 2.373 . . . . 0.0 117.408 167.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -68.21 -27.19 66.16 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 116.207 1.929 . . . . 0.0 116.207 166.568 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 79.9 mt -71.91 116.85 12.78 Favored 'General case' 0 N--CA 1.489 1.52 0 CA-C-N 120.967 1.712 . . . . 0.0 112.436 -170.855 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 159.41 173.36 27.76 Favored Glycine 0 CA--C 1.543 1.842 0 CA-C-O 122.484 1.047 . . . . 0.0 113.557 -178.597 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 53.9 m -85.19 141.08 30.41 Favored 'General case' 0 N--CA 1.493 1.714 0 CA-C-N 114.719 -0.74 . . . . 0.0 109.378 167.102 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 88.2 m95 -140.53 113.51 8.33 Favored 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 -174.046 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -100.69 150.01 23.19 Favored 'General case' 0 N--CA 1.496 1.863 0 CA-C-O 121.23 0.538 . . . . 0.0 110.554 176.047 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 22.5 tp -68.15 129.49 40.07 Favored 'General case' 0 N--CA 1.491 1.595 0 CA-C-O 121.932 0.872 . . . . 0.0 113.072 -174.437 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . 0.283 0.9 OUTLIER -105.05 -46.96 9.41 Favored 'Isoleucine or valine' 0 CA--C 1.576 1.967 0 CA-C-N 114.156 -1.384 . . . . 0.0 111.184 173.918 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -139.7 143.84 37.27 Favored 'General case' 0 N--CA 1.492 1.627 0 CA-C-N 119.754 1.161 . . . . 0.0 109.712 179.472 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 95.4 p -137.35 96.45 3.27 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.668 -0.645 . . . . 0.0 110.248 166.819 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -91.55 126.59 36.68 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 123.413 0.685 . . . . 0.0 109.679 177.385 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.27 62.6 m-20 69.45 37.17 2.05 Favored 'General case' 0 N--CA 1.502 2.174 0 N-CA-C 116.105 1.891 . . . . 0.0 116.105 -176.068 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 47.3 t80 -69.22 -59.56 2.93 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.759 -1.213 . . . . 0.0 112.8 175.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -45.91 -45.68 15.52 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 118.376 2.732 . . . . 0.0 118.376 171.076 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -61.12 -46.81 89.07 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 115.07 1.507 . . . . 0.0 115.07 172.516 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 87.2 t80 -55.84 -49.61 72.83 Favored 'General case' 0 CA--C 1.573 1.857 0 N-CA-C 115.025 1.491 . . . . 0.0 115.025 169.388 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 19.3 mmt -63.78 -44.61 92.85 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 114.829 1.418 . . . . 0.0 114.829 177.719 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 21.1 tptm -60.96 -37.65 83.17 Favored 'General case' 0 CA--C 1.571 1.753 0 N-CA-C 116.18 1.918 . . . . 0.0 116.18 167.67 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 17.1 t -58.85 -41.12 86.23 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 115.74 1.756 . . . . 0.0 115.74 169.47 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 79.1 mt -62.37 -44.3 96.79 Favored 'General case' 0 CA--C 1.568 1.641 0 N-CA-C 115.898 1.814 . . . . 0.0 115.898 166.315 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 123.63 65.24 0.2 Allowed Glycine 0 N--CA 1.483 1.813 0 C-N-CA 124.173 0.892 . . . . 0.0 111.991 -175.388 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 24.2 t -144.45 112.11 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 N-CA-C 105.084 -2.191 . . . . 0.0 105.084 -174.445 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -96.5 -100.27 1.93 Allowed Glycine 0 N--CA 1.484 1.834 0 N-CA-C 113.694 0.238 . . . . 0.0 113.694 -173.323 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 69.3 t80 -96.16 143.38 27.33 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 123.511 0.725 . . . . 0.0 111.784 -173.023 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . 0.352 . . 80.87 -51.04 0.31 Allowed 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 116.494 2.035 . . . . 0.0 116.494 168.516 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 91.8 m -70.28 -40.51 74.28 Favored 'General case' 0 N--CA 1.498 1.974 0 N-CA-C 113.938 1.088 . . . . 0.0 113.938 171.657 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 51.6 ttp180 -58.13 -41.04 82.78 Favored 'General case' 0 CA--C 1.572 1.818 0 N-CA-C 114.99 1.478 . . . . 0.0 114.99 164.457 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 42.9 mt-30 -73.94 -47.25 38.88 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 115.583 1.698 . . . . 0.0 115.583 178.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 81.3 t -63.84 -42.79 97.02 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.168 0 CA-C-N 120.01 1.277 . . . . 0.0 113.158 176.582 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -68.02 -31.61 71.42 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 117.052 2.242 . . . . 0.0 117.052 173.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 82.2 p -67.35 -39.38 85.73 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 115.889 1.811 . . . . 0.0 115.889 167.43 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 47.3 ttm -65.72 -41.7 91.96 Favored 'General case' 0 CA--C 1.566 1.575 0 N-CA-C 115.816 1.784 . . . . 0.0 115.816 175.595 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 5.9 t -81.0 165.73 21.45 Favored 'General case' 0 N--CA 1.493 1.686 0 CA-C-N 118.949 0.795 . . . . 0.0 112.933 178.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.17 105.68 33.9 Favored Pre-proline 0 CA--C 1.57 1.713 0 CA-C-O 118.093 -0.956 . . . . 0.0 110.127 172.54 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -80.76 99.77 1.16 Allowed 'Trans proline' 0 CA--C 1.558 1.715 0 C-N-CA 122.656 2.237 . . . . 0.0 112.308 -179.597 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 97.4 m -80.83 118.24 22.18 Favored 'General case' 0 N--CA 1.487 1.419 0 CA-C-N 115.417 -0.811 . . . . 0.0 110.934 -165.429 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 79.3 m -90.9 117.24 29.35 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 178.519 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 5.2 mp -108.41 109.29 27.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 N-CA-C 106.32 -1.733 . . . . 0.0 106.32 174.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 20.8 mt -100.49 117.35 45.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 N-CA-C 106.348 -1.723 . . . . 0.0 106.348 177.342 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -142.17 127.85 19.19 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.643 -0.661 . . . . 0.0 109.434 -170.386 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.68 156.1 32.83 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 113.972 1.101 . . . . 0.0 113.972 -178.727 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 25.9 t30 -141.91 74.74 1.46 Allowed 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 170.429 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 71.04 -102.23 1.05 Allowed Glycine 0 CA--C 1.546 1.991 0 O-C-N 122.119 -0.363 . . . . 0.0 112.732 -167.213 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 42.4 t0 -94.91 -20.76 19.13 Favored 'General case' 0 CA--C 1.573 1.86 0 N-CA-C 115.318 1.599 . . . . 0.0 115.318 166.816 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 18.6 mm -87.23 110.73 20.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 CA-C-N 120.542 1.519 . . . . 0.0 109.133 -169.081 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 30.7 mt -78.74 124.31 28.07 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 123.613 0.765 . . . . 0.0 111.935 176.275 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 86.7 m -109.19 99.48 8.76 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 106.922 -1.51 . . . . 0.0 106.922 179.532 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 9.7 tt -99.63 109.68 22.16 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 178.797 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -104.0 105.87 16.19 Favored 'General case' 0 N--CA 1.484 1.228 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 -179.187 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 48.8 m -89.02 95.26 10.25 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 174.441 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 22.0 m170 -76.9 175.58 9.38 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 124.132 0.973 . . . . 0.0 111.844 176.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 22.6 t . . . . . 0 N--CA 1.497 1.892 0 N-CA-C 115.069 1.507 . . . . 0.0 115.069 176.151 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 26.0 m-20 . . . . . 0 N--CA 1.491 1.622 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 60.4 p -106.59 131.98 53.13 Favored 'General case' 0 N--CA 1.496 1.865 0 C-N-CA 123.327 0.651 . . . . 0.0 110.952 -176.444 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 4.5 tm-20 -118.07 127.79 54.13 Favored 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 123.953 0.901 . . . . 0.0 110.081 -173.66 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 44.7 pt -116.94 132.76 65.74 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 C-N-CA 123.595 0.758 . . . . 0.0 109.267 172.196 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 73.5 p -116.2 112.95 22.38 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 176.397 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 40.2 p90 -144.35 146.33 32.49 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 114.498 1.295 . . . . 0.0 114.498 -161.331 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 57.6 mtmt -102.59 151.23 22.59 Favored 'General case' 0 N--CA 1.489 1.491 0 CA-C-N 115.133 -0.94 . . . . 0.0 109.126 159.146 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -74.15 115.95 14.23 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.66 -0.65 . . . . 0.0 111.709 -172.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 88.18 45.53 5.01 Favored Glycine 0 CA--C 1.55 2.225 0 N-CA-C 116.454 1.341 . . . . 0.0 116.454 -167.539 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 94.4 t -136.88 121.96 25.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 N-CA-C 107.024 -1.473 . . . . 0.0 107.024 178.086 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -87.97 125.73 34.68 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 123.05 0.54 . . . . 0.0 110.522 172.401 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 37.0 p90 -135.59 128.39 31.11 Favored 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 123.938 0.895 . . . . 0.0 109.026 -177.393 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -72.16 110.32 6.54 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.254 -0.904 . . . . 0.0 112.177 177.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 12.4 tp10 -109.9 129.13 55.69 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 123.804 0.842 . . . . 0.0 109.855 -169.314 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 67.6 m -96.91 118.87 34.27 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 175.635 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 38.8 p -88.2 168.33 12.84 Favored 'General case' 0 N--CA 1.49 1.54 0 CA-C-N 115.368 -0.833 . . . . 0.0 112.191 -172.612 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -62.2 -28.02 69.38 Favored 'General case' 0 CA--C 1.569 1.682 0 N-CA-C 117.154 2.279 . . . . 0.0 117.154 164.121 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -69.58 -1.22 8.21 Favored 'General case' 0 CA--C 1.58 2.105 0 N-CA-C 116.694 2.109 . . . . 0.0 116.694 164.247 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 65.32 67.31 0.51 Allowed 'General case' 0 N--CA 1.496 1.844 0 C-N-CA 125.449 1.5 . . . . 0.0 111.922 -176.183 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 38.9 ttp180 -148.2 117.49 6.9 Favored 'General case' 0 N--CA 1.485 1.307 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 -166.309 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -76.47 111.39 11.89 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 172.703 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 10.4 m -127.27 128.04 69.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 -172.241 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 47.5 mmtm -80.9 102.88 10.36 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 123.27 0.628 . . . . 0.0 109.526 -179.56 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 40.8 m -95.76 91.95 6.32 Favored 'General case' 0 N--CA 1.48 1.072 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.932 -167.077 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 6.1 tp -104.02 108.15 23.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 176.304 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 1.5 p -124.56 124.42 68.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 C-N-CA 123.851 0.861 . . . . 0.0 109.289 -173.28 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 9.8 t -138.53 152.78 48.52 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-O 122.467 1.127 . . . . 0.0 110.891 -178.794 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 35.3 tp -89.88 111.37 22.4 Favored 'General case' 0 N--CA 1.488 1.434 0 CA-C-N 114.85 -1.068 . . . . 0.0 109.394 174.099 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -104.61 81.99 1.85 Allowed 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 123.629 0.772 . . . . 0.0 110.266 -176.04 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 57.01 46.31 91.53 Favored Glycine 0 CA--C 1.551 2.327 0 N-CA-C 118.032 1.973 . . . . 0.0 118.032 -176.514 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 82.77 12.88 79.18 Favored Glycine 0 CA--C 1.557 2.681 0 N-CA-C 118.748 2.259 . . . . 0.0 118.748 -167.698 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 59.2 mtpt -125.2 103.88 8.21 Favored 'General case' 0 N--CA 1.487 1.394 0 CA-C-N 119.365 1.583 . . . . 0.0 106.799 177.825 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 5.5 tt -85.57 97.52 10.12 Favored 'General case' 0 CA--C 1.56 1.359 0 CA-C-O 122.013 0.911 . . . . 0.0 109.584 -174.824 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 71.6 t -96.37 110.47 24.7 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 N-CA-C 106.778 -1.564 . . . . 0.0 106.778 -170.308 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 20.1 t-160 -102.02 108.55 20.03 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 122.995 0.518 . . . . 0.0 109.697 173.681 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 40.8 tp -95.12 118.31 31.69 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 175.637 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 31.4 mt-30 -106.93 117.65 34.61 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 172.632 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 37.5 ttmt -124.76 127.37 47.11 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 123.195 0.598 . . . . 0.0 109.846 -172.617 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 32.3 p90 -145.93 114.76 6.89 Favored 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 123.241 0.616 . . . . 0.0 110.569 -174.575 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . 0.339 13.8 t70 67.04 -99.74 0.05 Allowed 'General case' 0 N--CA 1.494 1.751 0 C-N-CA 124.595 1.158 . . . . 0.0 112.403 173.01 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -128.61 50.54 0.89 Allowed Glycine 0 N--CA 1.487 2.04 0 CA-C-N 118.615 0.643 . . . . 0.0 114.197 163.216 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 14.1 mt-30 -150.65 128.85 11.95 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 177.807 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -137.09 130.79 31.79 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 123.139 0.576 . . . . 0.0 111.195 -176.756 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 7.1 t -121.88 129.3 52.47 Favored 'General case' 0 N--CA 1.495 1.809 0 C-N-CA 122.543 0.337 . . . . 0.0 111.486 176.129 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 39.7 p -99.31 124.62 44.55 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-O 121.755 0.788 . . . . 0.0 110.115 173.185 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 5.5 mp -100.91 88.27 3.51 Favored 'General case' 0 CA--C 1.559 1.29 0 N-CA-C 106.984 -1.487 . . . . 0.0 106.984 178.082 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 98.5 t -92.56 101.1 12.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 -168.102 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 77.7 mtt85 -96.47 125.44 40.96 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 123.221 0.608 . . . . 0.0 109.849 -178.309 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -144.95 128.17 16.73 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-O 120.847 0.356 . . . . 0.0 111.329 -172.367 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -82.42 115.64 21.53 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 123.144 0.577 . . . . 0.0 111.408 -177.245 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 96.1 mt -127.85 107.17 15.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 N-CA-C 104.993 -2.225 . . . . 0.0 104.993 179.701 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 23.4 m-20 58.08 52.76 7.32 Favored 'General case' 0 N--CA 1.5 2.063 0 N-CA-C 114.788 1.403 . . . . 0.0 114.788 176.523 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 63.15 21.21 63.7 Favored Glycine 0 CA--C 1.556 2.635 0 N-CA-C 119.734 2.653 . . . . 0.0 119.734 -171.258 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -128.92 127.54 41.96 Favored 'General case' 0 N--CA 1.488 1.445 0 CA-C-N 119.534 1.667 . . . . 0.0 108.51 -173.586 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 16.0 tp -79.33 109.99 14.19 Favored 'General case' 0 CA--C 1.557 1.236 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 176.751 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 32.5 mm -98.45 97.02 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 N-CA-C 106.467 -1.679 . . . . 0.0 106.467 -175.792 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 30.3 tp -87.23 103.96 15.93 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 124.003 0.921 . . . . 0.0 109.553 178.118 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 88.4 m -100.8 99.15 9.62 Favored 'General case' 0 CA--C 1.562 1.405 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 -177.408 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 71.0 mt -88.17 104.01 16.3 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 123.911 0.884 . . . . 0.0 109.672 -176.76 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 6.7 m -106.79 122.4 46.31 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.586 -0.696 . . . . 0.0 109.502 -171.83 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 77.8 t60 -148.15 113.5 5.59 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 173.797 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 74.89 -116.39 5.03 Favored Glycine 0 N--CA 1.484 1.883 0 C-N-CA 123.115 0.388 . . . . 0.0 113.849 173.083 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 15.2 t -119.22 53.45 1.02 Allowed 'General case' 0 N--CA 1.496 1.844 0 CA-C-O 121.271 0.557 . . . . 0.0 111.641 166.658 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -159.93 104.91 1.55 Allowed 'General case' 0 N--CA 1.483 1.203 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 175.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 7.4 p -111.24 125.89 68.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 C-N-CA 123.706 0.802 . . . . 0.0 110.113 -179.082 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 35.6 t -98.35 108.49 21.2 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 122.788 0.435 . . . . 0.0 111.693 175.626 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 88.6 m -92.2 117.19 29.63 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 177.868 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 75.6 mtp180 -124.46 115.78 21.46 Favored 'General case' 0 N--CA 1.488 1.444 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.054 -165.229 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 74.1 m -87.82 133.72 33.83 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 122.98 0.512 . . . . 0.0 109.794 178.017 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 40.0 m-85 -128.69 130.11 46.71 Favored 'General case' 0 CA--C 1.56 1.351 0 C-N-CA 123.388 0.675 . . . . 0.0 109.419 177.467 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -91.22 154.16 19.49 Favored 'General case' 0 N--CA 1.494 1.741 0 CA-C-O 122.23 1.014 . . . . 0.0 112.193 169.556 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 69.6 tttt -86.01 119.4 26.27 Favored 'General case' 0 N--CA 1.484 1.273 0 CA-C-N 115.257 -0.883 . . . . 0.0 111.414 -170.787 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 25.3 mm-40 -117.22 51.22 1.03 Allowed 'General case' 0 CA--C 1.564 1.508 0 C-N-CA 124.58 1.152 . . . . 0.0 111.26 -174.61 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 0.984 0 CA-C-O 123.059 1.409 . . . . 0.0 110.594 -159.732 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 4.1 p . . . . . 0 CA--C 1.576 1.971 0 N-CA-C 116.051 1.871 . . . . 0.0 116.051 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -66.86 -34.25 77.38 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 116.922 2.193 . . . . 0.0 116.922 -175.456 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -57.67 -31.63 66.51 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 117.387 2.366 . . . . 0.0 117.387 169.404 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -66.96 -26.5 66.86 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 116.686 2.106 . . . . 0.0 116.686 168.702 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 49.8 mt -77.07 107.07 9.17 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-N 120.887 1.676 . . . . 0.0 111.624 -164.057 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 157.18 176.97 29.85 Favored Glycine 0 CA--C 1.542 1.749 0 CA-C-O 122.511 1.062 . . . . 0.0 113.11 -169.744 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 85.6 m -91.78 143.56 26.4 Favored 'General case' 0 N--CA 1.489 1.48 0 CA-C-N 114.406 -0.897 . . . . 0.0 109.071 177.14 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 93.5 m95 -138.48 111.5 7.85 Favored 'General case' 0 N--CA 1.485 1.319 0 N-CA-C 107.548 -1.278 . . . . 0.0 107.548 -175.145 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -100.31 143.11 30.89 Favored 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 123.681 0.792 . . . . 0.0 110.648 -178.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 17.6 tp -66.91 124.62 23.49 Favored 'General case' 0 N--CA 1.488 1.445 0 CA-C-O 121.929 0.871 . . . . 0.0 113.135 -172.457 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . 0.267 1.2 t -97.37 -48.45 12.35 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.816 0 CA-C-N 114.261 -1.336 . . . . 0.0 111.601 174.472 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -143.89 150.25 38.12 Favored 'General case' 0 N--CA 1.489 1.494 0 CA-C-N 119.356 0.98 . . . . 0.0 110.046 178.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 88.1 p -130.65 98.14 4.57 Favored 'General case' 0 N--CA 1.489 1.514 0 CA-C-O 121.243 0.544 . . . . 0.0 109.922 170.042 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -84.51 128.27 34.5 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 123.168 0.587 . . . . 0.0 110.055 177.616 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 56.3 m-20 65.09 24.91 12.52 Favored 'General case' 0 N--CA 1.503 2.207 0 N-CA-C 117.964 2.579 . . . . 0.0 117.964 171.748 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 29.8 t80 -69.42 -53.24 20.31 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 120.032 -1.668 . . . . 0.0 113.982 -176.156 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -39.35 -44.64 1.34 Allowed 'General case' 0 N--CA 1.499 1.977 0 N-CA-C 118.948 2.944 . . . . 0.0 118.948 159.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -63.91 -50.35 69.06 Favored 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 115.214 1.561 . . . . 0.0 115.214 172.709 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 75.4 t80 -52.11 -48.0 64.99 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 115.591 1.7 . . . . 0.0 115.591 166.866 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 36.6 mmm -65.59 -40.11 92.33 Favored 'General case' 0 CA--C 1.565 1.548 0 N-CA-C 115.176 1.547 . . . . 0.0 115.176 176.352 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -60.85 -43.11 98.76 Favored 'General case' 0 CA--C 1.569 1.677 0 N-CA-C 114.873 1.435 . . . . 0.0 114.873 165.583 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 50.1 m -59.14 -39.45 82.44 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 115.82 1.785 . . . . 0.0 115.82 170.493 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 77.7 mt -64.62 -42.43 95.5 Favored 'General case' 0 CA--C 1.565 1.543 0 N-CA-C 116.214 1.931 . . . . 0.0 116.214 168.53 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 111.85 73.77 0.69 Allowed Glycine 0 N--CA 1.483 1.807 0 C-N-CA 123.708 0.671 . . . . 0.0 111.911 -172.445 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 37.6 t -136.3 127.84 43.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 N-CA-C 106.335 -1.728 . . . . 0.0 106.335 179.421 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -66.53 -80.19 0.19 Allowed Glycine 0 N--CA 1.485 1.966 0 N-CA-C 116.653 1.421 . . . . 0.0 116.653 -173.603 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 46.3 p90 -153.04 -50.29 0.1 Allowed 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 114.298 1.222 . . . . 0.0 114.298 -178.176 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.02 -41.67 96.99 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 116.871 2.175 . . . . 0.0 116.871 -176.519 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 59.0 m -80.06 -36.24 35.93 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 113.521 0.934 . . . . 0.0 113.521 169.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 44.2 ttp180 -58.72 -44.05 90.31 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 115.722 1.749 . . . . 0.0 115.722 176.677 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 18.2 mm100 -86.91 -33.64 19.65 Favored 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 115.315 1.598 . . . . 0.0 115.315 178.864 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 89.1 t -69.44 -46.19 76.86 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 CA-C-N 120.875 1.67 . . . . 0.0 111.941 173.373 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -65.97 -24.43 66.79 Favored 'General case' 0 CA--C 1.569 1.685 0 N-CA-C 117.559 2.429 . . . . 0.0 117.559 175.075 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 87.4 p -68.17 -49.48 60.66 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 114.863 1.431 . . . . 0.0 114.863 167.052 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 3.3 ppp? -65.26 -23.31 67.01 Favored 'General case' 0 N--CA 1.499 2.012 0 N-CA-C 117.792 2.516 . . . . 0.0 117.792 170.408 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 48.6 m -68.99 150.74 47.35 Favored 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 124.507 1.123 . . . . 0.0 112.119 177.189 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.8 98.81 6.64 Favored Pre-proline 0 CA--C 1.571 1.786 0 CA-C-O 118.072 -0.966 . . . . 0.0 110.022 166.319 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_endo -82.12 90.34 1.12 Allowed 'Trans proline' 0 CA--C 1.562 1.878 0 C-N-CA 122.805 2.337 . . . . 0.0 110.758 179.32 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 80.3 m -79.8 110.63 15.34 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 123.715 0.806 . . . . 0.0 110.487 -160.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 58.6 m -86.27 116.42 24.44 Favored 'General case' 0 CA--C 1.562 1.41 0 C-N-CA 123.085 0.554 . . . . 0.0 109.962 -171.247 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 71.9 mt -113.12 105.24 18.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 N-CA-C 106.434 -1.691 . . . . 0.0 106.434 178.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 3.8 mp -94.56 123.05 46.53 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 174.567 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -132.48 117.88 18.58 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 -176.866 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 38.7 ttpt -90.24 117.22 28.81 Favored 'General case' 0 CA--C 1.557 1.227 0 CA-C-O 121.296 0.57 . . . . 0.0 110.911 177.511 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 21.2 t-20 -77.27 -56.14 4.81 Favored 'General case' 0 CA--C 1.568 1.651 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.85 164.245 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -159.49 -85.62 0.05 OUTLIER Glycine 0 N--CA 1.48 1.614 0 N-CA-C 109.066 -1.613 . . . . 0.0 109.066 171.039 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -74.04 -37.87 64.17 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 114.502 1.297 . . . . 0.0 114.502 161.108 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 45.9 mm -76.68 120.54 27.09 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.514 0 C-N-CA 123.954 0.902 . . . . 0.0 110.466 -174.116 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 47.1 mt -99.67 108.99 21.48 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.745 0.818 . . . . 0.0 109.037 168.014 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 93.7 m -95.43 100.63 12.37 Favored 'General case' 0 CA--C 1.559 1.308 0 N-CA-C 107.513 -1.291 . . . . 0.0 107.513 -177.018 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 9.6 tt -100.44 106.38 17.95 Favored 'General case' 0 N--CA 1.483 1.178 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 -178.47 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -101.88 111.64 23.97 Favored 'General case' 0 N--CA 1.485 1.305 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 178.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 95.2 m -95.07 94.46 7.97 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 178.192 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 22.3 m-70 -81.12 100.99 9.34 Favored 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 123.276 0.63 . . . . 0.0 111.603 -171.257 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 32.1 t . . . . . 0 CA--C 1.555 1.152 0 C-N-CA 123.904 0.882 . . . . 0.0 109.397 -176.304 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 7.6 p-10 . . . . . 0 N--CA 1.49 1.548 0 N-CA-C 112.493 0.553 . . . . 0.0 112.493 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 73.1 p -93.85 126.37 39.0 Favored 'General case' 0 N--CA 1.493 1.716 0 C-N-CA 122.718 0.407 . . . . 0.0 110.538 178.783 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -105.81 113.92 27.76 Favored 'General case' 0 N--CA 1.485 1.292 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 174.037 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 19.8 pt -116.59 128.82 73.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 179.72 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 61.7 p -116.83 113.4 22.45 Favored 'General case' 0 N--CA 1.492 1.659 0 C-N-CA 123.741 0.817 . . . . 0.0 109.447 -172.466 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 42.6 p90 -141.31 145.65 35.75 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 114.929 1.455 . . . . 0.0 114.929 -165.228 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 34.8 mtmm -116.82 23.94 11.6 Favored 'General case' 0 N--CA 1.498 1.929 0 N-CA-C 115.982 1.845 . . . . 0.0 115.982 -174.168 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . 0.275 2.0 mp 65.75 94.21 0.06 Allowed 'General case' 0 N--CA 1.494 1.725 0 C-N-CA 124.964 1.306 . . . . 0.0 113.635 168.632 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 83.27 34.06 21.42 Favored Glycine 0 CA--C 1.551 2.323 0 N-CA-C 117.095 1.598 . . . . 0.0 117.095 -164.601 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 95.6 t -135.27 118.19 23.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 N-CA-C 106.453 -1.684 . . . . 0.0 106.453 -178.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -85.6 136.27 33.45 Favored 'General case' 0 CA--C 1.565 1.55 0 C-N-CA 123.563 0.745 . . . . 0.0 111.86 179.448 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 47.9 p90 -143.89 139.29 29.13 Favored 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 123.663 0.785 . . . . 0.0 111.392 -171.872 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -75.57 135.42 40.55 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.252 -0.905 . . . . 0.0 112.688 172.413 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -146.1 136.49 23.94 Favored 'General case' 0 N--CA 1.49 1.528 0 CA-C-O 120.997 0.427 . . . . 0.0 111.207 -170.53 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 79.3 m -96.88 130.09 44.23 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 172.037 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 26.7 p -89.2 171.8 9.54 Favored 'General case' 0 N--CA 1.492 1.671 0 CA-C-O 121.989 0.9 . . . . 0.0 112.661 -176.336 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -54.48 -40.33 68.39 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 117.207 2.299 . . . . 0.0 117.207 169.018 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -93.93 59.7 2.78 Favored 'General case' 0 N--CA 1.495 1.813 0 CA-C-N 119.362 0.983 . . . . 0.0 111.337 170.267 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 9.5 t70 21.7 76.26 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.007 0 N-CA-C 118.771 2.878 . . . . 0.0 118.771 -178.687 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 38.4 ttp180 -139.73 117.92 11.95 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 -169.204 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.42 114.81 12.06 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 122.901 0.48 . . . . 0.0 110.195 172.252 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 17.3 m -135.01 132.27 53.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 CA-C-O 121.431 0.634 . . . . 0.0 109.642 -170.135 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 39.5 ttpt -87.02 118.09 26.17 Favored 'General case' 0 CA--C 1.558 1.263 0 C-N-CA 123.829 0.852 . . . . 0.0 110.237 178.77 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 71.0 m -117.35 109.76 17.21 Favored 'General case' 0 N--CA 1.488 1.452 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.259 -157.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 6.6 tp -122.73 115.88 47.2 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 C-N-CA 123.834 0.854 . . . . 0.0 109.091 -179.105 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -123.53 129.58 74.57 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 C-N-CA 124.431 1.092 . . . . 0.0 109.29 178.76 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 15.1 t -133.89 156.97 47.14 Favored 'General case' 0 N--CA 1.493 1.693 0 CA-C-O 122.632 1.206 . . . . 0.0 111.34 169.532 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 19.3 tp -94.16 117.99 30.91 Favored 'General case' 0 N--CA 1.489 1.476 0 CA-C-N 114.726 -1.124 . . . . 0.0 110.558 -178.388 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -104.52 81.5 1.8 Allowed 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 123.231 0.612 . . . . 0.0 110.079 175.835 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 78.07 -74.92 1.96 Allowed Glycine 0 N--CA 1.487 2.1 0 CA-C-O 121.473 0.485 . . . . 0.0 113.832 -174.72 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -148.63 53.95 0.52 Allowed Glycine 0 CA--C 1.546 1.99 0 CA-C-N 114.425 -0.887 . . . . 0.0 112.885 167.451 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 38.7 mtmm -145.26 111.68 5.73 Favored 'General case' 0 N--CA 1.484 1.263 0 N-CA-C 106.682 -1.599 . . . . 0.0 106.682 -175.641 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 46.7 mt -82.4 96.35 7.94 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-O 122.757 1.265 . . . . 0.0 109.424 174.248 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 95.5 t -86.81 94.93 4.6 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.342 0 CA-C-N 113.029 -1.896 . . . . 0.0 105.936 -179.651 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 16.8 t-160 -98.89 147.95 24.43 Favored 'General case' 0 CA--C 1.559 1.319 0 C-N-CA 124.612 1.165 . . . . 0.0 109.608 179.209 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.414 HD11 ' HB2' ' A' ' 101' ' ' GLU . 23.2 tp -145.48 119.89 9.65 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 179.571 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 94.4 mt-30 -105.67 122.6 46.38 Favored 'General case' 0 N--CA 1.486 1.325 0 C-N-CA 124.707 1.203 . . . . 0.0 108.341 176.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 7.9 mtpm? -125.44 130.69 52.35 Favored 'General case' 0 N--CA 1.494 1.736 0 C-N-CA 123.023 0.529 . . . . 0.0 110.048 -170.779 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 19.2 p90 -153.34 112.85 3.83 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.67 -0.644 . . . . 0.0 110.091 -175.066 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 4.5 t70 51.93 53.73 12.07 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 116.552 2.056 . . . . 0.0 116.552 168.091 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 86.64 -40.66 3.07 Favored Glycine 0 CA--C 1.552 2.344 0 N-CA-C 117.387 1.715 . . . . 0.0 117.387 -171.473 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 19.2 mt-30 -85.31 137.39 33.0 Favored 'General case' 0 N--CA 1.49 1.562 0 CA-C-N 118.316 1.058 . . . . 0.0 111.168 -179.804 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.414 ' HB2' HD11 ' A' ' 94' ' ' LEU . 12.5 pt-20 -143.38 133.13 23.85 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 122.837 0.455 . . . . 0.0 111.727 -179.077 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 14.8 t -116.69 128.67 55.56 Favored 'General case' 0 N--CA 1.494 1.746 0 C-N-CA 123.108 0.563 . . . . 0.0 110.575 175.378 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 40.8 p -91.86 125.6 36.63 Favored 'General case' 0 N--CA 1.494 1.758 0 C-N-CA 122.965 0.506 . . . . 0.0 109.955 170.866 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 5.2 mp -105.63 82.1 1.76 Allowed 'General case' 0 CA--C 1.565 1.53 0 C-N-CA 124.187 0.995 . . . . 0.0 108.384 178.207 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 88.4 t -88.91 106.0 16.39 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 -172.153 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 74.8 mtt85 -97.88 117.53 32.4 Favored 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 123.137 0.575 . . . . 0.0 109.73 179.587 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -137.14 131.11 32.13 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 123.168 0.587 . . . . 0.0 111.185 -171.038 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -80.83 118.1 22.05 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.83 -0.544 . . . . 0.0 111.609 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 46.6 mm -125.47 101.85 9.21 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.28 0 N-CA-C 105.365 -2.087 . . . . 0.0 105.365 178.422 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 59.12 50.24 8.33 Favored 'General case' 0 N--CA 1.5 2.059 0 N-CA-C 115.408 1.633 . . . . 0.0 115.408 174.177 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 65.67 30.48 77.43 Favored Glycine 0 CA--C 1.555 2.556 0 N-CA-C 118.736 2.255 . . . . 0.0 118.736 -170.548 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -136.4 129.41 31.19 Favored 'General case' 0 N--CA 1.489 1.506 0 CA-C-N 118.458 1.129 . . . . 0.0 108.688 -176.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 12.2 tp -81.9 114.68 20.67 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 175.53 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 40.6 mm -104.74 100.04 9.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 N-CA-C 106.401 -1.703 . . . . 0.0 106.401 -174.882 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 38.6 tp -89.65 98.34 11.71 Favored 'General case' 0 CA--C 1.559 1.327 0 C-N-CA 123.657 0.783 . . . . 0.0 109.532 178.171 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 87.0 m -91.71 108.51 19.97 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 -178.771 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 87.7 mt -100.86 90.61 4.26 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 123.562 0.745 . . . . 0.0 109.467 -173.84 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 7.9 m -96.12 117.24 30.32 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.636 -0.665 . . . . 0.0 109.289 -173.489 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 83.4 t60 -127.57 91.02 3.22 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 168.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 73.1 -101.15 1.09 Allowed Glycine 0 N--CA 1.483 1.819 0 N-CA-C 114.49 0.556 . . . . 0.0 114.49 174.549 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 81.2 m -88.67 -54.52 4.12 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-O 118.486 -0.769 . . . . 0.0 112.045 175.62 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -85.1 106.36 16.51 Favored 'General case' 0 N--CA 1.484 1.246 0 CA-C-N 119.721 1.146 . . . . 0.0 112.256 -171.34 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 5.8 p -98.88 125.78 52.24 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 C-N-CA 123.83 0.852 . . . . 0.0 109.883 176.056 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 40.4 t -107.13 103.77 13.25 Favored 'General case' 0 CA--C 1.553 1.062 0 CA-C-O 121.41 0.624 . . . . 0.0 111.774 179.17 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 60.6 m -88.84 111.69 22.35 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 123.421 0.688 . . . . 0.0 109.187 179.587 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 22.3 mtp180 -106.11 111.86 24.66 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 -178.064 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 95.2 m -89.26 136.3 33.1 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 123.711 0.804 . . . . 0.0 109.98 -179.725 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 65.7 m-85 -132.07 132.68 43.55 Favored 'General case' 0 CA--C 1.56 1.361 0 C-N-CA 123.527 0.731 . . . . 0.0 110.259 -176.296 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -92.79 156.16 17.18 Favored 'General case' 0 N--CA 1.495 1.796 0 CA-C-O 122.249 1.023 . . . . 0.0 111.835 165.084 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 40.3 tttp -86.2 137.9 32.29 Favored 'General case' 0 N--CA 1.487 1.385 0 CA-C-N 115.528 -0.76 . . . . 0.0 112.817 -171.092 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -120.58 57.27 0.97 Allowed 'General case' 0 N--CA 1.494 1.733 0 C-N-CA 123.447 0.699 . . . . 0.0 111.952 171.137 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.437 0 CA-C-O 124.15 1.929 . . . . 0.0 112.444 -179.289 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 4.7 p . . . . . 0 CA--C 1.578 2.046 0 N-CA-C 115.675 1.732 . . . . 0.0 115.675 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -66.01 -48.39 71.3 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 117.231 2.308 . . . . 0.0 117.231 -173.401 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -55.84 -27.73 52.91 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 117.841 2.534 . . . . 0.0 117.841 171.09 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -68.61 -26.53 65.41 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 116.199 1.926 . . . . 0.0 116.199 167.642 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 40.6 mt -76.87 111.88 12.88 Favored 'General case' 0 N--CA 1.49 1.526 0 CA-C-N 120.78 1.627 . . . . 0.0 112.04 -168.768 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 164.63 176.05 35.99 Favored Glycine 0 CA--C 1.541 1.708 0 CA-C-O 122.706 1.17 . . . . 0.0 113.434 -173.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 63.3 m -90.0 140.22 29.85 Favored 'General case' 0 N--CA 1.493 1.699 0 CA-C-N 114.238 -0.981 . . . . 0.0 109.046 170.403 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 87.6 m95 -140.89 112.6 7.58 Favored 'General case' 0 N--CA 1.484 1.267 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 -174.044 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 8.6 mtpm? -96.67 146.04 25.23 Favored 'General case' 0 N--CA 1.495 1.789 0 CA-C-O 121.327 0.584 . . . . 0.0 110.273 174.833 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 23.8 tp -66.83 125.62 26.47 Favored 'General case' 0 N--CA 1.488 1.455 0 CA-C-O 121.89 0.853 . . . . 0.0 112.48 -177.062 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . 0.279 1.1 t -99.7 -47.93 11.87 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.795 0 CA-C-N 114.398 -1.274 . . . . 0.0 111.717 176.302 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -139.97 143.2 36.41 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-N 119.571 1.078 . . . . 0.0 109.67 177.528 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 78.5 p -126.09 94.07 3.99 Favored 'General case' 0 N--CA 1.49 1.526 0 CA-C-O 121.306 0.574 . . . . 0.0 110.486 169.067 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 57.5 tttp -83.22 119.49 24.62 Favored 'General case' 0 CA--C 1.557 1.243 0 C-N-CA 123.625 0.77 . . . . 0.0 109.71 175.528 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.259 24.5 m-20 73.45 26.47 1.99 Allowed 'General case' 0 N--CA 1.501 2.122 0 N-CA-C 116.736 2.125 . . . . 0.0 116.736 175.704 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.424 ' HD1' ' HG ' ' A' ' 124' ' ' CYS . 22.5 t80 -89.27 78.67 7.23 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.362 -1.461 . . . . 0.0 110.72 178.503 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -170.44 -58.03 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 125.0 1.32 . . . . 0.0 108.281 -176.576 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 29.0 t0 -54.45 -47.7 72.58 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 115.365 1.617 . . . . 0.0 115.365 166.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 92.3 t80 -49.3 -54.73 15.55 Favored 'General case' 0 CA--C 1.573 1.835 0 N-CA-C 115.133 1.531 . . . . 0.0 115.133 167.781 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 74.8 mtm -63.71 -41.17 98.14 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 116.01 1.855 . . . . 0.0 116.01 174.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 57.9 tttm -64.92 -43.28 93.34 Favored 'General case' 0 CA--C 1.567 1.626 0 N-CA-C 115.228 1.566 . . . . 0.0 115.228 173.432 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 60.9 m -59.97 -39.91 87.3 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 115.815 1.783 . . . . 0.0 115.815 169.837 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 64.9 mt -64.37 -30.84 71.87 Favored 'General case' 0 CA--C 1.566 1.568 0 N-CA-C 117.41 2.374 . . . . 0.0 117.41 168.587 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 91.32 75.92 1.31 Allowed Glycine 0 N--CA 1.482 1.722 0 CA-C-N 119.211 0.914 . . . . 0.0 111.978 -170.025 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 97.9 t -128.31 81.28 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 N-CA-C 106.643 -1.614 . . . . 0.0 106.643 -177.273 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 31.86 -118.51 0.13 Allowed Glycine 0 CA--C 1.55 2.273 0 N-CA-C 121.018 3.167 . . . . 0.0 121.018 174.361 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 10.7 t80 -148.43 -71.22 0.21 Allowed 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 178.485 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -72.69 -16.99 61.68 Favored 'General case' 0 CA--C 1.567 1.608 0 N-CA-C 116.615 2.08 . . . . 0.0 116.615 177.269 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 30.6 m -68.63 -42.63 77.75 Favored 'General case' 0 N--CA 1.497 1.904 0 CA-C-N 120.3 1.409 . . . . 0.0 113.495 162.76 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 37.1 ttp-105 -55.31 -44.64 75.97 Favored 'General case' 0 CA--C 1.571 1.787 0 N-CA-C 115.138 1.533 . . . . 0.0 115.138 164.64 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 5.9 tm0? -65.78 -52.33 51.74 Favored 'General case' 0 CA--C 1.565 1.547 0 N-CA-C 115.451 1.648 . . . . 0.0 115.451 174.38 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 92.6 t -66.1 -38.32 81.74 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.975 0 N-CA-C 113.583 0.957 . . . . 0.0 113.583 -179.602 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -65.68 -34.59 78.56 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 116.806 2.15 . . . . 0.0 116.806 175.755 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 88.4 p -67.63 -39.55 84.66 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 116.348 1.981 . . . . 0.0 116.348 167.01 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 38.3 ttm -64.65 -40.72 95.94 Favored 'General case' 0 CA--C 1.571 1.756 0 N-CA-C 115.87 1.804 . . . . 0.0 115.87 169.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 88.3 m -75.74 153.06 37.27 Favored 'General case' 0 CA--C 1.567 1.61 0 C-N-CA 124.276 1.031 . . . . 0.0 112.597 -177.015 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 64.0 mttp -102.91 100.06 15.66 Favored Pre-proline 0 CA--C 1.572 1.82 0 CA-C-N 115.405 -0.816 . . . . 0.0 109.735 172.268 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -82.36 113.62 2.36 Favored 'Trans proline' 0 CA--C 1.561 1.826 0 C-N-CA 123.36 2.707 . . . . 0.0 112.289 179.737 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 86.7 m -83.95 108.54 16.99 Favored 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 123.509 0.723 . . . . 0.0 110.67 -169.366 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 88.2 m -81.65 116.64 21.48 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 123.492 0.717 . . . . 0.0 109.808 -179.495 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 61.3 mt -115.56 107.87 23.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 N-CA-C 106.122 -1.807 . . . . 0.0 106.122 -176.584 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 22.8 mt -103.05 119.48 51.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 N-CA-C 107.653 -1.239 . . . . 0.0 107.653 -175.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -137.62 111.34 8.18 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 -169.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 60.4 tttm -86.46 114.56 23.32 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 123.369 0.668 . . . . 0.0 111.015 -179.306 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 33.5 t30 -115.87 82.47 1.77 Allowed 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 -179.481 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 61.23 59.53 9.84 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 116.411 1.324 . . . . 0.0 116.411 -174.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . 0.319 15.7 t0 68.92 -14.79 0.28 Allowed 'General case' 0 N--CA 1.498 1.946 0 N-CA-C 117.572 2.434 . . . . 0.0 117.572 -166.372 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 11.2 mm -87.72 98.96 8.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 CA-C-N 120.342 1.428 . . . . 0.0 107.631 -177.292 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 43.9 mt -80.21 107.31 12.9 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 123.523 0.729 . . . . 0.0 110.544 -178.41 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 30.6 m -97.48 94.56 7.09 Favored 'General case' 0 N--CA 1.485 1.292 0 N-CA-C 107.059 -1.46 . . . . 0.0 107.059 -175.059 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 9.7 tt -99.4 102.81 14.51 Favored 'General case' 0 N--CA 1.484 1.255 0 N-CA-C 108.007 -1.108 . . . . 0.0 108.007 -174.515 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 64.0 mttm -105.04 116.82 32.59 Favored 'General case' 0 N--CA 1.486 1.328 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 -173.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 89.1 m -100.55 92.05 4.95 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 -175.624 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 8.0 m170 -87.94 96.26 10.43 Favored 'General case' 0 N--CA 1.491 1.59 0 CA-C-O 122.373 1.083 . . . . 0.0 111.862 -169.676 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 28.1 t . . . . . 0 CA--C 1.561 1.385 0 CA-C-N 114.596 -1.184 . . . . 0.0 111.18 171.729 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 34.7 p-10 . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 121.093 0.473 . . . . 0.0 109.833 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 41.4 p -86.97 129.94 34.67 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-O 121.402 0.62 . . . . 0.0 111.028 -179.478 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -110.92 129.65 55.81 Favored 'General case' 0 N--CA 1.484 1.24 0 CA-C-N 115.127 -0.942 . . . . 0.0 109.416 178.763 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 41.5 pt -112.48 130.86 65.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 164.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 58.0 p -120.73 103.91 9.48 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 108.825 -0.805 . . . . 0.0 108.825 -177.81 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 45.7 p90 -138.8 133.67 32.39 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 114.052 1.131 . . . . 0.0 114.052 -158.829 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 56.4 mtmt -86.73 148.91 25.22 Favored 'General case' 0 CA--C 1.562 1.435 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.534 156.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -73.38 116.87 14.45 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.762 -0.586 . . . . 0.0 111.66 -174.602 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 90.69 45.19 4.34 Favored Glycine 0 CA--C 1.548 2.13 0 N-CA-C 116.515 1.366 . . . . 0.0 116.515 -167.352 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 96.3 t -135.4 122.25 34.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 N-CA-C 106.984 -1.487 . . . . 0.0 106.984 177.476 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -88.89 126.7 35.5 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 123.29 0.636 . . . . 0.0 110.386 170.334 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 43.0 p90 -139.62 133.06 30.15 Favored 'General case' 0 N--CA 1.494 1.766 0 C-N-CA 123.38 0.672 . . . . 0.0 111.172 -172.501 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -70.66 118.14 13.08 Favored 'General case' 0 CA--C 1.564 1.494 0 O-C-N 121.621 -0.675 . . . . 0.0 112.343 175.77 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 15.9 tp10 -125.72 136.44 53.19 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 123.775 0.83 . . . . 0.0 109.967 -170.324 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 57.8 m -91.24 123.46 34.7 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 174.461 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 31.7 p -82.48 170.68 14.97 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 113.056 0.762 . . . . 0.0 113.056 -175.695 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -53.28 -30.66 39.75 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 118.665 2.839 . . . . 0.0 118.665 173.078 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -78.7 -85.85 0.07 Allowed 'General case' 0 N--CA 1.489 1.488 0 CA-C-N 119.387 0.994 . . . . 0.0 109.23 168.261 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 179.01 82.86 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 168.634 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 22.0 mtm180 -140.22 124.81 18.05 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.847 -0.533 . . . . 0.0 109.92 -174.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.89 116.19 13.1 Favored 'General case' 0 CA--C 1.564 1.482 0 C-N-CA 123.63 0.772 . . . . 0.0 111.121 165.592 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 17.8 m -134.26 129.56 53.54 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 -170.246 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 46.2 mmtm -83.37 104.42 13.51 Favored 'General case' 0 N--CA 1.49 1.526 0 CA-C-O 121.759 0.79 . . . . 0.0 110.152 -178.076 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 75.2 m -101.24 95.86 6.81 Favored 'General case' 0 N--CA 1.484 1.238 0 CA-C-N 115.064 -0.971 . . . . 0.0 110.702 -162.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 7.2 tp -103.19 121.58 54.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 179.606 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 1.9 p -142.22 123.44 12.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 C-N-CA 123.171 0.589 . . . . 0.0 109.95 -172.085 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 15.1 t -136.96 159.72 41.03 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-O 122.579 1.18 . . . . 0.0 110.92 178.42 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 14.7 tp -90.54 111.17 22.36 Favored 'General case' 0 CA--C 1.562 1.437 0 CA-C-N 115.084 -0.962 . . . . 0.0 109.505 174.855 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -101.69 88.01 3.3 Favored 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 123.678 0.791 . . . . 0.0 109.793 -179.507 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 58.26 47.43 89.56 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 118.07 1.988 . . . . 0.0 118.07 -177.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 74.91 28.0 63.54 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 118.695 2.238 . . . . 0.0 118.695 -168.048 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 21.3 ttmm -134.51 116.7 15.39 Favored 'General case' 0 CA--C 1.552 1.044 0 N-CA-C 106.523 -1.658 . . . . 0.0 106.523 179.782 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 3.8 tt -86.45 97.98 10.77 Favored 'General case' 0 CA--C 1.563 1.475 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 -172.871 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 56.1 t -105.7 109.15 26.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 -165.097 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 23.6 t-160 -110.2 136.36 49.54 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 124.071 0.948 . . . . 0.0 109.905 179.638 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 30.3 tp -130.53 121.22 25.33 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 173.755 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 87.3 mt-30 -108.46 118.11 35.91 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 175.61 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 17.5 ptpt -121.76 134.9 54.93 Favored 'General case' 0 N--CA 1.496 1.849 0 CA-C-N 118.472 0.578 . . . . 0.0 111.933 -172.697 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 18.0 p90 -158.21 109.94 2.25 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 123.465 0.706 . . . . 0.0 109.897 -176.638 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 6.4 t70 53.44 54.11 10.61 Favored 'General case' 0 N--CA 1.501 2.077 0 N-CA-C 116.625 2.083 . . . . 0.0 116.625 164.236 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 87.96 -42.75 3.11 Favored Glycine 0 CA--C 1.552 2.35 0 N-CA-C 116.937 1.535 . . . . 0.0 116.937 -170.71 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 16.6 mt-30 -86.4 131.26 34.24 Favored 'General case' 0 N--CA 1.487 1.404 0 CA-C-N 118.086 0.943 . . . . 0.0 110.84 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -141.79 126.37 17.88 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 122.96 0.504 . . . . 0.0 110.36 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 1.4 t -121.07 124.07 43.89 Favored 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 123.528 0.731 . . . . 0.0 110.302 -175.032 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 40.1 p -97.76 141.96 30.13 Favored 'General case' 0 N--CA 1.492 1.648 0 CA-C-O 121.499 0.666 . . . . 0.0 111.738 179.764 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 5.6 mp -119.75 80.68 1.62 Allowed 'General case' 0 CA--C 1.564 1.494 0 N-CA-C 107.672 -1.233 . . . . 0.0 107.672 175.571 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 95.7 t -90.83 111.16 23.22 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 -172.464 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 83.7 mtt85 -104.63 130.21 52.66 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 123.292 0.637 . . . . 0.0 110.211 -177.383 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -145.94 129.26 16.78 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 123.167 0.587 . . . . 0.0 110.546 -174.095 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -79.71 116.8 20.1 Favored 'General case' 0 N--CA 1.488 1.469 0 CA-C-O 121.273 0.559 . . . . 0.0 111.108 177.117 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 48.9 mm -120.05 100.18 8.91 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.332 0 N-CA-C 105.485 -2.043 . . . . 0.0 105.485 177.72 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 57.38 49.78 12.5 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 114.915 1.45 . . . . 0.0 114.915 174.101 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 89.51 -38.61 3.19 Favored Glycine 0 CA--C 1.553 2.465 0 N-CA-C 117.572 1.789 . . . . 0.0 117.572 -169.019 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 54.0 mttm -82.64 132.79 35.18 Favored 'General case' 0 N--CA 1.488 1.448 0 CA-C-N 118.583 1.192 . . . . 0.0 112.075 -171.192 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 20.8 tp -81.66 112.66 19.05 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 172.68 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 37.6 mm -99.77 102.49 13.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 N-CA-C 106.732 -1.581 . . . . 0.0 106.732 -178.12 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 22.6 tp -90.43 102.73 15.46 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 123.815 0.846 . . . . 0.0 109.22 174.57 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 66.9 m -91.47 112.87 24.96 Favored 'General case' 0 CA--C 1.562 1.432 0 C-N-CA 124.181 0.992 . . . . 0.0 108.354 179.324 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 88.3 mt -104.61 87.34 2.67 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 123.746 0.818 . . . . 0.0 109.985 -171.819 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 9.9 m -103.17 112.51 25.41 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.727 -0.608 . . . . 0.0 109.576 -174.134 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 54.9 t60 -108.74 86.96 2.38 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 164.001 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 71.16 -101.54 0.97 Allowed Glycine 0 N--CA 1.483 1.795 0 N-CA-C 114.416 0.526 . . . . 0.0 114.416 179.461 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 61.2 m -87.19 -51.34 6.04 Favored 'General case' 0 CA--C 1.566 1.595 0 C-N-CA 123.653 0.781 . . . . 0.0 112.678 176.853 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -77.73 107.48 10.26 Favored 'General case' 0 N--CA 1.484 1.274 0 CA-C-N 119.756 1.162 . . . . 0.0 112.886 -173.641 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 4.7 p -107.68 124.18 63.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 C-N-CA 123.954 0.901 . . . . 0.0 110.37 -178.627 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' CYS . . . . . 0.424 ' HG ' ' HD1' ' A' ' 16' ' ' PHE . 2.7 t -101.25 108.57 20.25 Favored 'General case' 0 CA--C 1.556 1.188 0 C-N-CA 123.449 0.699 . . . . 0.0 110.614 173.134 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 53.5 m -89.2 111.06 21.76 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 177.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 36.1 mtt180 -108.06 117.23 33.58 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 123.187 0.595 . . . . 0.0 110.874 -179.296 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 86.0 m -88.91 134.34 33.99 Favored 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 123.53 0.732 . . . . 0.0 109.585 172.447 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 48.1 m-85 -128.58 135.62 49.61 Favored 'General case' 0 CA--C 1.559 1.308 0 C-N-CA 123.95 0.9 . . . . 0.0 109.371 179.127 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -100.99 154.0 19.06 Favored 'General case' 0 N--CA 1.493 1.718 0 CA-C-O 122.6 1.191 . . . . 0.0 111.414 167.439 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 36.2 tttp -84.86 125.69 32.84 Favored 'General case' 0 N--CA 1.483 1.218 0 CA-C-N 114.956 -1.02 . . . . 0.0 112.209 -168.367 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 16.7 mm-40 -123.3 50.14 1.6 Allowed 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 124.237 1.015 . . . . 0.0 111.712 -175.158 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 0.811 0 CA-C-O 123.005 1.384 . . . . 0.0 110.639 -161.36 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.32 2.5 t . . . . . 0 N--CA 1.489 1.487 0 CA-C-O 118.051 -0.976 . . . . 0.0 112.995 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -62.12 -36.13 80.84 Favored 'General case' 0 N--CA 1.497 1.881 0 N-CA-C 116.154 1.909 . . . . 0.0 116.154 179.587 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -62.41 -32.32 73.14 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 116.858 2.17 . . . . 0.0 116.858 163.259 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 88.8 m-85 -67.69 -27.62 66.99 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 116.146 1.906 . . . . 0.0 116.146 168.319 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 60.0 mt -72.75 116.42 13.22 Favored 'General case' 0 N--CA 1.49 1.543 0 CA-C-N 121.291 1.86 . . . . 0.0 111.512 -172.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 159.48 177.17 32.33 Favored Glycine 0 CA--C 1.541 1.692 0 CA-C-O 122.138 0.854 . . . . 0.0 114.133 -176.091 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 52.3 m -94.61 135.46 36.04 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 174.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 92.6 m95 -134.7 113.13 11.37 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 -172.247 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 7.7 mtmp? -98.76 144.21 28.25 Favored 'General case' 0 N--CA 1.489 1.477 0 CA-C-O 121.978 0.894 . . . . 0.0 110.541 175.084 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 51.4 tp -68.71 133.64 48.69 Favored 'General case' 0 N--CA 1.486 1.359 0 CA-C-O 122.283 1.039 . . . . 0.0 112.496 -176.469 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . 0.28 1.1 t -110.74 -43.3 5.2 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.744 0 CA-C-N 113.697 -1.592 . . . . 0.0 111.718 -178.411 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 41.8 t0 -143.78 131.89 21.79 Favored 'General case' 0 N--CA 1.49 1.525 0 CA-C-N 120.102 1.319 . . . . 0.0 109.63 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 86.4 p -112.93 96.83 6.16 Favored 'General case' 0 N--CA 1.492 1.663 0 CA-C-O 121.492 0.663 . . . . 0.0 110.366 171.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 43.7 mtmt -96.41 123.32 40.02 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 123.656 0.783 . . . . 0.0 108.92 -179.37 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 59.7 m-20 67.57 23.18 8.95 Favored 'General case' 0 N--CA 1.503 2.208 0 N-CA-C 117.532 2.419 . . . . 0.0 117.532 178.578 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 27.3 t80 -68.22 -51.75 41.9 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 120.155 -1.591 . . . . 0.0 113.981 -178.812 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -47.28 -36.19 8.86 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 117.542 2.423 . . . . 0.0 117.542 165.736 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 33.9 t0 -66.06 -55.49 16.33 Favored 'General case' 0 N--CA 1.499 2.021 0 CA-C-N 120.483 1.492 . . . . 0.0 114.245 172.232 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 71.6 t80 -48.22 -48.01 35.34 Favored 'General case' 0 CA--C 1.573 1.845 0 N-CA-C 116.135 1.902 . . . . 0.0 116.135 167.465 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 51.4 mmm -68.23 -46.03 71.67 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 114.84 1.422 . . . . 0.0 114.84 178.691 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -54.91 -46.34 74.84 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 115.533 1.679 . . . . 0.0 115.533 166.2 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 64.6 m -60.54 -38.55 84.85 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 116.199 1.926 . . . . 0.0 116.199 172.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 62.5 mt -63.06 -41.17 99.41 Favored 'General case' 0 CA--C 1.567 1.632 0 N-CA-C 115.78 1.771 . . . . 0.0 115.78 168.337 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 114.39 73.17 0.57 Allowed Glycine 0 N--CA 1.482 1.751 0 C-N-CA 123.899 0.762 . . . . 0.0 111.603 -176.192 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 57.3 t -140.36 121.82 14.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 N-CA-C 106.389 -1.708 . . . . 0.0 106.389 -173.772 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -72.18 170.69 49.68 Favored Glycine 0 CA--C 1.551 2.322 0 N-CA-C 116.414 1.326 . . . . 0.0 116.414 177.235 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . 0.25 33.0 p90 -57.47 -43.23 83.87 Favored 'General case' 0 N--CA 1.497 1.92 0 N-CA-C 118.92 2.933 . . . . 0.0 118.92 -167.515 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.36 -40.62 89.87 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 116.589 2.07 . . . . 0.0 116.589 178.75 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 94.7 m -71.52 -42.02 68.48 Favored 'General case' 0 N--CA 1.498 1.963 0 N-CA-C 113.792 1.034 . . . . 0.0 113.792 168.574 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 38.3 ttp180 -58.53 -38.91 78.75 Favored 'General case' 0 CA--C 1.569 1.708 0 N-CA-C 115.89 1.811 . . . . 0.0 115.89 173.879 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 51.4 mt-30 -81.66 -38.8 25.35 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 115.66 1.726 . . . . 0.0 115.66 176.71 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 46.9 t -73.11 -37.88 53.88 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.254 0 CA-C-N 121.381 1.901 . . . . 0.0 112.664 175.067 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -66.55 -31.37 72.05 Favored 'General case' 0 CA--C 1.567 1.601 0 N-CA-C 117.0 2.222 . . . . 0.0 117.0 170.462 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 85.9 p -67.0 -43.65 82.38 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 115.283 1.586 . . . . 0.0 115.283 164.257 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 49.6 ttm -64.73 -38.73 92.0 Favored 'General case' 0 CA--C 1.567 1.624 0 N-CA-C 116.49 2.033 . . . . 0.0 116.49 176.643 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 13.0 t -69.29 144.94 53.44 Favored 'General case' 0 N--CA 1.492 1.645 0 CA-C-N 119.432 1.014 . . . . 0.0 112.931 -179.417 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -102.69 103.16 30.85 Favored Pre-proline 0 CA--C 1.567 1.603 0 CA-C-O 118.201 -0.904 . . . . 0.0 108.802 176.009 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -72.96 119.78 6.26 Favored 'Trans proline' 0 CA--C 1.559 1.753 0 C-N-CA 123.052 2.501 . . . . 0.0 112.526 -179.244 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 95.7 m -84.58 99.59 10.85 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 179.859 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 86.9 m -97.37 104.53 16.56 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 -165.253 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 68.9 mt -100.5 112.69 33.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 N-CA-C 107.464 -1.31 . . . . 0.0 107.464 -174.45 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 35.8 mt -104.0 117.41 49.49 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 N-CA-C 107.121 -1.437 . . . . 0.0 107.121 179.548 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -141.43 119.42 11.97 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-O 121.078 0.466 . . . . 0.0 109.939 -170.154 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 56.3 tttm -91.84 121.95 33.92 Favored 'General case' 0 CA--C 1.56 1.347 0 C-N-CA 123.748 0.819 . . . . 0.0 111.802 -175.075 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 75.4 m-20 -116.61 92.16 3.79 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 -179.346 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 83.25 -92.95 1.68 Allowed Glycine 0 N--CA 1.486 1.998 0 O-C-N 121.774 -0.579 . . . . 0.0 111.776 -173.347 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -138.49 65.57 1.46 Allowed 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 155.808 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 33.9 mm -136.01 99.88 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 N-CA-C 105.258 -2.127 . . . . 0.0 105.258 -174.73 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 60.4 mt -81.45 102.09 10.31 Favored 'General case' 0 N--CA 1.486 1.342 0 CA-C-O 121.181 0.515 . . . . 0.0 110.482 -179.119 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 28.7 m -98.38 97.92 9.21 Favored 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 107.275 -1.379 . . . . 0.0 107.275 -173.301 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 10.4 tt -98.92 102.16 13.79 Favored 'General case' 0 N--CA 1.485 1.29 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 -177.402 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -98.77 111.5 23.86 Favored 'General case' 0 N--CA 1.484 1.25 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 -174.49 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 52.4 m -91.65 95.91 10.16 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 -179.366 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 23.1 m-70 -87.26 96.42 10.33 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 -176.556 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 37.4 t . . . . . 0 N--CA 1.484 1.227 0 C-N-CA 123.733 0.813 . . . . 0.0 109.96 -169.992 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 9.2 p30 . . . . . 0 N--CA 1.49 1.549 0 CA-C-O 120.333 0.111 . . . . 0.0 111.008 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 77.1 p -130.35 132.33 45.77 Favored 'General case' 0 N--CA 1.497 1.901 0 C-N-CA 123.091 0.556 . . . . 0.0 111.174 -169.561 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -117.89 130.55 56.31 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 123.784 0.833 . . . . 0.0 110.009 -176.433 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 39.1 pt -123.66 132.91 70.58 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 C-N-CA 123.456 0.703 . . . . 0.0 109.412 175.773 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 45.9 t -120.99 107.4 12.6 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 -176.669 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 49.0 p90 -136.42 136.73 39.8 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 115.204 1.557 . . . . 0.0 115.204 -159.435 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 50.5 mtmt -103.5 14.67 30.8 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 117.214 2.302 . . . . 0.0 117.214 -173.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . 0.295 3.3 mp 62.59 96.9 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.744 0 CA-C-N 120.648 1.567 . . . . 0.0 114.318 177.226 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 87.1 38.68 7.75 Favored Glycine 0 CA--C 1.55 2.28 0 N-CA-C 116.99 1.556 . . . . 0.0 116.99 -170.087 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 86.5 t -138.73 124.22 23.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 N-CA-C 106.839 -1.541 . . . . 0.0 106.839 -179.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -87.8 116.26 25.82 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 123.042 0.537 . . . . 0.0 109.961 171.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 45.0 p90 -125.43 131.8 52.84 Favored 'General case' 0 N--CA 1.491 1.624 0 C-N-CA 123.912 0.885 . . . . 0.0 109.851 -175.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -73.61 110.4 7.86 Favored 'General case' 0 CA--C 1.564 1.507 0 O-C-N 121.411 -0.806 . . . . 0.0 111.889 176.816 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 13.7 tp10 -106.41 132.94 51.84 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 124.115 0.966 . . . . 0.0 109.563 -174.441 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 52.2 m -96.96 117.59 31.49 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 174.255 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 20.3 p -84.9 166.83 16.5 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-O 121.664 0.745 . . . . 0.0 112.101 -174.704 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -67.36 -20.94 65.64 Favored 'General case' 0 CA--C 1.571 1.757 0 N-CA-C 117.677 2.473 . . . . 0.0 117.677 169.446 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -76.68 -0.24 22.84 Favored 'General case' 0 CA--C 1.581 2.137 0 N-CA-C 116.142 1.904 . . . . 0.0 116.142 160.536 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . 0.265 11.1 m-20 71.57 70.07 0.16 Allowed 'General case' 0 N--CA 1.495 1.811 0 C-N-CA 125.349 1.46 . . . . 0.0 111.729 -176.857 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 80.9 mtm180 -141.2 126.72 18.85 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 -175.302 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.57 97.17 8.9 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 123.37 0.668 . . . . 0.0 111.317 172.576 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 10.8 m -113.6 127.33 71.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 C-N-CA 123.165 0.586 . . . . 0.0 109.912 -168.268 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 29.9 mmtp -80.4 103.69 10.44 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 123.507 0.723 . . . . 0.0 110.118 179.632 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 70.8 m -100.21 95.84 7.07 Favored 'General case' 0 N--CA 1.483 1.198 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.947 -165.26 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 7.1 tp -107.71 113.84 44.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 177.35 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -130.4 128.12 63.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 C-N-CA 124.012 0.925 . . . . 0.0 109.129 -176.278 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 10.2 t -140.45 150.08 43.37 Favored 'General case' 0 N--CA 1.488 1.472 0 CA-C-O 122.719 1.247 . . . . 0.0 110.052 175.689 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 19.2 tp -85.07 114.18 22.02 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-N 114.616 -1.175 . . . . 0.0 109.321 176.501 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -101.63 81.09 2.12 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-O 121.239 0.542 . . . . 0.0 110.085 -178.562 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 57.07 45.14 92.74 Favored Glycine 0 N--CA 1.489 2.175 0 N-CA-C 118.016 1.967 . . . . 0.0 118.016 -177.127 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 102.87 -45.15 1.37 Allowed Glycine 0 N--CA 1.491 2.317 0 N-CA-C 116.481 1.352 . . . . 0.0 116.481 -165.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 83.6 tttt -81.33 106.81 13.59 Favored 'General case' 0 CA--C 1.559 1.3 0 C-N-CA 123.616 0.767 . . . . 0.0 110.87 -176.767 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 30.4 tp -82.52 114.59 21.03 Favored 'General case' 0 N--CA 1.484 1.232 0 CA-C-O 121.546 0.688 . . . . 0.0 110.948 -177.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 48.3 t -113.47 110.21 31.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 N-CA-C 106.72 -1.585 . . . . 0.0 106.72 -168.824 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 23.7 t-160 -106.2 142.46 35.84 Favored 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 124.113 0.965 . . . . 0.0 109.717 174.702 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 30.3 tp -131.74 122.81 26.47 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 174.441 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 81.9 mt-30 -115.41 105.61 13.04 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 176.089 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 71.0 mttt -107.36 135.69 48.43 Favored 'General case' 0 N--CA 1.495 1.782 0 C-N-CA 123.43 0.692 . . . . 0.0 111.656 -177.674 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 18.3 p90 -150.42 111.23 4.29 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 123.346 0.658 . . . . 0.0 109.946 178.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 4.8 t70 50.56 57.85 6.16 Favored 'General case' 0 N--CA 1.497 1.894 0 N-CA-C 116.304 1.965 . . . . 0.0 116.304 166.578 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 91.26 -44.8 2.8 Favored Glycine 0 CA--C 1.55 2.267 0 N-CA-C 116.789 1.476 . . . . 0.0 116.789 -171.62 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 19.6 mt-30 -92.34 134.72 34.65 Favored 'General case' 0 N--CA 1.489 1.52 0 CA-C-N 118.234 1.017 . . . . 0.0 111.577 -174.036 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -113.53 157.8 21.56 Favored 'General case' 0 N--CA 1.491 1.62 0 CA-C-O 121.612 0.72 . . . . 0.0 112.028 172.775 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 14.6 t -140.78 120.27 13.19 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 158.604 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 39.9 p -90.62 125.36 35.61 Favored 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 122.661 0.385 . . . . 0.0 110.519 172.15 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 5.5 mp -102.06 80.52 2.0 Allowed 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 177.57 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 71.1 t -88.69 105.71 16.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 -170.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 83.8 mtt85 -103.5 123.34 46.71 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 123.536 0.734 . . . . 0.0 109.742 -176.653 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -144.46 131.45 20.41 Favored 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 122.805 0.442 . . . . 0.0 110.974 -172.023 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -81.12 116.0 20.82 Favored 'General case' 0 N--CA 1.487 1.405 0 CA-C-O 121.281 0.562 . . . . 0.0 111.327 -179.131 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 86.1 mt -123.88 107.1 18.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 N-CA-C 104.66 -2.348 . . . . 0.0 104.66 176.518 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 58.4 50.48 9.37 Favored 'General case' 0 N--CA 1.5 2.029 0 N-CA-C 114.945 1.461 . . . . 0.0 114.945 176.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 66.91 18.13 68.3 Favored Glycine 0 CA--C 1.554 2.516 0 N-CA-C 119.758 2.663 . . . . 0.0 119.758 -171.833 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 38.8 mtmm -126.78 131.3 51.31 Favored 'General case' 0 N--CA 1.489 1.486 0 CA-C-N 119.981 1.891 . . . . 0.0 109.106 -173.626 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 14.1 tp -79.22 107.59 12.1 Favored 'General case' 0 CA--C 1.558 1.255 0 C-N-CA 123.334 0.654 . . . . 0.0 109.38 178.124 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 33.6 mm -99.54 100.41 10.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 N-CA-C 106.569 -1.641 . . . . 0.0 106.569 -175.255 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 29.8 tp -92.12 99.85 12.58 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 124.16 0.984 . . . . 0.0 109.647 178.234 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 1.8 p -86.84 114.67 23.69 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 123.689 0.796 . . . . 0.0 109.589 171.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 85.1 mt -101.96 89.05 3.51 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 123.971 0.908 . . . . 0.0 108.979 -176.36 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 7.6 m -100.4 108.93 21.06 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 108.798 -0.815 . . . . 0.0 108.798 -171.682 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 2.2 t60 -76.86 -63.31 1.38 Allowed 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 122.454 0.301 . . . . 0.0 111.348 167.578 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -165.37 -76.47 0.03 OUTLIER Glycine 0 N--CA 1.479 1.543 0 N-CA-C 109.499 -1.441 . . . . 0.0 109.499 178.699 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 72.9 m -73.28 -54.42 8.45 Favored 'General case' 0 CA--C 1.568 1.668 0 CA-C-O 118.693 -0.67 . . . . 0.0 112.787 169.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -97.4 112.62 24.38 Favored 'General case' 0 N--CA 1.483 1.207 0 CA-C-N 119.405 1.002 . . . . 0.0 112.552 -172.505 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 6.0 p -95.91 127.63 47.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 C-N-CA 123.825 0.85 . . . . 0.0 110.058 169.187 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 44.0 t -100.81 108.1 19.81 Favored 'General case' 0 N--CA 1.481 1.102 0 CA-C-O 121.062 0.458 . . . . 0.0 111.261 171.428 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 47.8 m -84.48 112.06 20.04 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 176.413 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 37.6 mtt180 -104.29 116.0 31.39 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 123.259 0.624 . . . . 0.0 110.114 175.045 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 92.9 m -90.09 129.32 36.4 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 173.848 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 58.7 m-85 -124.93 129.67 50.83 Favored 'General case' 0 CA--C 1.559 1.29 0 C-N-CA 123.546 0.738 . . . . 0.0 109.283 179.081 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -94.54 154.28 17.47 Favored 'General case' 0 N--CA 1.494 1.757 0 CA-C-O 122.326 1.06 . . . . 0.0 111.347 167.147 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 70.9 tttt -86.01 116.37 24.19 Favored 'General case' 0 N--CA 1.484 1.25 0 CA-C-N 115.554 -0.748 . . . . 0.0 112.059 -167.904 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 50.2 tp10 -75.03 -40.95 60.19 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 116.666 2.098 . . . . 0.0 116.666 172.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.97 0 CA-C-O 124.287 1.994 . . . . 0.0 107.882 173.749 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.251 4.0 p . . . . . 0 CA--C 1.576 1.971 0 N-CA-C 115.18 1.548 . . . . 0.0 115.18 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -77.5 -36.95 52.08 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 115.825 1.787 . . . . 0.0 115.825 -174.345 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -58.3 -24.49 59.75 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 117.714 2.487 . . . . 0.0 117.714 167.054 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -72.46 -19.46 61.56 Favored 'General case' 0 CA--C 1.566 1.566 0 N-CA-C 116.377 1.991 . . . . 0.0 116.377 168.833 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 44.4 mt -81.16 121.74 26.5 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-N 121.228 1.831 . . . . 0.0 111.554 -171.517 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 159.43 -177.23 36.04 Favored Glycine 0 N--CA 1.484 1.88 0 CA-C-O 121.9 0.722 . . . . 0.0 113.583 -179.159 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 63.7 m -92.11 139.79 30.28 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 170.702 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 90.2 m95 -141.19 109.5 5.88 Favored 'General case' 0 N--CA 1.487 1.381 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 -171.391 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 55.8 mttp -100.7 141.52 33.45 Favored 'General case' 0 N--CA 1.49 1.542 0 CA-C-O 121.222 0.534 . . . . 0.0 109.941 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 58.1 tp -68.08 123.01 19.46 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-O 122.178 0.99 . . . . 0.0 112.167 -175.135 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . 0.27 1.0 OUTLIER -103.5 -41.65 7.43 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.751 0 CA-C-N 113.9 -1.5 . . . . 0.0 112.737 -175.337 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -145.85 133.47 20.97 Favored 'General case' 0 N--CA 1.488 1.454 0 CA-C-N 119.922 1.237 . . . . 0.0 108.948 178.1 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 88.7 p -115.54 101.15 8.61 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 122.976 0.51 . . . . 0.0 110.662 175.021 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 59.2 mtpt -87.12 118.33 26.45 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 174.519 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 60.8 m-20 66.55 29.97 8.71 Favored 'General case' 0 N--CA 1.502 2.134 0 N-CA-C 117.173 2.286 . . . . 0.0 117.173 177.069 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.472 ' HB2' ' SG ' ' A' ' 124' ' ' CYS . 18.0 t80 -89.57 69.51 7.85 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 120.235 -1.54 . . . . 0.0 111.857 178.808 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 26.8 m-20 -162.61 -54.22 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 125.684 1.594 . . . . 0.0 108.044 -177.457 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 21.1 t0 -56.61 -45.27 81.56 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 115.422 1.638 . . . . 0.0 115.422 167.387 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 81.6 t80 -51.98 -54.43 29.89 Favored 'General case' 0 CA--C 1.57 1.716 0 N-CA-C 114.787 1.403 . . . . 0.0 114.787 169.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 70.4 mtm -63.98 -46.13 85.97 Favored 'General case' 0 N--CA 1.491 1.575 0 N-CA-C 115.539 1.681 . . . . 0.0 115.539 174.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -57.86 -44.99 86.92 Favored 'General case' 0 CA--C 1.57 1.713 0 N-CA-C 115.5 1.667 . . . . 0.0 115.5 173.582 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 23.3 t -61.51 -37.27 83.11 Favored 'General case' 0 CA--C 1.568 1.645 0 N-CA-C 116.367 1.988 . . . . 0.0 116.367 170.275 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 69.2 mt -64.79 -23.31 67.2 Favored 'General case' 0 CA--C 1.568 1.657 0 N-CA-C 117.96 2.578 . . . . 0.0 117.96 169.24 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 99.49 68.61 0.89 Allowed Glycine 0 N--CA 1.482 1.746 0 CA-C-N 119.416 1.007 . . . . 0.0 112.193 -171.156 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 33.8 t -144.95 112.66 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 N-CA-C 104.375 -2.454 . . . . 0.0 104.375 -177.842 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -70.83 -91.99 0.08 OUTLIER Glycine 0 N--CA 1.486 2.015 0 N-CA-C 117.676 1.83 . . . . 0.0 117.676 -160.763 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . 0.279 40.4 p90 -140.07 -60.91 0.53 Allowed 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 112.977 0.732 . . . . 0.0 112.977 -171.328 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.51 -39.91 92.39 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 115.575 1.695 . . . . 0.0 115.575 172.221 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 71.9 m -71.38 -37.44 71.59 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 113.961 1.097 . . . . 0.0 113.961 171.355 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 66.4 ttp85 -62.22 -42.79 99.63 Favored 'General case' 0 CA--C 1.572 1.795 0 N-CA-C 114.961 1.467 . . . . 0.0 114.961 170.117 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 9.5 tm0? -65.31 -49.87 67.83 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 114.497 1.295 . . . . 0.0 114.497 172.061 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 93.5 t -64.87 -36.68 78.29 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.925 0 CA-C-N 119.489 1.041 . . . . 0.0 113.762 177.72 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -64.6 -37.03 86.16 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 116.94 2.2 . . . . 0.0 116.94 172.688 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 96.6 p -67.65 -40.41 84.52 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 115.675 1.732 . . . . 0.0 115.675 165.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 48.9 ttp -69.35 -35.69 76.12 Favored 'General case' 0 CA--C 1.567 1.622 0 N-CA-C 116.979 2.214 . . . . 0.0 116.979 176.033 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 8.3 t -63.49 -31.4 72.55 Favored 'General case' 0 N--CA 1.498 1.965 0 N-CA-C 118.488 2.773 . . . . 0.0 118.488 -167.501 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . 0.261 34.2 ttpt 75.25 90.37 0.06 OUTLIER Pre-proline 0 CA--C 1.573 1.833 0 C-N-CA 124.832 1.253 . . . . 0.0 112.128 177.285 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -72.62 125.32 10.49 Favored 'Trans proline' 0 C--N 1.369 1.634 0 C-N-CA 123.292 2.661 . . . . 0.0 114.501 -176.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 97.9 m -97.06 92.71 6.19 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 -179.185 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 57.4 m -86.19 110.32 19.51 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 123.12 0.568 . . . . 0.0 110.099 -173.598 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 95.1 mt -101.64 110.31 28.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 N-CA-C 106.811 -1.552 . . . . 0.0 106.811 178.609 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 59.3 mt -100.48 116.19 43.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 -179.143 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 4.5 tm-20 -136.63 110.95 8.44 Favored 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 -171.506 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 81.7 tttt -95.0 113.24 24.92 Favored 'General case' 0 CA--C 1.554 1.126 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 171.848 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 14.6 t-20 -82.2 -58.65 2.86 Favored 'General case' 0 CA--C 1.564 1.511 0 C-N-CA 123.243 0.617 . . . . 0.0 112.478 -178.083 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -132.63 -95.55 0.6 Allowed Glycine 0 N--CA 1.483 1.816 0 N-CA-C 109.18 -1.568 . . . . 0.0 109.18 169.45 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -79.8 -30.9 40.68 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 114.917 1.451 . . . . 0.0 114.917 163.398 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 39.8 mm -77.93 111.85 15.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 CA-C-N 119.311 0.96 . . . . 0.0 109.507 -175.047 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 2.0 mt -78.72 137.95 38.02 Favored 'General case' 0 CA--C 1.561 1.376 0 C-N-CA 123.254 0.622 . . . . 0.0 110.379 160.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 10.7 m -133.72 103.43 5.87 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 -177.438 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 9.1 tt -96.7 112.31 24.11 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 107.358 -1.349 . . . . 0.0 107.358 177.095 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 89.4 mttt -112.87 98.88 7.47 Favored 'General case' 0 N--CA 1.485 1.285 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 -164.676 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 28.4 m -87.98 95.14 10.01 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.327 -0.858 . . . . 0.0 109.22 -174.467 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 77.8 m80 -85.03 28.83 0.68 Allowed 'General case' 0 CA--C 1.573 1.84 0 N-CA-C 116.59 2.07 . . . . 0.0 116.59 -173.273 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . 0.271 17.5 m . . . . . 0 CA--C 1.553 1.081 0 N-CA-C 105.29 -2.115 . . . . 0.0 105.29 153.138 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 42.9 m-20 . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 120.997 0.427 . . . . 0.0 111.787 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 40.4 p -105.2 133.78 49.4 Favored 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 123.532 0.733 . . . . 0.0 110.448 -174.158 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -122.48 122.14 38.24 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 123.344 0.658 . . . . 0.0 109.367 179.517 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 39.2 pt -93.64 136.26 25.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 C-N-CA 123.174 0.59 . . . . 0.0 109.587 163.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 33.0 t -125.02 116.69 22.53 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 173.655 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 41.2 p90 -149.4 148.18 29.16 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 113.837 1.051 . . . . 0.0 113.837 -153.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 62.7 mtpt -111.99 18.89 18.38 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 116.959 2.207 . . . . 0.0 116.959 -171.494 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . 0.28 1.5 mp 57.11 83.86 0.1 Allowed 'General case' 0 N--CA 1.495 1.802 0 CA-C-N 120.74 1.609 . . . . 0.0 114.532 177.678 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 98.02 42.9 2.95 Favored Glycine 0 CA--C 1.548 2.146 0 N-CA-C 116.221 1.248 . . . . 0.0 116.221 -171.429 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 70.8 t -145.08 127.72 10.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 N-CA-C 105.752 -1.944 . . . . 0.0 105.752 -178.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -87.25 116.72 25.53 Favored 'General case' 0 CA--C 1.566 1.566 0 CA-C-O 121.634 0.731 . . . . 0.0 110.129 173.079 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 25.4 p90 -114.91 -172.83 2.2 Favored 'General case' 0 N--CA 1.494 1.745 0 C-N-CA 124.796 1.238 . . . . 0.0 109.733 171.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -117.05 145.13 43.91 Favored 'General case' 0 N--CA 1.487 1.401 0 CA-C-O 123.25 1.5 . . . . 0.0 110.846 168.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 52.2 tp10 -129.34 148.15 51.24 Favored 'General case' 0 N--CA 1.488 1.456 0 CA-C-N 112.804 -1.998 . . . . 0.0 109.928 177.319 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 83.4 m -103.85 124.25 48.6 Favored 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 168.433 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 28.4 p -75.64 168.06 20.72 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-O 121.579 0.704 . . . . 0.0 112.851 -176.536 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -59.62 -29.41 67.99 Favored 'General case' 0 CA--C 1.563 1.454 0 N-CA-C 117.827 2.529 . . . . 0.0 117.827 178.748 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 62.5 m-20 -116.11 67.24 0.71 Allowed 'General case' 0 N--CA 1.491 1.625 0 CA-C-N 119.121 0.873 . . . . 0.0 110.491 165.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 47.06 72.46 0.24 Allowed 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 117.595 2.442 . . . . 0.0 117.595 164.84 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 63.1 mtm-85 -139.68 123.52 17.55 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 171.037 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -71.32 122.57 20.53 Favored 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 123.1 0.56 . . . . 0.0 110.505 164.3 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 32.8 m -138.92 135.09 42.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 -169.818 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 30.5 mmmt -82.17 101.02 10.17 Favored 'General case' 0 N--CA 1.488 1.434 0 CA-C-O 122.418 1.104 . . . . 0.0 110.224 178.267 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 22.4 p -93.1 107.14 18.99 Favored 'General case' 0 CA--C 1.555 1.164 0 CA-C-N 114.117 -1.401 . . . . 0.0 111.821 -170.637 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -113.33 121.26 65.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 174.424 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 1.1 p -131.76 130.42 61.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 C-N-CA 123.921 0.888 . . . . 0.0 109.598 -178.623 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 9.0 t -145.19 153.66 41.59 Favored 'General case' 0 N--CA 1.486 1.356 0 CA-C-O 122.942 1.353 . . . . 0.0 110.407 179.044 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 44.2 tp -86.42 123.58 31.81 Favored 'General case' 0 CA--C 1.562 1.438 0 CA-C-N 114.402 -1.272 . . . . 0.0 110.333 177.68 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -104.93 76.54 1.26 Allowed 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 123.54 0.736 . . . . 0.0 110.581 176.161 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 75.1 -76.4 1.24 Allowed Glycine 0 N--CA 1.487 2.069 0 N-CA-C 114.246 0.458 . . . . 0.0 114.246 -176.551 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -142.91 45.91 0.88 Allowed Glycine 0 CA--C 1.549 2.165 0 CA-C-N 114.428 -0.886 . . . . 0.0 114.293 167.043 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 56.3 mtpt -138.33 118.71 13.74 Favored 'General case' 0 N--CA 1.484 1.237 0 N-CA-C 105.593 -2.002 . . . . 0.0 105.593 178.115 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 4.4 tt -87.94 100.5 12.94 Favored 'General case' 0 CA--C 1.561 1.366 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 -178.482 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 78.6 t -106.33 102.28 13.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 N-CA-C 107.397 -1.334 . . . . 0.0 107.397 -164.466 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 20.5 t-160 -99.97 144.9 28.48 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 123.842 0.857 . . . . 0.0 110.329 173.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 17.8 tp -145.1 125.89 14.32 Favored 'General case' 0 N--CA 1.488 1.426 0 CA-C-O 122.035 0.921 . . . . 0.0 108.551 176.452 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 29.8 mt-30 -113.84 118.38 34.09 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 124.53 1.132 . . . . 0.0 108.615 -177.337 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -116.94 136.59 52.83 Favored 'General case' 0 N--CA 1.495 1.792 0 C-N-CA 123.26 0.624 . . . . 0.0 111.244 -173.351 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 16.7 p90 -153.59 111.02 3.49 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.231 -0.918 . . . . 0.0 110.64 -178.763 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 4.8 t70 55.07 55.0 8.14 Favored 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 116.009 1.855 . . . . 0.0 116.009 166.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 86.08 -45.76 3.52 Favored Glycine 0 CA--C 1.552 2.355 0 N-CA-C 116.389 1.316 . . . . 0.0 116.389 -168.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 25.4 mt-30 -78.09 149.97 33.81 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 123.547 0.739 . . . . 0.0 112.298 -178.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -150.07 150.49 31.8 Favored 'General case' 0 N--CA 1.488 1.451 0 CA-C-O 121.323 0.582 . . . . 0.0 111.735 175.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 14.2 t -128.47 124.95 37.44 Favored 'General case' 0 N--CA 1.49 1.56 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.353 170.189 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 36.1 p -85.99 134.19 33.88 Favored 'General case' 0 N--CA 1.492 1.665 0 CA-C-O 121.606 0.717 . . . . 0.0 110.251 168.032 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 5.2 mp -116.74 86.03 2.43 Favored 'General case' 0 CA--C 1.562 1.404 0 N-CA-C 106.727 -1.583 . . . . 0.0 106.727 176.159 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 52.1 t -94.22 100.11 10.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.775 0 N-CA-C 107.742 -1.206 . . . . 0.0 107.742 -170.076 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 20.0 mmt180 -90.0 126.27 35.69 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 123.929 0.891 . . . . 0.0 109.915 178.14 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -150.76 131.15 13.73 Favored 'General case' 0 N--CA 1.494 1.76 0 C-N-CA 122.605 0.362 . . . . 0.0 111.938 -172.016 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -77.69 117.53 19.19 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.5 -0.75 . . . . 0.0 111.403 175.378 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 84.3 mt -125.17 105.6 15.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 N-CA-C 104.764 -2.31 . . . . 0.0 104.764 176.653 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 57.16 53.73 7.53 Favored 'General case' 0 N--CA 1.499 1.978 0 N-CA-C 114.246 1.202 . . . . 0.0 114.246 177.63 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 79.65 -27.45 2.55 Favored Glycine 0 CA--C 1.555 2.574 0 N-CA-C 119.097 2.399 . . . . 0.0 119.097 -169.389 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 38.4 mtmm -102.28 131.61 48.75 Favored 'General case' 0 N--CA 1.486 1.336 0 CA-C-N 119.497 1.648 . . . . 0.0 110.214 -164.16 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 49.0 tp -83.98 114.21 21.54 Favored 'General case' 0 CA--C 1.556 1.195 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.797 -176.2 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 33.3 mm -102.88 108.82 25.11 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 -171.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 53.5 tp -89.16 111.06 21.75 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 123.9 0.88 . . . . 0.0 109.298 172.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 90.0 m -101.68 110.6 22.62 Favored 'General case' 0 N--CA 1.494 1.725 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 -179.421 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 97.7 mt -104.01 91.18 3.85 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 123.726 0.811 . . . . 0.0 110.227 -172.439 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 7.4 m -107.78 105.4 15.22 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 -175.864 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 16.7 t60 -83.07 -64.3 1.2 Allowed 'General case' 0 N--CA 1.493 1.684 0 C-N-CA 123.176 0.591 . . . . 0.0 111.631 172.3 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -152.2 -89.88 0.07 OUTLIER Glycine 0 N--CA 1.479 1.524 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 174.081 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 12.0 t -92.13 41.16 1.06 Allowed 'General case' 0 CA--C 1.577 1.995 0 N-CA-C 114.369 1.248 . . . . 0.0 114.369 169.825 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -158.86 97.69 1.43 Allowed 'General case' 0 N--CA 1.485 1.278 0 O-C-N 120.874 -1.141 . . . . 0.0 109.45 175.419 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 4.0 p -97.01 120.34 46.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 C-N-CA 123.842 0.857 . . . . 0.0 109.409 172.763 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' CYS . . . . . 0.472 ' SG ' ' HB2' ' A' ' 16' ' ' PHE . 41.4 t -112.03 102.87 11.06 Favored 'General case' 0 CA--C 1.557 1.214 0 CA-C-O 121.448 0.642 . . . . 0.0 110.943 177.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 90.5 m -92.43 110.19 21.59 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 123.756 0.822 . . . . 0.0 109.117 -176.367 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 38.4 mtm180 -113.26 121.07 43.32 Favored 'General case' 0 N--CA 1.488 1.475 0 C-N-CA 123.235 0.614 . . . . 0.0 110.912 -170.713 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 89.3 m -87.96 136.3 33.03 Favored 'General case' 0 N--CA 1.492 1.643 0 C-N-CA 123.751 0.82 . . . . 0.0 110.74 179.535 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 45.0 m-85 -130.66 125.98 35.4 Favored 'General case' 0 CA--C 1.56 1.343 0 C-N-CA 123.796 0.838 . . . . 0.0 109.162 -179.185 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -95.55 153.58 17.64 Favored 'General case' 0 N--CA 1.495 1.792 0 CA-C-O 122.239 1.018 . . . . 0.0 111.435 169.891 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 72.2 tttt -85.44 119.34 25.68 Favored 'General case' 0 N--CA 1.485 1.318 0 CA-C-N 115.221 -0.9 . . . . 0.0 111.559 -170.368 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -103.36 45.73 0.95 Allowed 'General case' 0 N--CA 1.492 1.675 0 N-CA-C 113.655 0.984 . . . . 0.0 113.655 176.865 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.02 0 CA-C-O 124.327 2.013 . . . . 0.0 107.841 -178.987 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.258 5.6 p . . . . . 0 CA--C 1.577 1.984 0 N-CA-C 115.993 1.849 . . . . 0.0 115.993 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -66.16 -40.08 90.27 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 116.27 1.952 . . . . 0.0 116.27 -176.343 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -59.53 -29.38 67.85 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 117.442 2.386 . . . . 0.0 117.442 168.687 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -68.26 -24.62 64.91 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 116.243 1.942 . . . . 0.0 116.243 167.728 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 39.3 mt -74.81 120.46 20.38 Favored 'General case' 0 N--CA 1.488 1.456 0 CA-C-N 120.759 1.618 . . . . 0.0 111.476 -174.282 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 162.76 168.95 25.46 Favored Glycine 0 N--CA 1.479 1.531 0 CA-C-O 122.822 1.235 . . . . 0.0 113.471 -173.459 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 78.3 m -86.75 136.42 33.01 Favored 'General case' 0 N--CA 1.49 1.535 0 CA-C-N 114.061 -1.069 . . . . 0.0 108.805 164.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 81.4 m95 -140.65 111.69 7.12 Favored 'General case' 0 N--CA 1.484 1.269 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 -174.258 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 8.9 mtpm? -91.97 145.61 24.4 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.866 -0.522 . . . . 0.0 110.278 173.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 48.7 tp -68.07 124.44 23.43 Favored 'General case' 0 N--CA 1.488 1.466 0 CA-C-O 121.94 0.876 . . . . 0.0 111.497 179.394 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . 0.279 1.2 t -96.91 -45.84 12.82 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.79 0 CA-C-N 114.313 -1.312 . . . . 0.0 112.032 177.563 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 51.5 t0 -144.19 129.35 18.68 Favored 'General case' 0 N--CA 1.49 1.528 0 CA-C-N 119.989 1.268 . . . . 0.0 109.806 -177.107 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 75.7 p -104.69 102.3 11.89 Favored 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 123.217 0.607 . . . . 0.0 110.57 169.153 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 61.1 mtpt -101.12 111.45 23.67 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 -178.798 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.256 30.8 m-20 71.12 21.14 4.92 Favored 'General case' 0 N--CA 1.505 2.287 0 N-CA-C 117.028 2.232 . . . . 0.0 117.028 -177.46 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 27.1 t80 -67.36 -47.4 70.54 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 119.989 -1.694 . . . . 0.0 114.548 -178.588 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -40.82 -48.57 3.09 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 118.399 2.74 . . . . 0.0 118.399 161.602 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 18.3 t0 -59.54 -52.87 63.69 Favored 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 115.067 1.506 . . . . 0.0 115.067 172.815 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 93.1 t80 -52.16 -50.29 62.1 Favored 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 115.64 1.719 . . . . 0.0 115.64 170.281 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 40.8 mmm -62.49 -51.76 66.18 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 114.804 1.409 . . . . 0.0 114.804 -179.637 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 21.7 tptm -60.36 -37.11 79.69 Favored 'General case' 0 CA--C 1.571 1.759 0 N-CA-C 115.893 1.812 . . . . 0.0 115.893 172.722 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 17.5 t -61.71 -40.07 93.73 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 116.263 1.949 . . . . 0.0 116.263 169.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 80.2 mt -62.03 -23.45 66.46 Favored 'General case' 0 CA--C 1.569 1.692 0 N-CA-C 117.828 2.529 . . . . 0.0 117.828 168.216 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 97.71 67.96 0.93 Allowed Glycine 0 N--CA 1.482 1.729 0 CA-C-N 119.074 0.852 . . . . 0.0 112.046 -166.667 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 41.2 t -143.64 109.99 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 N-CA-C 104.348 -2.464 . . . . 0.0 104.348 177.824 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -68.61 168.37 43.14 Favored Glycine 0 CA--C 1.546 2.016 0 N-CA-C 116.174 1.23 . . . . 0.0 116.174 -177.343 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 25.3 p90 -53.07 -38.6 62.64 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 119.127 3.01 . . . . 0.0 119.127 -170.121 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.32 -45.17 81.19 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 116.003 1.853 . . . . 0.0 116.003 176.48 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 56.0 m -72.51 -35.54 68.15 Favored 'General case' 0 N--CA 1.501 2.101 0 N-CA-C 114.045 1.128 . . . . 0.0 114.045 171.196 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 48.2 ttp180 -54.59 -49.3 70.73 Favored 'General case' 0 CA--C 1.569 1.681 0 N-CA-C 115.463 1.653 . . . . 0.0 115.463 169.092 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 24.1 mm100 -74.22 -39.43 63.11 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 115.388 1.625 . . . . 0.0 115.388 176.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 73.8 t -61.33 -47.08 95.12 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.03 0 CA-C-N 120.129 1.331 . . . . 0.0 113.135 172.589 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -68.58 -31.9 71.42 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 117.204 2.298 . . . . 0.0 117.204 176.141 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 94.0 p -68.62 -43.6 76.03 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 115.552 1.686 . . . . 0.0 115.552 167.467 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 49.7 ttp -60.33 -41.7 94.1 Favored 'General case' 0 CA--C 1.568 1.666 0 N-CA-C 115.782 1.771 . . . . 0.0 115.782 168.447 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 95.0 m -68.3 136.15 53.01 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 124.141 0.976 . . . . 0.0 110.591 170.668 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 5.3 mptp? -106.69 95.96 13.27 Favored Pre-proline 0 CA--C 1.567 1.621 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 175.401 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -83.22 147.12 12.78 Favored 'Trans proline' 0 C--N 1.372 1.804 0 C-N-CA 122.854 2.37 . . . . 0.0 113.452 -172.234 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 44.9 m -98.41 102.94 14.83 Favored 'General case' 0 CA--C 1.563 1.443 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.586 -169.758 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 79.8 m -80.09 113.4 18.24 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 123.896 0.879 . . . . 0.0 109.744 177.687 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 89.3 mt -115.61 107.69 23.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 N-CA-C 106.024 -1.843 . . . . 0.0 106.024 -175.131 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 4.2 mp -97.68 120.23 46.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 N-CA-C 107.378 -1.341 . . . . 0.0 107.378 174.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -134.99 116.2 14.39 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.245 -1.021 . . . . 0.0 108.245 -179.107 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 84.3 tttt -89.02 111.83 22.63 Favored 'General case' 0 CA--C 1.557 1.234 0 C-N-CA 123.175 0.59 . . . . 0.0 110.267 178.04 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 28.3 t30 -99.42 87.91 3.74 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.642 -0.874 . . . . 0.0 108.642 178.729 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 78.82 -96.4 1.43 Allowed Glycine 0 N--CA 1.484 1.869 0 CA-C-N 116.445 -0.343 . . . . 0.0 112.396 -171.817 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 86.4 m-20 -109.22 -17.11 13.92 Favored 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 115.265 1.58 . . . . 0.0 115.265 169.062 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 24.2 mm -93.34 118.46 39.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 CA-C-N 120.512 1.505 . . . . 0.0 109.14 -167.078 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 42.2 mt -84.87 114.33 22.03 Favored 'General case' 0 N--CA 1.486 1.325 0 C-N-CA 123.763 0.825 . . . . 0.0 111.434 179.701 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 87.6 m -102.25 102.29 12.67 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 -178.277 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 8.7 tt -104.15 105.21 15.3 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.307 -0.998 . . . . 0.0 108.307 -179.531 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -108.72 121.48 45.14 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 123.917 0.887 . . . . 0.0 109.565 -178.734 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 91.6 m -101.68 95.11 6.22 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 108.083 -1.081 . . . . 0.0 108.083 179.217 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 17.5 m-70 -81.26 99.79 8.8 Favored 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 123.564 0.745 . . . . 0.0 110.544 -170.312 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 85.6 p . . . . . 0 N--CA 1.491 1.617 0 N-CA-C 117.198 2.295 . . . . 0.0 117.198 -175.768 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 54.1 t30 . . . . . 0 N--CA 1.488 1.445 0 CA-C-O 120.662 0.268 . . . . 0.0 110.436 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 77.5 p -89.26 127.66 35.79 Favored 'General case' 0 N--CA 1.492 1.655 0 C-N-CA 122.855 0.462 . . . . 0.0 110.34 -179.777 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -123.51 122.25 37.74 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 123.584 0.753 . . . . 0.0 109.427 -169.408 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 48.7 pt -116.67 126.63 74.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 169.371 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 77.4 p -116.06 101.76 9.03 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 177.815 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 43.1 p90 -132.86 142.4 48.92 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 114.522 1.304 . . . . 0.0 114.522 -157.561 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 30.6 mtpp -98.23 146.72 25.34 Favored 'General case' 0 N--CA 1.489 1.501 0 CA-C-N 115.132 -0.94 . . . . 0.0 109.789 160.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -74.23 113.38 11.37 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 -173.83 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 86.64 45.5 5.47 Favored Glycine 0 CA--C 1.548 2.132 0 N-CA-C 115.848 1.099 . . . . 0.0 115.848 -169.259 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 76.7 t -141.79 121.58 10.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 N-CA-C 106.242 -1.762 . . . . 0.0 106.242 179.663 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -85.69 133.05 34.04 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 123.074 0.55 . . . . 0.0 111.147 175.193 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 52.0 p90 -139.32 149.83 44.67 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 124.006 0.922 . . . . 0.0 111.138 -174.383 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -74.64 133.49 42.14 Favored 'General case' 0 CA--C 1.567 1.607 0 O-C-N 121.234 -0.916 . . . . 0.0 112.703 173.189 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 17.3 tp10 -145.82 136.73 24.5 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 123.362 0.665 . . . . 0.0 110.252 -173.477 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 63.1 m -111.08 128.24 55.81 Favored 'General case' 0 N--CA 1.495 1.791 0 C-N-CA 123.279 0.632 . . . . 0.0 109.545 178.666 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 27.0 p -86.45 164.0 17.23 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 113.195 0.813 . . . . 0.0 113.195 -175.749 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -54.82 -32.17 60.11 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 118.779 2.881 . . . . 0.0 118.779 174.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -77.47 -85.44 0.06 Allowed 'General case' 0 N--CA 1.494 1.774 0 CA-C-N 120.416 1.462 . . . . 0.0 109.23 171.299 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -176.67 87.5 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 165.472 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 52.1 mtm-85 -139.95 115.11 9.76 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 -179.844 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -79.83 114.8 19.03 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 123.032 0.533 . . . . 0.0 109.604 166.589 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 13.9 m -125.47 138.76 53.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 CA-C-O 121.365 0.602 . . . . 0.0 110.116 -167.58 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 71.9 mmtt -84.92 107.95 17.32 Favored 'General case' 0 N--CA 1.488 1.426 0 CA-C-O 121.916 0.865 . . . . 0.0 109.179 170.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 47.3 t -106.95 100.84 10.31 Favored 'General case' 0 CA--C 1.555 1.144 0 CA-C-N 114.907 -1.042 . . . . 0.0 110.381 -161.403 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 6.4 tp -113.15 115.8 50.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 -176.494 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 1.4 p -134.26 126.93 50.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 C-N-CA 123.618 0.767 . . . . 0.0 109.735 -175.758 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 15.3 t -133.01 157.7 44.57 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-O 122.65 1.214 . . . . 0.0 110.98 176.065 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 14.9 tp -88.5 113.81 24.47 Favored 'General case' 0 N--CA 1.489 1.486 0 CA-C-N 114.833 -1.076 . . . . 0.0 108.505 168.36 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -107.0 87.22 2.46 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 123.322 0.649 . . . . 0.0 109.415 -174.518 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 61.4 48.26 86.15 Favored Glycine 0 CA--C 1.551 2.311 0 N-CA-C 117.262 1.665 . . . . 0.0 117.262 -174.265 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 69.36 26.42 74.58 Favored Glycine 0 CA--C 1.556 2.625 0 N-CA-C 118.662 2.225 . . . . 0.0 118.662 -167.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.17 109.87 5.76 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 107.151 -1.426 . . . . 0.0 107.151 -175.77 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 4.6 tt -88.63 106.28 18.22 Favored 'General case' 0 CA--C 1.56 1.343 0 CA-C-O 121.705 0.764 . . . . 0.0 111.249 -162.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 83.2 t -103.72 110.71 30.89 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 N-CA-C 107.113 -1.44 . . . . 0.0 107.113 -170.884 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 23.2 t-160 -103.75 138.82 39.83 Favored 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 124.023 0.929 . . . . 0.0 109.554 173.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 41.2 tp -132.52 121.1 22.79 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 107.837 -1.172 . . . . 0.0 107.837 173.413 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 29.9 mt-30 -106.51 129.47 54.46 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 124.198 0.999 . . . . 0.0 108.515 172.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 46.1 mtpt -129.86 130.31 45.05 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.809 -0.557 . . . . 0.0 110.065 -169.471 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 26.3 p90 -154.46 112.16 3.46 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.384 -0.823 . . . . 0.0 111.193 -175.834 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . 0.341 13.2 t70 66.67 -108.73 0.13 Allowed 'General case' 0 N--CA 1.495 1.781 0 C-N-CA 124.582 1.153 . . . . 0.0 112.457 170.527 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -116.42 44.82 1.38 Allowed Glycine 0 N--CA 1.488 2.163 0 CA-C-N 118.887 0.767 . . . . 0.0 115.007 165.096 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 14.9 mt-30 -152.3 126.52 9.23 Favored 'General case' 0 N--CA 1.484 1.273 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 178.704 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 13.4 mp0 -139.41 130.86 27.0 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 -179.194 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 5.2 t -125.13 134.25 52.51 Favored 'General case' 0 N--CA 1.495 1.805 0 C-N-CA 123.144 0.578 . . . . 0.0 111.569 -178.4 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 57.8 p -95.53 138.64 32.92 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-O 121.596 0.712 . . . . 0.0 111.705 172.144 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 5.9 mp -113.6 82.11 1.63 Allowed 'General case' 0 CA--C 1.563 1.449 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 173.812 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 48.1 t -90.73 112.59 25.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 -169.147 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 83.4 mtt85 -106.13 127.7 53.38 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 123.021 0.528 . . . . 0.0 110.086 -177.383 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 8.7 pm0 -139.62 132.86 29.83 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 123.234 0.614 . . . . 0.0 110.816 -178.665 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -80.19 112.92 17.97 Favored 'General case' 0 N--CA 1.487 1.404 0 CA-C-O 121.355 0.597 . . . . 0.0 110.892 175.792 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 73.2 mt -118.71 107.06 20.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 N-CA-C 104.805 -2.294 . . . . 0.0 104.805 176.486 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 59.3 49.85 8.49 Favored 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 114.692 1.367 . . . . 0.0 114.692 177.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 63.32 21.18 64.03 Favored Glycine 0 CA--C 1.555 2.572 0 N-CA-C 119.726 2.65 . . . . 0.0 119.726 -170.629 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 49.0 mtpt -130.95 131.4 44.4 Favored 'General case' 0 N--CA 1.488 1.47 0 CA-C-N 119.713 1.756 . . . . 0.0 108.665 -173.178 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 20.5 tp -81.91 108.53 15.49 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.312 0.645 . . . . 0.0 109.95 -175.155 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 29.8 mm -100.59 103.23 14.53 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 N-CA-C 106.463 -1.681 . . . . 0.0 106.463 -175.872 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 23.9 tp -92.03 98.28 11.46 Favored 'General case' 0 CA--C 1.56 1.328 0 C-N-CA 124.04 0.936 . . . . 0.0 109.47 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 90.8 m -88.12 109.12 19.64 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 124.291 1.036 . . . . 0.0 108.729 178.019 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 90.3 mt -100.29 93.75 5.84 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 124.045 0.938 . . . . 0.0 109.164 -172.449 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 4.7 m -106.41 112.53 25.58 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 -172.291 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 19.9 t60 -100.65 -75.27 0.59 Allowed 'General case' 0 N--CA 1.491 1.591 0 CA-C-O 118.793 -0.623 . . . . 0.0 110.492 172.553 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -142.2 -97.91 0.29 Allowed Glycine 0 N--CA 1.483 1.773 0 N-CA-C 110.558 -1.017 . . . . 0.0 110.558 -178.883 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 8.2 t -89.1 30.78 0.92 Allowed 'General case' 0 N--CA 1.5 2.051 0 N-CA-C 115.498 1.666 . . . . 0.0 115.498 173.468 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -158.44 107.72 2.01 Favored 'General case' 0 N--CA 1.481 1.114 0 O-C-N 121.045 -1.034 . . . . 0.0 108.979 177.351 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 7.5 p -108.56 126.35 65.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 C-N-CA 123.583 0.753 . . . . 0.0 109.827 175.231 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 40.9 t -109.87 106.94 16.71 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 123.003 0.521 . . . . 0.0 111.851 179.033 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 77.5 m -90.18 100.51 13.32 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 178.866 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 33.5 mtm180 -99.41 121.13 40.69 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 123.108 0.563 . . . . 0.0 110.552 -174.667 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 95.7 m -89.78 131.27 35.82 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 123.438 0.695 . . . . 0.0 109.822 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 42.0 m-85 -127.26 131.13 50.61 Favored 'General case' 0 CA--C 1.559 1.297 0 C-N-CA 123.612 0.765 . . . . 0.0 109.587 178.634 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -96.31 150.12 20.92 Favored 'General case' 0 CA--C 1.56 1.358 0 CA-C-O 121.943 0.878 . . . . 0.0 111.457 172.481 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 67.4 tttt -80.77 127.07 32.09 Favored 'General case' 0 N--CA 1.486 1.33 0 CA-C-O 121.642 0.734 . . . . 0.0 112.204 -173.439 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 15.2 mm-40 -125.02 52.3 1.59 Allowed 'General case' 0 CA--C 1.563 1.449 0 C-N-CA 124.253 1.021 . . . . 0.0 111.252 -173.438 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.968 0 CA-C-O 123.057 1.408 . . . . 0.0 109.989 -163.688 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 79.0 t . . . . . 0 CA--C 1.559 1.3 0 N-CA-C 106.605 -1.628 . . . . 0.0 106.605 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -145.45 -53.36 0.28 Allowed 'General case' 0 N--CA 1.494 1.749 0 C-N-CA 123.9 0.88 . . . . 0.0 111.242 -175.373 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -57.8 -27.43 63.11 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 117.066 2.247 . . . . 0.0 117.066 161.571 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -63.8 -20.52 65.85 Favored 'General case' 0 CA--C 1.568 1.659 0 N-CA-C 117.209 2.3 . . . . 0.0 117.209 165.189 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 64.7 mt -82.45 120.16 25.11 Favored 'General case' 0 N--CA 1.487 1.425 0 CA-C-N 121.034 1.743 . . . . 0.0 111.361 -169.239 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 155.99 173.25 24.36 Favored Glycine 0 CA--C 1.543 1.83 0 CA-C-O 122.542 1.079 . . . . 0.0 113.013 -171.734 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 76.9 m -85.73 140.75 30.24 Favored 'General case' 0 N--CA 1.492 1.673 0 CA-C-N 114.548 -0.826 . . . . 0.0 109.475 168.21 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 88.7 m95 -140.68 112.86 7.82 Favored 'General case' 0 N--CA 1.485 1.319 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 -174.034 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 51.2 mtpt -99.11 147.86 24.65 Favored 'General case' 0 N--CA 1.494 1.74 0 CA-C-O 121.548 0.689 . . . . 0.0 110.702 177.069 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 61.8 tp -69.87 131.67 44.82 Favored 'General case' 0 N--CA 1.488 1.475 0 CA-C-O 121.847 0.832 . . . . 0.0 112.856 -175.586 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . 0.271 0.9 OUTLIER -116.7 -39.27 2.4 Favored 'Isoleucine or valine' 0 CA--C 1.576 1.971 0 CA-C-N 114.335 -1.302 . . . . 0.0 112.434 -176.87 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -136.22 132.63 36.13 Favored 'General case' 0 N--CA 1.491 1.618 0 CA-C-N 120.513 1.506 . . . . 0.0 109.474 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 83.5 p -128.52 90.41 3.06 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-O 121.5 0.667 . . . . 0.0 111.031 176.509 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -100.56 124.25 45.88 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 123.569 0.748 . . . . 0.0 109.26 177.827 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.267 57.2 m-20 71.33 16.13 6.17 Favored 'General case' 0 N--CA 1.506 2.367 0 N-CA-C 117.677 2.473 . . . . 0.0 117.677 177.788 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 20.4 t80 -70.41 -40.08 74.06 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 115.77 1.767 . . . . 0.0 115.77 -176.371 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -63.86 -29.5 70.68 Favored 'General case' 0 N--CA 1.499 1.995 0 N-CA-C 116.053 1.872 . . . . 0.0 116.053 170.55 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 27.8 t0 -64.45 -49.21 72.37 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 114.527 1.306 . . . . 0.0 114.527 165.329 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 90.9 t80 -52.45 -52.85 51.96 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 115.311 1.597 . . . . 0.0 115.311 172.203 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 77.9 mtm -62.02 -41.3 97.95 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 115.295 1.591 . . . . 0.0 115.295 175.053 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.4 tmtp? -58.77 -44.75 90.73 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 115.276 1.584 . . . . 0.0 115.276 168.818 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 49.3 m -58.72 -38.24 77.91 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 116.332 1.975 . . . . 0.0 116.332 172.009 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 80.3 mt -65.79 -41.38 92.01 Favored 'General case' 0 CA--C 1.567 1.6 0 N-CA-C 116.368 1.988 . . . . 0.0 116.368 169.516 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 113.7 76.33 0.72 Allowed Glycine 0 N--CA 1.483 1.778 0 N-CA-C 111.055 -0.818 . . . . 0.0 111.055 -171.467 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 67.5 t -141.98 123.04 12.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 N-CA-C 105.512 -2.032 . . . . 0.0 105.512 -175.445 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -69.41 160.29 52.83 Favored Glycine 0 CA--C 1.548 2.119 0 N-CA-C 115.948 1.139 . . . . 0.0 115.948 179.143 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 28.7 p90 -54.57 -41.25 69.62 Favored 'General case' 0 N--CA 1.498 1.95 0 N-CA-C 118.726 2.861 . . . . 0.0 118.726 -171.091 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.59 -43.31 94.22 Favored 'General case' 0 CA--C 1.564 1.499 0 N-CA-C 115.594 1.702 . . . . 0.0 115.594 173.769 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 58.7 m -67.28 -35.11 78.81 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 114.53 1.308 . . . . 0.0 114.53 170.064 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 58.1 mtm180 -58.36 -48.48 80.45 Favored 'General case' 0 N--CA 1.493 1.718 0 CA-C-N 120.407 1.458 . . . . 0.0 114.911 168.398 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 37.2 mm-40 -68.57 -39.79 80.86 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 115.455 1.65 . . . . 0.0 115.455 177.565 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 74.6 t -60.97 -47.84 91.74 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.019 0 CA-C-N 119.656 1.117 . . . . 0.0 113.103 169.622 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -67.74 -39.19 84.27 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 117.032 2.234 . . . . 0.0 117.032 178.544 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 87.8 p -65.52 -39.11 91.43 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 116.175 1.917 . . . . 0.0 116.175 168.53 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 54.7 tpp -66.87 -40.82 87.95 Favored 'General case' 0 CA--C 1.566 1.589 0 N-CA-C 115.997 1.851 . . . . 0.0 115.997 173.636 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 5.8 t -75.37 161.93 28.83 Favored 'General case' 0 N--CA 1.493 1.682 0 CA-C-N 119.428 1.013 . . . . 0.0 112.846 179.211 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 3.5 mtmt -99.28 104.0 23.9 Favored Pre-proline 0 CA--C 1.568 1.649 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 170.706 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -77.93 90.92 1.22 Allowed 'Trans proline' 0 CA--C 1.56 1.782 0 C-N-CA 123.165 2.577 . . . . 0.0 111.155 178.414 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 52.0 m -79.49 109.24 13.67 Favored 'General case' 0 N--CA 1.488 1.43 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.258 -161.216 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 90.7 m -83.59 116.61 22.68 Favored 'General case' 0 CA--C 1.56 1.349 0 C-N-CA 123.541 0.737 . . . . 0.0 109.468 -174.336 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 73.7 mt -113.16 106.99 21.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 N-CA-C 105.805 -1.924 . . . . 0.0 105.805 179.02 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 20.6 mt -100.58 120.91 50.7 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 -177.512 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -136.35 111.82 9.25 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 -170.886 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 82.1 tttt -91.28 115.7 28.24 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 123.309 0.644 . . . . 0.0 110.789 -177.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 32.8 t30 -116.04 80.87 1.51 Allowed 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 178.821 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 62.91 59.77 8.64 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 116.209 1.244 . . . . 0.0 116.209 -173.902 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . 0.324 3.9 t70 71.25 -20.15 0.23 Allowed 'General case' 0 N--CA 1.499 2.021 0 N-CA-C 117.415 2.376 . . . . 0.0 117.415 -167.506 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 11.0 mm -82.3 102.73 8.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 CA-C-N 120.19 1.359 . . . . 0.0 107.906 -175.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 45.7 mt -89.0 104.98 17.49 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 123.146 0.578 . . . . 0.0 110.268 -174.069 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 64.1 m -92.19 95.27 9.64 Favored 'General case' 0 N--CA 1.484 1.272 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 -177.714 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 9.8 tt -99.57 101.77 13.08 Favored 'General case' 0 N--CA 1.484 1.234 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 -175.287 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -100.22 108.2 20.24 Favored 'General case' 0 N--CA 1.485 1.303 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 -175.826 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 89.2 m -94.64 99.5 11.61 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 -179.534 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 29.2 m170 -86.97 91.88 8.84 Favored 'General case' 0 N--CA 1.491 1.581 0 CA-C-O 121.578 0.704 . . . . 0.0 111.271 -172.221 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 25.2 t . . . . . 0 N--CA 1.486 1.33 0 C-N-CA 124.003 0.921 . . . . 0.0 110.783 177.447 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 8.9 p30 . . . . . 0 N--CA 1.49 1.529 0 N-CA-C 112.087 0.403 . . . . 0.0 112.087 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 82.7 p -91.81 128.83 37.8 Favored 'General case' 0 N--CA 1.493 1.715 0 C-N-CA 122.837 0.455 . . . . 0.0 110.871 -176.905 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -117.77 117.08 28.34 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 -179.782 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 37.9 pt -112.11 131.57 63.19 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 174.124 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 79.7 p -116.81 101.88 8.93 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 -179.853 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 46.6 p90 -130.85 133.11 45.64 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 114.137 1.162 . . . . 0.0 114.137 -161.167 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 30.8 mtpp -88.71 145.05 25.87 Favored 'General case' 0 CA--C 1.561 1.379 0 CA-C-N 114.883 -1.053 . . . . 0.0 109.625 161.299 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -74.79 117.7 16.92 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.831 -0.543 . . . . 0.0 111.882 -173.141 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 86.13 44.07 6.09 Favored Glycine 0 CA--C 1.549 2.157 0 N-CA-C 116.457 1.343 . . . . 0.0 116.457 -168.83 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 98.8 t -140.15 121.14 14.55 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 N-CA-C 106.332 -1.729 . . . . 0.0 106.332 179.767 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -86.09 128.73 34.93 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 123.072 0.549 . . . . 0.0 111.045 176.207 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 47.9 p90 -133.77 128.59 35.14 Favored 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 123.619 0.768 . . . . 0.0 110.475 -174.248 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -71.1 117.43 12.6 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.411 -0.806 . . . . 0.0 112.206 175.207 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 15.7 tp10 -124.38 133.63 53.36 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 123.435 0.694 . . . . 0.0 110.616 -168.349 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 61.0 m -95.24 123.4 38.72 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 172.277 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 43.1 p -85.67 172.99 10.44 Favored 'General case' 0 CA--C 1.568 1.662 0 CA-C-O 121.854 0.835 . . . . 0.0 112.758 -173.813 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -60.76 -35.24 75.9 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 117.344 2.35 . . . . 0.0 117.344 165.739 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -98.09 82.08 2.91 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 106.376 -1.713 . . . . 0.0 106.376 166.293 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -39.35 108.95 0.09 Allowed 'General case' 0 N--CA 1.497 1.881 0 N-CA-C 117.747 2.499 . . . . 0.0 117.747 -155.169 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 39.6 ttm-85 -149.04 126.59 11.64 Favored 'General case' 0 N--CA 1.487 1.389 0 CA-C-N 114.878 -1.055 . . . . 0.0 108.493 -167.727 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.44 117.87 15.71 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 170.58 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 13.6 m -135.57 125.7 42.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 -174.081 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 30.9 mmtp -82.35 103.47 11.94 Favored 'General case' 0 N--CA 1.489 1.476 0 CA-C-O 121.894 0.854 . . . . 0.0 109.472 179.116 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 44.5 t -103.56 100.16 9.99 Favored 'General case' 0 CA--C 1.554 1.119 0 CA-C-N 115.012 -0.994 . . . . 0.0 110.718 -160.677 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 6.5 tp -109.46 120.35 60.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 -178.045 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 1.6 p -139.99 123.64 18.16 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 -173.354 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 14.3 t -133.56 160.35 37.74 Favored 'General case' 0 N--CA 1.487 1.42 0 CA-C-O 122.978 1.371 . . . . 0.0 111.254 179.647 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 63.8 tp -88.64 107.86 19.15 Favored 'General case' 0 N--CA 1.487 1.424 0 CA-C-N 114.44 -1.254 . . . . 0.0 108.523 170.873 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -108.19 87.62 2.54 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 123.377 0.671 . . . . 0.0 109.351 -171.609 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 56.54 49.43 69.58 Favored Glycine 0 CA--C 1.548 2.14 0 N-CA-C 117.614 1.805 . . . . 0.0 117.614 -177.89 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 102.26 -45.85 1.32 Allowed Glycine 0 N--CA 1.488 2.136 0 N-CA-C 116.852 1.501 . . . . 0.0 116.852 -168.43 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 36.0 ttpt -90.01 130.4 36.21 Favored 'General case' 0 CA--C 1.556 1.175 0 CA-C-N 117.419 0.609 . . . . 0.0 111.704 -169.111 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 4.7 tt -84.53 103.57 13.78 Favored 'General case' 0 CA--C 1.563 1.455 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 178.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 78.8 t -109.65 111.62 36.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 -167.805 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 21.1 t-160 -113.11 125.32 54.24 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 124.416 1.086 . . . . 0.0 109.22 -177.241 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 25.8 tp -122.45 121.81 37.48 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 107.799 -1.185 . . . . 0.0 107.799 175.167 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 93.1 mt-30 -107.69 126.03 52.09 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 171.867 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 10.2 ptpp? -126.88 139.34 53.15 Favored 'General case' 0 N--CA 1.494 1.75 0 CA-C-O 121.343 0.592 . . . . 0.0 112.193 -176.686 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 26.6 p90 -157.57 110.25 2.44 Favored 'General case' 0 N--CA 1.488 1.475 0 C-N-CA 123.781 0.832 . . . . 0.0 108.953 -173.657 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 3.8 t70 54.52 50.69 15.51 Favored 'General case' 0 N--CA 1.499 1.977 0 N-CA-C 116.382 1.993 . . . . 0.0 116.382 167.346 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 86.08 -40.67 3.05 Favored Glycine 0 CA--C 1.554 2.478 0 N-CA-C 117.372 1.709 . . . . 0.0 117.372 -169.495 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 57.6 mt-30 -80.37 136.12 36.32 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 123.921 0.888 . . . . 0.0 111.138 179.727 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -145.61 130.23 17.96 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.827 -0.546 . . . . 0.0 111.442 178.892 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 7.7 t -114.23 134.57 54.83 Favored 'General case' 0 N--CA 1.494 1.74 0 C-N-CA 123.22 0.608 . . . . 0.0 111.009 175.725 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 39.3 p -103.53 129.11 50.67 Favored 'General case' 0 N--CA 1.49 1.575 0 CA-C-O 121.615 0.722 . . . . 0.0 110.885 173.222 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 5.6 mp -106.67 80.72 1.49 Allowed 'General case' 0 CA--C 1.565 1.554 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 176.333 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 67.9 t -88.8 108.21 18.68 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 N-CA-C 108.272 -1.011 . . . . 0.0 108.272 -169.322 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 80.1 mtt85 -100.93 125.66 47.52 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 123.265 0.626 . . . . 0.0 110.352 -177.6 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -143.26 133.6 24.67 Favored 'General case' 0 N--CA 1.491 1.606 0 C-N-CA 123.308 0.643 . . . . 0.0 111.157 -176.042 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -81.33 117.82 22.12 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.66 -0.65 . . . . 0.0 111.356 177.232 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 46.9 mm -120.83 104.9 15.94 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.374 0 N-CA-C 105.115 -2.18 . . . . 0.0 105.115 174.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 22.2 m-20 58.93 50.37 8.51 Favored 'General case' 0 N--CA 1.499 2.02 0 N-CA-C 115.101 1.519 . . . . 0.0 115.101 175.414 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 63.76 27.45 71.13 Favored Glycine 0 CA--C 1.555 2.566 0 N-CA-C 119.242 2.457 . . . . 0.0 119.242 -170.581 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -135.87 127.13 28.26 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-N 119.002 1.401 . . . . 0.0 108.339 -174.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 19.1 tp -78.4 111.46 14.44 Favored 'General case' 0 CA--C 1.559 1.312 0 C-N-CA 123.474 0.709 . . . . 0.0 110.374 -179.215 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 30.4 mm -98.89 100.85 11.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 -177.075 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 30.3 tp -91.5 104.48 16.98 Favored 'General case' 0 CA--C 1.559 1.305 0 C-N-CA 123.85 0.86 . . . . 0.0 109.276 177.65 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 85.5 m -97.42 114.62 26.48 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 124.083 0.953 . . . . 0.0 108.621 -177.161 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 85.2 mt -110.79 96.66 6.31 Favored 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 123.63 0.772 . . . . 0.0 109.375 -168.001 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 11.1 m -105.85 117.14 33.26 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.947 -0.471 . . . . 0.0 109.89 -171.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 53.9 t60 -156.4 122.16 4.88 Favored 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 123.157 0.583 . . . . 0.0 109.53 171.566 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 61.71 64.92 3.57 Favored Glycine 0 N--CA 1.488 2.143 0 N-CA-C 117.237 1.655 . . . . 0.0 117.237 165.605 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . 0.391 5.2 t 46.57 39.86 7.48 Favored 'General case' 0 N--CA 1.5 2.049 0 N-CA-C 117.624 2.453 . . . . 0.0 117.624 -169.041 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -153.14 88.57 1.32 Allowed 'General case' 0 N--CA 1.483 1.203 0 O-C-N 121.531 -0.731 . . . . 0.0 109.276 -176.924 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 4.5 p -92.9 119.77 41.14 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.401 0 C-N-CA 123.508 0.723 . . . . 0.0 109.582 173.771 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 42.2 t -110.31 100.76 9.58 Favored 'General case' 0 CA--C 1.551 1.014 0 CA-C-O 121.594 0.712 . . . . 0.0 110.25 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 87.6 m -90.74 106.24 18.37 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 -177.287 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 39.4 mtm180 -112.22 121.67 45.57 Favored 'General case' 0 N--CA 1.487 1.375 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.59 -169.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 89.8 m -85.02 136.61 33.51 Favored 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 123.35 0.66 . . . . 0.0 110.033 177.16 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 40.7 m-85 -129.73 126.11 37.46 Favored 'General case' 0 CA--C 1.558 1.259 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 177.308 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -92.62 152.12 19.75 Favored 'General case' 0 N--CA 1.494 1.726 0 CA-C-O 121.943 0.878 . . . . 0.0 111.82 173.23 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 71.2 tttt -83.03 121.58 27.2 Favored 'General case' 0 N--CA 1.486 1.364 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.926 -169.255 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -119.92 51.2 1.2 Allowed 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 124.283 1.033 . . . . 0.0 111.525 -174.302 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 0.829 0 CA-C-O 124.448 2.071 . . . . 0.0 109.882 -161.269 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.297 42.6 t . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 117.257 -1.354 . . . . 0.0 112.982 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -56.68 -41.3 77.07 Favored 'General case' 0 N--CA 1.499 1.995 0 N-CA-C 116.282 1.956 . . . . 0.0 116.282 178.648 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -61.38 -33.88 74.4 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 116.766 2.136 . . . . 0.0 116.766 164.697 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -70.96 -22.67 62.18 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 116.273 1.953 . . . . 0.0 116.273 169.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 82.6 mt -70.84 118.03 13.1 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-N 121.26 1.845 . . . . 0.0 111.476 -175.817 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 154.53 172.3 22.24 Favored Glycine 0 CA--C 1.54 1.632 0 CA-C-O 122.661 1.145 . . . . 0.0 112.941 -176.736 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 45.9 m -87.59 142.54 27.77 Favored 'General case' 0 N--CA 1.489 1.504 0 CA-C-N 114.555 -0.822 . . . . 0.0 109.095 172.624 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 92.1 m95 -136.43 110.73 8.43 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 -173.761 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 39.8 mttp -94.31 142.85 26.94 Favored 'General case' 0 N--CA 1.489 1.478 0 CA-C-O 121.612 0.72 . . . . 0.0 110.73 174.318 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 14.2 tp -70.1 123.55 21.89 Favored 'General case' 0 N--CA 1.487 1.393 0 CA-C-O 122.218 1.008 . . . . 0.0 111.806 -176.859 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . 0.286 1.1 t -96.02 -47.98 12.79 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.741 0 CA-C-N 113.711 -1.586 . . . . 0.0 111.661 175.875 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -142.38 145.38 33.8 Favored 'General case' 0 N--CA 1.49 1.536 0 CA-C-N 119.859 1.209 . . . . 0.0 110.099 176.865 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 88.0 p -121.94 100.87 7.22 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.75 -0.594 . . . . 0.0 110.075 170.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -89.23 119.56 29.82 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 36.7 m-20 67.47 30.83 6.62 Favored 'General case' 0 N--CA 1.5 2.046 0 N-CA-C 116.515 2.042 . . . . 0.0 116.515 178.163 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.431 ' HB2' ' SG ' ' A' ' 124' ' ' CYS . 31.1 t80 -90.4 69.56 6.95 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 120.236 -1.54 . . . . 0.0 111.955 -179.859 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -159.72 -52.32 0.06 Allowed 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 125.434 1.494 . . . . 0.0 108.689 179.106 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 22.0 t0 -53.81 -41.27 67.14 Favored 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 116.034 1.864 . . . . 0.0 116.034 164.771 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 81.6 t80 -55.03 -53.17 59.22 Favored 'General case' 0 CA--C 1.571 1.754 0 N-CA-C 114.536 1.31 . . . . 0.0 114.536 169.769 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 73.8 mtm -62.83 -38.53 91.14 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 115.879 1.807 . . . . 0.0 115.879 171.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 57.1 mtpt -58.23 -51.2 70.76 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 115.596 1.702 . . . . 0.0 115.596 168.539 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 21.3 t -62.95 -34.58 77.79 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 116.221 1.934 . . . . 0.0 116.221 174.44 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 68.1 mt -66.41 -39.95 89.29 Favored 'General case' 0 CA--C 1.565 1.545 0 N-CA-C 116.084 1.883 . . . . 0.0 116.084 168.364 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 105.46 78.47 1.2 Allowed Glycine 0 CA--C 1.54 1.649 0 CA-C-N 118.807 0.73 . . . . 0.0 111.474 -172.184 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 58.1 t -138.02 123.27 24.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 N-CA-C 105.752 -1.944 . . . . 0.0 105.752 -179.5 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -82.4 -157.93 22.58 Favored Glycine 0 CA--C 1.547 2.087 0 N-CA-C 115.965 1.146 . . . . 0.0 115.965 -177.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 8.6 p90 -69.39 156.61 38.54 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 113.319 0.859 . . . . 0.0 113.319 178.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . 0.317 . . 76.6 -50.1 0.57 Allowed 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 115.647 1.721 . . . . 0.0 115.647 179.616 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 30.4 m -70.98 -36.11 72.37 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 113.903 1.075 . . . . 0.0 113.903 170.322 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 27.8 mtm180 -57.18 -46.88 82.43 Favored 'General case' 0 N--CA 1.499 1.987 0 CA-C-N 120.819 1.645 . . . . 0.0 114.472 162.409 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 3.4 tm0? -66.3 -49.77 65.91 Favored 'General case' 0 CA--C 1.562 1.434 0 N-CA-C 114.756 1.391 . . . . 0.0 114.756 -178.864 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 95.6 t -65.69 -40.12 86.93 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 CA-C-N 119.42 1.009 . . . . 0.0 113.426 175.146 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -66.26 -39.91 89.79 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 116.383 1.994 . . . . 0.0 116.383 176.368 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 92.8 p -63.78 -40.72 97.34 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 116.144 1.905 . . . . 0.0 116.144 165.794 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 17.9 ttm -60.71 -47.16 87.52 Favored 'General case' 0 CA--C 1.568 1.653 0 N-CA-C 115.861 1.8 . . . . 0.0 115.861 171.752 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 5.4 t -78.79 158.26 28.25 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 113.511 0.93 . . . . 0.0 113.511 -166.302 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 14.1 mptt -102.34 101.69 21.01 Favored Pre-proline 0 CA--C 1.57 1.728 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 175.091 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -77.76 100.39 1.38 Allowed 'Trans proline' 0 CA--C 1.561 1.848 0 C-N-CA 123.027 2.485 . . . . 0.0 111.562 -177.198 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 80.9 m -83.55 102.72 12.34 Favored 'General case' 0 N--CA 1.489 1.486 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.808 -164.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 32.3 m -97.31 112.75 24.43 Favored 'General case' 0 N--CA 1.485 1.279 0 CA-C-O 120.63 0.252 . . . . 0.0 111.243 -167.898 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 5.2 mp -91.07 107.16 18.34 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.454 0 N-CA-C 107.103 -1.443 . . . . 0.0 107.103 170.774 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.413 HD11 HH11 ' A' ' 106' ' ' ARG . 44.9 mt -90.75 123.3 42.85 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 N-CA-C 106.762 -1.57 . . . . 0.0 106.762 167.372 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 15.0 tt0 -134.05 179.54 6.19 Favored 'General case' 0 CA--C 1.567 1.597 0 CA-C-O 121.817 0.817 . . . . 0.0 109.659 -175.233 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.49 157.77 45.83 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-O 122.515 1.15 . . . . 0.0 112.7 -178.865 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 33.2 t30 -150.62 82.59 1.35 Allowed 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 106.257 -1.757 . . . . 0.0 106.257 167.739 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 76.23 -107.96 2.46 Favored Glycine 0 CA--C 1.547 2.072 0 N-CA-C 111.944 -0.462 . . . . 0.0 111.944 -165.15 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -122.68 61.15 1.0 Allowed 'General case' 0 N--CA 1.493 1.696 0 CA-C-O 121.133 0.492 . . . . 0.0 109.9 159.279 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 39.4 mm -124.84 94.86 2.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 N-CA-C 103.368 -2.827 . . . . 0.0 103.368 172.04 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 36.1 mt -89.81 105.5 17.84 Favored 'General case' 0 N--CA 1.483 1.196 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.683 -165.508 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 85.5 m -97.32 100.6 12.05 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 -165.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 9.2 tt -101.9 100.86 11.21 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 107.802 -1.185 . . . . 0.0 107.802 -177.406 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -100.01 106.3 18.06 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 179.856 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 96.3 m -93.38 102.81 15.06 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 -179.616 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 31.4 m-70 -89.98 85.13 6.26 Favored 'General case' 0 N--CA 1.493 1.709 0 CA-C-O 122.132 0.968 . . . . 0.0 110.98 -174.408 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 24.7 t . . . . . 0 N--CA 1.485 1.319 0 CA-C-N 115.165 -0.925 . . . . 0.0 111.078 173.405 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 7.3 p30 . . . . . 0 N--CA 1.491 1.605 0 N-CA-C 111.985 0.365 . . . . 0.0 111.985 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 76.3 p -91.39 128.04 37.06 Favored 'General case' 0 N--CA 1.493 1.683 0 C-N-CA 122.809 0.444 . . . . 0.0 111.433 -173.516 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -111.23 115.92 30.17 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 179.303 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 35.4 pt -114.72 130.42 69.16 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 171.475 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 71.2 p -117.95 116.39 26.82 Favored 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 123.751 0.82 . . . . 0.0 108.983 -179.499 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 51.1 p90 -140.26 140.4 35.74 Favored 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 115.115 1.524 . . . . 0.0 115.115 -160.109 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 52.8 mtmt -102.81 14.3 32.28 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 117.29 2.33 . . . . 0.0 117.29 -172.69 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . 0.291 3.2 mp 61.74 98.81 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.731 0 CA-C-N 120.692 1.587 . . . . 0.0 114.484 177.173 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 86.22 37.27 9.16 Favored Glycine 0 CA--C 1.553 2.419 0 N-CA-C 116.859 1.504 . . . . 0.0 116.859 -167.441 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 88.0 t -139.21 124.67 21.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 -178.569 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -88.76 123.66 33.39 Favored 'General case' 0 CA--C 1.562 1.406 0 C-N-CA 123.55 0.74 . . . . 0.0 110.526 173.846 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 40.1 p90 -130.35 124.49 32.37 Favored 'General case' 0 N--CA 1.494 1.754 0 C-N-CA 123.605 0.762 . . . . 0.0 110.42 -175.152 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -71.07 117.41 12.54 Favored 'General case' 0 CA--C 1.564 1.512 0 O-C-N 121.599 -0.688 . . . . 0.0 112.505 177.209 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 12.2 tp10 -126.99 133.91 50.47 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 123.742 0.817 . . . . 0.0 110.091 -167.882 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 45.3 m -91.23 122.83 34.2 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 176.239 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 33.9 p -83.56 167.22 17.56 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 113.019 0.748 . . . . 0.0 113.019 -174.504 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -53.82 -28.01 32.89 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 118.646 2.832 . . . . 0.0 118.646 168.541 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -74.6 -91.14 0.02 OUTLIER 'General case' 0 CA--C 1.57 1.733 0 CA-C-N 119.734 1.152 . . . . 0.0 109.076 168.269 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -176.17 90.16 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 105.143 -2.169 . . . . 0.0 105.143 158.55 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 45.8 mtt-85 -142.19 123.07 14.4 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 122.257 -0.277 . . . . 0.0 110.371 -171.711 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.586 ' H ' ' HD3' ' A' ' 79' ' ' LYS . 0.0 OUTLIER -80.47 93.77 6.09 Favored 'General case' 0 CA--C 1.564 1.511 0 C-N-CA 124.094 0.958 . . . . 0.0 110.679 172.413 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 13.4 m -112.03 130.54 65.51 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 C-N-CA 122.998 0.519 . . . . 0.0 110.676 -167.559 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 1.5 mptm? -84.34 98.53 10.08 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 123.808 0.843 . . . . 0.0 109.339 -179.332 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 72.2 m -94.2 98.25 10.82 Favored 'General case' 0 N--CA 1.483 1.191 0 CA-C-N 115.133 -0.939 . . . . 0.0 110.933 -166.139 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 6.4 tp -107.77 115.44 48.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 -179.295 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.0 p -133.15 131.66 58.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 C-N-CA 124.03 0.932 . . . . 0.0 109.673 -172.639 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 15.1 t -143.68 159.9 41.65 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-O 122.495 1.14 . . . . 0.0 110.577 177.213 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 18.2 tp -93.9 107.13 19.06 Favored 'General case' 0 N--CA 1.489 1.506 0 CA-C-N 115.162 -0.926 . . . . 0.0 108.633 172.129 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -102.88 84.58 2.4 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 123.382 0.673 . . . . 0.0 109.662 -171.84 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 56.5 48.35 76.96 Favored Glycine 0 CA--C 1.548 2.141 0 N-CA-C 117.608 1.803 . . . . 0.0 117.608 -176.088 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 100.38 -47.6 1.25 Allowed Glycine 0 N--CA 1.489 2.172 0 N-CA-C 116.215 1.246 . . . . 0.0 116.215 -166.657 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 30.9 ttpt -84.62 116.33 23.12 Favored 'General case' 0 CA--C 1.556 1.2 0 CA-C-N 117.915 0.858 . . . . 0.0 111.131 -170.075 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 3.0 tt -88.05 101.77 14.11 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-O 121.686 0.755 . . . . 0.0 109.659 -173.005 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 54.3 t -104.66 107.4 22.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 -168.418 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 19.9 t-160 -99.35 140.1 34.02 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 123.943 0.897 . . . . 0.0 109.655 169.679 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 15.6 tp -138.9 124.91 19.96 Favored 'General case' 0 N--CA 1.488 1.44 0 CA-C-O 122.03 0.919 . . . . 0.0 108.803 175.557 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -107.92 126.62 52.9 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 124.603 1.161 . . . . 0.0 108.378 178.537 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -125.45 133.2 52.53 Favored 'General case' 0 N--CA 1.496 1.847 0 C-N-CA 122.986 0.514 . . . . 0.0 110.571 -173.734 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 22.9 p90 -158.18 114.57 2.8 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.125 -0.985 . . . . 0.0 110.5 -176.034 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 11.1 t70 50.21 58.07 5.89 Favored 'General case' 0 N--CA 1.503 2.176 0 N-CA-C 116.704 2.112 . . . . 0.0 116.704 163.508 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 80.89 -25.22 3.56 Favored Glycine 0 CA--C 1.559 2.79 0 N-CA-C 119.212 2.445 . . . . 0.0 119.212 -171.327 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 66.7 mt-30 -102.01 133.79 46.26 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 124.785 1.234 . . . . 0.0 110.464 -179.044 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -141.38 135.78 30.77 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.341 -0.849 . . . . 0.0 112.416 173.165 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 14.9 t -117.13 129.21 55.82 Favored 'General case' 0 N--CA 1.496 1.857 0 C-N-CA 123.302 0.641 . . . . 0.0 111.506 177.635 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 40.3 p -94.7 120.43 34.91 Favored 'General case' 0 N--CA 1.493 1.715 0 C-N-CA 123.306 0.642 . . . . 0.0 110.028 172.346 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 5.2 mp -103.56 90.86 3.8 Favored 'General case' 0 CA--C 1.562 1.428 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 174.729 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 92.9 t -94.99 102.66 13.84 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 N-CA-C 107.567 -1.272 . . . . 0.0 107.567 -174.294 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.413 HH11 HD11 ' A' ' 42' ' ' ILE . 45.8 mtt180 -91.5 128.08 37.19 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 122.966 0.506 . . . . 0.0 109.652 172.45 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -147.81 129.56 15.16 Favored 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 123.197 0.599 . . . . 0.0 110.429 -172.035 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -77.11 121.14 23.17 Favored 'General case' 0 N--CA 1.487 1.404 0 CA-C-O 121.865 0.841 . . . . 0.0 112.736 178.647 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . 0.279 1.5 mp -76.41 171.89 1.22 Allowed 'Isoleucine or valine' 0 CA--C 1.575 1.938 0 CA-C-N 114.94 -1.027 . . . . 0.0 109.231 143.12 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -68.62 73.72 0.25 Allowed 'General case' 0 CA--C 1.565 1.543 0 N-CA-C 114.866 1.432 . . . . 0.0 114.866 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 121.22 -56.95 0.61 Allowed Glycine 0 N--CA 1.485 1.911 0 CA-C-N 114.093 -1.412 . . . . 0.0 113.781 -171.003 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 51.1 mttp -91.12 139.72 30.49 Favored 'General case' 0 N--CA 1.487 1.376 0 CA-C-O 121.713 0.768 . . . . 0.0 112.172 -173.307 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 25.1 tp -92.9 135.93 33.7 Favored 'General case' 0 CA--C 1.557 1.247 0 C-N-CA 123.605 0.762 . . . . 0.0 110.741 173.783 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 44.5 mm -114.18 108.68 26.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 -178.156 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 48.8 tp -93.58 106.21 18.2 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 123.813 0.845 . . . . 0.0 109.195 173.108 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 83.7 m -97.74 112.56 24.4 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 -179.669 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 92.9 mt -106.88 98.48 8.14 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 123.698 0.799 . . . . 0.0 109.483 -173.09 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 7.5 m -109.88 115.65 30.2 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 -175.526 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 86.1 t60 -134.21 116.19 15.05 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 108.507 -0.924 . . . . 0.0 108.507 173.147 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 75.2 -111.14 3.26 Favored Glycine 0 N--CA 1.484 1.845 0 C-N-CA 122.928 0.299 . . . . 0.0 113.011 176.167 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 73.4 p -122.37 68.55 0.95 Allowed 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 108.987 -0.745 . . . . 0.0 108.987 163.763 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -160.37 93.96 1.06 Allowed 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 123.368 0.667 . . . . 0.0 109.533 178.674 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 4.9 p -96.51 121.75 47.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 C-N-CA 123.797 0.839 . . . . 0.0 109.801 175.713 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' CYS . . . . . 0.431 ' SG ' ' HB2' ' A' ' 16' ' ' PHE . 43.8 t -116.91 105.46 12.37 Favored 'General case' 0 CA--C 1.555 1.149 0 C-N-CA 123.334 0.654 . . . . 0.0 110.544 -179.466 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 91.7 m -92.54 105.34 17.53 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 123.648 0.779 . . . . 0.0 109.073 -175.252 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 53.6 mtp180 -105.64 116.99 32.88 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 123.144 0.578 . . . . 0.0 109.596 -172.53 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 41.7 m -86.73 141.37 28.94 Favored 'General case' 0 N--CA 1.493 1.701 0 C-N-CA 123.717 0.807 . . . . 0.0 110.511 178.765 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 40.6 m-85 -137.84 135.13 35.92 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 124.094 0.958 . . . . 0.0 109.497 -175.07 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -102.14 155.18 18.37 Favored 'General case' 0 N--CA 1.495 1.778 0 CA-C-O 122.421 1.105 . . . . 0.0 111.712 166.057 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 71.0 tttt -88.33 124.28 33.74 Favored 'General case' 0 N--CA 1.483 1.209 0 CA-C-N 115.199 -0.91 . . . . 0.0 111.816 -168.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -99.17 49.48 0.95 Allowed 'General case' 0 CA--C 1.57 1.738 0 C-N-CA 123.58 0.752 . . . . 0.0 112.354 170.541 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.129 0 CA-C-O 123.2 1.476 . . . . 0.0 108.252 -176.287 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 4.6 p . . . . . 0 CA--C 1.576 1.972 0 N-CA-C 116.227 1.936 . . . . 0.0 116.227 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -66.19 -35.43 80.44 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 116.669 2.1 . . . . 0.0 116.669 -176.045 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -61.0 -27.08 68.05 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 117.514 2.413 . . . . 0.0 117.514 168.128 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -72.18 -20.2 61.62 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 116.037 1.865 . . . . 0.0 116.037 168.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 55.0 mt -78.29 119.65 21.95 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-N 121.034 1.743 . . . . 0.0 111.69 -171.745 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 163.87 175.9 35.22 Favored Glycine 0 N--CA 1.481 1.666 0 CA-C-O 122.251 0.917 . . . . 0.0 113.239 -177.766 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 63.1 m -92.3 137.28 32.49 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 167.847 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 87.3 m95 -138.6 112.58 8.51 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 -170.142 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 52.4 mtmt -99.94 144.37 29.08 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 123.103 0.561 . . . . 0.0 110.228 178.93 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 25.0 tp -67.72 131.66 46.0 Favored 'General case' 0 N--CA 1.488 1.427 0 CA-C-O 122.371 1.082 . . . . 0.0 112.419 -177.609 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . 0.285 1.0 OUTLIER -111.81 -47.81 6.03 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.797 0 CA-C-N 113.669 -1.605 . . . . 0.0 110.875 179.054 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -137.07 140.12 41.79 Favored 'General case' 0 N--CA 1.487 1.412 0 CA-C-N 119.566 1.075 . . . . 0.0 109.505 175.539 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 78.8 p -132.94 114.48 14.06 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 168.444 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -77.22 -72.41 0.35 Allowed 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 112.532 0.567 . . . . 0.0 112.532 -172.614 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 62.6 m-80 -105.41 47.12 0.89 Allowed 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 113.291 0.848 . . . . 0.0 113.291 -178.854 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 11.9 t80 -92.74 74.18 4.96 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.795 -1.191 . . . . 0.0 110.352 177.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 179.76 -59.82 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 126.082 1.753 . . . . 0.0 106.648 -168.793 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 22.8 t0 -58.42 -46.65 86.06 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 115.01 1.485 . . . . 0.0 115.01 163.85 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 90.0 t80 -51.9 -55.07 22.43 Favored 'General case' 0 CA--C 1.57 1.735 0 N-CA-C 114.896 1.443 . . . . 0.0 114.896 170.315 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 72.9 mtm -62.84 -39.21 93.65 Favored 'General case' 0 CA--C 1.567 1.626 0 N-CA-C 115.947 1.832 . . . . 0.0 115.947 174.816 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 28.9 ttpp -58.63 -46.56 86.82 Favored 'General case' 0 CA--C 1.569 1.686 0 N-CA-C 115.115 1.524 . . . . 0.0 115.115 168.685 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 16.7 t -62.01 -34.83 76.92 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 116.59 2.07 . . . . 0.0 116.59 172.57 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 86.2 mt -65.31 -44.25 88.49 Favored 'General case' 0 CA--C 1.567 1.616 0 N-CA-C 115.64 1.718 . . . . 0.0 115.64 167.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 113.95 70.35 0.52 Allowed Glycine 0 N--CA 1.483 1.808 0 C-N-CA 123.966 0.793 . . . . 0.0 111.889 -172.058 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 66.8 t -127.67 122.27 58.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 N-CA-C 105.586 -2.005 . . . . 0.0 105.586 -176.785 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -63.25 153.92 45.28 Favored Glycine 0 CA--C 1.549 2.211 0 N-CA-C 115.801 1.08 . . . . 0.0 115.801 177.81 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 31.5 p90 -55.2 -42.78 73.73 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 118.663 2.838 . . . . 0.0 118.663 -167.191 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.85 -43.28 93.55 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 115.75 1.759 . . . . 0.0 115.75 175.307 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 63.2 m -69.38 -37.83 77.73 Favored 'General case' 0 N--CA 1.497 1.924 0 N-CA-C 114.185 1.18 . . . . 0.0 114.185 170.689 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 45.5 ttp85 -59.46 -45.37 91.8 Favored 'General case' 0 CA--C 1.57 1.728 0 N-CA-C 115.151 1.537 . . . . 0.0 115.151 171.528 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 46.4 mt-30 -72.71 -39.89 66.6 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 115.104 1.52 . . . . 0.0 115.104 176.077 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 69.4 t -63.68 -48.18 87.84 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 CA-C-N 119.943 1.247 . . . . 0.0 112.443 170.446 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -61.89 -31.17 71.44 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 117.595 2.442 . . . . 0.0 117.595 177.435 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 84.0 p -62.91 -47.04 84.98 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 115.96 1.837 . . . . 0.0 115.96 169.484 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 51.9 tpp -70.76 -34.49 71.89 Favored 'General case' 0 CA--C 1.572 1.824 0 N-CA-C 116.13 1.9 . . . . 0.0 116.13 170.731 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 46.4 m -66.48 144.06 56.71 Favored 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 124.825 1.25 . . . . 0.0 112.538 -179.22 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -108.08 99.89 33.59 Favored Pre-proline 0 CA--C 1.571 1.753 0 CA-C-O 118.38 -0.819 . . . . 0.0 110.028 -177.366 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -75.48 141.68 25.59 Favored 'Trans proline' 0 CA--C 1.561 1.839 0 C-N-CA 123.206 2.604 . . . . 0.0 114.077 -179.689 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 100.0 m -107.47 100.74 10.14 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 -174.135 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 44.2 m -90.72 111.33 22.64 Favored 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 123.666 0.786 . . . . 0.0 109.448 -175.133 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 47.5 mt -102.82 108.09 23.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 N-CA-C 106.629 -1.619 . . . . 0.0 106.629 -178.768 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 33.7 mt -101.91 115.12 43.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 N-CA-C 106.744 -1.576 . . . . 0.0 106.744 -178.641 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -139.39 112.13 7.85 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 -171.385 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 28.1 ttpp -84.4 112.0 19.95 Favored 'General case' 0 CA--C 1.561 1.37 0 CA-C-O 121.43 0.633 . . . . 0.0 110.212 174.911 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 19.6 t-20 -100.57 92.49 5.15 Favored 'General case' 0 N--CA 1.485 1.32 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 -175.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 77.03 -99.64 1.42 Allowed Glycine 0 N--CA 1.485 1.939 0 N-CA-C 111.197 -0.761 . . . . 0.0 111.197 -166.094 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 25.1 m-20 -133.43 63.52 1.63 Allowed 'General case' 0 N--CA 1.494 1.748 0 CA-C-O 121.073 0.463 . . . . 0.0 109.844 160.17 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 27.2 mm -139.47 104.63 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 N-CA-C 104.994 -2.224 . . . . 0.0 104.994 177.348 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 35.9 mt -74.94 110.58 9.35 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 122.873 0.469 . . . . 0.0 111.527 177.703 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 38.3 m -105.41 101.84 11.35 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 106.266 -1.754 . . . . 0.0 106.266 -179.65 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 9.4 tt -104.65 108.64 20.2 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 -174.241 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 43.7 mttp -109.5 96.81 6.53 Favored 'General case' 0 N--CA 1.483 1.175 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 -165.647 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 60.0 m -87.95 92.7 9.23 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 -177.377 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 70.2 m80 -83.54 91.65 7.46 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 123.824 0.85 . . . . 0.0 110.191 -176.271 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 82.5 p . . . . . 0 N--CA 1.489 1.518 0 N-CA-C 118.427 2.751 . . . . 0.0 118.427 -167.237 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 8.7 p30 . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 111.914 0.339 . . . . 0.0 111.914 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 45.6 p -97.98 130.89 44.81 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-O 121.212 0.53 . . . . 0.0 110.949 -173.471 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 5.4 mp0 -115.65 129.76 56.61 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 123.382 0.673 . . . . 0.0 109.84 179.76 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 49.3 pt -112.79 126.05 70.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 N-CA-C 108.091 -1.078 . . . . 0.0 108.091 168.638 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 39.0 t -109.54 109.68 20.54 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 107.208 -1.405 . . . . 0.0 107.208 175.704 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 42.9 p90 -140.34 141.8 35.64 Favored 'General case' 0 N--CA 1.489 1.501 0 CA-C-O 122.25 1.024 . . . . 0.0 113.737 -164.447 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 55.1 mtmt -100.87 150.96 22.29 Favored 'General case' 0 CA--C 1.562 1.437 0 CA-C-N 114.478 -1.237 . . . . 0.0 109.061 159.729 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -74.46 115.48 14.05 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.564 -0.71 . . . . 0.0 111.894 -171.426 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 89.31 44.59 4.95 Favored Glycine 0 CA--C 1.549 2.186 0 N-CA-C 116.582 1.393 . . . . 0.0 116.582 -166.688 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 92.3 t -136.0 123.66 35.17 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 178.345 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -87.73 132.67 34.05 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 123.464 0.705 . . . . 0.0 110.791 170.668 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 44.9 p90 -145.55 134.42 22.45 Favored 'General case' 0 N--CA 1.494 1.739 0 C-N-CA 123.318 0.647 . . . . 0.0 110.556 -174.399 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -73.04 117.88 15.31 Favored 'General case' 0 CA--C 1.564 1.481 0 O-C-N 121.558 -0.713 . . . . 0.0 112.644 178.207 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 15.1 tp10 -128.97 134.15 48.08 Favored 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 123.626 0.77 . . . . 0.0 110.088 -170.681 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 51.9 m -92.7 121.91 34.58 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 174.097 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 27.1 p -84.31 174.5 10.1 Favored 'General case' 0 N--CA 1.494 1.726 0 CA-C-O 121.663 0.744 . . . . 0.0 112.869 -175.013 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -60.07 -34.68 73.77 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 116.815 2.154 . . . . 0.0 116.815 171.258 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -89.02 31.66 0.86 Allowed 'General case' 0 CA--C 1.58 2.1 0 N-CA-C 114.601 1.334 . . . . 0.0 114.601 167.394 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 22.5 m-20 53.34 67.82 0.94 Allowed 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 115.057 1.503 . . . . 0.0 115.057 174.768 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 46.1 mtm105 -137.64 120.98 16.98 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 109.036 -0.728 . . . . 0.0 109.036 -175.74 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.06 108.99 8.17 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 123.379 0.671 . . . . 0.0 111.305 169.444 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 17.7 m -125.39 142.15 43.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 CA-C-O 121.335 0.588 . . . . 0.0 110.302 -168.912 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 4.7 mptp? -85.62 98.01 10.42 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 123.629 0.772 . . . . 0.0 109.122 176.575 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 58.0 m -91.38 93.37 9.0 Favored 'General case' 0 N--CA 1.485 1.283 0 CA-C-N 115.262 -0.881 . . . . 0.0 111.12 -170.549 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 6.8 tp -104.71 116.73 49.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 178.322 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 1.5 p -136.52 122.56 29.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 C-N-CA 123.343 0.657 . . . . 0.0 109.55 -169.856 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 14.9 t -136.88 157.5 46.61 Favored 'General case' 0 N--CA 1.491 1.592 0 CA-C-O 122.629 1.204 . . . . 0.0 111.351 178.384 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 15.2 tp -95.37 119.78 34.47 Favored 'General case' 0 N--CA 1.489 1.514 0 CA-C-N 114.768 -1.106 . . . . 0.0 110.067 177.832 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -106.52 81.23 1.57 Allowed 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 123.205 0.602 . . . . 0.0 110.604 -178.204 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 61.06 46.52 94.38 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 117.673 1.829 . . . . 0.0 117.673 -177.096 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 75.03 35.96 48.03 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 118.206 2.043 . . . . 0.0 118.206 -168.341 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -145.93 104.36 3.84 Favored 'General case' 0 CA--C 1.553 1.077 0 N-CA-C 105.369 -2.086 . . . . 0.0 105.369 -177.774 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -86.33 121.42 28.88 Favored 'General case' 0 N--CA 1.481 1.12 0 CA-C-O 121.903 0.858 . . . . 0.0 110.989 -170.853 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 61.2 t -122.98 107.42 19.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 N-CA-C 106.103 -1.814 . . . . 0.0 106.103 -166.138 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 20.6 t-160 -110.75 113.34 25.85 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 123.777 0.831 . . . . 0.0 109.78 179.514 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 31.5 tp -107.74 123.25 48.26 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 123.775 0.83 . . . . 0.0 108.857 177.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -110.86 120.8 43.58 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 178.186 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -117.39 137.63 52.35 Favored 'General case' 0 N--CA 1.495 1.796 0 CA-C-N 118.675 0.67 . . . . 0.0 111.134 -178.401 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 22.7 p90 -155.82 109.08 2.72 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.419 -0.8 . . . . 0.0 109.892 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 5.5 t70 55.96 50.16 14.41 Favored 'General case' 0 N--CA 1.499 2.015 0 N-CA-C 116.237 1.94 . . . . 0.0 116.237 168.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 86.99 -43.82 3.26 Favored Glycine 0 CA--C 1.552 2.396 0 N-CA-C 116.706 1.443 . . . . 0.0 116.706 -168.85 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 64.4 mt-30 -73.68 132.23 42.48 Favored 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 123.874 0.87 . . . . 0.0 111.571 179.372 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -141.77 135.02 29.3 Favored 'General case' 0 N--CA 1.49 1.542 0 CA-C-O 121.202 0.525 . . . . 0.0 112.237 176.553 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 13.7 t -118.07 133.26 56.08 Favored 'General case' 0 N--CA 1.495 1.79 0 CA-C-N 115.597 -0.728 . . . . 0.0 111.087 176.818 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 37.4 p -101.84 135.25 43.72 Favored 'General case' 0 N--CA 1.494 1.736 0 CA-C-O 122.057 0.932 . . . . 0.0 110.713 171.047 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 5.4 mp -118.26 85.52 2.37 Favored 'General case' 0 CA--C 1.562 1.415 0 N-CA-C 106.535 -1.654 . . . . 0.0 106.535 -178.575 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 99.5 t -95.02 103.66 14.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 -168.866 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 83.7 mtt85 -94.58 129.29 41.47 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 123.794 0.838 . . . . 0.0 110.181 179.416 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -146.91 132.23 18.51 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 122.849 0.459 . . . . 0.0 110.837 -176.741 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -80.6 114.73 19.7 Favored 'General case' 0 N--CA 1.486 1.337 0 CA-C-O 121.328 0.585 . . . . 0.0 111.315 179.506 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 48.3 mm -118.56 105.06 17.01 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.361 0 N-CA-C 105.075 -2.194 . . . . 0.0 105.075 175.362 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 58.68 50.4 8.95 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 115.204 1.557 . . . . 0.0 115.204 175.854 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 65.6 25.56 71.61 Favored Glycine 0 CA--C 1.555 2.583 0 N-CA-C 119.351 2.501 . . . . 0.0 119.351 -171.072 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 92.6 mttt -133.78 128.45 34.82 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-N 119.203 1.501 . . . . 0.0 108.678 -173.663 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 15.0 tp -78.53 109.71 12.96 Favored 'General case' 0 CA--C 1.558 1.288 0 C-N-CA 123.272 0.629 . . . . 0.0 110.306 -179.917 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 31.8 mm -98.95 97.34 5.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 N-CA-C 107.192 -1.41 . . . . 0.0 107.192 -175.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 24.6 tp -91.21 104.19 16.78 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 123.972 0.909 . . . . 0.0 109.996 -179.85 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 85.1 m -96.1 108.76 21.23 Favored 'General case' 0 CA--C 1.562 1.43 0 C-N-CA 124.0 0.92 . . . . 0.0 108.804 -176.277 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 92.4 mt -103.04 103.68 13.79 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 123.537 0.735 . . . . 0.0 109.956 -174.491 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 12.8 m -112.18 117.39 32.44 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 -175.402 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 73.5 t60 -152.84 117.16 4.93 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 174.496 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 60.41 61.9 6.59 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 117.418 1.727 . . . . 0.0 117.418 169.462 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . 0.291 3.2 m 52.36 50.28 18.67 Favored 'General case' 0 CA--C 1.576 1.97 0 N-CA-C 114.878 1.436 . . . . 0.0 114.878 -172.206 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -158.87 87.85 0.88 Allowed 'General case' 0 N--CA 1.485 1.291 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 -178.708 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 3.6 p -94.73 113.66 29.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 C-N-CA 123.649 0.78 . . . . 0.0 109.348 175.62 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 45.9 t -103.99 105.62 15.86 Favored 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 123.081 0.552 . . . . 0.0 110.062 176.585 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 91.8 m -90.06 103.52 16.18 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 -179.533 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 69.0 mtp180 -104.02 114.64 29.03 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 123.042 0.537 . . . . 0.0 109.893 -166.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 91.1 m -84.15 129.07 34.92 Favored 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 122.882 0.473 . . . . 0.0 109.905 176.188 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 40.7 m-85 -125.81 127.69 46.51 Favored 'General case' 0 CA--C 1.558 1.253 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 176.241 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -95.34 157.01 16.08 Favored 'General case' 0 N--CA 1.493 1.699 0 CA-C-O 122.431 1.11 . . . . 0.0 111.572 171.08 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 72.8 tttt -91.04 126.37 36.11 Favored 'General case' 0 N--CA 1.484 1.262 0 CA-C-N 115.423 -0.808 . . . . 0.0 112.51 -164.064 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -99.84 51.1 0.92 Allowed 'General case' 0 N--CA 1.497 1.92 0 CA-C-O 121.912 0.863 . . . . 0.0 111.383 167.88 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.063 0 CA-C-O 123.216 1.484 . . . . 0.0 107.638 -177.459 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.265 5.9 p . . . . . 0 CA--C 1.576 1.955 0 N-CA-C 116.376 1.991 . . . . 0.0 116.376 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -65.71 -37.84 87.53 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 116.449 2.018 . . . . 0.0 116.449 -178.61 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -59.56 -29.85 68.22 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 117.313 2.338 . . . . 0.0 117.313 167.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -69.98 -23.55 63.18 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 116.287 1.958 . . . . 0.0 116.287 168.337 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 58.5 mt -75.0 120.02 19.97 Favored 'General case' 0 N--CA 1.49 1.539 0 CA-C-N 121.028 1.74 . . . . 0.0 111.689 -173.645 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 160.29 176.39 32.33 Favored Glycine 0 CA--C 1.541 1.708 0 CA-C-O 122.447 1.026 . . . . 0.0 113.744 -176.007 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 75.2 m -93.22 135.46 34.4 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 170.495 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 94.2 m95 -138.4 115.63 11.06 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 -169.796 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 24.9 mmmt -102.17 145.65 29.08 Favored 'General case' 0 N--CA 1.492 1.628 0 CA-C-O 121.536 0.684 . . . . 0.0 111.021 178.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 43.9 tp -70.13 125.42 26.73 Favored 'General case' 0 N--CA 1.489 1.477 0 CA-C-O 122.039 0.923 . . . . 0.0 112.118 -176.852 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . 0.275 1.0 OUTLIER -107.84 -39.26 4.32 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.883 0 CA-C-N 113.997 -1.456 . . . . 0.0 112.435 -178.701 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -137.21 138.0 39.7 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-N 120.305 1.411 . . . . 0.0 109.64 176.15 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 78.3 p -121.56 103.47 8.94 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 167.624 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 8.9 tmtm? -79.92 -78.35 0.17 Allowed 'General case' 0 N--CA 1.491 1.602 0 CA-C-O 118.877 -0.582 . . . . 0.0 112.554 -167.309 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 85.0 m-20 -105.15 48.26 0.84 Allowed 'General case' 0 N--CA 1.498 1.967 0 CA-C-N 118.89 0.768 . . . . 0.0 112.795 177.684 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 10.0 t80 -92.09 75.78 5.44 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.704 -1.247 . . . . 0.0 110.973 -174.341 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -172.21 -61.27 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 124.668 1.187 . . . . 0.0 108.987 -168.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 12.3 t0 -61.66 -38.29 87.2 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 115.859 1.8 . . . . 0.0 115.859 166.924 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 87.9 t80 -48.74 -53.86 17.28 Favored 'General case' 0 CA--C 1.574 1.893 0 N-CA-C 114.755 1.391 . . . . 0.0 114.755 163.592 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 56.8 mtm -66.24 -29.98 70.34 Favored 'General case' 0 CA--C 1.571 1.768 0 N-CA-C 116.549 2.055 . . . . 0.0 116.549 171.735 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 55.8 mttp -61.18 -48.65 80.56 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 114.942 1.46 . . . . 0.0 114.942 166.459 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 23.1 t -66.26 -32.44 73.86 Favored 'General case' 0 CA--C 1.567 1.599 0 N-CA-C 116.465 2.024 . . . . 0.0 116.465 173.248 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 65.2 mt -66.27 -43.64 85.87 Favored 'General case' 0 CA--C 1.565 1.522 0 N-CA-C 116.084 1.883 . . . . 0.0 116.084 172.372 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 105.84 86.67 1.92 Allowed Glycine 0 N--CA 1.482 1.742 0 N-CA-C 110.744 -0.943 . . . . 0.0 110.744 -170.098 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 41.3 t -140.61 144.11 27.83 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 N-CA-C 107.575 -1.269 . . . . 0.0 107.575 -174.455 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -73.13 163.08 54.91 Favored Glycine 0 CA--C 1.552 2.361 0 O-C-N 120.958 -1.089 . . . . 0.0 115.137 169.045 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 25.2 p90 -62.93 -39.61 95.1 Favored 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 117.071 2.249 . . . . 0.0 117.071 -178.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.45 -45.08 94.71 Favored 'General case' 0 CA--C 1.56 1.347 0 N-CA-C 115.777 1.769 . . . . 0.0 115.777 177.799 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . 0.288 0.6 OUTLIER -81.51 -19.07 42.96 Favored 'General case' 0 N--CA 1.499 2.002 0 N-CA-C 116.177 1.917 . . . . 0.0 116.177 173.141 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 34.3 ttm105 -61.58 -46.92 87.83 Favored 'General case' 0 CA--C 1.57 1.744 0 CA-C-N 121.18 1.809 . . . . 0.0 113.646 160.756 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 22.7 tt0 -62.99 -49.42 74.78 Favored 'General case' 0 CA--C 1.563 1.473 0 N-CA-C 115.282 1.586 . . . . 0.0 115.282 171.414 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 89.1 t -63.66 -43.82 98.25 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 CA-C-O 117.273 -1.346 . . . . 0.0 112.983 174.345 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -63.07 -41.17 99.38 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 116.478 2.029 . . . . 0.0 116.478 177.754 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 97.3 p -61.15 -42.64 98.92 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 116.619 2.081 . . . . 0.0 116.619 168.254 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 48.1 ttp -66.61 -36.85 83.6 Favored 'General case' 0 CA--C 1.572 1.824 0 N-CA-C 116.421 2.008 . . . . 0.0 116.421 169.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 52.3 m -73.29 135.19 44.39 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 124.28 1.032 . . . . 0.0 111.807 -175.578 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -103.74 102.28 29.73 Favored Pre-proline 0 CA--C 1.571 1.77 0 CA-C-N 114.554 -1.203 . . . . 0.0 109.81 175.228 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -76.44 126.19 8.87 Favored 'Trans proline' 0 CA--C 1.562 1.893 0 C-N-CA 123.235 2.624 . . . . 0.0 112.861 -178.134 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 15.4 m -84.59 107.05 16.61 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 -179.828 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 47.5 m -100.93 104.3 15.49 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 -168.614 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 48.9 mt -98.68 112.15 30.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 N-CA-C 106.991 -1.485 . . . . 0.0 106.991 -179.169 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 42.7 mt -106.31 115.11 47.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 N-CA-C 106.733 -1.58 . . . . 0.0 106.733 -177.435 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -139.38 115.06 10.02 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 -173.591 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 84.7 tttt -87.49 112.64 22.42 Favored 'General case' 0 CA--C 1.556 1.211 0 C-N-CA 123.075 0.55 . . . . 0.0 110.025 173.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 20.4 t-20 -82.65 -69.78 0.6 Allowed 'General case' 0 CA--C 1.564 1.496 0 C-N-CA 123.314 0.646 . . . . 0.0 111.298 -176.359 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -149.56 89.55 0.14 Allowed Glycine 0 N--CA 1.482 1.74 0 N-CA-C 108.867 -1.693 . . . . 0.0 108.867 172.241 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . 0.295 12.6 m-20 69.54 -20.05 0.18 Allowed 'General case' 0 N--CA 1.499 1.978 0 N-CA-C 117.569 2.433 . . . . 0.0 117.569 -164.519 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 16.4 mm -101.19 111.9 32.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 -171.055 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 16.2 mt -79.97 115.18 19.4 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 123.611 0.764 . . . . 0.0 110.797 173.47 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 44.3 m -104.0 96.34 6.61 Favored 'General case' 0 CA--C 1.56 1.338 0 N-CA-C 106.557 -1.645 . . . . 0.0 106.557 -176.5 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 9.1 tt -96.85 102.92 14.79 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 -179.271 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -97.42 107.87 20.47 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 123.721 0.808 . . . . 0.0 108.87 -173.154 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 34.7 m -95.14 90.98 6.09 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 -176.167 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 20.6 m170 -84.76 101.88 12.58 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 -174.053 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 23.4 t . . . . . 0 N--CA 1.485 1.312 0 C-N-CA 123.556 0.743 . . . . 0.0 110.335 -167.313 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 9.8 p30 . . . . . 0 N--CA 1.489 1.518 0 N-CA-C 112.475 0.546 . . . . 0.0 112.475 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 75.1 p -101.08 126.66 47.79 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-O 121.405 0.622 . . . . 0.0 110.617 -174.764 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -110.01 118.25 35.92 Favored 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 177.126 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 14.3 pt -107.66 126.71 64.0 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 178.799 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 77.9 p -115.87 109.24 17.35 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 -175.662 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 48.1 p90 -141.33 138.39 33.06 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 114.682 1.364 . . . . 0.0 114.682 -161.832 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 60.7 mtpt -95.95 145.6 25.28 Favored 'General case' 0 CA--C 1.562 1.432 0 CA-C-N 115.036 -0.984 . . . . 0.0 109.148 162.086 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -73.47 116.66 14.3 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.575 -0.703 . . . . 0.0 112.208 -173.171 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 79.9 40.61 14.05 Favored Glycine 0 CA--C 1.549 2.2 0 N-CA-C 117.013 1.565 . . . . 0.0 117.013 -170.428 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 91.6 t -139.3 117.76 12.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 N-CA-C 105.34 -2.096 . . . . 0.0 105.34 -179.209 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -81.41 132.25 35.32 Favored 'General case' 0 N--CA 1.49 1.53 0 CA-C-O 121.578 0.704 . . . . 0.0 111.267 178.905 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 19.5 p90 -134.28 145.55 49.2 Favored 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 124.158 0.983 . . . . 0.0 110.313 -174.133 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -73.44 128.55 35.81 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 123.204 0.602 . . . . 0.0 112.413 178.355 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -131.41 131.81 43.89 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 123.267 0.627 . . . . 0.0 109.785 -168.35 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 90.6 m -112.82 119.32 37.6 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 107.135 -1.431 . . . . 0.0 107.135 170.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 42.7 p -80.87 175.3 10.8 Favored 'General case' 0 N--CA 1.495 1.785 0 CA-C-N 115.545 -0.752 . . . . 0.0 112.745 -174.078 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -59.49 -40.07 85.82 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 116.193 1.923 . . . . 0.0 116.193 169.864 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -74.97 -7.41 53.54 Favored 'General case' 0 CA--C 1.578 2.039 0 N-CA-C 116.256 1.947 . . . . 0.0 116.256 165.571 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . 0.256 6.1 m-20 67.48 68.18 0.38 Allowed 'General case' 0 N--CA 1.496 1.874 0 C-N-CA 125.512 1.525 . . . . 0.0 111.714 -178.103 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 31.0 ttm-85 -116.38 18.04 15.32 Favored 'General case' 0 N--CA 1.498 1.926 0 N-CA-C 116.11 1.892 . . . . 0.0 116.11 -167.745 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . 0.31 0.1 OUTLIER 39.4 71.47 0.17 Allowed 'General case' 0 N--CA 1.499 1.982 0 N-CA-C 118.14 2.644 . . . . 0.0 118.14 176.023 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 4.5 m -112.1 144.07 20.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 CA-C-O 121.386 0.613 . . . . 0.0 111.172 -166.454 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 1.2 mppt? -97.99 102.32 14.04 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 174.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 61.5 p -93.56 113.98 26.23 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.577 0.751 . . . . 0.0 111.874 -170.267 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 5.7 tp -123.0 117.38 51.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 179.004 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 1.1 p -134.11 125.97 49.08 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 C-N-CA 123.786 0.834 . . . . 0.0 109.729 -174.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 15.3 t -132.29 152.0 51.58 Favored 'General case' 0 N--CA 1.495 1.807 0 CA-C-O 122.331 1.062 . . . . 0.0 112.32 178.811 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 53.5 tp -82.75 128.79 34.71 Favored 'General case' 0 N--CA 1.491 1.59 0 CA-C-N 114.644 -1.162 . . . . 0.0 110.067 170.704 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -131.45 83.42 2.1 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 123.444 0.698 . . . . 0.0 109.519 -179.046 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 58.51 47.23 91.1 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 117.863 1.905 . . . . 0.0 117.863 -178.822 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 76.32 37.74 35.75 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 117.571 1.788 . . . . 0.0 117.571 -167.646 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 36.3 ttmt -149.67 105.93 3.49 Favored 'General case' 0 N--CA 1.481 1.091 0 N-CA-C 106.572 -1.64 . . . . 0.0 106.572 -176.567 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 3.7 mp -79.97 114.41 18.86 Favored 'General case' 0 N--CA 1.485 1.288 0 CA-C-O 121.607 0.718 . . . . 0.0 109.811 172.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 95.3 t -109.78 101.76 13.03 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 N-CA-C 104.964 -2.236 . . . . 0.0 104.964 -173.713 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 23.1 t-160 -99.38 136.92 38.62 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 123.807 0.843 . . . . 0.0 109.69 178.11 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 24.8 tp -134.99 120.23 18.92 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 176.775 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 29.7 mt-30 -112.0 126.2 54.89 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 177.117 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 9.8 mtmp? -126.49 134.45 50.91 Favored 'General case' 0 N--CA 1.496 1.835 0 C-N-CA 122.989 0.515 . . . . 0.0 110.902 -170.58 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 25.8 p90 -152.38 116.12 4.83 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.469 -0.769 . . . . 0.0 110.433 -175.459 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . 0.344 12.6 t70 67.37 -101.76 0.06 Allowed 'General case' 0 N--CA 1.495 1.797 0 C-N-CA 124.515 1.126 . . . . 0.0 112.319 172.965 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -127.41 55.06 0.76 Allowed Glycine 0 N--CA 1.488 2.151 0 CA-C-N 118.96 0.8 . . . . 0.0 113.377 162.331 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 47.7 mt-30 -154.34 129.98 9.98 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 -173.425 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -140.09 125.58 19.07 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.595 -0.691 . . . . 0.0 111.489 -179.311 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 14.3 t -107.94 134.03 51.44 Favored 'General case' 0 N--CA 1.495 1.782 0 C-N-CA 122.98 0.512 . . . . 0.0 110.534 173.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 33.7 p -100.74 134.81 43.15 Favored 'General case' 0 N--CA 1.492 1.669 0 CA-C-O 121.408 0.623 . . . . 0.0 110.77 168.826 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 5.3 mp -118.61 78.54 1.28 Allowed 'General case' 0 CA--C 1.561 1.404 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 178.202 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 62.8 t -86.53 103.41 12.94 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 121.108 -0.995 . . . . 0.0 108.489 -170.6 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 22.0 mmt180 -88.15 124.61 33.98 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 124.21 1.004 . . . . 0.0 109.71 177.081 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -149.52 127.86 12.17 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 122.115 -0.366 . . . . 0.0 111.455 -169.442 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -78.0 117.64 19.52 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.63 -0.669 . . . . 0.0 111.524 177.64 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 48.1 mm -117.58 100.41 10.12 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.312 0 N-CA-C 105.131 -2.174 . . . . 0.0 105.131 173.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 23.2 m-20 56.5 48.79 16.04 Favored 'General case' 0 N--CA 1.498 1.963 0 N-CA-C 115.094 1.516 . . . . 0.0 115.094 174.844 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 89.57 -42.14 3.0 Favored Glycine 0 CA--C 1.552 2.344 0 N-CA-C 117.35 1.7 . . . . 0.0 117.35 -169.53 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 50.7 mttp -83.06 128.69 34.7 Favored 'General case' 0 N--CA 1.487 1.4 0 CA-C-N 118.658 1.229 . . . . 0.0 111.842 -172.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 56.9 tp -86.08 116.33 24.23 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 123.486 0.714 . . . . 0.0 110.715 -177.354 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 33.5 mm -101.49 107.11 20.78 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 -172.09 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 52.7 tp -85.28 106.83 16.97 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 123.778 0.831 . . . . 0.0 109.359 171.399 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 75.5 m -99.73 106.14 18.02 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 -173.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 91.5 mt -103.78 96.44 6.7 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 123.274 0.63 . . . . 0.0 110.091 -169.699 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 9.2 m -111.68 116.06 30.14 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 -174.549 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 75.8 t60 -147.24 115.49 6.61 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 173.669 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 62.52 59.13 9.79 Favored Glycine 0 N--CA 1.488 2.143 0 N-CA-C 117.051 1.58 . . . . 0.0 117.051 172.475 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . 0.288 2.7 m 51.9 51.66 16.06 Favored 'General case' 0 CA--C 1.576 1.945 0 N-CA-C 115.129 1.529 . . . . 0.0 115.129 -172.445 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -157.24 89.26 1.05 Allowed 'General case' 0 N--CA 1.484 1.272 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 -179.614 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 4.8 p -94.34 116.28 35.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 C-N-CA 123.685 0.794 . . . . 0.0 109.88 178.187 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 42.9 t -103.69 110.3 22.33 Favored 'General case' 0 CA--C 1.553 1.058 0 C-N-CA 123.265 0.626 . . . . 0.0 110.026 174.252 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 79.8 m -90.64 97.76 11.37 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 -176.677 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 21.6 mtm180 -101.63 116.98 33.96 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 122.752 0.421 . . . . 0.0 111.042 -171.118 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 75.8 m -88.33 140.62 29.28 Favored 'General case' 0 N--CA 1.494 1.739 0 C-N-CA 123.544 0.737 . . . . 0.0 110.877 -177.214 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 34.6 m-85 -132.7 131.62 41.47 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 123.67 0.788 . . . . 0.0 109.825 -178.317 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -96.21 150.42 20.55 Favored 'General case' 0 N--CA 1.494 1.744 0 CA-C-O 122.121 0.963 . . . . 0.0 112.25 171.734 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 72.2 tttt -87.33 119.1 27.24 Favored 'General case' 0 N--CA 1.483 1.187 0 CA-C-N 115.142 -0.936 . . . . 0.0 111.149 -173.723 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 28.8 mm-40 -107.07 49.74 0.79 Allowed 'General case' 0 CA--C 1.567 1.629 0 C-N-CA 124.069 0.947 . . . . 0.0 111.709 178.566 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.035 0 CA-C-O 123.126 1.441 . . . . 0.0 108.397 -173.126 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 4.0 p . . . . . 0 CA--C 1.577 2.002 0 N-CA-C 116.028 1.862 . . . . 0.0 116.028 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 -63.77 -45.53 89.35 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 117.817 2.525 . . . . 0.0 117.817 -174.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -56.74 -25.54 55.11 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 118.084 2.624 . . . . 0.0 118.084 172.513 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -67.8 -30.68 70.17 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 116.181 1.919 . . . . 0.0 116.181 165.355 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 32.9 mt -72.05 107.01 4.53 Favored 'General case' 0 N--CA 1.489 1.496 0 CA-C-N 120.182 1.355 . . . . 0.0 111.445 -167.594 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 163.33 169.54 26.93 Favored Glycine 0 CA--C 1.544 1.864 0 CA-C-O 122.645 1.136 . . . . 0.0 113.581 -169.349 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 73.7 m -86.35 142.48 28.45 Favored 'General case' 0 N--CA 1.491 1.595 0 CA-C-N 114.266 -0.967 . . . . 0.0 110.071 170.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 77.5 m95 -143.87 117.21 9.04 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 -174.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -101.08 145.6 28.54 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.9 -0.5 . . . . 0.0 110.38 176.263 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 22.2 tp -68.12 122.86 19.16 Favored 'General case' 0 N--CA 1.49 1.564 0 CA-C-O 122.169 0.985 . . . . 0.0 111.757 -178.525 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . 0.282 0.9 OUTLIER -101.31 -46.87 11.51 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.8 0 CA-C-N 113.752 -1.567 . . . . 0.0 111.516 179.082 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -139.81 145.26 37.95 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-N 119.714 1.143 . . . . 0.0 109.647 175.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 79.7 p -131.67 89.42 2.7 Favored 'General case' 0 N--CA 1.491 1.613 0 CA-C-O 121.671 0.748 . . . . 0.0 110.091 168.448 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -78.29 127.39 32.17 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 123.534 0.734 . . . . 0.0 110.378 178.046 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.254 42.1 m-20 68.74 32.97 3.9 Favored 'General case' 0 N--CA 1.505 2.304 0 N-CA-C 116.391 1.997 . . . . 0.0 116.391 178.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 42.2 t80 -68.9 -62.95 1.17 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.631 -1.293 . . . . 0.0 113.09 -175.653 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -44.89 -36.02 3.11 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 118.637 2.829 . . . . 0.0 118.637 168.209 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -65.55 -48.67 71.61 Favored 'General case' 0 N--CA 1.498 1.944 0 CA-C-N 120.745 1.611 . . . . 0.0 114.64 172.413 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 85.7 t80 -55.38 -46.97 76.49 Favored 'General case' 0 CA--C 1.572 1.815 0 N-CA-C 115.179 1.548 . . . . 0.0 115.179 167.623 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 16.3 mmm -59.52 -42.52 92.44 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 115.493 1.664 . . . . 0.0 115.493 174.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 70.1 tttt -64.96 -41.05 95.81 Favored 'General case' 0 CA--C 1.568 1.64 0 N-CA-C 115.248 1.573 . . . . 0.0 115.248 170.091 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 50.9 m -56.74 -41.8 78.15 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 116.031 1.863 . . . . 0.0 116.031 171.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 45.4 mt -66.11 -36.83 84.22 Favored 'General case' 0 CA--C 1.565 1.532 0 N-CA-C 117.088 2.255 . . . . 0.0 117.088 168.353 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 100.08 78.98 1.4 Allowed Glycine 0 CA--C 1.54 1.622 0 CA-C-N 118.867 0.758 . . . . 0.0 111.644 -169.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 57.3 t -136.59 122.08 27.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 N-CA-C 105.48 -2.045 . . . . 0.0 105.48 -179.639 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -64.04 159.51 39.99 Favored Glycine 0 CA--C 1.548 2.125 0 N-CA-C 116.19 1.236 . . . . 0.0 116.19 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 27.8 p90 -56.27 -40.82 74.85 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 118.854 2.909 . . . . 0.0 118.854 -167.04 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.06 -42.01 81.11 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 116.022 1.86 . . . . 0.0 116.022 176.333 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 41.0 m -70.09 -39.94 75.28 Favored 'General case' 0 N--CA 1.499 1.986 0 CA-C-N 119.377 0.99 . . . . 0.0 113.663 171.069 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 68.1 ttt-85 -55.99 -42.77 76.86 Favored 'General case' 0 CA--C 1.571 1.766 0 N-CA-C 115.989 1.848 . . . . 0.0 115.989 168.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 25.6 tt0 -77.84 -42.79 32.42 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 115.355 1.613 . . . . 0.0 115.355 175.169 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 75.7 t -65.2 -41.62 92.09 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 CA-C-N 119.756 1.162 . . . . 0.0 113.011 174.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -64.36 -33.0 74.84 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 116.873 2.175 . . . . 0.0 116.873 172.301 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 93.3 p -67.05 -42.88 84.04 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 115.506 1.669 . . . . 0.0 115.506 167.422 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 42.5 ttm -60.89 -36.66 79.79 Favored 'General case' 0 CA--C 1.572 1.798 0 N-CA-C 116.135 1.902 . . . . 0.0 116.135 167.234 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 99.4 m -69.06 136.26 52.07 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 124.49 1.116 . . . . 0.0 111.328 176.589 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -108.35 92.43 9.76 Favored Pre-proline 0 CA--C 1.569 1.683 0 C-N-CA 123.824 0.85 . . . . 0.0 108.973 172.211 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -81.92 145.38 14.1 Favored 'Trans proline' 0 C--N 1.37 1.706 0 C-N-CA 122.83 2.353 . . . . 0.0 113.237 -174.206 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 85.5 m -99.2 102.31 13.92 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 -173.579 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 94.3 m -80.42 120.8 24.92 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 123.773 0.829 . . . . 0.0 109.319 175.391 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 36.9 mt -123.73 111.4 28.94 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 N-CA-C 106.399 -1.704 . . . . 0.0 106.399 -176.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 3.9 mp -94.09 128.1 45.65 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 175.35 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 22.0 mm-40 -128.57 169.32 14.53 Favored 'General case' 0 N--CA 1.489 1.496 0 CA-C-O 122.095 0.95 . . . . 0.0 110.551 178.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.69 157.2 42.78 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 123.869 0.868 . . . . 0.0 111.526 178.427 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 65.0 m-80 -134.55 -78.51 0.46 Allowed 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 177.352 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -153.13 86.65 0.14 Allowed Glycine 0 N--CA 1.482 1.749 0 N-CA-C 108.1 -2.0 . . . . 0.0 108.1 168.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . 0.277 14.4 m-20 66.62 -12.05 0.22 Allowed 'General case' 0 N--CA 1.498 1.945 0 N-CA-C 117.726 2.491 . . . . 0.0 117.726 -161.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 26.8 mm -90.27 103.75 14.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 CA-C-N 120.147 1.34 . . . . 0.0 107.445 -177.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 44.4 mt -93.61 110.8 22.39 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 123.005 0.522 . . . . 0.0 110.79 -174.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 90.5 m -99.32 98.76 9.67 Favored 'General case' 0 CA--C 1.562 1.411 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 -170.295 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 9.6 tt -97.78 113.49 25.29 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 178.231 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 45.6 mtpt -112.05 106.98 15.78 Favored 'General case' 0 N--CA 1.484 1.262 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 -173.135 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 82.5 m -92.15 101.71 14.23 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 177.612 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 72.4 m80 -88.41 90.53 8.43 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 123.883 0.873 . . . . 0.0 110.533 -173.467 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 60.5 p -103.49 161.12 14.13 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 113.265 0.839 . . . . 0.0 113.265 -178.295 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 17.8 m -86.02 60.41 6.22 Favored 'General case' 0 N--CA 1.498 1.945 0 CA-C-O 121.979 0.895 . . . . 0.0 110.697 163.414 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 20.6 t80 -157.04 -81.46 0.07 Allowed 'General case' 0 CA--C 1.559 1.316 0 N-CA-C 105.768 -1.938 . . . . 0.0 105.768 176.23 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 32.0 mtmm -143.15 133.64 24.88 Favored 'General case' 0 N--CA 1.491 1.595 0 CA-C-N 118.996 0.816 . . . . 0.0 108.836 166.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 70.9 m-20 -80.48 113.68 18.84 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 123.172 0.589 . . . . 0.0 110.433 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 61.6 p -98.56 129.43 45.11 Favored 'General case' 0 N--CA 1.493 1.721 0 CA-C-O 121.221 0.534 . . . . 0.0 110.886 -176.491 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -115.26 116.55 28.5 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 179.465 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 28.8 pt -113.08 129.6 68.46 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 176.442 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 77.6 p -117.8 114.3 23.07 Favored 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 123.871 0.868 . . . . 0.0 109.298 -176.219 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 51.0 p90 -141.12 139.42 33.97 Favored 'General case' 0 N--CA 1.499 1.982 0 N-CA-C 115.499 1.666 . . . . 0.0 115.499 -161.514 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 62.2 mtpt -105.99 23.9 13.26 Favored 'General case' 0 CA--C 1.574 1.867 0 N-CA-C 116.877 2.177 . . . . 0.0 116.877 -175.084 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . 0.284 1.2 mp 60.78 90.21 0.07 Allowed 'General case' 0 N--CA 1.495 1.825 0 CA-C-N 120.536 1.517 . . . . 0.0 114.772 171.545 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 87.76 38.51 7.47 Favored Glycine 0 CA--C 1.551 2.302 0 N-CA-C 116.779 1.472 . . . . 0.0 116.779 -166.581 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 82.6 t -139.3 120.45 15.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 N-CA-C 106.131 -1.803 . . . . 0.0 106.131 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -87.46 124.06 33.04 Favored 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 122.953 0.501 . . . . 0.0 111.122 178.304 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 45.8 p90 -127.58 133.99 49.72 Favored 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 123.775 0.83 . . . . 0.0 111.166 -172.56 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -70.58 128.8 37.34 Favored 'General case' 0 CA--C 1.564 1.513 0 O-C-N 121.447 -0.783 . . . . 0.0 112.567 173.352 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 14.7 tp10 -142.46 135.73 28.73 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 123.193 0.597 . . . . 0.0 109.963 -168.683 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 53.1 m -92.56 127.47 38.07 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 171.214 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 31.1 p -84.25 171.68 12.53 Favored 'General case' 0 N--CA 1.495 1.781 0 CA-C-O 121.429 0.633 . . . . 0.0 112.443 -177.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -62.88 -31.35 72.38 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 116.438 2.014 . . . . 0.0 116.438 166.646 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -81.0 21.06 0.73 Allowed 'General case' 0 CA--C 1.582 2.193 0 N-CA-C 114.956 1.465 . . . . 0.0 114.956 165.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 56.31 69.23 0.76 Allowed 'General case' 0 N--CA 1.496 1.837 0 C-N-CA 125.928 1.691 . . . . 0.0 114.517 176.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 50.8 mtm180 -144.12 126.84 16.14 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-O 121.116 0.484 . . . . 0.0 110.683 -174.519 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 62.5 pttt -66.12 118.29 9.65 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 123.957 0.903 . . . . 0.0 111.929 165.368 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 15.8 m -140.25 130.13 28.41 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 -173.342 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 30.5 mmmt -87.41 112.22 21.92 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-O 121.593 0.711 . . . . 0.0 109.669 178.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 67.3 m -109.99 105.92 15.25 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 123.515 0.726 . . . . 0.0 111.108 -158.155 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 6.9 tp -114.66 105.84 19.46 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 C-N-CA 123.795 0.838 . . . . 0.0 109.53 -175.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -115.92 126.23 73.35 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 C-N-CA 124.551 1.14 . . . . 0.0 108.933 178.223 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 15.4 t -132.24 157.13 45.17 Favored 'General case' 0 N--CA 1.492 1.644 0 CA-C-O 122.625 1.203 . . . . 0.0 111.296 172.005 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 17.6 tp -93.31 116.24 28.81 Favored 'General case' 0 N--CA 1.487 1.419 0 CA-C-N 114.837 -1.074 . . . . 0.0 110.785 -176.465 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -110.36 82.74 1.64 Allowed 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 123.576 0.75 . . . . 0.0 109.679 178.731 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 56.68 46.16 89.6 Favored Glycine 0 CA--C 1.552 2.369 0 N-CA-C 118.203 2.041 . . . . 0.0 118.203 -177.042 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 78.59 44.76 10.27 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 117.0 1.56 . . . . 0.0 117.0 -167.609 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 41.1 ttmt -151.13 111.28 4.12 Favored 'General case' 0 CA--C 1.551 0.994 0 N-CA-C 106.481 -1.674 . . . . 0.0 106.481 -177.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 65.5 mt -85.21 95.3 9.13 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-O 122.976 1.369 . . . . 0.0 109.428 177.526 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 88.7 t -87.1 97.76 6.67 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.334 0 CA-C-N 112.617 -2.083 . . . . 0.0 105.876 -178.405 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 22.7 t-160 -102.44 139.39 38.11 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 124.396 1.078 . . . . 0.0 109.405 -176.513 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 28.2 tp -136.69 115.29 11.98 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 178.514 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 89.4 mt-30 -104.22 115.77 30.99 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 175.726 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt -121.87 135.68 54.9 Favored 'General case' 0 N--CA 1.493 1.701 0 C-N-CA 123.335 0.654 . . . . 0.0 111.789 -171.741 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 16.3 p90 -159.0 110.91 2.15 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 123.333 0.653 . . . . 0.0 110.536 -174.607 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 5.7 t70 52.59 54.45 10.58 Favored 'General case' 0 N--CA 1.498 1.948 0 N-CA-C 116.567 2.062 . . . . 0.0 116.567 165.328 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 88.76 -46.0 3.27 Favored Glycine 0 CA--C 1.549 2.206 0 N-CA-C 116.434 1.334 . . . . 0.0 116.434 -169.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 16.3 mt-30 -83.6 129.21 34.96 Favored 'General case' 0 N--CA 1.488 1.446 0 CA-C-N 117.957 0.878 . . . . 0.0 111.233 -178.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -141.21 124.75 16.74 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 122.786 0.435 . . . . 0.0 110.664 177.005 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 13.0 t -110.8 135.52 51.24 Favored 'General case' 0 N--CA 1.492 1.656 0 C-N-CA 123.108 0.563 . . . . 0.0 110.643 176.273 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 37.9 p -100.27 131.02 46.44 Favored 'General case' 0 N--CA 1.492 1.628 0 C-N-CA 123.021 0.528 . . . . 0.0 110.761 174.608 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 5.4 mp -111.73 76.18 0.96 Allowed 'General case' 0 CA--C 1.563 1.447 0 C-N-CA 124.005 0.922 . . . . 0.0 108.783 -179.446 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 87.5 t -87.04 110.1 20.0 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 -168.242 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 83.9 mtt85 -102.38 118.49 36.99 Favored 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 122.975 0.51 . . . . 0.0 109.939 -175.777 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -135.32 127.96 30.85 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 123.34 0.656 . . . . 0.0 110.665 -169.539 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -80.91 114.64 19.93 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.833 -0.542 . . . . 0.0 111.395 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 85.8 mt -124.14 106.98 17.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 N-CA-C 105.015 -2.217 . . . . 0.0 105.015 178.512 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 23.4 m-20 58.17 50.3 10.1 Favored 'General case' 0 N--CA 1.499 1.989 0 N-CA-C 115.15 1.537 . . . . 0.0 115.15 177.031 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 60.73 31.24 74.76 Favored Glycine 0 CA--C 1.554 2.503 0 N-CA-C 118.964 2.346 . . . . 0.0 118.964 -169.453 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 92.1 mttt -133.65 128.55 35.3 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-N 119.135 1.468 . . . . 0.0 108.686 -175.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 12.3 tp -79.76 107.42 12.52 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 123.433 0.693 . . . . 0.0 109.389 177.61 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 31.6 mm -99.42 99.29 8.26 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 N-CA-C 106.536 -1.653 . . . . 0.0 106.536 -175.598 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 21.9 tp -87.86 102.99 15.24 Favored 'General case' 0 N--CA 1.486 1.372 0 CA-C-O 121.843 0.83 . . . . 0.0 109.549 178.699 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 90.9 m -95.76 103.61 15.5 Favored 'General case' 0 CA--C 1.561 1.389 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 -175.545 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 90.3 mt -97.61 100.49 11.89 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 123.581 0.752 . . . . 0.0 109.809 -174.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 8.1 m -113.89 125.28 53.87 Favored 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 -175.035 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 82.9 t60 -129.48 -102.9 0.31 Allowed 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.982 -0.748 . . . . 0.0 108.982 175.352 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -112.32 88.6 0.5 Allowed Glycine 0 N--CA 1.485 1.923 0 CA-C-N 119.183 0.901 . . . . 0.0 112.003 -171.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . 0.298 2.6 m 54.49 44.61 28.53 Favored 'General case' 0 CA--C 1.578 2.032 0 N-CA-C 115.381 1.623 . . . . 0.0 115.381 -175.68 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -163.66 95.68 0.82 Allowed 'General case' 0 N--CA 1.483 1.193 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 178.12 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 2.9 p -91.69 115.87 31.67 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 C-N-CA 123.402 0.681 . . . . 0.0 109.415 174.717 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 53.3 t -95.7 105.4 17.39 Favored 'General case' 0 CA--C 1.551 1.01 0 CA-C-O 121.302 0.573 . . . . 0.0 110.572 173.187 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 75.7 m -91.88 113.53 25.82 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 -178.64 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 83.3 mtp180 -113.53 109.36 18.52 Favored 'General case' 0 N--CA 1.486 1.332 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.615 -168.457 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 88.4 m -84.01 127.21 33.72 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 123.165 0.586 . . . . 0.0 109.947 178.058 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 43.1 m-85 -123.71 127.94 48.89 Favored 'General case' 0 CA--C 1.56 1.345 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 175.292 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -91.1 152.59 20.55 Favored 'General case' 0 N--CA 1.496 1.83 0 CA-C-O 121.879 0.847 . . . . 0.0 111.736 170.142 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 70.9 tttt -82.15 122.71 28.22 Favored 'General case' 0 N--CA 1.487 1.404 0 CA-C-O 121.587 0.708 . . . . 0.0 111.975 -171.456 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 24.5 mm-40 -119.04 50.94 1.16 Allowed 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 124.225 1.01 . . . . 0.0 111.605 -174.258 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 0.872 0 CA-C-O 123.155 1.455 . . . . 0.0 110.131 -162.634 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.253 5.1 p . . . . . 0 CA--C 1.576 1.968 0 N-CA-C 114.581 1.326 . . . . 0.0 114.581 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -85.12 -36.59 21.02 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 115.561 1.689 . . . . 0.0 115.561 -173.609 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -58.52 -24.73 61.28 Favored 'General case' 0 N--CA 1.497 1.891 0 N-CA-C 117.694 2.479 . . . . 0.0 117.694 168.558 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -68.72 -20.17 64.38 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 116.84 2.163 . . . . 0.0 116.84 167.101 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 56.2 mt -80.44 126.81 31.66 Favored 'General case' 0 N--CA 1.486 1.352 0 CA-C-N 120.627 1.558 . . . . 0.0 111.882 -170.402 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 155.79 178.14 29.7 Favored Glycine 0 CA--C 1.541 1.713 0 CA-C-O 122.03 0.795 . . . . 0.0 113.557 -178.112 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 43.1 m -92.94 135.69 33.93 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 168.53 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 89.3 m95 -137.21 113.79 10.26 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 -170.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 26.7 mtpt -93.49 148.69 21.85 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 121.927 0.87 . . . . 0.0 111.366 172.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 20.2 tp -71.4 135.61 47.34 Favored 'General case' 0 N--CA 1.486 1.368 0 CA-C-O 122.32 1.057 . . . . 0.0 112.53 -178.478 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . 0.271 1.1 t -114.52 -43.76 4.06 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.878 0 CA-C-N 113.786 -1.552 . . . . 0.0 111.953 -177.589 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -127.28 150.8 49.4 Favored 'General case' 0 N--CA 1.494 1.76 0 CA-C-N 119.986 1.267 . . . . 0.0 110.65 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 81.1 p -145.2 88.71 1.89 Allowed 'General case' 0 N--CA 1.49 1.544 0 CA-C-O 121.22 0.533 . . . . 0.0 110.244 167.484 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -102.22 125.24 48.87 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 123.4 0.68 . . . . 0.0 109.201 177.165 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.288 53.6 m-20 72.57 17.07 4.69 Favored 'General case' 0 N--CA 1.503 2.206 0 N-CA-C 117.491 2.404 . . . . 0.0 117.491 -178.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 30.9 t80 -68.77 -41.91 78.16 Favored 'General case' 0 N--CA 1.497 1.894 0 N-CA-C 115.091 1.515 . . . . 0.0 115.091 178.202 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -49.58 -49.01 48.28 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 116.009 1.855 . . . . 0.0 116.009 165.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 18.4 t0 -59.21 -50.59 73.44 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 115.397 1.628 . . . . 0.0 115.397 172.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 88.2 t80 -52.67 -51.79 58.67 Favored 'General case' 0 CA--C 1.572 1.794 0 N-CA-C 115.6 1.704 . . . . 0.0 115.6 170.349 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 5.5 mmm -64.78 -40.07 94.64 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 115.124 1.527 . . . . 0.0 115.124 176.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 21.7 ttmm -55.96 -45.29 78.92 Favored 'General case' 0 CA--C 1.571 1.769 0 N-CA-C 115.14 1.534 . . . . 0.0 115.14 166.317 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 12.8 t -59.77 -38.42 81.77 Favored 'General case' 0 CA--C 1.571 1.763 0 N-CA-C 116.407 2.003 . . . . 0.0 116.407 170.42 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 75.8 mt -65.16 -25.47 67.75 Favored 'General case' 0 CA--C 1.568 1.661 0 N-CA-C 117.601 2.445 . . . . 0.0 117.601 168.49 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 98.76 70.36 0.97 Allowed Glycine 0 N--CA 1.482 1.731 0 CA-C-N 119.085 0.857 . . . . 0.0 112.256 -171.026 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 45.3 t -142.28 120.13 7.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 N-CA-C 105.502 -2.036 . . . . 0.0 105.502 -178.338 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -81.1 -157.49 17.36 Favored Glycine 0 CA--C 1.547 2.065 0 N-CA-C 115.534 0.973 . . . . 0.0 115.534 -179.413 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 12.1 p90 -70.01 160.72 31.42 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 113.385 0.883 . . . . 0.0 113.385 179.637 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . 0.329 . . 78.25 -50.07 0.48 Allowed 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 115.439 1.644 . . . . 0.0 115.439 178.431 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 34.0 m -70.51 -37.49 74.17 Favored 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 113.604 0.964 . . . . 0.0 113.604 167.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 42.3 mtm105 -57.97 -44.6 87.2 Favored 'General case' 0 N--CA 1.498 1.97 0 N-CA-C 115.232 1.567 . . . . 0.0 115.232 164.52 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 10.3 tm0? -68.68 -52.8 27.1 Favored 'General case' 0 CA--C 1.561 1.389 0 N-CA-C 114.871 1.434 . . . . 0.0 114.871 176.697 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 85.5 t -66.4 -40.62 87.08 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 CA-C-O 117.763 -1.113 . . . . 0.0 113.166 -179.064 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -71.27 -26.84 63.06 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 117.052 2.241 . . . . 0.0 117.052 176.107 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 90.6 p -68.91 -47.37 65.96 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 115.022 1.49 . . . . 0.0 115.022 164.134 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 52.1 ttp -61.91 -39.6 92.56 Favored 'General case' 0 CA--C 1.57 1.731 0 N-CA-C 116.482 2.03 . . . . 0.0 116.482 171.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 52.7 m -67.35 146.97 53.55 Favored 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 124.764 1.225 . . . . 0.0 111.941 178.441 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -102.23 100.37 15.21 Favored Pre-proline 0 CA--C 1.57 1.744 0 N-CA-C 108.307 -0.998 . . . . 0.0 108.307 172.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -79.11 104.39 1.77 Allowed 'Trans proline' 0 CA--C 1.562 1.888 0 C-N-CA 123.223 2.615 . . . . 0.0 111.293 -178.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 96.2 m -80.16 108.33 13.67 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 123.352 0.661 . . . . 0.0 110.495 -164.714 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 28.7 m -91.39 109.79 21.07 Favored 'General case' 0 CA--C 1.559 1.318 0 C-N-CA 123.336 0.654 . . . . 0.0 110.03 -170.442 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 75.0 mt -100.56 109.36 25.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 N-CA-C 106.567 -1.642 . . . . 0.0 106.567 176.321 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 30.4 mt -104.82 118.31 51.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 N-CA-C 106.906 -1.516 . . . . 0.0 106.906 -179.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -137.79 117.24 12.86 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 -175.101 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 7.7 ttpm? -91.5 116.26 28.71 Favored 'General case' 0 CA--C 1.557 1.217 0 CA-C-O 121.439 0.637 . . . . 0.0 110.051 172.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 22.7 t-20 -71.64 -50.52 29.86 Favored 'General case' 0 CA--C 1.57 1.72 0 N-CA-C 112.982 0.734 . . . . 0.0 112.982 166.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -172.25 -82.4 0.05 OUTLIER Glycine 0 N--CA 1.481 1.659 0 N-CA-C 109.25 -1.54 . . . . 0.0 109.25 173.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 24.3 t0 -72.14 -37.69 69.38 Favored 'General case' 0 CA--C 1.57 1.741 0 N-CA-C 115.096 1.517 . . . . 0.0 115.096 162.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 31.6 mm -91.11 120.32 39.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 CA-C-N 118.993 0.815 . . . . 0.0 109.69 -173.524 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 12.7 mt -86.38 125.88 33.97 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 123.419 0.688 . . . . 0.0 109.811 158.651 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 57.7 m -113.91 103.79 11.52 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 -179.795 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 9.5 tt -102.48 108.55 19.9 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 178.598 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -104.75 111.8 24.65 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 -179.469 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 98.2 m -98.51 99.98 11.18 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 20.6 m-70 -90.48 95.96 10.42 Favored 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 123.393 0.677 . . . . 0.0 110.344 -172.198 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 22.8 t -109.52 150.44 28.14 Favored 'General case' 0 CA--C 1.554 1.121 0 CA-C-O 121.981 0.896 . . . . 0.0 110.322 -179.345 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 25.2 m -55.08 -24.01 23.31 Favored 'General case' 0 N--CA 1.499 2.016 0 N-CA-C 115.806 1.78 . . . . 0.0 115.806 163.74 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 72.0 t80 -78.69 -63.19 1.47 Allowed 'General case' 0 CA--C 1.564 1.512 0 CA-C-N 119.465 1.03 . . . . 0.0 111.913 172.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 14.5 ttpt -154.27 142.66 20.59 Favored 'General case' 0 N--CA 1.49 1.538 0 CA-C-N 119.332 0.969 . . . . 0.0 110.392 172.248 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 83.0 m-20 -84.17 111.31 19.24 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 123.145 0.578 . . . . 0.0 109.938 174.636 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 31.8 p -105.58 132.39 51.79 Favored 'General case' 0 N--CA 1.496 1.874 0 C-N-CA 123.355 0.662 . . . . 0.0 110.825 -177.551 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -121.43 118.3 29.04 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 123.918 0.887 . . . . 0.0 108.813 -178.116 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 39.5 pt -110.35 129.57 65.18 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.875 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 173.684 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 52.2 p -115.75 114.26 24.55 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 178.276 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 45.9 p90 -142.68 146.54 34.52 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 114.306 1.225 . . . . 0.0 114.306 -161.162 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 50.2 mtmt -115.5 28.12 8.88 Favored 'General case' 0 CA--C 1.572 1.823 0 N-CA-C 115.678 1.733 . . . . 0.0 115.678 -171.122 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . 0.308 0.1 OUTLIER 52.81 82.73 0.07 Allowed 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 115.866 1.802 . . . . 0.0 115.866 175.551 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 101.88 39.24 2.96 Favored Glycine 0 CA--C 1.55 2.234 0 N-CA-C 116.336 1.294 . . . . 0.0 116.336 -171.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 94.7 t -139.74 127.52 25.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 N-CA-C 106.442 -1.688 . . . . 0.0 106.442 -179.199 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -89.01 128.92 35.73 Favored 'General case' 0 CA--C 1.564 1.499 0 C-N-CA 122.997 0.519 . . . . 0.0 110.366 175.592 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 43.5 p90 -138.91 123.14 18.1 Favored 'General case' 0 N--CA 1.494 1.764 0 C-N-CA 123.391 0.677 . . . . 0.0 109.855 -176.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -72.37 112.85 8.79 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.097 -1.002 . . . . 0.0 112.382 178.462 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -115.33 135.91 53.65 Favored 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 124.024 0.929 . . . . 0.0 110.241 -168.103 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 42.9 m -86.96 122.79 31.3 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-O 121.61 0.719 . . . . 0.0 109.529 173.173 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 43.1 p -82.45 177.76 8.58 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 113.197 0.814 . . . . 0.0 113.197 -173.546 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -55.85 -35.75 66.78 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 117.69 2.478 . . . . 0.0 117.69 168.46 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -92.47 17.19 10.36 Favored 'General case' 0 CA--C 1.577 1.991 0 N-CA-C 115.136 1.532 . . . . 0.0 115.136 170.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 63.01 80.17 0.24 Allowed 'General case' 0 N--CA 1.496 1.854 0 C-N-CA 125.281 1.432 . . . . 0.0 113.272 -178.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 14.9 ttm180 -146.09 126.13 13.71 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 -176.176 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.77 120.51 15.62 Favored 'General case' 0 N--CA 1.493 1.678 0 CA-C-N 118.124 0.42 . . . . 0.0 110.272 168.174 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 12.4 m -138.69 121.42 18.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 N-CA-C 107.999 -1.112 . . . . 0.0 107.999 -176.156 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 1.5 mptm? -76.76 104.13 7.09 Favored 'General case' 0 N--CA 1.489 1.487 0 CA-C-O 121.89 0.852 . . . . 0.0 109.599 -177.349 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 74.0 m -98.95 96.41 7.81 Favored 'General case' 0 N--CA 1.481 1.116 0 CA-C-N 114.894 -1.048 . . . . 0.0 109.92 -164.44 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -106.39 108.31 24.81 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 177.422 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 1.4 p -121.88 126.76 74.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 C-N-CA 124.025 0.93 . . . . 0.0 109.304 -174.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 9.8 t -146.34 152.1 38.57 Favored 'General case' 0 N--CA 1.489 1.515 0 CA-C-O 122.531 1.158 . . . . 0.0 110.643 -177.859 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 24.8 tp -87.73 103.47 15.64 Favored 'General case' 0 N--CA 1.49 1.536 0 CA-C-N 114.889 -1.051 . . . . 0.0 109.425 175.778 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -107.01 93.57 4.63 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 123.607 0.763 . . . . 0.0 109.41 -175.674 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 59.3 49.1 82.2 Favored Glycine 0 N--CA 1.488 2.108 0 N-CA-C 117.712 1.845 . . . . 0.0 117.712 -179.825 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 91.59 -37.44 3.39 Favored Glycine 0 CA--C 1.551 2.31 0 N-CA-C 117.232 1.653 . . . . 0.0 117.232 -170.352 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.72 122.32 29.64 Favored 'General case' 0 N--CA 1.486 1.368 0 CA-C-N 118.92 1.36 . . . . 0.0 110.328 -176.857 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 5.8 tt -85.98 95.86 9.64 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 108.569 -0.901 . . . . 0.0 108.569 179.032 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 53.0 t -97.61 108.09 21.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 -166.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 21.6 t-160 -101.92 108.64 20.17 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 123.255 0.622 . . . . 0.0 110.032 175.682 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 31.8 tp -98.0 116.32 29.97 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 175.587 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -100.22 129.45 46.23 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 168.64 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 16.7 ptmt -140.08 128.63 22.9 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.746 -0.596 . . . . 0.0 111.399 -173.238 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 30.8 p90 -154.44 119.17 4.9 Favored 'General case' 0 N--CA 1.491 1.606 0 C-N-CA 123.808 0.843 . . . . 0.0 109.727 -168.059 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 4.5 t70 45.34 59.58 3.48 Favored 'General case' 0 N--CA 1.503 2.18 0 N-CA-C 117.616 2.45 . . . . 0.0 117.616 164.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 63.8 31.05 79.48 Favored Glycine 0 CA--C 1.558 2.73 0 N-CA-C 119.42 2.528 . . . . 0.0 119.42 -171.617 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -152.44 123.6 7.6 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 106.705 -1.591 . . . . 0.0 106.705 -176.193 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -138.56 132.49 31.19 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.47 -0.769 . . . . 0.0 112.261 179.128 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 14.6 t -116.32 134.01 55.37 Favored 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 123.581 0.752 . . . . 0.0 110.406 173.755 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 34.9 p -100.8 131.07 46.86 Favored 'General case' 0 N--CA 1.493 1.699 0 CA-C-O 122.143 0.973 . . . . 0.0 110.128 169.292 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 5.4 mp -112.47 87.0 2.47 Favored 'General case' 0 CA--C 1.56 1.347 0 N-CA-C 106.407 -1.701 . . . . 0.0 106.407 -178.71 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 72.4 t -92.88 99.89 10.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 -169.186 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 20.5 mmt180 -86.27 125.26 33.46 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 124.126 0.971 . . . . 0.0 109.883 176.052 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -151.89 131.74 13.29 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.877 -0.514 . . . . 0.0 112.11 -173.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -78.73 120.24 23.09 Favored 'General case' 0 N--CA 1.49 1.525 0 CA-C-O 121.295 0.569 . . . . 0.0 111.755 177.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 92.3 mt -129.16 105.72 13.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 N-CA-C 104.603 -2.369 . . . . 0.0 104.603 176.445 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 57.75 52.31 8.28 Favored 'General case' 0 N--CA 1.499 2.001 0 N-CA-C 114.997 1.481 . . . . 0.0 114.997 175.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 67.85 12.07 61.63 Favored Glycine 0 CA--C 1.557 2.673 0 N-CA-C 119.962 2.745 . . . . 0.0 119.962 -171.655 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -124.73 126.59 45.92 Favored 'General case' 0 N--CA 1.486 1.358 0 CA-C-N 119.645 1.723 . . . . 0.0 108.626 -175.196 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 58.7 tp -83.96 108.57 17.01 Favored 'General case' 0 N--CA 1.483 1.189 0 CA-C-O 121.508 0.67 . . . . 0.0 110.226 -179.622 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 28.1 mm -97.51 106.8 19.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 -172.02 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 44.4 tp -86.04 111.84 20.69 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 123.557 0.743 . . . . 0.0 109.075 171.232 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 88.1 m -105.7 105.9 16.16 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 -176.347 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 88.6 mt -101.37 100.6 11.11 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 123.486 0.714 . . . . 0.0 109.948 -171.33 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 7.8 m -116.37 121.1 40.95 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 -174.516 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 83.1 t60 -126.42 -101.51 0.36 Allowed 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 175.571 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -111.0 92.71 0.68 Allowed Glycine 0 N--CA 1.483 1.814 0 CA-C-N 119.375 0.989 . . . . 0.0 111.454 -172.683 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . 0.395 6.4 t 49.03 40.38 17.0 Favored 'General case' 0 N--CA 1.499 2.011 0 N-CA-C 117.746 2.499 . . . . 0.0 117.746 -172.864 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -155.49 93.68 1.51 Allowed 'General case' 0 N--CA 1.483 1.211 0 O-C-N 121.569 -0.707 . . . . 0.0 109.217 178.384 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 4.3 p -89.39 121.23 39.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 C-N-CA 123.418 0.687 . . . . 0.0 109.602 172.352 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 45.0 t -105.28 120.44 41.57 Favored 'General case' 0 CA--C 1.553 1.077 0 C-N-CA 123.045 0.538 . . . . 0.0 111.4 177.65 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 80.1 m -87.21 110.61 20.28 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 175.196 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 6.2 mmm180 -115.03 95.87 5.42 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 107.448 -1.316 . . . . 0.0 107.448 -179.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 86.2 m -82.76 143.51 30.81 Favored 'General case' 0 N--CA 1.494 1.774 0 C-N-CA 123.721 0.809 . . . . 0.0 110.402 -177.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 47.1 m-85 -131.34 127.61 38.0 Favored 'General case' 0 CA--C 1.557 1.232 0 C-N-CA 123.442 0.697 . . . . 0.0 109.767 -178.096 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -95.77 156.89 16.14 Favored 'General case' 0 N--CA 1.492 1.668 0 CA-C-O 122.671 1.224 . . . . 0.0 111.294 165.115 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 73.8 tttt -90.47 114.49 26.67 Favored 'General case' 0 N--CA 1.484 1.244 0 CA-C-N 114.895 -1.048 . . . . 0.0 111.712 -165.698 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -74.11 -33.99 63.79 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 117.116 2.265 . . . . 0.0 117.116 172.452 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.125 0 CA-C-O 124.198 1.952 . . . . 0.0 108.527 173.731 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 5.4 p . . . . . 0 CA--C 1.578 2.041 0 N-CA-C 115.883 1.809 . . . . 0.0 115.883 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -64.85 -36.71 85.22 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 116.764 2.135 . . . . 0.0 116.764 -175.168 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -58.13 -29.25 65.38 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 117.742 2.497 . . . . 0.0 117.742 169.146 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -69.47 -25.29 64.01 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 116.231 1.937 . . . . 0.0 116.231 169.576 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 45.8 mt -77.37 110.22 11.94 Favored 'General case' 0 N--CA 1.489 1.518 0 CA-C-N 121.012 1.733 . . . . 0.0 111.466 -162.715 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 157.8 172.02 24.47 Favored Glycine 0 CA--C 1.546 2.024 0 CA-C-O 122.718 1.177 . . . . 0.0 112.797 -167.571 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 54.1 m -87.25 139.42 30.58 Favored 'General case' 0 N--CA 1.494 1.731 0 CA-C-N 114.296 -0.952 . . . . 0.0 109.734 172.257 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 82.8 m95 -136.62 113.67 10.55 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 -177.444 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -95.41 146.51 24.35 Favored 'General case' 0 N--CA 1.494 1.726 0 CA-C-O 121.439 0.638 . . . . 0.0 110.292 173.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 48.6 tp -68.48 120.16 14.11 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-O 121.649 0.737 . . . . 0.0 111.738 -179.164 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . 0.263 1.1 t -83.66 -51.02 14.76 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.753 0 CA-C-N 114.676 -1.147 . . . . 0.0 111.666 170.495 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -148.36 125.39 11.36 Favored 'General case' 0 CA--C 1.557 1.244 0 CA-C-N 119.032 0.833 . . . . 0.0 109.619 -168.057 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 72.7 p -102.93 100.27 10.23 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 123.373 0.669 . . . . 0.0 110.441 172.508 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 33.7 mmtp -95.9 116.49 28.99 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 109.508 -0.552 . . . . 0.0 109.508 -179.225 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.258 28.6 m-20 71.2 24.53 3.8 Favored 'General case' 0 N--CA 1.504 2.265 0 N-CA-C 117.101 2.26 . . . . 0.0 117.101 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 40.0 t80 -69.58 -50.31 45.87 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 120.138 -1.601 . . . . 0.0 114.727 -175.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 71.1 m-20 -51.58 -27.76 12.0 Favored 'General case' 0 N--CA 1.497 1.925 0 N-CA-C 117.909 2.559 . . . . 0.0 117.909 168.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 24.2 t0 -66.35 -52.9 42.33 Favored 'General case' 0 N--CA 1.496 1.869 0 CA-C-N 120.251 1.387 . . . . 0.0 114.199 166.59 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 88.5 t80 -50.63 -46.23 58.15 Favored 'General case' 0 CA--C 1.573 1.852 0 N-CA-C 115.683 1.734 . . . . 0.0 115.683 168.369 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 47.9 mmm -63.49 -41.33 98.57 Favored 'General case' 0 CA--C 1.567 1.631 0 N-CA-C 114.718 1.377 . . . . 0.0 114.718 174.047 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 13.6 tmtt? -61.18 -44.79 96.73 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 115.248 1.573 . . . . 0.0 115.248 167.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 15.1 t -57.03 -39.62 75.15 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 116.31 1.967 . . . . 0.0 116.31 172.385 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 75.1 mt -65.07 -43.57 91.77 Favored 'General case' 0 CA--C 1.567 1.606 0 N-CA-C 115.572 1.693 . . . . 0.0 115.572 165.164 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 117.98 68.97 0.36 Allowed Glycine 0 N--CA 1.483 1.807 0 C-N-CA 124.148 0.88 . . . . 0.0 112.03 -178.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 18.3 t -140.74 114.98 5.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 N-CA-C 105.919 -1.882 . . . . 0.0 105.919 -174.208 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -85.99 -79.69 1.17 Allowed Glycine 0 N--CA 1.483 1.806 0 N-CA-C 114.724 0.65 . . . . 0.0 114.724 -175.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 20.8 p90 -132.16 163.32 28.8 Favored 'General case' 0 N--CA 1.492 1.655 0 C-N-CA 123.472 0.709 . . . . 0.0 111.474 -177.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . 0.333 . . 79.13 -58.13 0.41 Allowed 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 115.023 1.49 . . . . 0.0 115.023 173.335 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 80.2 m -69.98 -39.75 75.75 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 113.31 0.856 . . . . 0.0 113.31 166.069 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 45.0 ttp180 -63.77 -41.55 97.95 Favored 'General case' 0 CA--C 1.565 1.529 0 N-CA-C 114.966 1.469 . . . . 0.0 114.966 168.704 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 11.5 tm0? -66.55 -49.2 67.23 Favored 'General case' 0 CA--C 1.562 1.438 0 N-CA-C 115.127 1.529 . . . . 0.0 115.127 173.106 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 73.7 t -63.96 -42.39 95.58 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.026 0 CA-C-N 119.912 1.233 . . . . 0.0 113.271 178.593 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -73.15 -32.55 64.96 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 116.938 2.199 . . . . 0.0 116.938 176.704 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 85.7 p -68.63 -44.14 74.83 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 115.265 1.579 . . . . 0.0 115.265 167.248 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 51.7 tpp -68.7 -35.75 77.58 Favored 'General case' 0 CA--C 1.564 1.513 0 N-CA-C 116.459 2.022 . . . . 0.0 116.459 177.192 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 5.1 t -75.16 165.65 24.89 Favored 'General case' 0 N--CA 1.494 1.764 0 CA-C-N 119.9 1.227 . . . . 0.0 112.853 178.726 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.74 100.25 10.64 Favored Pre-proline 0 CA--C 1.57 1.746 0 CA-C-O 118.281 -0.866 . . . . 0.0 109.426 168.044 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -77.08 95.16 1.06 Allowed 'Trans proline' 0 C--N 1.373 1.83 0 C-N-CA 123.294 2.663 . . . . 0.0 111.124 -179.758 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 98.0 m -82.44 105.75 13.75 Favored 'General case' 0 N--CA 1.487 1.412 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.643 -158.466 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 93.5 m -81.34 112.97 19.12 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 123.746 0.818 . . . . 0.0 110.072 -175.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 79.1 mt -112.49 107.18 22.32 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 N-CA-C 105.985 -1.857 . . . . 0.0 105.985 -179.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 4.0 mp -94.7 123.67 46.9 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 175.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 5.8 tm-20 -136.11 112.18 9.67 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 -176.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 83.8 tttt -90.18 113.12 24.84 Favored 'General case' 0 CA--C 1.556 1.211 0 C-N-CA 123.023 0.529 . . . . 0.0 109.825 174.253 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 21.9 t-20 -80.56 -64.76 1.12 Allowed 'General case' 0 CA--C 1.564 1.504 0 C-N-CA 123.31 0.644 . . . . 0.0 111.768 179.233 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -131.68 -94.63 0.63 Allowed Glycine 0 N--CA 1.485 1.903 0 N-CA-C 108.941 -1.664 . . . . 0.0 108.941 169.024 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -77.46 -29.26 52.68 Favored 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 115.361 1.615 . . . . 0.0 115.361 162.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 35.3 mm -88.96 124.95 42.02 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.475 0 CA-C-N 119.108 0.867 . . . . 0.0 109.656 -168.438 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 21.2 mt -89.65 121.07 31.49 Favored 'General case' 0 N--CA 1.485 1.294 0 CA-C-N 114.901 -1.045 . . . . 0.0 110.53 169.103 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 87.0 m -108.8 104.07 13.26 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 179.371 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 7.9 tt -104.56 109.97 22.08 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -106.51 116.88 32.7 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 123.503 0.721 . . . . 0.0 109.205 178.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 94.1 m -102.91 101.28 11.29 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 177.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 23.0 m-70 -88.27 93.96 9.68 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 123.473 0.709 . . . . 0.0 111.838 -170.007 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 33.3 t -101.06 154.79 18.41 Favored 'General case' 0 CA--C 1.557 1.23 0 CA-C-O 122.019 0.914 . . . . 0.0 110.548 176.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 47.0 m -59.79 -22.94 62.86 Favored 'General case' 0 CA--C 1.578 2.026 0 N-CA-C 115.439 1.644 . . . . 0.0 115.439 162.339 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 34.5 t80 -107.88 83.27 1.77 Allowed 'General case' 0 N--CA 1.488 1.43 0 CA-C-N 119.764 1.166 . . . . 0.0 108.234 169.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 28.1 mmmt 61.41 123.29 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 115.483 1.66 . . . . 0.0 115.483 174.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 9.7 p30 -80.83 126.66 31.61 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.502 -0.749 . . . . 0.0 112.311 175.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 78.3 p -95.23 127.46 41.3 Favored 'General case' 0 N--CA 1.496 1.844 0 C-N-CA 122.917 0.487 . . . . 0.0 110.509 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -119.16 111.95 18.9 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 -176.63 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 39.1 pt -105.64 128.3 59.86 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 173.357 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 42.2 t -116.74 108.38 15.82 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 179.552 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 48.6 p90 -140.39 157.9 44.83 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 114.947 1.462 . . . . 0.0 114.947 -159.222 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 54.9 mtpt -120.15 150.38 40.72 Favored 'General case' 0 CA--C 1.563 1.449 0 CA-C-N 113.971 -1.468 . . . . 0.0 108.68 165.177 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -75.04 113.18 12.06 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.566 -0.709 . . . . 0.0 112.246 -170.213 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 83.61 39.68 9.49 Favored Glycine 0 CA--C 1.551 2.326 0 N-CA-C 116.631 1.412 . . . . 0.0 116.631 -169.522 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 76.5 t -140.76 117.64 8.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 N-CA-C 105.339 -2.097 . . . . 0.0 105.339 -175.284 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -83.17 135.62 34.73 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 122.823 0.449 . . . . 0.0 111.919 -179.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 36.0 p90 -140.92 133.43 28.52 Favored 'General case' 0 N--CA 1.494 1.743 0 C-N-CA 123.687 0.795 . . . . 0.0 110.83 -174.431 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -75.04 117.81 17.29 Favored 'General case' 0 CA--C 1.565 1.521 0 O-C-N 121.478 -0.764 . . . . 0.0 112.314 176.159 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 25.7 tp10 -118.31 135.52 54.26 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 123.954 0.902 . . . . 0.0 110.416 -171.406 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 84.8 m -97.01 119.79 36.15 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 171.648 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 22.9 p -86.14 -178.12 6.44 Favored 'General case' 0 N--CA 1.494 1.762 0 CA-C-O 122.192 0.996 . . . . 0.0 113.308 -171.636 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -52.7 -40.13 62.66 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 117.692 2.479 . . . . 0.0 117.692 167.097 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 42.5 m-20 -81.82 5.31 19.14 Favored 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 116.151 1.908 . . . . 0.0 116.151 169.377 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . 0.251 10.0 m-20 62.58 75.22 0.41 Allowed 'General case' 0 N--CA 1.496 1.868 0 C-N-CA 125.265 1.426 . . . . 0.0 112.048 -171.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 42.1 ttp180 -138.05 120.58 16.09 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 -168.051 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.16 95.39 5.59 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 123.407 0.683 . . . . 0.0 111.922 -178.634 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 12.0 m -116.74 127.05 74.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 -167.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 33.5 mmtp -83.6 104.44 13.73 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 123.605 0.762 . . . . 0.0 109.974 -178.593 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 74.5 m -102.28 107.87 19.05 Favored 'General case' 0 N--CA 1.483 1.189 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.022 -161.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 7.2 tp -115.92 104.22 16.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 C-N-CA 124.027 0.931 . . . . 0.0 108.64 -178.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -118.33 124.61 73.38 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 C-N-CA 124.127 0.971 . . . . 0.0 109.117 178.422 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 15.2 t -125.92 157.75 36.92 Favored 'General case' 0 N--CA 1.493 1.691 0 CA-C-O 122.471 1.129 . . . . 0.0 111.496 170.751 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 14.5 tp -92.49 122.61 35.09 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-N 114.938 -1.028 . . . . 0.0 110.138 175.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -122.75 79.58 1.65 Allowed 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 123.307 0.643 . . . . 0.0 109.885 -178.054 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 64.3 49.34 66.53 Favored Glycine 0 CA--C 1.55 2.235 0 N-CA-C 117.188 1.635 . . . . 0.0 117.188 -175.126 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 74.2 43.77 31.19 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 117.321 1.688 . . . . 0.0 117.321 -171.343 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -153.67 108.61 3.14 Favored 'General case' 0 CA--C 1.554 1.107 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 -169.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 50.9 mt -83.05 96.57 8.4 Favored 'General case' 0 N--CA 1.492 1.655 0 CA-C-O 122.812 1.292 . . . . 0.0 109.56 177.225 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 93.0 t -87.88 100.68 10.59 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.356 0 CA-C-N 112.972 -1.922 . . . . 0.0 105.944 179.125 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 22.6 t-160 -105.83 141.8 36.64 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 124.075 0.95 . . . . 0.0 109.598 -176.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 34.8 tp -140.13 121.24 14.75 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 177.231 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 87.7 mt-30 -115.55 110.38 19.15 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 -177.585 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -107.73 134.51 50.59 Favored 'General case' 0 N--CA 1.494 1.752 0 C-N-CA 122.986 0.514 . . . . 0.0 111.351 -174.101 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 17.5 p90 -151.04 108.72 3.66 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.398 -0.814 . . . . 0.0 109.877 177.539 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 7.1 t70 55.66 52.2 11.35 Favored 'General case' 0 N--CA 1.499 2.007 0 N-CA-C 116.408 2.003 . . . . 0.0 116.408 168.468 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 85.71 -42.55 3.16 Favored Glycine 0 CA--C 1.553 2.445 0 N-CA-C 116.768 1.467 . . . . 0.0 116.768 -169.339 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 62.9 mt-30 -78.62 125.8 29.86 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 123.744 0.818 . . . . 0.0 111.037 179.44 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -136.03 128.2 29.88 Favored 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 122.717 0.407 . . . . 0.0 111.452 178.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 7.7 t -113.44 132.57 55.6 Favored 'General case' 0 N--CA 1.495 1.791 0 C-N-CA 123.163 0.585 . . . . 0.0 110.921 177.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 41.2 p -101.01 130.39 47.0 Favored 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 122.896 0.478 . . . . 0.0 110.982 174.145 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 5.3 mp -111.16 79.68 1.23 Allowed 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.288 -1.005 . . . . 0.0 108.288 177.756 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 51.8 t -89.09 108.63 19.28 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 -169.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 80.5 mtt85 -104.35 113.95 27.86 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 122.946 0.498 . . . . 0.0 110.255 -174.776 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -126.0 136.99 53.62 Favored 'General case' 0 N--CA 1.493 1.677 0 C-N-CA 123.307 0.643 . . . . 0.0 111.617 179.08 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -81.81 115.69 21.14 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 123.277 0.631 . . . . 0.0 110.793 175.4 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 86.4 mt -124.75 107.94 19.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 N-CA-C 105.081 -2.192 . . . . 0.0 105.081 179.247 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 20.9 m-20 57.97 51.66 8.7 Favored 'General case' 0 N--CA 1.499 1.988 0 N-CA-C 114.971 1.471 . . . . 0.0 114.971 176.455 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 65.51 16.68 63.41 Favored Glycine 0 CA--C 1.555 2.584 0 N-CA-C 119.857 2.703 . . . . 0.0 119.857 -170.486 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 8.7 mtmp? -128.65 128.66 44.57 Favored 'General case' 0 N--CA 1.488 1.445 0 CA-C-N 119.877 1.838 . . . . 0.0 109.315 -173.447 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 22.2 tp -78.35 113.78 16.64 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 123.847 0.859 . . . . 0.0 109.843 178.501 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 34.9 mm -103.15 101.34 12.05 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 N-CA-C 106.42 -1.696 . . . . 0.0 106.42 -174.63 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 23.6 tp -90.17 103.0 15.72 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 123.915 0.886 . . . . 0.0 109.594 179.414 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 91.8 m -96.82 107.25 19.7 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 -175.335 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 71.9 mt -102.65 99.51 9.5 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 123.762 0.825 . . . . 0.0 109.476 -172.176 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 6.5 m -109.08 119.62 40.1 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 -176.414 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 75.6 t60 -141.12 120.62 13.22 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 171.032 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 74.88 -117.05 5.26 Favored Glycine 0 N--CA 1.484 1.863 0 CA-C-N 116.37 -0.377 . . . . 0.0 112.656 179.013 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 76.6 m -122.19 68.37 0.94 Allowed 'General case' 0 CA--C 1.565 1.553 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 167.471 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -164.06 99.09 0.85 Allowed 'General case' 0 N--CA 1.485 1.314 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 175.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 4.2 p -96.95 122.17 48.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 C-N-CA 123.929 0.892 . . . . 0.0 109.71 176.292 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 42.0 t -110.0 102.44 11.17 Favored 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 123.225 0.61 . . . . 0.0 110.731 178.063 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 63.9 m -90.74 100.39 13.25 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 -176.062 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 30.5 mtm180 -102.44 121.67 42.79 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 122.802 0.441 . . . . 0.0 111.106 -171.038 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 94.6 m -91.05 132.89 35.74 Favored 'General case' 0 CA--C 1.563 1.46 0 C-N-CA 123.763 0.825 . . . . 0.0 110.442 -177.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 37.5 m-85 -131.49 140.35 49.53 Favored 'General case' 0 CA--C 1.562 1.425 0 C-N-CA 124.298 1.039 . . . . 0.0 109.194 179.322 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 1.4 pp20? -111.31 157.8 19.76 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.637 -0.665 . . . . 0.0 111.837 166.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 22.9 ttpt -85.45 129.33 34.84 Favored 'General case' 0 N--CA 1.489 1.498 0 CA-C-O 121.906 0.86 . . . . 0.0 112.241 -167.67 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 28.2 mm-40 -118.27 55.76 0.89 Allowed 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 124.956 1.302 . . . . 0.0 111.089 -173.609 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.9 0 CA-C-O 124.447 2.07 . . . . 0.0 109.074 -168.359 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 3.3 p . . . . . 0 CA--C 1.577 2.0 0 N-CA-C 116.112 1.894 . . . . 0.0 116.112 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -68.19 -33.21 74.02 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 116.709 2.114 . . . . 0.0 116.709 -175.495 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -59.44 -25.27 64.23 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 117.707 2.484 . . . . 0.0 117.707 168.192 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -73.72 -24.3 59.89 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 116.133 1.901 . . . . 0.0 116.133 167.785 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 52.0 mt -79.9 113.84 18.37 Favored 'General case' 0 N--CA 1.489 1.505 0 CA-C-N 120.975 1.716 . . . . 0.0 111.451 -166.369 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 158.91 177.39 31.95 Favored Glycine 0 CA--C 1.543 1.785 0 CA-C-O 122.798 1.221 . . . . 0.0 112.985 -175.063 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 63.1 m -84.81 142.88 29.46 Favored 'General case' 0 N--CA 1.492 1.641 0 CA-C-N 114.57 -0.815 . . . . 0.0 109.817 171.356 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 82.6 m95 -140.9 113.95 8.47 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 107.659 -1.237 . . . . 0.0 107.659 -176.402 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 58.9 mttp -97.68 141.17 31.03 Favored 'General case' 0 N--CA 1.492 1.636 0 CA-C-O 121.016 0.436 . . . . 0.0 109.999 175.476 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 55.8 tp -66.71 124.66 23.51 Favored 'General case' 0 N--CA 1.49 1.56 0 CA-C-O 122.135 0.969 . . . . 0.0 111.668 -178.615 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . 0.284 0.9 OUTLIER -103.78 -43.42 8.58 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.784 0 CA-C-N 113.893 -1.503 . . . . 0.0 112.036 -178.222 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -142.63 129.13 20.17 Favored 'General case' 0 N--CA 1.49 1.545 0 CA-C-N 120.336 1.425 . . . . 0.0 109.778 177.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 87.8 p -111.77 116.5 30.81 Favored 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 123.236 0.614 . . . . 0.0 109.82 167.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -83.99 -75.45 0.34 Allowed 'General case' 0 N--CA 1.492 1.664 0 C-N-CA 122.78 0.432 . . . . 0.0 111.66 -173.519 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 71.4 m-20 -106.44 44.2 1.08 Allowed 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 113.307 0.854 . . . . 0.0 113.307 179.671 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 15.2 t80 -91.37 65.69 5.37 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 120.714 -1.241 . . . . 0.0 111.796 -177.705 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -168.2 -53.47 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 126.534 1.934 . . . . 0.0 107.079 -176.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -55.54 -47.72 75.87 Favored 'General case' 0 N--CA 1.498 1.947 0 N-CA-C 115.228 1.566 . . . . 0.0 115.228 161.648 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 92.8 t80 -52.41 -55.58 20.79 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 114.786 1.402 . . . . 0.0 114.786 170.415 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 75.2 mtm -66.22 -31.65 72.6 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 116.481 2.03 . . . . 0.0 116.481 174.787 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -64.58 -45.26 87.75 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-N 120.197 1.362 . . . . 0.0 114.564 168.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 23.2 t -59.14 -38.88 80.75 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 115.762 1.764 . . . . 0.0 115.762 170.339 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 95.2 mt -64.22 -39.43 93.95 Favored 'General case' 0 CA--C 1.57 1.749 0 N-CA-C 115.472 1.656 . . . . 0.0 115.472 164.785 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 129.51 -95.49 0.36 Allowed Glycine 0 CA--C 1.54 1.604 0 N-CA-C 108.887 -1.685 . . . . 0.0 108.887 -174.028 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . 0.285 13.2 t 56.73 66.95 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.058 0 N-CA-C 114.044 1.127 . . . . 0.0 114.044 168.075 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 34.47 -128.73 0.56 Allowed Glycine 0 CA--C 1.553 2.435 0 N-CA-C 120.077 2.791 . . . . 0.0 120.077 177.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 43.0 p90 -146.37 -54.88 0.26 Allowed 'General case' 0 N--CA 1.494 1.749 0 C-N-CA 124.202 1.001 . . . . 0.0 110.044 169.323 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.96 -33.5 75.51 Favored 'General case' 0 CA--C 1.564 1.49 0 N-CA-C 116.245 1.943 . . . . 0.0 116.245 164.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 29.8 m -63.49 -38.76 92.36 Favored 'General case' 0 N--CA 1.498 1.925 0 CA-C-N 120.284 1.402 . . . . 0.0 114.258 168.14 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 22.7 ttp180 -58.33 -43.67 88.36 Favored 'General case' 0 CA--C 1.573 1.847 0 N-CA-C 115.102 1.519 . . . . 0.0 115.102 167.554 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 8.1 tm0? -65.87 -51.25 60.37 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 115.116 1.524 . . . . 0.0 115.116 173.137 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 94.2 t -60.6 -45.43 97.3 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 CA-C-N 119.249 0.932 . . . . 0.0 113.01 176.332 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -65.42 -36.79 84.99 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 116.472 2.027 . . . . 0.0 116.472 175.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 95.5 p -64.07 -42.14 97.08 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 116.161 1.912 . . . . 0.0 116.161 168.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 35.8 ttm -66.5 -39.71 88.84 Favored 'General case' 0 CA--C 1.57 1.722 0 N-CA-C 115.921 1.822 . . . . 0.0 115.921 169.806 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 54.1 m -70.77 144.25 50.95 Favored 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 124.354 1.062 . . . . 0.0 112.331 -176.609 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? -102.91 99.59 14.28 Favored Pre-proline 0 CA--C 1.573 1.864 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 173.107 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -78.48 111.0 2.95 Favored 'Trans proline' 0 CA--C 1.56 1.804 0 C-N-CA 123.388 2.725 . . . . 0.0 111.594 -178.254 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 97.0 m -78.65 104.84 9.53 Favored 'General case' 0 N--CA 1.491 1.625 0 CA-C-O 121.372 0.606 . . . . 0.0 109.969 -173.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 86.4 m -87.55 114.79 24.48 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 124.086 0.954 . . . . 0.0 109.091 -174.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 81.9 mt -112.46 108.47 25.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 N-CA-C 106.557 -1.646 . . . . 0.0 106.557 -177.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 17.0 mt -97.14 121.24 47.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 -179.21 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -140.7 118.0 11.38 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 -169.728 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 45.2 tttp -90.62 114.91 27.29 Favored 'General case' 0 CA--C 1.557 1.214 0 C-N-CA 123.267 0.627 . . . . 0.0 111.36 -176.365 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 51.4 m-80 -105.82 83.39 1.92 Allowed 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 -179.603 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 80.6 -97.63 1.73 Allowed Glycine 0 N--CA 1.486 2.028 0 O-C-N 121.704 -0.623 . . . . 0.0 112.13 -169.007 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -130.34 62.53 1.58 Allowed 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 159.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 30.8 mm -138.28 100.69 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 N-CA-C 104.818 -2.29 . . . . 0.0 104.818 -178.047 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 71.0 mt -85.35 99.9 11.47 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 122.663 0.385 . . . . 0.0 110.47 -179.132 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 46.9 m -92.4 105.51 17.69 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 107.14 -1.43 . . . . 0.0 107.14 -178.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 10.0 tt -104.68 96.45 6.58 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 106.957 -1.497 . . . . 0.0 106.957 -170.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 58.9 mttp -94.83 106.84 18.85 Favored 'General case' 0 N--CA 1.482 1.133 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 -163.41 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 45.4 m -90.08 92.03 8.8 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 -175.27 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 75.4 m80 -87.64 93.64 9.49 Favored 'General case' 0 N--CA 1.488 1.47 0 CA-C-O 121.733 0.778 . . . . 0.0 110.688 -173.282 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 41.9 t -113.35 151.43 31.24 Favored 'General case' 0 CA--C 1.555 1.144 0 C-N-CA 124.051 0.941 . . . . 0.0 110.078 -175.658 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 27.2 m -55.92 -27.36 51.88 Favored 'General case' 0 N--CA 1.501 2.102 0 N-CA-C 115.265 1.579 . . . . 0.0 115.265 159.539 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 36.2 t80 -115.19 104.72 12.12 Favored 'General case' 0 N--CA 1.485 1.281 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 173.34 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 32.6 mmmt 62.55 90.51 0.07 Allowed 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 113.951 1.093 . . . . 0.0 113.951 168.831 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 7.4 p-10 -79.33 120.12 23.34 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 122.95 0.5 . . . . 0.0 111.501 177.142 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 73.7 p -133.87 132.68 40.63 Favored 'General case' 0 N--CA 1.496 1.836 0 C-N-CA 123.146 0.579 . . . . 0.0 110.076 -170.805 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -118.95 140.74 49.49 Favored 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 122.944 0.498 . . . . 0.0 112.161 178.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 42.9 pt -117.22 129.97 72.88 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 C-N-CA 123.405 0.682 . . . . 0.0 109.447 -178.66 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 88.2 p -106.46 118.49 36.78 Favored 'General case' 0 N--CA 1.493 1.7 0 C-N-CA 123.745 0.818 . . . . 0.0 110.209 -178.195 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 50.2 p90 -140.82 135.86 31.84 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 115.188 1.551 . . . . 0.0 115.188 -167.55 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 53.1 mtmt -102.74 19.33 19.42 Favored 'General case' 0 CA--C 1.574 1.883 0 N-CA-C 116.556 2.058 . . . . 0.0 116.556 -175.42 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . 0.294 1.3 mp 63.21 93.07 0.06 Allowed 'General case' 0 N--CA 1.494 1.739 0 CA-C-N 120.418 1.463 . . . . 0.0 114.293 173.365 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 85.79 39.59 8.06 Favored Glycine 0 CA--C 1.55 2.259 0 N-CA-C 116.716 1.446 . . . . 0.0 116.716 -167.072 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 87.7 t -139.47 122.71 18.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 N-CA-C 106.324 -1.732 . . . . 0.0 106.324 178.597 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -87.63 125.8 34.58 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 123.448 0.699 . . . . 0.0 110.948 176.41 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 40.8 p90 -132.79 127.7 35.15 Favored 'General case' 0 N--CA 1.493 1.722 0 C-N-CA 123.558 0.743 . . . . 0.0 110.65 -173.179 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -69.52 126.59 30.2 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.607 -0.683 . . . . 0.0 112.734 174.288 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 12.9 tp10 -138.73 133.87 32.79 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 123.193 0.597 . . . . 0.0 110.156 -167.164 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 58.9 m -92.55 121.33 33.89 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 176.22 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 32.0 p -81.41 172.0 14.07 Favored 'General case' 0 N--CA 1.493 1.705 0 CA-C-O 122.041 0.924 . . . . 0.0 113.316 -173.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -51.6 -35.34 41.12 Favored 'General case' 0 CA--C 1.568 1.638 0 N-CA-C 118.038 2.607 . . . . 0.0 118.038 166.415 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -111.18 51.32 0.78 Allowed 'General case' 0 CA--C 1.574 1.867 0 CA-C-N 119.197 0.908 . . . . 0.0 112.177 171.621 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 51.84 73.67 0.31 Allowed 'General case' 0 N--CA 1.5 2.044 0 N-CA-C 116.584 2.068 . . . . 0.0 116.584 168.678 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 67.9 mtt-85 -143.03 125.11 15.3 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.808 -0.558 . . . . 0.0 109.665 -176.094 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.75 91.8 8.06 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 123.411 0.685 . . . . 0.0 111.483 177.372 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 10.6 m -111.97 128.59 68.46 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 121.808 -0.558 . . . . 0.0 111.426 -163.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 29.8 mmtp -83.7 104.3 13.7 Favored 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 123.672 0.789 . . . . 0.0 110.514 178.734 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 68.8 m -103.26 99.86 9.73 Favored 'General case' 0 N--CA 1.483 1.216 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.952 -160.447 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 7.0 tp -110.6 105.07 18.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 C-N-CA 123.646 0.778 . . . . 0.0 109.264 -177.483 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -116.96 125.54 73.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 C-N-CA 124.447 1.099 . . . . 0.0 108.353 177.32 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 11.0 t -130.16 152.52 49.51 Favored 'General case' 0 N--CA 1.492 1.632 0 CA-C-O 122.577 1.179 . . . . 0.0 111.024 172.644 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 26.3 tp -87.33 109.13 19.32 Favored 'General case' 0 N--CA 1.487 1.404 0 CA-C-N 114.64 -1.163 . . . . 0.0 109.676 177.543 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -123.51 95.26 4.52 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 -174.592 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 63.32 49.48 70.27 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 117.343 1.697 . . . . 0.0 117.343 -177.559 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 67.27 24.24 73.44 Favored Glycine 0 CA--C 1.557 2.691 0 N-CA-C 119.001 2.36 . . . . 0.0 119.001 -169.746 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 56.3 mtmt -131.93 125.45 31.67 Favored 'General case' 0 N--CA 1.487 1.425 0 CA-C-N 118.735 1.267 . . . . 0.0 107.848 -176.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 58.8 mt -84.56 94.86 8.68 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-O 123.03 1.395 . . . . 0.0 109.467 171.173 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 98.4 t -89.17 101.12 11.7 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.361 0 CA-C-N 112.643 -2.071 . . . . 0.0 105.844 -174.332 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 22.4 t-160 -105.78 139.88 39.67 Favored 'General case' 0 N--CA 1.486 1.348 0 CA-C-N 114.94 -1.027 . . . . 0.0 109.883 -173.5 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 29.1 tp -138.53 121.2 16.32 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 176.709 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 88.9 mt-30 -113.28 121.52 44.67 Favored 'General case' 0 N--CA 1.487 1.425 0 C-N-CA 124.233 1.013 . . . . 0.0 108.45 179.328 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 9.8 mtmp? -123.76 133.15 53.9 Favored 'General case' 0 N--CA 1.497 1.895 0 C-N-CA 122.994 0.517 . . . . 0.0 111.008 -170.314 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 13.5 p90 -156.45 112.66 3.03 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.689 -0.632 . . . . 0.0 110.325 -175.414 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 9.1 t70 53.76 52.51 12.96 Favored 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 116.279 1.955 . . . . 0.0 116.279 167.574 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 87.41 -44.01 3.24 Favored Glycine 0 CA--C 1.551 2.324 0 N-CA-C 116.687 1.435 . . . . 0.0 116.687 -169.492 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 21.7 mt-30 -79.47 139.72 37.55 Favored 'General case' 0 N--CA 1.488 1.452 0 CA-C-N 117.841 0.82 . . . . 0.0 112.124 -178.179 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -144.16 130.25 19.57 Favored 'General case' 0 N--CA 1.491 1.586 0 CA-C-O 121.16 0.505 . . . . 0.0 111.779 177.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 12.4 t -118.63 131.15 56.18 Favored 'General case' 0 N--CA 1.492 1.673 0 C-N-CA 123.525 0.73 . . . . 0.0 110.717 177.554 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 35.5 p -99.01 137.77 37.06 Favored 'General case' 0 N--CA 1.492 1.654 0 CA-C-O 121.311 0.576 . . . . 0.0 111.188 173.203 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 5.3 mp -122.11 74.74 1.17 Allowed 'General case' 0 CA--C 1.564 1.518 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 -179.368 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 87.0 t -84.97 108.06 16.55 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 121.085 -1.01 . . . . 0.0 108.484 -169.555 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 82.9 mtt85 -99.53 120.96 40.48 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 123.234 0.614 . . . . 0.0 109.823 -175.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -141.35 130.81 23.81 Favored 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 123.107 0.563 . . . . 0.0 111.084 -170.689 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -81.69 112.52 18.95 Favored 'General case' 0 N--CA 1.487 1.413 0 CA-C-O 121.51 0.671 . . . . 0.0 111.029 -179.577 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 50.3 mm -118.5 105.46 17.79 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.352 0 N-CA-C 105.171 -2.159 . . . . 0.0 105.171 179.221 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 57.86 49.58 11.8 Favored 'General case' 0 N--CA 1.499 2.02 0 N-CA-C 114.763 1.394 . . . . 0.0 114.763 176.136 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 82.51 -29.28 3.28 Favored Glycine 0 CA--C 1.554 2.522 0 N-CA-C 118.807 2.283 . . . . 0.0 118.807 -169.504 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 89.9 mttt -93.72 136.11 34.33 Favored 'General case' 0 N--CA 1.486 1.371 0 CA-C-N 119.275 1.537 . . . . 0.0 111.189 -168.369 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 20.6 tp -80.73 115.93 20.48 Favored 'General case' 0 CA--C 1.558 1.279 0 C-N-CA 123.24 0.616 . . . . 0.0 110.105 177.551 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 39.2 mm -104.0 101.57 12.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 N-CA-C 106.835 -1.543 . . . . 0.0 106.835 -175.3 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 16.2 tp -91.81 102.22 14.81 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 124.009 0.924 . . . . 0.0 109.729 179.604 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 58.5 m -91.54 112.87 24.97 Favored 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 123.883 0.873 . . . . 0.0 109.286 -175.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 96.7 mt -111.09 97.48 6.84 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 123.71 0.804 . . . . 0.0 109.708 -169.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 10.2 m -113.08 117.75 32.86 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.875 -0.516 . . . . 0.0 109.788 -172.405 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 78.9 t60 -152.34 116.4 4.91 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 174.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 60.6 61.18 7.33 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 117.061 1.584 . . . . 0.0 117.061 171.39 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . 0.297 4.3 m 51.65 51.53 16.49 Favored 'General case' 0 CA--C 1.576 1.953 0 N-CA-C 114.928 1.455 . . . . 0.0 114.928 -172.098 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -158.11 86.62 0.9 Allowed 'General case' 0 N--CA 1.484 1.228 0 CA-C-O 121.542 0.687 . . . . 0.0 109.194 -179.618 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 3.4 p -91.23 111.85 24.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 C-N-CA 123.691 0.796 . . . . 0.0 109.257 175.4 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 48.4 t -105.17 102.05 11.57 Favored 'General case' 0 CA--C 1.552 1.032 0 CA-C-O 121.461 0.648 . . . . 0.0 109.662 176.052 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 86.0 m -90.56 94.2 9.61 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 -175.706 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 32.5 mtm180 -91.88 120.98 33.06 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 122.927 0.491 . . . . 0.0 111.019 -169.426 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 87.6 m -86.61 131.83 34.06 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 123.463 0.705 . . . . 0.0 110.096 179.09 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 35.9 m-85 -128.43 126.59 40.87 Favored 'General case' 0 CA--C 1.558 1.275 0 C-N-CA 123.82 0.848 . . . . 0.0 108.835 178.538 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -93.99 150.98 19.87 Favored 'General case' 0 N--CA 1.492 1.672 0 CA-C-O 122.08 0.943 . . . . 0.0 111.526 169.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 68.9 tttt -83.06 119.56 24.63 Favored 'General case' 0 N--CA 1.486 1.329 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.706 -169.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 11.8 mm-40 -110.09 49.36 0.85 Allowed 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 123.934 0.894 . . . . 0.0 113.03 179.49 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.301 0 CA-C-O 123.27 1.509 . . . . 0.0 113.569 169.928 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.303 8.5 t . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 118.248 -0.882 . . . . 0.0 112.984 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -60.48 -37.46 81.13 Favored 'General case' 0 N--CA 1.497 1.895 0 N-CA-C 116.224 1.935 . . . . 0.0 116.224 179.505 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -63.55 -29.07 70.39 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 117.047 2.24 . . . . 0.0 117.047 164.057 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -72.93 -21.67 60.84 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 116.145 1.905 . . . . 0.0 116.145 170.589 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 48.2 mt -69.64 114.74 8.14 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-N 121.516 1.962 . . . . 0.0 111.917 -172.541 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 157.93 172.94 25.72 Favored Glycine 0 CA--C 1.543 1.808 0 CA-C-O 122.442 1.023 . . . . 0.0 113.428 -173.554 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 80.1 m -92.88 140.52 29.41 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 171.177 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 85.2 m95 -138.7 114.75 10.16 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 -173.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 48.5 mtmt -97.18 147.16 24.37 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-O 121.54 0.686 . . . . 0.0 111.32 177.297 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 57.3 tp -70.76 126.26 29.1 Favored 'General case' 0 N--CA 1.487 1.421 0 CA-C-O 121.905 0.859 . . . . 0.0 112.438 -175.505 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . 0.271 1.1 t -104.58 -44.16 8.54 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.852 0 CA-C-N 114.327 -1.306 . . . . 0.0 112.421 178.542 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -140.45 134.31 30.55 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-N 120.004 1.275 . . . . 0.0 109.687 -178.487 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 79.9 p -122.17 113.99 20.24 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 123.456 0.702 . . . . 0.0 110.053 171.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 10.7 mtpm? -81.92 -88.16 0.09 Allowed 'General case' 0 N--CA 1.492 1.646 0 CA-C-O 118.962 -0.542 . . . . 0.0 111.472 -177.152 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 70.9 m-80 -98.1 43.03 1.07 Allowed 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 113.831 1.049 . . . . 0.0 113.831 -174.222 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 17.5 t80 -76.83 -43.11 37.67 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 115.722 1.749 . . . . 0.0 115.722 -168.325 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 33.3 m-20 -63.69 -36.51 84.1 Favored 'General case' 0 N--CA 1.499 1.999 0 N-CA-C 115.112 1.523 . . . . 0.0 115.112 169.763 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 24.1 t0 -60.87 -47.32 86.9 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 115.174 1.546 . . . . 0.0 115.174 167.226 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 83.7 t80 -53.95 -53.02 58.62 Favored 'General case' 0 CA--C 1.569 1.702 0 N-CA-C 115.194 1.553 . . . . 0.0 115.194 170.448 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 79.0 mtm -63.76 -34.58 78.21 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 116.149 1.907 . . . . 0.0 116.149 173.704 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -57.59 -50.61 72.55 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 114.65 1.352 . . . . 0.0 114.65 165.194 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 22.9 t -60.28 -36.58 78.15 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 116.318 1.97 . . . . 0.0 116.318 171.482 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.493 ' HB3' HH12 ' A' ' 78' ' ' ARG . 31.2 mt -64.1 -34.75 78.75 Favored 'General case' 0 CA--C 1.565 1.53 0 N-CA-C 117.309 2.337 . . . . 0.0 117.309 169.74 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 101.25 76.26 1.19 Allowed Glycine 0 N--CA 1.482 1.741 0 CA-C-N 119.118 0.872 . . . . 0.0 112.02 -171.415 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 58.3 t -138.33 122.76 21.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 N-CA-C 105.585 -2.006 . . . . 0.0 105.585 -179.554 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -63.27 147.53 50.53 Favored Glycine 0 N--CA 1.488 2.116 0 N-CA-C 115.431 0.932 . . . . 0.0 115.431 177.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . 0.257 25.2 p90 -55.34 -41.64 72.74 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 118.834 2.901 . . . . 0.0 118.834 -166.169 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.57 -44.48 96.21 Favored 'General case' 0 CA--C 1.565 1.541 0 N-CA-C 115.979 1.844 . . . . 0.0 115.979 175.157 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 86.6 m -68.78 -38.6 80.12 Favored 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 114.439 1.274 . . . . 0.0 114.439 168.772 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 48.8 ttp180 -56.57 -45.14 81.47 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 115.421 1.637 . . . . 0.0 115.421 174.373 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 18.8 mm100 -70.5 -38.13 74.3 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 115.167 1.543 . . . . 0.0 115.167 173.196 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 95.3 t -63.45 -44.09 98.71 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.094 0 CA-C-N 120.093 1.315 . . . . 0.0 113.46 171.525 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -63.98 -31.06 72.11 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 117.371 2.36 . . . . 0.0 117.371 174.641 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 93.7 p -68.57 -42.2 78.62 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 116.15 1.907 . . . . 0.0 116.15 168.072 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 3.7 ppp? -71.87 -26.91 62.54 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 117.582 2.438 . . . . 0.0 117.582 175.34 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 5.3 t -74.79 162.95 28.2 Favored 'General case' 0 N--CA 1.493 1.699 0 CA-C-N 120.335 1.425 . . . . 0.0 112.592 175.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -99.97 103.51 22.84 Favored Pre-proline 0 CA--C 1.567 1.61 0 CA-C-O 118.008 -0.996 . . . . 0.0 108.853 172.394 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -78.89 90.32 1.29 Allowed 'Trans proline' 0 CA--C 1.56 1.81 0 C-N-CA 123.208 2.606 . . . . 0.0 111.225 177.292 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 94.4 m -80.19 111.79 16.89 Favored 'General case' 0 N--CA 1.489 1.513 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.574 -161.164 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 36.5 m -86.42 113.28 22.24 Favored 'General case' 0 CA--C 1.559 1.323 0 C-N-CA 123.598 0.759 . . . . 0.0 109.446 -171.711 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 71.6 mt -109.59 103.62 15.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 N-CA-C 106.033 -1.84 . . . . 0.0 106.033 177.649 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 3.7 mp -91.68 123.41 43.79 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 N-CA-C 106.881 -1.526 . . . . 0.0 106.881 172.175 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -148.21 125.61 11.62 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 -169.626 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.32 153.65 29.68 Favored 'General case' 0 CA--C 1.565 1.54 0 CA-C-O 122.173 0.987 . . . . 0.0 113.656 178.249 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 67.1 m-80 -141.77 75.3 1.49 Allowed 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 106.389 -1.708 . . . . 0.0 106.389 171.16 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 71.17 -110.99 3.47 Favored Glycine 0 CA--C 1.548 2.108 0 O-C-N 121.885 -0.51 . . . . 0.0 112.86 -166.5 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 21.1 m-20 -82.75 -21.14 34.79 Favored 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 116.033 1.864 . . . . 0.0 116.033 168.024 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 42.8 mm -84.93 114.88 25.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 CA-C-N 119.863 1.21 . . . . 0.0 109.614 -168.191 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.4 HD12 HD13 ' A' ' 66' ' ' LEU . 44.5 mt -86.79 114.94 23.87 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 123.057 0.543 . . . . 0.0 110.342 174.164 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 88.5 m -107.81 102.82 12.0 Favored 'General case' 0 N--CA 1.486 1.342 0 N-CA-C 106.728 -1.582 . . . . 0.0 106.728 -174.358 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 8.9 tt -104.37 107.11 17.87 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -103.37 114.82 29.39 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 179.331 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 91.7 m -100.67 98.11 8.7 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 179.246 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 20.2 m-70 -85.08 91.26 8.06 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 123.411 0.684 . . . . 0.0 112.555 -169.456 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 15.2 t -100.65 155.09 18.08 Favored 'General case' 0 CA--C 1.557 1.241 0 C-N-CA 123.814 0.846 . . . . 0.0 110.302 174.486 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 63.4 p -59.19 -19.51 45.91 Favored 'General case' 0 N--CA 1.504 2.263 0 N-CA-C 116.459 2.022 . . . . 0.0 116.459 162.192 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 52.0 t80 -101.42 75.08 1.58 Allowed 'General case' 0 CA--C 1.562 1.408 0 CA-C-N 119.242 0.928 . . . . 0.0 108.903 165.213 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 31.9 mtmm 64.44 132.62 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 115.682 1.734 . . . . 0.0 115.682 176.165 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 8.8 p30 -81.98 112.83 19.43 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 123.054 0.541 . . . . 0.0 110.952 172.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 77.9 p -90.67 122.63 33.61 Favored 'General case' 0 N--CA 1.492 1.661 0 CA-C-O 121.178 0.513 . . . . 0.0 110.775 -174.559 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -108.12 115.82 30.83 Favored 'General case' 0 N--CA 1.486 1.341 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 -175.112 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 29.8 pt -111.24 129.63 66.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 N-CA-C 108.531 -0.915 . . . . 0.0 108.531 174.087 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 44.1 t -118.73 113.0 20.48 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.38 -0.971 . . . . 0.0 108.38 -174.574 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 43.8 p90 -144.89 140.77 28.55 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 115.093 1.516 . . . . 0.0 115.093 -162.1 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 29.5 mtpp -109.16 18.43 20.56 Favored 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 117.325 2.343 . . . . 0.0 117.325 -177.486 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.4 HD13 HD12 ' A' ' 49' ' ' LEU 0.296 1.3 mp 65.6 93.57 0.07 Allowed 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 125.03 1.332 . . . . 0.0 113.278 176.723 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 92.32 37.67 5.85 Favored Glycine 0 CA--C 1.55 2.228 0 N-CA-C 117.01 1.564 . . . . 0.0 117.01 -166.631 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 92.3 t -135.62 122.86 35.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 N-CA-C 107.035 -1.468 . . . . 0.0 107.035 178.311 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -88.08 131.91 34.5 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 123.401 0.68 . . . . 0.0 110.476 170.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 37.0 p90 -143.0 130.74 21.43 Favored 'General case' 0 N--CA 1.493 1.72 0 C-N-CA 123.333 0.653 . . . . 0.0 110.087 -174.069 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -72.56 114.02 10.24 Favored 'General case' 0 CA--C 1.564 1.501 0 O-C-N 121.546 -0.721 . . . . 0.0 111.933 175.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 14.0 tp10 -119.08 134.5 55.16 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 123.842 0.857 . . . . 0.0 109.782 -167.706 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 73.4 m -90.57 121.74 32.77 Favored 'General case' 0 N--CA 1.491 1.577 0 CA-C-O 121.258 0.551 . . . . 0.0 109.663 176.084 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 30.0 p -85.0 169.74 13.69 Favored 'General case' 0 N--CA 1.493 1.712 0 CA-C-O 121.54 0.686 . . . . 0.0 112.203 -177.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -59.37 -34.82 72.88 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 116.68 2.104 . . . . 0.0 116.68 166.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -76.53 9.24 2.84 Favored 'General case' 0 CA--C 1.581 2.144 0 N-CA-C 115.909 1.818 . . . . 0.0 115.909 167.309 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . 0.252 11.6 m-20 66.78 69.74 0.4 Allowed 'General case' 0 N--CA 1.494 1.77 0 C-N-CA 125.749 1.62 . . . . 0.0 112.669 176.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.493 HH12 ' HB3' ' A' ' 23' ' ' LEU . 60.4 mtm180 -143.56 128.17 18.1 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 122.915 0.486 . . . . 0.0 110.23 -175.117 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.36 117.56 13.05 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 123.491 0.716 . . . . 0.0 111.075 164.822 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 14.3 m -133.49 127.37 53.36 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 -171.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 33.2 mmtp -77.54 102.9 7.17 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 123.567 0.747 . . . . 0.0 110.557 -178.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 69.2 m -101.19 92.67 5.08 Favored 'General case' 0 N--CA 1.482 1.149 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.575 -165.074 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 7.2 tp -106.1 116.64 50.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 178.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 1.4 p -134.15 131.72 55.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 C-N-CA 123.806 0.842 . . . . 0.0 109.564 -170.808 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 10.1 t -148.63 152.17 36.25 Favored 'General case' 0 N--CA 1.49 1.533 0 CA-C-O 122.745 1.26 . . . . 0.0 110.359 179.691 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 26.4 tp -85.67 119.94 26.55 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-N 114.726 -1.125 . . . . 0.0 110.298 176.424 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -109.4 79.22 1.19 Allowed 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 123.52 0.728 . . . . 0.0 109.613 -178.357 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 54.9 44.26 81.96 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 118.477 2.151 . . . . 0.0 118.477 -177.454 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 107.12 -42.52 1.91 Allowed Glycine 0 N--CA 1.49 2.295 0 N-CA-C 116.558 1.383 . . . . 0.0 116.558 -168.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 35.9 ttmt -82.33 112.06 18.96 Favored 'General case' 0 CA--C 1.559 1.289 0 CA-C-N 118.164 0.982 . . . . 0.0 109.881 179.584 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.8 tt -88.28 102.72 15.12 Favored 'General case' 0 N--CA 1.488 1.459 0 CA-C-O 121.659 0.742 . . . . 0.0 109.311 -176.739 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 62.7 t -100.7 110.41 27.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 -166.656 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 22.8 t-160 -104.47 134.39 47.75 Favored 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 123.822 0.849 . . . . 0.0 109.713 171.774 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 24.4 tp -120.09 120.99 37.87 Favored 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 124.655 1.182 . . . . 0.0 107.944 172.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 27.6 mt-30 -109.2 113.71 26.79 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 171.522 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 38.0 ttmt -122.77 132.82 54.4 Favored 'General case' 0 CA--C 1.563 1.465 0 C-N-CA 123.461 0.704 . . . . 0.0 110.397 -174.592 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 34.9 p90 -149.09 115.2 5.76 Favored 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 123.36 0.664 . . . . 0.0 109.989 -176.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . 0.343 17.4 t70 67.15 -101.36 0.06 Allowed 'General case' 0 N--CA 1.495 1.796 0 C-N-CA 124.511 1.124 . . . . 0.0 111.972 176.179 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -127.88 56.23 0.74 Allowed Glycine 0 N--CA 1.487 2.059 0 CA-C-N 118.736 0.698 . . . . 0.0 113.16 162.568 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 49.1 mt-30 -149.15 110.41 4.41 Favored 'General case' 0 N--CA 1.485 1.31 0 N-CA-C 107.032 -1.47 . . . . 0.0 107.032 -177.481 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -117.01 124.42 49.27 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 122.894 0.477 . . . . 0.0 110.777 176.577 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 10.7 t -115.58 122.71 46.48 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 110.051 -0.351 . . . . 0.0 110.051 167.421 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 35.7 p -93.19 125.79 37.96 Favored 'General case' 0 N--CA 1.489 1.505 0 CA-C-O 121.274 0.559 . . . . 0.0 110.598 172.345 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 5.6 mp -99.08 86.73 3.51 Favored 'General case' 0 CA--C 1.561 1.387 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 175.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 93.3 t -94.21 108.53 20.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 -168.455 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 79.1 mtt85 -108.41 121.98 46.06 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 123.173 0.589 . . . . 0.0 110.143 -173.239 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -141.53 137.51 32.07 Favored 'General case' 0 N--CA 1.495 1.776 0 C-N-CA 123.114 0.566 . . . . 0.0 110.938 177.199 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -81.17 119.62 23.83 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.518 -0.739 . . . . 0.0 111.271 176.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 74.6 mt -123.97 110.89 26.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 N-CA-C 104.949 -2.241 . . . . 0.0 104.949 177.369 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 29.3 m-20 59.3 48.49 10.11 Favored 'General case' 0 N--CA 1.5 2.057 0 N-CA-C 114.767 1.395 . . . . 0.0 114.767 179.126 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 60.45 28.06 66.79 Favored Glycine 0 CA--C 1.554 2.473 0 N-CA-C 119.336 2.494 . . . . 0.0 119.336 -169.368 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 9.7 mtmp? -135.36 127.31 29.56 Favored 'General case' 0 N--CA 1.489 1.511 0 CA-C-N 119.482 1.641 . . . . 0.0 108.533 -173.649 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 35.0 tp -75.36 112.19 11.41 Favored 'General case' 0 CA--C 1.557 1.235 0 C-N-CA 123.493 0.717 . . . . 0.0 110.811 -179.561 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 31.0 mm -100.42 104.92 16.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 N-CA-C 106.409 -1.7 . . . . 0.0 106.409 -176.533 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 23.7 tp -97.96 101.17 12.59 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 123.81 0.844 . . . . 0.0 109.103 179.541 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 97.7 m -93.86 109.96 21.64 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 124.177 0.991 . . . . 0.0 108.769 -178.546 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 74.7 mt -103.8 90.32 3.6 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 123.913 0.885 . . . . 0.0 109.734 -168.534 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 7.5 m -100.06 118.18 35.88 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 -168.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 80.1 t60 -132.59 -105.49 0.25 Allowed 'General case' 0 N--CA 1.492 1.629 0 CA-C-O 118.77 -0.633 . . . . 0.0 109.652 176.105 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -119.63 91.14 0.49 Allowed Glycine 0 N--CA 1.486 1.989 0 CA-C-N 119.321 0.964 . . . . 0.0 112.65 -167.015 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . 0.297 1.6 m 54.62 34.37 21.27 Favored 'General case' 0 CA--C 1.582 2.179 0 N-CA-C 115.885 1.809 . . . . 0.0 115.885 -173.029 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -161.68 84.22 0.61 Allowed 'General case' 0 N--CA 1.485 1.308 0 O-C-N 121.15 -0.968 . . . . 0.0 108.768 -177.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 4.7 p -91.91 116.67 33.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 175.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 42.2 t -101.85 102.35 12.92 Favored 'General case' 0 CA--C 1.553 1.066 0 CA-C-O 121.187 0.518 . . . . 0.0 111.096 -179.63 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 96.2 m -87.7 111.75 21.64 Favored 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 177.424 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 28.9 mtm180 -114.4 119.28 36.39 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 122.898 0.479 . . . . 0.0 110.529 -170.347 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 88.9 m -84.42 134.97 34.45 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 123.234 0.614 . . . . 0.0 110.043 175.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 36.9 m-85 -130.11 128.43 41.83 Favored 'General case' 0 CA--C 1.56 1.345 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 178.367 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -93.77 150.72 20.16 Favored 'General case' 0 CA--C 1.564 1.503 0 CA-C-O 122.06 0.933 . . . . 0.0 111.202 172.173 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 69.3 tttt -82.97 124.83 30.76 Favored 'General case' 0 N--CA 1.486 1.342 0 N-CA-C 112.916 0.709 . . . . 0.0 112.916 -168.559 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 40.1 tp10 -99.06 47.95 0.96 Allowed 'General case' 0 CA--C 1.57 1.724 0 C-N-CA 123.772 0.829 . . . . 0.0 113.044 169.548 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.043 0 CA-C-O 124.263 1.982 . . . . 0.0 108.241 -176.94 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.306 5.0 t . . . . . 0 N--CA 1.49 1.526 0 CA-C-O 117.795 -1.098 . . . . 0.0 113.302 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -61.19 -36.99 81.38 Favored 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 115.991 1.849 . . . . 0.0 115.991 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -61.31 -32.23 72.09 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 116.957 2.206 . . . . 0.0 116.957 163.428 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -71.96 -25.41 61.86 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 115.978 1.844 . . . . 0.0 115.978 170.248 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 55.3 mt -71.71 117.32 13.14 Favored 'General case' 0 N--CA 1.492 1.652 0 CA-C-N 121.375 1.898 . . . . 0.0 111.112 -175.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 160.1 170.0 24.12 Favored Glycine 0 CA--C 1.54 1.627 0 CA-C-O 122.418 1.01 . . . . 0.0 113.853 -172.422 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 90.3 m -92.62 136.74 32.97 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-N 114.464 -0.868 . . . . 0.0 108.812 171.031 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 94.8 m95 -137.64 115.17 11.2 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.685 -0.858 . . . . 0.0 108.685 -170.193 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 23.0 mmmt -108.27 145.22 34.67 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-O 121.791 0.805 . . . . 0.0 110.536 179.627 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 25.8 tp -68.81 128.82 38.01 Favored 'General case' 0 N--CA 1.487 1.407 0 CA-C-O 122.222 1.011 . . . . 0.0 112.91 -171.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . 0.28 1.1 t -106.69 -45.67 8.01 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.725 0 CA-C-N 113.805 -1.543 . . . . 0.0 111.767 178.811 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 43.7 t0 -142.01 140.08 32.56 Favored 'General case' 0 N--CA 1.488 1.429 0 CA-C-N 119.437 1.017 . . . . 0.0 109.079 178.641 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 81.0 p -127.79 94.26 3.9 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.784 -0.572 . . . . 0.0 109.853 172.4 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 47.9 mtmt -91.99 120.8 32.97 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 123.57 0.748 . . . . 0.0 109.355 -176.408 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.264 42.1 m-20 71.53 21.17 4.56 Favored 'General case' 0 N--CA 1.504 2.264 0 N-CA-C 117.113 2.264 . . . . 0.0 117.113 -178.726 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 10.1 t80 -71.85 -41.13 68.47 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 115.853 1.797 . . . . 0.0 115.853 -175.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -60.52 -32.25 71.29 Favored 'General case' 0 N--CA 1.499 1.976 0 N-CA-C 116.014 1.857 . . . . 0.0 116.014 168.442 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 20.1 t0 -64.85 -50.72 65.54 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 114.331 1.234 . . . . 0.0 114.331 167.776 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 89.6 t80 -50.54 -54.83 19.39 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 115.349 1.611 . . . . 0.0 115.349 171.74 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 77.7 mtm -59.85 -41.85 92.35 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 115.231 1.567 . . . . 0.0 115.231 175.418 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.3 tmtp? -62.57 -43.94 97.57 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 114.788 1.403 . . . . 0.0 114.788 171.526 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 61.3 m -58.18 -39.39 78.8 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 116.574 2.064 . . . . 0.0 116.574 171.022 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 51.8 mt -61.54 -45.86 92.39 Favored 'General case' 0 CA--C 1.567 1.632 0 N-CA-C 115.747 1.758 . . . . 0.0 115.747 167.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 121.03 71.69 0.3 Allowed Glycine 0 N--CA 1.482 1.735 0 C-N-CA 123.979 0.8 . . . . 0.0 111.266 -172.101 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 40.5 t -141.6 122.0 12.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 N-CA-C 105.083 -2.191 . . . . 0.0 105.083 -176.294 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -77.15 -171.48 35.35 Favored Glycine 0 CA--C 1.548 2.154 0 N-CA-C 116.663 1.425 . . . . 0.0 116.663 -174.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 11.0 p90 -67.27 158.32 31.76 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 113.387 0.884 . . . . 0.0 113.387 176.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . 0.325 . . 78.76 -52.05 0.46 Allowed 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 114.995 1.48 . . . . 0.0 114.995 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 89.1 m -64.48 -40.93 96.61 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 114.241 1.201 . . . . 0.0 114.241 167.682 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 48.1 mtm180 -61.26 -43.66 98.52 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 114.996 1.48 . . . . 0.0 114.996 167.555 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -60.52 -49.81 76.07 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 115.058 1.503 . . . . 0.0 115.058 174.056 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 69.1 t -63.69 -43.84 98.2 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 CA-C-N 119.429 1.013 . . . . 0.0 112.742 174.819 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -62.7 -35.98 81.48 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 117.053 2.242 . . . . 0.0 117.053 176.234 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 96.7 p -65.66 -43.44 89.39 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 116.395 1.998 . . . . 0.0 116.395 170.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 20.0 ptm -68.21 -31.02 70.25 Favored 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 117.067 2.247 . . . . 0.0 117.067 168.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 38.0 m -71.85 143.47 49.41 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 124.279 1.031 . . . . 0.0 112.257 -178.025 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -104.52 102.97 37.16 Favored Pre-proline 0 CA--C 1.57 1.723 0 CA-C-O 118.145 -0.931 . . . . 0.0 109.1 175.25 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -79.2 116.88 3.72 Favored 'Trans proline' 0 CA--C 1.561 1.849 0 C-N-CA 122.913 2.409 . . . . 0.0 112.185 -178.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 24.4 m -78.8 105.36 10.06 Favored 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 123.675 0.79 . . . . 0.0 109.701 -170.536 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 61.0 m -101.12 106.77 18.05 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 -167.234 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 52.0 mt -111.69 107.19 22.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 N-CA-C 107.16 -1.422 . . . . 0.0 107.16 -172.149 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 3.9 mp -96.18 121.56 46.84 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 174.637 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 7.9 tm-20 -137.23 120.6 16.97 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 -178.03 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -86.23 115.9 24.07 Favored 'General case' 0 CA--C 1.56 1.339 0 C-N-CA 123.15 0.58 . . . . 0.0 111.052 179.431 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 12.5 t30 -105.79 86.87 2.46 Favored 'General case' 0 CA--C 1.561 1.374 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 179.282 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 80.92 -99.75 1.92 Allowed Glycine 0 N--CA 1.486 1.982 0 N-CA-C 111.883 -0.487 . . . . 0.0 111.883 -172.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -130.11 59.36 1.63 Allowed 'General case' 0 N--CA 1.494 1.747 0 CA-C-O 120.958 0.409 . . . . 0.0 110.065 160.399 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 42.6 mm -137.81 108.16 5.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 N-CA-C 104.889 -2.263 . . . . 0.0 104.889 -179.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 42.8 mt -83.11 106.67 15.1 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 122.756 0.422 . . . . 0.0 110.871 179.204 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 73.3 m -98.98 96.99 8.2 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 -173.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 9.1 tt -97.68 103.19 15.1 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 -179.227 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 91.3 mttt -98.94 111.14 23.62 Favored 'General case' 0 N--CA 1.485 1.276 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 -175.306 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 45.8 m -100.13 87.03 3.35 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 -177.601 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 12.0 m170 -89.87 98.63 11.88 Favored 'General case' 0 N--CA 1.492 1.642 0 CA-C-O 121.702 0.763 . . . . 0.0 110.053 -173.224 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 22.9 t -98.09 -24.27 15.39 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 116.962 2.208 . . . . 0.0 116.962 -172.54 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . 0.363 4.4 m 89.4 -43.46 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.274 0 CA-C-N 121.074 1.761 . . . . 0.0 112.486 -161.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 73.4 t80 -62.1 -70.97 0.17 Allowed 'General case' 0 N--CA 1.491 1.618 0 CA-C-N 119.43 1.013 . . . . 0.0 111.611 166.399 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 54.5 mtpt -145.88 135.41 23.16 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 174.151 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -85.55 101.09 12.38 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 122.971 0.508 . . . . 0.0 110.777 173.134 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 60.2 p -96.19 127.85 42.56 Favored 'General case' 0 N--CA 1.494 1.75 0 CA-C-O 121.396 0.617 . . . . 0.0 109.949 -179.577 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -124.52 125.09 43.65 Favored 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 123.426 0.69 . . . . 0.0 109.344 -171.582 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 48.2 pt -117.6 131.48 70.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 C-N-CA 123.524 0.73 . . . . 0.0 109.077 175.644 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 80.6 p -121.2 104.14 9.52 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 -178.055 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 50.1 p90 -136.9 147.09 46.23 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 114.809 1.411 . . . . 0.0 114.809 -156.555 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 25.9 mtpp -110.77 20.29 17.74 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 117.679 2.474 . . . . 0.0 117.679 -170.693 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . 0.311 1.7 mp 60.65 88.7 0.08 Allowed 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 114.93 1.456 . . . . 0.0 114.93 172.639 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 92.39 39.81 5.26 Favored Glycine 0 CA--C 1.549 2.194 0 N-CA-C 115.951 1.141 . . . . 0.0 115.951 -168.506 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 74.9 t -141.62 123.86 14.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 N-CA-C 105.533 -2.025 . . . . 0.0 105.533 -176.421 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -88.14 129.55 35.29 Favored 'General case' 0 CA--C 1.565 1.547 0 C-N-CA 122.924 0.49 . . . . 0.0 110.497 176.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 48.6 p90 -138.95 131.55 28.87 Favored 'General case' 0 N--CA 1.496 1.831 0 C-N-CA 123.231 0.612 . . . . 0.0 111.435 -174.201 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -69.17 131.56 45.14 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.303 -0.873 . . . . 0.0 113.133 173.602 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 17.4 tp10 -142.97 137.85 29.67 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 123.426 0.69 . . . . 0.0 110.028 -168.343 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 56.6 m -93.06 122.8 35.8 Favored 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 123.035 0.534 . . . . 0.0 109.639 176.238 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 26.9 p -84.14 177.8 8.08 Favored 'General case' 0 N--CA 1.496 1.86 0 CA-C-O 121.415 0.626 . . . . 0.0 112.549 -177.3 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -67.4 -27.97 67.53 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 117.416 2.376 . . . . 0.0 117.416 169.612 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 25.6 m-20 -77.96 8.3 4.88 Favored 'General case' 0 CA--C 1.579 2.096 0 N-CA-C 115.918 1.822 . . . . 0.0 115.918 161.39 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 64.01 68.81 0.55 Allowed 'General case' 0 N--CA 1.496 1.837 0 C-N-CA 125.366 1.466 . . . . 0.0 112.891 -179.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 63.7 mtm180 -137.05 127.96 27.46 Favored 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 123.001 0.521 . . . . 0.0 109.74 -171.457 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.04 102.8 6.64 Favored 'General case' 0 CA--C 1.565 1.53 0 C-N-CA 123.331 0.652 . . . . 0.0 111.141 173.071 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 19.9 m -120.36 129.99 74.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 -170.622 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 69.6 mmtt -81.74 107.13 14.23 Favored 'General case' 0 N--CA 1.49 1.531 0 CA-C-O 121.841 0.829 . . . . 0.0 109.867 176.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 74.3 m -102.07 102.49 12.98 Favored 'General case' 0 N--CA 1.481 1.08 0 CA-C-N 114.838 -1.073 . . . . 0.0 110.114 -165.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -106.91 115.04 47.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 175.67 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -128.26 128.15 68.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 C-N-CA 123.799 0.84 . . . . 0.0 109.32 -178.835 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 9.3 t -139.97 151.26 45.37 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-O 122.705 1.24 . . . . 0.0 111.337 -179.249 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 50.5 tp -82.2 125.48 30.97 Favored 'General case' 0 N--CA 1.489 1.498 0 CA-C-N 114.523 -1.217 . . . . 0.0 109.921 176.476 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -126.5 83.44 2.17 Favored 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 123.462 0.705 . . . . 0.0 109.771 -178.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 58.56 46.13 93.63 Favored Glycine 0 CA--C 1.552 2.395 0 N-CA-C 117.934 1.933 . . . . 0.0 117.934 -178.444 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 76.77 31.82 52.33 Favored Glycine 0 CA--C 1.555 2.544 0 N-CA-C 117.833 1.893 . . . . 0.0 117.833 -166.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 60.4 mtpt -141.13 112.82 7.62 Favored 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 106.629 -1.619 . . . . 0.0 106.629 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 3.7 mp -81.67 111.04 17.58 Favored 'General case' 0 N--CA 1.487 1.404 0 CA-C-O 121.94 0.876 . . . . 0.0 109.858 173.76 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 95.6 t -106.84 102.03 13.35 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 N-CA-C 105.324 -2.102 . . . . 0.0 105.324 -172.646 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 23.6 t-160 -104.85 136.95 43.39 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 124.35 1.06 . . . . 0.0 109.474 -178.306 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 33.7 tp -132.65 119.4 20.38 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 177.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 81.9 mt-30 -111.87 111.84 23.08 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 179.372 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 10.3 ptpp? -120.04 138.61 53.42 Favored 'General case' 0 N--CA 1.494 1.732 0 C-N-CA 123.228 0.611 . . . . 0.0 112.027 -172.324 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 13.7 p90 -156.79 109.8 2.57 Favored 'General case' 0 N--CA 1.488 1.475 0 C-N-CA 123.379 0.672 . . . . 0.0 109.825 -174.165 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 6.7 t70 54.5 54.4 9.38 Favored 'General case' 0 N--CA 1.498 1.949 0 N-CA-C 116.066 1.876 . . . . 0.0 116.066 168.62 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 87.2 -41.91 3.12 Favored Glycine 0 CA--C 1.552 2.38 0 N-CA-C 116.919 1.528 . . . . 0.0 116.919 -169.797 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -86.17 135.71 33.48 Favored 'General case' 0 N--CA 1.483 1.208 0 CA-C-N 117.979 0.89 . . . . 0.0 111.454 -174.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -144.86 137.73 26.51 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.911 -0.493 . . . . 0.0 112.006 -178.868 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 9.9 t -131.46 129.25 40.94 Favored 'General case' 0 N--CA 1.493 1.722 0 C-N-CA 123.356 0.662 . . . . 0.0 110.682 179.648 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 41.8 p -98.52 129.57 45.09 Favored 'General case' 0 N--CA 1.494 1.732 0 C-N-CA 122.884 0.474 . . . . 0.0 111.769 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 5.7 mp -103.91 80.26 1.73 Allowed 'General case' 0 CA--C 1.564 1.51 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 177.059 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 59.9 t -89.69 108.85 19.77 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 -168.73 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 81.8 mtt85 -102.96 122.09 43.88 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 123.425 0.69 . . . . 0.0 110.234 -176.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -138.73 139.74 38.46 Favored 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 123.04 0.536 . . . . 0.0 111.66 178.035 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -83.12 118.04 23.29 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 123.084 0.554 . . . . 0.0 111.412 178.536 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 46.5 mm -119.01 105.72 18.09 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 N-CA-C 105.287 -2.116 . . . . 0.0 105.287 174.277 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 58.61 49.29 10.58 Favored 'General case' 0 N--CA 1.5 2.037 0 N-CA-C 115.316 1.599 . . . . 0.0 115.316 175.641 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 65.75 26.78 72.21 Favored Glycine 0 CA--C 1.555 2.575 0 N-CA-C 119.142 2.417 . . . . 0.0 119.142 -170.291 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -134.08 125.46 28.06 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-N 119.017 1.409 . . . . 0.0 108.457 -173.785 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 16.7 tp -77.64 110.05 12.14 Favored 'General case' 0 CA--C 1.558 1.28 0 C-N-CA 123.361 0.665 . . . . 0.0 110.381 179.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 30.7 mm -97.92 101.89 12.75 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 N-CA-C 106.544 -1.651 . . . . 0.0 106.544 -176.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 29.4 tp -92.7 99.49 12.17 Favored 'General case' 0 N--CA 1.486 1.359 0 CA-C-O 121.812 0.815 . . . . 0.0 109.258 178.052 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 87.1 m -93.87 105.84 17.84 Favored 'General case' 0 CA--C 1.56 1.361 0 CA-C-N 114.884 -1.053 . . . . 0.0 108.26 -178.007 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 83.5 mt -97.12 100.69 12.17 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 123.816 0.846 . . . . 0.0 109.13 -174.193 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 7.1 m -100.63 119.58 38.77 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.71 -0.619 . . . . 0.0 109.751 -170.636 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 74.7 t60 -151.7 114.63 4.69 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 122.475 0.31 . . . . 0.0 110.376 171.24 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 52.54 71.44 0.68 Allowed Glycine 0 N--CA 1.488 2.146 0 N-CA-C 117.745 1.858 . . . . 0.0 117.745 162.053 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . 0.506 2.7 t 66.58 -44.32 0.43 Allowed 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 117.676 2.472 . . . . 0.0 117.676 -166.729 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -86.39 94.35 9.36 Favored 'General case' 0 N--CA 1.483 1.191 0 CA-C-N 119.563 1.074 . . . . 0.0 112.405 -177.288 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 6.4 p -98.11 128.61 49.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 C-N-CA 123.825 0.85 . . . . 0.0 109.803 174.521 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 42.7 t -109.45 107.48 17.64 Favored 'General case' 0 CA--C 1.553 1.068 0 C-N-CA 123.035 0.534 . . . . 0.0 112.125 -179.206 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 89.0 m -86.19 112.1 21.02 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 176.184 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 71.1 mtp180 -113.25 114.18 26.35 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 -174.107 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 85.5 m -86.72 133.54 33.66 Favored 'General case' 0 N--CA 1.495 1.782 0 C-N-CA 123.288 0.635 . . . . 0.0 110.106 177.37 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 48.4 m-85 -129.77 125.52 36.0 Favored 'General case' 0 CA--C 1.558 1.264 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 179.245 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -93.23 154.55 17.96 Favored 'General case' 0 N--CA 1.493 1.724 0 CA-C-O 122.481 1.134 . . . . 0.0 111.783 171.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 72.5 tttt -84.88 129.11 34.86 Favored 'General case' 0 N--CA 1.485 1.278 0 CA-C-N 115.04 -0.982 . . . . 0.0 112.534 -167.319 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 14.6 mm-40 -111.52 50.97 0.8 Allowed 'General case' 0 CA--C 1.567 1.597 0 C-N-CA 124.125 0.97 . . . . 0.0 111.572 175.709 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.967 0 CA-C-O 124.28 1.991 . . . . 0.0 108.121 -171.257 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.266 8.0 p . . . . . 0 CA--C 1.577 2.016 0 N-CA-C 116.127 1.899 . . . . 0.0 116.127 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -69.8 -38.99 76.84 Favored 'General case' 0 N--CA 1.497 1.891 0 N-CA-C 116.385 1.995 . . . . 0.0 116.385 -177.625 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -59.08 -27.88 65.95 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 117.513 2.412 . . . . 0.0 117.513 168.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -68.6 -24.87 64.63 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 116.29 1.959 . . . . 0.0 116.29 169.008 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 34.6 mt -78.7 115.44 18.4 Favored 'General case' 0 N--CA 1.489 1.521 0 CA-C-N 121.09 1.768 . . . . 0.0 111.29 -167.297 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 161.1 172.58 28.63 Favored Glycine 0 CA--C 1.543 1.79 0 CA-C-O 122.467 1.037 . . . . 0.0 113.454 -172.321 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 81.7 m -85.11 141.62 30.09 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-N 114.739 -0.731 . . . . 0.0 109.733 168.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 80.4 m95 -141.88 112.79 7.36 Favored 'General case' 0 N--CA 1.484 1.235 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 -174.516 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 9.0 mtpm? -96.22 147.33 23.88 Favored 'General case' 0 N--CA 1.495 1.802 0 C-N-CA 122.771 0.429 . . . . 0.0 110.209 174.369 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 57.9 tp -69.5 120.89 15.99 Favored 'General case' 0 N--CA 1.491 1.617 0 CA-C-O 121.864 0.84 . . . . 0.0 111.51 179.663 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . 0.271 1.2 t -98.85 -43.47 11.65 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.82 0 CA-C-N 114.194 -1.366 . . . . 0.0 112.588 -179.565 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -146.35 139.71 25.85 Favored 'General case' 0 N--CA 1.49 1.543 0 CA-C-N 119.652 1.114 . . . . 0.0 109.179 -179.468 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 89.2 p -128.91 100.27 5.61 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.933 -0.479 . . . . 0.0 110.939 175.47 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 59.3 mtpt -86.88 127.96 35.05 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 123.149 0.58 . . . . 0.0 109.612 173.124 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 58.5 m-20 66.79 22.59 10.25 Favored 'General case' 0 N--CA 1.504 2.235 0 N-CA-C 118.082 2.623 . . . . 0.0 118.082 173.732 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 23.6 t80 -67.24 -45.33 77.08 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 120.215 -1.553 . . . . 0.0 115.083 -178.806 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 85.8 m-20 -62.13 -27.0 68.63 Favored 'General case' 0 CA--C 1.572 1.811 0 N-CA-C 116.613 2.079 . . . . 0.0 116.613 171.443 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -69.05 -49.91 53.24 Favored 'General case' 0 N--CA 1.497 1.914 0 CA-C-N 120.275 1.398 . . . . 0.0 114.36 166.381 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 87.8 t80 -51.43 -50.3 59.99 Favored 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 115.397 1.628 . . . . 0.0 115.397 169.139 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 16.7 mmm -57.98 -46.55 84.98 Favored 'General case' 0 CA--C 1.566 1.595 0 N-CA-C 114.647 1.351 . . . . 0.0 114.647 172.424 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.2 tmtp? -57.35 -48.41 79.08 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 115.408 1.633 . . . . 0.0 115.408 170.806 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 83.5 p -59.63 -36.33 76.14 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 117.151 2.278 . . . . 0.0 117.151 174.148 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 34.4 mt -66.46 -33.62 76.09 Favored 'General case' 0 CA--C 1.566 1.562 0 N-CA-C 116.945 2.202 . . . . 0.0 116.945 167.375 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 108.5 72.36 0.75 Allowed Glycine 0 N--CA 1.482 1.742 0 CA-C-N 118.878 0.763 . . . . 0.0 111.788 -173.133 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 43.0 t -141.78 130.46 22.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 N-CA-C 106.808 -1.552 . . . . 0.0 106.808 -176.232 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -72.53 173.2 47.15 Favored Glycine 0 CA--C 1.549 2.16 0 N-CA-C 116.791 1.476 . . . . 0.0 116.791 -179.599 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 38.9 p90 -66.7 -39.58 88.14 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 117.599 2.444 . . . . 0.0 117.599 -175.385 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.15 -43.95 96.88 Favored 'General case' 0 CA--C 1.561 1.397 0 N-CA-C 115.803 1.779 . . . . 0.0 115.803 179.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.1 t -78.02 -21.54 50.59 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 115.835 1.791 . . . . 0.0 115.835 171.53 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 62.3 mtm180 -58.72 -42.81 89.57 Favored 'General case' 0 N--CA 1.495 1.824 0 CA-C-N 120.915 1.689 . . . . 0.0 114.524 162.64 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -63.13 -56.49 16.38 Favored 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 114.304 1.224 . . . . 0.0 114.304 168.166 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 47.9 t -62.81 -40.89 90.42 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 N-CA-C 113.883 1.068 . . . . 0.0 113.883 -178.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -70.68 -32.49 69.76 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 116.724 2.12 . . . . 0.0 116.724 175.453 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 94.6 p -65.93 -45.28 82.45 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 115.666 1.728 . . . . 0.0 115.666 170.173 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 3.5 ppp? -63.44 -28.29 69.87 Favored 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 116.923 2.194 . . . . 0.0 116.923 167.259 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 97.2 m -70.95 138.91 50.43 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 124.11 0.964 . . . . 0.0 110.83 172.188 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.76 102.43 11.69 Favored Pre-proline 0 CA--C 1.57 1.715 0 CA-C-O 118.023 -0.989 . . . . 0.0 109.32 166.683 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -80.77 95.75 0.98 Allowed 'Trans proline' 0 C--N 1.371 1.744 0 C-N-CA 122.817 2.345 . . . . 0.0 111.135 -176.614 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 99.4 m -81.32 111.45 17.72 Favored 'General case' 0 N--CA 1.489 1.48 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.452 -159.654 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 87.4 m -87.14 116.23 25.07 Favored 'General case' 0 CA--C 1.56 1.338 0 C-N-CA 123.916 0.886 . . . . 0.0 109.233 -175.32 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 79.6 mt -112.33 110.41 32.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 N-CA-C 106.224 -1.769 . . . . 0.0 106.224 177.341 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 22.6 mt -100.95 119.03 48.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 -176.39 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -137.55 108.05 6.54 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 -169.595 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 83.8 tttt -85.55 121.95 28.98 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 123.385 0.674 . . . . 0.0 111.175 179.795 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 19.0 m120 -89.25 -69.15 0.73 Allowed 'General case' 0 N--CA 1.49 1.575 0 C-N-CA 123.654 0.782 . . . . 0.0 110.543 177.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -151.58 76.56 0.23 Allowed Glycine 0 N--CA 1.484 1.868 0 N-CA-C 110.116 -1.194 . . . . 0.0 110.116 169.309 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . 0.336 2.1 t70 70.99 -23.96 0.17 Allowed 'General case' 0 N--CA 1.499 2.006 0 N-CA-C 116.805 2.15 . . . . 0.0 116.805 -160.417 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 21.2 mm -75.34 106.6 5.24 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.561 0 C-N-CA 124.536 1.134 . . . . 0.0 108.05 173.198 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 26.4 mt -92.45 113.77 26.13 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 123.878 0.871 . . . . 0.0 109.66 -179.459 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 57.1 m -97.79 97.45 8.99 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 106.836 -1.542 . . . . 0.0 106.836 -177.712 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 9.4 tt -100.5 98.74 9.31 Favored 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 -177.302 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -93.66 115.57 28.03 Favored 'General case' 0 N--CA 1.484 1.26 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 -174.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 28.9 m -100.89 103.42 14.59 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 -179.7 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 21.1 m-70 -90.53 105.25 17.69 Favored 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 123.479 0.712 . . . . 0.0 109.444 -170.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 5.9 m -147.26 154.92 41.58 Favored 'General case' 0 N--CA 1.491 1.588 0 CA-C-O 121.234 0.54 . . . . 0.0 112.125 -164.524 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . 0.298 11.9 t -94.87 46.61 1.13 Allowed 'General case' 0 N--CA 1.501 2.082 0 N-CA-C 113.281 0.845 . . . . 0.0 113.281 154.648 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 69.2 t80 -164.41 -79.01 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 107.259 -1.386 . . . . 0.0 107.259 173.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 4.5 tppp? -92.92 72.98 4.81 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 123.462 0.705 . . . . 0.0 109.754 -179.509 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 17.4 t30 -91.27 81.95 5.48 Favored 'General case' 0 N--CA 1.484 1.257 0 N-CA-C 108.69 -0.855 . . . . 0.0 108.69 179.192 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 81.9 p -131.83 126.84 35.3 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 -164.537 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -109.66 120.27 41.96 Favored 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 177.659 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 43.0 pt -110.94 128.45 67.35 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 177.079 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 35.9 t -118.05 95.7 5.02 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 107.791 -1.189 . . . . 0.0 107.791 -175.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 45.1 p90 -130.71 142.25 50.42 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 114.241 1.201 . . . . 0.0 114.241 -156.645 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 29.6 mtpp -100.15 146.43 26.84 Favored 'General case' 0 N--CA 1.488 1.444 0 CA-C-N 115.218 -0.901 . . . . 0.0 109.126 165.608 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -73.44 116.89 14.54 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.433 -0.792 . . . . 0.0 112.106 -172.217 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 80.88 43.41 8.94 Favored Glycine 0 CA--C 1.549 2.186 0 N-CA-C 116.535 1.374 . . . . 0.0 116.535 -166.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 93.1 t -138.6 122.56 20.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 N-CA-C 106.469 -1.678 . . . . 0.0 106.469 177.603 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -85.64 133.34 34.04 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 123.634 0.773 . . . . 0.0 111.285 179.07 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -141.22 149.78 41.83 Favored 'General case' 0 N--CA 1.493 1.695 0 CA-C-O 121.764 0.793 . . . . 0.0 111.443 -173.784 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -74.24 136.08 42.71 Favored 'General case' 0 CA--C 1.565 1.542 0 O-C-N 121.387 -0.82 . . . . 0.0 112.866 172.195 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 32.1 tp10 -145.34 139.15 26.81 Favored 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 123.186 0.594 . . . . 0.0 110.018 -178.152 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 56.0 m -100.54 123.71 45.12 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 177.519 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 29.4 p -85.18 -179.69 7.06 Favored 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 113.432 0.901 . . . . 0.0 113.432 -174.746 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -54.38 -38.99 66.79 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 117.266 2.321 . . . . 0.0 117.266 167.683 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -83.54 13.32 4.64 Favored 'General case' 0 CA--C 1.578 2.035 0 N-CA-C 115.615 1.709 . . . . 0.0 115.615 170.704 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . 0.255 8.7 t70 58.33 72.51 0.52 Allowed 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 125.443 1.497 . . . . 0.0 113.446 -174.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 44.2 mtm180 -132.87 124.96 28.9 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 -174.011 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.6 106.89 8.52 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 123.096 0.558 . . . . 0.0 111.648 174.136 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 18.2 m -118.36 134.01 63.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 C-N-CA 122.996 0.518 . . . . 0.0 109.74 -169.131 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 31.5 mmtp -82.84 104.01 12.75 Favored 'General case' 0 N--CA 1.488 1.456 0 CA-C-O 121.92 0.867 . . . . 0.0 109.451 176.215 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 43.3 t -106.27 99.04 8.65 Favored 'General case' 0 CA--C 1.553 1.083 0 CA-C-N 114.68 -1.146 . . . . 0.0 110.044 -161.299 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 7.4 tp -110.61 116.82 53.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 C-N-CA 124.229 1.012 . . . . 0.0 108.631 -177.05 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -134.89 120.06 29.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 C-N-CA 123.612 0.765 . . . . 0.0 109.279 -174.062 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 10.5 t -129.4 157.96 40.5 Favored 'General case' 0 N--CA 1.493 1.676 0 CA-C-O 122.473 1.13 . . . . 0.0 112.223 178.241 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 61.1 tp -84.18 127.28 33.83 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-N 114.805 -1.088 . . . . 0.0 110.577 174.365 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -131.44 85.13 2.23 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 123.905 0.882 . . . . 0.0 109.249 -176.179 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 55.54 44.36 85.73 Favored Glycine 0 N--CA 1.493 2.447 0 N-CA-C 118.658 2.223 . . . . 0.0 118.658 -179.381 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 82.41 16.92 70.08 Favored Glycine 0 CA--C 1.557 2.66 0 N-CA-C 118.627 2.211 . . . . 0.0 118.627 -167.542 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 53.8 mtpt -129.55 119.82 24.31 Favored 'General case' 0 N--CA 1.487 1.39 0 CA-C-N 119.064 1.432 . . . . 0.0 107.691 177.104 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 3.1 mp -82.3 107.9 15.33 Favored 'General case' 0 N--CA 1.485 1.294 0 CA-C-O 122.071 0.939 . . . . 0.0 109.369 169.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 70.4 t -99.47 102.19 13.09 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.333 0 N-CA-C 105.16 -2.163 . . . . 0.0 105.16 -174.621 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 20.8 t-160 -107.35 131.81 53.83 Favored 'General case' 0 N--CA 1.484 1.226 0 CA-C-N 114.486 -1.233 . . . . 0.0 108.613 -175.546 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 35.6 tp -131.01 121.3 24.81 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 177.556 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 90.7 mt-30 -111.5 113.43 25.85 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 175.567 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 10.7 ptpp? -118.78 140.36 50.08 Favored 'General case' 0 N--CA 1.494 1.749 0 C-N-CA 123.25 0.62 . . . . 0.0 112.052 -176.336 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 30.5 p90 -153.61 110.81 3.45 Favored 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 123.15 0.58 . . . . 0.0 109.813 -175.68 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . 0.339 8.8 t70 66.84 -101.5 0.07 Allowed 'General case' 0 N--CA 1.494 1.734 0 C-N-CA 124.602 1.161 . . . . 0.0 112.63 172.833 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -124.43 50.27 0.87 Allowed Glycine 0 N--CA 1.488 2.155 0 CA-C-N 118.941 0.791 . . . . 0.0 114.482 164.713 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 52.3 mt-30 -153.42 124.85 7.59 Favored 'General case' 0 N--CA 1.485 1.289 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 -178.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -136.46 133.47 36.64 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.859 -0.525 . . . . 0.0 111.453 176.23 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 6.4 t -120.06 129.48 54.24 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 123.379 0.672 . . . . 0.0 110.718 175.462 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 41.0 p -95.71 133.88 39.28 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-O 121.528 0.68 . . . . 0.0 111.052 173.515 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 5.6 mp -111.68 74.01 0.85 Allowed 'General case' 0 CA--C 1.564 1.519 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 178.811 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 59.2 t -83.17 109.42 16.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 121.126 -0.984 . . . . 0.0 108.507 -167.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 76.6 mtt85 -101.32 120.72 40.69 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 123.269 0.628 . . . . 0.0 109.905 -174.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -141.72 127.46 19.19 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 122.872 0.469 . . . . 0.0 110.754 -169.52 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -79.23 114.85 18.5 Favored 'General case' 0 N--CA 1.487 1.418 0 CA-C-O 121.359 0.6 . . . . 0.0 111.331 -179.272 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 47.5 mm -121.4 106.39 18.21 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.338 0 N-CA-C 105.026 -2.213 . . . . 0.0 105.026 177.24 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 58.73 50.14 9.19 Favored 'General case' 0 N--CA 1.5 2.029 0 N-CA-C 115.064 1.505 . . . . 0.0 115.064 175.232 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 67.07 18.99 69.6 Favored Glycine 0 CA--C 1.555 2.577 0 N-CA-C 119.668 2.627 . . . . 0.0 119.668 -171.16 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 89.6 mttt -132.68 129.72 39.17 Favored 'General case' 0 N--CA 1.488 1.463 0 CA-C-N 119.63 1.715 . . . . 0.0 109.294 -174.387 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 18.2 tp -77.72 110.22 12.39 Favored 'General case' 0 CA--C 1.557 1.231 0 C-N-CA 123.98 0.912 . . . . 0.0 110.298 -179.523 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 30.5 mm -96.55 101.63 12.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 N-CA-C 106.748 -1.575 . . . . 0.0 106.748 -177.452 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 29.9 tp -88.99 101.36 14.01 Favored 'General case' 0 CA--C 1.559 1.307 0 C-N-CA 123.754 0.821 . . . . 0.0 109.361 176.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 87.4 m -95.61 105.94 17.97 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 -175.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 86.8 mt -99.3 98.77 9.69 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 123.588 0.755 . . . . 0.0 109.896 -171.302 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 6.7 m -113.6 115.8 28.5 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 -174.138 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 58.6 t60 -103.19 -87.46 0.42 Allowed 'General case' 0 N--CA 1.491 1.6 0 CA-C-O 118.5 -0.762 . . . . 0.0 108.986 170.411 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -106.64 -106.73 3.14 Favored Glycine 0 N--CA 1.484 1.869 0 CA-C-N 119.201 0.909 . . . . 0.0 111.09 179.359 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 13.8 t -100.79 49.24 0.89 Allowed 'General case' 0 N--CA 1.498 1.937 0 N-CA-C 113.346 0.869 . . . . 0.0 113.346 174.04 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -158.39 93.71 1.23 Allowed 'General case' 0 N--CA 1.483 1.223 0 O-C-N 121.206 -0.934 . . . . 0.0 108.648 175.398 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 4.2 p -91.47 121.26 41.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 C-N-CA 123.352 0.661 . . . . 0.0 109.753 175.36 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 45.7 t -101.44 100.03 10.43 Favored 'General case' 0 CA--C 1.553 1.081 0 CA-C-O 121.556 0.693 . . . . 0.0 111.214 175.424 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 63.0 m -86.14 111.06 20.0 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 179.433 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 32.8 mtm180 -114.99 118.33 33.13 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 122.992 0.517 . . . . 0.0 110.331 -172.104 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 93.3 m -86.79 132.87 33.72 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 123.433 0.693 . . . . 0.0 110.304 177.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 38.0 m-85 -127.47 127.05 43.41 Favored 'General case' 0 CA--C 1.559 1.296 0 C-N-CA 123.648 0.779 . . . . 0.0 109.253 178.321 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -90.83 151.15 21.27 Favored 'General case' 0 N--CA 1.487 1.404 0 CA-C-O 121.788 0.804 . . . . 0.0 111.889 173.805 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 67.3 tttt -80.68 119.29 23.1 Favored 'General case' 0 N--CA 1.486 1.335 0 CA-C-O 121.563 0.697 . . . . 0.0 111.655 -174.585 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 18.1 mm-40 -119.89 50.33 1.29 Allowed 'General case' 0 CA--C 1.564 1.512 0 C-N-CA 124.422 1.089 . . . . 0.0 111.306 -171.077 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.897 0 CA-C-O 124.654 2.168 . . . . 0.0 109.946 -160.521 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 71.4 t . . . . . 0 CA--C 1.56 1.337 0 N-CA-C 106.201 -1.777 . . . . 0.0 106.201 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -140.49 -55.44 0.52 Allowed 'General case' 0 N--CA 1.494 1.746 0 C-N-CA 124.021 0.928 . . . . 0.0 111.051 -174.31 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -57.39 -29.99 64.54 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 116.914 2.19 . . . . 0.0 116.914 160.662 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -60.82 -18.89 58.2 Favored 'General case' 0 CA--C 1.571 1.76 0 N-CA-C 117.813 2.523 . . . . 0.0 117.813 163.768 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 82.4 mt -84.2 125.94 32.67 Favored 'General case' 0 N--CA 1.489 1.513 0 CA-C-N 121.329 1.877 . . . . 0.0 111.77 -169.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 153.92 176.3 26.14 Favored Glycine 0 CA--C 1.542 1.728 0 CA-C-O 122.602 1.112 . . . . 0.0 113.317 -173.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 71.4 m -84.75 140.17 31.44 Favored 'General case' 0 N--CA 1.49 1.564 0 CA-C-N 114.679 -0.76 . . . . 0.0 109.262 165.063 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 85.8 m95 -141.85 113.23 7.64 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 -174.292 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 6.3 mtpm? -102.03 145.48 29.25 Favored 'General case' 0 N--CA 1.494 1.75 0 CA-C-O 121.034 0.445 . . . . 0.0 110.017 178.558 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 17.5 tp -65.95 127.06 30.56 Favored 'General case' 0 N--CA 1.491 1.59 0 CA-C-O 122.349 1.071 . . . . 0.0 112.495 -175.59 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . 0.283 1.0 OUTLIER -104.51 -46.65 9.68 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.897 0 CA-C-N 113.845 -1.525 . . . . 0.0 111.448 177.288 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -137.36 140.34 41.36 Favored 'General case' 0 N--CA 1.49 1.542 0 CA-C-N 119.994 1.27 . . . . 0.0 109.848 177.31 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 71.8 p -131.37 118.05 19.75 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 123.462 0.705 . . . . 0.0 109.532 169.246 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 30.6 mtpp -88.05 -87.14 0.16 Allowed 'General case' 0 N--CA 1.491 1.625 0 CA-C-O 119.14 -0.457 . . . . 0.0 111.335 -172.621 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 65.0 m-80 -95.12 49.58 1.22 Allowed 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 113.503 0.927 . . . . 0.0 113.503 -175.594 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 23.7 t80 -77.25 -54.48 6.43 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.6 -1.313 . . . . 0.0 113.462 -173.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -51.19 -35.64 37.31 Favored 'General case' 0 N--CA 1.499 2.014 0 N-CA-C 116.722 2.119 . . . . 0.0 116.722 166.75 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 35.4 t0 -63.11 -55.71 23.02 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 114.179 1.178 . . . . 0.0 114.179 168.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 85.7 t80 -49.99 -47.21 53.01 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 116.403 2.001 . . . . 0.0 116.403 169.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 26.0 mmm -62.47 -45.58 92.38 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 114.771 1.397 . . . . 0.0 114.771 177.033 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 42.0 tptt -64.16 -38.8 92.36 Favored 'General case' 0 CA--C 1.566 1.585 0 N-CA-C 115.787 1.773 . . . . 0.0 115.787 171.101 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 65.6 m -58.38 -40.41 82.27 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 115.937 1.828 . . . . 0.0 115.937 168.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 77.2 mt -61.96 -37.34 84.39 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 116.694 2.109 . . . . 0.0 116.694 166.662 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 112.08 69.77 0.56 Allowed Glycine 0 N--CA 1.481 1.681 0 C-N-CA 124.055 0.836 . . . . 0.0 111.875 -173.704 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 37.3 t -140.83 117.45 7.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 N-CA-C 105.006 -2.22 . . . . 0.0 105.006 -177.145 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -68.33 -80.61 0.22 Allowed Glycine 0 N--CA 1.485 1.963 0 N-CA-C 117.078 1.591 . . . . 0.0 117.078 -166.472 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . 0.262 46.2 p90 -149.05 -50.37 0.15 Allowed 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 114.543 1.312 . . . . 0.0 114.543 -175.565 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.66 -39.84 91.8 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 116.511 2.041 . . . . 0.0 116.511 -178.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 60.0 m -79.32 -36.81 38.95 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 113.635 0.976 . . . . 0.0 113.635 170.255 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 33.4 ttp85 -61.1 -44.2 97.73 Favored 'General case' 0 CA--C 1.566 1.591 0 N-CA-C 115.543 1.683 . . . . 0.0 115.543 174.565 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 39.1 mt-30 -79.6 -40.42 29.39 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 115.026 1.491 . . . . 0.0 115.026 177.738 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 47.1 t -74.48 -37.72 44.86 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 CA-C-N 120.503 1.501 . . . . 0.0 112.524 179.305 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -66.99 -34.36 77.57 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 116.612 2.078 . . . . 0.0 116.612 172.074 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 92.0 p -65.18 -44.72 87.52 Favored 'General case' 0 N--CA 1.493 1.725 0 N-CA-C 115.783 1.772 . . . . 0.0 115.783 167.69 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 44.6 ttm -62.0 -36.97 83.09 Favored 'General case' 0 CA--C 1.571 1.765 0 N-CA-C 116.141 1.904 . . . . 0.0 116.141 168.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 52.4 m -68.26 151.93 46.21 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 124.455 1.102 . . . . 0.0 112.523 176.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 4.2 ttmp? -104.09 97.47 11.54 Favored Pre-proline 0 CA--C 1.574 1.896 0 CA-C-N 115.173 -0.921 . . . . 0.0 109.674 176.378 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -75.57 145.72 29.87 Favored 'Trans proline' 0 CA--C 1.561 1.839 0 C-N-CA 123.697 2.931 . . . . 0.0 113.444 178.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 98.8 m -117.34 97.4 5.88 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 -171.003 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 90.9 m -79.48 117.41 20.41 Favored 'General case' 0 N--CA 1.492 1.664 0 C-N-CA 123.77 0.828 . . . . 0.0 110.037 178.687 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 62.3 mt -119.02 111.79 34.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 N-CA-C 106.324 -1.732 . . . . 0.0 106.324 -174.382 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 17.8 mt -110.79 116.81 53.45 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 -173.013 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -127.36 123.67 36.79 Favored 'General case' 0 N--CA 1.494 1.769 0 C-N-CA 123.485 0.714 . . . . 0.0 109.841 179.721 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 82.1 tttt -97.5 120.53 38.05 Favored 'General case' 0 CA--C 1.557 1.217 0 C-N-CA 123.649 0.78 . . . . 0.0 110.335 177.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 -83.61 -81.03 0.17 Allowed 'General case' 0 N--CA 1.49 1.545 0 CA-C-O 118.793 -0.622 . . . . 0.0 110.125 178.242 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -99.94 -87.2 1.94 Allowed Glycine 0 N--CA 1.486 2.013 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 166.782 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -119.15 55.84 0.93 Allowed 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 153.69 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 15.0 mm -128.94 104.91 12.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 N-CA-C 104.888 -2.264 . . . . 0.0 104.888 -176.127 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 36.0 mt -95.29 107.41 19.52 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 123.048 0.539 . . . . 0.0 111.24 -170.798 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 31.5 m -92.72 94.02 8.77 Favored 'General case' 0 CA--C 1.559 1.302 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 -176.561 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 10.4 tt -98.24 102.25 13.94 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 -176.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 50.7 mttp -102.47 106.37 17.09 Favored 'General case' 0 N--CA 1.486 1.341 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 -174.505 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 59.3 m -92.23 97.22 10.76 Favored 'General case' 0 N--CA 1.493 1.675 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 178.736 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 22.4 m170 -91.76 94.76 9.51 Favored 'General case' 0 N--CA 1.488 1.458 0 CA-C-O 121.909 0.862 . . . . 0.0 110.089 -174.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 27.9 t -105.3 147.22 28.36 Favored 'General case' 0 N--CA 1.484 1.265 0 CA-C-N 115.041 -0.981 . . . . 0.0 109.879 173.503 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 74.0 p -79.46 63.99 4.22 Favored 'General case' 0 N--CA 1.503 2.203 0 CA-C-O 122.582 1.182 . . . . 0.0 112.298 170.617 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 13.6 t80 -172.02 -60.99 0.02 OUTLIER 'General case' 0 CA--C 1.566 1.576 0 C-N-CA 125.892 1.677 . . . . 0.0 107.583 -178.24 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -146.66 124.54 11.97 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 123.715 0.806 . . . . 0.0 110.492 175.204 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 43.7 m-20 -91.86 128.55 37.74 Favored 'General case' 0 N--CA 1.492 1.643 0 C-N-CA 123.242 0.617 . . . . 0.0 109.765 174.286 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 61.9 p -126.45 131.36 51.69 Favored 'General case' 0 N--CA 1.496 1.869 0 C-N-CA 123.063 0.545 . . . . 0.0 110.069 -176.767 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -128.75 123.67 33.56 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 123.512 0.725 . . . . 0.0 109.556 -172.642 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 41.8 pt -118.65 134.2 63.04 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 C-N-CA 123.709 0.804 . . . . 0.0 108.976 174.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 67.2 p -119.73 104.38 10.19 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 178.478 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 53.0 p90 -132.27 141.15 48.88 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 115.204 1.557 . . . . 0.0 115.204 -159.404 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 62.4 mtpt -94.51 143.17 26.65 Favored 'General case' 0 CA--C 1.562 1.408 0 CA-C-N 114.378 -1.283 . . . . 0.0 109.761 166.197 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -77.91 120.57 22.97 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.851 -0.53 . . . . 0.0 111.606 -175.402 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 83.03 43.48 7.56 Favored Glycine 0 CA--C 1.549 2.19 0 N-CA-C 116.5 1.36 . . . . 0.0 116.5 -169.512 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 94.2 t -140.69 123.68 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 N-CA-C 106.458 -1.682 . . . . 0.0 106.458 -178.523 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -86.32 130.16 34.61 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 123.227 0.611 . . . . 0.0 110.872 171.654 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 45.3 p90 -144.23 128.9 18.21 Favored 'General case' 0 N--CA 1.492 1.656 0 C-N-CA 123.619 0.767 . . . . 0.0 109.744 -175.341 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -72.48 111.65 7.85 Favored 'General case' 0 CA--C 1.564 1.493 0 O-C-N 121.327 -0.858 . . . . 0.0 112.657 177.198 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 13.4 tp10 -113.64 132.92 55.59 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 124.29 1.036 . . . . 0.0 109.537 -171.591 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 57.1 m -92.86 122.62 35.42 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 176.532 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 24.1 p -85.9 172.26 10.86 Favored 'General case' 0 N--CA 1.495 1.808 0 CA-C-O 121.588 0.709 . . . . 0.0 112.403 -176.296 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -58.41 -35.17 71.65 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 117.306 2.336 . . . . 0.0 117.306 167.451 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -77.57 12.74 1.49 Allowed 'General case' 0 CA--C 1.581 2.157 0 N-CA-C 115.981 1.845 . . . . 0.0 115.981 167.399 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 10.4 t70 58.08 71.93 0.55 Allowed 'General case' 0 N--CA 1.492 1.643 0 C-N-CA 125.545 1.538 . . . . 0.0 113.483 -176.723 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 80.5 mtm180 -136.82 121.64 18.7 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 -176.271 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.55 99.32 5.68 Favored 'General case' 0 CA--C 1.563 1.452 0 C-N-CA 123.179 0.592 . . . . 0.0 111.042 170.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 10.7 m -113.51 128.05 70.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 -170.104 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 72.0 mmtt -77.72 99.41 5.84 Favored 'General case' 0 N--CA 1.488 1.474 0 CA-C-O 121.674 0.749 . . . . 0.0 110.04 177.139 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 47.6 m -93.36 93.22 8.06 Favored 'General case' 0 N--CA 1.48 1.056 0 CA-C-N 115.009 -0.996 . . . . 0.0 110.501 -169.415 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 6.0 tp -101.97 103.26 14.7 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 175.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.0 p -121.96 125.0 72.56 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.364 0 CA-C-N 115.307 -0.861 . . . . 0.0 109.209 -174.639 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 15.3 t -135.53 156.52 48.75 Favored 'General case' 0 N--CA 1.489 1.482 0 CA-C-O 122.921 1.343 . . . . 0.0 111.21 178.717 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 63.7 tp -89.52 108.36 19.61 Favored 'General case' 0 N--CA 1.486 1.368 0 CA-C-N 114.173 -1.376 . . . . 0.0 108.899 171.122 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -109.6 87.01 2.4 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 123.45 0.7 . . . . 0.0 109.993 -173.7 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 61.3 48.93 82.68 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 117.623 1.809 . . . . 0.0 117.623 -178.63 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 73.46 27.54 67.49 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 118.915 2.326 . . . . 0.0 118.915 -169.297 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -143.88 112.46 6.52 Favored 'General case' 0 CA--C 1.553 1.063 0 N-CA-C 107.134 -1.432 . . . . 0.0 107.134 -174.685 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 4.7 tt -86.61 102.88 14.58 Favored 'General case' 0 CA--C 1.561 1.376 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 -172.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 77.7 t -104.35 108.05 23.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 -171.578 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 21.8 t-160 -105.97 109.18 21.05 Favored 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 123.378 0.671 . . . . 0.0 109.954 177.013 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 38.0 tp -102.88 121.04 41.7 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 178.24 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 31.5 mt-30 -114.13 115.88 28.22 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 83.5 mttt -113.28 135.53 53.74 Favored 'General case' 0 N--CA 1.495 1.793 0 CA-C-N 118.812 0.733 . . . . 0.0 111.103 -178.364 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 27.3 p90 -152.69 110.57 3.63 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.354 -0.841 . . . . 0.0 109.898 178.713 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 3.8 t70 53.56 50.88 16.28 Favored 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 116.392 1.997 . . . . 0.0 116.392 170.008 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 89.66 -43.46 2.99 Favored Glycine 0 CA--C 1.551 2.311 0 N-CA-C 116.685 1.434 . . . . 0.0 116.685 -169.34 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 15.0 mt-30 -80.88 124.6 29.24 Favored 'General case' 0 N--CA 1.488 1.428 0 CA-C-N 118.309 1.054 . . . . 0.0 111.318 -177.114 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -132.61 131.39 41.38 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 123.072 0.549 . . . . 0.0 111.712 178.685 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 8.8 t -118.45 133.03 56.21 Favored 'General case' 0 N--CA 1.496 1.866 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.365 176.534 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 35.8 p -102.76 132.72 48.72 Favored 'General case' 0 N--CA 1.495 1.819 0 CA-C-O 121.678 0.751 . . . . 0.0 110.85 172.602 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 5.3 mp -114.54 89.36 3.08 Favored 'General case' 0 CA--C 1.562 1.412 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 -179.448 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 97.1 t -98.49 106.05 18.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 -167.543 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 83.9 mtt85 -99.51 125.13 45.22 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 123.179 0.592 . . . . 0.0 110.402 -176.367 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -140.14 130.12 24.79 Favored 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 123.084 0.554 . . . . 0.0 111.092 -174.764 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -82.43 112.88 19.78 Favored 'General case' 0 N--CA 1.488 1.463 0 CA-C-O 121.256 0.55 . . . . 0.0 111.086 -178.557 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 82.8 mt -123.46 109.43 23.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 N-CA-C 105.052 -2.203 . . . . 0.0 105.052 179.412 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 57.87 50.18 10.85 Favored 'General case' 0 N--CA 1.499 2.012 0 N-CA-C 114.849 1.425 . . . . 0.0 114.849 177.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 62.24 24.65 65.64 Favored Glycine 0 CA--C 1.555 2.536 0 N-CA-C 119.502 2.561 . . . . 0.0 119.502 -170.699 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 91.2 mttt -132.31 131.07 41.62 Favored 'General case' 0 N--CA 1.488 1.435 0 CA-C-N 119.951 1.876 . . . . 0.0 109.534 -176.093 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 20.1 tp -77.58 110.08 12.08 Favored 'General case' 0 N--CA 1.484 1.275 0 C-N-CA 123.955 0.902 . . . . 0.0 110.144 -179.644 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 27.7 mm -99.39 95.58 4.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 N-CA-C 107.062 -1.459 . . . . 0.0 107.062 -175.047 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 17.4 tp -86.94 104.4 16.22 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 124.068 0.947 . . . . 0.0 110.098 179.542 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 84.8 m -99.66 104.16 15.89 Favored 'General case' 0 CA--C 1.561 1.392 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 -173.098 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 91.1 mt -98.52 102.43 14.17 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 123.659 0.784 . . . . 0.0 110.111 -172.497 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 9.6 m -113.44 125.9 54.74 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 -176.124 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 83.3 t60 -136.45 -98.33 0.22 Allowed 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 175.408 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -110.45 93.0 0.71 Allowed Glycine 0 N--CA 1.483 1.829 0 CA-C-N 118.816 0.734 . . . . 0.0 111.684 -169.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . 0.387 5.2 t 47.47 39.33 9.18 Favored 'General case' 0 N--CA 1.5 2.07 0 N-CA-C 117.546 2.425 . . . . 0.0 117.546 -172.097 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -157.64 93.6 1.29 Allowed 'General case' 0 N--CA 1.483 1.197 0 O-C-N 121.484 -0.76 . . . . 0.0 109.575 -174.461 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 2.8 p -92.87 112.25 25.86 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 C-N-CA 123.643 0.777 . . . . 0.0 109.288 173.141 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 41.1 t -97.5 104.34 16.36 Favored 'General case' 0 CA--C 1.551 1.017 0 CA-C-O 121.016 0.436 . . . . 0.0 110.292 175.179 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 89.2 m -90.04 100.96 13.68 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 -178.581 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 59.3 mtp180 -103.43 114.74 29.25 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 123.107 0.563 . . . . 0.0 109.749 -167.535 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 56.6 m -84.8 131.92 34.48 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 123.091 0.556 . . . . 0.0 109.954 177.772 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 41.0 m-85 -129.49 126.31 38.37 Favored 'General case' 0 CA--C 1.561 1.385 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 178.378 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -88.62 150.54 22.99 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 123.515 0.726 . . . . 0.0 112.127 174.68 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 71.0 tttt -81.67 118.14 22.58 Favored 'General case' 0 N--CA 1.486 1.346 0 CA-C-O 121.43 0.633 . . . . 0.0 111.577 -174.503 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 37.3 mm-40 -118.24 51.38 1.08 Allowed 'General case' 0 CA--C 1.564 1.505 0 C-N-CA 124.216 1.007 . . . . 0.0 111.31 -174.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.875 0 CA-C-O 123.105 1.431 . . . . 0.0 110.151 -161.931 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 5.7 p . . . . . 0 CA--C 1.578 2.028 0 N-CA-C 115.24 1.571 . . . . 0.0 115.24 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -78.84 -38.71 37.32 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 115.648 1.721 . . . . 0.0 115.648 -176.087 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -58.95 -24.03 62.11 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 117.649 2.463 . . . . 0.0 117.649 167.428 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -69.62 -20.19 63.62 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 116.575 2.065 . . . . 0.0 116.575 167.333 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 42.9 mt -81.17 121.99 26.82 Favored 'General case' 0 N--CA 1.488 1.475 0 CA-C-N 120.829 1.65 . . . . 0.0 111.168 -170.709 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 157.34 174.75 27.45 Favored Glycine 0 CA--C 1.541 1.703 0 CA-C-O 122.379 0.988 . . . . 0.0 113.369 -172.283 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 63.0 m -93.12 136.88 32.97 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 170.516 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 87.5 m95 -138.34 113.37 9.24 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 -171.431 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 9.4 mtmp? -97.81 143.54 28.33 Favored 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 123.247 0.619 . . . . 0.0 110.547 -179.506 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 60.0 tp -70.87 117.27 12.16 Favored 'General case' 0 N--CA 1.492 1.639 0 CA-C-O 121.856 0.836 . . . . 0.0 111.177 -177.573 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . 0.27 1.0 OUTLIER -97.48 -42.38 11.62 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.757 0 CA-C-N 114.337 -1.301 . . . . 0.0 112.725 -178.702 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -148.06 134.82 19.99 Favored 'General case' 0 N--CA 1.487 1.386 0 CA-C-N 119.677 1.126 . . . . 0.0 109.035 -177.53 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 88.8 p -121.59 100.84 7.24 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 122.976 0.51 . . . . 0.0 110.496 176.741 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 61.1 mtpt -92.77 123.02 35.75 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 176.644 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 52.1 m-20 67.22 21.66 9.9 Favored 'General case' 0 N--CA 1.503 2.204 0 N-CA-C 117.513 2.412 . . . . 0.0 117.513 176.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 17.3 t80 -71.2 -40.21 71.31 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 119.988 -1.695 . . . . 0.0 115.345 -179.273 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -60.19 -31.45 70.14 Favored 'General case' 0 CA--C 1.571 1.766 0 N-CA-C 115.935 1.828 . . . . 0.0 115.935 165.337 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 14.3 t0 -64.92 -47.25 78.4 Favored 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 114.843 1.423 . . . . 0.0 114.843 166.012 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 94.2 t80 -54.0 -51.95 62.33 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 115.104 1.52 . . . . 0.0 115.104 172.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 75.8 mtm -63.67 -34.37 77.69 Favored 'General case' 0 CA--C 1.568 1.636 0 N-CA-C 115.697 1.74 . . . . 0.0 115.697 172.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 38.4 ttmt -61.44 -47.55 85.22 Favored 'General case' 0 CA--C 1.569 1.674 0 N-CA-C 114.412 1.264 . . . . 0.0 114.412 167.506 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 60.1 m -58.67 -36.15 73.71 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 116.412 2.004 . . . . 0.0 116.412 171.617 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 33.4 mt -63.05 -43.91 97.33 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 116.178 1.918 . . . . 0.0 116.178 166.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 120.22 71.1 0.32 Allowed Glycine 0 N--CA 1.483 1.781 0 C-N-CA 123.79 0.71 . . . . 0.0 111.588 -176.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 23.9 t -142.24 120.88 8.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 N-CA-C 105.166 -2.161 . . . . 0.0 105.166 -176.452 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -78.92 -86.48 0.52 Allowed Glycine 0 N--CA 1.488 2.129 0 N-CA-C 115.859 1.104 . . . . 0.0 115.859 -169.23 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 15.2 p90 -139.36 160.3 40.15 Favored 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 123.498 0.719 . . . . 0.0 110.767 178.605 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . 0.313 . . 76.41 -50.91 0.59 Allowed 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 115.386 1.625 . . . . 0.0 115.386 177.68 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 52.8 m -64.92 -39.86 94.16 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 113.964 1.098 . . . . 0.0 113.964 167.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 38.0 mtm180 -61.34 -43.59 98.62 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 115.063 1.505 . . . . 0.0 115.063 166.073 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 7.4 tm0? -61.74 -49.09 77.8 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 115.403 1.631 . . . . 0.0 115.403 174.074 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 97.2 t -64.56 -41.11 91.32 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 CA-C-N 119.503 1.047 . . . . 0.0 113.207 177.227 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -67.72 -40.71 84.23 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 116.504 2.038 . . . . 0.0 116.504 176.251 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 95.2 p -66.79 -39.42 87.77 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 116.332 1.975 . . . . 0.0 116.332 169.549 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 54.5 tpp -64.97 -37.21 86.91 Favored 'General case' 0 CA--C 1.569 1.7 0 N-CA-C 115.992 1.849 . . . . 0.0 115.992 169.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 54.4 m -69.96 145.88 51.55 Favored 'General case' 0 CA--C 1.566 1.589 0 C-N-CA 124.047 0.939 . . . . 0.0 111.79 174.649 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -103.12 100.73 18.28 Favored Pre-proline 0 CA--C 1.57 1.742 0 CA-C-O 118.143 -0.932 . . . . 0.0 109.147 173.224 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -81.82 100.67 1.11 Allowed 'Trans proline' 0 C--N 1.371 1.727 0 C-N-CA 123.027 2.485 . . . . 0.0 111.649 -179.379 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 99.8 m -79.15 112.95 16.87 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 123.522 0.729 . . . . 0.0 110.228 -168.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 46.5 m -87.28 114.78 24.19 Favored 'General case' 0 CA--C 1.561 1.395 0 C-N-CA 123.557 0.743 . . . . 0.0 109.147 -174.137 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 98.3 mt -108.75 108.45 25.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 N-CA-C 106.356 -1.72 . . . . 0.0 106.356 176.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 18.8 mt -101.72 120.3 51.16 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 -178.718 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 6.8 tm-20 -133.24 116.48 16.25 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 -172.233 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 80.7 tttt -93.62 114.97 27.42 Favored 'General case' 0 CA--C 1.557 1.243 0 C-N-CA 123.335 0.654 . . . . 0.0 110.374 176.523 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 23.8 t30 -86.78 -70.59 0.6 Allowed 'General case' 0 N--CA 1.492 1.628 0 C-N-CA 123.043 0.537 . . . . 0.0 111.026 178.307 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -143.11 75.92 0.31 Allowed Glycine 0 N--CA 1.487 2.068 0 N-CA-C 110.522 -1.031 . . . . 0.0 110.522 170.039 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . 0.284 6.3 t70 49.43 48.21 21.51 Favored 'General case' 0 N--CA 1.497 1.924 0 N-CA-C 115.518 1.673 . . . . 0.0 115.518 -155.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 31.0 mm -134.51 99.9 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 N-CA-C 103.589 -2.745 . . . . 0.0 103.589 178.47 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 65.2 mt -88.11 101.49 13.85 Favored 'General case' 0 N--CA 1.481 1.097 0 CA-C-O 121.281 0.562 . . . . 0.0 110.039 -177.614 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 91.1 m -94.46 97.02 9.87 Favored 'General case' 0 N--CA 1.485 1.29 0 N-CA-C 106.973 -1.492 . . . . 0.0 106.973 -176.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 9.8 tt -99.22 99.56 10.55 Favored 'General case' 0 N--CA 1.484 1.246 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 -174.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -96.6 126.65 41.93 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 123.782 0.833 . . . . 0.0 109.166 -175.675 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 28.0 m -102.63 93.7 5.25 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.134 -1.062 . . . . 0.0 108.134 -175.619 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 16.8 m-70 -86.25 104.33 15.69 Favored 'General case' 0 N--CA 1.491 1.591 0 CA-C-O 121.451 0.643 . . . . 0.0 109.709 -173.03 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 23.1 t -144.5 142.03 29.96 Favored 'General case' 0 N--CA 1.483 1.183 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.274 -161.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . 0.294 13.9 t -82.33 64.83 7.18 Favored 'General case' 0 N--CA 1.499 2.024 0 CA-C-O 122.552 1.167 . . . . 0.0 111.735 160.516 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 88.0 t80 -166.13 -70.16 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 106.78 -1.563 . . . . 0.0 106.78 -176.433 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 14.7 tptp -153.74 130.26 10.66 Favored 'General case' 0 CA--C 1.558 1.284 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 179.353 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 53.6 m-80 -92.94 91.48 7.42 Favored 'General case' 0 N--CA 1.491 1.582 0 CA-C-O 121.052 0.453 . . . . 0.0 110.076 175.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 73.9 p -98.41 132.17 44.08 Favored 'General case' 0 N--CA 1.493 1.709 0 C-N-CA 123.417 0.687 . . . . 0.0 110.603 -177.013 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -123.87 123.57 40.73 Favored 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 123.674 0.79 . . . . 0.0 109.067 -176.714 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 40.8 pt -118.74 132.01 69.86 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 174.467 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 46.1 t -120.6 111.11 17.24 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 -177.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 50.4 p90 -140.94 140.72 34.48 Favored 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 115.119 1.525 . . . . 0.0 115.119 -160.015 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 63.6 mtpt -106.25 17.62 23.2 Favored 'General case' 0 CA--C 1.573 1.852 0 N-CA-C 117.011 2.226 . . . . 0.0 117.011 -172.608 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . 0.294 0.1 OUTLIER 60.35 92.7 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.736 0 CA-C-N 120.546 1.521 . . . . 0.0 114.292 177.981 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 92.68 38.73 5.46 Favored Glycine 0 CA--C 1.551 2.295 0 N-CA-C 116.863 1.505 . . . . 0.0 116.863 -167.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 86.6 t -140.06 122.7 16.68 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 N-CA-C 106.93 -1.507 . . . . 0.0 106.93 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -87.62 133.27 33.84 Favored 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 123.299 0.64 . . . . 0.0 111.136 173.749 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 47.5 p90 -145.56 133.72 21.6 Favored 'General case' 0 N--CA 1.493 1.682 0 C-N-CA 123.888 0.875 . . . . 0.0 109.306 -175.082 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -76.35 142.66 41.14 Favored 'General case' 0 N--CA 1.49 1.54 0 CA-C-O 123.028 1.394 . . . . 0.0 112.117 176.211 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 15.4 tp10 -146.54 138.91 25.04 Favored 'General case' 0 N--CA 1.488 1.444 0 CA-C-N 113.18 -1.827 . . . . 0.0 110.351 -167.053 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 55.7 m -97.18 121.96 39.65 Favored 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 123.281 0.633 . . . . 0.0 109.424 177.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 25.1 p -86.39 170.54 11.9 Favored 'General case' 0 N--CA 1.495 1.815 0 CA-C-O 121.894 0.854 . . . . 0.0 113.128 -173.565 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -58.77 -34.23 71.21 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 118.627 2.825 . . . . 0.0 118.627 173.267 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -101.57 54.72 0.82 Allowed 'General case' 0 CA--C 1.574 1.886 0 CA-C-N 119.327 0.967 . . . . 0.0 110.847 168.038 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 15.3 t70 34.89 80.75 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 117.827 2.528 . . . . 0.0 117.827 178.015 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 60.5 mtm-85 -141.45 130.41 23.16 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 110.165 -0.309 . . . . 0.0 110.165 177.497 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.04 121.24 16.27 Favored 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 122.878 0.471 . . . . 0.0 110.493 158.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 16.3 m -137.89 132.24 43.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 -176.013 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -85.29 104.01 14.75 Favored 'General case' 0 N--CA 1.486 1.336 0 CA-C-O 121.882 0.849 . . . . 0.0 109.265 177.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 53.3 m -92.52 97.7 10.99 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 124.353 1.061 . . . . 0.0 110.946 -170.668 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 6.8 tp -107.65 118.79 56.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 175.3 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 1.5 p -136.84 132.61 47.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 C-N-CA 123.677 0.791 . . . . 0.0 109.298 -169.708 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 13.1 t -146.82 159.02 44.03 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-O 122.738 1.256 . . . . 0.0 110.545 178.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 17.5 tp -89.3 106.36 18.4 Favored 'General case' 0 CA--C 1.561 1.403 0 CA-C-N 114.81 -1.086 . . . . 0.0 108.871 173.611 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -105.43 94.09 5.03 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 123.493 0.717 . . . . 0.0 109.534 -177.472 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 60.97 49.59 76.88 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 117.506 1.762 . . . . 0.0 117.506 -178.699 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 69.59 18.96 74.31 Favored Glycine 0 CA--C 1.557 2.663 0 N-CA-C 119.158 2.423 . . . . 0.0 119.158 -168.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 38.7 mtmm -127.96 117.77 22.34 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 -178.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 4.5 tt -82.82 99.36 9.65 Favored 'General case' 0 CA--C 1.563 1.468 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 -177.051 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 55.0 t -103.61 108.49 24.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 N-CA-C 106.748 -1.575 . . . . 0.0 106.748 -169.175 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 19.9 t-160 -108.83 107.14 17.44 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 123.447 0.699 . . . . 0.0 110.054 179.201 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 42.5 tp -96.84 122.99 40.41 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 123.523 0.729 . . . . 0.0 109.262 177.201 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 30.2 mt-30 -113.88 113.88 25.48 Favored 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 107.54 -1.281 . . . . 0.0 107.54 175.521 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.59 145.0 41.14 Favored 'General case' 0 N--CA 1.493 1.725 0 C-N-CA 123.223 0.609 . . . . 0.0 111.574 178.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 32.9 p90 -155.55 111.03 3.03 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 123.355 0.662 . . . . 0.0 110.012 -177.454 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . 0.336 12.1 t70 69.0 -96.08 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.854 0 C-N-CA 124.438 1.095 . . . . 0.0 112.484 173.591 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -132.85 56.3 0.74 Allowed Glycine 0 CA--C 1.547 2.067 0 CA-C-N 118.424 0.557 . . . . 0.0 113.066 162.234 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 46.7 mt-30 -154.83 124.61 6.58 Favored 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 106.936 -1.505 . . . . 0.0 106.936 -174.166 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -132.52 144.25 50.3 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.886 -0.509 . . . . 0.0 112.301 178.285 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 6.2 t -130.27 126.71 37.93 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 122.815 0.446 . . . . 0.0 111.115 171.538 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 40.0 p -94.1 128.87 40.75 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 121.982 0.896 . . . . 0.0 110.577 170.487 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 5.7 mp -103.94 88.32 3.0 Favored 'General case' 0 CA--C 1.558 1.256 0 N-CA-C 106.637 -1.616 . . . . 0.0 106.637 175.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 81.0 t -93.54 97.94 7.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 N-CA-C 107.354 -1.35 . . . . 0.0 107.354 -169.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 78.4 mtt85 -91.42 127.62 36.93 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 123.367 0.667 . . . . 0.0 109.579 177.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -148.06 133.36 18.48 Favored 'General case' 0 N--CA 1.493 1.719 0 CA-C-O 120.82 0.343 . . . . 0.0 111.284 -176.078 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -79.66 114.15 18.36 Favored 'General case' 0 N--CA 1.487 1.41 0 CA-C-O 121.318 0.58 . . . . 0.0 111.442 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 90.4 mt -122.7 109.08 22.92 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 N-CA-C 104.534 -2.395 . . . . 0.0 104.534 176.189 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 23.4 m-20 59.19 48.98 9.72 Favored 'General case' 0 N--CA 1.5 2.029 0 N-CA-C 114.934 1.457 . . . . 0.0 114.934 177.608 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 62.74 24.4 66.35 Favored Glycine 0 CA--C 1.555 2.545 0 N-CA-C 119.555 2.582 . . . . 0.0 119.555 -170.306 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 59.9 mtmt -130.97 131.21 44.25 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-N 119.589 1.695 . . . . 0.0 108.863 -174.005 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 15.7 tp -77.98 107.61 10.64 Favored 'General case' 0 CA--C 1.558 1.276 0 CA-C-O 121.42 0.629 . . . . 0.0 109.676 178.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 32.7 mm -99.33 98.87 7.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 N-CA-C 106.432 -1.692 . . . . 0.0 106.432 -175.466 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 32.3 tp -88.71 103.41 15.93 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 123.976 0.91 . . . . 0.0 109.352 179.088 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 88.1 m -98.96 108.33 20.98 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 -177.169 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 67.1 mt -100.62 101.48 12.39 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 123.705 0.802 . . . . 0.0 109.436 -171.663 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 6.9 m -113.89 111.91 22.49 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 -175.57 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 70.5 t60 -102.95 -85.32 0.45 Allowed 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 173.617 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -109.56 -108.99 3.21 Favored Glycine 0 N--CA 1.484 1.872 0 N-CA-C 110.635 -0.986 . . . . 0.0 110.635 178.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 45.4 m -100.93 66.34 1.15 Allowed 'General case' 0 N--CA 1.494 1.757 0 CA-C-O 121.348 0.594 . . . . 0.0 109.593 173.408 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -172.8 96.1 0.13 Allowed 'General case' 0 N--CA 1.484 1.237 0 N-CA-C 108.123 -1.065 . . . . 0.0 108.123 173.279 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 3.7 p -94.68 122.55 46.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 C-N-CA 123.482 0.713 . . . . 0.0 109.61 174.253 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 44.4 t -108.21 102.11 11.27 Favored 'General case' 0 CA--C 1.553 1.067 0 CA-C-O 121.455 0.645 . . . . 0.0 111.356 179.384 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 90.6 m -88.12 108.0 19.04 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 179.379 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 35.9 mtm180 -111.42 120.05 40.88 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 123.044 0.538 . . . . 0.0 110.394 -172.657 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 94.8 m -86.28 131.17 34.29 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 123.343 0.657 . . . . 0.0 110.309 178.552 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 40.9 m-85 -125.84 125.48 42.93 Favored 'General case' 0 CA--C 1.56 1.354 0 C-N-CA 123.566 0.746 . . . . 0.0 109.035 176.443 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -92.72 158.34 15.97 Favored 'General case' 0 N--CA 1.495 1.816 0 CA-C-O 122.345 1.069 . . . . 0.0 111.849 170.287 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 73.5 tttt -91.16 125.97 36.1 Favored 'General case' 0 N--CA 1.484 1.256 0 CA-C-N 115.512 -0.767 . . . . 0.0 112.46 -165.447 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -97.86 46.74 1.01 Allowed 'General case' 0 N--CA 1.495 1.788 0 C-N-CA 123.853 0.861 . . . . 0.0 112.896 166.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.152 0 CA-C-O 123.168 1.461 . . . . 0.0 108.312 -174.821 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.315 8.9 t . . . . . 0 N--CA 1.491 1.585 0 CA-C-O 117.625 -1.178 . . . . 0.0 113.394 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -60.03 -37.58 80.19 Favored 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 116.274 1.953 . . . . 0.0 116.274 -178.309 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -62.78 -28.89 70.3 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 117.252 2.316 . . . . 0.0 117.252 164.169 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -73.12 -25.09 60.72 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 116.131 1.9 . . . . 0.0 116.131 168.278 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 74.4 mt -73.25 108.42 6.12 Favored 'General case' 0 N--CA 1.49 1.56 0 CA-C-N 120.747 1.612 . . . . 0.0 111.381 -173.115 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 161.34 171.59 27.56 Favored Glycine 0 CA--C 1.538 1.509 0 CA-C-O 123.254 1.474 . . . . 0.0 113.892 -175.103 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 96.8 m -84.85 144.85 28.15 Favored 'General case' 0 N--CA 1.487 1.378 0 CA-C-N 113.531 -1.334 . . . . 0.0 110.004 172.436 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 84.4 m95 -140.4 113.35 8.27 Favored 'General case' 0 N--CA 1.483 1.222 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 -175.228 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 45.3 mtmt -102.91 141.43 35.72 Favored 'General case' 0 N--CA 1.492 1.648 0 CA-C-O 121.457 0.646 . . . . 0.0 110.104 173.74 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 55.7 tp -69.63 130.52 42.62 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-O 122.444 1.116 . . . . 0.0 113.244 -170.492 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . 0.272 1.6 t -110.38 -41.77 4.69 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.781 0 CA-C-N 113.512 -1.676 . . . . 0.0 111.818 -172.671 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -142.14 138.94 31.97 Favored 'General case' 0 N--CA 1.492 1.633 0 CA-C-N 120.249 1.386 . . . . 0.0 109.738 175.307 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 86.6 p -124.3 102.39 7.66 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 123.416 0.686 . . . . 0.0 110.832 176.33 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -101.09 127.2 47.74 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 123.207 0.603 . . . . 0.0 109.424 174.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 66.2 m-20 67.62 22.04 9.22 Favored 'General case' 0 N--CA 1.504 2.25 0 N-CA-C 117.813 2.523 . . . . 0.0 117.813 173.452 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -72.4 -38.47 68.42 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 115.905 1.817 . . . . 0.0 115.905 -175.4 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -58.41 -30.68 67.05 Favored 'General case' 0 N--CA 1.498 1.96 0 N-CA-C 116.477 2.028 . . . . 0.0 116.477 164.708 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 13.5 t0 -66.13 -50.93 62.29 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 114.28 1.215 . . . . 0.0 114.28 169.486 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 93.7 t80 -55.17 -50.33 69.59 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 115.296 1.591 . . . . 0.0 115.296 172.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 72.7 mtm -60.53 -44.43 96.07 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 114.992 1.478 . . . . 0.0 114.992 173.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 14.5 tmtt? -57.29 -45.16 84.39 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 115.611 1.708 . . . . 0.0 115.611 168.35 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 13.8 t -59.13 -37.75 78.0 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 116.473 2.027 . . . . 0.0 116.473 173.073 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 63.6 mt -66.58 -42.28 87.24 Favored 'General case' 0 CA--C 1.564 1.514 0 N-CA-C 116.451 2.019 . . . . 0.0 116.451 170.315 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 115.13 77.27 0.71 Allowed Glycine 0 N--CA 1.482 1.718 0 N-CA-C 110.73 -0.948 . . . . 0.0 110.73 -168.309 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 62.4 t -143.04 122.64 9.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 N-CA-C 105.103 -2.184 . . . . 0.0 105.103 -177.027 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -81.58 -164.3 32.9 Favored Glycine 0 CA--C 1.548 2.127 0 N-CA-C 116.25 1.26 . . . . 0.0 116.25 -177.321 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 83.6 t80 -67.22 145.56 55.08 Favored 'General case' 0 CA--C 1.566 1.588 0 C-N-CA 123.501 0.72 . . . . 0.0 112.608 177.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . 0.377 . . 79.83 -41.11 0.22 Allowed 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 116.364 1.987 . . . . 0.0 116.364 179.395 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 56.9 m -69.36 -40.79 77.28 Favored 'General case' 0 N--CA 1.501 2.076 0 CA-C-N 120.152 1.342 . . . . 0.0 113.374 162.756 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 72.0 mtp180 -50.49 -42.51 54.79 Favored 'General case' 0 N--CA 1.498 1.946 0 N-CA-C 116.073 1.879 . . . . 0.0 116.073 160.022 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 81.4 mt-30 -76.41 -48.98 17.93 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 115.033 1.494 . . . . 0.0 115.033 -178.239 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 58.7 t -63.8 -43.16 97.83 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 CA-C-N 119.534 1.061 . . . . 0.0 112.922 178.004 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -65.35 -37.83 88.25 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 116.625 2.083 . . . . 0.0 116.625 174.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 90.5 p -62.46 -42.4 99.45 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 116.355 1.983 . . . . 0.0 116.355 170.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 19.2 ptp -74.23 -31.26 62.53 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 117.163 2.283 . . . . 0.0 117.163 173.172 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 65.7 m -77.96 144.31 36.89 Favored 'General case' 0 N--CA 1.491 1.577 0 CA-C-N 119.184 0.902 . . . . 0.0 111.743 -173.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 17.7 ptpt -98.25 104.97 25.86 Favored Pre-proline 0 CA--C 1.572 1.799 0 CA-C-O 118.431 -0.795 . . . . 0.0 111.591 170.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -78.06 112.98 3.34 Favored 'Trans proline' 0 CA--C 1.563 1.944 0 C-N-CA 123.056 2.504 . . . . 0.0 112.671 178.709 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 94.6 m -72.5 104.38 3.81 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 124.975 1.31 . . . . 0.0 110.1 175.563 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 29.7 m -106.65 118.26 36.21 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.844 -0.535 . . . . 0.0 110.142 -173.011 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 4.5 mp -106.71 112.95 41.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 -177.366 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 52.9 mt -99.05 119.11 46.61 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 N-CA-C 106.938 -1.504 . . . . 0.0 106.938 172.505 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -137.86 123.94 20.3 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 -178.23 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 36.8 ttpt -84.0 116.57 22.89 Favored 'General case' 0 CA--C 1.559 1.31 0 C-N-CA 123.124 0.57 . . . . 0.0 111.201 179.27 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -107.93 73.52 0.9 Allowed 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 123.6 0.76 . . . . 0.0 109.051 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 62.66 69.34 1.34 Allowed Glycine 0 N--CA 1.49 2.264 0 N-CA-C 115.312 0.885 . . . . 0.0 115.312 -173.755 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . 0.278 10.5 m-20 64.81 -2.99 0.61 Allowed 'General case' 0 N--CA 1.501 2.093 0 N-CA-C 118.299 2.703 . . . . 0.0 118.299 -168.629 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 42.5 mm -99.27 99.44 8.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 N-CA-C 107.105 -1.443 . . . . 0.0 107.105 -177.044 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 40.7 mt -77.55 106.99 9.69 Favored 'General case' 0 N--CA 1.488 1.429 0 CA-C-O 121.487 0.66 . . . . 0.0 111.12 178.728 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 34.1 m -100.75 94.54 6.13 Favored 'General case' 0 CA--C 1.559 1.319 0 N-CA-C 107.084 -1.451 . . . . 0.0 107.084 -171.128 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 8.8 tt -92.22 107.93 19.57 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 -177.484 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 52.6 mttp -107.64 93.53 4.59 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 -169.103 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 42.1 m -84.14 92.63 7.96 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.718 -0.614 . . . . 0.0 109.658 -178.283 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 28.9 m170 -88.93 121.36 31.21 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 124.005 0.922 . . . . 0.0 109.214 -179.441 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 13.6 t -137.39 159.21 42.58 Favored 'General case' 0 N--CA 1.49 1.548 0 CA-C-O 121.657 0.742 . . . . 0.0 110.876 -176.6 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 27.3 m -80.99 69.92 7.69 Favored 'General case' 0 N--CA 1.498 1.969 0 CA-C-O 122.099 0.952 . . . . 0.0 110.103 170.424 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 33.4 t80 170.96 -60.2 0.01 OUTLIER 'General case' 0 CA--C 1.571 1.778 0 C-N-CA 126.594 1.957 . . . . 0.0 107.506 -168.149 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.42 142.95 25.38 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 124.311 1.044 . . . . 0.0 111.006 -172.061 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 8.1 m-20 -120.35 110.82 16.99 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 107.921 -1.141 . . . . 0.0 107.921 172.009 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 35.8 p -122.91 133.11 54.41 Favored 'General case' 0 N--CA 1.495 1.806 0 C-N-CA 123.357 0.663 . . . . 0.0 110.832 -176.086 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -112.82 126.14 55.12 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 124.138 0.975 . . . . 0.0 109.222 179.794 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 12.0 pt -122.33 129.97 74.89 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 178.201 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 85.4 p -114.39 124.0 50.87 Favored 'General case' 0 N--CA 1.493 1.701 0 C-N-CA 123.635 0.774 . . . . 0.0 110.786 -173.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 41.8 p90 -146.41 139.12 25.35 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 116.069 1.877 . . . . 0.0 116.069 -168.631 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 57.1 mtmt -106.41 24.29 12.79 Favored 'General case' 0 N--CA 1.498 1.951 0 N-CA-C 116.518 2.044 . . . . 0.0 116.518 -178.371 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . 0.275 2.4 mp 61.95 92.43 0.06 Allowed 'General case' 0 N--CA 1.496 1.867 0 CA-C-N 120.904 1.684 . . . . 0.0 115.05 170.609 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 81.97 37.17 16.54 Favored Glycine 0 CA--C 1.55 2.28 0 N-CA-C 116.984 1.553 . . . . 0.0 116.984 -169.424 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 65.4 t -139.29 117.46 12.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 N-CA-C 105.534 -2.024 . . . . 0.0 105.534 -179.432 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -78.8 124.44 28.21 Favored 'General case' 0 N--CA 1.489 1.475 0 CA-C-O 121.415 0.626 . . . . 0.0 111.155 -179.638 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 14.9 p90 -127.07 134.1 50.33 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 124.393 1.077 . . . . 0.0 110.016 -176.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -72.05 137.23 47.01 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 112.873 0.694 . . . . 0.0 112.873 177.169 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -136.94 132.57 34.59 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 122.987 0.515 . . . . 0.0 110.518 -162.649 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 61.3 m -100.0 128.57 46.07 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 166.436 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 60.4 p -81.25 174.73 11.25 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 113.748 1.018 . . . . 0.0 113.748 -170.395 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -45.06 -37.15 3.97 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 118.591 2.811 . . . . 0.0 118.591 162.122 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -130.95 91.09 2.99 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 106.547 -1.649 . . . . 0.0 106.547 166.284 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -8.05 99.77 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.098 0 N-CA-C 119.301 3.074 . . . . 0.0 119.301 -175.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 3.3 ttm180 -136.27 13.68 3.28 Favored 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 116.961 2.208 . . . . 0.0 116.961 -175.046 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . 0.318 0.0 OUTLIER 42.93 77.04 0.07 Allowed 'General case' 0 N--CA 1.498 1.963 0 N-CA-C 116.898 2.185 . . . . 0.0 116.898 172.129 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 11.0 m -117.68 144.86 24.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 C-N-CA 123.378 0.671 . . . . 0.0 110.145 -166.576 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -96.35 102.65 14.46 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 178.497 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 58.0 m -90.41 125.79 35.67 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 123.401 0.68 . . . . 0.0 112.024 -171.364 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 6.2 tp -137.7 108.89 5.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 179.296 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -118.26 131.02 72.24 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 C-N-CA 124.558 1.143 . . . . 0.0 109.183 177.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 14.6 t -135.12 154.42 51.66 Favored 'General case' 0 N--CA 1.492 1.674 0 CA-C-O 122.777 1.275 . . . . 0.0 111.848 171.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 15.6 tp -88.56 113.3 23.99 Favored 'General case' 0 N--CA 1.487 1.419 0 CA-C-N 114.339 -1.3 . . . . 0.0 110.166 177.753 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -115.79 81.8 1.66 Allowed 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 123.42 0.688 . . . . 0.0 109.921 -176.195 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 62.65 48.58 80.38 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 117.299 1.68 . . . . 0.0 117.299 -175.06 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 74.28 44.06 29.68 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 117.446 1.739 . . . . 0.0 117.446 -171.155 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 40.5 ttpt -154.38 108.25 2.95 Favored 'General case' 0 CA--C 1.552 1.047 0 N-CA-C 106.549 -1.649 . . . . 0.0 106.549 -172.298 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 41.4 mt -81.72 96.86 7.68 Favored 'General case' 0 N--CA 1.491 1.579 0 CA-C-O 122.625 1.202 . . . . 0.0 110.109 175.526 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 96.2 t -87.81 98.57 7.68 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.235 0 CA-C-N 113.293 -1.776 . . . . 0.0 106.32 -178.477 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 22.4 t-160 -95.27 139.34 31.73 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 123.533 0.733 . . . . 0.0 109.818 177.262 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 20.5 tp -135.73 118.7 16.34 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 106.701 -1.592 . . . . 0.0 106.701 178.356 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 28.7 mt-30 -114.01 125.96 54.59 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 176.229 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -139.71 128.28 23.02 Favored 'General case' 0 N--CA 1.494 1.769 0 CA-C-N 118.685 0.675 . . . . 0.0 112.743 -165.402 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 21.4 p90 -151.32 115.8 5.11 Favored 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 123.908 0.883 . . . . 0.0 110.699 -167.178 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . 0.341 18.1 t70 67.96 -93.32 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.886 0 C-N-CA 124.766 1.226 . . . . 0.0 112.883 171.146 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -135.28 52.11 0.81 Allowed Glycine 0 CA--C 1.546 2.014 0 CA-C-O 119.743 -0.476 . . . . 0.0 113.887 163.159 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 15.6 mt-30 -151.02 131.29 13.61 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 176.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -133.42 116.2 15.74 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 123.089 0.556 . . . . 0.0 110.27 179.364 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 1.8 t -110.33 124.36 51.54 Favored 'General case' 0 N--CA 1.492 1.636 0 C-N-CA 123.265 0.626 . . . . 0.0 109.988 -178.523 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 35.6 p -100.72 137.95 38.43 Favored 'General case' 0 N--CA 1.492 1.633 0 CA-C-O 121.213 0.53 . . . . 0.0 111.244 179.38 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 5.0 mp -121.4 79.5 1.55 Allowed 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 -178.292 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 46.4 t -93.2 112.42 26.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 -165.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 45.3 mtt180 -102.71 129.42 49.32 Favored 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 122.854 0.462 . . . . 0.0 110.745 -177.589 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -148.83 139.33 22.58 Favored 'General case' 0 N--CA 1.494 1.744 0 C-N-CA 123.061 0.544 . . . . 0.0 111.97 178.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -83.7 113.97 21.25 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 123.094 0.558 . . . . 0.0 111.727 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 1.7 mp -103.79 102.02 13.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 N-CA-C 104.688 -2.338 . . . . 0.0 104.688 170.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 53.75 50.41 17.07 Favored 'General case' 0 N--CA 1.499 1.987 0 N-CA-C 115.257 1.577 . . . . 0.0 115.257 176.232 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 88.55 -37.93 3.25 Favored Glycine 0 CA--C 1.552 2.396 0 N-CA-C 117.857 1.903 . . . . 0.0 117.857 -169.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 10.4 mtmp? -85.93 127.45 34.62 Favored 'General case' 0 N--CA 1.487 1.377 0 CA-C-N 119.336 1.568 . . . . 0.0 111.08 -172.698 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 2.6 tt -80.14 118.77 22.13 Favored 'General case' 0 CA--C 1.556 1.202 0 CA-C-O 121.823 0.821 . . . . 0.0 111.082 -179.584 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 39.2 mm -100.91 108.81 23.99 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.347 0 N-CA-C 106.324 -1.732 . . . . 0.0 106.324 -178.502 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 47.2 tp -91.19 101.53 14.26 Favored 'General case' 0 CA--C 1.56 1.363 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 173.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 58.2 m -93.8 109.13 20.82 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 -177.622 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 62.7 mt -103.72 83.87 2.2 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 123.339 0.656 . . . . 0.0 110.372 -169.59 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 8.5 m -95.97 116.59 29.17 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.617 -0.677 . . . . 0.0 109.949 -170.173 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 85.0 t60 -146.49 115.9 7.09 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 176.342 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 75.82 -109.45 2.79 Favored Glycine 0 N--CA 1.484 1.86 0 C-N-CA 122.96 0.314 . . . . 0.0 113.538 173.675 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 14.9 t -129.82 55.09 1.8 Allowed 'General case' 0 N--CA 1.495 1.812 0 CA-C-O 121.405 0.621 . . . . 0.0 111.078 163.213 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -154.36 89.2 1.26 Allowed 'General case' 0 N--CA 1.483 1.177 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 177.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 5.6 p -92.96 117.93 37.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 C-N-CA 123.276 0.631 . . . . 0.0 110.004 176.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 44.2 t -99.98 104.39 16.0 Favored 'General case' 0 CA--C 1.553 1.093 0 CA-C-O 121.443 0.639 . . . . 0.0 111.419 175.302 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 57.5 m -92.02 110.18 21.54 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 -178.621 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 21.5 mtm105 -115.17 114.53 25.39 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 123.163 0.585 . . . . 0.0 110.561 -171.022 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 90.8 m -84.55 140.34 31.49 Favored 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 123.714 0.806 . . . . 0.0 110.987 -178.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 42.0 m-85 -133.98 135.92 43.78 Favored 'General case' 0 CA--C 1.559 1.298 0 C-N-CA 124.079 0.952 . . . . 0.0 109.903 -178.365 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -99.47 152.63 19.78 Favored 'General case' 0 N--CA 1.495 1.814 0 CA-C-O 122.058 0.932 . . . . 0.0 111.315 166.093 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 65.6 tttt -82.78 120.47 25.67 Favored 'General case' 0 N--CA 1.486 1.365 0 CA-C-N 115.465 -0.789 . . . . 0.0 111.19 -173.19 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 59.0 mm-40 -114.49 53.89 0.79 Allowed 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 124.073 0.949 . . . . 0.0 111.552 -172.205 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.894 0 CA-C-O 124.414 2.054 . . . . 0.0 108.956 -170.66 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.255 4.4 p . . . . . 0 CA--C 1.575 1.935 0 N-CA-C 116.141 1.904 . . . . 0.0 116.141 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -67.36 -39.61 85.74 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 116.385 1.995 . . . . 0.0 116.385 -177.011 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -59.59 -28.2 66.94 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 117.408 2.373 . . . . 0.0 117.408 167.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -68.21 -27.19 66.16 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 116.207 1.929 . . . . 0.0 116.207 166.568 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 79.9 mt -71.91 116.85 12.78 Favored 'General case' 0 N--CA 1.489 1.52 0 CA-C-N 120.967 1.712 . . . . 0.0 112.436 -170.855 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 159.41 173.36 27.76 Favored Glycine 0 CA--C 1.543 1.842 0 CA-C-O 122.484 1.047 . . . . 0.0 113.557 -178.597 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 53.9 m -85.19 141.08 30.41 Favored 'General case' 0 N--CA 1.493 1.714 0 CA-C-N 114.719 -0.74 . . . . 0.0 109.378 167.102 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 88.2 m95 -140.53 113.51 8.33 Favored 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 -174.046 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -100.69 150.01 23.19 Favored 'General case' 0 N--CA 1.496 1.863 0 CA-C-O 121.23 0.538 . . . . 0.0 110.554 176.047 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 22.5 tp -68.15 129.49 40.07 Favored 'General case' 0 N--CA 1.491 1.595 0 CA-C-O 121.932 0.872 . . . . 0.0 113.072 -174.437 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . 0.283 0.9 OUTLIER -105.05 -46.96 9.41 Favored 'Isoleucine or valine' 0 CA--C 1.576 1.967 0 CA-C-N 114.156 -1.384 . . . . 0.0 111.184 173.918 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -139.7 143.84 37.27 Favored 'General case' 0 N--CA 1.492 1.627 0 CA-C-N 119.754 1.161 . . . . 0.0 109.712 179.472 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 95.4 p -137.35 96.45 3.27 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.668 -0.645 . . . . 0.0 110.248 166.819 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -91.55 126.59 36.68 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 123.413 0.685 . . . . 0.0 109.679 177.385 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.27 62.6 m-20 69.45 37.17 2.05 Favored 'General case' 0 N--CA 1.502 2.174 0 N-CA-C 116.105 1.891 . . . . 0.0 116.105 -176.068 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 47.3 t80 -69.22 -59.56 2.93 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.759 -1.213 . . . . 0.0 112.8 175.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -45.91 -45.68 15.52 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 118.376 2.732 . . . . 0.0 118.376 171.076 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -61.12 -46.81 89.07 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 115.07 1.507 . . . . 0.0 115.07 172.516 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 87.2 t80 -55.84 -49.61 72.83 Favored 'General case' 0 CA--C 1.573 1.857 0 N-CA-C 115.025 1.491 . . . . 0.0 115.025 169.388 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 19.3 mmt -63.78 -44.61 92.85 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 114.829 1.418 . . . . 0.0 114.829 177.719 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 21.1 tptm -60.96 -37.65 83.17 Favored 'General case' 0 CA--C 1.571 1.753 0 N-CA-C 116.18 1.918 . . . . 0.0 116.18 167.67 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 17.1 t -58.85 -41.12 86.23 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 115.74 1.756 . . . . 0.0 115.74 169.47 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 79.1 mt -62.37 -44.3 96.79 Favored 'General case' 0 CA--C 1.568 1.641 0 N-CA-C 115.898 1.814 . . . . 0.0 115.898 166.315 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 123.63 65.24 0.2 Allowed Glycine 0 N--CA 1.483 1.813 0 C-N-CA 124.173 0.892 . . . . 0.0 111.991 -175.388 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 24.2 t -144.45 112.11 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 N-CA-C 105.084 -2.191 . . . . 0.0 105.084 -174.445 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -96.5 -100.27 1.93 Allowed Glycine 0 N--CA 1.484 1.834 0 N-CA-C 113.694 0.238 . . . . 0.0 113.694 -173.323 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 69.3 t80 -96.16 143.38 27.33 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 123.511 0.725 . . . . 0.0 111.784 -173.023 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . 0.352 . . 80.87 -51.04 0.31 Allowed 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 116.494 2.035 . . . . 0.0 116.494 168.516 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 91.8 m -70.28 -40.51 74.28 Favored 'General case' 0 N--CA 1.498 1.974 0 N-CA-C 113.938 1.088 . . . . 0.0 113.938 171.657 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 51.6 ttp180 -58.13 -41.04 82.78 Favored 'General case' 0 CA--C 1.572 1.818 0 N-CA-C 114.99 1.478 . . . . 0.0 114.99 164.457 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 42.9 mt-30 -73.94 -47.25 38.88 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 115.583 1.698 . . . . 0.0 115.583 178.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 81.3 t -63.84 -42.79 97.02 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.168 0 CA-C-N 120.01 1.277 . . . . 0.0 113.158 176.582 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -68.02 -31.61 71.42 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 117.052 2.242 . . . . 0.0 117.052 173.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 82.2 p -67.35 -39.38 85.73 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 115.889 1.811 . . . . 0.0 115.889 167.43 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 47.3 ttm -65.72 -41.7 91.96 Favored 'General case' 0 CA--C 1.566 1.575 0 N-CA-C 115.816 1.784 . . . . 0.0 115.816 175.595 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 5.9 t -81.0 165.73 21.45 Favored 'General case' 0 N--CA 1.493 1.686 0 CA-C-N 118.949 0.795 . . . . 0.0 112.933 178.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.17 105.68 33.9 Favored Pre-proline 0 CA--C 1.57 1.713 0 CA-C-O 118.093 -0.956 . . . . 0.0 110.127 172.54 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -80.76 99.77 1.16 Allowed 'Trans proline' 0 CA--C 1.558 1.715 0 C-N-CA 122.656 2.237 . . . . 0.0 112.308 -179.597 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 97.4 m -80.83 118.24 22.18 Favored 'General case' 0 N--CA 1.487 1.419 0 CA-C-N 115.417 -0.811 . . . . 0.0 110.934 -165.429 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 79.3 m -90.9 117.24 29.35 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 178.519 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 5.2 mp -108.41 109.29 27.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 N-CA-C 106.32 -1.733 . . . . 0.0 106.32 174.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 20.8 mt -100.49 117.35 45.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 N-CA-C 106.348 -1.723 . . . . 0.0 106.348 177.342 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -142.17 127.85 19.19 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.643 -0.661 . . . . 0.0 109.434 -170.386 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.68 156.1 32.83 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 113.972 1.101 . . . . 0.0 113.972 -178.727 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 25.9 t30 -141.91 74.74 1.46 Allowed 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 170.429 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 71.04 -102.23 1.05 Allowed Glycine 0 CA--C 1.546 1.991 0 O-C-N 122.119 -0.363 . . . . 0.0 112.732 -167.213 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 42.4 t0 -94.91 -20.76 19.13 Favored 'General case' 0 CA--C 1.573 1.86 0 N-CA-C 115.318 1.599 . . . . 0.0 115.318 166.816 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 18.6 mm -87.23 110.73 20.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 CA-C-N 120.542 1.519 . . . . 0.0 109.133 -169.081 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 30.7 mt -78.74 124.31 28.07 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 123.613 0.765 . . . . 0.0 111.935 176.275 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 86.7 m -109.19 99.48 8.76 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 106.922 -1.51 . . . . 0.0 106.922 179.532 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 9.7 tt -99.63 109.68 22.16 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 178.797 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -104.0 105.87 16.19 Favored 'General case' 0 N--CA 1.484 1.228 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 -179.187 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 48.8 m -89.02 95.26 10.25 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 174.441 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 22.0 m170 -76.9 175.58 9.38 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 124.132 0.973 . . . . 0.0 111.844 176.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 22.6 t -164.58 -25.89 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 115.069 1.507 . . . . 0.0 115.069 176.151 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . 0.296 6.7 m 62.59 50.44 3.54 Favored 'General case' 0 N--CA 1.504 2.264 0 CA-C-N 120.185 1.357 . . . . 0.0 111.978 -157.399 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 7.2 t80 -177.66 -67.73 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 106.082 -1.822 . . . . 0.0 106.082 -167.697 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.59 137.47 48.43 Favored 'General case' 0 CA--C 1.563 1.45 0 C-N-CA 124.064 0.946 . . . . 0.0 110.998 164.165 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 26.0 m-20 -119.78 104.17 9.99 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 173.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 60.4 p -106.59 131.98 53.13 Favored 'General case' 0 N--CA 1.496 1.865 0 C-N-CA 123.327 0.651 . . . . 0.0 110.952 -176.444 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 4.5 tm-20 -118.07 127.79 54.13 Favored 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 123.953 0.901 . . . . 0.0 110.081 -173.66 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 44.7 pt -116.94 132.76 65.74 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 C-N-CA 123.595 0.758 . . . . 0.0 109.267 172.196 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 73.5 p -116.2 112.95 22.38 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 176.397 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 40.2 p90 -144.35 146.33 32.49 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 114.498 1.295 . . . . 0.0 114.498 -161.331 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 57.6 mtmt -102.59 151.23 22.59 Favored 'General case' 0 N--CA 1.489 1.491 0 CA-C-N 115.133 -0.94 . . . . 0.0 109.126 159.146 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -74.15 115.95 14.23 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.66 -0.65 . . . . 0.0 111.709 -172.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 88.18 45.53 5.01 Favored Glycine 0 CA--C 1.55 2.225 0 N-CA-C 116.454 1.341 . . . . 0.0 116.454 -167.539 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 94.4 t -136.88 121.96 25.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 N-CA-C 107.024 -1.473 . . . . 0.0 107.024 178.086 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -87.97 125.73 34.68 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 123.05 0.54 . . . . 0.0 110.522 172.401 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 37.0 p90 -135.59 128.39 31.11 Favored 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 123.938 0.895 . . . . 0.0 109.026 -177.393 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -72.16 110.32 6.54 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.254 -0.904 . . . . 0.0 112.177 177.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 12.4 tp10 -109.9 129.13 55.69 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 123.804 0.842 . . . . 0.0 109.855 -169.314 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 67.6 m -96.91 118.87 34.27 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 175.635 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 38.8 p -88.2 168.33 12.84 Favored 'General case' 0 N--CA 1.49 1.54 0 CA-C-N 115.368 -0.833 . . . . 0.0 112.191 -172.612 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -62.2 -28.02 69.38 Favored 'General case' 0 CA--C 1.569 1.682 0 N-CA-C 117.154 2.279 . . . . 0.0 117.154 164.121 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -69.58 -1.22 8.21 Favored 'General case' 0 CA--C 1.58 2.105 0 N-CA-C 116.694 2.109 . . . . 0.0 116.694 164.247 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 65.32 67.31 0.51 Allowed 'General case' 0 N--CA 1.496 1.844 0 C-N-CA 125.449 1.5 . . . . 0.0 111.922 -176.183 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 38.9 ttp180 -148.2 117.49 6.9 Favored 'General case' 0 N--CA 1.485 1.307 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 -166.309 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -76.47 111.39 11.89 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 172.703 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 10.4 m -127.27 128.04 69.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 -172.241 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 47.5 mmtm -80.9 102.88 10.36 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 123.27 0.628 . . . . 0.0 109.526 -179.56 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 40.8 m -95.76 91.95 6.32 Favored 'General case' 0 N--CA 1.48 1.072 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.932 -167.077 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 6.1 tp -104.02 108.15 23.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 176.304 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 1.5 p -124.56 124.42 68.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 C-N-CA 123.851 0.861 . . . . 0.0 109.289 -173.28 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 9.8 t -138.53 152.78 48.52 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-O 122.467 1.127 . . . . 0.0 110.891 -178.794 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 35.3 tp -89.88 111.37 22.4 Favored 'General case' 0 N--CA 1.488 1.434 0 CA-C-N 114.85 -1.068 . . . . 0.0 109.394 174.099 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -104.61 81.99 1.85 Allowed 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 123.629 0.772 . . . . 0.0 110.266 -176.04 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 57.01 46.31 91.53 Favored Glycine 0 CA--C 1.551 2.327 0 N-CA-C 118.032 1.973 . . . . 0.0 118.032 -176.514 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 82.77 12.88 79.18 Favored Glycine 0 CA--C 1.557 2.681 0 N-CA-C 118.748 2.259 . . . . 0.0 118.748 -167.698 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 59.2 mtpt -125.2 103.88 8.21 Favored 'General case' 0 N--CA 1.487 1.394 0 CA-C-N 119.365 1.583 . . . . 0.0 106.799 177.825 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 5.5 tt -85.57 97.52 10.12 Favored 'General case' 0 CA--C 1.56 1.359 0 CA-C-O 122.013 0.911 . . . . 0.0 109.584 -174.824 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 71.6 t -96.37 110.47 24.7 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 N-CA-C 106.778 -1.564 . . . . 0.0 106.778 -170.308 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 20.1 t-160 -102.02 108.55 20.03 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 122.995 0.518 . . . . 0.0 109.697 173.681 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 40.8 tp -95.12 118.31 31.69 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 175.637 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 31.4 mt-30 -106.93 117.65 34.61 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 172.632 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 37.5 ttmt -124.76 127.37 47.11 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 123.195 0.598 . . . . 0.0 109.846 -172.617 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 32.3 p90 -145.93 114.76 6.89 Favored 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 123.241 0.616 . . . . 0.0 110.569 -174.575 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . 0.339 13.8 t70 67.04 -99.74 0.05 Allowed 'General case' 0 N--CA 1.494 1.751 0 C-N-CA 124.595 1.158 . . . . 0.0 112.403 173.01 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -128.61 50.54 0.89 Allowed Glycine 0 N--CA 1.487 2.04 0 CA-C-N 118.615 0.643 . . . . 0.0 114.197 163.216 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 14.1 mt-30 -150.65 128.85 11.95 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 177.807 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -137.09 130.79 31.79 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 123.139 0.576 . . . . 0.0 111.195 -176.756 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 7.1 t -121.88 129.3 52.47 Favored 'General case' 0 N--CA 1.495 1.809 0 C-N-CA 122.543 0.337 . . . . 0.0 111.486 176.129 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 39.7 p -99.31 124.62 44.55 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-O 121.755 0.788 . . . . 0.0 110.115 173.185 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 5.5 mp -100.91 88.27 3.51 Favored 'General case' 0 CA--C 1.559 1.29 0 N-CA-C 106.984 -1.487 . . . . 0.0 106.984 178.082 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 98.5 t -92.56 101.1 12.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 -168.102 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 77.7 mtt85 -96.47 125.44 40.96 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 123.221 0.608 . . . . 0.0 109.849 -178.309 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -144.95 128.17 16.73 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-O 120.847 0.356 . . . . 0.0 111.329 -172.367 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -82.42 115.64 21.53 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 123.144 0.577 . . . . 0.0 111.408 -177.245 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 96.1 mt -127.85 107.17 15.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 N-CA-C 104.993 -2.225 . . . . 0.0 104.993 179.701 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 23.4 m-20 58.08 52.76 7.32 Favored 'General case' 0 N--CA 1.5 2.063 0 N-CA-C 114.788 1.403 . . . . 0.0 114.788 176.523 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 63.15 21.21 63.7 Favored Glycine 0 CA--C 1.556 2.635 0 N-CA-C 119.734 2.653 . . . . 0.0 119.734 -171.258 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -128.92 127.54 41.96 Favored 'General case' 0 N--CA 1.488 1.445 0 CA-C-N 119.534 1.667 . . . . 0.0 108.51 -173.586 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 16.0 tp -79.33 109.99 14.19 Favored 'General case' 0 CA--C 1.557 1.236 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 176.751 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 32.5 mm -98.45 97.02 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 N-CA-C 106.467 -1.679 . . . . 0.0 106.467 -175.792 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 30.3 tp -87.23 103.96 15.93 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 124.003 0.921 . . . . 0.0 109.553 178.118 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 88.4 m -100.8 99.15 9.62 Favored 'General case' 0 CA--C 1.562 1.405 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 -177.408 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 71.0 mt -88.17 104.01 16.3 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 123.911 0.884 . . . . 0.0 109.672 -176.76 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 6.7 m -106.79 122.4 46.31 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.586 -0.696 . . . . 0.0 109.502 -171.83 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 77.8 t60 -148.15 113.5 5.59 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 173.797 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 74.89 -116.39 5.03 Favored Glycine 0 N--CA 1.484 1.883 0 C-N-CA 123.115 0.388 . . . . 0.0 113.849 173.083 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 15.2 t -119.22 53.45 1.02 Allowed 'General case' 0 N--CA 1.496 1.844 0 CA-C-O 121.271 0.557 . . . . 0.0 111.641 166.658 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -159.93 104.91 1.55 Allowed 'General case' 0 N--CA 1.483 1.203 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 175.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 7.4 p -111.24 125.89 68.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 C-N-CA 123.706 0.802 . . . . 0.0 110.113 -179.082 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 35.6 t -98.35 108.49 21.2 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 122.788 0.435 . . . . 0.0 111.693 175.626 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 88.6 m -92.2 117.19 29.63 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 177.868 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 75.6 mtp180 -124.46 115.78 21.46 Favored 'General case' 0 N--CA 1.488 1.444 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.054 -165.229 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 74.1 m -87.82 133.72 33.83 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 122.98 0.512 . . . . 0.0 109.794 178.017 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 40.0 m-85 -128.69 130.11 46.71 Favored 'General case' 0 CA--C 1.56 1.351 0 C-N-CA 123.388 0.675 . . . . 0.0 109.419 177.467 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -91.22 154.16 19.49 Favored 'General case' 0 N--CA 1.494 1.741 0 CA-C-O 122.23 1.014 . . . . 0.0 112.193 169.556 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 69.6 tttt -86.01 119.4 26.27 Favored 'General case' 0 N--CA 1.484 1.273 0 CA-C-N 115.257 -0.883 . . . . 0.0 111.414 -170.787 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 25.3 mm-40 -117.22 51.22 1.03 Allowed 'General case' 0 CA--C 1.564 1.508 0 C-N-CA 124.58 1.152 . . . . 0.0 111.26 -174.61 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 0.984 0 CA-C-O 123.059 1.409 . . . . 0.0 110.594 -159.732 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 4.1 p . . . . . 0 CA--C 1.576 1.971 0 N-CA-C 116.051 1.871 . . . . 0.0 116.051 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -66.86 -34.25 77.38 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 116.922 2.193 . . . . 0.0 116.922 -175.456 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -57.67 -31.63 66.51 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 117.387 2.366 . . . . 0.0 117.387 169.404 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -66.96 -26.5 66.86 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 116.686 2.106 . . . . 0.0 116.686 168.702 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 49.8 mt -77.07 107.07 9.17 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-N 120.887 1.676 . . . . 0.0 111.624 -164.057 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 157.18 176.97 29.85 Favored Glycine 0 CA--C 1.542 1.749 0 CA-C-O 122.511 1.062 . . . . 0.0 113.11 -169.744 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 85.6 m -91.78 143.56 26.4 Favored 'General case' 0 N--CA 1.489 1.48 0 CA-C-N 114.406 -0.897 . . . . 0.0 109.071 177.14 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 93.5 m95 -138.48 111.5 7.85 Favored 'General case' 0 N--CA 1.485 1.319 0 N-CA-C 107.548 -1.278 . . . . 0.0 107.548 -175.145 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -100.31 143.11 30.89 Favored 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 123.681 0.792 . . . . 0.0 110.648 -178.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 17.6 tp -66.91 124.62 23.49 Favored 'General case' 0 N--CA 1.488 1.445 0 CA-C-O 121.929 0.871 . . . . 0.0 113.135 -172.457 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . 0.267 1.2 t -97.37 -48.45 12.35 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.816 0 CA-C-N 114.261 -1.336 . . . . 0.0 111.601 174.472 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -143.89 150.25 38.12 Favored 'General case' 0 N--CA 1.489 1.494 0 CA-C-N 119.356 0.98 . . . . 0.0 110.046 178.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 88.1 p -130.65 98.14 4.57 Favored 'General case' 0 N--CA 1.489 1.514 0 CA-C-O 121.243 0.544 . . . . 0.0 109.922 170.042 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -84.51 128.27 34.5 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 123.168 0.587 . . . . 0.0 110.055 177.616 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 56.3 m-20 65.09 24.91 12.52 Favored 'General case' 0 N--CA 1.503 2.207 0 N-CA-C 117.964 2.579 . . . . 0.0 117.964 171.748 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 29.8 t80 -69.42 -53.24 20.31 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 120.032 -1.668 . . . . 0.0 113.982 -176.156 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -39.35 -44.64 1.34 Allowed 'General case' 0 N--CA 1.499 1.977 0 N-CA-C 118.948 2.944 . . . . 0.0 118.948 159.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -63.91 -50.35 69.06 Favored 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 115.214 1.561 . . . . 0.0 115.214 172.709 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 75.4 t80 -52.11 -48.0 64.99 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 115.591 1.7 . . . . 0.0 115.591 166.866 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 36.6 mmm -65.59 -40.11 92.33 Favored 'General case' 0 CA--C 1.565 1.548 0 N-CA-C 115.176 1.547 . . . . 0.0 115.176 176.352 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -60.85 -43.11 98.76 Favored 'General case' 0 CA--C 1.569 1.677 0 N-CA-C 114.873 1.435 . . . . 0.0 114.873 165.583 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 50.1 m -59.14 -39.45 82.44 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 115.82 1.785 . . . . 0.0 115.82 170.493 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 77.7 mt -64.62 -42.43 95.5 Favored 'General case' 0 CA--C 1.565 1.543 0 N-CA-C 116.214 1.931 . . . . 0.0 116.214 168.53 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 111.85 73.77 0.69 Allowed Glycine 0 N--CA 1.483 1.807 0 C-N-CA 123.708 0.671 . . . . 0.0 111.911 -172.445 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 37.6 t -136.3 127.84 43.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 N-CA-C 106.335 -1.728 . . . . 0.0 106.335 179.421 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -66.53 -80.19 0.19 Allowed Glycine 0 N--CA 1.485 1.966 0 N-CA-C 116.653 1.421 . . . . 0.0 116.653 -173.603 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 46.3 p90 -153.04 -50.29 0.1 Allowed 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 114.298 1.222 . . . . 0.0 114.298 -178.176 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.02 -41.67 96.99 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 116.871 2.175 . . . . 0.0 116.871 -176.519 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 59.0 m -80.06 -36.24 35.93 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 113.521 0.934 . . . . 0.0 113.521 169.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 44.2 ttp180 -58.72 -44.05 90.31 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 115.722 1.749 . . . . 0.0 115.722 176.677 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 18.2 mm100 -86.91 -33.64 19.65 Favored 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 115.315 1.598 . . . . 0.0 115.315 178.864 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 89.1 t -69.44 -46.19 76.86 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 CA-C-N 120.875 1.67 . . . . 0.0 111.941 173.373 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -65.97 -24.43 66.79 Favored 'General case' 0 CA--C 1.569 1.685 0 N-CA-C 117.559 2.429 . . . . 0.0 117.559 175.075 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 87.4 p -68.17 -49.48 60.66 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 114.863 1.431 . . . . 0.0 114.863 167.052 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 3.3 ppp? -65.26 -23.31 67.01 Favored 'General case' 0 N--CA 1.499 2.012 0 N-CA-C 117.792 2.516 . . . . 0.0 117.792 170.408 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 48.6 m -68.99 150.74 47.35 Favored 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 124.507 1.123 . . . . 0.0 112.119 177.189 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.8 98.81 6.64 Favored Pre-proline 0 CA--C 1.571 1.786 0 CA-C-O 118.072 -0.966 . . . . 0.0 110.022 166.319 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_endo -82.12 90.34 1.12 Allowed 'Trans proline' 0 CA--C 1.562 1.878 0 C-N-CA 122.805 2.337 . . . . 0.0 110.758 179.32 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 80.3 m -79.8 110.63 15.34 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 123.715 0.806 . . . . 0.0 110.487 -160.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 58.6 m -86.27 116.42 24.44 Favored 'General case' 0 CA--C 1.562 1.41 0 C-N-CA 123.085 0.554 . . . . 0.0 109.962 -171.247 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 71.9 mt -113.12 105.24 18.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 N-CA-C 106.434 -1.691 . . . . 0.0 106.434 178.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 3.8 mp -94.56 123.05 46.53 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 174.567 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -132.48 117.88 18.58 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 -176.866 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 38.7 ttpt -90.24 117.22 28.81 Favored 'General case' 0 CA--C 1.557 1.227 0 CA-C-O 121.296 0.57 . . . . 0.0 110.911 177.511 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 21.2 t-20 -77.27 -56.14 4.81 Favored 'General case' 0 CA--C 1.568 1.651 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.85 164.245 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -159.49 -85.62 0.05 OUTLIER Glycine 0 N--CA 1.48 1.614 0 N-CA-C 109.066 -1.613 . . . . 0.0 109.066 171.039 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -74.04 -37.87 64.17 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 114.502 1.297 . . . . 0.0 114.502 161.108 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 45.9 mm -76.68 120.54 27.09 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.514 0 C-N-CA 123.954 0.902 . . . . 0.0 110.466 -174.116 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 47.1 mt -99.67 108.99 21.48 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.745 0.818 . . . . 0.0 109.037 168.014 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 93.7 m -95.43 100.63 12.37 Favored 'General case' 0 CA--C 1.559 1.308 0 N-CA-C 107.513 -1.291 . . . . 0.0 107.513 -177.018 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 9.6 tt -100.44 106.38 17.95 Favored 'General case' 0 N--CA 1.483 1.178 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 -178.47 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -101.88 111.64 23.97 Favored 'General case' 0 N--CA 1.485 1.305 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 178.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 95.2 m -95.07 94.46 7.97 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 178.192 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 22.3 m-70 -81.12 100.99 9.34 Favored 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 123.276 0.63 . . . . 0.0 111.603 -171.257 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 32.1 t -112.68 145.41 40.51 Favored 'General case' 0 CA--C 1.555 1.152 0 C-N-CA 123.904 0.882 . . . . 0.0 109.397 -176.304 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 53.1 m -52.46 -25.24 9.57 Favored 'General case' 0 N--CA 1.502 2.154 0 N-CA-C 115.729 1.751 . . . . 0.0 115.729 158.731 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 72.2 t80 -109.43 83.07 1.69 Allowed 'General case' 0 CA--C 1.562 1.406 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 169.826 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 28.2 mtpp 61.79 115.55 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.997 0 N-CA-C 115.706 1.743 . . . . 0.0 115.706 172.495 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 7.6 p-10 -79.43 121.33 25.04 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.713 -0.617 . . . . 0.0 112.493 175.604 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 73.1 p -93.85 126.37 39.0 Favored 'General case' 0 N--CA 1.493 1.716 0 C-N-CA 122.718 0.407 . . . . 0.0 110.538 178.783 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -105.81 113.92 27.76 Favored 'General case' 0 N--CA 1.485 1.292 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 174.037 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 19.8 pt -116.59 128.82 73.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 179.72 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 61.7 p -116.83 113.4 22.45 Favored 'General case' 0 N--CA 1.492 1.659 0 C-N-CA 123.741 0.817 . . . . 0.0 109.447 -172.466 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 42.6 p90 -141.31 145.65 35.75 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 114.929 1.455 . . . . 0.0 114.929 -165.228 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 34.8 mtmm -116.82 23.94 11.6 Favored 'General case' 0 N--CA 1.498 1.929 0 N-CA-C 115.982 1.845 . . . . 0.0 115.982 -174.168 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . 0.275 2.0 mp 65.75 94.21 0.06 Allowed 'General case' 0 N--CA 1.494 1.725 0 C-N-CA 124.964 1.306 . . . . 0.0 113.635 168.632 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 83.27 34.06 21.42 Favored Glycine 0 CA--C 1.551 2.323 0 N-CA-C 117.095 1.598 . . . . 0.0 117.095 -164.601 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 95.6 t -135.27 118.19 23.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 N-CA-C 106.453 -1.684 . . . . 0.0 106.453 -178.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -85.6 136.27 33.45 Favored 'General case' 0 CA--C 1.565 1.55 0 C-N-CA 123.563 0.745 . . . . 0.0 111.86 179.448 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 47.9 p90 -143.89 139.29 29.13 Favored 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 123.663 0.785 . . . . 0.0 111.392 -171.872 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -75.57 135.42 40.55 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.252 -0.905 . . . . 0.0 112.688 172.413 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -146.1 136.49 23.94 Favored 'General case' 0 N--CA 1.49 1.528 0 CA-C-O 120.997 0.427 . . . . 0.0 111.207 -170.53 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 79.3 m -96.88 130.09 44.23 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 172.037 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 26.7 p -89.2 171.8 9.54 Favored 'General case' 0 N--CA 1.492 1.671 0 CA-C-O 121.989 0.9 . . . . 0.0 112.661 -176.336 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -54.48 -40.33 68.39 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 117.207 2.299 . . . . 0.0 117.207 169.018 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -93.93 59.7 2.78 Favored 'General case' 0 N--CA 1.495 1.813 0 CA-C-N 119.362 0.983 . . . . 0.0 111.337 170.267 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 9.5 t70 21.7 76.26 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.007 0 N-CA-C 118.771 2.878 . . . . 0.0 118.771 -178.687 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 38.4 ttp180 -139.73 117.92 11.95 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 -169.204 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.42 114.81 12.06 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 122.901 0.48 . . . . 0.0 110.195 172.252 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 17.3 m -135.01 132.27 53.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 CA-C-O 121.431 0.634 . . . . 0.0 109.642 -170.135 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 39.5 ttpt -87.02 118.09 26.17 Favored 'General case' 0 CA--C 1.558 1.263 0 C-N-CA 123.829 0.852 . . . . 0.0 110.237 178.77 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 71.0 m -117.35 109.76 17.21 Favored 'General case' 0 N--CA 1.488 1.452 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.259 -157.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 6.6 tp -122.73 115.88 47.2 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 C-N-CA 123.834 0.854 . . . . 0.0 109.091 -179.105 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -123.53 129.58 74.57 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 C-N-CA 124.431 1.092 . . . . 0.0 109.29 178.76 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 15.1 t -133.89 156.97 47.14 Favored 'General case' 0 N--CA 1.493 1.693 0 CA-C-O 122.632 1.206 . . . . 0.0 111.34 169.532 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 19.3 tp -94.16 117.99 30.91 Favored 'General case' 0 N--CA 1.489 1.476 0 CA-C-N 114.726 -1.124 . . . . 0.0 110.558 -178.388 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -104.52 81.5 1.8 Allowed 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 123.231 0.612 . . . . 0.0 110.079 175.835 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 78.07 -74.92 1.96 Allowed Glycine 0 N--CA 1.487 2.1 0 CA-C-O 121.473 0.485 . . . . 0.0 113.832 -174.72 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -148.63 53.95 0.52 Allowed Glycine 0 CA--C 1.546 1.99 0 CA-C-N 114.425 -0.887 . . . . 0.0 112.885 167.451 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 38.7 mtmm -145.26 111.68 5.73 Favored 'General case' 0 N--CA 1.484 1.263 0 N-CA-C 106.682 -1.599 . . . . 0.0 106.682 -175.641 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 46.7 mt -82.4 96.35 7.94 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-O 122.757 1.265 . . . . 0.0 109.424 174.248 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 95.5 t -86.81 94.93 4.6 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.342 0 CA-C-N 113.029 -1.896 . . . . 0.0 105.936 -179.651 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 16.8 t-160 -98.89 147.95 24.43 Favored 'General case' 0 CA--C 1.559 1.319 0 C-N-CA 124.612 1.165 . . . . 0.0 109.608 179.209 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.414 HD11 ' HB2' ' A' ' 101' ' ' GLU . 23.2 tp -145.48 119.89 9.65 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 179.571 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 94.4 mt-30 -105.67 122.6 46.38 Favored 'General case' 0 N--CA 1.486 1.325 0 C-N-CA 124.707 1.203 . . . . 0.0 108.341 176.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 7.9 mtpm? -125.44 130.69 52.35 Favored 'General case' 0 N--CA 1.494 1.736 0 C-N-CA 123.023 0.529 . . . . 0.0 110.048 -170.779 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 19.2 p90 -153.34 112.85 3.83 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.67 -0.644 . . . . 0.0 110.091 -175.066 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 4.5 t70 51.93 53.73 12.07 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 116.552 2.056 . . . . 0.0 116.552 168.091 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 86.64 -40.66 3.07 Favored Glycine 0 CA--C 1.552 2.344 0 N-CA-C 117.387 1.715 . . . . 0.0 117.387 -171.473 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 19.2 mt-30 -85.31 137.39 33.0 Favored 'General case' 0 N--CA 1.49 1.562 0 CA-C-N 118.316 1.058 . . . . 0.0 111.168 -179.804 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.414 ' HB2' HD11 ' A' ' 94' ' ' LEU . 12.5 pt-20 -143.38 133.13 23.85 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 122.837 0.455 . . . . 0.0 111.727 -179.077 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 14.8 t -116.69 128.67 55.56 Favored 'General case' 0 N--CA 1.494 1.746 0 C-N-CA 123.108 0.563 . . . . 0.0 110.575 175.378 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 40.8 p -91.86 125.6 36.63 Favored 'General case' 0 N--CA 1.494 1.758 0 C-N-CA 122.965 0.506 . . . . 0.0 109.955 170.866 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 5.2 mp -105.63 82.1 1.76 Allowed 'General case' 0 CA--C 1.565 1.53 0 C-N-CA 124.187 0.995 . . . . 0.0 108.384 178.207 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 88.4 t -88.91 106.0 16.39 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 -172.153 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 74.8 mtt85 -97.88 117.53 32.4 Favored 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 123.137 0.575 . . . . 0.0 109.73 179.587 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -137.14 131.11 32.13 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 123.168 0.587 . . . . 0.0 111.185 -171.038 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -80.83 118.1 22.05 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.83 -0.544 . . . . 0.0 111.609 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 46.6 mm -125.47 101.85 9.21 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.28 0 N-CA-C 105.365 -2.087 . . . . 0.0 105.365 178.422 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 59.12 50.24 8.33 Favored 'General case' 0 N--CA 1.5 2.059 0 N-CA-C 115.408 1.633 . . . . 0.0 115.408 174.177 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 65.67 30.48 77.43 Favored Glycine 0 CA--C 1.555 2.556 0 N-CA-C 118.736 2.255 . . . . 0.0 118.736 -170.548 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -136.4 129.41 31.19 Favored 'General case' 0 N--CA 1.489 1.506 0 CA-C-N 118.458 1.129 . . . . 0.0 108.688 -176.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 12.2 tp -81.9 114.68 20.67 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 175.53 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 40.6 mm -104.74 100.04 9.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 N-CA-C 106.401 -1.703 . . . . 0.0 106.401 -174.882 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 38.6 tp -89.65 98.34 11.71 Favored 'General case' 0 CA--C 1.559 1.327 0 C-N-CA 123.657 0.783 . . . . 0.0 109.532 178.171 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 87.0 m -91.71 108.51 19.97 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 -178.771 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 87.7 mt -100.86 90.61 4.26 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 123.562 0.745 . . . . 0.0 109.467 -173.84 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 7.9 m -96.12 117.24 30.32 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.636 -0.665 . . . . 0.0 109.289 -173.489 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 83.4 t60 -127.57 91.02 3.22 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 168.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 73.1 -101.15 1.09 Allowed Glycine 0 N--CA 1.483 1.819 0 N-CA-C 114.49 0.556 . . . . 0.0 114.49 174.549 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 81.2 m -88.67 -54.52 4.12 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-O 118.486 -0.769 . . . . 0.0 112.045 175.62 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -85.1 106.36 16.51 Favored 'General case' 0 N--CA 1.484 1.246 0 CA-C-N 119.721 1.146 . . . . 0.0 112.256 -171.34 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 5.8 p -98.88 125.78 52.24 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 C-N-CA 123.83 0.852 . . . . 0.0 109.883 176.056 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 40.4 t -107.13 103.77 13.25 Favored 'General case' 0 CA--C 1.553 1.062 0 CA-C-O 121.41 0.624 . . . . 0.0 111.774 179.17 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 60.6 m -88.84 111.69 22.35 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 123.421 0.688 . . . . 0.0 109.187 179.587 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 22.3 mtp180 -106.11 111.86 24.66 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 -178.064 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 95.2 m -89.26 136.3 33.1 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 123.711 0.804 . . . . 0.0 109.98 -179.725 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 65.7 m-85 -132.07 132.68 43.55 Favored 'General case' 0 CA--C 1.56 1.361 0 C-N-CA 123.527 0.731 . . . . 0.0 110.259 -176.296 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -92.79 156.16 17.18 Favored 'General case' 0 N--CA 1.495 1.796 0 CA-C-O 122.249 1.023 . . . . 0.0 111.835 165.084 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 40.3 tttp -86.2 137.9 32.29 Favored 'General case' 0 N--CA 1.487 1.385 0 CA-C-N 115.528 -0.76 . . . . 0.0 112.817 -171.092 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -120.58 57.27 0.97 Allowed 'General case' 0 N--CA 1.494 1.733 0 C-N-CA 123.447 0.699 . . . . 0.0 111.952 171.137 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.437 0 CA-C-O 124.15 1.929 . . . . 0.0 112.444 -179.289 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 4.7 p . . . . . 0 CA--C 1.578 2.046 0 N-CA-C 115.675 1.732 . . . . 0.0 115.675 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -66.01 -48.39 71.3 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 117.231 2.308 . . . . 0.0 117.231 -173.401 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -55.84 -27.73 52.91 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 117.841 2.534 . . . . 0.0 117.841 171.09 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -68.61 -26.53 65.41 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 116.199 1.926 . . . . 0.0 116.199 167.642 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 40.6 mt -76.87 111.88 12.88 Favored 'General case' 0 N--CA 1.49 1.526 0 CA-C-N 120.78 1.627 . . . . 0.0 112.04 -168.768 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 164.63 176.05 35.99 Favored Glycine 0 CA--C 1.541 1.708 0 CA-C-O 122.706 1.17 . . . . 0.0 113.434 -173.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 63.3 m -90.0 140.22 29.85 Favored 'General case' 0 N--CA 1.493 1.699 0 CA-C-N 114.238 -0.981 . . . . 0.0 109.046 170.403 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 87.6 m95 -140.89 112.6 7.58 Favored 'General case' 0 N--CA 1.484 1.267 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 -174.044 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 8.6 mtpm? -96.67 146.04 25.23 Favored 'General case' 0 N--CA 1.495 1.789 0 CA-C-O 121.327 0.584 . . . . 0.0 110.273 174.833 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 23.8 tp -66.83 125.62 26.47 Favored 'General case' 0 N--CA 1.488 1.455 0 CA-C-O 121.89 0.853 . . . . 0.0 112.48 -177.062 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . 0.279 1.1 t -99.7 -47.93 11.87 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.795 0 CA-C-N 114.398 -1.274 . . . . 0.0 111.717 176.302 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -139.97 143.2 36.41 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-N 119.571 1.078 . . . . 0.0 109.67 177.528 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 78.5 p -126.09 94.07 3.99 Favored 'General case' 0 N--CA 1.49 1.526 0 CA-C-O 121.306 0.574 . . . . 0.0 110.486 169.067 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 57.5 tttp -83.22 119.49 24.62 Favored 'General case' 0 CA--C 1.557 1.243 0 C-N-CA 123.625 0.77 . . . . 0.0 109.71 175.528 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.259 24.5 m-20 73.45 26.47 1.99 Allowed 'General case' 0 N--CA 1.501 2.122 0 N-CA-C 116.736 2.125 . . . . 0.0 116.736 175.704 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.424 ' HD1' ' HG ' ' A' ' 124' ' ' CYS . 22.5 t80 -89.27 78.67 7.23 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.362 -1.461 . . . . 0.0 110.72 178.503 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -170.44 -58.03 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 125.0 1.32 . . . . 0.0 108.281 -176.576 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 29.0 t0 -54.45 -47.7 72.58 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 115.365 1.617 . . . . 0.0 115.365 166.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 92.3 t80 -49.3 -54.73 15.55 Favored 'General case' 0 CA--C 1.573 1.835 0 N-CA-C 115.133 1.531 . . . . 0.0 115.133 167.781 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 74.8 mtm -63.71 -41.17 98.14 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 116.01 1.855 . . . . 0.0 116.01 174.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 57.9 tttm -64.92 -43.28 93.34 Favored 'General case' 0 CA--C 1.567 1.626 0 N-CA-C 115.228 1.566 . . . . 0.0 115.228 173.432 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 60.9 m -59.97 -39.91 87.3 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 115.815 1.783 . . . . 0.0 115.815 169.837 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 64.9 mt -64.37 -30.84 71.87 Favored 'General case' 0 CA--C 1.566 1.568 0 N-CA-C 117.41 2.374 . . . . 0.0 117.41 168.587 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 91.32 75.92 1.31 Allowed Glycine 0 N--CA 1.482 1.722 0 CA-C-N 119.211 0.914 . . . . 0.0 111.978 -170.025 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 97.9 t -128.31 81.28 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 N-CA-C 106.643 -1.614 . . . . 0.0 106.643 -177.273 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 31.86 -118.51 0.13 Allowed Glycine 0 CA--C 1.55 2.273 0 N-CA-C 121.018 3.167 . . . . 0.0 121.018 174.361 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 10.7 t80 -148.43 -71.22 0.21 Allowed 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 178.485 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -72.69 -16.99 61.68 Favored 'General case' 0 CA--C 1.567 1.608 0 N-CA-C 116.615 2.08 . . . . 0.0 116.615 177.269 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 30.6 m -68.63 -42.63 77.75 Favored 'General case' 0 N--CA 1.497 1.904 0 CA-C-N 120.3 1.409 . . . . 0.0 113.495 162.76 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 37.1 ttp-105 -55.31 -44.64 75.97 Favored 'General case' 0 CA--C 1.571 1.787 0 N-CA-C 115.138 1.533 . . . . 0.0 115.138 164.64 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 5.9 tm0? -65.78 -52.33 51.74 Favored 'General case' 0 CA--C 1.565 1.547 0 N-CA-C 115.451 1.648 . . . . 0.0 115.451 174.38 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 92.6 t -66.1 -38.32 81.74 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.975 0 N-CA-C 113.583 0.957 . . . . 0.0 113.583 -179.602 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -65.68 -34.59 78.56 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 116.806 2.15 . . . . 0.0 116.806 175.755 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 88.4 p -67.63 -39.55 84.66 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 116.348 1.981 . . . . 0.0 116.348 167.01 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 38.3 ttm -64.65 -40.72 95.94 Favored 'General case' 0 CA--C 1.571 1.756 0 N-CA-C 115.87 1.804 . . . . 0.0 115.87 169.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 88.3 m -75.74 153.06 37.27 Favored 'General case' 0 CA--C 1.567 1.61 0 C-N-CA 124.276 1.031 . . . . 0.0 112.597 -177.015 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 64.0 mttp -102.91 100.06 15.66 Favored Pre-proline 0 CA--C 1.572 1.82 0 CA-C-N 115.405 -0.816 . . . . 0.0 109.735 172.268 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -82.36 113.62 2.36 Favored 'Trans proline' 0 CA--C 1.561 1.826 0 C-N-CA 123.36 2.707 . . . . 0.0 112.289 179.737 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 86.7 m -83.95 108.54 16.99 Favored 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 123.509 0.723 . . . . 0.0 110.67 -169.366 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 88.2 m -81.65 116.64 21.48 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 123.492 0.717 . . . . 0.0 109.808 -179.495 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 61.3 mt -115.56 107.87 23.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 N-CA-C 106.122 -1.807 . . . . 0.0 106.122 -176.584 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 22.8 mt -103.05 119.48 51.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 N-CA-C 107.653 -1.239 . . . . 0.0 107.653 -175.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -137.62 111.34 8.18 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 -169.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 60.4 tttm -86.46 114.56 23.32 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 123.369 0.668 . . . . 0.0 111.015 -179.306 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 33.5 t30 -115.87 82.47 1.77 Allowed 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 -179.481 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 61.23 59.53 9.84 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 116.411 1.324 . . . . 0.0 116.411 -174.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . 0.319 15.7 t0 68.92 -14.79 0.28 Allowed 'General case' 0 N--CA 1.498 1.946 0 N-CA-C 117.572 2.434 . . . . 0.0 117.572 -166.372 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 11.2 mm -87.72 98.96 8.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 CA-C-N 120.342 1.428 . . . . 0.0 107.631 -177.292 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 43.9 mt -80.21 107.31 12.9 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 123.523 0.729 . . . . 0.0 110.544 -178.41 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 30.6 m -97.48 94.56 7.09 Favored 'General case' 0 N--CA 1.485 1.292 0 N-CA-C 107.059 -1.46 . . . . 0.0 107.059 -175.059 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 9.7 tt -99.4 102.81 14.51 Favored 'General case' 0 N--CA 1.484 1.255 0 N-CA-C 108.007 -1.108 . . . . 0.0 108.007 -174.515 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 64.0 mttm -105.04 116.82 32.59 Favored 'General case' 0 N--CA 1.486 1.328 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 -173.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 89.1 m -100.55 92.05 4.95 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 -175.624 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 8.0 m170 -87.94 96.26 10.43 Favored 'General case' 0 N--CA 1.491 1.59 0 CA-C-O 122.373 1.083 . . . . 0.0 111.862 -169.676 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 28.1 t -96.94 158.35 15.47 Favored 'General case' 0 CA--C 1.561 1.385 0 CA-C-N 114.596 -1.184 . . . . 0.0 111.18 171.729 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 76.7 p -81.45 65.92 6.78 Favored 'General case' 0 N--CA 1.501 2.102 0 CA-C-O 122.297 1.046 . . . . 0.0 111.179 163.762 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 33.3 t80 176.45 -59.8 0.01 OUTLIER 'General case' 0 CA--C 1.57 1.742 0 C-N-CA 126.001 1.72 . . . . 0.0 107.762 -166.558 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 1.5 pptp? -136.42 162.9 31.77 Favored 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 125.008 1.323 . . . . 0.0 111.316 -175.565 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 34.7 p-10 -143.19 87.58 1.97 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.015 -1.053 . . . . 0.0 109.833 164.767 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 41.4 p -86.97 129.94 34.67 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-O 121.402 0.62 . . . . 0.0 111.028 -179.478 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -110.92 129.65 55.81 Favored 'General case' 0 N--CA 1.484 1.24 0 CA-C-N 115.127 -0.942 . . . . 0.0 109.416 178.763 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 41.5 pt -112.48 130.86 65.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 164.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 58.0 p -120.73 103.91 9.48 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 108.825 -0.805 . . . . 0.0 108.825 -177.81 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 45.7 p90 -138.8 133.67 32.39 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 114.052 1.131 . . . . 0.0 114.052 -158.829 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 56.4 mtmt -86.73 148.91 25.22 Favored 'General case' 0 CA--C 1.562 1.435 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.534 156.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -73.38 116.87 14.45 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.762 -0.586 . . . . 0.0 111.66 -174.602 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 90.69 45.19 4.34 Favored Glycine 0 CA--C 1.548 2.13 0 N-CA-C 116.515 1.366 . . . . 0.0 116.515 -167.352 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 96.3 t -135.4 122.25 34.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 N-CA-C 106.984 -1.487 . . . . 0.0 106.984 177.476 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -88.89 126.7 35.5 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 123.29 0.636 . . . . 0.0 110.386 170.334 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 43.0 p90 -139.62 133.06 30.15 Favored 'General case' 0 N--CA 1.494 1.766 0 C-N-CA 123.38 0.672 . . . . 0.0 111.172 -172.501 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -70.66 118.14 13.08 Favored 'General case' 0 CA--C 1.564 1.494 0 O-C-N 121.621 -0.675 . . . . 0.0 112.343 175.77 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 15.9 tp10 -125.72 136.44 53.19 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 123.775 0.83 . . . . 0.0 109.967 -170.324 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 57.8 m -91.24 123.46 34.7 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 174.461 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 31.7 p -82.48 170.68 14.97 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 113.056 0.762 . . . . 0.0 113.056 -175.695 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -53.28 -30.66 39.75 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 118.665 2.839 . . . . 0.0 118.665 173.078 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -78.7 -85.85 0.07 Allowed 'General case' 0 N--CA 1.489 1.488 0 CA-C-N 119.387 0.994 . . . . 0.0 109.23 168.261 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 179.01 82.86 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 168.634 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 22.0 mtm180 -140.22 124.81 18.05 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.847 -0.533 . . . . 0.0 109.92 -174.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.89 116.19 13.1 Favored 'General case' 0 CA--C 1.564 1.482 0 C-N-CA 123.63 0.772 . . . . 0.0 111.121 165.592 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 17.8 m -134.26 129.56 53.54 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 -170.246 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 46.2 mmtm -83.37 104.42 13.51 Favored 'General case' 0 N--CA 1.49 1.526 0 CA-C-O 121.759 0.79 . . . . 0.0 110.152 -178.076 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 75.2 m -101.24 95.86 6.81 Favored 'General case' 0 N--CA 1.484 1.238 0 CA-C-N 115.064 -0.971 . . . . 0.0 110.702 -162.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 7.2 tp -103.19 121.58 54.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 179.606 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 1.9 p -142.22 123.44 12.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 C-N-CA 123.171 0.589 . . . . 0.0 109.95 -172.085 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 15.1 t -136.96 159.72 41.03 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-O 122.579 1.18 . . . . 0.0 110.92 178.42 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 14.7 tp -90.54 111.17 22.36 Favored 'General case' 0 CA--C 1.562 1.437 0 CA-C-N 115.084 -0.962 . . . . 0.0 109.505 174.855 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -101.69 88.01 3.3 Favored 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 123.678 0.791 . . . . 0.0 109.793 -179.507 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 58.26 47.43 89.56 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 118.07 1.988 . . . . 0.0 118.07 -177.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 74.91 28.0 63.54 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 118.695 2.238 . . . . 0.0 118.695 -168.048 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 21.3 ttmm -134.51 116.7 15.39 Favored 'General case' 0 CA--C 1.552 1.044 0 N-CA-C 106.523 -1.658 . . . . 0.0 106.523 179.782 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 3.8 tt -86.45 97.98 10.77 Favored 'General case' 0 CA--C 1.563 1.475 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 -172.871 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 56.1 t -105.7 109.15 26.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 -165.097 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 23.6 t-160 -110.2 136.36 49.54 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 124.071 0.948 . . . . 0.0 109.905 179.638 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 30.3 tp -130.53 121.22 25.33 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 173.755 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 87.3 mt-30 -108.46 118.11 35.91 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 175.61 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 17.5 ptpt -121.76 134.9 54.93 Favored 'General case' 0 N--CA 1.496 1.849 0 CA-C-N 118.472 0.578 . . . . 0.0 111.933 -172.697 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 18.0 p90 -158.21 109.94 2.25 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 123.465 0.706 . . . . 0.0 109.897 -176.638 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 6.4 t70 53.44 54.11 10.61 Favored 'General case' 0 N--CA 1.501 2.077 0 N-CA-C 116.625 2.083 . . . . 0.0 116.625 164.236 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 87.96 -42.75 3.11 Favored Glycine 0 CA--C 1.552 2.35 0 N-CA-C 116.937 1.535 . . . . 0.0 116.937 -170.71 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 16.6 mt-30 -86.4 131.26 34.24 Favored 'General case' 0 N--CA 1.487 1.404 0 CA-C-N 118.086 0.943 . . . . 0.0 110.84 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -141.79 126.37 17.88 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 122.96 0.504 . . . . 0.0 110.36 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 1.4 t -121.07 124.07 43.89 Favored 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 123.528 0.731 . . . . 0.0 110.302 -175.032 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 40.1 p -97.76 141.96 30.13 Favored 'General case' 0 N--CA 1.492 1.648 0 CA-C-O 121.499 0.666 . . . . 0.0 111.738 179.764 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 5.6 mp -119.75 80.68 1.62 Allowed 'General case' 0 CA--C 1.564 1.494 0 N-CA-C 107.672 -1.233 . . . . 0.0 107.672 175.571 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 95.7 t -90.83 111.16 23.22 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 -172.464 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 83.7 mtt85 -104.63 130.21 52.66 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 123.292 0.637 . . . . 0.0 110.211 -177.383 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -145.94 129.26 16.78 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 123.167 0.587 . . . . 0.0 110.546 -174.095 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -79.71 116.8 20.1 Favored 'General case' 0 N--CA 1.488 1.469 0 CA-C-O 121.273 0.559 . . . . 0.0 111.108 177.117 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 48.9 mm -120.05 100.18 8.91 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.332 0 N-CA-C 105.485 -2.043 . . . . 0.0 105.485 177.72 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 57.38 49.78 12.5 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 114.915 1.45 . . . . 0.0 114.915 174.101 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 89.51 -38.61 3.19 Favored Glycine 0 CA--C 1.553 2.465 0 N-CA-C 117.572 1.789 . . . . 0.0 117.572 -169.019 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 54.0 mttm -82.64 132.79 35.18 Favored 'General case' 0 N--CA 1.488 1.448 0 CA-C-N 118.583 1.192 . . . . 0.0 112.075 -171.192 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 20.8 tp -81.66 112.66 19.05 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 172.68 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 37.6 mm -99.77 102.49 13.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 N-CA-C 106.732 -1.581 . . . . 0.0 106.732 -178.12 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 22.6 tp -90.43 102.73 15.46 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 123.815 0.846 . . . . 0.0 109.22 174.57 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 66.9 m -91.47 112.87 24.96 Favored 'General case' 0 CA--C 1.562 1.432 0 C-N-CA 124.181 0.992 . . . . 0.0 108.354 179.324 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 88.3 mt -104.61 87.34 2.67 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 123.746 0.818 . . . . 0.0 109.985 -171.819 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 9.9 m -103.17 112.51 25.41 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.727 -0.608 . . . . 0.0 109.576 -174.134 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 54.9 t60 -108.74 86.96 2.38 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 164.001 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 71.16 -101.54 0.97 Allowed Glycine 0 N--CA 1.483 1.795 0 N-CA-C 114.416 0.526 . . . . 0.0 114.416 179.461 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 61.2 m -87.19 -51.34 6.04 Favored 'General case' 0 CA--C 1.566 1.595 0 C-N-CA 123.653 0.781 . . . . 0.0 112.678 176.853 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -77.73 107.48 10.26 Favored 'General case' 0 N--CA 1.484 1.274 0 CA-C-N 119.756 1.162 . . . . 0.0 112.886 -173.641 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 4.7 p -107.68 124.18 63.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 C-N-CA 123.954 0.901 . . . . 0.0 110.37 -178.627 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' CYS . . . . . 0.424 ' HG ' ' HD1' ' A' ' 16' ' ' PHE . 2.7 t -101.25 108.57 20.25 Favored 'General case' 0 CA--C 1.556 1.188 0 C-N-CA 123.449 0.699 . . . . 0.0 110.614 173.134 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 53.5 m -89.2 111.06 21.76 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 177.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 36.1 mtt180 -108.06 117.23 33.58 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 123.187 0.595 . . . . 0.0 110.874 -179.296 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 86.0 m -88.91 134.34 33.99 Favored 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 123.53 0.732 . . . . 0.0 109.585 172.447 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 48.1 m-85 -128.58 135.62 49.61 Favored 'General case' 0 CA--C 1.559 1.308 0 C-N-CA 123.95 0.9 . . . . 0.0 109.371 179.127 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -100.99 154.0 19.06 Favored 'General case' 0 N--CA 1.493 1.718 0 CA-C-O 122.6 1.191 . . . . 0.0 111.414 167.439 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 36.2 tttp -84.86 125.69 32.84 Favored 'General case' 0 N--CA 1.483 1.218 0 CA-C-N 114.956 -1.02 . . . . 0.0 112.209 -168.367 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 16.7 mm-40 -123.3 50.14 1.6 Allowed 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 124.237 1.015 . . . . 0.0 111.712 -175.158 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 0.811 0 CA-C-O 123.005 1.384 . . . . 0.0 110.639 -161.36 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.32 2.5 t . . . . . 0 N--CA 1.489 1.487 0 CA-C-O 118.051 -0.976 . . . . 0.0 112.995 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -62.12 -36.13 80.84 Favored 'General case' 0 N--CA 1.497 1.881 0 N-CA-C 116.154 1.909 . . . . 0.0 116.154 179.587 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -62.41 -32.32 73.14 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 116.858 2.17 . . . . 0.0 116.858 163.259 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 88.8 m-85 -67.69 -27.62 66.99 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 116.146 1.906 . . . . 0.0 116.146 168.319 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 60.0 mt -72.75 116.42 13.22 Favored 'General case' 0 N--CA 1.49 1.543 0 CA-C-N 121.291 1.86 . . . . 0.0 111.512 -172.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 159.48 177.17 32.33 Favored Glycine 0 CA--C 1.541 1.692 0 CA-C-O 122.138 0.854 . . . . 0.0 114.133 -176.091 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 52.3 m -94.61 135.46 36.04 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 174.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 92.6 m95 -134.7 113.13 11.37 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 -172.247 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 7.7 mtmp? -98.76 144.21 28.25 Favored 'General case' 0 N--CA 1.489 1.477 0 CA-C-O 121.978 0.894 . . . . 0.0 110.541 175.084 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 51.4 tp -68.71 133.64 48.69 Favored 'General case' 0 N--CA 1.486 1.359 0 CA-C-O 122.283 1.039 . . . . 0.0 112.496 -176.469 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . 0.28 1.1 t -110.74 -43.3 5.2 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.744 0 CA-C-N 113.697 -1.592 . . . . 0.0 111.718 -178.411 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 41.8 t0 -143.78 131.89 21.79 Favored 'General case' 0 N--CA 1.49 1.525 0 CA-C-N 120.102 1.319 . . . . 0.0 109.63 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 86.4 p -112.93 96.83 6.16 Favored 'General case' 0 N--CA 1.492 1.663 0 CA-C-O 121.492 0.663 . . . . 0.0 110.366 171.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 43.7 mtmt -96.41 123.32 40.02 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 123.656 0.783 . . . . 0.0 108.92 -179.37 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 59.7 m-20 67.57 23.18 8.95 Favored 'General case' 0 N--CA 1.503 2.208 0 N-CA-C 117.532 2.419 . . . . 0.0 117.532 178.578 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 27.3 t80 -68.22 -51.75 41.9 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 120.155 -1.591 . . . . 0.0 113.981 -178.812 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -47.28 -36.19 8.86 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 117.542 2.423 . . . . 0.0 117.542 165.736 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 33.9 t0 -66.06 -55.49 16.33 Favored 'General case' 0 N--CA 1.499 2.021 0 CA-C-N 120.483 1.492 . . . . 0.0 114.245 172.232 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 71.6 t80 -48.22 -48.01 35.34 Favored 'General case' 0 CA--C 1.573 1.845 0 N-CA-C 116.135 1.902 . . . . 0.0 116.135 167.465 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 51.4 mmm -68.23 -46.03 71.67 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 114.84 1.422 . . . . 0.0 114.84 178.691 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -54.91 -46.34 74.84 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 115.533 1.679 . . . . 0.0 115.533 166.2 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 64.6 m -60.54 -38.55 84.85 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 116.199 1.926 . . . . 0.0 116.199 172.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 62.5 mt -63.06 -41.17 99.41 Favored 'General case' 0 CA--C 1.567 1.632 0 N-CA-C 115.78 1.771 . . . . 0.0 115.78 168.337 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 114.39 73.17 0.57 Allowed Glycine 0 N--CA 1.482 1.751 0 C-N-CA 123.899 0.762 . . . . 0.0 111.603 -176.192 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 57.3 t -140.36 121.82 14.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 N-CA-C 106.389 -1.708 . . . . 0.0 106.389 -173.772 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -72.18 170.69 49.68 Favored Glycine 0 CA--C 1.551 2.322 0 N-CA-C 116.414 1.326 . . . . 0.0 116.414 177.235 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . 0.25 33.0 p90 -57.47 -43.23 83.87 Favored 'General case' 0 N--CA 1.497 1.92 0 N-CA-C 118.92 2.933 . . . . 0.0 118.92 -167.515 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.36 -40.62 89.87 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 116.589 2.07 . . . . 0.0 116.589 178.75 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 94.7 m -71.52 -42.02 68.48 Favored 'General case' 0 N--CA 1.498 1.963 0 N-CA-C 113.792 1.034 . . . . 0.0 113.792 168.574 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 38.3 ttp180 -58.53 -38.91 78.75 Favored 'General case' 0 CA--C 1.569 1.708 0 N-CA-C 115.89 1.811 . . . . 0.0 115.89 173.879 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 51.4 mt-30 -81.66 -38.8 25.35 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 115.66 1.726 . . . . 0.0 115.66 176.71 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 46.9 t -73.11 -37.88 53.88 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.254 0 CA-C-N 121.381 1.901 . . . . 0.0 112.664 175.067 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -66.55 -31.37 72.05 Favored 'General case' 0 CA--C 1.567 1.601 0 N-CA-C 117.0 2.222 . . . . 0.0 117.0 170.462 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 85.9 p -67.0 -43.65 82.38 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 115.283 1.586 . . . . 0.0 115.283 164.257 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 49.6 ttm -64.73 -38.73 92.0 Favored 'General case' 0 CA--C 1.567 1.624 0 N-CA-C 116.49 2.033 . . . . 0.0 116.49 176.643 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 13.0 t -69.29 144.94 53.44 Favored 'General case' 0 N--CA 1.492 1.645 0 CA-C-N 119.432 1.014 . . . . 0.0 112.931 -179.417 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -102.69 103.16 30.85 Favored Pre-proline 0 CA--C 1.567 1.603 0 CA-C-O 118.201 -0.904 . . . . 0.0 108.802 176.009 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -72.96 119.78 6.26 Favored 'Trans proline' 0 CA--C 1.559 1.753 0 C-N-CA 123.052 2.501 . . . . 0.0 112.526 -179.244 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 95.7 m -84.58 99.59 10.85 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 179.859 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 86.9 m -97.37 104.53 16.56 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 -165.253 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 68.9 mt -100.5 112.69 33.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 N-CA-C 107.464 -1.31 . . . . 0.0 107.464 -174.45 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 35.8 mt -104.0 117.41 49.49 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 N-CA-C 107.121 -1.437 . . . . 0.0 107.121 179.548 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -141.43 119.42 11.97 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-O 121.078 0.466 . . . . 0.0 109.939 -170.154 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 56.3 tttm -91.84 121.95 33.92 Favored 'General case' 0 CA--C 1.56 1.347 0 C-N-CA 123.748 0.819 . . . . 0.0 111.802 -175.075 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 75.4 m-20 -116.61 92.16 3.79 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 -179.346 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 83.25 -92.95 1.68 Allowed Glycine 0 N--CA 1.486 1.998 0 O-C-N 121.774 -0.579 . . . . 0.0 111.776 -173.347 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -138.49 65.57 1.46 Allowed 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 155.808 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 33.9 mm -136.01 99.88 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 N-CA-C 105.258 -2.127 . . . . 0.0 105.258 -174.73 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 60.4 mt -81.45 102.09 10.31 Favored 'General case' 0 N--CA 1.486 1.342 0 CA-C-O 121.181 0.515 . . . . 0.0 110.482 -179.119 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 28.7 m -98.38 97.92 9.21 Favored 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 107.275 -1.379 . . . . 0.0 107.275 -173.301 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 10.4 tt -98.92 102.16 13.79 Favored 'General case' 0 N--CA 1.485 1.29 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 -177.402 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -98.77 111.5 23.86 Favored 'General case' 0 N--CA 1.484 1.25 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 -174.49 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 52.4 m -91.65 95.91 10.16 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 -179.366 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 23.1 m-70 -87.26 96.42 10.33 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 -176.556 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 37.4 t -127.27 140.95 51.87 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 123.733 0.813 . . . . 0.0 109.96 -169.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 71.6 p -83.88 48.52 1.46 Allowed 'General case' 0 N--CA 1.498 1.96 0 N-CA-C 113.883 1.068 . . . . 0.0 113.883 174.553 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 13.3 t80 -159.08 -68.98 0.08 Allowed 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 163.855 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 13.5 ptmm? -125.14 100.52 6.59 Favored 'General case' 0 CA--C 1.56 1.354 0 C-N-CA 123.519 0.727 . . . . 0.0 109.761 179.079 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 9.2 p30 -90.55 124.52 35.09 Favored 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 123.764 0.826 . . . . 0.0 111.008 178.735 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 77.1 p -130.35 132.33 45.77 Favored 'General case' 0 N--CA 1.497 1.901 0 C-N-CA 123.091 0.556 . . . . 0.0 111.174 -169.561 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -117.89 130.55 56.31 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 123.784 0.833 . . . . 0.0 110.009 -176.433 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 39.1 pt -123.66 132.91 70.58 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 C-N-CA 123.456 0.703 . . . . 0.0 109.412 175.773 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 45.9 t -120.99 107.4 12.6 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 -176.669 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 49.0 p90 -136.42 136.73 39.8 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 115.204 1.557 . . . . 0.0 115.204 -159.435 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 50.5 mtmt -103.5 14.67 30.8 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 117.214 2.302 . . . . 0.0 117.214 -173.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . 0.295 3.3 mp 62.59 96.9 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.744 0 CA-C-N 120.648 1.567 . . . . 0.0 114.318 177.226 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 87.1 38.68 7.75 Favored Glycine 0 CA--C 1.55 2.28 0 N-CA-C 116.99 1.556 . . . . 0.0 116.99 -170.087 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 86.5 t -138.73 124.22 23.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 N-CA-C 106.839 -1.541 . . . . 0.0 106.839 -179.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -87.8 116.26 25.82 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 123.042 0.537 . . . . 0.0 109.961 171.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 45.0 p90 -125.43 131.8 52.84 Favored 'General case' 0 N--CA 1.491 1.624 0 C-N-CA 123.912 0.885 . . . . 0.0 109.851 -175.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -73.61 110.4 7.86 Favored 'General case' 0 CA--C 1.564 1.507 0 O-C-N 121.411 -0.806 . . . . 0.0 111.889 176.816 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 13.7 tp10 -106.41 132.94 51.84 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 124.115 0.966 . . . . 0.0 109.563 -174.441 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 52.2 m -96.96 117.59 31.49 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 174.255 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 20.3 p -84.9 166.83 16.5 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-O 121.664 0.745 . . . . 0.0 112.101 -174.704 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -67.36 -20.94 65.64 Favored 'General case' 0 CA--C 1.571 1.757 0 N-CA-C 117.677 2.473 . . . . 0.0 117.677 169.446 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -76.68 -0.24 22.84 Favored 'General case' 0 CA--C 1.581 2.137 0 N-CA-C 116.142 1.904 . . . . 0.0 116.142 160.536 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . 0.265 11.1 m-20 71.57 70.07 0.16 Allowed 'General case' 0 N--CA 1.495 1.811 0 C-N-CA 125.349 1.46 . . . . 0.0 111.729 -176.857 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 80.9 mtm180 -141.2 126.72 18.85 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 -175.302 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.57 97.17 8.9 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 123.37 0.668 . . . . 0.0 111.317 172.576 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 10.8 m -113.6 127.33 71.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 C-N-CA 123.165 0.586 . . . . 0.0 109.912 -168.268 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 29.9 mmtp -80.4 103.69 10.44 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 123.507 0.723 . . . . 0.0 110.118 179.632 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 70.8 m -100.21 95.84 7.07 Favored 'General case' 0 N--CA 1.483 1.198 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.947 -165.26 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 7.1 tp -107.71 113.84 44.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 177.35 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -130.4 128.12 63.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 C-N-CA 124.012 0.925 . . . . 0.0 109.129 -176.278 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 10.2 t -140.45 150.08 43.37 Favored 'General case' 0 N--CA 1.488 1.472 0 CA-C-O 122.719 1.247 . . . . 0.0 110.052 175.689 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 19.2 tp -85.07 114.18 22.02 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-N 114.616 -1.175 . . . . 0.0 109.321 176.501 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -101.63 81.09 2.12 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-O 121.239 0.542 . . . . 0.0 110.085 -178.562 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 57.07 45.14 92.74 Favored Glycine 0 N--CA 1.489 2.175 0 N-CA-C 118.016 1.967 . . . . 0.0 118.016 -177.127 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 102.87 -45.15 1.37 Allowed Glycine 0 N--CA 1.491 2.317 0 N-CA-C 116.481 1.352 . . . . 0.0 116.481 -165.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 83.6 tttt -81.33 106.81 13.59 Favored 'General case' 0 CA--C 1.559 1.3 0 C-N-CA 123.616 0.767 . . . . 0.0 110.87 -176.767 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 30.4 tp -82.52 114.59 21.03 Favored 'General case' 0 N--CA 1.484 1.232 0 CA-C-O 121.546 0.688 . . . . 0.0 110.948 -177.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 48.3 t -113.47 110.21 31.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 N-CA-C 106.72 -1.585 . . . . 0.0 106.72 -168.824 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 23.7 t-160 -106.2 142.46 35.84 Favored 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 124.113 0.965 . . . . 0.0 109.717 174.702 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 30.3 tp -131.74 122.81 26.47 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 174.441 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 81.9 mt-30 -115.41 105.61 13.04 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 176.089 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 71.0 mttt -107.36 135.69 48.43 Favored 'General case' 0 N--CA 1.495 1.782 0 C-N-CA 123.43 0.692 . . . . 0.0 111.656 -177.674 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 18.3 p90 -150.42 111.23 4.29 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 123.346 0.658 . . . . 0.0 109.946 178.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 4.8 t70 50.56 57.85 6.16 Favored 'General case' 0 N--CA 1.497 1.894 0 N-CA-C 116.304 1.965 . . . . 0.0 116.304 166.578 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 91.26 -44.8 2.8 Favored Glycine 0 CA--C 1.55 2.267 0 N-CA-C 116.789 1.476 . . . . 0.0 116.789 -171.62 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 19.6 mt-30 -92.34 134.72 34.65 Favored 'General case' 0 N--CA 1.489 1.52 0 CA-C-N 118.234 1.017 . . . . 0.0 111.577 -174.036 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -113.53 157.8 21.56 Favored 'General case' 0 N--CA 1.491 1.62 0 CA-C-O 121.612 0.72 . . . . 0.0 112.028 172.775 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 14.6 t -140.78 120.27 13.19 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 158.604 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 39.9 p -90.62 125.36 35.61 Favored 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 122.661 0.385 . . . . 0.0 110.519 172.15 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 5.5 mp -102.06 80.52 2.0 Allowed 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 177.57 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 71.1 t -88.69 105.71 16.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 -170.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 83.8 mtt85 -103.5 123.34 46.71 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 123.536 0.734 . . . . 0.0 109.742 -176.653 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -144.46 131.45 20.41 Favored 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 122.805 0.442 . . . . 0.0 110.974 -172.023 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -81.12 116.0 20.82 Favored 'General case' 0 N--CA 1.487 1.405 0 CA-C-O 121.281 0.562 . . . . 0.0 111.327 -179.131 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 86.1 mt -123.88 107.1 18.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 N-CA-C 104.66 -2.348 . . . . 0.0 104.66 176.518 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 58.4 50.48 9.37 Favored 'General case' 0 N--CA 1.5 2.029 0 N-CA-C 114.945 1.461 . . . . 0.0 114.945 176.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 66.91 18.13 68.3 Favored Glycine 0 CA--C 1.554 2.516 0 N-CA-C 119.758 2.663 . . . . 0.0 119.758 -171.833 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 38.8 mtmm -126.78 131.3 51.31 Favored 'General case' 0 N--CA 1.489 1.486 0 CA-C-N 119.981 1.891 . . . . 0.0 109.106 -173.626 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 14.1 tp -79.22 107.59 12.1 Favored 'General case' 0 CA--C 1.558 1.255 0 C-N-CA 123.334 0.654 . . . . 0.0 109.38 178.124 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 33.6 mm -99.54 100.41 10.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 N-CA-C 106.569 -1.641 . . . . 0.0 106.569 -175.255 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 29.8 tp -92.12 99.85 12.58 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 124.16 0.984 . . . . 0.0 109.647 178.234 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 1.8 p -86.84 114.67 23.69 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 123.689 0.796 . . . . 0.0 109.589 171.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 85.1 mt -101.96 89.05 3.51 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 123.971 0.908 . . . . 0.0 108.979 -176.36 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 7.6 m -100.4 108.93 21.06 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 108.798 -0.815 . . . . 0.0 108.798 -171.682 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 2.2 t60 -76.86 -63.31 1.38 Allowed 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 122.454 0.301 . . . . 0.0 111.348 167.578 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -165.37 -76.47 0.03 OUTLIER Glycine 0 N--CA 1.479 1.543 0 N-CA-C 109.499 -1.441 . . . . 0.0 109.499 178.699 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 72.9 m -73.28 -54.42 8.45 Favored 'General case' 0 CA--C 1.568 1.668 0 CA-C-O 118.693 -0.67 . . . . 0.0 112.787 169.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -97.4 112.62 24.38 Favored 'General case' 0 N--CA 1.483 1.207 0 CA-C-N 119.405 1.002 . . . . 0.0 112.552 -172.505 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 6.0 p -95.91 127.63 47.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 C-N-CA 123.825 0.85 . . . . 0.0 110.058 169.187 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 44.0 t -100.81 108.1 19.81 Favored 'General case' 0 N--CA 1.481 1.102 0 CA-C-O 121.062 0.458 . . . . 0.0 111.261 171.428 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 47.8 m -84.48 112.06 20.04 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 176.413 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 37.6 mtt180 -104.29 116.0 31.39 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 123.259 0.624 . . . . 0.0 110.114 175.045 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 92.9 m -90.09 129.32 36.4 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 173.848 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 58.7 m-85 -124.93 129.67 50.83 Favored 'General case' 0 CA--C 1.559 1.29 0 C-N-CA 123.546 0.738 . . . . 0.0 109.283 179.081 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -94.54 154.28 17.47 Favored 'General case' 0 N--CA 1.494 1.757 0 CA-C-O 122.326 1.06 . . . . 0.0 111.347 167.147 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 70.9 tttt -86.01 116.37 24.19 Favored 'General case' 0 N--CA 1.484 1.25 0 CA-C-N 115.554 -0.748 . . . . 0.0 112.059 -167.904 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 50.2 tp10 -75.03 -40.95 60.19 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 116.666 2.098 . . . . 0.0 116.666 172.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.97 0 CA-C-O 124.287 1.994 . . . . 0.0 107.882 173.749 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.251 4.0 p . . . . . 0 CA--C 1.576 1.971 0 N-CA-C 115.18 1.548 . . . . 0.0 115.18 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -77.5 -36.95 52.08 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 115.825 1.787 . . . . 0.0 115.825 -174.345 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -58.3 -24.49 59.75 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 117.714 2.487 . . . . 0.0 117.714 167.054 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -72.46 -19.46 61.56 Favored 'General case' 0 CA--C 1.566 1.566 0 N-CA-C 116.377 1.991 . . . . 0.0 116.377 168.833 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 44.4 mt -81.16 121.74 26.5 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-N 121.228 1.831 . . . . 0.0 111.554 -171.517 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 159.43 -177.23 36.04 Favored Glycine 0 N--CA 1.484 1.88 0 CA-C-O 121.9 0.722 . . . . 0.0 113.583 -179.159 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 63.7 m -92.11 139.79 30.28 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 170.702 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 90.2 m95 -141.19 109.5 5.88 Favored 'General case' 0 N--CA 1.487 1.381 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 -171.391 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 55.8 mttp -100.7 141.52 33.45 Favored 'General case' 0 N--CA 1.49 1.542 0 CA-C-O 121.222 0.534 . . . . 0.0 109.941 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 58.1 tp -68.08 123.01 19.46 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-O 122.178 0.99 . . . . 0.0 112.167 -175.135 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . 0.27 1.0 OUTLIER -103.5 -41.65 7.43 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.751 0 CA-C-N 113.9 -1.5 . . . . 0.0 112.737 -175.337 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -145.85 133.47 20.97 Favored 'General case' 0 N--CA 1.488 1.454 0 CA-C-N 119.922 1.237 . . . . 0.0 108.948 178.1 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 88.7 p -115.54 101.15 8.61 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 122.976 0.51 . . . . 0.0 110.662 175.021 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 59.2 mtpt -87.12 118.33 26.45 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 174.519 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 60.8 m-20 66.55 29.97 8.71 Favored 'General case' 0 N--CA 1.502 2.134 0 N-CA-C 117.173 2.286 . . . . 0.0 117.173 177.069 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.472 ' HB2' ' SG ' ' A' ' 124' ' ' CYS . 18.0 t80 -89.57 69.51 7.85 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 120.235 -1.54 . . . . 0.0 111.857 178.808 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 26.8 m-20 -162.61 -54.22 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 125.684 1.594 . . . . 0.0 108.044 -177.457 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 21.1 t0 -56.61 -45.27 81.56 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 115.422 1.638 . . . . 0.0 115.422 167.387 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 81.6 t80 -51.98 -54.43 29.89 Favored 'General case' 0 CA--C 1.57 1.716 0 N-CA-C 114.787 1.403 . . . . 0.0 114.787 169.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 70.4 mtm -63.98 -46.13 85.97 Favored 'General case' 0 N--CA 1.491 1.575 0 N-CA-C 115.539 1.681 . . . . 0.0 115.539 174.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -57.86 -44.99 86.92 Favored 'General case' 0 CA--C 1.57 1.713 0 N-CA-C 115.5 1.667 . . . . 0.0 115.5 173.582 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 23.3 t -61.51 -37.27 83.11 Favored 'General case' 0 CA--C 1.568 1.645 0 N-CA-C 116.367 1.988 . . . . 0.0 116.367 170.275 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 69.2 mt -64.79 -23.31 67.2 Favored 'General case' 0 CA--C 1.568 1.657 0 N-CA-C 117.96 2.578 . . . . 0.0 117.96 169.24 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 99.49 68.61 0.89 Allowed Glycine 0 N--CA 1.482 1.746 0 CA-C-N 119.416 1.007 . . . . 0.0 112.193 -171.156 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 33.8 t -144.95 112.66 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 N-CA-C 104.375 -2.454 . . . . 0.0 104.375 -177.842 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -70.83 -91.99 0.08 OUTLIER Glycine 0 N--CA 1.486 2.015 0 N-CA-C 117.676 1.83 . . . . 0.0 117.676 -160.763 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . 0.279 40.4 p90 -140.07 -60.91 0.53 Allowed 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 112.977 0.732 . . . . 0.0 112.977 -171.328 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.51 -39.91 92.39 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 115.575 1.695 . . . . 0.0 115.575 172.221 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 71.9 m -71.38 -37.44 71.59 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 113.961 1.097 . . . . 0.0 113.961 171.355 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 66.4 ttp85 -62.22 -42.79 99.63 Favored 'General case' 0 CA--C 1.572 1.795 0 N-CA-C 114.961 1.467 . . . . 0.0 114.961 170.117 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 9.5 tm0? -65.31 -49.87 67.83 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 114.497 1.295 . . . . 0.0 114.497 172.061 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 93.5 t -64.87 -36.68 78.29 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.925 0 CA-C-N 119.489 1.041 . . . . 0.0 113.762 177.72 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -64.6 -37.03 86.16 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 116.94 2.2 . . . . 0.0 116.94 172.688 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 96.6 p -67.65 -40.41 84.52 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 115.675 1.732 . . . . 0.0 115.675 165.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 48.9 ttp -69.35 -35.69 76.12 Favored 'General case' 0 CA--C 1.567 1.622 0 N-CA-C 116.979 2.214 . . . . 0.0 116.979 176.033 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 8.3 t -63.49 -31.4 72.55 Favored 'General case' 0 N--CA 1.498 1.965 0 N-CA-C 118.488 2.773 . . . . 0.0 118.488 -167.501 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . 0.261 34.2 ttpt 75.25 90.37 0.06 OUTLIER Pre-proline 0 CA--C 1.573 1.833 0 C-N-CA 124.832 1.253 . . . . 0.0 112.128 177.285 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -72.62 125.32 10.49 Favored 'Trans proline' 0 C--N 1.369 1.634 0 C-N-CA 123.292 2.661 . . . . 0.0 114.501 -176.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 97.9 m -97.06 92.71 6.19 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 -179.185 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 57.4 m -86.19 110.32 19.51 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 123.12 0.568 . . . . 0.0 110.099 -173.598 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 95.1 mt -101.64 110.31 28.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 N-CA-C 106.811 -1.552 . . . . 0.0 106.811 178.609 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 59.3 mt -100.48 116.19 43.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 -179.143 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 4.5 tm-20 -136.63 110.95 8.44 Favored 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 -171.506 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 81.7 tttt -95.0 113.24 24.92 Favored 'General case' 0 CA--C 1.554 1.126 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 171.848 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 14.6 t-20 -82.2 -58.65 2.86 Favored 'General case' 0 CA--C 1.564 1.511 0 C-N-CA 123.243 0.617 . . . . 0.0 112.478 -178.083 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -132.63 -95.55 0.6 Allowed Glycine 0 N--CA 1.483 1.816 0 N-CA-C 109.18 -1.568 . . . . 0.0 109.18 169.45 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -79.8 -30.9 40.68 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 114.917 1.451 . . . . 0.0 114.917 163.398 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 39.8 mm -77.93 111.85 15.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 CA-C-N 119.311 0.96 . . . . 0.0 109.507 -175.047 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 2.0 mt -78.72 137.95 38.02 Favored 'General case' 0 CA--C 1.561 1.376 0 C-N-CA 123.254 0.622 . . . . 0.0 110.379 160.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 10.7 m -133.72 103.43 5.87 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 -177.438 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 9.1 tt -96.7 112.31 24.11 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 107.358 -1.349 . . . . 0.0 107.358 177.095 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 89.4 mttt -112.87 98.88 7.47 Favored 'General case' 0 N--CA 1.485 1.285 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 -164.676 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 28.4 m -87.98 95.14 10.01 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.327 -0.858 . . . . 0.0 109.22 -174.467 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 77.8 m80 -85.03 28.83 0.68 Allowed 'General case' 0 CA--C 1.573 1.84 0 N-CA-C 116.59 2.07 . . . . 0.0 116.59 -173.273 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . 0.271 17.5 m -145.17 -94.24 0.1 Allowed 'General case' 0 CA--C 1.553 1.081 0 N-CA-C 105.29 -2.115 . . . . 0.0 105.29 153.138 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . 0.444 2.9 t 44.88 23.49 0.08 Allowed 'General case' 0 N--CA 1.501 2.095 0 N-CA-C 119.076 2.991 . . . . 0.0 119.076 -170.615 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . 0.33 30.4 t80 85.11 -62.39 0.07 Allowed 'General case' 0 N--CA 1.497 1.905 0 C-N-CA 125.548 1.539 . . . . 0.0 111.972 -168.915 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -119.5 128.23 53.77 Favored 'General case' 0 N--CA 1.485 1.307 0 N-CA-C 106.378 -1.712 . . . . 0.0 106.378 175.846 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 42.9 m-20 -70.7 106.77 3.65 Favored 'General case' 0 N--CA 1.491 1.62 0 CA-C-O 120.997 0.427 . . . . 0.0 111.787 -173.814 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 40.4 p -105.2 133.78 49.4 Favored 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 123.532 0.733 . . . . 0.0 110.448 -174.158 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -122.48 122.14 38.24 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 123.344 0.658 . . . . 0.0 109.367 179.517 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 39.2 pt -93.64 136.26 25.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 C-N-CA 123.174 0.59 . . . . 0.0 109.587 163.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 33.0 t -125.02 116.69 22.53 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 173.655 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 41.2 p90 -149.4 148.18 29.16 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 113.837 1.051 . . . . 0.0 113.837 -153.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 62.7 mtpt -111.99 18.89 18.38 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 116.959 2.207 . . . . 0.0 116.959 -171.494 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . 0.28 1.5 mp 57.11 83.86 0.1 Allowed 'General case' 0 N--CA 1.495 1.802 0 CA-C-N 120.74 1.609 . . . . 0.0 114.532 177.678 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 98.02 42.9 2.95 Favored Glycine 0 CA--C 1.548 2.146 0 N-CA-C 116.221 1.248 . . . . 0.0 116.221 -171.429 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 70.8 t -145.08 127.72 10.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 N-CA-C 105.752 -1.944 . . . . 0.0 105.752 -178.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -87.25 116.72 25.53 Favored 'General case' 0 CA--C 1.566 1.566 0 CA-C-O 121.634 0.731 . . . . 0.0 110.129 173.079 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 25.4 p90 -114.91 -172.83 2.2 Favored 'General case' 0 N--CA 1.494 1.745 0 C-N-CA 124.796 1.238 . . . . 0.0 109.733 171.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -117.05 145.13 43.91 Favored 'General case' 0 N--CA 1.487 1.401 0 CA-C-O 123.25 1.5 . . . . 0.0 110.846 168.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 52.2 tp10 -129.34 148.15 51.24 Favored 'General case' 0 N--CA 1.488 1.456 0 CA-C-N 112.804 -1.998 . . . . 0.0 109.928 177.319 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 83.4 m -103.85 124.25 48.6 Favored 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 168.433 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 28.4 p -75.64 168.06 20.72 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-O 121.579 0.704 . . . . 0.0 112.851 -176.536 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -59.62 -29.41 67.99 Favored 'General case' 0 CA--C 1.563 1.454 0 N-CA-C 117.827 2.529 . . . . 0.0 117.827 178.748 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 62.5 m-20 -116.11 67.24 0.71 Allowed 'General case' 0 N--CA 1.491 1.625 0 CA-C-N 119.121 0.873 . . . . 0.0 110.491 165.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 47.06 72.46 0.24 Allowed 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 117.595 2.442 . . . . 0.0 117.595 164.84 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 63.1 mtm-85 -139.68 123.52 17.55 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 171.037 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -71.32 122.57 20.53 Favored 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 123.1 0.56 . . . . 0.0 110.505 164.3 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 32.8 m -138.92 135.09 42.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 -169.818 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 30.5 mmmt -82.17 101.02 10.17 Favored 'General case' 0 N--CA 1.488 1.434 0 CA-C-O 122.418 1.104 . . . . 0.0 110.224 178.267 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 22.4 p -93.1 107.14 18.99 Favored 'General case' 0 CA--C 1.555 1.164 0 CA-C-N 114.117 -1.401 . . . . 0.0 111.821 -170.637 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -113.33 121.26 65.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 174.424 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 1.1 p -131.76 130.42 61.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 C-N-CA 123.921 0.888 . . . . 0.0 109.598 -178.623 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 9.0 t -145.19 153.66 41.59 Favored 'General case' 0 N--CA 1.486 1.356 0 CA-C-O 122.942 1.353 . . . . 0.0 110.407 179.044 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 44.2 tp -86.42 123.58 31.81 Favored 'General case' 0 CA--C 1.562 1.438 0 CA-C-N 114.402 -1.272 . . . . 0.0 110.333 177.68 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -104.93 76.54 1.26 Allowed 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 123.54 0.736 . . . . 0.0 110.581 176.161 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 75.1 -76.4 1.24 Allowed Glycine 0 N--CA 1.487 2.069 0 N-CA-C 114.246 0.458 . . . . 0.0 114.246 -176.551 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -142.91 45.91 0.88 Allowed Glycine 0 CA--C 1.549 2.165 0 CA-C-N 114.428 -0.886 . . . . 0.0 114.293 167.043 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 56.3 mtpt -138.33 118.71 13.74 Favored 'General case' 0 N--CA 1.484 1.237 0 N-CA-C 105.593 -2.002 . . . . 0.0 105.593 178.115 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 4.4 tt -87.94 100.5 12.94 Favored 'General case' 0 CA--C 1.561 1.366 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 -178.482 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 78.6 t -106.33 102.28 13.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 N-CA-C 107.397 -1.334 . . . . 0.0 107.397 -164.466 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 20.5 t-160 -99.97 144.9 28.48 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 123.842 0.857 . . . . 0.0 110.329 173.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 17.8 tp -145.1 125.89 14.32 Favored 'General case' 0 N--CA 1.488 1.426 0 CA-C-O 122.035 0.921 . . . . 0.0 108.551 176.452 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 29.8 mt-30 -113.84 118.38 34.09 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 124.53 1.132 . . . . 0.0 108.615 -177.337 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -116.94 136.59 52.83 Favored 'General case' 0 N--CA 1.495 1.792 0 C-N-CA 123.26 0.624 . . . . 0.0 111.244 -173.351 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 16.7 p90 -153.59 111.02 3.49 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.231 -0.918 . . . . 0.0 110.64 -178.763 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 4.8 t70 55.07 55.0 8.14 Favored 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 116.009 1.855 . . . . 0.0 116.009 166.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 86.08 -45.76 3.52 Favored Glycine 0 CA--C 1.552 2.355 0 N-CA-C 116.389 1.316 . . . . 0.0 116.389 -168.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 25.4 mt-30 -78.09 149.97 33.81 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 123.547 0.739 . . . . 0.0 112.298 -178.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -150.07 150.49 31.8 Favored 'General case' 0 N--CA 1.488 1.451 0 CA-C-O 121.323 0.582 . . . . 0.0 111.735 175.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 14.2 t -128.47 124.95 37.44 Favored 'General case' 0 N--CA 1.49 1.56 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.353 170.189 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 36.1 p -85.99 134.19 33.88 Favored 'General case' 0 N--CA 1.492 1.665 0 CA-C-O 121.606 0.717 . . . . 0.0 110.251 168.032 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 5.2 mp -116.74 86.03 2.43 Favored 'General case' 0 CA--C 1.562 1.404 0 N-CA-C 106.727 -1.583 . . . . 0.0 106.727 176.159 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 52.1 t -94.22 100.11 10.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.775 0 N-CA-C 107.742 -1.206 . . . . 0.0 107.742 -170.076 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 20.0 mmt180 -90.0 126.27 35.69 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 123.929 0.891 . . . . 0.0 109.915 178.14 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -150.76 131.15 13.73 Favored 'General case' 0 N--CA 1.494 1.76 0 C-N-CA 122.605 0.362 . . . . 0.0 111.938 -172.016 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -77.69 117.53 19.19 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.5 -0.75 . . . . 0.0 111.403 175.378 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 84.3 mt -125.17 105.6 15.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 N-CA-C 104.764 -2.31 . . . . 0.0 104.764 176.653 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 57.16 53.73 7.53 Favored 'General case' 0 N--CA 1.499 1.978 0 N-CA-C 114.246 1.202 . . . . 0.0 114.246 177.63 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 79.65 -27.45 2.55 Favored Glycine 0 CA--C 1.555 2.574 0 N-CA-C 119.097 2.399 . . . . 0.0 119.097 -169.389 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 38.4 mtmm -102.28 131.61 48.75 Favored 'General case' 0 N--CA 1.486 1.336 0 CA-C-N 119.497 1.648 . . . . 0.0 110.214 -164.16 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 49.0 tp -83.98 114.21 21.54 Favored 'General case' 0 CA--C 1.556 1.195 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.797 -176.2 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 33.3 mm -102.88 108.82 25.11 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 -171.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 53.5 tp -89.16 111.06 21.75 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 123.9 0.88 . . . . 0.0 109.298 172.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 90.0 m -101.68 110.6 22.62 Favored 'General case' 0 N--CA 1.494 1.725 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 -179.421 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 97.7 mt -104.01 91.18 3.85 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 123.726 0.811 . . . . 0.0 110.227 -172.439 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 7.4 m -107.78 105.4 15.22 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 -175.864 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 16.7 t60 -83.07 -64.3 1.2 Allowed 'General case' 0 N--CA 1.493 1.684 0 C-N-CA 123.176 0.591 . . . . 0.0 111.631 172.3 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -152.2 -89.88 0.07 OUTLIER Glycine 0 N--CA 1.479 1.524 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 174.081 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 12.0 t -92.13 41.16 1.06 Allowed 'General case' 0 CA--C 1.577 1.995 0 N-CA-C 114.369 1.248 . . . . 0.0 114.369 169.825 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -158.86 97.69 1.43 Allowed 'General case' 0 N--CA 1.485 1.278 0 O-C-N 120.874 -1.141 . . . . 0.0 109.45 175.419 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 4.0 p -97.01 120.34 46.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 C-N-CA 123.842 0.857 . . . . 0.0 109.409 172.763 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' CYS . . . . . 0.472 ' SG ' ' HB2' ' A' ' 16' ' ' PHE . 41.4 t -112.03 102.87 11.06 Favored 'General case' 0 CA--C 1.557 1.214 0 CA-C-O 121.448 0.642 . . . . 0.0 110.943 177.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 90.5 m -92.43 110.19 21.59 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 123.756 0.822 . . . . 0.0 109.117 -176.367 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 38.4 mtm180 -113.26 121.07 43.32 Favored 'General case' 0 N--CA 1.488 1.475 0 C-N-CA 123.235 0.614 . . . . 0.0 110.912 -170.713 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 89.3 m -87.96 136.3 33.03 Favored 'General case' 0 N--CA 1.492 1.643 0 C-N-CA 123.751 0.82 . . . . 0.0 110.74 179.535 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 45.0 m-85 -130.66 125.98 35.4 Favored 'General case' 0 CA--C 1.56 1.343 0 C-N-CA 123.796 0.838 . . . . 0.0 109.162 -179.185 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -95.55 153.58 17.64 Favored 'General case' 0 N--CA 1.495 1.792 0 CA-C-O 122.239 1.018 . . . . 0.0 111.435 169.891 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 72.2 tttt -85.44 119.34 25.68 Favored 'General case' 0 N--CA 1.485 1.318 0 CA-C-N 115.221 -0.9 . . . . 0.0 111.559 -170.368 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -103.36 45.73 0.95 Allowed 'General case' 0 N--CA 1.492 1.675 0 N-CA-C 113.655 0.984 . . . . 0.0 113.655 176.865 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.02 0 CA-C-O 124.327 2.013 . . . . 0.0 107.841 -178.987 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.258 5.6 p . . . . . 0 CA--C 1.577 1.984 0 N-CA-C 115.993 1.849 . . . . 0.0 115.993 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -66.16 -40.08 90.27 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 116.27 1.952 . . . . 0.0 116.27 -176.343 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -59.53 -29.38 67.85 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 117.442 2.386 . . . . 0.0 117.442 168.687 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -68.26 -24.62 64.91 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 116.243 1.942 . . . . 0.0 116.243 167.728 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 39.3 mt -74.81 120.46 20.38 Favored 'General case' 0 N--CA 1.488 1.456 0 CA-C-N 120.759 1.618 . . . . 0.0 111.476 -174.282 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 162.76 168.95 25.46 Favored Glycine 0 N--CA 1.479 1.531 0 CA-C-O 122.822 1.235 . . . . 0.0 113.471 -173.459 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 78.3 m -86.75 136.42 33.01 Favored 'General case' 0 N--CA 1.49 1.535 0 CA-C-N 114.061 -1.069 . . . . 0.0 108.805 164.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 81.4 m95 -140.65 111.69 7.12 Favored 'General case' 0 N--CA 1.484 1.269 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 -174.258 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 8.9 mtpm? -91.97 145.61 24.4 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.866 -0.522 . . . . 0.0 110.278 173.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 48.7 tp -68.07 124.44 23.43 Favored 'General case' 0 N--CA 1.488 1.466 0 CA-C-O 121.94 0.876 . . . . 0.0 111.497 179.394 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . 0.279 1.2 t -96.91 -45.84 12.82 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.79 0 CA-C-N 114.313 -1.312 . . . . 0.0 112.032 177.563 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 51.5 t0 -144.19 129.35 18.68 Favored 'General case' 0 N--CA 1.49 1.528 0 CA-C-N 119.989 1.268 . . . . 0.0 109.806 -177.107 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 75.7 p -104.69 102.3 11.89 Favored 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 123.217 0.607 . . . . 0.0 110.57 169.153 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 61.1 mtpt -101.12 111.45 23.67 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 -178.798 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.256 30.8 m-20 71.12 21.14 4.92 Favored 'General case' 0 N--CA 1.505 2.287 0 N-CA-C 117.028 2.232 . . . . 0.0 117.028 -177.46 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 27.1 t80 -67.36 -47.4 70.54 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 119.989 -1.694 . . . . 0.0 114.548 -178.588 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -40.82 -48.57 3.09 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 118.399 2.74 . . . . 0.0 118.399 161.602 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 18.3 t0 -59.54 -52.87 63.69 Favored 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 115.067 1.506 . . . . 0.0 115.067 172.815 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 93.1 t80 -52.16 -50.29 62.1 Favored 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 115.64 1.719 . . . . 0.0 115.64 170.281 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 40.8 mmm -62.49 -51.76 66.18 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 114.804 1.409 . . . . 0.0 114.804 -179.637 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 21.7 tptm -60.36 -37.11 79.69 Favored 'General case' 0 CA--C 1.571 1.759 0 N-CA-C 115.893 1.812 . . . . 0.0 115.893 172.722 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 17.5 t -61.71 -40.07 93.73 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 116.263 1.949 . . . . 0.0 116.263 169.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 80.2 mt -62.03 -23.45 66.46 Favored 'General case' 0 CA--C 1.569 1.692 0 N-CA-C 117.828 2.529 . . . . 0.0 117.828 168.216 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 97.71 67.96 0.93 Allowed Glycine 0 N--CA 1.482 1.729 0 CA-C-N 119.074 0.852 . . . . 0.0 112.046 -166.667 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 41.2 t -143.64 109.99 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 N-CA-C 104.348 -2.464 . . . . 0.0 104.348 177.824 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -68.61 168.37 43.14 Favored Glycine 0 CA--C 1.546 2.016 0 N-CA-C 116.174 1.23 . . . . 0.0 116.174 -177.343 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 25.3 p90 -53.07 -38.6 62.64 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 119.127 3.01 . . . . 0.0 119.127 -170.121 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.32 -45.17 81.19 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 116.003 1.853 . . . . 0.0 116.003 176.48 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 56.0 m -72.51 -35.54 68.15 Favored 'General case' 0 N--CA 1.501 2.101 0 N-CA-C 114.045 1.128 . . . . 0.0 114.045 171.196 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 48.2 ttp180 -54.59 -49.3 70.73 Favored 'General case' 0 CA--C 1.569 1.681 0 N-CA-C 115.463 1.653 . . . . 0.0 115.463 169.092 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 24.1 mm100 -74.22 -39.43 63.11 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 115.388 1.625 . . . . 0.0 115.388 176.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 73.8 t -61.33 -47.08 95.12 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.03 0 CA-C-N 120.129 1.331 . . . . 0.0 113.135 172.589 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -68.58 -31.9 71.42 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 117.204 2.298 . . . . 0.0 117.204 176.141 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 94.0 p -68.62 -43.6 76.03 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 115.552 1.686 . . . . 0.0 115.552 167.467 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 49.7 ttp -60.33 -41.7 94.1 Favored 'General case' 0 CA--C 1.568 1.666 0 N-CA-C 115.782 1.771 . . . . 0.0 115.782 168.447 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 95.0 m -68.3 136.15 53.01 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 124.141 0.976 . . . . 0.0 110.591 170.668 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 5.3 mptp? -106.69 95.96 13.27 Favored Pre-proline 0 CA--C 1.567 1.621 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 175.401 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -83.22 147.12 12.78 Favored 'Trans proline' 0 C--N 1.372 1.804 0 C-N-CA 122.854 2.37 . . . . 0.0 113.452 -172.234 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 44.9 m -98.41 102.94 14.83 Favored 'General case' 0 CA--C 1.563 1.443 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.586 -169.758 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 79.8 m -80.09 113.4 18.24 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 123.896 0.879 . . . . 0.0 109.744 177.687 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 89.3 mt -115.61 107.69 23.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 N-CA-C 106.024 -1.843 . . . . 0.0 106.024 -175.131 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 4.2 mp -97.68 120.23 46.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 N-CA-C 107.378 -1.341 . . . . 0.0 107.378 174.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -134.99 116.2 14.39 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.245 -1.021 . . . . 0.0 108.245 -179.107 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 84.3 tttt -89.02 111.83 22.63 Favored 'General case' 0 CA--C 1.557 1.234 0 C-N-CA 123.175 0.59 . . . . 0.0 110.267 178.04 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 28.3 t30 -99.42 87.91 3.74 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.642 -0.874 . . . . 0.0 108.642 178.729 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 78.82 -96.4 1.43 Allowed Glycine 0 N--CA 1.484 1.869 0 CA-C-N 116.445 -0.343 . . . . 0.0 112.396 -171.817 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 86.4 m-20 -109.22 -17.11 13.92 Favored 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 115.265 1.58 . . . . 0.0 115.265 169.062 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 24.2 mm -93.34 118.46 39.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 CA-C-N 120.512 1.505 . . . . 0.0 109.14 -167.078 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 42.2 mt -84.87 114.33 22.03 Favored 'General case' 0 N--CA 1.486 1.325 0 C-N-CA 123.763 0.825 . . . . 0.0 111.434 179.701 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 87.6 m -102.25 102.29 12.67 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 -178.277 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 8.7 tt -104.15 105.21 15.3 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.307 -0.998 . . . . 0.0 108.307 -179.531 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -108.72 121.48 45.14 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 123.917 0.887 . . . . 0.0 109.565 -178.734 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 91.6 m -101.68 95.11 6.22 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 108.083 -1.081 . . . . 0.0 108.083 179.217 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 17.5 m-70 -81.26 99.79 8.8 Favored 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 123.564 0.745 . . . . 0.0 110.544 -170.312 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 85.6 p -100.09 -24.75 14.51 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 117.198 2.295 . . . . 0.0 117.198 -175.768 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . 0.361 5.9 m 84.61 -40.82 0.06 Allowed 'General case' 0 N--CA 1.506 2.368 0 CA-C-N 120.586 1.539 . . . . 0.0 113.44 -161.667 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 73.4 t80 -62.77 -77.9 0.05 OUTLIER 'General case' 0 CA--C 1.568 1.66 0 C-N-CA 124.487 1.115 . . . . 0.0 111.447 170.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 4.1 mppt? -144.31 131.85 21.03 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 167.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 54.1 t30 -80.11 113.82 18.56 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 123.179 0.591 . . . . 0.0 110.436 176.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 77.5 p -89.26 127.66 35.79 Favored 'General case' 0 N--CA 1.492 1.655 0 C-N-CA 122.855 0.462 . . . . 0.0 110.34 -179.777 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -123.51 122.25 37.74 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 123.584 0.753 . . . . 0.0 109.427 -169.408 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 48.7 pt -116.67 126.63 74.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 169.371 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 77.4 p -116.06 101.76 9.03 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 177.815 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 43.1 p90 -132.86 142.4 48.92 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 114.522 1.304 . . . . 0.0 114.522 -157.561 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 30.6 mtpp -98.23 146.72 25.34 Favored 'General case' 0 N--CA 1.489 1.501 0 CA-C-N 115.132 -0.94 . . . . 0.0 109.789 160.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -74.23 113.38 11.37 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 -173.83 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 86.64 45.5 5.47 Favored Glycine 0 CA--C 1.548 2.132 0 N-CA-C 115.848 1.099 . . . . 0.0 115.848 -169.259 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 76.7 t -141.79 121.58 10.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 N-CA-C 106.242 -1.762 . . . . 0.0 106.242 179.663 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -85.69 133.05 34.04 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 123.074 0.55 . . . . 0.0 111.147 175.193 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 52.0 p90 -139.32 149.83 44.67 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 124.006 0.922 . . . . 0.0 111.138 -174.383 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -74.64 133.49 42.14 Favored 'General case' 0 CA--C 1.567 1.607 0 O-C-N 121.234 -0.916 . . . . 0.0 112.703 173.189 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 17.3 tp10 -145.82 136.73 24.5 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 123.362 0.665 . . . . 0.0 110.252 -173.477 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 63.1 m -111.08 128.24 55.81 Favored 'General case' 0 N--CA 1.495 1.791 0 C-N-CA 123.279 0.632 . . . . 0.0 109.545 178.666 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 27.0 p -86.45 164.0 17.23 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 113.195 0.813 . . . . 0.0 113.195 -175.749 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -54.82 -32.17 60.11 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 118.779 2.881 . . . . 0.0 118.779 174.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -77.47 -85.44 0.06 Allowed 'General case' 0 N--CA 1.494 1.774 0 CA-C-N 120.416 1.462 . . . . 0.0 109.23 171.299 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -176.67 87.5 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 165.472 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 52.1 mtm-85 -139.95 115.11 9.76 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 -179.844 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -79.83 114.8 19.03 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 123.032 0.533 . . . . 0.0 109.604 166.589 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 13.9 m -125.47 138.76 53.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 CA-C-O 121.365 0.602 . . . . 0.0 110.116 -167.58 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 71.9 mmtt -84.92 107.95 17.32 Favored 'General case' 0 N--CA 1.488 1.426 0 CA-C-O 121.916 0.865 . . . . 0.0 109.179 170.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 47.3 t -106.95 100.84 10.31 Favored 'General case' 0 CA--C 1.555 1.144 0 CA-C-N 114.907 -1.042 . . . . 0.0 110.381 -161.403 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 6.4 tp -113.15 115.8 50.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 -176.494 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 1.4 p -134.26 126.93 50.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 C-N-CA 123.618 0.767 . . . . 0.0 109.735 -175.758 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 15.3 t -133.01 157.7 44.57 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-O 122.65 1.214 . . . . 0.0 110.98 176.065 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 14.9 tp -88.5 113.81 24.47 Favored 'General case' 0 N--CA 1.489 1.486 0 CA-C-N 114.833 -1.076 . . . . 0.0 108.505 168.36 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -107.0 87.22 2.46 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 123.322 0.649 . . . . 0.0 109.415 -174.518 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 61.4 48.26 86.15 Favored Glycine 0 CA--C 1.551 2.311 0 N-CA-C 117.262 1.665 . . . . 0.0 117.262 -174.265 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 69.36 26.42 74.58 Favored Glycine 0 CA--C 1.556 2.625 0 N-CA-C 118.662 2.225 . . . . 0.0 118.662 -167.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.17 109.87 5.76 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 107.151 -1.426 . . . . 0.0 107.151 -175.77 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 4.6 tt -88.63 106.28 18.22 Favored 'General case' 0 CA--C 1.56 1.343 0 CA-C-O 121.705 0.764 . . . . 0.0 111.249 -162.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 83.2 t -103.72 110.71 30.89 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 N-CA-C 107.113 -1.44 . . . . 0.0 107.113 -170.884 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 23.2 t-160 -103.75 138.82 39.83 Favored 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 124.023 0.929 . . . . 0.0 109.554 173.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 41.2 tp -132.52 121.1 22.79 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 107.837 -1.172 . . . . 0.0 107.837 173.413 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 29.9 mt-30 -106.51 129.47 54.46 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 124.198 0.999 . . . . 0.0 108.515 172.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 46.1 mtpt -129.86 130.31 45.05 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.809 -0.557 . . . . 0.0 110.065 -169.471 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 26.3 p90 -154.46 112.16 3.46 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.384 -0.823 . . . . 0.0 111.193 -175.834 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . 0.341 13.2 t70 66.67 -108.73 0.13 Allowed 'General case' 0 N--CA 1.495 1.781 0 C-N-CA 124.582 1.153 . . . . 0.0 112.457 170.527 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -116.42 44.82 1.38 Allowed Glycine 0 N--CA 1.488 2.163 0 CA-C-N 118.887 0.767 . . . . 0.0 115.007 165.096 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 14.9 mt-30 -152.3 126.52 9.23 Favored 'General case' 0 N--CA 1.484 1.273 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 178.704 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 13.4 mp0 -139.41 130.86 27.0 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 -179.194 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 5.2 t -125.13 134.25 52.51 Favored 'General case' 0 N--CA 1.495 1.805 0 C-N-CA 123.144 0.578 . . . . 0.0 111.569 -178.4 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 57.8 p -95.53 138.64 32.92 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-O 121.596 0.712 . . . . 0.0 111.705 172.144 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 5.9 mp -113.6 82.11 1.63 Allowed 'General case' 0 CA--C 1.563 1.449 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 173.812 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 48.1 t -90.73 112.59 25.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 -169.147 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 83.4 mtt85 -106.13 127.7 53.38 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 123.021 0.528 . . . . 0.0 110.086 -177.383 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 8.7 pm0 -139.62 132.86 29.83 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 123.234 0.614 . . . . 0.0 110.816 -178.665 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -80.19 112.92 17.97 Favored 'General case' 0 N--CA 1.487 1.404 0 CA-C-O 121.355 0.597 . . . . 0.0 110.892 175.792 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 73.2 mt -118.71 107.06 20.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 N-CA-C 104.805 -2.294 . . . . 0.0 104.805 176.486 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 59.3 49.85 8.49 Favored 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 114.692 1.367 . . . . 0.0 114.692 177.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 63.32 21.18 64.03 Favored Glycine 0 CA--C 1.555 2.572 0 N-CA-C 119.726 2.65 . . . . 0.0 119.726 -170.629 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 49.0 mtpt -130.95 131.4 44.4 Favored 'General case' 0 N--CA 1.488 1.47 0 CA-C-N 119.713 1.756 . . . . 0.0 108.665 -173.178 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 20.5 tp -81.91 108.53 15.49 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.312 0.645 . . . . 0.0 109.95 -175.155 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 29.8 mm -100.59 103.23 14.53 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 N-CA-C 106.463 -1.681 . . . . 0.0 106.463 -175.872 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 23.9 tp -92.03 98.28 11.46 Favored 'General case' 0 CA--C 1.56 1.328 0 C-N-CA 124.04 0.936 . . . . 0.0 109.47 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 90.8 m -88.12 109.12 19.64 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 124.291 1.036 . . . . 0.0 108.729 178.019 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 90.3 mt -100.29 93.75 5.84 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 124.045 0.938 . . . . 0.0 109.164 -172.449 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 4.7 m -106.41 112.53 25.58 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 -172.291 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 19.9 t60 -100.65 -75.27 0.59 Allowed 'General case' 0 N--CA 1.491 1.591 0 CA-C-O 118.793 -0.623 . . . . 0.0 110.492 172.553 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -142.2 -97.91 0.29 Allowed Glycine 0 N--CA 1.483 1.773 0 N-CA-C 110.558 -1.017 . . . . 0.0 110.558 -178.883 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 8.2 t -89.1 30.78 0.92 Allowed 'General case' 0 N--CA 1.5 2.051 0 N-CA-C 115.498 1.666 . . . . 0.0 115.498 173.468 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -158.44 107.72 2.01 Favored 'General case' 0 N--CA 1.481 1.114 0 O-C-N 121.045 -1.034 . . . . 0.0 108.979 177.351 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 7.5 p -108.56 126.35 65.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 C-N-CA 123.583 0.753 . . . . 0.0 109.827 175.231 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 40.9 t -109.87 106.94 16.71 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 123.003 0.521 . . . . 0.0 111.851 179.033 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 77.5 m -90.18 100.51 13.32 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 178.866 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 33.5 mtm180 -99.41 121.13 40.69 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 123.108 0.563 . . . . 0.0 110.552 -174.667 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 95.7 m -89.78 131.27 35.82 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 123.438 0.695 . . . . 0.0 109.822 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 42.0 m-85 -127.26 131.13 50.61 Favored 'General case' 0 CA--C 1.559 1.297 0 C-N-CA 123.612 0.765 . . . . 0.0 109.587 178.634 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -96.31 150.12 20.92 Favored 'General case' 0 CA--C 1.56 1.358 0 CA-C-O 121.943 0.878 . . . . 0.0 111.457 172.481 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 67.4 tttt -80.77 127.07 32.09 Favored 'General case' 0 N--CA 1.486 1.33 0 CA-C-O 121.642 0.734 . . . . 0.0 112.204 -173.439 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 15.2 mm-40 -125.02 52.3 1.59 Allowed 'General case' 0 CA--C 1.563 1.449 0 C-N-CA 124.253 1.021 . . . . 0.0 111.252 -173.438 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.968 0 CA-C-O 123.057 1.408 . . . . 0.0 109.989 -163.688 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 79.0 t . . . . . 0 CA--C 1.559 1.3 0 N-CA-C 106.605 -1.628 . . . . 0.0 106.605 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -145.45 -53.36 0.28 Allowed 'General case' 0 N--CA 1.494 1.749 0 C-N-CA 123.9 0.88 . . . . 0.0 111.242 -175.373 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -57.8 -27.43 63.11 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 117.066 2.247 . . . . 0.0 117.066 161.571 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -63.8 -20.52 65.85 Favored 'General case' 0 CA--C 1.568 1.659 0 N-CA-C 117.209 2.3 . . . . 0.0 117.209 165.189 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 64.7 mt -82.45 120.16 25.11 Favored 'General case' 0 N--CA 1.487 1.425 0 CA-C-N 121.034 1.743 . . . . 0.0 111.361 -169.239 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 155.99 173.25 24.36 Favored Glycine 0 CA--C 1.543 1.83 0 CA-C-O 122.542 1.079 . . . . 0.0 113.013 -171.734 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 76.9 m -85.73 140.75 30.24 Favored 'General case' 0 N--CA 1.492 1.673 0 CA-C-N 114.548 -0.826 . . . . 0.0 109.475 168.21 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 88.7 m95 -140.68 112.86 7.82 Favored 'General case' 0 N--CA 1.485 1.319 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 -174.034 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 51.2 mtpt -99.11 147.86 24.65 Favored 'General case' 0 N--CA 1.494 1.74 0 CA-C-O 121.548 0.689 . . . . 0.0 110.702 177.069 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 61.8 tp -69.87 131.67 44.82 Favored 'General case' 0 N--CA 1.488 1.475 0 CA-C-O 121.847 0.832 . . . . 0.0 112.856 -175.586 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . 0.271 0.9 OUTLIER -116.7 -39.27 2.4 Favored 'Isoleucine or valine' 0 CA--C 1.576 1.971 0 CA-C-N 114.335 -1.302 . . . . 0.0 112.434 -176.87 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -136.22 132.63 36.13 Favored 'General case' 0 N--CA 1.491 1.618 0 CA-C-N 120.513 1.506 . . . . 0.0 109.474 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 83.5 p -128.52 90.41 3.06 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-O 121.5 0.667 . . . . 0.0 111.031 176.509 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -100.56 124.25 45.88 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 123.569 0.748 . . . . 0.0 109.26 177.827 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.267 57.2 m-20 71.33 16.13 6.17 Favored 'General case' 0 N--CA 1.506 2.367 0 N-CA-C 117.677 2.473 . . . . 0.0 117.677 177.788 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 20.4 t80 -70.41 -40.08 74.06 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 115.77 1.767 . . . . 0.0 115.77 -176.371 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -63.86 -29.5 70.68 Favored 'General case' 0 N--CA 1.499 1.995 0 N-CA-C 116.053 1.872 . . . . 0.0 116.053 170.55 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 27.8 t0 -64.45 -49.21 72.37 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 114.527 1.306 . . . . 0.0 114.527 165.329 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 90.9 t80 -52.45 -52.85 51.96 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 115.311 1.597 . . . . 0.0 115.311 172.203 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 77.9 mtm -62.02 -41.3 97.95 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 115.295 1.591 . . . . 0.0 115.295 175.053 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.4 tmtp? -58.77 -44.75 90.73 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 115.276 1.584 . . . . 0.0 115.276 168.818 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 49.3 m -58.72 -38.24 77.91 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 116.332 1.975 . . . . 0.0 116.332 172.009 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 80.3 mt -65.79 -41.38 92.01 Favored 'General case' 0 CA--C 1.567 1.6 0 N-CA-C 116.368 1.988 . . . . 0.0 116.368 169.516 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 113.7 76.33 0.72 Allowed Glycine 0 N--CA 1.483 1.778 0 N-CA-C 111.055 -0.818 . . . . 0.0 111.055 -171.467 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 67.5 t -141.98 123.04 12.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 N-CA-C 105.512 -2.032 . . . . 0.0 105.512 -175.445 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -69.41 160.29 52.83 Favored Glycine 0 CA--C 1.548 2.119 0 N-CA-C 115.948 1.139 . . . . 0.0 115.948 179.143 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 28.7 p90 -54.57 -41.25 69.62 Favored 'General case' 0 N--CA 1.498 1.95 0 N-CA-C 118.726 2.861 . . . . 0.0 118.726 -171.091 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.59 -43.31 94.22 Favored 'General case' 0 CA--C 1.564 1.499 0 N-CA-C 115.594 1.702 . . . . 0.0 115.594 173.769 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 58.7 m -67.28 -35.11 78.81 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 114.53 1.308 . . . . 0.0 114.53 170.064 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 58.1 mtm180 -58.36 -48.48 80.45 Favored 'General case' 0 N--CA 1.493 1.718 0 CA-C-N 120.407 1.458 . . . . 0.0 114.911 168.398 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 37.2 mm-40 -68.57 -39.79 80.86 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 115.455 1.65 . . . . 0.0 115.455 177.565 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 74.6 t -60.97 -47.84 91.74 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.019 0 CA-C-N 119.656 1.117 . . . . 0.0 113.103 169.622 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -67.74 -39.19 84.27 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 117.032 2.234 . . . . 0.0 117.032 178.544 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 87.8 p -65.52 -39.11 91.43 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 116.175 1.917 . . . . 0.0 116.175 168.53 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 54.7 tpp -66.87 -40.82 87.95 Favored 'General case' 0 CA--C 1.566 1.589 0 N-CA-C 115.997 1.851 . . . . 0.0 115.997 173.636 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 5.8 t -75.37 161.93 28.83 Favored 'General case' 0 N--CA 1.493 1.682 0 CA-C-N 119.428 1.013 . . . . 0.0 112.846 179.211 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 3.5 mtmt -99.28 104.0 23.9 Favored Pre-proline 0 CA--C 1.568 1.649 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 170.706 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -77.93 90.92 1.22 Allowed 'Trans proline' 0 CA--C 1.56 1.782 0 C-N-CA 123.165 2.577 . . . . 0.0 111.155 178.414 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 52.0 m -79.49 109.24 13.67 Favored 'General case' 0 N--CA 1.488 1.43 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.258 -161.216 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 90.7 m -83.59 116.61 22.68 Favored 'General case' 0 CA--C 1.56 1.349 0 C-N-CA 123.541 0.737 . . . . 0.0 109.468 -174.336 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 73.7 mt -113.16 106.99 21.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 N-CA-C 105.805 -1.924 . . . . 0.0 105.805 179.02 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 20.6 mt -100.58 120.91 50.7 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 -177.512 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -136.35 111.82 9.25 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 -170.886 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 82.1 tttt -91.28 115.7 28.24 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 123.309 0.644 . . . . 0.0 110.789 -177.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 32.8 t30 -116.04 80.87 1.51 Allowed 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 178.821 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 62.91 59.77 8.64 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 116.209 1.244 . . . . 0.0 116.209 -173.902 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . 0.324 3.9 t70 71.25 -20.15 0.23 Allowed 'General case' 0 N--CA 1.499 2.021 0 N-CA-C 117.415 2.376 . . . . 0.0 117.415 -167.506 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 11.0 mm -82.3 102.73 8.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 CA-C-N 120.19 1.359 . . . . 0.0 107.906 -175.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 45.7 mt -89.0 104.98 17.49 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 123.146 0.578 . . . . 0.0 110.268 -174.069 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 64.1 m -92.19 95.27 9.64 Favored 'General case' 0 N--CA 1.484 1.272 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 -177.714 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 9.8 tt -99.57 101.77 13.08 Favored 'General case' 0 N--CA 1.484 1.234 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 -175.287 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -100.22 108.2 20.24 Favored 'General case' 0 N--CA 1.485 1.303 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 -175.826 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 89.2 m -94.64 99.5 11.61 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 -179.534 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 29.2 m170 -86.97 91.88 8.84 Favored 'General case' 0 N--CA 1.491 1.581 0 CA-C-O 121.578 0.704 . . . . 0.0 111.271 -172.221 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 25.2 t -101.67 153.85 19.4 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 124.003 0.921 . . . . 0.0 110.783 177.447 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 27.6 m -82.77 67.7 8.94 Favored 'General case' 0 N--CA 1.499 1.988 0 CA-C-O 122.081 0.943 . . . . 0.0 110.5 170.497 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 83.6 t80 -167.61 -81.18 0.02 OUTLIER 'General case' 0 CA--C 1.563 1.46 0 N-CA-C 104.755 -2.313 . . . . 0.0 104.755 -178.226 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 61.4 mtpt -147.83 123.82 10.71 Favored 'General case' 0 N--CA 1.486 1.342 0 N-CA-C 106.531 -1.655 . . . . 0.0 106.531 174.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -82.42 119.05 23.69 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.905 -0.497 . . . . 0.0 112.087 -179.748 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 82.7 p -91.81 128.83 37.8 Favored 'General case' 0 N--CA 1.493 1.715 0 C-N-CA 122.837 0.455 . . . . 0.0 110.871 -176.905 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -117.77 117.08 28.34 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 -179.782 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 37.9 pt -112.11 131.57 63.19 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 174.124 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 79.7 p -116.81 101.88 8.93 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 -179.853 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 46.6 p90 -130.85 133.11 45.64 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 114.137 1.162 . . . . 0.0 114.137 -161.167 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 30.8 mtpp -88.71 145.05 25.87 Favored 'General case' 0 CA--C 1.561 1.379 0 CA-C-N 114.883 -1.053 . . . . 0.0 109.625 161.299 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -74.79 117.7 16.92 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.831 -0.543 . . . . 0.0 111.882 -173.141 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 86.13 44.07 6.09 Favored Glycine 0 CA--C 1.549 2.157 0 N-CA-C 116.457 1.343 . . . . 0.0 116.457 -168.83 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 98.8 t -140.15 121.14 14.55 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 N-CA-C 106.332 -1.729 . . . . 0.0 106.332 179.767 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -86.09 128.73 34.93 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 123.072 0.549 . . . . 0.0 111.045 176.207 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 47.9 p90 -133.77 128.59 35.14 Favored 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 123.619 0.768 . . . . 0.0 110.475 -174.248 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -71.1 117.43 12.6 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.411 -0.806 . . . . 0.0 112.206 175.207 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 15.7 tp10 -124.38 133.63 53.36 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 123.435 0.694 . . . . 0.0 110.616 -168.349 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 61.0 m -95.24 123.4 38.72 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 172.277 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 43.1 p -85.67 172.99 10.44 Favored 'General case' 0 CA--C 1.568 1.662 0 CA-C-O 121.854 0.835 . . . . 0.0 112.758 -173.813 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -60.76 -35.24 75.9 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 117.344 2.35 . . . . 0.0 117.344 165.739 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -98.09 82.08 2.91 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 106.376 -1.713 . . . . 0.0 106.376 166.293 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -39.35 108.95 0.09 Allowed 'General case' 0 N--CA 1.497 1.881 0 N-CA-C 117.747 2.499 . . . . 0.0 117.747 -155.169 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 39.6 ttm-85 -149.04 126.59 11.64 Favored 'General case' 0 N--CA 1.487 1.389 0 CA-C-N 114.878 -1.055 . . . . 0.0 108.493 -167.727 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.44 117.87 15.71 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 170.58 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 13.6 m -135.57 125.7 42.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 -174.081 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 30.9 mmtp -82.35 103.47 11.94 Favored 'General case' 0 N--CA 1.489 1.476 0 CA-C-O 121.894 0.854 . . . . 0.0 109.472 179.116 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 44.5 t -103.56 100.16 9.99 Favored 'General case' 0 CA--C 1.554 1.119 0 CA-C-N 115.012 -0.994 . . . . 0.0 110.718 -160.677 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 6.5 tp -109.46 120.35 60.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 -178.045 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 1.6 p -139.99 123.64 18.16 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 -173.354 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 14.3 t -133.56 160.35 37.74 Favored 'General case' 0 N--CA 1.487 1.42 0 CA-C-O 122.978 1.371 . . . . 0.0 111.254 179.647 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 63.8 tp -88.64 107.86 19.15 Favored 'General case' 0 N--CA 1.487 1.424 0 CA-C-N 114.44 -1.254 . . . . 0.0 108.523 170.873 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -108.19 87.62 2.54 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 123.377 0.671 . . . . 0.0 109.351 -171.609 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 56.54 49.43 69.58 Favored Glycine 0 CA--C 1.548 2.14 0 N-CA-C 117.614 1.805 . . . . 0.0 117.614 -177.89 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 102.26 -45.85 1.32 Allowed Glycine 0 N--CA 1.488 2.136 0 N-CA-C 116.852 1.501 . . . . 0.0 116.852 -168.43 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 36.0 ttpt -90.01 130.4 36.21 Favored 'General case' 0 CA--C 1.556 1.175 0 CA-C-N 117.419 0.609 . . . . 0.0 111.704 -169.111 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 4.7 tt -84.53 103.57 13.78 Favored 'General case' 0 CA--C 1.563 1.455 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 178.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 78.8 t -109.65 111.62 36.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 -167.805 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 21.1 t-160 -113.11 125.32 54.24 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 124.416 1.086 . . . . 0.0 109.22 -177.241 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 25.8 tp -122.45 121.81 37.48 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 107.799 -1.185 . . . . 0.0 107.799 175.167 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 93.1 mt-30 -107.69 126.03 52.09 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 171.867 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 10.2 ptpp? -126.88 139.34 53.15 Favored 'General case' 0 N--CA 1.494 1.75 0 CA-C-O 121.343 0.592 . . . . 0.0 112.193 -176.686 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 26.6 p90 -157.57 110.25 2.44 Favored 'General case' 0 N--CA 1.488 1.475 0 C-N-CA 123.781 0.832 . . . . 0.0 108.953 -173.657 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 3.8 t70 54.52 50.69 15.51 Favored 'General case' 0 N--CA 1.499 1.977 0 N-CA-C 116.382 1.993 . . . . 0.0 116.382 167.346 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 86.08 -40.67 3.05 Favored Glycine 0 CA--C 1.554 2.478 0 N-CA-C 117.372 1.709 . . . . 0.0 117.372 -169.495 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 57.6 mt-30 -80.37 136.12 36.32 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 123.921 0.888 . . . . 0.0 111.138 179.727 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -145.61 130.23 17.96 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.827 -0.546 . . . . 0.0 111.442 178.892 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 7.7 t -114.23 134.57 54.83 Favored 'General case' 0 N--CA 1.494 1.74 0 C-N-CA 123.22 0.608 . . . . 0.0 111.009 175.725 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 39.3 p -103.53 129.11 50.67 Favored 'General case' 0 N--CA 1.49 1.575 0 CA-C-O 121.615 0.722 . . . . 0.0 110.885 173.222 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 5.6 mp -106.67 80.72 1.49 Allowed 'General case' 0 CA--C 1.565 1.554 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 176.333 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 67.9 t -88.8 108.21 18.68 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 N-CA-C 108.272 -1.011 . . . . 0.0 108.272 -169.322 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 80.1 mtt85 -100.93 125.66 47.52 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 123.265 0.626 . . . . 0.0 110.352 -177.6 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -143.26 133.6 24.67 Favored 'General case' 0 N--CA 1.491 1.606 0 C-N-CA 123.308 0.643 . . . . 0.0 111.157 -176.042 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -81.33 117.82 22.12 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.66 -0.65 . . . . 0.0 111.356 177.232 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 46.9 mm -120.83 104.9 15.94 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.374 0 N-CA-C 105.115 -2.18 . . . . 0.0 105.115 174.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 22.2 m-20 58.93 50.37 8.51 Favored 'General case' 0 N--CA 1.499 2.02 0 N-CA-C 115.101 1.519 . . . . 0.0 115.101 175.414 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 63.76 27.45 71.13 Favored Glycine 0 CA--C 1.555 2.566 0 N-CA-C 119.242 2.457 . . . . 0.0 119.242 -170.581 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -135.87 127.13 28.26 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-N 119.002 1.401 . . . . 0.0 108.339 -174.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 19.1 tp -78.4 111.46 14.44 Favored 'General case' 0 CA--C 1.559 1.312 0 C-N-CA 123.474 0.709 . . . . 0.0 110.374 -179.215 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 30.4 mm -98.89 100.85 11.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 -177.075 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 30.3 tp -91.5 104.48 16.98 Favored 'General case' 0 CA--C 1.559 1.305 0 C-N-CA 123.85 0.86 . . . . 0.0 109.276 177.65 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 85.5 m -97.42 114.62 26.48 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 124.083 0.953 . . . . 0.0 108.621 -177.161 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 85.2 mt -110.79 96.66 6.31 Favored 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 123.63 0.772 . . . . 0.0 109.375 -168.001 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 11.1 m -105.85 117.14 33.26 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.947 -0.471 . . . . 0.0 109.89 -171.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 53.9 t60 -156.4 122.16 4.88 Favored 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 123.157 0.583 . . . . 0.0 109.53 171.566 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 61.71 64.92 3.57 Favored Glycine 0 N--CA 1.488 2.143 0 N-CA-C 117.237 1.655 . . . . 0.0 117.237 165.605 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . 0.391 5.2 t 46.57 39.86 7.48 Favored 'General case' 0 N--CA 1.5 2.049 0 N-CA-C 117.624 2.453 . . . . 0.0 117.624 -169.041 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -153.14 88.57 1.32 Allowed 'General case' 0 N--CA 1.483 1.203 0 O-C-N 121.531 -0.731 . . . . 0.0 109.276 -176.924 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 4.5 p -92.9 119.77 41.14 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.401 0 C-N-CA 123.508 0.723 . . . . 0.0 109.582 173.771 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 42.2 t -110.31 100.76 9.58 Favored 'General case' 0 CA--C 1.551 1.014 0 CA-C-O 121.594 0.712 . . . . 0.0 110.25 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 87.6 m -90.74 106.24 18.37 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 -177.287 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 39.4 mtm180 -112.22 121.67 45.57 Favored 'General case' 0 N--CA 1.487 1.375 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.59 -169.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 89.8 m -85.02 136.61 33.51 Favored 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 123.35 0.66 . . . . 0.0 110.033 177.16 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 40.7 m-85 -129.73 126.11 37.46 Favored 'General case' 0 CA--C 1.558 1.259 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 177.308 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -92.62 152.12 19.75 Favored 'General case' 0 N--CA 1.494 1.726 0 CA-C-O 121.943 0.878 . . . . 0.0 111.82 173.23 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 71.2 tttt -83.03 121.58 27.2 Favored 'General case' 0 N--CA 1.486 1.364 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.926 -169.255 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -119.92 51.2 1.2 Allowed 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 124.283 1.033 . . . . 0.0 111.525 -174.302 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 0.829 0 CA-C-O 124.448 2.071 . . . . 0.0 109.882 -161.269 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.297 42.6 t . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 117.257 -1.354 . . . . 0.0 112.982 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -56.68 -41.3 77.07 Favored 'General case' 0 N--CA 1.499 1.995 0 N-CA-C 116.282 1.956 . . . . 0.0 116.282 178.648 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -61.38 -33.88 74.4 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 116.766 2.136 . . . . 0.0 116.766 164.697 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -70.96 -22.67 62.18 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 116.273 1.953 . . . . 0.0 116.273 169.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 82.6 mt -70.84 118.03 13.1 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-N 121.26 1.845 . . . . 0.0 111.476 -175.817 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 154.53 172.3 22.24 Favored Glycine 0 CA--C 1.54 1.632 0 CA-C-O 122.661 1.145 . . . . 0.0 112.941 -176.736 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 45.9 m -87.59 142.54 27.77 Favored 'General case' 0 N--CA 1.489 1.504 0 CA-C-N 114.555 -0.822 . . . . 0.0 109.095 172.624 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 92.1 m95 -136.43 110.73 8.43 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 -173.761 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 39.8 mttp -94.31 142.85 26.94 Favored 'General case' 0 N--CA 1.489 1.478 0 CA-C-O 121.612 0.72 . . . . 0.0 110.73 174.318 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 14.2 tp -70.1 123.55 21.89 Favored 'General case' 0 N--CA 1.487 1.393 0 CA-C-O 122.218 1.008 . . . . 0.0 111.806 -176.859 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . 0.286 1.1 t -96.02 -47.98 12.79 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.741 0 CA-C-N 113.711 -1.586 . . . . 0.0 111.661 175.875 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -142.38 145.38 33.8 Favored 'General case' 0 N--CA 1.49 1.536 0 CA-C-N 119.859 1.209 . . . . 0.0 110.099 176.865 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 88.0 p -121.94 100.87 7.22 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.75 -0.594 . . . . 0.0 110.075 170.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -89.23 119.56 29.82 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 36.7 m-20 67.47 30.83 6.62 Favored 'General case' 0 N--CA 1.5 2.046 0 N-CA-C 116.515 2.042 . . . . 0.0 116.515 178.163 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.431 ' HB2' ' SG ' ' A' ' 124' ' ' CYS . 31.1 t80 -90.4 69.56 6.95 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 120.236 -1.54 . . . . 0.0 111.955 -179.859 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -159.72 -52.32 0.06 Allowed 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 125.434 1.494 . . . . 0.0 108.689 179.106 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 22.0 t0 -53.81 -41.27 67.14 Favored 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 116.034 1.864 . . . . 0.0 116.034 164.771 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 81.6 t80 -55.03 -53.17 59.22 Favored 'General case' 0 CA--C 1.571 1.754 0 N-CA-C 114.536 1.31 . . . . 0.0 114.536 169.769 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 73.8 mtm -62.83 -38.53 91.14 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 115.879 1.807 . . . . 0.0 115.879 171.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 57.1 mtpt -58.23 -51.2 70.76 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 115.596 1.702 . . . . 0.0 115.596 168.539 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 21.3 t -62.95 -34.58 77.79 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 116.221 1.934 . . . . 0.0 116.221 174.44 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 68.1 mt -66.41 -39.95 89.29 Favored 'General case' 0 CA--C 1.565 1.545 0 N-CA-C 116.084 1.883 . . . . 0.0 116.084 168.364 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 105.46 78.47 1.2 Allowed Glycine 0 CA--C 1.54 1.649 0 CA-C-N 118.807 0.73 . . . . 0.0 111.474 -172.184 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 58.1 t -138.02 123.27 24.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 N-CA-C 105.752 -1.944 . . . . 0.0 105.752 -179.5 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -82.4 -157.93 22.58 Favored Glycine 0 CA--C 1.547 2.087 0 N-CA-C 115.965 1.146 . . . . 0.0 115.965 -177.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 8.6 p90 -69.39 156.61 38.54 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 113.319 0.859 . . . . 0.0 113.319 178.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . 0.317 . . 76.6 -50.1 0.57 Allowed 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 115.647 1.721 . . . . 0.0 115.647 179.616 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 30.4 m -70.98 -36.11 72.37 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 113.903 1.075 . . . . 0.0 113.903 170.322 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 27.8 mtm180 -57.18 -46.88 82.43 Favored 'General case' 0 N--CA 1.499 1.987 0 CA-C-N 120.819 1.645 . . . . 0.0 114.472 162.409 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 3.4 tm0? -66.3 -49.77 65.91 Favored 'General case' 0 CA--C 1.562 1.434 0 N-CA-C 114.756 1.391 . . . . 0.0 114.756 -178.864 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 95.6 t -65.69 -40.12 86.93 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 CA-C-N 119.42 1.009 . . . . 0.0 113.426 175.146 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -66.26 -39.91 89.79 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 116.383 1.994 . . . . 0.0 116.383 176.368 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 92.8 p -63.78 -40.72 97.34 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 116.144 1.905 . . . . 0.0 116.144 165.794 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 17.9 ttm -60.71 -47.16 87.52 Favored 'General case' 0 CA--C 1.568 1.653 0 N-CA-C 115.861 1.8 . . . . 0.0 115.861 171.752 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 5.4 t -78.79 158.26 28.25 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 113.511 0.93 . . . . 0.0 113.511 -166.302 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 14.1 mptt -102.34 101.69 21.01 Favored Pre-proline 0 CA--C 1.57 1.728 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 175.091 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -77.76 100.39 1.38 Allowed 'Trans proline' 0 CA--C 1.561 1.848 0 C-N-CA 123.027 2.485 . . . . 0.0 111.562 -177.198 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 80.9 m -83.55 102.72 12.34 Favored 'General case' 0 N--CA 1.489 1.486 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.808 -164.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 32.3 m -97.31 112.75 24.43 Favored 'General case' 0 N--CA 1.485 1.279 0 CA-C-O 120.63 0.252 . . . . 0.0 111.243 -167.898 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 5.2 mp -91.07 107.16 18.34 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.454 0 N-CA-C 107.103 -1.443 . . . . 0.0 107.103 170.774 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.413 HD11 HH11 ' A' ' 106' ' ' ARG . 44.9 mt -90.75 123.3 42.85 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 N-CA-C 106.762 -1.57 . . . . 0.0 106.762 167.372 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 15.0 tt0 -134.05 179.54 6.19 Favored 'General case' 0 CA--C 1.567 1.597 0 CA-C-O 121.817 0.817 . . . . 0.0 109.659 -175.233 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.49 157.77 45.83 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-O 122.515 1.15 . . . . 0.0 112.7 -178.865 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 33.2 t30 -150.62 82.59 1.35 Allowed 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 106.257 -1.757 . . . . 0.0 106.257 167.739 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 76.23 -107.96 2.46 Favored Glycine 0 CA--C 1.547 2.072 0 N-CA-C 111.944 -0.462 . . . . 0.0 111.944 -165.15 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -122.68 61.15 1.0 Allowed 'General case' 0 N--CA 1.493 1.696 0 CA-C-O 121.133 0.492 . . . . 0.0 109.9 159.279 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 39.4 mm -124.84 94.86 2.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 N-CA-C 103.368 -2.827 . . . . 0.0 103.368 172.04 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 36.1 mt -89.81 105.5 17.84 Favored 'General case' 0 N--CA 1.483 1.196 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.683 -165.508 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 85.5 m -97.32 100.6 12.05 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 -165.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 9.2 tt -101.9 100.86 11.21 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 107.802 -1.185 . . . . 0.0 107.802 -177.406 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -100.01 106.3 18.06 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 179.856 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 96.3 m -93.38 102.81 15.06 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 -179.616 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 31.4 m-70 -89.98 85.13 6.26 Favored 'General case' 0 N--CA 1.493 1.709 0 CA-C-O 122.132 0.968 . . . . 0.0 110.98 -174.408 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 24.7 t -92.11 161.56 14.71 Favored 'General case' 0 N--CA 1.485 1.319 0 CA-C-N 115.165 -0.925 . . . . 0.0 111.078 173.405 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 35.8 m -82.89 68.09 9.23 Favored 'General case' 0 N--CA 1.499 1.983 0 CA-C-O 121.949 0.881 . . . . 0.0 110.302 170.021 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 71.2 t80 -165.77 -81.98 0.02 OUTLIER 'General case' 0 CA--C 1.561 1.375 0 N-CA-C 105.302 -2.111 . . . . 0.0 105.302 179.384 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 62.6 mtpt -146.69 126.14 13.2 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 176.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -81.91 112.97 19.5 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 122.007 -0.433 . . . . 0.0 111.985 -178.665 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 76.3 p -91.39 128.04 37.06 Favored 'General case' 0 N--CA 1.493 1.683 0 C-N-CA 122.809 0.444 . . . . 0.0 111.433 -173.516 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -111.23 115.92 30.17 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 179.303 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 35.4 pt -114.72 130.42 69.16 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 171.475 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 71.2 p -117.95 116.39 26.82 Favored 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 123.751 0.82 . . . . 0.0 108.983 -179.499 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 51.1 p90 -140.26 140.4 35.74 Favored 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 115.115 1.524 . . . . 0.0 115.115 -160.109 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 52.8 mtmt -102.81 14.3 32.28 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 117.29 2.33 . . . . 0.0 117.29 -172.69 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . 0.291 3.2 mp 61.74 98.81 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.731 0 CA-C-N 120.692 1.587 . . . . 0.0 114.484 177.173 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 86.22 37.27 9.16 Favored Glycine 0 CA--C 1.553 2.419 0 N-CA-C 116.859 1.504 . . . . 0.0 116.859 -167.441 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 88.0 t -139.21 124.67 21.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 -178.569 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -88.76 123.66 33.39 Favored 'General case' 0 CA--C 1.562 1.406 0 C-N-CA 123.55 0.74 . . . . 0.0 110.526 173.846 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 40.1 p90 -130.35 124.49 32.37 Favored 'General case' 0 N--CA 1.494 1.754 0 C-N-CA 123.605 0.762 . . . . 0.0 110.42 -175.152 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -71.07 117.41 12.54 Favored 'General case' 0 CA--C 1.564 1.512 0 O-C-N 121.599 -0.688 . . . . 0.0 112.505 177.209 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 12.2 tp10 -126.99 133.91 50.47 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 123.742 0.817 . . . . 0.0 110.091 -167.882 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 45.3 m -91.23 122.83 34.2 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 176.239 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 33.9 p -83.56 167.22 17.56 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 113.019 0.748 . . . . 0.0 113.019 -174.504 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -53.82 -28.01 32.89 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 118.646 2.832 . . . . 0.0 118.646 168.541 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -74.6 -91.14 0.02 OUTLIER 'General case' 0 CA--C 1.57 1.733 0 CA-C-N 119.734 1.152 . . . . 0.0 109.076 168.269 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -176.17 90.16 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 105.143 -2.169 . . . . 0.0 105.143 158.55 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 45.8 mtt-85 -142.19 123.07 14.4 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 122.257 -0.277 . . . . 0.0 110.371 -171.711 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.586 ' H ' ' HD3' ' A' ' 79' ' ' LYS . 0.0 OUTLIER -80.47 93.77 6.09 Favored 'General case' 0 CA--C 1.564 1.511 0 C-N-CA 124.094 0.958 . . . . 0.0 110.679 172.413 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 13.4 m -112.03 130.54 65.51 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 C-N-CA 122.998 0.519 . . . . 0.0 110.676 -167.559 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 1.5 mptm? -84.34 98.53 10.08 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 123.808 0.843 . . . . 0.0 109.339 -179.332 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 72.2 m -94.2 98.25 10.82 Favored 'General case' 0 N--CA 1.483 1.191 0 CA-C-N 115.133 -0.939 . . . . 0.0 110.933 -166.139 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 6.4 tp -107.77 115.44 48.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 -179.295 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.0 p -133.15 131.66 58.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 C-N-CA 124.03 0.932 . . . . 0.0 109.673 -172.639 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 15.1 t -143.68 159.9 41.65 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-O 122.495 1.14 . . . . 0.0 110.577 177.213 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 18.2 tp -93.9 107.13 19.06 Favored 'General case' 0 N--CA 1.489 1.506 0 CA-C-N 115.162 -0.926 . . . . 0.0 108.633 172.129 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -102.88 84.58 2.4 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 123.382 0.673 . . . . 0.0 109.662 -171.84 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 56.5 48.35 76.96 Favored Glycine 0 CA--C 1.548 2.141 0 N-CA-C 117.608 1.803 . . . . 0.0 117.608 -176.088 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 100.38 -47.6 1.25 Allowed Glycine 0 N--CA 1.489 2.172 0 N-CA-C 116.215 1.246 . . . . 0.0 116.215 -166.657 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 30.9 ttpt -84.62 116.33 23.12 Favored 'General case' 0 CA--C 1.556 1.2 0 CA-C-N 117.915 0.858 . . . . 0.0 111.131 -170.075 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 3.0 tt -88.05 101.77 14.11 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-O 121.686 0.755 . . . . 0.0 109.659 -173.005 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 54.3 t -104.66 107.4 22.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 -168.418 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 19.9 t-160 -99.35 140.1 34.02 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 123.943 0.897 . . . . 0.0 109.655 169.679 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 15.6 tp -138.9 124.91 19.96 Favored 'General case' 0 N--CA 1.488 1.44 0 CA-C-O 122.03 0.919 . . . . 0.0 108.803 175.557 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -107.92 126.62 52.9 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 124.603 1.161 . . . . 0.0 108.378 178.537 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -125.45 133.2 52.53 Favored 'General case' 0 N--CA 1.496 1.847 0 C-N-CA 122.986 0.514 . . . . 0.0 110.571 -173.734 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 22.9 p90 -158.18 114.57 2.8 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.125 -0.985 . . . . 0.0 110.5 -176.034 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 11.1 t70 50.21 58.07 5.89 Favored 'General case' 0 N--CA 1.503 2.176 0 N-CA-C 116.704 2.112 . . . . 0.0 116.704 163.508 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 80.89 -25.22 3.56 Favored Glycine 0 CA--C 1.559 2.79 0 N-CA-C 119.212 2.445 . . . . 0.0 119.212 -171.327 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 66.7 mt-30 -102.01 133.79 46.26 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 124.785 1.234 . . . . 0.0 110.464 -179.044 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -141.38 135.78 30.77 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.341 -0.849 . . . . 0.0 112.416 173.165 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 14.9 t -117.13 129.21 55.82 Favored 'General case' 0 N--CA 1.496 1.857 0 C-N-CA 123.302 0.641 . . . . 0.0 111.506 177.635 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 40.3 p -94.7 120.43 34.91 Favored 'General case' 0 N--CA 1.493 1.715 0 C-N-CA 123.306 0.642 . . . . 0.0 110.028 172.346 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 5.2 mp -103.56 90.86 3.8 Favored 'General case' 0 CA--C 1.562 1.428 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 174.729 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 92.9 t -94.99 102.66 13.84 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 N-CA-C 107.567 -1.272 . . . . 0.0 107.567 -174.294 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.413 HH11 HD11 ' A' ' 42' ' ' ILE . 45.8 mtt180 -91.5 128.08 37.19 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 122.966 0.506 . . . . 0.0 109.652 172.45 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -147.81 129.56 15.16 Favored 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 123.197 0.599 . . . . 0.0 110.429 -172.035 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -77.11 121.14 23.17 Favored 'General case' 0 N--CA 1.487 1.404 0 CA-C-O 121.865 0.841 . . . . 0.0 112.736 178.647 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . 0.279 1.5 mp -76.41 171.89 1.22 Allowed 'Isoleucine or valine' 0 CA--C 1.575 1.938 0 CA-C-N 114.94 -1.027 . . . . 0.0 109.231 143.12 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -68.62 73.72 0.25 Allowed 'General case' 0 CA--C 1.565 1.543 0 N-CA-C 114.866 1.432 . . . . 0.0 114.866 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 121.22 -56.95 0.61 Allowed Glycine 0 N--CA 1.485 1.911 0 CA-C-N 114.093 -1.412 . . . . 0.0 113.781 -171.003 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 51.1 mttp -91.12 139.72 30.49 Favored 'General case' 0 N--CA 1.487 1.376 0 CA-C-O 121.713 0.768 . . . . 0.0 112.172 -173.307 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 25.1 tp -92.9 135.93 33.7 Favored 'General case' 0 CA--C 1.557 1.247 0 C-N-CA 123.605 0.762 . . . . 0.0 110.741 173.783 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 44.5 mm -114.18 108.68 26.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 -178.156 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 48.8 tp -93.58 106.21 18.2 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 123.813 0.845 . . . . 0.0 109.195 173.108 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 83.7 m -97.74 112.56 24.4 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 -179.669 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 92.9 mt -106.88 98.48 8.14 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 123.698 0.799 . . . . 0.0 109.483 -173.09 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 7.5 m -109.88 115.65 30.2 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 -175.526 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 86.1 t60 -134.21 116.19 15.05 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 108.507 -0.924 . . . . 0.0 108.507 173.147 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 75.2 -111.14 3.26 Favored Glycine 0 N--CA 1.484 1.845 0 C-N-CA 122.928 0.299 . . . . 0.0 113.011 176.167 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 73.4 p -122.37 68.55 0.95 Allowed 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 108.987 -0.745 . . . . 0.0 108.987 163.763 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -160.37 93.96 1.06 Allowed 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 123.368 0.667 . . . . 0.0 109.533 178.674 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 4.9 p -96.51 121.75 47.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 C-N-CA 123.797 0.839 . . . . 0.0 109.801 175.713 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' CYS . . . . . 0.431 ' SG ' ' HB2' ' A' ' 16' ' ' PHE . 43.8 t -116.91 105.46 12.37 Favored 'General case' 0 CA--C 1.555 1.149 0 C-N-CA 123.334 0.654 . . . . 0.0 110.544 -179.466 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 91.7 m -92.54 105.34 17.53 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 123.648 0.779 . . . . 0.0 109.073 -175.252 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 53.6 mtp180 -105.64 116.99 32.88 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 123.144 0.578 . . . . 0.0 109.596 -172.53 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 41.7 m -86.73 141.37 28.94 Favored 'General case' 0 N--CA 1.493 1.701 0 C-N-CA 123.717 0.807 . . . . 0.0 110.511 178.765 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 40.6 m-85 -137.84 135.13 35.92 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 124.094 0.958 . . . . 0.0 109.497 -175.07 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -102.14 155.18 18.37 Favored 'General case' 0 N--CA 1.495 1.778 0 CA-C-O 122.421 1.105 . . . . 0.0 111.712 166.057 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 71.0 tttt -88.33 124.28 33.74 Favored 'General case' 0 N--CA 1.483 1.209 0 CA-C-N 115.199 -0.91 . . . . 0.0 111.816 -168.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -99.17 49.48 0.95 Allowed 'General case' 0 CA--C 1.57 1.738 0 C-N-CA 123.58 0.752 . . . . 0.0 112.354 170.541 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.129 0 CA-C-O 123.2 1.476 . . . . 0.0 108.252 -176.287 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 4.6 p . . . . . 0 CA--C 1.576 1.972 0 N-CA-C 116.227 1.936 . . . . 0.0 116.227 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -66.19 -35.43 80.44 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 116.669 2.1 . . . . 0.0 116.669 -176.045 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -61.0 -27.08 68.05 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 117.514 2.413 . . . . 0.0 117.514 168.128 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -72.18 -20.2 61.62 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 116.037 1.865 . . . . 0.0 116.037 168.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 55.0 mt -78.29 119.65 21.95 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-N 121.034 1.743 . . . . 0.0 111.69 -171.745 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 163.87 175.9 35.22 Favored Glycine 0 N--CA 1.481 1.666 0 CA-C-O 122.251 0.917 . . . . 0.0 113.239 -177.766 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 63.1 m -92.3 137.28 32.49 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 167.847 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 87.3 m95 -138.6 112.58 8.51 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 -170.142 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 52.4 mtmt -99.94 144.37 29.08 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 123.103 0.561 . . . . 0.0 110.228 178.93 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 25.0 tp -67.72 131.66 46.0 Favored 'General case' 0 N--CA 1.488 1.427 0 CA-C-O 122.371 1.082 . . . . 0.0 112.419 -177.609 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . 0.285 1.0 OUTLIER -111.81 -47.81 6.03 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.797 0 CA-C-N 113.669 -1.605 . . . . 0.0 110.875 179.054 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -137.07 140.12 41.79 Favored 'General case' 0 N--CA 1.487 1.412 0 CA-C-N 119.566 1.075 . . . . 0.0 109.505 175.539 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 78.8 p -132.94 114.48 14.06 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 168.444 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -77.22 -72.41 0.35 Allowed 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 112.532 0.567 . . . . 0.0 112.532 -172.614 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 62.6 m-80 -105.41 47.12 0.89 Allowed 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 113.291 0.848 . . . . 0.0 113.291 -178.854 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 11.9 t80 -92.74 74.18 4.96 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.795 -1.191 . . . . 0.0 110.352 177.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 179.76 -59.82 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 126.082 1.753 . . . . 0.0 106.648 -168.793 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 22.8 t0 -58.42 -46.65 86.06 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 115.01 1.485 . . . . 0.0 115.01 163.85 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 90.0 t80 -51.9 -55.07 22.43 Favored 'General case' 0 CA--C 1.57 1.735 0 N-CA-C 114.896 1.443 . . . . 0.0 114.896 170.315 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 72.9 mtm -62.84 -39.21 93.65 Favored 'General case' 0 CA--C 1.567 1.626 0 N-CA-C 115.947 1.832 . . . . 0.0 115.947 174.816 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 28.9 ttpp -58.63 -46.56 86.82 Favored 'General case' 0 CA--C 1.569 1.686 0 N-CA-C 115.115 1.524 . . . . 0.0 115.115 168.685 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 16.7 t -62.01 -34.83 76.92 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 116.59 2.07 . . . . 0.0 116.59 172.57 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 86.2 mt -65.31 -44.25 88.49 Favored 'General case' 0 CA--C 1.567 1.616 0 N-CA-C 115.64 1.718 . . . . 0.0 115.64 167.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 113.95 70.35 0.52 Allowed Glycine 0 N--CA 1.483 1.808 0 C-N-CA 123.966 0.793 . . . . 0.0 111.889 -172.058 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 66.8 t -127.67 122.27 58.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 N-CA-C 105.586 -2.005 . . . . 0.0 105.586 -176.785 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -63.25 153.92 45.28 Favored Glycine 0 CA--C 1.549 2.211 0 N-CA-C 115.801 1.08 . . . . 0.0 115.801 177.81 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 31.5 p90 -55.2 -42.78 73.73 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 118.663 2.838 . . . . 0.0 118.663 -167.191 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.85 -43.28 93.55 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 115.75 1.759 . . . . 0.0 115.75 175.307 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 63.2 m -69.38 -37.83 77.73 Favored 'General case' 0 N--CA 1.497 1.924 0 N-CA-C 114.185 1.18 . . . . 0.0 114.185 170.689 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 45.5 ttp85 -59.46 -45.37 91.8 Favored 'General case' 0 CA--C 1.57 1.728 0 N-CA-C 115.151 1.537 . . . . 0.0 115.151 171.528 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 46.4 mt-30 -72.71 -39.89 66.6 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 115.104 1.52 . . . . 0.0 115.104 176.077 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 69.4 t -63.68 -48.18 87.84 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 CA-C-N 119.943 1.247 . . . . 0.0 112.443 170.446 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -61.89 -31.17 71.44 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 117.595 2.442 . . . . 0.0 117.595 177.435 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 84.0 p -62.91 -47.04 84.98 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 115.96 1.837 . . . . 0.0 115.96 169.484 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 51.9 tpp -70.76 -34.49 71.89 Favored 'General case' 0 CA--C 1.572 1.824 0 N-CA-C 116.13 1.9 . . . . 0.0 116.13 170.731 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 46.4 m -66.48 144.06 56.71 Favored 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 124.825 1.25 . . . . 0.0 112.538 -179.22 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -108.08 99.89 33.59 Favored Pre-proline 0 CA--C 1.571 1.753 0 CA-C-O 118.38 -0.819 . . . . 0.0 110.028 -177.366 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -75.48 141.68 25.59 Favored 'Trans proline' 0 CA--C 1.561 1.839 0 C-N-CA 123.206 2.604 . . . . 0.0 114.077 -179.689 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 100.0 m -107.47 100.74 10.14 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 -174.135 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 44.2 m -90.72 111.33 22.64 Favored 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 123.666 0.786 . . . . 0.0 109.448 -175.133 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 47.5 mt -102.82 108.09 23.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 N-CA-C 106.629 -1.619 . . . . 0.0 106.629 -178.768 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 33.7 mt -101.91 115.12 43.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 N-CA-C 106.744 -1.576 . . . . 0.0 106.744 -178.641 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -139.39 112.13 7.85 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 -171.385 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 28.1 ttpp -84.4 112.0 19.95 Favored 'General case' 0 CA--C 1.561 1.37 0 CA-C-O 121.43 0.633 . . . . 0.0 110.212 174.911 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 19.6 t-20 -100.57 92.49 5.15 Favored 'General case' 0 N--CA 1.485 1.32 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 -175.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 77.03 -99.64 1.42 Allowed Glycine 0 N--CA 1.485 1.939 0 N-CA-C 111.197 -0.761 . . . . 0.0 111.197 -166.094 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 25.1 m-20 -133.43 63.52 1.63 Allowed 'General case' 0 N--CA 1.494 1.748 0 CA-C-O 121.073 0.463 . . . . 0.0 109.844 160.17 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 27.2 mm -139.47 104.63 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 N-CA-C 104.994 -2.224 . . . . 0.0 104.994 177.348 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 35.9 mt -74.94 110.58 9.35 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 122.873 0.469 . . . . 0.0 111.527 177.703 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 38.3 m -105.41 101.84 11.35 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 106.266 -1.754 . . . . 0.0 106.266 -179.65 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 9.4 tt -104.65 108.64 20.2 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 -174.241 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 43.7 mttp -109.5 96.81 6.53 Favored 'General case' 0 N--CA 1.483 1.175 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 -165.647 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 60.0 m -87.95 92.7 9.23 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 -177.377 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 70.2 m80 -83.54 91.65 7.46 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 123.824 0.85 . . . . 0.0 110.191 -176.271 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 82.5 p -94.88 4.21 54.08 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 118.427 2.751 . . . . 0.0 118.427 -167.237 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . 0.315 6.8 m 74.46 -46.08 0.6 Allowed 'General case' 0 N--CA 1.504 2.232 0 CA-C-N 120.693 1.588 . . . . 0.0 113.848 -166.286 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 69.9 t80 -71.62 -74.6 0.15 Allowed 'General case' 0 CA--C 1.565 1.553 0 C-N-CA 124.323 1.049 . . . . 0.0 111.661 179.004 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 56.7 mtmt -141.88 120.57 12.6 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 173.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 8.7 p30 -77.03 111.01 12.14 Favored 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 122.969 0.508 . . . . 0.0 111.914 -177.717 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 45.6 p -97.98 130.89 44.81 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-O 121.212 0.53 . . . . 0.0 110.949 -173.471 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 5.4 mp0 -115.65 129.76 56.61 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 123.382 0.673 . . . . 0.0 109.84 179.76 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 49.3 pt -112.79 126.05 70.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 N-CA-C 108.091 -1.078 . . . . 0.0 108.091 168.638 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 39.0 t -109.54 109.68 20.54 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 107.208 -1.405 . . . . 0.0 107.208 175.704 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 42.9 p90 -140.34 141.8 35.64 Favored 'General case' 0 N--CA 1.489 1.501 0 CA-C-O 122.25 1.024 . . . . 0.0 113.737 -164.447 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 55.1 mtmt -100.87 150.96 22.29 Favored 'General case' 0 CA--C 1.562 1.437 0 CA-C-N 114.478 -1.237 . . . . 0.0 109.061 159.729 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -74.46 115.48 14.05 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.564 -0.71 . . . . 0.0 111.894 -171.426 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 89.31 44.59 4.95 Favored Glycine 0 CA--C 1.549 2.186 0 N-CA-C 116.582 1.393 . . . . 0.0 116.582 -166.688 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 92.3 t -136.0 123.66 35.17 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 178.345 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -87.73 132.67 34.05 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 123.464 0.705 . . . . 0.0 110.791 170.668 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 44.9 p90 -145.55 134.42 22.45 Favored 'General case' 0 N--CA 1.494 1.739 0 C-N-CA 123.318 0.647 . . . . 0.0 110.556 -174.399 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -73.04 117.88 15.31 Favored 'General case' 0 CA--C 1.564 1.481 0 O-C-N 121.558 -0.713 . . . . 0.0 112.644 178.207 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 15.1 tp10 -128.97 134.15 48.08 Favored 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 123.626 0.77 . . . . 0.0 110.088 -170.681 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 51.9 m -92.7 121.91 34.58 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 174.097 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 27.1 p -84.31 174.5 10.1 Favored 'General case' 0 N--CA 1.494 1.726 0 CA-C-O 121.663 0.744 . . . . 0.0 112.869 -175.013 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -60.07 -34.68 73.77 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 116.815 2.154 . . . . 0.0 116.815 171.258 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -89.02 31.66 0.86 Allowed 'General case' 0 CA--C 1.58 2.1 0 N-CA-C 114.601 1.334 . . . . 0.0 114.601 167.394 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 22.5 m-20 53.34 67.82 0.94 Allowed 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 115.057 1.503 . . . . 0.0 115.057 174.768 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 46.1 mtm105 -137.64 120.98 16.98 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 109.036 -0.728 . . . . 0.0 109.036 -175.74 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.06 108.99 8.17 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 123.379 0.671 . . . . 0.0 111.305 169.444 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 17.7 m -125.39 142.15 43.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 CA-C-O 121.335 0.588 . . . . 0.0 110.302 -168.912 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 4.7 mptp? -85.62 98.01 10.42 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 123.629 0.772 . . . . 0.0 109.122 176.575 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 58.0 m -91.38 93.37 9.0 Favored 'General case' 0 N--CA 1.485 1.283 0 CA-C-N 115.262 -0.881 . . . . 0.0 111.12 -170.549 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 6.8 tp -104.71 116.73 49.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 178.322 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 1.5 p -136.52 122.56 29.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 C-N-CA 123.343 0.657 . . . . 0.0 109.55 -169.856 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 14.9 t -136.88 157.5 46.61 Favored 'General case' 0 N--CA 1.491 1.592 0 CA-C-O 122.629 1.204 . . . . 0.0 111.351 178.384 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 15.2 tp -95.37 119.78 34.47 Favored 'General case' 0 N--CA 1.489 1.514 0 CA-C-N 114.768 -1.106 . . . . 0.0 110.067 177.832 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -106.52 81.23 1.57 Allowed 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 123.205 0.602 . . . . 0.0 110.604 -178.204 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 61.06 46.52 94.38 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 117.673 1.829 . . . . 0.0 117.673 -177.096 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 75.03 35.96 48.03 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 118.206 2.043 . . . . 0.0 118.206 -168.341 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -145.93 104.36 3.84 Favored 'General case' 0 CA--C 1.553 1.077 0 N-CA-C 105.369 -2.086 . . . . 0.0 105.369 -177.774 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -86.33 121.42 28.88 Favored 'General case' 0 N--CA 1.481 1.12 0 CA-C-O 121.903 0.858 . . . . 0.0 110.989 -170.853 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 61.2 t -122.98 107.42 19.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 N-CA-C 106.103 -1.814 . . . . 0.0 106.103 -166.138 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 20.6 t-160 -110.75 113.34 25.85 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 123.777 0.831 . . . . 0.0 109.78 179.514 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 31.5 tp -107.74 123.25 48.26 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 123.775 0.83 . . . . 0.0 108.857 177.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -110.86 120.8 43.58 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 178.186 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -117.39 137.63 52.35 Favored 'General case' 0 N--CA 1.495 1.796 0 CA-C-N 118.675 0.67 . . . . 0.0 111.134 -178.401 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 22.7 p90 -155.82 109.08 2.72 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.419 -0.8 . . . . 0.0 109.892 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 5.5 t70 55.96 50.16 14.41 Favored 'General case' 0 N--CA 1.499 2.015 0 N-CA-C 116.237 1.94 . . . . 0.0 116.237 168.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 86.99 -43.82 3.26 Favored Glycine 0 CA--C 1.552 2.396 0 N-CA-C 116.706 1.443 . . . . 0.0 116.706 -168.85 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 64.4 mt-30 -73.68 132.23 42.48 Favored 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 123.874 0.87 . . . . 0.0 111.571 179.372 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -141.77 135.02 29.3 Favored 'General case' 0 N--CA 1.49 1.542 0 CA-C-O 121.202 0.525 . . . . 0.0 112.237 176.553 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 13.7 t -118.07 133.26 56.08 Favored 'General case' 0 N--CA 1.495 1.79 0 CA-C-N 115.597 -0.728 . . . . 0.0 111.087 176.818 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 37.4 p -101.84 135.25 43.72 Favored 'General case' 0 N--CA 1.494 1.736 0 CA-C-O 122.057 0.932 . . . . 0.0 110.713 171.047 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 5.4 mp -118.26 85.52 2.37 Favored 'General case' 0 CA--C 1.562 1.415 0 N-CA-C 106.535 -1.654 . . . . 0.0 106.535 -178.575 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 99.5 t -95.02 103.66 14.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 -168.866 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 83.7 mtt85 -94.58 129.29 41.47 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 123.794 0.838 . . . . 0.0 110.181 179.416 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -146.91 132.23 18.51 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 122.849 0.459 . . . . 0.0 110.837 -176.741 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -80.6 114.73 19.7 Favored 'General case' 0 N--CA 1.486 1.337 0 CA-C-O 121.328 0.585 . . . . 0.0 111.315 179.506 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 48.3 mm -118.56 105.06 17.01 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.361 0 N-CA-C 105.075 -2.194 . . . . 0.0 105.075 175.362 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 58.68 50.4 8.95 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 115.204 1.557 . . . . 0.0 115.204 175.854 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 65.6 25.56 71.61 Favored Glycine 0 CA--C 1.555 2.583 0 N-CA-C 119.351 2.501 . . . . 0.0 119.351 -171.072 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 92.6 mttt -133.78 128.45 34.82 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-N 119.203 1.501 . . . . 0.0 108.678 -173.663 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 15.0 tp -78.53 109.71 12.96 Favored 'General case' 0 CA--C 1.558 1.288 0 C-N-CA 123.272 0.629 . . . . 0.0 110.306 -179.917 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 31.8 mm -98.95 97.34 5.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 N-CA-C 107.192 -1.41 . . . . 0.0 107.192 -175.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 24.6 tp -91.21 104.19 16.78 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 123.972 0.909 . . . . 0.0 109.996 -179.85 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 85.1 m -96.1 108.76 21.23 Favored 'General case' 0 CA--C 1.562 1.43 0 C-N-CA 124.0 0.92 . . . . 0.0 108.804 -176.277 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 92.4 mt -103.04 103.68 13.79 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 123.537 0.735 . . . . 0.0 109.956 -174.491 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 12.8 m -112.18 117.39 32.44 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 -175.402 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 73.5 t60 -152.84 117.16 4.93 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 174.496 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 60.41 61.9 6.59 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 117.418 1.727 . . . . 0.0 117.418 169.462 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . 0.291 3.2 m 52.36 50.28 18.67 Favored 'General case' 0 CA--C 1.576 1.97 0 N-CA-C 114.878 1.436 . . . . 0.0 114.878 -172.206 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -158.87 87.85 0.88 Allowed 'General case' 0 N--CA 1.485 1.291 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 -178.708 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 3.6 p -94.73 113.66 29.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 C-N-CA 123.649 0.78 . . . . 0.0 109.348 175.62 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 45.9 t -103.99 105.62 15.86 Favored 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 123.081 0.552 . . . . 0.0 110.062 176.585 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 91.8 m -90.06 103.52 16.18 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 -179.533 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 69.0 mtp180 -104.02 114.64 29.03 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 123.042 0.537 . . . . 0.0 109.893 -166.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 91.1 m -84.15 129.07 34.92 Favored 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 122.882 0.473 . . . . 0.0 109.905 176.188 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 40.7 m-85 -125.81 127.69 46.51 Favored 'General case' 0 CA--C 1.558 1.253 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 176.241 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -95.34 157.01 16.08 Favored 'General case' 0 N--CA 1.493 1.699 0 CA-C-O 122.431 1.11 . . . . 0.0 111.572 171.08 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 72.8 tttt -91.04 126.37 36.11 Favored 'General case' 0 N--CA 1.484 1.262 0 CA-C-N 115.423 -0.808 . . . . 0.0 112.51 -164.064 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -99.84 51.1 0.92 Allowed 'General case' 0 N--CA 1.497 1.92 0 CA-C-O 121.912 0.863 . . . . 0.0 111.383 167.88 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.063 0 CA-C-O 123.216 1.484 . . . . 0.0 107.638 -177.459 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.265 5.9 p . . . . . 0 CA--C 1.576 1.955 0 N-CA-C 116.376 1.991 . . . . 0.0 116.376 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -65.71 -37.84 87.53 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 116.449 2.018 . . . . 0.0 116.449 -178.61 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -59.56 -29.85 68.22 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 117.313 2.338 . . . . 0.0 117.313 167.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -69.98 -23.55 63.18 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 116.287 1.958 . . . . 0.0 116.287 168.337 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 58.5 mt -75.0 120.02 19.97 Favored 'General case' 0 N--CA 1.49 1.539 0 CA-C-N 121.028 1.74 . . . . 0.0 111.689 -173.645 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 160.29 176.39 32.33 Favored Glycine 0 CA--C 1.541 1.708 0 CA-C-O 122.447 1.026 . . . . 0.0 113.744 -176.007 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 75.2 m -93.22 135.46 34.4 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 170.495 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 94.2 m95 -138.4 115.63 11.06 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 -169.796 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 24.9 mmmt -102.17 145.65 29.08 Favored 'General case' 0 N--CA 1.492 1.628 0 CA-C-O 121.536 0.684 . . . . 0.0 111.021 178.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 43.9 tp -70.13 125.42 26.73 Favored 'General case' 0 N--CA 1.489 1.477 0 CA-C-O 122.039 0.923 . . . . 0.0 112.118 -176.852 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . 0.275 1.0 OUTLIER -107.84 -39.26 4.32 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.883 0 CA-C-N 113.997 -1.456 . . . . 0.0 112.435 -178.701 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -137.21 138.0 39.7 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-N 120.305 1.411 . . . . 0.0 109.64 176.15 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 78.3 p -121.56 103.47 8.94 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 167.624 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 8.9 tmtm? -79.92 -78.35 0.17 Allowed 'General case' 0 N--CA 1.491 1.602 0 CA-C-O 118.877 -0.582 . . . . 0.0 112.554 -167.309 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 85.0 m-20 -105.15 48.26 0.84 Allowed 'General case' 0 N--CA 1.498 1.967 0 CA-C-N 118.89 0.768 . . . . 0.0 112.795 177.684 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 10.0 t80 -92.09 75.78 5.44 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.704 -1.247 . . . . 0.0 110.973 -174.341 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -172.21 -61.27 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 124.668 1.187 . . . . 0.0 108.987 -168.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 12.3 t0 -61.66 -38.29 87.2 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 115.859 1.8 . . . . 0.0 115.859 166.924 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 87.9 t80 -48.74 -53.86 17.28 Favored 'General case' 0 CA--C 1.574 1.893 0 N-CA-C 114.755 1.391 . . . . 0.0 114.755 163.592 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 56.8 mtm -66.24 -29.98 70.34 Favored 'General case' 0 CA--C 1.571 1.768 0 N-CA-C 116.549 2.055 . . . . 0.0 116.549 171.735 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 55.8 mttp -61.18 -48.65 80.56 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 114.942 1.46 . . . . 0.0 114.942 166.459 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 23.1 t -66.26 -32.44 73.86 Favored 'General case' 0 CA--C 1.567 1.599 0 N-CA-C 116.465 2.024 . . . . 0.0 116.465 173.248 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 65.2 mt -66.27 -43.64 85.87 Favored 'General case' 0 CA--C 1.565 1.522 0 N-CA-C 116.084 1.883 . . . . 0.0 116.084 172.372 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 105.84 86.67 1.92 Allowed Glycine 0 N--CA 1.482 1.742 0 N-CA-C 110.744 -0.943 . . . . 0.0 110.744 -170.098 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 41.3 t -140.61 144.11 27.83 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 N-CA-C 107.575 -1.269 . . . . 0.0 107.575 -174.455 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -73.13 163.08 54.91 Favored Glycine 0 CA--C 1.552 2.361 0 O-C-N 120.958 -1.089 . . . . 0.0 115.137 169.045 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 25.2 p90 -62.93 -39.61 95.1 Favored 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 117.071 2.249 . . . . 0.0 117.071 -178.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.45 -45.08 94.71 Favored 'General case' 0 CA--C 1.56 1.347 0 N-CA-C 115.777 1.769 . . . . 0.0 115.777 177.799 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . 0.288 0.6 OUTLIER -81.51 -19.07 42.96 Favored 'General case' 0 N--CA 1.499 2.002 0 N-CA-C 116.177 1.917 . . . . 0.0 116.177 173.141 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 34.3 ttm105 -61.58 -46.92 87.83 Favored 'General case' 0 CA--C 1.57 1.744 0 CA-C-N 121.18 1.809 . . . . 0.0 113.646 160.756 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 22.7 tt0 -62.99 -49.42 74.78 Favored 'General case' 0 CA--C 1.563 1.473 0 N-CA-C 115.282 1.586 . . . . 0.0 115.282 171.414 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 89.1 t -63.66 -43.82 98.25 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 CA-C-O 117.273 -1.346 . . . . 0.0 112.983 174.345 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -63.07 -41.17 99.38 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 116.478 2.029 . . . . 0.0 116.478 177.754 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 97.3 p -61.15 -42.64 98.92 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 116.619 2.081 . . . . 0.0 116.619 168.254 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 48.1 ttp -66.61 -36.85 83.6 Favored 'General case' 0 CA--C 1.572 1.824 0 N-CA-C 116.421 2.008 . . . . 0.0 116.421 169.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 52.3 m -73.29 135.19 44.39 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 124.28 1.032 . . . . 0.0 111.807 -175.578 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -103.74 102.28 29.73 Favored Pre-proline 0 CA--C 1.571 1.77 0 CA-C-N 114.554 -1.203 . . . . 0.0 109.81 175.228 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -76.44 126.19 8.87 Favored 'Trans proline' 0 CA--C 1.562 1.893 0 C-N-CA 123.235 2.624 . . . . 0.0 112.861 -178.134 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 15.4 m -84.59 107.05 16.61 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 -179.828 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 47.5 m -100.93 104.3 15.49 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 -168.614 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 48.9 mt -98.68 112.15 30.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 N-CA-C 106.991 -1.485 . . . . 0.0 106.991 -179.169 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 42.7 mt -106.31 115.11 47.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 N-CA-C 106.733 -1.58 . . . . 0.0 106.733 -177.435 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -139.38 115.06 10.02 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 -173.591 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 84.7 tttt -87.49 112.64 22.42 Favored 'General case' 0 CA--C 1.556 1.211 0 C-N-CA 123.075 0.55 . . . . 0.0 110.025 173.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 20.4 t-20 -82.65 -69.78 0.6 Allowed 'General case' 0 CA--C 1.564 1.496 0 C-N-CA 123.314 0.646 . . . . 0.0 111.298 -176.359 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -149.56 89.55 0.14 Allowed Glycine 0 N--CA 1.482 1.74 0 N-CA-C 108.867 -1.693 . . . . 0.0 108.867 172.241 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . 0.295 12.6 m-20 69.54 -20.05 0.18 Allowed 'General case' 0 N--CA 1.499 1.978 0 N-CA-C 117.569 2.433 . . . . 0.0 117.569 -164.519 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 16.4 mm -101.19 111.9 32.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 -171.055 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 16.2 mt -79.97 115.18 19.4 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 123.611 0.764 . . . . 0.0 110.797 173.47 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 44.3 m -104.0 96.34 6.61 Favored 'General case' 0 CA--C 1.56 1.338 0 N-CA-C 106.557 -1.645 . . . . 0.0 106.557 -176.5 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 9.1 tt -96.85 102.92 14.79 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 -179.271 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -97.42 107.87 20.47 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 123.721 0.808 . . . . 0.0 108.87 -173.154 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 34.7 m -95.14 90.98 6.09 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 -176.167 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 20.6 m170 -84.76 101.88 12.58 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 -174.053 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 23.4 t -137.82 151.45 48.11 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 123.556 0.743 . . . . 0.0 110.335 -167.313 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 80.8 p -83.57 67.92 9.6 Favored 'General case' 0 N--CA 1.498 1.932 0 CA-C-O 122.134 0.968 . . . . 0.0 112.559 178.374 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 57.5 t80 -155.52 -95.61 0.04 OUTLIER 'General case' 0 CA--C 1.562 1.413 0 N-CA-C 103.777 -2.675 . . . . 0.0 103.777 170.792 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 3.9 mppt? -129.22 127.64 41.68 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 106.819 -1.549 . . . . 0.0 106.819 159.016 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 9.8 p30 -75.27 120.65 21.04 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 123.268 0.627 . . . . 0.0 112.475 -179.502 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 75.1 p -101.08 126.66 47.79 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-O 121.405 0.622 . . . . 0.0 110.617 -174.764 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -110.01 118.25 35.92 Favored 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 177.126 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 14.3 pt -107.66 126.71 64.0 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 178.799 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 77.9 p -115.87 109.24 17.35 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 -175.662 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 48.1 p90 -141.33 138.39 33.06 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 114.682 1.364 . . . . 0.0 114.682 -161.832 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 60.7 mtpt -95.95 145.6 25.28 Favored 'General case' 0 CA--C 1.562 1.432 0 CA-C-N 115.036 -0.984 . . . . 0.0 109.148 162.086 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -73.47 116.66 14.3 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.575 -0.703 . . . . 0.0 112.208 -173.171 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 79.9 40.61 14.05 Favored Glycine 0 CA--C 1.549 2.2 0 N-CA-C 117.013 1.565 . . . . 0.0 117.013 -170.428 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 91.6 t -139.3 117.76 12.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 N-CA-C 105.34 -2.096 . . . . 0.0 105.34 -179.209 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -81.41 132.25 35.32 Favored 'General case' 0 N--CA 1.49 1.53 0 CA-C-O 121.578 0.704 . . . . 0.0 111.267 178.905 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 19.5 p90 -134.28 145.55 49.2 Favored 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 124.158 0.983 . . . . 0.0 110.313 -174.133 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -73.44 128.55 35.81 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 123.204 0.602 . . . . 0.0 112.413 178.355 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -131.41 131.81 43.89 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 123.267 0.627 . . . . 0.0 109.785 -168.35 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 90.6 m -112.82 119.32 37.6 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 107.135 -1.431 . . . . 0.0 107.135 170.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 42.7 p -80.87 175.3 10.8 Favored 'General case' 0 N--CA 1.495 1.785 0 CA-C-N 115.545 -0.752 . . . . 0.0 112.745 -174.078 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -59.49 -40.07 85.82 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 116.193 1.923 . . . . 0.0 116.193 169.864 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -74.97 -7.41 53.54 Favored 'General case' 0 CA--C 1.578 2.039 0 N-CA-C 116.256 1.947 . . . . 0.0 116.256 165.571 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . 0.256 6.1 m-20 67.48 68.18 0.38 Allowed 'General case' 0 N--CA 1.496 1.874 0 C-N-CA 125.512 1.525 . . . . 0.0 111.714 -178.103 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 31.0 ttm-85 -116.38 18.04 15.32 Favored 'General case' 0 N--CA 1.498 1.926 0 N-CA-C 116.11 1.892 . . . . 0.0 116.11 -167.745 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . 0.31 0.1 OUTLIER 39.4 71.47 0.17 Allowed 'General case' 0 N--CA 1.499 1.982 0 N-CA-C 118.14 2.644 . . . . 0.0 118.14 176.023 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 4.5 m -112.1 144.07 20.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 CA-C-O 121.386 0.613 . . . . 0.0 111.172 -166.454 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 1.2 mppt? -97.99 102.32 14.04 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 174.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 61.5 p -93.56 113.98 26.23 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.577 0.751 . . . . 0.0 111.874 -170.267 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 5.7 tp -123.0 117.38 51.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 179.004 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 1.1 p -134.11 125.97 49.08 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 C-N-CA 123.786 0.834 . . . . 0.0 109.729 -174.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 15.3 t -132.29 152.0 51.58 Favored 'General case' 0 N--CA 1.495 1.807 0 CA-C-O 122.331 1.062 . . . . 0.0 112.32 178.811 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 53.5 tp -82.75 128.79 34.71 Favored 'General case' 0 N--CA 1.491 1.59 0 CA-C-N 114.644 -1.162 . . . . 0.0 110.067 170.704 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -131.45 83.42 2.1 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 123.444 0.698 . . . . 0.0 109.519 -179.046 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 58.51 47.23 91.1 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 117.863 1.905 . . . . 0.0 117.863 -178.822 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 76.32 37.74 35.75 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 117.571 1.788 . . . . 0.0 117.571 -167.646 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 36.3 ttmt -149.67 105.93 3.49 Favored 'General case' 0 N--CA 1.481 1.091 0 N-CA-C 106.572 -1.64 . . . . 0.0 106.572 -176.567 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 3.7 mp -79.97 114.41 18.86 Favored 'General case' 0 N--CA 1.485 1.288 0 CA-C-O 121.607 0.718 . . . . 0.0 109.811 172.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 95.3 t -109.78 101.76 13.03 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 N-CA-C 104.964 -2.236 . . . . 0.0 104.964 -173.713 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 23.1 t-160 -99.38 136.92 38.62 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 123.807 0.843 . . . . 0.0 109.69 178.11 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 24.8 tp -134.99 120.23 18.92 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 176.775 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 29.7 mt-30 -112.0 126.2 54.89 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 177.117 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 9.8 mtmp? -126.49 134.45 50.91 Favored 'General case' 0 N--CA 1.496 1.835 0 C-N-CA 122.989 0.515 . . . . 0.0 110.902 -170.58 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 25.8 p90 -152.38 116.12 4.83 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.469 -0.769 . . . . 0.0 110.433 -175.459 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . 0.344 12.6 t70 67.37 -101.76 0.06 Allowed 'General case' 0 N--CA 1.495 1.797 0 C-N-CA 124.515 1.126 . . . . 0.0 112.319 172.965 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -127.41 55.06 0.76 Allowed Glycine 0 N--CA 1.488 2.151 0 CA-C-N 118.96 0.8 . . . . 0.0 113.377 162.331 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 47.7 mt-30 -154.34 129.98 9.98 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 -173.425 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -140.09 125.58 19.07 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.595 -0.691 . . . . 0.0 111.489 -179.311 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 14.3 t -107.94 134.03 51.44 Favored 'General case' 0 N--CA 1.495 1.782 0 C-N-CA 122.98 0.512 . . . . 0.0 110.534 173.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 33.7 p -100.74 134.81 43.15 Favored 'General case' 0 N--CA 1.492 1.669 0 CA-C-O 121.408 0.623 . . . . 0.0 110.77 168.826 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 5.3 mp -118.61 78.54 1.28 Allowed 'General case' 0 CA--C 1.561 1.404 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 178.202 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 62.8 t -86.53 103.41 12.94 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 121.108 -0.995 . . . . 0.0 108.489 -170.6 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 22.0 mmt180 -88.15 124.61 33.98 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 124.21 1.004 . . . . 0.0 109.71 177.081 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -149.52 127.86 12.17 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 122.115 -0.366 . . . . 0.0 111.455 -169.442 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -78.0 117.64 19.52 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.63 -0.669 . . . . 0.0 111.524 177.64 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 48.1 mm -117.58 100.41 10.12 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.312 0 N-CA-C 105.131 -2.174 . . . . 0.0 105.131 173.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 23.2 m-20 56.5 48.79 16.04 Favored 'General case' 0 N--CA 1.498 1.963 0 N-CA-C 115.094 1.516 . . . . 0.0 115.094 174.844 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 89.57 -42.14 3.0 Favored Glycine 0 CA--C 1.552 2.344 0 N-CA-C 117.35 1.7 . . . . 0.0 117.35 -169.53 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 50.7 mttp -83.06 128.69 34.7 Favored 'General case' 0 N--CA 1.487 1.4 0 CA-C-N 118.658 1.229 . . . . 0.0 111.842 -172.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 56.9 tp -86.08 116.33 24.23 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 123.486 0.714 . . . . 0.0 110.715 -177.354 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 33.5 mm -101.49 107.11 20.78 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 -172.09 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 52.7 tp -85.28 106.83 16.97 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 123.778 0.831 . . . . 0.0 109.359 171.399 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 75.5 m -99.73 106.14 18.02 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 -173.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 91.5 mt -103.78 96.44 6.7 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 123.274 0.63 . . . . 0.0 110.091 -169.699 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 9.2 m -111.68 116.06 30.14 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 -174.549 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 75.8 t60 -147.24 115.49 6.61 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 173.669 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 62.52 59.13 9.79 Favored Glycine 0 N--CA 1.488 2.143 0 N-CA-C 117.051 1.58 . . . . 0.0 117.051 172.475 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . 0.288 2.7 m 51.9 51.66 16.06 Favored 'General case' 0 CA--C 1.576 1.945 0 N-CA-C 115.129 1.529 . . . . 0.0 115.129 -172.445 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -157.24 89.26 1.05 Allowed 'General case' 0 N--CA 1.484 1.272 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 -179.614 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 4.8 p -94.34 116.28 35.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 C-N-CA 123.685 0.794 . . . . 0.0 109.88 178.187 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 42.9 t -103.69 110.3 22.33 Favored 'General case' 0 CA--C 1.553 1.058 0 C-N-CA 123.265 0.626 . . . . 0.0 110.026 174.252 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 79.8 m -90.64 97.76 11.37 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 -176.677 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 21.6 mtm180 -101.63 116.98 33.96 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 122.752 0.421 . . . . 0.0 111.042 -171.118 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 75.8 m -88.33 140.62 29.28 Favored 'General case' 0 N--CA 1.494 1.739 0 C-N-CA 123.544 0.737 . . . . 0.0 110.877 -177.214 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 34.6 m-85 -132.7 131.62 41.47 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 123.67 0.788 . . . . 0.0 109.825 -178.317 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -96.21 150.42 20.55 Favored 'General case' 0 N--CA 1.494 1.744 0 CA-C-O 122.121 0.963 . . . . 0.0 112.25 171.734 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 72.2 tttt -87.33 119.1 27.24 Favored 'General case' 0 N--CA 1.483 1.187 0 CA-C-N 115.142 -0.936 . . . . 0.0 111.149 -173.723 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 28.8 mm-40 -107.07 49.74 0.79 Allowed 'General case' 0 CA--C 1.567 1.629 0 C-N-CA 124.069 0.947 . . . . 0.0 111.709 178.566 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.035 0 CA-C-O 123.126 1.441 . . . . 0.0 108.397 -173.126 . . . . . . . . 0 0 . 1 stop_ save_